PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bensing, BA; Loukachevitch, LV; McCulloch, KM; Yu, H; Vann, KR; Wawrzak, Z; Anderson, S; Chen, X; Sullam, PM; Iverson, TM				Bensing, Barbara A.; Loukachevitch, Lioudmila V.; McCulloch, Kathryn M.; Yu, Hai; Vann, Kendra R.; Wawrzak, Zdzislaw; Anderson, Spencer; Chen, Xi; Sullam, Paul M.; Iverson, T. M.			Structural Basis for Sialoglycan Binding by the Streptococcus sanguinis SrpA Adhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE GLYCOPROTEINS GSPB; INFECTIVE ENDOCARDITIS; GORDONII; HSA; SIALYLTRANSFERASE; PLATELETS; SYSTEM; DOMAIN; PHENIX	Streptococcus sanguinis is a leading cause of infective endocarditis, a life-threatening infection of the cardiovascular system. An important interaction in the pathogenesis of infective endocarditis is attachment of the organisms to host platelets. S. sanguinis expresses a serine-rich repeat adhesin, SrpA, similar in sequence to platelet-binding adhesins associated with increased virulence in this disease. In this study, we determined the first crystal structure of the putative binding region of SrpA (SrpA(BR)) both unliganded and in complex with a synthetic disaccharide ligand at 1.8 and 2.0 angstrom resolution, respectively. We identified a conserved Thr-Arg motif that orients the sialic acid moiety and is required for binding to platelet monolayers. Furthermore, we propose that sequence insertions in closely related family members contribute to the modulation of structural and functional properties, including the quaternary structure, the tertiary structure, and the ligand-binding site.	[Bensing, Barbara A.; Sullam, Paul M.] Univ Calif San Francisco, Dept Med, Vet Affairs Med Ctr, Div Infect Dis, San Francisco, CA 94121 USA; [Bensing, Barbara A.; Sullam, Paul M.] Northern Calif Inst Res & Educ, San Francisco, CA 94121 USA; [Loukachevitch, Lioudmila V.; McCulloch, Kathryn M.; Iverson, T. M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Vann, Kendra R.; Iverson, T. M.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Wawrzak, Zdzislaw; Anderson, Spencer] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Northern California Institute for Research & Education; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California Davis; Northwestern University	Iverson, TM (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.; Iverson, TM (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.; Iverson, TM (corresponding author), Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA.; Iverson, TM (corresponding author), Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA.	tina.iverson@vanderbilt.edu	chen, xi/GXH-3653-2022; Chen, Xi/H-1811-2018	Chen, Xi/0000-0002-3160-614X; McCulloch, Kathryn/0000-0001-9077-3821; Vann, Kendra R./0000-0002-6366-6112	United States Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant [085P1000817]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041513, R01AI106987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE025826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, R25GM062459] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor Grant 085P1000817.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Deng LQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004540; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Li YH, 2008, APPL MICROBIOL BIOT, V79, P963, DOI 10.1007/s00253-008-1506-2; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Pyburn TM, 2010, ACTA CRYSTALLOGR F, V66, P1503, DOI 10.1107/S1744309110036535; Ramboarina S, 2010, J BIOL CHEM, V285, P32446, DOI 10.1074/jbc.M110.128165; Schulte T, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130090; Seo HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064204; Sugiarto G, 2012, ACS CHEM BIOL, V7, P1232, DOI 10.1021/cb300125k; SULLAM PM, 1992, J LAB CLIN MED, V120, P507; Sundaresan R, 2015, INT J BIOL MACROMOL, V75, P97, DOI 10.1016/j.ijbiomac.2014.12.048; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thornhill Martin H, 2011, BMJ, V342, pd2392, DOI 10.1136/bmj.d2392; Tleyjeh IM, 2005, JAMA-J AM MED ASSOC, V293, P3022, DOI 10.1001/jama.293.24.3022; Turner LS, 2009, INFECT IMMUN, V77, P4966, DOI 10.1128/IAI.00760-09; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004; Yang Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/145641; Yu H, 2005, J AM CHEM SOC, V127, P17618, DOI 10.1021/ja0561690; Yu H, 2004, BIOORGAN MED CHEM, V12, P6427, DOI 10.1016/j.bmc.2004.09.030; Yu H, 2006, NAT PROTOC, V1, P2485, DOI 10.1038/nprot.2006.401	33	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7230	7240		10.1074/jbc.M115.701425	http://dx.doi.org/10.1074/jbc.M115.701425			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26833566	Green Published, hybrid			2022-12-26	WOS:000383447600003
J	Reynolds, AL; Alvarez, Y; Sasore, T; Waghorne, N; Butler, CT; Kilty, C; Smith, AJ; McVicar, C; Wong, VHY; Galvin, O; Merrigan, S; Osman, J; Grebnev, G; Sjolander, A; Stitt, AW; Kennedy, BN				Reynolds, Alison L.; Alvarez, Yolanda; Sasore, Temitope; Waghorne, Nora; Butler, Clare T.; Kilty, Claire; Smith, Andrew J.; McVicar, Carmel; Wong, Vickie H. Y.; Galvin, Orla; Merrigan, Stephanie; Osman, Janina; Grebnev, Gleb; Sjolander, Anita; Stitt, Alan W.; Kennedy, Breandan N.			Phenotype-based Discovery of 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol as a Novel Regulator of Ocular Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINYL LEUKOTRIENE RECEPTOR; OXYGEN-INDUCED RETINOPATHY; ENDOTHELIAL GROWTH-FACTOR; PATHOLOGICAL NEOVASCULARIZATION; RETINAL ANGIOGENESIS; ZEBRAFISH; MOUSE; D-4; RANIBIZUMAB; VASCULATURE	Retinal angiogenesis is tightly regulated to meet oxygenation and nutritional requirements. In diseases such as proliferative diabetic retinopathy and neovascular age-related macular degeneration, uncontrolled angiogenesis can lead to blindness. Our goal is to better understand the molecular processes controlling retinal angiogenesis and discover novel drugs that inhibit retinal neovascularization. Phenotype-based chemical screens were performed using the ChemBridge Diverset (TM) library and inhibition of hyaloid vessel angiogenesis in Tg(fli1: EGFP) zebrafish. 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol, (quininib) robustly inhibits developmental angiogenesis at 4-10 mu M in zebrafish and significantly inhibits angiogenic tubule formation in HMEC-1 cells, angiogenic sprouting in aortic ring explants, and retinal revascularization in oxygen-induced retinopathy mice. Quininib is well tolerated in zebrafish, human cell lines, and murine eyes. Profiling screens of 153 angiogenic and inflammatory targets revealed that quininib does not directly target VEGF receptors but antagonizes cysteinyl leukotriene receptors 1 and 2 (CysLT1-2) at micromolar IC50 values. In summary, quininib is a novel anti-angiogenic small-molecule CysLT receptor antagonist. Quininib inhibits angiogenesis in a range of cell and tissue systems, revealing novel physiological roles for CysLT signaling. Quininib has potential as a novel therapeutic agent to treat ocular neovascular pathologies and may complement current anti-VEGF biological agents.	[Reynolds, Alison L.; Alvarez, Yolanda; Sasore, Temitope; Waghorne, Nora; Butler, Clare T.; Kilty, Claire; Smith, Andrew J.; Galvin, Orla; Merrigan, Stephanie; Grebnev, Gleb; Kennedy, Breandan N.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst, Dublin 4, Ireland; [McVicar, Carmel; Wong, Vickie H. Y.; Stitt, Alan W.] Queens Univ Belfast, Ctr Med Expt, Wellcome Wolfson Bldg,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Osman, Janina; Sjolander, Anita] Lund Univ, Skane Univ Hosp, Dept Translat Med, Div Cell & Expt Pathol, S-20502 Malmo, Sweden	University College Dublin; Queens University Belfast; Lund University; Skane University Hospital	Kennedy, BN (corresponding author), Univ Coll Dublin, Conway Inst, UCD Sch Biomol & Biomed Sci, UCD Conway Inst F062, Dublin 4, Ireland.	brendan.kennedy@ucd.ie	Wong, Vickie/AAL-5158-2020; kennedy, Breandan/H-5643-2019; Stitt, Alan/A-9842-2009	Wong, Vickie/0000-0001-9356-7556; kennedy, Breandan/0000-0001-7991-4689; Stitt, Alan/0000-0002-8647-9918; Reynolds, Alison/0000-0002-3147-0094	Enterprise Ireland; Health Research Board Ireland; Science Foundation Ireland; MRC [G0801962] Funding Source: UKRI; Medical Research Council [G0801962] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [10JTA] Funding Source: researchfish	Enterprise Ireland; Health Research Board Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust	This work was supported by funding from an Enterprise Ireland proof of concept award, an Enterprise Ireland Commercialisation Fund award, a Health Research Board Ireland Health Research Award, and a Science Foundation Ireland Technology innovation development award. B. N. K. and Y. A. are authors on granted patent WO2012095836 A1. A. R., C. K., and B. N. K. are authors on patent filing WO2014012889 A1.	Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Alvarez Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007867; Back M, 2014, BRIT J PHARMACOL, V171, P3551, DOI 10.1111/bph.12665; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Balantic M, 2012, MOL DIAGN THER, V16, P173, DOI 10.2165/11631710-000000000-00000; Barajas-Espinosa A, 2012, FASEB J, V26, P1100, DOI 10.1096/fj.11-195792; Brockerhoff SE, 2006, NAT PROTOC, V1, P2448, DOI 10.1038/nprot.2006.255; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dhakal S, 2013, INVEST OPHTH VIS SCI, V54; Dhakal S, 2015, DEV DYNAM, V244, P1439, DOI 10.1002/dvdy.24322; Duah E, 2013, SCI REP-UK, V3, DOI 10.1038/srep03274; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Folkman J, 1997, EXS, V79, P1; Frost & Sullivan, 2010, M4AC52 FROST SULL; Frost & Sullivan, 2011, NC7752 FROST SULL; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gagnidze K, 2008, J MED CHEM, V51, P3378, DOI 10.1021/jm7015478; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Hartsock A, 2014, DEV BIOL, V394, P327, DOI 10.1016/j.ydbio.2014.07.024; Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jiang Y, 2007, BLOOD, V110, P3263, DOI 10.1182/blood-2007-07-100453; Kalen M, 2009, CHEM BIOL, V16, P432, DOI 10.1016/j.chembiol.2009.02.010; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kanaoka Y, 2014, ALLERGY ASTHMA IMMUN, V6, P288, DOI 10.4168/aair.2014.6.4.288; Kanaoka Y, 2013, J BIOL CHEM, V288, P10967, DOI 10.1074/jbc.C113.453704; KANAYASU T, 1989, BIOCHEM BIOPH RES CO, V159, P572, DOI 10.1016/0006-291X(89)90032-6; Kim MH, 2010, J CELL BIOCHEM, V111, P686, DOI 10.1002/jcb.22755; Kitambi SS, 2009, MECH DEVELOP, V126, P464, DOI 10.1016/j.mod.2009.01.002; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee KS, 2004, J ALLERGY CLIN IMMUN, V114, P1093, DOI 10.1016/j.jaci.2004.07.039; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; LoRusso PM, 2011, J CLIN ONCOL, V29, P2952, DOI 10.1200/JCO.2011.36.1311; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Marschallinger J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9466; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Meltzer EO, 2000, J ALLERGY CLIN IMMUN, V105, P917, DOI 10.1067/mai.2000.106040; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Qian XD, 2006, EUR J PHARMACOL, V549, P35, DOI 10.1016/j.ejphar.2006.07.056; Rehak M, 2010, J THROMB HAEMOST, V8, P1886, DOI 10.1111/j.1538-7836.2010.03909.x; Reiss TF, 1996, J ALLERGY CLIN IMMUN, V98, P528, DOI 10.1016/S0091-6749(96)70086-6; Rennekamp AJ, 2015, CURR OPIN CHEM BIOL, V24, P58, DOI 10.1016/j.cbpa.2014.10.025; Reynolds AL, 2014, ADV EXP MED BIOL, V801, P797, DOI 10.1007/978-1-4614-3209-8_100; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Salim T, 2014, EXP CELL RES, V321, P255, DOI 10.1016/j.yexcr.2013.10.021; Sasore T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105280; Savari S, 2014, WORLD J GASTROENTERO, V20, P968, DOI 10.3748/wjg.v20.i4.968; Savari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073466; Shastry BS, 2009, CLIN EXP OPHTHALMOL, V37, P884, DOI 10.1111/j.1442-9071.2009.02150.x; Sidman RL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4882; Singh RK, 2010, PHARMACOLOGY, V85, P336, DOI 10.1159/000312669; Smith GA, 2004, PHARM RES, V21, P1539, DOI 10.1023/B:PHAM.0000041445.76931.27; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; TSOPANOGLOU NE, 1994, EUR J PHARMACOL, V258, P151, DOI 10.1016/0014-2999(94)90068-X; Wang XY, 2013, NEUROCHEM INT, V62, P340, DOI 10.1016/j.neuint.2013.01.002; Wangsa-Wirawan ND, 2003, ARCH OPHTHALMOL-CHIC, V121, P547, DOI 10.1001/archopht.121.4.547; Xu L, 2010, PHARMAZIE, V65, P750, DOI 10.1691/ph.2010.9810; Yuan YM, 2009, J PHARMACOL SCI, V109, P285, DOI 10.1254/jphs.08321FP; ZAMBONI R, 1992, J MED CHEM, V35, P3832, DOI 10.1021/jm00099a011	67	26	26	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7242	7255		10.1074/jbc.M115.710665	http://dx.doi.org/10.1074/jbc.M115.710665			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26846851	Green Published, hybrid			2022-12-26	WOS:000383447600004
J	Cui, JY; Miao, H; Ding, LH; Wehner, TC; Liu, PN; Wang, Y; Zhang, SP; Gu, XF				Cui, Jin-Ying; Miao, Han; Ding, Li-Hong; Wehner, Todd C.; Liu, Pan-Na; Wang, Ye; Zhang, Sheng-Ping; Gu, Xing-Fang			A New Glabrous Gene (csgl3) Identified in Trichome Development in Cucumber (Cucumis sativus L.)	PLOS ONE			English	Article							CELL-DIFFERENTIATION; ARABIDOPSIS; ENCODES; PROTEIN; MODEL; FRUIT; MARKERS; MEMBERS; FAMILY	Spines or trichomes on the fruit of cucumbers enhance their commercial value in China. In addition, glabrous mutants exhibit resistance to aphids and therefore their use by growers can reduce pesticide residues. Previous studies have reported two glabrous mutant plants containing the genes, csgl1 and csgl2. In the present study, a new glabrous mutant, NCG157, was identified showing a gene interaction effect with csgl1 and csgl2. This mutant showed the glabrous character on stems, leaves, tendrils, receptacles and ovaries, and there were no spines or tumors on the fruit surface. Inheritance analysis showed that a single recessive gene, named csgl3, determined the glabrous trait. An F-2 population derived from the cross of two inbred lines 9930 (a fresh market type from Northern China that exhibits trichomes) and NCG157 (an American processing type with glabrous surfaces) was used for genetic mapping of the csgl3 gene. By combining bulked segregant analysis (BAS) with molecular markers, 18 markers, including two simple sequence repeats (SSR), nine insertion deletions (InDel) and seven derived cleaved amplified polymorphism sequences (dCAPs), were identified to link to the csgl3 gene. All of the linked markers were used as anchor loci to locate the csgl3 gene on cucumber chromosome 6. The csgl3 gene was mapped between the dCAPs markers dCAPs-21 and dCAPs-19, at genetic distances of 0.05 cM and 0.15 cM, respectively. The physical distance of this region was 19.6 kb. Three markers, InDel-19, dCAPs-2 and dCAPs-11, co-segregated with csgl3. There were two candidate genes in the region, Csa6M514860 and Csa6M514870. Quantitative real-time PCR showed that the expression of Csa6M514870 was higher in the tissues of 9930 than that of NCG157, and this was consistent with their phenotypic characters. Csa6M514870 is therefore postulated to be the candidate gene for the development of trichomes in cucumber. This study will facilitate marker-assisted selection (MAS) of the smooth plant trait in cucumber breeding and provide for future cloning of csgl3.	[Cui, Jin-Ying; Miao, Han; Ding, Li-Hong; Liu, Pan-Na; Wang, Ye; Zhang, Sheng-Ping; Gu, Xing-Fang] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Wehner, Todd C.] N Carolina State Univ, Dept Hort Sci, Raleigh, NC 27695 USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of North Carolina; North Carolina State University	Zhang, SP; Gu, XF (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China.	zhangshengping@caas.cn; guxingfang@caas.cn			National Natural Science Foundation of China [31372082]; earmarked fund for Modern Agro-industry Technology Research System [CARS-25]; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for Modern Agro-industry Technology Research System; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, China	This work was supported by National Natural Science Foundation of China (31372082); the earmarked fund for Modern Agro-industry Technology Research System (CARS-25), and the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, DEVELOPMENT, V130, P635, DOI 10.1242/dev.00292; Aso K, 1999, MOL BIOL EVOL, V16, P544, DOI 10.1093/oxfordjournals.molbev.a026135; BASSAM BJ, 1991, ANAL BIOCHEM, V198, P217; Cao ChenXing, 1999, China Vegetables, P29; Chen CH, 2014, J EXP BOT, V65, P4943, DOI 10.1093/jxb/eru258; Guan, 2008, THESIS SHANGHAI JIAO; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Hulskamp M, 1999, INT REV CYTOL, V186, P147; Hulskamp M, 2004, NAT REV MOL CELL BIO, V5, P471, DOI 10.1038/nrm1404; HULSKAMP M, 1994, CELL, V76, P555, DOI 10.1016/0092-8674(94)90118-X; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Jiang S, 2005, PLANT MOL BIOL, V57, P835, DOI 10.1007/s11103-005-2859-x; Kamata N, 2013, PLANT J, V75, P430, DOI 10.1111/tpj.12211; Kang JH, 2010, J EXP BOT, V61, P1053, DOI 10.1093/jxb/erp370; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; Li Q, 2015, J EXP BOT, V66, P2515, DOI 10.1093/jxb/erv046; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Payne CT, 2000, GENETICS, V156, P1349; Pesch M, 2004, CURR OPIN GENET DEV, V14, P422, DOI 10.1016/j.gde.2004.06.007; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; SAMUELS AL, 1993, ANN BOT-LONDON, V72, P433, DOI 10.1006/anbo.1993.1129; Schellmann S, 2005, INT J DEV BIOL, V49, P579, DOI 10.1387/ijdb.051983ss; SCHENA M, 1992, P NATL ACAD SCI USA, V89, P3894, DOI 10.1073/pnas.89.9.3894; Serna L, 2006, TRENDS PLANT SCI, V11, P274, DOI 10.1016/j.tplants.2006.04.008; Sessa G, 1998, PLANT MOL BIOL, V38, P609, DOI 10.1023/A:1006016319613; Staub J, 1996, HORTSCIENCE, V31, P262, DOI 10.21273/HORTSCI.31.2.262; Tominaga-Wada R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054019; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Yang CX, 2011, P NATL ACAD SCI USA, V108, P11836, DOI 10.1073/pnas.1100532108; Yang ShuangJuan, 2011, Acta Horticulturae Sinica, V38, P1685; Zhang Chi, 2009, Journal of Shanghai Jiaotong University - Agricultural Science, V27, P380; Zhang WW, 2010, THEOR APPL GENET, V120, P645, DOI 10.1007/s00122-009-1182-3	36	39	44	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148422	10.1371/journal.pone.0148422	http://dx.doi.org/10.1371/journal.pone.0148422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845560	Green Submitted, Green Published, gold			2022-12-26	WOS:000369552800056
J	Ku, HC; Lee, SY; Yang, KC; Kuo, YH; Su, MJ				Ku, Hui-Chun; Lee, Shih-Yi; Yang, Kai-Chien; Kuo, Yueh-Hsiung; Su, Ming-Jai			Modification of Caffeic Acid with Pyrrolidine Enhances Antioxidant Ability by Activating AKT/HO-1 Pathway in Heart	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; PRESERVES CARDIAC-FUNCTION; HEME OXYGENASE-1; OXIDATIVE STRESS; TRANSGENIC MICE; INFARCT SIZE; EXPRESSION; PROTECTION; RATS; AKT	Overproduction of free radicals during ischemia/reperfusion (I/R) injury leads to an interest in using antioxidant therapy. Activating an endogenous antioxidant signaling pathway is more important due to the fact that the free radical scavenging behavior in vitro does not always correlate with a cytoprotection effect in vivo. Caffeic acid (CA), an antioxidant, is a major phenolic constituent in nature. Pyrrolidinyl caffeamide (PLCA), a derivative of CA, was compared with CA for their antioxidant and cytoprotective effects. Our results indicate that CA and PLCA exert the same ability to scavenge DPPH in vitro. In response to myocardial I/R stress, PLCA was shown to attenuate lipid peroxydation and troponin release more than CA. These responses were accompanied with a prominent elevation in AKT and HO-1 expression and a preservation of mnSOD expression and catalase activity. PLCA also improved cell viability and alleviated the intracellular ROS level more than CA in cardiomyocytes exposed to H2O2. When inhibiting the AKT or HO-1 pathways, PLCA lost its ability to recover mnSOD expression and catalase activity to counteract with oxidative stress, suggesting AKT/HO-1 pathway activation by PLCA plays an important role. In addition, inhibition of AKT signaling further abolished HO-1 activity, while inhibition of HO-1 signaling attenuated AKT expression, indicating cross-talk between the AKT and HO-1 pathways. These protective effects may contribute to the cardiac function improvement by PLCA. These findings provide new insight into therapeutic approaches using a modified natural compound against oxidative stress from myocardial injuries.	[Ku, Hui-Chun; Lee, Shih-Yi; Yang, Kai-Chien; Su, Ming-Jai] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Lee, Shih-Yi] Mackay Mem Hosp, Div Pulm & Crit Care Med, Taipei, Taiwan; [Lee, Shih-Yi] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Kuo, Yueh-Hsiung] China Med Univ, Dept Chinese Pharmaceut Sci, Taichung, Taiwan; [Kuo, Yueh-Hsiung] China Med Univ, Chinese Med Resources, Taichung, Taiwan; [Kuo, Yueh-Hsiung] Asia Univ, Dept Biotechnol, Taichung, Taiwan	National Taiwan University; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Su, MJ (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	kcyang@ntu.edu.tw; mingja@ntu.edu.tw	Yang, Kai-Chien/AAO-6991-2021	Yang, Kai-Chien/0000-0002-9128-9166	Ministry of Science and Technology [MOST 103-2325-B-002-020]; National Taiwan University [NTU 104R4000]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University(National Taiwan University)	The author work was supported by the grant from Ministry of Science and Technology (MOST 103-2325-B-002-020), and National Taiwan University (NTU 104R4000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunt KR, 2006, ARTERIOSCL THROM VAS, V26, P2027, DOI 10.1161/01.ATV.0000236204.37119.8d; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Collino M, 2013, DIS MODEL MECH, V6, P1012, DOI 10.1242/dmm.011528; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Galiuto L, 2000, Ital Heart J, V1, P108; Golias C, 2007, IN VIVO, V21, P757; Gulcin I, 2006, TOXICOLOGY, V217, P213, DOI 10.1016/j.tox.2005.09.011; He MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084800; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Jayasooriya RGPT, 2014, FOOD CHEM TOXICOL, V65, P82, DOI 10.1016/j.fct.2013.12.011; Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X; Koskenkorva-Frank TS, 2013, FREE RADICAL BIO MED, V65, P1174, DOI 10.1016/j.freeradbiomed.2013.09.001; Kristinova V, 2009, J AGR FOOD CHEM, V57, P10377, DOI 10.1021/jf901072t; Ku HC, 2015, N-S ARCH PHARMACOL, V388, P539, DOI 10.1007/s00210-015-1098-1; Ku HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085634; Ku HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054518; Ku HC, 2011, N-S ARCH PHARMACOL, V384, P197, DOI 10.1007/s00210-011-0665-3; Ku HC, 2010, N-S ARCH PHARMACOL, V382, P463, DOI 10.1007/s00210-010-0559-9; Lakkisto P, 2009, SCAND J CLIN LAB INV, V69, P209, DOI 10.1080/00365510802474392; Lee SY, 2015, J BIOMED SCI, V22, DOI [10.1186/s12929-015-0188-1, 10.1186/s12929-015-0125-3]; LITT MR, 1989, CIRCULATION, V80, P1816, DOI 10.1161/01.CIR.80.6.1816; Liu XQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054077, 10.1371/journal.pone.0077367, 10.1371/journal.pone.0058489]; LLESUY SF, 1994, BBA-MOL CELL RES, V1223, P9, DOI 10.1016/0167-4889(94)90067-1; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Meng X, 2014, FREE RADICAL RES, V48, P823, DOI 10.3109/10715762.2014.911853; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; NAYLER WG, 1992, J CARDIOVASC PHARM, V20, pS14; Novo G, 2011, TRANSL RES, V157, P285, DOI 10.1016/j.trsl.2011.01.003; Pae HO, 2008, J CLIN BIOCHEM NUTR, V42, P197, DOI 10.3164/jcbn.2008029; Pan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114186; Ramaraj R, 2007, NEW ENGL J MED, V357, P2408; Ravingerova T, 2007, MOL CELL BIOCHEM, V297, P111, DOI 10.1007/s11010-006-9335-z; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776; Senthil K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123360; Siow RCM, 2007, REDOX REP, V12, P11, DOI 10.1179/135100007X162167; Son Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/639541; Turkseven S, 2005, AM J PHYSIOL-HEART C, V289, pH701, DOI 10.1152/ajpheart.00024.2005; Uang YS, 1997, BIOPHARM DRUG DISPOS, V18, P727, DOI 10.1002/(SICI)1099-081X(199711)18:8<727::AID-BDD58>3.3.CO;2-6; Verma S, 2002, CIRCULATION, V105, P2332, DOI 10.1161/01.CIR.0000016602.96363.36; Wang Chao-Yung, 2010, Chang Gung Med J, V33, P13; Wang SJ, 2014, PHARM BIOL, V52, P1150, DOI 10.3109/13880209.2013.879906; Wu ML, 2011, AM J CARDIOVASC DIS, V1, P150; Xu X, 2015, MEDIAT INFLAMM, V2015, DOI [10.1155/2015/810798, 10.1155/2015/380218]; Yang J, 2012, BIOMED CHROMATOGR, V26, P594, DOI 10.1002/bmc.1702; Yang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108024; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Yoshida T, 2001, CIRCULATION, V103, P1695, DOI 10.1161/01.CIR.103.12.1695	52	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148545	10.1371/journal.pone.0148545	http://dx.doi.org/10.1371/journal.pone.0148545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845693	Green Submitted, Green Published, gold			2022-12-26	WOS:000369552800067
J	Wilder, HK; Raffel, SJ; Barbour, AG; Porcella, SF; Sturdevant, DE; Vaisvil, B; Kapatral, V; Schmitt, DP; Schwan, TG; Lopez, JE				Wilder, Hannah K.; Raffel, Sandra J.; Barbour, Alan G.; Porcella, Stephen F.; Sturdevant, Daniel E.; Vaisvil, Benjamin; Kapatral, Vinayak; Schmitt, Daniel P.; Schwan, Tom G.; Lopez, Job E.			Transcriptional Profiling the 150 kb Linear Megaplasmid of Borrelia turicatae Suggests a Role in Vector Colonization and Initiating Mammalian Infection	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; ACIDIC REPETITIVE PROTEINS; RELAPSING FEVER; SURFACE PROTEIN; ORNITHODOROS-TURICATA; ANTIGENIC VARIATION; TRYPANOSOMA-BRUCEI; GENOME SEQUENCE; GENE-EXPRESSION; SALIVARY-GLANDS	Adaptation is key for survival as vector-borne pathogens transmit between the arthropod and vertebrate, and temperature change is an environmental signal inducing alterations in gene expression of tick-borne spirochetes. While plasmids are often associated with adaptation, complex genomes of relapsing fever spirochetes have hindered progress in understanding the mechanisms of vector colonization and transmission. We utilized recent advances in genome sequencing to generate the most complete version of the Borrelia turicatae 150 kb linear megaplasmid (lp150). Additionally, a transcriptional analysis of open reading frames (ORFs) in lp150 was conducted and identified regions that were up-regulated during in vitro cultivation at tick-like growth temperatures (22 degrees C), relative to bacteria grown at 35 degrees C and infected murine blood. Evaluation of the 3' end of lp150 identified a cluster of ORFs that code for putative surface lipoproteins. With a microbe's surface proteome serving important roles in pathogenesis, we confirmed the ORFs expression in vitro and in the tick compared to spirochetes infecting murine blood. Transcriptional evaluation of lp150 indicates the plasmid likely has essential roles in vector colonization and/or initiating mammalian infection. These results also provide a much needed transcriptional framework to delineate the molecular mechanisms utilized by relapsing fever spirochetes during their enzootic cycle.	[Wilder, Hannah K.; Lopez, Job E.] Baylor Coll Med, Dept Pediat, Sect Trop Med, Houston, TX 77030 USA; [Wilder, Hannah K.; Lopez, Job E.] Texas Childrens Hosp, Houston, TX 77030 USA; [Raffel, Sandra J.; Schwan, Tom G.] NIAID, Rocky Mt Labs, Lab Zoonot Pathogens, NIH, Hamilton, MT 59840 USA; [Barbour, Alan G.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Barbour, Alan G.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Barbour, Alan G.] Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92717 USA; [Porcella, Stephen F.; Sturdevant, Daniel E.] NIAID, Rocky Mt Labs, Genom Unit, Res Technol Sect,NIH, Hamilton, MT 59840 USA; [Vaisvil, Benjamin; Kapatral, Vinayak; Schmitt, Daniel P.] Igenbio Inc, Chicago, IL USA; [Lopez, Job E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Baylor College of Medicine	Lopez, JE (corresponding author), Baylor Coll Med, Dept Pediat, Sect Trop Med, Houston, TX 77030 USA.; Lopez, JE (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.; Lopez, JE (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	job.lopez@bcm.edu		Lopez, Job/0000-0003-4802-5779; Vaisvil, Benjamin/0000-0003-1688-0295; Barbour, Alan/0000-0002-0719-5248; KAPATRAL, VINAYAK/0000-0002-0501-3738	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Igenbio, Inc.;  [AI091652];  [AI103724];  [AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI091652, R21AI103724, U54AI065359] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Igenbio, Inc.; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by AI091652 (JEL), AI103724 (JEL), AI065359 (AGB), and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Igenbio, Inc. provided support in the form of salaries for authors BV, VK and DPS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barbour AG, 2000, INFECT IMMUN, V68, P7114, DOI 10.1128/IAI.68.12.7114-7121.2000; Barbour AG, 2014, GENOME ANNOUNC, V2; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Battisti James M., 2008, V431, P69; BENACH JL, 1983, NEW ENGL J MED, V308, P740, DOI 10.1056/NEJM198303313081302; Boyle WK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002767; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; CLAYTON CE, 1989, J BIOL CHEM, V264, P15088; COFFEY EM, 1967, J INFECT DIS, V117, P29, DOI 10.1093/infdis/117.1.29; Dai QY, 2006, MOL MICROBIOL, V60, P1329, DOI 10.1111/j.1365-2958.2006.05177.x; Davis GE, 1943, PUBLIC HEALTH REP, V58, P839, DOI 10.2307/4584474; Davis GE, 1941, PUBLIC HEALTH REP, V56, P1799, DOI 10.2307/4583854; Elbir H, 2014, GENOME ANNOUNC, V2; Elbir H, 2012, J BACTERIOL, V194, P3723, DOI 10.1128/JB.00118-12; Fikrig E, 2000, J IMMUNOL, V164, P5344, DOI 10.4049/jimmunol.164.10.5344; Fine LM, 2014, INFECT IMMUN, V82, P3324, DOI 10.1128/IAI.01892-14; Fine LM, 2011, J BACTERIOL, V193, P3241, DOI 10.1128/JB.05037-11; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilmore RD, 2010, P NATL ACAD SCI USA, V107, P7515, DOI 10.1073/pnas.1000268107; Guyard C, 2005, INFECT IMMUN, V73, P3025, DOI 10.1128/IAI.73.5.3025-3037.2005; Iyer R, 2015, MOL MICROBIOL, V95, P509, DOI 10.1111/mmi.12882; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; KITTEN T, 1990, P NATL ACAD SCI USA, V87, P6077, DOI 10.1073/pnas.87.16.6077; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez JE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002514; Lopez JE, 2008, VECTOR-BORNE ZOONOT, V8, P813, DOI 10.1089/vbz.2008.0033; Marcsisin RA, 2012, INFECT IMMUN, V80, P1881, DOI 10.1128/IAI.06419-11; Meri T, 2006, INFECT IMMUN, V74, P4157, DOI 10.1128/IAI.00007-06; Miller SC, 2013, J BACTERIOL, V195, P3629, DOI 10.1128/JB.00347-13; MOWATT MR, 1989, MOL CELL BIOL, V9, P1332, DOI 10.1128/MCB.9.3.1332; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Pal U, 2000, J CLIN INVEST, V106, P561, DOI 10.1172/JCI9427; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pennington PM, 1999, MOL MICROBIOL, V34, P1120, DOI 10.1046/j.1365-2958.1999.01675.x; Pettersson J, 2007, INFECT IMMUN, V75, P3877, DOI 10.1128/IAI.00199-07; PIESMAN J, 1991, J INFECT DIS, V163, P895, DOI 10.1093/infdis/163.4.895; PIESMAN J, 1987, J CLIN MICROBIOL, V25, P557, DOI 10.1128/JCM.25.3.557-558.1987; PIESMAN J, 1995, J MED ENTOMOL, V32, P519, DOI 10.1093/jmedent/32.4.519; PIESMAN J, 1993, J INFECT DIS, V167, P1082, DOI 10.1093/infdis/167.5.1082; PIESMAN J, 1990, AM J TROP MED HYG, V42, P352, DOI 10.4269/ajtmh.1990.42.352; PLASTERK RHA, 1985, NATURE, V318, P257, DOI 10.1038/318257a0; Porcella SF, 2005, INFECT IMMUN, V73, P6647, DOI 10.1128/IAI.73.10.6647-6658.2005; Raffel SJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004056; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; RESTREPO BI, 1994, CELL, V78, P867, DOI 10.1016/S0092-8674(94)90642-4; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rossmann E, 2007, J IMMUNOL, V178, P7292, DOI 10.4049/jimmunol.178.11.7292; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Schwan TG, 2002, EMERG INFECT DIS, V8, P115, DOI 10.3201/eid0802.010198; Schwan TG, 2005, J CLIN MICROBIOL, V43, P3851, DOI 10.1128/JCM.43.8.3851-3859.2005; Schwan TG, 1996, INFECT AGENT DIS, V5, P167; Schwan TG, 1998, SCIENCE, V280, P1938, DOI 10.1126/science.280.5371.1938; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; SIMPSON WJ, 1990, MICROB PATHOGENESIS, V8, P109, DOI 10.1016/0882-4010(90)90075-2; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; Varma MGR, 1962, S ZOOLOGICAL SOC LON; Woodman ME, 2009, J LEUKOCYTE BIOL, V86, P727, DOI 10.1189/jlb.0309169	61	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147707	10.1371/journal.pone.0147707	http://dx.doi.org/10.1371/journal.pone.0147707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845332	Green Published, gold			2022-12-26	WOS:000369552800014
J	Cui, Y; Wei, HY; Lu, FG; Liu, XW; Liu, DL; Gu, L; Ouyang, CH				Cui, Yi; Wei, Hongyun; Lu, Fanggen; Liu, Xiaowei; Liu, Deliang; Gu, Li; Ouyang, Chunhui			Different Effects of Three Selected Lactobacillus Strains in Dextran Sulfate Sodium-Induced Colitis in BALB/c Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INDUCED ULCERATIVE-COLITIS; MURINE COLITIS; DSS; MICROFLORA; PROBIOTICS; PREBIOTICS; MICROBIOTA; INDUCTION; REMISSION	Aim To analyze the changes of different Lactobacillus species in ulcerative colitis patients and to further assess the therapeutic effects of selected Lactobacillus strains on dextran sulfate sodium (DSS)-induced experimental colitis in BALB/c mice. Methods Forty-five active ulcerative colitis (UC) patients and 45 population-based healthy controls were enrolled. Polymerase chain reaction (PCR) amplification and real-time PCR were performed for qualitative and quantitative analyses, respectively, of the Lactobacillus species in UC patients. Three Lactobacillus strains from three species were selected to assess the therapeutic effects on experimental colitis. Sixty 8-week-old BALB/c mice were divided into six groups. The five groups that had received DSS were administered normal saline, mesalazine, L. fermentum CCTCC M206110 strain, L. crispatus CCTCC M206119 strain, or L. plantarum NCIMB8826 strain. We assessed the severity of colitis based on disease activity index (DAI), body weight loss, colon length, and histologic damage. Results The detection rate of four of the 11 Lactobacillus species decreased significantly (P < 0.05), and the detection rate of two of the 11 Lactobacillus species increased significantly (P < 0.05) in UC patients. Relative quantitative analysis revealed that eight Lactobacillus species declined significantly in UC patients (P < 0.05), while three Lactobacillus species increased significantly (P < 0.05). The CCTCC M206110 treatment group had less weight loss and colon length shortening, lower DAI scores, and lower histologic scores (P < 0.05), while the CCTCC M206119 treatment group had greater weight loss and colon length shortening, higher histologic scores, and more severe inflammatory infiltration (P < 0.05). NCIMB8826 improved weight loss and colon length shortening (P < 0.05) with no significant influence on DAI and histologic damage in the colitis model. Conclusions Administration of an L. crispatus CCTCC M206119 supplement aggravated DSS-induced colitis. L. fermentum CCTCC M206110 proved to be effective at attenuating DSS-induced colitis. The potential probiotic effect of L. plantarum NCIMB8826 on UC has yet to be assessed.	[Cui, Yi; Wei, Hongyun; Lu, Fanggen; Liu, Xiaowei; Liu, Deliang; Gu, Li; Ouyang, Chunhui] Cent S Univ, Xiangya Hosp 2, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Cui, Yi] Missouri Univ Sci & Technol, Dept Biol Sci, Rolla, MO USA	Central South University; University of Missouri System; Missouri University of Science & Technology	Gu, L; Ouyang, CH (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Gastroenterol, Changsha, Hunan, Peoples R China.	liguxy2yy@gmail.com; ouyangchxy2yy@gmail.com			National Natural Science Foundation of China [81470801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NO. 81470801), received by F. Lu.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Cammarota G, 2015, PHARMACOL THERAPEUT, V149, P191, DOI 10.1016/j.pharmthera.2014.12.006; Castagliuolo I, 2005, FEMS IMMUNOL MED MIC, V43, P197, DOI 10.1016/j.femsim.2004.08.011; Chen LL, 2013, WORLD J GASTROENTERO, V19, P5347, DOI 10.3748/wjg.v19.i32.5347; COOPER HS, 1993, LAB INVEST, V69, P238; Dijkstra G, 2002, SCAND J GASTROENTERO, V37, P37, DOI 10.1080/003655202320621436; Feng YN, 2010, VET MICROBIOL, V140, P116, DOI 10.1016/j.vetmic.2009.07.001; Geier MS, 2007, INT J FOOD MICROBIOL, V114, P267, DOI 10.1016/j.ijfoodmicro.2006.09.018; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Herias MV, 2005, INT J FOOD MICROBIOL, V103, P143, DOI 10.1016/j.ijfoodmicro.2004.11.032; Jang SE, 2014, INT IMMUNOPHARMACOL, V21, P186, DOI 10.1016/j.intimp.2014.04.021; Koido S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086702; Kokesova A, 2006, FOLIA MICROBIOL, V51, P478, DOI 10.1007/BF02931595; Kumar CSVS, 2015, INT IMMUNOPHARMACOL, V25, P504, DOI 10.1016/j.intimp.2015.02.026; Liu YW, 2011, INT IMMUNOPHARMACOL, V11, P2159, DOI 10.1016/j.intimp.2011.09.013; Macfarlane GT, 2009, CURR PHARM DESIGN, V15, P1528, DOI 10.2174/138161209788168146; Martin R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0400-1; Miele E, 2009, AM J GASTROENTEROL, V104, P437, DOI 10.1038/ajg.2008.118; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Navidshad B, 2012, INT J MOL SCI, V13, P2119, DOI 10.3390/ijms13022119; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Oliva S, 2012, ALIMENT PHARM THER, V35, P327, DOI 10.1111/j.1365-2036.2011.04939.x; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Sanchez B, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/159094; Sanchez-Fidalgo S, 2015, J NUTR BIOCHEM, V26, P513, DOI 10.1016/j.jnutbio.2014.12.001; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schultz M, 2002, INFLAMM BOWEL DIS, V8, P71, DOI 10.1097/00054725-200203000-00001; Sood A, 2009, CLIN GASTROENTEROL H, V7, P1202, DOI 10.1016/j.cgh.2009.07.016; Ulinski T, 2010, CURR MED CHEM, V17, P847, DOI 10.2174/092986710790712174; Wasilewski A, 2015, INFLAMM BOWEL DIS, V21, P1674, DOI 10.1097/MIB.0000000000000364; Zhang J, 2013, WORLD J MICROB BIOT, V29, P2293, DOI 10.1007/s11274-013-1395-0; Zocco MA, 2006, ALIMENT PHARM THER, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x; Zuo FL, 2014, APPL MICROBIOL BIOT, V98, P7523, DOI 10.1007/s00253-014-5851-z	35	23	23	14	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148241	10.1371/journal.pone.0148241	http://dx.doi.org/10.1371/journal.pone.0148241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840426	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200108
J	Rallos, LEE; Baudoin, AB				Rallos, Lynn Esther E.; Baudoin, Anton B.			Co-Occurrence of Two Allelic Variants of CYP51 in Erysiphe necator and Their Correlation with Over-Expression for DMI Resistance	PLOS ONE			English	Article							POWDERY MILDEW FUNGUS; DEMETHYLATION INHIBITOR FUNGICIDES; 14-ALPHA-DEMETHYLASE GENE CYP51; UNCINULA-NECATOR; STEROL DEMETHYLATION; DIFFERENTIAL SENSITIVITY; ASPERGILLUS-FUMIGATUS; MONILINIA-FRUCTICOLA; FUSARIUM-GRAMINEARUM; AZOLE FUNGICIDE	Demethylation inhibitors (DMIs) have been an important tool in the management of grapevine powdery mildew caused by Erysiphe necator. Long-term, intensive use of DMIs has resulted in reduced sensitivity in field populations. To further characterize DMI resistance and understand resistance mechanisms in this pathogen, we investigated the cyp51 sequence of 24 single-spored isolates from Virginia and surrounding states and analyzed gene expression in isolates representing a wide range of sensitivity. Two cyp51 alleles were found with respect to the 136th codon of the predicted EnCYP51 sequence: the wildtype (TAT) and the mutant (TTT), which results in the known Y136F amino acid change. Some isolates possessed both alleles, demonstrating gene duplication or increased gene copy number and possibly a requirement for at least one mutant copy of CYP51 for resistance. Cyp51 was over-expressed 1.4- to 19-fold in Y136F-mutant isolates. However, the Y136F mutation was absent in one isolate with moderate to high resistance factor. Two additional synonymous mutations were detected as well, one of which, A1119C was present only in isolates with high cyp51 expression. Overall, our results indicate that at least two mechanisms, cyp51 over-expression and the known target-site mutation in CYP51, contribute to resistance in E. necator, and may be working in conjunction with each other.	[Rallos, Lynn Esther E.; Baudoin, Anton B.] Virginia Tech, Coll Agr & Life Sci, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University	Rallos, LEE (corresponding author), Virginia Tech, Coll Agr & Life Sci, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA.	lynn.e.rallos@dupont.com			Virginia Wine Board; Viticulture Consortium-East; North Carolina Wine Grape Council	Virginia Wine Board; Viticulture Consortium-East; North Carolina Wine Grape Council	This work was supported by Virginia Wine Board (http://www.virginiawine.org/industry/wine-board), Viticulture Consortium-East (http://portal.nifa.usda.gov/web/crisprojectpages/0218903-viticulture-consortium-east.html), and North Carolina Wine & Grape Council (no current website, referenced at http://www.ncagr.gov/markets/ncwine/about-us/ncwine-history.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini C, 2003, EUR J PLANT PATHOL, V109, P117, DOI 10.1023/A:1022584822191; Amrani L, 2006, PLANT PATHOL, V55, P505, DOI 10.1111/j.1365-3059.2006.01390.x; Aoyama Y, 2005, FRONT BIOSCI, V10, P1546, DOI 10.2741/1639; Aoyama Y, 1996, J BIOCHEM-TOKYO, V119, P926; Araya C, 2014, VITIS, V53, P163; Becher R, 2012, APPL MICROBIOL BIOT, V95, P825, DOI 10.1007/s00253-012-4195-9; Becher R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-52; Bellamine A, 2004, J LIPID RES, V45, P2000, DOI 10.1194/jlr.M400239-JLR200; Blatter RHE, 1998, PLANT PATHOL, V47, P570, DOI 10.1046/j.1365-3059.1998.00276.x; Bolton MD, 2012, PHYTOPATHOLOGY, V102, P298, DOI 10.1094/PHYTO-07-11-0212; Boudon-Padieu E., 2015, COMPENDIUM GRAPE DIS, V2nd ed., P103; Brent K.J., 2007, FRAC MONOGRAPH, V2; Brewer MT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-268; Butters JA, 2000, PEST MANAG SCI, V56, P257, DOI 10.1002/(SICI)1526-4998(200003)56:3<257::AID-PS131>3.3.CO;2-2; Canas-Gutierrez GP, 2009, PEST MANAG SCI, V65, P892, DOI 10.1002/ps.1770; Chen FP, 2012, PLANT DIS, V96, P416, DOI 10.1094/PDIS-06-11-0495; Colcol JF, 2012, PLANT DIS, V96, P111, DOI 10.1094/PDIS-12-10-0883; DEBIEU D, 1995, PHYTOCHEMISTRY, V39, P293, DOI 10.1016/0031-9422(95)00015-Y; Delye C, 1998, CURR GENET, V34, P399, DOI 10.1007/s002940050413; Delye C, 1997, GENE, V195, P29, DOI 10.1016/S0378-1119(97)00141-8; Delye C, 1999, APPL ENVIRON MICROB, V65, P3950; Delye C, 1997, APPL ENVIRON MICROB, V63, P2966; Donald TM, 2002, THEOR APPL GENET, V104, P610, DOI 10.1007/s00122-001-0768-1; DOSTER MA, 1985, AM J ENOL VITICULT, V36, P101; Dufour MC, 2011, PEST MANAG SCI, V67, P60, DOI 10.1002/ps.2032; Erickson EO, 1997, PHYTOPATHOLOGY, V87, P784, DOI 10.1094/PHYTO.1997.87.8.784; Ferreira MED, 2005, MED MYCOL, V43, pS313, DOI 10.1080/13693780400029114; Fraaije BA, 2007, MOL PLANT PATHOL, V8, P245, DOI [10.1111/j.1364-3703.2007.00388.x, 10.1111/j.1364-3703.2007.00388.X]; FRAC, 2012, FRAC COD LIST 2012 F; Frenkel O, 2012, PLANT PATHOL, V61, P106, DOI 10.1111/j.1365-3059.2011.02502.x; Frenkel O, 2015, PHYTOPATHOLOGY, V105, P370, DOI 10.1094/PHYTO-07-14-0202-R; GADHER P, 1983, PESTIC BIOCHEM PHYS, V19, P1, DOI 10.1016/0048-3575(83)90034-2; Gubler WD, 1996, PLANT DIS, V80, P902, DOI 10.1094/PD-80-0902; Gubler WD, 1992, GRAPE PEST MANAGEMEN, P57; Hamamoto H, 2000, APPL ENVIRON MICROB, V66, P3421, DOI 10.1128/AEM.66.8.3421-3426.2000; Hayashi K, 2002, PESTIC BIOCHEM PHYS, V73, P110, DOI 10.1016/S0048-3575(02)00015-9; Hoffman LE, 2003, PLANT DIS, V87, P273, DOI 10.1094/PDIS.2003.87.3.273; Jones L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1081; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Leroux P, 2007, PEST MANAG SCI, V63, P688, DOI 10.1002/ps.1390; Liu X, 2011, FUNGAL GENET BIOL, V48, P113, DOI 10.1016/j.fgb.2010.10.004; Luo CX, 2008, APPL ENVIRON MICROB, V74, P359, DOI 10.1128/AEM.02159-07; Ma ZH, 2006, APPL ENVIRON MICROB, V72, P2581, DOI 10.1128/AEM.72.4.2581-2585.2006; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Marichal P, 1997, ANTIMICROB AGENTS CH, V41, P2229, DOI 10.1128/AAC.41.10.2229; Mellado E, 2001, J CLIN MICROBIOL, V39, P2431, DOI 10.1128/JCM.39.7.2431-2438.2001; Miazzi M, 2011, J PLANT PATHOL, V93, P729; Miller TC, 2004, PLANT DIS, V88, P1205, DOI 10.1094/PDIS.2004.88.11.1205; Mullins JGL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020973; Nikou D, 2009, PESTIC BIOCHEM PHYS, V95, P18, DOI 10.1016/j.pestbp.2009.04.014; Northover J, 2001, CAN J PLANT PATHOL, V23, P337, DOI 10.1080/07060660109506954; Osherov N, 2001, J ANTIMICROB CHEMOTH, V48, P75, DOI 10.1093/jac/48.1.75; Rallos LEE, 2013, THESIS; Rallos LEE, 2014, PLANT DIS, V98, P1494, DOI 10.1094/PDIS-12-13-1202-RE; Reimann S, 2005, APPL ENVIRON MICROB, V71, P3269, DOI 10.1128/AEM.71.6.3269-3275.2005; Rozen S, 2000, Methods Mol Biol, V132, P365; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Savocchia S, 2004, AUSTRALAS PLANT PATH, V33, P465, DOI 10.1071/AP04066; Schnabel G, 2003, PEST MANAG SCI, V59, P1143, DOI 10.1002/ps.744; Schnabel G, 2001, PHYTOPATHOLOGY, V91, P102, DOI 10.1094/PHYTO.2001.91.1.102; Stammler G, 2009, CROP PROT, V28, P891, DOI 10.1016/j.cropro.2009.05.007; Steinkellner S., 2001, Bodenkultur, V52, P213; STEVA H, 1990, Mededelingen van de Faculteit Landbouwwetenschappen Universiteit Gent, V55, P983; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wong FP, 2002, PLANT DIS, V86, P394, DOI 10.1094/PDIS.2002.86.4.394; Wyand RA, 2005, FUNGAL GENET BIOL, V42, P726, DOI 10.1016/j.fgb.2005.04.007; Ypema HL, 1997, PLANT DIS, V81, P293, DOI 10.1094/PDIS.1997.81.3.293; Ziogas BN, 2015, FUNGICIDE RESISTANCE; Zwiers LH, 2002, ANTIMICROB AGENTS CH, V46, P3900, DOI 10.1128/AAC.46.12.3900-3906.2002	69	23	25	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148025	10.1371/journal.pone.0148025	http://dx.doi.org/10.1371/journal.pone.0148025			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839970	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200078
J	Scharf, AK; LaPoint, S; Wikelski, M; Safi, K				Scharf, Anne K.; LaPoint, Scott; Wikelski, Martin; Safi, Kamran			Acceleration Data Reveal Highly Individually Structured Energetic Landscapes in Free-Ranging Fishers (Pekania pennanti)	PLOS ONE			English	Article							HABITAT FRAGMENTATION; BODY ACCELERATION; MOVEMENT; SHAPE	Investigating animal energy expenditure across space and time may provide more detailed insight into how animals interact with their environment. This insight should improve our understanding of how changes in the environment affect animal energy budgets and is particularly relevant for animals living near or within human altered environments where habitat change can occur rapidly. We modeled fisher (Pekania pennanti) energy expenditure within their home ranges and investigated the potential environmental and spatial drivers of the predicted spatial patterns. As a proxy for energy expenditure we used overall dynamic body acceleration (ODBA) that we quantified from tri-axial accelerometer data during the active phases of 12 individuals. We used a generalized additive model (GAM) to investigate the spatial distribution of ODBA by associating the acceleration data to the animals' GPS-recorded locations. We related the spatial patterns of ODBA to the utilization distributions and habitat suitability estimates across individuals. The ODBA of fishers appears highly structured in space and was related to individual utilization distribution and habitat suitability estimates. However, we were not able to predict ODBA using the environmental data we selected. Our results suggest an unexpected complexity in the space use of animals that was only captured partially by re-location data-based concepts of home range and habitat suitability. We suggest future studies recognize the limits of ODBA that arise from the fact that acceleration is often collected at much finer spatio-temporal scales than the environmental data and that ODBA lacks a behavioral correspondence. Overcoming these limits would improve the interpretation of energy expenditure in relation to the environment.	[Scharf, Anne K.; LaPoint, Scott; Wikelski, Martin; Safi, Kamran] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Scharf, Anne K.; LaPoint, Scott; Wikelski, Martin; Safi, Kamran] Univ Konstanz, Dept Biol, Constance, Germany	Max Planck Society; University of Konstanz	Scharf, AK (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.; Scharf, AK (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	annekscharf@gmail.com	Safi, Kamran/B-2079-2008; Scharf, Anne K./P-6348-2019	Safi, Kamran/0000-0002-8418-6759; Scharf, Anne K./0000-0002-3357-8533	NSF [0756920]; New York State Museum; Max-Planck-Institute for Ornithology; International Max Planck Research School for Organismal Biology; North Carolina Museum of Natural Sciences; National Geographic Society Waitt Grant Program [W157-11]; Max-Planck-Poland Biodiversity Fund	NSF(National Science Foundation (NSF)); New York State Museum; Max-Planck-Institute for Ornithology; International Max Planck Research School for Organismal Biology; North Carolina Museum of Natural Sciences; National Geographic Society Waitt Grant Program(National Geographic Society); Max-Planck-Poland Biodiversity Fund	This work was supported in part by NSF (Grant 0756920 to Roland Kays), the New York State Museum, the Max-Planck-Institute for Ornithology, the International Max Planck Research School for Organismal Biology (AKS), the North Carolina Museum of Natural Sciences, and the National Geographic Society Waitt Grant Program (Grant W157-11 to SL). SL was supported by the Max-Planck-Poland Biodiversity Fund.	Amelineau F, 2014, J EXP BIOL, V217, P876, DOI 10.1242/jeb.097915; [Anonymous], 2014, MCLOGIT MIXED CONDIT; Barton K, 2014, MUMIN MULTIMODEL INF; Brown DD, 2012, WILDLIFE SOC B, V36, P139, DOI 10.1002/wsb.111; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Genz A., 2014, MVTNORM MULTIVARIATE; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Jin SM, 2013, REMOTE SENS ENVIRON, V132, P159, DOI 10.1016/j.rse.2013.01.012; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; LaPoint SD, 2013, LANDSCAPE ECOL, V28, P1645; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; McElroy B, 2012, ECOLOGY, V93, P29, DOI 10.1890/11-1082.1; Mosser AA, 2014, J ANIM ECOL, V83, P916, DOI 10.1111/1365-2656.12187; New York State Office of Cyber Security, 2006, NEW YORK STAT STREET; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Okuyama J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0040; Poessel SA, 2014, BIOL CONSERV, V180, P224, DOI 10.1016/j.biocon.2014.10.010; Powell R.A., 1993, FISHER LIFE HIST ECO, V2nd ed.; R Core Team, 2021, R LANGUAGE ENV STAT; Rees WG, 2004, COMPUT GEOSCI-UK, V30, P203, DOI 10.1016/j.cageo.2003.11.001; Riley SPD, 2003, CONSERV BIOL, V17, P566, DOI 10.1046/j.1523-1739.2003.01458.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Shepard ELC, 2013, AM NAT, V182, P298, DOI 10.1086/671257; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Smolla M, 2014, MOVE VISUALIZING ANA; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; United States Census Bureau, 2008, AM FACT FIND; United States Census Bureau, 2011, TIGER LIN SHAP TIGER; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049; Wang Y, 2014, THESIS UC SANTA CRUZ; Weir RD, 2003, J WILDLIFE MANAGE, V67, P73, DOI 10.2307/3803063; White G.C., 1990, ANAL WILDLIFE RADIO; Williams TM, 2014, SCIENCE, V346, P81, DOI 10.1126/science.1254885; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2012, P ROY SOC B-BIOL SCI, V279, P975, DOI 10.1098/rspb.2011.1544; WOODS SN, 2006, GEN ADDITIVE MODELS	44	12	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0145732	10.1371/journal.pone.0145732	http://dx.doi.org/10.1371/journal.pone.0145732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840399	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200003
J	Toby, GG; Liu, TY; Yang, BY; Zhang, X; Bitonti, AJ; Pierce, GF; Sommer, JM; Jiang, HY; Peters, RT				Toby, Garabet G.; Liu, Tongyao; Yang Buyue; Zhang, Xin; Bitonti, Alan J.; Pierce, Glenn F.; Sommer, Jurg M.; Jiang, Haiyan; Peters, Robert T.			Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice	PLOS ONE			English	Article							FACTOR-VIII; BLOOD-COAGULATION; DOSING FREQUENCY; PROPHYLAXIS; ADHERENCE; IMMUNOGLOBULINS; CATABOLISM; RECEPTOR; MODERATE; THERAPY	Introduction Hemophilia B is an inherited X chromosome-linked disorder characterized by impaired blood clotting owing to the absence of functional coagulation factor IX. Due to the relatively short half-life of factor IX, patients with hemophilia B require frequent factor IX infusions to maintain prophylaxis. We have developed a recombinant factor IX (rFIX) fused to the Fc region of IgG (rFIXFc) with an extended half-life in animals and humans. Materials and Methods Procoagulant properties of rFIXFc and rFIX (BENEFIX (R)) were compared to determine the effect of the Fc region on rFIXFc hemostatic function. Specifically, we assessed rFIXFc activation, intermolecular interactions within the Xase complex, inactivation by antithrombin III (AT) and thrombin generation potential compared with rFIX. We also assessed the acute and prophylactic efficacy profiles of rFIXFc and rFIX in vivo in hemophilia B mouse bleeding models. Results and Conclusions The activation by factor XIa or factor VIIa/tissue factor, inhibition by AT, interaction profiles with phospholipids, affinities for factor VIIIa within the context of the Xase complex, and thrombin generation profiles were similar for rFIXFc and rFIX. Xase complexes formed with either molecule exhibited similar kinetic profiles for factor Xa generation. In acute efficacy models, mice infused with rFIXFc or rFIX were equally protected from bleeding. However, in prophylactic efficacy models, protection from bleeding was maintained approximately three times longer in rFIXFc-dosed mice than in those given rFIX; this prolonged efficacy correlates with the previously observed half-life extension. We conclude that rFIXFc retains critical FIX procoagulant attributes and that the extension in rFIXFc half-life translates into prolonged efficacy in hemophilia B mice.	[Toby, Garabet G.; Liu, Tongyao; Yang Buyue; Zhang, Xin; Bitonti, Alan J.; Pierce, Glenn F.; Sommer, Jurg M.; Jiang, Haiyan; Peters, Robert T.] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA	Biogen	Peters, RT (corresponding author), Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	robert.peters@biogen.com			Biogen	Biogen(Biogen)	This study was funded by Biogen. Garabet G. Toby, Tongyao Liu, Yang Buyue, Xin Zhang, Alan J. Bitonti, Glenn F. Pierce, Jurg M. Sommer, Haiyan Jiang, and Robert T. Peters were employees of and held equity interest in Biogen at the time of this research. This work is directly related to the marketed product, ALPROLIX (R) (rFIXFc), and several of the authors are named as inventors on a number of patents and pending applications covering rFIXFc, filed in the US and throughout the world (for example, US Patent Nos. 7,404,956; 7,348,004; 7,862,820; 8,329,182; and 8,932,830: "Immunoglobulin chimeric monomer-dimer hybrids"; and USSN 13/793,796: "Factor IX polypeptides and methods of use thereof"). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Biss TT, 2008, HAEMOPHILIA, V14, P923, DOI 10.1111/j.1365-2516.2008.01810.x; Bond M, 1998, SEMIN HEMATOL, V35, P11; BRAMBELL FW, 1964, NATURE, V203, P1352, DOI 10.1038/2031352a0; BRAMBELL FW, 1966, LANCET, V2, P1087, DOI 10.1016/S0140-6736(66)92190-8; Chang JY, 1997, J CLIN INVEST, V100, P886, DOI 10.1172/JCI119604; De Moerloose P, 2008, HAEMOPHILIA, V14, P931, DOI 10.1111/j.1365-2516.2008.01843.x; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; Dumont JA, 2015, THROMB RES, V136, P371, DOI 10.1016/j.thromres.2015.01.020; Ewenstein BM, 2002, TRANSFUSION, V42, P190, DOI 10.1046/j.1537-2995.2002.00039.x; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; Giangrande P, 2005, EXPERT OPIN PHARMACO, V6, P1517, DOI 10.1517/14656566.6.9.1517; GRAY E, 1995, THROMB HAEMOSTASIS, V73, P675; Hacker MR, 2001, HAEMOPHILIA, V7, P392, DOI 10.1046/j.1365-2516.2001.00534.x; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Krishnan S, 2015, HAEMOPHILIA, V21, P64, DOI 10.1111/hae.12533; Larson PJ, 1996, J BIOL CHEM, V271, P3869; Ljung RCR, 1999, THROMB HAEMOSTASIS, V82, P525; LOZIER JN, 1990, BLOOD, V75, P1097; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; McCue J, 2014, HAEMOPHILIA, V20, pe327, DOI 10.1111/hae.12451; Mei BS, 2010, BLOOD, V116, P270, DOI 10.1182/blood-2009-11-254755; Pan JL, 2009, BLOOD, V114, P2802, DOI 10.1182/blood-2009-03-212423; Peters RT, 2013, J THROMB HAEMOST, V11, P132, DOI 10.1111/jth.12076; Peters RT, 2010, BLOOD, V115, P2057, DOI 10.1182/blood-2009-08-239665; PIETERS J, 1988, J BIOL CHEM, V263, P15313; Powell J, 2015, BRIT J HAEMATOL, V168, P113, DOI 10.1111/bjh.13109; Powell JS, 2013, NEW ENGL J MED, V369, P2313, DOI 10.1056/NEJMoa1305074; Recker RR, 2005, MAYO CLIN PROC, V80, P856, DOI 10.4065/80.7.856; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Saini SD, 2009, AM J MANAG CARE, V15, pE22; SIMISTER NE, 1985, EUR J IMMUNOL, V15, P733, DOI 10.1002/eji.1830150718; Theusinger OM, 2010, EUR J CARDIO-THORAC, V37, P677, DOI 10.1016/j.ejcts.2009.07.038; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; White GC, 1997, THROMB HAEMOSTASIS, V78, P261; World Federation of Hemophilia, 2012, GUIDELINES FOR THE M	36	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148255	10.1371/journal.pone.0148255	http://dx.doi.org/10.1371/journal.pone.0148255			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840952	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200113
J	Wang, PZ; Zhang, FJ; He, QL; Wang, JQ; Shiu, HT; Shu, YL; Tsang, WP; Liang, S; Zhao, K; Wan, C				Wang, Pengzhen; Zhang, Fengjie; He, Qiling; Wang, Jianqi; Shiu, Hoi Ting; Shu, Yinglan; Tsang, Wing Pui; Liang, Shuang; Zhao, Kai; Wan, Chao			Flavonoid Compound Icariin Activates Hypoxia Inducible Factor-1 alpha in Chondrocytes and Promotes Articular Cartilage Repair	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX SYNTHESIS; BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; LIMB BUD MESENCHYME; OXYGEN-TENSION; GROWTH-PLATE; IN-VITRO; ENDOCHONDRAL OSSIFICATION; INFLAMMATORY RESPONSES; FRACTURE REPAIR	Articular cartilage has poor capability for repair following trauma or degenerative pathology due to avascular property, low cell density and migratory ability. Discovery of novel therapeutic approaches for articular cartilage repair remains a significant clinical need. Hypoxia is a hallmark for cartilage development and pathology. Hypoxia inducible factor-1alpha (HIF-1 alpha) has been identified as a key mediator for chondrocytes to response to fluctuations of oxygen availability during cartilage development or repair. This suggests that HIF-1 alpha may serve as a target for modulating chondrocyte functions. In this study, using phenotypic cellular screen assays, we identify that Icariin, an active flavonoid component from Herba Epimedii, activates HIF-1 alpha expression in chondrocytes. We performed systemic in vitro and in vivo analysis to determine the roles of Icariin in regulation of chondrogenesis. Our results show that Icariin significantly increases hypoxia responsive element luciferase reporter activity, which is accompanied by increased accumulation and nuclear translocation of HIF-1 alpha in murine chondrocytes. The phenotype is associated with inhibiting PHD activity through interaction between Icariin and iron ions. The upregulation of HIF-1 alpha mRNA levels in chondrocytes persists during chondrogenic differentiation for 7 and 14 days. Icariin (10(-6) M) increases the proliferation of chondrocytes or chondroprogenitors examined by MTT, BrdU incorporation or colony formation assays. Icariin enhances chondrogenic marker expression in a micromass culture including Sox9, collagen type 2 (Col2 alpha 1) and aggrecan as determined by real-time PCR and promotes extracellular matrix (ECM) synthesis indicated by Alcian blue staining. ELISA assays show dramatically increased production of aggrecan and hydroxyproline in Icariin-treated cultures at day 14 of chondrogenic differentiation as compared with the controls. Meanwhile, the expression of chondrocyte catabolic marker genes including Mmp2, Mmp9, Mmp13, Adamts4 and Adamts5 was downregulated following Icariin treatment for 14 days. In a differentiation assay using bone marrow mesenchymal stem cells (MSCs) carrying HIF-1 alpha floxed allele, the promotive effect of Icariin on chondrogenic differentiation is largely decreased following Cre recombinase-mediated deletion of HIF-1 alpha in MSCs as indicated by Alcian blue staining for proteoglycan synthesis. In an alginate hydrogel 3D culture system, Icariin increases Safranin O positive (SO+) cartilage area. This phenotype is accompanied by upregulation of HIF-1 alpha, increased proliferating cell nuclear antigen positive (PCNA+) cell numbers, SOX9+ chondrogenic cell numbers, and Col2 expression in the newly formed cartilage. Coincide with the micromass culture, Icariin treatment upregulates mRNA levels of Sox9, Col2 alpha 1, aggrecan and Col10 alpha 1 in the 3D cultures. We then generated alginate hydrogel 3D complexes incorporated with Icariin. The 3D complexes were transplanted in a mouse osteochondral defect model. ICRS II histological scoring at 6 and 12 weeks post-transplantation shows that 3D complexes incorporated with Icariin significantly enhance articular cartilage repair with higher scores particularly in selected parameters including SO+ cartilage area, subchondral bone and overall assessment than that of the controls. The results suggest that Icariin may inhibit PHD activity likely through competition for cellular iron ions and therefore it may serve as an HIF-1 alpha activator to promote articular cartilage repair through regulating chondrocyte proliferation, differentiation and integration with subchondral bone formation.	[Wang, Pengzhen; Wan, Chao] Chinese Univ Hong Kong, Jinan Univ, Key Lab Regenerat Med, Minist Educ, Guangzhou 510000, Guangdong, Peoples R China; [Wang, Pengzhen; Zhang, Fengjie; Shu, Yinglan; Tsang, Wing Pui; Liang, Shuang; Zhao, Kai; Wan, Chao] Chinese Univ Hong Kong, Shenzhen Res Inst, Inst Stem Cell Genom & Translat Res, Sch Biomed Sci,Core Lab, Shenzhen 518057, Peoples R China; [Zhang, Fengjie; Shiu, Hoi Ting; Shu, Yinglan; Tsang, Wing Pui; Liang, Shuang; Zhao, Kai; Wan, Chao] Chinese Univ Hong Kong, Jinan Univ, Sch Biomed Sci, Minist Educ,Key Lab Regenerat Med,Fac Med, Shatin, Hong Kong, Peoples R China; [He, Qiling] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Wang, Jianqi] Chinese Univ Hong Kong, Fac Sci, Dept Chem, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Jinan University; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; University of Alabama System; University of Alabama Birmingham; Chinese University of Hong Kong	Wan, C (corresponding author), Chinese Univ Hong Kong, Jinan Univ, Key Lab Regenerat Med, Minist Educ, Guangzhou 510000, Guangdong, Peoples R China.	cwan@cuhk.edu.hk	Wan, Chao/J-9277-2013	Wan, Chao/0000-0001-6780-2006	Hong Kong RGC GRF [475910]; National Natural Science Foundation of China (NSFC) [81130034]; Guangdong Science and Technology Department [20130501C]; Shenzhen Synergistic Innovation Program [GJHS20120702105445379]	Hong Kong RGC GRF(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department; Shenzhen Synergistic Innovation Program	The work was partially supported by Hong Kong RGC GRF (475910), National Natural Science Foundation of China (NSFC) (81130034), Guangdong Science and Technology Department (20130501C), and Shenzhen Synergistic Innovation Program GJHS20120702105445379 to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Araldi E, 2011, NAT MED, V17, P25, DOI 10.1038/nm0111-25; BRIGHTON CT, 1971, J BONE JOINT SURG AM, VA 53, P719, DOI 10.2106/00004623-197153040-00011; Cao H, 2012, INT J MOL MED, V29, P435, DOI 10.3892/ijmm.2011.845; Chen KM, 2007, PHARMAZIE, V62, P388, DOI 10.1691/ph.2007.5.6682; Danisovic L, 2012, TISSUE CELL, V44, P69, DOI 10.1016/j.tice.2011.11.005; Eltawil NM, 2009, OSTEOARTHR CARTILAGE, V17, P695, DOI 10.1016/j.joca.2008.11.003; Fan HB, 2010, J BIOMED MATER RES A, V95A, P982, DOI 10.1002/jbm.a.32899; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Gelse K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2508; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Hsieh TP, 2011, PHYTOMEDICINE, V18, P176, DOI 10.1016/j.phymed.2010.04.003; Hsieh TP, 2010, PHYTOMEDICINE, V17, P414, DOI 10.1016/j.phymed.2009.08.007; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Komatsu DE, 2004, BONE, V34, P680, DOI 10.1016/j.bone.2003.12.024; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Leopoldini M, 2006, J AGR FOOD CHEM, V54, P6343, DOI 10.1021/jf060986h; Li B, 2014, INT IMMUNOPHARMACOL, V19, P381, DOI 10.1016/j.intimp.2014.01.009; Li D, 2012, OSTEOARTHR CARTILAGE, V20, P1647, DOI 10.1016/j.joca.2012.08.009; Li TF, 2006, J BIOL CHEM, V281, P21296, DOI 10.1074/jbc.M600514200; Li ZJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/391512; Liu MH, 2010, NUTR RES, V30, P57, DOI 10.1016/j.nutres.2009.10.020; Lopiz-Morales Y, 2010, EUR CELLS MATER, V20, P367; LUNDOLESEN K, 1970, ARTHRITIS RHEUM-US, V13, P769, DOI 10.1002/art.1780130606; Mainil-Varlet P, 2010, AM J SPORT MED, V38, P880, DOI 10.1177/0363546509359068; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Oldershaw RA, 2012, INT J EXP PATHOL, V93, P389, DOI 10.1111/j.1365-2613.2012.00837.x; Park SS, 2008, J CELL BIOCHEM, V103, P1989, DOI 10.1002/jcb.21588; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Pfander D, 2004, DEVELOPMENT, V131, P2497, DOI 10.1242/dev.01138; Provot S, 2007, ANN NY ACAD SCI, V1117, P26, DOI 10.1196/annals.1402.076; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Schindler OS, 2011, ACTA ORTHOP BELG, V77, P709; Schipani E, 2001, GENE DEV, V15, P2865; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2000, GENE DEV, V14, P1983; Shen X, 2009, J ORTHOP RES, V27, P1298, DOI 10.1002/jor.20886; Solchaga LA, 2010, TISSUE ENG PT A, V16, P1009, DOI [10.1089/ten.tea.2009.0100, 10.1089/ten.TEA.2009.0100]; Song YH, 2011, J PHARM PHARMACOL, V63, P541, DOI 10.1111/j.2042-7158.2010.01241.x; Stewart AJ, 2006, J CELL PHYSIOL, V206, P435, DOI 10.1002/jcp.20481; Thoms BL, 2013, ARTHRITIS RHEUM-US, V65, P1302, DOI 10.1002/art.37867; Tiwary R, 2014, CARTILAGE, V5, P43, DOI 10.1177/1947603513499366; TREUHAFT PS, 1971, ARTHRITIS RHEUM, V14, P475, DOI 10.1002/art.1780140407; Tuan RS, 2013, J AM ACAD ORTHOP SUR, V21, P303, DOI 10.5435/JAAOS-21-05-303; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102010; Wang L, 2009, EUR J PHARMACOL, V609, P40, DOI 10.1016/j.ejphar.2009.03.033; Wang ZC, 2014, EXP THER MED, V8, P1528, DOI 10.3892/etm.2014.1950; Xu CQ, 2010, EUR J PHARMACOL, V642, P146, DOI 10.1016/j.ejphar.2010.05.012; Yang HS, 2011, TISSUE ENG PT A, V17, P1809, DOI 10.1089/ten.tea.2010.0540; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Zhang L, 2012, PHYTOTHER RES, V26, P1385, DOI 10.1002/ptr.3733; Zhao J, 2008, BIOCHEM BIOPH RES CO, V369, P444, DOI 10.1016/j.bbrc.2008.02.054; Zhao JY, 2010, TISSUE ENG PT A, V16, P233, DOI [10.1089/ten.tea.2009.0165, 10.1089/ten.TEA.2009.0165]	57	57	64	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148372	10.1371/journal.pone.0148372	http://dx.doi.org/10.1371/journal.pone.0148372			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841115	Green Submitted, gold, Green Published			2022-12-26	WOS:000369550200129
J	Minelli, C; Dean, CH; Hind, M; Alves, AC; Amaral, AFS; Siroux, V; Huikari, V; Artigas, MS; Evans, DM; Loth, DW; Bosse, Y; Postma, DS; Sin, D; Thompson, J; Demenais, F; Henderson, J; Bouzigon, E; Jarvis, D; Jarvelin, MR; Burney, P				Minelli, Cosetta; Dean, Charlotte H.; Hind, Matthew; Alves, Alexessander Couto; Amaral, Andre F. S.; Siroux, Valerie; Huikari, Ville; Artigas, Maria Soler; Evans, David M.; Loth, Daan W.; Bosse, Yohan; Postma, Dirkje S.; Sin, Don; Thompson, John; Demenais, Florence; Henderson, John; Bouzigon, Emmanuelle; Jarvis, Deborah; Jarvelin, Marjo-Riitta; Burney, Peter		SpiroMeta Consortium; CHARGE Consortium	Association of Forced Vital Capacity with the Developmental Gene NCOR2	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-FUNCTION; HERITABILITY; REGENERATION; MECHANISMS; EXPRESSION; SERPINE2	Background Forced Vital Capacity (FVC) is an important predictor of all-cause mortality in the absence of chronic respiratory conditions. Epidemiological evidence highlights the role of early life factors on adult FVC, pointing to environmental exposures and genes affecting lung development as risk factors for low FVC later in life. Although highly heritable, a small number of genes have been found associated with FVC, and we aimed at identifying further genetic variants by focusing on lung development genes. Methods Per-allele effects of 24,728 SNPs in 403 genes involved in lung development were tested in 7,749 adults from three studies (NFBC1966, ECRHS, EGEA). The most significant SNP for the top 25 genes was followed-up in 46,103 adults (CHARGE and SpiroMeta consortia) and 5,062 children (ALSPAC). Associations were considered replicated if the replication p-value survived Bonferroni correction (p < 0.002; 0.05/25), with a nominal p-value considered as suggestive evidence. For SNPs with evidence of replication, effects on the expression levels of nearby genes in lung tissue were tested in 1,111 lung samples (Lung eQTL consortium), with further functional investigation performed using public epigenomic profiling data (ENCODE). Results NCOR2-rs12708369 showed strong replication in children (p = 0.0002), with replication unavailable in adults due to low imputation quality. This intronic variant is in a strong transcriptional enhancer element in lung fibroblasts, but its eQTL effects could not be tested due to low imputation quality in the eQTL dataset. SERPINE2-rs6754561 replicated at nominal level in both adults (p = 0.036) and children (p = 0.045), while WNT16-rs2707469 replicated at nominal level only in adults (p = 0.026). The eQTL analyses showed association of WNT16-rs2707469 with expression levels of the nearby gene CPED1. We found no statistically significant eQTL effects for SERPINE2-rs6754561. Conclusions We have identified a new gene, NCOR2, in the retinoic acid signalling pathway pointing to a role of vitamin A metabolism in the regulation of FVC. Our findings also support SERPINE2, a COPD gene with weak previous evidence of association with FVC, and suggest WNT16 as a further promising candidate.	[Minelli, Cosetta; Amaral, Andre F. S.; Jarvis, Deborah; Burney, Peter] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol Occupat Med & Publ Hlth, London, England; [Dean, Charlotte H.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Leukocyte Biol, London, England; [Dean, Charlotte H.] MRC Harwell, Mammalian Genet Unit, Didcot, Oxon, England; [Hind, Matthew] Royal Brompton & Harefield NHS Fdn Trust, Resp Dept, London, England; [Alves, Alexessander Couto; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Amaral, Andre F. S.; Jarvis, Deborah; Jarvelin, Marjo-Riitta; Burney, Peter] MRC PHE Ctr Environm & Hlth, London, England; [Siroux, Valerie] Univ Grenoble Alpes, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, F-38000 Grenoble, France; [Siroux, Valerie] INSERM, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, F-38000 Grenoble, France; [Siroux, Valerie] CHU Grenoble, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, F-38000 Grenoble, France; [Huikari, Ville; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Artigas, Maria Soler] Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Leicester, Leics, England; [Evans, David M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Evans, David M.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Loth, Daan W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Bosse, Yohan] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Dept Mol Med, Quebec City, PQ, Canada; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands; [Sin, Don] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada; [Thompson, John] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Demenais, Florence; Bouzigon, Emmanuelle] INSERM, Genet Variat Human Dis Unit, UMRS 946, Paris, France; [Henderson, John] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [SpiroMeta Consortium] Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, SpiroMeta Consortium, Leicester, Leics, England; [CHARGE Consortium] CHARGE Consortium, Inst Hlth, Dept Hlth & Human Serv, Res Triangle Pk, NC USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Fac Med, Ctr Life Course Epidemiol, FI-90014 Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, FI-90220 Oulu, Finland	Imperial College London; Imperial College London; MRC Harwell; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Oulu; University of Leicester; University of Queensland; University of Bristol; Erasmus University Rotterdam; Erasmus MC; Laval University; University of Groningen; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of Leicester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Bristol; University of Leicester; University of Oulu; University of Oulu	Minelli, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol Occupat Med & Publ Hlth, London, England.	cosetta.minelli1@imperial.ac.uk	Amaral, Andre F. S./M-4202-2019; Lederer, David/W-7957-2018; Amaral, Andre FS/A-7662-2008; siroux, valerie/N-1865-2013; Artigas, María Soler/L-6529-2013; Schulz, Holger/J-5643-2015; Viñuela, Ana/L-5015-2019; Hind, Matthew/AAC-4384-2021; Polasek, Ozren/B-6002-2011; Sin, Don/AAC-2219-2021; Evans, David M/H-6325-2013; London, Stephanie/C-3734-2019; Demenais, Florence/G-3298-2013; Bouzigon, Emmanuelle/L-2766-2017; Lee, Mikyeong/C-3046-2017; Aspelund, Thor/C-5983-2008; Heinrich, Joachim/N-1720-2013; Rantanen, Taina/O-6579-2016; Smith, Albert Vernon/K-5150-2015; Scott, Rodney/B-2827-2013; Kolcic, Ivana/E-2713-2017; Smith, Blair/G-2834-2012	Amaral, Andre F. S./0000-0002-0369-9449; Lederer, David/0000-0001-5258-0228; Amaral, Andre FS/0000-0002-0369-9449; siroux, valerie/0000-0001-7329-7237; Artigas, María Soler/0000-0002-3213-1107; Schulz, Holger/0000-0002-1157-200X; Viñuela, Ana/0000-0003-3771-8537; Polasek, Ozren/0000-0002-5765-1862; Evans, David M/0000-0003-0663-4621; London, Stephanie/0000-0003-4911-5290; Demenais, Florence/0000-0001-8361-0936; Bouzigon, Emmanuelle/0000-0001-5756-4286; GHARIB, SINA A./0000-0002-2480-4367; Rich, Stephen/0000-0003-3872-7793; Kahonen, Mika/0000-0002-4510-7341; Hui, Jennie/0000-0002-1653-2496; Bracke, Ken/0000-0001-5906-4605; Hall, Ian/0000-0001-9933-3216; Morrison, Alanna/0000-0001-6381-4296; Pottinger, Tess/0000-0003-0647-5712; Smith, Lewis J/0000-0002-4728-1562; Tobin, Martin/0000-0002-3596-7874; Lee, Mikyeong/0000-0002-3036-3684; Gieger, Christian/0000-0001-6986-9554; Aspelund, Thor/0000-0002-7998-5433; Heinrich, Joachim/0000-0002-9620-1629; Wain, Louise/0000-0003-4951-1867; Couto Alves, Alex/0000-0001-8519-7356; Burney, Peter/0000-0001-8635-5678; Rantanen, Taina/0000-0002-1604-1945; Smith, Albert Vernon/0000-0003-1942-5845; Zemunik, Tatijana/0000-0001-8120-2891; Sayers, Ian/0000-0001-5601-5410; Scott, Rodney/0000-0001-7724-3404; Kolcic, Ivana/0000-0001-7918-6052; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Loth, Daan/0000-0003-1260-9326; Hysi, Pirro/0000-0001-5752-2510; Cassano, Patricia A./0000-0003-4827-5073; Loehr, Laura/0000-0002-9054-1825; de Jong, Kim/0000-0002-3948-1046; Jarvis, Deborah/0000-0002-1753-3896; Pietilainen, Kirsi/0000-0002-8522-1288; Smith, Blair/0000-0002-5362-9430; Kumar, Rajesh/0000-0002-1962-7108; Hind, Matthew/0000-0002-9966-9446; Oldmeadow, Christopher/0000-0001-6104-1322	Academy of Finland [104781, 120315, 129269, 1114194, 24300796]; University Hospital Oulu; Biocenter, University of Oulu, Finland [75617]; NHLBI through the STAMPEED program [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706: 02]; ENGAGE project; EU FP7 EurHEALTHAgeing [277849]; Medical Research Council, UK [G0500539, G0600705, G1002319]; MRC, Centenary Early Career Award; Dyna-HEALTH action [H2020-633595]; academy of Finland EGEA-project;  [HEALTH-F4-2007-201413]; MRC [G0600705, MR/M022501/1, G1002319, MC_UU_12013/4, G0901214, G1000861, MC_UU_12015/1] Funding Source: UKRI; Medical Research Council [MC_PC_13048, G1002319, G1000861, MC_PC_15018, G9815508, MC_U106179471, G0901214, MR/M022501/1, MC_UU_12015/1, MC_UU_12013/4, G0600705] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756, R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062633, R01MH063706, RL1MH083268] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); University Hospital Oulu; Biocenter, University of Oulu, Finland; NHLBI through the STAMPEED program; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE project(General Electric); EU FP7 EurHEALTHAgeing; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC, Centenary Early Career Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dyna-HEALTH action; academy of Finland EGEA-project(Academy of Finland); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	NFBC1966 received financial support from the Academy of Finland (project grants 104781, 120315, 129269, 1114194, 24300796, Center of Excellence in Complex Disease Genetics and SALVE), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), NIH/NIMH (5R01MH63706: 02), ENGAGE project and grant agreement HEALTH-F4-2007-201413, EU FP7 EurHEALTHAgeing -277849, the Medical Research Council, UK (G0500539, G0600705, G1002319, PrevMetSyn/SALVE) and the MRC, Centenary Early Career Award. The program is currently being funded by the H2020-633595 Dyna-HEALTH action and academy of Finland EGEA-project.	Bartley M, 2012, AM J EPIDEMIOL, V175, P33, DOI 10.1093/aje/kwr284; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; Collins SA, 2013, EUR RESPIR J, V41, P756, DOI 10.1183/09031936.00171712; Corradin O, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0085-3; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; DeMeo DL, 2006, AM J HUM GENET, V78, P253, DOI 10.1086/499828; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Hallberg J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-92; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Hegewald MJ, 2007, CHEST, V132, P1608, DOI 10.1378/chest.07-1405; Himes BE, 2011, CHEST, V140, P667, DOI 10.1378/chest.10-2973; Hind M, 2009, THORAX, V64, P451, DOI 10.1136/thx.2008.105437; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kauffmann F, 1999, CLIN EXP ALLERGY, V29, P17; Kerkhof M, 2014, J ALLERGY CLIN IMMUN, V133, P68, DOI 10.1016/j.jaci.2013.06.004; Kho AT, 2009, AM J RESP CELL MOL, V40, P47, DOI 10.1165/rcmb.2008-0048OC; Klimentidis Yann C., 2013, Frontiers in Genetics, V4, P174, DOI 10.3389/fgene.2013.00174; Krauss-Etschmann S, 2013, THORAX, V68, P380, DOI 10.1136/thoraxjnl-2012-201902; Kreiner-Moller E, 2014, J ALLERGY CLIN IMMUN, V134, P1036, DOI 10.1016/j.jaci.2014.04.003; Kulkarni N, 2006, NEW ENGL J MED, V355, P21, DOI 10.1056/NEJMoa052972; Loth DW, 2014, NAT GENET, V46, P669, DOI 10.1038/ng.3011; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Massaro D, 2010, NEW ENGL J MED, V362, P1829, DOI 10.1056/NEJMe1002366; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Palmer LJ, 2001, EUR RESPIR J, V17, P696, DOI 10.1183/09031936.01.17406960; Rai MF, 2013, G3-GENES GENOM GENET, V3, P1881, DOI 10.1534/g3.113.007302; Rantakallio P, 1988, Paediatr Perinat Epidemiol, V2, P59, DOI 10.1111/j.1365-3016.1988.tb00180.x; Shi W, 2007, CHEST, V132, P651, DOI 10.1378/chest.06-2663; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Thomas DC, 2009, STAT SCI, V24, P414, DOI 10.1214/09-STS288; Twisk JWR, 1998, EUR RESPIR J, V12, P627, DOI 10.1183/09031936.98.12030627; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yates LL, 2011, ORGANOGENESIS, V7, P209, DOI 10.4161/org.7.3.18462; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0147388	10.1371/journal.pone.0147388	http://dx.doi.org/10.1371/journal.pone.0147388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26836265	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548500002
J	Ahmed, S; Hoque, ME; Sarker, AR; Sultana, M; Islam, Z; Gazi, R; Khan, JAM				Ahmed, Sayem; Hoque, Mohammad Enamul; Sarker, Abdur Razzaque; Sultana, Marufa; Islam, Ziaul; Gazi, Rukhsana; Khan, Jahangir A. M.			Willingness-to-Pay for Community-Based Health Insurance among Informal Workers in Urban Bangladesh	PLOS ONE			English	Article							CONTINGENT VALUATION; SECTOR WORKERS; COUNTRIES; PAYMENTS; INDIA; CARE; PARTICIPATION; DEMAND; STATE; POOR	Introduction Reliance on out-of-pocket payment for healthcare may lead poor households to undertake catastrophic health expenditure, and risk-pooling mechanisms have been recommended to mitigate such burdens for households in Bangladesh. About 88% of the population of Bangladesh depends on work in the informal sector. We aimed to estimate willingness-to-pay (WTP) for CBHI and identify its determinants among three categories of urban informal workers rickshaw-pullers, shopkeepers and restaurant workers. Methods The bidding game version of contingent valuation method was used to estimate weekly WTP. In three urban locations 557 workers were interviewed using a structured questionnaire during 2010 and 2011. Multiple-regression analysis was used to predict WTP by demographic and household characteristics, occupation, education level and past illness. Results WTP for a CBHI scheme was expressed by 86.7% of informal workers. Weekly average WTP was 22.8 BDT [Bangladeshi Taka; 95% confidence interval (CI) 20.9-24.8] or 0.32 USD and varied significantly across occupational groups (p = 0.000) and locations (p = 0.003). WTP was highest among rickshaw-pullers (28.2 BDT or 0.40 USD; 95% CI: 24.7-31.7), followed by restaurant workers (20.4 BDT 0.29 USD; 95% CI: 17.0-23.8) and shopkeepers (19.2 BDT or 0.27 USD; 95% CI: 16.1-22.4). Multiple regression analysis identified monthly income, occupation, geographical location and educational level as the key determinants of WTP. WTP increased 0.196% with each 1% increase in monthly income, and was 26.9% lower among workers with up to a primary level of education versus those with higher than primary, but less than one year of education. Conclusion Informal workers in urban areas thus are willing to pay for CBHI and socioeconomic differences explain the magnitude of WTP. The policy maker might think introducing community-based model including public-community partnership model for healthcare financing of informal workers. Decision making regarding the implementation of such schemes should consider worker location and occupation.	[Ahmed, Sayem; Sarker, Abdur Razzaque; Sultana, Marufa; Islam, Ziaul; Gazi, Rukhsana; Khan, Jahangir A. M.] Int Ctr Diarrhoeal Dis Res, Hlth Econ & Financing Res Grp, Ctr Equ & Hlth Syst, GPO Box 128, Dhaka 1000, Bangladesh; [Ahmed, Sayem; Khan, Jahangir A. M.] Karolinska Inst, Hlth Econ & Policy Res Grp, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden; [Hoque, Mohammad Enamul] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Khan, Jahangir A. M.] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Khan, Jahangir A. M.] Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh; [Khan, Jahangir A. M.] Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England	International Centre for Diarrhoeal Disease Research (ICDDR); Karolinska Institutet; University of Queensland; Bangladesh Rural Advancement Committee BRAC; BRAC University; International Centre for Diarrhoeal Disease Research (ICDDR); Liverpool School of Tropical Medicine; University of Liverpool	Ahmed, S (corresponding author), Int Ctr Diarrhoeal Dis Res, Hlth Econ & Financing Res Grp, Ctr Equ & Hlth Syst, GPO Box 128, Dhaka 1000, Bangladesh.; Ahmed, S (corresponding author), Karolinska Inst, Hlth Econ & Policy Res Grp, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden.	sayemahmed@icddrb.org	Khan, Jahangir/AAG-4014-2019; Ahmed, Sayem/AAI-6500-2021; Ahmed, Sayem/G-1439-2015	Ahmed, Sayem/0000-0001-9499-1500; Ahmed, Sayem/0000-0001-9499-1500; KHAN, JAHANGIR/0000-0002-6151-764X	International Labor Organization and Microinsurance Innovation Facility	International Labor Organization and Microinsurance Innovation Facility	This work was supported by the International Labor Organization and Microinsurance Innovation Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2013, POLICY RES WORK PAP; Adams R, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0806-3; Akazili J., 2010, EQUITY HLTH CARE FIN; Lara JLA, 2011, INT J HEALTH CARE FI, V11, P83, DOI 10.1007/s10754-011-9089-3; [Anonymous], EXPLAINING INC UNPUB; Asenso-Okyere WK, 1997, HEALTH POLICY, V42, P223, DOI 10.1016/S0168-8510(97)00069-9; Asgary Ali, 2004, Eur J Health Econ, V5, P209, DOI 10.1007/s10198-004-0233-6; Barnighausen T, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-114; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Basaza R, 2008, HEALTH POLICY, V87, P172, DOI 10.1016/j.healthpol.2007.12.008; Bawa SK, 2011, INT J HUMANIT SOC SC, V1, P100; Binnendijk E, 2013, SOC SCI MED, V76, P67, DOI 10.1016/j.socscimed.2012.10.006; Cavaniol C., 2020, UNIVERSAL HLTH COVER; Churchill C., 2006, PROTECTING POOR MICR; Cohen M, 2006, PROTECTING POOR MICR; Cole S, 2013, AM ECON J-APPL ECON, V5, P104, DOI 10.1257/app.5.1.104; Danis M., 2007, Economic and Political Weekly, V42, P3331; Das J, 2011, EC POLIT WKLY, Vxlvi; Donfouet HPP, 2011, INT J HEALTH CARE FI, V11, P209, DOI 10.1007/s10754-011-9097-3; Dong HJ, 2003, HEALTH ECON, V12, P849, DOI 10.1002/hec.771; Dror DM, 2012, INDIAN J MED RES, V135, P56, DOI 10.4103/0971-5916.93425; Dror DM, 2007, HEALTH POLICY, V82, P12, DOI 10.1016/j.healthpol.2006.07.011; Dror DM, 2007, SOC SCI MED, V64, P884, DOI 10.1016/j.socscimed.2006.10.032; Dror DM., 2002, SOCIAL REINSURANCE N; Drummond MF, 2008, METHODS EC EVALUATIO; Dupas P, 2014, AM ECON REV, V104, P291; Ekman B, 2004, HEALTH POLICY PLANN, V19, P249, DOI 10.1093/heapol/czh031; Engel E., 1895, INT STATISTICAL I B, V9, P1; Folland S, 2007, EC HLTH HLTH CARE; Gujarati D., 2008, MCGRAW HILL ED; Gustafsson-Wright E, 2009, SOC SCI MED, V69, P1351, DOI 10.1016/j.socscimed.2009.08.011; HADI AS, 1994, J ROY STAT SOC B MET, V56, P393; Haile M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-591; Hussmanns R, 1998, DEV DESIGN IMPLEMENT; Jain A, 2014, J EPIDEMIOL GLOB HEA, V4, P159, DOI 10.1016/j.jegh.2013.12.004; JPGSPH, 2015, BANGL HLTH WATCH 201; Jutting J, 2004, WORLD DEV; Kartman B, 1996, MED DECIS MAKING, V16, P248, DOI 10.1177/0272989X9601600309; Khan JAM, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-12; Kobelt G, 2002, HLTH EC INTRO EC EVA; Leftley R, 2006, EFFECTIVE MICROINSUR; Logie DE, 2008, LANCET, V372, P256, DOI 10.1016/S0140-6736(08)60962-9; Maligalig DS, 2009, SSRN ELECT J MAN APR, DOI [10.2139/ssrn.1611402, DOI 10.2139/SSRN.1611402]; Mathauer I, 2008, INT J HEALTH PLAN M, V23, P51, DOI 10.1002/hpm.914; Mathiyazhagan K, 1998, INT J HEALTH PLAN M, V13, P47, DOI 10.1002/(SICI)1099-1751(199801/03)13:1&lt;47::AID-HPM495&gt;3.0.CO;2-I; McCord MJ, 2008, VISIONS FUTURE MICRO; MoHFW, 2015, BANGL NAT HLTH ACC 1; Muhit AMA, 2013, 4 YEARS PROGR BANGLA; Musango L, 2009, MUTUALISATION RISQUE; Nguyen H, 2010, SOC SCI MED, V71, P2074, DOI 10.1016/j.socscimed.2010.09.033; Nosratnejad Shirin, 2014, Glob J Health Sci, V6, P154, DOI 10.5539/gjhs.v6n5p154; O'Brien BJ, 1998, MED CARE, V36, P370, DOI 10.1097/00005650-199803000-00013; OBRIEN B, 1994, MED DECIS MAKING, V14, P289, DOI 10.1177/0272989X9401400311; OECD, 1982, OECD LIST SOC IND; Onwujekwe O, 2010, HEALTH POLICY PLANN, V25, P155, DOI 10.1093/heapol/czp046; Panda P, 2015, TROP MED INT HEALTH, V20, P1093, DOI 10.1111/tmi.12524; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; PERTHEL D, 1975, INT STAT REV, V43, P211, DOI 10.2307/1402900; Radermacher R, 2009, WHAT DO WE KNOW ABOU; Rahman MM, 2013, B WORLD HEALTH ORGAN, V91, P449, DOI 10.2471/BLT.12.115428; Roth J, 2007, LANDSCAPE MICROINSUR; Shafie AA, 2013, SOC SCI MED, V96, P272, DOI 10.1016/j.socscimed.2013.02.045; Twahirwa A, 2008, B WORLD HEALTH ORGAN, V86, P823, DOI 10.2471/BLT.08.021108; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; WHO, 2010, WOR HEALT REP, P1; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Ying XH, 2007, HEALTH ECON, V16, P1041, DOI 10.1002/hec.1206	69	47	47	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148211	10.1371/journal.pone.0148211	http://dx.doi.org/10.1371/journal.pone.0148211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828935	Green Accepted, Green Published, gold			2022-12-26	WOS:000369548200084
J	Kinoshita-Kikuta, E; Kinoshita, E; Eguchi, Y; Koike, T				Kinoshita-Kikuta, Emiko; Kinoshita, Eiji; Eguchi, Yoko; Koike, Tohru			Validation of Cis and Trans Modes in Multistep Phosphotransfer Signaling of Bacterial Tripartite Sensor Kinases by Using Phos-Tag SDS-PAGE	PLOS ONE			English	Article							PHOSPHORELAY; PHOSPHORYLATION; ELECTROPHORESIS; PROTEIN	Tripartite sensor kinases (TSKs) have three phosphorylation sites on His, Asp, and His residues, which are conserved in a histidine kinase (HK) domain, a receiver domain, and a histidine-containing phosphotransmitter (HPt) domain, respectively. By means of a three-step phosphorelay, TSKs convey a phosphoryl group from the.-phosphate group of ATP to the first His residue in the HK domain, then to the Asp residue in the receiver domain, and finally to the second His residue in the HPt domain. Although TSKs generally form homodimers, it was unknown whether the mode of phosphorylation in each step was intramolecular (cis) or intermolecular (trans). To examine this mode, we performed in vitro complementation analyses using Ala-substituted mutants of the ATP-binding region and three phosphorylation sites of recombinant ArcB, EvgS, and BarA TSKs derived from Escherichia coli. Phosphorylation profiles of these kinases, determined by using Phos-tag SDS-PAGE, showed that the sequential modes of the three-step phosphoryl-transfer reactions of ArcB, EvgS, and BarA are all different: cis-trans-trans, cis-cis-cis, and trans-trans-trans, respectively. The inclusion of a trans mode is consistent with the need to form a homodimer; the fact that all the steps for EvgS have cis modes is particularly interesting. Phos-tag SDS-PAGE therefore provides a simple method for identifying the unique and specific phosphotransfer mode for a given kinase, without taking complicated intracellular elements into consideration.	[Kinoshita-Kikuta, Emiko; Kinoshita, Eiji; Koike, Tohru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Funct Mol Sci, Hiroshima, Japan; [Eguchi, Yoko] Kinki Univ, Fac Biol Oriented Sci & Technol, Dept Sci & Technol Food Safety, Kinokawa, Japan	Hiroshima University; Kindai University (Kinki University)	Kinoshita, E (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Funct Mol Sci, Hiroshima, Japan.	kinoeiji@hiroshima-u.ac.jp	Kinoshita, Eiji/H-2284-2019	Emiko, Kinoshita/0000-0001-7355-1784	KAKENHI [25293005, 25560417, 15K07887, 26460036]; Takeda Science Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by KAKENHI Grant no. 25293005 to EK, no. 25560417 to EK, no. 15K07887 to EK-K, and no. 26460036 to TK, and by research grants from the Takeda Science Foundation to EK and EK-K.	Ashenberg O, 2013, J MOL BIOL, V425, P1198, DOI 10.1016/j.jmb.2013.01.011; Bantscheff M, 2000, INT J MED MICROBIOL, V290, P317; Besant PG, 2005, BBA-PROTEINS PROTEOM, V1754, P281, DOI 10.1016/j.bbapap.2005.07.026; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Dutta R, 1999, MOL MICROBIOL, V34, P633, DOI 10.1046/j.1365-2958.1999.01646.x; Ferris HU, 2014, J STRUCT BIOL, V186, P376, DOI 10.1016/j.jsb.2014.03.014; Jourlin C, 1997, J MOL BIOL, V267, P770, DOI 10.1006/jmbi.1997.0919; Jovanovic G, 2015, MOL BIOSYST, V11, P1348, DOI 10.1039/c4mb00720d; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2008, PROTEOMICS, V8, P2994, DOI 10.1002/pmic.200800243; Kinoshita E, 2014, PROTEOMICS, V14, P668, DOI 10.1002/pmic.201300533; Kinoshita E, 2009, ELECTROPHORESIS, V30, P550, DOI 10.1002/elps.200800386; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Kinoshita-Kikuta E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132598; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Mizuno T, 1998, J BIOCHEM, V123, P555; Pena-Sandoval GR, 2010, J BACTERIOL, V192, P1735, DOI 10.1128/JB.01401-09; Sommer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077708; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; UTSUMI R, 1994, GENE, V140, P73, DOI 10.1016/0378-1119(94)90733-1; Wagner PD, 1997, P NATL ACAD SCI USA, V94, P9000, DOI 10.1073/pnas.94.17.9000; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057	25	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148294	10.1371/journal.pone.0148294	http://dx.doi.org/10.1371/journal.pone.0148294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828204	Green Published, gold			2022-12-26	WOS:000369548200094
J	Kotkowiak, W; Pasternak, A; Kierzek, R				Kotkowiak, Weronika; Pasternak, Anna; Kierzek, Ryszard			Studies on Transcriptional Incorporation of 5 '-N-Triphosphates of 5 '-Amino-5 '-Deoxyribonucleosides	PLOS ONE			English	Article							T7 RNA-POLYMERASE; PHOSPHORAMIDATE BONDS; NUCLEOTIDE CHEMISTRY; ENZYMATIC-SYNTHESIS; SINGLE MISMATCHES; DNA-POLYMERASE; PHIX174 DNA; TEMPLATE; CLEAVAGE; PURIFICATION	In this study, several RNA polymerases were used for the first time to examine the possibility of transcriptional incorporation of 5'-N-triphosphates of 5'-amino-5'-deoxyribonucleosides (5'NH NTPs). The T3, T7, Sp6 and T7 Y639F RNA polymerases were employed to show that the full-length transcript cannot be synthesized. The results suggest that the application of 5'NH NTPs could decrease transcription reaction rates. What is more, the modification of transcription conditions had no influence on the rate of 5'NH NTPs incorporation. Based on experimental data it is postulated that 5'NH NTPs can be used as potential transcription inhibitors. Our findings expand the knowledge on suitable uses of the 5'-N-triphosphates of 5'-amino-5'-deoxyribonucleoside and the exact mechanism of transcriptional inhibition.	[Kotkowiak, Weronika; Pasternak, Anna; Kierzek, Ryszard] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Kierzek, R (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	rkierzek@ibch.poznan.pl	Pasternak, Anna/H-9411-2013	Kierzek, Ryszard/0000-0002-7644-0016; Pasternak, Anna/0000-0002-9666-4148; Kotkowiak, Weronika/0000-0002-9776-0924	National Science Center grant [UMO-2011/03/B/NZ1/00576]; Polish Ministry of Science and Higher Education grant [Mlod-WK 500-8051]; Polish Ministry of Science and Higher Education under KNOW program	National Science Center grant; Polish Ministry of Science and Higher Education grant(Ministry of Science and Higher Education, Poland); Polish Ministry of Science and Higher Education under KNOW program	This work has been financed by the National Science Center grant (UMO-2011/03/B/NZ1/00576 to R.K.) and by the Polish Ministry of Science and Higher Education grant (Mlod-WK 500-8051 to W.K.). This publication was also supported by the Polish Ministry of Science and Higher Education, under the KNOW program.	AURUP H, 1992, BIOCHEMISTRY-US, V31, P9636, DOI 10.1021/bi00155a016; BANNWARTH W, 1988, HELV CHIM ACTA, V71, P1517, DOI 10.1002/hlca.19880710618; Baranowski DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137674; Beckmann BM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq437; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; CHEN MS, 1976, J BIOL CHEM, V251, P4833; CHEN MS, 1976, J BIOL CHEM, V251, P4839; Davis AR, 2008, BIOCHEMISTRY-US, V47, P10178, DOI 10.1021/bi800471z; Gopalakrishna S, 2004, RNA, V10, P1820, DOI 10.1261/rna.5222504; Huang Y, 1997, BIOCHEMISTRY-US, V36, P13718, DOI 10.1021/bi971609o; Imashimizu M, 2013, NUCLEIC ACIDS RES, V41, P9090, DOI 10.1093/nar/gkt698; Kashkina E, 2006, MOL CELL, V24, P257, DOI 10.1016/j.molcel.2006.10.001; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4461, DOI 10.1093/nar/gkg632; Kierzek R, 1999, BIOCHEMISTRY-US, V38, P14214, DOI 10.1021/bi991186l; Kotkowiak W, 2014, BIOCHEM J, V464, P203, DOI 10.1042/BJ20141023; LETSINGER RL, 1976, BIOCHEMISTRY-US, V15, P2810, DOI 10.1021/bi00658a017; LETSINGER RL, 1976, NUCLEIC ACIDS RES, V3, P1053, DOI 10.1093/nar/3.4.1053; LETSINGER RL, 1972, J AM CHEM SOC, V94, P292, DOI 10.1021/ja00756a060; Lin LN, 2011, RNA, V17, P1932, DOI 10.1261/rna.2719311; MAG M, 1989, NUCLEIC ACIDS RES, V17, P5973, DOI 10.1093/nar/17.15.5973; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MCBRIDE LJ, 1983, TETRAHEDRON LETT, V24, P245, DOI 10.1016/S0040-4039(00)81376-3; Nilson KA, 2015, MOL CELL, V59, P576, DOI 10.1016/j.molcel.2015.06.032; Olejnik J, 1996, NUCLEIC ACIDS RES, V24, P361, DOI 10.1093/nar/24.2.361; Padilla R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf138; Padilla R, 1999, NUCLEIC ACIDS RES, V27, P1561, DOI 10.1093/nar/27.6.1561; Pal S, 2013, J BIOMOL STRUCT DYN, V31, P288, DOI 10.1080/07391102.2012.698237; Pomerantz RT, 2006, MOL CELL, V24, P245, DOI 10.1016/j.molcel.2006.08.014; Shchepinov MS, 2001, NUCLEIC ACIDS RES, V29, P3864, DOI 10.1093/nar/29.18.3864; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; Suga H, 1998, BIOCHEMISTRY-US, V37, P10118, DOI 10.1021/bi980432a; Ueno Y, 2008, TETRAHEDRON, V64, P11328, DOI 10.1016/j.tet.2008.08.117; Williamson D, 2008, ORG BIOMOL CHEM, V6, P1056, DOI 10.1039/b717896d; Wolfe JL, 2003, J AM CHEM SOC, V125, P10500, DOI 10.1021/ja035646g; Wolfe JL, 2002, NUCLEIC ACIDS RES, V30, P3739, DOI 10.1093/nar/gkf502; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Zhu B, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv367	38	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148282	10.1371/journal.pone.0148282	http://dx.doi.org/10.1371/journal.pone.0148282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829482	Green Published, gold			2022-12-26	WOS:000369548200091
J	Kuismin, M; Sillanpaa, MJ				Kuismin, Markku; Sillanpaa, Mikko J.			Use of Wishart Prior and Simple Extensions for Sparse Precision Matrix Estimation	PLOS ONE			English	Article							COVARIANCE ESTIMATION; PRIOR DISTRIBUTIONS; SELECTION	A conjugate Wishart prior is used to present a simple and rapid procedure for computing the analytic posterior (mode and uncertainty) of the precision matrix elements of a Gaussian distribution. An interpretation of covariance estimates in terms of eigenvalues is presented, along with a simple decision-rule step to improve the performance of the estimation of sparse precision matrices and associated graphs. In this, elements of the estimated precision matrix that are zero or near zero can be detected and shrunk to zero. Simulated data sets are used to compare posterior estimation with decision-rule with two other Wishart-based approaches and with graphical lasso. Furthermore, an empirical Bayes procedure is used to select prior hyperparameters in high dimensional cases with extension to sparsity.	[Kuismin, Markku; Sillanpaa, Mikko J.] Univ Oulu, Dept Math Sci, Oulu, Finland; [Sillanpaa, Mikko J.] Bioctr, Oulu, Finland	University of Oulu	Sillanpaa, MJ (corresponding author), Univ Oulu, Dept Math Sci, Oulu, Finland.; Sillanpaa, MJ (corresponding author), Bioctr, Oulu, Finland.	mikko.sillanpaa@oulu.fi		Sillanpaa, Mikko J./0000-0003-2808-2768; Kuismin, Markku/0000-0001-9074-7420	Biocenter Oulu	Biocenter Oulu	This work was supported by Biocenter Oulu (http://www.oulu.fi/biocenter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bien J, 2011, BIOMETRIKA, V98, P807, DOI 10.1093/biomet/asr054; Bouriga M, 2013, J STAT PLAN INFER, V143, P795, DOI 10.1016/j.jspi.2012.09.006; Buhlmann P, 2014, ANNU REV STAT APPL, V1, P255, DOI 10.1146/annurev-statistics-022513-115545; DEMPSTER AP, 1972, BIOMETRICS, V28, P157, DOI 10.2307/2528966; Edwards D., 2000, INTRO GRAPHICAL MODE; FOYGEL R., 2010, P ADV NEURAL INFORM, P604; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Hsu CW, 2012, ANN I STAT MATH, V64, P319, DOI 10.1007/s10463-010-0314-5; Huang A, 2013, BAYESIAN ANAL, V8, P439, DOI 10.1214/13-BA815; Khondker ZS, 2013, STAT INTERFACE, V6, P243; Kubokawa T, 2008, J MULTIVARIATE ANAL, V99, P1906, DOI 10.1016/j.jmva.2008.01.016; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; LEONARD T, 1992, ANN STAT, V20, P1669, DOI 10.1214/aos/1176348885; Lessmann K, 2002, THESIS U OSNABRUCK; Li ZT, 2012, THEOR APPL GENET, V125, P419, DOI 10.1007/s00122-012-1892-9; Liu Han, 2010, Adv Neural Inf Process Syst, V24, P1432; Mazumder R., 2012, J MACHINE LEARNING R, V13, P723; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Pourahmadi M., 2013, HIGH DIMENSIONAL COV, VVolume 882; Rowe D. B., 2003, MULTIVARIATE BAYESIA; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang H, 2012, BAYESIAN ANAL, V7, P867, DOI 10.1214/12-BA729; Witten DM, 2011, J COMPUT GRAPH STAT, V20, P892, DOI 10.1198/jcgs.2011.11051a; Won J. H., 2009, TECHNICAL REPORT; YANG RY, 1994, ANN STAT, V22, P1195, DOI 10.1214/aos/1176325625; Yuan T, 2013, STAT ANAL DATA MIN, V6, P431, DOI 10.1002/sam.11185	29	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148171	10.1371/journal.pone.0148171	http://dx.doi.org/10.1371/journal.pone.0148171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828427	Green Published, gold			2022-12-26	WOS:000369548200077
J	Zundler, S; Caioni, M; Muller, M; Strauch, U; Kunst, C; Woelfel, G				Zundler, Sebastian; Caioni, Massimiliano; Mueller, Martina; Strauch, Ulrike; Kunst, Claudia; Woelfel, Gisela			K+ Channel Inhibition Differentially Regulates Migration of Intestinal Epithelial Cells in Inflamed vs. Non-Inflamed Conditions in a PI3K/Akt-Mediated Manner	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ACTIVATED POTASSIUM CHANNEL; INTERFERON-GAMMA; PHOSPHATIDYLINOSITOL 3-KINASE; BARRIER DYSFUNCTION; CHLORIDE SECRETION; POTENTIAL ROLE; ION-TRANSPORT; MOUSE MODEL; EXPRESSION	Background Potassium channels have been shown to determine wound healing in different tissues, but their role in intestinal epithelial restitution-the rapid closure of superficial wounds by intestinal epithelial cells (IEC)-remains unclear. Methods In this study, the regulation of IEC migration by potassium channel modulation was explored with and without additional epidermal growth factor (EGF) under baseline and interferon-gamma (IFN-gamma)-pretreated conditions in scratch assays and Boyden chamber assays using the intestinal epithelial cell lines IEC-18 and HT-29. To identify possibly involved subcellular pathways, Western Blot (WB)-analysis of ERK and Akt phosphorylation was conducted and PI3K and ERK inhibitors were used in scratch assays. Furthermore, mRNA-levels of the potassium channel KCNN4 were determined in IEC from patients suffering from inflammatory bowel diseases (IBD). Results Inhibition of Ca2+-dependent potassium channels significantly increased intestinal epithelial restitution, which could not be further promoted by additional EGF. In contrast, inhibition of KCNN4 after pretreatment with IFN-gamma led to decreased or unaffected migration. This effect was abolished by EGF. Changes in Akt, but not in ERK phosphorylation strongly correlated with these findings and PI3K but not ERK inhibition abrogated the effect of KCNN4 inhibition. Levels of KCNN4 mRNA were higher in samples from IBD patients compared with controls. Conclusions Taken together, we demonstrate that inhibition of KCNN4 differentially regulates IEC migration in IFN-gamma-pretreated vs. non pretreated conditions. Moreover, our data propose that the PI3K signaling cascade is responsible for this differential regulation. Therefore, we present a cellular model that contributes new aspects to epithelial barrier dysfunction in chronic intestinal inflammation, resulting in propagation of inflammation and symptoms like ulcers or diarrhea.	[Zundler, Sebastian; Caioni, Massimiliano; Mueller, Martina; Strauch, Ulrike; Kunst, Claudia; Woelfel, Gisela] Univ Regensburg, Med Ctr, Dept Internal Med 1, D-93053 Regensburg, Germany; [Zundler, Sebastian] Univ Erlangen Nurnberg, Kussmaul Campus Med Res & Translat Res Ctr, Dept Med 1, D-91054 Erlangen, Germany	University of Regensburg; University of Erlangen Nuremberg	Woelfel, G (corresponding author), Univ Regensburg, Med Ctr, Dept Internal Med 1, D-93053 Regensburg, Germany.	gisela.woelfel@ukr.de			ReForM A (Regensburger Forschungsforderung in der Medizin Baustein A) grant of the University of Regensburg; German Research Foundation (DFG) within the funding programme Open Access Publishing	ReForM A (Regensburger Forschungsforderung in der Medizin Baustein A) grant of the University of Regensburg; German Research Foundation (DFG) within the funding programme Open Access Publishing(German Research Foundation (DFG))	This study was supported by a ReForM A (Regensburger Forschungsforderung in der Medizin Baustein A) grant of the University of Regensburg to GW and by the German Research Foundation (DFG) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dr. Thomas Karrasch and Dr. Rocio Lopez-Posadas for generously providing IEC-18 and HT-29 cells, respectively. This work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing.	Agarwal JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063028; Al-Hazza A, 2012, J PATHOL, V226, P463, DOI 10.1002/path.2994; Arcangeli A, 2006, TRENDS CELL BIOL, V16, P631, DOI 10.1016/j.tcb.2006.10.003; Artym VV, 2002, J GEN PHYSIOL, V120, P29, DOI 10.1085/jgp.20028607; Ayabe T, 2002, J BIOL CHEM, V277, P3793, DOI 10.1074/jbc.M107507200; Barmeyer C, 2010, AM J PHYSIOL-CELL PH, V299, pC251, DOI 10.1152/ajpcell.00091.2009; Basalingappa KM, 2011, AM J PHYSIOL-GASTR L, V301, pG905, DOI 10.1152/ajpgi.00558.2010; Basavappa S, 2005, J CELL PHYSIOL, V202, P21, DOI 10.1002/jcp.20085; Baumgart DC, 2002, CURR OPIN CLIN NUTR, V5, P685, DOI 10.1097/00075197-200211000-00012; Bertelsen LS, 2004, J BIOL CHEM, V279, P6271, DOI 10.1074/jbc.M311612200; Bertelsen LS, 2004, AM J PHYSIOL-GASTR L, V286, pG157, DOI 10.1152/ajpgi.00227.2003; Boivin MA, 2009, J INTERF CYTOK RES, V29, P45, DOI 10.1089/jir.2008.0128; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Cao L, 2011, INVEST OPHTH VIS SCI, V52, P2272, DOI 10.1167/iovs.10-5972; Chen Hong-Chen, 2004, V294, P15; Chiu T, 2005, AM J PHYSIOL-GASTR L, V288, pG182, DOI 10.1152/ajpgi.00200.2004; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; Dieckgraefe BK, 1997, BIOCHEM BIOPH RES CO, V233, P389, DOI 10.1006/bbrc.1997.6469; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; DIGNASS AU, 1994, GASTROENTEROLOGY, V106, P1254, DOI 10.1016/0016-5085(94)90017-5; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Dong H, 2006, AM J PHYSIOL-GASTR L, V291, pG1120, DOI 10.1152/ajpgi.00566.2005; Egan LJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1028, DOI 10.1152/ajpcell.00167.2003; Felderbauer P, 2007, INT J COLORECTAL DIS, V22, P1475, DOI 10.1007/s00384-007-0321-z; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Girault A, 2014, AM J PHYSIOL-CELL PH, V306, pC307, DOI 10.1152/ajpcell.00226.2013; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Karrasch T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026340; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotz MM, 2004, WOUND REPAIR REGEN, V12, P565, DOI 10.1111/j.1067-1927.2004.012509.x; MacVinish LJ, 2001, PFLUG ARCH EUR J PHY, V443, pS127; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Ohya S, 2014, AM J PHYSIOL-GASTR L, V306, pG873, DOI 10.1152/ajpgi.00156.2013; Paul G, 2012, J BIOL CHEM, V287, P2144, DOI 10.1074/jbc.M111.318139; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Polk DB, 1998, GASTROENTEROLOGY, V114, P493, DOI 10.1016/S0016-5085(98)70532-3; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rezzonico R, 2003, J BONE MINER RES, V18, P1863, DOI 10.1359/jbmr.2003.18.10.1863; Riegler M, 1996, GASTROENTEROLOGY, V111, P28, DOI 10.1053/gast.1996.v111.pm8698221; Roderick C, 2003, J MEMBRANE BIOL, V196, P41, DOI 10.1007/s00232-003-0623-1; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; Santos MF, 1997, J CLIN INVEST, V100, P216, DOI 10.1172/JCI119515; SASAKI T, 1992, GASTROENTEROL JPN, V27, P29; Schneider SW, 2000, PFLUG ARCH EUR J PHY, V439, P297, DOI 10.1007/s004240050943; Schwab A, 1999, PFLUG ARCH EUR J PHY, V438, P330, DOI 10.1007/s004240050917; Schwab A, 2008, PHYSIOLOGY, V23, P212, DOI 10.1152/physiol.00003.2008; Schwab A, 2012, J CELL PHYSIOL, V227, P686, DOI 10.1002/jcp.22776; Sciaccaluga M, 2010, AM J PHYSIOL-CELL PH, V299, pC175, DOI 10.1152/ajpcell.00344.2009; Shao ZF, 2011, AM J RESP CELL MOL, V45, P962, DOI 10.1165/rcmb.2010-0514OC; Simms LA, 2010, AM J GASTROENTEROL, V105, P2209, DOI 10.1038/ajg.2010.161; Sones WR, 2009, BRIT J PHARMACOL, V158, P521, DOI 10.1111/j.1476-5381.2009.00332.x; Strobaek D, 2013, BRIT J PHARMACOL, V168, P432, DOI 10.1111/j.1476-5381.2012.02143.x; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang Y, 2012, ONCOGENE, V31, P2512, DOI 10.1038/onc.2011.435; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wilson AJ, 1999, EXP CELL RES, V250, P187, DOI 10.1006/excr.1999.4496; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314; Zimmerman NP, 2011, LAB INVEST, V91, P1040, DOI 10.1038/labinvest.2011.77	71	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147736	10.1371/journal.pone.0147736	http://dx.doi.org/10.1371/journal.pone.0147736			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824610	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600053
J	Webster, CI; Caram-Salas, N; Haqqani, AS; Thom, G; Brown, L; Rennie, K; Yogi, A; Costain, W; Brunette, E; Stanimirovic, DB				Webster, Carl I.; Caram-Salas, Nadia; Haqqani, Arsalan S.; Thom, George; Brown, Lee; Rennie, Kerry; Yogi, Alvaro; Costain, Willard; Brunette, Eric; Stanimirovic, Danica B.			Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1	FASEB JOURNAL			English	Article						pain; receptor-mediated transcytosis; brain endothelial cells; mass spectrometry	PHAGE DISPLAY; INFLAMMATORY PAIN; ENDOTHELIAL-CELLS; PHARMACOKINETICS; PROTEIN; MODELS; FRAGMENTS; SYSTEM; MECHANISMS; GENERATION	Receptor mediated transcytosis harnessing the cellular uptake and transport of natural ligands across the blood-brain barrier (BBB) has been identified as a means for antibody delivery to the CNS. In this study, we characterized bispecific antibodies in which a BBB-crossing antibody fragment FC5 was used as a BBB carrier. Cargo antibodies were either a high-affinity, selective antibody antagonist of the metabotropic glutamate receptor-1 (BBB-mGluR1), a widely abundant CNS target, or an IgG that does not bind the CNS target (BBB-NiP). Both BBB-NiP and BBB-mGluR1 demonstrated a similar 20-fold enhanced rate of transcytosis across an in vitro BBB model compared with mGluR1 IgG fused to a control antibody fragment. All 3 bispecific antibodies exhibited identical pharmacokinetics in vivo. Comparative assessment of BBB-NiP and BBB-mGluR1 revealed that, whereas their serum pharmacokinetics and BBB penetration were identical, their central disposition (brain levels) and elimination (cerebrospinal fluid levels) were widely different, due to central target-mediated removal of the mGluR1-engaging antibody. Central mGluR1 target engagement after systemic administration was demonstrated by a dose-dependent inhibition of mGluR-1-mediated thermal hyperalgesia and by colocalization of the antibody with thalamic neurons involved in mGluR1-mediated pain processing. We demonstrate the feasibility of targeting central G-protein-coupled receptors using a BBB-crossing bispecific antibody approach and emerging principles that govern brain distribution and disposition of these antibodies. These data will be important for designing safe and selective CNS antibody therapeutics.-Webster, C. I., Caram-Salas, N., Haqqani, A. S., Thom, G., Brown, L., Rennie, K., Yogi, A., Costain, W., Brunette, E., Stanimirovic, D. B. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1 www.fasebj.org	[Webster, Carl I.; Thom, George] MedImmune, Antibody Discovery & Prot Engn, Cambridge CB21 6GH, England; [Brown, Lee] MedImmune, Translat Sci, Cambridge CB21 6GH, England; [Caram-Salas, Nadia; Haqqani, Arsalan S.; Rennie, Kerry; Yogi, Alvaro; Costain, Willard; Brunette, Eric; Stanimirovic, Danica B.] Natl Res Council Canada, Human Hlth Therapeut Portfolio, Ottawa, ON, Canada	AstraZeneca; Medimmune; AstraZeneca; Medimmune; National Research Council Canada	Webster, CI (corresponding author), MedImmune, Milstein Bldg,Granta Pk, Cambridge CB21 6GH, England.	websterc@medimmune.com	Costain, Willard J/F-5128-2011; Caram-Salas, Nadia L/F-1977-2019; Costain, Will/M-5669-2019; Salas, Nadia Lizeth Caram/AAG-4767-2020	Costain, Willard J/0000-0002-7476-6450; Costain, Will/0000-0002-7476-6450; Salas, Nadia Lizeth Caram/0000-0002-1894-9498; Rennie, Kerry/0000-0001-9216-2514	Medimmune; NRC (Therapeutics Beyond Brain Barriers Program); NRC	Medimmune(AstraZenecaMedimmune); NRC (Therapeutics Beyond Brain Barriers Program); NRC(National Research Centre (NRC))	The authors acknowledge expert technical help of the following contributors in performing analytical, cell-based and immunochemistry assays and animal handling: Marguerite Ball, Susan Jiang, Wen Ding, Christie Delaney, Eve Boileau, Ewa Baumann, and Debbie Callaghan [all from Human Health Therapeutics, National Research Council of Canada (NRC)] and Judy Paterson and Arron Hearn (both from Medimmune). The work reported in the manuscript was funded jointly by Medimmune and the NRC (Therapeutics Beyond Brain Barriers Program). NRC and MedImmune jointly performed the work described in the submitted manuscript under a Sponsored Research Agreement. NRC coauthors have no financial or managerial interest in the company. MedImmune staff members are paid by MedImmune and may hold stock options in AstraZeneca.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Boado RJ, 2014, BIOTECHNOL BIOENG, V111, P2317, DOI 10.1002/bit.25289; Boado RJ, 2010, MOL PHARMACEUT, V7, P237, DOI 10.1021/mp900235k; Conaghan PG, 2015, RHEUMATOLOGY, V54, P270, DOI 10.1093/rheumatology/keu332; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; D'Antoni S, 2008, NEUROCHEM RES, V33, P2436, DOI 10.1007/s11064-008-9694-9; Daramola O, 2014, BIOTECHNOL PROGR, V30, P132, DOI 10.1002/btpr.1809; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; Dobson CL, 2009, MABS-AUSTIN, V1, P552, DOI 10.4161/mabs.1.6.10057; Farrington GK, 2014, FASEB J, V28, P4764, DOI 10.1096/fj.14-253369; Fluttert M, 2000, LAB ANIM, V34, P372, DOI 10.1258/002367700780387714; Garberg P, 2005, TOXICOL IN VITRO, V19, P299, DOI 10.1016/j.tiv.2004.06.011; Haqqani AS, 2013, MOL PHARMACEUT, V10, P1542, DOI 10.1021/mp3004995; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Hovelso N, 2012, CURR NEUROPHARMACOL, V10, P12, DOI 10.2174/157015912799362805; Hutchings Catherine, 2001, P93; Iliff J. J., 2012, TRANSL MED, V4; Li WD, 2004, J NEUROPHYSIOL, V91, P13, DOI 10.1152/jn.00485.2003; Lloyd C, 2009, PROTEIN ENG DES SEL, V22, P159, DOI 10.1093/protein/gzn058; MCCAFFERTY J, 1994, APPL BIOCHEM BIOTECH, V47, P157, DOI 10.1007/BF02787932; Miraglia S, 1999, J BIOMOL SCREEN, V4, P193, DOI 10.1177/108705719900400407; Miyata M, 2003, J NEUROSCI, V23, P8098; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; More L, 2007, BEHAV PHARMACOL, V18, P273; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Oganesyan V, 2008, ACTA CRYSTALLOGR D, V64, P700, DOI 10.1107/S0907444908007877; Ohshima-Hosoyama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039036; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palazzo E, 2014, EUR J NEUROSCI, V39, P444, DOI 10.1111/ejn.12398; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Pepinsky RB, 2011, J PHARMACOL EXP THER, V339, P519, DOI 10.1124/jpet.111.183483; Persic L, 1997, GENE, V187, P9, DOI 10.1016/S0378-1119(96)00628-2; Phillips D., 2008, THESIS U READING REA; Picker MJ, 2011, BEHAV PHARMACOL, V22, P785, DOI 10.1097/FBP.0b013e32834d13a2; Regina A, 2015, MOL CANCER THER, V14, P129, DOI 10.1158/1535-7163.MCT-14-0399; ROBEN PW, 1995, J IMMUNOL, V154, P6437; Salt TE, 2014, NEUROPHARMACOLOGY, V79, P405, DOI 10.1016/j.neuropharm.2013.12.016; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Wolak DJ, 2015, J CONTROL RELEASE, V197, P78, DOI 10.1016/j.jconrel.2014.10.034; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230	46	46	48	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1927	1940		10.1096/fj.201500078	http://dx.doi.org/10.1096/fj.201500078			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26839377				2022-12-26	WOS:000374879400021
J	Huang, HR; Yang, XJ; Bao, ML; Cao, HH; Miao, XP; Zhang, XY; Gan, L; Qiu, MS; Zhang, ZY				Huang, Huarong; Yang, Xiaojuan; Bao, Meiling; Cao, Huanhuan; Miao, Xiaoping; Zhang, Xiaoyun; Gan, Lin; Qiu, Mengsheng; Zhang, Zunyi			Ablation of the Sox11 Gene Results in Clefting of the Secondary Palate Resembling the Pierre Robin Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; craniofacial development; FGF; gene regulation; mouse; micrognathia; Pierre Robin sequence; cleft palate; Sox11	CRANIAL NEURAL CREST; ABNORMAL TONGUE DEVELOPMENT; GROWTH-FACTOR RECEPTOR; TRANSCRIPTION FACTORS; MUTANT MICE; EPITHELIAL DIFFERENTIATION; SHELF ELEVATION; BINDING-SITE; MOUSE; PALATOGENESIS	Mouse gene inactivation has shown that the transcription factor Sox11 is required for mouse palatogenesis. However, whether Sox11 is primarily involved in the regulation of palatogenesis still remains elusive. In this study, we explored the role of Sox11 in palatogenesis by analyzing the developmental mechanism in cleft palate formation in mutants deficient in Sox11. Sox11 is expressed both in the developing palatal shelf and in the surrounding structures, including the mandible. We found that cleft palate occurs only in the mutant in which Sox11 is directly deleted. As in the wild type, the palatal shelves in the Sox11 mutant undergo outgrowth in a downward direction and exhibit potential for fusion and elevation. However, mutant palatal shelves encounter clefting, which is associated with a malpositioned tongue that results in physical obstruction of palatal shelf elevation at embryonic day 14.5 (E14.5). We found that loss of Sox11 led to reduced cell proliferation in the developing mandibular mesenchyme via Cyclin D1, leading to mandibular hypoplasia, which blocks tongue descent. Extensive analyses of gene expression in Sox11 deficiency identified FGF9 as a potential candidate target of Sox11 in the modulation of cell proliferation both in the mandible and the palatal shelf between E12.5 and E13.5. Finally we show, using in vitro assays, that Sox11 directly regulates the expression of Fgf9 and that application of FGF9 protein to Sox11-deficient palatal shelves restores the rate of BrdU incorporation. Taken together, the palate defects presented in the Sox11 loss mutant mimic the clefting in the Pierre Robin sequence in humans.	[Huang, Huarong; Yang, Xiaojuan; Bao, Meiling; Cao, Huanhuan; Miao, Xiaoping; Zhang, Xiaoyun; Gan, Lin; Qiu, Mengsheng; Zhang, Zunyi] Hangzhou Normal Univ, Coll Biol & Environm Sci, Inst Dev & Regenerat Biol, Zhejiang Key Lab Mammalian Organogenesis & Regene, 16 Xuelin St, Hangzhou 310036, Zhejiang, Peoples R China	Hangzhou Normal University	Zhang, ZY (corresponding author), Hangzhou Normal Univ, 16 Xuelin St, Hangzhou 310036, Zhejiang, Peoples R China.	zunyi_zhang@idrbio.org			Natural Science Foundation of China [31071287, 31101046]; Natural Science Foundation of Zhejiang Province [LZ12C12002, LY15C070005]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by Natural Science Foundation of China Grant 31071287 and Natural Science Foundation of Zhejiang Province Grant LZ12C12002 (to Z.Z) and Natural Science Foundation of China Grant 31101046 and Natural Science Foundation of Zhejiang Province Grant LY15C070005 (to H.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alappat SR, 2005, DEV BIOL, V277, P102, DOI 10.1016/j.ydbio.2004.09.010; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Blavier L, 2001, MOL BIOL CELL, V12, P1457, DOI 10.1091/mbc.12.5.1457; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Casey LM, 2006, DEV DYNAM, V235, P1830, DOI 10.1002/dvdy.20821; Chew LJ, 2009, J NEUROSCI RES, V87, P3277, DOI 10.1002/jnr.22128; Cinaroglu A, 2005, J NEUROSCI RES, V79, P329, DOI 10.1002/jnr.20363; Cizelsky W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069372; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Donner AL, 2006, DEV DYNAM, V235, P1358, DOI 10.1002/dvdy.20722; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; FERGUSON MWJ, 1977, VIRCHOWS ARCH A, V375, P97, DOI 10.1007/BF00428098; Gadi J, 2013, J BIOL CHEM, V288, P25400, DOI 10.1074/jbc.M112.413377; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Han J, 2009, DEVELOPMENT, V136, P4225, DOI 10.1242/dev.036723; Hargrave M, 1997, DEV DYNAM, V210, P79, DOI 10.1002/(SICI)1097-0177(199710)210:2<79::AID-AJA1>3.0.CO;2-6; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Hoser M, 2008, MOL CELL BIOL, V28, P4675, DOI 10.1128/MCB.00338-08; Huang X, 2008, DEV DYNAM, V237, P3079, DOI 10.1002/dvdy.21714; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Jiang Y, 2013, J BIOL CHEM, V288, P18429, DOI 10.1074/jbc.M113.478503; Jin JZ, 2008, CELL TISSUE RES, V333, P29, DOI 10.1007/s00441-008-0612-x; Juriloff DM, 2008, BIRTH DEFECTS RES A, V82, P63, DOI 10.1002/bdra.20430; Liu WJ, 2008, DEVELOPMENT, V135, P3959, DOI 10.1242/dev.025304; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Moreno LM, 2004, AM J MED GENET A, V125A, P135, DOI 10.1002/ajmg.a.20425; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Parada C, 2015, CURR TOP DEV BIOL, V115, P31, DOI 10.1016/bs.ctdb.2015.07.023; Parada C, 2015, DEVELOPMENT, V142, P3734, DOI 10.1242/dev.125328; Paul MH, 2014, CELL MOL LIFE SCI, V71, P2931, DOI 10.1007/s00018-013-1523-x; Penzo-Mendez AI, 2010, INT J BIOCHEM CELL B, V42, P425, DOI 10.1016/j.biocel.2009.07.018; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; Ramaesh T, 2003, J ANAT, V203, P213, DOI 10.1046/j.1469-7580.2003.00210.x; Scapoli L, 1997, GENOMICS, V43, P216, DOI 10.1006/geno.1997.4798; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schmahl J, 2004, DEVELOPMENT, V131, P3627, DOI 10.1242/dev.01239; Schultz RE, 2004, AM J MED GENET A, V125A, P17, DOI 10.1002/ajmg.a.20424; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Song ZC, 2013, J BIOL CHEM, V288, P10440, DOI 10.1074/jbc.M112.432286; Tan TY, 2013, AM J MED GENET C, V163, P295, DOI 10.1002/ajmg.c.31374; Wang C, 2013, J BIOL CHEM, V288, P22174, DOI 10.1074/jbc.M113.463620; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Yu K, 2015, DEV DYNAM, V244, P1427, DOI 10.1002/dvdy.24319; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	54	18	20	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7107	7118		10.1074/jbc.M115.690875	http://dx.doi.org/10.1074/jbc.M115.690875			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26826126	hybrid, Green Published			2022-12-26	WOS:000373299700044
J	Marco-Jimenez, F; Jimenez-Trigos, E; Almela-Miralles, V; Vicente, JS				Marco-Jimenez, Francisco; Jimenez-Trigos, Estrella; Almela-Miralles, Victoria; Salvador Vicente, Jose			Development of Cheaper Embryo Vitrification Device Using the Minimum Volume Method	PLOS ONE			English	Article							HIGHLY EFFICIENT VITRIFICATION; CRYOTOP VITRIFICATION; RABBIT EMBRYOS; SURVIVAL RATE; HUMAN OOCYTES; CRYOPRESERVATION; STAGE; BLASTOCYSTS; EQUIVALENT; BOVINE	This study was designed to compare the efficiency of the Cryotop and Calibrated plastic inoculation loop (CPIL) devices for vitrification of rabbit embryos on in vitro development and implantation rate, offspring rate at birth and embryonic and fetal losses. CPIL is a simple tool used mainly by microbiologists to retrieve an inoculum from a culture of microorganisms. In experiment 1, embryos were vitrified using a Cryotop device and a CPIL device. There were no significant differences in hatched/hatching blastocyst stage rates after 48 h of culture among the vitrified groups (62 +/- 4.7% and 62 +/- 4.9%, respectively); however, the rates were significantly lower (P< 0.05) than those of the fresh group (95 +/- 3.4%). In experiment 2, vitrified embryos were transferred using laparoscopic technique. The number of implanted embryos was estimated by laparoscopy as number of implantation sites at day 14 of gestation. At birth, total offspring were recorded. Embryonic and fetal losses were calculated as the difference between implanted embryos and embryos transferred and total born at birth and implanted embryos, respectively. The rate of implantation and development to term was similar between both vitrification devices (56 +/- 7.2% and 50 +/- 6.8% for implantation rate and 40 +/- 7.1% and 35 +/- 6.5% for offspring rate at birth); but significantly lower than in the fresh group (78 +/- 6.6% for implantation rate and 70 +/- 7.2% for offspring rate at birth, P< 0.05). Likewise, embryonic losses were similar between both vitrification devices (44 +/- 7.2% and 50 +/- 6.8%), but significantly higher than in the fresh group (23 +/- 6.6%, P < 0.05). However, fetal losses were similar between groups (10 +/- 4.4%, 15 +/- 4.8% and 8 +/- 4.2%, for vitrified, Cryotop or CPIL and fresh, respectively). These results indicate that the CPIL device is as effective as the Cryotop device for vitrification of rabbit embryos, but at a cost of (sic)0.05 per device.	[Marco-Jimenez, Francisco; Almela-Miralles, Victoria; Salvador Vicente, Jose] Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46022 Valencia, Spain; [Jimenez-Trigos, Estrella] CEU Cardenal Herrera Univ, Fac Vet Med, Dept Anim Prod Anim Hlth & Sci & Food Technol, Inst Biomed Sci, Valencia, Spain	Universitat Politecnica de Valencia; Universidad CEU Cardenal Herrera	Marco-Jimenez, F (corresponding author), Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46022 Valencia, Spain.	fmarco@dca.upv.es	Jiménez, Francisco Marco/I-7126-2012; Trigos, M Estrella Jiménez/M-2254-2017; Vicente, Jose/F-7738-2017	Jiménez, Francisco Marco/0000-0002-5226-4118; Jimenez Trigos/0000-0002-0320-4813; Vicente, Jose/0000-0003-0481-3802	Comision Interministerial de Ciencia y Tecnologia [AGL2014-53405-C2-1-P]; Generalitat Valenciana research program [Prometeo II 2014/036]	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Generalitat Valenciana research program	This research was supported by the projects Spanish Research project AGL2014-53405-C2-1-P Comision Interministerial de Ciencia y Tecnologia (FMJ, JSV) and Generalitat Valenciana research program (Prometeo II 2014/036, JSV, FMJ).	Arav A., 1992, Embryonic development and manipulation in animal production: trends in research and applications., P255; Arav A, 2014, THERIOGENOLOGY, V81, P96, DOI 10.1016/j.theriogenology.2013.09.011; Arav A, 2002, MOL CELL ENDOCRINOL, V187, P77, DOI 10.1016/S0303-7207(01)00700-6; Arav A., 1997, Theriogenology, V47, P341, DOI 10.1016/S0093-691X(97)82468-5; Arav A., 1989, THESIS BOLOGNA U BOL; Arav A., 1987, IVF M BARCELONA, V373, P118; Attanasio L, 2010, REPROD DOMEST ANIM, V45, P997, DOI 10.1111/j.1439-0531.2009.01475.x; BESENFELDER U, 1993, J REPROD FERTIL, V99, P53, DOI 10.1530/jrf.0.0990053; Casillas F, 2015, CRYOBIOLOGY, V71, P299, DOI 10.1016/j.cryobiol.2015.08.003; Cobo A, 2008, REPROD BIOMED ONLINE, V17, P68, DOI 10.1016/S1472-6483(10)60295-7; Saenz-de-Juano MD, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100677; Esaki R, 2004, BIOL REPROD, V71, P432, DOI 10.1095/biolreprod.103.026542; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Garcia ML, 2002, LIVEST PROD SCI, V74, P45, DOI 10.1016/S0301-6226(01)00280-9; Hochi S, 2004, THERIOGENOLOGY, V61, P267, DOI 10.1016/S0093-691X(03)00232-2; Isachenko V, 2001, CRYO-LETT, V22, P157; Kasai M., 1992, BIOL REPROD, V39, P284; Katayama KP, 2003, FERTIL STERIL, V80, P223, DOI 10.1016/S0015-0282(03)00551-X; Kato O, 2012, EUR J OBSTET GYN R B, V161, P46, DOI 10.1016/j.ejogrb.2011.12.005; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Kuwayama M., 2000, J ASSIST REPROD GEN, P477, DOI DOI 10.1023/A:1017399518757; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Laowtammathron C, 2005, THERIOGENOLOGY, V64, P1185, DOI 10.1016/j.theriogenology.2005.02.001; Lavara R, 2011, THERIOGENOLOGY, V76, P652, DOI 10.1016/j.theriogenology.2011.03.018; Liang YY, 2012, ANIM SCI J, V83, P630, DOI 10.1111/j.1740-0929.2012.01013.x; Ling XF, 2009, REPROD BIOMED ONLINE, V19, P708, DOI 10.1016/j.rbmo.2009.09.006; Lopez-Bejar M, 2002, THERIOGENOLOGY, V58, P1541, DOI 10.1016/S0093-691X(02)01045-2; Marco-Jimenez F, 2013, THERIOGENOLOGY, V79, P1124, DOI 10.1016/j.theriogenology.2013.02.008; Marco-Jimenez F, 2014, CRYOLETTERS, V35, P320; Marco-Jimenez F, 2014, CRYOLETTERS, V35, P286; Mazur P, 2011, CRYOBIOLOGY, V62, P1, DOI 10.1016/j.cryobiol.2010.10.159; Mikolajewska N, 2012, REPROD DOMEST ANIM, V47, P295, DOI 10.1111/rda.12044; Moce ML, 2010, THERIOGENOLOGY, V73, P704, DOI 10.1016/j.theriogenology.2009.11.010; Morato R, 2008, CRYOBIOLOGY, V57, P137, DOI 10.1016/j.cryobiol.2008.07.003; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Roy TK, 2014, HUM REPROD, V29, P2431, DOI 10.1093/humrep/deu214; Roy TK, 2014, FERTIL STERIL, V101, P1294, DOI 10.1016/j.fertnstert.2014.01.046; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Takahashi K, 2005, FERTIL STERIL, V84, P88, DOI 10.1016/j.fertnstert.2004.12.051; Ushijima H, 2004, J REPROD DEVELOP, V50, P481, DOI 10.1262/jrd.50.481; Vicente JS, 2013, REPROD DOMEST ANIM, V48, P402, DOI 10.1111/rda.12087; VICENTE JS, 1994, THERIOGENOLOGY, V42, P1205, DOI 10.1016/0093-691X(94)90869-9; Vicente JS, 1999, REPROD NUTR DEV, V42, P1205	43	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148661	10.1371/journal.pone.0148661	http://dx.doi.org/10.1371/journal.pone.0148661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848960	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000149
J	Nagpal, S; Haque, MM; Mande, SS				Nagpal, Sunil; Haque, Mohammed Monzoorul; Mande, Sharmila S.			Vikodak - A Modular Framework for Inferring Functional Potential of Microbial Communities from 16S Metagenomic Datasets	PLOS ONE			English	Article							LACTAMASE-PRODUCING BACTERIA; TAXONOMIC CLASSIFICATION; PERIODONTITIS; DATABASE; ALGORITHM; PROFILES; RESOURCE; SERVER	Background The overall metabolic/functional potential of any given environmental niche is a function of the sum total of genes/proteins/enzymes that are encoded and expressed by various interacting microbes residing in that niche. Consequently, prior (collated) information pertaining to genes, enzymes encoded by the resident microbes can aid in indirectly (re) constructing/inferring the metabolic/functional potential of a given microbial community (given its taxonomic abundance profile). In this study, we present Vikodak-a multi-modular package that is based on the above assumption and automates inferring and/or comparing the functional characteristics of an environment using taxonomic abundance generated from one or more environmental sample datasets. With the underlying assumptions of co-metabolism and independent contributions of different microbes in a community, a concerted effort has been made to accommodate microbial co-existence patterns in various modules incorporated in Vikodak. Results Validation experiments on over 1400 metagenomic samples have confirmed the utility of Vikodak in (a) deciphering enzyme abundance profiles of any KEGG metabolic pathway, (b) functional resolution of distinct metagenomic environments, (c) inferring patterns of functional interaction between resident microbes, and (d) automating statistical comparison of functional features of studied microbiomes. Novel features incorporated in Vikodak also facilitate automatic removal of false positives and spurious functional predictions. Conclusions With novel provisions for comprehensive functional analysis, inclusion of microbial co-existence pattern based algorithms, automated inter-environment comparisons; in-depth analysis of individual metabolic pathways and greater flexibilities at the user end, Vikodak is expected to be an important value addition to the family of existing tools for 16S based function prediction. Availability and Implementation A web implementation of Vikodak can be publicly accessed at: http://metagenomics.atc.tcs.com/vikodak. This web service is freely available for all categories of users (academic as well as commercial).	[Nagpal, Sunil; Haque, Mohammed Monzoorul; Mande, Sharmila S.] Tata Res Dev & Design Ctr, TCS Innovat Labs, Biosci R&D Div, 54-B Hadapsar Ind Estate, Pune 411013, Maharashtra, India		Mande, SS (corresponding author), Tata Res Dev & Design Ctr, TCS Innovat Labs, Biosci R&D Div, 54-B Hadapsar Ind Estate, Pune 411013, Maharashtra, India.	sharmila.mande@tcs.com	Nagpal, Sunil/K-8617-2019	Nagpal, Sunil/0000-0001-9221-1443	Tata Consultancy Services Limited - a commercial company	Tata Consultancy Services Limited - a commercial company	The authors [SN, MMH, and SSM] of this study declare that they are employees of Tata Consultancy Services Limited - a commercial company. The company has provided support for this study in the form of salaries to authors [SN, MMH, and SSM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-31; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Chew J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-189; Cui ZL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-276; Dhotre P.S., 2012, EUR J GEN MED, V9, P81, DOI [10.29333/ejgm/82469, DOI 10.29333/EJGM/82469]; Eid H., 2014, SAUDI J HLTH SCI, V3, P80, DOI [DOI 10.4103/2278-0521.134855, 10.4103/2278-0521.134855]; Botero LE, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-29; Ghosh TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095547; Ghosh TS, 2012, GENOMICS, V99, P195, DOI 10.1016/j.ygeno.2012.01.008; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Handal T, 2000, EUR J ORAL SCI, V108, P163, DOI 10.1034/j.1600-0722.2000.108003163.x; Herrera D, 2000, J CLIN PERIODONTOL, V27, P520, DOI 10.1034/j.1600-051x.2000.027007520.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kato T, 2014, DNA RES, V21, P469, DOI 10.1093/dnares/dsu013; Kesic L, 2008, MED BIOL, V15, P1; LAI CH, 1983, INT J SYST BACTERIOL, V33, P628, DOI 10.1099/00207713-33-3-628; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lu R, 2014, J PERIODONTAL RES, V49, P574, DOI 10.1111/jre.12137; Maidak BL, 1996, NUCLEIC ACIDS RES, V24, P82, DOI 10.1093/nar/24.1.82; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mohammed MH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S4; Mohammed MH, 2011, BIOINFORMATICS, V27, P22, DOI 10.1093/bioinformatics/btq608; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Ochiai K, 2011, J ORAL BIOSCI, V53, P213, DOI 10.2330/joralbiosci.53.213; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rams TE, 2013, J PERIODONTAL RES, V48, P493, DOI 10.1111/jre.12031; Rams TE, 2015, ODONTOLOGY, V103, P286, DOI 10.1007/s10266-014-0166-1; Reddy RM, 2012, GENE, V505, P259, DOI 10.1016/j.gene.2012.06.014; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; VITTEK J, 1984, J PERIODONTAL RES, V19, P545, DOI 10.1111/j.1600-0765.1984.tb01311.x; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Xiao SM, 2014, FEMS MICROBIOL ECOL, V87, P357, DOI 10.1111/1574-6941.12228; Zakrzewski M, 2013, J BIOTECHNOL, V167, P156, DOI 10.1016/j.jbiotec.2012.09.013	39	37	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148347	10.1371/journal.pone.0148347	http://dx.doi.org/10.1371/journal.pone.0148347			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848568	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000074
J	Kanzaki, M; Asano, Y; Ishibashi-Ueda, H; Oiki, E; Nishida, T; Asanuma, H; Kato, H; Oka, T; Ohtani, T; Tsukamoto, O; Higo, S; Kioka, H; Matsuoka, K; Sawa, Y; Komuro, I; Kitakaze, M; Takashima, S; Sakata, Y				Kanzaki, Machiko; Asano, Yoshihiro; Ishibashi-Ueda, Hatsue; Oiki, Eiji; Nishida, Tomoki; Asanuma, Hiroshi; Kato, Hisakazu; Oka, Toru; Ohtani, Tomohito; Tsukamoto, Osamu; Higo, Shuichiro; Kioka, Hidetaka; Matsuoka, Ken; Sawa, Yoshiki; Komuro, Issei; Kitakaze, Masafumi; Takashima, Seiji; Sakata, Yasushi			A Development of Nucleic Chromatin Measurements as a New Prognostic Marker for Severe Chronic Heart Failure	PLOS ONE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; VENTRICULAR ASSIST DEVICES; COLLEGE-OF-CARDIOLOGY; MANAGEMENT; ASSOCIATION; RECOVERY; THERAPY	Background Accurate prediction of both mortality and morbidity is of significant importance, but it is challenging in patients with severe heart failure. It is especially difficult to detect the optimal time for implanting mechanical circulatory support devices in such patients. We aimed to analyze the morphometric ultrastructure of nuclear chromatin in cardiomyocytes by developing an original clinical histopathological method. Using this method, we developed a biomarker to predict poor outcome in patients with dilated cardiomyopathy (DCM). Methods and Results As a part of their diagnostic evaluation, 171 patients underwent endomyocardial biopsy (EMB). Of these, 63 patients diagnosed with DCM were included in this study. We used electron microscopic imaging of cardiomyocyte nuclei and an automated image analysis software program to assess whether it was possible to detect discontinuity of the nuclear periphery. Twelve months after EMB, all patients with a discontinuous nuclear periphery (Group A, n = 11) died from heart failure or underwent left ventricular assist device (VAD) implantation. In contrast, in patients with a continuous nuclear periphery (Group N, n = 52) only 7 patients (13%) underwent VAD implantation and there were no deaths (p<0.01). We then evaluated chromatin particle density (Nuc-CS) and chromatin thickness in the nuclear periphery (Per-CS) in Group N patients; these new parameters were able to identify patients with poor prognosis. Conclusions We developed novel morphometric methods based on cardiomyocyte nuclear chromatin that may provide pivotal information for early prediction of poor prognosis in patients with DCM.	[Kanzaki, Machiko; Asano, Yoshihiro; Oka, Toru; Ohtani, Tomohito; Higo, Shuichiro; Kioka, Hidetaka; Matsuoka, Ken; Komuro, Issei; Takashima, Seiji; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka, Japan; [Oiki, Eiji] Osaka Univ, Grad Sch Med, Ctr Med Res & Educ, Suita, Osaka, Japan; [Nishida, Tomoki] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Osaka, Japan; [Asanuma, Hiroshi] Kyoto Prefectural Univ, Sch Med, Dept Cardiovasc Sci & Technol, Kyoto 606, Japan; [Kato, Hisakazu; Tsukamoto, Osamu; Takashima, Seiji] Osaka Univ, Grad Sch Med, Dept Med Biochem, Suita, Osaka, Japan; [Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan; [Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Clin Med & Dev, Suita, Osaka, Japan	Osaka University; National Cerebral & Cardiovascular Center - Japan; Osaka University; Osaka University; Kyoto Prefectural University; Osaka University; Osaka University; University of Tokyo; National Cerebral & Cardiovascular Center - Japan	Asano, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan.	asano@cardiology.med.osaka-u.ac.jp		Kato, Hisakazu/0000-0003-4619-3680; Tsukamoto, Osamu/0000-0002-9504-8001; Ohtani, Tomohito/0000-0002-2963-7895; Sakata, Yasushi/0000-0002-5618-4721	Japanese Circulation Society Grant for Translational Research; Ministry of Health, Labor, and Welfare-Japan; Japan agency for medical research and development [15Aek0109069h0002]; Japan Society for the Promotion of Science [24591097, 15K09139]; Ministry of Education, Culture, Sports, Science, and Technology-Japan [26670402]; Japan Heart Foundation; Japan Intractable Diseases Research Foundation; Inoue Foundation for Science; Japan vascular disease research foundation; Takeda Science Foundation; Japan Foundation of Applied Enzymology; Mochida Memorial Foundation; Banyu Foundation; Osaka Medical Research foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [12024046]	Japanese Circulation Society Grant for Translational Research; Ministry of Health, Labor, and Welfare-Japan(Ministry of Health, Labour and Welfare, Japan); Japan agency for medical research and development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Heart Foundation; Japan Intractable Diseases Research Foundation; Inoue Foundation for Science(Inoue Foundation for Science); Japan vascular disease research foundation(Japan Vascular Disease Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Foundation of Applied Enzymology(Japan Foundation of Applied Enzymology); Mochida Memorial Foundation; Banyu Foundation; Osaka Medical Research foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japanese Circulation Society Grant for Translational Research 2014 to Y. Sakata (http://www.j-circ.or.jp/translational_research/index.htm); the Ministry of Health, Labor, and Welfare-Japan to IK (http://www.mhlw.go.jp/english/); the Japan agency for medical research and development, Grant number 15Aek0109069h0002 to ST (http://www.amed.go.jp/); the Japan Society for the Promotion of Science, Grant numbers 24591097 and 15K09139 to YA (http://www.jsps.go.jp/english/); the Ministry of Education, Culture, Sports, Science, and Technology-Japan, Project numbers 26670402 to ST (http://www.mext.go.jp/english/); Japan Heart Foundation to YA (http://www.jhf.or.jp/english/); Japan Intractable Diseases Research Foundation to YA (http://www.nanbyou.or.jp/english/index.htm); Inoue Foundation for Science to YA (http://www.inoue-zaidan.or.jp/); Japan vascular disease research foundation to YA (http://www.disclo-koeki.org/02b/00412/); Takeda Science Foundation to YA (http://www.takeda-sci.or.jp/); Japan Foundation of Applied Enzymology to YA (https://www.jfae.or.jp/); Mochida Memorial Foundation to YA (http://www.mochida.co.jp/zaidan/); Banyu Foundation to YA (http://www.banyu-zaidan.or.jp/); Osaka Medical Research foundation for intractable diseases to YA (http://www.nanbyo.or.jp/zaidan/info2013.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staffs of "Nanotechnology Platform (project No. 12024046) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan" for the technical help in the ultra-HVEM study.	Alba AC, 2009, J HEART LUNG TRANSPL, V28, P827, DOI 10.1016/j.healun.2009.04.033; Allen LA, 2012, CIRCULATION, V125, P1928, DOI 10.1161/CIR.0b013e31824f2173; Asano Y, 2004, NAT GENET, V36, P123, DOI 10.1038/ng1294; Asimaki A, 2009, NEW ENGL J MED, V360, P1075, DOI 10.1056/NEJMoa0808138; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; BARRETTO ACP, 1989, CIRCULATION, V80, P177; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; CROSS AM, 1995, AM HEART J, V129, P24, DOI 10.1016/0002-8703(95)90038-1; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; GAUBATZ JW, 1990, J BIOL CHEM, V265, P17753; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krishnamani R, 2010, NAT REV CARDIOL, V7, P71, DOI 10.1038/nrcardio.2009.222; Kubanek M, 2013, J AM COLL CARDIOL, V61, P54, DOI 10.1016/j.jacc.2012.07.072; Miller LW, 2013, J AM COLL CARDIOL, V61, P1209, DOI 10.1016/j.jacc.2012.08.1029; Moravsky G, 2013, J AM SOC ECHOCARDIOG, V26, P893, DOI 10.1016/j.echo.2013.05.012; Nohria A, 2002, JAMA-J AM MED ASSOC, V287, P628, DOI 10.1001/jama.287.5.628; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; PELLICCIA F, 1994, AM HEART J, V128, P316, DOI 10.1016/0002-8703(94)90485-5; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; SCHWARZ F, 1983, AM J CARDIOL, V51, P501, DOI 10.1016/S0002-9149(83)80088-5; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shimura Shinichiro, 2009, Tokai J Exp Clin Med, V34, P1; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Takaoka A, 2008, ULTRAMICROSCOPY, V108, P230, DOI 10.1016/j.ultramic.2007.06.008; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; YAMADA T, 1993, J AM COLL CARDIOL, V21, P628, DOI 10.1016/0735-1097(93)90094-H; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yokota Takashi, 2011, Nihon Rinsho, V69, P1691; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	33	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148209	10.1371/journal.pone.0148209	http://dx.doi.org/10.1371/journal.pone.0148209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845691	Green Published, Green Submitted, gold			2022-12-26	WOS:000369552800037
J	Komoto, S; Tacharoenmuang, R; Guntapong, R; Ide, T; Tsuji, T; Yoshikawa, T; Tharmaphornpilas, P; Sangkitporn, S; Taniguchi, K				Komoto, Satoshi; Tacharoenmuang, Ratana; Guntapong, Ratigorn; Ide, Tomihiko; Tsuji, Takao; Yoshikawa, Tetsushi; Tharmaphornpilas, Piyanit; Sangkitporn, Somchai; Taniguchi, Koki			Reassortment of Human and Animal Rotavirus Gene Segments in Emerging DS-1-Like G1P[8] Rotavirus Strains	PLOS ONE			English	Article							WHOLE-GENOMIC ANALYSIS; SEQUENCE ANALYSES; BOVINE; PORCINE; IDENTIFICATION; CLASSIFICATION; GENOTYPE; REVEALS; NSP4	The emergence and rapid spread of novel DS-1-like G1P[8] human rotaviruses in Japan were recently reported. More recently, such intergenogroup reassortant strains were identified in Thailand, implying the ongoing spread of unusual rotavirus strains in Asia. During rotavirus surveillance in Thailand, three DS-1-like intergenogroup reassortant strains having G3P[8] (RVA/Human-wt/THA/SKT-281/2013/G3P[8] and RVA/Human-wt/THA/SKT289/2013/G3P[8]) and G2P[8] (RVA/Human-wt/THA/LS-04/2013/G2P[8]) genotypes were identified in fecal samples from hospitalized children with acute gastroenteritis. In this study, we sequenced and characterized the complete genomes of strains SKT-281, SKT-289, and LS-04. On whole genomic analysis, all three strains exhibited unique genotype constellations including both genogroup 1 and 2 genes: G3-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2 for strains SKT-281 and SKT-289, and G2-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2 for strain LS-04. Except for the G genotype, the unique genotype constellation of the three strains (P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2) is commonly shared with DS-1-like G1P[8] strains. On phylogenetic analysis, nine of the 11 genes of strains SKT-281 and SKT-289 (VP4, VP6, VP1-3, NSP1-3, and NSP5) appeared to have originated from DS-1-like G1P[8] strains, while the remaining VP7 and NSP4 genes appeared to be of equine and bovine origin, respectively. Thus, strains SKT-281 and SKT-289 appeared to be reassortant strains as to DS-1-like G1P[8], animal-derived human, and/or animal rotaviruses. On the other hand, seven of the 11 genes of strain LS-04 (VP7, VP6, VP1, VP3, and NSP3-5) appeared to have originated from locally circulating DS-1-like G2P[4] human rotaviruses, while three genes (VP4, VP2, and NSP1) were assumed to be derived from DS-1-like G1P[8] strains. Notably, the remaining NSP2 gene of strain LS-04 appeared to be of bovine origin. Thus, strain LS-04 was assumed to be a multiple reassortment strain as to DS-1-like G1P[8], locally circulating DS-1-like G2P[4], bovine-like human, and/or bovine rotaviruses. Overall, the great genomic diversity among the DS-1-like G1P[8] strains seemed to have been generated through reassortment involving human and animal strains. To our knowledge, this is the first report on whole genome-based characterization of DS-1-like intergenogroup reassortant strains having G3P[8] and G2P[8] genotypes that have emerged in Thailand. Our observations will provide important insights into the evolutionary dynamics of emerging DS-1-like G1P[8] strains and related reassortant ones.	[Komoto, Satoshi; Ide, Tomihiko; Taniguchi, Koki] Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan; [Tacharoenmuang, Ratana; Guntapong, Ratigorn; Sangkitporn, Somchai] Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan; [Yoshikawa, Tetsushi] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 47011, Japan; [Tharmaphornpilas, Piyanit] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand	Fujita Health University; Ministry of Public Health - Thailand; Fujita Health University; Fujita Health University; Ministry of Public Health - Thailand	Komoto, S (corresponding author), Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan.	satoshik@fujita-hu.ac.jp			MEXT; Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development, AMED; Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand; Grants-in-Aid for Scientific Research [15K08478] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2010-2014 (KT), the Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development, AMED (KT), and the Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooney MA, 2001, J MED MICROBIOL, V50, P462, DOI 10.1099/0022-1317-50-5-462; Donato CM, 2014, INFECT GENET EVOL, V25, P97, DOI 10.1016/j.meegid.2014.04.009; Doro R, 2014, INFECT GENET EVOL, V28, P495, DOI 10.1016/j.meegid.2014.09.016; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fujii Y, 2014, INFECT GENET EVOL, V28, P426, DOI 10.1016/j.meegid.2014.08.001; Ghosh S, 2011, FUTURE MICROBIOL, V6, P1049, DOI [10.2217/FMB.11.90, 10.2217/fmb.11.90]; Gulati BR, 2007, J CLIN MICROBIOL, V45, P972, DOI 10.1128/JCM.01696-06; Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08; Ide T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124965; Jere KC, 2012, VET MICROBIOL, V159, P245, DOI 10.1016/j.vetmic.2012.03.040; Kahn G, 2012, INDIAN PEDIATR, V49, P467, DOI 10.1007/s13312-012-0076-7; Komoto S, 2006, P NATL ACAD SCI USA, V103, P4646, DOI 10.1073/pnas.0509385103; Komoto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141739; Komoto S, 2014, VET MICROBIOL, V174, P577, DOI 10.1016/j.vetmic.2014.09.033; Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002; Kuzuya M, 2014, J MED VIROL, V86, P1056, DOI 10.1002/jmv.23746; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Malasao R, 2015, VIRUS GENES, V50, P129, DOI 10.1007/s11262-014-1135-z; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; Nyaga MM, 2015, INFECT GENET EVOL, V31, P321, DOI 10.1016/j.meegid.2015.02.011; O'Shea H, 2014, VET MICROBIOL, V170, P151, DOI 10.1016/j.vetmic.2014.01.012; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Schoondermark-van de Ven E, 2013, VET MICROBIOL, V166, P154, DOI 10.1016/j.vetmic.2013.05.028; Steyer A, 2013, INFECT GENET EVOL, V13, P89, DOI 10.1016/j.meegid.2012.09.004; Tacharoenmuang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139381; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Yamamoto SP, 2014, EMERG INFECT DIS, V20, P1030, DOI 10.3201/eid2006.131326	35	62	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148416	10.1371/journal.pone.0148416	http://dx.doi.org/10.1371/journal.pone.0148416			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845439	gold, Green Submitted, Green Published			2022-12-26	WOS:000369552800055
J	Zelle, DM; Corpeleijn, E; Klaassen, G; Schutte, E; Navis, G; Bakker, SJL				Zelle, Dorien M.; Corpeleijn, Eva; Klaassen, Gerald; Schutte, Elise; Navis, Gerjan; Bakker, Stephan J. L.			Fear of Movement and Low Self-Efficacy Are Important Barriers in Physical Activity after Renal Transplantation	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; LEISURE-TIME; KIDNEY-TRANSPLANTATION; ACTIVITY QUESTIONNAIRE; HEMODIALYSIS-PATIENTS; PSYCHOMETRIC PROPERTIES; PRIMARY PREVENTION; DIABETES-MELLITUS; AVOIDANCE MODEL; CHRONIC PAIN	Background Physical activity (PA) and exercise are commonly used as preventive measures for cardiovascular disease in the general population, and could be effective in the management of post-transplantation cardiovascular risk. PA levels are low after renal transplantation and very few renal transplant recipients (RTR) meet the PA guidelines. Identification of barriers to regular PA is important to identify targets for intervention to improve PA levels after renal transplantation. We investigated fear of movement and physical self-efficacy as barriers to PA in RTR. Methods RTR were investigated between 2001-2003. The Tampa Score of Kinesiophobia-Dutch Version (TSK-11) was used to assess fear of movement. Physical self-efficacy was measured with the LIVAS-scale. PA was assessed using validated questionnaires (Tecumseh Occupational Activity Questionnaire and the Minnesota Leisure Time Physical Activity Questionnaire). Results A total of 487 RTR (age 51+/-12 years, 55% men) were studied. Median score [interquartile range] on TSK-11 was 22 [17-26]. Low physical self-efficacy (Exp B:0.41[0.31-0.54], p<0.001) and history of myocardial infarction, transient ischemic attack and cerebrovascular accident (Exp B: 1.30[1.03-1.63], p = 0.03) were independent determinants for fear of movement. Fear of movement was associated with lower daily PA, occupational, sports and leisure time PA. Mediation-analysis showed that a large part (73%) of the effect of fear of movement on PA was explained by low physical self-efficacy. Conclusions This study was the first to examine fear of movement and self-efficacy in relation to PA in RTR. Fear of movement was associated with a low PA level, and the larger part of this relation was mediated by low physical self-efficacy. Both fear of movement and physical self-efficacy level are important targets for intervention during rehabilitation after renal transplantation.	[Zelle, Dorien M.; Klaassen, Gerald; Schutte, Elise; Navis, Gerjan; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Corpeleijn, Eva] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen	Zelle, DM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands.	d.m.zelle@umcg.nl		Corpeleijn, Eva/0000-0002-2974-3305				Aakhus S, 2004, CLIN TRANSPLANT, V18, P596, DOI 10.1111/j.1399-0012.2004.00235.x; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; AINSWORTH BE, 1993, J OCCUP ENVIRON MED, V35, P1017; Ainsworth BE, 1999, J CLIN EPIDEMIOL, V52, P219, DOI 10.1016/S0895-4356(98)00158-9; [Anonymous], 2009, AM J TRANSPLANT, V9, pS1, DOI [10.1111/j.1600-6143.2009.02834.x, DOI 10.1111/J.1600-6143.2009.02834.X]; Arrindell WA, 2003, SCL 90 SYMPTOM CHECK; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2366, DOI 10.1097/01.ASN.0000083905.72794.E6; Blanchard C, 2015, REHABIL PSYCHOL, V60, P59, DOI 10.1037/rep0000024; Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294; Conway JM, 2002, J CLIN EPIDEMIOL, V55, P392, DOI 10.1016/S0895-4356(01)00497-8; Cook AJ, 2006, PAIN, V121, P195, DOI 10.1016/j.pain.2005.11.018; de Vries APJ, 2004, AM J TRANSPLANT, V4, P1675, DOI 10.1111/j.1600-6143.2004.00558.x; Dontje ML, 2014, CLIN TRANSPLANT, V28, P394, DOI 10.1111/ctr.12325; FOLSOM AR, 1986, J CHRON DIS, V39, P505, DOI 10.1016/0021-9681(86)90195-5; Goedendorp MM, 2013, TRANSPL INT, V26, P1007, DOI 10.1111/tri.12166; Gordon EJ, 2009, CHRONIC ILLN, V5, P75, DOI 10.1177/1742395309103558; Hart DL, 2009, PHYS THER, V89, P770, DOI 10.2522/ptj.20080227; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; JENNINGS G, 1986, CIRCULATION, V73, P30, DOI 10.1161/01.CIR.73.1.30; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Koho P, 2011, J REHABIL MED, V43, P794, DOI 10.2340/16501977-0850; Kumar R, 2012, TRANSPL P, V44, P1270, DOI 10.1016/j.transproceed.2012.01.111; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee LL, 2008, INT J NURS STUD, V45, P1690, DOI 10.1016/j.ijnurstu.2008.02.012; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Leventhal H., 2003, SELF REGULATION HLTH, P42, DOI DOI 10.4324/9780203553220; Luk WSC, 2004, J CLIN NURS, V13, P201; MERCIER JG, 1995, AM J RESP CRIT CARE, V151, P1532, DOI 10.1164/ajrccm.151.5.7735611; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Montoye HJ, 1996, MEASURING PHYS ACTIV; Nijs J, 2004, ARCH PHYS MED REHAB, V85, P1586, DOI 10.1016/j.apmr.2003.12.033; Olander EK, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-29; Oterdoom LH, 2009, ATHEROSCLEROSIS, V207, P534, DOI 10.1016/j.atherosclerosis.2009.05.010; Oterdoom LH, 2009, TRANSPLANTATION, V87, P1562, DOI 10.1097/TP.0b013e3181a4bb80; Painter P, 1999, ADV RENAL REPLACE TH, V6, P159, DOI 10.1016/S1073-4449(99)70034-8; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Proctor DN, 1999, AM J PHYSIOL-ENDOC M, V277, pE489, DOI 10.1152/ajpendo.1999.277.3.E489; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; RYCKMAN RM, 1982, J PERS SOC PSYCHOL, V42, P891, DOI 10.1037/0022-3514.42.5.891; Sato Y, 2003, EXP BIOL MED, V228, P1208, DOI 10.1177/153537020322801017; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Stevens M, 2005, PATIENT EDUC COUNS, V58, P121, DOI 10.1016/j.pec.2004.07.005; Tkachuk GA, 2012, J PAIN, V13, P970, DOI 10.1016/j.jpain.2012.07.001; van den Ham ECH, 2005, AM J TRANSPLANT, V5, P1957, DOI 10.1111/j.1600-6143.2005.00944.x; van den Ham ECH, 2007, TRANSPLANTATION, V83, P1059, DOI 10.1097/01.tp.0000259552.55689.fd; Van der Mei SF, 2007, DISABIL REHABIL, V29, P473, DOI 10.1080/09638280600841257; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Williams SL, 2011, HEALTH EDUC RES, V26, P308, DOI 10.1093/her/cyr005; Woby SR, 2005, PAIN, V117, P137, DOI 10.1016/j.pain.2005.05.029; Young MD, 2014, OBES REV, V15, P983, DOI 10.1111/obr.12225; Zelle DM, 2013, CLIN TRANSPLANT, V27, pE484, DOI 10.1111/ctr.12149; Zelle DM, 2012, TRANSPLANTATION, V94, P1033, DOI 10.1097/TP.0b013e31826bc3c8; Zelle DM, 2011, CLIN J AM SOC NEPHRO, V6, P898, DOI 10.2215/CJN.03340410	59	48	57	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147609	10.1371/journal.pone.0147609	http://dx.doi.org/10.1371/journal.pone.0147609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26844883	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800011
J	Darshan, A; Kachari, A; Dutta, R; Ganguly, A; Das, DN				Darshan, Achom; Kachari, Akash; Dutta, Rashmi; Ganguly, Arijit; Das, Debangshu Narayan			Amblyceps waikhomi, a New Species of Catfish (Siluriformes: Amblycipitidae) from the Brahmaputra Drainage of Arunachal Pradesh, India	PLOS ONE			English	Article							TELEOSTEI; GENUS	Amblyceps waikhomi sp. nov. is described from the Nongkon stream which drains into the Noa Dehing River, a tributary of the Brahmaputra River, in Arunachal Pradesh, India. The new species can be distinguished from congeners (except A. torrentis) in having a deeper body depth at anus. It further differs from congeners (except A. mangois and A. serratum) in having fewer vertebrae, from A. mangois in lacking (vs. having) strongly-developed projections on the proximal lepidotrichia of the median caudal-fin rays, and in having a longer, wider, and deeper head; and from A. serratum in having a posteriorly smooth (vs. with 4-5 serrations) pectoral spine, and unequal jaw length (lower jaw longer and weakly-projecting anteriorly vs. equal upper and lower jaws). It additionally differs from A. murraystuarti, A. torrentis, A. apangi, A. laticeps, and A. cerinum in having a deeply forked (vs. emarginate or truncate) caudal fin. This species is the seventh amblycipitid species known to occur in the Ganga-Brahmaputra River system.	[Darshan, Achom; Dutta, Rashmi; Das, Debangshu Narayan] Rajiv Gandhi Univ, Ctr Potential Excellence Biodivers, Rono Hills, Doimukh, India; [Kachari, Akash; Dutta, Rashmi; Ganguly, Arijit; Das, Debangshu Narayan] Rajiv Gandhi Univ, Dept Zool, Fishery & Aquat Ecol Lab, Rono Hills, Doimukh, India; [Ganguly, Arijit] Achhruram Mem Coll, Dept Zool, Jhalda, Purulia, India	Rajiv Gandhi University, Itanagar; Rajiv Gandhi University, Itanagar	Darshan, A (corresponding author), Rajiv Gandhi Univ, Ctr Potential Excellence Biodivers, Rono Hills, Doimukh, India.	achom_darshan@yahoo.com	Das, Debangshu/AAU-1538-2020	Das, Debangshu/0000-0001-5164-4322; Singh, Achom/0000-0001-7679-3519; Das, Debangshu/0000-0002-8747-2267	University Grants Commission (UGC), New Delhi [1-15/2002/2011, F1.17.1/2013-14/RGNF.2013-14-ST-ASS-41715]	University Grants Commission (UGC), New Delhi(University Grants Commission, India)	This work has been supported by University Grants Commission (UGC), New Delhi, through the Centre with Potential for Excellence in Biodiversity (CPEB) scheme [F.No. 1-15/2002/2011 (NS/PE), dated 20th March, 2012] to carry out the research work, and also through Rajiv Gandhi National Fellowship scheme (F1.17.1/2013-14/RGNF.2013-14-ST-ASS-41715, dated 6th February, 2014) as fellowship to the second author. However no fund has been allotted for publication under the mentioned schemes.	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Chen XP, 1995, COPEIA, P780; Eschmeyer WN, CATALOG FISHES GENER; HOLLISTER GLORIA, 1934, ZOOLOGICA [NEW YORK], V12, P89; Linthoingambi I, 2008, ICHTHYOL EXPLOR FRES, V19, P167; Ng H.H., 2001, Ichthyological Exploration of Freshwaters, V12, P201; Ng H.H., 2000, Ichthyological Exploration of Freshwaters, V11, P335; Ng HH, 2010, ZOOTAXA, P50; Ng HH, 2009, COPEIA, P369, DOI 10.1643/CI-08-113; Ng HH, 2005, RAFFLES B ZOOL, V53, P243; Roberts T.R., 1992, Ichthyological Exploration of Freshwaters, V3, P77; Roberts Tyson R., 1994, Ichthyological Exploration of Freshwaters, V5, P241	12	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147283	10.1371/journal.pone.0147283	http://dx.doi.org/10.1371/journal.pone.0147283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840400	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200030
J	Glass, JR; Davis, M; Walsh, TJ; Sargis, EJ; Caccone, A				Glass, Jessica R.; Davis, Matt; Walsh, Timothy J.; Sargis, Eric J.; Caccone, Adalgisa			Was Frozen Mammoth or Giant Ground Sloth Served for Dinner at The Explorers Club?	PLOS ONE			English	Article							EXPLOITATION; MEGALONYX	Accounts of woolly mammoths (Mammuthus primigenius) preserved so well in ice that their meat is still edible have a long history of intriguing the public and influencing paleontological thought on Quaternary extinctions and climate, with some scientists resorting to catastrophism to explain the instantaneous freezing necessary to preserve edible meat. Famously, members of The Explorers Club purportedly dined on frozen mammoth from Alaska, USA, in 1951. This event, well received by the press and general public, became an enduring legend for the Club and popularized the notorious annual tradition of serving rare and exotic food at Club dinners that continues to this day. The Yale Peabody Museum holds a sample of meat preserved from the 1951 meal, interestingly labeled as a South American giant ground sloth (Megatherium), not mammoth. We sequenced a fragment of the mitochondrial cytochrome-b gene and studied archival material to verify its identity, which if genuine, would extend the range of Megatherium over 600% and alter our views on ground sloth evolution. Our results indicate that the meat was not mammoth or Megatherium but green sea turtle (Chelonia mydas). The prehistoric dinner was likely an elaborate publicity stunt. Our study emphasizes the value of museums collecting and curating voucher specimens, particularly those used for evidence of extraordinary claims.	[Glass, Jessica R.; Sargis, Eric J.; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Glass, Jessica R.; Sargis, Eric J.] Yale Univ, Div Vertebrate Zool, Yale Peabody Museum Nat Hist, New Haven, CT USA; [Davis, Matt] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Walsh, Timothy J.] Bruce Museum, Greenwich, CT USA; [Sargis, Eric J.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Caccone, Adalgisa] Yale Univ, Inst Biospher Studies, Mol Systemat & Conservat Genet Ctr, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	Glass, JR (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.; Glass, JR (corresponding author), Yale Univ, Div Vertebrate Zool, Yale Peabody Museum Nat Hist, New Haven, CT USA.	jessica.glass@yale.edu	Caccone, Adalgisa/AAE-4238-2021	Caccone, Adalgisa/0000-0002-8949-9260; Glass, Jessica/0000-0002-9843-1786	Explorers Club Exploration Fund; Yale Institute for Biospheric Studies	Explorers Club Exploration Fund; Yale Institute for Biospheric Studies	Funding was received by JRG from The Explorers Club Exploration Fund (https://explorers.org/expeditions/funding/expedition_grants) and by AC from the Yale Institute for Biospheric Studies (http://yibs.yale.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2007, THE STRAIGHT DOPE; Adelman L, 1957, HARTFORD COURAN 0118, P17; Adelman L, 1957, THE HARTFORD COURANT, p1B; [Anonymous], 1951, NEW YORK HERALD TRIB, P40; [Anonymous], 1950, NY TIMES, P10; [Anonymous], 1962, NY TIMES, P27; [Anonymous], 1951, W AUSTR         0219, P4; Cartelle C, 2006, J SYST PALAEONTOL, V4, P199, DOI 10.1017/S1477201905001781; Cowen RC, 1983, CHRISTIAN SCI MONITO, P24; Darwin C., 1887, LIFE LETT C DARWIN; Darwin C, 1839, J AND REMARKS; Dodge WP, 1950, EXPLOR J, V28, P17; Dodge WP, 1951, EXPLOR J, V29, P45; FARRAND WR, 1961, SCIENCE, V133, P729, DOI 10.1126/science.133.3455.729; Graham R.W., 2010, FAUNMAP 2 NEW DATA N; Grayson DK, 2015, J ARCHAEOL SCI, V56, P177, DOI 10.1016/j.jas.2015.02.009; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Haverlee AH, 1971, EXPLORERS COOKBOOK, P103; Howland JA, 1912, CHICAGO DAILY TRIBUN, pD2; Hubbard BR, 1932, MUSH YOU MALEMUTES; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keyser H, 2014, MENTAL FLOSS; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kosco WG, 2010, FOX 10 NEWS     0902; Lee PY, 2013, GAME; Louie E, 2013, NY TIMES; Lucas FA, 1901, ANN REP BOARD REGENT, P353; McDonald HG, 2000, ARCTIC, V53, P213; Murphy T, 1957, HARTFORD COURAN 0117, P12; Nichols HB, 1951, CHRISTIAN SCI MONITO, P3; Pfizenmayer EW, 1939, SIBERIAN MAN MAMMOTH; Ramde D, 2008, US TODAY; Rasmussen Pamela C., 2003, Bulletin of the British Ornithologists' Club, V123A, P66; Ray CE, 1979, NOTULAE NATURAE ACAD, V455, P1; Redmond BG, 2012, WORLD ARCHAEOL, V44, P75, DOI 10.1080/00438243.2012.647576; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schoch RM, 2002, HORNS TUSKS HOOVES A; Seminoff J.A., 2004, 2004 IUCN RED LIST T, DOI [https://dx.doi.org/10.2305/IUCN.UK.2004.RLTS.T4615A11037468.en, DOI 10.2305/IUCN.UK.2004.RLTS.T4615A11037468.EN]; Shapiro Beth, 2015, CLONE MAMMOTH; Sparks F, 1946, DAILY BOSTON GL 1205, P16; Stein FW, 1842, SCHRIFTEN ST PETERSB, V1, P199; Stone R, 2001, MAMMOTH; Tait J, 1954, NEW YORK HERALD TRIB, P13; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TIKHOMIROV BA, 1962, GEOGR J, V128, P443, DOI 10.2307/1792040; Tolmachoff IP., 1929, T AM PHILOS SOC, V23, pi, DOI [10.2307/1005437, DOI 10.2307/1005437]; Veltre DW, 2008, QUATERNARY RES, V70, P40, DOI 10.1016/j.yqres.2008.03.006; Whiton LC, 1980, EXPLOR J, V58, P110; Williams CS, 1971, THE EXPLORERS COOKBO, P219	51	4	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146825	10.1371/journal.pone.0146825	http://dx.doi.org/10.1371/journal.pone.0146825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840445	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200018
J	Hevia, A; Milani, C; Lopez, P; Donado, CD; Cuervo, A; Gonzalez, S; Suarez, A; Turroni, F; Gueimonde, M; Ventura, M; Sanchez, B; Margolles, A				Hevia, Arancha; Milani, Christian; Lopez, Patricia; Donado, Carmen D.; Cuervo, Adriana; Gonzalez, Sonia; Suarez, Ana; Turroni, Francesca; Gueimonde, Miguel; Ventura, Marco; Sanchez, Borja; Margolles, Abelardo			Allergic Patients with Long-Term Asthma Display Low Levels of Bifidobacterium adolescentis	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; FECAL MICROBIOTA; GUT MICROBIOTA; IMMUNE-RESPONSES; DISEASE; DIVERSITY; INFANTS; HEALTHY; RISK; MILK	Accumulated evidence suggests a relationship between specific allergic processes, such as atopic eczema in children, and an aberrant fecal microbiota. However, little is known about the complete microbiota profile of adult individuals suffering from asthma. We determined the fecal microbiota in 21 adult patients suffering allergic asthma (age 39.43 +/- 10.98 years old) and compare it with the fecal microbiota of 22 healthy controls (age 39.29 +/- 9.21 years old) using culture independent techniques. An Ion-Torrent 16S rRNA gene-based amplification and sequencing protocol was used to determine the fecal microbiota profile of the individuals. Sequence microbiota analysis showed that the microbial alpha-diversity was not significantly different between healthy and allergic individuals and no clear clustering of the samples was obtained using an unsupervised principal component analysis. However, the analysis of specific bacterial groups allowed us to detect significantly lower levels of bifidobacteria in patients with long-term asthma. Also, in allergic individuals the Bifidobacterium adolescentis species prevailed within the bifidobacterial population. The reduction in the levels on bifidobacteria in patients with long-term asthma suggests a new target in allergy research and opens possibilities for the therapeutic modulation of the gut microbiota in this group of patients.	[Hevia, Arancha; Gueimonde, Miguel; Sanchez, Borja; Margolles, Abelardo] CSIC, IPLA, Villaviciosa, Asturias, Spain; [Milani, Christian; Turroni, Francesca; Ventura, Marco] Univ Parma, Dept Life Sci, Lab Probiogen, I-43100 Parma, Italy; [Lopez, Patricia; Suarez, Ana] Univ Oviedo, Dept Funct Biol, Immunol Area, Oviedo, Asturias, Spain; [Donado, Carmen D.] Hosp Univ Cent Asturias, Allergy Unit, Oviedo, Asturias, Spain; [Cuervo, Adriana; Gonzalez, Sonia] Univ Oviedo, Dept Funct Biol, Physiol Area, Oviedo, Asturias, Spain; [Sanchez, Borja] Univ Vigo, Fac Food Sci & Technol, Dept Analyt Chem & Food Sci, Orense, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); University of Parma; University of Oviedo; Central University Hospital Asturias; University of Oviedo; Universidade de Vigo	Sanchez, B; Margolles, A (corresponding author), CSIC, IPLA, Villaviciosa, Asturias, Spain.; Sanchez, B (corresponding author), Univ Vigo, Fac Food Sci & Technol, Dept Analyt Chem & Food Sci, Orense, Spain.	borja.sanchez@uvigo.es; amargolles@ipla.csic.es	Turroni, Francesca/K-9660-2016; Milani, Christian/ABA-8160-2020; Margolles, Abelardo/H-3871-2012; López, Patricia/B-8603-2018; González-Solares, Sonia/P-6720-2015; ventura, marco/M-8230-2015; Gueimonde, Miguel/A-2106-2008; Donado, Carmen Diaz/AAL-5678-2021; Suarez, Ana/F-4492-2015; Hevia-Gonzalez, Arancha/Q-9758-2017	Turroni, Francesca/0000-0001-5363-0231; Margolles, Abelardo/0000-0003-2278-1816; López, Patricia/0000-0002-1843-0653; González-Solares, Sonia/0000-0003-2602-7036; Gueimonde, Miguel/0000-0002-0192-901X; Donado, Carmen Diaz/0000-0001-8919-972X; Suarez, Ana/0000-0002-4452-7539; Hevia-Gonzalez, Arancha/0000-0001-8446-7203	 [AGL2010-14952]		This work was supported by AGL2010-14952, http://www.idi.mineco.gob.es/.	[Anonymous], 1997, J ALLERGY CLIN IMMUN, V99, P583; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Executive Committee GEMA 2009, 2010, J Investig Allergol Clin Immunol, V20 Suppl 1, P1; Fiocchi A, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0055-2; Fujimoto T, 2013, J GASTROEN HEPATOL, V28, P613, DOI 10.1111/jgh.12073; GINA Global Initiative for Asthma, 2014, NHBLI WHO WORKSH; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; He F, 2001, FEMS IMMUNOL MED MIC, V30, P43, DOI 10.1111/j.1574-695X.2001.tb01548.x; Hevia A, 2014, MBIO, V5, DOI 10.1128/mBio.01548-14; Lau S, 2006, LANCET, V367, P1556, DOI 10.1016/S0140-6736(06)68670-4; Ling ZX, 2014, APPL ENVIRON MICROB, V80, P2546, DOI 10.1128/AEM.00003-14; Maizels RM, 2014, CLIN EXP IMMUNOL, V177, P38, DOI 10.1111/cei.12353; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P37, DOI 10.1111/j.1348-0421.2007.tb03888.x; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Nylund L, 2015, ALLERGY, V70, P241, DOI 10.1111/all.12549; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Singh M, 2010, PEDIAT ALLERG IMM-UK, V21, pE368, DOI 10.1111/j.1399-3038.2009.00921.x; Stsepetove J, 2007, FEMS IMMUNOL MED MIC, V51, P260, DOI 10.1111/j.1574-695X.2007.00306.x; Thompson-Chagoyan OC, 2010, PEDIAT ALLERG IMM-UK, V21, pE394, DOI 10.1111/j.1399-3038.2009.00961.x; West CE, 2015, CLIN EXP ALLERGY, V45, P43, DOI 10.1111/cea.12332; Wopereis H, 2014, PEDIAT ALLERG IMM-UK, V25, P428, DOI 10.1111/pai.12232	28	62	67	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147809	10.1371/journal.pone.0147809	http://dx.doi.org/10.1371/journal.pone.0147809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840903	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200062
J	Rulifson, IC; Cao, P; Miao, L; Kopecky, D; Huang, LD; White, RD; Samayoa, K; Gardner, J; Wu, XS; Chen, K; Tsuruda, T; Homann, O; Baribault, H; Yamane, H; Carlson, T; Wiltzius, J; Li, Y				Rulifson, Ingrid C.; Cao, Ping; Miao, Li; Kopecky, David; Huang, Linda; White, Ryan D.; Samayoa, Kim; Gardner, Jonitha; Wu, Xiaosu; Chen, Kui; Tsuruda, Trace; Homann, Oliver; Baribault, Helene; Yamane, Harvey; Carlson, Tim; Wiltzius, Jed; Li, Yang			Identification of Human Islet Amyloid Polypeptide as a BACE2 Substrate	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; PRECURSOR PROTEIN; FIBRIL FORMATION; ALZHEIMERS-DISEASE; HUMAN AMYLIN; FULL-LENGTH; SECRETASE; INSULIN; LANGERHANS; IAPP	Pancreatic amyloid formation by islet amyloid polypeptide ( IAPP) is a hallmark pathological feature of type 2 diabetes. IAPP is stored in the secretory granules of pancreatic beta-cells and co-secreted with insulin to maintain glucose homeostasis. IAPP is innocuous under homeostatic conditions but imbalances in production or processing of IAPP may result in homodimer formation leading to the rapid production of cytotoxic oligomers and amyloid fibrils. The consequence is beta-cell dysfunction and the accumulation of proteinaceous plaques in and around pancreatic islets. Beta-site APP-cleaving enzyme 2, BACE2, is an aspartyl protease commonly associated with BACE1, a related homolog responsible for amyloid processing in the brain and strongly implicated in Alzheimer's disease. Herein, we identify two distinct sites of the mature human IAPP sequence that are susceptible to BACE2-mediated proteolytic activity. The result of proteolysis is modulation of human IAPP fibrillation and human IAPP protein degradation. These results suggest a potential therapeutic role for BACE2 in type 2 diabetes-associated hyperamylinaemia.	[Rulifson, Ingrid C.; Miao, Li; Gardner, Jonitha; Wu, Xiaosu; Baribault, Helene; Li, Yang] Amgen Inc, Cardiometab Disorders, San Francisco, CA USA; [Cao, Ping; Huang, Linda] Amgen Inc, Mol Struct & Characterizat, San Francisco, CA USA; [Kopecky, David] Amgen Inc, Med Chem, Thousand Oaks, CA USA; [White, Ryan D.] Amgen Inc, Med Chem, Cambridge, MA USA; [Samayoa, Kim] Amgen Inc, Pathol, San Francisco, CA USA; [Chen, Kui] Amgen Inc, Discovery Technol, Thousand Oaks, CA USA; [Tsuruda, Trace; Yamane, Harvey] Amgen Inc, Biol, Thousand Oaks, CA USA; [Homann, Oliver; Wiltzius, Jed] Amgen Inc, Genome Anal Unit, San Francisco, CA USA; [Carlson, Tim] Amgen Inc, Pharmacokinet & Drug Metab, San Francisco, CA USA	Amgen; Amgen; Amgen; Amgen; Amgen; Amgen; Amgen; Amgen; Amgen	Rulifson, IC (corresponding author), Amgen Inc, Cardiometab Disorders, San Francisco, CA USA.	ingridr@amgen.com						Abdul-Hay SO, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-46; Alcarraz-Vizan G, 2015, FASEB J, V29, P95, DOI 10.1096/fj.14-255489; Altirriba J, 2010, DIABETOLOGIA, V53, P1406, DOI 10.1007/s00125-010-1728-6; Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; Azkona G, 2010, AMINO ACIDS, V39, P1571, DOI 10.1007/s00726-010-0662-8; Badman MK, 1996, FEBS LETT, V378, P227, DOI 10.1016/0014-5793(95)01460-8; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Bolder SG, 2007, LANGMUIR, V23, P4144, DOI 10.1021/la063048k; Casas S, 2010, AM J PHYSIOL-ENDOC M, V299, pE1087, DOI 10.1152/ajpendo.00420.2010; Cheng Y, 2015, ACS MED CHEM LETT, V6, P210, DOI 10.1021/ml500458t; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; EHRLICH JC, 1961, AM J PATHOL, V38, P49; Esterhazy D, 2011, CELL METAB, V14, P365, DOI 10.1016/j.cmet.2011.06.018; Exley C, 2010, J INORG BIOCHEM, V104, P1125, DOI 10.1016/j.jinorgbio.2010.05.012; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Finzi G, 2008, ULTRASTRUCT PATHOL, V32, P246, DOI 10.1080/01913120802486217; Gebre-Medhin S, 2000, DIABETOLOGIA, V43, P687, DOI 10.1007/s001250051364; Gilead S, 2006, ANGEW CHEM INT EDIT, V45, P6476, DOI 10.1002/anie.200602034; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; Green J, 2003, J MOL BIOL, V326, P1147, DOI 10.1016/S0022-2836(02)01377-3; Gregory L, 2007, JOVE-J VIS EXP, V7, P255, DOI [10.3791/255, DOI 10.3791/255]; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hussain I, 2000, MOL CELL NEUROSCI, V16, P609, DOI 10.1006/mcne.2000.0884; HUTTON JC, 1989, DIABETOLOGIA, V32, P271, DOI 10.1007/BF00265542; Jackson K, 2013, ANN NEUROL, V74, P517, DOI 10.1002/ana.23956; Jaikaran ETAS, 2004, BIOCHEM J, V377, P709, DOI 10.1042/bj20030852; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Kahn SE, 1998, DIABETES, V47, P640, DOI 10.2337/diabetes.47.4.640; Kim YT, 2002, EUR J BIOCHEM, V269, P5668, DOI 10.1046/j.1432-1033.2002.03277.x; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Krampert M, 2000, CHEM BIOL, V7, P855, DOI 10.1016/S1074-5521(00)00034-X; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g; National Research Council, 2011, GUID CAR US LAB AN, P8; Nilsson MR, 1999, J MOL BIOL, V294, P1375, DOI 10.1006/jmbi.1999.3286; NISHI M, 1990, J BIOL CHEM, V265, P4173; Opie Eugene L, 1900, J Boston Soc Med Sci, V4, P251; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Peter ODonnell UN, 2014, ALZHEIMERS AND DEMEN, V10, pP491; Pillay K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/826706; Rondas D, 2013, DIABETES OBES METAB, V15, P185, DOI 10.1111/dom.12165; Stutzer I, 2013, J BIOL CHEM, V288, P10536, DOI 10.1074/jbc.M112.444703; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; Turner RT, 2001, BIOCHEMISTRY-US, V40, P10001, DOI 10.1021/bi015546s; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; Vignini A, 2013, CURR DIABETES REV, V9, P218, DOI 10.2174/1573399811309030003; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Wiltzius JJW, 2009, PROTEIN SCI, V18, P1521, DOI 10.1002/pro.145; Wright AW, 1927, AM J PATHOL, V3, P461; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X	56	25	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147254	10.1371/journal.pone.0147254	http://dx.doi.org/10.1371/journal.pone.0147254			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840340	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200029
J	Schaefer, A; Schneeberger, Y; Stenzig, J; Biermann, D; Jelinek, M; Reichenspurner, H; Eschenhagen, T; Ehmke, H; Schwoerer, AP				Schaefer, Andreas; Schneeberger, Yvonne; Stenzig, Justus; Biermann, Daniel; Jelinek, Marisa; Reichenspurner, Hermann; Eschenhagen, Thomas; Ehmke, Heimo; Schwoerer, Alexander P.			A New Animal Model for Investigation of Mechanical Unloading in Hypertrophic and Failing Hearts: Combination of Transverse Aortic Constriction and Heterotopic Heart Transplantation	PLOS ONE			English	Article							RATS; FAILURE; DIAGNOSIS	Objectives Previous small animal models for simulation of mechanical unloading are solely performed in healthy or infarcted hearts, not representing the pathophysiology of hypertrophic and dilated hearts emerging in heart failure patients. In this article, we present a new and economic small animal model to investigate mechanical unloading in hypertrophic and failing hearts: the combination of transverse aortic constriction (TAC) and heterotopic heart transplantation (hHTx) in rats. Methods To induce cardiac hypertrophy and failure in rat hearts, three-week old rats underwent TAC procedure. Three and six weeks after TAC, hHTx with hypertrophic and failing hearts in Lewis rats was performed to induce mechanical unloading. After 14 days of mechanical unloading animals were euthanatized and grafts were explanted for further investigations. Results 50 TAC procedures were performed with a survival of 92% (46/50). When compared to healthy rats left ventricular surface decreased to 5.8 +/- 1.0 mm(2) (vs. 9.6 +/- 2.4 mm(2)) (p = 0.001) after three weeks with a fractional shortening (FS) of 23.7 +/- 4.3% vs. 28.2 +/- 1.5% (p = 0.01). Six weeks later, systolic function decreased to 17.1 +/- 3.2% vs. 28.2 +/- 1.5% (p = 0.0001) and left ventricular inner surface increased to 19.9 +/- 1.1 mm(2) (p = 0.0001). Intraoperative graft survival during hHTx was 80% with 46 performed procedures (37/46). All transplanted organs survived two weeks of mechanical unloading. Discussion Combination of TAC and hHTx in rats offers an economic and reproducible small animal model enabling serial examination of mechanical unloading in a truly hypertrophic and failing heart, representing the typical pressure overloaded and dilated LV, occurring in patients with moderate to severe heart failure.	[Schaefer, Andreas; Schneeberger, Yvonne; Biermann, Daniel; Reichenspurner, Hermann] Univ Heart Ctr Hamburg, Dept Cardiovasc Surg, Hamburg, Germany; [Schaefer, Andreas; Schneeberger, Yvonne; Stenzig, Justus; Reichenspurner, Hermann; Eschenhagen, Thomas; Ehmke, Heimo; Schwoerer, Alexander P.] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany; [Stenzig, Justus; Eschenhagen, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Hamburg, Germany; [Jelinek, Marisa; Ehmke, Heimo; Schwoerer, Alexander P.] Univ Med Ctr Hamburg Eppendorf, Dept Cellular & Integrat Physiol, Ctr Med Expt, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schaefer, A (corresponding author), Univ Heart Ctr Hamburg, Dept Cardiovasc Surg, Hamburg, Germany.; Schaefer, A (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany.	and.schaefer@uke.de	Schäfer, Andreas/GPJ-9458-2022					Bernhardt AM, 2014, CURR OPIN ORGAN TRAN, V19, P494, DOI 10.1097/MOT.0000000000000118; Demirozu ZT, 2011, J HEART LUNG TRANSPL, V30, P849, DOI 10.1016/j.healun.2011.03.008; Didie M, 2013, AM J PHYSIOL-HEART C, V305, pH533, DOI 10.1152/ajpheart.00218.2013; El-Armouche A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014263; Guha K, 2013, CURR CARDIOL REV, V9, P123, DOI 10.2174/1573403X11309020005; Khush KK, 2015, AM J TRANSPLANT, V15, P642, DOI 10.1111/ajt.13055; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Knapp J, 2013, RESUSCITATION, V84, P1450, DOI 10.1016/j.resuscitation.2013.04.012; Liu YH, 2015, J HEART LUNG TRANSPL, V34, P594, DOI 10.1016/j.healun.2014.11.015; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Schwoerer AP, 2013, PFLUG ARCH EUR J PHY, V465, P1763, DOI 10.1007/s00424-013-1316-y; Schwoerer AP, 2008, J MOL CELL CARDIOL, V45, P846, DOI 10.1016/j.yjmcc.2008.09.003; Schwoerer AP, 2008, J MOL CELL CARDIOL, V45, P633, DOI 10.1016/j.yjmcc.2008.02.271; Shingu Y, 2013, THORAC CARDIOV SURG, V61, P718, DOI 10.1055/s-0032-1326775; Sperry BW, 2015, HEART FAIL REV, V20, P251, DOI 10.1007/s10741-014-9459-2; Wang DH, 2006, MICROSURG, V26, P470, DOI 10.1002/micr.20272; Wang WJ, 2012, MOL BIOL REP, V39, P277, DOI 10.1007/s11033-011-0736-z; Zaha V, 2003, THORAC CARDIOV SURG, V51, P211	19	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148259	10.1371/journal.pone.0148259	http://dx.doi.org/10.1371/journal.pone.0148259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841021	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200114
J	Zetsche, EM; Baussant, T; Meysman, FJR; van Oevelen, D				Zetsche, Eva-Maria; Baussant, Thierry; Meysman, Filip J. R.; van Oevelen, Dick			Direct Visualization of Mucus Production by the Cold-Water Coral Lophelia pertusa with Digital Holographic Microscopy	PLOS ONE			English	Article							ROCKALL BANK; NE ATLANTIC; SCLERACTINIA; SEDIMENT; COMMUNITY; IMPACT	Lophelia pertusa is the dominant reef-building organism of cold-water coral reefs, and is known to produce significant amounts of mucus, which could involve an important metabolic cost. Mucus is involved in particle removal and feeding processes, yet the triggers and dynamics of mucus production are currently still poorly described because the existing tools to study these processes are not appropriate. Using a novel microscopic technique-digital holographic microscopy (DHM)-we studied the mucus release of L. pertusa under various experimental conditions. DHM technology permits mu m-scale observations and allows the visualization of transparent mucoid substances in real time without staining. Fragments of L. pertusa were first maintained in flow-through chambers without stressors and imaged with DHM, then exposed to various stressors (suspended particles, particulate food and air exposure) and re-imaged. Under non-stressed conditions no release of mucus was observed, whilst mucus strings and sheaths were produced in response to suspended particles (activated charcoal and drill cuttings sediment) i.e. in a stressed condition. Mucus strings and so-called 'string balls' were also observed in response to exposure to particulate food (brine shrimp Artemia salina). Upon air-exposure, mucus production was clearly visible once the fragments were returned to the flow chamber. Distinct optical properties such as optical path length difference (OPD) were measured with DHM in response to the various stimuli suggesting that different mucus types are produced by L. pertusa. Mucus produced to reject particles is similar in refractive index to the surrounding seawater, suggesting that the energy content of this mucus is low. In contrast, mucus produced in response to either food particle addition or air exposure had a higher refractive index, suggesting a higher metabolic investment in the production of these mucoid substances. This paper shows for the first time the potential of DHM technology for the detection, characterization and quantification of mucus production through OPD measurements in L. pertusa.	[Zetsche, Eva-Maria; Meysman, Filip J. R.] Vrije Univ Brussel, Analyt Environm & Geochem, Brussels, Belgium; [Zetsche, Eva-Maria; Meysman, Filip J. R.; van Oevelen, Dick] Royal Netherlands Inst Sea Res NIOZ Yerseke, Dept Ecosyst Studies, Yerseke, Netherlands; [Baussant, Thierry] Int Res Inst Stavanger IRIS, Randaberg, Norway; [Zetsche, Eva-Maria] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden	Vrije Universiteit Brussel; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Gothenburg	Zetsche, EM (corresponding author), Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.	eva-maria.zetsche@nioz.nl	Meysman, Filip JR/C-9585-2009; Zetsche, Eva-Maria/J-5790-2012	Meysman, Filip JR/0000-0001-5334-7655; Zetsche, Eva-Maria/0000-0001-5460-5134	Brussels Institute for Research and Innovation (INNOVIRIS - Impulse-Environment grant); Netherlands Organization for Scientific Research (NWO-VIDI); Statoil [4502229690]; Research Council of Norway's programme HavKyst [204025]	Brussels Institute for Research and Innovation (INNOVIRIS - Impulse-Environment grant)(Innoviris); Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); Statoil; Research Council of Norway's programme HavKyst(Research Council of Norway)	This work was financially supported by the Brussels Institute for Research and Innovation (INNOVIRIS - Impulse-Environment grant to FJRM) in the framework of the HoloFlow Impulse-Environment Project and by the Netherlands Organization for Scientific Research (NWO-VIDI grant to DvO). Funding for travel and subsistence for the laboratory work in Norway was provided by Statoil (contract 4502229690). The Research Council of Norway's programme HavKyst (Project number 204025) provided access to specimens of Lophelia pertusa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers E, 2013, MAR POLLUT BULL, V74, P132, DOI 10.1016/j.marpolbul.2013.07.016; Alm K., 2013, HOLOGRAPHY BASIC PRI, P335, DOI DOI 10.5772/54505; Beckmann A, 2012, INT J DEV BIOL, V56, P577, DOI 10.1387/ijdb.113472ab; Brooke SD, 2009, MAR ECOL PROG SER, V390, P137, DOI 10.3354/meps08191; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; Bythell JC, 2011, J EXP MAR BIOL ECOL, V408, P88, DOI 10.1016/j.jembe.2011.07.028; Cathalot C, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00037; COFFROTH MA, 1990, MAR BIOL, V105, P39, DOI 10.1007/BF01344269; Dubois F, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357174; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P715, DOI 10.4319/lo.1979.24.4.0715; Duerden JE, 1906, Q J MICROSC SCI, V49, P591; Duineveld GCA, 2007, B MAR SCI, V81, P449; EDMUNDS PJ, 1989, CORAL REEFS, V8, P37, DOI 10.1007/BF00304690; Freiwald A., 2004, COLD WATER CORAL REE; Freiwald Andre, 1998, Historical Biology, V13, P37; Gass SE, 2006, THESIS OPEN U; Godo OR, 2014, MAR POLLUT BULL, V84, P236, DOI 10.1016/j.marpolbul.2014.05.007; Jatkar AA, 2010, MAR BIOL, V157, P261, DOI 10.1007/s00227-009-1313-z; Kemper B, 2008, APPL OPTICS, V47, pA52, DOI 10.1364/AO.47.000A52; Larsson AI, 2013, MAR POLLUT BULL, V70, P176, DOI 10.1016/j.marpolbul.2013.02.033; Larsson AI, 2011, MAR POLLUT BULL, V62, P1159, DOI 10.1016/j.marpolbul.2011.03.041; LEWIS JB, 1976, J ZOOL, V178, P77; LEWIS JB, 1975, J ZOOL, V176, P527, DOI 10.1111/j.1469-7998.1975.tb03219.x; McClain CR, 2012, P NATL ACAD SCI USA, V109, P15366, DOI 10.1073/pnas.1208976109; Mienis F, 2007, DEEP-SEA RES PT I, V54, P1655, DOI 10.1016/j.dsr.2007.05.013; Minetti C, 2008, APPL OPTICS, V47, P5305, DOI 10.1364/AO.47.005305; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Mueller CE, 2014, BIOGEOSCIENCES, V11, P123, DOI 10.5194/bg-11-123-2014; Mueller CE, 2014, THESIS U UTRECHT; Naumann MS, 2011, J EXP BIOL, V214, P3570, DOI 10.1242/jeb.061390; Neulinger SC, 2008, APPL ENVIRON MICROB, V74, P7272, DOI 10.1128/AEM.01777-08; Neulinger SC, 2009, APPL ENVIRON MICROB, V75, P1437, DOI 10.1128/AEM.01781-08; Nevalainen TJ, 2004, COMP BIOCHEM PHYS B, V139, P731, DOI 10.1016/j.cbpc.2004.09.006; Ostman C, 1758, ACTA ZOOLOG IN PRESS; Palanques A, 2001, LIMNOL OCEANOGR, V46, P1100, DOI 10.4319/lo.2001.46.5.1100; Purser A, 2010, J EXP MAR BIOL ECOL, V395, P55, DOI 10.1016/j.jembe.2010.08.013; Qurban MA, 2014, DEEP-SEA RES PT I, V89, P35, DOI 10.1016/j.dsr.2014.04.002; RIEGL B, 1995, J EXP MAR BIOL ECOL, V186, P259, DOI 10.1016/0022-0981(94)00164-9; Ritchie KB, 2004, CORAL HEALTH AND DISEASE, P259; Roberts JM, 2009, MAR ECOL PROG SER, V397, P139, DOI 10.3354/meps08112; Roder C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02802; Shapiro OH, 2014, P NATL ACAD SCI USA, V111, P13391, DOI 10.1073/pnas.1323094111; SHELTON GAB, 1980, J MAR BIOL ASSOC UK, V60, P517, DOI 10.1017/S0025315400028538; van Oevelen D, 2009, LIMNOL OCEANOGR, V54, P1829, DOI 10.4319/lo.2009.54.6.1829; Wijgerde T, 2011, J EXP BIOL, V214, P3351, DOI 10.1242/jeb.058354; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Wild C, 2010, AQUAT BIOL, V10, P41, DOI 10.3354/ab00269; Wild C, 2008, MAR ECOL PROG SER, V372, P67, DOI 10.3354/meps07724; Zetsche EM, 2014, LIMNOL OCEANOGR-METH, V12, P757, DOI 10.4319/lom.2014.12.757	49	20	20	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146766	10.1371/journal.pone.0146766	http://dx.doi.org/10.1371/journal.pone.0146766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840074	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200014
J	Zhang, H; Yi, HP; Wu, MZ; Zhang, YB; Zhang, XJ; Li, MH; Wang, GZ				Zhang, Hong; Yi, Hongping; Wu, Mingzhu; Zhang, Yongbin; Zhang, Xuejin; Li, Meihua; Wang, Guangzhi			Mapping the Flavor Contributing Traits on "Fengwei Melon" (Cucumis melo L.) Chromosomes Using Parent Resequencing and Super Bulked-Segregant Analysis	PLOS ONE			English	Article							MITOCHONDRIAL CITRATE SYNTHASE; MOLECULAR MARKERS; SNP DISCOVERY; GENETIC-MAP; FRUIT; IDENTIFICATION; ACCUMULATION; EXPRESSION; GENOME; DEHYDROGENASE	We used a next-generation high-throughput sequencing platform to resequence the Xinguowei and Shouxing melon cultivars, the parents of Fengwei melon. We found 84% of the reads (under a coverage rate of "13x") placed on the reference genome DHL92. There were 2,550,000 single-nucleotide polymorphisms and 140,000 structural variations in the two genomes. We also identified 1,290 polymorphic genes between Xinguowei and Shouxing. We combined specific length amplified fragment sequencing (SLAF-seq) and bulked-segregant analysis (super-BSA) to analyze the two parents and the F-2 extreme phenotypes. This combined method yielded 12,438,270 reads, 46,087 SLAF tags, and 4,480 polymorphic markers (average depth of 161.81x). There were six sweet trait-related regions containing 13 differential SLAF markers, and 23 sour trait-related regions containing 48 differential SLAF markers. We further fine-mapped the sweet trait to the genomic regions on chromosomes 6, 10, 11, and 12. Correspondingly, we mapped the sour trait-related genomic regions to chromosomes 2, 3, 4, 5, 9, and 12. Finally, we positioned nine of the 61 differential markers in the sweet and sour trait candidate regions on the parental genome. These markers corresponded to one sweet and eight sour trait-related genes. Our study provides a basis for marker-assisted breeding of desirable sweet and sour traits in Fengwei melons.	[Zhang, Hong; Yi, Hongping; Wu, Mingzhu; Zhang, Yongbin; Zhang, Xuejin; Li, Meihua; Wang, Guangzhi] Xinjiang Acad Agr Sci, Hami Melon Res Ctr, Urumqi, Xinjiang, Peoples R China		Zhang, H (corresponding author), Xinjiang Acad Agr Sci, Hami Melon Res Ctr, Urumqi, Xinjiang, Peoples R China.	hzhang0625@163.com			National Natural Science Foundation of China [31160395]; Key Laboratory of Crop Biotechnology, Xinjiang Uighur Autonomous Region, China [XJYS03022011-01];  [131620]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Crop Biotechnology, Xinjiang Uighur Autonomous Region, China; 	This research was supported by the National Natural Science Foundation of China (31160395, http://www.nsfc.gov.cn), the postdoctoral program (131620, http://res.chinapostdoctor.org.cn/BshWeb/index.shtml) and the Key Laboratory of Crop Biotechnology, Xinjiang Uighur Autonomous Region, China (XJYS03022011-01) to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073514; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Burger Y, 2003, J AM SOC HORTIC SCI, V128, P537, DOI 10.21273/JASHS.128.4.0537; Burger Y., 2009, HORTICULT REV J AM S, V36, P165; Burger Y, 2007, J AM SOC HORTIC SCI, V132, P704, DOI 10.21273/JASHS.132.5.704; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cohen S, 2012, THEOR APPL GENET, V125, P343, DOI 10.1007/s00122-012-1837-3; Cohen S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5026; Dai N, 2011, PLANT MOL BIOL, V76, P1, DOI 10.1007/s11103-011-9757-1; Danin-Poleg Y, 2002, EUPHYTICA, V125, P373, DOI 10.1023/A:1016021926815; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Harel-Beja R, 2010, THEOR APPL GENET, V121, P511, DOI 10.1007/s00122-010-1327-4; Iannetta PPM, 2004, PHYSIOL PLANTARUM, V121, P15, DOI 10.1111/j.0031-9317.2004.00302.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KUBICKI B., 1962, GENET POLON, V3, P265; Leone A, 2006, J AGR FOOD CHEM, V54, P6835, DOI 10.1021/jf061457g; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-444; [刘蓉蓉 Liu Rongrong], 2008, [生物技术通报, Biotechnology Bulletin], P10; Liu SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036406; Lucchetta L, 2007, J AGR FOOD CHEM, V55, P5213, DOI 10.1021/jf070210w; Manriquez D, 2006, PLANT MOL BIOL, V61, P675, DOI 10.1007/s11103-006-0040-9; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Blanca JM, 2011, PLANT GENOME-US, V4, P118, DOI 10.3835/plantgenome2011.01.0003; Moing A, 2000, PHYSIOL PLANTARUM, V108, P1, DOI 10.1034/j.1399-3054.2000.108001001.x; Murray MG, 1980, NUCLEIC ACIDS RES, V8, P668; Pitrat M, 2000, ACTA HORTIC, P29, DOI 10.17660/ActaHortic.2000.510.4; Rowan DD, 1996, J AGR FOOD CHEM, V44, P3276, DOI 10.1021/jf9508209; Sadka A, 2000, PLANT SCI, V158, P173, DOI 10.1016/S0168-9452(00)00328-9; Sadka A, 2001, AUST J PLANT PHYSIOL, V28, P383, DOI 10.1071/PP00136; Sadka A, 2000, PHYSIOL PLANTARUM, V2000, P3, DOI DOI 10.1034/J.1399-3054.2000.108003255.X.108; Saradhuldhat P, 2007, SCI HORTIC-AMSTERDAM, V112, P297, DOI 10.1016/j.scienta.2006.12.031; Schaffer A., 1996, PHOTOASSIMILATE DIST; Sherman A, 2013, THEOR APPL GENET, V126, P349, DOI 10.1007/s00122-012-1983-7; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Tang GM, 2008, STUDIES ON VOLATILE; TAUREILLESSAUREL C, 1995, AM J ENOL VITICULT, V46, P29; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Wang YM, 1996, J AGR FOOD CHEM, V44, P210, DOI 10.1021/jf9503568; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; Wu MZ, 2005, CHINA WATERMELON MUS, V1, P1; Wyllie SG, 2000, J AGR FOOD CHEM, V48, P3493, DOI 10.1021/jf0001841; Xia C, 2015, EUPHYTICA, V202, P35, DOI 10.1007/s10681-014-1202-5; Xu XW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15829; YAMAGUCHI M, 1977, SCI HORTIC-AMSTERDAM, V6, P59, DOI 10.1016/0304-4238(77)90079-6; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; [伊鸿平 Yi Hongping], 2013, [园艺学报, Acta Horticulturae Sinica], V40, P1779; Zhang Bo, 2007, Acta Horticulturae Sinica, V34, P245; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114; Zhou T., 2011, THESIS CHINESE ACAD; ZHU H. Q, 2013, CHINA VEGETABLES, V18, P29	58	24	29	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148150	10.1371/journal.pone.0148150	http://dx.doi.org/10.1371/journal.pone.0148150			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840947	Green Submitted, gold, Green Published			2022-12-26	WOS:000369550200087
J	Chiang, JY; Huang, JW; Lin, LY; Chang, CH; Chu, FY; Lin, YH; Wu, CK; Lee, JK; Hwang, JJ; Lin, JL; Chiang, FT				Chiang, Jiun-Yang; Huang, Jenq-Wen; Lin, Lian-Yu; Chang, Chin-Hao; Chu, Fang-Ying; Lin, Yen-Hung; Wu, Cho-Kai; Lee, Jen-Kuang; Hwang, Juei-Jen; Lin, Jiunn-Lee; Chiang, Fu-Tien			Detrended Fluctuation Analysis of Heart Rate Dynamics Is an Important Prognostic Factor in Patients with End-Stage Renal Disease Receiving Peritoneal Dialysis	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; R INTERVAL DYNAMICS; RATE-VARIABILITY; SYMPATHETIC OVERACTIVITY; MORTALITY; SURVIVAL	Background and Objectives Patients with severe kidney function impairment often have autonomic dysfunction, which could be evaluated noninvasively by heart rate variability (HRV) analysis. Nonlinear HRV parameters such as detrended fluctuation analysis (DFA) has been demonstrated to be an important outcome predictor in patients with cardiovascular diseases. Whether cardiac autonomic dysfunction measured by DFA is also a useful prognostic factor in patients with end-stage renal disease (ESRD) receiving peritoneal dialysis (PD) remains unclear. The purpose of the present study was designed to test the hypothesis. Materials and Methods Patients with ESRD receiving PD were included for the study. Twenty-four hour Holter monitor was obtained from each patient together with other important traditional prognostic makers such as underlying diseases, left ventricular ejection fraction (LVEF) and serum biochemistry profiles. Short-term (DFA alpha 1) and long-term (DFA alpha 2) DFA as well as other linear HRV parameters were calculated. Results A total of 132 patients (62 men, 72 women) with a mean age of 53.7+/-12.5 years were recruited from July 2007 to March 2009. During a median follow-up period of around 34 months, eight cardiac and six non-cardiac deaths were observed. Competing risk analysis demonstrated that decreased DFA alpha 1 was a strong prognostic predictor for increased cardiac and total mortality. ROC analysis showed that the AUC of DFAa1 (< 0.95) to predict mortality was 0.761 (95% confidence interval (CI). = 0.617-0.905). DFA alpha 1 >=. 0.95 was associated with lower cardiac mortality (Hazard ratio (HR) 0.062, 95% CI = 0.007-0.571, P = 0.014) and total mortality (HR = 0.109, 95% CI = 0.033-0.362, P = 0.0003). Conclusion Cardiac autonomic dysfunction evaluated by DFAa1 is an independent predictor for cardiac and total mortality in patients with ESRD receiving PD.	[Chiang, Jiun-Yang] Natl Taiwan Univ Hosp, Div Cardiol, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan; [Huang, Jenq-Wen] Natl Taiwan Univ, Coll Med & Hosp, Div Nephrol, Dept Internal Med, Taipei 10764, Taiwan; [Lin, Lian-Yu; Lin, Yen-Hung; Wu, Cho-Kai; Lee, Jen-Kuang; Hwang, Juei-Jen; Lin, Jiunn-Lee; Chiang, Fu-Tien] Natl Taiwan Univ, Coll Med & Hosp, Div Cardiol, Dept Internal Med, Taipei 10764, Taiwan; [Chang, Chin-Hao] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Chu, Fang-Ying] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chiang, Fu-Tien] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chiang, FT (corresponding author), Natl Taiwan Univ, Coll Med & Hosp, Div Cardiol, Dept Internal Med, Taipei 10764, Taiwan.; Chiang, FT (corresponding author), Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan.	futienc@ntuh.gov.tw	Lin, Yen-Hung/AAQ-1242-2020	Lin, Yen-Hung/0000-0001-8153-1441; HUANG, JENQ-WEN/0000-0001-8011-2317; LIN, LIAN-YU/0000-0001-7505-6429; WU, CHO-KAI/0000-0002-3867-150X; CHIANG, FU-TIEN/0000-0003-4936-8968	Taiwan's Ministry of Science and Technology [MOST 103-2220-E-002 -011]	Taiwan's Ministry of Science and Technology	This study was partially supported by Taiwan's Ministry of Science and Technology on data analysis, MOST 103-2220-E-002 -011, http://www.most.gov.tw/mp.aspx?mp=7. There was no other financial support, and the remaining data collection and analysis were performed by the authors.	CONVERSE RL, 1992, NEW ENGL J MED, V327, P1912, DOI 10.1056/NEJM199212313272704; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x; Ho KKL, 1997, CIRCULATION, V96, P842; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Lim HJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-97; Makikallio TH, 2001, J AM COLL CARDIOL, V37, P1395, DOI 10.1016/S0735-1097(01)01171-8; Mylonopoulou M, 2010, NEPHROL DIAL TRANSPL, V25, P3749, DOI 10.1093/ndt/gfq226; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Oikawa K, 2009, INT J CARDIOL, V131, P370, DOI 10.1016/j.ijcard.2007.10.033; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Tulppo MP, 2005, CIRCULATION, V112, P314, DOI 10.1161/CIRCULATIONAHA.104.523712; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH810, DOI 10.1152/ajpheart.1998.274.3.H810; Vikman S, 1999, CIRCULATION, V100, P2079, DOI 10.1161/01.CIR.100.20.2079; Vonend O, 2008, SEMIN DIALYSIS, V21, P326, DOI 10.1111/j.1525-139X.2008.00456.x; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; WOO MA, 1994, J AM COLL CARDIOL, V23, P565, DOI 10.1016/0735-1097(94)90737-4; Ye SH, 2006, HYPERTENSION, V48, P309, DOI 10.1161/01.HYP.0000231307.69761.2e	21	29	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147282	10.1371/journal.pone.0147282	http://dx.doi.org/10.1371/journal.pone.0147282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828209	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200018
J	Govindan, J; Tun, KM; Iovine, MK				Govindan, Jayalakshmi; Tun, Kyaw Min; Iovine, M. Kathryn			Cx43-Dependent Skeletal Phenotypes Are Mediated by Interactions between the Hapln1a-ECM and Sema3d during Fin Regeneration	PLOS ONE			English	Article							HUMAN HYALURONAN SYNTHASE; EXTRACELLULAR-MATRIX; LINK-PROTEIN; GAP-JUNCTIONS; OCULODENTODIGITAL DYSPLASIA; INTERCELLULAR COMMUNICATION; CRANIOFACIAL ABNORMALITIES; CONNEXIN43 GJA1; CARCINOMA-CELLS; ZEBRAFISH FINS	Skeletal development is a tightly regulated process and requires proper communication between the cells for efficient exchange of information. Analysis of fin length mutants has revealed that the gap junction protein Connexin43 (Cx43) coordinates cell proliferation (growth) and joint formation (patterning) during zebrafish caudal fin regeneration. Previous studies have shown that the extra cellular matrix (ECM) protein Hyaluronan and Proteoglycan Link Protein1a (Hapln1a) is molecularly and functionally downstream of Cx43, and that hapln1a knockdown leads to reduction of the glycosaminoglycan hyaluronan. Here we find that the proteoglycan aggrecan is similarly reduced following Hapln1a knockdown. Notably, we demonstrate that both hyaluronan and aggrecan are required for growth and patterning. Moreover, we provide evidence that the Hapln1a-ECM stabilizes the secreted growth factor Semaphorin3d (Sema3d), which has been independently shown to mediate Cx43 dependent phenotypes during regeneration. Double knockdown of hapln1a and sema3d reveal synergistic interactions. Further, hapln1a knockdown phenotypes were rescued by Sema3d overexpression. Therefore, Hapln1a maintains the composition of specific components of the ECM, which appears to be required for the stabilization of at least one growth factor, Sema3d. We propose that the Hapln1a dependent ECM provides the required conditions for Sema3d stabilization and function. Interactions between the ECM and signaling molecules are complex and our study demonstrates the requirement for components of the Hapln1a-ECM for Sema3d signal transduction.	[Govindan, Jayalakshmi; Tun, Kyaw Min; Iovine, M. Kathryn] Lehigh Univ, Dept Biol Sci, 111 Res Dr,Iacocca B217, Bethlehem, PA 18015 USA	Lehigh University	Iovine, MK (corresponding author), Lehigh Univ, Dept Biol Sci, 111 Res Dr,Iacocca B217, Bethlehem, PA 18015 USA.	mki3@lehigh.edu			National Science Foundation [IOS 1145582]; Direct For Biological Sciences [1145582] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation: IOS 1145582. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; Batra N, 2012, BBA-BIOMEMBRANES, V1818, P1909, DOI 10.1016/j.bbamem.2011.09.018; Bhadra J, 2015, MECH DEVELOP, V138, P364, DOI 10.1016/j.mod.2015.06.004; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Casini P, 2012, DEV DYNAM, V241, P294, DOI 10.1002/dvdy.23715; Contreras EG, 2009, DEVELOPMENT, V136, P2987, DOI 10.1242/dev.035501; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Flenniken AM, 2005, DEVELOPMENT, V132, P4375, DOI 10.1242/dev.02011; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghokale JRPaB, 2001, BIOCH BONE OSTEOPORO, P82; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Govindan J, 2015, GENE EXPR PATTERNS; Govindan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088574; HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; Hoptak-Solga AD, 2008, DEV BIOL, V317, P541, DOI 10.1016/j.ydbio.2008.02.051; Hoptak-Solga AD, 2007, FEBS LETT, V581, P3297, DOI 10.1016/j.febslet.2007.06.030; Hynes RO, 2014, NAT REV MOL CELL BIO, V15, P761, DOI 10.1038/nrm3908; Iovine MK, 2005, DEV BIOL, V278, P208, DOI 10.1016/j.ydbio.2004.11.005; Iovine MK, 2000, GENETICS, V155, P1321; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; JONES SJ, 1993, ANAT EMBRYOL, V187, P343; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; KOSHER RA, 1981, J EMBRYOL EXP MORPH, V63, P85; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Law LY, 2002, DEV GROWTH DIFFER, V44, P537; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; LI H, 1993, J BIOL CHEM, V268, P23504; Li Xiao-ying, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P941; Liu Y, 2004, J NEUROSCI, V24, P310, DOI 10.1523/JNEUROSCI.4287-03.2004; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; McGonnell IM, 2001, DEV DYNAM, V222, P420, DOI 10.1002/dvdy.1208; MELCHING LI, 1985, J BIOL CHEM, V260, P6279; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Moffatt P, 2011, DEV DYNAM, V240, P404, DOI 10.1002/dvdy.22529; Munch J, 2013, DEVELOPMENT, V140, P1402, DOI 10.1242/dev.087346; NEAME PJ, 1993, EXPERIENTIA, V49, P393, DOI 10.1007/BF01923584; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; PERIN JP, 1987, J BIOL CHEM, V262, P13269; Rodriguez E, 2006, J BIOL CHEM, V281, P18444, DOI 10.1074/jbc.M512531200; Roughley PJ, 2013, THE ROLE OF HA AND H, P219; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2; Shyjan AM, 1996, J BIOL CHEM, V271, P23395, DOI 10.1074/jbc.271.38.23395; Sims K, 2009, DEV BIOL, V327, P410, DOI 10.1016/j.ydbio.2008.12.027; SINGLEY CT, 1981, DEV BIOL, V84, P102, DOI 10.1016/0012-1606(81)90375-4; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Spicer AP, 1997, GENOMICS, V41, P493, DOI 10.1006/geno.1997.4696; Sztrolovics R, 2002, BIOCHEM J, V362, P465, DOI 10.1042/0264-6021:3620465; THOROGOOD PV, 1975, J EMBRYOL EXP MORPH, V33, P581; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Ton QV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081240; Ton QV, 2012, DEV BIOL, V366, P195, DOI 10.1016/j.ydbio.2012.03.020; TOOLE BP, 1971, DEV BIOL, V25, P57, DOI 10.1016/0012-1606(71)90019-4; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Torronen K, 2014, HISTOCHEM CELL BIOL, V141, P17, DOI 10.1007/s00418-013-1143-4; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Wai AWK, 1998, DEV GENET, V22, P349, DOI 10.1002/(SICI)1520-6408(1998)22:4<349::AID-DVG5>3.0.CO;2-6; WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497	73	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148202	10.1371/journal.pone.0148202	http://dx.doi.org/10.1371/journal.pone.0148202			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828861	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200082
J	Averett, JP; McCune, B; Parks, CG; Naylor, BJ; DelCurto, T; Mata-Gonzalez, R				Averett, Joshua P.; McCune, Bruce; Parks, Catherine G.; Naylor, Bridgett J.; DelCurto, Tim; Mata-Gonzalez, Ricardo			Non-Native Plant Invasion along Elevation and Canopy Closure Gradients in a Middle Rocky Mountain Ecosystem	PLOS ONE			English	Article							WESTERN NORTH-AMERICA; LAND-USE; PATTERNS; RESTORATION; FORESTS; CLIMATE; ROADS	Mountain environments are currently among the ecosystems least invaded by non-native species; however, mountains are increasingly under threat of non-native plant invasion. The slow pace of exotic plant invasions in mountain ecosystems is likely due to a combination of low anthropogenic disturbances, low propagule supply, and extreme/steep environmental gradients. The importance of any one of these factors is debated and likely ecosystem dependent. We evaluated the importance of various correlates of plant invasions in the Wallowa Mountain Range of northeastern Oregon and explored whether non-native species distributions differed from native species along an elevation gradient. Vascular plant communities were sampled in summer 2012 along three mountain roads. Transects (n = 20) were evenly stratified by elevation (similar to 70 m intervals) along each road. Vascular plant species abundances and environmental parameters were measured. We used indicator species analysis to identify habitat affinities for non-native species. Plots were ordinated in species space, joint plots and non-parametric multiplicative regression were used to relate species and community variation to environmental variables. Non-native species richness decreased continuously with increasing elevation. In contrast, native species richness displayed a unimodal distribution with maximum richness occurring at mid-elevations. Species composition was strongly related to elevation and canopy openness. Overlays of trait and environmental factors onto non-metric multidimensional ordinations identified the montane-subalpine community transition and over-story canopy closure exceeding 60% as potential barriers to non-native species establishment. Unlike native species, non-native species showed little evidence for high-elevation or closed-canopy specialization. These data suggest that non-native plants currently found in the Wallowa Mountains are dependent on open canopies and disturbance for establishment in low and mid elevations. Current management objectives including restoration to more open canopies in dry Rocky Mountain forests, may increase immigration pressure of non-native plants from lower elevations into the montane and subalpine zones.	[Averett, Joshua P.; DelCurto, Tim] Oregon State Univ, Eastern Oregon Agr & Nat Resource Program, La Grande, OR USA; [McCune, Bruce] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Parks, Catherine G.; Naylor, Bridgett J.] USDA Forest Serv, Pacific Northwest Res Stn, La Grande, OR USA; [Mata-Gonzalez, Ricardo] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; Oregon State University	Averett, JP (corresponding author), Oregon State Univ, Eastern Oregon Agr & Nat Resource Program, La Grande, OR USA.	averettj@onid.oregonstate.edu			U.S.D.A. Forest Service Pacific Northwest Research Station [11-JV-11261967-064]; Oregon State University	U.S.D.A. Forest Service Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Oregon State University	This project was funded by U.S.D.A. Forest Service Pacific Northwest Research Station, URL: http://www.fs.fed.us/pnw/, Contract (Joint Ventura Agreement with Oregon State University): 11-JV-11261967-064. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2002, ECOL APPL, V12, P1418; Andersen KM, 2015, APPL VEG SCI, V18, P683, DOI 10.1111/avsc.12185; Anderson E.W., 1998, ECOLOGICAL PROVINCES; [Anonymous], [No title captured]; [Anonymous], 2013, MEASUREMENTS TERREST; Averett JP, 2014, THESIS OREGON STATE; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Daehler CC, 2005, PERSPECT PLANT ECOL, V7, P203, DOI 10.1016/j.ppees.2005.08.002; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Dufrene M, 1989, ECOL MONOGR, V67, P345; Dukes JS, 2004, REV CHIL HIST NAT, V77, P411; Federal Geographic Data Committee, 1997, FGDCSTD005 US GEOL S; Fitzgerald SA, 2005, PSWGTR198 USDA FOR S; Franklin JF, 2012, J FOREST, V110, P429, DOI 10.5849/jof.10-006; Gelbard JL, 2003, CONSERV BIOL, V17, P420, DOI 10.1046/j.1523-1739.2003.01408.x; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Johnson C. G., 1994, PNWGTR339 USDA FOR S; Johnson CG, 2004, TECHNICAL PUBLICATIO, VR6-NR-ECOL-TP-03-04; Johnson CG, 2005, PNWGTR641 USDA FOR S, P119; Jovan S, 2005, ECOL APPL, V15, P1712, DOI 10.1890/03-5368; Kalwij JM, 2008, APPL VEG SCI, V11, P491, DOI 10.3170/2008-7-18555; Klenner W, 2008, FOREST ECOL MANAG, V256, P1711, DOI 10.1016/j.foreco.2008.02.047; Lembrechts JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089664; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lichthardt J., 1997, STATUS CONSERVATION; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; MACK RN, 1982, AM NAT, V119, P757, DOI 10.1086/283953; Mack RN, 2001, BIOSCIENCE, V51, P95, DOI 10.1641/0006-3568(2001)051[0095:HAGPDG]2.0.CO;2; Mallen-Cooper J., 2008, VICTORIAN NAT, V125, P64; Martin PH, 2009, FRONT ECOL ENVIRON, V7, P142, DOI 10.1890/070096; McCune B., 2011, PC ORD VERSION 6 06; McCune B., 2009, HYPERNICHE V 2 1 3 N; McCune B., 2011, NONPARAMETRIC MULTIP; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McCune B, 2006, J VEG SCI, V17, P819, DOI 10.1111/j.1654-1103.2006.tb02505.x; Milbau A, 2013, NEW PHYTOL, V197, P1002, DOI 10.1111/nph.12054; Mortensen DA, 2009, INVAS PLANT SCI MANA, V2, P191, DOI 10.1614/IPSM-08-125.1; Northam FE, 1994, INT313 USDA FOR SERV; Parks CG, 2005, PERSPECT PLANT ECOL, V7, P137, DOI 10.1016/j.ppees.2005.09.007; Pauchard A, 2004, CONSERV BIOL, V18, P238, DOI 10.1111/j.1523-1739.2004.00300.x; Pauchard A, 2009, FRONT ECOL ENVIRON, V7, P479, DOI 10.1890/080072; Petryna L, 2002, APPL VEG SCI, V5, P195, DOI 10.1111/j.1654-109X.2002.tb00549.x; Pickering C, 2007, MT RES DEV, V27, P359, DOI 10.1659/mrd.0805; Pollnac F, 2012, BIOL INVASIONS, V14, P1753, DOI 10.1007/s10530-012-0188-y; Pysek Petr, 2007, V193, P97; Pysek P, 2011, P NATL ACAD SCI USA, V108, P439, DOI 10.1073/pnas.1017682108; Quigley TM, 1997, PNWGTR405 USDA FOR S, V2; Quiroz CL, 2011, BIOL INVASIONS, V13, P2889, DOI 10.1007/s10530-011-9971-4; Roberts DW, 1989, LAND CLASSIFICATIONS, P90; Ross LC, 2008, PERSPECT PLANT ECOL, V10, P251, DOI 10.1016/j.ppees.2008.06.001; del Rio CMR, 2006, CAN J FOREST RES, V36, P2943, DOI 10.1139/X06-169; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; US Department of Agriculture Forest Service, 2014, BLUE MOUNT NAT FOR P; Wallace JM, 2015, INVAS PLANT SCI MANA, V8, P57, DOI 10.1614/IPSM-D-14-00034.1; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Wisdom MJ, 2009, RESTOR ECOL, V17, P740, DOI 10.1111/j.1526-100X.2009.00591.x	58	36	36	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147826	10.1371/journal.pone.0147826	http://dx.doi.org/10.1371/journal.pone.0147826			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824750	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528600063
J	Morgan, WH; House, PH; Hazelton, ML; Betz-Stablein, BD; Chauhan, BC; Viswanathan, A; Yu, DY				Morgan, William H.; House, Philip H.; Hazelton, Martin L.; Betz-Stablein, Brigid D.; Chauhan, Balwantray C.; Viswanathan, Ananth; Yu, Dao-Yi			Intraocular Pressure Reduction Is Associated with Reduced Venous Pulsation Pressure	PLOS ONE			English	Article							CENTRAL RETINAL VEIN; OPTIC-NERVE HEAD; INTRACRANIAL-PRESSURE; LAMINA-CRIBROSA	Purpose To explore whether alterations in intraocular pressure (IOP) affect vein pulsation properties using ophthalmodynamometric measures of vein pulsation pressure. Patients and Methods Glaucoma patients had two retinal vein pulsation pressure (VPP) measurements from upper and lower hemiveins performed by ophthalmodynamometry at least 3 months apart. All subjects had VPP and IOP recorded at two visits, with standard automated perimetry, central corneal thickness (CCT) recorded at the initial visit. Where venous pulsation was spontaneous ophthalmodynamometry could not be performed and VPP was considered equal to IOP. Change in VPP was calculated and binarized with reduction in pressure scored 1 and no change or increase scored as 0. Data analysis used a mixed logistic regression model with change in VPP as response variable and change in IOP, visual field loss (mean deviation), CCT and time interval as explanatory variables. Results 31 subjects (20 females) with mean age 60 years (sd 11) were examined with change in VPP being significantly associated with change in IOP (odds ratio 1.6/mmHg, 95% CI 1.2 to 2.1 in the glaucoma patients but not suspect patients (p = 0.0005). Conclusion Change in VPP is strongly associated with change in IOP such that a reduced intraocular pressure is associated with a subsequent reduction in VPP. This indicates that reduced IOP alters some retinal vein properties however the nature and time course of these changes is not known.	[Morgan, William H.; House, Philip H.; Yu, Dao-Yi] Univ Western Australia, Lions Eye Inst, Nedlands, WA 6009, Australia; [Hazelton, Martin L.; Betz-Stablein, Brigid D.] Massey Univ, Stat & Bioinformat Grp, Inst Fundamental Sci, Palmerston North, New Zealand; [Chauhan, Balwantray C.] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada; [Viswanathan, Ananth] City Univ London, Moorfields Eye Hosp, London EC1V 0HB, England	Lions Eye Institute; University of Western Australia; Massey University; Dalhousie University; City University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Morgan, WH (corresponding author), Univ Western Australia, Lions Eye Inst, Nedlands, WA 6009, Australia.	billmorgan@lei.org.au	Betz-Stablein, Brigid/S-6925-2018; Hazelton, Martin/AAB-9373-2019	Betz-Stablein, Brigid/0000-0003-3876-501X; Hazelton, Martin/0000-0001-7831-725X; Chauhan, Balwantray/0000-0002-7936-6907; Yu, Dao-Yi/0000-0002-9490-534X	National Health and Medical Research Council, Australia (NHMRC) [1020367]	National Health and Medical Research Council, Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by The National Health and Medical Research Council, Australia (NHMRC Project Grant 1020367) (https://www.nhmrc.gov.au/) (WHM D-YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, ARCH OPHTHALMOL-CHIC, V111, P545; Balaratnasingam C, 2007, BRIT J OPHTHALMOL, V91, P441, DOI 10.1136/bjo.2006.105338; BEAUMONT PE, 1994, AUST NZ J OPHTHALMOL, V22, P271, DOI 10.1111/j.1442-9071.1994.tb00796.x; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Fatehee N, 2011, INVEST OPHTH VIS SCI, V52, P6192, DOI 10.1167/iovs.10-7137; FRY DL, 1968, CIRC RES, V22, P165, DOI 10.1161/01.RES.22.2.165; Joshua SP, 2011, CLIN NEUROL NEUROSUR, V113, P635, DOI 10.1016/j.clineuro.2011.05.012; Kang MH, 2013, EXP EYE RES, V111, P50, DOI 10.1016/j.exer.2013.03.005; Kang MH, 2011, INVEST OPHTH VIS SCI, V52, P1359, DOI 10.1167/iovs.10-6366; Legler U, 2009, J GLAUCOMA, V18, P210, DOI 10.1097/IJG.0b013e318182edd2; Leske M Cristina, 2004, Curr Opin Ophthalmol, V15, P102; McCulley TJ, 2003, AM J OPHTHALMOL, V135, P706, DOI 10.1016/S0002-9394(03)00122-3; MEYERSCHWICKERATH R, 1995, GRAEF ARCH CLIN EXP, V233, P783, DOI 10.1007/BF00184090; Morgan WH, 2009, BRIT J OPHTHALMOL, V93, P594, DOI 10.1136/bjo.2008.149963; Morgan WH, 2004, OPHTHALMOLOGY, V111, P1489, DOI 10.1016/j.ophtha.2003.12.053; Morgan WH, 2002, INVEST OPHTH VIS SCI, V43, P3236; Morgan WH, 2010, GRAEF ARCH CLIN EXP, V248, P401, DOI 10.1007/s00417-009-1288-y; R Core Team, 2018, R LANG ENV STAT COMP; RIOSMONTENEGRO EN, 1973, ARCH OPHTHALMOL-CHIC, V89, P52; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; ROSNER B, 1984, BIOMETRICS, V40, P1025, DOI 10.2307/2531153; Seo JH KT, 2013, OPHTHALMOLOGY, V119, P2254; Stodtmeister R, 2013, INVEST OPHTH VIS SCI, V54, P4698, DOI 10.1167/iovs.12-10607	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147915	10.1371/journal.pone.0147915	http://dx.doi.org/10.1371/journal.pone.0147915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824849	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600072
J	Jung, SI; Shin, JH; Kim, SH; Kim, J; Kim, JH; Choi, MJ; Chung, EK; Lee, K; Koo, SH; Chang, HH; Bougnoux, ME; d'Enfert, C				Jung, Sook-In; Shin, Jong Hee; Kim, Soo Hyun; Kim, Jin; Kim, Joo Hee; Choi, Min Ji; Chung, Eun-Kyung; Lee, Kyungwon; Koo, Sun Hoe; Chang, Hyun Ha; Bougnoux, Marie-Elisabeth; d'Enfert, Christophe			Comparison of E,E-Farnesol Secretion and the Clinical Characteristics of Candida albicans Bloodstream Isolates from Different Multilocus Sequence Typing Clades	PLOS ONE			English	Article							QUORUM-SENSING MOLECULE; INVASIVE CANDIDIASIS; BIOFILM FORMATION; MOUSE MODEL; MORTALITY; FARNESOL; EPIDEMIOLOGY; GROWTH; INFECTIONS; PREDICTORS	Using multilocus sequence typing (MLST), Candida albicans can be subdivided into 18 different clades. Farnesol, a quorum-sensing molecule secreted by C. albicans, is thought to play an important role in the development of C. albicans biofilms and is also a virulence factor. This study evaluated whether C. albicans bloodstream infection (BSI) strains belonging to different MLST clades secrete different levels of E, E-farnesol (FOH) and whether they have different clinical characteristics. In total, 149 C. albicans BSI isolates from ten Korean hospitals belonging to clades 18 (n = 28), 4 (n = 23), 1 (n = 22), 12 (n = 17), and other clades (n = 59) were assessed. For each isolate, the FOH level in 24-hour biofilms was determined in filtered (0.45 mu m) culture supernatant using high-performance liquid chromatography. Marked differences in FOH secretion from biofilms (0.10-6.99 mu M) were observed among the 149 BSI isolates. Clade 18 isolates secreted significantly more FOH than did non-clade 18 isolates (mean +/- SEM; 2.66 +/- 0.22 vs. 1.69 +/- 0.10 mu M; P < 0.001). Patients with isolates belonging to clade 18 had a lower mean severity of illness than other patients, as measured using the "acute physiology and chronic health evaluation" (APACHE) III score (14.4 +/- 1.1 vs. 18.0 +/- 0.7; P < 0.05). This study provides evidence that C. albicans BSI isolates belonging to the most prevalent MLST clade (clade 18) in Korea are characterized by increased levels of FOH secretion and less severe illness.	[Jung, Sook-In] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea; [Shin, Jong Hee; Kim, Soo Hyun; Kim, Joo Hee; Choi, Min Ji] Chonnam Natl Univ, Sch Med, Dept Lab Med, Gwangju, South Korea; [Kim, Jin] Chonnam Natl Univ Hosp, Biomed Res Inst, Gwangju, South Korea; [Chung, Eun-Kyung] Chonnam Natl Univ, Sch Med, Dept Med Educ, Gwangju, South Korea; [Lee, Kyungwon] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Lee, Kyungwon] Yonsei Univ, Coll Med, Res Inst Bacterial Resistance, Seoul, South Korea; [Koo, Sun Hoe] Chungnam Natl Univ, Coll Med, Dept Lab Med, Daejeon, South Korea; [Chang, Hyun Ha] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Bougnoux, Marie-Elisabeth; d'Enfert, Christophe] Inst Pasteur, Unite Biol & Pathogenicite Fong, F-75015 Paris, France; [Bougnoux, Marie-Elisabeth; d'Enfert, Christophe] INRA, USC2019, F-75015 Paris, France; [Bougnoux, Marie-Elisabeth] Univ Paris 05, Fac Med, Microbiol Serv, Lab Parasitol Mycol,Hop Necker Enfants Malad, F-75015 Paris, France	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University Hospital; Chonnam National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chungnam National University; Kyungpook National University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Shin, JH (corresponding author), Chonnam Natl Univ, Sch Med, Dept Lab Med, Gwangju, South Korea.	shinjh@chonnam.ac.kr		Lee, Kyungwon/0000-0003-3788-2134; Koo, Sun Hoe/0000-0003-3715-7151; d'Enfert, Christophe/0000-0002-6235-3886	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2A10058555]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2A10058555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005; Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004; Andes DR, 2012, CLIN INFECT DIS, V54, P1110, DOI 10.1093/cid/cis021; Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z; Chandra J, 2008, NAT PROTOC, V3, P1909, DOI 10.1038/nprot.2008.192; Charles PE, 2003, INTENS CARE MED, V29, P2162, DOI 10.1007/s00134-003-2002-x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Crump JA, 2000, EUR J CLIN MICROBIOL, V19, P1, DOI 10.1007/s100960050001; Dumitru R, 2004, ANTIMICROB AGENTS CH, V48, P2350, DOI 10.1128/AAC.48.7.2350-2354.2004; Escribano P, 2013, J CLIN MICROBIOL, V51, P2118, DOI 10.1128/JCM.00516-13; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Hargarten JC, 2015, INFECT IMMUN, V83, P3857, DOI 10.1128/IAI.00886-15; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Joo MY, 2013, MED MYCOL, V51, P892, DOI 10.3109/13693786.2013.824623; Kim MN, 2009, CLIN INFECT DIS, V48, pe57, DOI 10.1086/597108; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Kuhn DM, 2002, INFECT IMMUN, V70, P878, DOI 10.1128/IAI.70.2.878-888.2002; Lim CSY, 2012, EUR J CLIN MICROBIOL, V31, P21, DOI 10.1007/s10096-011-1273-3; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; McManus BA, 2014, INFECT GENET EVOL, V21, P166, DOI 10.1016/j.meegid.2013.11.008; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P4006, DOI 10.1128/IAI.00397-07; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P1609, DOI 10.1128/IAI.01182-06; Odds FC, 2008, EUKARYOT CELL, V7, P1075, DOI 10.1128/EC.00062-08; Odds FC, 2010, FUTURE MICROBIOL, V5, P67, DOI 10.2217/FMB.09.113; Pfaller MA, 1998, J CLIN MICROBIOL, V36, P1518, DOI 10.1128/JCM.36.6.1518-1529.1998; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Saisho Y, 1997, ANAL BIOCHEM, V252, P89, DOI 10.1006/abio.1997.2314; Schmid J, 2011, J CLIN MICROBIOL, V49, P3250, DOI 10.1128/JCM.00941-11; Shin JH, 2011, J CLIN MICROBIOL, V49, P2572, DOI 10.1128/JCM.02153-10; Tumbarello Mario, 2012, PLoS One, V7, pe33705, DOI 10.1371/journal.pone.0033705; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828; Weber K, 2008, ANTIMICROB AGENTS CH, V52, P1859, DOI 10.1128/AAC.01646-07; Weber K, 2010, YEAST, V27, P727, DOI 10.1002/yea.1769	34	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148400	10.1371/journal.pone.0148400	http://dx.doi.org/10.1371/journal.pone.0148400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848577	gold, Green Submitted, Green Published			2022-12-26	WOS:000369554000086
J	Charest-Morin, X; Marceau, F				Charest-Morin, Xavier; Marceau, Francois			Biotechnological Fluorescent Ligands of the Bradykinin B-1 Receptor: Protein Ligands for a Peptide Receptor	PLOS ONE			English	Article							MONONUCLEAR-CELLS; KININ RECEPTORS; EXPRESSION; B1; TRANSLOCATION	The bradykinin (BK) B-1 receptor (B1R) is a peculiar G protein coupled receptor that is strongly regulated to the point of being inducible in immunopathology. Limited clinical evidence suggests that its expression in peripheral blood mononuclear cells is a biomarker of active inflammatory states. In an effort to develop a novel imaging/diagnostic tool, we report the rational design and testing of a fusion protein that is a ligand of the human B1R but not likely to label peptidases. This ligand is composed of a fluorescent protein (FP) (enhanced green FP [EGFP] or mCherry) prolonged at its N-terminus by a spacer peptide and a classical peptide agonist or antagonist (des-Arg(9)-BK, [Leu(8)]des-Arg(9)-BK, respectively). The design of the spacer-ligand joint peptide was validated by a competition assay for [H-3]Lysdes-Arg(9)-BK binding to the human B1R applied to 4 synthetic peptides of 18 or 19 residues. The labeling of B1R-expressing cells with EGFP or mCherry fused with 7 of such peptides was performed in parallel (microscopy). Both assays indicated that the best design was FP(Asn-Gly)(n)-Lys-des-Arg(9)-BK; n = 15 was superior to n = 5, suggesting benefits from minimizing steric hindrance between the FP and the receptor. Cell labeling concerned mostly plasma membranes and was inhibited by a B1R antagonist. EGFP-(Asn-Gly)(15)-Lys-des-Arg(9)-BK competed for the binding of [H-3]Lys-des-Arg(9)-BK to human recombinant B1R, being only 10-fold less potent than the unlabeled form of Lys-des-Arg(9)-BK to do so. The fusion protein did not label HEK 293a cells expressing recombinant human BK B-2 receptors or angiotensin converting enzyme. This study identifies a modular C-terminal sequence that can be adapted to protein cargoes, conferring high affinity for the BK B1R, with possible applications in diagnostic cytofluorometry, histology and drug delivery (e.g., in oncology).	[Marceau, Francois] Univ Laval, CHU Quebec, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1V 4G2, Canada; [Marceau, Francois] Univ Laval, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University	Marceau, F (corresponding author), Univ Laval, CHU Quebec, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1V 4G2, Canada.; Marceau, F (corresponding author), Univ Laval, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ G1V 4G2, Canada.	francois.marceau@crchul.ulaval.ca	Marceau, François/C-7471-2011	Marceau, François/0000-0003-1691-6083	Canadian Institutes of Health Research [MOP-93773]; Fonds de recherche du Quebec - Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	This study was supported by the Canadian Institutes of Health Research (grant MOP-93773 to F.M.) and the Fonds de recherche du Quebec - Sante (Studentship to X.C.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Bastian S, 1997, BRIT J PHARMACOL, V122, P393, DOI 10.1038/sj.bjp.0701380; Bawolak MT, 2009, J PHARMACOL EXP THER, V329, P159, DOI 10.1124/jpet.108.149724; Charest-Morin X, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.119; Charest-Morin X, 2013, PHARMACOL RES PERSPE, V1, DOI 10.1002/prp2.4; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cyr M, 2001, AM J PHYSIOL-HEART C, V281, pH275, DOI 10.1152/ajpheart.2001.281.1.H275; Dabek J, 2008, INTERN MED J, V38, P892, DOI 10.1111/j.1445-5994.2008.01718.x; Dabek J, 2007, SCAND CARDIOVASC J, V41, P391, DOI 10.1080/14017430701499379; Enquist J, 2007, MOL PHARMACOL, V71, P494, DOI 10.1124/mol.106.030858; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Gera L, 2011, J PHARMACOL EXP THER, V337, P33, DOI 10.1124/jpet.110.177147; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Koumbadinga GA, 2010, EUR J PHARMACOL, V647, P117, DOI 10.1016/j.ejphar.2010.08.008; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Lin KS, 2015, CANCER RES, V75, P387, DOI 10.1158/0008-5472.CAN-14-1603; Liu ZB, 2015, MOL PHARMACEUT, V12, P974, DOI 10.1021/acs.molpharmaceut.5b00003; Marceau F, 1997, CAN J PHYSIOL PHARM, V75, P725, DOI 10.1139/cjpp-75-6-725; Marceau F., 2013, J ANGIOEDEMA, V1, P9; Moreau ME, 2007, MOL PHARMACOL, V71, P949, DOI 10.1124/mol.106.030684; Morissette G, 2004, J PHARMACOL EXP THER, V311, P1121, DOI 10.1124/jpet.104.071266; Morissette G, 2008, PEPTIDES, V29, P606, DOI 10.1016/j.peptides.2007.12.004; Morissette G, 2006, CAN J PHYSIOL PHARM, V84, P1107, DOI 10.1139/Y06-031; Prat A, 2005, ARCH NEUROL-CHICAGO, V62, P795, DOI 10.1001/archneur.62.5.795; Sabourin T, 2002, MOL PHARMACOL, V61, P546, DOI 10.1124/mol.61.3.546	25	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148246	10.1371/journal.pone.0148246	http://dx.doi.org/10.1371/journal.pone.0148246			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844555	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800039
J	Guseman, AJ; Miller, K; Kunkle, G; Dively, GP; Pettis, JS; Evans, JD; vanEngelsdorp, D; Hawthorne, DJ				Guseman, Alex J.; Miller, Kaliah; Kunkle, Grace; Dively, Galen P.; Pettis, Jeffrey S.; Evans, Jay D.; vanEngelsdorp, Dennis; Hawthorne, David J.			Multi-Drug Resistance Transporters and a Mechanism-Based Strategy for Assessing Risks of Pesticide Combinations to Honey Bees	PLOS ONE			English	Article							GLYCOPROTEIN-MEDIATED TRANSPORT; P-GLYCOPROTEIN; MALPIGHIAN TUBULES; ABC TRANSPORTERS; TRANSEPITHELIAL TRANSPORT; INSECTICIDE TOXICITY; DRUG INTERACTIONS; APIS-MELLIFERA; EXPRESSION; IVERMECTIN	Annual losses of honey bee colonies remain high and pesticide exposure is one possible cause. Dangerous combinations of pesticides, plant-produced compounds and antibiotics added to hives may cause or contribute to losses, but it is very difficult to test the many combinations of those compounds that bees encounter. We propose a mechanism-based strategy for simplifying the assessment of combinations of compounds, focusing here on compounds that interact with xenobiotic handling ABC transporters. We evaluate the use of ivermectin as a model substrate for these transporters. Compounds that increase sensitivity of bees to ivermectin may be inhibiting key transporters. We show that several compounds commonly encountered by honey bees (fumagillin, Pristine, quercetin) significantly increased honey bee mortality due to ivermectin and significantly reduced the LC50 of ivermectin suggesting that they may interfere with transporter function. These inhibitors also significantly increased honey bees sensitivity to the neonicotinoid insecticide acetamiprid. This mechanism-based strategy may dramatically reduce the number of tests needed to assess the possibility of adverse combinations among pesticides. We also demonstrate an in vivo transporter assay that provides physical evidence of transporter inhibition by tracking the dynamics of a fluorescent substrate of these transporters (Rhodamine B) in bee tissues. Significantly more Rhodamine B remains in the head and hemolymph of bees pretreated with higher concentrations of the transporter inhibitor verapamil. Mechanism-based strategies for simplifying the assessment of adverse chemical interactions such as described here could improve our ability to identify those combinations that pose significantly greater risk to bees and perhaps improve the risk assessment protocols for honey bees and similar sensitive species.	[Guseman, Alex J.; Miller, Kaliah; Kunkle, Grace; Dively, Galen P.; vanEngelsdorp, Dennis; Hawthorne, David J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Guseman, Alex J.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [Pettis, Jeffrey S.; Evans, Jay D.] ARS, Bee Res Lab, USDA, Beltsville, MD USA	University System of Maryland; University of Maryland College Park; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Agriculture (USDA)	Hawthorne, DJ (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	djh@umd.edu	vanEngelsdorp, Dennis/E-7934-2010; Evans, Jay/C-8408-2012	Evans, Jay/0000-0002-0036-4651; Guseman, Alex/0000-0002-9796-5719	USDA-ARS Bee Research Laboratory; Maryland Agricultural Experiment Station; UMD Libraries Open Access Publishing Fund; National Socio-Environmental Synthesis Center (SESYNC)-National Science Foundation (NSF) [DBI-1052875]; Direct For Biological Sciences [1052875] Funding Source: National Science Foundation; ARS [ARS-0425645] Funding Source: Federal RePORTER	USDA-ARS Bee Research Laboratory; Maryland Agricultural Experiment Station; UMD Libraries Open Access Publishing Fund; National Socio-Environmental Synthesis Center (SESYNC)-National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded primarily by a Cooperative Agreement with the USDA-ARS Bee Research Laboratory, and received partial funding by the Maryland Agricultural Experiment Station. Funding for Open Access was provided by the UMD Libraries Open Access Publishing Fund. D.J.H. received support from the National Socio-Environmental Synthesis Center (SESYNC)-National Science Foundation (NSF) award DBI-1052875. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson O, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.50; Andersson O, 2013, J PHARMACOL EXP THER, V346, P211, DOI 10.1124/jpet.113.205476; Bain LJ, 1997, ENVIRON HEALTH PERSP, V105, P812, DOI 10.1289/ehp.97105812; Bain LJ, 1996, TOXICOL APPL PHARM, V141, P288, DOI 10.1016/S0041-008X(96)80035-4; Bartley DJ, 2009, PARASITOLOGY, V136, P1081, DOI 10.1017/S0031182009990345; Borst P, 2013, J CLIN INVEST, V123, P4131, DOI 10.1172/JCI70430; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; Buss DS, 2002, MED VET ENTOMOL, V16, P218, DOI 10.1046/j.1365-2915.2002.00365.x; Chahine S, 2011, J EXP BIOL, V214, P462, DOI 10.1242/jeb.048884; Chahine S, 2009, J INSECT PHYSIOL, V55, P927, DOI 10.1016/j.jinsphys.2009.06.005; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chiu LY, 2010, TOXICOL LETT, V192, P408, DOI 10.1016/j.toxlet.2009.11.018; CLARK JM, 1995, ANNU REV ENTOMOL, V40, P1, DOI 10.1146/annurev.en.40.010195.000245; CORNWALL R, 1995, AQUAT TOXICOL, V31, P277, DOI 10.1016/0166-445X(94)00070-7; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Dunn ST, 2011, DRUG METAB DISPOS, V39, P789, DOI 10.1124/dmd.110.034827; Dupuy J, 2006, J VET PHARMACOL THER, V29, P489, DOI 10.1111/j.1365-2885.2006.00780.x; Dupuy J, 2003, VET PARASITOL, V112, P337, DOI 10.1016/S0304-4017(03)00008-6; FISHER MH, 1992, ANNU REV PHARMACOL, V32, P537, DOI 10.1146/annurev.pa.32.040192.002541; Frazier M, 2008, AM BEE J, V148, P521; Gaertner LS, 1998, J EXP BIOL, V201, P2637; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2013, J APPL ENTOMOL, V137, P35, DOI 10.1111/j.1439-0418.2012.01718.x; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Hull JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113046; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kerboeuf D, 2011, ANTIMICROB AGENTS CH, V55, P2224, DOI 10.1128/AAC.01477-10; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Labbe R, 2011, J EXP BIOL, V214, P937, DOI 10.1242/jeb.051060; Leader JP, 2005, J EXP BIOL, V208, P4363, DOI 10.1242/jeb.01911; Lee KV, 2015, NATL SURVEY MANAGED; Leroux P, 2013, EUR J PLANT PATHOL, V135, P683, DOI 10.1007/s10658-012-0105-3; Lespine A, 2009, CURR DRUG METAB, V10, P272, DOI 10.2174/138920009787846297; Lespine A, 2012, INT J PARASITOL-DRUG, V2, P58, DOI 10.1016/j.ijpddr.2011.10.001; Limtrakul P, 2005, J CHEMOTHERAPY, V17, P86, DOI 10.1179/joc.2005.17.1.86; Luo L, 2013, INSECT BIOCHEM MOLEC, V43, P627, DOI 10.1016/j.ibmb.2013.04.006; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Mayer F, 2009, J NEUROSCI, V29, P3538, DOI 10.1523/JNEUROSCI.5564-08.2009; McFadzen I, 2000, MAR ENVIRON RES, V50, P319, DOI 10.1016/S0141-1136(00)00057-X; Merzendorfer H, 2014, ADV INSECT PHYSIOL, V46, P1, DOI 10.1016/B978-0-12-417010-0.00001-X; Morris ME, 2006, LIFE SCI, V78, P2116, DOI 10.1016/j.lfs.2005.12.003; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Pal D, 2006, J NEUROIMMUNE PHARM, V1, P323, DOI 10.1007/s11481-006-9034-2; Pang KS, 2009, MOL PHARMACEUT, V6, P1734, DOI 10.1021/mp900258z; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Podsiadlowski L, 1998, COMP BIOCHEM PHYS B, V121, P443, DOI 10.1016/S0305-0491(98)10137-2; Pohl PC, 2014, VET PARASITOL, V204, P316, DOI 10.1016/j.vetpar.2014.05.042; Pohl PC, 2011, INT J PARASITOL, V41, P1323, DOI 10.1016/j.ijpara.2011.08.004; Reybroeck W, 2012, VET MICROBIOL, V158, P1, DOI 10.1016/j.vetmic.2012.01.012; Schrickx J, 2007, J VET PHARMACOL THER, V30, P25, DOI 10.1111/j.1365-2885.2007.00808.x; Smital T, 2000, COMP BIOCHEM PHYS C, V126, P175, DOI 10.1016/S0742-8413(00)00110-9; Spurgeon DJ, 2010, SCI TOTAL ENVIRON, V408, P3725, DOI 10.1016/j.scitotenv.2010.02.038; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; TOMASBARBERAN FA, 1993, Z LEBENSM UNTERS FOR, V196, P38, DOI 10.1007/BF01192982; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; WEBSTER TC, 1994, J ECON ENTOMOL, V87, P601, DOI 10.1093/jee/87.3.601; Wolstenholme AJ, 2010, INVERTEBR NEUROSCI, V10, P5, DOI 10.1007/s10158-010-0105-y; Yoon KS, 2011, INSECT MOL BIOL, V20, P687, DOI 10.1111/j.1365-2583.2011.01097.x; Yoshida N, 2006, FOOD CHEM TOXICOL, V44, P2033, DOI 10.1016/j.fct.2006.07.003	68	21	22	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148242	10.1371/journal.pone.0148242	http://dx.doi.org/10.1371/journal.pone.0148242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840460	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200109
J	Teraguchi, M; Yoshimura, N; Hashizume, H; Muraki, S; Yamada, H; Oka, H; Minamide, A; Ishimoto, Y; Nagata, K; Kagotani, R; Tanaka, S; Kawaguchi, H; Nakamura, K; Akune, T; Yoshida, M				Teraguchi, Masatoshi; Yoshimura, Noriko; Hashizume, Hiroshi; Muraki, Shigeyuki; Yamada, Hiroshi; Oka, Hiroyuki; Minamide, Akihito; Ishimoto, Yuyu; Nagata, Keiji; Kagotani, Ryohei; Tanaka, Sakae; Kawaguchi, Hiroshi; Nakamura, Kozo; Akune, Toru; Yoshida, Munehito			Metabolic Syndrome Components Are Associated with Intervertebral Disc Degeneration: The Wakayama Spine Study	PLOS ONE			English	Article							LOW-BACK-PAIN; FOLLOW-UP; LUMBAR SPINE; KNEE OSTEOARTHRITIS; NUCLEUS PULPOSUS; EXPRESSION; LEPTIN; CLASSIFICATION; CALCIFICATION; HYPERTENSION	Objective The objective of the present study was to examine the associations between metabolic syndrome (MS) components, such as overweight (OW), hypertension (HT), dyslipidemia (DL), and impaired glucose tolerance (IGT), and intervertebral disc degeneration (DD). Design The present study included 928 participants (308 men, 620 women) of the 1,011 participants in the Wakayama Spine Study. DD on magnetic resonance imaging was classified according to the Pfirrmann system. OW, HT, DL, and IGT were assessed using the criteria of the Examination Committee of Criteria for MS in Japan. Results Multivariable logistic regression analysis revealed that OW was significantly associated with cervical, thoracic, and lumbar DD (cervical: odds ratio [OR], 1.28; 95% confidence interval [CI], 0.92-1.78; thoracic: OR, 1.75; 95% CI, 1.24-2.51; lumbar: OR, 1.87; 95% CI, 1.06-3.48). HT and IGT were significantly associated with thoracic DD (HT: OR, 1.54; 95% CI, 1.09-2.18; IGT: OR, 1.65; 95% CI, 1.12-2.48). Furthermore, subjects with 1 or more MS components had a higher OR for thoracic DD compared with those without MS components (vs. no component; 1 component: OR, 1.58; 95% CI, 1.03-2.42; 2 components: OR, 2.60; 95% CI, 1.62-4.20; >= 3 components: OR, 2.62; 95% CI, 1.42-5.00). Conclusion MS components were significantly associated with thoracic DD. Furthermore, accumulation of MS components significantly increased the OR for thoracic DD. These findings support the need for further studies of the effects of metabolic abnormality on DD.	[Teraguchi, Masatoshi; Hashizume, Hiroshi; Yamada, Hiroshi; Minamide, Akihito; Ishimoto, Yuyu; Nagata, Keiji; Kagotani, Ryohei; Yoshida, Munehito] Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418509, Japan; [Yoshimura, Noriko; Muraki, Shigeyuki] Univ Tokyo, Dept Joint Dis, Century Med & Res Ctr 22, Fac Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Oka, Hiroyuki] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, Century Med & Res Ctr 22, Fac Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Kawaguchi, Hiroshi] Japan Community Healthcare Org, Tokyo Shinjuku Med Ctr, Shinjuku Ku, 5-1 Tsukudo Chome, Tokyo 1628543, Japan; [Nakamura, Kozo; Akune, Toru] Natl Rehabil Ctr Persons Disabil, Rehabil Serv Bur, 1 Namiki 4 Chome, Tokorozawa, Saitama 3598555, Japan	Wakayama Medical University; University of Tokyo; University of Tokyo; University of Tokyo	Hashizume, H (corresponding author), Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418509, Japan.	hashizum@wakayama-med.ac.jp	Tanaka, Sakae/Y-3061-2019; Hashizume, Hiroshi/V-6888-2019	Tanaka, Sakae/0000-0001-9210-9414; Hashizume, Hiroshi/0000-0002-9064-0284; Nagata, Keiji/0000-0002-9251-672X	Ministry of Health, Labour and Welfare [H23-Choujyu-002, H-25-Choujyu-007, H25-Nanchitou (Men)-005, 201417014A, H22-Choujyu-Wakate-007]; JSPS KAKENHI [B26293139, B23390172, B2629333, C20591774, C26462249, C25462305, B25860448, B26861286, B26860419, B15K20013, 15K15219, 26670307, 24659666, 25670293]; Japanese Orthopaedics and Traumatology Foundation, Inc. [287]; NSF from the Ministry of Education, Culture, Sports, Science and Technology in Japan [08033011-00262]; Japan Osteoporosis Society; JA Kyosai Research Institute; Mitsui Sumitomo Insurance Welfare Foundation; Japanese Orthopaedic Association (JOA) [2006-1, 2010-2]; Grants-in-Aid for Scientific Research [26462249] Funding Source: KAKEN	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Orthopaedics and Traumatology Foundation, Inc.; NSF from the Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Osteoporosis Society(Japan Osteoporosis Society); JA Kyosai Research Institute; Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Japanese Orthopaedic Association (JOA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by H23-Choujyu-002 (Director, Toru Akune), H-25-Choujyu-007 (Director, Noriko Yoshimura), H25-Nanchitou (Men)-005 (Director, Sakae Tanaka), 201417014A (Director, Noriko Yoshimura), and H22-Choujyu-Wakate-007 (Director, Shigeyuki Muraki) from the Ministry of Health, Labour and Welfare; a Grant-in-Aid for Scientific Research (B26293139, B23390172 to Noriko Yoshimura, B2629333, C20591774 to Shigeyuki Muraki, C26462249 to Hiroshi Hashizume, C25462305 to Hiroshi Yamada) and a Grant-in-Aid for Young Researcher (B25860448 to Yuyu Ishimoto, B26861286 to Masatoshi Teraguchi, B26860419 to Ryohei Kagotani, B15K20013 to Hiroki Iwahashi), and Grant-in-Aid for Challenging Exploratory Research (15K15219 to Noriko Yoshimura, 26670307 to Shigeyuki Muraki, 24659666 to Hiroyuki Oka, 25670293 to Toru Akune) of JSPS KAKENHI grant; a Grant from the Japanese Orthopaedics and Traumatology Foundation, Inc. (No. 287) to Masatoshi Teraguchi; and Collaborating Research with NSF 08033011-00262 (Director, Noriko Yoshimura) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. This study was also supported by grants from the Japan Osteoporosis Society (Noriko Yoshimura, Shigeyuki Muraki, Hiroyuki Oka, and Toru Akune), a grant from JA Kyosai Research Institute (Hiroyuki Oka), a grant from Mitsui Sumitomo Insurance Welfare Foundation (Shigeyuki Muraki), and research aid from the Japanese Orthopaedic Association (JOA-Subsidized Science Project Research 2006-1 & 2010-2; Director, Hiroshi Kawaguchi).	ALEXANDER RW, 1995, HYPERTENSION, V25, P155, DOI 10.1161/01.HYP.25.2.155; Anekstein Y, 2010, ISR MED ASSOC J, V12, P16; Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Benneker LM, 2005, EUR SPINE J, V14, P27, DOI 10.1007/s00586-004-0759-4; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Borenstein DG, 2001, J BONE JOINT SURG AM, V83A, P1306, DOI 10.2106/00004623-200109000-00002; de Schepper EIT, 2010, SPINE, V35, P531, DOI 10.1097/BRS.0b013e3181aa5b33; Gruber HE, 2007, SPINE J, V7, P437, DOI 10.1016/j.spinee.2006.08.001; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hangai M, 2008, SPINE J, V8, P732, DOI 10.1016/j.spinee.2007.07.392; HART DJ, 1995, J RHEUMATOL, V22, P1118; Jhawar Balraj S, 2006, Spine J, V6, P684, DOI 10.1016/j.spinee.2006.04.016; Katz JN, 2008, NEW ENGL J MED, V358, P818, DOI 10.1056/NEJMcp0708097; Kauppila LI, 1997, SPINE, V22, P1642, DOI 10.1097/00007632-199707150-00023; Kauppila LI, 2004, SPINE, V29, P2147, DOI 10.1097/01.brs.0000141168.77393.b8; Kauppila LI, 1997, ANN RHEUM DIS, V56, P591, DOI 10.1136/ard.56.10.591; Leino-Arjas P, 2006, SPINE, V31, P1032, DOI 10.1097/01.brs.0000214889.31505.08; Li Z, 2013, J ORTHOP RES, V31, P847, DOI 10.1002/jor.22308; Liuke M, 2005, INT J OBESITY, V29, P903, DOI 10.1038/sj.ijo.0802974; Lotan R, 2008, J SPINAL DISORD TECH, V21, P247, DOI 10.1097/BSD.0b013e31813707af; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Matsumoto M, 1998, J BONE JOINT SURG BR, V80B, P19, DOI 10.1302/0301-620X.80B1.7929; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Ministry of Health Labour and Welfare, 2008, OUTL RES NAT HLTH NU; Okada E, 2009, SPINE, V34, P706, DOI 10.1097/BRS.0b013e31819c2003; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Samartzis D, 2012, ARTHRITIS RHEUM-US, V64, P1488, DOI 10.1002/art.33462; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450, DOI 10.1111/j.2040-1124.2010.00074.x; Shibata Kiyoshi, 2010, Environmental Health and Preventive Medicine, V15, P229, DOI 10.1007/s12199-009-0132-7; Suri P, 2012, SPINE J, V12, P315, DOI 10.1016/j.spinee.2012.03.033; Takatalo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056244; Teraguchi M, 2014, OSTEOARTHR CARTILAGE, V22, P104, DOI 10.1016/j.joca.2013.10.019; The Examination Committee of Criteria for Metabolic Syndrome, 2005, J JPN SOC INT MED, V94, P794; Tsai TT, 2014, J ORTHOP RES, V32, P238, DOI 10.1002/jor.22508; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Videman T, 2000, J ORTHOPAED RES, V18, P768, DOI 10.1002/jor.1100180514; Vitale C, 2006, Minerva Med, V97, P219; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yoshimura N, 2012, OSTEOARTHR CARTILAGE, V20, P1217, DOI 10.1016/j.joca.2012.06.006; Yoshimura N, 2000, J RHEUMATOL, V27, P429; Yoshimura N, 2011, J RHEUMATOL, V38, P921, DOI 10.3899/jrheum.100569; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Zhao CQ, 2008, SPINE, V33, pE858, DOI 10.1097/BRS.0b013e31818338e5; ZIV I, 1992, J ORTHOPAED RES, V10, P205, DOI 10.1002/jor.1100100207	46	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147565	10.1371/journal.pone.0147565	http://dx.doi.org/10.1371/journal.pone.0147565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840834	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200047
J	Vallejos, MAV; Padial, AA; Vitule, JRS				Villegas Vallejos, Marcelo Alejandro; Padial, Andre Andrian; Simoes Vitule, Jean Ricardo			Human-Induced Landscape Changes Homogenize Atlantic Forest Bird Assemblages through Nested Species Loss	PLOS ONE			English	Article							URBAN-RURAL GRADIENT; BIOTIC HOMOGENIZATION; ARAUCARIA FOREST; BETA-DIVERSITY; CITIZEN SCIENCE; GLOBAL PATTERNS; URBANIZATION; COMMUNITIES; CONSERVATION; BIODIVERSITY	The increasing number of quantitative assessments of homogenization using citizen science data is particularly important in the Neotropics, given its high biodiversity and ecological peculiarity, and whose communities may react differently to landscape changes. We looked for evidence of taxonomic homogenization in terrestrial birds by investigating patterns of beta diversity along a gradient of human-altered landscapes (HAL), trying to identify species associated with this process. We analyzed bird data from 87 sites sampled in a citizen science program in the south Brazilian Atlantic Forest. Regional-scale taxonomic homogenization was assessed by comparing beta diversity among sites in different HALs (natural, rural or urban landscapes) accounting for variation derived from geographical distance and zoogeographical affinities by georeferencing sites and determining their position in a phytogeographical domain. Beta diversity was calculated by multivariate dispersion and by testing compositional changes due to turnover and nestedness among HALs and phytogeographical domains. Finally, we assessed which species were typical for each group using indicator species analysis. Bird homogenization was indicated by decreases in beta diversity following landscape changes. Beta diversity of rural sites was roughly half that of natural habitats, while urban sites held less than 10% of the natural areas' beta diversity. Species composition analysis revealed that the turnover component was important in differentiating sites depending on HAL and phytogeography; the nestedness component was important among HALs, where directional species loss is maintained even considering effects of sampling effort. A similar result was obtained among phytogeographical domains, indicating nested-pattern dissimilarity among compositions of overlapping communities. As expected, a few native generalists and non-native urban specialists were characteristic of rural and urban sites. We generated strong evidence that taxonomic homogenization occurs in the south Brazilian Atlantic Forest as a result of a directional and nested species loss, with the resultant assemblages composed of few disturbance-tolerant birds.	[Villegas Vallejos, Marcelo Alejandro] Hori Consultoria Ambiental, Curitiba, Parana, Brazil; [Padial, Andre Andrian] Univ Fed Parana, Dept Bot, BR-80060000 Curitiba, Parana, Brazil; [Padial, Andre Andrian; Simoes Vitule, Jean Ricardo] Univ Fed Parana, Setor Ciencias Biol, Programa Posgrad Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil; [Simoes Vitule, Jean Ricardo] Univ Fed Parana, Setor Tecnol, Dept Engn Ambiental, Lab Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal do Parana	Vallejos, MAV (corresponding author), Hori Consultoria Ambiental, Curitiba, Parana, Brazil.	mvillegas.bio@gmail.com	Vitule, Jean Ricardo Simões/D-9822-2012; Padial, Andre Andrian/H-8977-2012; Villegas, Marcelo/Z-1438-2019	Vitule, Jean Ricardo Simões/0000-0001-6543-7439; Padial, Andre Andrian/0000-0002-8766-5974; Villegas, Marcelo/0000-0002-0275-1719	Brazilian National Council for Scientific and Technological Development (CNPq)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JRSV and AAP thank the Brazilian National Council for Scientific and Technological Development (CNPq) for providing constant financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2012, GLOBAL ECOL BIOGEOGR, V21, P772, DOI 10.1111/j.1466-8238.2011.00709.x; Borges FJA, 2010, BIODIVERS CONSERV, V19, P223, DOI 10.1007/s10531-009-9718-z; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Gonzalez-Oreja JA, 2011, BIOL CONSERV, V144, P234, DOI 10.1016/j.biocon.2010.08.021; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Baeten L, 2012, BIODIVERS CONSERV, V21, P1399, DOI 10.1007/s10531-012-0251-0; Baiser B, 2012, P ROY SOC B-BIOL SCI, V279, P4772, DOI 10.1098/rspb.2012.1651; Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Baselga A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127913; Baselga A, 2015, METHODS ECOL EVOL, V6, P1069, DOI 10.1111/2041-210X.12388; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Behling H, 2007, PHILOS T R SOC B, V362, P243, DOI 10.1098/rstb.2006.1984; Bispo AA, 2010, BIOTA NEOTROP, V10, P121, DOI 10.1590/S1676-06032010000100012; Blair R, 2004, ECOL SOC, V9; Bregman TP, 2014, BIOL CONSERV, V169, P372, DOI 10.1016/j.biocon.2013.11.024; BROWN JH, 1978, AM ZOOL, V18, P687; Cardoso GC, 2014, GLOBAL CHANGE BIOL, V20, P803, DOI 10.1111/gcb.12410; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carvalho JC, 2013, OIKOS, V122, P825, DOI 10.1111/j.1600-0706.2012.20980.x; CAVALCANTI RB, 1988, CONDOR, V90, P40, DOI 10.2307/1368430; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Clergeau P, 2006, BIOL CONSERV, V127, P336, DOI 10.1016/j.biocon.2005.06.035; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Cockle KL, 2011, FRONT ECOL ENVIRON, V9, P377, DOI 10.1890/110013; Conole LE, 2014, PEERJ, V2, DOI 10.7717/peerj.306; Costa Lilian Mariana, 2013, Ornitologia Neotropical, V24, P95; Croci S, 2008, CONDOR, V110, P223, DOI 10.1525/cond.2008.8409; Daga VS, 2015, HYDROBIOLOGIA, V746, P327, DOI 10.1007/s10750-014-2032-0; Solar RRD, 2015, ECOL LETT, V18, P1108, DOI 10.1111/ele.12494; Vasconcelos Marcelo Ferreira de, 2013, Pap. Avulsos Zool. (São Paulo), V53, P327, DOI 10.1590/S0031-10492013002500001; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Devictor V, 2007, CONSERV BIOL, V21, P741, DOI 10.1111/j.1523-1739.2007.00671.x; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dobson A. J, 2002, INTRO GEN LINEAR MOD; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2015, ECOL MONOGR, V85, P287, DOI 10.1890/14-2274.1; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; EMLEN JT, 1974, CONDOR, V76, P184, DOI 10.2307/1366729; Ensing DJ, 2015, ECOL COMPLEX, V21, P62, DOI 10.1016/j.ecocom.2014.11.008; Ferenc M, 2014, GLOBAL ECOL BIOGEOGR, V23, P479, DOI 10.1111/geb.12130; Fleishman E., 2005, Animal Biodiversity and Conservation, V28, P45; Fontana CS, 2011, URBAN ECOSYST, V14, P341, DOI 10.1007/s11252-011-0156-9; Fontana Carla Suertegaray, 2005, Comunicacoes do Museu de Ciencias e Tecnologia da PUCRS Serie Zoologia, V18, P161; Franz I, 2010, BRAZ J BIOL, V70, P1137, DOI 10.1590/S1519-69842010000600002; Fuller RA, 2009, DIVERS DISTRIB, V15, P328, DOI 10.1111/j.1472-4642.2008.00537.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris DJ, 2011, AM NAT, V177, P535, DOI 10.1086/658990; Hernandez-Brito D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100593; Isaac B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091049; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; KRUGEL M.M., 2000, ORNITOL NEOTROP, V11, P315; La Sorte FA, 2007, J BIOGEOGR, V34, P2159, DOI 10.1111/j.1365-2699.2007.01761.x; Las-Casas FMG, 2012, BRAZ J BIOL, V72, P51, DOI 10.1590/S1519-69842012000100006; Lees AC, 2014, IBIS; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Lim HC, 2004, LANDSCAPE URBAN PLAN, V66, P199, DOI 10.1016/S0169-2046(03)00111-7; Luck GW, 2007, J BIOGEOGR, V34, P201, DOI 10.1111/j.1365-2699.2006.01575.x; Luck GW, 2011, J BIOGEOGR, V38, P894, DOI 10.1111/j.1365-2699.2010.02449.x; Luzar JB, 2011, BIOSCIENCE, V61, P771, DOI 10.1525/bio.2011.61.10.7; MacGregor-Fors I, 2012, REV MEX BIODIVERS, V83, P477; Maron M, 2013, DIVERS DISTRIB, V19, P1468, DOI 10.1111/ddi.12128; McGill BJ, 2015, TRENDS ECOL EVOL, V30, P104, DOI 10.1016/j.tree.2014.11.006; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Meffert PJ, 2013, LANDSCAPE ECOL, V28, P943, DOI 10.1007/s10980-013-9867-z; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Ortega-Alvarez R, 2011, LANDSCAPE URBAN PLAN, V101, P1, DOI 10.1016/j.landurbplan.2010.12.020; Parker TA III, 1996, NEOTROPICAL BIRDS EC, P131; Pautasso M, 2011, GLOBAL ECOL BIOGEOGR, V20, P426, DOI 10.1111/j.1466-8238.2010.00616.x; Pinheiro RT, 2008, REV BRAS ORNITOL, V16, P339; Pizo MA, 2001, WILSON BULL, V113, P388, DOI 10.1676/0043-5643(2001)113[0388:TDLOTS]2.0.CO;2; Podani J, 2011, OIKOS, V120, P1625, DOI 10.1111/j.1600-0706.2011.19451.x; Puttker T, 2015, OIKOS, V124, P206, DOI 10.1111/oik.01018; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; RAUP DM, 1979, J PALEONTOL, V53, P1213; Reis E, 2012, LANDSCAPE URBAN PLAN, V107, P31, DOI 10.1016/j.landurbplan.2012.04.009; Reynaud PA, 2000, J ENVIRON MANAGE, V59, P121, DOI 10.1006/jema.2000.0338; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Roberts D., 2007, LABDSV ORDINATION MU; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roderjan CV, 2002, CIENCIA AMBIENTE, V24, P75; Sarukhan J, 2015, BIOSCIENCE, V65, P164, DOI 10.1093/biosci/biu195; Scherer-Neto P, 2012, IHERINGIA SER ZOOL, V102, P412, DOI 10.1590/S0073-47212012000400007; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Vitule JRS, 2012, DIVERS DISTRIB, V18, P111, DOI 10.1111/j.1472-4642.2011.00821.x; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; STRAUBE FC, 2007, CIENCIA AMBIENTE, V35, P137; Straube FC, 2009, AVES CURITIBA COLETA; Straube FC, 2013, IPAVE 2012 INVENTARI; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Tewksbury JJ, 2006, ECOLOGY, V87, P759, DOI 10.1890/04-1790; Toledo MCB, 2008, BRAZ J BIOL, V68, P419, DOI 10.1590/S1519-69842008000200027; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; van Rensburg BJ, 2009, LANDSCAPE URBAN PLAN, V92, P233, DOI 10.1016/j.landurbplan.2009.05.002; Villegas Mariana, 2010, Urban Ecosystems, V13, P375, DOI 10.1007/s11252-010-0126-7; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Volpato GH, 2010, FOREST ECOL MANAG, V260, P1156, DOI 10.1016/j.foreco.2010.07.006	114	17	17	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147058	10.1371/journal.pone.0147058	http://dx.doi.org/10.1371/journal.pone.0147058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840957	Green Submitted, gold, Green Published			2022-12-26	WOS:000369550200023
J	Walachowski, S; Tabouret, G; Foucras, G				Walachowski, Sarah; Tabouret, Guillaume; Foucras, Gilles			Triggering Dectin-1-Pathway Alone Is Not Sufficient to Induce Cytokine Production by Murine Macrophages	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; INFLAMMATORY RESPONSES; IMMUNE-RESPONSES; TNF-ALPHA; RECOGNITION; INNATE; PARTICULATE; ACTIVATION; MONOCYTES; YEAST	beta-glucans (BG) are abundant polysaccharides of the Saccharomyces cerevisiae cell wall (Sc CW), an industry byproduct. They have immuno-stimulatory properties upon engagement of dectin-1 (Clec7a), their main receptor on particular immune cells, and they actually become of great interest because of their preventive or therapeutic potentials. Zymosan, a crude extract of Sc CW was studied as a prototypic BG, despite its miscellaneous PAMPs content. Here, we examined the response of murine wild type or Clec7a(-/-) bone marrow-derived macrophages (BMDM) to products with increasing BG content (15, 65 or 75%) and compared their effects with those of other dectin-1 ligands. The enrichment process removed TLR ligands while preserving dectin-1 activity. The most enriched extracts have very low NF kappa B activity and triggered low amounts of cytokine production in contrast with crude products like zymosan and BG15. Furthermore, MyD88(-/-) BMDM did not produce TNF alpha in response to crude Sc CW extracts, whereas their response to BG-enriched extracts was unaffected, suggesting that BG alone are not able to initiate cytokine secretion. Although Sc CW-derived BG stimulated the late and strong expression of Csf2 in a dectin-1-dependent manner, they remain poor inducers of chemokine and cytokine production in murine macrophages.	[Walachowski, Sarah; Tabouret, Guillaume; Foucras, Gilles] Univ Toulouse, INP ENVT, UMR 1225, IHAP, Toulouse, France; [Walachowski, Sarah; Tabouret, Guillaume; Foucras, Gilles] INRA, UMR1225, IHAP, F-31931 Toulouse, France	Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; INRAE	Foucras, G (corresponding author), Univ Toulouse, INP ENVT, UMR 1225, IHAP, Toulouse, France.	g.foucras@envt.fr	FOUCRAS, Gilles/A-3061-2014	FOUCRAS, Gilles/0000-0002-0363-0337; Walachowski, Sarah/0000-0001-5702-3404; TABOURET, Guillaume/0000-0002-7976-4438	Phileo-Lesaffre Animal Care; Institut National de la Recherche Agronomique (INRA); Institut National Polytechnique - Ecole Nationale Veterinaire de Toulouse (INP-ENVT)	Phileo-Lesaffre Animal Care; Institut National de la Recherche Agronomique (INRA); Institut National Polytechnique - Ecole Nationale Veterinaire de Toulouse (INP-ENVT)	This work was partly financed by Phileo-Lesaffre Animal Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other sources of funding were from Institut National de la Recherche Agronomique (INRA) and Institut National Polytechnique - Ecole Nationale Veterinaire de Toulouse (INP-ENVT).	Accarias S, 2015, EUR J IMMUNOL, V45, P794, DOI 10.1002/eji.201445098; Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011; Dabritz J, 2015, J IMMUNOL, V194, P2424, DOI 10.4049/jimmunol.1401482; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Elcombe SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060086; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gersuk GM, 2008, J IMMUNOL METHODS, V329, P157, DOI 10.1016/j.jim.2007.10.003; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Huang HB, 2012, J IMMUNOL, V189, P312, DOI 10.4049/jimmunol.1200603; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Ifrim DC, 2013, J IMMUNOL, V190, P4129, DOI 10.4049/jimmunol.1202611; Ito K, 2009, INT IMMUNOPHARMACOL, V9, P1189, DOI 10.1016/j.intimp.2009.06.007; Jimenez-A MD, 2008, GENES IMMUN, V9, P338, DOI 10.1038/gene.2008.23; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kataoka K, 2002, J BIOL CHEM, V277, P36825, DOI 10.1074/jbc.M206756200; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Lastrucci C, 2015, FASEB J, V29, P1914, DOI 10.1096/fj.14-259341; Le Cabec V, 2000, INFECT IMMUN, V68, P4736, DOI 10.1128/IAI.68.8.4736-4745.2000; Li XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080399; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; MacKenzie S, 2002, J LEUKOCYTE BIOL, V71, P1026; Masuda Y, 2012, J LEUKOCYTE BIOL, V91, P547, DOI 10.1189/jlb.0711386; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; Min L, 2012, J IMMUNOL, V188, P1789, DOI 10.4049/jimmunol.1101755; Munemoto Y, 2002, INT J ONCOL, DOI [10.3892/ijo.20.2.403, DOI 10.3892/IJO.20.2.403]; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Ohman T, 2014, J IMMUNOL, V192, P5952, DOI 10.4049/jimmunol.1303213; OLIVAS E, 1995, J IMMUNOL METHODS, V182, P73, DOI 10.1016/0022-1759(95)00024-5; PILLEMER L, 1956, J EXP MED, V103, P1, DOI 10.1084/jem.103.1.1; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Rice PJ, 2002, J LEUKOCYTE BIOL, V72, P140; RIGGI SJ, 1961, AM J PHYSIOL, V200, P297, DOI 10.1152/ajplegacy.1961.200.2.297; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Roy S, 2011, WOUND REPAIR REGEN, V19, P411, DOI 10.1111/j.1524-475X.2011.00688.x; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Shah VB, 2008, J IMMUNOL, V180, P2777, DOI 10.4049/jimmunol.180.5.2777; SKLAR MD, 1985, J CELL PHYSIOL, V125, P403, DOI 10.1002/jcp.1041250307; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Viriyakosol S, 2013, MBIO, V4, DOI 10.1128/mBio.00597-12; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406	56	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148464	10.1371/journal.pone.0148464	http://dx.doi.org/10.1371/journal.pone.0148464			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840954	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200140
J	Wang, LL; Dumoulin, A; Renner, M; Triller, A; Specht, CG				Wang, Lili; Dumoulin, Andrea; Renner, Marianne; Triller, Antoine; Specht, Christian G.			The Role of Synaptopodin in Membrane Protein Diffusion in the Dendritic Spine Neck	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; ACTIN-ASSOCIATED PROTEIN; SYNAPTIC PLASTICITY; ENDOPLASMIC-RETICULUM; AMPA RECEPTORS; APPARATUS; DYNAMICS; NEURONS; RAT; COMPARTMENTALIZATION	The dynamic exchange of neurotransmitter receptors at synapses relies on their lateral diffusion in the plasma membrane. At synapses located on dendritic spines this process is limited by the geometry of the spine neck that restricts the passage of membrane proteins. Biochemical compartmentalisation of the spine is believed to underlie the input-specificity of excitatory synapses and to set the scale on which functional changes can occur. Synaptopodin is located predominantly in the neck of dendritic spines, and is thus ideally placed to regulate the exchange of synaptic membrane proteins. The central aim of our study was to assess whether the presence of synaptopodin influences the mobility of membrane proteins in the spine neck and to characterise whether this was due to direct molecular interactions or to spatial constraints that are related to the structural organisation of the neck. Using single particle tracking we have identified a specific effect of synaptopodin on the diffusion of metabotropic mGluR5 receptors in the spine neck. However, super-resolution STORM/PALM imaging showed that this was not due to direct interactions between the two proteins, but that the presence of synaptopodin is associated with an altered local organisation of the F-actin cytoskeleton, that in turn could restrict the diffusion of membrane proteins with large intracellular domains through the spine neck. This study contributes new data on the way in which the spine neck compartmentalises excitatory synapses. Our data complement models that consider the impact of the spine neck as a function of its shape, by showing that the internal organisation of the neck imposes additional physical barriers to membrane protein diffusion.	[Wang, Lili; Dumoulin, Andrea; Renner, Marianne; Triller, Antoine; Specht, Christian G.] Ecole Normale Super, CNRS 8197, INSERM, Biol Cellulaire Synapse,U1024,Inst Biol, 24 Rue Lhomond, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Triller, A (corresponding author), Ecole Normale Super, CNRS 8197, INSERM, Biol Cellulaire Synapse,U1024,Inst Biol, 24 Rue Lhomond, F-75231 Paris, France.	triller@biologie.ens.fr	wang, lili/HDL-7210-2022; Renner, Marianne/H-5315-2011	TRILLER, Antoine/0000-0002-7530-1233; Specht, Christian G/0000-0001-6038-7735; Dumoulin, Andrea/0000-0003-1309-3448; Renner, Marianne/0000-0002-8727-6581	Agence Nationale de la Recherche (ANR, Synaptune); European Research Council (ERC); Labex (Memolife); France-BioImaging (FBI); China Scholarship Council (CSC) [2011614094]	Agence Nationale de la Recherche (ANR, Synaptune)(French National Research Agency (ANR)); European Research Council (ERC)(European Research Council (ERC)); Labex (Memolife); France-BioImaging (FBI)(French National Research Agency (ANR)); China Scholarship Council (CSC)(China Scholarship Council)	This research was funded by the Agence Nationale de la Recherche (ANR, Synaptune), European Research Council (ERC), Labex (Memolife), and France-BioImaging (FBI). LW was supported by the China Scholarship Council (CSC, fellowship No. 2011614094). The funding organisations had no influence in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00142; Araya R, 2014, P NATL ACAD SCI USA, V111, pE2895, DOI 10.1073/pnas.1321869111; Arizono M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002498; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; BUCKLE PJ, 1982, J PHYSIOL-LONDON, V326, P109, DOI 10.1113/jphysiol.1982.sp014180; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; Deller T, 2000, J COMP NEUROL, V418, P164, DOI 10.1002/(SICI)1096-9861(20000306)418:2<164::AID-CNE4>3.0.CO;2-0; Domanov YA, 2011, P NATL ACAD SCI USA, V108, P12605, DOI 10.1073/pnas.1102646108; Enz R, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00052; Ewers H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113916; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hennekinne L, 2013, J NEUROSCI, V33, P11432, DOI 10.1523/JNEUROSCI.5247-12.2013; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Kalinowska M, 2015, J BIOL CHEM; Korkotian E, 2014, J NEUROSCI, V34, P11641, DOI 10.1523/JNEUROSCI.0381-14.2014; Kusters R, 2013, BIOPHYS J, V105, P2743, DOI [10.1016/j.bpj.2013.41.016, 10.1016/j.bpj.2013.11.016]; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Orth CB, 2005, J COMP NEUROL, V487, P227, DOI 10.1002/cne.20539; Ouyang Y, 2007, BRAIN RES, V1143, P238, DOI 10.1016/j.brainres.2007.01.077; Perroy J, 2008, J BIOL CHEM, V283, P6799, DOI 10.1074/jbc.M705661200; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Renner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025731; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Ribrault C, 2011, J NEUROSCI, V31, P17590, DOI 10.1523/JNEUROSCI.4065-11.2011; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Segal M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00064; Simon CM, 2014, J COMPUT NEUROSCI, V36, P483, DOI 10.1007/s10827-013-0482-4; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takasaki K, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00029; Tonnesen J, 2014, NAT NEUROSCI, V17, P678, DOI 10.1038/nn.3682; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Vlachos A, 2013, P NATL ACAD SCI USA, V110, P8242, DOI 10.1073/pnas.1213677110; Vlachos A, 2012, ANN ANAT, V194, P317, DOI 10.1016/j.aanat.2011.10.014; Vlachos A, 2009, J NEUROSCI, V29, P1017, DOI 10.1523/JNEUROSCI.5528-08.2009; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009	49	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148310	10.1371/journal.pone.0148310	http://dx.doi.org/10.1371/journal.pone.0148310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840625	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200124
J	Liu, CB; Tsow, F; Zou, Y; Tao, NJ				Liu, Chenbin; Tsow, Francis; Zou, Yi; Tao, Nongjian			Particle Pollution Estimation Based on Image Analysis	PLOS ONE			English	Article							AIR-POLLUTION; VISIBILITY	Exposure to fine particles can cause various diseases, and an easily accessible method to monitor the particles can help raise public awareness and reduce harmful exposures. Here we report a method to estimate PM air pollution based on analysis of a large number of outdoor images available for Beijing, Shanghai (China) and Phoenix (US). Six image features were extracted from the images, which were used, together with other relevant data, such as the position of the sun, date, time, geographic information and weather conditions, to predict PM2.5 index. The results demonstrate that the image analysis method provides good prediction of PM2.5 indexes, and different features have different significance levels in the prediction.	[Liu, Chenbin; Tao, Nongjian] Nanjing Univ, Sch Chem & Chem Engn, Nanjing 210008, Jiangsu, Peoples R China; [Tsow, Francis; Tao, Nongjian] Arizona State Univ, Biodesign Inst, Ctr Bioelect & Biosensors, Tempe, AZ USA; [Zou, Yi] Beijing Kinto Investment Management Co Ltd, Beijing, Peoples R China	Nanjing University; Arizona State University; Arizona State University-Tempe	Tao, NJ (corresponding author), Nanjing Univ, Sch Chem & Chem Engn, Nanjing 210008, Jiangsu, Peoples R China.; Tao, NJ (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Bioelect & Biosensors, Tempe, AZ USA.	njtao@asu.edu	Liu, Chenbin/J-4691-2019	Liu, Chenbin/0000-0002-2037-5630	National Natural Science Foundation of China [21575062, 21327902]; Beijing Kinto Investment Management Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Kinto Investment Management Co., Ltd	This study was supported by the National Natural Science Foundation of China, grant numbers 21575062, 21327902, http://isisn.nsfc.gov.cn/egrantweb/, Nongjian Tao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beijing Kinto Investment Management Co., Ltd provided support in the form of salaries for an author [YZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the author contributions section.	Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1; Anderson TL, 1998, AEROSOL SCI TECH, V29, P57, DOI 10.1080/02786829808965551; Byun H, 2002, LECT NOTES COMPUT SC, V2388, P213; Carr P, 2009, 2009 DIGITAL IMAGE COMPUTING: TECHNIQUES AND APPLICATIONS (DICTA 2009), P103, DOI 10.1109/DICTA.2009.25; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Day DE, 2001, ATMOS ENVIRON, V35, P5169, DOI 10.1016/S1352-2310(01)00320-X; dos Santos EM, 2001, XIV BRAZILIAN SYMPOSIUM ON COMPUTER GRAPHICS AND IMAGE PROCESSING, PROCEEDINGS, P399, DOI 10.1109/SIBGRAPI.2001.963105; Fattal R, 2014, ACM T GRAPHIC, V34, DOI 10.1145/2651362; Fattal R, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360671; Hauck H, 2004, J AEROSOL SCI, V35, P1135, DOI 10.1016/j.jaerosci.2004.04.004; Huang W, 2009, SCI TOTAL ENVIRON, V407, P3295, DOI 10.1016/j.scitotenv.2009.02.019; Hyslop NP, 2009, ATMOS ENVIRON, V43, P182, DOI 10.1016/j.atmosenv.2008.09.067; Jacobs N, 2007, IEEE I CONF COMP VIS, P1305; Jolliffe I., 2014, PRINCIPAL COMPONENT; KOSCHMIEDER H., 1924, BEITR PHYS FREIEN AT, V12, P171; MACIAS ES, 1976, ENVIRON SCI TECHNOL, V10, P904, DOI 10.1021/es60120a015; MALM WC, 1980, JAPCA J AIR WASTE MA, V30, P122, DOI 10.1080/00022470.1980.10465927; McCartney EJ, 1975, OPTICS ATMOSPHERE SC; MUIR D, 1995, ATMOS ENVIRON, V29, P959, DOI 10.1016/1352-2310(94)00370-Z; Narasimhan SG, 2002, INT J COMPUT VISION, V48, P233, DOI 10.1023/A:1016328200723; Ni KS, 2007, IEEE T IMAGE PROCESS, V16, P1596, DOI 10.1109/TIP.2007.896644; Noble CA, 2001, AEROSOL SCI TECH, V34, P457, DOI 10.1080/027868201750172914; Olman CA, 2004, VISION RES, V44, P669, DOI 10.1016/j.visres.2003.10.022; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Reda I, 2004, SOL ENERGY, V76, P577, DOI 10.1016/j.solener.2003.12.003; Ruppecht E, 1992, J AEROSOL SCI, V23, P635, DOI [DOI 10.1016/0021-8502(92)90492-E, 10.1016/0021-8502(92)90492-E]; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Smith JD, 2001, ANALYST, V126, P1216, DOI 10.1039/b101491i; Swietlicki E, 1999, ATMOS RES, V50, P205, DOI 10.1016/S0169-8095(98)00105-7; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Wang HQ, 2014, 2014 IEEE VISUAL COMMUNICATIONS AND IMAGE PROCESSING CONFERENCE, P326, DOI 10.1109/VCIP.2014.7051572	33	43	45	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0145955	10.1371/journal.pone.0145955	http://dx.doi.org/10.1371/journal.pone.0145955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828757	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200004
J	DebRoy, C; Fratamico, PM; Yan, XH; Baranzoni, GM; Liu, YH; Needleman, DS; Tebbs, R; O'Connell, CD; Allred, A; Swimley, M; Mwangi, M; Kapur, V; Garay, JAR; Roberts, EL; Katani, R				DebRoy, Chitrita; Fratamico, Pina M.; Yan, Xianghe; Baranzoni, GianMarco; Liu, Yanhong; Needleman, David S.; Tebbs, Robert; O'Connell, Catherine D.; Allred, Adam; Swimley, Michelle; Mwangi, Michael; Kapur, Vivek; Garay, Juan A. Raygoza; Roberts, Elisabeth L.; Katani, Robab			Comparison of O-Antigen Gene Clusters of All O-Serogroups of Escherichia coli and Proposal for Adopting a New Nomenclature for O-Typing	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ABC TRANSPORTER; DNA MICROARRAY; IDENTIFICATION; SEQUENCE; STRAINS; O145; BIOSYNTHESIS; DIVERSITY; PATHWAYS	Escherichia coli strains are classified based on O-antigens that are components of the lipopolysaccharide (LPS) in the cell envelope. O-antigens are important virulence factors, targets of both the innate and adaptive immune system, and play a role in host-pathogen interactions. Because they are highly immunogenic and display antigenic specificity unique for each strain, O-antigens are the biomarkers for designating O-types. Immunologically, 185 O-serogroups and 11 OX-groups exist for classification. Conventional serotyping for O-typing entails agglutination reactions between the O-antigen and antisera generated against each O-group. The procedure is labor intensive, not always accurate, and exhibits equivocal results. In this report, we present the sequences of 71 O-antigen gene clusters (O-AGC) and a comparison of all 196 O- and OX-groups. Many of the designated O-types, applied for classification over several decades, exhibited similar nucleotide sequences of the O-AGCs and cross-reacted serologically. Some O-AGCs carried insertion sequences and others had only a few nucleotide differences between them. Thus, based on these findings, it is proposed that several of the E. coli O-groups may be merged. Knowledge of the O-AGC sequences facilitates the development of molecular diagnostic platforms that are rapid, accurate, and reliable that can replace conventional serotyping. Additionally, with the scientific knowledge presented, new frontiers in the discovery of biomarkers, understanding the roles of O-antigens in the innate and adaptive immune system and pathogenesis, the development of glycoconjugate vaccines, and other investigations, can be explored.	[DebRoy, Chitrita; Mwangi, Michael; Kapur, Vivek; Garay, Juan A. Raygoza; Roberts, Elisabeth L.; Katani, Robab] Penn State Univ, Dept Vet & Biomed Sci, E Coli Reference Ctr, Univ Pk, Pennsauken, NJ USA; [Fratamico, Pina M.; Yan, Xianghe; Baranzoni, GianMarco; Liu, Yanhong; Needleman, David S.] ARS, USDA, Eastern Reg Res Ctr, Wyndmoor, PA USA; [Tebbs, Robert; O'Connell, Catherine D.; Allred, Adam; Swimley, Michelle] Thermo Fisher Sci, Anim Hlth & Food Safety Life Sci Solut, Austin, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; United States Department of Agriculture (USDA); Thermo Fisher Scientific	DebRoy, C (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, E Coli Reference Ctr, Univ Pk, Pennsauken, NJ USA.	rcd3@psu.edu	Garay, Juan Antonio Raygoza/AAM-9568-2021; Katani, Robab/AAS-1292-2020; Liu, Yanhong/L-7093-2019	Liu, Yanhong/0000-0002-0759-7597	Thermo Fisher Scientific	Thermo Fisher Scientific	Thermo Fisher Scientific partially supported sequencing of the O-antigen gene clusters and purchased some of the reference standard strains. Robert Tebbs and Michelle Swimley contributed on a technical level through generating whole genome sequencing results for some of the strains. Adam Aldred was involved in genome assembly.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; BRONNER D, 1994, MOL MICROBIOL, V14, P505, DOI 10.1111/j.1365-2958.1994.tb02185.x; Bugarel M, 2010, INT J FOOD MICROBIOL, V142, P318, DOI 10.1016/j.ijfoodmicro.2010.07.010; Cheng JS, 2006, CURR MICROBIOL, V53, P470, DOI 10.1007/s00284-006-0032-7; Coimbra RS, 2000, RES MICROBIOL, V151, P639, DOI 10.1016/S0923-2508(00)00134-0; DebRoy Chitrita, 2011, Animal Health Research Reviews, V12, P169, DOI 10.1017/S1466252311000193; DebRoy C, 2011, FOODBORNE PATHOG DIS, V8, P651, DOI 10.1089/fpd.2010.0769; DebRoy C, 2010, FOODBORNE PATHOG DIS, V7, P1407, DOI 10.1089/fpd.2010.0614; Duda KA, 2011, MICROBIOL-SGM, V157, P1750, DOI 10.1099/mic.0.046912-0; Ewing W., 1972, GENUS ESCHERICHIA; Ewing WH, 1956, STUD SER ESCH COL GR; Feng L, 2004, J BACTERIOL, V186, P4510, DOI 10.1128/JB.186.14.4510-4519.2004; Fratamico PM, 2010, CAN J MICROBIOL, V56, P308, DOI [10.1139/W10-010, 10.1139/w10-010]; Fratamico PM, 2009, FOODBORNE PATHOG DIS, V6, P605, DOI 10.1089/fpd.2008.0254; Gehring A, 2013, SENSORS-BASEL, V13, P5737, DOI 10.3390/s130505737; Geue L, 2014, MICROBIOL IMMUNOL, V58, P77, DOI 10.1111/1348-0421.12120; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; Han WQ, 2007, APPL ENVIRON MICROB, V73, P4082, DOI 10.1128/AEM.01820-06; Hegde NV, 2013, J MICROBIOL METH, V93, P273, DOI 10.1016/j.mimet.2013.03.024; Hegde NV, 2012, FOODBORNE PATHOG DIS, V9, P1044, DOI 10.1089/fpd.2012.1231; Hegde NV, 2012, J CLIN MICROBIOL, V50, P2137, DOI 10.1128/JCM.00137-12; HOBBS M, 1994, MOL MICROBIOL, V12, P855, DOI 10.1111/j.1365-2958.1994.tb01071.x; Iguchi A, 2015, DNA RES, V22, P101, DOI 10.1093/dnares/dsu043; Jensen SO, 2004, CAN J MICROBIOL, V50, P299, DOI 10.1139/W04-010; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Kauffmann F., 1943, ACTA PATH ET MICROBIOL SCAND, V20, P21; Kauffmann F., 1944, ADA PATH ET MICROBIOL SCAND, V21, P20; KAUFFMANN F, 1947, J IMMUNOL, V57, P71; Lacher DW, 2014, APPL ENVIRON MICROB, V80, P4677, DOI 10.1128/AEM.01049-14; Lin A, 2011, J MICROBIOL METH, V87, P105, DOI 10.1016/j.mimet.2011.07.019; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Liu B, 2010, VET MICROBIOL, V142, P373, DOI 10.1016/j.vetmic.2009.10.019; Liu YH, 2008, FOODBORNE PATHOG DIS, V5, P449, DOI 10.1089/fpd.2008.0096; Liu YH, 2006, MOL CELL PROBE, V20, P239, DOI 10.1016/j.mcp.2006.01.001; Liu YH, 2015, BIOSENSORS-BASEL, V5, P51, DOI 10.3390/bios5010051; Medina MB, 2012, J FOOD PROTECT, V75, P819, DOI 10.4315/0362-028X.JFP-11-430; ORSKOV F, 1984, METHOD MICROBIOL, V14, P43, DOI 10.1016/S0580-9517(08)70447-1; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Perepelov AV, 2010, CARBOHYD RES, V345, P1594, DOI 10.1016/j.carres.2010.04.023; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Sanchez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117660; Scheutz F, 2004, APMIS, V112, P569, DOI 10.1111/j.1600-0463.2004.apm1120903.x; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang L, 2001, GENE, V270, P231, DOI 10.1016/S0378-1119(01)00471-1; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; Wang QA, 2010, MOL CELL PROBE, V24, P286, DOI 10.1016/j.mcp.2010.06.002; Wang W, 2007, MICROBIOL-SGM, V153, P2159, DOI 10.1099/mic.0.2007/004192-0; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001	51	67	77	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147434	10.1371/journal.pone.0147434	http://dx.doi.org/10.1371/journal.pone.0147434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824864	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528600032
J	He, JS; Zhu, QZ; Wani, G; Sharma, N; Wani, AA				He, Jinshan; Zhu, Qianzheng; Wani, Gulzar; Sharma, Nidhi; Wani, Altaf A.			Valosin-containing Protein (VCP)/p97 Segregase Mediates Proteolytic Processing of Cockayne Syndrome Group B (CSB) in Damaged Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; NUCLEOTIDE EXCISION-REPAIR; UV-SENSITIVE SYNDROME; DOUBLE-STRAND BREAKS; DNA-DAMAGE; AAA-ATPASE; IN-VIVO; UBIQUITIN; XPC	Cockayne syndrome group A and B (CSB) proteins act in transcription-coupled repair, a subpathway of nucleotide excision repair. Here we demonstrate that valosin-containing protein (VCP)/p97 segregase functions in ultraviolet radiation (UVR)induced ubiquitin-mediated CSB degradation. We show that VCP/p97 inhibition and siRNA-mediated ablation of VCP/p97 and its cofactors UFD1 and UBXD7 impair CSB degradation. VCP/p97 inhibition also results in the accumulation of CSB in chromatin. Moreover, VCP/p97 interacts with both native and ubiquitin-conjugated forms of CSB. The localized cellular UVR exposures lead to VCP/p97 accumulation at DNA damage spots, forming distinct UVR-induced foci. However, manifestation of VCP/p97 foci is independent of CSB and UBXD7. Furthermore, VCP/p97 and UBXD7 associate with the Cockayne syndrome group A-DDB1-Cul4A complex, an E3 ligase responsible for CSB ubiquitination. Compromising proteasome and VCP/p97 function allows accumulation of both native and ubiquitinated CSB and results in an increase of UBXD7, proteasomal RPN2, and Sug1 in the chromatin compartment. Surprisingly, both biochemical inhibition and genetic defect of VCP/p97 enhance the recovery of RNA synthesis following UVR, whereas both VCP/p97 and proteasome inhibitions decrease cell viability. Our findings reveal a new role of VCP/p97 segregase in the timely processing of ubiquitinated CSB from damaged chromatin.	[He, Jinshan; Zhu, Qianzheng; Wani, Gulzar; Sharma, Nidhi; Wani, Altaf A.] Ohio State Univ, Dept Radiol, 1036 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Zhu, QZ; Wani, AA (corresponding author), Ohio State Univ, Dept Radiol, 1036 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	zhu.49@osu.edu; wani.2@osu.edu			National Institute of Health [ES002388, ES012991]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012991, R01ES002388] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Health Grants ES002388 and ES012991 (to A. A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cho I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003407; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Citterio E, 1998, J BIOL CHEM, V273, P11844, DOI 10.1074/jbc.273.19.11844; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; den Besten W, 2012, NAT STRUCT MOL BIOL, V19, P511, DOI 10.1038/nsmb.2269; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Fei J, 2012, J BIOL CHEM, V287, P35118, DOI 10.1074/jbc.M112.398131; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Ford JM, 1997, CURR TOP MICROBIOL, V221, P47; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; Gool AJ, 1997, EMBO J, V16, P5955; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meyer H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-48; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Puumalainen MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4695; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Sharma N, 2014, CELL CYCLE, V13, P106, DOI 10.4161/cc.26814; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Wang YM, 2014, P NATL ACAD SCI USA, V111, P14454, DOI 10.1073/pnas.1412569111; Wei LZ, 2011, CANCER SCI, V102, P1840, DOI 10.1111/j.1349-7006.2011.02037.x; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228; Zhu QZ, 2015, CELL CYCLE, V14, P1413, DOI 10.1080/15384101.2015.1007785	49	20	20	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7396	7408		10.1074/jbc.M115.705350	http://dx.doi.org/10.1074/jbc.M115.705350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26826127	Green Published, hybrid			2022-12-26	WOS:000383447600016
J	Onos, KD; Francoeur, MJ; Wormwood, BA; Miller, RLA; Gibson, BM; Mair, RG				Onos, Kristen D.; Francoeur, Miranda J.; Wormwood, Benjamin A.; Miller, Rikki L. A.; Gibson, Brett M.; Mair, Robert G.			Prefrontal Neurons Encode Actions and Outcomes in Conjunction with Spatial Location in Rats Performing a Dynamic Delayed Non-Match to Position Task	PLOS ONE			English	Article							WORKING-MEMORY; FRONTAL-CORTEX; PREPARATORY ATTENTION; PRELIMBIC CORTEX; CINGULATE CORTEX; LESIONS; HIPPOCAMPAL; REPRESENTATION; DISSOCIATION; INFORMATION	To respond adaptively to change organisms must utilize information about recent events and environmental context to select actions that are likely to produce favorable outcomes. We developed a dynamic delayed nonmatching to position task to study the influence of spatial context on event-related activity of medial prefrontal cortex neurons during reinforcement-guided decision-making. We found neurons with responses related to preparation, movement, lever press responses, reinforcement, and memory delays. Combined eventrelated and video tracking analyses revealed variability in spatial tuning of neurons with similar event-related activity. While all correlated neurons exhibited spatial tuning broadly consistent with relevant task events, for instance reinforcement-related activity concentrated in locations where reinforcement was delivered, some had elevated activity in more specific locations, for instance reinforcement-related activity in one of several locations where reinforcement was delivered. Timing analyses revealed a limited set of distinct response types with activity time-locked to critical behavioral events that represent the temporal organization of dDNMTP trials. Our results suggest that reinforcement-guided decision-making emerges from discrete populations of medial prefrontal neurons that encode information related to planned or ongoing movements and actions and anticipated or actual action-outcomes in conjunction with information about spatial context.	[Onos, Kristen D.; Francoeur, Miranda J.; Wormwood, Benjamin A.; Miller, Rikki L. A.; Gibson, Brett M.; Mair, Robert G.] Univ New Hampshire, Dept Psychol, Durham, NH 03824 USA; [Onos, Kristen D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	University System Of New Hampshire; University of New Hampshire; Jackson Laboratory	Mair, RG (corresponding author), Univ New Hampshire, Dept Psychol, Durham, NH 03824 USA.	rgm@unh.edu	Miller, Rikki/AAI-2830-2020; Francoeur, Miranda/ABD-6626-2021	Francoeur, Miranda/0000-0001-5694-8122; Onos, Kristen/0000-0001-6443-6557	Research Leveraging Initiative grant from the University of New Hampshire	Research Leveraging Initiative grant from the University of New Hampshire	This work was funded by a Research Leveraging Initiative grant from the University of New Hampshire.	Ables M, 1982, J NEUROSCI METH, V4, P317; AGGLETON JP, 1995, J NEUROSCI, V15, P7270; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Bailey KR, 2007, EUR J NEUROSCI, V25, P2905, DOI 10.1111/j.1460-9568.2007.05492.x; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Chang JY, 2002, EXP BRAIN RES, V142, P67, DOI 10.1007/s00221-001-0918-3; Chudasama Y, 2011, BEHAV NEUROSCI, V125, P327, DOI 10.1037/a0023766; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Cowen SL, 2007, J NEUROPHYSIOL, V98, P303, DOI 10.1152/jn.00150.2007; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; de Saint Blanquat P, 2010, BEHAV BRAIN RES, V209, P267, DOI 10.1016/j.bbr.2010.02.004; Dwyer DM, 2010, Q J EXP PSYCHOL, V63, P417, DOI 10.1080/17470210903411049; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Euston DR, 2006, J NEUROSCI, V26, P13143, DOI 10.1523/JNEUROSCI.3803-06.2006; Funahashi S, 2006, NEUROSCIENCE, V139, P251, DOI 10.1016/j.neuroscience.2005.07.003; Funahashi S, 2013, PROG NEUROBIOL, V103, P131, DOI 10.1016/j.pneurobio.2012.04.002; Gemmell C, 2002, BEHAV BRAIN RES, V133, P1; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Grillner S, 2015, CURR OPIN NEUROBIOL, V33, P47, DOI 10.1016/j.conb.2015.01.019; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Hok V, 2005, P NATL ACAD SCI USA, V102, P4602, DOI 10.1073/pnas.0407332102; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Horst NK, 2012, J NEUROPHYSIOL, V108, P3276, DOI 10.1152/jn.01192.2011; Hyman JM, 2013, CEREB CORTEX, V23, P1257, DOI 10.1093/cercor/bhs104; Hyman JM, 2012, P NATL ACAD SCI USA, V109, P5086, DOI 10.1073/pnas.1114415109; Insel N, 2015, CEREB CORTEX, V25, P2631, DOI 10.1093/cercor/bhu062; Jin X, 2014, NAT NEUROSCI, V17, P423, DOI 10.1038/nn.3632; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; Kennerley SW, 2004, J NEUROPHYSIOL, V91, P978, DOI 10.1152/jn.00651.2003; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Kim J, 2013, J NEUROSCI, V33, P13834, DOI 10.1523/JNEUROSCI.1443-13.2013; Liu D, 2014, SCIENCE, V346, P458, DOI 10.1126/science.1256573; Mair RG, 1998, BEHAV NEUROSCI, V112, P772, DOI 10.1037/0735-7044.112.4.772; Merten K, 2013, J NEUROPHYSIOL, V110, P19, DOI 10.1152/jn.00686.2012; MULLER RU, 1987, J NEUROSCI, V7, P1935; Murakami M, 2015, CURR OPIN NEUROBIOL, V33, P40, DOI 10.1016/j.conb.2015.01.005; Ostlund SB, 2009, J NEUROSCI, V29, P8280, DOI 10.1523/JNEUROSCI.1176-09.2009; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peters J, 2009, HIPPOCAMPUS, V19, P141, DOI 10.1002/hipo.20490; Plakke B, 2013, NEUROSCIENCE, V244, P62, DOI 10.1016/j.neuroscience.2013.04.002; Porter MC, 2000, BEHAV BRAIN RES, V109, P69, DOI 10.1016/S0166-4328(99)00161-8; Poucet B, 1997, BEHAV BRAIN RES, V84, P151, DOI 10.1016/S0166-4328(96)00144-1; Powell NJ, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00120; Pratt WE, 2001, BEHAV BRAIN RES, V123, P165, DOI 10.1016/S0166-4328(01)00204-2; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Ragozzino ME, 2001, NEUROSCI LETT, V308, P145, DOI 10.1016/S0304-3940(01)02020-1; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Robbins AA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00181; Ruitenberg MFL, 2014, NEUROPSYCHOLOGIA, V56, P229, DOI 10.1016/j.neuropsychologia.2014.01.014; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Sloan HL, 2006, BEHAV BRAIN RES, V171, P116, DOI 10.1016/j.bbr.2006.03.030; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Totah NKB, 2013, CEREB CORTEX, V23, P729, DOI 10.1093/cercor/bhs057; Totah NKB, 2009, J NEUROSCI, V29, P6418, DOI 10.1523/JNEUROSCI.1142-09.2009; Warden MR, 2007, CEREB CORTEX, V17, pI41, DOI 10.1093/cercor/bhm070	60	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0149019	10.1371/journal.pone.0149019	http://dx.doi.org/10.1371/journal.pone.0149019			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848579	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000194
J	Sevin, DC; Stahlin, JN; Pollak, GR; Kuehne, A; Sauer, U				Sevin, Daniel C.; Staehlin, Jacqueline N.; Pollak, Georg R.; Kuehne, Andreas; Sauer, Uwe			Global Metabolic Responses to Salt Stress in Fifteen Species	PLOS ONE			English	Article							ESCHERICHIA-COLI; OSMOTIC-STRESS; COMPATIBLE SOLUTES; COENZYME-A; TOLERANCE; OSMOREGULATION; TREHALOSE; SODIUM; YEAST; ACCUMULATION	Cells constantly adapt to unpredictably changing extracellular solute concentrations. A cornerstone of the cellular osmotic stress response is the metabolic supply of energy and building blocks to mount appropriate defenses. Yet, the extent to which osmotic stress impinges on the metabolic network remains largely unknown. Moreover, it is mostly unclear which, if any, of the metabolic responses to osmotic stress are conserved among diverse organisms or confined to particular groups of species. Here we investigate the global metabolic responses of twelve bacteria, two yeasts and two human cell lines exposed to sustained hyperosmotic salt stress by measuring semiquantitative levels of hundreds of cellular metabolites using nontargeted metabolomics. Beyond the accumulation of osmoprotectants, we observed significant changes of numerous metabolites in all species. Global metabolic responses were predominantly species-specific, yet individual metabolites were characteristically affected depending on species' taxonomy, natural habitat, envelope structure or salt tolerance. Exploiting the breadth of our dataset, the correlation of individual metabolite response magnitudes across all species implicated lower glycolysis, tricarboxylic acid cycle, branched-chain amino acid metabolism and heme biosynthesis to be generally important for salt tolerance. Thus, our findings place the global metabolic salt stress response into a phylogenetic context and provide insights into the cellular phenotype associated with salt tolerance.	[Sevin, Daniel C.; Staehlin, Jacqueline N.; Pollak, Georg R.; Kuehne, Andreas; Sauer, Uwe] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Sevin, Daniel C.; Kuehne, Andreas] Life Sci Zurich, PhD Program Syst Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Sevin, DC; Sauer, U (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.; Sevin, DC (corresponding author), Life Sci Zurich, PhD Program Syst Biol, Zurich, Switzerland.	dsevin@ethz.ch; sauer@ethz.ch	Sauer, Uwe/Y-3556-2019		MetaNetX project of the Swiss Initiative for Systems Biology (SystemsX.ch); Swiss Federal Government through the Federal Office of Education and Science	MetaNetX project of the Swiss Initiative for Systems Biology (SystemsX.ch); Swiss Federal Government through the Federal Office of Education and Science	This work was funded by the MetaNetX project of the Swiss Initiative for Systems Biology (SystemsX.ch; http://www.metanetx.org/) evaluated by the Swiss National Science Foundation, and the Swiss Federal Government through the Federal Office of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argandona M, 2010, APPL ENVIRON MICROB, V76, P3575, DOI 10.1128/AEM.03136-09; Balcells L, 1997, EUR J BIOCHEM, V250, P476, DOI 10.1111/j.1432-1033.1997.0476a.x; Behrends V, 2010, MOL BIOSYST, V6, P562, DOI 10.1039/b918710c; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BOTSFORD JL, 1990, APPL ENVIRON MICROB, V56, P488, DOI 10.1128/AEM.56.2.488-494.1990; Bougouffa S, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau100; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; CALAMITA G, 1995, J BIOL CHEM, V270, P29063, DOI 10.1074/jbc.270.49.29063; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; CAYLEY S, 1992, J BACTERIOL, V174, P1586, DOI 10.1128/jb.174.5.1586-1595.1992; Chae YK, 2013, B KOREAN CHEM SOC, V34, P3602, DOI 10.5012/bkcs.2013.34.12.3602; Chohnan S, 1998, BIOSCI BIOTECH BIOCH, V62, P1122, DOI 10.1271/bbb.62.1122; Christen S, 2011, FEMS YEAST RES, V11, P263, DOI 10.1111/j.1567-1364.2010.00713.x; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; Courtenay ES, 2000, BIOCHEMISTRY-US, V39, P4455, DOI 10.1021/bi992887l; da Costa M. S., 1998, V61, P117; Empadinhas N., 2009, CONTRIB SCI, V5, P95, DOI DOI 10.2436/20.7010.01.65; Empadinhas N, 2008, INT MICROBIOL, V11, P151, DOI 10.2436/20.1501.01.55; Flowers TJ, 2015, ANN BOT-LONDON, V115, P419, DOI 10.1093/aob/mcu217; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; GARNER MM, 1994, AM J PHYSIOL, V266, pC877, DOI 10.1152/ajpcell.1994.266.4.C877; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; Hamada-Kanazawa M, 2011, BIOL PHARM BULL, V34, P1455, DOI 10.1248/bpb.34.1455; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Hernandez VA, 2015, BBA-BIOMEMBRANES, V1848, P2233, DOI 10.1016/j.bbamem.2015.05.002; Horta BAC, 2010, J MOL GRAPH MODEL, V29, P331, DOI 10.1016/j.jmgm.2010.09.013; JIA ZP, 1992, EMBO J, V11, P1631, DOI 10.1002/j.1460-2075.1992.tb05209.x; KALIR A, 1981, ANN BOT-LONDON, V47, P75, DOI 10.1093/oxfordjournals.aob.a086002; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Klumpp S, 2014, CURR OPIN BIOTECH, V28, P96, DOI 10.1016/j.copbio.2014.01.001; Kol S, 2010, APPL ENVIRON MICROB, V76, P2574, DOI 10.1128/AEM.01992-09; Kono N, 2009, PLOS ONE, V4, pA47, DOI 10.1371/journal.pone.0007710; KOPPENOL WH, 1993, FREE RADICAL BIO MED, V15, P645, DOI 10.1016/0891-5849(93)90168-T; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Lowe RGT, 2008, FUNGAL GENET BIOL, V45, P1479, DOI 10.1016/j.fgb.2008.08.006; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; OSMOND CB, 1972, PLANT PHYSIOL, V49, P260, DOI 10.1104/pp.49.2.260; PALEG LG, 1985, PLANT SOIL, V89, P83, DOI 10.1007/BF02182235; Pereira CS, 2008, BIOPHYS J, V95, P3525, DOI 10.1529/biophysj.108.131656; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P190, DOI 10.1016/S0968-0004(98)01207-9; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P143, DOI 10.1016/S0968-0004(98)01196-7; RESCIGNO M, 1994, BIOCHEMISTRY-US, V33, P5721, DOI 10.1021/bi00185a008; ROBERTSON GL, 1976, KIDNEY INT, V10, P25, DOI 10.1038/ki.1976.76; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; Rubio S, 2008, PLANT PHYSIOL, V148, P546, DOI 10.1104/pp.108.124057; Sevin DC, 2015, CURR OPIN BIOTECH, V34, P1, DOI 10.1016/j.copbio.2014.10.001; Sevin DC, 2014, NAT CHEM BIOL, V10, P266, DOI 10.1038/nchembio.1437; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Smirnova GV, 2000, FEMS MICROBIOL LETT, V186, P209, DOI 10.1111/j.1574-6968.2000.tb09106.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Ventosa A, 1998, MICROBIOL MOL BIOL R, V62, P504, DOI 10.1128/MMBR.62.2.504-544.1998; Virlouvet L, 2011, PLANT PHYSIOL, V157, P917, DOI 10.1104/pp.111.176818; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2521, DOI 10.1099/00221287-136-12-2521; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Yoshida H, 1998, J GEN APPL MICROBIOL, V44, P19, DOI 10.2323/jgam.44.19	60	40	40	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148888	10.1371/journal.pone.0148888	http://dx.doi.org/10.1371/journal.pone.0148888			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848578	Green Submitted, gold, Green Published			2022-12-26	WOS:000369554000182
J	Begin, C; Schelten, CK; Nugues, MM; Hawkins, J; Roberts, C; Cote, IM				Begin, Chantale; Schelten, Christiane K.; Nugues, Maggy M.; Hawkins, Julie; Roberts, Callum; Cote, Isabelle M.			Effects of Protection and Sediment Stress on Coral Reefs in Saint Lucia	PLOS ONE			English	Article							REGION-WIDE DECLINES; FALSE DISCOVERY RATE; GREAT-BARRIER-REEF; MARINE RESERVES; PHASE-SHIFTS; SURFACE SEDIMENT; CONSERVATION; CARBONATE; GROWTH; COVER	The extent to which Marine Protected Areas (MPAs) benefit corals is contentious. On one hand, MPAs could enhance coral growth and survival through increases in herbivory within their borders; on the other, they are unlikely to prevent disturbances, such as terrestrial runoff, that originate outside their boundaries. We examined the effect of spatial protection and terrestrial sediment on the benthic composition of coral reefs in Saint Lucia. In 2011 (10 to 16 years after MPAs were created), we resurveyed 21 reefs that had been surveyed in 2001 and analyzed current benthic assemblages as well as changes in benthic cover over that decade in relation to protection status, terrestrial sediment influence (measured as the proportion of terrigenous material in reef-associated sediment) and depth. The cover of all benthic biotic components has changed significantly over the decade, including a decline in coral and increase in macroalgae. Protection status was not a significant predictor of either current benthic composition or changes in composition, but current cover and change in cover of several components were related to terrigenous content of sediment deposited recently. Sites with a higher proportion of terrigenous sediment had lower current coral cover, higher macroalgal cover and greater coral declines. Our results suggest that terrestrial sediment is an important factor in the recent degradation of coral reefs in Saint Lucia and that the current MPA network should be complemented by measures to reduce runoff from land.	[Begin, Chantale; Cote, Isabelle M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Schelten, Christiane K.] Helmholtz Ctr Ocean Res Kiel, GEOMAR, Dusternbrooker Weg 20, D-24105 Kiel, Germany; [Nugues, Maggy M.] Lab Excellence CORAIL, 58 Ave Paul Alduy, F-66860 Perpignan, France; [Nugues, Maggy M.] USR 3278 CRIOBE EPHE CNRS UPVD, 58 Ave Paul Alduy, F-66860 Perpignan, France; [Hawkins, Julie; Roberts, Callum] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	Simon Fraser University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); University of York - UK	Begin, C (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	cbegin@usf.edu	Cote, Isabelle/ABD-5898-2021; Nugues, Maggy M/O-4314-2015	Nugues, Maggy M/0000-0002-1399-9787	International Coral Reef Conservation Grant from the National Oceanic and Atmospheric Administration [NA09NOS4630011]; Natural Science and Engineering Research Council of Canada (NSERC) [328224-2012]	International Coral Reef Conservation Grant from the National Oceanic and Atmospheric Administration; Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by an International Coral Reef Conservation Grant #NA09NOS4630011 from the National Oceanic and Atmospheric Administration to CB and IMC and Discovery Grant #328224-2012 from the Natural Science and Engineering Research Council of Canada (NSERC) to IMC. Neither funding agency was involved in the study design, analysis or decision to publish.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; [Anonymous], 2001, CORAL REEFS, V20, P137; [Anonymous], 2011, MACROSOCIOECONOMIC E; [Anonymous], 2010, DISASTER RISK MANAGE; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; BABCOCK R, 1991, CORAL REEFS, V9, P205, DOI 10.1007/BF00290423; Badran MI, 2005, AMBIO, V34, P615, DOI 10.1639/0044-7447(2005)034[0615:EQOJCS]2.0.CO;2; Begin C., 2012, LAND USE SEDIMENTATI; Begin C, 2014, OCEAN COAST MANAGE, V95, P35, DOI 10.1016/j.ocecoaman.2014.03.018; Begin C, 2013, MAR BIOL, V160, P343, DOI 10.1007/s00227-012-2092-5; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Brooks GR, 2007, CARIBB J SCI, V43, P226; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burke L., 2008, COASTAL CAPITAL EC V; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Dearing JA, 2003, GLOBAL PLANET CHANGE, V39, P147, DOI 10.1016/S0921-8181(03)00022-5; DODGE RE, 1974, NATURE, V247, P574, DOI 10.1038/247574a0; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferrari R, 2012, CORAL REEFS, V31, P683, DOI 10.1007/s00338-012-0889-9; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Harborne AR, 2006, ECOLOGY, V87, P2871, DOI 10.1890/0012-9658(2006)87[2871:MTBDOC]2.0.CO;2; Hawkins JP, 2006, BIOL CONSERV, V127, P487, DOI 10.1016/j.biocon.2005.09.008; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; HODGSON G, 1990, CORAL REEFS, V9, P41, DOI 10.1007/BF00686720; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jameson SC, 2002, MAR POLLUT BULL, V44, P1177, DOI 10.1016/S0025-326X(02)00258-8; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Klein CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012431; Lewis D.W., 1994, ANAL SEDIMENTOLOGY; Magdaong ET, 2014, HYDROBIOLOGIA, V733, P5, DOI 10.1007/s10750-013-1720-5; Manfrino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075432; MAXWELL WGH, 1970, GEOL SOC AM BULL, V81, P691, DOI 10.1130/0016-7606(1970)81[691:GBRRVI]2.0.CO;2; McClanahan TR, 1998, ENVIRON CONSERV, V25, P122, DOI 10.1017/S0376892998000174; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Nowlis JS, 1997, AMBIO, V26, P515; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; Nugues MM, 2002, MAR ECOL PROG SER, V229, P61, DOI 10.3354/meps229061; Nugues MM, 2003, MAR POLLUT BULL, V46, P314, DOI 10.1016/S0025-326X(02)00402-2; Orpin AR, 2004, AUST J EARTH SCI, V51, P665, DOI 10.1111/j.1400-0952.2004.01083.x; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pandolfi JM, 2008, MAR ECOL PROG SER, V369, P89, DOI 10.3354/meps07570; Perry CT, 1996, J SEDIMENT RES, V66, P459; Perry CT, 2004, J COASTAL RES, V20, P1070, DOI 10.2112/03-0016.1; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Piniak GA, 2008, PAC SCI, V62, P39, DOI 10.2984/1534-6188(2008)62[39:GAMOCT]2.0.CO;2; Richmond RH, 2007, BIOSCIENCE, V57, P598, DOI 10.1641/B570710; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; ROGERS CS, 1983, MAR POLLUT BULL, V14, P378, DOI 10.1016/0025-326X(83)90602-1; Ryan KE, 2008, MAR POLLUT BULL, V56, P1177, DOI 10.1016/j.marpolbul.2008.02.017; Schelten CK, 2002, IMPACTS MULTIPLE STR; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; SHEPPARD CRC, 1982, MAR ECOL PROG SER, V7, P83, DOI 10.3354/meps007083; Shulman MJ, 1996, CORAL REEFS, V15, P231, DOI 10.1007/s003380050048; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sotka EE, 2009, CORAL REEFS, V28, P555, DOI 10.1007/s00338-009-0529-1; Tallis H, 2008, CONSERV BIOL, V22, P120, DOI 10.1111/j.1523-1739.2007.00861.x; Torres JL, 2002, CARIBB J SCI, V38, P222; Toth LT, 2014, CORAL REEFS, V33, P565, DOI 10.1007/s00338-014-1158-x; Tulsie B, 2006, NAT RESOUR FORUM, V30, P102, DOI 10.1111/j.1477-8947.2006.00163.x; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Waite TA, 2006, ECOSCIENCE, V13, P439, DOI 10.2980/1195-6860(2006)13[439:CTFDRA]2.0.CO;2; Wilkinson C, 2005, STATUS CARIBBEAN COR; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Zuur Alain F., 2009, P1	78	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0146855	10.1371/journal.pone.0146855	http://dx.doi.org/10.1371/journal.pone.0146855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845451	Green Accepted, gold, Green Published			2022-12-26	WOS:000369552800005
J	Ho, JY; Chang, FW; Huang, FS; Liu, JM; Liu, YP; Chen, SP; Liu, YL; Cheng, KC; Yu, CP; Hsu, RJ				Ho, Jar-Yi; Chang, Fung-Wei; Huang, Fong Shung; Liu, Jui-Ming; Liu, Yueh-Ping; Chen, Shu-Pin; Liu, Yung-Liang; Cheng, Kuan-Chen; Yu, Cheng-Ping; Hsu, Ren-Jun			Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ER alpha-Delta Np63-Integrin beta 4 Signaling Pathway	PLOS ONE			English	Article							ALPHA-6-BETA-4 INTEGRIN; STEM-CELL; MESENCHYMAL TRANSITION; CARCINOMA-CELLS; MAMMARY-GLAND; P53 HOMOLOG; P63; EXPRESSION; DELTA-NP63; METASTASIS	Estrogen induces ER alpha-positive breast cancer aggressiveness via the promotion of cell proliferation and survival, the epithelial-mesenchymal transition, and stem-like properties. Integrin beta 4 signaling has been implicated in estrogen/ER alpha-induced tumorigenicity and antiapoptosis; however, this signaling cascade poorly understood. Delta Np63, an N-terminally truncated isoform of the p63 transcription factor, functions as a transcription factor of integrin-beta 4 and therefore regulates cellular adhesion and survival. Therefore, the aim of the present study was to investigate the estrogen-induced interaction between ER alpha, Delta Np63 and integrin beta 4 in breast cancer cells. In ER alpha-positive MCF-7 cells, estrogen activated ER alpha transcription, which induced Delta Np63 expression. And Delta Np63 subsequently induced integrin beta 4 expression, which resulted in AKT phosphorylation and enhanced cell viability and motility. Conversely, there was no inductive effect of estrogen on Delta Np63-integrin beta 4-AKT signaling or on cell viability and motility in ER alpha-negative MDA-MB-231 cells. Delta Np63 knockdown abolishes these estrogen-induced effects and reduces cell viability and motility in MCF-7 cells. Nevertheless, Delta Np63 knockdown also inhibited cell migration in MDA-MB-231 cells through reducing integrin beta 4 expression and AKT phosphorylation. In conclusion, estrogen enhances ER alpha-positive breast cancer cell viability and motility through activating the ER alpha-Delta Np63-integrin beta 4 signaling pathway to induce AKT phosphorylated activation. Those findings should be useful to elucidate the crosstalk between estrogen/ER signaling and Delta Np63 signaling and provide novel insights into the effects of estrogen on breast cancer progression.	[Ho, Jar-Yi; Yu, Cheng-Ping; Hsu, Ren-Jun] Natl Def Med Ctr, Dept Pathol, Triserv Gen Hosp, Taipei, Taiwan; [Ho, Jar-Yi; Yu, Cheng-Ping; Hsu, Ren-Jun] Natl Def Med Ctr, Grad Inst Pathol & Parasitol, Taipei, Taiwan; [Chang, Fung-Wei; Liu, Yung-Liang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Huang, Fong Shung] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Liu, Jui-Ming] Minist Hlth & Welf, Taoyuan Gen Hosp, Div Urol, Dept Surg, Taoyuan, Taiwan; [Liu, Yueh-Ping; Yu, Cheng-Ping] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Chen, Shu-Pin] Chang Gung Childrens Hosp, Div Med Genet, Dept Pediat, Taoyuan, Taiwan; [Cheng, Kuan-Chen] Natl Taiwan Univ, Inst Biotechnol, 1 Sec 4,Roosevelt Rd, Taipei 10764, Taiwan; [Hsu, Ren-Jun] Natl Def Med Ctr, Biobank Management Ctr, Triserv Gen Hosp, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital	Yu, CP; Hsu, RJ (corresponding author), Natl Def Med Ctr, Dept Pathol, Triserv Gen Hosp, Taipei, Taiwan.; Yu, CP; Hsu, RJ (corresponding author), Natl Def Med Ctr, Grad Inst Pathol & Parasitol, Taipei, Taiwan.; Yu, CP (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.; Hsu, RJ (corresponding author), Natl Def Med Ctr, Biobank Management Ctr, Triserv Gen Hosp, Taipei, Taiwan.	cpyupath@yahoo.com.tw; hsurnai@gmail.com	Jui-Ming, Liu/H-3452-2019	Jui-Ming, Liu/0000-0003-3868-085X; Ho, Jar-Yi/0000-0001-6933-041X; Yu, Cheng-Ping/0000-0002-0693-5056	Ministry of Science and Technology Taiwan [MOST 104-2320-B-016-012-MY3, MOST 103-2320-B-016-013, MOST 103-2320-B-016-019]; Tri-Service General Hospital [TSGH-C103-101, TSGH-C104-072, TSGH-C104-188, TSGH-C104-210, TSGH-C105-003, TSGH-C105-070, TSGH-C105-168]; Teh-Tzer Study Group for Human Medical Research Foundation [A1021094]	Ministry of Science and Technology Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; Teh-Tzer Study Group for Human Medical Research Foundation	This work was supported by grants from the Ministry of Science and Technology Taiwan (MOST 104-2320-B-016-012-MY3, MOST 103-2320-B-016-013 and MOST 103-2320-B-016-019), the Tri-Service General Hospital (TSGH-C103-101, TSGH-C104-072, TSGH-C104-188, TSGH-C104-210, TSGH-C105-003, TSGH-C105-070, and TSGH-C105-168), and the Teh-Tzer Study Group for Human Medical Research Foundation (A1021094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam A, 2014, CELL PHYSIOL BIOCHEM, V34, P491, DOI 10.1159/000363017; Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; Balboni AL, 2013, CANCER RES, V73, P1020, DOI 10.1158/0008-5472.CAN-12-2862; Band AM, 2011, J MAMMARY GLAND BIOL, V16, P109, DOI 10.1007/s10911-011-9203-7; Bid HK, 2014, CANCER RES, V74, P320, DOI 10.1158/0008-5472.CAN-13-0894; Bon G, 2006, CLIN CANCER RES, V12, P3280, DOI 10.1158/1078-0432.CCR-05-2223; Bouris P, 2015, MATRIX BIOL, V43, P42, DOI 10.1016/j.matbio.2015.02.008; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chalcrabarti R, 2014, NAT CELL BIOL, V16, P1004, DOI 10.1038/ncb3040; DeYoung MP, 2006, CANCER RES, V66, P9362, DOI 10.1158/0008-5472.CAN-06-1619; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Du ZJ, 2010, CANCER SCI, V101, P2417, DOI 10.1111/j.1349-7006.2010.01700.x; Gallegos JR, 2008, J BIOL CHEM, V283, P66, DOI 10.1074/jbc.M704686200; Gaya JM, 2015, J UROLOGY, V193, P1144, DOI 10.1016/j.juro.2014.10.098; Giacobbe A, 2016, ONCOGENE, V35, P1602, DOI 10.1038/onc.2015.230; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hagiwara K, 1999, CANCER RES, V59, P4165; Hanstein B, 2004, EUR J ENDOCRINOL, V150, P243, DOI 10.1530/eje.0.1500243; Humphries LA, 2013, BRIT J HAEMATOL, V163, P590, DOI 10.1111/bjh.12580; Kayisli UA, 2005, ACTA HISTOCHEM, V107, P173, DOI 10.1016/j.acthis.2005.01.005; Khokhar SK, 2008, CELL RES, V18, P1061, DOI 10.1038/cr.2008.82; Kumar RMR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-559; Latina A, 2016, ONCOGENE, V35, P1493, DOI 10.1038/onc.2015.222; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Leary A, 2006, BRIT J CANCER, V95, P661, DOI 10.1038/sj.bjc.6603316; Lewis-Wambi Joan S, 2005, Breast Dis, V24, P93; Lombardo Y, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3675; Marjon NA, 2014, MOL CANCER RES, V12, P1644, DOI 10.1158/1541-7786.MCR-14-0128-T; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Massion PP, 2003, CANCER RES, V63, P7113; Matsubara R, 2011, INT J ONCOL, V39, P1391, DOI 10.3892/ijo.2011.1151; Melino G, 2011, CELL DEATH DIFFER, V18, P1487, DOI 10.1038/cdd.2011.81; Memmi EM, 2015, P NATL ACAD SCI USA, V112, P3499, DOI 10.1073/pnas.1500762112; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Park BJ, 2000, CANCER RES, V60, P3370; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Planas-Silva MD, 2007, J STEROID BIOCHEM, V104, P11, DOI 10.1016/j.jsbmb.2006.09.039; Raymond K, 2007, MOL BIOL CELL, V18, P4210, DOI 10.1091/mbc.E06-08-0720; Rhodes LV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-295; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Soltysik K, 2013, J PHYSIOL PHARMACOL, V64, P129; Spiesbach K, 2005, INT J CANCER, V114, P555, DOI 10.1002/ijc.20766; Stewart RL, 2015, LAB INVEST, V95, P976, DOI 10.1038/labinvest.2015.82; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Sun Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-137; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Tyson JJ, 2011, NAT REV CANCER, V11, P523, DOI 10.1038/nrc3081; Vieira AF, 2014, ONCOTARGET, V5, P679, DOI 10.18632/oncotarget.1459; Wan X, 2009, ONCOGENE, V28, P3401, DOI 10.1038/onc.2009.206; Wu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.239; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang XF, 2009, J CELL SCI, V122, P2473, DOI 10.1242/jcs.049148; Yang ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07758; Ye S, 2014, INT J ONCOL, V44, P2153, DOI 10.3892/ijo.2014.2374; Zhang XHF, 2013, CLIN CANCER RES, V19, P6389, DOI 10.1158/1078-0432.CCR-13-0838; Zheng SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022439	68	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148301	10.1371/journal.pone.0148301	http://dx.doi.org/10.1371/journal.pone.0148301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845172	gold, Green Submitted, Green Published			2022-12-26	WOS:000369552800043
J	Wei, Y; Li, JL; Qing, J; Huang, MJ; Wu, M; Gao, FH; Li, DM; Hong, ZY; Kong, LB; Huang, WQ; Lin, JP				Wei, Yu; Li, Jinlong; Qing, Jie; Huang, Mingjie; Wu, Ming; Gao, Fenghua; Li, Dongmei; Hong, Zhangyong; Kong, Lingbao; Huang, Weiqiang; Lin, Jianping			Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; STRUCTURE-BASED DESIGN; MACHINE LEARNING-METHODS; ALLOSTERIC INHIBITORS; HCVNS5B POLYMERASE; MOLECULAR DOCKING; NONNUCLEOSIDE INHIBITORS; BINDING AFFINITIES; POTENT INHIBITORS; CRYSTAL-STRUCTURE	The NS5B polymerase is one of the most attractive targets for developing new drugs to block Hepatitis C virus (HCV) infection. We describe the discovery of novel potent HCV NS5B polymerase inhibitors by employing a virtual screening (VS) approach, which is based on random forest (RB-VS), e-pharmacophore (PB-VS), and docking (DB-VS) methods. In the RB-VS stage, after feature selection, a model with 16 descriptors was used. In the PB-VS stage, six energy-based pharmacophore (e-pharmacophore) models from different crystal structures of the NS5B polymerase with ligands binding at the palm I, thumb I and thumb II regions were used. In the DB-VS stage, the Glide SP and XP docking protocols with default parameters were employed. In the virtual screening approach, the RB-VS, PB-VS and DB-VS methods were applied in increasing order of complexity to screen the InterBioScreen database. From the final hits, we selected 5 compounds for further anti-HCV activity and cellular cytotoxicity assay. All 5 compounds were found to inhibit NS5B polymerase with IC50 values of 2.01-23.84 mu M and displayed anti-HCV activities with EC50 values ranging from 1.61 to 21.88 mu M, and all compounds displayed no cellular cytotoxicity (CC50 > 100 mu M) except compound N2, which displayed weak cytotoxicity with a CC50 value of 51.3 mu M. The hit compound N2 had the best antiviral activity against HCV, with a selective index of 32.1. The 5 hit compounds with new scaffolds could potentially serve as NS5B polymerase inhibitors through further optimization and development.	[Wei, Yu; Li, Jinlong; Li, Dongmei; Lin, Jianping] Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Wei, Yu; Li, Jinlong; Li, Dongmei; Lin, Jianping] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China; [Li, Jinlong; Lin, Jianping] Tianjin Joint Acad Biomed & Technol, High Throughput Mol Drug Discovery Ctr, Tianjin 300457, Peoples R China; [Huang, Weiqiang] PracticaChem China, Tianjin 300192, Peoples R China; [Qing, Jie; Wu, Ming; Gao, Fenghua] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Hong, Zhangyong] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Huang, Mingjie; Kong, Lingbao] Jiangxi Agr Univ, Coll Biosci & Engn, Nanchang 330045, Peoples R China	Nankai University; Nankai University; Tsinghua University; Nankai University; Jiangxi Agricultural University	Lin, JP (corresponding author), Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Lin, JP (corresponding author), Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China.; Lin, JP (corresponding author), Tianjin Joint Acad Biomed & Technol, High Throughput Mol Drug Discovery Ctr, Tianjin 300457, Peoples R China.; Huang, WQ (corresponding author), PracticaChem China, Tianjin 300192, Peoples R China.; Kong, LB (corresponding author), Jiangxi Agr Univ, Coll Biosci & Engn, Nanchang 330045, Peoples R China.	lingbaok@hotmail.com; practicachem@gmail.com; jianpinglin@nankai.edu.cn			National Basic Research Program (973 Program) [2011CBA00800, 2013CB911100]; National Natural Science Foundation (NSFC) [21203101, 31270926]; Natural Science Foundation of Tianjin [13JCZDJC28300]; PracticaChem	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); PracticaChem	This work was supported by the National Basic Research Program (973 Program, No. 2011CBA00800 and No. 2013CB911100), the National Natural Science Foundation (NSFC, No. 21203101 and No. 31270926), and the Natural Science Foundation of Tianjin (13JCZDJC28300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PracticaChem provided support in the form of salaries for author [WH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. WH (founder of PracticaChem) played a role in synthesizing 5 compounds in our study. However, PracticaChem (a commercial affiliation) did not provide funding for this study.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Anilkumar GN, 2011, BIOORG MED CHEM LETT, V21, P5336, DOI 10.1016/j.bmcl.2011.07.021; [Anonymous], 2013, SCHROD SUIT 2013 PRO; [Anonymous], 2013, GLID VERS 6 1; [Anonymous], 2011, DRAGON VERS 6 0; [Anonymous], 2013, LIGPREP VERS 2 8; [Anonymous], 2013, EPIK VERS 2 5; [Anonymous], 2013, QIKPROP VERSION 3 8; [Anonymous], 2013, PHAS VERS 3 7; Barreca ML, 2014, J CHEM INF MODEL, V54, P481, DOI 10.1021/ci400367m; Barreca ML, 2011, FUTURE MED CHEM, V3, P1027, DOI [10.4155/FMC.11.53, 10.4155/fmc.11.53]; Beaulieu PL, 2013, BIOORG MED CHEM LETT, V23, P4132, DOI 10.1016/j.bmcl.2013.05.037; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Canales E, 2012, BIOORG MED CHEM LETT, V22, P4288, DOI 10.1016/j.bmcl.2012.05.025; Cao HY, 2008, CURR MED CHEM, V15, P1462, DOI 10.2174/092986708784638906; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Cereto-Massague A, 2012, BIOINFORMATICS, V28, P1661, DOI 10.1093/bioinformatics/bts249; CHAVKIN C, 1984, P NATL ACAD SCI-BIOL, V81, P7253, DOI 10.1073/pnas.81.22.7253; Corbeil CR, 2008, J CHEM INF MODEL, V48, P902, DOI 10.1021/ci700398h; Cui HK, 2013, BIOORGAN MED CHEM, V21, P3547, DOI 10.1016/j.bmc.2013.02.011; Cummings MD, 2012, ANGEW CHEM INT EDIT, V51, P4637, DOI 10.1002/anie.201200110; Das D, 2011, BIOORGAN MED CHEM, V19, P4690, DOI 10.1016/j.bmc.2011.06.079; de Vicente J, 2009, BIOORG MED CHEM LETT, V19, P5652, DOI 10.1016/j.bmcl.2009.08.022; Deng YQ, 2009, BIOORG MED CHEM LETT, V19, P5363, DOI 10.1016/j.bmcl.2009.07.124; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Dillon JF, 2004, J VIRAL HEPATITIS, V11, P23, DOI 10.1111/j.1365-2893.2004.00573.x; Ding M, 2011, ORG BIOMOL CHEM, V9, P6654, DOI 10.1039/c1ob05525a; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Donner P, 2013, BIOORG MED CHEM LETT, V23, P4367, DOI 10.1016/j.bmcl.2013.05.078; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Golub AG, 2012, EUR J MED CHEM, V58, P258, DOI 10.1016/j.ejmech.2012.09.010; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005; Harper S, 2005, J MED CHEM, V48, P4547, DOI 10.1021/jm050056+; Huang SD, 2014, ORG BIOMOL CHEM, V12, P2344, DOI 10.1039/c3ob42525h; Hucke O, 2014, J MED CHEM, V57, P1932, DOI 10.1021/jm4004522; Jin G, 2014, EUR J MED CHEM, V75, P413, DOI 10.1016/j.ejmech.2014.01.062; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kim SH, 2008, BIOORG MED CHEM LETT, V18, P4181, DOI 10.1016/j.bmcl.2008.05.083; Kong LB, 2013, ANTIVIR RES, V98, P44, DOI 10.1016/j.antiviral.2013.02.003; Krueger AC, 2013, BIOORG MED CHEM LETT, V23, P3487, DOI 10.1016/j.bmcl.2013.04.057; Kumar DV, 2011, BIOORG MED CHEM LETT, V21, P82, DOI 10.1016/j.bmcl.2010.11.068; Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Le Pogam S, 2006, J VIROL, V80, P6146, DOI 10.1128/JVI.02628-05; Lee JC, 2010, ANAL BIOCHEM, V403, P52, DOI 10.1016/j.ab.2010.04.004; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Louise-May S, 2007, BIOORG MED CHEM LETT, V17, P3905, DOI 10.1016/j.bmcl.2007.04.103; Loving K, 2009, J COMPUT AID MOL DES, V23, P541, DOI 10.1007/s10822-009-9268-1; Lu W, 2011, ACTA PHYS-CHIM SIN, V27, P1407, DOI 10.3866/PKU.WHXB20110608; Lv W, 2010, EUR J MED CHEM, V45, P1167, DOI 10.1016/j.ejmech.2009.12.038; Martin TM, 2012, J CHEM INF MODEL, V52, P2570, DOI 10.1021/ci300338w; May MM, 2012, ANTIVIR RES, V95, P182, DOI 10.1016/j.antiviral.2012.04.008; Maynard A, 2014, J MED CHEM, V57, P1902, DOI 10.1021/jm400317w; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Melagraki G, 2007, BIOORGAN MED CHEM, V15, P7237, DOI 10.1016/j.bmc.2007.08.036; Moradpour D, 2004, J VIROL, V78, P13278, DOI 10.1128/JVI.78.23.13278-13284.2004; Musmuca I, 2010, J CHEM INF MODEL, V50, P662, DOI 10.1021/ci9004749; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Obrezanova O, 2010, J CHEM INF MODEL, V50, P1053, DOI 10.1021/ci900406x; Palmer DS, 2007, J CHEM INF MODEL, V47, P150, DOI 10.1021/ci060164k; Patel PD, 2008, J CHEM INF MODEL, V48, P42, DOI 10.1021/ci700266z; Patil VM, 2011, MED CHEM RES, V20, P1616, DOI 10.1007/s00044-010-9435-x; Pourbasheer E, 2011, MOL DIVERS, V15, P645, DOI 10.1007/s11030-010-9283-0; Ren JX, 2011, J CHEM INF MODEL, V51, P1364, DOI 10.1021/ci100464b; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Ruebsam F, 2009, BIOORG MED CHEM LETT, V19, P6404, DOI 10.1016/j.bmcl.2009.09.045; Ryckmans T, 2009, BIOORG MED CHEM LETT, V19, P4406, DOI 10.1016/j.bmcl.2009.05.062; Ryu K, 2009, BIOORGAN MED CHEM, V17, P2975, DOI 10.1016/j.bmc.2009.03.024; Salam NK, 2009, J CHEM INF MODEL, V49, P2356, DOI 10.1021/ci900212v; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Shaw AN, 2009, BIOORG MED CHEM LETT, V19, P4350, DOI 10.1016/j.bmcl.2009.05.091; Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j; Stammers TA, 2013, BIOORG MED CHEM LETT, V23, P6879, DOI 10.1016/j.bmcl.2013.09.102; Stammers TA, 2013, BIOORG MED CHEM LETT, V23, P2585, DOI 10.1016/j.bmcl.2013.02.110; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Talele TT, 2010, BIOORGAN MED CHEM, V18, P4630, DOI 10.1016/j.bmc.2010.05.030; Teixeira AL, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-9; Therese PJ, 2014, J CHEM INF MODEL, V54, P539, DOI 10.1021/ci400644r; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Vandyck K, 2009, J MED CHEM, V52, P4099, DOI 10.1021/jm9005548; Venkatraman S, 2014, BIOORGAN MED CHEM, V22, P447, DOI 10.1016/j.bmc.2013.11.007; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Watts KS, 2010, J CHEM INF MODEL, V50, P534, DOI 10.1021/ci100015j; Weidlich IE, 2013, BIOORGAN MED CHEM, V21, P3127, DOI 10.1016/j.bmc.2013.03.032; Xue WW, 2014, ANTIVIR RES, V104, P40, DOI 10.1016/j.antiviral.2014.01.006; Yan SQ, 2007, BIOORG MED CHEM LETT, V17, P1991, DOI 10.1016/j.bmcl.2007.01.024; Yan SQ, 2007, BIOORG MED CHEM LETT, V17, P63, DOI 10.1016/j.bmcl.2006.09.095; Yan SQ, 2006, BIOORG MED CHEM LETT, V16, P5888, DOI 10.1016/j.bmcl.2006.08.056; Yang HB, 2010, BIOORG MED CHEM LETT, V20, P4614, DOI 10.1016/j.bmcl.2010.06.008; Ye L, 2005, ACTA VIROL, V49, P83; Zeng QB, 2013, BIOORG MED CHEM LETT, V23, P6585, DOI 10.1016/j.bmcl.2013.10.060	95	39	40	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148181	10.1371/journal.pone.0148181	http://dx.doi.org/10.1371/journal.pone.0148181			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845440	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800035
J	Han, XB; Yang, JC; Li, LQ; Huang, JS; King, G; Quarles, LD				Han, Xiaobin; Yang, Jiancheng; Li, Linqiang; Huang, Jinsong; King, Gwendalyn; Quarles, L. Darryl			Conditional Deletion of Fgfr1 in the Proximal and Distal Tubule Identifies Distinct Roles in Phosphate and Calcium Transport	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; BLOOD-PRESSURE; KLOTHO; FGF23; RECEPTOR; EXPRESSION; KIDNEY; MICE; BONE; HOMEOSTASIS	A postnatal role of fibroblast growth factor receptor-1 (FGFR1) in the kidney is suggested by its binding to a-Klotho to form an obligate receptor for the hormone fibroblast growth factor-23 (FGF-23). FGFR1 is expressed in both the proximal and distal renal tubular segments, but its tubular specific functions are unclear. In this study, we crossed Fgfr1(flox/flox) mice with either gamma-glutamyltransferase-Cre (gamma GT-Cre) or kidney specific-Cre (Ksp-Cre) mice to selectively create proximal tubule (PT) and distal tubule (DT) Fgfr1 conditional knockout mice (designated Fgfr1(PT-cKO) and Fgfr1(DT-cKO), respectively). Fgfr1(PT-cKO) mice exhibited an increase in sodium-dependent phosphate co-transporter expression, hyperphosphatemia, and refractoriness to the phosphaturic actions of FGF-23, consistent with a direct role of FGFR1 in mediating the proximal tubular phosphate responses to FGF-23. In contrast, Fgfr1(DT-cKO) mice unexpectedly developed hypercalciuria, secondary elevations of parathyroid hormone (PTH), hypophosphatemia and enhanced urinary phosphate excretion. Fgfr1(PT-cKO) mice also developed a curly tail/spina bifida-like skeletal phenotype, whereas Fgfr1(DT-cKO) mice developed renal tubular micro-calcifications and reductions in cortical bone thickness. Thus, FGFR1 has dual functions to directly regulate proximal and distal tubule phosphate and calcium reabsorption, indicating a physiological role of FGFR1 signaling in both phosphate and calcium homeostasis.	[Han, Xiaobin; Yang, Jiancheng; Li, Linqiang; Huang, Jinsong; Quarles, L. Darryl] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [King, Gwendalyn] Univ Alabama Birmingham, Birmingham, AL USA	University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham	Quarles, LD (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA.	dquarles@uthsc.edu	yang, jian/HIK-0188-2022	Quarles, L. Darryl/0000-0002-5082-7896	NIAMS of the National Institutes of Health [R01-AR045955]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045955] Funding Source: NIH RePORTER	NIAMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the NIAMS of the National Institutes of Health under award number R01-AR045955, www.NIH.gov.	Andrukhova O, 2014, EMBO MOL MED, V6, P744, DOI 10.1002/emmm.201303716; Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; Baum M, 2005, KIDNEY INT, V68, P1148, DOI 10.1111/j.1523-1755.2005.00506.x; Cancilla B, 2001, KIDNEY INT, V60, P147, DOI 10.1046/j.1523-1755.2001.00781.x; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Dai B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044161; David V, 2013, ENDOCRINOLOGY, V154, P4469, DOI 10.1210/en.2013-1627; Deng CX, 1997, DEV BIOL, V185, P42, DOI 10.1006/dbio.1997.8553; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Farrow EG, 2009, J AM SOC NEPHROL, V20, P955, DOI 10.1681/ASN.2008070783; Gattineni J, 2011, AM J PHYSIOL-RENAL, V301, pF371, DOI 10.1152/ajprenal.00740.2010; Gattineni J, 2010, PEDIATR NEPHROL, V25, P591, DOI 10.1007/s00467-009-1273-z; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hughes SE, 1997, J HISTOCHEM CYTOCHEM, V45, P1005, DOI 10.1177/002215549704500710; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Li H, 2011, AM J PHYSIOL-ENDOC M, V300, pE508, DOI 10.1152/ajpendo.00499.2010; Liu SG, 2007, J AM SOC NEPHROL, V18, P1637, DOI 10.1681/ASN.2007010068; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Pi M, 2011, J BONE MINER RES; Pond AC, 2010, CANCER RES, V70, P4868, DOI 10.1158/0008-5472.CAN-09-4404; PROIA AD, 1985, ARCH PATHOL LAB MED, V109, P186; Quabius ES, 1996, AM J PHYSIOL-RENAL, V270, pF220, DOI 10.1152/ajprenal.1996.270.1.F220; Quarles LD, 2011, NAT MED, V17, P428, DOI 10.1038/nm0411-428; Quarles LD, 2003, J CLIN INVEST, V112, P642, DOI 10.1172/JC1200319687; Quarles LD, 2003, AM J PHYSIOL-ENDOC M, V285, pE1, DOI 10.1152/ajpendo.00016.2003; Riazi S, 2006, AM J PHYSIOL-RENAL, V291, pF597, DOI 10.1152/ajprenal.00508.2005; Shalhoub V, 2011, CALCIFIED TISSUE INT, V89, P140, DOI 10.1007/s00223-011-9501-5; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Sitara D, 2006, AM J PATHOL, V169, P2161, DOI 10.2353/ajpath.2006.060329; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Worcester E, 2006, AM J PHYSIOL-RENAL, V291, pF1061, DOI 10.1152/ajprenal.00033.2006; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xiao ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101251; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yamazaki Y, 2008, J BONE MINER RES, V23, P1509, DOI 10.1359/JBMR.080417; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670	46	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147845	10.1371/journal.pone.0147845	http://dx.doi.org/10.1371/journal.pone.0147845			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839958	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200065
J	Liu, YN; Zhou, JL; Luo, XM; Yang, CX; Zhang, Y; Shi, SJ				Liu, Yani; Zhou, Jiali; Luo, Xiaomei; Yang, Chunxiao; Zhang, Yu; Shi, Shaojun			Association of RAC1 Gene Polymorphisms with Primary End-Stage Renal Disease in Chinese Renal Recipients	PLOS ONE			English	Article							KIDNEY-FUNCTION; ACTIVATION; GTPASE; RISK; HYPERTENSION; EXPRESSION	Background/Objective RAC1 gene could influence susceptibility to renal failure by altering the activity and expression of Rac1, which is a member of the Rho family of small GTP-binding proteins. In clinical practice, renal transplantation provides the optimal treatment for people with end-stage renal disease (ESRD). The objective of this present study was to determine whether the RAC1 gene polymorphisms were associated with primary ESRD susceptibility in Chinese renal recipients. Methods Six single nucleotide polymorphisms (SNPs) of RAC1 gene, including rs836488 T>C, rs702482 A>T, rs10951982 G>A, rs702483 A>G, rs6954996 G>A, and rs9374 G>A, were genotyped in 300 renal transplant recipients (cases) and 998 healthy Chinese subjects (controls) by using TaqMan SNP genotyping assay. Allele, genotype, and haplotype frequencies of the six SNPs were compared between cases and controls. Odds ratios (OR) and 95% confidence intervals (CI) were calculated in logistic regression models to evaluate the associations of the six SNPs with ESRD risk. Results The genotype distributions for the six SNPs in controls were consistent with Hardy-Weinberg equilibrium (P > 0.05). Association analysis revealed that three SNPs were significantly associated with ESRD risk. Positive associations with ESRD risk were found for the rs836488, rs702482, and rs702483 in the co-dominant model (minor allele homozygotes versus major allele homozygotes); specifically, the frequencies of the minor allele homozygotes and the minor allele for the three SNPs were higher in the cases than in the controls. In addition, these three SNPs also had associations with increased ESRD risk under the additive model (P < 0.05), and positive associations were also found for the rs836488 in the dominant model (P < 0.05) and for the rs702483 in the recessive model (P < 0.05). All these associations were independent of confounding factors. The other three SNPs (rs10951982, rs6954996, and rs9374), in all comparison models, were not associated with ESRD risk (P > 0.05). In haplotype analysis, carriers with "C-T-G-G-G-G" haplotype had a significantly higher risk of ESRD compared with the most common haplotype "T-A-G-A-G-G" (P = 0.011, OR = 1.46, 95% CI = 1.09-1.94). Conclusion This study suggested that polymorphisms of RAC1 gene might influence the susceptibility to ESRD in Chinese Han population. Further studies are necessary to confirm our findings.	[Liu, Yani; Zhou, Jiali; Luo, Xiaomei; Yang, Chunxiao; Zhang, Yu; Shi, Shaojun] Huazhong Univ Sci & Technol, Dept Pharm, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Shi, SJ (corresponding author), Huazhong Univ Sci & Technol, Dept Pharm, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	sjshicn@163.com			National Natural Science Foundation of China [81273591]; Natural Science Foundation of Hubei Province (P.R. China) [2009CDB380]; Fundamental Research Funds for the Central Universities (P.R. China) [2014YGYL003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province (P.R. China)(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities (P.R. China)(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (grant number 81273591), the Natural Science Foundation of Hubei Province (P.R. China) (grant number 2009CDB380), and the Fundamental Research Funds for the Central Universities (P.R. China) (grant number 2014YGYL003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Borkar M, 2011, INFLAMM RES, V60, P399, DOI 10.1007/s00011-010-0284-3; Bourgine J, 2011, PHARMACOGENET GENOM, V21, P313, DOI 10.1097/FPC.0b013e3283449200; Cao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090869; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; Derijks LJJ, 2010, CURR PHARM DESIGN, V16, P145, DOI 10.2174/138161210790112773; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gastonguay AJ, 2012, CANCER BIOL THER, V13, P647, DOI 10.4161/cbt.20082; George GP, 2011, TRANSPL IMMUNOL, V24, P220, DOI 10.1016/j.trim.2011.03.003; Hwang H, 2014, INTEGR BIOL-UK, V6, P267, DOI 10.1039/c3ib40183a; Iwashima F, 2008, ENDOCRINOLOGY, V149, P1009, DOI 10.1210/en.2007-0864; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Koh MS, 2011, BIOCHEM BIOPH RES CO, V406, P25, DOI 10.1016/j.bbrc.2011.01.092; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Ma Q, 2009, P NATL ACAD SCI USA, V106, P8683, DOI 10.1073/pnas.0812688106; Mao S, 2013, INTERNAL MED, V52, P2423, DOI 10.2169/internalmedicine.52.0866; Matos P, 2000, BIOCHEM BIOPH RES CO, V277, P741, DOI 10.1006/bbrc.2000.3743; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Misra MK, 2014, J INTERF CYTOK RES, V34, P148, DOI 10.1089/jir.2013.0069; Muise AM, 2011, GASTROENTEROLOGY, V141, P633, DOI 10.1053/j.gastro.2011.04.057; Nagase M, 2013, CURR OPIN NEPHROL HY, V22, P148, DOI 10.1097/MNH.0b013e32835d0751; Nagase M, 2013, NAT REV NEPHROL, V9, P86, DOI 10.1038/nrneph.2012.282; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Prakash S, 2012, CYTOKINE, V58, P261, DOI 10.1016/j.cyto.2012.01.020; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Skvortsov S, 2011, RADIOTHER ONCOL, V101, P177, DOI 10.1016/j.radonc.2011.05.067; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Taher M, 2014, CLIN RES HEPATOL GAS; Tapia-Castillo A, 2014, AM J HYPERTENS, V27, P299, DOI 10.1093/ajh/hpt277; Trabulus S, 2012, MOL BIOL REP, V39, P6995, DOI 10.1007/s11033-012-1529-8; Wang TX, 2008, NEUROSCI LETT, V437, P71, DOI 10.1016/j.neulet.2008.01.022; Yalovsky S, 2008, PLANT PHYSIOL, V147, P1527, DOI 10.1104/pp.108.122150; Zuo L, 2010, CLIN NEPHROL, V74, pS20	34	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148270	10.1371/journal.pone.0148270	http://dx.doi.org/10.1371/journal.pone.0148270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841219	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200116
J	Rodriguez-Centeno, J; Sastre, L				Rodriguez-Centeno, Javier; Sastre, Leandro			Biological Activity of the Alternative Promoters of the Dictyostelium discoideum Adenylyl Cyclase A Gene	PLOS ONE			English	Article							STALK CELL-DIFFERENTIATION; DEPENDENT PROTEIN-KINASE; SOCIAL AMEBAS; TRANSCRIPTIONAL REGULATION; PRESPORE DIFFERENTIATION; EXTRACELLULAR CAMP; CYCLIC-AMP; EXPRESSION; AGGREGATION; EVOLUTION	Amoebae of the Dictyostelium discoideum species form multicellular fruiting bodies upon starvation. Cyclic adenosine monophosphate (cAMP) is used as intercellular signalling molecule in cell-aggregation, cell differentiation and morphogenesis. This molecule is synthesized by three adenylyl cyclases, one of which, ACA, is required for cell aggregation. The gene coding for ACA (acaA) is transcribed from three different promoters that are active at different developmental stages. Promoter 1 is active during cell-aggregation, promoters 2 and 3 are active in prespore and prestalk tip cells at subsequent developmental stages. The biological relevance of acaA expression from each of the promoters has been studied in this article. The acaA gene was expressed in acaA-mutant cells, that do not aggregate, under control of each of the three acaA promoters. acaA expression under promoter 1 control induced cell aggregation although subsequent development was delayed, very small fruiting bodies were formed and cell differentiation genes were expressed at very low levels. Promoter 2-driven acaA expression induced the formation of small aggregates and small fruiting bodies were formed at the same time as in wild-type strains and differentiation genes were also expressed at lower levels. Expression of acaA from promoter 3 induced aggregates and fruiting bodies formation and their size and the expression of differentiation genes were more similar to that of wild-type cells. Expression of acaA from promoters 1 and 2 in AX4 cells also produced smaller structures. In conclusion, the expression of acaA under control of the aggregation-specific Promoter 1 is able to induce cell aggregation in acaA-mutant strains. Expression from promoters 2 and 3 also recovered aggregation and development although promoter 3 induced a more complete recovery of fruiting body formation.	[Rodriguez-Centeno, Javier; Sastre, Leandro] Inst Investi Biomed CSIC UAM, C Arturo Duperier 4, Madrid 28029, Spain; [Sastre, Leandro] CIBERER, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Sastre, L (corresponding author), Inst Investi Biomed CSIC UAM, C Arturo Duperier 4, Madrid 28029, Spain.; Sastre, L (corresponding author), CIBERER, Valencia, Spain.	lsastre@iib.uam.es		Sastre, Leandro/0000-0003-3613-5938; Rodriguez-Centeno, Javier/0000-0001-8137-2225	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) [BFU2008-02249]; Ministry of Health (Ministerio de Sanidad, Servicios Sociales e Igualdad) - FEDER funds [PI11/00949]; Ministry of Health (Ministerio de Sanidad, Servicios Sociales e Igualdad) - FEDER (Federacion Espanola de Asociaciones de Enfermedades Raras) funds [PI11/00949]	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Health (Ministerio de Sanidad, Servicios Sociales e Igualdad) - FEDER funds; Ministry of Health (Ministerio de Sanidad, Servicios Sociales e Igualdad) - FEDER (Federacion Espanola de Asociaciones de Enfermedades Raras) funds	The authors are indebted to Zhi-Hui Chen and Pauline Schaap (University of Dundee, Dundee, UK) for the plasmid vector used to generate the acaA-mutant strain by homologous recombination. This work was supported by grants BFU2008-02249 from the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) and PI11/00949 from the Ministry of Health (Ministerio de Sanidad, Servicios Sociales e Igualdad), supported by FEDER funds.; This work was supported by grants BFU2008-02249 from the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) and PI11/00949 from the Ministry of Health (Ministerio de Sanidad, Servicios Sociales e Igualdad), supported by FEDER (Federacion Espanola de Asociaciones de Enfermedades Raras) funds.	Alvarez-Curto E, 2005, P NATL ACAD SCI USA, V102, P6385, DOI 10.1073/pnas.0502238102; Alvarez-Curto E, 2007, DEVELOPMENT, V134, P959, DOI 10.1242/dev.02775; Bader S, 2007, BIOCHEM J, V402, P153, DOI 10.1042/BJ20061153; BARKLIS E, 1983, CELL, V32, P1139, DOI 10.1016/0092-8674(83)90297-0; BERKS M, 1988, DEV BIOL, V126, P108, DOI 10.1016/0012-1606(88)90244-8; Chen ZH, 2014, J BIOTECHNOL, V191, P246, DOI 10.1016/j.jbiotec.2014.08.008; Dormann D, 2000, PHILOS T R SOC B, V355, P983, DOI 10.1098/rstb.2000.0634; Dubin M, 2010, GENE, V465, P1, DOI 10.1016/j.gene.2010.06.010; FAURE M, 1990, MOL CELL BIOL, V10, P1921, DOI 10.1128/MCB.10.5.1921; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Galardi-Castilla M, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-12; Galardi-Castilla M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013286; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; HOPPER NA, 1993, DEVELOPMENT, V119, P147; Iranfar N, 2006, DEV BIOL, V290, P460, DOI 10.1016/j.ydbio.2005.11.035; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Iranfar N, 2001, MOL BIOL CELL, V12, P2590, DOI 10.1091/mbc.12.9.2590; Kim HJ, 1998, J BIOL CHEM, V273, P30859, DOI 10.1074/jbc.273.47.30859; KONIJN TM, 1967, P NATL ACAD SCI USA, V58, P1152, DOI 10.1073/pnas.58.3.1152; Kriebel PW, 2004, IUBMB LIFE, V56, P541, DOI 10.1080/15216540400013887; Loomis WF, 2014, DEV BIOL, V391, P1, DOI 10.1016/j.ydbio.2014.04.001; Loomis WF, 2011, DEV GROWTH DIFFER, V53, P567, DOI 10.1111/j.1440-169X.2010.01241.x; LOUIS JM, 1993, P NATL ACAD SCI USA, V90, P5969, DOI 10.1073/pnas.90.13.5969; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Maeda M, 2003, EUKARYOT CELL, V2, P627, DOI 10.1128/EC.2.3.627-637.2003; MANN SKO, 1993, DEVELOPMENT, V119, P135; MEHDY MC, 1983, CELL, V32, P763, DOI 10.1016/0092-8674(83)90062-4; Miranda ER, 2015, DEV BIOL, V397, P203, DOI 10.1016/j.ydbio.2014.11.006; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; PITT GS, 1993, GENE DEV, V7, P2172, DOI 10.1101/gad.7.11.2172; Ritchie AV, 2008, MOL BIOL EVOL, V25, P2109, DOI 10.1093/molbev/msn156; Rosengarten RD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1491-7; Saran S, 2002, J MUSCLE RES CELL M, V23, P793, DOI 10.1023/A:1024483829878; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Schaap P, 2011, DEV GROWTH DIFFER, V53, P452, DOI 10.1111/j.1440-169X.2011.01263.x; Schaap P, 2011, DEVELOPMENT, V138, P387, DOI 10.1242/dev.048934; Siol O, 2006, EUKARYOT CELL, V5, P658, DOI 10.1128/EC.5.4.658-664.2006; SMITH E, 1980, J EMBRYOL EXP MORPH, V57, P233; Soderbom F, 1999, DEVELOPMENT, V126, P5463; vanEs S, 1996, J BIOL CHEM, V271, P23623, DOI 10.1074/jbc.271.39.23623; Verkerke-van Wijk I, 2001, DEV BIOL, V234, P151, DOI 10.1006/dbio.2001.0232; Williams JG, 2010, GENETICS, V185, P717, DOI 10.1534/genetics.110.119297; Williams JG, 2006, EMBO REP, V7, P694, DOI 10.1038/sj.embor.7400714	44	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148533	10.1371/journal.pone.0148533	http://dx.doi.org/10.1371/journal.pone.0148533			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840347	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200146
J	Tholen, ATR; Schinkel, J; Molenkamp, R; Ang, CW				Tholen, Aletta T. R.; Schinkel, Janke; Molenkamp, Richard; Ang, C. Wim			Hepatitis E virus as a Cause of Acute Hepatitis in The Netherlands	PLOS ONE			English	Article							INFECTION; RECIPIENTS; REVERSE; HEV	Background Recent studies indicate that 27% of Dutch blood donors have evidence of past infection with HEV. However, the low number of diagnosed HEV infections indicates either an asymptomatic course or under diagnosis. Objectives We investigated whether HEV is a cause of acute hepatitis in Dutch patients and which diagnostic modality (serology or PCR) should be used for optimal detection. Study design Serum samples were retrospectively selected from non-severely immuno-compromised patients from a university hospital population, suspected of having an infectious hepatitis. Criteria were: elevated alanine aminotransferase (ALT> 34 U/l) and request for antibody testing for CMV, EBV or Hepatitis A (HAV). Results All samples were tested for HEV using ELISA and PCR. Ninety patients/sera were tested, of which 22% were HEV IgG positive. Only one serum was IgM positive. HEV PCR was positive in two patients: one patient was both HEV IgM and IgG positive, the other patient was only IgG positive. Both HEV RNA positive samples belonged to genotype 3. Evidence of recent infection with CMV, EBV and HAV was found in 13%, 10% and 3% respectively. Conclusions Although our study is limited by small numbers, we conclude that HEV is a cause of acute hepatitis in hospital associated patients in The Netherlands. Moreover, in our study population the prevalence of acute HAV (3%) was almost similar to acute HEV (2%). We propose to incorporate HEV testing in panels for acute infectious hepatitis. Negative results obtained for HEV IgM in a HEV PCR positive patient, indicates that antibody testing alone may not be sufficient and argues for PCR as a primary diagnostic tool in hospital associated patients. The high percentage of HEV IgG seropositivity confirms earlier epidemiological studies.	[Tholen, Aletta T. R.; Ang, C. Wim] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Schinkel, Janke; Molenkamp, Richard] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Sect Clin Virol, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	Ang, CW (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands.	w.ang@vumc.nl	Schinkel, Janke/I-3099-2012	Schinkel, Janke/0000-0002-1112-0644				Ahmed A, 2015, INT J HEPATOL, V2015, DOI 10.1155/2015/872431; Ahn JM, 2006, DIAGN MICR INFEC DIS, V56, P269, DOI 10.1016/j.diagmicrobio.2006.04.010; Andriesse Gunnar I, 2010, Ned Tijdschr Geneeskd, V154, pA1865; Dalton HR, 2007, J VIRAL HEPATITIS, V14, P304, DOI 10.1111/j.1365-2893.2006.00800.x; Echevarria JM, 2011, J CLIN VIROL, V50, P69, DOI 10.1016/j.jcv.2010.09.016; Haagsman A, 2007, J MED VIROL, V79, P927, DOI 10.1002/jmv.20869; Harvala H, 2014, J CLIN VIROL, V59, P184, DOI 10.1016/j.jcv.2014.01.001; Hogema BM, 2015, TRANSFUSION; Hogema BM, 2014, TRANSFUSION, V54, P3092, DOI 10.1111/trf.12733; Kantala T, 2009, J CLIN VIROL, V45, P109, DOI 10.1016/j.jcv.2009.03.006; Koot H, 2015, J CLIN VIROL, V62, P38, DOI 10.1016/j.jcv.2014.11.020; Manka P, 2015, CLIN GASTROENTEROL H, V13, P1836, DOI 10.1016/j.cgh.2015.04.014; Pas SD, 2013, J CLIN VIROL, V58, P629, DOI 10.1016/j.jcv.2013.10.010; Pas SD, 2012, EMERG INFECT DIS, V18, P869, DOI 10.3201/eid1805.111712; Petrik J, 2015, VOX SANG; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Riezebos-Brilman A, 2013, J CLIN VIROL, V58, P509, DOI 10.1016/j.jcv.2013.08.022; Slot E, 2012, EUROSURVEILLANCE, V2013, P18, DOI DOI 10.2807/1560-7917.ES2013.18.31.20550; Waar K, 2005, J CLIN VIROL, V33, P145, DOI 10.1016/j.jcv.2004.10.015; Xu CY, 2013, TRANSFUSION, V53, P2505, DOI 10.1111/trf.12326; Zaki ME, 2006, FEMS IMMUNOL MED MIC, V48, P16, DOI 10.1111/j.1574-695X.2006.00111.x; Zanetti AR, 1999, J MED VIROL, V57, P356, DOI 10.1002/(SICI)1096-9071(199904)57:4&lt;356::AID-JMV5&gt;3.0.CO;2-D	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146906	10.1371/journal.pone.0146906	http://dx.doi.org/10.1371/journal.pone.0146906			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840767	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200021
J	Cross, PJ; Heyes, LC; Zhang, SW; Nazmi, AR; Parker, EJ				Cross, Penelope J.; Heyes, Logan C.; Zhang, Shiwen; Nazmi, Ali Reza; Parker, Emily J.			The Functional Unit of Neisseria meningitidis 3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate Synthase Is Dimeric	PLOS ONE			English	Article							AMINO-ACID BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS; MACROMOLECULAR CRYSTALLOGRAPHY; SYNERGISTIC ALLOSTERY; SHIKIMATE PATHWAY; DATA QUALITY; ULTRACENTRIFUGATION; PHENYLALANINE; REFINEMENT; SOFTWARE	Neisseria meningitidis 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (Nme-DAH7PS) adopts a homotetrameric structure consisting of an extensive and a less extensive interface. Perturbation of the less extensive interface through a single mutation of a salt bridge (Arg126-Glu27) formed at the tetramer interface of all chains resulted in a dimeric DAH7PS in solution, as determined by small angle X-ray scattering, analytical ultracentrifugation and analytical size-exclusion chromatography. The dimeric NmeDAH7PS(R126S) variant was shown to be catalytically active in the aldol-like condensation reaction between D-erythrose 4-phosphate and phosphoenolpyruvate, and allosterically inhibited by L-phenylalanine to the same extent as the wild-type enzyme. The dimeric NmeDAH7PS(R126S) variant exhibited a slight reduction in thermal stability by differential scanning calorimetry experiments and a slow loss of activity over time compared to the wild-type enzyme. Although NmeDAH7PS(R126S) crystallised as a tetramer, like the wild-type enzyme, structural asymmetry at the less extensive interface was observed consistent with its destabilisation. The tetrameric association enabled by this Arg126-Glu27 salt-bridge appears to contribute solely to the stability of the protein, ultimately revealing that the functional unit of NmeDAH7PS is dimeric.	[Parker, Emily J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; Univ Canterbury, Dept Chem, Christchurch 1, New Zealand	University of Canterbury; University of Canterbury	Parker, EJ (corresponding author), Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand.	emily.parker@canterbury.ac.nz		Parker, Emily/0000-0002-9571-9987; Nazmi, Ali Reza/0000-0003-1262-5078	New Zealand Marsden fund [UoC1105]; New Zealand Synchrotron Group; Australian Synchrotron; Marsden	New Zealand Marsden fund(Royal Society of New ZealandMarsden Fund (NZ)); New Zealand Synchrotron Group; Australian Synchrotron; Marsden(Royal Society of New ZealandMarsden Fund (NZ))	This work was funded by the New Zealand Marsden fund (UoC1105). This work was also supported by the New Zealand Synchrotron Group and the Australian Synchrotron. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; Part of this research was undertaken on the MX and SAXS/WAXS beamlines at the Australian Synchrotron, Victoria, Australia with access administered by the New Zealand Synchrotron Group. L.C.H is grateful for a BIC administered Marsden funded PhD Doctoral scholarship. This research was funded, in part, by the New Zealand Marsden Fund (UOC1105).	BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Blackmore NJ, 2013, J MOL BIOL, V425, P1582, DOI 10.1016/j.jmb.2012.12.019; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cross PJ, 2013, PROTEIN SCI, V22, P1087, DOI 10.1002/pro.2293; Cross PJ, 2013, P NATL ACAD SCI USA, V110, P2111, DOI 10.1073/pnas.1217923110; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Konig V, 2004, J MOL BIOL, V337, P675, DOI 10.1016/j.jmb.2004.01.055; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Light SH, 2013, PROTEIN SCI, V22, P395, DOI 10.1002/pro.2233; Lynch M, 2013, P NATL ACAD SCI USA, V110, pE2821, DOI 10.1073/pnas.1310980110; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nazmi AR, 2014, J MOL BIOL, V426, P656, DOI 10.1016/j.jmb.2013.11.008; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shumilin IA, 1999, STRUCTURE, V7, P865, DOI 10.1016/S0969-2126(99)80109-9; Shumilin IA, 2003, BIOCHEMISTRY-US, V42, P3766, DOI 10.1021/bi027257p; Shumilin IA, 2002, J MOL BIOL, V320, P1147, DOI 10.1016/S0022-2836(02)00545-4; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Swint-Kruse L, 2005, BIOINFORMATICS, V21, P3327, DOI 10.1093/bioinformatics/bti511; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Wilkins MR, 1999, METH MOL B, V112, P531; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200	32	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0145187	10.1371/journal.pone.0145187	http://dx.doi.org/10.1371/journal.pone.0145187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828675	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200003
J	Xu, YB; Guo, N; Dou, DQ; Ran, XK; Ma, XD; Kuang, HX				Xu, Yubin; Guo, Na; Dou, Deqiang; Ran, Xiaoku; Ma, Xiande; Kuang, Haixue			Proteomics Study on Nonallergic Hypersensitivity Induced by Compound 4880 and Ovalbumin	PLOS ONE			English	Article							COMPLEMENT ACTIVATION; MAST-CELL; G-PROTEINS; IN-VITRO; ANAPHYLAXIS; INJECTION; DERMCIDIN; BINDING; ROLES; MODEL	Nonallergic hypersensitivity reaction (NHR) accounts for more than 77% of all immune-mediated immediate hypersensitivity reactions and has become a serious threat to public health. Here, proteomics was used to study the NHR mechanism of two typical substances, the compound 4880 and ovalbumin. Twelve different proteins were suggested as potential biomarkers for examining the NHR mechanism, and our results revealed that the mechanism mainly encompassed 2 processes, i.e., generation and effect processes. The generation process could be classified as direct stimulation, complement (classical and alternative), coagulation, kallikrein-kinin, and integrated pathways. Thus glutathione peroxidase 1, terminal complement complex (complement factor 4d and Bb), coagulation 13, kininogen-1, and IgE could be used as candidate biomarkers for the indication of the corresponding pathways respectively, the proteins were further confirmed by ELISA. And the effect process was mainly composed of histamine as well as proteins such as DCD and MYLPF, which could be used as important indices for the symptoms of NHR. Our study differs from previous studies in that C4880 was found to not only be involved in the direct stimulation pathway, but also in the activated complement and kallikrein-kinin pathways through the coagulation pathway. We also report for the first time that ovalbumin-induced NHR could be a combination of the coagulation, classical complement, and integrated pathways.	[Xu, Yubin; Dou, Deqiang; Ran, Xiaoku; Ma, Xiande] Liaoning Univ Tradit Chinese Med, Coll Pharm, Dalian, Liaoning, Peoples R China; [Kuang, Haixue] Heilongjiang Univ Chinese Med, Coll Pharm, Harbin, Heilongjiang, Peoples R China; [Guo, Na] China Acad Chinese Med Sci, Expt Res Ctr, Beijing, Peoples R China	Liaoning University of Traditional Chinese Medicine; Heilongjiang University of Chinese Medicine; China Academy of Chinese Medical Sciences; Experimental Research Center, CACMS	Dou, DQ (corresponding author), Liaoning Univ Tradit Chinese Med, Coll Pharm, Dalian, Liaoning, Peoples R China.; Kuang, HX (corresponding author), Heilongjiang Univ Chinese Med, Coll Pharm, Harbin, Heilongjiang, Peoples R China.	deqiangdou@126.com; hxkuang@hotmail.com	ma, xiande/AAK-5895-2020; Dou, Deqiang/GLR-4592-2022; Xu, Yubin/O-3562-2019; Xu, Yubin/F-4017-2015	Xu, Yubin/0000-0003-0340-4425; Xu, Yubin/0000-0003-0340-4425	Natural Science Foundation of China [81373939, 81370095]; Innovation Team Project of Colleges and Universities in Liaoning Province [LT2013020]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Project of Colleges and Universities in Liaoning Province	The authors gratefully acknowledge the support of this work by the funding of the Natural Science Foundation of China (81373939, 81370095) and Innovation Team Project of Colleges and Universities in Liaoning Province of 2013 (LT2013020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin AE, 2012, J BIOL CHEM, V287, P10210, DOI 10.1074/jbc.M111.327809; Asano E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114452; Chanan-Khan A, 2003, ANN ONCOL, V14, P1430, DOI 10.1093/annonc/mdg374; Choi YH, 2010, ANAT CELL BIOL, V43, P36, DOI 10.5115/acb.2010.43.1.36; Coors EA, 2005, ANN ALLERG ASTHMA IM, V95, P593, DOI 10.1016/S1081-1206(10)61024-1; Doroszko A, 2010, SHOCK, V34, P592, DOI 10.1097/SHK.0b013e3181e14f1d; Ferry X, 2002, PEPTIDES, V23, P1507, DOI 10.1016/S0196-9781(02)00090-6; Gautam P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046153; Giles TD, 2012, J CLIN HYPERTENS, V14, P198, DOI 10.1111/j.1751-7176.2012.00606.x; Golias Ch, 2007, Hippokratia, V11, P124; Gomez E, 2013, CURR OPIN ALLERGY CL, V13, P345, DOI 10.1097/ACI.0b013e328362b926; GROSSMANN A, 1983, EUR J BIOCHEM, V135, P549, DOI 10.1111/j.1432-1033.1983.tb07687.x; Gueant-Rodriguez RM, 2006, CURR PHARM DESIGN, V12, P3359, DOI 10.2174/138161206778193999; Hanzlik PJ, 1920, J PHARMACOL EXP THER, V14, P379; Hashimoto T, 2006, J PHARMACOL SCI, V100, P82, DOI 10.1254/jphs.FPJ05030X; Hobson DJ, 2007, FOOD CHEM TOXICOL, V45, P2372, DOI 10.1016/j.fct.2007.06.039; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P4633, DOI 10.1021/bi00364a027; Ishii T, 2012, J CLIN BIOCHEM NUTR, V50, P91, DOI 10.3164/jcbn.11-109; JAKUBOWSKI HV, 1986, J BIOL CHEM, V261, P3876; Kilis-Pstrusinska K, 2012, POSTEP HIG MED DOSW, V66, P215, DOI 10.5604/17322693.991600; Kim HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095332; Kobek M, 2014, Arch Med Sadowej Kryminol, V64, P102; Krishnan V, 2009, ACTA CRYSTALLOGR D, V65, P266, DOI 10.1107/S0907444909000389; Li XM, 2003, J ALLERGY CLIN IMMUN, V112, P159, DOI 10.1067/mai.2003.1622; Li YH, 2011, CLIN CARDIOL, V34, P30, DOI 10.1002/clc.20832; Li ZG, 2010, ASIAN PAC J ALLERGY, V28, P185; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Meng QG, 2014, FISH SHELLFISH IMMUN, V40, P182, DOI 10.1016/j.fsi.2014.06.029; Mi YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090199; MOUSLI M, 1990, FEBS LETT, V259, P260, DOI 10.1016/0014-5793(90)80023-C; Nauta AJ, 2002, EUR J IMMUNOL, V32, P1726, DOI 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R; Nie JZ, 2013, J PROTEOME RES, V12, P3843, DOI 10.1021/pr301044b; Palomaki VAB, 2006, BRIT J PHARMACOL, V147, P596, DOI 10.1038/sj.bjp.0706671; Rieg S, 2004, BRIT J DERMATOL, V151, P534, DOI 10.1111/j.1365-2133.2004.06081.x; Sala-Cunill A, 2015, J ALLERGY CLIN IMMUN, V135, P1031, DOI 10.1016/j.jaci.2014.07.057; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Szabo K.E., 2009, REDOX SIGNALING REGU, P143; Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023; Szebeni J, 1998, JNCI-J NATL CANCER I, V90, P300, DOI 10.1093/jnci/90.4.300; Szebeni J, 2003, METHOD ENZYMOL, V373, P136; Tarr J, 2005, CRIT REV IMMUNOL, V25, P305, DOI 10.1615/CritRevImmunol.v25.i4.40; TOMAN M, 1992, VET MED-CZECH, V37, P417; Toncic RJ, 2009, ACTA DERMATOVENER CR, V17, P54; Wang ZG, 2012, J TRADIT CHIN MED, V32, P641, DOI 10.1016/S0254-6272(13)60085-0; Xiang Z, 2013, PLANTA MED, V79, P1043, DOI 10.1055/s-0032-1328746; Xu CP, 2015, J PROTEOMICS, V114, P234, DOI 10.1016/j.jprot.2014.11.002; Yang CS, 2007, J EXP MED, V204, P583, DOI 10.1084/jem.20061849; Yang R, 2015, J APPL TOXICOL, V35, P295, DOI 10.1002/jat.3069	48	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148262	10.1371/journal.pone.0148262	http://dx.doi.org/10.1371/journal.pone.0148262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829397	Green Submitted, gold, Green Published			2022-12-26	WOS:000369548200090
J	Amor, R; McDonald, A; Tragardh, J; Robb, G; Wilson, L; Rahman, NZA; Dempster, J; Amos, WB; Bushell, TJ; McConnell, G				Amor, Rumelo; McDonald, Alison; Traegardh, Johanna; Robb, Gillian; Wilson, Louise; Rahman, Nor Zaihana Abdul; Dempster, John; Amos, William Bradshaw; Bushell, Trevor J.; McConnell, Gail			Widefield Two-Photon Excitation without Scanning: Live Cell Microscopy with High Time Resolution and Low Photo-Bleaching	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; MULTIPHOTON; SINGLE; TRANSIENTS; INDICATOR; SPINES; DEEP	We demonstrate fluorescence imaging by two-photon excitation without scanning in biological specimens as previously described by Hwang and co-workers, but with an increased field size and with framing rates of up to 100 Hz. During recordings of synaptically-driven Ca2+ events in primary rat hippocampal neurone cultures loaded with the fluorescent Ca2+ indicator Fluo-4 AM, we have observed greatly reduced photo-bleaching in comparison with single-photon excitation. This method, which requires no costly additions to the microscope, promises to be useful for work where high time-resolution is required.	[Amor, Rumelo; McDonald, Alison; Traegardh, Johanna; Robb, Gillian; Amos, William Bradshaw; McConnell, Gail] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Ctr Biophoton, Glasgow, Lanark, Scotland; [Wilson, Louise; Rahman, Nor Zaihana Abdul; Dempster, John; Bushell, Trevor J.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Amos, William Bradshaw] MRC Lab Mol Biol, Cambridge Biomed Campus, Cambridge, England	University of Strathclyde; University of Strathclyde; MRC Laboratory Molecular Biology	Amor, R (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Ctr Biophoton, Glasgow, Lanark, Scotland.	rumelo.amor@gmail.com	RAHMAN, NOR ZAIHANA ABDUL/AAP-6207-2020; Trägårdh, Johanna/N-2761-2014	RAHMAN, NOR ZAIHANA ABDUL/0000-0002-7497-7637; Trägårdh, Johanna/0000-0002-8662-9509; Amor, Rumelo/0000-0001-9206-8878; Dempster, John/0000-0003-2199-2945; Bushell, Trevor/0000-0003-4145-9670; McConnell, Gail/0000-0002-7213-0686	Medical Research Council [MR/K015583/1]; Engineering and Physical Sciences Research Council [EP/I006826/1]; Biotechnology and Biological Sciences Research Council [BB/M018903/1]; Scottish Universities Physics Alliance INSPIRE studentship; BBSRC [BB/M018903/1] Funding Source: UKRI; EPSRC [EP/I006826/1] Funding Source: UKRI; MRC [MR/K015583/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Universities Physics Alliance INSPIRE studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported in part by the Medical Research Council (http://www.mrc.ac.uk/, grant no. MR/K015583/1, WBA and GM), the Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/, grant no. EP/I006826/1, GM), and the Biotechnology and Biological Sciences Research Council (BB/M018903/1). RA is supported by a Scottish Universities Physics Alliance INSPIRE studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by the Medical Research Council (http://www.mrc.ac.uk/, grant no. MR/K015583/1, WBA and GM), the Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/, grant no. EP/I006826/1, GM), and the Biotechnology and Biological Sciences Research Council (BB/M018903/1). R.A. is supported by a Scottish Universities Physics Alliance INSPIRE studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bewersdorf J, 1998, OPT LETT, V23, P655, DOI 10.1364/OL.23.000655; Brakenhoff GJ, 1996, J MICROSC-OXFORD, V181, P253, DOI 10.1046/j.1365-2818.1996.97379.x; Centonze VE, 1998, BIOPHYS J, V75, P2015, DOI 10.1016/S0006-3495(98)77643-X; Chen XW, 2012, NAT PROTOC, V7, P1818, DOI 10.1038/nprot.2012.106; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Dempster J., 2014, WINFLUOR FLUORESCENC; Deniset-Besseau A, 2007, APPL OPTICS, V46, P8045, DOI 10.1364/AO.46.008045; Diaspro A., 2006, HDB BIOL CONFOCAL MI, P690, DOI 10.1007/978-0-387-45524-2_39; Donnert G, 2007, NAT METHODS, V4, P81, DOI 10.1038/NMETH986; Dunn GA, 2002, J MICROSC-OXFORD, V205, P109, DOI 10.1046/j.0022-2720.2001.001007.x; Fittinghoff DN, 2000, OPT EXPRESS, V7, P273, DOI 10.1364/OE.7.000273; Gan J, 2011, BRIT J PHARMACOL, V163, P984, DOI 10.1111/j.1476-5381.2011.01293.x; Hwang JY, 2011, BIOMED OPT EXPRESS, V2, P356, DOI 10.1364/BOE.2.000356; Knight MM, 2003, AM J PHYSIOL-CELL PH, V284, pC1083, DOI 10.1152/ajpcell.00276.2002; KOGELNIK H, 1966, APPL OPTICS, V5, P1550, DOI 10.1364/AO.5.001550; Ledgerwood CJ, 2011, BRIT J PHARMACOL, V162, P286, DOI 10.1111/j.1476-5381.2010.01015.x; Malkani N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018586; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P5510, DOI 10.1021/bi047581f; McDonald A, 2012, BIOMED OPT EXPRESS, V3, P1266, DOI 10.1364/BOE.3.001266; Nguyen QT, 2001, CELL CALCIUM, V30, P383, DOI 10.1054/ceca.2001.0246; Niesner R, 2007, BIOPHYS J, V93, P2519, DOI 10.1529/biophysj.106.102459; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Patterson GH, 2000, BIOPHYS J, V78, P2159, DOI 10.1016/S0006-3495(00)76762-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schonle A, 1998, OPT LETT, V23, P325, DOI 10.1364/OL.23.000325; Smith NI, 2006, LASER PHYS LETT, V3, P154, DOI 10.1002/lapl.200510067; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Tsien R. Y., 2006, HDB BIOL CONFOCAL MI, V3rd, P338, DOI [10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2_16]; VANDERKOOY D, 1979, SCIENCE, V204, P873, DOI 10.1126/science.441742; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; Weiss M, 2004, TRAFFIC, V5, P662, DOI 10.1111/j.1600-0854.2004.00215.x; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345; Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899; [No title captured]	36	11	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147115	10.1371/journal.pone.0147115	http://dx.doi.org/10.1371/journal.pone.0147115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824845	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000369528600016
J	Cooper, JE; McCann, CJ; Natarajan, D; Choudhury, S; Boesmans, W; Delalande, JM; Vanden Berghe, P; Burns, AJ; Thapar, N				Cooper, Julie E.; McCann, Conor J.; Natarajan, Dipa; Choudhury, Shanas; Boesmans, Werend; Delalande, Jean-Marie; Vanden Berghe, Pieter; Burns, Alan J.; Thapar, Nikhil			In Vivo Transplantation of Enteric Neural Crest Cells into Mouse Gut; Engraftment, Functional Integration and Long-Term Safety	PLOS ONE			English	Article							SLOW-TRANSIT CONSTIPATION; NERVOUS-SYSTEM; HIRSCHSPRUNG DISEASE; STEM-CELLS; GASTROINTESTINAL-TRACT; INTERSTITIAL-CELLS; PRECURSOR CELLS; IMAGE-ANALYSIS; GLIAL-CELLS; NEURONS	Objectives Enteric neuropathies are severe gastrointestinal disorders with unsatisfactory outcomes. We aimed to investigate the potential of enteric neural stem cell therapy approaches for such disorders by transplanting mouse enteric neural crest cells (ENCCs) into ganglionic and aganglionic mouse gut in vivo and analysing functional integration and long-term safety. Design Neurospheres generated from yellow fluorescent protein (YFP) expressing ENCCs selected from postnatal Wnt1-cre; R26R-YFP/YFP murine gut were transplanted into ganglionic hindgut of wild-type littermates or aganglionic hindgut of Ednrb(tm1Ywa) mice (lacking functional endothelin receptor type-B). Intestines were then assessed for ENCC integration and differentiation using immunohistochemistry, cell function using calcium imaging, and long-term safety using PCR to detect off-target YFP expression. Results YFP+ ENCCs engrafted, proliferated and differentiated into enteric neurons and glia within recipient ganglionic gut. Transplanted cells and their projections spread along the endogenous myenteric plexus to form branching networks. Electrical point stimulation of endogenous nerve fibres resulted in calcium transients (F/F0 = 1.16 +/- 0.01; 43 cells, n = 6) in YFP+ transplanted ENCCs (abolished with TTX). Long-term follow-up (24 months) showed transplanted ENCCs did not give rise to tumours or spread to other organs (PCR negative in extraintestinal sites). In aganglionic gut ENCCs similarly spread and differentiated to form neuronal and glial networks with projections closely associated with endogenous neural networks of the transition zone. Conclusions Transplanted ENCCs successfully engrafted into recipient ganglionic and aganglionic gut showing appropriate spread, localisation and, importantly, functional integration without any long-term safety issues. This study provides key support for the development and use of enteric neural stem cell therapies.	[Cooper, Julie E.; McCann, Conor J.; Natarajan, Dipa; Choudhury, Shanas; Delalande, Jean-Marie; Burns, Alan J.; Thapar, Nikhil] UCL Inst Child Hlth, Stem Cells & Regenerat Med, 30 Guilford St, London, England; [Boesmans, Werend; Vanden Berghe, Pieter] Univ Leuven, Dept Clin & Expt Med, Translat Res Ctr GastroIntestinal Disorders, Lab Enter NeuroSci, Leuven, Belgium; [Delalande, Jean-Marie] Univ London, Barts & London Sch Med & Dent, Ctr Digest Dis, Blizard Bldg, London, England; [Burns, Alan J.] Erasmus MC Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Thapar, Nikhil] Great Ormond St Hosp NHS Fdn Trust, Dept Gastroenterol, Great Ormond St, London, England	University of London; University College London; KU Leuven; University of London; Queen Mary University London; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Burns, AJ; Thapar, N (corresponding author), UCL Inst Child Hlth, Stem Cells & Regenerat Med, 30 Guilford St, London, England.; Burns, AJ (corresponding author), Erasmus MC Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands.; Thapar, N (corresponding author), Great Ormond St Hosp NHS Fdn Trust, Dept Gastroenterol, Great Ormond St, London, England.	n.thapar@ucl.ac.uk; alan.burns@ucl.ac.uk	Burns, Alan/AAC-1266-2022; Burns, Alan J/C-4988-2008	Burns, Alan/0000-0002-1725-1071; Boesmans, Werend/0000-0002-2426-0451; Vanden Berghe, Pieter/0000-0002-0009-2094; McCann, Conor/0000-0002-9324-5984	Great Ormond Street Children's Charity (GOSHCC); GOSHCC grant; Medical Research Council [G0800973]; Fonds Wetenschappelijk Onderzoek [G.0501.10]; Bijzonder Onderzoeksfonds [OT 10/046]; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London; MRC [G0800973] Funding Source: UKRI; Great Ormond Street Hospital Childrens Charity [V1258] Funding Source: researchfish	Great Ormond Street Children's Charity (GOSHCC); GOSHCC grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fonds Wetenschappelijk Onderzoek(FWO); Bijzonder Onderzoeksfonds; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Great Ormond Street Hospital Childrens Charity	NT is supported by Great Ormond Street Children's Charity (GOSHCC). JC, DN, CM and JMD are funded through a GOSHCC grant. JC was part-funded by the Medical Research Council (G0800973). PVB is supported by Fonds Wetenschappelijk Onderzoek (G.0501.10) and Bijzonder Onderzoeksfonds (OT 10/046). WB is a post-doctoral fellow of the Fonds Wetenschappelijk Onderzoek. The work was supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Belkind-Gerson J, 2013, NEUROGASTROENT MOTIL, V25, P61, DOI 10.1111/nmo.12015; Binder E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119467; Boesmans W, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00183; Bondurand N, 2006, DEVELOPMENT, V133, P2075, DOI 10.1242/dev.02375; Bondurand N, 2003, DEVELOPMENT, V130, P6387, DOI 10.1242/dev.00857; Burns AJ, 2006, NEUROGASTROENT MOTIL, V18, P876, DOI 10.1111/j.1365-2982.2006.00806.x; Burns AJ, 2005, INT J DEV BIOL, V49, P143, DOI 10.1387/ijdb.041935ab; Burns AJ, 2014, NAT REV GASTRO HEPAT, V11, P317, DOI 10.1038/nrgastro.2013.226; Chuenkova MV, 2011, ADV PARASIT, V76, P195, DOI 10.1016/B978-0-12-385895-5.00009-8; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; De Giorgio R, 2004, NEUROGASTROENT MOTIL, V16, P515, DOI 10.1111/j.1365-2982.2004.00538.x; Dettmann HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097792; Dickson EJ, 2010, AM J PHYSIOL-GASTR L, V298, pG222, DOI 10.1152/ajpgi.00399.2009; Druckenbrod NR, 2005, DEV BIOL, V287, P125, DOI 10.1016/j.ydbio.2005.08.040; Facer P, 2001, BRIT J SURG, V88, P545, DOI 10.1046/j.1365-2168.2001.01731.x; Findlay Q, 2014, AM J PHYSIOL-GASTR L, V307, pG741, DOI 10.1152/ajpgi.00225.2014; FOX DA, 1983, J PHARMACOL EXP THER, V227, P538; Furness JB, 2006, AUTON NEUROSCI-BASIC, V125, P81, DOI 10.1016/j.autneu.2006.01.007; Geramizadeh B, 2009, HEPATO-GASTROENTEROL, V56, P1670; Ghoshal UC, 2012, WORLD J GASTROENTERO, V18, P3050, DOI 10.3748/wjg.v18.i24.3050; Giorgio V, 2013, NEUROGASTROENT MOTIL, V25, P70, DOI 10.1111/nmo.12016; Goto K, 2016, J PHYSIOL SCI, V66, P67, DOI 10.1007/s12576-015-0396-1; Hagl C, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12119; Hao MM, 2011, J NEUROSCI, V31, P15352, DOI 10.1523/JNEUROSCI.3053-11.2011; Hetz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093605; Hotta R, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01411.x; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Hotta Ryo, 2011, J Pediatr Gastroenterol Nutr, V53 Suppl 2, pS43; Hotta R, 2011, CURR OPIN PHARMACOL, V11, P617, DOI 10.1016/j.coph.2011.09.004; KAPUR RP, 1992, DEVELOPMENT, V116, P167; Kwok CKM, 2013, J PEDIATR SURG, V48, P619, DOI 10.1016/j.jpedsurg.2012.08.026; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Le Douarin NM, 1999, NEURAL CREST, V2; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Lindley RM, 2009, J PEDIATR SURG, V44, P1249, DOI 10.1016/j.jpedsurg.2009.02.048; McKeown SJ, 2013, WIRES DEV BIOL, V2, P113, DOI 10.1002/wdev.57; Metzger M, 2009, GASTROENTEROLOGY, V137, P2063, DOI 10.1053/j.gastro.2009.06.038; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Nishikawa R, 2015, CYTOTECHNOLOGY, V67, P661, DOI 10.1007/s10616-014-9754-8; Rauch U, 2006, INT J COLORECTAL DIS, V21, P554, DOI 10.1007/s00384-005-0051-z; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stamp LA, 2015, J NEUROGASTROENTEROL, V21, P552, DOI 10.5056/jnm15079; Takahashi T, 2003, J GASTROENTEROL, V38, P421, DOI 10.1007/s00535-003-1094-y; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wagner JP, 2014, J PEDIATR SURG, V49, P1809, DOI 10.1016/j.jpedsurg.2014.09.023; Wagner JP, 2014, J PEDIATR SURG, V49, P1319, DOI 10.1016/j.jpedsurg.2014.01.061; Wedel T, 2002, GASTROENTEROLOGY, V123, P1459, DOI 10.1053/gast.2002.36600	52	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147989	10.1371/journal.pone.0147989	http://dx.doi.org/10.1371/journal.pone.0147989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824433	Green Published, gold			2022-12-26	WOS:000369528600084
J	Dominguez, A; Soldevila, N; Toledo, D; Godoy, P; Castilla, J; Force, L; Morales, M; Mayoral, JM; Egurrola, M; Tamames, S; Martin, V; Astray, J				Dominguez, Angela; Soldevila, Nuria; Toledo, Diana; Godoy, Pere; Castilla, Jesus; Force, Lluis; Morales, Maria; Maria Mayoral, Jose; Egurrola, Mikel; Tamames, Sonia; Martin, Vicente; Astray, Jenaro		Project Pl 12 02079	Factors Associated with Influenza Vaccination of Hospitalized Elderly Patients in Spain	PLOS ONE			English	Article							SEASONAL INFLUENZA; HIGH-RISK; OLDER-ADULTS; HEALTH; IMMUNIZATION; PEOPLE; RATES; CARE; COVERAGE; DEATHS	Vaccination of the elderly is an important factor in limiting the impact of influenza in the community. The aim of this study was to investigate the factors associated with influenza vaccination coverage in hospitalized patients aged >= 65 years hospitalized due to causes unrelated to influenza in Spain. We carried out a cross-sectional study. Bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking in to account sociodemographic variables and medical risk conditions. Multivariate analysis was performed using multilevel regression models. We included 1038 patients: 602 (58%) had received the influenza vaccine in the 2013-14 season. Three or more general practitioner visits (OR = 1.61; 95% CI 1.19-2.18); influenza vaccination in any of the 3 previous seasons (OR = 13.57; 95% CI 9.45-19.48); and 23-valent pneumococcal polysaccharide vaccination (OR = 1.97; 95% CI 1.38-2.80) were associated with receiving the influenza vaccine. Vaccination coverage of hospitalized elderly people is low in Spain and some predisposing characteristics influence vaccination coverage. Healthcare workers should take these characteristics into account and be encouraged to proactively propose influenza vaccination to all patients aged >= 65 years.	[Dominguez, Angela; Toledo, Diana] Univ Barcelona, Dept Salut Publ, Barcelona, Spain; [Dominguez, Angela; Soldevila, Nuria; Godoy, Pere; Castilla, Jesus; Morales, Maria] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Godoy, Pere] Agencia Salut Publ Catalunya, Barcelona, Spain; [Godoy, Pere] Univ Lleida, Inst Recerca Biomed Lleida, Lleida, Spain; [Castilla, Jesus] Inst Invest Sanitaria Navarra, Inst Salud Publ, Pamplona, Spain; [Force, Lluis] Hosp Mataro, Mataro, Spain; [Morales, Maria] Univ Valencia, Valencia, Spain; [Maria Mayoral, Jose] Serv Vigilancia Andalucia, Seville, Spain; [Egurrola, Mikel] Hosp Galdakao, Usansolo, Spain; [Tamames, Sonia] Junta Castilla & Leon, Direcc Gen Salud Publ Invest Desarrollo & Innovac, Leon, Spain; [Martin, Vicente] Univ Leon, E-24071 Leon, Spain; [Astray, Jenaro] Consejeria Sanidad, Madrid, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University of Valencia; Galdakao Hospital; Universidad de Leon	Dominguez, A (corresponding author), Univ Barcelona, Dept Salut Publ, Barcelona, Spain.; Dominguez, A (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.	angela.dominguez@ub.edu	Casado, Itziar/AAE-2973-2021; Fernández-Villa, Tania/R-6534-2017; Perez-Ruiz, Manuel/C-4419-2016; Martin, Vicente/A-1597-2008; Martin, Vicente/GRE-8306-2022; Casado, Itziar/B-1341-2017; Martin, Vicente/ABF-2276-2021; Castilla, Jesus/B-9048-2008; Antón, Andrés/B-3308-2011; Fernandez Natal, Isabel/C-9328-2015	Casado, Itziar/0000-0001-6879-4984; Martin, Vicente/0000-0003-0552-2804; Martin, Vicente/0000-0003-0552-2804; Casado, Itziar/0000-0001-6879-4984; Castilla, Jesus/0000-0002-6396-7265; Antón, Andrés/0000-0002-1476-0815; Fernandez Natal, Isabel/0000-0002-2701-9815; Espejo, Elena/0000-0001-9018-7515; Tamames, Sonia/0000-0001-5548-2594; Godoy, Pere/0000-0002-2896-7286; Dominguez-Berjon, Maria Felicitas/0000-0003-3551-0660; Torner, Nuria/0000-0003-0143-5295; Sanz, Francisco/0000-0003-4076-0816	National Plan; ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion [PI12/02079]; Fondo Europeo de Desarrollo Regional (FEDER. Union Europea. Una manera de hacer Europa); Catalan Agency for the Management of Grants for University Research (AGAUR) [2014/ SGR 1403]	National Plan; ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion; Fondo Europeo de Desarrollo Regional (FEDER. Union Europea. Una manera de hacer Europa); Catalan Agency for the Management of Grants for University Research (AGAUR)	This study was funded by the National Plan of I+D+I 2008-2011 and ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion (Project PI12/02079) and cofounded by Fondo Europeo de Desarrollo Regional (FEDER. Union Europea. Una manera de hacer Europa), and the Catalan Agency for the Management of Grants for University Research (AGAUR Grant number 2014/ SGR 1403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The other members of the Project PI12/02079 Working Group are: J. Diaz-Borrego (Servicio Andaluz de Salud), A. Morillo (Hospital Universitario Virgen del Rocio), M.J. Perez-Lozano (Hospital Universitario Virgen de Valme), J. Gutierrez (Hospital Universitario Puerta del Mar), M. Perez-Ruiz, M.A. Fernandez-Sierra (Hospital Universitario San Cecilio y Virgen de las Nieves), S. Rojo-Rello, R. Ortiz de Lejarazu (Hospital Clinico Universitario de Valladolid), M.I. Fernandez-Natal (Complejo Asistencial Universitario de Leon), T. Fernandez-Villa (GII-GAS-Grupo de Investigacion en Interaccion Gen-Ambiente y Salud, Universidad de Leon), A. Pueyo (Hospital Universitario de Burgos), A. Vilella (Hospital Clinic), A. Anton (Hospital Universitari Vall d'Hebron; Universitat Autonoma de Barcelona), G. Navarro (Corporacio Sanitaria i Universitaria Parc Tauli), M. Riera (Hospital Universitari Mutua Terrassa), E. Espejo (Hospital de Terrassa), M.D. Mas, R. Perez (ALTHAIA, Xarxa Hospitalaria de Manresa), J.A. Cayla, C. Rius (Agencia de Salut Publica de Barcelona; CIBERESP), N. Torner (Agencia de Salut Publica de Catalunya; Universitat de Barcelona; CIBERESP), I. Crespo (CIBERESP, Universitat de Barcelona), C. Izquierdo, R. Torra (Agencia de Salut Publica de Catalunya), M.F. Dominguez-Berjon, M.A. Gutierrez, S. Jimenez, E. Gil, F. Martin, R. Genova-Maleras (Consejeria de Sanidad), M.C. Prados, F. Ezzine de Blas (Hospital Universitario la Paz), J.C. Galan, E. Navas, L. Rodriguez (Hospital Ramon y Cajal), C.J. Alvarez, E. Banderas (Hospital Universitario 12 de Octubre), J. Chamorro (Complejo Hospitalario de Navarra), I. Casado, J. Diaz (Instituto de Salud Publica de Navarra), M.J. Lopez de Goicoechea (Hospital de Galdakao), F. Sanz (Consorci Hospital General Universitari de Valencia).	AGUILAR I, 2010, EUROSURVEILLANCE, V17, P20154; Al-Sukhni W, 2008, VACCINE, V26, P1432, DOI 10.1016/j.vaccine.2008.01.001; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Armstrong BG, 2004, BMJ-BRIT MED J, V329, P660, DOI 10.1136/bmj.38198.594109.AE; Baxter R, 2010, J INFECT DIS, V201, P186, DOI 10.1086/649568; Blank PR, 2009, INFECTION, V37, P390, DOI 10.1007/s15010-009-8467-y; Blank PR, 2008, WIEN MED WOCHENSCHR, V158, P583, DOI 10.1007/s10354-008-0582-3; Blaser, 2015, PRINCIPLES PRACTICE, P2000, DOI DOI 10.1016/B978-1-4557-4801-3.00167-3; Bohmer MM, 2011, VACCINE, V29, P4492, DOI 10.1016/j.vaccine.2011.04.039; Campos EC, 2012, CAD SAUDE PUBLICA, V28, P878, DOI 10.1590/S0102-311X2012000500007; Chiatti C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-207; Crawford VLS, 2011, AGE AGEING, V40, P35, DOI 10.1093/ageing/afq152; Endrich MM, 2009, VACCINE, V27, P4018, DOI 10.1016/j.vaccine.2009.04.029; European Centre for Disease Prevention and Control, 2015, SEAS INFL VACC EUR O; Fiore AE, 2013, VACCINES, P257; Gil de Miguel A, 2008, MED PREVENTIVA SALUD, P992; Godoy P, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0259-0; Hottes TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022618; INE, POP HOUS CENS 2011 P; INE, 2013, REV MUN REG 2013; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jefferson T, 2010, COCHRANE DB SYST REV, V17, DOI DOI 10.1002/14651858.CD004876.PUB3; Katz MH., 2011, MULTIVARIABLE ANAL, P197, DOI [10.1017/CBO9780511974175, DOI 10.1017/CBO9780511974175]; Kroneman M, 2006, VACCINE, V24, P622, DOI 10.1016/j.vaccine.2005.08.040; Lau L, 2009, INT J NURS STUD, V46, P768, DOI 10.1016/j.ijnurstu.2008.12.006; Nagata JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-388; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Ompad DC, 2006, EPIDEMIOL REV, V28, P54, DOI 10.1093/epirev/mxj004; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pena-Rey I, 2004, PUBLIC HEALTH, V118, P582, DOI 10.1016/j.puhe.2004.04.010; Privileggio L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-246; Reed C, 2014, MMWR-MORBID MORTAL W, V63, P1151; Regional Committee for Europe, 2012, STRATEGY ACTION PLAN; Ridenhour BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076318; Sarriá Antonio, 2002, Rev. Esp. Salud Publica, V76, P17, DOI 10.1590/S1135-57272002000100003; Schwartz AW, 2013, PREV MED, V56, P337, DOI 10.1016/j.ypmed.2013.01.019; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Cruzeta APS, 2013, INT J INFECT DIS, V17, pE1194, DOI 10.1016/j.ijid.2013.07.013; The Council of the European Union, COUNC REC SEAS INFL; Thomas RE, 2014, VACCINE, V32, P6884, DOI 10.1016/j.vaccine.2014.08.090; World Health Organization, 2003, PREV CONTR INFL PAND	44	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147931	10.1371/journal.pone.0147931	http://dx.doi.org/10.1371/journal.pone.0147931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824383	Green Published, gold			2022-12-26	WOS:000369528600075
J	Li, J; Olshansky, M; Carbone, FR; Ma, JZ				Li, Jane; Olshansky, Moshe; Carbone, Francis R.; Ma, Joel Z.			Transcriptional Analysis of T Cells Resident in Human Skin	PLOS ONE			English	Article							TISSUE; EXPRESSION; INFECTION; SURVEILLANCE; IMMUNITY	Human skin contains various populations of memory T cells in permanent residence and in transit. Arguably, the best characterized of the skin subsets are the CD8(+) permanently resident memory T cells (T-RM) expressing the integrin subunit, CD103. In order to investigate the remaining skin T cells, we isolated skin-tropic (CLA(+)) helper T cells, regulatory T cells, and CD8(+) CD103-T cells from skin and blood for RNA microarray analysis to compare the transcriptional profiles of these groups. We found that despite their common tropism, the T cells isolated from skin were transcriptionally distinct from blood-derived CLA(+) T cells. A shared pool of genes contributed to the skin/blood discrepancy, with substantial overlap in differentially expressed genes between each T cell subset. Gene set enrichment analysis further showed that the differential gene profiles of each human skin T cell subset were significantly enriched for previously identified TRM core signature genes. Our results support the hypothesis that human skin may contain additional TRM or TRM-like populations.	[Li, Jane; Olshansky, Moshe; Carbone, Francis R.; Ma, Joel Z.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Li, Jane] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia	University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Li, J; Ma, JZ (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.; Li, J (corresponding author), Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia.	jane.melb@gmail.com; jzma@unimelb.edu.au	Carbone, Francis/ABF-2141-2020	Olshansky, Moshe/0000-0003-2085-9851; Ma, Joel/0000-0002-0448-6744	Australian National Health and Medical Research Council; Elizabeth and Vernon Puzey Scholarship; Victorian Government	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Elizabeth and Vernon Puzey Scholarship; Victorian Government	The work was supported by grants from the Australian National Health and Medical Research Council to FRC. JL is a recipient of the Elizabeth and Vernon Puzey Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all patients for participating in this study, and the team at the Royal Women's Hospital for assistance in obtaining tissue samples. We are grateful to Dr. D Fernandez-Ruiz for help in compiling the T<INF>RM</INF> gene set lists. Biospecimens and data used in this research were obtained from the Victorian Cancer Biobank, Victoria, Australia, with appropriate ethics approval. The Victorian Cancer Biobank is supported by the Victorian Government. We thank Dr. K Shaw for assistance with proofreading.	Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Dunning M, 2015, ILLUMINAHUMANV4 DB I; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Gagnon-Bartsch JA, 2014, RUV DETECT REMOVE UN; Gagnon-Bartsch JA, 2012, BIOSTATISTICS, V13, P539, DOI 10.1093/biostatistics/kxr034; Gebhardt T, 2013, TRENDS IMMUNOL, V34, P27, DOI 10.1016/j.it.2012.08.008; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kataoka T, 2009, J ANTIBIOT, V62, P655, DOI 10.1038/ja.2009.98; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Morel Y, 1999, BIOCHEM J, V342, P481, DOI 10.1042/0264-6021:3420481; Nakatsuji T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2441; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; SPEED T. P, 2013, 820 U CAL DEP STAT; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang VA, 2010, J REPROD IMMUNOL, V87, P39, DOI 10.1016/j.jri.2010.06.155; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Turner DL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00331; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110	38	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148351	10.1371/journal.pone.0148351	http://dx.doi.org/10.1371/journal.pone.0148351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824609	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600117
J	Lin, MY; Chang, DCK; Shen, YD; Lin, YK; Lin, CP; Wang, IJ				Lin, Meng-Yin; Chang, David C. K.; Shen, Yun-Dun; Lin, Yen-Kuang; Lin, Chang-Ping; Wang, I-Jong			Factors Influencing Intraocular Pressure Changes after Laser In Situ Keratomileusis with Flaps Created by Femtosecond Laser or Mechanical Microkeratome	PLOS ONE			English	Article							GOLDMANN APPLANATION TONOMETRY; CORVIS ST TONOMETER; PHOTOREFRACTIVE KERATECTOMY; REFRACTIVE SURGERY; CORNEAL THICKNESS; STROMAL BED; LASIK; MYOPIA; ASTIGMATISM; NONCONTACT	The aim of this study is to describe factors that influence the measured intraocular pressure (IOP) change and to develop a predictive model after myopic laser in situ keratomileusis (LASIK) with a femtosecond (FS) laser or a microkeratome (MK). We retrospectively reviewed preoperative, intraoperative, and 12-month postoperative medical records in 2485 eyes of 1309 patients who underwent LASIK with an FS laser or an MK for myopia and myopic astigmatism. Data were extracted, such as preoperative age, sex, IOP, manifest spherical equivalent (MSE), central corneal keratometry (CCK), central corneal thickness (CCT), and intended flap thickness and postoperative IOP (postIOP) at 1, 6 and 12 months. Linear mixed model (LMM) and multivariate linear regression (MLR) method were used for data analysis. In both models, the preoperative CCT and ablation depth had significant effects on predicting IOP changes in the FS and MK groups. The intended flap thickness was a significant predictor only in the FS laser group (P <.0001 in both models). In the FS group, LMM and MLR could respectively explain 47.00% and 18.91% of the variation of postoperative IOP underestimation (R-2 = 0.47 and R-2 = 0.1891). In the MK group, LMM and MLR could explain 37.79% and 19.13% of the variation of IOP underestimation (R-2 = 0.3779 and 0.1913 respectively). The best-fit model for prediction of IOP changes was the LMM in LASIK with an FS laser.	[Lin, Meng-Yin; Shen, Yun-Dun] Taipei Med Univ, Taipei Med Sch Med, Shuang Ho Hosp, Dept Ophthalmol, Taipei, Taipei County, Taiwan; [Lin, Meng-Yin] Natl Taiwan Univ, Sch Med, Inst Clin Med, Taipei 10764, Taiwan; [Chang, David C. K.] Nobel Eye Clin, Taipei, Taiwan; [Lin, Yen-Kuang] Taipei Med Univ, Biostat Ctr, Taipei, Taiwan; [Lin, Chang-Ping; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Wang, I-Jong] China Med Univ, Sch Med, Inst Clin Med, Taichung, Taiwan	Taipei Medical University; Shuang Ho Hospital; National Taiwan University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan	Lin, CP; Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.; Wang, IJ (corresponding author), China Med Univ, Sch Med, Inst Clin Med, Taichung, Taiwan.	cpiling59@gmail.com; ijong@ms8.hinet.net		LIN, CHANG-PING/0000-0003-0302-7711; Wang, I-Jong/0000-0002-3045-0614				Agudelo LM, 2002, J REFRACT SURG, V18, P472; Alio JL, 2008, J REFRACT SURG, V24, P12, DOI 10.3928/1081597X-20080101-03; [Anonymous], 2006, COMPR REP GLOB REFR; [Anonymous], 2010, FTN EQUITY CAPITAL M; Aristeidou AP, 2011, GRAEF ARCH CLIN EXP, V249, P767, DOI 10.1007/s00417-010-1431-9; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Chan A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1484, DOI 10.1001/archopht.126.11.1484; Chang DH, 2005, OPHTHALMOLOGY, V112, P1009, DOI 10.1016/j.ophtha.2004.12.033; Chihara E, 2005, BRIT J OPHTHALMOL, V89, P160, DOI 10.1136/bjo.2004.048074; Cook JA, 2012, OPHTHALMOLOGY, V119, P1552, DOI 10.1016/j.ophtha.2012.02.030; Gimeno JAS, 2000, CORNEA, V19, P512, DOI 10.1097/00003226-200007000-00022; Hong JX, 2015, OPTOMETRY VISION SCI, V92, P589, DOI 10.1097/OPX.0000000000000575; Hong JX, 2013, INVEST OPHTH VIS SCI, V54, P659, DOI 10.1167/iovs.12-10984; Iester M, 2009, J CATARACT REFR SURG, V35, P1623, DOI 10.1016/j.jcrs.2009.05.015; Jordao MLS, 2009, EYE, V23, P1364, DOI 10.1038/eye.2008.278; Kezirian GM, 2004, J CATARACT REFR SURG, V30, P804, DOI 10.1016/j.jcrs.2003.10.026; Ko YC, 2005, EYE, V19, P327, DOI 10.1038/sj.eye.6701458; Kohlhaas M, 2006, J REFRACT SURG, V22, P263, DOI 10.3928/1081-597X-20060301-11; Kymionis GD, 2014, BRIT J OPHTHALMOL, V98, P133, DOI 10.1136/bjophthalmol-2013-304023; Lam AKC, 2010, J CATARACT REFR SURG, V36, P631, DOI 10.1016/j.jcrs.2009.10.045; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Montes-Mico R, 2002, J REFRACT SURG, V18, P88; Moshirfar M, 2010, J CATARACT REFR SURG, V36, P1925, DOI 10.1016/j.jcrs.2010.05.027; Patel SV, 2007, OPHTHALMOLOGY, V114, P1482, DOI 10.1016/j.ophtha.2006.10.057; Pepose JS, 2007, AM J OPHTHALMOL, V143, P39, DOI 10.1016/j.ajo.2006.09.036; Qazi MA, 2009, J CATARACT REFR SURG, V35, P1774, DOI 10.1016/j.jcrs.2009.05.041; Sanchez-Naves J, 2008, J GLAUCOMA, V17, P611, DOI 10.1097/IJG.0b013e3181639ae2; Santhiago MR, 2015, J CATARACT REFRACTIV; Sarayba MA, 2007, J REFRACT SURG, V23, P331; Schallhorn JM, 2015, OPHTHALMOLOGY, V122, P471, DOI 10.1016/j.ophtha.2014.09.033; Shaikh NM, 2005, J REFRACT SURG, V21, P353; Shemesh G, 2007, J REFRACT SURG, V23, P405; SHIELDS MB, 1980, SURV OPHTHALMOL, V24, P211, DOI 10.1016/0039-6257(80)90042-9; Sugar A, 2002, OPHTHALMOLOGY, V109, P175, DOI 10.1016/S0161-6420(01)00966-6; Winkler M, 2013, INVEST OPHTH VIS SCI, V54, P7293, DOI 10.1167/iovs.13-13150; Yang CC, 2006, AM J OPHTHALMOL, V141, P530, DOI 10.1016/j.ajo.2005.10.022; Zadok D, 1999, J CATARACT REFR SURG, V25, P1344, DOI 10.1016/S0886-3350(99)00202-3	38	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147699	10.1371/journal.pone.0147699	http://dx.doi.org/10.1371/journal.pone.0147699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824754	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600047
J	Bonventre, JA; Zielke, RA; Korotkov, KV; Sikora, AE				Bonventre, Josephine A.; Zielke, Ryszard A.; Korotkov, Konstantin V.; Sikora, Aleksandra E.			Targeting an Essential GTPase Obg for the Development of Broad-Spectrum Antibiotics	PLOS ONE			English	Article							50S RIBOSOMAL-SUBUNIT; THROUGHPUT SCREENING ASSAYS; BINDING PROTEIN OBG; NEISSERIA-GONORRHOEAE; ANTIMICROBIAL RESISTANCE; ANTIBACTERIAL DISCOVERY; BACILLUS-SUBTILIS; IDENTIFICATION; CHALLENGES; DRUGS	A promising new drug target for the development of novel broad-spectrum antibiotics is the highly conserved small GTPase Obg (YhbZ, CgtA), a protein essential for the survival of all bacteria including Neisseria gonorrhoeae (GC). GC is the agent of gonorrhea, a prevalent sexually transmitted disease resulting in serious consequences on reproductive and neonatal health. A preventive anti-gonorrhea vaccine does not exist, and options for effective antibiotic treatments are increasingly limited. To address the dire need for alternative antimicrobial strategies, we have designed and optimized a 384-well GTPase assay to identify inhibitors of Obg using as a model Obg protein from GC, Obg(GC). The assay was validated with a pilot screen of 40,000 compounds and achieved an average Z' value of 0.58 +/- 0.02, which suggests a robust assay amenable to high-throughput screening. We developed secondary assessments for identified lead compounds that utilize the interaction between Obg(GC) and fluorescent guanine nucleotide analogs, mant-GTP and mant-GDP, and an Obg(GC) variant with multiple alterations in the G-domains that prevent nucleotide binding. To evaluate the broad-spectrum potential of Obg(GC) inhibitors, Obg proteins of Klebsiella pneumoniae and methicillin-resistant Staphylococcus aureus were assessed using the colorimetric and fluorescence-based activity assays. These approaches can be useful in identifying broad-spectrum Obg inhibitors and advancing the therapeutic battle against multidrug resistant bacteria.	[Bonventre, Josephine A.; Zielke, Ryszard A.; Sikora, Aleksandra E.] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97330 USA; [Korotkov, Konstantin V.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Korotkov, Konstantin V.] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA	Oregon State University; University of Kentucky; University of Kentucky	Sikora, AE (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97330 USA.	Aleksandra.Sikora@oregonstate.edu	Sikora, Aleksandra E/HGD-6641-2022	Korotkov, Konstantin/0000-0002-2182-6843	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01-AI117235]; College of Pharmacy (OSU); National Institute of General Medical Sciences of the National Institutes of Health [P20GM103486]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); College of Pharmacy (OSU); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided to AES by grant R01-AI117235 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health and by a pilot grant provided by the College of Pharmacy (OSU). Research reported in this publication was partially supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103486 to KVK.	Arias CA, 2015, NEW ENGL J MED, V372, P1168, DOI 10.1056/NEJMcibr1500292; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Bharat A, 2013, J BIOMOL SCREEN, V18, P830, DOI 10.1177/1087057113486001; Blaxill Z, 2009, J BIOMOL SCREEN, V14, P547, DOI 10.1177/1087057109335327; Blombach F, 2011, BIOCHEM SOC T, V39, P45, DOI 10.1042/BST0390045; Bolken TC, 2008, ANTIVIR RES, V77, P1, DOI 10.1016/j.antiviral.2007.07.003; Buglino J, 2002, STRUCTURE, V10, P1581, DOI 10.1016/S0969-2126(02)00882-1; Buxser S, 2005, ANAL BIOCHEM, V340, P1, DOI 10.1016/j.ab.2005.01.034; CDC, 2013, ANT ANT RES 2013; Cent. Dis. Control Prev, 2013, ANT RES THREATS US 2; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; Copeland RA, 2003, ANAL BIOCHEM, V320, P1, DOI 10.1016/S0003-2697(03)00346-4; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P1433, DOI 10.1086/375081; Edwards JL, 2004, CLIN MICROBIOL REV, V17, P965, DOI 10.1128/CMR.17.4.965-981.2004; Feng BY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001866; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Holmes NE, 2015, SEMIN RESP CRIT CARE, V36, P17, DOI 10.1055/s-0034-1397040; Hook EW, 2013, MMWR-MORBID MORTAL W, V62, P103; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Kint C, 2014, CRIT REV MICROBIOL, V40, P207, DOI 10.3109/1040841X.2013.776510; Kukimoto-Niino M, 2004, J MOL BIOL, V337, P761, DOI 10.1016/j.jmb.2004.01.047; Larson RA, 2008, J VIROL, V82, P10768, DOI 10.1128/JVI.00941-08; Lee Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012597; Lin B, 1999, J BACTERIOL, V181, P5825, DOI 10.1128/JB.181.18.5825-5832.1999; Lin B, 2004, J BACTERIOL, V186, P481, DOI 10.1128/JB.186.2.481-489.2004; Lin B, 2001, FEBS LETT, V489, P107, DOI 10.1016/S0014-5793(00)02214-6; Lin B, 2001, MOL MICROBIOL, V39, P924, DOI 10.1046/j.1365-2958.2001.02285.x; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Maddock J, 1997, J BACTERIOL, V179, P6426, DOI 10.1128/jb.179.20.6426-6431.1997; Monroy CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062247; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Okamoto S, 1998, MOL MICROBIOL, V30, P107, DOI 10.1046/j.1365-2958.1998.01042.x; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Sandoz KM, 2012, ANTIMICROB AGENTS CH, V56, P4296, DOI 10.1128/AAC.00356-12; Schroter G, 2015, J BIOL CHEM, V290, P17085, DOI 10.1074/jbc.M115.651190; Shah S, 2008, J BACTERIOL, V190, P4764, DOI 10.1128/JB.02021-07; Sikora AE, 2006, J BACTERIOL, V188, P1205, DOI 10.1128/JB.188.3.1205-1210.2006; Sikora AE, 2006, BIOCHEM BIOPH RES CO, V339, P1165, DOI 10.1016/j.bbrc.2005.11.129; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Tenson T, 2006, MOL MICROBIOL, V59, P1664, DOI 10.1111/j.1365-2958.2006.05063.x; TRACH K, 1989, J BACTERIOL, V171, P1362, DOI 10.1128/jb.171.3.1362-1371.1989; Unemo M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1029-2; Unemo M, 2014, PATHOG GLOB HEALTH, V108, P214, DOI 10.1179/2047772414Z.000000000216; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; WELSH KM, 1994, J BACTERIOL, V176, P7161, DOI 10.1128/JB.176.23.7161-7168.1994; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; World Health Organization, 2014, ANT RES GLOB REP SUR, P232; World Health Organization, 2012, GLOB ACT PLAN CONTR; World Health Organization (WHO), 2015, ANT RES DRAFT GLOB A; Wout P, 2004, J BACTERIOL, V186, P5249, DOI 10.1128/JB.186.16.5249-5257.2004; Zalacain M, 2003, J MOL MICROB BIOTECH, V6, P109, DOI 10.1159/000076741; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zielke RA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0453-1; Zitha-Bovens E, 2009, J BIOMOL SCREEN, V14, P557, DOI 10.1177/1087057109336953	59	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148222	10.1371/journal.pone.0148222	http://dx.doi.org/10.1371/journal.pone.0148222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848972	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000053
J	van Twillert, I; Marinovic, AAB; van Gaans-van den Brink, JAM; Kuipers, B; Berbers, GAM; van der Maas, NAT; Verheij, TJM; Versteegh, FGA; Teunis, PFM; van Els, CACM				van Twillert, Inonge; Marinovic, Axel A. Bonacic; van Gaans-van den Brink, Jacqueline A. M.; Kuipers, Betsy; Berbers, Guy A. M.; van der Maas, Nicoline A. T.; Verheij, Theo J. M.; Versteegh, Florens G. A.; Teunis, Peter F. M.; van Els, Cecile A. C. M.			The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; ANTIBODY-RESPONSES; TOXIN IGG; INFECTION; VACCINATION; VACCINES; SEROEPIDEMIOLOGY; EPIDEMIOLOGY; IMMUNIZATION; IMMUNOASSAY	Bordetella pertussis circulates even in highly vaccinated countries affecting all age groups. Insight into the scale of concealed reinfections is important as they may contribute to transmission. We therefore investigated whether current single-point serodiagnostic methods are suitable to estimate the prevalence of pertussis reinfection. Two methods based on IgG-Ptx plasma levels alone were used to evaluate the proportion of renewed seroconversions in the past year in a cohort of retrospective pertussis cases >= 24 months after a proven earlier symptomatic infection. A Dutch population database was used as a baseline. Applying a classical 62.5 IU/ml IgG-Ptx cut-off, we calculated a seroprevalence of 15% in retrospective cases, higher than the 10% observed in the population baseline. However, this method could not discriminate between renewed seroconversion and waning of previously infection-enhanced IgG-Ptx levels. Two-component cluster analysis of the IgG-Ptx datasets of both pertussis cases and the general population revealed a continuum of intermediate IgG-Ptx levels, preventing the establishment of a positive population and the comparison of prevalence by this alternative method. Next, we investigated the complementary serodiagnostic value of IgA-Ptx levels. When modelling datasets including both convalescent and retrospective cases we obtained new cut-offs for both IgG-Ptx and IgA-Ptx that were optimized to evaluate renewed seroconversions in the ex-cases target population. Combining these cut-offs two-dimensionally, we calculated 8.0% reinfections in retrospective cases, being below the baseline seroprevalence. Our study for the first time revealed the shortcomings of using only IgG-Ptx data in conventional serodiagnostic methods to determine pertussis reinfections. Improved results can be obtained with two-dimensional serodiagnostic profiling. The proportion of reinfections thus established suggests a relatively increased period of protection to renewed infection after clinical pertussis.	[van Twillert, Inonge; Marinovic, Axel A. Bonacic; van Gaans-van den Brink, Jacqueline A. M.; Kuipers, Betsy; Berbers, Guy A. M.; van der Maas, Nicoline A. T.; Teunis, Peter F. M.; van Els, Cecile A. C. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Verheij, Theo J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Versteegh, Florens G. A.] Groene Hart Ziekenhuis, Dept Pediat, Gouda, Netherlands; [Versteegh, Florens G. A.] Ghent Univ Hosp, Dept Pediat, Ghent, Belgium; [Teunis, Peter F. M.] Emory Univ, RSPH, Atlanta, GA 30322 USA	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Ghent University; Ghent University Hospital; Emory University	van Els, CACM (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	Cecile.van.Els@rivm.nl		Versteegh, Florens G.A./0000-0003-4773-5592	European research network 'Child Innovac', E.C. FP7 program [201502]; Dutch Ministry of Health, Welfare and Sport	European research network 'Child Innovac', E.C. FP7 program; Dutch Ministry of Health, Welfare and Sport	The project was partly funded by the European research network 'Child Innovac', E.C. FP7 program, grant agreement #201502, and partly funded by the Dutch Ministry of Health, Welfare and Sport.	Baron S, 1998, PEDIATR INFECT DIS J, V17, P412, DOI 10.1097/00006454-199805000-00013; Baughman AL, 2006, STAT MED, V25, P2994, DOI 10.1002/sim.2442; Bonhoeffer J, 2005, INFECTION, V33, P13, DOI 10.1007/s15010-005-4004-9; Cagney M, 2006, EPIDEMIOL INFECT, V134, P1208, DOI 10.1017/S095026880600625X; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Dalby T, 2010, J MED MICROBIOL, V59, P1029, DOI 10.1099/jmm.0.020826-0; de Greeff SC, 2012, CLIN VACCINE IMMUNOL, V19, P1452, DOI 10.1128/CVI.00229-12; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; DEVILLE JG, 1995, CLIN INFECT DIS, V21, P639, DOI 10.1093/clinids/21.3.639; Fry NK, 2013, J MED MICROBIOL, V62, P1281, DOI 10.1099/jmm.0.062000-0; Giammanco A, 2008, VACCINE, V26, P4486, DOI 10.1016/j.vaccine.2008.06.051; Giuliano M, 1998, J PEDIATR-US, V132, P983, DOI 10.1016/S0022-3476(98)70395-6; Guiso N, 2011, EUR J CLIN MICROBIOL, V30, P307, DOI 10.1007/s10096-010-1104-y; Hallander HO, 2009, APMIS, V117, P797, DOI 10.1111/j.1600-0463.2009.02530.x; Han WGH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083583; He Q, 2012, EURO SURVEILL, V17; HEININGER U, 1994, VACCINE, V12, P81, DOI 10.1016/0264-410X(94)90014-0; Hendrikx LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027681; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; Hodder SL, 2000, CLIN INFECT DIS, V31, P7, DOI 10.1086/313913; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Klement E, 2003, EPIDEMIOL INFECT, V131, P1049, DOI 10.1017/S0950268803001110; LAMBERT HJ, 1965, PUBLIC HEALTH REP, V80, P365, DOI 10.2307/4592424; Le T, 2004, J INFECT DIS, V190, P535, DOI 10.1086/422035; Masseria C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1269-1; May ML, 2013, PATHOLOGY, V45, P172, DOI 10.1097/PAT.0b013e32835c76e2; May ML, 2012, CLIN VACCINE IMMUNOL, V19, P190, DOI 10.1128/CVI.05430-11; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Prince HE, 2012, CLIN VACCINE IMMUNOL, V19, P545, DOI 10.1128/CVI.05725-11; Tan TN, 2015, PEDIATR INFECT DIS J, V34, pE222, DOI 10.1097/INF.0000000000000795; van Boven M, 2005, P ROY SOC B-BIOL SCI, V272, P1617, DOI 10.1098/rspb.2005.3108; van der Klis FRM, 2009, NETH J MED, V67, P301; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Twillert I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085227; Versteegh FGA, 2005, EPIDEMIOL INFECT, V133, P737, DOI 10.1017/S0950268805003833; Versteegh FGA, 2002, ACTA PAEDIATR, V91, P95, DOI 10.1080/080352502753458030; von Konig CHW, 1999, EUR J CLIN MICROBIOL, V18, P341, DOI 10.1007/PL00015016; VONKONIG CHW, 1995, LANCET, V346, P1326, DOI 10.1016/S0140-6736(95)92343-8; Warfel JM, 2015, CURR OPIN IMMUNOL, V35, P48, DOI 10.1016/j.coi.2015.05.008; Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110; Wearing HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000647; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148507	10.1371/journal.pone.0148507	http://dx.doi.org/10.1371/journal.pone.0148507			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848833	Green Published, gold			2022-12-26	WOS:000369554000112
J	Zhou, W; Wu, S; Ding, M; Li, JJ; Shi, ZB; Wei, W; Guo, J; Zhang, H; Jiang, YR; Rong, JK				Zhou, Wei; Wu, Shasha; Ding, Mingquan; Li, Jingjuan; Shi, Zhaobin; Wei, Wei; Guo, Jialian; Zhang, Hua; Jiang, Yurong; Rong, Junkang			Mapping of Ppd-B1, a Major Candidate Gene for Late Heading on Wild Emmer Chromosome Arm 2BS and Assessment of Its Interactions with Early Heading QTLs on 3AL	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PSEUDO-RESPONSE-REGULATOR; FLOWERING-TIME GENES; LYCOPERSICON-PENNELLII; SUBSTITUTION LINES; EMERGENCE TIME; COMPLEX TRAITS; LINKAGE MAP; BREAD WHEAT; PHOTOPERIOD	Wheat heading date is an important agronomic trait determining maturation time and yield. A set of common wheat (Triticum aestivum var. Chinese Spring; CS)-wild emmer (T. turgidum L. subsp. dicoccoides (TDIC)) chromosome arm substitution lines (CASLs) was used to identify and allocate QTLs conferring late or early spike emergence by examining heading date. Genetic loci accelerating heading were found on TDIC chromosome arms 3AL and 7BS, while loci delaying heading were located on 4AL and 2BS. To map QTLs conferring late heading on 2BS, F-2 populations derived from two cross combinations of CASL2BS x CS and CASL3AL x CASL2BS were developed and each planted at two times, constituting four F2 mapping populations. Heading date varied continuously among individuals of these four populations, suggesting quantitative characteristics. A genetic map of 2BS, consisting of 23 SSR and one single-stranded conformation polymorphism (SSCP) marker(s), was constructed using these F-2 populations. This map spanned a genetic length of 53.2 cM with average marker density of 2.3 cM. The photoperiod-sensitivity gene Ppd-B1 was mapped to chromosome arm 2BS as a SSCP molecular marker, and was validated as tightly linked to a major QTL governing late heading of CASL2BS in all mapping populations. A significant dominance by additive effect of Ppd-B1 with the LUX gene located on 3AL was also detected. CS had more copies of Ppd-B1 than CASL2BS, implying that increased copy number could elevate the expression of Ppd-1 in CS, also increasing expression of LUX and FT genes and causing CS to have an earlier heading date than CASL2BS in long days.	[Zhou, Wei; Wu, Shasha; Ding, Mingquan; Li, Jingjuan; Shi, Zhaobin; Wei, Wei; Guo, Jialian; Zhang, Hua; Jiang, Yurong; Rong, Junkang] Zhejiang A&F Univ, Sch Agr & Food Sci, Key Lab Qual Improvement Agr Prod Zhejiang Prov, Hangzhou 311300, Zhejiang, Peoples R China	Zhejiang A&F University	Rong, JK (corresponding author), Zhejiang A&F Univ, Sch Agr & Food Sci, Key Lab Qual Improvement Agr Prod Zhejiang Prov, Hangzhou 311300, Zhejiang, Peoples R China.	junkangrong@126.com		Yurong, Jiang/0000-0003-2245-265X	National Natural Science Foundation of China [31201208, 31071421]; Zhejiang province public technology applied research projects [2014C32027]; Zhejiang Provincial Natural Science Foundation of China [LQ12C13003]; Zhejiang province science and technology development special project on breeding new varieties of wheat and barley [2012C12902-2-6]; Program for Zhejiang Leading Team of ST Innovation [2011R50026-24]; NSFC [31071421]; ZJNSF [LQ12C13003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang province public technology applied research projects; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang province science and technology development special project on breeding new varieties of wheat and barley; Program for Zhejiang Leading Team of ST Innovation; NSFC(National Natural Science Foundation of China (NSFC)); ZJNSF(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China (31201208 sponsored for WZ and 31071421 sponsored for JKR, the URL is http://www.nsfc.gov.cn/), Zhejiang province public technology applied research projects (2014C32027 sponsored for YRJ, the URL is http://www.zjkjt.gov.cn/), Zhejiang Provincial Natural Science Foundation of China (LQ12C13003 sponsored for WZ, the URL is http://www.zjnsf.gov.cn/index.aspx), Zhejiang province science and technology development special project on breeding new varieties of wheat and barley (2012C12902-2-6 sponsored for WZ, the URL is http://www.zjkjt.gov.cn/) and the Program for Zhejiang Leading Team of S&T Innovation (2011R50026-24 sponsored for WZ and the URL is http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The 28 CASLs and their parents (CS and TDIC 140) were kindly provided by Prof. M. Feldman at Weizmann Institute of Science, Israel. This work was supported by NSFC (31071421), Zhejiang province public technology applied research projects (2014C32027), ZJNSF(LQ12C13003), the Zhejiang province science and technology development special project on breeding new varieties of wheat and barley (2012C12902-2-6) and the Program for Zhejiang Leading Team of S&T Innovation (2011R50026-24).	Alpert KB, 1996, P NATL ACAD SCI USA, V93, P15503, DOI 10.1073/pnas.93.26.15503; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bonnin I, 2008, THEOR APPL GENET, V116, P383, DOI 10.1007/s00122-007-0676-0; Borner A, 2002, THEOR APPL GENET, V105, P921, DOI 10.1007/s00122-002-0994-1; CHAO S, 1989, THEOR APPL GENET, V78, P495, DOI 10.1007/BF00290833; Deng WW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6882; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Distelfeld A, 2009, PLANT PHYSIOL, V149, P245, DOI 10.1104/pp.108.129353; Doerge RW, 1996, GENETICS, V142, P285; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; ESHED Y, 1995, GENETICS, V141, P1147; FELDMAN M, 1981, SCI AM, V244, P102, DOI 10.1038/scientificamerican0181-102; Feldman M., 1994, P EUR ASS RES PLANT, P151; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Fujita M, 2003, P 10 INT WHEAT GEN S, V3, P971; Gawronski P, 2014, GENETICS, V196, P1253, DOI 10.1534/genetics.113.158444; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; He SE, 2013, PLANT BREEDING, V132, P337, DOI 10.1111/pbr.12030; Holtan HEE, 2003, GENETICS, V165, P1541; HOOGENDOORN J, 1985, EUPHYTICA, V34, P545, DOI 10.1007/BF00022954; JOPPA LR, 1993, CROP SCI, V33, P908, DOI 10.2135/cropsci1993.0011183X003300050006x; Kato H, 2001, PLANT BREEDING, V120, P115, DOI 10.1046/j.1439-0523.2001.00586.x; Kato K, 1999, PLANT BREEDING, V118, P391, DOI 10.1046/j.1439-0523.1999.00395.x; Kato K, 1999, THEOR APPL GENET, V98, P472, DOI 10.1007/s001220051094; Khavkin E, 1997, THEOR APPL GENET, V95, P343, DOI 10.1007/s001220050569; Kitagawa S, 2012, GENES GENET SYST, V87, P161, DOI 10.1266/ggs.87.161; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kulwal PL, 2003, PLANT SCI, V164, P267, DOI 10.1016/S0168-9452(02)00409-0; Laurie DA, 1997, PLANT MOL BIOL, V35, P167, DOI 10.1023/A:1005726329248; LAW CN, 1978, HEREDITY, V41, P185, DOI 10.1038/hdy.1978.87; Lin F, 2008, EUPHYTICA, V164, P769, DOI 10.1007/s10681-008-9724-3; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; MANGIN B, 1994, GENETICS, V138, P1301; Millet E, 2013, EUPHYTICA, V190, P1, DOI 10.1007/s10681-012-0725-x; Mohler V, 2004, EUPHYTICA, V138, P33, DOI 10.1023/B:EUPH.0000047056.58938.76; Nakamichi N, 2011, PLANT CELL PHYSIOL, V52, P1709, DOI 10.1093/pcp/pcr118; Nishida H, 2013, MOL BREEDING, V31, P27, DOI 10.1007/s11032-012-9765-0; Paillard S, 2003, THEOR APPL GENET, V107, P1235, DOI 10.1007/s00122-003-1361-6; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Pestsova E, 2000, THEOR APPL GENET, V101, P95, DOI 10.1007/s001220051455; PUGSLEY AT, 1971, AUST J AGR RES, V22, P21, DOI 10.1071/AR9710021; Rawson HM, 1998, FIELD CROP RES, V57, P289, DOI 10.1016/S0378-4290(98)00073-2; Reif JC, 2005, THEOR APPL GENET, V110, P859, DOI 10.1007/s00122-004-1881-8; Roder MS, 1998, GENOME, V41, P278, DOI 10.1139/gen-41-2-278; Rong JK, 2000, EUPHYTICA, V115, P121, DOI 10.1023/A:1003950431049; SCARTH R, 1983, HEREDITY, V51, P607, DOI 10.1038/hdy.1983.73; Shaw LM, 2012, PLANT J, V71, P71, DOI 10.1111/j.1365-313X.2012.04971.x; Shindo C, 2003, HEREDITY, V90, P56, DOI 10.1038/sj.hdy.6800178; Snape JW, 2001, EUPHYTICA, V119, P185, DOI 10.1023/A:1017594422176; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Sourdille P, 2003, THEOR APPL GENET, V106, P530, DOI 10.1007/s00122-002-1044-8; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; Worland AJ, 1996, EUPHYTICA, V89, P49, DOI 10.1007/BF00015718; Xin Z.Y., 1995, P 8 INT WHEAT GENETI, P19; Xue SL, 2008, THEOR APPL GENET, V117, P181, DOI 10.1007/s00122-008-0764-9; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Yoshida T, 2010, THEOR APPL GENET, V120, P543, DOI 10.1007/s00122-009-1174-3; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang KP, 2009, GENETICA, V135, P257, DOI 10.1007/s10709-008-9274-6; Zhou W, 2013, CROP SCI, V53, P1555, DOI 10.2135/cropsci2012.05.0287	69	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147377	10.1371/journal.pone.0147377	http://dx.doi.org/10.1371/journal.pone.0147377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848576	Green Published, gold			2022-12-26	WOS:000369554000014
J	Endres, HG; Kaufmann-Kolle, P; Steeb, V; Bauer, E; Bottner, C; Thurmann, P				Endres, Heinz G.; Kaufmann-Kolle, Petra; Steeb, Valerie; Bauer, Erik; Boettner, Caroline; Thuermann, Petra			Association between Potentially Inappropriate Medication (PIM) Use and Risk of Hospitalization in Older Adults: An Observational Study Based on Routine Data Comparing PIM Use with Use of PIM Alternatives	PLOS ONE			English	Article							BEERS CRITERIA; POLYPHARMACY; POPULATION; MANAGEMENT; PEOPLE; IMPACT; DRUGS	Objective The safety of potentially inappropriate medications (PIMs) in elderly patients is still debated. Using the PRISCUS list, we examined the incident all-cause hospitalization risk associated with PIMs compared to PIM alternatives during the 180 days post individual first pharmacy dispensing (index date). Methods Routine claims data from a German health insurer on 392,337 ambulatory patients aged >= 65 years, were used to estimate adjusted hazard ratios (HRs) for hospitalization associated with incident PIM use. Observation period was January 2009-December 2010. Users of PIM alternatives, as defined by the PRISCUS list, were the reference group. Patients with PIM dispensing or hospital stay in a six month "washout" period (second half of 2008) were excluded. All potential confounders were determined in the half year before the individual index date. Results In the total cohort 60.7% were female. Median age was 73 years. Of 79,041 incident PIM users, 58.4% had PIMs dispensed in one quarter of 2009 or 2010, 19.3% in two quarters, and 22.3% in three or more quarters. There were 126,535 hospitalizations during the observation period, and 47,470 of them occurred within 180 days post first dispensing. Multivariable Cox regression analysis revealed PIM use as a significant risk factor for hospitalization (HR 1.378; 95% CI 1.349-1.407) compared to use of PIM alternatives. Conclusions PIM use compared to use of PIM alternatives is associated with an increased risk of all-cause hospitalization in the 180 days following individual index date. Future analyses comparing a single PIM with its corresponding alternative may help identify those PIMs responsible for this.	[Endres, Heinz G.; Kaufmann-Kolle, Petra; Steeb, Valerie; Bauer, Erik; Boettner, Caroline] AQUA Inst Goettingen, Gottingen, Germany; [Thuermann, Petra] Univ Witten Herdecke, Chair Clin Pharmacol, Fac Hlth, Witten, Germany	Witten Herdecke University	Endres, HG (corresponding author), AQUA Inst Goettingen, Gottingen, Germany.	heinz.endres@aqua-institut.de		Thurmann, Petra/0000-0001-9724-1422				Albert SM, 2010, DRUG AGING, V27, P407, DOI 10.2165/11315990-000000000-00000; Amann U, 2012, DTSCH ARZTEBL INT, V109, P69, DOI 10.3238/arztebl.2012.0069; Bauer TK, 2012, PHARMACOEPIDEM DR S, V21, P1321, DOI 10.1002/pds.3357; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Benetos A, 2015, JAMA-J AM MED ASSOC, V314, P170, DOI 10.1001/jama.2015.7517; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Chang CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094350; Eggli Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-25; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fromm MF, 2013, EUR J CLIN PHARMACOL, V69, P975, DOI 10.1007/s00228-012-1425-0; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Hamar GB, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0834-z; Hamilton H, 2011, ARCH INTERN MED, V171, P1013, DOI 10.1001/archinternmed.2011.215; Henschel Frank, 2015, Drugs Real World Outcomes, V2, P249; Holt S, 2010, DTSCH ARZTEBL INT, V107, P543, DOI 10.3238/arztebl.2010.0543; Jano E, 2007, ANN PHARMACOTHER, V41, P438, DOI 10.1345/aph.1H473; Laroche ML, 2007, BRIT J CLIN PHARMACO, V63, P177, DOI 10.1111/j.1365-2125.2006.02831.x; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; McLeod PJ, 1997, CAN MED ASSOC J, V156, P385; Narayan Sujita W, 2015, Drugs Real World Outcomes, V2, P137; Price SD, 2014, DRUG AGING, V31, P311, DOI 10.1007/s40266-014-0164-6; Prinja Shankar, 2010, Indian J Community Med, V35, P217, DOI 10.4103/0970-0218.66859; Reich O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105425; Renom-Guiteras A, 2015, EUR J CLIN PHARMACOL, V71, P861, DOI 10.1007/s00228-015-1860-9; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schubert I, 2013, PHARMACOEPIDEM DR S, V22, P719, DOI 10.1002/pds.3429; Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324; Zimmermann T, 2013, BUNDESGESUNDHEITSBLA, V56, P941, DOI 10.1007/s00103-013-1767-5	28	53	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146811	10.1371/journal.pone.0146811	http://dx.doi.org/10.1371/journal.pone.0146811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840396	gold, Green Submitted, Green Published			2022-12-26	WOS:000369550200016
J	Kinstlinger, IS; Bastian, A; Paulsen, SJ; Hwang, DH; Ta, AH; Yalacki, DR; Schmidt, T; Miller, JS				Kinstlinger, Ian S.; Bastian, Andreas; Paulsen, Samantha J.; Hwang, Daniel H.; Ta, Anderson H.; Yalacki, David R.; Schmidt, Tim; Miller, Jordan S.			Open-Source Selective Laser Sintering (OpenSLS) of Nylon and Biocompatible Polycaprolactone	PLOS ONE			English	Article							TRICALCIUM PHOSPHATE SCAFFOLDS; IN-VITRO; OSTEOGENIC-DIFFERENTIATION; MECHANICAL-PROPERTIES; SURFACE-ROUGHNESS; POROUS SCAFFOLD; STEM-CELLS; STEREOLITHOGRAPHY; FABRICATION; NETWORKS	Selective Laser Sintering (SLS) is an additive manufacturing process that uses a laser to fuse powdered starting materials into solid 3D structures. Despite the potential for fabrication of complex, high-resolution structures with SLS using diverse starting materials (including biomaterials), prohibitive costs of commercial SLS systems have hindered the wide adoption of this technology in the scientific community. Here, we developed a low-cost, open-source SLS system (OpenSLS) and demonstrated its capacity to fabricate structures in nylon with sub-millimeter features and overhanging regions. Subsequently, we demonstrated fabrication of polycaprolactone (PCL) into macroporous structures such as a diamond lattice. Widespread interest in using PCL for bone tissue engineering suggests that PCL lattices are relevant model scaffold geometries for engineering bone. SLS of materials with large powder grain size (similar to 500 mu m) leads to part surfaces with high roughness, so we further introduced a simple vapor-smoothing technique to reduce the surface roughness of sintered PCL structures which further improves their elastic modulus and yield stress. Vapor-smoothed PCL can also be used for sacrificial templating of perfusable fluidic networks within orthogonal materials such as poly(dimethylsiloxane) silicone. Finally, we demonstrated that human mesenchymal stem cells were able to adhere, survive, and differentiate down an osteogenic lineage on sintered and smoothed PCL surfaces, suggesting that OpenSLS has the potential to produce PCL scaffolds useful for cell studies. OpenSLS provides the scientific community with an accessible platform for the study of laser sintering and the fabrication of complex geometries in diverse materials.	[Kinstlinger, Ian S.; Bastian, Andreas; Paulsen, Samantha J.; Hwang, Daniel H.; Ta, Anderson H.; Yalacki, David R.; Miller, Jordan S.] Rice Univ, Dept Bioengn, Houston, TX USA; [Schmidt, Tim] Lansing Makers Network, Lansing, MI USA	Rice University	Miller, JS (corresponding author), Rice Univ, Dept Bioengn, Houston, TX USA.	jmil@rice.edu		Kinstlinger, Ian/0000-0002-7335-6644	John S. Dunn Collaborative Research Award of the Gulf Coast Consortia; Cancer Prevention Research Institute of Texas [RP120713-P2]	John S. Dunn Collaborative Research Award of the Gulf Coast Consortia; Cancer Prevention Research Institute of Texas	This work was supported by a 2013 John S. Dunn Collaborative Research Award of the Gulf Coast Consortia and the Cancer Prevention Research Institute of Texas (RP120713-P2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centenero SAH, 2012, J CRANIO MAXILL SURG, V40, P162, DOI 10.1016/j.jcms.2011.03.014; Agarwala M, 1995, RAPID PROTOTYPING J, V1, P26, DOI 10.1108/13552549510078113; [Anonymous], 2015, SCI TRANSL MED; [Anonymous], 2008, P 3 INT C POL MOULDS; Antonov EN, 2006, LASER PHYS, V16, P774, DOI 10.1134/S1054660X06050070; Arcaute K, 2006, ANN BIOMED ENG, V34, P1429, DOI 10.1007/s10439-006-9156-y; Arcaute K, 2010, ACTA BIOMATER, V6, P1047, DOI 10.1016/j.actbio.2009.08.017; Beaman J. J., 1990, U.S. Patent, Patent No. [4938816A, 4938816, US4938816A]; Berman B, 2012, BUS HORIZONS, V55, P155, DOI 10.1016/j.bushor.2011.11.003; Berry E, 1997, MED ENG PHYS, V19, P90, DOI 10.1016/S1350-4533(96)00039-2; Bertassoni LE, 2014, LAB CHIP, V14, P2202, DOI 10.1039/c4lc00030g; Bertrand P, 2007, APPL SURF SCI, V254, P989, DOI 10.1016/j.apsusc.2007.08.085; Bertsch A, 2000, RAPID PROTOTYPING J, V6, P259, DOI 10.1108/13552540010373362; Binder TM, 2000, J AM COLL CARDIOL, V35, P230, DOI 10.1016/S0735-1097(99)00498-2; Bugeda G, 1999, RAPID PROTOTYPING J, V5, P21, DOI 10.1108/13552549910251846; Campbell TA, 2013, TECHNOL INNOV, V15, P67, DOI 10.3727/194982413X13608676060655; Chen AA, 2011, P NATL ACAD SCI USA, V108, P11842, DOI 10.1073/pnas.1101791108; Chen TB, 2006, J MANUF SCI E-T ASME, V128, P299, DOI 10.1115/1.2122947; Childs T.H.C., 1994, CIRP ANN, V43, P163, DOI [10.1016/S0007-8506(07)62187-8, DOI 10.1016/S0007-8506(07)62187-8]; Chung H, 2010, J MECH SCI TECHNOL, V24, P241, DOI 10.1007/s12206-009-1141-6; Crump SS., 1992, United States Patent, Patent No. [No. 5,121,329A, 5121329, 5,121,329]; D'Urso PS, 2000, BRIT J PLAST SURG, V53, P200, DOI 10.1054/bjps.1999.3268; Deckard CR, 1989, United States Patent, Patent No. [US4863538A, 4863538, 4,863,538]; Dhariwala B, 2004, TISSUE ENG, V10, P1316, DOI 10.1089/1076327042500256; Doyle H, 2014, ANN BIOMED ENG, V42, P661, DOI 10.1007/s10439-013-0913-4; Ejaz F, 2014, RAPID PROTOTYPING J, V20, P336, DOI 10.1108/RPJ-11-2012-0105; Eosoly S, 2010, ACTA BIOMATER, V6, P2511, DOI 10.1016/j.actbio.2009.07.018; Eshraghi S, 2010, ACTA BIOMATER, V6, P2467, DOI 10.1016/j.actbio.2010.02.002; Faia-Torres AB, 2014, BIOMATERIALS, V35, P9023, DOI 10.1016/j.biomaterials.2014.07.015; Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029; Goodridge RD, 2007, ACTA BIOMATER, V3, P221, DOI 10.1016/j.actbio.2006.10.005; Gu DD, 2009, MATER DESIGN, V30, P2903, DOI 10.1016/j.matdes.2009.01.013; Hao L, 2007, P ROY SOC A-MATH PHY, V463, P1857, DOI 10.1098/rspa.2007.1854; Hockaday LA, 2014, 3D PRINT ADDIT MANUF, V1, P122, DOI 10.1089/3dp.2014.0018; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037; Hull CW, 1986, US Patent, Patent No. [4575330A, 4575330, 4,575,330]; Jacobs Stephan, 2008, Interact Cardiovasc Thorac Surg, V7, P6, DOI 10.1510/icvts.2007.156588; Karuppuswamy P, 2015, MATER LETT, V141, P180, DOI 10.1016/j.matlet.2014.11.044; Kaveh K, 2011, J ANIM VET ADV, V10, P2317, DOI 10.3923/javaa.2011.2317.2330; Khajavi SH, 2014, COMPUT IND, V65, P50, DOI 10.1016/j.compind.2013.07.008; Kim MP, 2015, INT J SURG CASE REP, V16, P127, DOI 10.1016/j.ijscr.2015.09.037; Kolan KCR, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/025004; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Kruth J., 2010, P 16 INT S EL, V16; Kruth JP, 2007, CIRP ANN-MANUF TECHN, V56, P730, DOI 10.1016/j.cirp.2007.10.004; Kruth JP, 2004, J MATER PROCESS TECH, V149, P616, DOI 10.1016/j.jmatprotec.2003.11.051; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Layerwise 3D Systems, ADD MAN EN INN SHOCK; Leiggener C, 2009, INT J ORAL MAX SURG, V38, P187, DOI 10.1016/j.ijom.2008.11.026; Liao HT, 2011, VIRTUAL PHYS PROTOTY, V6, P57, DOI 10.1080/17452759.2011.559742; Lohfeld S., 2010, Journal of Biomedical Science & Engineering, V3, P138, DOI 10.4236/jbise.2010.32019; Madurantakam PA, 2009, BIOMATERIALS, V30, P5456, DOI 10.1016/j.biomaterials.2009.06.043; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Murr LE, 2010, PHILOS T R SOC A, V368, P1999, DOI 10.1098/rsta.2010.0010; Myers JG, 2001, ANN BIOMED ENG, V29, P109, DOI 10.1114/1.1349703; Partee B, 2006, J MANUF SCI E-T ASME, V128, P531, DOI 10.1115/1.2162589; Pereira TF, 2012, VIRTUAL PHYS PROTOTY, V7, P275, DOI 10.1080/17452759.2012.738551; Pham DT, 1998, INT J MACH TOOL MANU, V38, P1257, DOI 10.1016/S0890-6955(97)00137-5; Pham DT, 1999, P I MECH ENG B-J ENG, V213, P435, DOI 10.1243/0954405991516912; Rai B, 2010, BIOMATERIALS, V31, P7960, DOI 10.1016/j.biomaterials.2010.07.001; Roszelle BN, 2013, NEURORADIOLOGY, V55, P751, DOI 10.1007/s00234-013-1169-2; Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8; Saggiomo V, 2015, ADV SCI, V2, DOI 10.1002/advs.201500125; Salerno A, 2009, ACTA BIOMATER, V5, P1082, DOI 10.1016/j.actbio.2008.10.012; Salmoria GV, 2014, ADV MECH ENG, DOI 10.1155/2014/640496; Salmoria GV, 2012, POLYM TEST, V31, P411, DOI 10.1016/j.polymertesting.2011.12.006; Sharaf B, 2012, J ORAL MAXIL SURG, V70, P647, DOI 10.1016/j.joms.2011.07.029; Shirazi SFS, 2015, SCI TECHNOL ADV MAT, V16, DOI 10.1088/1468-6996/16/3/033502; Shuai CJ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285703; Simchi A, 2003, J MATER PROCESS TECH, V141, P319, DOI 10.1016/S0924-0136(03)00283-8; Tan KH, 2003, BIOMATERIALS, V24, P3115, DOI 10.1016/S0142-9612(03)00131-5; Tarafder S, 2014, ACS APPL MATER INTER, V6, P9955, DOI 10.1021/am501048n; Thadavirul N, 2014, J BIOMED MATER RES A, V102, P3379, DOI 10.1002/jbm.a.35010; Therriault D, 2003, NAT MATER, V2, P265, DOI 10.1038/nmat863; Trachtenberg JE, 2014, J BIOMED MATER RES A, V102, P4326, DOI 10.1002/jbm.a.35108; Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057; Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008; Wittbrodt BT, 2013, MECHATRONICS, V23, P713, DOI 10.1016/j.mechatronics.2013.06.002; Wong Kaufui V., 2012, ISRN Mechanical Engineering, DOI 10.5402/2012/208760; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002; Wurm G, 2004, SURG NEUROL, V62, P510, DOI 10.1016/j.surneu.2004.01.025; Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004; Zhou LJ, 2012, BIOMATERIALS, V33, P2734, DOI 10.1016/j.biomaterials.2011.11.009; Zhou WY, 2008, J MATER SCI-MATER M, V19, P2535, DOI 10.1007/s10856-007-3089-3; Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319; Zorlutuna P, 2011, ADV FUNCT MATER, V21, P3642, DOI 10.1002/adfm.201101023	88	54	59	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147399	10.1371/journal.pone.0147399	http://dx.doi.org/10.1371/journal.pone.0147399			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841023	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200037
J	Saif, Z; Dyson, RM; Palliser, HK; Wright, IMR; Lu, N; Clifton, VL				Saif, Zarqa; Dyson, Rebecca M.; Palliser, Hannah K.; Wright, Ian M. R.; Lu, Nick; Clifton, Vicki L.			Identification of Eight Different Isoforms of the Glucocorticoid Receptor in Guinea Pig Placenta: Relationship to Preterm Delivery, Sex and Betamethasone Exposure	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ANTENATAL BETAMETHASONE; TISSUE DISTRIBUTION; GESTATIONAL-AGE; MATERNAL ASTHMA; P-GLYCOPROTEIN; BIRTH-WEIGHT; FETAL SHEEP; FOLLOW-UP; EXPRESSION	The placental glucocorticoid receptor (GR) is central to glucocorticoid signalling and for mediating steroid effects on pathways associated with fetal growth and lung maturation but the GR has not been examined in the guinea pig placenta even though this animal is regularly used as a model of preterm birth and excess glucocorticoid exposure. Guinea pig dams received subcutaneous injections of either vehicle or betamethasone at 24 and 12 hours prior to preterm or term caesarean-section delivery. At delivery pup and organ weights were recorded. Placentae were dissected, weighed and analysed using Western blot to examine GR isoform expression in nuclear and cytoplasmic extracts. A comparative examination of the guinea pig GR gene identified it is capable of producing seven of the eight translational GR isoforms which include GRa-A, C1, C2, C3, D1, D2, and D3. GR alpha-B is not produced in the Guinea Pig. Total GR antibody identified 10 specific bands from term (n = 29) and preterm pregnancies (n = 27). Known isoforms included GR., GRa A, GR beta, GRP, GRA and GRa D1-3. There were sex and gestational age differences in placental GR isoform expression. Placental GRa A was detected in the cytoplasm of all groups but was significantly increased in the cytoplasm and nucleus of preterm males and females exposed to betamethasone and untreated term males (KW-ANOVA, P = 0.0001, P = 0.001). Cytoplasmic expression of GR beta was increased in female preterm placentae and preterm and term male placentae exposed to betamethasone (P = 0.01). Nuclear expression of GR beta was increased in all placentae exposed to betamethasone (P = 0.0001). GRa D2 and GRa D3 were increased in male preterm placentae when exposed to betamethasone (P = 0.01, P = 0.02). The current data suggests the sex-specific placental response to maternal betamethasone may be dependent on the expression of a combination of GR isoforms.	[Saif, Zarqa; Clifton, Vicki L.] Univ Queensland, Mater Med Res Inst, Brisbane, Qld, Australia; [Saif, Zarqa; Clifton, Vicki L.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia; [Dyson, Rebecca M.; Palliser, Hannah K.; Wright, Ian M. R.] Mothers & Babies Res Ctr, New Lambton Hts, NSW 2305, Australia; [Dyson, Rebecca M.; Palliser, Hannah K.; Wright, Ian M. R.] Hunter Med Res Inst, New Lambton Hts, NSW 2305, Australia; [Dyson, Rebecca M.; Palliser, Hannah K.; Wright, Ian M. R.] Univ Newcastle, Fac Hlth, Callaghan, NSW 2308, Australia; [Dyson, Rebecca M.; Wright, Ian M. R.] Univ Wollongong, Grad Sch Med, Wollongong, NSW 2522, Australia; [Dyson, Rebecca M.; Wright, Ian M. R.] Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Lu, Nick] Northwestern Univ, Dept Med, Div Allergy Immunol, Chicago, IL 60611 USA	Mater Research; University of Queensland; Robinson Research Institute; University of Adelaide; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Wollongong; University of Wollongong; Northwestern University	Clifton, VL (corresponding author), Univ Queensland, Mater Med Res Inst, Brisbane, Qld, Australia.; Clifton, VL (corresponding author), Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia.	Vicki.clifton@mater.uq.edu.au	saif, zarqa/V-3562-2018; Clifton, Vicki/A-1445-2012; Clifton, Vicki/AAV-2749-2021; Saif, Zarqa/AAE-8327-2020	saif, zarqa/0000-0002-2916-1428; Clifton, Vicki/0000-0002-4892-6748; Clifton, Vicki/0000-0002-4892-6748; Saif, Zarqa/0000-0002-2916-1428; Palliser, Hannah/0000-0001-5783-9737; Dyson, Rebecca/0000-0003-2319-6897; Wright, Ian/0000-0001-5337-0134	National Health and Medical Research Council [APP1041918]; Hunter Children's Research Foundation; National Institute of Allergy and Infectious Diseases [R21AI113935]; National Heart, Lung, and Blood Institute [R37HL068546]; John Hunter Hospital Charitable Trust; University of Adelaide; Mater Medical Research Institute-University of Queensland; Translational Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL068546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113935] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Hunter Children's Research Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); John Hunter Hospital Charitable Trust; University of Adelaide; Mater Medical Research Institute-University of Queensland; Translational Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	VC's salary is funded by the National Health and Medical Research Council senior Research Fellowship (APP1041918). RD was supported by the Hunter Children's Research Foundation. NL is funded by National Institute of Allergy and Infectious Diseases (R21AI113935) National Heart, Lung, and Blood Institute (R37HL068546). Animal work was funded by project grants from the John Hunter Hospital Charitable Trust awarded to IMRW, HKP, and RMD. This research work was funded by the University of Adelaide, Mater Medical Research Institute-University of Queensland and Translational Research Institute.	[Anonymous], 1985, N ENGL J MED, V313, P517; Beger C, 2003, BRIT J HAEMATOL, V122, P245, DOI 10.1046/j.1365-2141.2003.04426.x; Braun T, 2014, REPROD SCI; Crowther CA, 2007, NEW ENGL J MED, V357, P1179, DOI 10.1056/NEJMoa071152; Crudo A, 2012, ENDOCRINOLOGY, V153, P3269, DOI 10.1210/en.2011-2160; Dalziel SR, 2006, THORAX, V61, P678, DOI 10.1136/thx.2005.051763; Dalziel SR, 2007, INT J EPIDEMIOL, V36, P907, DOI 10.1093/ije/dym067; Dalziel SR, 2007, DEV MED CHILD NEUROL, V49, P597, DOI 10.1111/j.1469-8749.2007.00597.x; Dalziel SR, 2006, J BONE MINER RES, V21, P1175, DOI 10.1359/JBMR.060516; Dunn E, 2010, J PHYSIOL-LONDON, V588, P887, DOI 10.1113/jphysiol.2009.182139; Gatford KL, 2008, AM J PHYSIOL-ENDOC M, V295, pE170, DOI 10.1152/ajpendo.00047.2008; Haarman EG, 2004, LEUKEMIA, V18, P530, DOI 10.1038/sj.leu.2403225; Hodyl NA, 2013, PLACENTA, V34, P325, DOI 10.1016/j.placenta.2013.01.013; Hodyl NA, 2010, THORAX, V65, P677, DOI 10.1136/thx.2009.123091; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; Jobe AH, 1998, PEDIATRICS, V102, P1116, DOI 10.1542/peds.102.5.1116; Jobe AH, 2003, AM J OBSTET GYNECOL, V188, P22, DOI 10.1067/mob.2003.61; KEIGHTLEY MC, 1995, STEROIDS, V60, P87, DOI 10.1016/0039-128X(94)00014-4; KRAFT N, 1979, ENDOCRINOLOGY, V104, P344, DOI 10.1210/endo-104-2-344; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Mathai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081840; Mathai S, 2012, DIABETES, V61, P2479, DOI 10.2337/db11-1672; Matthews S G, 2001, Semin Neonatol, V6, P309, DOI 10.1053/siny.2001.0066; Moss TJM, 2003, J SOC GYNECOL INVEST, V10, P474, DOI 10.1016/S1071-5576(03)00152-7; Murphy VE, 2003, AM J RESP CRIT CARE, V168, P1317, DOI 10.1164/rccm.200303-374OC; Murphy VE, 2003, PLACENTA, V24, P739, DOI 10.1016/S0143-4004(03)00103-6; Palliser HK, 2010, REPROD SCI, V17, P776, DOI 10.1177/1933719110371517; Saif Z, 2015, PLACENTA, V36, P723, DOI 10.1016/j.placenta.2015.05.001; Saif Z, 2014, PLACENTA, V35, P260, DOI 10.1016/j.placenta.2014.01.012; Sampath-Kumar R, 1998, BIOL REPROD, V59, P1378, DOI 10.1095/biolreprod59.6.1378; Soo PS, 2012, REPROD TOXICOL, V33, P374, DOI 10.1016/j.reprotox.2012.01.013; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; Turner JD, 2007, ANN NY ACAD SCI, V1095, P334, DOI 10.1196/annals.1397.037; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001	35	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148226	10.1371/journal.pone.0148226	http://dx.doi.org/10.1371/journal.pone.0148226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840867	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000369550200101
J	Seppelt, PC; Schwill, S; Weymann, A; Arif, R; Weber, A; Zaradzki, M; Richter, K; Ensminger, S; Robinson, PN; Wagner, AH; Karck, M; Kallenbach, K				Seppelt, Philipp Christian; Schwill, Simon; Weymann, Alexander; Arif, Rawa; Weber, Antje; Zaradzki, Marcin; Richter, Karsten; Ensminger, Stephan; Robinson, Peter Nicholas; Wagner, Andreas H.; Karck, Matthias; Kallenbach, Klaus			Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe Inflammation after Adenoviral Gene Therapy	PLOS ONE			English	Article							MUSCLE-CELL MIGRATION; MOLECULAR-MECHANISMS; NEOINTIMA FORMATION; TISSUE INHIBITOR; VEIN GRAFTS; MOUSE MODEL; OVEREXPRESSION; ANEURYSM; TIMP-1	Objectives Marfan syndrome is an autosomal dominant inherited disorder of connective tissue. The vascular complications of Marfan syndrome have the biggest impact on life expectancy. The aorta of Marfan patients reveals degradation of elastin layers caused by increased proteolytic activity of matrix metalloproteinases (MMPs). In this study we performed adenoviral gene transfer of human tissue inhibitor of matrix metalloproteinases-1 (hTIMP-1) in aortic grafts of fibrillin-1 deficient Marfan mice (mgR/mgR) in order to reduce elastolysis. Methods We performed heterotopic infrarenal transplantation of the thoracic aorta in female mice (n = 7 per group). Before implantation, mgR/mgR and wild-type aortas (WT, C57BL/6) were transduced ex vivo with an adenoviral vector coding for human TIMP-1 (Ad.hTIMP-1) or beta-galactosidase (Ad.beta-Gal). As control mgR/mgR and wild-type aortas received no gene therapy. Thirty days after surgery, overexpression of the transgene was assessed by immunohistochemistry (IHC) and collagen in situ zymography. Histologic staining was performed to investigate inflammation, the neointimal index (NI), and elastin breaks. Endothelial barrier function of native not virus-exposed aortas was evaluated by perfusion of fluorescent albumin and examinations of virus-exposed tissue were performed by transmission electron microscopy (TEM). Results IHC and ISZ revealed sufficient expression of the transgene. Severe cellular inflammation and intima hyperplasia were seen only in adenovirus treated mgR/mgR aortas (Ad.beta-Gal, Ad.hTIMP-1 NI: 0.23; 0.43), but not in native and Ad.hTIMP-1 treated WT (NI: 0.01; 0.00). Compared to native mgR/mgR and Ad.hTIMP-1 treated WT aorta, the NI is highly significant greater in Ad.hTIMP-1 transduced mgR/mgR aorta (p = 0.001; p = 0.001). As expected, untreated Marfan grafts showed significant more elastolysis compared to WT (p = 0.001). However, elastolysis in Marfan aortas was not reduced by adenoviral overexpression of hTIMP-1 (compared to untreated Marfan aorta: Ad.hTIMP-1 p = 0.902; control Ad.beta-Gal. p = 0.165). The virus-untreated and not transplanted mgR/mgR aorta revealed a significant increase of albumin diffusion through the endothelial barrier (p = 0.037). TEM analysis of adenovirus-exposed mgR/mgR aortas displayed disruption of the basement membrane and basolateral space. Conclusions Murine Marfan aortic grafts developed severe inflammation after adenoviral contact. We demonstrated that fibrillin-1 deficiency is associated with relevant dysfunction of the endothelial barrier that enables adenovirus to induce vessel-harming inflammation. Endothelial dysfunction may play a pivotal role in the development of the vascular phenotype of Marfan syndrome.	[Seppelt, Philipp Christian; Schwill, Simon; Weymann, Alexander; Arif, Rawa; Weber, Antje; Zaradzki, Marcin; Karck, Matthias; Kallenbach, Klaus] Univ Heidelberg Hosp, Dept Cardiac Surg, Heidelberg, Germany; [Richter, Karsten] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Ensminger, Stephan] Clin Thorac & Cardiovasc Surg, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany; [Robinson, Peter Nicholas] Charite, Inst Med Genet & Human Genet, Berlin, Germany; [Robinson, Peter Nicholas] Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany; [Robinson, Peter Nicholas] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Wagner, Andreas H.] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Ruprecht Karls University Heidelberg	Seppelt, PC (corresponding author), Univ Heidelberg Hosp, Dept Cardiac Surg, Heidelberg, Germany.	Philipp.Seppelt@med.uni-heidelberg.de	Weymann, Alexander/AAQ-5115-2021; Ensminger, Stephan Prof. Dr./AAQ-2141-2021	Ensminger, Stephan Prof. Dr./0000-0002-9508-3261	Deutsche Forschungsgemeinschaft [KA 1169/3-1]; Deutsche Herzstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Herzstiftung	The work was supported by grant from the Deutsche Forschungsgemeinschaft (KA 1169/3-1), www.dfg.de. S. Schwill received personal funding from the Deutsche Herzstiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2007, STROKE, V38, P2337, DOI 10.1161/STROKEAHA.107.481838; Bode W, 1999, ANN NY ACAD SCI, V878, P73, DOI 10.1111/j.1749-6632.1999.tb07675.x; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; Fernandez HA, 1999, J SURG RES, V82, P156, DOI 10.1006/jsre.1998.5534; Fernandez HA, 1998, SURGERY, V124, P129, DOI 10.1016/S0039-6060(98)70112-6; Forough R, 1998, ARTERIOSCL THROM VAS, V18, P803, DOI 10.1161/01.ATV.18.5.803; George SJ, 2000, CIRCULATION, V101, P296, DOI 10.1161/01.CIR.101.3.296; George SJ, 1998, HUM GENE THER, V9, P867, DOI 10.1089/hum.1998.9.6-867; Guo G, 2011, PLOS ONE, V6, P7; Guo G, 2006, CIRCULATION, V114, P1855, DOI 10.1161/CIRCULATIONAHA.105.601674; Guo Gao, 2013, Aorta (Stamford), V1, P5, DOI 10.12945/j.aorta.2013.13.007; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Kallenbach K, 2003, ARTERIOSCL THROM VAS, V23, P1008, DOI 10.1161/01.ATV.0000069880.81136.38; Kallenbach K, 2008, CLIN RES CARDIOL, V97, pP110; Kallenbach K, 2007, ANN THORAC SURG, V83, pS764, DOI 10.1016/j.athoracsur.2006.10.097; Kallenbach K, 2009, J VASC SURG, V49, P750, DOI 10.1016/j.jvs.2008.11.001; Karck M, 2004, J THORAC CARDIOV SUR, V127, P391, DOI 10.1016/j.jtcvs.2003.07.049; Kroner ESJ, 2013, INT J CARDIOL, V167, P2977, DOI 10.1016/j.ijcard.2012.08.057; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Nasuno A, 2004, CARDIOVASC PATHOL, V13, P79, DOI 10.1016/s1054-8807(03)00137-6; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Newman KD, 1995, J CLIN INVEST, V96, P2955, DOI 10.1172/JCI118367; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Rigg AS, 2001, CANCER GENE THER, V8, P869, DOI 10.1038/sj.cgt.7700387; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Schwill S, 2013, J VASC SURG, V57, P1628, DOI 10.1016/j.jvs.2012.10.007; Sekhon BS, 2010, RES REP BIOL, V1, P1, DOI 10.2147/RRB.S12043; STERN DM, 1991, DIABETES CARE, V14, P160, DOI 10.2337/diacare.14.2.160; Subbotin VM, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-41; Walters RW, 1999, J BIOL CHEM, V274, P10219, DOI 10.1074/jbc.274.15.10219; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wilson DG, 1999, CIRCULATION, V99, P909, DOI 10.1161/01.CIR.99.7.909; Xiong W, 2008, J VASC SURG, V47, P166, DOI 10.1016/j.jvs.2007.09.016	38	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148012	10.1371/journal.pone.0148012	http://dx.doi.org/10.1371/journal.pone.0148012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840980	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200076
J	Zhao, YN; Wang, FZ; Zhang, XY; Zhang, SH; Guo, SL; Zhu, GP; Liu, Q; Li, M				Zhao, Yanni; Wang, Fengzhu; Zhang, Xinyue; Zhang, Suhua; Guo, Shilong; Zhu, Gengping; Liu, Qiang; Li, Min			Transcriptome and Expression Patterns of Chemosensory Genes in Antennae of the Parasitoid Wasp Chouioia cunea	PLOS ONE			English	Article							PHEROMONE-BINDING-PROTEINS; NEURON MEMBRANE-PROTEINS; ODORANT-BINDING; DIFFERENTIAL EXPRESSION; OLFACTORY RECEPTORS; MOLECULAR EVOLUTION; REGENERATING LEGS; DROSOPHILA; FAMILY; IDENTIFICATION	Chouioia cunea Yang is an endoparasitic wasp that attacks pupae of Hyphantria cunea (Drury), an invasive moth species that severely damages forests in China. Chemosensory systems of insects are used to detect volatile chemical odors such as female sex pheromones and host plant volatiles. The antennae of parasite wasps are important for host detection and other sensory-mediated behaviors. We identified and documented differential expression profiles of chemoreception genes in C. cunea antennae. A total of 25 OBPs, 80 ORs, 10 IRs, 11 CSP, 1 SNMPs, and 17 GRs were annotated from adult male and female C. cunea antennal transcriptomes. The expression profiles of 25 OBPs, 16 ORs, and 17 GRs, 5 CSP, 5 IRs and 1 SNMP were determined by RT-PCR and RT-qPCR for the antenna, head, thorax, and abdomen of male and female C. cunea. A total of 8 OBPs, 14 ORs, and 8 GRs, 1 CSP, 4 IRs and 1 SNMPs were exclusively or primarily expressed in female antennae. These female antennal-specific or dominant expression profiles may assist in locating suitable host and oviposition sites. These genes will provide useful targets for advanced study of their biological functions.	[Zhao, Yanni; Wang, Fengzhu; Zhang, Xinyue; Guo, Shilong; Zhu, Gengping; Liu, Qiang; Li, Min] Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Tianjin 300387, Peoples R China; [Zhang, Suhua] Nat Enemy Breeding Ctr Luohe Cent South Forestry, Luohe 462000, Henan, Peoples R China	Tianjin Normal University	Li, M (corresponding author), Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Tianjin 300387, Peoples R China.	skylm@mail.tjnu.edu.cn	Zhu, Gengping/CAF-4192-2022	Zhu, Gengping/0000-0001-6823-5840	Natural Science Foundation of China [31401962, 31201730]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the Natural Science Foundation of China (No. 31401962, No. 31201730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001319; Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson I, 1998, BIOINFORMATICS, V14, P349, DOI 10.1093/bioinformatics/14.4.349; Andersson MN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-501; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Barbarossa IT, 1998, ITAL J ZOOL, V65, P367, DOI 10.1080/11250009809386775; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bigiani A, 2005, REV PHYSIOL BIOCH P, V154, P1, DOI 10.1007/s10254-004-0038-0; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corcoran JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128596; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Fiala A, 2007, CURR OPIN NEUROBIOL, V17, P720, DOI 10.1016/j.conb.2007.11.009; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Gardiner A, 2008, MOL ECOL, V17, P1648, DOI 10.1111/j.1365-294X.2008.03713.x; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073524; Gu SH, 2013, J INSECT PHYSIOL, V59, P430, DOI 10.1016/j.jinsphys.2013.02.003; Gu SH, 2013, INSECT BIOCHEM MOLEC, V43, P237, DOI 10.1016/j.ibmb.2012.12.009; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Gu XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125159; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Jacquin-Joly E, 2004, J CHEM ECOL, V30, P2359, DOI 10.1007/s10886-004-7941-3; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jin X, 2005, CELL MOL LIFE SCI, V62, P1156, DOI 10.1007/s00018-005-5014-6; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Koenig C, 2015, INSECT BIOCHEM MOLEC, V66, P51, DOI 10.1016/j.ibmb.2015.09.007; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121504; Li ZQ, 2015, COMP BIOCHEM PHYS D, V15, P28, DOI 10.1016/j.cbd.2015.05.002; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Mamidala P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056555; McBride CS, 2007, GENETICS, V177, P1395, DOI 10.1534/genetics.107.078683; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; Nishimura O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050664; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Pitts RJ, 2014, P NATL ACAD SCI USA, V111, P2566, DOI 10.1073/pnas.1322923111; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Qu B. X., 1987, J NW COLL FOR, V2, P41; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Rogers ME, 2001, CELL TISSUE RES, V303, P433, DOI 10.1007/s004410000305; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Schoonhoven L. M., 2005, Insect-plant biology; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vinson SB, 1998, BIOL CONTROL, V11, P79, DOI 10.1006/bcon.1997.0601; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang SN, 2015, INT J BIOL SCI, V11, P737, DOI 10.7150/ijbs.11786; Wang ZF, 2015, CELL MOL LIFE SCI, V72, P4429, DOI 10.1007/s00018-015-2009-9; WANG ZP, 1995, INTEGRATED CONTROL T; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Wu ZZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129794; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu XiaoRui, 2013, Journal of Shenyang Agricultural University, V44, P42; YANG Z, 1989, Entomotaxonomia, V11, P117; Yang Z. Q., 1990, FOREST PEST DIS, V2, P17; Yang ZQ, 2006, BIOCONTROL, V51, P401, DOI 10.1007/s10526-006-9010-z; Yang Zhongqi, 1998, Chinese Journal of Biological Control, V14, P49; YANG ZQ, 1990, SCI SILVAE SINICAE, V31, P23; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang J, 2014, INSECT SCI IN PRESS, DOI [10.1111/1744-7917.12131, DOI 10.1111/1744-7917.12131]; Zhang J, 2015, INSECT SCI, V22, P399, DOI 10.1111/1744-7917.12131; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhao Yan-Ni, 2014, Chinese Journal of Applied Entomology, V51, P1026, DOI 10.7679/j.issn.2095-1353.2014.121; Zhou JingJiang, 2010, Outlooks on Pest Management, V21, P31, DOI 10.1564/21feb08; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x	105	39	45	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148159	10.1371/journal.pone.0148159	http://dx.doi.org/10.1371/journal.pone.0148159			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841106	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200089
J	Rocha, JN; Cohen, ND; Bordin, AI; Brake, CN; Giguere, S; Coleman, MC; Alaniz, RC; Lawhon, SD; Mwangi, W; Pillai, SD				Rocha, Joana N.; Cohen, Noah D.; Bordin, Angela I.; Brake, Courtney N.; Giguere, Steeve; Coleman, Michelle C.; Alaniz, Robert C.; Lawhon, Sara D.; Mwangi, Waithaka; Pillai, Suresh D.			Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equi	PLOS ONE			English	Article							MEDIATED IMMUNE-RESPONSES; HYPERIMMUNE PLASMA; ADULT HORSES; CLINICAL-MANIFESTATIONS; ENDEMIC INFECTIONS; NEONATAL FOALS; IGG SUBCLASSES; PNEUMONIA; IMMUNIZATION; VACCINE	There is currently no licensed vaccine that protects foals against Rhodococcus equi-induced pneumonia. Oral administration of live, virulent R. equi to neonatal foals has been demonstrated to protect against subsequent intrabronchial challenge with virulent R. equi. Electron beam (eBeam)-inactivated R. equi are structurally intact and have been demonstrated to be immunogenic when administered orally to neonatal foals. Thus, we investigated whether eBeam inactivated R. equi could protect foals against developing pneumonia after experimental infection with live, virulent R. equi. Foals (n = 8) were vaccinated by gavaging with eBeam-inactivated R. equi at ages 2, 7, and 14 days, or gavaged with equal volume of saline solution (n = 4), and subsequently infected intrabronchially with live, virulent R. equi at age 21 days. The proportion of vaccinated foals that developed pneumonia following challenge was similar among the vaccinated (7/8; 88%) and unvaccinated foals (3/4; 75%). This vaccination regimen did not appear to be strongly immunogenic in foals. Alternative dosing regimens or routes of administration need further investigation and may prove to be immunogenic and protective.	[Rocha, Joana N.; Cohen, Noah D.; Bordin, Angela I.; Brake, Courtney N.; Coleman, Michelle C.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA; [Giguere, Steeve] Univ Georgia, Coll Vet Med, Dept Large Anim Med, Athens, GA 30602 USA; [Alaniz, Robert C.] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA; [Lawhon, Sara D.; Mwangi, Waithaka] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Pillai, Suresh D.] Texas A&M Univ, IAEA Collaborat Ctr Electron Beam Technol, Natl Ctr Electron Beam Res, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; University System of Georgia; University of Georgia; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Cohen, ND (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA.; Pillai, SD (corresponding author), Texas A&M Univ, IAEA Collaborat Ctr Electron Beam Technol, Natl Ctr Electron Beam Res, College Stn, TX 77843 USA.	NCohen@cvm.tamu.edu; S-Pillai@tamu.edu	Lawhon, Sara D./G-5147-2011	Lawhon, Sara D./0000-0001-9154-8909	Grayson-Jockey Club Research Foundation; Link Equine Research Endowment; Texas AM University; University Libraries; Office of the Vice President for Research	Grayson-Jockey Club Research Foundation; Link Equine Research Endowment; Texas AM University; University Libraries; Office of the Vice President for Research	Funded by Grayson-Jockey Club Research Foundation (https://www.grayson-jockeyclub.org/) (Grant to NDC) and Link Equine Research Endowment (Support to NDC) The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research.	Ashour J, 2003, J BACTERIOL, V185, P2644, DOI 10.1128/JB.185.8.2644-2652.2003; Becu T, 1997, VET MICROBIOL, V56, P193, DOI 10.1016/S0378-1135(97)00088-6; Bordin AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105367; Bordin AI, 2012, VET IMMUNOL IMMUNOP, V145, P290, DOI 10.1016/j.vetimm.2011.11.012; Boyd NK, 2003, VET IMMUNOL IMMUNOP, V92, P75, DOI 10.1016/S0165-2427(03)00021-7; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; Burton AJ, 2015, EQUINE VET J, V47, P467, DOI 10.1111/evj.12309; Caston SS, 2006, VET THER, V7, P361; Cauchard J, 2004, VET MICROBIOL, V104, P73, DOI 10.1016/j.vetmic.2004.09.006; Chaffin M. K., 2013, Proceedings of the 59th Annual Convention of the American Association of Equine Practitioners, Nashville, Tennessee, USA, 7-11 December 2013, P267; Chaffin MK, 2008, JAVMA-J AM VET MED A, V232, P1035, DOI 10.2460/javma.232.7.1035; Chauhan O. P., 2015, ELECT BEAM PASTEURIZ, P157, DOI DOI 10.1533/9781782421085.2.157; CHIRINOTREJO JM, 1987, CAN J VET RES, V51, P444; Cohen ND, 2003, AM J VET RES, V64, P153, DOI 10.2460/ajvr.2003.64.153; Donecker JM, 2006, EFFICACY IMMUNOMODUL; Giguere S, 1999, INFECT IMMUN, V67, P3548; Giguere S, 1997, VET MICROBIOL, V56, P313, DOI 10.1016/S0378-1135(97)00099-0; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Giguere S, 2003, J AM VET MED ASSOC, V222, P775, DOI 10.2460/javma.2003.222.775; Giguere S, 2002, J AM VET MED ASSOC, V220, P59, DOI 10.2460/javma.2002.220.59; Giles C, 2015, EQUINE VET J, V47, P510, DOI 10.1111/evj.12310; Hooper-McGrevy KE, 2005, VACCINE, V23, P5760, DOI 10.1016/j.vaccine.2005.07.050; Hooper-McGrevy KE, 2003, CLIN DIAGN LAB IMMUN, V10, P345, DOI 10.1128/CDLI.10.3.345-351.2003; HURLEY JR, 1995, AUST VET J, V72, P418, DOI 10.1111/j.1751-0813.1995.tb06192.x; Jacks S, 2007, CLIN VACCINE IMMUNOL, V14, P669, DOI 10.1128/CVI.00042-07; Joller N, 2010, P NATL ACAD SCI USA, V107, P20441, DOI 10.1073/pnas.1013827107; Kohler AK, 2003, INFECT IMMUN, V71, P6329, DOI 10.1128/IAI.71.11.6329-6337.2003; Lewis MJ, 2008, MOL IMMUNOL, V45, P818, DOI 10.1016/j.molimm.2007.06.158; Lopez AM, 2002, CLIN DIAGN LAB IMMUN, V9, P1270, DOI 10.1128/CDLI.9.6.1270-1276.2002; MADIGAN JE, 1991, J REPROD FERTIL, P571; MARTENS RJ, 1989, EQUINE VET J, V21, P249, DOI 10.1111/j.2042-3306.1989.tb02161.x; Martens RJ, 1991, EQUINE VET J S, V12, P19; McQueen CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098710; Mealey RH, 2007, VACCINE, V25, P7582, DOI 10.1016/j.vaccine.2007.07.055; Muscatello G, 2012, VET J, V192, P20, DOI 10.1016/j.tvjl.2011.08.014; Pei Y, 2007, VET MICROBIOL, V125, P100, DOI 10.1016/j.vetmic.2007.05.007; Perkins GA, 2015, EQUINE VET J, V47, P267, DOI 10.1111/evj.12387; Phumoonna T, 2008, VACCINE, V26, P2457, DOI 10.1016/j.vaccine.2008.03.015; PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20, DOI 10.1128/CMR.4.1.20-34.1991; Prescott JF, 1997, AM J VET RES, V58, P356; Ryan C, 2010, CLIN VACCINE IMMUNOL, V17, P1896, DOI 10.1128/CVI.00328-10; Sanz M, 2013, VET MICROBIOL, V167, P623, DOI 10.1016/j.vetmic.2013.09.018; Sanz MG, 2016, EQUINE VET J, V48, P103, DOI 10.1111/evj.12363; Sanz MG, 2015, VET IMMUNOL IMMUNOP, V164, P10, DOI 10.1016/j.vetimm.2015.01.004; Sedlinska M, 2006, ACTA VET BRNO, V75, P175, DOI 10.2754/avb200675020175; Sturgill TL, 2011, VET IMMUNOL IMMUNOP, V141, P124, DOI 10.1016/j.vetimm.2011.01.015; Sturgill TL, 2014, VACCINE, V32, P1362, DOI 10.1016/j.vaccine.2014.01.032; TAKAI S, 1991, INFECT IMMUN, V59, P4056, DOI 10.1128/IAI.59.11.4056-4060.1991; Takai S, 1997, VET MICROBIOL, V56, P167, DOI 10.1016/S0378-1135(97)00085-0; Takai S., 1995, J EQUINE SCI, V6, P105; TKACHUKSAAD O, 1991, J CLIN MICROBIOL, V29, P2696, DOI 10.1128/JCM.29.12.2696-2700.1991; Venner M, 2007, RES VET SCI, V83, P311, DOI 10.1016/j.rvsc.2007.01.009; Venner M, 2012, VET J, V192, P293, DOI 10.1016/j.tvjl.2011.07.004; Wilson EM, 2009, J VET INTERN MED, V23, P323, DOI 10.1111/j.1939-1676.2008.0254.x; Witonsky S, 2010, EQUINE VET EDUC, V22, P400, DOI 10.1111/j.2042-3292.2010.00106.x; WOOLCOCK JB, 1987, VET MICROBIOL, V14, P215, DOI 10.1016/0378-1135(87)90108-8	56	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148111	10.1371/journal.pone.0148111	http://dx.doi.org/10.1371/journal.pone.0148111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828865	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200063
J	Xia, LF; Xie, HX; Yu, YJ; Zhou, H; Wang, T; Yan, JC				Xia, Longfei; Xie, Hongxiang; Yu, Yinjing; Zhou, Hong; Wang, Ting; Yan, Jinchuan			The Effects of NF-kappa B and c-Jun/AP-1 on the Expression of Prothrombotic and Proinflammatory Molecules Induced by Anti-beta(2)GPI in Mouse	PLOS ONE			English	Article							ENDOTHELIAL-CELL ACTIVATION; TISSUE FACTOR EXPRESSION; ANTIPHOSPHOLIPID ANTIBODY SYNDROME; GLYCOPROTEIN-I ANTIBODIES; SMOOTH-MUSCLE-CELLS; BETA(2)-GLYCOPROTEIN I; PROTEIN-KINASE; FACTOR GENE; SIGNALING PATHWAYS; GROWTH-FACTOR	Our previous data demonstrated that nuclear factor-kappa B (NF-kappa B) and activator protein-1 (AP-1) are involved in the process of anti-beta(2)GPI/beta(2)GPI-induced tissue factor (TF) expression in monocytes. However, the role of NF-kappa B and AP-1 in pathogenic mechanisms of antiphospholipid syndrome (APS) in vivo has been rarely studied. This study aimed to investigate whether NF-kappa B and c-Jun/AP-1 are involved in anti-beta(2)-GPI-induced expression of prothrombotic and proinflammatory molecules in mouse. IgG-APS or anti-beta(2)GPI antibodies were injected into BALB/c mice in the presence or absence of PDTC (a specific inhibitor of NF kappa B) and Curcumin (a potent inhibitor of AP-1) treatment. Our data showed that both IgGAPS and anti-beta(2)GPI could induce the activation of NF-kappa B and c-Jun/AP-1 in mouse peritoneal macrophages. The anti-beta(2)GPI-induced TF activity in homogenates of carotid arteries and peritoneal macrophages from mice could significantly decrease after PDTC and/or Curcumin treatment, in which PDTC showed the strongest inhibitory effect, but combination of two inhibitors had no synergistic effect. Furthermore, anti-beta(2)-GPI-induced expression of TF, VCAM-1, ICAM-1 and E-selectin in the aorta and expression of TF, IL-1 beta, IL-6 and TNF-alpha in peritoneal macrophages of mice were also significantly attenuated by PDTC and/or Curcumin treatment. These results indicate that both NF-kappa B and c-Jun/AP-1 are involved in regulating anti-beta(2)-GPI-induced expression of prothrombotic and proinflammatory molecules in vivo. Inhibition of NF-kappa B and c-Jun/AP-1 pathways may be beneficial for the prevention and treatment of thrombosis and inflammation in patients with APS.	[Xia, Longfei; Xie, Hongxiang; Yu, Yinjing; Zhou, Hong; Wang, Ting] Jiangsu Univ, Sch Med, Jiangsu Key Lab Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Zhou, Hong; Yan, Jinchuan] Affiliated Hosp Jiangsu Univ, Dept Cardiol, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Zhou, H (corresponding author), Jiangsu Univ, Sch Med, Jiangsu Key Lab Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China.; Zhou, H; Yan, JC (corresponding author), Affiliated Hosp Jiangsu Univ, Dept Cardiol, Zhenjiang, Jiangsu, Peoples R China.	hongzhou@ujs.edu.cn; yanjinchuan@hotmail.com			National Natural Science Foundation of China [81370614, 81170279]; Sci-Tech Innovation Team of Jiangsu Province [LJ201116]; Natural Science Foundation of Jiangsu Province, China [BK2011486]; Key Laboratory of Cardiovascular disease of Zhenjiang [SS2012002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sci-Tech Innovation Team of Jiangsu Province; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Key Laboratory of Cardiovascular disease of Zhenjiang	This project was supported by National Natural Science Foundation of China (no. 81370614) to Hong Zhou, Sci-Tech Innovation Team of Jiangsu Province (no. LJ201116), Natural Science Foundation of Jiangsu Province, China (BK2011486) and National Natural Science Foundation of China (81170279) and Key Laboratory of Cardiovascular disease of Zhenjiang (SS2012002) to Jinchuan Yan. The funders didn't play any role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Allen KL, 2012, BLOOD, V119, P884, DOI 10.1182/blood-2011-03-344671; Arad A, 2011, BLOOD, V117, P3453, DOI 10.1182/blood-2010-08-300715; Bierhaus A, 1997, THROMB HAEMOSTASIS, V77, P772; Bohgaki M, 2004, INT IMMUNOL, V16, P1633, DOI 10.1093/intimm/dxh166; Boles J, 2010, LUPUS, V19, P370, DOI 10.1177/0961203309360810; Borghi MO, 2014, LUPUS, V23, P1302, DOI 10.1177/0961203314536479; Cervera R, 2015, ANN RHEUM DIS, V74, P1011, DOI 10.1136/annrheumdis-2013-204838; Chabicovsky M, 2010, BASIC CLIN PHARMACOL, V107, P758, DOI 10.1111/j.1742-7843.2010.00573.x; Chaturvedi S, 2014, CURR OPIN HEMATOL, V21, P371, DOI 10.1097/MOH.0000000000000067; Clemens N, 2009, ANN NY ACAD SCI, V1173, P805, DOI 10.1111/j.1749-6632.2009.04632.x; Colasanti T, 2012, BLOOD, V120, P3360, DOI 10.1182/blood-2011-09-378851; de Larranaga GF, 2005, LUPUS, V14, P967, DOI 10.1191/0961203305lu2232cr; Dunoyer-Geindre S, 2002, THROMB HAEMOSTASIS, V88, P851, DOI 10.1055/s-0037-1613313; Efthymiou M, 2015, THROMB RES, V135, P1191, DOI 10.1016/j.thromres.2015.03.030; Erkan D, 2014, ANN RHEUM DIS, V73, P1176, DOI 10.1136/annrheumdis-2013-203622; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Guo DL, 2011, TUMOR BIOL, V32, P921, DOI 10.1007/s13277-011-0194-1; Jankowski M, 2003, BLOOD, V101, P157, DOI 10.1182/blood-2002-05-1310; Kappelmann M, 2014, EUR J CELL BIOL, V93, P76, DOI 10.1016/j.ejcb.2013.10.003; Ko WC, 2012, ACTA PHARMACOL SIN, V33, P49, DOI 10.1038/aps.2011.178; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM-US, V54, P301, DOI 10.1002/art.21549; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; Mackman N, 2006, BLOOD CELL MOL DIS, V36, P104, DOI 10.1016/j.bcmd.2005.12.008; MACKMAN N, 1995, FASEB J, V9, P883, DOI 10.1096/fasebj.9.10.7615158; Mehdi AA, 2010, EUR J CLIN INVEST, V40, P451, DOI 10.1111/j.1365-2362.2010.02281.x; Meng Z, 2013, ACTA PHARMACOL SIN, V34, P901, DOI 10.1038/aps.2013.24; Meroni PL, 2012, LUPUS, V21, P708, DOI 10.1177/0961203312438116; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Pierangeli SS, 1999, CIRCULATION, V99, P1997, DOI 10.1161/01.CIR.99.15.1997; PIERANGELI SS, 1995, THROMB HAEMOSTASIS, V74, P1361; Raschi E, 2008, LUPUS, V17, P937, DOI 10.1177/0961203308095140; Raschi E, 2003, BLOOD, V101, P3495, DOI 10.1182/blood-2002-08-2349; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Seol DW, 2000, ONCOGENE, V19, P1132, DOI 10.1038/sj.onc.1203404; Seshan SV, 2009, BLOOD, V114, P1675, DOI 10.1182/blood-2009-01-199117; Sorice M, 2007, ARTHRITIS RHEUM-US, V56, P2687, DOI 10.1002/art.22802; Vaiopoulos AG, 2010, INT J BIOCHEM CELL B, V42, P1061, DOI 10.1016/j.biocel.2010.03.018; Vega-Ostertag M, 2005, ARTHRITIS RHEUM-US, V52, P1545, DOI 10.1002/art.21009; Vega-Ostertag ME, 2007, J THROMB HAEMOST, V5, P1828, DOI 10.1111/j.1538-7836.2007.02680.x; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Williams FMK, 2000, THROMB HAEMOSTASIS, V84, P742; Willis R, 2013, ANN NY ACAD SCI, V1285, P44, DOI 10.1111/nyas.12080; Xia LF, 2013, THROMB HAEMOSTASIS, V109, P643, DOI 10.1160/TH12-09-0655; Xie HX, 2014, BRIT J HAEMATOL, V164, P165, DOI 10.1111/bjh.12587; Xie HX, 2013, MOL IMMUNOL, V53, P246, DOI 10.1016/j.molimm.2012.08.012; Zhang JW, 2005, BLOOD, V105, P1964, DOI 10.1182/blood-2004-05-1708; Zhang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107634; Zhou H, 2013, THROMB RES, V132, P742, DOI 10.1016/j.thromres.2013.09.039; Zhou H, 2007, CELL RES, V17, P737, DOI 10.1038/cr.2007.33	49	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147958	10.1371/journal.pone.0147958	http://dx.doi.org/10.1371/journal.pone.0147958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829121	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200048
J	Bartels, K; Mayes, LM; Dingmann, C; Bullard, KJ; Hopfer, CJ; Binswanger, IA				Bartels, Karsten; Mayes, Lena M.; Dingmann, Colleen; Bullard, Kenneth J.; Hopfer, Christian J.; Binswanger, Ingrid A.			Opioid Use and Storage Patterns by Patients after Hospital Discharge following Surgery	PLOS ONE			English	Article							ABUSE; RATES	Introduction Opioid-based analgesic therapy represents a cornerstone of pain management after surgery. The recent rise in opioid sales and opioid overdoses suggests it is important to maximize the safety of opioid prescribing after surgery. Given that patients may live with other family members in the home, safe storage and appropriate disposal of excess opioids after hospital discharge are necessary to prevent unintended secondary exposures. Identifying characteristics of patients who are likely to be prescribed excess opioids after surgery may enable more targeted prescription practices and safety interventions. Our study aimed to elucidate patient-reported opioid use patterns and modes of home storage of opioids among patients discharged home after Cesarean section (C-section) and thoracic surgery. Specifically, we sought to identify characteristics of patients who reported using about half or more versus less of the opioids prescribed to them for use after hospital discharge. Methods For this cohort study, we developed a survey on quality of analgesia following hospital discharge, amounts of opioids taken relative to the amount prescribed, reasons for not taking all prescribed medications, and storage and disposal methods for leftover opioids. Adult patients, who had C-section or thoracic surgery at a tertiary academic medical center, were given a web-based self-administered survey after discharge. Descriptive statistics (means and standard deviations, proportions) were used to describe the study sample and survey results. Comparisons between patients who reported taking about half or more versus less of the opioids prescribed to them for use after hospital discharge were made using unpaired t-tests, Mann-Whitney tests, and Chi-square tests as appropriate. Results The majority (53%) of respondents after C-section (N = 30) reported taking either no or very few (less than 5) prescribed opioid pills; 83% reported taking half or less; and 17% of women, reported taking all or nearly all (5 or fewer pills left over) of their opioid prescription. In a cohort of patients after thoracic surgery (n = 31) 45% reported taking either no or very few (5 or less) prescribed opioid pills; 71% reported taking half or less; and 29% of patients reported taking all or nearly all (5 or fewer pills left over) of their opioid prescription. In both cohorts, use of opioids while hospitalized was higher in the group reporting using about half or more of prescribed opioids after discharge. Leftover opioids were stored in an unlocked location in 77% and 73% of cases following C-section and thoracic surgery, respectively. Conclusion Our findings from surveys in two distinct patient populations at a single academic medical center suggest that current opioid prescribing practices for pain management at hospital discharge following Cesarean section and thoracic surgery may not account for individual patients' analgesic requirements. Excess opioid pills are commonly stored in unsecured locations and represent a potential source for non-medical opioid use and associated morbidity and mortality in patients and their families. Research to develop goal-directed and patient-centered post-discharge opioid prescription practices and encourage opioid safety practices after surgery is needed.	[Bartels, Karsten; Dingmann, Colleen; Bullard, Kenneth J.] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA; [Mayes, Lena M.] Childrens Hosp Colorado, Dept Anesthesiol, Aurora, CO USA; [Hopfer, Christian J.; Binswanger, Ingrid A.] Univ Colorado Denver, Dept Psychiat, Div Substance Dependence, Aurora, CO USA; [Binswanger, Ingrid A.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA; [Binswanger, Ingrid A.] Univ Colorado Denver, Dept Med, Div Gen Internal Med, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bartels, K (corresponding author), Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA.	karsten.bartels@ucdenver.edu	Binswanger, Ingrid/X-4496-2019; Bartels, Karsten/ABE-9152-2020	Binswanger, Ingrid/0000-0001-8862-8078; Bartels, Karsten/0000-0003-2028-4664	National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards [UL1 TR001082]; National Institute On Drug Abuse of the National Institutes of Health [K24DA03255, R01DA035804, R34DA035952]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R34DA035952, R01DA035804] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards; National Institute On Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards Grant Number UL1 TR001082. Dr. Hopfer was supported was supported by the National Institute On Drug Abuse of the National Institutes of Health under Award Number K24DA03255 and Award Number R01DA035804. Dr. Binswanger was supported by the National Institute On Drug Abuse of the National Institutes of Health under Award Number R34DA035952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards Grant Number UL1 TR001082. Dr. Hopfer was supported by the National Institute On Drug Abuse of the National Institutes of Health Award Number K24DA03255 and Award Number R01DA035804. Dr. Binswanger was supported by the National Institute On Drug Abuse of the National Institutes of Health Award Number R34DA035952.	Bates C, 2011, J UROLOGY, V185, P551, DOI 10.1016/j.juro.2010.09.088; Binswanger IA, 2015, SUBST ABUS, V36, P141, DOI 10.1080/08897077.2014.991058; Centers for Disease Control and Prevention, 2010, NUMB ALL LIST PROC D; Clarke H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1251; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Dillman D., 2008, INTERNET MAIL MIXED; DILLMAN DA, 1974, AM SOCIOL REV, V39, P744, DOI 10.2307/2094318; Gammaitoni AR, 2003, CLIN J PAIN, V19, P286, DOI 10.1097/00002508-200309000-00002; Goodman L.S., 2011, GOODMAN GILMANS PHAR, V13th ed.; Groves R.M., 2004, SURVEY ERRORS SURVEY; GROVES RM, 1992, PUBLIC OPIN QUART, V56, P475, DOI 10.1086/269338; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Harris K, 2013, JAMA DERMATOL, V149, P317, DOI 10.1001/jamadermatol.2013.1871; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; KAVANAGH BP, 1994, ANESTHESIOLOGY, V81, P737, DOI 10.1097/00000542-199409000-00028; Kincaid J. P., 1988, Journal of Instructional Development, V11, P8, DOI 10.1007/BF02904998; Lavonas EJ, 2013, J PEDIATR-US, V163, P1377, DOI 10.1016/j.jpeds.2013.06.058; Longnecker DE, 2012, ANESTHESIOLOGY; Mack KA, 2013, MMWR-MORBID MORTAL W, V62, P537; Maher DP, 2014, BRIT J ANAESTH, V113, P88, DOI 10.1093/bja/aeu192; Paulozzi LJ, 2012, J SAFETY RES, V43, P283, DOI 10.1016/j.jsr.2012.08.009; Rodgers J, 2012, J HAND SURG-AM, V37A, P645, DOI 10.1016/j.jhsa.2012.01.035; Savic RM, 2012, CLIN PHARMACOL THER, V92, P575, DOI 10.1038/clpt.2012.137; Tanabe P, 2012, J EMERG NURS, V38, P273, DOI 10.1016/j.jen.2011.09.023; Thibaut J., 1959, SOCIAL PSYCHOL GROUP; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1346, DOI 10.1001/jama.2011.369	29	256	257	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147972	10.1371/journal.pone.0147972	http://dx.doi.org/10.1371/journal.pone.0147972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824844	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600080
J	Daryadel, A; Bourgeois, S; Figueiredo, MFL; Moreira, AG; Kampik, NB; Oberli, L; Mohebbi, N; Lu, XF; Meima, ME; Danser, AHJ; Wagner, CA				Daryadel, Arezoo; Bourgeois, Soline; Figueiredo, Marta F. L.; Moreira, Ana Gomes; Kampik, Nicole B.; Oberli, Lisa; Mohebbi, Nilufar; Lu, Xifeng; Meima, Marcel E.; Danser, A. H. Jan; Wagner, Carsten A.			Colocalization of the (Pro) renin Receptor/Atp6ap2 with H+-ATPases in Mouse Kidney but Prorenin Does Not Acutely Regulate Intercalated Cell H+-ATPase Activity	PLOS ONE			English	Article							RENAL TUBULAR-ACIDOSIS; (PRO)RENIN RECEPTOR; V-ATPASE; METABOLIC-ACIDOSIS; PROTEIN-KINASE; MOLECULAR-CLONING; LUMINAL MEMBRANE; TURTLE-BLADDER; UP-REGULATION; RAT-KIDNEY	The (Pro) renin receptor (P)RR/Atp6ap2 is a cell surface protein capable of binding and non-proteolytically activate prorenin. Additionally, (P)RR is associated with H+-ATPases and alternative functions in H+-ATPase regulation as well as in Wnt signalling have been reported. Kidneys express very high levels of H+-ATPases which are involved in multiple functions such as endocytosis, membrane protein recycling as well as urinary acidification, bicarbonate reabsorption, and salt absorption. Here, we wanted to localize the (P)RR/Atp6ap2 along the murine nephron, exmaine whether the (P)RR/Atp6ap2 is coregulated with other H+-ATPase subunits, and whether acute stimulation of the (P)RR/Atp6ap2 with prorenin regulates H+-ATPase activity in intercalated cells in freshly isolated collecting ducts. We localized (P)PR/Atp6ap2 along the murine nephron by qPCR and immunohistochemistry. (P)RR/Atp6ap2 mRNA was detected in all nephron segments with highest levels in the collecting systemcoinciding with H+-ATPases. Further experiments demonstrated expression at the brush border membrane of proximal tubules and in all types of intercalated cells colocalizing with H+-ATPases. In mice treated with NH4Cl, NaHCO3, KHCO3, NaCl, or the mineralocorticoid DOCA for 7 days, (P)RR/Atp6ap2 and H+-ATPase subunits were regulated but not co-regulated at protein and mRNA levels. Immunolocalization in kidneys from control, NH4Cl or NaHCO3 treated mice demonstrated always colocalization of PRR/Atp6ap2 with H+-ATPase subunits at the brush border membrane of proximal tubules, the apical pole of type A intercalated cells, and at basolateral and/or apicalmembranes of non-type A intercalated cells. Microperfusion of isolated cortical collecting ducts and luminal application of prorenin did not acutely stimulate H+-ATPase activity. However, incubation of isolated collecting ducts with prorenin non-significantly increased ERK1/2 phosphorylation. Our results suggest that the PRR/Atp6ap2 may form a complex with H+-ATPases in proximal tubule and intercalated cells but that prorenin has no acute effect on H+-ATPase activity in intercalated cells.	[Daryadel, Arezoo; Bourgeois, Soline; Figueiredo, Marta F. L.; Moreira, Ana Gomes; Kampik, Nicole B.; Oberli, Lisa; Mohebbi, Nilufar; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Mohebbi, Nilufar] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Lu, Xifeng; Meima, Marcel E.; Danser, A. H. Jan] Erasmus MC, Dept Internal Med, Div Vasc Med & Pharmacol, Rotterdam, Netherlands	University of Zurich; University of Zurich; University Zurich Hospital; Erasmus University Rotterdam; Erasmus MC	Wagner, CA (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	Wagnerca@access.uzh.ch	Danser, Jan/GLR-1479-2022	Kampik Kijewski, Nicole Beate/0000-0002-2278-5940; Lu, Xifeng/0000-0002-4782-0300	Swiss National Science Foundation [31003A_138143]; Hartmann-Muller Stiftung (Zurich, Switzerland)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hartmann-Muller Stiftung (Zurich, Switzerland)	This work was supported by the Swiss National Science Foundation (grant No. 31003A_138143) to C. A. Wagner and Hartmann-Muller Stiftung (Zurich, Switzerland) to A. Daryadel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Alzamora R, 2010, J BIOL CHEM, V285, P24676, DOI 10.1074/jbc.M110.106278; Aruga S, 2000, KIDNEY INT, V58, P206, DOI 10.1046/j.1523-1755.2000.00155.x; BASTANI B, 1991, J CLIN INVEST, V88, P126, DOI 10.1172/JCI115268; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Bonnici B, 2004, PFLUG ARCH EUR J PHY, V448, P16, DOI 10.1007/s00424-003-1227-4; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; BROWN D, 1988, NATURE, V331, P622, DOI 10.1038/331622a0; BROWN D, 1991, KIDNEY INT, V40, pS79; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; CANNON C, 1985, NATURE, V314, P443, DOI 10.1038/314443a0; Christensen EI, 2012, COMPR PHYSIOL, V2, P805, DOI 10.1002/cphy.c100073; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Finberg KE, 2003, GENE, V318, P25, DOI 10.1016/S0378-1119(03)00790-X; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; GLUCK S, 1982, P NATL ACAD SCI-BIOL, V79, P4327, DOI 10.1073/pnas.79.14.4327; Gong F, 2010, AM J PHYSIOL-RENAL, V298, pF1162, DOI 10.1152/ajprenal.00645.2009; Gonzalez AA, 2014, AM J MED SCI, V348, P416, DOI 10.1097/MAJ.0000000000000335; Gonzalez AA, 2014, AM J PHYSIOL-RENAL, V307, pF962, DOI 10.1152/ajprenal.00267.2014; Gonzalez AA, 2013, HYPERTENSION, V61, P443, DOI 10.1161/HYPERTENSIONAHA.112.196303; Gonzalez AA, 2011, HYPERTENSION, V57, P859, DOI 10.1161/HYPERTENSIONAHA.110.167957; Hafner P, 2008, AM J PHYSIOL-CELL PH, V295, pC1658, DOI 10.1152/ajpcell.00419.2008; Hennings JC, 2012, EMBO MOL MED, V4, P1057, DOI 10.1002/emmm.201201527; Hermle T, 2013, EMBO J, V32, P245, DOI 10.1038/emboj.2012.323; Hermle T, 2010, CURR BIOL, V20, P1269, DOI 10.1016/j.cub.2010.05.057; Huang JQ, 2013, HYPERTENSION, V62, P317, DOI 10.1161/HYPERTENSIONAHA.113.01324; Huang JQ, 2012, HYPERTENSION, V59, P317, DOI 10.1161/HYPERTENSIONAHA.111.186056; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Krop M, 2013, HYPERTENSION, V61, P1075, DOI 10.1161/HYPERTENSIONAHA.111.00967; Krop M, 2013, PFLUG ARCH EUR J PHY, V465, P87, DOI 10.1007/s00424-012-1105-z; Krop M, 2011, J HYPERTENS, V29, P2138, DOI 10.1097/HJH.0b013e32834b1978; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Lu XF, 2013, AM J PHYSIOL-RENAL, V305, pF417, DOI 10.1152/ajprenal.00037.2013; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; Matavelli LC, 2012, AM J PHYSIOL-RENAL, V303, pF1652, DOI 10.1152/ajprenal.00204.2012; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Mohebbi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055286; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Norgett EE, 2012, P NATL ACAD SCI USA, V109, P13775, DOI 10.1073/pnas.1204257109; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; Nowik M, 2010, CELL PHYSIOL BIOCHEM, V26, P1059, DOI 10.1159/000323984; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; Pech V, 2006, AM J PHYSIOL RENAL P; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Rong R, 2015, PEPTIDES, V63, P156, DOI 10.1016/j.peptides.2014.12.007; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Schulz N, 2007, CELL PHYSIOL BIOCHEM, V20, P109, DOI 10.1159/000104159; SCHWARTZ GJ, 1985, J CLIN INVEST, V75, P1638, DOI 10.1172/JCI111871; SCHWARTZ GJ, 1985, NATURE, V318, P368, DOI 10.1038/318368a0; Sihn G, 2010, KIDNEY INT, V78, P246, DOI 10.1038/ki.2010.151; Smith AN, 2001, J BIOL CHEM, V276, P42382, DOI 10.1074/jbc.M107267200; Song RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063835; Stehberger PA, 2003, J AM SOC NEPHROL, V14, P3027, DOI 10.1097/01.ASN.0000099375.74789.AB; Stehberger PA, 2007, J AM SOC NEPHROL, V18, P1408, DOI 10.1681/ASN.2006101072; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wagner CA, 2003, PFLUG ARCH EUR J PHY, V446, P623, DOI 10.1007/s00424-003-1082-3; Wagner CA, 2002, KIDNEY INT, V62, P2109, DOI 10.1046/j.1523-1755.2002.00671.x; Wagner CA, 1998, P NATL ACAD SCI USA, V95, P9665, DOI 10.1073/pnas.95.16.9665; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wagner CA, 2011, CELL PHYSIOL BIOCHEM, V28, P513, DOI 10.1159/000335112; WATTS BA, 1994, J BIOL CHEM, V269, P20250; Welsh-Bacic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025240; Winter C, 2004, P NATL ACAD SCI USA, V101, P2636, DOI 10.1073/pnas.0307321101; Winter C, 2011, AM J PHYSIOL-CELL PH, V301, pC1251, DOI 10.1152/ajpcell.00076.2011	73	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147831	10.1371/journal.pone.0147831	http://dx.doi.org/10.1371/journal.pone.0147831			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824839	Green Published, Green Accepted, gold			2022-12-26	WOS:000369528600064
J	Marzullo, TC				Marzullo, Timothy C.			Leg Regrowth in Blaberus discoidalis (Discoid Cockroach) following Limb Autotomy versus Limb Severance and Relevance to Neurophysiology Experiments	PLOS ONE			English	Article							REGENERATION; INSECTS	Background Many insects can regenerate limbs, but less is known about the regrowth process with regard to limb injury type. As part of our neurophysiology education experiments involving the removal of a cockroach leg, 1) the ability of Blaberus discoidalis cockroaches to regenerate a metathoracic leg was examined following autotomy at the femur/trochanter joint versus severance via a transverse coxa-cut, and 2) the neurophysiology of the detached legs with regard to leg removal type was studied by measuring spike firing rate and microstimulation movement thresholds. Leg Regrowth Results First appearance of leg regrowth was after 5 weeks in the autotomy group and 12 weeks in the coxa-cut group. Moreover, regenerated legs in the autotomy group were 72% of full size on first appearance, significantly larger (p<0.05) than coxa-cut legs (29% of full size at first appearance). Regenerated legs in both groups grew in size with each subsequent molt; the autotomy-removed legs grew to full size within 18 weeks, whereas coxa-cut legs took longer than 28 weeks to regrow. Removal of the metathoracic leg in both conditions did not have an effect on mortality compared to matched controls with unmolested legs. Neurophysiology Results Autotomy-removed legs had lower spontaneous firing rates, similar marked increased firing rates upon tactile manipulation of tibial barbs, and a 10% higher electrical microstimulation threshold for movement. Summary It is recommended that neurophysiology experiments on cockroach legs remove the limb at autotomy joints instead of coxa cuts, as the leg regenerates significantly faster when autotomized and does not detract from the neurophysiology educational content.	[Marzullo, Timothy C.] Backyard Brains Inc, Res & Dev, Ann Arbor, MI USA		Marzullo, TC (corresponding author), Backyard Brains Inc, Res & Dev, Ann Arbor, MI USA.	tim@backyardbrains.com			National Institutes of Mental Health Small Business Innovation Research [1-R43-MH-093334-01, 2-R44-MH-093334-03]; NATIONAL INSTITUTE OF MENTAL HEALTH [R44MH093334, R43MH093334] Funding Source: NIH RePORTER	National Institutes of Mental Health Small Business Innovation Research; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This experiment was supported by the National Institutes of Mental Health Small Business Innovation Research grant 1-R43-MH-093334-01 and 2-R44-MH-093334-03: "Backyard Brains: Bringing Neurophysiology into Secondary Schools." The funder provided support in the form of salary for author TCM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Backyard Brains, the recipient of the research grant, is a small business specializing in physiology education services and equipment design, of which author TCM is a co-owner.	BADEN T, 2015, PLOS BIOL, V13, P7794; Bell W. J., 2007, COCKROACHES ECOLOGY; BODENSTEIN D, 1955, J EXP ZOOL, V129, P209, DOI 10.1002/jez.1401290110; Brindley H. H., 1897, Proceedings of the Zoological Society of London, P903; CHAPMAN KM, 1965, J EXP BIOL, V42, P191; COWDEN RR, 1961, EMBRYOLOGIA, V6, P36, DOI 10.1111/j.1440-169X.1961.tb00111.x; Cruse H, 2009, COGN SYST MONOGR, V1, P43; Dagda Ruben K, 2013, J Undergrad Neurosci Educ, V12, pA66; Harley CM, 2009, J EXP BIOL, V212, P1463, DOI 10.1242/jeb.028381; KUNKEL JG, 1977, BIOL BULL, V153, P145, DOI 10.2307/1540698; KUNKEL JG, 1966, J INSECT PHYSIOL, V12, P227, DOI 10.1016/0022-1910(66)90137-5; LINDER T M, 1992, American Journal of Physiology, V262, pS18; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; MARKS EP, 1970, SCIENCE, V167, P61, DOI 10.1126/science.167.3914.61; Marzullo TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030837; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Mongeau JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038003; Nijenhuis E. D., 1955, Proceedings Akademie van Wetenschappen Amsterdam (C), V58, P121; Nijenhuis ED, 1955, P KON NED AKAD WET C, VC58, P131; OFARRELL AF, 1953, AUST J BIOL SCI, V6, P485, DOI 10.1071/BI9530485; Penzlin H., 1963, Roux Archiv fuer Entwicklungsmechanik, V154, P434; Pringle JWS, 1939, J EXP BIOL, V16, P220; Ramos Raddy L, 2007, J Undergrad Neurosci Educ, V5, pA28; Reaumur Rene Antoine Ferchault de, 1734, MEMOIRES SERVIR HIST; Spence AJ, 2010, J EXP BIOL, V213, P1907, DOI 10.1242/jeb.042515; TRUBY PR, 1985, J EMBRYOL EXP MORPH, V85, P177; Truby RR, 1983, J EMBRYOL EXP MORPH, V75, P151; Watson JT, 2002, J COMP PHYSIOL A, V188, P55, DOI 10.1007/s00359-002-0278-x; WILLIS EDWIN R., 1958, ANN ENT SOC AMER, V51, P53; WOODRUFF LAURENCE C., 1939, ANN ENT SOC AMERICA, V32, P589; ZILL SN, 1980, BRAIN RES, V198, P253, DOI 10.1016/0006-8993(80)90743-X	31	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0146778	10.1371/journal.pone.0146778	http://dx.doi.org/10.1371/journal.pone.0146778			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824931	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600009
J	Nebel, RA; Zhao, DJ; Pedrosa, E; Kirschen, J; Lachman, HM; Zheng, DY; Abrahams, BS				Nebel, Rebecca A.; Zhao, Dejian; Pedrosa, Erika; Kirschen, Jill; Lachman, Herbert M.; Zheng, Deyou; Abrahams, Brett S.			Reduced CYFIP1 in Human Neural Progenitors Results in Dysregulation of Schizophrenia and Epilepsy Gene Networks	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; COPY-NUMBER VARIANTS; AUTISM SPECTRUM DISORDERS; RECURRENT MICRODELETIONS; EXPRESSION ANALYSIS; BIPOLAR DISORDER; BREAKPOINTS 1; RISK-FACTORS; PROTEIN; 15Q11.2	Deletions encompassing the BP1-2 region at 15q11.2 increase schizophrenia and epilepsy risk, but only some carriers have either disorder. To investigate the role of CYFIP1, a gene within the region, we performed knockdown experiments in human neural progenitors derived from donors with 2 copies of each gene at the BP1-2 locus. RNA-seq and cellular assays determined that knockdown of CYFIP1 compromised cytoskeletal remodeling. FMRP targets and postsynaptic density genes, each implicated in schizophrenia, were significantly overrepresented among differentially expressed genes (DEGs). Schizophrenia and/or epilepsy genes, but not those associated with randomly selected disorders, were likewise significantly overrepresented. Mirroring the variable expressivity seen in deletion carriers, marked between-line differences were observed for dysregulation of disease genes. Finally, a subset of DEGs showed a striking similarity to known epilepsy genes and represents novel disease candidates. Results support a role for CYFIP1 in disease and demonstrate that disease-related biological signatures are apparent prior to neuronal differentiation.	[Nebel, Rebecca A.; Lachman, Herbert M.; Zheng, Deyou; Abrahams, Brett S.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Zhao, Dejian; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Pedrosa, Erika; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Kirschen, Jill; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Lachman, Herbert M.; Zheng, Deyou; Abrahams, Brett S.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Abrahams, BS (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.; Abrahams, BS (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA.	brett.abrahams@einstein.yu.edu	Zhao, Dejian/C-8321-2009	Zhao, Dejian/0000-0002-2105-3799; Zheng, Deyou/0000-0003-4354-5337	Albert Einstein New Investigator Development Award; IDDRC pilot award (NICHD) [P30HD071593]; Autism Center of Excellence Network Award (NIMH) [9R01 MH100027]; Training Program in Cellular and Molecular Biology and Genetics [T32 GM007491]; CTSA Grants [UL1RR025750, KL2RR025749, TL1RR025748, 8UL1 TR000086]; NIMH [MH097893, MH087840, MH099452]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073, UL1TR000086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025749, TL1RR025748, UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099427, R21MH099452, R21MH097893, R01MH100027] Funding Source: NIH RePORTER	Albert Einstein New Investigator Development Award; IDDRC pilot award (NICHD); Autism Center of Excellence Network Award (NIMH); Training Program in Cellular and Molecular Biology and Genetics; CTSA Grants; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported through an Albert Einstein New Investigator Development Award, an IDDRC pilot award (P30HD071593; NICHD), and a subcontract from an Autism Center of Excellence Network Award (9R01 MH100027; NIMH) to BSA. Support for RAN was provided through the Training Program in Cellular and Molecular Biology and Genetics (T32 GM007491; NIGMS). Clinical recruitment efforts were supported by CTSA Grants (UL1RR025750, KL2RR025749, and TL1RR025748; NCRR and 8UL1 TR000086; NCATS). Support to HML was provided by the NIMH (MH097893 and MH087840). Support to D. Zheng was provided by the NIMH (MH099452).	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baum L, 2014, HUM GENET, V133, P651, DOI 10.1007/s00439-013-1405-1; Bavamian S, 2015, MOL PSYCHIATR, V20, P573, DOI 10.1038/mp.2014.176; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bogdan S, 2004, DEVELOPMENT, V131, P3981, DOI 10.1242/dev.01274; Born HA, 2014, J NEUROSCI, V34, P3826, DOI 10.1523/JNEUROSCI.5171-13.2014; Bozdagi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042422; Brennand K, 2015, MOL PSYCHIATR, V20, P361, DOI 10.1038/mp.2014.22; Buntup D, 2008, NEUROCHEM RES, V33, P248, DOI 10.1007/s11064-007-9527-2; Burnside R, 2011, HUM GENET, V130, P517, DOI 10.1007/s00439-011-0970-4; Chaste P, 2014, AUTISM RES, V7, P355, DOI 10.1002/aur.1378; Chen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124597; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Das D K, 2015, Mol Neuropsychiatry, V1, P116; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; Doornbos M, 2009, EUR J MED GENET, V52, P108, DOI 10.1016/j.ejmg.2009.03.010; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Germain ND, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-44; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Gurses C, 2014, GENE, V538, P323, DOI 10.1016/j.gene.2014.01.030; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hashemi B, 2015, AM J MED GENET A, V167, P2098, DOI 10.1002/ajmg.a.37134; Hindorff LA, 2015, CATALOG PUBLISHED GE; HOLT IJ, 1990, AM J HUM GENET, V46, P428; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lin MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094968; Lin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044017; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Madison JM, 2015, MOL PSYCHIATR, V20, P703, DOI 10.1038/mp.2015.7; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mirza N, 2011, HUM MOL GENET, V20, P4381, DOI 10.1093/hmg/ddr365; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Oguro-Ando A, 2015, MOL PSYCHIATR, V20, P1069, DOI 10.1038/mp.2014.124; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Pathania M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.16; Pedrosa E, 2011, J NEUROGENET, V25, P88, DOI 10.3109/01677063.2011.597908; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017073; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Puschmann A, 2009, PARKINSONISM RELAT D, V15, P390, DOI 10.1016/j.parkreldis.2008.08.002; Robicsek O, 2013, MOL PSYCHIATR, V18, P1067, DOI 10.1038/mp.2013.67; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Schwindinger WF, 2004, MOL CELL BIOL, V24, P7758, DOI 10.1128/MCB.24.17.7758-7768.2004; Sima XT, 2014, MOL MED REP, V9, P1242, DOI 10.3892/mmr.2014.1977; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Topol A, 2015, BIOL PSYCHIAT, V78, pE29, DOI 10.1016/j.biopsych.2014.12.028; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Zeng LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059685; Zhao DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132387; Zhao Q, 2013, SCHIZOPHRENIA BULL, V39, P712, DOI 10.1093/schbul/sbr197	74	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148039	10.1371/journal.pone.0148039	http://dx.doi.org/10.1371/journal.pone.0148039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824476	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528600092
J	Wang, Z; Fu, CF; Chen, Y; Xu, F; Wang, ZY; Qu, ZG; Liu, Y				Wang, Zheng; Fu, Changfeng; Chen, Yong; Xu, Feng; Wang, Zhenyu; Qu, Zhigang; Liu, Yi			FoxC2 Enhances BMP7-Mediated Anabolism in Nucleus Pulposus Cells of the Intervertebral Disc	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; ADULT ARTICULAR CHONDROCYTES; OSTEOGENIC PROTEIN-1; TRANSCRIPTION FACTOR; TNF-ALPHA; TGF-BETA; KAPPA-B; MATRIX METALLOPROTEINASE-13; EXTRACELLULAR-MATRIX; WNT/BETA-CATENIN	Bone-morphogenetic protein-7 (BMP-7) is a growth factor that plays a major role in mediating anabolism and anti-catabolism of the intervertebral disc matrix and cell homeostasis. In osteoblasts, Forkhead box protein C2 (FoxC2) is a downstream target of BMPs and promotes cell proliferation and differentiation. However, the role FoxC2 may play in degenerative human intervertebral disc tissue and the relationship between FoxC2 and BMP-7 in nucleus pulposus (NP) cells remain to be elucidated. This study aims to investigate the presence and signaling mechanisms of FoxC2 in degenerative human intervertebral disc tissue and NP cells. Western blot and real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) analyses were used to measure FoxC2 expression in the NP tissue and cells. Transfections were carried out to measure the effect of FoxC2 on BMP-7-mediated extracellular matrix upregulation. Adenoviral knock-down of Smad1 was performed to investigate the mechanism of BMP-7-induced FoxC2 expression. In degenerative NP tissue, FoxC2 was markedly upregulated and positively correlated with increased disc degeneration. Induction of NP cell proliferation was confirmed by using cell counting kit-8 assay, immunocytochemistry and real-time qRT-PCR for Ki67. FoxC2 led to decreased noggin expression and increased Smad1/5/8 phosphorylation. During combined treatment with BMP-7, FoxC2 greatly potentiated anabolism through synergistic mechanisms on ECM formation. Combination therapy using BMP-7 and FoxC2 may be beneficial to the treatment of intervertebral disc degeneration.	[Wang, Zheng; Fu, Changfeng; Xu, Feng; Wang, Zhenyu; Qu, Zhigang; Liu, Yi] Jilin Univ, Hosp 1, Dept Spinal Surg, 71 Xinmin Ave, Changchun 130021, Jilin Province, Peoples R China; [Chen, Yong] Jilin Univ, Hosp 1, Dept Neurosurg, 71 Xinmin Ave, Changchun 130021, Jilin Province, Peoples R China	Jilin University; Jilin University	Qu, ZG; Liu, Y (corresponding author), Jilin Univ, Hosp 1, Dept Spinal Surg, 71 Xinmin Ave, Changchun 130021, Jilin Province, Peoples R China.	spinal9493@foxmail.com; Liuyi89757@gmail.com						Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Applebaum M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0053-9; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Fujita H, 2006, CIRC RES, V98, P626, DOI 10.1161/01.RES.0000207407.51752.3c; Gozo MC, 2013, CELL DEATH DIFFER, V20, P1031, DOI 10.1038/cdd.2013.34; Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647; Hader C, 2010, ONCOGENE, V29, P1031, DOI 10.1038/onc.2009.397; Hayashi H, 2008, J BIOL CHEM, V283, P23791, DOI 10.1074/jbc.M800190200; Hiyama A, 2008, BIOCHEM BIOPH RES CO, V369, P679, DOI 10.1016/j.bbrc.2008.02.087; Hiyama A, 2011, J CELL PHYSIOL, V226, P1139, DOI 10.1002/jcp.22438; Hiyama A, 2010, ARTHRITIS RHEUM-US, V62, P3036, DOI 10.1002/art.27599; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; Hwang PY, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026360; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; Imai Y, 2007, SPINE, V32, P1197, DOI 10.1097/BRS.0b013e3180574d26; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Masuda K, 2006, SPINE, V31, P742, DOI 10.1097/01.brs.0000206358.66412.7b; Masuda K, 2008, EUR SPINE J, V17, pS441, DOI 10.1007/s00586-008-0749-z; Mayer JE, 2013, SPINE J, V13, P299, DOI 10.1016/j.spinee.2013.01.041; McCulloch JA, 1996, THE LUMBAR SPINE, P492; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Muddasani P, 2007, J BIOL CHEM, V282, P31409, DOI 10.1074/jbc.M706508200; Nasto LA, 2012, SPINE, V37, P1819, DOI 10.1097/BRS.0b013e31824ee8f7; Nifuji A, 2001, J BONE MINER RES, V16, P1765, DOI 10.1359/jbmr.2001.16.10.1765; Park SJ, 2011, BONE, V49, P428, DOI 10.1016/j.bone.2011.05.012; Pockert AJ, 2009, ARTHRITIS RHEUM-US, V60, P482, DOI 10.1002/art.24291; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Sartori R, 2014, TRENDS ENDOCRIN MET, V25, P464, DOI 10.1016/j.tem.2014.06.002; Seguin CA, 2008, SPINE, V33, P356, DOI 10.1097/BRS.0b013e3181642a5e; Takegami K, 2002, SPINE, V27, P1318, DOI 10.1097/00007632-200206150-00014; Than KD, 2012, NEUROSURGERY, V70, P996, DOI 10.1227/NEU.0b013e318235d65f; TOLONEN J, 1995, SPINE, V20, P271, DOI 10.1097/00007632-199502000-00003; Wang CF, 2011, J ORTHOP RES, V29, P838, DOI 10.1002/jor.21310; Wang S, 2014, CELL PROLIFERAT, V47, P381, DOI 10.1111/cpr.12121; Yamanishi Y, 2002, J IMMUNOL, V168, P1405, DOI 10.4049/jimmunol.168.3.1405; Yoon ST, 2006, EUR SPINE J, V15, pS379, DOI 10.1007/s00586-006-0155-3; You WL, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-199; Yu X. C., 2014, SCI CHINA EARTH SCI, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083080; Zhang Y, 2008, SPINE, V33, P831, DOI 10.1097/BRS.0b013e31816b1f38; Zhang Y, 2007, SPINE, V32, P2515, DOI 10.1097/BRS.0b013e318158cc09; Zhang YJ, 2004, AM J PHYS MED REHAB, V83, P515, DOI 10.1097/01.PHM.0000130031.64343.59	46	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147764	10.1371/journal.pone.0147764	http://dx.doi.org/10.1371/journal.pone.0147764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824865	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600056
J	Thevenet, J; De Marchi, U; Domingo, JS; Christinat, N; Bultot, L; Lefebvre, G; Sakamoto, K; Descombes, P; Masoodi, M; Wiederkehr, A				Thevenet, Jonathan; De Marchi, Umberto; Domingo, Jaime Santo; Christinat, Nicolas; Bultot, Laurent; Lefebvre, Gregory; Sakamoto, Kei; Descombes, Patrick; Masoodi, Mojgan; Wiederkehr, Andreas			Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketone body shuttle systems	FASEB JOURNAL			English	Article						medium-chain triglycerides; energy metabolism; NAD(P)H; iPSC	KETOGENIC DIETS; BRAIN METABOLISM; DEPENDENT REGULATION; GLUCOSE-UTILIZATION; CHILDHOOD EPILEPSY; ENERGY-METABOLISM; ATP; TRANSPORT; OXIDATION; SEIZURES	Medium-chain triglycerides have been used as part of a ketogenic diet effective in reducing epileptic episodes. The health benefits of the derived medium-chain fatty acids (MCFAs) are thought to result from the stimulation of liver ketogenesis providing fuel for the brain. We tested whether MCFAs have direct effects on energy metabolism in induced pluripotent stem cell-derived human astrocytes and neurons. Using single-cell imaging, we observed an acute pronounced reduction of the mitochondrial electrical potential and a concomitant drop of the NAD(P)H signal in astrocytes, but not in neurons. Despite the observed effects on mitochondrial function, MCFAs did not lower intracellular ATP levels or activate the energy sensor AMP-activated protein kinase. ATP concentrations in astrocytes were unaltered, even when blocking the respiratory chain, suggesting compensation through accelerated glycolysis. The MCFA decanoic acid (300 mu M) promoted glycolysis and augmented lactate formation by 49.6%. The shorter fatty acid octanoic acid (300 mu M) did not affect glycolysis but increased the rates of astrocyte ketogenesis 2.17-fold compared with that of control cells. MCFAs may have brain health benefits through the modulation of astrocyte metabolism leading to activation of shuttle systems that provide fuel to neighboring neurons in the form of lactate and ketone bodies.-Thevenet, J., De Marchi, U., Santo Domingo, J., Christinat, N., Bultot, L., Lefebvre, G., Sakamoto, K., Descombes, P., Masoodi, M., Wiederkehr, A. Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketonebody shuttle systems. www.fasebj.org	[Thevenet, Jonathan; De Marchi, Umberto; Domingo, Jaime Santo; Wiederkehr, Andreas] Nestle Inst Hlth Sci, Mitochondrial Funct, CH-1015 Lausanne, Switzerland; [Christinat, Nicolas; Masoodi, Mojgan] Nestle Inst Hlth Sci, Lipid Biol, CH-1015 Lausanne, Switzerland; [Bultot, Laurent; Sakamoto, Kei] Nestle Inst Hlth Sci, Diabet & Circadian Rhythms, CH-1015 Lausanne, Switzerland; [Lefebvre, Gregory; Descombes, Patrick] Nestle Inst Hlth Sci, Funct Genom, CH-1015 Lausanne, Switzerland	Nestle SA; Nestle SA; Nestle SA; Nestle SA	Wiederkehr, A (corresponding author), Nestle Inst Hlth Sci, EPFL Innovat Pk,Bldg G, CH-1015 Lausanne, Switzerland.	andreas.wiederkehr@rd.nestle.com	Domingo, Jaime Santo/AAE-1100-2021; Domingo, Jaime Santo/AAA-4995-2020; sakamoto, kei/C-8806-2019; MASOODI, MOJGAN/P-1499-2019	Domingo, Jaime Santo/0000-0001-5501-0482; sakamoto, kei/0000-0001-8839-5980; MASOODI, MOJGAN/0000-0001-9840-1731; De Marchi, Umberto/0000-0002-6011-5446; Lefebvre, Greg/0000-0001-7519-2316; Bultot, Laurent/0000-0002-5088-0101				Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; [Anonymous], 2003, T AM CLIN CLIMATOL A; AUESTAD N, 1991, J NEUROCHEM, V56, P1376, DOI 10.1111/j.1471-4159.1991.tb11435.x; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Berardi MJ, 2014, CELL METAB, V20, P541, DOI 10.1016/j.cmet.2014.07.004; Bernardinelli Y, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/232105; BIXEL MG, 1995, J NEUROCHEM, V65, P2450; Cahill George F Jr, 2003, Trans Am Clin Climatol Assoc, V114, P149; Danial NN, 2013, J CHILD NEUROL, V28, P1027, DOI 10.1177/0883073813487598; DEAN HG, 1989, CLIN CHEM, V35, P1945; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008; Ebert D, 2003, J NEUROSCI, V23, P5928; Fuehrlein BS, 2004, J CLIN ENDOCR METAB, V89, P1641, DOI 10.1210/jc.2003-031796; Gano LB, 2014, J LIPID RES, V55, P2211, DOI 10.1194/jlr.R048975; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Guzman M, 2001, TRENDS ENDOCRIN MET, V12, P169, DOI 10.1016/S1043-2760(00)00370-2; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; HASSELBALCH SG, 1994, J CEREBR BLOOD F MET, V14, P125, DOI 10.1038/jcbfm.1994.17; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; HUTTENLOCHER PR, 1976, PEDIATR RES, V10, P536, DOI 10.1203/00006450-197605000-00006; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Lai YC, 2014, BIOCHEM J, V460, P363, DOI 10.1042/BJ20131673; Lambert HP, 2014, J BIOL CHEM, V289, P31014, DOI 10.1074/jbc.M114.570879; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Neal EG, 2010, J HUM NUTR DIET, V23, P113, DOI 10.1111/j.1365-277X.2010.01043.x; Neal EG, 2009, EPILEPSIA, V50, P1109, DOI 10.1111/j.1528-1167.2008.01870.x; OLSON JE, 1992, METAB BRAIN DIS, V7, P183, DOI 10.1007/BF01000245; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Pan JW, 2000, J CEREBR BLOOD F MET, V20, P1502, DOI 10.1097/00004647-200010000-00012; Paoli A, 2013, EUR J CLIN NUTR, V67, P789, DOI 10.1038/ejcn.2013.116; Passonneau J.V., 1993, ENZYMATIC ANAL, DOI [10.1007/978-1-60327-407-4, DOI 10.1007/978-1-60327-407-4]; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; RUDERMAN NB, 1974, BIOCHEM J, V138, P1; Sampol Denys, 2013, Front Neuroenergetics, V5, P5, DOI 10.3389/fnene.2013.00005; SEATON TB, 1986, AM J CLIN NUTR, V44, P630, DOI 10.1093/ajcn/44.5.630; Stobart JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00038; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302	42	86	88	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1913	1926		10.1096/fj.201500182	http://dx.doi.org/10.1096/fj.201500182			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26839375				2022-12-26	WOS:000374879400020
J	Koenig, S; Wolf, R; Heisenberg, M				Koenig, Sebastian; Wolf, Reinhard; Heisenberg, Martin			Vision in Flies: Measuring the Attention Span	PLOS ONE			English	Article							VISUAL FLIGHT ORIENTATION; DROSOPHILA-MELANOGASTER; FINE-STRUCTURE; YAW TORQUE; BEHAVIOR; CORTEX; FLY	A visual stimulus at a particular location of the visual field may elicit a behavior while at the same time equally salient stimuli in other parts do not. This property of visual systems is known as selective visual attention (SVA). The animal is said to have a focus of attention (FoA) which it has shifted to a particular location. Visual attention normally involves an attention span at the location to which the FoA has been shifted. Here the attention span is measured in Drosophila. The fly is tethered and hence has its eyes fixed in space. It can shift its FoA internally. This shift is revealed using two simultaneous test stimuli with characteristic responses at their particular locations. In tethered flight a wild type fly keeps its FoA at a certain location for up to 4s. Flies with a mutation in the radish gene, that has been suggested to be involved in attention-like mechanisms, display a reduced attention span of only 1s.	[Koenig, Sebastian; Wolf, Reinhard; Heisenberg, Martin] Rudolf Virchow Ctr, Joseph Schneider Str 2, D-97080 Wurzburg, Germany	University of Wurzburg	Heisenberg, M (corresponding author), Rudolf Virchow Ctr, Joseph Schneider Str 2, D-97080 Wurzburg, Germany.	heisenberg@biozentrum.uni-wuerzburg.de			German Science Foundation [He986/20-1]; Rudolf-Virchow-Center	German Science Foundation(German Research Foundation (DFG)); Rudolf-Virchow-Center	This work was funded by the German Science Foundation (Reinhart Koselleck Project, He986/20-1). The fundershad no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank A. Haberberger for help with the experiments, K. Oechsner and H. Kaderschabek for technical support and J. Dubnau, Cold Spring Harbor Laboratories for fly stocks. This work was supported by the Rudolf-Virchow-Center.	COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; Heisenberg M., 1984, VISION DROSOPHILA GE; KLEIN R, 1988, NATURE, V334, P430, DOI 10.1038/334430a0; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Paulk AC, 2014, P NATL ACAD SCI US; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Sareen P, 2011, VISUAL ATTENTION DRO; Sareen P, 2011, P NATL ACAD SCI US, V2011; Sareen P, 2011, P NATL ACAD SCI USA, V108, P7230, DOI 10.1073/pnas.1102522108; Serences JT, 2004, CEREB CORTEX, V14, P1346, DOI 10.1093/cercor/bhh095; Tang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014455; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; TIPPER SP, 1991, Q J EXP PSYCHOL-A, V43, P289, DOI 10.1080/14640749108400971; van Swinderen B, 2007, FLY, V1, P187, DOI 10.4161/fly.4561; van Swinderen B, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00096; van Swinderen B, 2010, J NEUROSCI, V30, P1003, DOI 10.1523/JNEUROSCI.4516-09.2010; van Swinderen B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005989; von Helmholtz H., 1866, HDB PHYSL OPTIK; Warren RM, 1986, HELMHOLTZ PERCEPTION; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; WURTZ RH, 1972, INVEST OPHTH VISUAL, V11, P441; Ye YZ, 2004, EUR J NEUROSCI, V20, P1001, DOI 10.1111/j.1460-9568.2004.03575.x	26	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148208	10.1371/journal.pone.0148208	http://dx.doi.org/10.1371/journal.pone.0148208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848852	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000052
J	Meredith, SL; Bryant, JL; Babur, M; Riddell, PW; Behrouzi, R; Williams, KJ; White, A				Meredith, Suzanne L.; Bryant, Jennifer L.; Babur, Muhammad; Riddell, Philip W.; Behrouzi, Roya; Williams, Kaye J.; White, Anne			Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; RADIATION; LINES	Background Small cell lung cancer (SCLC) is an extremely aggressive disease, commonly displaying therapy-resistant relapse. We have previously identified neuroendocrine and epithelial phenotypes in SCLC tumours and the neuroendocrine marker, pro-opiomelanocortin (POMC), correlated with worse overall survival in patients. However, the effect of treatment on these phenotypes is not understood. The current study aimed to determine the effect of repeated irradiation treatment on SCLC cell phenotype, focussing on the neuroendocrine marker, POMC. Results Human SCLC cells (DMS 79) were established as subcutaneous xenograft tumours in CBA nude mice and then exposed to repeated 2Gy irradiation. In untreated animals, POMC in the blood closely mirrored tumour growth; an ideal characteristic for a circulating biomarker. Following repeated localised irradiation in vivo, circulating POMC decreased (p< 0.01), in parallel with a decrease in tumour size, but remained low even when the tumours re-established. The excised tumours displayed reduced and distinctly heterogeneous expression of POMC compared to untreated tumours. There was no difference in the epithelial marker, cytokeratin. However, there were significantly more N-cadherin positive cells in the irradiated tumours. To investigate the tumour response to irradiation, DMS79 cells were repeatedly irradiated in vitro and the surviving cells selected. POMC expression was reduced, while mesenchymal markers N-cadherin, beta 1-integrin, fibroblast-specific protein 1, beta-catenin and Zeb1 expression were amplified in the more irradiation-primed cells. There were no consistent changes in epithelial marker expression. Cell morphology changed dramatically with repeatedly irradiated cells displaying a more elongated shape, suggesting a switch to a more mesenchymal phenotype. Conclusions In summary, POMC biomarker expression and secretion were reduced in SCLC tumours which regrew after irradiation and in repeatedly irradiation (irradiation-primed) cells. Therefore, POMC was no longer predictive of tumour burden. This highlights the importance of fully evaluating biomarkers during and after therapy to assess clinical utility. Furthermore, the gain in mesenchymal characteristics in irradiated cells could be indicative of a more invasive phenotype.	[Meredith, Suzanne L.; Bryant, Jennifer L.; Babur, Muhammad; Behrouzi, Roya; Williams, Kaye J.; White, Anne] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [Bryant, Jennifer L.; Riddell, Philip W.; White, Anne] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	White, A (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England.; White, A (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	anne.white@manchester.ac.uk	White, Anne/G-7717-2015	White, Anne/0000-0002-7686-2884; Behrouzi, Roya/0000-0002-1978-6539	Barbara Mawer Endowment fund, BBSRC, Society for Endocrinology; EU FP7 Metoxia Grant [222741]; Biotechnology and Biological Sciences Research Council [1065661] Funding Source: researchfish	Barbara Mawer Endowment fund, BBSRC, Society for Endocrinology; EU FP7 Metoxia Grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for SLM, JLB, PWR and RB was provided by The Barbara Mawer Endowment fund, BBSRC, Society for Endocrinology. Funding was also provided by the EU FP7 Metoxia Grant agreement no. 222741 (to K.J. Williams, supporting M. Babur).	Bryant JL, 2012, BRIT J CANCER, V106, P148, DOI 10.1038/bjc.2011.465; Burrows N, 2013, RADIOTHER ONCOL; Canadas I, 2014, ONCOTARGET, V5, P5246, DOI 10.18632/oncotarget.2124; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Dasari V, 2006, AM J RESP CELL MOL, V35, P3, DOI 10.1165/rcmb.2006-0051SF; Davey RA, 2004, ANTICANCER RES, V24, P465; Gibson S, 1996, J CLIN ENDOCR METAB, V81, P497, DOI 10.1210/jc.81.2.497; Gomez-Casal R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-94; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henness S, 2002, INT J RADIAT ONCOL, V54, P895, DOI 10.1016/S0360-3016(02)03037-7; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Kalemkerian GP, 2011, J NATL COMPR CANC NE, V9, P1086, DOI 10.6004/jnccn.2011.0092; Kawata M, 2012, J BIOCHEM, V151, P205, DOI 10.1093/jb/mvr136; Komaki R, 2012, INT J RADIAT ONCOL, V83, pE531, DOI 10.1016/j.ijrobp.2012.01.075; Krohn A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100249; Oliver Robert L, 2003, Pituitary, V6, P119, DOI 10.1023/B:PITU.0000011172.26649.df; Page-Wilson G, 2014, J CLIN ENDOCR METAB, V99, pE1838, DOI 10.1210/jc.2014-1448; PETTENGILL OS, 1980, CANCER-AM CANCER SOC, V45, P906, DOI 10.1002/1097-0142(19800301)45:5<906::AID-CNCR2820450513>3.0.CO;2-H; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Riaz SP, 2012, LUNG CANCER, V75, P280, DOI 10.1016/j.lungcan.2011.08.004; Sato M, 2012, RESPIROLOGY, V17, P1048, DOI 10.1111/j.1440-1843.2012.02173.x; Shintani Y, 2011, ANN THORAC SURG, V92, P1794, DOI 10.1016/j.athoracsur.2011.07.032; STEWART PM, 1994, CLIN ENDOCRINOL, V40, P199, DOI 10.1111/j.1365-2265.1994.tb02468.x; Stovold R, 2013, BRIT J CANCER, V108, P1704, DOI 10.1038/bjc.2013.112; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; West MJ, 2012, BASIC STEREOLOGY BIO; WHITE A, 1989, J MOL ENDOCRINOL, V3, P65, DOI 10.1677/jme.0.0030065; Yamamoto H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14579; Zhang X, 2011, BIOCHEM BIOPH RES CO, V412, P188, DOI 10.1016/j.bbrc.2011.07.074	30	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148404	10.1371/journal.pone.0148404	http://dx.doi.org/10.1371/journal.pone.0148404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848743	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000087
J	van Dijk, A; van Eldik, M; Veldhuizen, EJA; Tjeerdsma-van Bokhoven, HLM; de Zoete, MR; Bikker, FJ; Haagsman, HP				van Dijk, Albert; van Eldik, Mandy; Veldhuizen, Edwin J. A.; Tjeerdsma-van Bokhoven, Hanne L. M.; de Zoete, Marcel R.; Bikker, Floris J.; Haagsman, Henk P.			Immunomodulatory and Anti-Inflammatory Activities of Chicken Cathelicidin-2 Derived Peptides	PLOS ONE			English	Article							OUTER-MEMBRANE-PERMEABILIZATION; CATIONIC ANTIMICROBIAL PEPTIDES; HOST-DEFENSE PEPTIDES; ANTIBIOTIC USE; POLYMYXIN-B; LIPOPOLYSACCHARIDE; BINDING; LL-37; DIFFERENTIATION; NEUTRALIZATION	Host Defence Peptides and derived peptides are promising classes of antimicrobial and immunomodulatory lead compounds. For this purpose we examined whether chicken cathelicidin-2 (CATH-2)-derived peptides modulate the function and inflammatory response of avian immune cells. Using a chicken macrophage cell line (HD11) we found that full-length CATH-2 dose-dependently induced transcription of chemokines CXCLi2/IL-8, MCP3 and CCLi4/RANTES, but not of pro-inflammatory cytokine IL-1 beta. In addition, CATH-2 efficiently inhibited IL-1 beta and nitric oxide production by HD11 cells induced by different sources of lipopolysaccharides (LPS). N-terminal truncated CATH-2 derived peptides maintained the capacity to selectively induce chemokine transcription, but despite their high LPS affinity several analogs lacked LPS-neutralizing capacity. Substitution of phenylalanine residues by tryptophan introduced endotoxin neutralization capacity in inactive truncated CATH-2 derived peptides. In contrast, amino acid substitution of phenylalanine by tyrosine abrogated endotoxin neutralization activity of CATH-2 analogs. These findings support a pivotal role for aromatic residues in peptide-mediated endotoxin neutralization by CATH-2 analogs and were shown to be independent of LPS affinity. The capacity to modulate chemokine production and dampen endotoxin-induced pro-inflammatory responses in chicken immune cells implicates that small CATH-2 based peptides could serve as leads for the design of CATH-2 based immunomodulatory anti-infectives.	[van Dijk, Albert; van Eldik, Mandy; Veldhuizen, Edwin J. A.; Tjeerdsma-van Bokhoven, Hanne L. M.; Haagsman, Henk P.] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Div Mol Host Def, Utrecht, Netherlands; [de Zoete, Marcel R.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Bikker, Floris J.] Vrije Univ Amsterdam, Univ Amsterdam, Dept Oral Biochem, Acad Ctr Dent Amsterdam, Amsterdam, Netherlands	Utrecht University; Yale University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Haagsman, HP (corresponding author), Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Div Mol Host Def, Utrecht, Netherlands.	h.p.haagsman@uu.nl	Bikker, Floris/R-1941-2019; Haagsman, Henk P/F-8919-2010; de Zoete, Marcel R/O-3012-2014; de Zoete, Marcel/ABA-7918-2021; Bikker, Floris/B-1187-2012	Bikker, Floris/0000-0002-9453-4630; de Zoete, Marcel/0000-0002-6561-5810	Immuno Valley ALTANT ASIA2 program of the Dutch Ministry of Economic Affairs	Immuno Valley ALTANT ASIA2 program of the Dutch Ministry of Economic Affairs	The work was financially supported by the Immuno Valley ALTANT ASIA2 program of the Dutch Ministry of Economic Affairs.	BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bommineni YR, 2010, PEPTIDES, V31, P1225, DOI 10.1016/j.peptides.2010.03.037; Bosca L, 2005, TOXICOLOGY, V208, P249, DOI 10.1016/j.tox.2004.11.035; Bowdish DME, 2004, J IMMUNOL, V172, P3758, DOI 10.4049/jimmunol.172.6.3758; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2000, STRUCTURE, V8, P585; Hancock REW, 2005, LANCET INFECT DIS, V5, P209, DOI 10.1016/S1473-3099(05)70051-7; JACOBS RE, 1989, BIOCHEMISTRY-US, V28, P3421, DOI 10.1021/bi00434a042; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Kaiser P, 2005, J INTERF CYTOK RES, V25, P467, DOI 10.1089/jir.2005.25.467; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Li XZ, 2007, VET MICROBIOL, V121, P197, DOI 10.1016/j.vetmic.2007.01.015; Molhoek EM, 2010, INT J ANTIMICROB AG, V36, P271, DOI 10.1016/j.ijantimicag.2010.06.001; Mookherjee N, 2006, J LEUKOCYTE BIOL, V80, P1563, DOI 10.1189/jlb.0106048; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; Nagaoka I, 2002, CLIN DIAGN LAB IMMUN, V9, P972, DOI 10.1128/CDLI.9.5.972-982.2002; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pristovsek P, 1999, J MED CHEM, V42, P4604, DOI 10.1021/jm991031b; Ramanathan B, 2004, DEV COMP IMMUNOL, V28, P163, DOI 10.1016/S0145-305X(03)00135-6; Sanchez KM, 2011, BIOPHYS J, V100, P2121, DOI 10.1016/j.bpj.2011.03.018; SCHINDLER PRG, 1975, ANTIMICROB AGENTS CH, V8, P95, DOI 10.1128/AAC.8.1.95; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Scrutton NS, 1996, BIOCHEM J, V319, P1; Shryock TR, 2010, ANN NY ACAD SCI, V1213, P92, DOI 10.1111/j.1749-6632.2010.05788.x; Tsubery H, 2002, MOL PHARMACOL, V62, P1036, DOI 10.1124/mol.62.5.1036; van Dijk A, 2009, MOL IMMUNOL, V46, P2465, DOI 10.1016/j.molimm.2009.05.019; Van Dijk A, 2009, MOL IMMUNOL, V46, P1517, DOI 10.1016/j.molimm.2008.12.015; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; WIMLEY WC, 1993, BIOCHEMISTRY-US, V32, P6307, DOI 10.1021/bi00076a001; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	42	45	45	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147919	10.1371/journal.pone.0147919	http://dx.doi.org/10.1371/journal.pone.0147919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848845	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000028
J	Verma, R; Venkatareddy, M; Kalinowski, A; Patel, SR; Garg, P				Verma, Rakesh; Venkatareddy, Madhusudan; Kalinowski, Anne; Patel, Sanjeevkumar R.; Garg, Puneet			Integrin Ligation Results in Nephrin Tyrosine Phosphorylation In Vitro	PLOS ONE			English	Article							FOCAL ADHESION KINASE; SRC-FAMILY KINASES; ADAPTER PROTEIN NCK; CELL MOTILITY; ACTIN POLYMERIZATION; CYTOPLASMIC DOMAIN; SIGNAL-TRANSDUCTION; GLOMERULAR INJURY; CANCER-CELLS; KIDNEY	Nephrin is expressed at the basolateral aspect of podocytes and is an important signaling protein at the glomerular slit diaphragm. In vitro studies have demonstrated that Nephrin phosphorylation-dependent signaling is able to assemble a protein complex that is able to polymerize actin. However, proximal signaling events that result in nephrin tyrosine phosphorylation are not well understood. Nephrin deletion in mice and human nephrin mutations result in developmental failure of the podocyte intercellular junction resutling in proteinuria. This has been presumed to be due to a failure to respond to an external polarized cue in the absence of nephrin or a failure to transduce an outside-in signal in patients with nephrin mutations. The nephrin extracellular domain binds to itself or neph1 across the foot process intercellular junction. Nephrin is tyrosine phosphorylation-silent in healthy glomeruli when presumably the nephrin extracellular domain is in an engaged state. These observations raise the possibility of an alternate proximal signaling mechanism that might be responsible for nephrin tyrosine phosphorylation. Here we present data showing that integrin engagement at the basal aspect of cultured podocytes results in nephrin tyrosine phosphorylation. This is abrogated by incubating podocytes with an antibody that prevents integrin beta 1 ligation and activation in response to binding to extracellular matrix. Furthermore, nephrin tyrosine phosphorylation was observed in podocytes expressing a membrane-targeted nephrin construct that lacks the extracellular domain. We propose, integrin-activation based signaling might be responsible for nephrin phosphorylation rather than engagment of the nephrin extracellular domain by a ligand.	[Verma, Rakesh; Venkatareddy, Madhusudan; Kalinowski, Anne; Patel, Sanjeevkumar R.; Garg, Puneet] Univ Michigan, Dept Internal Med, Div Nephrol, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Garg, P (corresponding author), Univ Michigan, Dept Internal Med, Div Nephrol, Sch Med, Ann Arbor, MI 48109 USA.	pungarg@umich.edu		Garg, Puneet/0000-0001-7439-459X	NIDDK [DK097027, DK081403, DK096053]; American Society of Nephrology Carl Gottshalk Research Scholar Award; University of Michigan's George M. O'Brien Translational Research Core Center [P30 DK0801943]; MDTRC Cell and Molecular Biology Core Grant [P60 DK020572];  [DK082409]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081403, P60DK020572, R01DK082409, R03DK096053, R01DK097027] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Society of Nephrology Carl Gottshalk Research Scholar Award; University of Michigan's George M. O'Brien Translational Research Core Center; MDTRC Cell and Molecular Biology Core Grant; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to P. Garg from NIDDK (DK097027, DK081403, and DK096053) and American Society of Nephrology Carl Gottshalk Research Scholar Award (PG). The work was also supported by grant to Sanjeevkumar Patel (DK082409). Support was also obtained from the cores of the University of Michigan's George M. O'Brien Translational Research Core Center Grant P30 DK0801943 and MDTRC Cell and Molecular Biology Core Grant P60 DK020572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Borza CM, 2008, J AM SOC NEPHROL, V19, P677, DOI 10.1681/ASN.2007070793; Borza CM, 2012, J AM SOC NEPHROL, V23, P1027, DOI 10.1681/ASN.2011040367; Borza CM, 2012, EXP CELL RES, V318, P1001, DOI 10.1016/j.yexcr.2012.02.033; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Eke I, 2012, J CLIN INVEST, V122, P1529, DOI 10.1172/JCI61350; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Garg P, 2007, NEPHRON EXP NEPHROL, V106, pE67, DOI 10.1159/000101795; Garg P, 2011, ADV CHRONIC KIDNEY D, V18, P233, DOI 10.1053/j.ackd.2011.06.001; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Goerge B, 2012, J CLIN INVESTIGATION; Has C, 2012, NEW ENGL J MED, V366, P1508, DOI 10.1056/NEJMoa1110813; Heikkila E, 2011, BIOCHEM J, V435, P619, DOI 10.1042/BJ20101599; Holzman LB, 1999, KIDNEY INT, V56, P1481, DOI 10.1046/j.1523-1755.1999.00719.x; Hsia DA, 2005, MOL CELL BIOL, V25, P9700, DOI 10.1128/MCB.25.21.9700-9712.2005; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikonomov OC, 2015, BIOCH BIOPHYS ACTA; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Kreidberg JA, 2000, AM J PHYSIOL-RENAL, V279, pF233, DOI 10.1152/ajprenal.2000.279.2.F233; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Li HP, 2006, BIOCHEM BIOPH RES CO, V349, P310, DOI 10.1016/j.bbrc.2006.08.053; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nagashima KI, 2002, MOL BIOL CELL, V13, P4231, DOI 10.1091/mbc.E02-04-0181; Ni L, 2012, NEPHROLOGY, V17, P525, DOI 10.1111/j.1440-1797.2012.01619.x; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Pozzi A, 2008, DEV BIOL, V316, P288, DOI 10.1016/j.ydbio.2008.01.022; Pozzi A, 2013, J AM SOC NEPHROL, V24, P1034, DOI 10.1681/ASN.2013010012; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Sawai H, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-37; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; SYMINGTON BE, 1995, J CELL SCI, V108, P831; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Uchida K, 2008, KIDNEY INT, V73, P926, DOI [10.1038/ki.2008.19, 10.1038/KI.2008.19]; Venkatareddy M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028710; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Verma R, 2015, MOL CELL BIOL; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; Yang XQ, 2010, MOL CELL BIOL, V30, P5306, DOI 10.1128/MCB.00326-10; Yuan HP, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134946; Yuan HP, 2002, AM J PHYSIOL-RENAL, V282, pF585, DOI 10.1152/ajprenal.00290.2001; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	62	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148906	10.1371/journal.pone.0148906	http://dx.doi.org/10.1371/journal.pone.0148906			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848974	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000185
J	Tezuka, M; Kitamura, N; Tanaka, K; Miki, N				Tezuka, Mayuko; Kitamura, Norihide; Tanaka, Kohei; Miki, Norihisa			Presentation of Various Tactile Sensations Using Micro-Needle Electrotactile Display	PLOS ONE			English	Article							HUMAN HAND; TOUCH; SKIN	Tactile displays provoke tactile sensations by artificially stimulating tactile receptors. While many types of tactile displays have been developed, electrotactile displays that exploit electric stimulation can be designed to be thin, light, flexible and thus, wearable. However, the high voltages required to stimulate tactile receptors and limited varieties of possible sensations pose problems. In our previous work, we developed an electrotactile display using a micro-needle electrode array that can drastically reduce the required voltage by penetrating through the high-impedance stratum corneum painlessly, but displaying various tactile sensations was still a challenge. In this work, we demonstrate presentation of tactile sensation of different roughness to the subjects, which is enabled by the arrangement of the electrodes; the needle electrodes are on the fingertip and the ground electrode is on the fingernail. With this arrangement, the display can stimulate the tactile receptors that are located not only in the shallow regions of the finger but also those in the deep regions. It was experimentally revealed that the required voltage was further reduced compared to previous devices and that the roughness presented by the display was controlled by the pulse frequency and the switching time, or the stimulation flow rate. The proposed electrotactile display is readily applicable as a new wearable haptic device for advanced information communication technology.	[Tezuka, Mayuko; Kitamura, Norihide; Tanaka, Kohei; Miki, Norihisa] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 223, Japan; [Miki, Norihisa] JST PRESTO, Chiyoda Ku, Tokyo, Japan	Keio University; Japan Science & Technology Agency (JST)	Tezuka, M; Miki, N (corresponding author), Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 223, Japan.; Miki, N (corresponding author), JST PRESTO, Chiyoda Ku, Tokyo, Japan.	mayukotezuka@a8.keio.jp; miki@mech.keio.ac.jp	Miki, Norihisa/F-7659-2014		Precursory Research for Embryonic Science and Technology (PRESTO, Information Environment and Human), Japan Science and Technology Agency	Precursory Research for Embryonic Science and Technology (PRESTO, Information Environment and Human), Japan Science and Technology Agency	This work was supported by Precursory Research for Embryonic Science and Technology (PRESTO, Information Environment and Human), Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/presto/en/). NM recieved this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arouette X, 2010, SENSORS-BASEL, V10, P2946, DOI 10.3390/s100402946; Biet M, 2007, IEEE T ULTRASON FERR, V54, P2678, DOI 10.1109/TUFFC.2007.596; Deguchi T., 2010, J SURF FINISH SOC JA, V61, P305, DOI [10.4139/sfj.61.305, DOI 10.4139/SFJ.61.305]; Hirayama H, 1961, J MED ASS NIPPON MED, V28, P81; Hoshi T, 2010, IEEE T HAPTICS, V3, P155, DOI [10.1109/ToH.2010.4, 10.1109/TOH.2010.4]; Ishii T., 2002, Sixth International Conference on Motion and Vibration Control. Proceedings, P547; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; Ju BF, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3529880; Jungmann M, 2002, P EUR 2002, P12; Kajimoto H, 2004, IEEE COMPUT GRAPH, V24, P36, DOI 10.1109/MCG.2004.1255807; Kajimoto H, 2003, 11TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS - HAPTICS 2003, PROCEEDINGS, P40, DOI 10.1109/HAPTIC.2003.1191225; Kajimoto H, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P303, DOI 10.1109/HAPTIC.2002.998973; Kajimoto H, 2001, P IEEE VIRT REAL ANN, P289, DOI 10.1109/VR.2001.913801; Kajimoto H., 2003, PROC 13 INT S MEAS C, V13, P83; KAJIMOTO H, 1999, P 9 INT C ART REAL T, P107; Kitamura N, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/2/025016; Kitamura N., 2013, 2013 Transducers & Eurosensors XXVII: 17th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS & EUROSENSORS XXVII), P106, DOI 10.1109/Transducers.2013.6626712; KITAMURA N, 2014, MEMS 14, P1183, DOI DOI 10.1109/MEMSYS.2014.6765858; Kosemura Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JM11; Martanto W, 2006, J CONTROL RELEASE, V112, P357, DOI 10.1016/j.jconrel.2006.02.017; Montagna W, 1964, THE EPIDERMIS; Nakagawa H., 2010, J SURF FINISH SOC JA, V61, P58, DOI DOI 10.4139/SFJ.61.58; Srinivasan MA, 1996, J BIOMECH ENG-T ASME, V118, P48, DOI 10.1115/1.2795945; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3; WATANABE T, 1995, IEEE INT CONF ROBOT, P1134, DOI 10.1109/ROBOT.1995.525433; Yang TH, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P13, DOI 10.1109/WHC.2009.4810818; Zhang Y., 2011, IEEJ T SENSORS MICRO, V131, P141, DOI DOI 10.1541/ieejsmas.131.141; Zhang YH, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/8/085012	28	20	21	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148410	10.1371/journal.pone.0148410	http://dx.doi.org/10.1371/journal.pone.0148410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845336	Green Submitted, Green Published, gold			2022-12-26	WOS:000369552800054
J	Chen, TT; Zhang, L; Shang, HH; Liu, SD; Peng, J; Gong, WK; Shi, YZ; Zhang, SP; Li, JW; Gong, JW; Ge, Q; Liu, AY; Ma, HJ; Zhao, XH; Yuan, YL				Chen, Tingting; Zhang, Lei; Shang, Haihong; Liu, Shaodong; Peng, Jun; Gong, Wankui; Shi, Yuzhen; Zhang, Siping; Li, Junwen; Gong, Juwu; Ge, Qun; Liu, Aiying; Ma, Huijuan; Zhao, Xinhua; Yuan, Youlu			iTRAQ-Based Quantitative Proteomic Analysis of Cotton Roots and Leaves Reveals Pathways Associated with Salt Stress	PLOS ONE			English	Article							PROTEIN PROFILE ANALYSIS; SALINITY TOLERANCE; NA+/H+ ANTIPORT; PLANT-GROWTH; NACL STRESS; LIGNIN; MECHANISMS; BIOSYNTHESIS; RESPONSES; DROUGHT	Salinity is a major abiotic stress that affects plant growth and development. In this study, we performed a proteomic analysis of cotton roots and leaf tissue following exposure to saline stress. 611 and 1477 proteins were differentially expressed in the roots and leaves, respectively. In the roots, 259 (42%) proteins were up-regulated and 352 (58%) were down-regulated. In the leaves, 748 (51%) proteins were up-regulated and 729 (49%) were down-regulated. On the basis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, we concluded that the phenylalanine metabolism and starch and sucrose metabolism were active for energy homeostasis to cope with salt stress in cotton roots. Moreover, photosynthesis, pyruvate metabolism, glycolysis/gluconeogenesis, carbon fixation in photosynthetic organisms and phenylalanine metabolism were inhabited to reduce energy consumption. Characterization of the signaling pathways will help elucidate the mechanism activated by cotton in response to salt stress.	[Chen, Tingting; Zhang, Lei; Shang, Haihong; Liu, Shaodong; Peng, Jun; Gong, Wankui; Shi, Yuzhen; Zhang, Siping; Li, Junwen; Gong, Juwu; Ge, Qun; Liu, Aiying; Ma, Huijuan; Zhao, Xinhua; Yuan, Youlu] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Yuan, YL (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Peoples R China.	zhaoxh510@163.com; yylcri@126.com	Gǒng, Wànkuí/AAL-5622-2020	Gǒng, Wànkuí/0000-0002-8556-0669	National Natural Science Foundation of China [31301262, 31501343]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31301262 and 31501343).	Aharon GS, 2003, PLANT SOIL, V253, P245, DOI 10.1023/A:1024577205697; [Anonymous], [No title captured]; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; BLUMWALD E, 1987, PLANT PHYSIOL, V83, P884, DOI 10.1104/pp.83.4.884; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Casado-Vela J, 2010, PROTEOMICS, V10, P343, DOI 10.1002/pmic.200900509; Chu P, 2015, J PROTEOMICS, V113, P244, DOI 10.1016/j.jprot.2014.10.005; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Degenhardt B, 2000, J EXP BOT, V51, P595, DOI 10.1093/jexbot/51.344.595; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Gao L, 2011, PHYTOCHEMISTRY, V72, P1180, DOI 10.1016/j.phytochem.2010.12.008; Garratt LC, 2002, FREE RADICAL BIO MED, V33, P502, DOI 10.1016/S0891-5849(02)00838-9; Ge XY, 2015, J PROTEOME RES, V14, P268, DOI 10.1021/pr500688g; GOSSETT DR, 1994, CROP SCI, V34, P706, DOI 10.2135/cropsci1994.0011183X003400030020x; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Guo WX, 2012, PRECIS AGRIC, V13, P678, DOI 10.1007/s11119-012-9277-2; Hansson A, 2009, PHYSIOL PLANTARUM, V135, P214, DOI 10.1111/j.1399-3054.2008.01181.x; Hassan, 2002, ASIAN J PLANT SCI, DOI [10.3923/ajps.2002.715.719, DOI 10.3923/AJPS.2002.715.719]; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Jorrin-Novo JV, 2013, PLANT PROTEOMICS; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCL ACIDS RES; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; LANGE BM, 1995, PLANT PHYSIOL, V108, P1277, DOI 10.1104/pp.108.3.1277; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Liu J, 2015, J PROTEOMICS, V126, P68, DOI 10.1016/j.jprot.2015.05.031; Makowski GS, 2010, ADV CLIN CHEM, P188; Malakshah SN, 2007, BIOSCI BIOTECH BIOCH, V71, P2144, DOI 10.1271/bbb.70027; MARCUM KB, 1994, J AM SOC HORTIC SCI, V119, P779, DOI 10.21273/JASHS.119.4.779; Meloni DA, 2001, J PLANT NUTR, V24, P599, DOI 10.1081/PLN-100104983; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Neves GYS, 2010, J AGRON CROP SCI, V196, P467, DOI 10.1111/j.1439-037X.2010.00432.x; Nogueira FCS, 2012, J PROTEOME RES, V11, P3046, DOI 10.1021/pr300192f; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Owiti J, 2011, PLANT J, V67, P145, DOI 10.1111/j.1365-313X.2011.04582.x; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Qian P-Y, 2009, HUMAN GENOMICS PROTE, V2009, P239; Qidar M, 1997, J AGRON CROP SCI, V179, P101; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Salekdeh GH, 2007, PROTEOMICS, V7, P2976, DOI 10.1002/pmic.200700181; Sanchez-Aguayo I, 2004, PLANTA, V220, P278, DOI 10.1007/s00425-004-1350-2; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Schulze WX, 2010, ANNU REV PLANT BIOL, V61, P491, DOI 10.1146/annurev-arplant-042809-112132; Shi HT, 2014, PLANT PHYSIOL BIOCH, V82, P218, DOI 10.1016/j.plaphy.2014.06.006; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; SINGH AK, 1995, PHOTOSYNTHETICA, V31, P489; Song Y, 2011, J PROTEOMICS, V74, P1045, DOI 10.1016/j.jprot.2011.03.009; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Wienkoop S, 2006, J EXP BOT, V57, P1529, DOI 10.1093/jxb/erj157; Xie FL, 2014, PLANT BIOTECHNOL J, V12, P354, DOI 10.1111/pbi.12142; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yang LT, 2013, J PROTEOMICS, V93, P179, DOI 10.1016/j.jprot.2013.04.025; Yao Y, 2006, ELECTROPHORESIS, V27, P4559, DOI 10.1002/elps.200600111; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112807; Zhang L, 2013, J PLANT RES, V126, P293, DOI 10.1007/s10265-012-0533-3; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; Zhou YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065906; Zhu MM, 2009, MOL CELL PROTEOMICS, V8, P752, DOI 10.1074/mcp.M800343-MCP200	63	61	64	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148487	10.1371/journal.pone.0148487	http://dx.doi.org/10.1371/journal.pone.0148487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841024	Green Submitted, gold, Green Published			2022-12-26	WOS:000369550200141
J	Donertas, HM; Cuesta, SM; Rahman, SA; Thornton, JM				Donertas, Handan Melike; Cuesta, Sergio Martinez; Rahman, Syed Asad; Thornton, Janet M.			Characterising Complex Enzyme Reaction Data	PLOS ONE			English	Article							GENOME-SCALE CLASSIFICATION; METABOLIC REACTIONS; CATALYTIC PROMISCUITY; EC NUMBERS; PREDICTION; EVOLUTION; TOOL; CHLOROPEROXIDASE; REPRESENTATION; PURIFICATION	The relationship between enzyme-catalysed reactions and the Enzyme Commission (EC) number, the widely accepted classification scheme used to characterise enzyme activity, is complex and with the rapid increase in our knowledge of the reactions catalysed by enzymes needs revisiting. We present a manual and computational analysis to investigate this complexity and found that almost one-third of all known EC numbers are linked to more than one reaction in the secondary reaction databases (e.g., KEGG). Although this complexity is often resolved by defining generic, alternative and partial reactions, we have also found individual EC numbers with more than one reaction catalysing different types of bond changes. This analysis adds a new dimension to our understanding of enzyme function and might be useful for the accurate annotation of the function of enzymes and to study the changes in enzyme function during evolution.	[Donertas, Handan Melike; Cuesta, Sergio Martinez; Rahman, Syed Asad; Thornton, Janet M.] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England; [Donertas, Handan Melike] Middle E Tech Univ, Dept Biol Sci, TR-06531 Ankara, Turkey; [Cuesta, Sergio Martinez] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Middle East Technical University; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Thornton, JM (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.	thornton@ebi.ac.uk	Cuesta, Sergio Martínez/H-4820-2019; Donertas, Handan Melike/J-5451-2019	Cuesta, Sergio Martínez/0000-0001-9806-2805; Donertas, Handan Melike/0000-0002-9788-6535; Rahman, Syed Asad/0000-0002-7602-6675; Thornton, Janet/0000-0003-0824-4096	European Molecular Biology Laboratory; Turkish National Agency [2012-1-TR1-ERA02-37071]	European Molecular Biology Laboratory; Turkish National Agency(Turkiye Cumhuriyeti Kalkinma Bakanligi)	This work was supported by the European Molecular Biology Laboratory (SMC, SAR, JMT) (http://www.embl.de/), the European Molecular Biology Laboratory International PhD programme (SMC) (http://www.embl.de/training/eipp/) and the Turkish National Agency (2012-1-TR1-ERA02-37071) for funding through an Erasmus Placement Activity (HMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara R, 2012, NUCLEIC ACIDS RES, V40, pD754, DOI 10.1093/nar/gkr1126; Anton BP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001638; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Apweiler R, 2010, NAT CHEM BIOL, V6, P785, DOI 10.1038/nchembio.460; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babbitt PC, 2003, CURR OPIN CHEM BIOL, V7, P230, DOI 10.1016/S1367-5931(03)00028-0; Bastard K, 2014, NAT CHEM BIOL, V10, P42, DOI 10.1038/NCHEMBIO.1387; Bernard T, 2014, BRIEF BIOINFORM, V15, P123, DOI 10.1093/bib/bbs058; Brecher J, 2008, PURE APPL CHEM, V80, P277, DOI 10.1351/pac200880020277; Chen WL, 2013, WIRES COMPUT MOL SCI, V3, P560, DOI 10.1002/wcms.1140; Cornish-Bowden A., 2014, PERSPECT SCI, V1, P74, DOI DOI 10.1016/J.PISC.2014.02.006; Cuesta SM, 2014, CURR OPIN STRUC BIOL, V26, P121, DOI 10.1016/j.sbi.2014.06.002; Daenzer JMI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002721; desJardins M, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P92; Egelhofer V, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000661; Foster JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013576; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Gardossi L, 2010, TRENDS BIOTECHNOL, V28, P171, DOI 10.1016/j.tibtech.2010.01.001; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Geyer P, 2013, WORLD PAT INF, V35, P178, DOI 10.1016/j.wpi.2013.05.002; Green ML, 2005, NUCLEIC ACIDS RES, V33, P4035, DOI 10.1093/nar/gki711; Hofmann B, 1998, J MOL BIOL, V279, P889, DOI 10.1006/jmbi.1998.1802; Holliday GL, 2011, FEBS J, V278, P3835, DOI 10.1111/j.1742-4658.2011.08190.x; Hu XY, 2010, J CHEM INF MODEL, V50, P1089, DOI 10.1021/ci9004833; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; Kaltenbach M, 2014, J EXP ZOOL PART B, V322, P468, DOI 10.1002/jez.b.22562; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kawashima S, 2003, GENOME INFORMATICS, V14, P673; Kazlauskas RJ, 2005, CURR OPIN CHEM BIOL, V9, P195, DOI 10.1016/j.cbpa.2005.02.008; Kimura Y, 2001, PLANT CELL PHYSIOL, V42, P1169, DOI 10.1093/pcp/pce130; Kotera M, 2004, J AM CHEM SOC, V126, P16487, DOI 10.1021/ja0466457; Kotera M., 2014, PERSPECT SCI, V1, P24; Kotera M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001537; Kraut H, 2013, J CHEM INF MODEL, V53, P2884, DOI 10.1021/ci400442f; KUHM AE, 1990, BIOCHEM J, V266, P877; Kumar A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-6; Lang MR, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-42; Latino DARS, 2006, ANGEW CHEM INT EDIT, V45, P2066, DOI 10.1002/anie.200503833; Latino DARS, 2008, BIOINFORMATICS, V24, P2236, DOI 10.1093/bioinformatics/btn405; Latino DARS, 2009, J CHEM INF MODEL, V49, P1839, DOI 10.1021/ci900104b; LIM YH, 1993, J BACTERIOL, V175, P4213, DOI 10.1128/JB.175.13.4213-4217.1993; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; McDonald AG, 2014, FEBS J, V281, P583, DOI 10.1111/febs.12530; McDonald AG, 2009, NUCLEIC ACIDS RES, V37, pD593, DOI 10.1093/nar/gkn582; Messerschmidt A, 1996, P NATL ACAD SCI USA, V93, P392, DOI 10.1073/pnas.93.1.392; Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870; Mu FP, 2006, BIOINFORMATICS, V22, P3082, DOI 10.1093/bioinformatics/btl535; Mu FP, 2011, BIOINFORMATICS, V27, P1537, DOI 10.1093/bioinformatics/btr177; O'Boyle NM, 2007, J MOL BIOL, V368, P1484, DOI 10.1016/j.jmb.2007.02.065; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Oberhardt MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001116; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; Ott MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-517; PIEPER DH, 1993, ARCH MICROBIOL, V160, P169; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rahman SA, 2014, NAT METHODS, V11, P171, DOI [10.1038/NMETH.2803, 10.1038/nmeth.2803]; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Renirie R, 2000, BIOCHEMISTRY-US, V39, P1133, DOI 10.1021/bi9921790; Sacher O, 2009, J CHEM INF MODEL, V49, P1525, DOI 10.1021/ci800277f; Saha R, 2014, CURR OPIN BIOTECH, V29, P39, DOI 10.1016/j.copbio.2014.02.011; Schomburg I, 2014, PERSPECTIVESCI, V1, P15, DOI DOI 10.1016/J.PISC.2014.02.002; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Schomburg KT, 2013, DRUG DISCOV TODAY, V18, P651, DOI 10.1016/j.drudis.2013.02.001; Shaw R, 2012, CURR SCI INDIA, V103, P1328; Shearer AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097250; SIMMONS ES, 1991, J CHEM INF COMP SCI, V31, P45, DOI 10.1021/ci00001a007; Sorokina M, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-10; Tipton K, 2000, BIOINFORMATICS, V16, P34, DOI 10.1093/bioinformatics/16.1.34; Tipton K. F., 2014, PERSPECT SCI, V1, P131, DOI [10.1016/j.pisc.2014.02.012, DOI 10.1016/J.PISC.2014.02.012]; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Trivino JC, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-46; Warr WA, 2014, MOL INFORM, V33, P469, DOI 10.1002/minf.201400052; Warr WA, 2011, WIRES COMPUT MOL SCI, V1, P557, DOI 10.1002/wcms.36; Woggon WD, 2001, J INORG BIOCHEM, V83, P289, DOI 10.1016/S0162-0134(00)00175-6; ZASS E, 1990, J CHEM INF COMP SCI, V30, P360, DOI 10.1021/ci00068a004	76	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147952	10.1371/journal.pone.0147952	http://dx.doi.org/10.1371/journal.pone.0147952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840640	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200073
J	Logan, JJ; Jolly, AM; Blanford, JI				Logan, James J.; Jolly, Ann M.; Blanford, Justine I.			The Sociospatial Network: Risk and the Role of Place in the Transmission of Infectious Diseases	PLOS ONE			English	Article							INJECTION-DRUG USERS; SEXUAL NETWORK; HIV; GONORRHEA; TUBERCULOSIS; PREVALENCE; CENTRALITY; DYNAMICS; OUTBREAK; MEXICO	Control of sexually transmitted infections and blood-borne pathogens is challenging due to their presence in groups exhibiting complex social interactions. In particular, sharing injection drug use equipment and selling sex (prostitution) puts people at high risk. Previous work examining the involvement of risk behaviours in social networks has suggested that social and geographic distance of persons within a group contributes to these pathogens' endemicity. In this study, we examine the role of place in the connectedness of street people, selected by respondent driven sampling, in the transmission of blood-borne and sexually transmitted pathogens. A sample of 600 injection drug users, men who have sex with men, street youth and homeless people were recruited in Winnipeg, Canada from January to December, 2009. The residences of participants and those of their social connections were linked to each other and to locations where they engaged in risk activity. Survey responses identified 101 unique sites where respondents participated in injection drug use or sex transactions. Risk sites and respondents' residences were geocoded, with residence representing the individuals. The sociospatial network and estimations of geographic areas most likely to be frequented were mapped with network graphs and spatially using a Geographic Information System (GIS). The network with the most nodes connected 7.7% of respondents; consideration of the sociospatial network increased this to 49.7%. The mean distance between any two locations in the network was within 3.5 kilometres. Kernel density estimation revealed key activity spaces where the five largest networks overlapped. Here, the combination of spatial and social entities in network analysis defines the overlap of vulnerable populations in risk space, over and above the person to person links. Implications of this work are far reaching, not just for understanding transmission dynamics of sexually transmitted infections by identifying activity "hotspots" and their intersection with each social network, but also for the spread of other diseases (e.g. tuberculosis) and targeting prevention services.	[Logan, James J.; Jolly, Ann M.] Univ Ottawa, Sch Epidemiol Publ Hlth & Preventat Med, Ottawa, ON, Canada; [Logan, James J.; Blanford, Justine I.] Penn State Univ, Dept Geog, Dutton Inst E Educ, University Pk, PA 16802 USA; [Logan, James J.; Blanford, Justine I.] Penn State Univ, GeoVISTA Ctr, University Pk, PA 16802 USA	University of Ottawa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Logan, JJ (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Preventat Med, Ottawa, ON, Canada.; Logan, JJ (corresponding author), Penn State Univ, Dept Geog, Dutton Inst E Educ, University Pk, PA 16802 USA.; Logan, JJ (corresponding author), Penn State Univ, GeoVISTA Ctr, University Pk, PA 16802 USA.	jay.logan@gmail.com		Blanford, Justine/0000-0003-0844-9390	Canadian Institutes of Health Research [177297]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work in this manuscript was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) grant number 177297. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alere, 2012, ACT PROM SUMM CLIN E; ArcGIS. Environmental Systems Research Institute, ARCGIS; Batagelj V., 1996, PAJEK PROGRAM LARGE; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brewer DD, 2002, ADV MED SOC, V8, P131; Brouwer KC, 2012, ANN ASSOC AM GEOGR, V102, P1190, DOI 10.1080/00045608.2012.674896; Cabral T, 2003, J INFECT DIS, V187, P279, DOI 10.1086/346048; Centers for Disease Control and Prevention, 2013, CDC FACT SHEET INC P; City of Winnipeg, CITY OF WINNIPEG OPE; Cummins S, 2007, SOC SCI MED, V65, P1825, DOI 10.1016/j.socscimed.2007.05.036; DAngelo-Scott H, 2015, CAN J INFEC IN PRESS; De P, 2004, SEX TRANSM INFECT, V80, P280, DOI 10.1136/sti.2003.007187; De P, 2007, ADDICTION, V102, P1730, DOI 10.1111/j.1360-0443.2007.01936.x; Emch M, 2012, ANN ASSOC AM GEOGR, V102, P1004, DOI 10.1080/00045608.2012.671129; Frost SDW, 2006, J URBAN HEALTH, V83, pI83, DOI 10.1007/s11524-006-9104-z; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; Heckathorn DD, 2002, AIDS BEHAV, V6, P55; Jolly AM, 2001, SEX TRANSM DIS, V28, P200, DOI 10.1097/00007435-200104000-00003; Khan K, 2011, EMERG INFECT DIS, V17, P357, DOI 10.3201/eid1703.100833; Klovdahl AS, 2001, SOC SCI MED, V52, P681, DOI 10.1016/S0277-9536(00)00170-2; Martinez AN, 2014, INT J DRUG POLICY, V25, P516, DOI 10.1016/j.drugpo.2013.11.008; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; POTTERAT JJ, 1985, SEX TRANSM DIS, V12, P25, DOI 10.1097/00007435-198501000-00006; Public Health Agency of Canada, 2014, GLANC HIV AIDS CAN S; Public Health Agency of Canada, 2010, CAN GUID SEX TRANSM; Remis RS, 2007, MODELLING INCIDENCE; Rothenberg R, 2005, SEX TRANSM DIS, V32, P506, DOI 10.1097/01.olq.0000161191.12026.ca; ROTHENBERG RB, 1983, AM J EPIDEMIOL, V117, P688, DOI 10.1093/oxfordjournals.aje.a113602; Rudolph AE, 2013, ANN EPIDEMIOL, V23, P267, DOI 10.1016/j.annepidem.2013.02.006; Shane A, 2011, ISS SUBST C VANC BC; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHO, 2012, GLOB INC PREV SEL CU; Wylie JL, 2005, J INFECT DIS, V191, P899, DOI 10.1086/427661; Wylie JL, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-93	38	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146915	10.1371/journal.pone.0146915	http://dx.doi.org/10.1371/journal.pone.0146915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840891	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200022
J	Mansfeldt, CB; Richter, LV; Ahner, BA; Cochlan, WP; Richardson, RE				Mansfeldt, Cresten B.; Richter, Lubna V.; Ahner, Beth A.; Cochlan, William P.; Richardson, Ruth E.			Use of De Novo Transcriptome Libraries to Characterize a Novel Oleaginous Marine Chlorella Species during the Accumulation of Triacylglycerols	PLOS ONE			English	Article							ARTIFICIAL SEAWATER MEDIUM; RNA-SEQ ANALYSIS; LIPID-ACCUMULATION; NITROGEN DEPRIVATION; BIOFUEL PRODUCTION; CHLAMYDOMONAS; MICROALGAE; GENE; EXPRESSION; BIODIESEL	Marine chlorophytes of the genus Chlorella are unicellular algae capable of accumulating a high proportion of cellular lipids that can be used for biodiesel production. In this study, we examined the broad physiological capabilities of a subtropical strain (C596) of Chlorella sp. "SAG-211-18" including its heterotrophic growth and tolerance to low salt. We found that the alga replicates more slowly at diluted salt concentrations and can grow on a wide range of carbon substrates in the dark. We then sequenced the RNA of Chlorella strain C596 to elucidate key metabolic genes and investigate the transcriptomic response of the organism when transitioning from a nutrient-replete to a nutrient-deficient condition when neutral lipids accumulate. Specific transcripts encoding for enzymes involved in both starch and lipid biosynthesis, among others, were up-regulated as the cultures transitioned into a lipid-accumulating state whereas photosynthesis-related genes were down-regulated. Transcripts encoding for two of the up-regulated enzymes-a galactoglycerolipid lipase and a diacylglyceride acyl-transferase-were also monitored by reverse transcription quantitative polymerase chain reaction assays. The results of these assays confirmed the transcriptome-sequencing data. The present transcriptomic study will assist in the greater understanding, more effective application, and efficient design of Chlorella-based biofuel production systems.	[Mansfeldt, Cresten B.; Richter, Lubna V.; Ahner, Beth A.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Cochlan, William P.] San Francisco State Univ, Romberg Tiburon Ctr Environm Studies, Tiburon, CA USA; [Richardson, Ruth E.] Cornell Univ, Dept Civil & Environm Engn, Ithaca, NY 14853 USA	Cornell University; California State University System; San Francisco State University; Cornell University	Mansfeldt, CB (corresponding author), Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA.	cbm59@cornell.edu	Richardson, Ruth E/B-8265-2017		United States Department of Energy [DE-EE0003371]; Direct For Biological Sciences [1227231] Funding Source: National Science Foundation	United States Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The United States Department of Energy (www.energy.gov) provided funding under grant number DE-EE0003371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Peter Schweitzer, Dr. Qi Sun and Dr. Jennifer Mosher at Cornell University's Core Genomics Facility and Computational Biology Service Unit for sample preparation and sequencing and for advice on transcriptome analyses. Additionally, we thank Dr. Robert Bidigare (University of Hawaii) for performing lipid analyses, Dr. Zachary Johnson (Duke University) and Susan Brown (University of Hawaii) for providing the algal cultures, and Mr. Julian Herndon and Mr. Christopher Ikeda (SFSU) for assisting with culture experimentation. We also thank our funding source, the Department of Energy (DE-EE0003371).	Alexander H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00385; Andersen RA, 2005, RECIPES FRESHWATER S, P429; Berges JA, 2004, J PHYCOL, V40, P619, DOI 10.1111/j.1529-8817.2004.40301.x; Berges JA, 2001, J PHYCOL, V37, P1138, DOI 10.1046/j.1529-8817.2001.01052.x; Bittar TB, 2013, J PHYCOL, V49, P523, DOI 10.1111/jpy.12060; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Bogren K, 2002, 31115011H QUICKCHEM; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Bradley T, 2015, APPL ENERG, V154, P1052, DOI 10.1016/j.apenergy.2014.12.087; Cagliari A., 2011, International Journal of Plant Biology, V2, P40; Cakmak ZE, 2014, BIORESOURCE TECHNOL, V155, P379, DOI 10.1016/j.biortech.2013.12.093; Campenni' L, 2013, APPL MICROBIOL BIOT, V97, P1383, DOI 10.1007/s00253-012-4570-6; Cochlan WP, 2014, POSTER PRESENTED AT; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fan JH, 2015, PLANT PHYSIOL, V169, P2444, DOI 10.1104/pp.15.01174; Fan JH, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-17; Gao CF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-582; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Goodenough U, 2014, EUKARYOT CELL, V13, P591, DOI 10.1128/EC.00013-14; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HARRISON PJ, 1980, J PHYCOL, V16, P28, DOI 10.1111/j.1529-8817.1980.tb02994.x; Hildebrand M, 2013, CURR OPIN CHEM BIOL, V17, P506, DOI 10.1016/j.cbpa.2013.02.027; Ho SH, 2014, BIOTECHNOL ADV, V32, P1448, DOI 10.1016/j.biotechadv.2014.09.002; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hung CH, 2013, FEBS LETT, V587, P2364, DOI 10.1016/j.febslet.2013.06.002; Huss VAR, 1999, J PHYCOL, V35, P587, DOI 10.1046/j.1529-8817.1999.3530587.x; Johnson ZI, PLOS ONE IN PRESS; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim S, 2013, BIORESOURCE TECHNOL, V144, P8, DOI 10.1016/j.biortech.2013.06.068; Klok AJ, 2014, TRENDS BIOTECHNOL, V32, P521, DOI 10.1016/j.tibtech.2014.07.004; Koid A, 2012, APPL ENVIRON MICROB, V78, P3958, DOI 10.1128/AEM.06941-11; Kong WB, 2013, FOOD TECHNOL BIOTECH, V51, P62; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2015, ALGAL RES, V11, P381, DOI 10.1016/j.algal.2015.02.028; Li TT, 2013, BIORESOURCE TECHNOL, V131, P60, DOI 10.1016/j.biortech.2012.11.121; Li XB, 2012, PLANT CELL, V24, P4670, DOI 10.1105/tpc.112.105106; Li XB, 2012, EUKARYOT CELL, V11, P1451, DOI 10.1128/EC.00268-12; Li-Beisson Y, 2015, PLANT J, V82, P504, DOI 10.1111/tpj.12787; Liang YN, 2009, BIOTECHNOL LETT, V31, P1043, DOI 10.1007/s10529-009-9975-7; Lu WD, 2015, BIORESOURCE TECHNOL, V191, P433, DOI 10.1016/j.biortech.2015.02.069; Martin GJO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103389; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Muhlroth A, 2013, MAR DRUGS, V11, P4662, DOI 10.3390/md11114662; Nan Y, 2015, J SUPERCRIT FLUID, V97, P174, DOI 10.1016/j.supflu.2014.08.025; National Research Council, 2012, SUST DEV ALG BIOF US; PRICE N M, 1988, Biological Oceanography, V6, P443; Qiao HJ, 2009, CHIN J OCEANOL LIMN, V27, P762, DOI 10.1007/s00343-009-9216-x; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sheehan J., 1998, LOOK BACK US DEP ENE, V328; SHIFRIN NS, 1981, J PHYCOL, V17, P374, DOI 10.1111/j.0022-3646.1981.00374.x; Simon DF, 2013, APPL ENVIRON MICROB, V79, P4774, DOI 10.1128/AEM.00998-13; SMITH P, 2001, 31107041E QUICKCHEM; Sun X, 2014, GENET MOL RES, V13, P8411, DOI 10.4238/2014.October.20.17; Sun X, 2014, BOT MAR, V57, P403, DOI 10.1515/bot-2014-0013; Sun ZL, 2016, PLANT BIOTECHNOL J, V14, P557, DOI 10.1111/pbi.12398; Tang HY, 2011, BIOTECHNOL BIOENG, V108, P2280, DOI 10.1002/bit.23160; Vieler A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003064; VOLKMAN JK, 1989, J EXP MAR BIOL ECOL, V128, P219, DOI 10.1016/0022-0981(89)90029-4; Wan MX, 2014, APPL MICROBIOL BIOT, V98, P9473, DOI 10.1007/s00253-014-6088-6; Williams PJL, 2010, ENERG ENVIRON SCI, V3, P554, DOI 10.1039/b924978h; Yu MJ, 2016, MAR GENOM, V25, P69, DOI 10.1016/j.margen.2015.11.005; Zhu LD, 2015, RENEW SUST ENERG REV, V41, P1376, DOI 10.1016/j.rser.2014.09.040	71	9	10	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147527	10.1371/journal.pone.0147527	http://dx.doi.org/10.1371/journal.pone.0147527			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840425	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200043
J	Moll, J; Hoppe, B; Konig, S; Wubet, T; Buscot, F; Kruger, D				Moll, Julia; Hoppe, Bjoern; Koenig, Stephan; Wubet, Tesfaye; Buscot, Francois; Krueger, Dirk			Spatial Distribution of Fungal Communities in an Arable Soil	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; MICROBIAL COMMUNITIES; MULTIVARIATE-ANALYSIS; VERTICAL-DISTRIBUTION; SPECIES RICHNESS; LAND-USE; DIVERSITY; BACTERIAL; YEASTS; ROOTS	Fungi are prominent drivers of ecological processes in soils, so that fungal communities across different soil ecosystems have been well investigated. However, for arable soils taxonomically resolved fine-scale studies including vertical itemization of fungal communities are still missing. Here, we combined a cloning/Sanger sequencing approach of the ITS/LSU region as marker for general fungi and of the partial SSU region for arbuscular mycorrhizal fungi (AMF) to characterize the microbiome in different maize soil habitats. Four compartments were analyzed over two annual cycles 2009 and 2010: a) ploughed soil in 0-10 cm, b) rooted soil in 40-50 cm, c) root-free soil in 60-70 cm soil depth and d) maize roots. Ascomycota was the most dominant phylum across all compartments. Fungal communities including yeasts and AMF differed strongly between compartments. Inter alia, Tetracladium, the overall largest MOTU (molecular operational taxonomic unit), occurred in all compartments, whereas Trichosporon dominated all soil compartments. Sequences belonging to unclassified Helotiales were forming the most abundant MOTUs exclusively present in roots. This study gives new insights on spatial distribution of fungi and helps to link fungal communities to specific ecological properties such as varying resources, which characterize particular niches of the heterogeneous soil environment.	[Moll, Julia; Hoppe, Bjoern; Wubet, Tesfaye; Buscot, Francois; Krueger, Dirk] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Theodor Lieser Str 4, D-06120 Halle, Saale, Germany; [Moll, Julia; Buscot, Francois] Univ Leipzig, Inst Biol, Johannisallee 21-23, D-04103 Leipzig, Germany; [Koenig, Stephan] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants JKI Inst Natl & Int, Messeweg 11-12, D-38104 Braunschweig, Germany; [Wubet, Tesfaye; Buscot, Francois] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Julius Kuhn-Institut	Moll, J (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Theodor Lieser Str 4, D-06120 Halle, Saale, Germany.; Moll, J (corresponding author), Univ Leipzig, Inst Biol, Johannisallee 21-23, D-04103 Leipzig, Germany.	julia.moll@ufz.de	Koenig, Stephan/GRX-2480-2022; Buscot, Francois/A-4125-2016; Wubet, Tesfaye/C-6241-2012; Kruger, Dirk/C-3316-2012	Buscot, Francois/0000-0002-2364-0006; Wubet, Tesfaye/0000-0001-8572-4486; Kruger, Dirk/0000-0002-7305-5104; Hoppe, Bjorn/0000-0001-8689-4911	German Research Foundation (DFG) Research Unit FOR 918	German Research Foundation (DFG) Research Unit FOR 918(German Research Foundation (DFG))	The study was supported by the German Research Foundation (DFG) (http://www.dfg.de/) Research Unit FOR 918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguacil MM, 2008, ECOL APPL, V18, P527, DOI 10.1890/07-0521.1; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P2898, DOI 10.1111/j.1365-2486.2008.01716.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bahram M, 2015, NEW PHYTOL, V205, P1454, DOI 10.1111/nph.13206; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; Becklin KM, 2012, MICROB ECOL, V63, P682, DOI 10.1007/s00248-011-9968-7; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Blaalid R, 2012, MOL ECOL, V21, P1897, DOI 10.1111/j.1365-294X.2011.05214.x; Borriello R, 2012, BIOL FERT SOILS, V48, P911, DOI 10.1007/s00374-012-0683-4; Botha A, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P221, DOI 10.1007/3-540-30985-3_11; Botha A, 2011, SOIL BIOL BIOCHEM, V43, P1, DOI 10.1016/j.soilbio.2010.10.001; Bridge PD, 2009, FUNGAL ECOL, V2, P66, DOI 10.1016/j.funeco.2008.10.008; Brito I, 2012, SOIL TILL RES, V121, P63, DOI 10.1016/j.still.2012.01.012; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Buscot F, 2015, J PLANT PHYSIOL, V172, P55, DOI 10.1016/j.jplph.2014.08.013; Chagnon PL, 2013, TRENDS PLANT SCI, V18, P484, DOI 10.1016/j.tplants.2013.05.001; Ciccolini V, 2015, BIOL FERT SOILS, V51, P719, DOI 10.1007/s00374-015-1013-4; Cloete KJ, 2009, MICROB ECOL, V57, P624, DOI 10.1007/s00248-008-9457-9; Cocolin L, 2000, FEMS MICROBIOL LETT, V189, P81, DOI 10.1016/S0378-1097(00)00257-3; Connell L, 2006, SOIL BIOL BIOCHEM, V38, P3083, DOI 10.1016/j.soilbio.2006.02.016; Cuenca G, 2010, BOTANY, V88, P54, DOI 10.1139/B09-100; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; de Castro AP, 2008, ARCH MICROBIOL, V190, P129, DOI 10.1007/s00203-008-0374-6; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; El-Mehalawy A. A., 2004, International Journal of Agriculture and Biology, V6, P599; Gai JP, 2015, J SOIL SEDIMENT, V15, P1200, DOI 10.1007/s11368-015-1060-3; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartmann M, 2009, ENVIRON MICROBIOL, V11, P3045, DOI 10.1111/j.1462-2920.2009.02008.x; Helgason BL, 2010, APPL SOIL ECOL, V46, P390, DOI 10.1016/j.apsoil.2010.10.002; Higo M, 2013, BIOL FERT SOILS, V49, P1085, DOI 10.1007/s00374-013-0807-5; Hoffland E, 2004, FRONT ECOL ENVIRON, V2, P258; IUSS WGW, 2007, WORLD SOIL RES REP, V103; Jumpponen A, 2010, MYCOLOGIA, V102, P1027, DOI 10.3852/09-316; Klaubauf S, 2010, FUNGAL DIVERS, V44, P65, DOI 10.1007/s13225-010-0053-1; Konig S, 2010, APPL ENVIRON MICROB, V76, P3765, DOI 10.1128/AEM.02951-09; Kramer S, 2012, PEDOBIOLOGIA, V55, P111, DOI 10.1016/j.pedobi.2011.12.001; Kuhnert R, 2012, MICROB ECOL, V64, P79, DOI 10.1007/s00248-011-0001-y; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lynch MDJ, 2006, APPL ENVIRON MICROB, V72, P7050, DOI 10.1128/AEM.00826-06; Ma AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066146; Moll J, 2015, MICROB ECOL, V70, P390, DOI 10.1007/s00248-015-0569-8; Money N. P., 2007, BIOL FUNGAL CELL, P237; Morris EK, 2013, BIODIVERS CONSERV, V22, P2193, DOI 10.1007/s10531-013-0527-z; Muleta D, 2008, BIOL FERT SOILS, V44, P653, DOI 10.1007/s00374-007-0261-3; Oehl F, 2005, NEW PHYTOL, V165, P273, DOI 10.1111/j.1469-8137.2004.01235.x; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Pan JJ, 2008, NEW PHYTOL, V178, P147, DOI 10.1111/j.1469-8137.2007.02350.x; Pausch J, 2013, PLANT SOIL, V364, P273, DOI 10.1007/s11104-012-1363-8; Pausch J, 2012, SOIL BIOL BIOCHEM, V55, P40, DOI 10.1016/j.soilbio.2012.06.007; R Core Team, 2021, R LANGUAGE ENV STAT; Renker C, 2006, MYCORRHIZA, V16, P525, DOI 10.1007/s00572-006-0067-4; Renker C, 2004, FEMS YEAST RES, V4, P597, DOI 10.1016/j.femsyr.2004.01.001; Rime T, 2015, MOL ECOL, V24, P1091, DOI 10.1111/mec.13051; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Scharroba A, 2012, SOIL BIOL BIOCHEM, V50, P1, DOI 10.1016/j.soilbio.2012.03.002; Selosse MA, 2008, NEW PHYTOL, V178, P3, DOI 10.1111/j.1469-8137.2008.02390.x; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Singh BK, 2009, APPL SOIL ECOL, V41, P239, DOI 10.1016/j.apsoil.2008.10.003; Slavikova E, 2003, J BASIC MICROB, V43, P430, DOI 10.1002/jobm.200310277; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stursova M, 2012, FEMS MICROBIOL ECOL, V80, P735, DOI 10.1111/j.1574-6941.2012.01343.x; Tian H, 2011, APPL SOIL ECOL, V47, P141, DOI 10.1016/j.apsoil.2011.01.002; Torrecillas E, 2012, PLANT SOIL, V354, P97, DOI 10.1007/s11104-011-1047-9; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; Verbruggen E, 2012, MOL ECOL, V21, P2341, DOI 10.1111/j.1365-294X.2012.05534.x; Vishniac HS, 2006, MICROB ECOL, V52, P90, DOI 10.1007/s00248-006-9066-4; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Wubet T, 2006, MYCOL RES, V110, P1059, DOI 10.1016/j.mycres.2006.04.005; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Xu LH, 2012, FEMS MICROBIOL ECOL, V82, P736, DOI 10.1111/j.1574-6941.2012.01445.x; Yurkov AM, 2012, FUNGAL ECOL, V5, P24, DOI 10.1016/j.funeco.2011.07.004; Yurkov AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023671	77	46	48	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148130	10.1371/journal.pone.0148130	http://dx.doi.org/10.1371/journal.pone.0148130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840453	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200083
J	Rudolph, S; Klein, AN; Tusche, M; Schlosser, C; Elfgen, A; Brener, O; Teunissen, C; Gremer, L; Funke, SA; Kutzsche, J; Willbold, D				Rudolph, Stephan; Klein, Antonia Nicole; Tusche, Markus; Schlosser, Christine; Elfgen, Anne; Brener, Oleksandr; Teunissen, Charlotte; Gremer, Lothar; Funke, Susanne Aileen; Kutzsche, Janine; Willbold, Dieter			Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SECRETASE INHIBITORS; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; TRANSGENIC MICE; ION-CHANNEL; OLIGOMERS; LIGANDS; RELEVANCE; AD	Alzheimer's disease is the most prominent type of dementia and currently no causative treatment is available. According to recent studies, oligomeric species of the amyloid beta (A beta) peptide appear to be the most toxic A beta assemblies. A beta monomers, however, may be not toxic per se and may even have a neuroprotective role. Here we describe a competitive mirror image phage display procedure that allowed us to identify preferentially A beta(1-42) monomer binding and thereby stabilizing peptides, which destabilize and thereby eliminate toxic oligomer species. One of the peptides, called Mosd1 (monomer specific d-peptide 1), was characterized in more detail. Mosd1 abolished oligomers from a mixture of A beta(1-)42 species, reduced A beta(1-42) toxicity in cell culture, and restored the physiological phenotype in neuronal cells stably transfected with the gene coding for human amyloid precursor protein.	[Rudolph, Stephan; Klein, Antonia Nicole; Tusche, Markus; Schlosser, Christine; Elfgen, Anne; Brener, Oleksandr; Gremer, Lothar; Funke, Susanne Aileen; Kutzsche, Janine; Willbold, Dieter] Forschungszentrum Julich, Res Ctr, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany; [Funke, Susanne Aileen] Hsch Angew Wissensch Coburg, Fak Angew Nat Wissensch, D-96450 Coburg, Germany; [Brener, Oleksandr; Gremer, Lothar; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Teunissen, Charlotte] VU Univ Med Ctr Amsterdam, Neurochem Lab & Biobank, Amsterdam, Netherlands	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Willbold, D (corresponding author), Forschungszentrum Julich, Res Ctr, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany.; Willbold, D (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany.	d.willbold@fz-juelich.de	Willbold, Dieter/A-6280-2013; Kutzsche, Janine/G-6287-2013; Gremer, Lothar/H-9128-2013	Willbold, Dieter/0000-0002-0065-7366; Kutzsche, Janine/0000-0003-0271-7390; Gremer, Lothar/0000-0001-7065-5027; Brener, Oleksandr/0000-0001-9771-7515; Elfgen, Anne/0000-0002-0548-2964	Portfolio Technology and Medicine; Helmholtz-Validierungsfonds of "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft"; TT-Fonds of Technology Transfer Department of Forschungszentrum Julich	Portfolio Technology and Medicine; Helmholtz-Validierungsfonds of "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft"; TT-Fonds of Technology Transfer Department of Forschungszentrum Julich	D.W. was supported by grants from the "Portfolio Technology and Medicine", the "Portfolio Drug Re-search" and the Helmholtz-Validierungsfonds of the "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft". This project was also supported by the TT-Fonds of the Technology Transfer Department of the Forschungszentrum Julich.	BAUER J, 1994, FORTSCHR NEUROL PSYC, V62, P417, DOI 10.1055/s-2007-1002299; Brener O, 2015, SCI REP-UK, V5, DOI 10.1038/srep13222; Chang HN, 2015, ANGEW CHEM INT EDIT, V54, P11760, DOI 10.1002/anie.201506225; Chemerovski-Glikman M, 2014, TETRAHEDRON, V70, P7639, DOI 10.1016/j.tet.2014.07.097; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; Connelly L, 2012, J PHYS CHEM B, V116, P1728, DOI 10.1021/jp2108126; Du DG, 2011, BIOCHEMISTRY-US, V50, P1607, DOI 10.1021/bi1013744; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Funke SA, 2009, MOL BIOSYST, V5, P783, DOI 10.1039/b904138a; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hoffmann S, 2010, MOL BIOSYST, V6, P126, DOI 10.1039/b910945e; James TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049728; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Lu CJ, 2012, BIOORG MED CHEM LETT, V22, P7683, DOI 10.1016/j.bmcl.2012.09.105; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mikulca JA, 2014, J CLIN PHARM THER, V39, P25, DOI 10.1111/jcpt.12112; Olsauskas-Kuprys R, 2013, ONCOTARGETS THER, V6, P943, DOI 10.2147/OTT.S33766; Paranjape GS, 2013, J NEUROIMMUNE PHARM, V8, P312, DOI 10.1007/s11481-012-9424-6; Poduslo JF, 1999, J NEUROBIOL, V39, P371, DOI 10.1002/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.3.CO;2-5; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ritchie K, 2002, LANCET, V360, P1759, DOI 10.1016/S0140-6736(02)11667-9; Rzepecki P, 2004, J BIOL CHEM, V279, P47497, DOI 10.1074/jbc.M405914200; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Sela M, 1997, FASEB J, V11, P449; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sharoar MG, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-104; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Sun N, 2012, J BIOTECHNOL, V161, P121, DOI 10.1016/j.jbiotec.2012.05.019; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Tugyi R, 2005, P NATL ACAD SCI USA, V102, P413, DOI 10.1073/pnas.0407677102; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; van Groen T, 2009, CHEMMEDCHEM, V4, P276, DOI 10.1002/cmdc.200800289; Van Regenmortel MHV, 1998, CURR OPIN BIOTECH, V9, P377, DOI 10.1016/S0958-1669(98)80011-6; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; Welch BD, 2010, J VIROL, V84, P11235, DOI 10.1128/JVI.01339-10; Wiesehan K, 2003, CHEMBIOCHEM, V4, P811, DOI 10.1002/cbic.200300570; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Yin RH, 2014, CURR ALZHEIMER RES, V11, P755, DOI 10.2174/156720501108140910121425; Zahs KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00028; Zettl H, 2012, ACS CHEM BIOL, V7, P1488, DOI 10.1021/cb3001952	53	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147470	10.1371/journal.pone.0147470	http://dx.doi.org/10.1371/journal.pone.0147470			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840229	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200041
J	Bernard, J; Hutet, E; Paboeuf, F; Randriamparany, T; Holzmuller, P; Lancelot, R; Rodrigues, V; Vial, L; Le Potier, MF				Bernard, Jennifer; Hutet, Evelyne; Paboeuf, Frederic; Randriamparany, Tantely; Holzmuller, Philippe; Lancelot, Renaud; Rodrigues, Valerie; Vial, Laurence; Le Potier, Marie-Frederique			Effect of O. porcinus Tick Salivary Gland Extract on the African Swine Fever Virus Infection in Domestic Pig	PLOS ONE			English	Article							ORNITHODOROS-MOUBATA; DENDRITIC CELLS; LANGERHANS CELLS; INTRAMUSCULAR INOCULATION; ARGASID TICK; IMMUNE CELLS; SOFT TICKS; LYMPH-NODE; HOST; SKIN	African swine fever is a haemorrhagic disease in pig production that can have disastrous financial consequences for farming. No vaccines are currently available and animal slaughtering or area zoning to restrict risk-related movements are the only effective measures to prevent the spread of the disease. Ornithodoros soft ticks are known to transmit the African swine fever virus (ASFV) to pigs in farms, following the natural epidemiologic cycle of the virus. Tick saliva has been shown to modulate the host physiological and immunological responses during feeding on skin, thus affecting viral infection. To better understand the interaction between soft tick, ASFV and pig at the bite location and the possible influence of tick saliva on pig infection by ASFV, salivary gland extract (SGE) of Ornithodoros porcinus, co-inoculated or not with ASFV, was used for intradermal auricular inoculation. Our results showed that, after the virus triggered the disease, pigs inoculated with virus and SGE presented greater hyperthermia than pigs inoculated with virus alone. The density of Langerhans cells was modulated at the tick bite or inoculation site, either through recruitment by ASFV or inhibition by SGE. Additionally, SGE and virus induced macrophage recruitment each. This effect was enhanced when they were co-inoculated. Finally, the co-inoculation of SGE and virus delayed the early local spread of virus to the first lymph node on the inoculation side. This study has shown that the effect of SGE was powerful enough to be quantified in pig both on the systemic and local immune response. We believe this model should be developed with infected tick and could improve knowledge of both tick vector competence and tick saliva immunomodulation.	[Bernard, Jennifer; Hutet, Evelyne; Paboeuf, Frederic; Le Potier, Marie-Frederique] Univ Bretagne Loire, Agence Natl Securite Sanit Anses, Lab Ploufragan Plouzane, Unite Virol & Immunol Porcines, Ploufragan, France; [Randriamparany, Tantely] Lab Natl Diagnost Vet, Antananarivo, Madagascar; [Bernard, Jennifer; Holzmuller, Philippe; Lancelot, Renaud; Rodrigues, Valerie; Vial, Laurence] Ctr Cooperat Int Rech Agron Dve CIRAD, UMR CMAEE, Montpellier, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ploufragan-Plouzane Niort Laboratory; CIRAD	Le Potier, MF (corresponding author), Univ Bretagne Loire, Agence Natl Securite Sanit Anses, Lab Ploufragan Plouzane, Unite Virol & Immunol Porcines, Ploufragan, France.	marie-frederique.lepotier@anses.fr	Holzmuller, Philippe/F-7231-2019; Lancelot, Renaud/HGE-1086-2022	Holzmuller, Philippe/0000-0002-8919-9081; Lancelot, Renaud/0000-0002-5826-5242; RANDRIAMPARANY, Tantely/0000-0002-4829-4146	European Union [311931 - ASFORCE]; General Council of the Cotes d'Armor department; Regional Council of Languedoc Roussillon; CIRAD; ANSES	European Union(European Commission); General Council of the Cotes d'Armor department; Regional Council of Languedoc Roussillon(Region Occitanie); CIRAD; ANSES	This work was partly funded by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant agreement no.311931 - ASFORCE, the General Council of the Cotes d'Armor department and the Regional Council of Languedoc Roussillon (Chercheur d'avenir project). JB received her Ph.D. grant from CIRAD and ANSES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JR, 1979, J IMMUNOL, V122, P563; Alonso C, 2013, VIRUS RES, V173, P42, DOI 10.1016/j.virusres.2012.12.006; Astigarraga A, 1997, PARASITE IMMUNOL, V19, P401, DOI 10.1046/j.1365-3024.1997.d01-236.x; Barclay AN, 2009, CURR OPIN IMMUNOL, V21, P47, DOI 10.1016/j.coi.2009.01.008; Barratt-Due A, 2013, J IMMUNOL, V191, P819, DOI 10.4049/jimmunol.1201909; Barratt-Due A, 2011, J IMMUNOL, V187, P4913, DOI 10.4049/jimmunol.1101000; Blome S, 2013, VIRUS RES, V173, P122, DOI 10.1016/j.virusres.2012.10.026; Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023; Brossard M, 1997, MED VET ENTOMOL, V11, P270, DOI 10.1111/j.1365-2915.1997.tb00406.x; Brossard M, 2004, PARASITOLOGY, V129, pS161, DOI 10.1017/S0031182004004834; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chmelar J, 2012, J PROTEOMICS, V75, P3842, DOI 10.1016/j.jprot.2012.04.026; Costard S, 2013, VIRUS RES, V173, P191, DOI 10.1016/j.virusres.2012.10.030; Davison AC, 1997, BOOTSTRAP METHODS TH; del Moral MG, 1999, J VIROL, V73, P2173; Dixon LK, 2013, VIRUS RES, V173, P3, DOI 10.1016/j.virusres.2012.10.020; Epaulard O, 2014, J IMMUNOL, V193, P2416, DOI 10.4049/jimmunol.1303339; Ezquerra A, 2009, DEV COMP IMMUNOL, V33, P284, DOI 10.1016/j.dci.2008.06.002; Ferreira HCD, 2013, VET MICROBIOL, V165, P296, DOI 10.1016/j.vetmic.2013.03.026; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Frischknecht F, 2007, CELL MICROBIOL, V9, P1630, DOI 10.1111/j.1462-5822.2007.00955.x; Galindo-Cardiel I, 2013, VIRUS RES, V173, P180, DOI 10.1016/j.virusres.2012.12.018; Goldstein H., 1999, MULTILEVEL STAT MODE; Gomez-Villamandos JC, 2013, VIRUS RES, V173, P140, DOI 10.1016/j.virusres.2013.01.017; GREGG DA, 1995, J VET DIAGN INVEST, V7, P44, DOI 10.1177/104063879500700106; GREGG DA, 1995, J VET DIAGN INVEST, V7, P23, DOI 10.1177/104063879500700104; Guinat C, 2014, VET RES, V45, DOI 10.1186/s13567-014-0093-8; Howey EB, 2013, VIRUS RES, V178, P328, DOI 10.1016/j.virusres.2013.09.024; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; Jamin A, 2006, VET IMMUNOL IMMUNOP, V114, P224, DOI 10.1016/j.vetimm.2006.08.009; JOHNSTON CM, 1985, INT J PARASITOL, V15, P621, DOI 10.1016/0020-7519(85)90007-4; King K, 2011, VACCINE, V29, P4593, DOI 10.1016/j.vaccine.2011.04.052; Kleiboeker SB, 1998, J VIROL, V72, P1711, DOI 10.1128/JVI.72.3.1711-1724.1998; Kleiboeker Steven B., 2001, Animal Health Research Reviews, V2, P121; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Kramer CD, 2011, EXP PARASITOL, V127, P665, DOI 10.1016/j.exppara.2010.11.012; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; Marquet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016320; Mason LMK, 2014, TRENDS PARASITOL, V30, P95, DOI 10.1016/j.pt.2013.12.003; MCLAREN DJ, 1983, EXP PARASITOL, V56, P153, DOI 10.1016/0014-4894(83)90058-9; Michaud V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069662; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; NITHIUTHAI S, 1985, IMMUNOLOGY, V55, P157; NITHIUTHAI S, 1984, IMMUNOLOGY, V51, P133; Nuttall PA, 2004, PARASITOLOGY, V129, pS177, DOI 10.1017/S0031182004005633; OIE, 2012, MANUAL DIAGNOSTIC TE, V2, P1067; Oliveira CJF, 2008, INT J PARASITOL, V38, P705, DOI 10.1016/j.ijpara.2007.10.006; Owen J, 2013, IMMUNOLOGY; Penrith ML, 2009, J S AFR VET ASSOC, V80, P58; Pinheiro J., 2006, MIXED EFFECTS MODELS; Piriou-Guzylack L, 2008, VET RES, V39, DOI 10.1051/vetres:2008030; PLOWRIGHT W, 1970, ARCH GES VIRUSFORSCH, V31, P33, DOI 10.1007/BF01241664; Ravaomanana J, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-115; RIBEIRO JMC, 1991, COMP BIOCHEM PHYS A, V100, P109, DOI 10.1016/0300-9629(91)90190-N; RIEK RF, 1954, T ROY SOC TROP MED H, V48, P8; RUTHERFORD MS, 1993, J LEUKOCYTE BIOL, V53, P602, DOI 10.1002/jlb.53.5.602; Salguero FJ, 2005, J COMP PATHOL, V132, P289, DOI 10.1016/j.jcpa.2004.11.004; Salguero FJ, 2002, VET IMMUNOL IMMUNOP, V90, P11, DOI 10.1016/S0165-2427(02)00225-8; Sanchez EG, 2013, VIRUS RES, V173, P58, DOI 10.1016/j.virusres.2012.10.025; SCHWAN EV, 1991, EXP APPL ACAROL, V13, P107, DOI 10.1007/BF01193661; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Skallova A, 2008, J IMMUNOL, V180, P6186, DOI 10.4049/jimmunol.180.9.6186; Sonenshine DE, 2013, BIOL TICKS, V2nd; THEIS JH, 1974, EXP PARASITOL, V36, P77, DOI 10.1016/0014-4894(74)90115-5; Tignon M, 2011, J VIROL METHODS, V178, P161, DOI 10.1016/j.jviromet.2011.09.007; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Vial L, 2009, PARASITE, V16, P191, DOI 10.1051/parasite/2009163191; Wikel SK, 2001, VET PARASITOL, V101, P275, DOI 10.1016/S0304-4017(01)00556-8; Wikel S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00337; Xu QL, 2007, J IMMUNOL, V178, P5109, DOI 10.4049/jimmunol.178.8.5109	72	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147869	10.1371/journal.pone.0147869	http://dx.doi.org/10.1371/journal.pone.0147869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828597	gold, Green Published, Green Submitted			2022-12-26	WOS:000369548200040
J	Eom, HS; Park, HR; Jo, SK; Kim, YS; Moon, C; Kim, SH; Jung, U				Eom, Hyeon Soo; Park, Hae Ran; Jo, Sung Kee; Kim, Young Sang; Moon, Changjong; Kim, Sung-Ho; Jung, Uhee			Ionizing Radiation Induces Altered Neuronal Differentiation by mGluR1 through PI3K-STAT3 Signaling in C17.2 Mouse Neural Stem-Like Cells	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SUBVENTRICULAR ZONE; HIPPOCAMPAL NEUROGENESIS; ENDOGENOUS ACTIVATION; DENTATE GYRUS; PC12 CELLS; PROLIFERATION; IRRADIATION; GROWTH; P53	Most studies of IR effects on neural cells and tissues in the brain are still focused on loss of neural stem cells. On the other hand, the effects of IR on neuronal differentiation and its implication in IR-induced brain damage are not well defined. To investigate the effects of IR on C17.2 mouse neural stem-like cells and mouse primary neural stem cells, neurite outgrowth and expression of neuronal markers and neuronal function-related genes were examined. To understand this process, the signaling pathways including PI3K, STAT3, metabotrophic glutamate receptor 1 (mGluR1) and p53 were investigated. In C17.2 cells, irradiation significantly increased the neurite outgrowth, a morphological hallmark of neuronal differentiation, in a dose-dependent manner. Also, the expression levels of neuronal marker proteins, beta-III tubulin were increased by IR. To investigate whether IR-induced differentiation is normal, the expression of neuronal function-related genes including synaptophysin, a synaptic vesicle forming proteins, synaptotagmin1, a calcium ion sensor,gamma-aminobutyric acid (GABA) receptors, inhibitory neurotransmitter receptors and glutamate receptors, excitatory neurotransmitter receptors was examined and compared to that of neurotrophin-stimulated differentiation. IR increased the expression of synaptophysin, synaptotagmin1 and GABA receptors mRNA similarly to normal differentiation by stimulation of neurotrophin. Interestingly, the overall expression of glutamate receptors was significantly higher in irradiated group than normal differentiation group, suggesting that the IR-induced neuronal differentiation may cause altered neuronal function in C17.2 cells. Next, the molecular mechanism of the altered neuronal differentiation induced by IR was studied by investigating signaling pathways including p53, mGluR1, STAT3 and PI3K. Increases of neurite outgrowth, neuronal marker and neuronal function-related gene expressions by IR were abolished by inhibition of p53, mGluR-1, STAT3 or PI3K. The inhibition of PI3K blocked both p53 signaling and STAT3-mGluR1 signaling but inhibition of p53 did not affect STAT3-mGluR1 signaling in irradiated C17.2 cells. Finally, these results of the IR-induced altered differentiation in C17.2 cells were verified in ex vivo experiments using mouse primary neural stem cells. In conclusion, the results of this study demonstrated that IR is able to trigger the altered neuronal differentiation in undifferentiated neural stem-like cells through PI3K-STAT3-mGluR1 and PI3K-p53 signaling. It is suggested that the IR-induced altered neuronal differentiation may play a role in the brain dysfunction caused by IR.	[Eom, Hyeon Soo; Park, Hae Ran; Jo, Sung Kee; Jung, Uhee] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Radiat Biotechnol Res Div, Jeongeup, South Korea; [Eom, Hyeon Soo; Kim, Young Sang] Chungnam Natl Univ, Coll Nat Sci, Dept Biochem, Daejeon, South Korea; [Moon, Changjong; Kim, Sung-Ho] Chonnam Natl Univ, Coll Vet Med, Dept Vet Anat, Gwangju, South Korea; [Park, Hae Ran; Jo, Sung Kee; Jung, Uhee] Univ Sci & Technol, Dept Radiat Biotechnol & Appl Radioisotope, Daejeon, South Korea	Korea Atomic Energy Research Institute (KAERI); Chungnam National University; Chonnam National University; University of Science & Technology (UST)	Jung, U (corresponding author), Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Radiat Biotechnol Res Div, Jeongeup, South Korea.; Jung, U (corresponding author), Univ Sci & Technol, Dept Radiat Biotechnol & Appl Radioisotope, Daejeon, South Korea.	uhjung@kaeri.re.kr	Moon, Changjong/AAI-2005-2020	Moon, Changjong/0000-0003-2451-0374	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2012M2A2A7035656]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2012M2A2A7035656).	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; ABEYAMA K, 1995, FEBS LETT, V364, P298, DOI 10.1016/0014-5793(95)00412-3; Baudry M, 2011, NEUROBIOL LEARN MEM, V95, P125, DOI 10.1016/j.nlm.2010.11.015; Bendel O, 2005, NEUROSCI LETT, V377, P31, DOI 10.1016/j.neulet.2004.11.064; BERSTEIN M, 1981, NEUROSURGERY, V9, P741, DOI 10.1227/00006123-198112000-00022; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Castiglione M, 2008, NEUROPHARMACOLOGY, V55, P560, DOI 10.1016/j.neuropharm.2008.05.021; Chen H, 2012, NEUROLOGY, V78, P020; CHIANG CS, 1993, RADIOTHER ONCOL, V29, P60, DOI 10.1016/0167-8140(93)90174-7; Chuang JH, 2015, WORLD J STEM CELLS, V7, P437, DOI 10.4252/wjsc.v7.i2.437; COPANI A, 1995, J NEUROCHEM, V64, P101; CROSSEN JR, 1994, J CLIN ONCOL, V12, P627, DOI 10.1200/JCO.1994.12.3.627; Di Giorgi-Gerevini V, 2005, CELL DEATH DIFFER, V12, P1124, DOI 10.1038/sj.cdd.4401639; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Eom HS, 2015, INT J RADIAT BIOL, V91, P585, DOI 10.3109/09553002.2015.1029595; Erichsen JL, 2015, BASIC CLIN PHARMACOL, V116, P329, DOI 10.1111/bcpt.12324; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gaiarsa JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00206; Gandhi R, 2008, J NEUROCHEM, V104, P155, DOI 10.1111/j.1471-4159.2007.04955.x; Girault JA, 2004, ARCH NEUROL-CHICAGO, V61, P641, DOI 10.1001/archneur.61.5.641; Greene-Schloesser D, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00073; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Hellstraom NAK, 2009, STEM CELLS, V27, P634, DOI 10.1634/stemcells.2008-0732; Henson MA, 2008, CEREB CORTEX, V18, P2560, DOI 10.1093/cercor/bhn017; Hughes AL, 2000, J BIOL CHEM, V275, P37829, DOI 10.1074/jbc.M003146200; Hwang SY, 2006, NEUROBIOL DIS, V21, P457, DOI 10.1016/j.nbd.2005.08.006; Hwang SY, 2006, INT J CANCER, V118, P2056, DOI 10.1002/ijc.21574; Hynds DL, 2003, J CELL SCI, V116, P1925, DOI 10.1242/jcs.00401; Inouye M, 2000, J RADIAT RES, V41, P303, DOI 10.1269/jrr.41.303; Isono M, 2012, NEUROSCI RES, V73, P263, DOI 10.1016/j.neures.2012.04.005; JENSH RP, 1995, INT J RADIAT BIOL, V67, P217, DOI 10.1080/09553009514550271; Jinguji S, 2013, J NEUROSURG-PEDIATR, V11, P454, DOI 10.3171/2012.12.PEDS12336; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kanzawa T, 2006, ONCOGENE, V25, P3638, DOI 10.1038/sj.onc.1209414; Kasid U, 1996, NATURE, V382, P813, DOI 10.1038/382813a0; Kiehna EN, 2006, J CLIN ONCOL, V24, P5283, DOI 10.1200/JCO.2005.03.8547; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Kyrkanides S, 1999, J NEUROIMMUNOL, V95, P95, DOI 10.1016/S0165-5728(98)00270-7; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; Lang M, 2014, PHYSIOL REP, V2, DOI [10.1002/phy2.278, 10.14814/phy2.278]; Lawrence YR, 2010, INT J RADIAT ONCOL, V76, pS20, DOI 10.1016/j.ijrobp.2009.02.091; Lee WH, 2010, INT J RADIAT BIOL, V86, P132, DOI 10.3109/09553000903419346; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; Maric D, 2000, J NEUROSCI RES, V61, P652, DOI 10.1002/1097-4547(20000915)61:6<652::AID-JNR9>3.0.CO;2-J; Mateos JM, 2000, J NEUROCHEM, V74, P1301; Mirza B, 2000, NEUROSCIENCE, V95, P425; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Montano X, 1997, ONCOGENE, V15, P245, DOI 10.1038/sj.onc.1201215; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Moore DL, 2011, DEV NEUROBIOL, V71, P1186, DOI 10.1002/dneu.20934; Mrak RE, 2007, J NEUROPATH EXP NEUR, V66, P683, DOI 10.1097/nen.0b013e31812503e1; N'Gouemo P, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu123; Natarajan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100405; Oh SB, 2013, BRIT J PHARMACOL, V168, P421, DOI 10.1111/j.1476-5381.2012.02142.x; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; Ozeki A, 2012, NEUROREPORT, V23, P290, DOI 10.1097/WNR.0b013e3283509a79; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Peissner W, 1999, MOL BRAIN RES, V71, P61, DOI 10.1016/S0169-328X(99)00170-9; Poluha W, 1997, J BIOL CHEM, V272, P24002, DOI 10.1074/jbc.272.38.24002; Poongodi GL, 2002, J BIOL CHEM, V277, P28200, DOI 10.1074/jbc.M202731200; Qian L, 2008, IMMUNOL RES, V41, P155, DOI 10.1007/s12026-008-8018-0; Qiao JB, 2012, BIOCHEM BIOPH RES CO, V424, P421, DOI 10.1016/j.bbrc.2012.06.125; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Roy NS, 2000, NAT MED, V6, P271; Schacter DL, 2011, PSYCHOLOGY, P80; Schlett K, 2006, CURR TOP MED CHEM, V6, P949, DOI 10.2174/156802606777323665; Schneider L, 2013, STEM CELL REP, V1, P123, DOI 10.1016/j.stemcr.2013.06.004; Sen A, 2002, BIOTECHNOL PROGR, V18, P337, DOI 10.1021/bp010150t; Shigemoto R, 1997, J NEUROSCI, V1, P722; Surma-aho O, 2001, NEUROLOGY, V56, P1285, DOI 10.1212/WNL.56.10.1285; Tada E, 1999, EXP NEUROL, V160, P66, DOI 10.1006/exnr.1999.7172; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Wei ZZ, 2014, CELL MOL NEUROBIOL, V34, P881, DOI 10.1007/s10571-014-0067-4; Willard SS, 2013, INT J BIOL SCI, V9, P948, DOI 10.7150/ijbs.6426; Wu PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037677; Yang PB, 2012, NEUROSCI BULL, V28, P704, DOI 10.1007/s12264-012-1286-7; Yoshida T, 2012, FREE RADICAL RES, V46, P147, DOI 10.3109/10715762.2011.645207; Zhang R, 2011, BASIC CLIN PHARMACOL, V108, P63, DOI 10.1111/j.1742-7843.2010.00629.x; Zhao LY, 2012, J NEUROSCI RES, V90, P447, DOI 10.1002/jnr.22751	87	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147538	10.1371/journal.pone.0147538	http://dx.doi.org/10.1371/journal.pone.0147538			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828720	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200023
J	Luo, HX; Du, H; Maurer, K; Belinson, JL; Wang, GX; Liu, ZH; Zhang, LJ; Zhou, YQ; Wang, C; Tang, JL; Qu, XF; Wu, RF				Luo, Hongxue; Du, Hui; Maurer, Kathryn; Belinson, Jerome L.; Wang, Guixiang; Liu, Zhihong; Zhang, Lijie; Zhou, Yanqiu; Wang, Chun; Tang, Jinlong; Qu, Xinfeng; Wu, Ruifang			An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; HYBRID CAPTURE 2; HUMAN-PAPILLOMAVIRUS; CLINICAL-EVALUATION; FTA CARTRIDGE; RISK; SAMPLES; WOMEN; ACCURACY; TRIAL	Objectives Determine the ability of the Cobas 4800 assay to detect high-risk human papillomavirus (HrHPV) and high-grade cervical lesions when using cervico-vaginal samples applied to liquid medium and solid media cards compared to a direct cervical sample. Methods Two cervico-vaginal specimens (pseudo self-collected) were obtained from 319 women. One was applied to an iFTA Card (FTA) then the brush placed in liquid-based medium (LSELF); the other was applied to a new solid media: POI card (POI). The clinical performance of Cobas4800 assay using the three aforementioned specimens was compared to direct collected endocervical specimens in liquid media (LDOC). Results The overall agreements of HrHPV detection were 84.2% (LSELF vs. LDOC), 81.0%(FTA vs. LDOC), and 82.3% (POI vs. LDOC). LSELF, FTA and POI identified 98.0%, 79.6%, and 97.5% positive cases of LDOC. Sensitivity to identify CIN2+ were 98.4% (LSELF), 73.8% (FTA), 95.1%(POI), and 93.4%(LDOC) respectively. FTA had 78.1% and 90.4% agreement with the LSELF samples for all HrHPV and HPV16/18 detection respectively, while POI had 91.6% for both. Conclusions Cobas4800 HPV test combined with cervico-vaginal specimens applied to both liquid media and POI solid card are accurate to detect HrHPV infection and high-grade cervical lesions as compared with direct endocervical samples in liquid media.	[Luo, Hongxue; Du, Hui; Wang, Guixiang; Liu, Zhihong; Zhang, Lijie; Zhou, Yanqiu; Wang, Chun; Tang, Jinlong; Wu, Ruifang] Peking Univ, Dept Obstet Gynecol, Shenzhen Hosp, Shenzhen, Peoples R China; [Luo, Hongxue; Du, Hui; Wang, Guixiang; Liu, Zhihong; Zhang, Lijie; Zhou, Yanqiu; Wang, Chun; Tang, Jinlong; Wu, Ruifang] Shenzhen Key Lab Technol Early Diag Major Gynecol, Shenzhen, Peoples R China; [Maurer, Kathryn; Belinson, Jerome L.] Cleveland Clin, Div Gynecol Oncol, Womens Hlth Inst, Cleveland, OH 44106 USA; [Belinson, Jerome L.; Qu, Xinfeng] Prevent Oncol Int, Cleveland Hts, OH USA	Peking University; Cleveland Clinic Foundation	Wu, RF (corresponding author), Peking Univ, Dept Obstet Gynecol, Shenzhen Hosp, Shenzhen, Peoples R China.; Wu, RF (corresponding author), Shenzhen Key Lab Technol Early Diag Major Gynecol, Shenzhen, Peoples R China.	wurfpush@126.com		Maurer, Kathryn/0000-0002-5917-0173	Shenzhen Municipal Science and Technical Innovation Committee, Shenzhen, PR China [JCYJ20140415162338808, GJHZ20130417100103783]; Preventive Oncology International, Inc., Cleveland, Heights, Ohio, USA	Shenzhen Municipal Science and Technical Innovation Committee, Shenzhen, PR China; Preventive Oncology International, Inc., Cleveland, Heights, Ohio, USA	The study was supported by Shenzhen Municipal Science and Technical Innovation Committee, Shenzhen, PR China (No. JCYJ20140415162338808 & No. GJHZ20130417100103783); and by Preventive Oncology International, Inc., Cleveland, Heights, Ohio, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais AG, 2007, INT J CANCER, V120, P1505, DOI 10.1002/ijc.22484; Belinson J, 2001, GYNECOL ONCOL, V83, P439, DOI 10.1006/gyno.2001.6370; Belinson JL, 2014, GYNECOL ONCOL, V132, P636, DOI 10.1016/j.ygyno.2014.01.006; Belinson JL, 2012, INT J CANCER, V130, P1855, DOI 10.1002/ijc.26202; Belinson JL, 2011, AM J CLIN PATHOL, V135, P790, DOI 10.1309/AJCPKA6ATAPBZ6JQ; Bos AB, 2006, INT J CANCER, V119, P2372, DOI 10.1002/ijc.22114; Castle PE, 2009, J CLIN MICROBIOL, V47, P3344, DOI 10.1128/JCM.00725-09; de Bie RP, 2011, J MOL DIAGN, V13, P371, DOI 10.1016/j.jmoldx.2011.02.003; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Geraets DT, 2013, J CLIN VIROL, V57, P125, DOI 10.1016/j.jcv.2013.02.016; Gilbert L, 2013, J CLIN MICROBIOL, V51, P3412, DOI 10.1128/JCM.01391-13; Gonzalez P, 2012, J CLIN MICROBIOL, V50, P3870, DOI 10.1128/JCM.01698-12; Guan YY, 2013, J VIROL METHODS, V189, P167, DOI 10.1016/j.jviromet.2012.11.010; Gustavsson I, 2009, J CLIN VIROL, V46, P112, DOI 10.1016/j.jcv.2009.06.021; Haguenoer K, 2014, GYNECOL ONCOL, V134, P302, DOI 10.1016/j.ygyno.2014.05.026; Isidean SD, 2014, EXPERT REV MOL DIAGN, V14, P5, DOI 10.1586/14737159.2014.865521; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Lenselink CH, 2009, J CLIN MICROBIOL, V47, P2564, DOI 10.1128/JCM.00285-09; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Lindemann MLM, 2012, J MOL DIAGN, V14, P65, DOI 10.1016/j.jmoldx.2011.09.005; Maurer KA, 2015, J CLIN VIROL ACCEPTE; Ogilvie GS, 2005, SEX TRANSM INFECT, V81, P207, DOI 10.1136/sti.2004.011858; Petignat P, 2007, GYNECOL ONCOL, V105, P530, DOI 10.1016/j.ygyno.2007.01.023; Porras C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju400; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Stanczuk GA, 2015, J CLIN PATHOL, V68, P567, DOI 10.1136/jclinpath-2014-202851; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Tirumala Radhika, 2013, 9 CLIN VIR S APR 26; Waller J, 2006, J MED SCREEN, V13, P208, DOI 10.1177/096914130601300409; Wang SM, 2014, ASIAN PAC J CANCER P, V15, P7085, DOI 10.7314/APJCP.2014.15.17.7085; Wolfgramm ED, 2009, FORENSIC SCI INT-GEN, V3, P125, DOI 10.1016/j.fsigen.2008.11.008; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	37	6	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148168	10.1371/journal.pone.0148168	http://dx.doi.org/10.1371/journal.pone.0148168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828360	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200076
J	Ouyang, M; White, EE; Ren, H; Guo, Q; Zhang, I; Gao, H; Yanyan, S; Chen, XB; Weng, YM; Da Fonseca, A; Shah, S; Manuel, ER; Zhang, LY; Vonderfecht, SL; Alizadeh, D; Berlin, JM; Badie, B				Ouyang, Mao; White, Ethan E.; Ren, Hui; Guo, Qin; Zhang, Ian; Gao, Hang; Yanyan, Song; Chen, Xuebo; Weng, Yiming; Da Fonseca, Anna; Shah, Sunny; Manuel, Edwin R.; Zhang, Leying; Vonderfecht, Steven L.; Alizadeh, Darya; Berlin, Jacob M.; Badie, Behnam			Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model	PLOS ONE			English	Article							RECURRENT GLIOBLASTOMA; MICE; MELANOMA; DELIVERY; GROWTH; CANCER; CELLS; TRIAL; OLIGODEOXYNUCLEOTIDE; MACROPHAGES	Even when treated with aggressive current therapies, most patients with glioblastoma survive less than two years. Rapid tumor growth, an invasive nature, and the blood-brain barrier, which limits the penetration of large molecules into the brain, all contribute to the poor tumor response associated with conventional therapies. Immunotherapy has emerged as a therapeutic approach that may overcome these challenges. We recently reported that single-walled carbon nanotubes (SWCNTs) can be used to dramatically increase the immunotherapeutic efficacy of CpG oligonucleotides in a mouse model of glioma. Following implantation in the mouse brain, the tumor cell line used in these previous studies (GL261) tends to form a spherical tumor with limited invasion into healthy brain. In order to evaluate SWCNT/CpG therapy under more clinically-relevant conditions, here we report the treatment of a more invasive mouse glioma model (K-Luc) that better recapitulates human disease. In addition, a CpG sequence previously tested in humans was used to formulate the SWCNT/CpG which was combined with temozolomide, the standard of care chemotherapy for glioblastoma patients. We found that, following two intracranial administrations, SWCNT/CpG is well-tolerated and improves the survival of mice bearing invasive gliomas. Interestingly, the efficacy of SWCNT/CpG was enhanced when combined with temozolomide. This enhanced anti-tumor efficacy was correlated to an increase of tumor-specific cytotoxic activity in splenocytes. These results reinforce the emerging understanding that immunotherapy can be enhanced by combining it with chemotherapy and support the continued development of SWCNT/CpG.	[Ouyang, Mao] Cent S Univ, Xiangya Hosp 3, Dept Cardiol, Changsha, Hunan, Peoples R China; [White, Ethan E.; Berlin, Jacob M.] Irell & Manella Grad Sch Biol Sci City Hope, Duarte, CA 91010 USA; [White, Ethan E.; Weng, Yiming; Berlin, Jacob M.] City Hope Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Ren, Hui] Jilin Univ, Hosp 2, Dept Gen Surg, Changchun 130023, Jilin Province, Peoples R China; [Guo, Qin] Cent S Univ, Xiangya Hosp 3, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Zhang, Ian; Shah, Sunny; Zhang, Leying; Alizadeh, Darya; Badie, Behnam] City Hope Beckman Res Inst, Div Neurosurg, Duarte, CA 91010 USA; [Gao, Hang] Jilin Univ, Hosp 1, Dept Bone & Joint Surg, Changchun 130023, Jilin Province, Peoples R China; [Yanyan, Song] Jilin Univ, Hosp 2, Dept Nephrol, Changchun 130023, Jilin Province, Peoples R China; [Chen, Xuebo] Jilin Univ, China Japan Union Hosp, Dept Gen Surg, Changchun 130023, Jilin Province, Peoples R China; [Da Fonseca, Anna] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Morfogenese Celular, Rio De Janeiro, Brazil; [Manuel, Edwin R.] City Hope Beckman Res Inst, Dept Virol, Div Translat Vaccine Res, Duarte, CA 91010 USA; [Vonderfecht, Steven L.] City Hope Beckman Res Inst, Div Comparat Med, Duarte, CA 91010 USA; [Badie, Behnam] City Hope Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA	Central South University; City of Hope; Beckman Research Institute of City of Hope; Jilin University; Central South University; City of Hope; Beckman Research Institute of City of Hope; Jilin University; Jilin University; Jilin University; Universidade Federal do Rio de Janeiro; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Berlin, JM (corresponding author), Irell & Manella Grad Sch Biol Sci City Hope, Duarte, CA 91010 USA.; Berlin, JM (corresponding author), City Hope Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA.; Badie, B (corresponding author), City Hope Beckman Res Inst, Div Neurosurg, Duarte, CA 91010 USA.; Badie, B (corresponding author), City Hope Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA.	jberlin@coh.org; bbadie@coh.org	da Fonseca, Anna Carolina Carvalho/AAQ-7440-2020; da Fonseca, Anna Carolina Carvalho/C-5825-2015	da Fonseca, Anna Carolina Carvalho/0000-0002-8366-3146; da Fonseca, Anna Carolina Carvalho/0000-0002-8366-3146; Manuel, Edwin/0000-0002-4602-7060	Kenneth T. and Eileen L. Norris Foundation; STOP Cancer; National Cancer Institute of the National Institutes of Health [P30CA33572];  [R01CA155769];  [R21CA189223];  [R21 NS081594]; NATIONAL CANCER INSTITUTE [R21CA189223, R01CA155769, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081594] Funding Source: NIH RePORTER	Kenneth T. and Eileen L. Norris Foundation; STOP Cancer; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank R01CA155769, R21CA189223, R21 NS081594, The Kenneth T. and Eileen L. Norris Foundation and STOP Cancer for research funding. Research reported in this publication included work performed in the Light Microscopy Digital Imaging Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572.	Alizadeh D, 2014, CANCER RES, V74, P2663, DOI 10.1158/0008-5472.CAN-14-0301; Alizadeh D, 2010, CLIN CANCER RES, V16, P3399, DOI 10.1158/1078-0432.CCR-09-3087; Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; Badie B, 2013, IMMUNOTHERAPY-UK, V5, P1, DOI [10.2217/IMT.12.148, 10.2217/imt.12.148]; Banissi C, 2009, CANCER IMMUNOL IMMUN, V58, P1627, DOI 10.1007/s00262-009-0671-1; Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.005; Carpentier A, 2006, NEURO-ONCOLOGY, V8, P60, DOI 10.1215/S1522851705000475; Carpentier A, 2010, NEURO-ONCOLOGY, V12, P401, DOI 10.1093/neuonc/nop047; Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f; Drezek RA, 2010, NAT NANOTECHNOL, V5, P168, DOI 10.1038/nnano.2010.37; Fadul CE, 2011, NEURO-ONCOLOGY, V13, P393, DOI 10.1093/neuonc/noq204; Fan HT, 2012, CLIN CANCER RES, V18, P5628, DOI 10.1158/1078-0432.CCR-12-1911; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Gomez GG, 2006, GENE THER MOL BIOL, V10A, P133; Hurt RH, 2006, CARBON, V44, P1028, DOI 10.1016/j.carbon.2005.12.023; Jahrsdorfer Bernd, 2008, Update Cancer Ther, V3, P27, DOI 10.1016/j.uct.2007.11.003; Kim HK, 2012, BIOMACROMOLECULES, V13, P636, DOI 10.1021/bm2014119; Kolosnjaj-Tabi J, 2010, ACS NANO, V4, P1481, DOI 10.1021/nn901573w; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee TH, 2009, SCAND J IMMUNOL, V70, P85, DOI 10.1111/j.1365-3083.2009.02273.x; Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978; Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105; Manuel ER, 2011, CANCER RES, V71, P4183, DOI 10.1158/0008-5472.CAN-10-4676; Morimoto Y, 2012, NANOTOXICOLOGY, V6, P766, DOI 10.3109/17435390.2011.620719; Neyns B, 2010, CANCER-AM CANCER SOC, V116, P2868, DOI 10.1002/cncr.25035; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001; Ridolfi L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-135; Sanchez-Perez LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059082; Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68; Sengupta S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831090; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Terada K, 2006, GENE THER, V13, P705, DOI 10.1038/sj.gt.3302717; Weber JS, 2009, CANCER, V115, P3944, DOI 10.1002/cncr.24473; Yamashita K, 2010, INFLAMMATION, V33, P276, DOI 10.1007/s10753-010-9182-7; ZALIPSKY S, 1993, BIOCONJUGATE CHEM, V4, P296, DOI 10.1021/bc00022a008; Zhang LY, 2009, GLIA, V57, P1458, DOI 10.1002/glia.20863; Zhao DC, 2011, CLIN CANCER RES, V17, P771, DOI 10.1158/1078-0432.CCR-10-2444	38	28	28	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148139	10.1371/journal.pone.0148139	http://dx.doi.org/10.1371/journal.pone.0148139			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829221	gold, Green Submitted, Green Published			2022-12-26	WOS:000369548200069
J	Tam, CC; O'Brien, SJ				Tam, Clarence C.; O'Brien, Sarah J.			Economic Cost of Campylobacter, Norovirus and Rotavirus Disease in the United Kingdom	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; GUILLAIN-BARRE-SYNDROME; GENERAL-PRACTICE; ENTERIC PATHOGENS; ENGLAND; COMMUNITY; GASTROENTERITIS; IMPACT; SALMONELLA; BURDEN	Objectives To estimate the annual cost to patients, the health service and society of infectious intestinal disease (IID) from Campylobacter, norovirus and rotavirus. Design Secondary data analysis. Setting The United Kingdom population, 2008-9. Main outcome measures Cases and frequency of health services usage due to these three pathogens; associated healthcare costs; direct, out-of-pocket expenses; indirect costs to patients and caregivers. Results The median estimated costs to patients and the health service at 2008-9 prices were: Campylobacter 50 pound million (95% CI: 33m- pound 75m) pound, norovirus 81 pound million (95% CI: 63m- pound 106m) pound, rotavirus 25m pound (95% CI: 18m- pound 35m) pound. The costs per case were approximately 30 pound for norovirus and rotavirus, and 85 pound for Campylobacter. This was mostly borne by patients and caregivers through lost income or out-of-pocket expenditure. The cost of Campylobacter- related Guillain-Barre syndrome hospitalisation was 1.26 pound million (95% CI: 0.4m- pound 4.2m) pound. Conclusions Norovirus causes greater economic burden than Campylobacter and rotavirus combined. Efforts to control IID must prioritise norovirus. For Campylobacter, estimated costs should be considered in the context of expenditure to control this pathogen in agriculture, food production and retail. Our estimates, prior to routine rotavirus immunisation in the UK, provide a baseline vaccine cost-effectiveness analyses.	[Tam, Clarence C.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Tam, Clarence C.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [O'Brien, Sarah J.] Univ Liverpool, NIHR, Hlth Protect Res Unit Gastrointestinal Infect, Liverpool L69 3BX, Merseyside, England; [O'Brien, Sarah J.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	National University of Singapore; University of London; London School of Hygiene & Tropical Medicine; University of Liverpool; University of Liverpool	Tam, CC (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.; Tam, CC (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	clarence_tam@nuhs.edu.sg		O'Brien, Sarah Jane/0000-0003-2896-8999; Tam, Clarence/0000-0003-1697-286X	Medical Research Council [MC_U122785837] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ajene AN, 2013, J HEALTH POPUL NUTR, V31, P299; Amar CFL, 2007, EUR J CLIN MICROBIOL, V26, P311, DOI 10.1007/s10096-007-0290-8; Bernsen RAJAM, 2002, J NEUROL SCI, V201, P13, DOI 10.1016/S0022-510X(02)00158-2; Curtis L., 2009, UNIT COSTS HLTH SOCI; Department of Health, 2009, NHS REF COSTS 2008 9; Food Standards Agency, 2000, REP STUD INF INT DIS; Food Standards Agency, 2011, FOODB DIS STRAT 2010; Harris JP, 2007, VACCINE, V25, P3962, DOI 10.1016/j.vaccine.2007.02.072; Haustein T, 2009, CLIN INFECT DIS, V49, P1890, DOI 10.1086/648440; Health & Social Care Information Centre, 2009, HOSP EP STAT ADM PAT; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; Lorgelly PK, 2008, EPIDEMIOL INFECT, V136, P34, DOI 10.1017/S0950268807008163; Morgan C, 2010, CURR MED RES OPIN, V26, P2449, DOI 10.1185/03007995.2010.518135; Munro J, 2001, EVALUATION NHS DIREC; Neal KR, 1997, BRIT MED J, V314, P779, DOI 10.1136/bmj.314.7083.779; NOEL JS, 1994, J CLIN PATHOL, V47, P67, DOI 10.1136/jcp.47.1.67; Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63; Rajabally YA, 2012, J NEUROL NEUROSUR PS, V83, P711, DOI 10.1136/jnnp-2011-301882; Roberts JA, 2003, EPIDEMIOL INFECT, V130, P1, DOI 10.1017/S0950268802007690; Santos AC, 2011, EPIDEMIOL INFECT, V139, P742, DOI 10.1017/S0950268810001615; Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Tsai CP, 2007, J CLIN NEUROSCI, V14, P625, DOI 10.1016/j.jocn.2006.03.020; Wall P G, 1996, Commun Dis Rep CDR Rev, V6, pR93; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046	25	60	60	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0138526	10.1371/journal.pone.0138526	http://dx.doi.org/10.1371/journal.pone.0138526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828435	gold, Green Accepted, Green Published			2022-12-26	WOS:000369548200001
J	Choung, RS; Marietta, EV; Van Dyke, CT; Brantner, TL; Rajasekaran, J; Pasricha, PJ; Wang, T; Bei, K; Krishna, K; Krishnamurthy, HK; Snyder, MR; Jayaraman, V; Murray, JA				Choung, Rok Seon; Marietta, Eric V.; Van Dyke, Carol T.; Brantner, Tricia L.; Rajasekaran, John; Pasricha, Pankaj J.; Wang, Tianhao; Bei, Kang; Krishna, Karthik; Krishnamurthy, Hari K.; Snyder, Melissa R.; Jayaraman, Vasanth; Murray, Joseph A.			Determination of B-Cell Epitopes in Patients with Celiac Disease: Peptide Microarrays	PLOS ONE			English	Article							ARRAYS; AUTOIMMUNITY; RECOGNITION; DISCOVERY; DIAGNOSIS; SERUM	Background Most antibodies recognize conformational or discontinuous epitopes that have a specific 3-dimensional shape; however, determination of discontinuous B-cell epitopes is a major challenge in bioscience. Moreover, the current methods for identifying peptide epitopes often involve laborious, high-cost peptide screening programs. Here, we present a novel microarray method for identifying discontinuous B-cell epitopes in celiac disease (CD) by using a silicon-based peptide array and computational methods. Methods Using a novel silicon-based microarray platform with a multi-pillar chip, overlapping 12-mer peptide sequences of all native and deamidated gliadins, which are known to trigger CD, were synthesized in situ and used to identify peptide epitopes. Results Using a computational algorithm that considered disease specificity of peptide sequences, 2 distinct epitope sets were identified. Further, by combining the most discriminative 3-mer gliadin sequences with randomly interpolated3- or 6-mer peptide sequences, novel discontinuous epitopes were identified and further optimized to maximize disease discrimination. The final discontinuous epitope sets were tested in a confirmatory cohort of CD patients and controls, yielding 99% sensitivity and 100% specificity. Conclusions These novel sets of epitopes derived from gliadin have a high degree of accuracy in differentiating CD from controls, compared with standard serologic tests. The method of ultra-high-density peptide microarray described here would be broadly useful to develop high-fidelity diagnostic tests and explore pathogenesis.	[Choung, Rok Seon; Marietta, Eric V.; Van Dyke, Carol T.; Brantner, Tricia L.; Murray, Joseph A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Rajasekaran, John; Wang, Tianhao; Bei, Kang; Krishna, Karthik; Krishnamurthy, Hari K.; Jayaraman, Vasanth] Vibrant Sci LLC, San Carlos, CA USA; [Pasricha, Pankaj J.] Johns Hopkins Univ, Ctr Neurogastroenterol, Baltimore, MD USA; [Snyder, Melissa R.] Mayo Clin, Div Clin Biochem & Immunol, Rochester, MN USA	Mayo Clinic; Johns Hopkins University; Mayo Clinic	Murray, JA (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA.	Murray.Joseph@mayo.edu	Choung, Rok Seon/GLT-1518-2022; Krishnamurthy, Hari/AAA-7882-2021	Krishnamurthy, Hari/0000-0002-7832-8423	Mayo Foundation; Vibrant Sciences LLC	Mayo Foundation; Vibrant Sciences LLC	JAM and RSC were supported by the Mayo Foundation. Vibrant Sciences LLC provided support in the form of salaries for authors JR, VJ, KB, TW, HKK and KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aleanzi M, 2001, CLIN CHEM, V47, P2023; Ballew JT, 2013, P NATL ACAD SCI USA, V110, P19330, DOI 10.1073/pnas.1314792110; Beyer M, 2007, SCIENCE, V318, P1888, DOI 10.1126/science.1149751; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Dam CE, 2014, SCAND J CLIN LAB INV, V74, P506, DOI 10.3109/00365513.2014.908474; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Gao XL, 2003, PROTEOMICS, V3, P2135, DOI 10.1002/pmic.200300597; Katz KD, 2011, AM J GASTROENTEROL, V106, P1333, DOI 10.1038/ajg.2011.21; Kijanka G, 2009, J PROTEOMICS, V72, P936, DOI 10.1016/j.jprot.2009.02.006; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Medical Advisory Secretariat, 2010, Ont Health Technol Assess Ser, V10, P1; Molberg O, 1997, SCAND J IMMUNOL, V46, P103, DOI 10.1046/j.1365-3083.1997.d01-93.x; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; Osman AA, 2000, CLIN EXP IMMUNOL, V121, P248, DOI 10.1046/j.1365-2249.2000.01312.x; Osorio C, 2012, FUNCT INTEGR GENOMIC, V12, P417, DOI 10.1007/s10142-012-0287-y; Pawloski AR, 2007, J VAC SCI TECHNOL B, V25, P2537, DOI 10.1116/1.2794325; Price JV, 2012, NAT MED, V18, P1434, DOI 10.1038/nm.2913; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Solier C, 2014, PROTEOMICS, V14, P774, DOI 10.1002/pmic.201300334; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Szekely GJ, 2005, J CLASSIF, V22, P151, DOI 10.1007/s00357-005-0012-9; ten Dam M, 1998, CLIN EXP IMMUNOL, V114, P189; Walker MM, 2010, GASTROENTEROLOGY, V139, P112, DOI 10.1053/j.gastro.2010.04.007	27	12	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147777	10.1371/journal.pone.0147777	http://dx.doi.org/10.1371/journal.pone.0147777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824466	Green Published, gold			2022-12-26	WOS:000369528600060
J	Galas, A; Miszczyk, J				Galas, Aleksander; Miszczyk, Justyna			Aberrations Involving Chromosome 1 as a Possible Predictor of Odds Ratio for Colon Cancer - Results from the Krakow Case-Control Study	PLOS ONE			English	Article							COLORECTAL-CANCER; RISK; DAMAGE; LYMPHOCYTES; FREQUENCY; COHORT	Background There is still an open question how to predict colorectal cancer risk before any morphological changes appear in the colon. Objective The purpose was to investigate aberrations in chromosomes 1, 2 and 4 in peripheral blood lymphocytes analyzed by fluorescence in situ hybridization technique as a tool to assess the likelihood of colorectal cancer. Methods A hospital-based case-control study included 20 colon cancer patients and 18 hospital-based controls. Information about potential covariates was collected by interview. The frequency of stable and unstable chromosome aberrations in chromosome 1, 2 and 4 was assessed by fluorescence in situ hybridization technique. Results Colorectal cancer patients, as compared to controls, had a relatively higher frequency of chromosome 1 translocations (median: 3.5 versus 1.0/1000 cells, p = 0.006), stable aberrations (3.8 versus 1.0/1000 cells, p = 0.007) and total aberrations (p = 0.009). There were no differences observed for chromosomes 2 and 4. Our results showed an increase in the odds of having colon cancer by about 50-80% associated with an increase by 1/1000 cells in the number of chromosome 1 aberrations. Conclusions The results revealed that the frequency of chromosomal aberrations, especially translocations in chromosome 1, seems to be a promising method to show a colon cancer risk. Additionally, our study suggests the reasonableness of use of biomarkers such as chromosome 1 aberrations in peripheral blood lymphocytes in screening prevention programs for individuals at higher colon cancer risk to identify those who are at increased risk and require more frequent investigations, e.g. by sigmoidoscopy.	[Galas, Aleksander] Jagiellonian Univ, Coll Med, Dept Epidemiol, Krakow, Poland; [Miszczyk, Justyna] Polish Acad Sci, Dept Expt Phys Complex Syst, Inst Nucl Phys, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences	Galas, A (corresponding author), Jagiellonian Univ, Coll Med, Dept Epidemiol, Krakow, Poland.	aleksander.galas@uj.edu.pl; mygalas@cyf-kr.edu.pl	Miszczyk, Justyna/V-8614-2018; Miszczyk, Justyna/AAL-1493-2020; Galas, Aleksander/G-9887-2013	Miszczyk, Justyna/0000-0001-7226-1750; Miszczyk, Justyna/0000-0001-7226-1750; Galas, Aleksander/0000-0002-9233-4301	National Science Centre, Poland [NN404034039, DEC-2013/09/D/NZ7/00324]; Ministry of Science and Education [2P05D05329]	National Science Centre, Poland(National Science Centre, Poland); Ministry of Science and Education	This research project was funded by the National Science Centre, Poland in 2010-2013 (No. NN404034039) - the principal investigator Aleksander Galas MD, PhD. Presented results were partially supported by the data from Ministry of Science and Education project (No. 2P05D05329) - the principal investigator Prof. Wieslaw Jedrychowski, MD, PhD. Some of these investigations were carried out as part of an extended examination of the 250 kV X-rays at IFJ PAN by cytogenetic and molecular methods and were partially supported by Grant DEC-2013/09/D/NZ7/00324 from the National Science Centre, Poland, principal investigator Justyna Miszczyk, PhD.	Arranz N, 2007, CHEM-BIOL INTERACT, V169, P63, DOI 10.1016/j.cbi.2007.05.006; Beaton LA, 2013, INT J RADIAT BIOL, V89, P1087, DOI 10.3109/09553002.2013.825060; Bishop R, 2010, BIOSCI HORIZONS, V3, P85, DOI DOI 10.1093/BIOHORIZONS/HZQ009; Boffetta P, 2007, AM J EPIDEMIOL, V165, P36, DOI 10.1093/aje/kwj367; BohlscheidThomas S, 1997, INT J EPIDEMIOL, V26, pS59, DOI 10.1093/ije/26.suppl_1.S59; Bonassi S, 2000, CANCER RES, V60, P1619; Bonassi S, 2008, CARCINOGENESIS, V29, P1178, DOI 10.1093/carcin/bgn075; Chen W, 2013, MOL BIOL REP, V40, P3457, DOI 10.1007/s11033-012-2338-9; Fucic A, 2007, TOXICOL LETT, V172, P4, DOI 10.1016/j.toxlet.2007.05.015; Galas A, 2015, EUR J NUTR, V54, P161, DOI 10.1007/s00394-014-0697-9; Galas A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-134; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Hagmar L, 2004, CANCER RES, V64, P2258, DOI 10.1158/0008-5472.CAN-03-3360; Hagmar Lars, 2004, IARC Sci Publ, P207; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; International Atomic Energy Agency, 2011, CYT DOS APPL PREP RE; Jedrychowski W, 2009, DIETARY PREVENTION C; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lipton L, 2006, FAM CANCER, V5, P221, DOI 10.1007/s10689-005-5673-3; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Munoz-Bellvis L, 2012, MODERN PATHOL, V25, P590, DOI 10.1038/modpathol.2011.195; Munro AF, 2012, BRIT J CANCER, V107, P71, DOI 10.1038/bjc.2012.232; Norat T, 2014, CANCER TREAT RES, V159, P35, DOI 10.1007/978-3-642-38007-5_3; Ogino S, 2015, CANCER CAUSE CONTROL, V26, P959, DOI 10.1007/s10552-015-0596-2; Rossner P, 2005, ENVIRON HEALTH PERSP, V113, P517, DOI 10.1289/ehp.6925; Terdiman JP, 1999, AM J GASTROENTEROL, V94, P2344; Turkez H, 2012, TOXICOL IND HEALTH, V28, P648, DOI 10.1177/0748233711420471; Xiao XY, 2007, DIAGN MOL PATHOL, V16, P96, DOI 10.1097/PDM.0b013e31803190f2; Zhou CZ, 2008, CHINESE MED J-PEKING, V121, P2479, DOI 10.1097/00029330-200812020-00003	34	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147658	10.1371/journal.pone.0147658	http://dx.doi.org/10.1371/journal.pone.0147658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824604	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528600045
J	Nayar, M; Vanderstay, R; Siegert, RJ; Turner-Stokes, L				Nayar, Meenakshi; Vanderstay, Roxana; Siegert, Richard J.; Turner-Stokes, Lynne			The UK Functional Assessment Measure (UK FIM plus FAM): Psychometric Evaluation in Patients Undergoing Specialist Rehabilitation following a Stroke from the National UK Clinical Dataset	PLOS ONE			English	Article							CROSS-CULTURAL ADAPTATION; INJURY REHABILITATION; INDEPENDENCE MEASURE; BRAIN INJURY; DISABILITY; NEGLECT; FIM+FAM; VERSION; SCALE	The UK Functional Assessment Measure (UKFIM+FAM) is the principal outcome measure for the UK Rehabilitation Outcomes Collaborative (UKROC) national database for specialist rehabilitation. Previously validated in a mixed neurorehabilitation cohort, this study is the first to explore its psychometric properties in a stroke population, and compare left and right hemispheric strokes (LHS vs RHS). We analysed in-patient episode data from 62 specialist rehabilitation units collated through the UKROC database 2010-2013. Complete data were analysed for 1,539 stroke patients (LHS: 588, RHS: 566 with clear localisation). For factor analysis, admission and discharge data were pooled and randomised into two equivalent samples; the first for exploratory factor analysis (EFA) using principal components analysis, and the second for confirmatory factor analysis (CFA). Responsiveness for each subject (change from admission to discharge) was examined using paired t-tests and differences between LHS and RHS for the entire group were examined using non-paired t-tests. EFA showed a strong general factor accounting for >48% of the total variance. A three-factor solution comprising motor, communication and psychosocial subscales, accounting for >69% total variance, provided acceptable fit statistics on CFA (Root Mean Square Error of Approximation was 0.08 and Comparative Fit Index/Tucker Lewis Index 0.922/0.907). All three subscales showed significant improvement between admission and discharge (p<0.001) with moderate effect sizes (>0.5). Total scores between LHS and RHS were not significantly different. However, LHS showed significantly higher motor scores (Mean 5.7, 95%CI 2.7, 8.6 p<0.001), while LHS had significantly lower cognitive scores, primarily in the communication domain (-6.8 95%CI -7.7, -5.8 p<0.001). To conclude, the UK FIM+FAM has a three-factor structure in stroke, similar to the general neurorehabilitation population. It is responsive to change during in-patient rehabilitation, and distinguishes between LHS and RHS. This tool extends stroke outcome measurement beyond physical disability to include cognitive, communication and psychosocial function.	[Nayar, Meenakshi; Vanderstay, Roxana; Turner-Stokes, Lynne] Kings Coll London, Fac Life Sci & Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Nayar, Meenakshi; Turner-Stokes, Lynne] Northwick Pk Hosp & Clin Res Ctr, Reg Hyper Acute Rehabil Unit RHRU, London, England; [Siegert, Richard J.] Auckland Univ Technol, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand; [Siegert, Richard J.] Auckland Univ Technol, Sch Rehabil & Occupat Studies, Auckland, New Zealand	University of London; King's College London; Imperial College London; Auckland University of Technology; Auckland University of Technology	Turner-Stokes, L (corresponding author), Kings Coll London, Fac Life Sci & Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.; Turner-Stokes, L (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Reg Hyper Acute Rehabil Unit RHRU, London, England.	lynne.turner-stokes@dial.pipex.com	Turner-Stokes, Lynne/F-4418-2012; Siegert, Richard J./K-2030-2019	Turner-Stokes, Lynne/0000-0002-3302-9462; Siegert, Richard/0000-0002-3074-0929	National Institute for Health Research (NIHR) [RP-PG-0407-10185]; Dunhill Medical Trust; National Institute for Health Research [ACF-2013-17-021, RP-PG-0407-10185] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme (RP-PG-0407-10185). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Financial support for the preparation of this manuscript was also provided by the Dunhill Medical Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3167; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; British Society of Rehabilitation Medicine, 2015, SPEC NEUR SERV PROV; Byrne Barbara M., 2013, STRUCTURAL EQUATION; COTE R, 1989, NEUROLOGY, V39, P638, DOI 10.1212/WNL.39.5.638; DEHAAN R, 1993, STROKE, V24, P1178, DOI 10.1161/01.STR.24.8.1178; Hadian MR, 2012, NEUROL NEUROCHIR POL, V46, P351, DOI 10.5114/ninp.2012.30268; Hall K.M., 1993, J HEAD TRAUMA REHAB, DOI [10.1097/00001199-199308020-00008, DOI 10.1097/00001199-199308020-00008]; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; Hillis AE, 2003, STROKE, V34, P2392, DOI 10.1161/01.STR.0000089681.84041.69; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Hsueh IP, 2002, J NEUROL NEUROSUR PS, V73, P188, DOI 10.1136/jnnp.73.2.188; Intercollegiate Stroke Working Party, 2011, NAT SENT STROK CLIN; Jorge LL, 2011, INT J REHABIL RES, V34, P89, DOI 10.1097/MRR.0b013e32833ba55f; Knecht S, 2000, BRAIN, V123, P74, DOI 10.1093/brain/123.1.74; Law J, 2009, DISABIL REHABIL, V31, P825, DOI 10.1080/09638280802355049; Linn R T, 1999, J Outcome Meas, V3, P339; Miki E, 2015, SCAND J OCCUP THER, V13, P1; Nilsson AL, 2011, J REHABIL MED, V43, P884, DOI 10.2340/16501977-0871; Ringman JM, 2004, NEUROLOGY, V63, P468, DOI 10.1212/01.WNL.0000133011.10689.CE; Spector P., 1994, SUMMATED RATING SCAL; Tabachnick B. G., 2001, USING MULTIVARIATE S; Thompson B, 2004, EXPLORATORY CONFIRMA; Turner-Stokes L, 2002, DISABIL REHABIL, V24, P383, DOI 10.1080/096382801101550; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 2013, DISABIL REHABIL, V35, P1885, DOI 10.3109/09638288.2013.766271; Turner-Stokes L, 2012, DISABIL REHABIL, V34, P1871, DOI 10.3109/09638288.2012.670033; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Ween JE, 1996, NEUROLOGY, V47, P388, DOI 10.1212/WNL.47.2.388	31	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147288	10.1371/journal.pone.0147288	http://dx.doi.org/10.1371/journal.pone.0147288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824696	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528600022
J	Roussel, M; Martinaud, O; Henon, H; Vercelletto, M; Bindschadler, C; Joseph, PA; Robert, P; Labauge, P; Godefroy, O				Roussel, Martine; Martinaud, Olivier; Henon, Hilde; Vercelletto, Martine; Bindschadler, Claire; Joseph, Pierre-Alain; Robert, Philippe; Labauge, Pierre; Godefroy, Olivier		GREFEX Study Grp	The Behavioral and Cognitive Executive Disorders of Stroke: The GREFEX Study	PLOS ONE			English	Article							IMPAIRMENT HARMONIZATION STANDARDS; MINI-MENTAL-STATE; POSTSTROKE DEPRESSION; FUNCTIONAL RECOVERY; APATHY; DYSFUNCTION; DEMENTIA; VALIDATION; FREQUENCY; INFARCTS	Background Many studies have highlighted the high prevalence of executive disorders in stroke. However, major uncertainties remain due to use of variable and non-validated methods. The objectives of this study were: 1) to characterize the executive disorder profile in stroke using a standardized battery, validated diagnosis criteria of executive disorders and validated framework for the interpretation of neuropsychological data and 2) examine the sensitivity of the harmonization standards protocol proposed by the National Institute of Neurological Disorders and Stroke and Canadian Stroke Network (NINDS-CSN) for the diagnosis of Vascular Cognitive Impairment. Methods 237 patients (infarct: 57; cerebral hemorrhage: 54; ruptured aneurysm of the anterior communicating artery (ACoA): 80; cerebral venous thrombosis (CVT): 46) were examined by using the GREFEX battery. The patients' test results were interpreted with a validated framework derived from normative data from 780 controls. Results Dysexecutive syndrome was observed in 88 (55.7%; 95%CI: 48-63.4) out of the 156 patients with full cognitive and behavioral data: 40 (45.5%) had combined behavioral and cognitive syndromes, 29 (33%) had a behavioral disorder alone and 19 (21.6%) had a cognitive syndrome alone. The dysexecutive profile was characterized by prominent impairments of initiation and generation in the cognitive domain and by hypoactivity with disinterest and anticipation loss in the behavioral domain. Cognitive impairment was more frequent (p = 0.014) in hemorrhage and behavioral disorders were more frequent (p = 0.004) in infarct and hemorrhage. The harmonization standards protocol underestimated (p = 0.007) executive disorders in CVT or ACoA. Conclusions This profile of executive disorders implies that the assessment should include both cognitive tests and a validated inventory for behavioral dysexecutive syndrome. Initial assessment may be performed with a short cognitive battery, such as the harmonization standards protocol. However, administration of a full cognitive battery is required in selected patients.	[Roussel, Martine; Godefroy, Olivier] Univ Hosp Amiens, Dept Neurol, Amiens, France; [Roussel, Martine; Godefroy, Olivier] Univ Hosp Amiens, Lab Funct Neurosci EA 4559, SFR CAP Sante FED 4231, Amiens, France; [Martinaud, Olivier] Univ Hosp Rouen, Dept Neurol, Rouen, France; [Henon, Hilde] Univ Hosp Lille, Dept Neurol, Lille, France; [Vercelletto, Martine] Univ Hosp Nantes, Res Memory Ctr, Nantes, France; [Bindschadler, Claire] Univ Lausanne Hosp, Dept Neuropsychol & Neurorehabilitat, Lausanne, Switzerland; [Joseph, Pierre-Alain] Univ Bordeaux, Res Grp EA Handicap & Nervous Syst Dis 4136, Bordeaux, France; [Robert, Philippe] Univ Nice Sophia Antipolis, CoBTeK Res Memory Ctr CHU, F-06189 Nice, France; [Labauge, Pierre] Univ Nimes Hosp, Dept Neurol, F-30006 Nimes, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU de Rouen; Universite de Lille - ISITE; CHU Lille; Nantes Universite; CHU de Nantes; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); UDICE-French Research Universities; Universite de Bordeaux; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Universite de Montpellier; CHU de Nimes	Roussel, M (corresponding author), Univ Hosp Amiens, Dept Neurol, Amiens, France.; Roussel, M (corresponding author), Univ Hosp Amiens, Lab Funct Neurosci EA 4559, SFR CAP Sante FED 4231, Amiens, France.	roussel.martine@chu-amiens.fr	LEYS, Didier/G-2955-2016; Martinaud, Olivier/AAS-9307-2020	LEYS, Didier/0000-0003-4408-4392; Verny, Marc/0000-0001-7960-9705; Godefroy, Olivier/0000-0001-6789-6620				Angelelli P, 2004, ACTA PSYCHIAT SCAND, V110, P55, DOI 10.1111/j.1600-0447.2004.00297.x; Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994; Benton AL, 1994, MULTILINGUAL APHASIA; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brodaty H, 2005, PSYCHOL MED, V35, P1707, DOI 10.1017/S0033291705006173; Bugnicourt JM, 2013, J NEUROL, V260, P1324, DOI 10.1007/s00415-012-6799-5; Burgess PW, 1996, CORTEX, V32, P241, DOI 10.1016/S0010-9452(96)80049-9; CAPLAN LR, 1990, ARCH NEUROL-CHICAGO, V47, P133, DOI 10.1001/archneur.1990.00530020029011; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Chabriat H, 2013, BEHAV COGNITIVE NEUR, P387; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garcia PY, 2013, J STROKE CEREBROVASC, V22, P80, DOI 10.1016/j.jstrokecerebrovasdis.2011.06.013; Godefroy O, 1996, BRAIN, V119, P191, DOI 10.1093/brain/119.1.191; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; Godefroy O, 2002, NEUROPSYCHOLOGIA, V40, P2234, DOI 10.1016/S0028-3932(02)00109-4; GODEFROY O, 1992, ARCH NEUROL-CHICAGO, V49, P1285, DOI 10.1001/archneur.1992.00530360087023; Godefroy O, 2014, CORTEX, V54, P51, DOI 10.1016/j.cortex.2014.01.016; Godefroy O, 2012, INT J STROKE, V7, P362, DOI 10.1111/j.1747-4949.2012.00794.x; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Godefroy O, 2010, CEREBROVASC DIS, V29, P508, DOI 10.1159/000297968; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hama S, 2007, INT J GERIATR PSYCH, V22, P1046, DOI 10.1002/gps.1866; Hama S, 2011, PSYCHOGERIATRICS, V11, P68, DOI 10.1111/j.1479-8301.2011.00358.x; Martinaud O, 2009, EUR J NEUROL, V16, P595, DOI 10.1111/j.1468-1331.2009.02546.x; Mayo NE, 2009, STROKE, V40, P3299, DOI 10.1161/STROKEAHA.109.554410; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nyenhuis D, 2013, BEHAV COGNITIVE NEUR, P410; Oveisgharan S, 2015, J NEUROL SCI, V349, P161, DOI 10.1016/j.jns.2015.01.010; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Pohjasvaara T, 2002, EUR J NEUROL, V9, P269, DOI 10.1046/j.1468-1331.2002.00396.x; Rasquin SMC, 2004, DEMENT GERIATR COGN, V18, P138, DOI 10.1159/000079193; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reyes S, 2009, NEUROLOGY, V72, P905, DOI 10.1212/01.wnl.0000344166.03470.f8; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Sala SD, 1995, ANN NY ACAD SCI, V769, P161, DOI 10.1111/j.1749-6632.1995.tb38137.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Wechsler D., 1997, WECHSLER ADULT INTEL; Wilson B.A., 1996, BEHAV ASSESSMENT DYS	42	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147602	10.1371/journal.pone.0147602	http://dx.doi.org/10.1371/journal.pone.0147602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824746	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600039
J	Wang, XL; Wang, Q; Wang, JJ; Bai, P; Shi, L; Shen, W; Zhou, M; Zhou, XS; Zhang, YX; Cai, MH				Wang, Xiaolong; Wang, Qi; Wang, Jinjia; Bai, Peng; Shi, Lei; Shen, Wei; Zhou, Mian; Zhou, Xiangshan; Zhang, Yuanxing; Cai, Menghao			Mit1 Transcription Factor Mediates Methanol Signaling and Regulates the Alcohol Oxidase 1 (AOX1) Promoter in Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-protein interaction; protein domain; signal transduction; transcription coactivator; transcription regulation; AOX1 promoter; Mit1; Pichia pastoris; glycerol repression; methanol induction	YEAST CANDIDA-BOIDINII; RECOMBINANT PROTEIN-PRODUCTION; SACCHAROMYCES-CEREVISIAE; UTILIZATION PATHWAY; HANSENULA-POLYMORPHA; METHYLOTROPHIC YEASTS; HETEROLOGOUS PROTEIN; MASTER REGULATOR; GENE ACTIVATION; EXPRESSION	The alcohol oxidase 1 (AOX1) promoter (P-AOX1) of Pichia pastoris is the most powerful and commonly used promoter for driving protein expression. However, mechanisms regulating its transcriptional activity are unclear. Here, we identified a Zn(II)(2)Cys(6)-type methanol-induced transcription factor 1 (Mit1) and elucidated its roles in regulating P-AOX1 activity in response to glycerol and methanol. Mit1 regulated the expression of many genes involved in methanol utilization pathway, including AOX1, but did not participate in peroxisome proliferation and transportation of peroxisomal proteins during methanol metabolism. Structural analysis of Mit1 by performing domain deletions confirmed its specific and critical role in the strict repression of P-AOX1 in glycerol medium. Importantly, Mit1, Mxr1, and Prm1, which positively regulated P-AOX1 in response to methanol, were bound to P-AOX1 at different sites and did not interact with each other. However, these factors cooperatively activated P-AOX1 through a cascade. Mxr1 mainly functioned during carbon derepression, whereas Mit1 and Prm1 functioned during methanol induction, with Prm1 transmitting methanol signal to Mit1 by binding to the MIT1 promoter (P-MIT1), thus increasingly expressing Mit1 and subsequently activating P-AOX1.	[Wang, Xiaolong; Wang, Qi; Wang, Jinjia; Bai, Peng; Shi, Lei; Shen, Wei; Zhou, Mian; Zhou, Xiangshan; Zhang, Yuanxing; Cai, Menghao] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, 130 Meilong Rd, Shanghai 200237, Peoples R China; [Zhang, Yuanxing] SCICB, Shanghai 200237, Peoples R China	East China University of Science & Technology	Cai, MH (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, 130 Meilong Rd, Shanghai 200237, Peoples R China.	cmh022199@ecust.edu.cn			National Special Fund for State Key Laboratory of Bioreactor Engineering [2060204]; Chinese National High Technology Research and Development Program [2014AA093501]	National Special Fund for State Key Laboratory of Bioreactor Engineering; Chinese National High Technology Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by Grant 2060204 from the National Special Fund for State Key Laboratory of Bioreactor Engineering and Grant 2014AA093501 from the Chinese National High Technology Research and Development Program. The authors declare that they have no conflicts of interest with the contents of this article.	Cregg J., 1988, DEV IND MICROBIOL, P33; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; FABER KN, 1995, YEAST, V11, P1331, DOI 10.1002/yea.320111402; Gellissen G, 2000, APPL MICROBIOL BIOT, V54, P741, DOI 10.1007/s002530000464; Gurvitz A, 2001, J BIOL CHEM, V276, P31825, DOI 10.1074/jbc.M105989200; Hartner FS, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-39; Karpichev IV, 2008, J BIOL CHEM, V283, P10264, DOI 10.1074/jbc.M708215200; Kranthi BV, 2010, YEAST, V27, P705, DOI 10.1002/yea.1766; Kranthi BV, 2009, BBA-GENE REGUL MECH, V1789, P460, DOI 10.1016/j.bbagrm.2009.05.004; Leao-Helder AN, 2003, J BIOL CHEM, V278, P40749, DOI 10.1074/jbc.M304029200; Liang SL, 2013, BIOTECHNOL LETT, V35, P1865, DOI 10.1007/s10529-013-1265-8; Lin-Cereghino GP, 2006, MOL CELL BIOL, V26, P883, DOI 10.1128/MCB.26.3.883-897.2006; Parua PK, 2012, MOL MICROBIOL, V85, P282, DOI 10.1111/j.1365-2958.2012.08112.x; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Porro D, 2005, MOL BIOTECHNOL, V31, P245, DOI 10.1385/MB:31:3:245; Raschke WC, 1996, GENE, V177, P163, DOI 10.1016/0378-1119(96)00293-4; Ratnakumar S, 2010, J BIOL CHEM, V285, P10703, DOI 10.1074/jbc.M109.079848; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rottensteiner H, 1997, EUR J BIOCHEM, V247, P776, DOI 10.1111/j.1432-1033.1997.00776.x; Sahu U, 2016, J BIOL CHEM, V291, P3648, DOI 10.1074/jbc.M115.673640; Sahu U, 2014, BIOCHEM BIOPH RES CO, V451, P158, DOI 10.1016/j.bbrc.2014.07.094; Sakai Y, 1999, FEBS LETT, V459, P233, DOI 10.1016/S0014-5793(99)01245-4; Sasano Y, 2008, EUKARYOT CELL, V7, P527, DOI 10.1128/EC.00403-07; Sasano Y, 2010, FEMS YEAST RES, V10, P535, DOI 10.1111/j.1567-1364.2010.00640.x; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Stasyk OV, 2008, METHOD ENZYMOL, V451, P229, DOI 10.1016/S0076-6879(08)03216-3; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Takagi S, 2012, United States patent, Patent No. [US 8,143,023, 8143023]; Vallini V, 2000, CURR GENET, V38, P163, DOI 10.1007/s002940000142; VERDUYN C, 1984, J MICROBIOL METH, V2, P15, DOI 10.1016/0167-7012(84)90027-7; Vogl T, 2013, NEW BIOTECHNOL, V30, P385, DOI 10.1016/j.nbt.2012.11.010; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; Xuan YJ, 2009, FEMS YEAST RES, V9, P1271, DOI 10.1111/j.1567-1364.2009.00571.x; Yurimoto H, 2000, BBA-GENE STRUCT EXPR, V1493, P56, DOI 10.1016/S0167-4781(00)00157-3; Yurimoto H., 2011, INT J MICROBIOL, V2011; Zhang P, 2010, APPL ENVIRON MICROB, V76, P6108, DOI 10.1128/AEM.00607-10; Zianni Michael, 2006, J Biomol Tech, V17, P103	38	60	65	6	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6245	6261		10.1074/jbc.M115.692053	http://dx.doi.org/10.1074/jbc.M115.692053			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26828066	Green Published, hybrid			2022-12-26	WOS:000372894200016
J	Chaves, OM; Bicca-Marques, JC				Chaves, Oscar M.; Bicca-Marques, Julio Cesar			Feeding Strategies of Brown Howler Monkeys in Response to Variations in Food Availability	PLOS ONE			English	Article							ALOUATTA-PALLIATA-MEXICANA; FALLBACK FOODS; BEHAVIORAL FLEXIBILITY; FOREST FRAGMENTATION; PRIMATE RESPONSES; ACTIVITY PATTERN; RAIN-FOREST; DIET; ECOLOGY; FRUIT	Primates display varying degrees of behavioral flexibility that allow them to adjust their diet to temporal changes in food availability. This trait might be critical for the survival of folivorous-frugivorous species inhabiting small forest fragments, where the availability of food resources tends to be lower than in large fragments and continuous forests. However, the scarcity of studies addressing this issue hampers our understanding of the adaptive behaviors that favor the survival of these primates in low-quality habitats. We conducted a 36-mo study testing the hypothesis that brown howler monkeys (Alouatta guariba clamitans) are able to adjust their diet in response to local and seasonal changes in resource availability. We compared the diet of six free-ranging groups inhabiting three small (<10 ha) and three large (>90 ha) Atlantic forest fragments in southern Brazil and estimated the temporal availability of their top food species (i.e., those species that together contribute >= 80% of total feeding records). We found that brown howlers exploited similarly rich diets in small (45, 54, and 57 plant species) and large (48, 51, and 56 species) fragments. However, intermonth diet similarity was higher for groups in small fragments, where howlers also fed on plant items from nine alien species. Fruits and leaves were the most consumed plant items in both small (42% and 49% of feeding records, respectively) and large (51% and 41%, respectively) fragments. The consumption of young leaves was higher in small than in large fragments, whereas the consumption of other plant items did not show a pattern related to fragment size. Regarding the contribution of growth forms as food sources, only the exploitation of palms showed a pattern related to fragment size. Palms contributed more to the diet of groups inhabiting large fragments. The availability of seasonal food items-ripe fruits and young leaves-influenced their consumption in both habitat types. Therefore, brown howlers cope with local and seasonal fluctuations in food availability by opportunistically exploiting resources. We believe that this feeding flexibility is a key component of the phenotypic plasticity that enables howlers to thrive in disturbed habitat patches, where periods of scarcity of preferred foods shall be more common.	[Chaves, Oscar M.; Bicca-Marques, Julio Cesar] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul	Bicca-Marques, JC (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil.	jcbicca@pucrs.br	Bicca-Marques, Júlio César/F-7487-2012; Chaves, Óscar M./AAF-1886-2021	Bicca-Marques, Júlio César/0000-0002-5400-845X; Chaves, Óscar M./0000-0001-6246-1265	Programa Nacional de Pos-Doutorado of the Brazilian Higher Education Authority/CAPES (PNPD grant) [2755/2010]; PNPD postdoctoral fellowship; Brazilian National Research Council/CNPq [303154/2009-8, 303306/2013-0]	Programa Nacional de Pos-Doutorado of the Brazilian Higher Education Authority/CAPES (PNPD grant); PNPD postdoctoral fellowship; Brazilian National Research Council/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by a grant from the Programa Nacional de Pos-Doutorado of the Brazilian Higher Education Authority/CAPES (PNPD grant # 2755/2010). OMC was supported by a PNPD postdoctoral fellowship. JCBM thanks the Brazilian National Research Council/CNPq for research fellowships (PQ # 303154/2009-8 and 303306/2013-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini I, 2010, AM J PRIMATOL, V72, P173, DOI 10.1002/ajp.20775; Alonso A, 2004, MONOGRAPH U FEDERAL; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson J, 2007, BIOL CONSERV, V135, P212, DOI 10.1016/j.biocon.2006.10.022; Arroyo-Rodriguez V, 2007, BIOTROPICA, V39, P760, DOI 10.1111/j.1744-7429.2007.00330.x; Arroyo-Rodriguez V, 2015, ECOLOGY OF LIANAS, P407; ARROYORODRIGUEZ V, 2010, AM J PRIMATOL, V72, P1, DOI DOI 10.1002/ajp.20753; Asensio N, 2009, BIOTROPICA, V41, P768, DOI 10.1111/j.1744-7429.2009.00533.x; Behie AM, 2015, DEV PRIMATOL-PROG PR, P357, DOI 10.1007/978-1-4939-1960-4_13; Bicca-Marques JC, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P283; BICCAMARQUES JC, 1994, FOLIA PRIMATOL, V63, P209, DOI 10.1159/000156821; BICCAMARQUES JC, 1994, FOLIA PRIMATOL, V63, P216, DOI 10.1159/000156823; BUSS G, 2001, THESIS U FEDERAL RIO; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; CHAPMAN C, 1987, FOLIA PRIMATOL, V49, P90, DOI 10.1159/000156311; CHAPMAN CA, 1990, PRIMATES, V31, P121, DOI 10.1007/BF02381035; Chapman CA, 2013, DEV PRIMATOL-PROG PR, P89, DOI 10.1007/978-1-4614-8839-2_7; Chaves OM, 2013, AM J PRIMATOL, V75, P16, DOI 10.1002/ajp.22075; Chaves OM, 2012, BIOTROPICA, V44, P105, DOI 10.1111/j.1744-7429.2011.00766.x; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2005, ESTIMATES STAT ESTIM, V7, P5; Constantino PJ, 2009, AM J PHYS ANTHROPOL, V140, P599, DOI 10.1002/ajpa.20978; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Cristobal-Azkarate J, 2007, AM J PRIMATOL, V69, P1013, DOI 10.1002/ajp.20420; Dias PAD, 2015, DEV PRIMATOL-PROG PR, P21, DOI 10.1007/978-1-4939-1960-4_2; Dias PAD, 2014, AM J PRIMATOL, V76, P1151, DOI 10.1002/ajp.22300; DILL LM, 1983, CAN J FISH AQUAT SCI, V40, P398, DOI 10.1139/f83-058; Dunn JC, 2012, BIOTROPICA, V44, P705, DOI 10.1111/j.1744-7429.2012.00856.x; Dunn JC, 2010, INT J PRIMATOL, V31, P887, DOI 10.1007/s10764-010-9436-0; Dunn JC, 2009, AM J PRIMATOL, V71, P654, DOI 10.1002/ajp.20700; FOURNIER LA, 1974, TURRIALBA, V24, P422; GENTRY AH, 1982, EVOL BIOL, V15, P1; Gouveia SF, 2014, J ANIM ECOL, V83, P1523, DOI 10.1111/1365-2656.12241; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Jones CB., 2005, BEHAV FLEXIBILITY PR, DOI [10.1007/978-0-387-23327-7, DOI 10.1007/978-0-387-23327-7]; Kinzey WG., 1982, BIOL DIVERSIFICATION, P455; Lambert JE, 2011, PRIMATES PERSPECTIVE, P512, DOI DOI 10.1002/ECY.2106; Lambert JE, 2015, ANNU REV ANTHROPOL, V44, P493, DOI 10.1146/annurev-anthro-102313-025928; Lansky EP, 2011, FIGS THE GENUS FICUS; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; Ludwig G, 2008, REV BRAS ZOOL, V25, P419, DOI 10.1590/S0101-81752008000300006; Maibeche Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118596; Marshall AJ, 2009, AM J PHYS ANTHROPOL, V140, P603, DOI 10.1002/ajpa.21082; McKinney T, 2015, DEV PRIMATOL-PROG PR, P281, DOI 10.1007/978-1-4939-1960-4_11; MILTON K, 1991, J ECOL, V79, P1, DOI 10.2307/2260781; Nowak K, 2013, DEV PRIMATOL-PROG PR, P199, DOI 10.1007/978-1-4614-8839-2_14; Onderdonk DA, 2000, INT J PRIMATOL, V21, P587, DOI 10.1023/A:1005509119693; PERES CA, 1994, BIOTROPICA, V26, P98, DOI 10.2307/2389114; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Printes Rodrigo C., 2001, Neotropical Primates, V9, P118; R Core Team, 2013, R LANG ENV STAT COMP; REICH PB, 1995, CAN J BOT, V73, P164, DOI 10.1139/b95-020; Rivera A, 2006, DEV PRIMATOL-PROG PR, P189, DOI 10.1007/0-387-25872-8_9; Salomao R. P., 2012, Floresta, V42, P115; Schnell JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065357; Serio-Silva JC, 2002, J TROP ECOL, V18, P913, DOI 10.1017/S0266467402002596; Setubal RB, 2011, CAMPOS MORROS PORTO; Sica YV, 2014, BIOTROPICA, V46, P696, DOI 10.1111/btp.12152; Silver SC, 1998, AM J PRIMATOL, V45, P263, DOI 10.1002/(SICI)1098-2345(1998)45:3<263::AID-AJP3>3.0.CO;2-U; Sobral M., 2006, FLORA ARBORESCENTE R; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Strier KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114099; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; Weinbeer M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00342; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Wong BBM, 2015, BEHAV ECOL, V26, P665, DOI 10.1093/beheco/aru183; Zimmerman JK, 2007, J TROP ECOL, V23, P231, DOI 10.1017/S0266467406003890	71	25	25	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0145819	10.1371/journal.pone.0145819	http://dx.doi.org/10.1371/journal.pone.0145819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848959	Green Published, gold			2022-12-26	WOS:000369554000005
J	Lee, JY; Paik, JS; Yun, M; Lee, SB; Yang, SW				Lee, Ji-Young; Paik, Ji-Sun; Yun, Mihee; Lee, Seong-Beom; Yang, Suk-Woo			The Effect of (-)- Epigallocatechin-3-Gallate on IL-1 beta Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy	PLOS ONE			English	Article							INDUCED SECRETION; EGCG; TISSUE; PATHOGENESIS; MECHANISMS	Orbital fibroblasts have been reported to be an important effector cells for the development of thyroid-associated ophthalmopathy (TAO). Orbital fibroblasts secrete various inflammatory cytokines in response to an inflammatory stimulation, leading to TAO-related tissue swelling. It has also been reported that (-)-epigallocatechin-3-gallate (EGCG), a major polyphenolic constituent of green tea, has antioxidant and anti-inflammatory properties. In the current study, we investigated the issue of whether or how EGCG affects the interleukin (IL)-1 beta-induced secretion of IL-8 in human orbital fibroblasts from TAO patients. Treatment with EGCG significantly reduced the level of IL-1 beta-induced secretion of IL-8 and the expression of IL-8 mRNA. IL-1 beta-induced the degradation of I kappa B alpha, and the phosphorylation of p38 and ERK, and the IL-1 beta-induced expression of IL-8 mRNA was inhibited by specific inhibitors, such as BAY-117085 for NF-kappa B, SB203580 for p38, and PD98059 for ERK. In addition, treatment with EGCG inhibited the IL-1 beta-induced degradation of I kappa B alpha, and the phosphorylation of p38 and ERK. However, pre-treatment with antioxidants, NVN and NAC, which suppressed ROS generation, did not reduce IL-8 expression in IL-1 beta-treated orbital fibroblasts, suggesting that the IL-1 beta-induced IL-8 expression is not mediated by the generation of ROS. These results show that EGCG suppresses the IL-1 beta-induced expression of IL-8 through inhibition of the NF-kappa B, p38, and ERK pathways. These findings could contribute to the development of new types of EGCG-containing pharmacological agents for use in the treatment of TAO.	[Lee, Ji-Young; Paik, Ji-Sun; Yang, Suk-Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Lee, Ji-Young; Yun, Mihee; Lee, Seong-Beom] Catholic Univ Korea, Coll Med, Dept Pathol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Paik, JS (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	rollipopp@hanmail.net		Lee, Seong-Beom/0000-0002-2767-6188	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A3007696]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by Basic Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A3007696).	BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Chang JZC, 2013, CLIN ORAL INVEST, V17, P455, DOI 10.1007/s00784-012-0713-5; Chang YC, 2012, J AGR FOOD CHEM, V60, P8395, DOI 10.1021/jf302223g; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; Douglas RS, 2011, CURR OPIN OPHTHALMOL, V22, P385, DOI 10.1097/ICU.0b013e3283499446; Gu LQ, 2009, ENDOCRINE, V36, P452, DOI 10.1007/s12020-009-9240-9; Hardtner C, 2012, EUR J PHARMACOL, V684, P36, DOI 10.1016/j.ejphar.2012.03.039; Hiromatsu Y, 2000, J CLIN ENDOCR METAB, V85, P1194, DOI 10.1210/jc.85.3.1194; Honicke AS, 2012, INT J ONCOL, V41, P753, DOI 10.3892/ijo.2012.1498; Hsieh SR, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-86; Hwang CJ, 2009, INVEST OPHTH VIS SCI, V50, P2262, DOI 10.1167/iovs.08-2328; Hwang YS, 2004, ONCOGENE, V23, P6603, DOI 10.1038/sj.onc.1207867; Inokawa S, 2015, GRAEF ARCH CLIN EXP, V253, P557, DOI 10.1007/s00417-014-2879-9; Kang JS, 2014, PHYTOTHER RES, V28, P98, DOI 10.1002/ptr.4971; KENDALLTAYLOR P, 1985, CLIN ENDOCRINOL META, V14, P331, DOI 10.1016/S0300-595X(85)80037-2; Ko JW, 2014, INT J BIOCHEM CELL B, V55, P164, DOI 10.1016/j.biocel.2014.08.017; Lee WM, 2013, CURR EYE RES, V38, P699, DOI 10.3109/02713683.2012.750368; Li M, 2012, PHARMACOL REP, V64, P912, DOI 10.1016/S1734-1140(12)70886-1; Nagle DG, 2006, PHYTOCHEMISTRY, V67, P1849, DOI 10.1016/j.phytochem.2006.06.020; Paik JS, 2012, MOL VIS, V18, P1467; Raychaudhuri Nupur, 2010, PLoS One, V5, pe15296, DOI 10.1371/journal.pone.0015296; Stan MN, 2012, MED CLIN N AM, V96, P311, DOI 10.1016/j.mcna.2012.01.014; van Steensel L, 2010, INVEST OPHTH VIS SCI, V51, P1002, DOI 10.1167/iovs.09-4338; Vezina A, 2012, CANCER IMMUNOL IMMUN, V61, P2321, DOI 10.1007/s00262-012-1301-x; Wakelkamp IMMJ, 2003, CLIN ENDOCRINOL, V58, P280, DOI 10.1046/j.1365-2265.2003.01708.x; Wang Y, 2014, INVEST OPHTH VIS SCI, V55, P1735, DOI 10.1167/iovs.14-14002; Wen WC, 2014, J PERIODONTOL, V85, P868, DOI 10.1902/jop.2013.120714; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang J, 2013, LIFE SCI, V92, P589, DOI 10.1016/j.lfs.2013.01.025; Yoon JS, 2012, BRIT J OPHTHALMOL, V96, P1117, DOI 10.1136/bjophthalmol-2012-301537	31	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148645	10.1371/journal.pone.0148645	http://dx.doi.org/10.1371/journal.pone.0148645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848751	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000147
J	Abegunde, D; Orobaton, N; Bassi, A; Oguntunde, O; Bamidele, M; Abdulkrim, M; Nwizugbe, E				Abegunde, Dele; Orobaton, Nosa; Bassi, Amos; Oguntunde, Olugbenga; Bamidele, Moyosola; Abdulkrim, Masduq; Nwizugbe, Ezenwa			The Impact of Integrated Community Case Management of Childhood Diseases Interventions to Prevent Malaria Fever in Children Less than Five Years Old in Bauchi State of Nigeria	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; BED NETS; COUNTRIES	Background Malaria accounts for about 300,000 childhood deaths and 30% of under-five year old mortality in Nigeria annually. We assessed the impact of intervention strategies that integrated Patent Medicines Vendors into community case management of childhood-diseases, improved access to artemisinin combination therapy (ACT) and distributed bed nets to households. We explored the influence of household socioeconomic characteristics on the impact of the interventions on fever in the under-five year olds in Bauchi State Nigeria. Methods A cross-sectional case-controlled, interventional study, which sampled 3077 and 2737 under-5 year olds from 1,588 and 1601 households in pre- and post-intervention periods respectively, was conducted from 2013 to 2015. Difference-in-differences and logistic regression analyses were performed to estimate the impact attributable to the interventions: integrated community case management of childhood illness which introduced trained public and private sector health providers and the possession of nets on the prevalence of fever. Results Two-week prevalence of fever among under-fives declined from 56.6% at pre-intervention to 42.5% at post-intervention. Fever-prevention fraction attributable to nets was statistically significant (OR = 0.217, 95% CI: 0.08-0.33). Children in the intervention group had significantly fewer incidence of fever than children in the control group had (OR = 0.765, 95% CI: 0.67-0.87). Although being in the intervention group significantly provided 23.5% protection against fever (95% CI: 0.13-0.33), the post-intervention likelihood of fever was also significantly less than at pre-intervention (OR = 0.57, 95% CI: 0.50-0.65). The intervention protection fraction against fever was statistically significant at 43.4%(OR = 0.434, 95% CI: 0.36-0.50). Logistic regression showed that the odds of fever were lower in households with nets (OR = 0.72, 95% CI: 0.60-0.88), among children whose mothers had higher education, in the post-intervention period (OR = 0.39, 95% CI: 0.33-0.46) and in the intervention group (OR = 0.52, 95% CI: 0.48-0.66). The odds of fever increased with higher socio-economic status of households (17.9%-19.5%). Difference-in-differences showed that the interventions significantly reduced occurrence of fever in the intervention group (OR = 1.70, 95% CI: 1.36-2.14). Conclusion The interventions were effective in reducing the prevalence and the likelihood of childhood malaria fever. Taken to scale, these can significantly reduce the burden of malaria fever in the under-five year old children.	[Abegunde, Dele; Orobaton, Nosa; Bassi, Amos; Oguntunde, Olugbenga; Bamidele, Moyosola; Abdulkrim, Masduq; Nwizugbe, Ezenwa] John Snow Inc, Res & Training Inst, Boston, MA USA; [Oguntunde, Olugbenga] Futures Grp Inc, Chapel Hill, NC USA		Abegunde, D (corresponding author), John Snow Inc, Res & Training Inst, Boston, MA USA.	dele.abegunde@yahoo.com		Bamidele, Moyosola/0000-0001-8444-7966				Consortium M, 2014, SOL WORLD RESP 2014; CORTINOVIS I, 1993, SOC SCI MED, V36, P1087, DOI 10.1016/0277-9536(93)90127-P; Eteng M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-316; Federal Ministry of Health NMCP Abuja Nigeria, 2008, ROAD MAP MAL CONTR N; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fund TG, 2014, GRANT PORTF 2014; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Kilian A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0640-4; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Nankinga Z, 2012, J COMMUN HEALTH, V37, P1006, DOI 10.1007/s10900-012-9546-z; National Population Commission (NPC) [Nigeria] ICF International, 2014, NIG DEM HLTH SURV 20; Njau JD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-245; Okafor IP, 2012, NIGER J CLIN PRACT, V15, P220, DOI 10.4103/1119-3077.97325; Oladosu O.O., 2013, ISRN INFECT DIS, V2013, P6, DOI DOI 10.5402/2013/914675; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x; Tanner M, 2008, B WORLD HEALTH ORGAN, V86, P82, DOI 10.2471/BLT.07.050633; United States Agency for interational Development, 2002, TOOLK COMM CAS MAN C; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization, 2009, INT COMM CAS MAN ICC; World Health Organization, 2012, EQ FOC STRAT IMPR AC	23	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148586	10.1371/journal.pone.0148586	http://dx.doi.org/10.1371/journal.pone.0148586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845546	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800076
J	Cavada, N; Barelli, C; Ciolli, M; Rovero, F				Cavada, Nathalie; Barelli, Claudia; Ciolli, Marco; Rovero, Francesco			Primates in Human-Modified and Fragmented Landscapes: The Conservation Relevance of Modelling Habitat and Disturbance Factors in Density Estimation	PLOS ONE			English	Article							UDZUNGWA RED COLOBUS; SPECIES DISTRIBUTION; IMPERFECT DETECTION; ABUNDANCE; MOUNTAINS; CONSEQUENCES; DIVERSITY; ECOLOGY; FOREST; DIET	Accurate density estimations of threatened animal populations is essential for management and conservation. This is particularly critical for species living in patchy and altered landscapes, as is the case for most tropical forest primates. In this study, we used a hierarchical modelling approach that incorporates the effect of environmental covariates on both the detection (i.e. observation) and the state (i.e. abundance) processes of distance sampling. We applied this method to already published data on three arboreal primates of the Udzungwa Mountains of Tanzania, including the endangered and endemic Udzungwa red colobus (Procolobus gordonorum). The area is a primate hotspot at continental level. Compared to previous, 'canonical' density estimates, we found that the inclusion of covariates in the modelling makes the inference process more informative, as it takes in full account the contrasting habitat and protection levels among forest blocks. The correction of density estimates for imperfect detection was especially critical where animal detectability was low. Relative to our approach, density was underestimated by the canonical distance sampling, particularly in the less protected forest. Group size had an effect on detectability, determining how the observation process varies depending on the socio-ecology of the target species. Lastly, as the inference on density is spatially-explicit to the scale of the covariates used in the modelling, we could confirm that primate densities are highest in low-to-mid elevations, where human disturbance tend to be greater, indicating a considerable resilience by target monkeys in disturbed habitats. However, the marked trend of lower densities in unprotected forests urgently calls for effective forest protection.	[Cavada, Nathalie; Ciolli, Marco] Univ Trento, DICAM Dept Civil Environm & Mech Engn, Trento, Italy; [Cavada, Nathalie; Barelli, Claudia; Rovero, Francesco] MUSE Museo Sci, Trop Biodivers Sect, Trento, Italy; [Barelli, Claudia] Res & Innovat Ctr Fdn Edmund Mach, Biodivers & Mol Ecol Dept, San Michele All Adige, TN, Italy; [Rovero, Francesco] Udzungwa Ecol Monitoring Ctr, Udzungwa Mountains Natl Pk, Mangula, Tanzania	University of Trento; Fondazione Edmund Mach	Cavada, N (corresponding author), Univ Trento, DICAM Dept Civil Environm & Mech Engn, Trento, Italy.; Cavada, N (corresponding author), MUSE Museo Sci, Trop Biodivers Sect, Trento, Italy.	nathalie.cavada@gmail.com	Ciolli, Marco/D-8613-2014; Rovero, Francesco/AAI-3157-2020	Ciolli, Marco/0000-0001-8370-9039; Rovero, Francesco/0000-0001-6688-1494; Cavada, Nathalie/0000-0002-9251-6471	MUSE-Museo delle Scienze; University of Trento	MUSE-Museo delle Scienze; University of Trento	The work was funded through doctoral scholarship to NC from MUSE-Museo delle Scienze and the University of Trento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Anderson J, 2007, INT J PRIMATOL, V28, P637, DOI 10.1007/s10764-007-9143-7; Araldi A, 2014, INT J PRIMATOL, V35, P941, DOI 10.1007/s10764-014-9772-6; Arroyo-Rodriguez V, 2015, ECOLOGY OF LIANAS, P407; Arroyo-Rodriguez V, 2014, AM J PRIMATOL, V76, P901, DOI 10.1002/ajp.22282; Baillie SR, 2000, J APPL ECOL, V37, P88, DOI 10.1046/j.1365-2664.2000.00555.x; Barelli C, 2015, INT J PRIMATOL, V36, P209, DOI 10.1007/s10764-015-9815-7; Barton K, 2014, MULTIMODEL INFERENCE, P46; Buckland S.T., 2001, pi; Buckland ST, 2010, INT J PRIMATOL, V31, P833, DOI 10.1007/s10764-010-9431-5; Buckland ST, 2010, INT J PRIMATOL, V31, P485, DOI 10.1007/s10764-010-9408-4; Chandler R, 2014, DISTANCE SAMPLING AN, P1; Chapman CA, 2001, EVOL ANTHROPOL, V10, P16, DOI 10.1002/1520-6505(2001)10:1<16::AID-EVAN1010>3.0.CO;2-O; Chapman CA, 1999, PRIMATES, V40, P215, DOI 10.1007/BF02557712; Davies A. Glyn, 1994, P285; Dunn JC, 2012, BIOTROPICA, V44, P705, DOI 10.1111/j.1744-7429.2012.00856.x; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; Johns AD, 1983, ECOLOGICAL EFFECTS S; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Kellner KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111436; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kumpel NF, 2008, INT J PRIMATOL, V29, P1065, DOI [10.1007/s10764-008-9254-9, 10.1007/s10764-008-9277-2]; Lahoz-Monfort JJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P504, DOI 10.1111/geb.12138; Levi T, 2009, J APPL ECOL, V46, P804, DOI 10.1111/j.1365-2664.2009.01661.x; Linder JM, 2011, BIOL CONSERV, V144, P738, DOI 10.1016/j.biocon.2010.10.023; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Lovett JC, 1993, BIOGEOGRAPHY AND ECO; Manduell KL, 2012, RESEARCH ARTICLE FOR, V15, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Marsh LK, 2013, DEV PRIMATOL-PROG PR, P3, DOI 10.1007/978-1-4614-8839-2_1; Marsh LK, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P1; Marshall AR, 2010, AM J PRIMATOL, V72, P325, DOI 10.1002/ajp.20787; Marshall AR, 2008, ECOLOGICAL REPORT MA; Marshall AR, 2007, DISTURBANCE UDZUNGWA; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; McGraw WS, 1996, AM J PHYS ANTHROPOL, V100, P507, DOI 10.1002/(SICI)1096-8644(199608)100:4<507::AID-AJPA5>3.0.CO;2-N; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Platts PJ, 2011, ENVIRON CONSERV, V38, P312, DOI 10.1017/S0376892911000191; Ramos-Fernandez G, 2013, DEV PRIMATOL-PROG PR, P475, DOI 10.1007/978-1-4614-8839-2_32; Rodriguez-Luna E, 2013, DEV PRIMATOL-PROG PR, P47, DOI 10.1007/978-1-4614-8839-2_4; Rovero F, 2007, AM J PRIMATOL, V69, P1242, DOI 10.1002/ajp.20431; Rovero F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118330; Rovero F, 2012, BIOL CONSERV, V146, P89, DOI 10.1016/j.biocon.2011.09.017; Rovero F, 2009, J ANTHROPOL SCI, V87, P93; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schmidt JH, 2012, J WILDLIFE MANAGE, V76, P317, DOI 10.1002/jwmg.216; Sillett TS, 2012, ECOL APPL, V22, P1997, DOI 10.1890/11-1400.1; Struhsaker TT, 2010, RED COLOBUS MONKEYS: VARIATION IN DEMOGRAPHY, BEHAVIOR, AND ECOLOGY OF ENDANGERED SPECIES, P1, DOI 10.1093/acprof:oso/9780198529583.001.0001; Struhsaker TT, 2004, INT J PRIMATOL, V25, P615, DOI 10.1023/B:IJOP.0000023578.08343.4e; Underhill L, 2002, CONSERV BIOL SER, V7, P34; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	56	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148289	10.1371/journal.pone.0148289	http://dx.doi.org/10.1371/journal.pone.0148289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844891	Green Submitted, Green Published, gold			2022-12-26	WOS:000369552800041
J	Fu, YL; Ong, LC; Ranganath, SH; Zheng, L; Kee, I; Zhan, WB; Yu, S; Chow, PKH; Wang, CH				Fu, Yilong; Ong, Lai-Chun; Ranganath, Sudhir H.; Zheng, Lin; Kee, Irene; Zhan, Wenbo; Yu, Sidney; Chow, Pierce K. H.; Wang, Chi-Hwa			A Dual Tracer F-18-FCH/F-18-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MINIMALLY INVASIVE SURGERY; RADIATION-DOSE ESCALATION; C-11 CHOLINE PET; GLIOBLASTOMA-MULTIFORME; FOLLOW-UP; F-18-FLUOROCHOLINE; PROLIFERATION; F-18-FDG; GLIOMAS	Early diagnosis of low grade glioma has been a challenge to clinicians. Positron Emission Tomography (PET) using F-18-FDG as a radio-tracer has limited utility in this area because of the high background in normal brain tissue. Other radiotracers such as F-18-Fluorocholine (F-18-FCH) could provide better contrast between tumor and normal brain tissue but with high incidence of false positives. In this study, the potential application of a dual tracer F-18-FCH/F-18-FDG-PET is investigated in order to improve the sensitivity of PET imaging for low grade glioma diagnosis based on a mouse orthotopic xenograft model. BALB/c nudemice with and without orthotopic glioma xenografts from U87 MG-luc2 glioma cell line are used for the study. The animals are subjected to F-18-FCH and F-18-FDG PET imaging, and images acquired from two separate scans are superimposed for analysis. The F-18-FCH counts are subtracted from the merged images to identify the tumor. Micro-CT, bioluminescence imaging (BLI), histology and measurement of the tumor diameter are also conducted for comparison. Results show that there is a significant contrast in F-18-FCH uptake between tumor and normal brain tissue (2.65 +/- 0.98), but with a high false positive rate of 28.6%. The difficulty of identifying the tumor by F-18-FDG only is also proved in this study. All the tumors can be detected based on the dual tracer technique of F-18-FCH/F-18-FDG-PET imaging in this study, while the false-positive caused by F-18-FCH can be eliminated. Dual tracer F-18-FCH/F-18-FDG PET imaging has the potential to improve the visualization of low grade glioma. F-18-FCH delineates tumor areas and the tumor can be identified by subtracting the F-18-FCH counts. The sensitivity was over 95%. Further studies are required to evaluate the possibility of applying this technique in clinical trials.	[Fu, Yilong; Ong, Lai-Chun; Ranganath, Sudhir H.; Wang, Chi-Hwa] Natl Univ Singapore, Dept Chem & Biomol Engn, 4 Engn Dr 4, Singapore 117585, Singapore; [Zheng, Lin; Kee, Irene] Singapore Gen Hosp, SingHlth Expt Med Ctr, Block 9,Level 3,Outram Rd, Singapore 169608, Singapore; [Zhan, Wenbo] Natl Univ Singapore, NUS Environm Res Inst, 1 Create Way,Create Tower 15-02, Singapore 138602, Singapore; [Yu, Sidney; Chow, Pierce K. H.] Natl Canc Ctr, 11 Hosp Dr, Singapore 169610, Singapore; [Chow, Pierce K. H.] Duke NUS Grad Med Sch, Off Clin Sci, Singapore 169857, Singapore; [Ranganath, Sudhir H.] Siddaganga Inst Technol, Dept Chem Engn, BH Rd, Tumkur 572103, India	National University of Singapore; Singapore General Hospital; National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; Siddaganga Institute of Technology	Wang, CH (corresponding author), Natl Univ Singapore, Dept Chem & Biomol Engn, 4 Engn Dr 4, Singapore 117585, Singapore.; Yu, S (corresponding author), Natl Canc Ctr, 11 Hosp Dr, Singapore 169610, Singapore.	sidney.yu.w.k@sgh.com.sg; chewch@nus.edu.sg	Zhan, Wenbo/O-7709-2018	Zhan, Wenbo/0000-0003-0268-5042; Chow, Pierce/0000-0003-0584-2584	Biomedical Research Council (BMRC), A*STAR [BMRC/07/1/21/19/508]; National Research Foundation (NRF), Prime Minister's Office, Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) programme; National University of Singapore [R-706-001-101-281]	Biomedical Research Council (BMRC), A*STAR(Agency for Science Technology & Research (A*STAR)); National Research Foundation (NRF), Prime Minister's Office, Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) programme(National Research Foundation, Singapore); National University of Singapore(National University of Singapore)	The authors acknowledge the funding support from Biomedical Research Council (BMRC), A*STAR under the grant numbers BMRC/07/1/21/19/508. CHW and WZ acknowledge the support from the National Research Foundation (NRF), Prime Minister's Office, Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) programme. Grant Number R-706-001-101-281, National University of Singapore.	BLASBERG RG, 1994, J NEURO-ONCOL, V22, P281, DOI 10.1007/BF01052934; Bradbury MS, 2008, J NUCL MED, V49, P422, DOI 10.2967/jnumed.107.047092; Casara D, 2001, EUR J NUCL MED, V28, P1351, DOI 10.1007/s002590100564; Chen W, 2007, J NUCL MED, V48, P1468, DOI 10.2967/jnumed.106.037689; Cook G, 2014, BRIT J RADIOLOGY; DeGrado TR, 2001, J NUCL MED, V42, P1805; Delbeke D, 1999, J NUCL MED, V40, P591; Douglas JG, 2006, INT J RADIAT ONCOL, V64, P886, DOI 10.1016/j.ijrobp.2005.08.013; Engel H, 1996, J NUCL MED, V37, P441; GALLAGHER BM, 1978, J NUCL MED, V19, P1154; Gomez-Rio M, 2015, EUR J NUCL MED MOL I, V42, P886, DOI 10.1007/s00259-015-2997-6; HAEFFNER EW, 1975, EUR J BIOCHEM, V51, P219, DOI 10.1111/j.1432-1033.1975.tb03922.x; Hara T, 1997, J NUCL MED, V38, P842; Hara T, 2001, J NUCL MED, V42, P1815; HernandezAlcoceba R, 1997, ONCOGENE, V15, P2289, DOI 10.1038/sj.onc.1201414; Joshi A, 2007, SOC NUCL MED ANN M S; Katz-Brull R, 1996, ANTICANCER RES, V16, P1375; Kwee SA, 2007, RADIOLOGY, V244, P557, DOI 10.1148/radiol.2442060898; Lam WWC, 2011, CLIN NEUROL NEUROSUR, V113, P156, DOI 10.1016/j.clineuro.2010.09.012; Rubello D, 2003, EUR J NUCL MED MOL I, V30, P189, DOI 10.1007/s00259-002-0983-2; Schaller B, 2004, NEUROBIOL DIS, V15, P437, DOI 10.1016/j.nbd.2003.11.023; Shinoura N, 1997, RADIOLOGY, V202, P497, DOI 10.1148/radiology.202.2.9015080; Strauss LG, 1996, EUR J NUCL MED, V23, P1409, DOI 10.1007/BF01367602; Tosi R, 2005, NUCL MAGNETIC RESONA; Tralins KS, 2002, J NUCL MED, V43, P1667; Utriainen M, 2003, J NEURO-ONCOL, V62, P329, DOI 10.1023/A:1023342516925; Vallabhajosula S, 2007, SEMINARS NUCL MED; Weber WA, 2000, EUR J NUCL MED, V27, P542, DOI 10.1007/s002590050541; Wong TZ, 2002, NEUROIMAG CLIN N AM, V12, P615, DOI 10.1016/S1052-5149(02)00033-3; Wyss MT, 2007, J NUCL MED, V48, P608, DOI 10.2967/jnumed.106.036251; Yoshimoto M, 2004, NUCL MED BIOL, V31, P859, DOI 10.1016/j.nucmedbio.2004.05.002	31	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148123	10.1371/journal.pone.0148123	http://dx.doi.org/10.1371/journal.pone.0148123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844770	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800030
J	Lopera-Vasquez, R; Hamdi, M; Fernandez-Fuertes, B; Maillo, V; Beltran-Brena, P; Calle, A; Redruello, A; Lopez-Martin, S; Gutierrez-Adan, A; Yanez-Mo, M; Ramirez, MA; Rizos, D				Lopera-Vasquez, Ricaurte; Hamdi, Meriem; Fernandez-Fuertes, Beatriz; Maillo, Veronica; Beltran-Brena, Paula; Calle, Alexandra; Redruello, Alberto; Lopez-Martin, Soraya; Gutierrez-Adan, Alfonso; Yanez-Mo, Maria; Angel Ramirez, Miguel; Rizos, Dimitrios			Extracellular Vesicles from BOEC in In Vitro Embryo Development and Quality	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; OVIDUCT EPITHELIAL-CELLS; DIFFERENT CULTURE SYSTEMS; BOVINE EMBRYOS; GENE-EXPRESSION; CONDITIONED MEDIUM; BLASTOCYST DEVELOPMENT; GENOME ACTIVATION; VIVO; PREGNANCY	To evaluate the effect of conditioned media (CM) and Extracellular Vesicles (EVs) derived from bovine oviduct epithelial cell (BOEC) lines on the developmental capacity of bovine zygotes and the quality of embryos produced in vitro, presumptive zygotes were cultured under specific conditions. In experiment 1, zygotes were cultured either on monolayers from BOEC extended culture (E), together with fresh BOEC suspension cells, or with BOEC-CM from fresh or E-monolayers. In experiment 2, EVs were isolated from BOEC-CM and characterized (150-200 nm) by Nanosight (R) and electron microscopy. Zygotes were cultured in the presence of 3x10(5)EVs/mL, 1.5x10(5)EVs/mL or 7.5x10(4)EVs/mL of fresh or frozen BOEC-EVs. In experiment 3, zygotes were cultured in absence of FCS but with EVs from BOEC-E that had been cultured in different culture media. In experiment 4, zygotes were cultured in SOF+5% normal-FCS, or EV-depleted-FCS. In all cases, cleavage rate (Day 2) and blastocyst development (Day 7-9) was assessed. Blastocysts on Days 7/8 were used for quality evaluation through differential cell count, cryotolerance and gene expression patterns. No differences were found among all FCS-containing groups in cleavage rate or blastocyst yield. However, embryos derived from BOEC-CM had more trophectoderm cells, while embryos derived from BOEC-EVs, both fresh and frozen, has more trophectoderm and total cells. More embryos survived vitrification in the BOEC-CM and BOEC-EV groups. In contrast, more embryos survived in the EV-depleted-FCS than in normal-FCS group. Gene expression patterns were modified for PAG1 for embryos cultured with EVs in the presence of FCS and for IFN-T, PLAC8, PAG1, CX43, and GAPDH in the absence of FCS. In conclusion, EVs from FCS have a deleterious effect on embryo quality. BOEC-CM and EVs during in vitro culture had a positive effect on the quality of in vitro produced bovine embryos, suggesting that EVs have functional communication between the oviduct and the embryo in the early stages of development.	[Lopera-Vasquez, Ricaurte; Hamdi, Meriem; Fernandez-Fuertes, Beatriz; Maillo, Veronica; Beltran-Brena, Paula; Calle, Alexandra; Gutierrez-Adan, Alfonso; Angel Ramirez, Miguel; Rizos, Dimitrios] INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Reprod Anim, Madrid, Spain; [Redruello, Alberto; Lopez-Martin, Soraya; Yanez-Mo, Maria] Hosp Univ Santa Cristina, Inst Invest Sanitarias Princesa IIs IP, Madrid, Spain; [Yanez-Mo, Maria] UAM, CBM SO, Dept Biol Mol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Rizos, D (corresponding author), INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Reprod Anim, Madrid, Spain.	drizos@inia.es	Fernandez-Fuertes, Beatriz/T-3307-2018; Hamdi, Meriem/AAT-3131-2020; de Paz, Miguel Ángel Ramírez/H-3171-2015; Rizos, Dimitrios/E-7058-2012; Gutierrez-Adan, Alfonso/A-1485-2014; Hamdi, Meriem/AAB-3539-2020; Maillo, Veronica/A-4934-2016	Fernandez-Fuertes, Beatriz/0000-0003-2303-8733; Hamdi, Meriem/0000-0002-5210-4915; de Paz, Miguel Ángel Ramírez/0000-0002-5868-2134; Rizos, Dimitrios/0000-0001-6813-3940; Gutierrez-Adan, Alfonso/0000-0001-9893-9179; Calle Arias, Alexandra/0000-0003-3903-5019; Maillo, Veronica/0000-0002-1154-3882	Spanish Ministry of Economy and Competitiveness [AGL2012-37510-AGA: AGL2012-39652-C02-01]; Spanish Institute of Health Carlos III [PI11/01645]; FPI [BES-2010-031873]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Institute of Health Carlos III(Instituto de Salud Carlos III); FPI(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness (DR: AGL2012-37510-AGA: AGL2012-39652-C02-01) and by the Spanish Institute of Health Carlos III (PI11/01645) to MYM. RLV was supported by FPI scholarship BES-2010-031873.	Abe H, 2002, MOL REPROD DEV, V61, P57, DOI 10.1002/mrd.1131; Abe H, 1996, HISTOL HISTOPATHOL, V11, P743; Al-Dossary AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080181; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442; Austin KJ, 1996, BIOL REPROD, V54, P600, DOI 10.1095/biolreprod54.3.600; Balasubramanian S, 2007, THERIOGENOLOGY, V68, P265, DOI 10.1016/j.theriogenology.2007.05.044; Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Cordova A, 2014, THERIOGENOLOGY, V81, P1163, DOI 10.1016/j.theriogenology.2014.01.012; da Silveira Juliano C, 2012, Biol Reprod, V86, P71, DOI 10.1095/biolreprod.111.093252; Ealy AD, 2009, AM J REPROD IMMUNOL, V61, P95, DOI 10.1111/j.1600-0897.2008.00673.x; Edwards LJ, 1997, MOL REPROD DEV, V46, P146, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;146::AID-MRD5&gt;3.0.CO;2-Q; El-Sayed A, 2006, PHYSIOL GENOMICS, V28, P84, DOI 10.1152/physiolgenomics.00111.2006; ELLINGTON JE, 1990, BIOL REPROD, V43, P97, DOI 10.1095/biolreprod43.1.97; ELLINGTON JE, 1993, BIOL REPROD, V48, P851, DOI 10.1095/biolreprod48.4.851; EYESTONE WH, 1989, J REPROD FERTIL, V85, P715, DOI 10.1530/jrf.0.0850715; EYESTONE WH, 1991, J REPROD FERTIL, V92, P59, DOI 10.1530/jrf.0.0920059; Fair T, 2001, MOL REPROD DEV, V58, P186, DOI 10.1002/1098-2795(200102)58:2&lt;186::AID-MRD8&gt;3.0.CO;2-N; FARIN CE, 1990, BIOL REPROD, V43, P210, DOI 10.1095/biolreprod43.2.210; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Farin PW, 2001, THERIOGENOLOGY, V55, P151, DOI 10.1016/S0093-691X(00)00452-0; Fazeli A, 2008, THERIOGENOLOGY, V70, P1182, DOI 10.1016/j.theriogenology.2008.06.010; Gad A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099697; Galaviz-Hernandez C, 2003, GENE, V309, P81, DOI 10.1016/S0378-1119(03)00508-0; Garbayo JM, 2008, ANIM REPROD SCI, V103, P120, DOI 10.1016/j.anireprosci.2006.12.002; Garcia-Herreros M, 2012, REPROD FERT DEVELOP, V24, P344, DOI 10.1071/RD11080; Graf A, 2014, ANIM REPROD SCI, V149, P46, DOI 10.1016/j.anireprosci.2014.05.016; Guerin B, 1997, THERIOGENOLOGY, V47, P33, DOI 10.1016/S0093-691X(96)00337-8; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Gutierrez-Adan A, 2000, MOL REPROD DEV, V55, P146, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;146::AID-MRD3&gt;3.0.CO;2-F; Gutierrez-Adan A, 2004, MOL REPROD DEV, V68, P441, DOI 10.1002/mrd.20113; HACKETT AJ, 1993, THERIOGENOLOGY, V40, P1147, DOI 10.1016/0093-691X(93)90285-D; Hashizume K, 2007, REPROD FERT DEVELOP, V19, P79, DOI 10.1071/RD06118; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; HERNANDEZLEDEZMA JJ, 1993, THERIOGENOLOGY, V39, P1267, DOI 10.1016/0093-691X(93)90229-X; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Kubisch HM, 1998, MOL REPROD DEV, V49, P254, DOI 10.1002/(SICI)1098-2795(199803)49:3&lt;254::AID-MRD5&gt;3.0.CO;2-N; Lazzari G, 2002, BIOL REPROD, V67, P767, DOI 10.1095/biolreprod.102.004481; Leese HJ, 2008, MOL HUM REPROD, V14, P667, DOI 10.1093/molehr/gan065; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd RE, 2009, REPRODUCTION, V137, P679, DOI 10.1530/REP-08-0405; Lonergan P, 2003, BIOL REPROD, V69, P1424, DOI 10.1095/biolreprod.103.018168; Lopes AS, 2007, THERIOGENOLOGY, V68, P223, DOI 10.1016/j.theriogenology.2007.04.055; Lopez-Gatius F, 2007, THERIOGENOLOGY, V67, P502, DOI 10.1016/j.theriogenology.2006.08.014; Luchsinger C, 2014, ZYGOTE, V22, P505, DOI 10.1017/S0967199413000099; Machado GM, 2013, MOL REPROD DEV, V80, P936, DOI 10.1002/mrd.22230; MERMILLOD P, 1993, BIOL REPROD, V49, P582, DOI 10.1095/biolreprod49.3.582; NANCARROW CD, 1994, CELL BIOL INT, V18, P1105, DOI 10.1006/cbir.1994.1037; Ng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058502; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; Patel OV, 1997, EUR J ENDOCRINOL, V137, P423, DOI 10.1530/eje.0.1370423; Perez-Hernandez D, 2013, J BIOL CHEM, V288, P11649, DOI 10.1074/jbc.M112.445304; Piehl LL, 2013, THERIOGENOLOGY, V79, P1071, DOI 10.1016/j.theriogenology.2013.01.028; Plourde D, 2012, THERIOGENOLOGY, V77, P1767, DOI 10.1016/j.theriogenology.2011.12.021; Pontes JHF, 2009, THERIOGENOLOGY, V71, P690, DOI 10.1016/j.theriogenology.2008.09.031; Ramos-Ibeas P, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118430; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rief S, 2002, REPRODUCTION, V124, P543, DOI 10.1530/rep.0.1240543; RIEGER D, 1995, J REPROD FERTIL, V105, P91, DOI 10.1530/jrf.0.1050091; Rizos D, 2008, REPROD DOMEST ANIM, V43, P44, DOI 10.1111/j.1439-0531.2008.01230.x; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; Rizos D, 2010, THERIOGENOLOGY, V73, P777, DOI 10.1016/j.theriogenology.2009.10.001; Rizos D, 2002, BIOL REPROD, V66, P589, DOI 10.1095/biolreprod66.3.589; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; Rizos D, 2002, MOL REPROD DEV, V62, P320, DOI 10.1002/mrd.10138; Rodriguez-Martinez H, 2007, THERIOGENOLOGY, V68, pS138, DOI 10.1016/j.theriogenology.2007.03.018; Rottmayer R, 2006, REPRODUCTION, V132, P637, DOI 10.1530/rep.1.01136; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Schmaltz-Panneau B, 2014, ANIM REPROD SCI, V149, P103, DOI 10.1016/j.anireprosci.2014.06.022; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Thery C, 2006, CURRENT PROTOCOLS CE; Thompson JG, 1997, REPROD FERT DEVELOP, V9, P341, DOI 10.1071/R96079; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; Trigal B, 2011, THERIOGENOLOGY, V75, P584, DOI 10.1016/j.theriogenology.2010.09.010; Tse PK, 2008, ENDOCRINOLOGY, V149, P1268, DOI 10.1210/en.2007-1277; Ulbrich SE, 2010, THERIOGENOLOGY, V73, P802, DOI 10.1016/j.theriogenology.2009.09.036; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VanLangendonckt A, 1997, J REPROD FERTIL, V109, P87, DOI 10.1530/jrf.0.1090087; WANG W L, 1990, Theriogenology, V33, P343, DOI 10.1016/0093-691X(90)90767-N; Wooding FBP, 2005, PLACENTA, V26, P807, DOI 10.1016/j.placenta.2004.10.014; Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893; Wrenzycki C, 2003, BIOL REPROD, V68, P2073, DOI 10.1095/biolreprod.102.012104; Wrenzycki C, 2002, BIOL REPROD, V66, P127, DOI 10.1095/biolreprod66.1.127; Wrenzycki Christine, 2005, Birth Defects Res C Embryo Today, V75, P1, DOI 10.1002/bdrc.20035	88	119	122	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148083	10.1371/journal.pone.0148083	http://dx.doi.org/10.1371/journal.pone.0148083			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845570	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800026
J	Paco, A; Brigido, C; Alexandre, A; Mateos, PF; Oliveira, S				Paco, Ana; Brigido, Clarisse; Alexandre, Ana; Mateos, Pedro F.; Oliveira, Solange			The Symbiotic Performance of Chickpea Rhizobia Can Be Improved by Additional Copies of the clpB Chaperone Gene	PLOS ONE			English	Article							MESORHIZOBIUM-LOTI MAFF303099; SINORHIZOBIUM-MELILOTI; LEGUME SYMBIOSIS; HEAT-SHOCK; PROTEIN DISAGGREGATION; BACTEROID DEVELOPMENT; MOLECULAR CHAPERONES; AGGREGATED PROTEINS; NITROGEN-FIXATION; HSP100 CHAPERONES	The ClpB chaperone is known to be involved in bacterial stress response. Moreover, recent studies suggest that this protein has also a role in the chickpea-rhizobia symbiosis. In order to improve both stress tolerance and symbiotic performance of a chickpea microsymbiont, the Mesorhizobium mediterraneum UPM-Ca36(T) strain was genetically transformed with pPHU231 containing an extra-copy of the clpB gene. To investigate if the clpB-transformed strain displays an improved stress tolerance, bacterial growth was evaluated under heat and acid stress conditions. In addition, the effect of the extra-copies of the clpB gene in the symbiotic performance was evaluated using plant growth assays (hydroponic and pot trials). The clpB-transformed strain is more tolerant to heat shock than the strain transformed with pPHU231, supporting the involvement of ClpB in rhizobia heat shock tolerance. Both plant growth assays showed that ClpB has an important role in chickpea-rhizobia symbiosis. The nodulation kinetics analysis showed a higher rate of nodule appearance with the clpB-transformed strain. This strain also induced a greater number of nodules and, more notably, its symbiotic effectiveness increased similar to 60% at pH5 and 83% at pH7, compared to the wild-type strain. Furthermore, a higher frequency of root hair curling was also observed in plants inoculated with the clpB-transformed strain, compared to the wild-type strain. The superior root hair curling induction, nodulation ability and symbiotic effectiveness of the clpB-transformed strain may be explained by an increased expression of symbiosis genes. Indeed, higher transcript levels of the nodulation genes nodA and nodC (similar to 3 folds) were detected in the clpB-transformed strain. The improvement of rhizobia by addition of extracopies of the clpB gene may be a promising strategy to obtain strains with enhanced stress tolerance and symbiotic effectiveness, thus contributing to their success as crop inoculants, particularly under environmental stresses. This is the first report on the successful improvement of a rhizobium with a chaperone gene.	[Paco, Ana; Brigido, Clarisse; Alexandre, Ana; Oliveira, Solange] Univ Evora, Lab Microbiol Solo, ICAAM, Nucleo Mitra, Ap 94, P-7002554 Evora, Portugal; [Brigido, Clarisse; Alexandre, Ana] Univ Evora, IIFA, Ap 94, P-7002554 Evora, Portugal; [Mateos, Pedro F.] Univ Salamanca, Ctr Hispano Luso Invest Agr, Dept Microbiol & Genet, Salamanca 37007, Spain	University of Evora; University of Evora; University of Salamanca	Oliveira, S (corresponding author), Univ Evora, Lab Microbiol Solo, ICAAM, Nucleo Mitra, Ap 94, P-7002554 Evora, Portugal.	ismo@uevora.pt	Mateos, Pedro/L-6001-2014; Teixeira, Ana Isabel do Paço/AAE-9104-2021; Brígido, Clarisse/M-2784-2016	Mateos, Pedro/0000-0003-1628-598X; Brígido, Clarisse/0000-0002-4167-5253; Alexandre, Ana/0000-0001-7033-4186	FEDER through the Operational Programme for Competitiveness Factors - COMPETE; National Funds through FCT-Foundation for Science and Technology [PEst-OE/AGR/UI0115/2014, FCOMP-01-0124-FEDER-028316 (PTDC/BIA-EVF/4158/2012)]; InAlentejo [ALENT-07-0262-FEDER-001871]; FCT [SFRH/BPD/73243/2010, SFRH/BPD/94751/2013]	FEDER through the Operational Programme for Competitiveness Factors - COMPETE; National Funds through FCT-Foundation for Science and Technology; InAlentejo; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by funds from FEDER through the Operational Programme for Competitiveness Factors - COMPETE, National Funds through FCT-Foundation for Science and Technology, under the Strategic Project PEst-OE/AGR/UI0115/2014 (ICAAM), Project no FCOMP-01-0124-FEDER-028316 (PTDC/BIA-EVF/4158/2012) and InAlentejo ALENT-07-0262-FEDER-001871. A.A. and C.B. acknowledge Post-Doc fellowships (SFRH/BPD/73243/2010 and SFRH/BPD/94751/2013) from FCT.	Acebron SP, 2009, FEBS LETT, V583, P2991, DOI 10.1016/j.febslet.2009.08.020; Adesemoye AO, 2009, MICROB ECOL, V58, P921, DOI 10.1007/s00248-009-9531-y; Alexandre A, 2014, DNA RES, V21, P195, DOI 10.1093/dnares/dst050; Alexandre A, 2013, CRIT REV MICROBIOL, V39, P219, DOI 10.3109/1040841X.2012.702097; Alexandre A, 2009, MICROB ECOL, V58, P930, DOI 10.1007/s00248-009-9536-6; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109; Bittner AN, 2007, J BACTERIOL, V189, P1884, DOI 10.1128/JB.01542-06; Brigido C, 2007, LETT APPL MICROBIOL, V44, P168, DOI 10.1111/j.1472-765X.2006.02061.x; Brigido C, 2013, MICROB ECOL, V65, P145, DOI 10.1007/s00248-012-0098-7; Brigido C, 2012, MOL PLANT MICROBE IN, V25, P1594, DOI 10.1094/MPMI-05-12-0140-R; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; CADAHIA E, 1986, ARCH MICROBIOL, V146, P239, DOI 10.1007/BF00403223; Cooper JE, 2007, J APPL MICROBIOL, V103, P1355, DOI 10.1111/j.1365-2672.2007.03366.x; de Lucena DKC, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-265; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Djordjevic MA, 2004, PROTEOMICS, V4, P1859, DOI 10.1002/pmic.200300802; Dominguez-Ferreras A, 2006, J BACTERIOL, V188, P7617, DOI 10.1128/JB.00719-06; Downie JA, 2014, CURR BIOL, V24, pR184, DOI 10.1016/j.cub.2014.01.028; Ekaza E, 2001, J BACTERIOL, V183, P2677, DOI 10.1128/JB.183.8.2677-2681.2001; Eriksson MJ, 2000, CELL STRESS CHAPERON, V5, P255, DOI 10.1379/1466-1268(2000)005<0255:TECHSP>2.0.CO;2; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Gibson A. H., 1987, Symbiotic Nitrogen Fixation Technology, P321; Haag AF, 2013, FEMS MICROBIOL REV, V37, P364, DOI 10.1111/1574-6976.12003; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; HUBNER P, 1991, J BACTERIOL, V173, P2993; Karunakaran R, 2009, J BACTERIOL, V191, P4002, DOI 10.1128/JB.00165-09; Kedzierska S, 2001, FEMS MICROBIOL LETT, V204, P355; Kereszt A, 2011, MOL PLANT MICROBE IN, V24, P1300, DOI 10.1094/MPMI-06-11-0152; Laranjo M, 2004, FEMS MICROBIOL ECOL, V48, P101, DOI 10.1016/j.femsec.2003.12.015; Laranjo M, 2008, FEMS MICROBIOL ECOL, V66, P391, DOI 10.1111/j.1574-6941.2008.00584.x; Laranjo M, 2014, APPL MICROBIOL BIOT, V98, P7137, DOI 10.1007/s00253-014-5875-4; Laranjo M, 2011, ANTON LEEUW INT J G, V99, P651, DOI 10.1007/s10482-010-9539-9; Mergaert P, 1997, MOL MICROBIOL, V25, P811, DOI 10.1111/j.1365-2958.1997.mmi526.x; Moscatiello R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-206; Nag S, 2005, BIOCHEM BIOPH RES CO, V331, P1365, DOI 10.1016/j.bbrc.2005.04.052; Nakazaki Y, 2014, GENES CELLS, V19, P891, DOI 10.1111/gtc.12188; Nascimento F, 2012, PLANT SOIL, V353, P221, DOI 10.1007/s11104-011-1025-2; Nomura M, 2010, SOIL SCI PLANT NUTR, V56, P579, DOI 10.1111/j.1747-0765.2010.00500.x; OGAWA J, 1995, GENE DEV, V9, P714, DOI 10.1101/gad.9.6.714; Oke V, 1999, CURR OPIN MICROBIOL, V2, P641, DOI 10.1016/S1369-5274(99)00035-1; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Priefer UB, 2001, J BIOTECHNOL, V91, P223, DOI 10.1016/S0168-1656(01)00329-7; Puskas LG, 2004, MOL GENET GENOMICS, V272, P275, DOI 10.1007/s00438-004-1051-3; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Rivas R, 2001, ELECTROPHORESIS, V22, P1086, DOI 10.1002/1522-2683()22:6<1086::AID-ELPS1086>3.0.CO;2-6; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Robledo M, 2011, MOL PLANT MICROBE IN, V24, P798, DOI 10.1094/MPMI-10-10-0249; Sambrook J., 2001, MOL CLONING LAB MANU; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Sarma AD, 2005, PROTEOMICS, V5, P4170, DOI 10.1002/pmic.200401296; Sauviac L, 2007, J BACTERIOL, V189, P4204, DOI 10.1128/JB.00175-07; SINGLETON PW, 1982, APPL ENVIRON MICROB, V44, P884, DOI 10.1128/AEM.44.4.884-890.1982; Srivastava P, 1999, MICROBIOL RES, V154, P49, DOI 10.1016/S0944-5013(99)80034-2; Uchiumi T, 2004, J BACTERIOL, V186, P2439, DOI 10.1128/JB.186.8.2439-2448.2004; Ventura M, 2005, MICROBIOL-SGM, V151, P2861, DOI 10.1099/mic.0.28176-0; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999; Zolkiewski M, 2012, ARCH BIOCHEM BIOPHYS, V520, P1, DOI 10.1016/j.abb.2012.01.012	63	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148221	10.1371/journal.pone.0148221	http://dx.doi.org/10.1371/journal.pone.0148221			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845770	Green Published, Green Submitted, gold			2022-12-26	WOS:000369552800038
J	Rady, HF; Dai, GX; Huang, WT; Shellito, JE; Ramsay, AJ				Rady, Hamada F.; Dai, Guixiang; Huang, Weitao; Shellito, Judd E.; Ramsay, Alistair J.			Flagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; T-CELL EPITOPE; MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE EFFICACY; ENHANCED IMMUNOGENICITY; DIRECT STIMULATION; DNA VACCINATION; FUSION PROTEINS; BOOST STRATEGY; RESPONSES	Flagellin has been tested as a protein-based vaccine adjuvant, with the majority of studies focused on antibody responses. Here, we evaluated the adjuvant activity of flagellin for both cellular and humoral immune responses in BALB/c mice in the setting of gene-based immunization, and have made several novel observations. DNA vaccines and adenovirus (Ad) vectors were engineered to encode mycobacterial protein Ag85B, with or without flagellin of Salmonella typhimurium (FliC). DNA-encoded flagellin given IM enhanced splenic CD4+ and CD8+ T cell responses to co-expressed vaccine antigen, including memory responses. Boosting either IM or intranasally with Ad vectors expressing Ag85B without flagellin led to durable enhancement of Ag85B-specific antibody and CD4+ and CD8+ T cell responses in both spleen and pulmonary tissues, correlating with significantly improved protection against challenge with pathogenic aerosolized M. tuberculosis. However, inclusion of flagellin in both DNA prime and Ad booster vaccines induced localized pulmonary inflammation and transient weight loss, with route-dependent effects on vaccine-induced T cell immunity. The latter included marked reductions in levels of mucosal CD4+ and CD8+ T cell responses following IM DNA/IN Ad mucosal prime-boosting, although antibody responses were not diminished. These findings indicate that flagellin has differential and route-dependent adjuvant activity when included as a component of systemic or mucosally-delivered gene-based prime-boost immunization. Clear adjuvant activity for both T and B cell responses was observed when flagellin was included in the DNA priming vaccine, but side effects occurred when given in an Ad boosting vector, particularly via the pulmonary route.	[Rady, Hamada F.; Dai, Guixiang; Huang, Weitao; Ramsay, Alistair J.] Louisiana State Univ Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Shellito, Judd E.; Ramsay, Alistair J.] Louisiana State Univ Hlth Sci Ctr, Dept Med, New Orleans, LA USA; [Rady, Hamada F.; Dai, Guixiang; Shellito, Judd E.; Ramsay, Alistair J.] Louisiana State Univ Hlth Sci Ctr, Louisiana Vaccine Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Ramsay, AJ (corresponding author), Louisiana State Univ Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA.	aramsa@lsuhsc.edu			National Institutes of Health [5R01AI58810, 3R01AI58810-06S2, P01HL076100]; Louisiana Vaccine Center - Louisiana Board of Regents; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058810] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Vaccine Center - Louisiana Board of Regents; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://nih.gov/) Grants 5R01AI58810 (AJR), 3R01AI58810-06S2 (AJR), and P01HL076100 (AJR and JES) and by the Louisiana Vaccine Center, funded by the Louisiana Board of Regents (http://www.regents.la.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Auten MW, 2012, VACCINE, V30, P2768, DOI 10.1016/j.vaccine.2012.02.020; Bates JT, 2008, MECH AGEING DEV, V129, P271, DOI 10.1016/j.mad.2008.01.009; Bates JT, 2009, J IMMUNOL, V182, P7539, DOI 10.4049/jimmunol.0804225; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Ben-Yedidia T, 1999, INFECT IMMUN, V67, P4360, DOI 10.1128/IAI.67.9.4360-4366.1999; Ben-Yedidia T, 1998, IMMUNOL LETT, V64, P9, DOI 10.1016/S0165-2478(98)00073-X; Boog CJP, 2009, IMMUNOL LETT, V122, P104, DOI 10.1016/j.imlet.2008.11.009; Braga CJM, 2010, VACCINE, V28, P1373, DOI 10.1016/j.vaccine.2009.11.003; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Nguyen CT, 2013, VACCINE, V31, P3879, DOI 10.1016/j.vaccine.2013.06.054; Ciacci-Woolwine F, 1998, INFECT IMMUN, V66, P1127, DOI 10.1128/IAI.66.3.1127-1134.1998; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; D'Souza S, 2006, INFECT IMMUN, V74, P2751, DOI 10.1128/IAI.74.5.2751-2759.2006; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Dalmia N, 2012, EXPERT REV VACCINES, V11, P1221, DOI [10.1586/erv.12.94, 10.1586/ERV.12.94]; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; DINARELLO CA, 1992, INT J TISSUE REACT, V14, P65; Estcourt MJ, 2002, INT IMMUNOL, V14, P31, DOI 10.1093/intimm/14.1.31; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Geiben-Lynn R, 2008, CLIN VACCINE IMMUNOL, V15, P691, DOI 10.1128/CVI.00418-07; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; HIRANO T, 1992, CLIN IMMUNOL IMMUNOP, V62, pS60, DOI 10.1016/0090-1229(92)90042-M; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kowalczyk DW, 1999, CELL MOL LIFE SCI, V55, P751, DOI 10.1007/s000180050330; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Liaudet L, 2002, INFECT IMMUN, V70, P192, DOI 10.1128/IAI.70.1.192-198.2002; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Morris AE, 2009, AM J PHYSIOL-LUNG C, V297, pL1112, DOI 10.1152/ajplung.00155.2009; Murray PJ, 1999, TRENDS MICROBIOL, V7, P366, DOI 10.1016/S0966-842X(99)01567-X; NEWTON SMC, 1995, RES MICROBIOL, V146, P203, DOI 10.1016/0923-2508(96)80276-2; Qian F, 2015, SALMONELLA FLAGELLIN, VS0264-410X, P00292; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Ramsay AJ, 1997, IMMUNOL CELL BIOL, V75, P382, DOI 10.1038/icb.1997.60; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rigato PO, 2011, INFECT IMMUN, V79, P2120, DOI 10.1128/IAI.01190-10; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; Schwarz K, 2003, EUR J IMMUNOL, V33, P1465, DOI 10.1002/eji.200323919; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shi W, 2012, J DENT RES, V91, P249, DOI 10.1177/0022034511424283; Skinner MA, 2003, IMMUNOLOGY, V108, P548, DOI 10.1046/j.1365-2567.2003.01589.x; Skountzou I, 2010, VACCINE, V28, P4103, DOI 10.1016/j.vaccine.2009.07.058; Strindelius L, 2004, VACCINE, V22, P3797, DOI 10.1016/j.vaccine.2003.12.035; Taylor DN, 2012, VACCINE, V30, P5761, DOI 10.1016/j.vaccine.2012.06.086; Treanor JJ, 2010, VACCINE, V28, P8268, DOI 10.1016/j.vaccine.2010.10.009; Tseng J, 2006, AM J PHYSIOL-CELL PH, V290, pC678, DOI 10.1152/ajpcell.00166.2005; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; VERMA NK, 1995, VACCINE, V13, P235, DOI 10.1016/0264-410X(95)93308-V; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08; Weimer ET, 2009, VACCINE, V27, P6762, DOI 10.1016/j.vaccine.2009.08.080; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Xiao Y, 2015, CELL MOL IMMUNOL, V12, P729, DOI 10.1038/cmi.2014.110; Yang JY, 2013, HUM VACC IMMUNOTHER, V9, P1084, DOI 10.4161/hv.23809	63	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148701	10.1371/journal.pone.0148701	http://dx.doi.org/10.1371/journal.pone.0148701			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844553	Green Published, Green Submitted, gold			2022-12-26	WOS:000369552800079
J	Vinjamur, DS; Alhashem, YN; Mohamad, SF; Amin, P; Williams, DC; Lloyd, JA				Vinjamur, Divya S.; Alhashem, Yousef N.; Mohamad, Safa F.; Amin, Parth; Williams, David C., Jr.; Lloyd, Joyce A.			Kruppel-Like Transcription Factor KLF1 Is Required for Optimal gamma- and beta-Globin Expression in Human Fetal Erythroblasts	PLOS ONE			English	Article							HUMAN ERYTHROID-CELLS; FACTOR EKLF; HEMOGLOBIN EXPRESSION; GENE; ERYTHROPOIESIS; BCL11A; ROLES; MICE; DIFFERENTIATION; THALASSEMIA	In human adult erythroid cells, lower than normal levels of Kruppel-like transcription factor 1 (KLF1) are generally associated with decreased adult beta- and increased fetal.-globin gene expression. KLF1 also regulates BCL11A, a known repressor of adult gamma-globin expression. In seeming contrast to the findings in adult cells, lower amounts of KLF1 correlate with both reduced embryonic and reduced fetal beta-like globin mRNA in mouse embryonic erythroid cells. The role of KLF1 in primary human fetal erythroid cells, which express both gamma- and gamma-globin mRNA, is less well understood. Therefore, we studied the role of KLF1 in ex vivo differentiated CD34+ umbilical cord blood cells (UCB erythroblasts), representing the fetal milieu. In UCB erythroblasts, KLF1 binds to the beta-globin locus control region (LCR), and the beta-globin promoter. There is very little KLF1 binding detectable at the.-globin promoter. Correspondingly, when cultured fetal UCB erythroblasts are subjected to lentiviral KLF1 knockdown, the active histone mark H3K4me3 and RNA pol II recruitment are diminished at the beta-but not the.-globin gene. The amount of KLF1 expression strongly positively correlates with gamma-globin mRNA and weakly positively correlates with BCL11AmRNA. With modest KLF1 knockdown, mimicking haplo insufficiency, gamma-globin mRNA is increased in UCB erythroblasts, as is common in adult cells. However, a threshold level of KLF1 is evidently required, or there is no absolute increase in gamma-globinmRNA in UCB erythroblasts. Therefore, the role of KLF1 in.-globin regulation in fetal erythroblasts is complex, with both positive and negative facets. Furthermore, in UCB erythroblasts, diminished BCL11A is not sufficient to induce.-globin in the absence of KLF1. These findings have implications for the manipulation of BCL11A and/or KLF1 to induce gamma-globin for therapy of the beta-hemoglobinopathies.	[Vinjamur, Divya S.; Alhashem, Yousef N.; Mohamad, Safa F.; Amin, Parth; Lloyd, Joyce A.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Williams, David C., Jr.; Lloyd, Joyce A.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA; [Williams, David C., Jr.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Williams, David C., Jr.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lloyd, JA (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA.; Lloyd, JA (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA.	jlloyd@vcu.edu		Vinjamur, Divya/0000-0002-9369-0412; Mohamad, Safa/0000-0002-6676-7912; Alhashem, Yousef N./0000-0003-4435-3003	National Institutes of Health [R01DK074694, R56DK097907]; NIH-NCI Cancer Center Support Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK097907, R01DK074694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health R01DK074694 and R56DK097907 to JAL. Services and products in support of the research project were generated by the VCU Massey Cancer Center Flow Cytometry Shared Resource, supported, in part, with funding from NIH-NCI Cancer Center Support Grant P30 CA016059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhashem YN, 2011, J BIOL CHEM, V286, P24819, DOI 10.1074/jbc.M111.247536; Amaya M, 2013, BLOOD, V121, P3493, DOI 10.1182/blood-2012-11-466227; Basu P, 2007, BLOOD, V110, P3417, DOI 10.1182/blood-2006-11-057307; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Bouilloux F, 2008, BLOOD, V112, P576, DOI 10.1182/blood-2007-07-098996; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Esteghamat F, 2013, BLOOD, V121, P2553, DOI 10.1182/blood-2012-06-434530; Gnanapragasam MN, 2011, P NATL ACAD SCI USA, V108, P7487, DOI 10.1073/pnas.1015341108; Grieco AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129431; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Liu D, 2014, BLOOD, V124, P803, DOI 10.1182/blood-2014-03-561779; Magor GW, 2015, BLOOD; Migliaccio G, 2002, BLOOD CELL MOL DIS, V28, P169, DOI 10.1006/bcmd.2002.0502; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Pilon AM, 2008, MOL CELL BIOL, V28, P7394, DOI 10.1128/MCB.01087-08; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Satta S, 2011, HAEMATOL-HEMATOL J, V96, P767, DOI 10.3324/haematol.2010.037333; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Tallack MR, 2012, GENOME RES, V22, P2385, DOI 10.1101/gr.135707.111; Trakarnsanga K, 2014, HAEMATOLOGICA, V99, P1677, DOI 10.3324/haematol.2014.110155; Vinjamur DS, 2014, HAEMATOLOGICA, V99, P1565, DOI 10.3324/haematol.2014.104943; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhou DW, 2006, J BIOL CHEM, V281, P16052, DOI 10.1074/jbc.M601182200; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	28	11	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146802	10.1371/journal.pone.0146802	http://dx.doi.org/10.1371/journal.pone.0146802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840243	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200015
J	Zhang, DL; Chen, DF; Cao, LR; Li, GH; Cheng, H				Zhang, Dinglin; Chen, Danfeng; Cao, Liaoran; Li, Guohui; Cheng, Hong			The Effect of Codon Mismatch on the Protein Translation System	PLOS ONE			English	Article							PEPTIDE-BOND FORMATION; TRANSFER-RNAS; RIBOSOMAL-SUBUNITS; ELONGATION; SEQUENCE; YEAST; DETERMINANTS; EFFICIENCY; INITIATION; GENES	Incorrect protein translation, caused by codon mismatch, is an important problem of living cells. In this work, a computational model was introduced to quantify the effects of codon mismatch and the model was used to study the protein translation of Saccharomyces cerevisiae. According to simulation results, the probability of codon mismatch will increase when the supply of amino acids is unbalanced, and the longer is the codon sequence, the larger is the probability for incorrect translation to occur, making the synthesis of long peptide chain difficult. By comparing to simulation results without codon mismatch effects taken into account, the fraction of mRNAs with bound ribosome decrease faster along the mRNAs, making the 5' ramp phenomenon more obvious. It was also found in our work that the premature mechanism resulted from codon mismatch can reduce the proportion of incorrect translation when the amino acid supply is extremely unbalanced, which is one possible source of high fidelity protein synthesis after peptidyl transfer.	[Zhang, Dinglin; Cao, Liaoran; Li, Guohui] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian 116023, Liaoning, Peoples R China; [Chen, Danfeng] Dalian City Fisherles Tech Extens Stn, Dalian 116025, Liaoning, Peoples R China; [Cheng, Hong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, GH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian 116023, Liaoning, Peoples R China.; Cheng, H (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai 200031, Peoples R China.	ghli@dicp.ac.cn; hcheng@sibs.ac.cn			National Science Foundation of China [31370714]; Ministry of Science and Technology of China 973 project [2012CB721002]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China 973 project(Ministry of Science and Technology, ChinaNational Basic Research Program of China)	This study was supported by the National Science Foundation of China [no. 31370714], http://www.nsfc.gov.cn/, GHL, and the Ministry of Science and Technology of China 973 project [no. 2012CB721002], http://www.most.gov.cn/eng/, GHL.	Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Cathopoulis TJT, 2008, BIOCHEMISTRY-US, V47, P7610, DOI 10.1021/bi800369q; Dana A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S6-S13; Effraim PR, 2009, NAT CHEM BIOL, V5, P947, DOI 10.1038/nchembio.255; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Fluitt A, 2007, COMPUT BIOL CHEM, V31, P335, DOI 10.1016/j.compbiolchem.2007.07.003; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Green R, 2012, COLD SPRING HARBOR P, P4; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; HARLEY CB, 1981, J BIOL CHEM, V256, P786; Hausmann CD, 2007, NUCLEIC ACIDS RES, V35, P6094, DOI 10.1093/nar/gkm534; Hernandez G, 2008, TRENDS BIOCHEM SCI, V33, P58, DOI 10.1016/j.tibs.2007.11.002; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Karpinets TV, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-30; Kochetov AV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-318; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Piques M, 2009, MOL SYSTEMS BIOL, P5; Qian WF, 2012, PLOS GENET, P8; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Reuveni S, 2011, PLOS COMPUTATIONAL B, P7; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Robbins-Pianka A, 2010, BIOINFORMATICS, V26, P2651, DOI 10.1093/bioinformatics/btq509; Schrader JM, 2009, J MOL BIOL, V386, P1255, DOI 10.1016/j.jmb.2009.01.021; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; Tuller T, 2013, PLOS COMPUTATIONAL B, P9; Tuller T, 2011, GENOME BIOL, P12; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; WALDRON C, 1975, J BACTERIOL, V122, P855, DOI 10.1128/JB.122.3.855-865.1975; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Weygand-Durasevic I, 2010, SCIENCE, V329, P1473, DOI 10.1126/science.1195567; Williams CW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-586; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582	48	2	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148302	10.1371/journal.pone.0148302	http://dx.doi.org/10.1371/journal.pone.0148302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840415	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200121
J	Zhang, KH; Liu, S; Feng, B; Yang, YL; Zhang, HY; Dong, R; Liu, Y; Gai, ZT				Zhang, Kaihui; Liu, Shu; Feng, Bing; Yang, Yali; Zhang, Haiyan; Dong, Rui; Liu, Yi; Gai, Zhongtao			Clinical Application of an Innovative Multiplex-Fluorescent-Labeled STRs Assay for Prader-Willi Syndrome and Angelman Syndrome	PLOS ONE			English	Article							UNIPARENTAL DISOMY; REGION; POPULATION; MECHANISMS; DIAGNOSIS; DELETION; UPDATE	Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are two clinically distinct neurodevelopmental disorders caused by absence of paternally or maternally expressed imprinted genes on chr15q11.2-q13.3. Three mechanisms are known to be involved in the pathogenesis: microdeletions, uniparental disomy (UPD) and imprinting defects. Both disorders are difficult to be definitely diagnosed at early age if no available molecular cytogenetic tests. In this study, we identified 5 AS patients with the maternal deletion and 26 PWS patients with paternal deletion on chr15q11-q13 by using an innovative multiplex-fluorescent-labeled short tandem repeats (STRs) assay based on linkage analysis, and validated by the methylation-specific PCR and array comparative genomic hybridization techniques. More interesting, one of these PWS patients was confirmed as maternal uniparental isodisomy by the STR linkage analysis. The phenotypic and genotypic characteristics of these individuals were also presented. Our results indicate that the new linkage analysis is much faster and easier for large-scale screening deletion and uniparental disomy, thus providing a valuable method for early diagnosis of PWS/AS patients, which is critical for genetic diagnosis, management and improvement of prognosis.	[Zhang, Kaihui; Zhang, Haiyan; Dong, Rui; Liu, Yi; Gai, Zhongtao] Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250022, Peoples R China; [Liu, Shu] Guangzhou Med Univ, Guangdong Women & Childrens Hosp, Ctr Med Genet, Guangzhou 511442, Guangdong, Peoples R China; [Feng, Bing] Shandong Univ, Qilu Childrens Hosp, Pediat Hlth Care Inst, Jinan 250022, Peoples R China; [Yang, Yali] Shandong Univ, Qilu Childrens Hosp, Rehabil Ctr, Jinan 250022, Peoples R China	Shandong University; Guangzhou Medical University; Shandong University; Shandong University	Liu, Y; Gai, ZT (corresponding author), Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250022, Peoples R China.	y.liu99@yahoo.com; gaizhongtao@sina.com	Yang, Ya-Li/GYU-4320-2022; Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022		Natural Science Training Foundation of Shandong Province [ZR2014HP051]; Science and Technology Developmental Plan of Shandong Province [2013GSF11829]; Ji'nan Science and Technology Bureau	Natural Science Training Foundation of Shandong Province; Science and Technology Developmental Plan of Shandong Province; Ji'nan Science and Technology Bureau	This study was funded by Natural Science Training Foundation of Shandong Province (ZR2014HP051) and Science and Technology Developmental Plan of Shandong Province (2013GSF11829).; The authors are grateful to the patients and their families for their contribution to the work. We'd like to thank Natural Science Training Foundation of Shandong Province (ZR2014HP051), Science and Technology Developmental Plan of Shandong Province (2013GSF11829), Ji'nan Science and Technology Bureau for financial support of Excellent Science Technology Innovation Team.	Bai JL, 2014, CLIN GENET, V85, P273, DOI 10.1111/cge.12155; Bhatt Arpan D, 2013, Indian J Hum Genet, V19, P311, DOI 10.4103/0971-6866.120819; Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273; Chen C, 2007, CLIN PEDIATR, V46, P580, DOI 10.1177/0009922807299314; Dimitropoulos A, 2013, J COMMUN DISORD, V46, P193, DOI 10.1016/j.jcomdis.2012.12.001; Engel E, 2006, EUR J HUM GENET, V14, P1158, DOI 10.1038/sj.ejhg.5201619; Gunay-Aygun M, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e92; Hashemi B, 2015, AM J MED GENET A, V167, P2098, DOI 10.1002/ajmg.a.37134; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Li Hongyi, 2007, Journal of Genetics and Genomics, V34, P885, DOI 10.1016/S1673-8527(07)60100-3; Liu Li-jun, 2009, Zhonghua Yixue Yichuanxue Zazhi, V26, P495, DOI 10.3760/cma.j.issn.1003-9406.2009.05.003; Lu W, 2014, EUR J PEDIATR, V173, P81, DOI 10.1007/s00431-013-2124-2; Margolis SS, 2015, NEUROTHERAPEUTICS, V12, P641, DOI 10.1007/s13311-015-0361-y; MICHAELIS RC, 1995, AM J MED GENET, V55, P120, DOI 10.1002/ajmg.1320550131; Rice LJ, 2015, CURR OPIN PSYCHIATR, V28, P102, DOI 10.1097/YCO.0000000000000135; Robinson WP, 2000, BIOESSAYS, V22, P452; Rocha CF, 2014, GENET MOL RES, V13, P2290, DOI 10.4238/2014.March.31.9; Sadikovic B, 2014, HUM MUTAT, V35, P1407, DOI 10.1002/humu.22687; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Tauber M, 2014, FRONT HORM RES, V42, P93, DOI 10.1159/000358317; Teng YN, 2002, J FORMOS MED ASSOC, V101, P488; Yamazawa K, 2010, AM J MED GENET C, V154C, P329, DOI 10.1002/ajmg.c.30270; Zhu JZ, 2013, INTRACTABLE RARE DIS, V2, P123, DOI 10.5582/irdr.2013.v2.4.123	23	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147824	10.1371/journal.pone.0147824	http://dx.doi.org/10.1371/journal.pone.0147824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841067	gold, Green Submitted, Green Published			2022-12-26	WOS:000369550200064
J	Harrison, JG; Gompert, Z; Fordyce, JA; Buerkle, CA; Grinstead, R; Jahner, JP; Mikel, S; Nice, CC; Santamaria, A; Forister, ML				Harrison, Joshua G.; Gompert, Zachariah; Fordyce, James A.; Buerkle, C. Alex; Grinstead, Rachel; Jahner, Joshua P.; Mikel, Scott; Nice, Christopher C.; Santamaria, Aldrin; Forister, Matthew L.			The Many Dimensions of Diet Breadth: Phytochemical, Genetic, Behavioral, and Physiological Perspectives on the Interaction between a Native Herbivore and an Exotic Host	PLOS ONE			English	Article							FORAGE QUALITY; PLANT; ALFALFA; COMMUNITY; PERFORMANCE; EVOLUTION; PREFERENCE; DIVERSITY; ASSOCIATION; CHEMISTRY	From the perspective of an herbivorous insect, conspecific host plants are not identical, and intraspecific variation in host nutritional quality or defensive capacity might mediate spatially variable outcomes in plant-insect interactions. Here we explore this possibility in the context of an ongoing host breadth expansion of a native butterfly (the Melissa blue, Lycaeides melissa) onto an exotic host plant (alfalfa, Medicago sativa). We examine variation among seven alfalfa populations that differed in terms of colonization by L. melissa; specifically, we examined variation in phytochemistry, foliar protein, and plant population genetic structure, as well as responses of caterpillars and adult butterflies to foliage from the same populations. Regional patterns of alfalfa colonization by L. melissa were well predicted by phytochemical variation, and colonized patches of alfalfa showed a similar level of inter-individual phytochemical diversity. However, phytochemical variation was a poor predictor of larval performance, despite the fact that survival and weight gain differed dramatically among caterpillars reared on plants from different alfalfa populations. Moreover, we observed a mismatch between alfalfa supporting the best larval performance and alfalfa favored by ovipositing females. Thus, the axes of plant variation that mediate interactions with L. melissa depend upon herbivore life history stage, which raises important issues for our understanding of adaptation to novel resources by an organism with a complex life history.	[Harrison, Joshua G.; Forister, Matthew L.] Univ Nevada, Dept Biol, Program Ecol Evolut & Conservat Biol, Reno, NV 89557 USA; [Harrison, Joshua G.; Grinstead, Rachel; Jahner, Joshua P.; Mikel, Scott; Santamaria, Aldrin; Forister, Matthew L.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Gompert, Zachariah] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Fordyce, James A.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Buerkle, C. Alex] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Nice, Christopher C.] SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Utah System of Higher Education; Utah State University; University of Tennessee System; University of Tennessee Knoxville; University of Wyoming; Texas State University System; Texas State University San Marcos	Harrison, JG (corresponding author), Univ Nevada, Dept Biol, Program Ecol Evolut & Conservat Biol, Reno, NV 89557 USA.; Harrison, JG (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	joshuaharrison@unr.edu	Harrison, Joshua/J-8031-2019	Harrison, Joshua/0000-0003-2524-0273; Jahner, Joshua/0000-0001-8121-6783; Fordyce, James/0000-0002-2731-0418; Gompert, Zachariah/0000-0003-2248-2488	National Science Foundation (NSF) [DEB-1050726, DEB-1145609]; NSF [DEB-0614223, DEB-1050947]; University of Nevada, Reno; NSF REU program [DEB-1050726]; Direct For Biological Sciences [1050355, 1050947] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); University of Nevada, Reno; NSF REU program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The Forister lab was supported by National Science Foundation (NSF) awards DEB-1050726 and DEB-1145609. The Fordyce lab was supported by NSF grants DEB-0614223 and DEB-1050947. J. G.H. was supported by the University of Nevada, Reno. R.G., S.M., and A.S. were supported by the NSF REU program (awards associated with DEB-1050726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Bangert RK, 2006, MOL ECOL, V15, P1379, DOI 10.1111/j.1365-294X.2005.02749.x; Barbour MA, 2015, FUNCT ECOL, V29, P995, DOI 10.1111/1365-2435.12409; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARROLL SP, 1992, EVOLUTION, V46, P1052, DOI 10.1111/j.1558-5646.1992.tb00619.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Denno RF, 2012, VARIABLE PLANTS HERB; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobler S, 1996, EVOLUTION, V50, P2373, DOI [10.2307/2410706, 10.1111/j.1558-5646.1996.tb03625.x]; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Dyer LA, 2004, ECOLOGY, V85, P2795, DOI 10.1890/03-0233; Elden TC, 1997, J ECON ENTOMOL, V90, P842, DOI 10.1093/jee/90.3.842; Fordyce JA, 2006, J EXP BIOL, V209, P2377, DOI 10.1242/jeb.02271; Fordyce JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026785; Forister ML, 2013, OECOLOGIA, V172, P177, DOI 10.1007/s00442-012-2476-8; Forister ML, 2013, OIKOS, V122, P657, DOI 10.1111/j.1600-0706.2013.00251.x; Forister ML, 2011, P ROY SOC B-BIOL SCI, V278, P1539, DOI 10.1098/rspb.2010.1959; Forister ML, 2009, OECOLOGIA, V160, P551, DOI 10.1007/s00442-009-1310-4; Golawska S, 2007, J CHEM ECOL, V33, P1598, DOI 10.1007/s10886-007-9333-y; Gompert Z, 2015, MOL ECOL, V24, P2777, DOI 10.1111/mec.13199; Gompert Z, 2014, MOL ECOL, V23, P4555, DOI 10.1111/mec.12811; Gompert Z, 2012, EVOLUTION, V66, P2167, DOI 10.1111/j.1558-5646.2012.01587.x; Gotelli N, 2013, PRIMER ECOLOGICAL ST, P109; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; HEMMING JDC, 1995, OECOLOGIA, V103, P79, DOI 10.1007/BF00328428; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hunter MD, 1996, CHEMOECOLOGY, V7, P45, DOI 10.1007/BF01240637; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Jahner JP, 2011, EVOLUTION, V65, P2719, DOI 10.1111/j.1558-5646.2011.01310.x; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Janzen D.H., 1985, Illinois Natural History Survey Bulletin, V33, P141; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Julier B, 2000, CROP SCI, V40, P365, DOI 10.2135/cropsci2000.402365x; Jung HG, 1997, CROP SCI, V37, P1361, DOI 10.2135/cropsci1997.0011183X003700040054x; Karban R., 1992, P195; Kruschke J. K, 2010, DOING BAYESIAN DATA; Lefevre T, 2011, P ROY SOC B-BIOL SCI, V278, P751, DOI 10.1098/rspb.2010.1479; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XH, 2009, CROP SCI, V49, P13, DOI 10.2135/cropsci2008.04.0205; Liu ZD, 2012, OECOLOGIA, V168, P459, DOI 10.1007/s00442-011-2103-0; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Marion Z.H., 2015, HIERDIVERSITY HIERAR; Marion ZH, 2015, AM NAT, V186, P348, DOI 10.1086/682369; MICHAUD R, 1988, AGRON MONOGR, V29, P25; NG D, 1988, NATURE, V334, P611, DOI 10.1038/334611a0; Nozzolillo C, 1997, J CHEM ECOL, V23, P995, DOI 10.1023/B:JOEC.0000006384.60488.94; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Preston MD, 2015, ECOL COMPLEX, V24, P1, DOI 10.1016/j.ecocom.2015.07.004; R Core Team, 2013, R LANG ENV STAT COMP; Ramirez RA, 2014, J CHEM ECOL, V40, P1099, DOI 10.1007/s10886-014-0504-3; Record S., 2012, VEGETARIAN JOST DIVE; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schakel A., 2015, OXFORD HDB TRANSFORM, P1; Scholl Cynthia F., 2012, International Journal of Ecology, P1; Seguin P, 2006, J SCI FOOD AGR, V86, P765, DOI 10.1002/jsfa.2412; Sen S, 1998, J AGR FOOD CHEM, V46, P131, DOI 10.1021/jf970389i; SINGER MC, 1992, AM NAT, V139, P9, DOI 10.1086/285310; SINGER MC, 1993, NATURE, V361, P251, DOI 10.1038/361251a0; Singer MC, 2000, ECOL LETT, V3, P101, DOI 10.1046/j.1461-0248.2000.00121.x; Singer MC, 2002, ECOL LETT, V5, P1, DOI 10.1046/j.1461-0248.2002.00282.x; Singer MC, 2012, ECOLOGY, V93, P2658, DOI 10.1890/11-2078.1; Singer MS, 2004, ECOLOGY, V85, P2747, DOI 10.1890/03-0827; Singer MS, 2001, OIKOS, V93, P194, DOI 10.1034/j.1600-0706.2001.930203.x; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Stochmal A, 2001, J AGR FOOD CHEM, V49, P753, DOI 10.1021/jf000876p; Strauss Sharon Y., 1998, P156; Szakiel A, 2011, PHYTOCHEM REV, V10, P471, DOI 10.1007/s11101-010-9177-x; Thompson J. N., 2005, INTERSPEC INTERACT; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Van Nouhuys S, 2003, ECOL ENTOMOL, V28, P193, DOI 10.1046/j.1365-2311.2003.00501.x; Venables WN., 2002, MODERN APPL STAT S 4; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wimp GM, 2007, MOL ECOL, V16, P5057, DOI 10.1111/j.1365-294X.2007.03544.x; ZANGERL AR, 1993, ECOLOGY, V74, P47, DOI 10.2307/1939500	79	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0147971	10.1371/journal.pone.0147971	http://dx.doi.org/10.1371/journal.pone.0147971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26836490	gold, Green Published, Green Submitted			2022-12-26	WOS:000369548500004
J	Almeida, AM; Palhinhas, RG; Kilminster, T; Scanlon, T; van Harten, S; Milton, J; Blache, D; Greeff, J; Oldham, C; Coelho, AV; Cardoso, LA				Almeida, Andre M.; Palhinhas, Rui G.; Kilminster, Tanya; Scanlon, Timothy; van Harten, Sofia; Milton, John; Blache, Dominique; Greeff, Johan; Oldham, Chris; Coelho, Ana Varela; Cardoso, Luis Alfaro			The Effect of Weight Loss on the Muscle Proteome in the Damara, Dorper and Australian Merino Ovine Breeds	PLOS ONE			English	Article							PLASMA LEPTIN CONCENTRATION; WINTER VELD HAY; PHOSPHOGLUCOMUTASE 1; LONGISSIMUS-DORSI; GENETIC-RESOURCES; ANIMAL PRODUCTION; FEED RESTRICTION; GUINEA-BISSAU; SHEEP BREEDS; MEAT QUALITY	Seasonal Weight Loss (SWL) is an important constraint, limiting animal production in the Tropics and the Mediterranean. As a result, the study of physiological and biochemical mechanisms by which domestic animal breeds respond to SWL is important to those interested in animal breeding and the improvement thereof. To that end, the study of the proteome has been instrumental in gathering important information on physiological mechanisms, including those underlying SWL. In spite of that, little information is available concerning physiological mechanisms of SWL in production animals. The objective of this study was to determine differential protein expression in the muscle of three different breeds of sheep, the Australian Merino, the Dorper and the Damara, each showing different levels of tolerance to weight loss (low, medium and high, respectively). Per breed, two experimental groups were established, one labeled "Growth" and the other labeled "Restricted." After forty-two days of dietary treatment, all animals were euthanized. Muscle samples were then taken. Total protein was extracted from the muscle, then quantified and two-dimensional gel electrophoresis were conducted using 24 cm pH 3-10 immobiline dry strips and colloidal coomassie staining. Gels were analyzed using Samespots (R) software and spots of interest were in-gel digested with trypsin. The isolated proteins were identified using MALDI-TOF/TOF. Results indicated relevant differences between breeds; several proteins are suggested as putative biomarkers of tolerance to weight loss: Desmin, Troponin T, Phosphoglucomutase and the Histidine Triad nucleotide-binding protein 1. This information is of relevance to and of possible use in selection programs aiming towards ruminant animal production in regions prone to droughts and weight loss.	[Almeida, Andre M.; van Harten, Sofia; Cardoso, Luis Alfaro] Fac Vet Med Lisbon, Ctr Interdisciplinar Invest Sanidade Anim, Lisbon, Portugal; [Almeida, Andre M.; Palhinhas, Rui G.; Coelho, Ana Varela] UNL, ITQB, Oeiras, Portugal; [Almeida, Andre M.] Ross Univ, Sch Vet Med, POB 334, Basseterre, St Kitts & Nevi; [Kilminster, Tanya; Scanlon, Timothy; Greeff, Johan; Oldham, Chris] Dept Agr & Food Western Australia, Perth, WA, Australia; [Milton, John; Blache, Dominique] Univ Western Australia, Inst Agr, Perth, WA 6009, Australia	Universidade de Lisboa; Universidade Nova de Lisboa; University of Western Australia	Almeida, AM (corresponding author), Fac Vet Med Lisbon, Ctr Interdisciplinar Invest Sanidade Anim, Lisbon, Portugal.; Almeida, AM (corresponding author), UNL, ITQB, Oeiras, Portugal.; Almeida, AM (corresponding author), Ross Univ, Sch Vet Med, POB 334, Basseterre, St Kitts & Nevi.	aalmeida@fmv.utl.pt	Blache, Dominique/H-4991-2014; Coelho, Ana V Varela/O-3977-2014; Coelho, Ana V/H-8885-2012; Almeida, Andre/I-4369-2013; van Harten, Sofia/K-8949-2016	Blache, Dominique/0000-0003-3476-3068; Coelho, Ana V Varela/0000-0002-6143-4203; Coelho, Ana V/0000-0002-6143-4203; Almeida, Andre/0000-0002-7810-3988; van Harten, Sofia/0000-0003-2091-4312; Scanlon, Timothy/0000-0001-5706-5487	FCT - Science and Technology Foundation of Portugal (Lisbon, Portugal) [POCI/CVT/57820/2004]; FCT [SFRH/BPD/90916/2012]; Department of Agriculture and Food of Government of Western Australia (Perth, WA, Australia)	FCT - Science and Technology Foundation of Portugal (Lisbon, Portugal); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Department of Agriculture and Food of Government of Western Australia (Perth, WA, Australia)	The Proteomics component of this work was supported by the FCT - Science and Technology Foundation of Portugal (Lisbon, Portugal), through the research project POCI/CVT/57820/2004 (Studies on genetic and physiological characterization of sheep adaptation to food restriction). Author AM Almeida acknowledges the FCT individual grant SFRH/BPD/90916/2012. Animal work was supported by the Department of Agriculture and Food of the Government of Western Australia (Perth, WA, Australia) to which author AM Almeida acknowledges a visiting scientist research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Animal work was supported by the Department of Agriculture and Food of the Government of Western Australia (Perth, WA, Australia) to which author AM Almeida acknowledges a visiting scientist research grant. The contribution of the technical staff of the Merredin Research Station: Alan Harrod, Leanne Young, Nicky Stanwyck, Elmer Kidson and Dr. Roy Butler, is appreciated. The Proteomics component of this work was supported by the FCT-Science and Technology Foundation of Portugal (Lisbon, Portugal), through the research project POCI/CVT/57820/2004 (Studies on genetic and physiological characterization of sheep adaptation to food restriction). Author AM Almeida acknowledges the FCT individual grant SFRH/BPD/90916/2012. Authors thank finally Mr. Blake Miller (RUSVM, St. Kitts and Nevis) for the English corrections made to this manuscript.	Almeida AM, 2007, SMALL RUMINANT RES, V73, P216, DOI 10.1016/j.smallrumres.2007.02.001; Almeida AM, 2006, TROP ANIM HEALTH PRO, V38, P443, DOI 10.1007/s11250-006-4368-6; Almeida AM, 2015, ANIMAL, V9, P1, DOI 10.1017/S1751731114002602; Almeida AM, 2010, ANIM GENET, V41, P260, DOI 10.1111/j.1365-2052.2009.01994.x; Almeida AM, 2008, SCAND J LAB ANIM SCI, V35, P259; Almeida AM, 2004, SMALL RUMINANT RES, V55, P141, DOI 10.1016/j.smallrumres.2004.01.009; Almeida AM, 2013, TROP ANIM HEALTH PRO, V45, P1305, DOI 10.1007/s11250-013-0361-z; Almeida AM, 2014, J PROTEOMICS, V103, P170, DOI 10.1016/j.jprot.2014.03.036; Almeida AM, 2011, TROP ANIM HEALTH PRO, V43, P1427, DOI 10.1007/s11250-011-9868-3; Alves SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077313; Anderson MJ, 2014, MEAT SCI, V96, P379, DOI 10.1016/j.meatsci.2013.07.017; Arianmanesh M, 2011, J ENDOCRINOL, V210, P47, DOI 10.1530/JOE-10-0336; Atti N, 2004, SMALL RUMINANT RES, V53, P151, DOI 10.1016/j.smallrumres.2003.08.016; Boffoli D, 1996, BBA-MOL BASIS DIS, V1315, P66, DOI 10.1016/0925-4439(95)00107-7; Bouley J, 2005, PROTEOMICS, V5, P490, DOI 10.1002/pmic.200400925; Brackley KI, 2009, CELL STRESS CHAPERON, V14, P23, DOI 10.1007/s12192-008-0057-x; Cardoso LA, 2013, FAO ANIMAL PRODUCTIO, V175, P37; Chelikani PK, 2004, DOMEST ANIM ENDOCRIN, V26, P33, DOI 10.1016/j.domaniend.2003.08.003; de Almeida AM, 2008, TROP ANIM HEALTH PRO, V40, P529, DOI 10.1007/s11250-008-9130-9; de Almeida AM, 2008, TROP ANIM HEALTH PRO, V40, P537, DOI 10.1007/s11250-008-9131-8; de Almeida AM, 2012, J PROTEOMICS, V75, P4296, DOI 10.1016/j.jprot.2012.04.010; Delavaud C, 2000, J ENDOCRINOL, V165, P519, DOI 10.1677/joe.0.1650519; Delavaud C, 2002, J ANIM SCI, V80, P1317; Eckersall PD, 2012, J PROTEOMICS, V75, P4187, DOI 10.1016/j.jprot.2012.05.014; Eryavuz A, 2007, REV MED VET-TOULOUSE, V158, P244; Ferlizza E, 2015, VET J, V204, P73, DOI 10.1016/j.tvjl.2015.01.023; Ferreira AM, 2013, J PROTEOMICS, V94, P110, DOI 10.1016/j.jprot.2013.09.012; Freer M., 2007, NUTR REQUIREMENTS DO; Ge L, 2015, PHARMACOL BIOCHEM BE, V131, P77, DOI 10.1016/j.pbb.2015.01.017; Hamelin M, 2006, J ANIM SCI, V84, P3266, DOI 10.2527/jas.2006-162; Hernandez-Castellano LE, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-85; Hnia K, 2014, CELL TISSUE IN PRESS; Holmstrom MH, 2013, METABOLISM, V62, P1258, DOI 10.1016/j.metabol.2013.04.001; Kim NK, 2008, MEAT SCI, V80, P1068, DOI 10.1016/j.meatsci.2008.04.027; Kim NK, 2009, BMB REP, V42, P433, DOI 10.5483/BMBRep.2009.42.7.433; Kunej T, 2007, OBESITY, V15, P2896, DOI 10.1038/oby.2007.344; Lamy E, 2012, ENV STRESS AMELIORAT, P19, DOI DOI 10.1007/978-3-642-29205-7_2; Lee Y, 2014, J BIOL CHEM, V289, P32010, DOI 10.1074/jbc.M114.597914; Martin J, 2011, BBA-BIOENERGETICS, V1807, P626, DOI 10.1016/j.bbabio.2011.02.001; Miller I, 2014, CURR PROTEIN PEPT SC, V15, P134, DOI 10.2174/1389203715666140221115135; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Paredi G, 2013, J PROTEOMICS, V88, P58, DOI 10.1016/j.jprot.2013.01.029; Paredi G, 2012, J PROTEOMICS, V75, P4275, DOI 10.1016/j.jprot.2012.04.011; Petriz BA, 2015, J PROTEOMICS, V113, P351, DOI 10.1016/j.jprot.2014.10.010; Ren MQ, 2002, DOMEST ANIM ENDOCRIN, V23, P371, DOI 10.1016/S0739-7240(02)00179-0; Scanlon TT, 2013, SMALL RUMINANT RES, V109, P101, DOI 10.1016/j.smallrumres.2012.08.004; Shibata M, 2009, J ANIM SCI, V87, P2700, DOI 10.2527/jas.2008-1486; Soares R, 2012, J PROTEOMICS, V75, P4190, DOI 10.1016/j.jprot.2012.04.009; Tshabalala PA, 2003, MEAT SCI, V65, P563, DOI 10.1016/S0309-1740(02)00249-8; van Harten S, 2013, ANIMAL, V7, P439, DOI 10.1017/S1751731112001589; van Harten S, 2003, NUTR RES, V23, P1447, DOI 10.1016/S0271-5317(03)00152-0; Vian Harten S, 2015, J SCI FOOD IN PRESS; Wilkes MJ, 2012, ANIM PROD SCI, V52, P30, DOI 10.1071/AN11033; Yu T.Y., 2015, EUPA OPEN PROTEOM, V6, P28, DOI [DOI 10.1016/J.EUPR0T.2015.01.001, 10.1016/j.euprot.2015.01.001, DOI 10.1016/J.EUPROT.2015.01.001]	54	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0146367	10.1371/journal.pone.0146367	http://dx.doi.org/10.1371/journal.pone.0146367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828937	Green Published, gold			2022-12-26	WOS:000369548200008
J	Li, Z; Tang, JJ; Guo, F				Li, Zhao; Tang, Jijun; Guo, Fei			Identification of 14-3-3 Proteins Phosphopeptide-Binding Specificity Using an Affinity-Based Computational Approach	PLOS ONE			English	Article							STRUCTURAL BASIS; PREDICTION; SELECTION; CANCER	The 14-3-3 proteins are a highly conserved family of homodimeric and heterodimeric molecules, expressed in all eukaryotic cells. In human cells, this family consists of seven distinct but highly homologous 14-3-3 isoforms. 14-3-3s is the only isoform directly linked to cancer in epithelial cells, which is regulated by major tumor suppressor genes. For each 14-3-3 isoform, we have 1,000 peptide motifs with experimental binding affinity values. In this paper, we present a novel method for identifying peptide motifs binding to 14-3-3s isoform. First, we propose a sampling criteria to build a predictor for each new peptide sequence. Then, we select nine physicochemical properties of amino acids to describe each peptide motif. We also use auto-cross covariance to extract correlative properties of amino acids in any two positions. Finally, we consider elastic net to predict affinity values of peptide motifs, based on ridge regression and least absolute shrinkage and selection operator ( LASSO). Our method tests on the 1,000 known peptide motifs binding to seven 14-3-3 isoforms. On the 14-3-3s isoform, our method has overall pearson-product-moment correlation coefficient (PCC) and root mean squared error (RMSE) values of 0.84 and 252.31 for N-terminal sublibrary, and 0.77 and 269.13 for C-terminal sublibrary. We predict affinity values of 16,000 peptide sequences and relative binding ability across six permutated positions similar with experimental values. We identify phosphopeptides that preferentially bind to 14-33s over other isoforms. Several positions on peptide motifs are in the same amino acid category with experimental substrate specificity of phosphopeptides binding to 14-3-3s. Our method is fast and reliable and is a general computational method that can be used in peptide-protein binding identification in proteomics research.	[Li, Zhao; Tang, Jijun; Guo, Fei] Tianjin Univ, Sch Comp Sci & Technol, 92 Weijin Rd, Tianjin 300072, Peoples R China; [Tang, Jijun] Univ S Carolina, Sch Computat Sci & Engn, Columbia, SC 29208 USA	Tianjin University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Guo, F (corresponding author), Tianjin Univ, Sch Comp Sci & Technol, 92 Weijin Rd, Tianjin 300072, Peoples R China.	fguo@tju.edu.cn	Tang, Jijun/ABH-6528-2020		National Science Foundation of China [NSFC 61402326]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by a grant from National Science Foundation of China (NSFC 61402326).	AITKEN A, 1995, J BIOL CHEM, V270, P5706, DOI 10.1074/jbc.270.11.5706; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Florencio P, 2002, CURR OPIN STRUC BIOL, V12, P368; Giguere S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-82; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Hastie R T Friedman, 2001, ELEMENTS STAT LEARNI; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Jang H, 2006, BIOINFORMATICS, V22, pE220, DOI 10.1093/bioinformatics/btl203; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Lu CHS, 2008, ANGEW CHEM INT EDIT, V47, P7438, DOI 10.1002/anie.200801395; Mathura VS, 2005, BIOINFORMATION, V1, P2, DOI 10.6026/97320630001002; Pan XY, 2010, J PROTEOME RES, V9, P4992, DOI 10.1021/pr100618t; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Qi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095386; Sluchanko NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072597; Stulp F, 2015, NEURAL NETWORKS, V69, P60, DOI 10.1016/j.neunet.2015.05.005; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; WAGNER I, 1983, ANGEW CHEM INT EDIT, V22, P816, DOI 10.1002/anie.198308161; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; You ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125811; You ZH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S8-S10; Zaki N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-150; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhang YD, 2014, TECHNOLOGIES, V2, DOI 10.3390/technologies2040164; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	31	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147467	10.1371/journal.pone.0147467	http://dx.doi.org/10.1371/journal.pone.0147467			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828594	Green Submitted, Green Published, gold			2022-12-26	WOS:000369548200021
J	Liang, HW; Hwang, YH				Liang, Huey-Wen; Hwang, Yaw-Huei			Mobile Phone Use Behaviors and Postures on Public Transportation Systems	PLOS ONE			English	Article							GENDER-DIFFERENCES; SYMPTOMS; PAIN	Mobile phones are common in our daily life, but the users' preferences for postures or screen operating styles have not been studied. This was a cross-sectional and observational study. We randomly sampled passengers who used mobile phones on the Mass Rapid Transit (MRT) system in metropolitan Taipei. A checklist was used to observe their body postures and screen operating styles while sitting or standing. As a result, 1,230 subjects from 400 trips were observed. Overall, of all the passengers who were sitting, 41% of them were using mobile phones. The majority of the tasks involved browsing (84%) with their phones in a portrait orientation (93%). Different-hand holding/operating was the most commonly used operating style while sitting (46%) and same-hand holding/operating was the most common while standing (46%). The distribution of screen operating styles was significantly different for those sitting than for those standing and for different genders and age groups. The most frequently observed postures while sitting were having one's trunk against a backrest, feet on the floor and with or without an arm supported (58%). As for the users who were standing, the both-and different-hands groups had a high proportion of arms unsupported, feet on the floor and either their trunk supported or not. In contrast, the same-hand group tended to have their trunk unsupported, were holding a pole or handstrap and had both feet on floor. Further studies are warranted to characterize the ergonomic exposure of these commonly used postures and operating styles, and our results will help guide the selection of experimental conditions for laboratory settings.	[Liang, Huey-Wen] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Liang, Huey-Wen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hwang, Yaw-Huei] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, 17 Xu Zhou Rd, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Liang, HW (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.; Liang, HW (corresponding author), Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan.	lianghw@ntu.edu.tw	LIANG, HUEY-WEN/AAN-8083-2020	LIANG, HUEY-WEN/0000-0003-0186-3126; HWANG, YAW-HUEI/0000-0003-1817-8969	Ministry of Science and Technology, Taiwan [104-2314-B-002-014-]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology, Taiwan, under Grant 104-2314-B-002-014-, https://www.most.gov.tw/, funding to HWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, MOBILE MARKETING STA; Babadi-Akashe Zahra, 2014, Addict Health, V6, P93; Barr GC, 2015, J EMERG MED, V48, P366, DOI 10.1016/j.jemermed.2014.09.055; Berolo S, 2011, APPL ERGON, V42, P371, DOI 10.1016/j.apergo.2010.08.010; Bianchi A, 2005, CYBERPSYCHOL BEHAV, V8, P39, DOI 10.1089/cpb.2005.8.39; Boase J, 2013, J COMPUT-MEDIAT COMM, V18, P508, DOI 10.1111/jcc4.12021; Brezmes T, 2009, LECT NOTES COMPUT SC, V5518, P796, DOI 10.1007/978-3-642-02481-8_120; de Waard D, 2015, ACCIDENT ANAL PREV, V76, P42, DOI 10.1016/j.aap.2015.01.004; Duh HBL., 2006, P 8 C HUM COMP INT M, P181, DOI DOI 10.1145/1152215.1152254; Gold JE, 2012, APPL ERGON, V43, P408, DOI 10.1016/j.apergo.2011.06.015; Gustafsson E, 2010, J ELECTROMYOGR KINES, V20, P127, DOI 10.1016/j.jelekin.2008.11.010; Hakala PT, 2006, EUR J PUBLIC HEALTH, V16, P536, DOI 10.1093/eurpub/ckl025; Huth V, 2015, ACCIDENT ANAL PREV, V74, P42, DOI 10.1016/j.aap.2014.10.008; Ipsos MediaCT Mobile Marketing Association Interactive Advertising Bureau, 2013, OUR MOBILE PLANET RE; Kamp I, 2011, ERGONOMICS, V54, P1029, DOI 10.1080/00140139.2011.618230; Kietrys DM, 2015, APPL ERGON, V50, P98, DOI 10.1016/j.apergo.2015.03.003; Kim GY, 2012, J PHYS THER SCI, V24, P1255, DOI 10.1589/jpts.24.1255; Ko PH, 2016, ERGONOMICS, V59, P821, DOI 10.1080/00140139.2015.1088075; Korpinen L, 2013, ERGONOMICS, V56, P1134, DOI 10.1080/00140139.2013.802018; Lee S, 2015, ERGONOMICS, V58, P220, DOI 10.1080/00140139.2014.967311; Lopez-Rosenfeld M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125772; Repacholi MH, 2001, TOXICOL LETT, V120, P323, DOI 10.1016/S0378-4274(01)00285-5; Slijper H, 2000, EXP BRAIN RES, V135, P81, DOI 10.1007/s002210000492; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; Takao M, 2009, CYBERPSYCHOL BEHAV, V12, P501, DOI 10.1089/cpb.2009.0022	25	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148419	10.1371/journal.pone.0148419	http://dx.doi.org/10.1371/journal.pone.0148419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828797	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200100
J	Min, JH; Lee, CH; Ji, YW; Yeo, A; Noh, H; Song, I; Kim, EK; Lee, HK				Min, Ji Hwan; Lee, Chul Hee; Ji, Yong Woo; Yeo, Areum; Noh, Hyemi; Song, Insil; Kim, Eung Kweon; Lee, Hyung Keun			Activation of Dll4/Notch Signaling and Hypoxia-Inducible Factor-1 Alpha Facilitates Lymphangiogenesis in Lacrimal Glands in Dry Eye	PLOS ONE			English	Article							CHRONIC SKIN INFLAMMATION; NOTCH; ANGIOGENESIS; STIMULATION; EXPRESSION; DISEASE	Purpose By using hypoxia-inducible factor-1 alpha conditional knockout (HIF-1 alpha CKO) mice and a dry eye (DE) mouse model, we aimed to determine the role played by delta-like ligand 4 (Dll4)/Notch signaling and HIF-1 alpha in the lymphangiogenesis of lacrimal glands (LGs). Methods C57BL/6 mice were housed in a controlled-environment chamber for DE induction. During DE induction, the expression level of Dll4/Notch signaling and lymphangiogenesis in LGs was measured by quantitative RT-PCR, immunoblot, and immunofluorescence staining. Next, lymphangiogenesis was measured after Dll4/Notch signal inhibition by anti-Dll4 antibody or.-secretase inhibitor. Using HIF-1 alpha CKO mice, the expression of Dll4/Notch signaling and lymphangiogenesis in LGs of DE-induced HIF-1 alpha CKO mice were assessed. Additionally, the infiltration of CD45(+) cells in LGs was assessed by immunohistochemical (IHC) staining and flow cytometry for each condition. Results DE significantly upregulated Dll4/Notch and lymphangiogenesis in LGs. Inhibition of Dll4/Notch significantly suppressed lymphangiogenesis in LGs. Compared to wild-type (WT) mice, DE induced HIF-1 alpha CKO mice showed markedly low levels of Dll4/Notch and lymphangiogenesis. Inhibition of lymphangiogenesis by Dll4/Notch suppression resulted in increased CD45+ cell infiltration in LGs. Likewise, CD45+ cells infiltrated more in the LGs of HIF-1 alpha CKO DE mice than in non-DE HIF-1 alpha CKO mice. Conclusions Dll4/Notch signaling and HIF-1a are closely related to lymphangiogenesis in DE-induced LGs. Lymphangiogenesis stimulated by Dll4/Notch and HIF-1 alpha may play a role in protecting LGs from DE-induced inflammation by aiding the clearance of immune cells from LGs.	[Min, Ji Hwan; Lee, Chul Hee; Ji, Yong Woo; Yeo, Areum; Noh, Hyemi; Song, Insil; Kim, Eung Kweon; Lee, Hyung Keun] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul 120749, South Korea; [Ji, Yong Woo; Kim, Eung Kweon; Lee, Hyung Keun] Yonsei Univ, Coll Med, Dept Ophthalmol, Corneal Dystrophy Res Inst, Seoul 120749, South Korea; [Lee, Hyung Keun] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, HK (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul 120749, South Korea.; Lee, HK (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Corneal Dystrophy Res Inst, Seoul 120749, South Korea.; Lee, HK (corresponding author), Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul 120749, South Korea.	shadik@yuhs.ac		Ji, Yong Woo/0000-0002-7211-6278; Lee, Chul Hee/0000-0002-4107-4677; Kim, Eung Kweon/0000-0002-1453-8042	National Research Foundation of Korea (NRF) [NRF-2012R1A2A2A02009081]; Korean Health Technology R&D Project, Ministry of Health and welfare, Korea [HI13C0055]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Health Technology R&D Project, Ministry of Health and welfare, Korea	This work was supported by National Research Foundation of Korea (NRF), NRF-2012R1A2A2A02009081, HKL; Korean Health Technology R&D Project, Ministry of Health and welfare, Korea, HI13C0055, HKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer D, 2014, ANGIOGENESIS, V17, P383, DOI 10.1007/s10456-013-9404-3; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Bridges JP, 2012, DEV BIOL, V362, P24, DOI 10.1016/j.ydbio.2011.10.033; Bron AJ, 2009, OCUL SURF, V7, P78, DOI 10.1016/S1542-0124(12)70299-9; Calonge M, 2010, OCUL IMMUNOL INFLAMM, V18, P244, DOI 10.3109/09273941003721926; Chauhan Sunil K, 2014, J Clin Cell Immunol, V5; Coursey TG, 2014, CLIN OPHTHALMOL, V8, P1447, DOI 10.2147/OPTH.S35685; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; D'Alessio S, 2014, J CLIN INVEST, V124, P3863, DOI 10.1172/JCI72189; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070667; Fatima A, 2014, DEV DYNAM, V243, P957, DOI [10.1002/DVDY.24129, 10.1002/dvdy.24129]; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hagura A, 2014, J DERMATOL SCI, V73, P135, DOI 10.1016/j.jdermsci.2013.10.006; Hayashi T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/407031; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Ji YW, 2013, INVEST OPHTH VIS SCI, V54, P7557, DOI 10.1167/iovs.12-11515; Kamoi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043688; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kim H, 2012, TRENDS IMMUNOL, V33, P350, DOI 10.1016/j.it.2012.03.006; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; NAKANO A, 1990, ACTA PATHOL JAPON, V40, P107; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Olsauskas-Kuprys R, 2013, ONCOTARGETS THER, V6, P943, DOI 10.2147/OTT.S33766; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Ran Sophia, 2012, Cancers (Basel), V4, P618, DOI 10.3390/cancers4030618; Seo Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.260; Shawber CJ, 2007, J CLIN INVEST, V117, P3369, DOI 10.1172/JCI24311; Xiao B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115333; Zampell JC, 2012, FASEB J, V26, P1027, DOI 10.1096/fj.11-195321; Zhang YJ, 2013, DEVELOPMENT, V140, P594, DOI 10.1242/dev.082842	32	12	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147846	10.1371/journal.pone.0147846	http://dx.doi.org/10.1371/journal.pone.0147846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828208	Green Submitted, Green Published, gold			2022-12-26	WOS:000369548200037
J	Sulaberidze, L; Mirzazadeh, A; Chikovani, I; Shengelia, N; Tsereteli, N; Gotsadze, G				Sulaberidze, Lela; Mirzazadeh, Ali; Chikovani, Ivdity; Shengelia, Natia; Tsereteli, Nino; Gotsadze, George			Population Size Estimation of Men Who Have Sex with Men in Tbilisi, Georgia; Multiple Methods and Triangulation of Findings	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CENTRAL TENDENCY; KEY POPULATIONS; HIV; RISK	Introduction An accurate estimation of the population size of men who have sex with men (MSM) is critical to the success of HIV program planning and to monitoring of the response to epidemic as a whole, but is quite often missing. In this study, our aim was to estimate the population size of MSM in Tbilisi, Georgia and compare it with other estimates in the region. Methods In the absence of a gold standard for estimating the population size of MSM, this study reports a range of methods, including network scale-up, mobile/web apps multiplier, service and unique object multiplier, network-based capture-recapture, Handcock RDS-based and Wisdom of Crowds methods. To apply all these methods, two surveys were conducted: first, a household survey among 1,015 adults from the general population, and second, a respondent driven sample of 210 MSM. We also conducted a literature review of MSM size estimation in Eastern European and Central Asian countries. Results The median population size of MSM generated from all previously mentioned methods was estimated to be 5,100 (95% Confidence Interval (CI): 3,243 +/- 9,088). This corresponds to 1.42% (95% CI: 0.9% +/- 2.53%) of the adult male population in Tbilisi. Conclusion Our size estimates of the MSM population (1.42% (95% CI: 0.9% +/- 2.53%) of the adult male population in Tbilisi) fall within ranges reported in other Eastern European and Central Asian countries. These estimates can provide valuable information for country level HIV prevention program planning and evaluation. Furthermore, we believe, that our results will narrow the gap in data availability on the estimates of the population size of MSM in the region.	[Sulaberidze, Lela; Chikovani, Ivdity; Shengelia, Natia; Gotsadze, George] Curatio Int Fdn, Tbilisi, Georgia; [Mirzazadeh, Ali] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA; [Mirzazadeh, Ali] Kerman Univ Med Sci, Reg Knowledge Hub, Kerman, Iran; [Mirzazadeh, Ali] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Inst Futures Studies Hlth, Kerman, Iran; [Tsereteli, Nino] Ctr Informat & Counseling Reprod Hlth Tanadgoma, Tbilisi, Georgia	University of California System; University of California San Francisco; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization	Sulaberidze, L (corresponding author), Curatio Int Fdn, Tbilisi, Georgia.	l.sulaberidze@curatio.com	Gotsadze, George/B-1129-2008; Sulaberidze, Lela/AAF-2133-2020; Mirzazadeh, Ali/AAJ-5907-2021; Chikovani, Ivdity/AAL-9870-2020	Gotsadze, George/0000-0002-8429-7125; Sulaberidze, Lela/0000-0003-3388-8731; Chikovani, Ivdity/0000-0001-6925-4904; Mirzazadeh, Ali/0000-0002-0478-3220	GFATM under the project "Establishment of the evidence base for national HIV/AIDS program by strengthening of HIV/AIDS surveillance system in the country" (GEO-H-GPIC)	GFATM under the project "Establishment of the evidence base for national HIV/AIDS program by strengthening of HIV/AIDS surveillance system in the country" (GEO-H-GPIC)	Funding for the Population Size Estimation study implementation was provided by GFATM under the project "Establishment of the evidence base for national HIV/AIDS program by strengthening of HIV/AIDS surveillance system in the country" (GEO-H-GPIC).	Abdul-Quader AS, 2014, CURR OPIN HIV AIDS, V9, P107, DOI 10.1097/COH.0000000000000041; AIDSinfo Online Database, 2014, AIDSINFO ONLINE DATA; [Anonymous], 2013, GLOB AIDS RESP PROGR; [Anonymous], 2014, RDS ANAL SOFTWARE AN; Berleva G., 2012, ESTIMATION SIZE POPU; Burrell ER, 2012, AIDS BEHAV, V16, P1816, DOI 10.1007/s10461-012-0277-z; Comiskey C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002203; Dombrowski Kirk, 2012, Adv Appl Sociol, V2, P245; Ezoe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031184; Guo W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071796; Handcock MS, 2015, BIOMETRICS, V71, P258, DOI 10.1111/biom.12255; Hosein SR, 2013, LANCET INFECT DIS, V13, P654, DOI 10.1016/S1473-3099(13)70185-3; Johnston LG, 2013, SEX TRANSM DIS, V40, P304, DOI 10.1097/OLQ.0b013e31827fd650; Killworth PD, 1998, EVALUATION REV, V22, P289, DOI 10.1177/0193841X9802200205; Lee MD, 2011, MEM COGNITION, V39, P914, DOI 10.3758/s13421-010-0059-7; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Manikandan S, 2011, J PHARMACOL PHARMACO, V2, P140, DOI 10.4103/0976-500X.81920; Manikandan S, 2011, J PHARMACOL PHARMACO, V2, P214, DOI 10.4103/0976-500X.83300; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Muessig KE, 2012, AIDS, V26, P2267, DOI 10.1097/QAD.0b013e328355713d; Okal J, 2013, SEX TRANSM INFECT, V89, P366, DOI 10.1136/sextrans-2013-051071; Paniotto V, 2009, ESTIMATING SIZE POPU; Politch JA, 2012, AIDS, V26, P1535, DOI 10.1097/QAD.0b013e328353b11b; Quaye S, 2015, AIDS BEHAV, V19, pS16, DOI 10.1007/s10461-014-0943-4; Rastegari Azam, 2013, Glob J Health Sci, V5, P217, DOI 10.5539/gjhs.v5n4p217; Republic of Mozambique National AIDS Control Council 2012, 2012, GLOB AIDS RESP PROGR; Rwanda Biomedical Center/Institute of HIV/AIDS Disease Prevention and Control Department (RBC/ IHDPC) School of Public Health (SPH) UNAIDS all, 2012, EST SIZ POP THOUGH H; Salganik MJ, 2011, SOC NETWORKS, V33, P70, DOI 10.1016/j.socnet.2010.10.006; Tsereteli N, 2012, HIV RISK PREVENTION; UNAIDS, 2009, GLOB AIDS RESP PROGR; UNAIDS, 2014, GLOB AIDS RESP PROGR; UNAIDS, 2005, DEV SOFTW PACK EPP V; UNAIDS, 2011, GLOB AIDS RESP PROGR; UNAIDS the US Office of the Global AIDS Coordinator, 2012, CONS NETW SCAL UP OT; Vallejo A, 2013, RES VET SCI, V95, P405, DOI 10.1016/j.rvsc.2013.04.005; WHO, 2013, NETW SCAL UP METH WO; Wu E, 2013, ESTIMATION POPULATIO	37	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147413	10.1371/journal.pone.0147413	http://dx.doi.org/10.1371/journal.pone.0147413			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828366	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200019
J	Williams, RC; Skelton, AJ; Todryk, SM; Rowan, AD; Preshaw, PM; Taylor, JJ				Williams, Rachel C.; Skelton, Andrew J.; Todryk, Stephen M.; Rowan, Andrew D.; Preshaw, Philip M.; Taylor, John J.			Leptin and Pro-Inflammatory Stimuli Synergistically Upregulate MMP-1 and MMP-3 Secretion in Human Gingival Fibroblasts	PLOS ONE			English	Article							NF-KAPPA-B; MATRIX METALLOPROTEINASES; PERIODONTAL-LIGAMENT; INTERLEUKIN (IL)-6; EXPRESSION; ACTIVATION; CARTILAGE; PATHWAYS; IL-8; LIPOPOLYSACCHARIDE	Introduction Gingival fibroblast-mediated extracellular matrix remodelling is implicated in the pathogenesis of periodontitis, yet the stimuli that regulate this response are not fully understood. The immunoregulatory adipokine leptin is detectable in the gingiva, human gingival fibroblasts express functional leptin receptor mRNA and leptin is known to regulate extracellular matrix remodelling responses in cardiac fibroblasts. We therefore hypothesised that leptin would enhance matrix metalloproteinase secretion in human gingival fibroblasts. Methods and Results We used in vitro cell culture to investigate leptin signalling and the effect of leptin on mRNA and protein expression in human gingival fibroblasts. We confirmed human gingival fibroblasts expressed cell surface leptin receptor, found leptin increased matrix metalloproteinase-1, -3, -8 and -14 expression in human gingival fibroblasts compared to unstimulated cells, and observed that leptin stimulation activated MAPK, STAT1/3 and Akt signalling in human gingival fibroblasts. Furthermore, leptin synergised with IL-1 or the TLR2 agonist pam2CSK4 to markedly enhance matrix metalloproteinase-1 and -3 production by human gingival fibroblasts. Signalling pathway inhibition demonstrated ERK was required for leptin-stimulated matrix metalloproteinase-1 expression in human gingival fibroblasts; whilst ERK, JNK, p38 and STAT3 were required for leptin+IL-1- and leptin+pam2CSK4-induced matrix metalloproteinase-1 expression. A genome-wide expression array and gene ontology analysis confirmed genes differentially expressed in leptin+ IL-1-stimulated human gingival fibroblasts (compared to unstimulated cells) were enriched for extracellular matrix organisation and disassembly, and revealed that matrix metalloproteinase-8 and -12 were also synergistically upregulated by leptin+ IL-1 in human gingival fibroblasts. Conclusions We conclude that leptin selectively enhances the expression and secretion of certain matrix metalloproteinases in human gingival fibroblasts, and suggest that gingival fibroblasts may have an ECM-degrading phenotype during conditions of hyperleptinaemia (e.g., obesity, type 2 diabetes mellitus, exogenous leptin therapy).	[Williams, Rachel C.; Preshaw, Philip M.; Taylor, John J.] Newcastle Univ, Ctr Oral Hlth Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Skelton, Andrew J.; Rowan, Andrew D.] Newcastle Univ, Musculoskeletal Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Skelton, Andrew J.] Newcastle Univ, Bioinformat Support Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Williams, Rachel C.; Rowan, Andrew D.; Preshaw, Philip M.; Taylor, John J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Todryk, Stephen M.] Northumbria Univ, Fac Hlth & Life Sci, Dept Appl Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Northumbria University	Taylor, JJ (corresponding author), Newcastle Univ, Ctr Oral Hlth Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.; Taylor, JJ (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	john.taylor@ncl.ac.uk	Todryk, Stephen/AAA-3950-2019; Taylor, John/R-5323-2018	Todryk, Stephen/0000-0003-4566-0793; Taylor, John/0000-0002-0766-186X	Medical Research Council; Faculty of Medical Sciences, Newcastle University; Oral and Dental Research trust [122602]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Faculty of Medical Sciences, Newcastle University; Oral and Dental Research trust	This work was funded by a PhD studentship awarded to RW (funded jointly by the Medical Research Council and the Faculty of Medical Sciences, Newcastle University) and a grant from the Oral and Dental Research trust (No.122602) to RW and JT (see http://www.mrc.ac.uk/ & http://odrt.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay ZY, 2012, ODONTOLOGY, V100, P222, DOI 10.1007/s10266-011-0043-0; Barchowsky A, 2000, CYTOKINE, V12, P1469, DOI 10.1006/cyto.2000.0743; Bartold PM, 2006, PERIODONTOL 2000, V40, P29, DOI 10.1111/j.1600-0757.2005.00140.x; Bodet C, 2007, J CELL PHYSIOL, V212, P189, DOI 10.1002/jcp.21018; Chen YQE, 2004, AM J PATHOL, V165, P1069, DOI 10.1016/S0002-9440(10)63368-8; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Cox SW, 2006, ORAL DIS, V12, P34, DOI 10.1111/j.1601-0825.2005.01153.x; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Domeij H, 2002, EUR J ORAL SCI, V110, P302, DOI 10.1034/j.1600-0722.2002.21247.x; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Herath TDK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-73; Hui W, 2012, ANN RHEUM DIS, V71, P455, DOI 10.1136/annrheumdis-2011-200372; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Iwayama T, 2012, J PERIODONTAL RES, V47, P563, DOI 10.1111/j.1600-0765.2012.01467.x; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Kida Y, 2005, CYTOKINE, V29, P159, DOI 10.1016/j.cyto.2004.10.009; Kiili M, 2002, J CLIN PERIODONTOL, V29, P224, DOI 10.1034/j.1600-051x.2002.290308.x; Koskinen A, 2011, CLIN EXP RHEUMATOL, V29, P57; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; Mahanonda R, 2007, J IMMUNOL, V178, P1151, DOI 10.4049/jimmunol.178.2.1151; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Milner JM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2034; Minami T, 2007, J DENT RES, V86, P1083, DOI 10.1177/154405910708601112; Morandini AC, 2013, J PERIODONTOL, V84, P1353, DOI 10.1902/jop.2012.120496; Morandini ACF, 2013, J PERIODONTOL, V84, P535, DOI 10.1902/jop.2012.120177; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park Hong-Gyu, 2013, International Journal of Oral Biology, V38, P73, DOI 10.11620/IJOB.2013.38.2.073; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Ruwanpura SMPM, 2004, J DENT RES, V83, P260, DOI 10.1177/154405910408300315; Saucillo DC, 2014, J IMMUNOL, V192, P136, DOI 10.4049/jimmunol.1301158; Schram K, 2011, ENDOCRINOLOGY, V152, P2037, DOI 10.1210/en.2010-1166; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Sorsa T, 2006, ANN MED, V38, P306, DOI 10.1080/07853890600800103; Souza PPC, 2010, J DENT RES, V89, P802, DOI 10.1177/0022034510366898; Sukkar TZ, 2007, J PERIODONTAL RES, V42, P580, DOI 10.1111/j.1600-0765.2007.00986.x; Taylor John J, 2013, J Periodontol, V84, pS113, DOI [10.1111/jcpe.12059, 10.1902/jop.2013.134005]; Wisler BA, 2011, CURR SIGNAL TRANSD T, V6, P279; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	43	27	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148024	10.1371/journal.pone.0148024	http://dx.doi.org/10.1371/journal.pone.0148024			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829555	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000369548200053
J	Benesova, V; Kinterova, V; Kanka, J; Toralova, T				Benesova, Veronika; Kinterova, Veronika; Kanka, Jiri; Toralova, Tereza			Characterization of SCF-Complex during Bovine Preimplantation Development	PLOS ONE			English	Article							F-BOX PROTEIN; EARLY EMBRYONIC LETHALITY; MESSENGER-RNA; GENOME ACTIVATION; CULLIN PARTNERS; GENE-EXPRESSION; IN-VIVO; UBIQUITIN; LIGASE; MOUSE	The degradation of maternal proteins is one of the most important events during early development, and it is presumed to be essential for embryonic genome activation (EGA), but the precise mechanism is still not known. It is thought that a large proportion of the degradation of maternal proteins is mediated by the ubiquitin-proteolytic system. In this study we focused on the expression of the Skp1-Cullin1-F-box (SCF) complex, a modular RING-type E3 ubiquitin-ligase, during bovine preimplantation development. The complex consists of three invariable components-Cul1, Skp1, Rbx1 and F-box protein, which determines the substrate specificity. The protein level and mRNA expression of all three invariable members were determined. Cul1 and Skp1 mRNA synthesis was activated at early embryonic stages, at the 4c and early 8c stage, respectively, which suggests that these transcripts are necessary for preparing the embryo for EGA. CUL1 protein level increased from MII to the morula stage, with a significant difference between MII and L8c, and between MII and the morula. The CUL1 protein was localized primarily to nuclei and to a lesser extent to the cytoplasm, with a lower signal in the inner cell mass (ICM) compared to the trophectoderm (TE) at the blastocyst stage. The level of SKP1 protein significantly increased from MII oocytes to 4c embryos, but then significantly decreased again. The localization of the SKP1 protein was analysed throughout the cell and similarly to CUL1 at the blastocyst stage, the staining was less intensive in the ICM. There were no statistical differences in RBX1 protein level and localization. The active SCF-complex, which is determined by the interaction of Cul1 and Skp1, was found throughout the whole embryo during preimplantation development, but there was a difference at the blastocyst stage, which exhibits a much stronger signal in the TE than in the ICM. These results suggest that all these genes could play an important role during preimplantation development. This paper reveals comprehensive expression profile, the basic but important knowledge necessary for further studying.	[Benesova, Veronika; Kinterova, Veronika; Kanka, Jiri; Toralova, Tereza] Acad Sci Czech Republ Vvi, Inst Anim Physiol & Genet, Dev Biol Lab, Libechov, Czech Republic; [Benesova, Veronika] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Kinterova, Veronika] Czech Univ Life Sci Prague, Dept Vet Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Charles University Prague; Czech University of Life Sciences Prague	Benesova, V (corresponding author), Acad Sci Czech Republ Vvi, Inst Anim Physiol & Genet, Dev Biol Lab, Libechov, Czech Republic.	benesova@iapg.cas.cz	Petruskova, Veronika/N-1321-2017; Toralová, Tereza/AAL-9914-2020; Kinterova, Veronika/AAM-1888-2020	Petruskova, Veronika/0000-0002-5337-7042; Kinterova, Veronika/0000-0003-4255-3300	Czech Science Foundation [GACR 13-24730P]; Grant Agency of Charles University in Prague [GAUK 1280214]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University in Prague	This work was supported by the Czech Science Foundation (GACR 13-24730P) (TT) and Grant Agency of Charles University in Prague (GAUK 1280214) (VB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader M, 2010, DEVELOPMENT, V137, P1679, DOI 10.1242/dev.050088; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Davis W, 2000, DEV BIOL, V218, P275, DOI 10.1006/dbio.1999.9486; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Filippov V, 2000, J EXP BIOL, V203, P2747; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Graf A, 2014, ANIM REPROD SCI, V149, P46, DOI 10.1016/j.anireprosci.2014.05.016; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Gutierrez GJ, 2006, NAT CELL BIOL, V8, P1084, DOI 10.1038/ncb1472; Hwang KC, 2004, MOL REPROD DEV, V69, P43, DOI 10.1002/mrd.20156; Jia LJ, 2011, J BIOL CHEM, V286, P3379, DOI 10.1074/jbc.M110.188425; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Kanka J, 2009, THERIOGENOLOGY, V72, P572, DOI 10.1016/j.theriogenology.2009.04.014; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Karabinova P, 2011, CELL TISSUE RES, V346, P1, DOI 10.1007/s00441-011-1235-1; Kepkova KV, 2011, THERIOGENOLOGY, V75, P1582, DOI 10.1016/j.theriogenology.2010.12.019; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Lee YL, 2003, BIOL REPROD, V68, P375, DOI 10.1095/biolreprod.102.007336; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Mandel SA, 2012, NEURODEGENER DIS, V10, P220, DOI 10.1159/000333223; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; Moore R, 2004, GENESIS, V38, P1, DOI 10.1002/gene.10243; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Mtango NR, 2007, PHYSIOL GENOMICS, V31, P1, DOI 10.1152/physiolgenomics.00040.2007; Muzzopappa M, 2005, DEVELOPMENT, V132, P2561, DOI 10.1242/dev.01839; Ohlmeyer JT, 2003, DEVELOPMENT, V130, P6339, DOI 10.1242/dev.00855; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Ohta T, 1999, ONCOGENE, V18, P6758, DOI 10.1038/sj.onc.1203115; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; PAVLOK A, 1992, MOL REPROD DEV, V31, P63, DOI 10.1002/mrd.1080310111; Pennetier S, 2005, BIOL REPROD, V73, P713, DOI 10.1095/biolreprod.105.041574; Piva R, 2002, MOL CELL BIOL, V22, P8375, DOI 10.1128/MCB.22.23.8375-8387.2002; Rhodes SL, 2013, ENVIRON RES, V126, P1, DOI 10.1016/j.envres.2013.08.001; Roovers EF, 2015, CELL REP, V10, P2069, DOI 10.1016/j.celrep.2015.02.062; Salilew-Wondim D, 2010, REPROD FERT DEVELOP, V22, P564, DOI 10.1071/RD09112; Sasagawa Y, 2003, GENES CELLS, V8, P857, DOI 10.1046/j.1365-2443.2003.00682.x; Shcherbata HR, 2004, DEVELOPMENT, V131, P3169, DOI 10.1242/dev.01172; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sutovsky P, 2001, Cloning Stem Cells, V3, P157, DOI 10.1089/153623001753205115; Suzumori N, 2003, P NATL ACAD SCI USA, V100, P550, DOI 10.1073/pnas.0234474100; Svarcova O, 2007, MOL REPROD DEV, V74, P1428, DOI 10.1002/mrd.20727; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Toralova T, 2012, REPRODUCTION, V144, P349, DOI 10.1530/REP-12-0033; Toralova T, 2009, REPRODUCTION, V138, P783, DOI 10.1530/REP-09-0234; Verlhac MH, 2010, CURR OPIN CELL BIOL, V22, P758, DOI 10.1016/j.ceb.2010.09.003; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; YOKOI H, 1993, BIOCHEM BIOPH RES CO, V195, P769, DOI 10.1006/bbrc.1993.2112; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhang Q, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.1; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057382, 10.1371/journal.pone.0073724]	60	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147096	10.1371/journal.pone.0147096	http://dx.doi.org/10.1371/journal.pone.0147096			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824694	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600014
J	Cullen, B; Brennan, D; Manly, T; Evans, JJ				Cullen, Breda; Brennan, David; Manly, Tom; Evans, Jonathan J.			Towards Validation of a New Computerised Test of Goal Neglect: Preliminary Evidence from Clinical and Neuroimaging Pilot Studies	PLOS ONE			English	Article							ROSTRAL PREFRONTAL CORTEX; PROSPECTIVE MEMORY; BRAIN-INJURY; COGNITIVE REHABILITATION; HUMAN MULTITASKING; FRONTAL-LOBE; AREA 10; BEHAVIOR; QUESTIONNAIRE; ORGANIZATION	Objective Goal neglect is a significant problem following brain injury, and is a target for rehabilitation. It is not yet known how neural activation might change to reflect rehabilitation gains. We developed a computerised multiple elements test (CMET), suitable for use in neuroimaging paradigms. Design Pilot correlational study and event-related fMRI study. Methods In Study 1, 18 adults with acquired brain injury were assessed using the CMET, other tests of goal neglect (Hotel Test; Modified Six Elements Test) and tests of reasoning. In Study 2, 12 healthy adults underwent fMRI, during which the CMET was administered under two conditions: self-generated switching and experimenter-prompted switching. Results Among the clinical sample, CMET performance was positively correlated with both the Hotel Test (r = 0.675, p = 0.003) and the Modified Six Elements Test (r = 0.568, p = 0.014), but not with other clinical or demographic measures. In the healthy sample, fMRI demonstrated significant activation in rostro-lateral prefrontal cortex in the self-generated condition compared with the prompted condition (peak 40, 44, 4; Z(E) = 4.25, p((FWEcorr)) = 0.026). Conclusions These pilot studies provide preliminary evidence towards the validation of the CMET as a measure of goal neglect. Future studies will aim to further establish its psychometric properties, and determine optimum pre- and post-rehabilitation fMRI paradigms.	[Cullen, Breda; Evans, Jonathan J.] Univ Glasgow, Inst Hlth & Wellbeing, Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Brennan, David] Queen Elizabeth Univ Hosp, Inst Neurol Sci, Dept Clin Phys, Glasgow, Lanark, Scotland; [Manly, Tom] MRC, Cognit & Brain Sci Unit, Cambridge, England	University of Glasgow; Queen Elizabeth University Hospital (QEUH); University of Glasgow	Cullen, B (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland.	Breda.Cullen@glasgow.ac.uk	Cullen, Breda/C-9154-2012; Cullen, Breda/N-3449-2019	Cullen, Breda/0000-0002-7259-9505; Cullen, Breda/0000-0002-7259-9505	Glasgow Neurosciences Foundation [2006/06]; West of Scotland RD Consortium [04CP17]; Dr Mortimer and Theresa Sackler Foundation; MRC [MC_U105559837] Funding Source: UKRI; Medical Research Council [MC_U105559837] Funding Source: researchfish	Glasgow Neurosciences Foundation; West of Scotland RD Consortium; Dr Mortimer and Theresa Sackler Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Glasgow Neurosciences Foundation (reference 2006/06) (BC, DB, JJE) and the West of Scotland R&D Consortium (reference 04CP17) (JJE). BC is supported by funding awarded to JJE by The Dr Mortimer and Theresa Sackler Foundation. The funders played no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit RG, 2012, CEREB CORTEX, V22, P1876, DOI 10.1093/cercor/bhr264; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Filippi M, 2012, RADIOLOGY, V262, P932, DOI 10.1148/radiol.11111299; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Hillary FG, 2002, J HEAD TRAUMA REHAB, V17, P411, DOI 10.1097/00001199-200210000-00004; Hynes SM., 2015, INT J DEV SCI, V9, P85, DOI [10.3233/DEV-140157, DOI 10.3233/DEV-140157]; Jansari A, 2004, BRAIN IMPAIR, V5, P110; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Munoz-Cespedes JM, 2005, NEUROPSYCHOL REV, V15, P169, DOI 10.1007/s11065-005-9178-5; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Roca M, 2011, NEUROPSYCHOLOGIA, V49, P3525, DOI 10.1016/j.neuropsychologia.2011.09.003; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Wechsler D, 1999, WECHSLER ADULT INTEL; Wechsler D., 2001, WECHSLER TEST ADULT; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148127	10.1371/journal.pone.0148127	http://dx.doi.org/10.1371/journal.pone.0148127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824704	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000369528600102
J	Stathopoulou, K; Wittig, I; Heidler, J; Piasecki, A; Richter, F; Diering, S; van der Velden, J; Buck, F; Donzelli, S; Schroder, E; Wijnker, PJM; Voigt, N; Dobrev, D; Sadayappan, S; Eschenhagen, T; Carrier, L; Eaton, P; Cuello, F				Stathopoulou, Konstantina; Wittig, Ilka; Heidler, Juliana; Piasecki, Angelika; Richter, Florian; Diering, Simon; van der Velden, Jolanda; Buck, Friedrich; Donzelli, Sonia; Schroder, Ewald; Wijnker, Paul J. M.; Voigt, Niels; Dobrev, Dobromir; Sadayappan, Sakthivel; Eschenhagen, Thomas; Carrier, Lucie; Eaton, Philip; Cuello, Friederike			S-glutathiolation impairs phosphoregulation and function of cardiac myosin-binding protein C in human heart failure	FASEB JOURNAL			English	Article						redox proteomics; post-translational modifications; cross-bridge cycling; contractile function; cardiac disease	HYPERTROPHIC CARDIOMYOPATHY; MICROSCALE THERMOPHORESIS; SARCOMERIC PROTEINS; OXIDATIVE STRESS; ACTIVATES SERCA; TROPONIN-I; KINASE-A; CMYBP-C; MYBP-C; PHOSPHORYLATION	Cardiac myosin-binding protein C (cMyBPC) regulates actin-myosin interaction and thereby cardiac myocyte contraction and relaxation. This physiologic function is regulated by cMyBP-C phosphorylation. In our study, reduced site-specific cMyBP-C phosphorylation coincided with increased S-glutathiolation in ventricular tissue from patients with dilated or ischemic cardiomyopathy compared to nonfailing donors. We used redox proteomics, to identify constitutive and disease-specific S-glutathiolation sites in cMyBP-C in donor and patient samples, respectively. Among those, a cysteine cluster in the vicinity of the regulatory phosphorylation sites within the myosin S2 interaction domain C1-M-C2 was identified and showed enhanced S-glutathiolation in patients. In vitro S-glutathiolation of recombinant cMyBP-C C1-M-C2 occurred predominantly at Cys(249), which attenuated phosphorylation by protein kinases. Exposure to glutathione disulfide induced cMyBP-C S-glutathiolation, which functionally decelerated the kinetics of Ca2+-activated force development in ventricular myocytes from wild-type, but not those from Mybpc3-targeted knockout mice. These oxidation events abrogate protein kinase-mediated phosphorylation of cMyBP-C and therefore potentially contribute to the reduction of its phosphorylation and the contractile dysfunction observed in human heart failure.	[Stathopoulou, Konstantina; Piasecki, Angelika; Richter, Florian; Diering, Simon; Donzelli, Sonia; Wijnker, Paul J. M.; Eschenhagen, Thomas; Carrier, Lucie; Cuello, Friederike] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Cardiovasc Res Ctr, D-20246 Hamburg, Germany; [Buck, Friedrich] Univ Med Ctr Hamburg Eppendorf, Cent Labs, Dept Clin Chem, D-20246 Hamburg, Germany; [Stathopoulou, Konstantina; Piasecki, Angelika; Diering, Simon; Donzelli, Sonia; Wijnker, Paul J. M.; Eschenhagen, Thomas; Carrier, Lucie; Cuello, Friederike] Partner Site Hamburg Kiel Lubeck, German Ctr Cardiovasc Res DZHK, Frankfurt, Germany; [Wittig, Ilka; Heidler, Juliana; Richter, Florian] Partner Site Rhein Main, Frankfurt, Germany; [Wittig, Ilka; Heidler, Juliana; Richter, Florian] Goethe Univ Frankfurt, Fac Med, Funct Prote, SFB Core Unit 815, D-60054 Frankfurt, Germany; [Wittig, Ilka; Heidler, Juliana; Richter, Florian] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60054 Frankfurt, Germany; [van der Velden, Jolanda; Wijnker, Paul J. M.] VU Univ Med Ctr Amsterdam, Inst Cardiovasc Res ICaR VU, Dept Physiol, Amsterdam, Netherlands; [van der Velden, Jolanda] ICIN, Utrecht, Netherlands; [Schroder, Ewald; Eaton, Philip] Kings Coll London, Kings British Heart Fdn Ctr, London WC2R 2LS, England; [Voigt, Niels; Dobrev, Dobromir] Univ Duisburg Essen, Inst Pharmacol, Fac Med, Essen, Germany; [Sadayappan, Sakthivel] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; Goethe University Frankfurt; Goethe University Frankfurt; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of London; King's College London; University of Duisburg Essen; Loyola University Chicago	Cuello, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Martinistr 52, D-20246 Hamburg, Germany.	f.cuello@uke.de	Dobrev, Prof. Dr. med. Dr. h.c. Dobromir/AAS-1666-2020; Stathopoulou, Konstantina/H-5684-2019; Voigt, Niels/AAS-1038-2020; Eaton, Philip/I-5444-2015	Dobrev, Prof. Dr. med. Dr. h.c. Dobromir/0000-0002-4612-117X; Stathopoulou, Konstantina/0000-0002-3746-3055; Voigt, Niels/0000-0001-8230-2341; van der Velden, Jolanda/0000-0001-5224-5788; Eaton, Philip/0000-0003-0748-2367; Sadayappan, Sakthivel/0000-0003-2006-7678	German Center for Cardiovascular Research (DZHK); German Ministry of Research and Education (BMBF); Deutsche Forschungsgemeinschaft (DFG) [CU 53/2-1]; Faculty of Medicine-University medical Center Hamburg-Eppendorf; Werner Otto Foundation; DFG [SFB815]; U.S. National Institutes of Health, National Heart, Lung and Blood Institute [R01HL105826, K02HL114749]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL114749, R01HL105826] Funding Source: NIH RePORTER; MRC [G0700320, MR/K003232/1, MR/L009684/1, G1000458, G0600785] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C503646/1] Funding Source: researchfish; British Heart Foundation [PG/10/98/28655, RG/12/12/29872, PG/15/26/31373, PG/13/13/30018, FS/11/45/28859] Funding Source: researchfish; Medical Research Council [MR/K003232/1, G0700320, 998501, MR/L009684/1, G0600785, G1000458] Funding Source: researchfish	German Center for Cardiovascular Research (DZHK); German Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Faculty of Medicine-University medical Center Hamburg-Eppendorf; Werner Otto Foundation; DFG(German Research Foundation (DFG)); U.S. National Institutes of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Prof. Dieter Braun and Susanne Seidel (Department of Systems Biophysics Ludwig Maximilian University of Munich, Munich, Germany) for introducing them to MST technology. The authors also thank Jana Meisterknecht (Goethe University, Frankfurt am Main, Germany) for excellent technical assistance with redox proteomics. F.C., K.S., Si. D., A.P., So. D., L.C., T.E. are supported by the German Center for Cardiovascular Research (DZHK) and the German Ministry of Research and Education (BMBF). This study was supported by Deutsche Forschungsgemeinschaft (DFG) Grant CU 53/2-1, the Faculty of Medicine-University medical Center Hamburg-Eppendorf, and the Werner Otto Foundation. I.W. was supported by DFG Grant SFB815, project Z01. S.S. was supported by U.S. National Institutes of Health, National Heart, Lung and Blood Institute Grants R01HL105826 and K02HL114749). The authors declare no conflicts of interest.	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Bardswell SC, 2012, J MUSCLE RES CELL M, V33, P53, DOI 10.1007/s10974-011-9276-3; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Brennan JP, 2006, MOL CELL PROTEOMICS, V5, P215, DOI 10.1074/mcp.M500212-MCP200; BRISTOW M R, 1988, European Heart Journal, V9, P35; Burgoyne JR, 2013, J PHARMACOL TOX MET, V68, P297, DOI 10.1016/j.vascn.2013.07.001; Carrier L, 2004, CARDIOVASC RES, V63, P293, DOI 10.1016/j.cardiores.2004.04.009; Carrier L, 2015, GENE, V573, P188, DOI 10.1016/j.gene.2015.09.008; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Cuello F, 2011, J BIOL CHEM, V286, P5300, DOI 10.1074/jbc.M110.202713; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; Ertl G, 2014, EUR HEART J, V35, P470, DOI 10.1093/eurheartj/eht555; Flenner F, 2016, CARDIOVASC RES, V109, P90, DOI 10.1093/cvr/cvv247; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Hafstad AD, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0359-8; Hamdani N, 2010, J MUSCLE RES CELL M, V31, P289, DOI 10.1007/s10974-010-9231-8; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Janssen-Heininger YMW, 2013, J CELL BIOCHEM, V114, P1962, DOI 10.1002/jcb.24551; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Kuster DWD, 2013, CIRC RES, V112, P633, DOI 10.1161/CIRCRESAHA.112.275602; Kuster DWD, 2012, J MUSCLE RES CELL M, V33, P43, DOI 10.1007/s10974-011-9280-7; Lancel S, 2009, CIRC RES, V104, P720, DOI 10.1161/CIRCRESAHA.108.188441; Lecarpentier Y, 2008, BIOPHYS J, V95, P720, DOI 10.1529/biophysj.107.127787; Lovelock JD, 2012, CIRC RES, V110, P841, DOI 10.1161/CIRCRESAHA.111.258251; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; Neuman RB, 2007, CLIN CHEM, V53, P1652, DOI 10.1373/clinchem.2006.083923; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Passarelli C, 2010, CYTOSKELETON, V67, P81, DOI 10.1002/cm.20425; Patel BG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00336; Pfuhl M, 2012, J MUSCLE RES CELL M, V33, P83, DOI 10.1007/s10974-012-9291-z; Pohlmann L, 2007, CIRC RES, V101, P928, DOI 10.1161/CIRCRESAHA.107.158774; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Shimano M, 2009, HEART RHYTHM, V6, P935, DOI 10.1016/j.hrthm.2009.03.012; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Steinberg SF, 2013, CIRC RES, V112, P393, DOI 10.1161/CIRCRESAHA.111.300496; Stelzer JE, 2006, CIRC RES, V98, P1212, DOI 10.1161/01.RES.0000219863.94390.ce; Stelzer JE, 2006, BIOPHYS J, V90, P4119, DOI 10.1529/biophysj.105.078147; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5; van Dijk SJ, 2012, CIRC-HEART FAIL, V5, P36, DOI 10.1161/CIRCHEARTFAILURE.111.963702; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wittkopper K, 2011, CARDIOVASC RES, V91, P392, DOI 10.1093/cvr/cvr058; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Zaremba R, 2007, PROTEOM CLIN APPL, V1, P1285, DOI 10.1002/prca.200600891	53	21	22	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1849	1864		10.1096/fj.201500048	http://dx.doi.org/10.1096/fj.201500048			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26839380	Green Published			2022-12-26	WOS:000374879400015
J	Copps, KD; Hancer, NJ; Qiu, W; White, MF				Copps, Kyle D.; Hancer, Nancy J.; Qiu, Wei; White, Morris F.			Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin receptor substrate 1 (IRS-1); insulin resistance; mammalian target of rapamycin (mTOR); S6 kinase; tuberous sclerosis complex (TSC); amino acids; gene knock-in; insulin signaling; serine; threonine phosphorylation	SKELETAL-MUSCLE CELLS; SERINE/THREONINE PHOSPHORYLATION; MAMMALIAN TARGET; TYROSINE PHOSPHORYLATION; METABOLIC-REGULATION; TUBEROUS SCLEROSIS; AMINO-ACID; RESISTANCE; DEGRADATION; PATHWAY	Constitutive activation of the mammalian target of rapamycin complex 1 and S6 kinase (mTORC1 S6K) attenuates insulin-stimulated Akt activity in certain tumors in part through feedback phosphorylation of the upstream insulin receptor substrate 1 (IRS1). However, the significance of this mechanism for regulating insulin sensitivity in normal tissue remains unclear. We investigated the function of Ser-302 in mouse IRS1, the major site of its phosphorylation by S6K in vitro, through genetic knock-in of a serine-to-alanine mutation (A302). Although insulin rapidly stimulated feedback phosphorylation of Ser-302 in mouse liver and muscle, homozygous A302 mice (A/A) and their knock-in controls (S/S) exhibited similar glucose homeostasis and muscle insulin signaling. Furthermore, both A302 and control primary hepatocytes from which Irs2 was deleted showed marked inhibition of insulin-stimulated IRS1 tyrosine phosphorylation and PI3K binding after emetine treatment to raise intracellular amino acids and activate mTORC1 S6K signaling. To specifically activate mTORC1 in mouse tissue, we deleted hepatic Tsc1 using Cre adenovirus. Although it moderately decreased IRS1/PI3K association and Akt phosphorylation in liver, Tsc1 deletion failed to cause glucose intolerance or promote hyperinsulinemia in mixed background A/A or S/S mice. Moreover, Tsc1 deletion failed to stimulate phospho-Ser-302 or other putative S6K sites within IRS1, whereas ribosomal S6 protein was constitutively phosphorylated. Following acute Tsc1 deletion from hepatocytes, Akt phosphorylation, but not IRS1/PI3K association, was rapidly restored by treatment with the mTORC1 inhibitor rapamycin. Thus, within the hepatic compartment, mTORC1 S6K signaling regulates Akt largely through IRS-independent means with little effect upon physiologic insulin sensitivity.	[Copps, Kyle D.; Hancer, Nancy J.; Qiu, Wei; White, Morris F.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Med,Div Endocrinol, Rm 16020,3 Blackfan Circle, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	White, MF (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Ctr Life Sci,Dept Med,Div Endocrinol, Rm 16020,3 Blackfan Circle, Boston, MA 02115 USA.	morris.white@childrens.harvard.edu			National Institutes of Health [DK38712, DK55326, DK098655, GM021700]; Juvenile Diabetes Foundation International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038712, R29DK038712, R55DK038712, R01DK098655, R01DK055326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Foundation International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK38712, DK55326, DK098655, and GM021700 (to M. F. W.) with further support by an award from the Juvenile Diabetes Foundation International (to M. F. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bergsten P, 2002, DIABETES, V51, P699, DOI 10.2337/diabetes.51.3.699; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Danielsson A, 2006, BIOCHEM BIOPH RES CO, V342, P1183, DOI 10.1016/j.bbrc.2006.02.075; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; HELLERHARRISON RA, 1995, J BIOL CHEM, V270, P24442, DOI 10.1074/jbc.270.41.24442; Herrema H, 2014, BIOCHEM BIOPH RES CO, V443, P689, DOI 10.1016/j.bbrc.2013.12.023; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Pollizzi K, 2009, HUM MOL GENET, V18, P2378, DOI 10.1093/hmg/ddp176; Rajan MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059725; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schlottmann SA, 2006, J IMMUNOL METHODS, V309, P75, DOI 10.1016/j.jim.2005.11.019; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Sopasakis VR, 2010, CELL METAB, V11, P220, DOI 10.1016/j.cmet.2010.02.002; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; White MF, 2010, ENDOCRINOLOGY, P636; Wick KR, 2003, J BIOL CHEM, V278, P8460, DOI 10.1074/jbc.M208518200; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	46	21	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8602	8617		10.1074/jbc.M116.714915	http://dx.doi.org/10.1074/jbc.M116.714915			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26846849	Green Published, hybrid			2022-12-26	WOS:000374773200024
J	Siu, KL; Gao, L; Cai, H				Siu, Kin Lung; Gao, Ling; Cai, Hua			Differential Roles of Protein Complexes NOX1-NOXO1 and NOX2-p47phox in Mediating Endothelial Redox Responses to Oscillatory and Unidirectional Laminar Shear Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NADPH oxidase; nitric oxide; nitric oxide synthase; oxidative stress; shear stress; signal transduction	NITRIC-OXIDE SYNTHASE; NADPH OXIDASE; HYDROGEN-PEROXIDE; UP-REGULATION; SUPEROXIDE-PRODUCTION; DIABETES-MELLITUS; MONOCYTE ADHESION; NAD(P)H OXIDASES; CHRONIC EXERCISE; ANGIOTENSIN-II	The endothelium is exposed to various flow patterns such as vasoprotective unidirectional laminar shear stress (LSS) and atherogenic oscillatory shear stress (OSS). A software-controlled, valve-operated OsciFlow device with parallel chambers was used to apply LSS and OSS to endothelial cells. Although LSS inhibited superoxide over time, OSS time-dependently increased superoxide production from endothelial cells. Immunocytochemical staining revealed that, at resting state, p47phox colocalizes with NOX2, whereas NOXO1 colocalizes with NOX1. RNAi of p47phox had no effects on superoxide or NO production in response to OSS but significantly reduced NO production in LSS, implicating a p47phox-bound NADPH oxidase (NOX) in mediating basal NO production. Indeed, RNAi of p47phox inhibited endothelial nitric oxide synthase (eNOS) serine 1179 phosphorylation, whereas PEG-catalase scavenging of intracellular hydrogen peroxide or RNAi of NOX2 produced similar results, indicating a role of NOX2/p47phox-derived hydrogen peroxide in mediating the basal activity of NO production from eNOS. In contrast, RNAi of NOXO1 resulted in no significant changes in NO and superoxide levels in response to LSS but significantly reduced superoxide while increasing NO in response to OSS. Furthermore, we identified, for the first time, that OSS uncouples eNOS, which was corrected by RNAi of NOXO1. In summary, LSS activates the NOX2-p47phox complex to activate eNOS phosphorylation and NO production. OSS instead activates the NOX1-NOXO1 complex to uncouple eNOS. These results demonstrate differential roles of NOXs in modulating the redox state in response to different shear stresses, which may promote the development of novel therapeutic agents to mimic the protective effects of LSS while inhibiting the injurious effects of OSS.	[Cai, Hua] Univ Calif Los Angeles, Div Mol Med, Dept Anesthesiol, Cardiovasc Res Labs,David Geffen Sch Med, 650 Charles E Young Dr, Los Angeles, CA 90095 USA; [Cai, Hua] Univ Calif Los Angeles, Div Cardiol, Dept Med, Cardiovasc Res Labs,David Geffen Sch Med, 650 Charles E Young Dr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cai, H (corresponding author), Univ Calif Los Angeles, Div Mol Med, Dept Anesthesiol, Cardiovasc Res Labs,David Geffen Sch Med, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.; Cai, H (corresponding author), Univ Calif Los Angeles, Div Cardiol, Dept Med, Cardiovasc Res Labs,David Geffen Sch Med, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.	hcai@mednet.ucla.edu			NHLBI/National Institutes of Health [HL077440, HL088975, HL108701, HL119968]; American Heart Association Established Investigator Award [12EIA8990025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077440, R01HL119968, R01HL108701, R01HL088975] Funding Source: NIH RePORTER	NHLBI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Established Investigator Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NHLBI/National Institutes of Health Grants HL077440 (to H. C.), HL088975 (to H. C.), HL108701 (to H. C. and D. G. H.), and HL119968 (to H. C.) and American Heart Association Established Investigator Award 12EIA8990025 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; BERLINER JA, 1990, J CLIN INVEST, V85, P1260, DOI 10.1172/JCI114562; Cai H, 2004, J MOL CELL CARDIOL, V37, P121, DOI 10.1016/j.yjmcc.2004.04.012; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Cai H, 2001, ARTERIOSCL THROM VAS, V21, P1571, DOI 10.1161/hq1001.097028; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775; Davis ME, 2003, AM J PHYSIOL-HEART C, V284, pH1449, DOI 10.1152/ajpheart.00918.2002; Davis ME, 2001, CIRC RES, V89, P1073, DOI 10.1161/hh2301.100806; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Dikalova AE, 2010, AM J PHYSIOL-HEART C, V299, pH673, DOI 10.1152/ajpheart.00242.2010; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Drummond GR, 2000, CIRC RES, V86, P347, DOI 10.1161/01.RES.86.3.347; Duerrschmidt N, 2006, J PHYSIOL-LONDON, V576, P557, DOI 10.1113/jphysiol.2006.111070; Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551; Gao L, 2009, J MOL CELL CARDIOL, V47, P752, DOI 10.1016/j.yjmcc.2009.07.025; Goettsch C, 2011, BASIC RES CARDIOL, V106, P551, DOI 10.1007/s00395-011-0170-3; Gray SP, 2013, CIRCULATION, V127, P1888, DOI 10.1161/CIRCULATIONAHA.112.132159; Harrison DG, 2003, J RENIN-ANGIO-ALDO S, V4, P51, DOI 10.3317/jraas.2003.014; Heitzer T, 2000, DIABETOLOGIA, V43, P1435, DOI 10.1007/s001250051551; Higashi Y, 2002, AM J HYPERTENS, V15, P326, DOI 10.1016/S0895-7061(01)02317-2; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hsiai TK, 2007, FREE RADICAL BIO MED, V42, P519, DOI 10.1016/j.freeradbiomed.2006.11.017; Hwang J, 2003, J BIOL CHEM, V278, P47291, DOI 10.1074/jbc.M305150200; Hwang J, 2003, CIRC RES, V93, P1225, DOI 10.1161/01.RES.0000104087.29395.66; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Kirk EA, 2000, ARTERIOSCL THROM VAS, V20, P1529, DOI 10.1161/01.ATV.20.6.1529; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Laude K, 2005, AM J PHYSIOL-HEART C, V288, pH7, DOI 10.1152/ajpheart.00637.2004; Lauer N, 2005, CARDIOVASC RES, V65, P254, DOI 10.1016/j.cardiores.2004.09.010; Laursen JB, 2001, CIRCULATION, V103, P1282; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Lehoux S, 2006, CARDIOVASC RES, V71, P269, DOI 10.1016/j.cardiores.2006.05.008; Li HG, 2006, J AM COLL CARDIOL, V47, P2536, DOI 10.1016/j.jacc.2006.01.071; Lu X, 2004, J PHYSIOL-LONDON, V561, P575, DOI 10.1113/jphysiol.2004.075218; Montezano AC, 2014, ANTIOXID REDOX SIGN, V20, P164, DOI 10.1089/ars.2013.5302; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Peshavariya H, 2009, N-S ARCH PHARMACOL, V380, P193, DOI 10.1007/s00210-009-0413-0; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; SESSA WC, 1994, CIRC RES, V74, P349, DOI 10.1161/01.RES.74.2.349; Sheehan AL, 2011, ATHEROSCLEROSIS, V216, P321, DOI 10.1016/j.atherosclerosis.2011.02.028; Siu KL, 2015, J MOL CELL CARDIOL, V78, P174, DOI 10.1016/j.yjmcc.2014.07.005; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Stroes E, 1997, J CLIN INVEST, V99, P41, DOI 10.1172/JCI119131; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; WANG J, 1993, CIRC RES, V73, P829, DOI 10.1161/01.RES.73.5.829; White SJ, 2011, J CELL PHYSIOL, V226, P2841, DOI 10.1002/jcp.22629; Woodman CR, 1997, AM J PHYSIOL-HEART C, V273, pH2575, DOI 10.1152/ajpheart.1997.273.6.H2575; Youn JY, 2012, DIABETOLOGIA, V55, P2069, DOI 10.1007/s00125-012-2557-6	56	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8653	8662		10.1074/jbc.M115.713149	http://dx.doi.org/10.1074/jbc.M115.713149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26826128	Green Published, hybrid			2022-12-26	WOS:000374773200028
J	Fujimoto, N; Kan-o, M; Ushijima, T; Kage, Y; Tominaga, R; Sumimoto, H; Takeya, R				Fujimoto, Noriko; Kan-o, Meikun; Ushijima, Tomoki; Kage, Yohko; Tominaga, Ryuji; Sumimoto, Hideki; Takeya, Ryu			Transgenic Expression of the Formin Protein Fhod3 Selectively in the Embryonic Heart: Role of Actin-Binding Activity of Fhod3 and Its Sarcomeric Localization during Myofibrillogenesis	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; MAMMALIAN FORMIN; MUSCLE; PHOSPHORYLATION; MECHANISM; FILAMENTS; SKELETAL; COMPLEX	Fhod3 is a cardiac member of the formin family proteins that play pivotal roles in actin filament assembly in various cellular contexts. The targeted deletion of mouse Fhod3 gene leads to defects in cardiogenesis, particularly during myofibrillogenesis, followed by lethality at embryonic day (E) 11.5. However, it remains largely unknown how Fhod3 functions during myofibrillogenesis. In this study, to assess the mechanism whereby Fhod3 regulates myofibrillogenesis during embryonic cardiogenesis, we generated transgenic mice expressing Fhod3 selectively in embryonic cardiomyocytes under the control of the beta-myosin heavy chain (MHC) promoter. Mice expressing wild-type Fhod3 in embryonic cardiomyocytes survive to adulthood and are fertile, whereas those expressing Fhod3 (I1127A) defective in binding to actin die by E11.5 with cardiac defects. This cardiac phenotype of the Fhod3 mutant embryos is almost identical to that observed in Fhod3 null embryos, suggesting that the actin-binding activity of Fhod3 is crucial for embryonic cardiogenesis. On the other hand, the beta-MHC promoter-driven expression of wild-type Fhod3 sufficiently rescues cardiac defects of Fhod3-null embryos, indicating that the Fhod3 protein expressed in a transgenic manner can function properly to achieve myofibril maturation in embryonic cardiomyocytes. Using the transgenic mice, we further examined detailed localization of Fhod3 during myofibrillogenesis in situ and found that Fhod3 localizes to the specific central region of nascent sarcomeres prior to massive rearrangement of actin filaments and remains there throughout myofibrillogenesis. Taken together, the present findings suggest that, during embryonic cardiogenesis, Fhod3 functions as the essential reorganizer of actin filaments at the central region of maturating sarcomeres via the actin-binding activity of the FH2 domain.	[Fujimoto, Noriko; Kan-o, Meikun; Ushijima, Tomoki; Kage, Yohko; Sumimoto, Hideki; Takeya, Ryu] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Fujimoto, Noriko; Ushijima, Tomoki; Kage, Yohko; Takeya, Ryu] Miyazaki Univ, Fac Med, Dept Pharmacol, Kiyotake, Miyazaki 8891692, Japan; [Kan-o, Meikun; Tominaga, Ryuji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Surg, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University; University of Miyazaki; Kyushu University	Takeya, R (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takeya@med.miyazaki-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23590337, 26460371]; Japan Society for the Promotion of Science (JSPS) SHINGAKUJUTSU [25117515]; Takeda Science Foundation; Institute of Seizon and Life Sciences; Grants-in-Aid for Scientific Research [25117515] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (JSPS) SHINGAKUJUTSU(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Institute of Seizon and Life Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI grant number 23590337 and 26460371, SHINGAKUJUTSU grant number 25117515, grants from the Takeda Science Foundation and the Institute of Seizon and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; GROVE BK, 1984, J CELL BIOL, V98, P518, DOI 10.1083/jcb.98.2.518; HANDEL SE, 1991, CELL TISSUE RES, V263, P419, DOI 10.1007/BF00327276; Iskratsch T, 2013, CELL MOL LIFE SCI, V70, P893, DOI 10.1007/s00018-012-1154-7; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Kan-o M, 2012, BIOL OPEN, V1, P889, DOI 10.1242/bio.20121370; Kan-o M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034765; Kanaya H, 2005, GENES CELLS, V10, P665, DOI 10.1111/j.1365-2443.2005.00867.x; Kutscheidt S, 2014, NAT CELL BIOL, V16, P708, DOI 10.1038/ncb2981; Liu R, 2010, BBA-MOL CELL RES, V1803, P207, DOI 10.1016/j.bbamcr.2008.09.016; Lopez JE, 2011, CIRC RES, V109, P629, DOI 10.1161/CIRCRESAHA.111.243410; McKeown CR, 2014, DEV DYNAM, V243, P800, DOI 10.1002/dvdy.24115; Molnar I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004166; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; Ono S, 2010, CYTOSKELETON, V67, P677, DOI 10.1002/cm.20476; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Randall TS, 2014, EUR J CELL BIOL, V93, P205, DOI 10.1016/j.ejcb.2013.11.004; RINDT H, 1993, J BIOL CHEM, V268, P5332; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Sparrow JC, 2009, NAT REV MOL CELL BIO, V10, P293, DOI 10.1038/nrm2634; Takeya R, 2003, J CELL SCI, V116, P4567, DOI 10.1242/jcs.00769; Taniguchi K, 2009, J BIOL CHEM, V284, P29873, DOI 10.1074/jbc.M109.059303; Zhukarev V, 1997, CELL MOTIL CYTOSKEL, V37, P363	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148472	10.1371/journal.pone.0148472	http://dx.doi.org/10.1371/journal.pone.0148472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848968	Green Submitted, gold, Green Published			2022-12-26	WOS:000369554000101
J	Solis, J; Baisakh, N; Brandt, SR; Villordon, A; La Bonte, D				Solis, Julio; Baisakh, Niranjan; Brandt, Steven R.; Villordon, Arthur; La Bonte, Don			Transcriptome Profiling of Beach Morning Glory (Ipomoea imperati) under Salinity and Its Comparative Analysis with Sweetpotato	PLOS ONE			English	Article							VACUOLAR H+-PYROPHOSPHATASE; OVERLY SENSITIVE PATHWAY; ENHANCES SALT TOLERANCE; STRESS TOLERANCE; NA+/H+ ANTIPORTER; FACTOR GENE; ROOT TRANSCRIPTOME; PROTEIN-KINASES; TOBACCO CELLS; UP-REGULATION	The response and adaption to salt remains poorly understood for beach morning glory [Ipomoea imperati (Vahl) Griseb], one of a few relatives of sweetpotato, known to thrive under salty and extreme drought conditions. In order to understand the genetic mechanisms underlying salt tolerance of a Convolvulaceae member, a genome-wide transcriptome study was carried out in beach morning glory by 454 pyrosequencing. A total of 286,584 filtered reads from both salt stressed and unstressed (control) root and shoot tissues were assembled into 95,790 unigenes with an average length of 667 base pairs (bp) and N50 of 706 bp. Putative differentially expressed genes (DEGs) were identified as transcripts over-represented under salt stressed tissues compared to the control, and were placed into metabolic pathways. Most of these DEGs were involved in stress response, membrane transport, signal transduction, transcription activity and other cellular and molecular processes. We further analyzed the gene expression of 14 candidate genes of interest for salt tolerance through quantitative reverse transcription PCR (qRT-PCR) and confirmed their differential expression under salt stress in both beach morning glory and sweetpotato. The results comparing transcripts of I. imperati against the transcriptome of other Ipomoea species, including sweetpotato are also presented in this study. In addition, 6,233 SSR markers were identified, and an in silico analysis predicted that 434 primer pairs out of 4,897 target an identifiable homologous sequence in other Ipomoea transcriptomes, including sweetpotato. The data generated in this study will help in understanding the basics of salt tolerance of beach morning glory and the SSR resources generated will be useful for comparative genomics studies and further enhance the path to the marker-assisted breeding of sweetpotato for salt tolerance.	[Solis, Julio; Baisakh, Niranjan; La Bonte, Don] Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA; [Brandt, Steven R.] Louisiana State Univ, Louisiana Digital Media Ctr, Baton Rouge, LA 70803 USA; [Villordon, Arthur] Louisiana State Univ, Ctr Agr, Sweet Potato Res Stn, Chase, LA USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	La Bonte, D (corresponding author), Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA.	nbaisakh@agcenter.lsu.edu; dlabonte@agcenter.Isu.edu	Brandt, Steven/GRJ-9979-2022	Brandt, Steven/0000-0002-7979-2906; SOLIS SARMIENTO, JULIO/0000-0001-5183-6332	HATCH grant from the USDA-NIFA	HATCH grant from the USDA-NIFA	The study was supported by a HATCH grant from the USDA-NIFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi FS, 2013, J AGR SCI TECH-IRAN, V15, P369; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bassil E, 2012, J EXP BOT, V63, P5727, DOI 10.1093/jxb/ers250; Batistic O, 2011, SIGNAL COMMUN PLANTS, P235, DOI 10.1007/978-3-642-20829-4_12; BINZEL ML, 1985, PLANT PHYSIOL, V79, P118, DOI 10.1104/pp.79.1.118; Brini F, 2007, J EXP BOT, V58, P301, DOI 10.1093/jxb/erl251; Cervantes-Flores JC, 2011, MOL BREEDING, V28, P201, DOI 10.1007/s11032-010-9474-5; Chakraborty K, 2012, PLANT PHYSIOL BIOCH, V51, P90, DOI 10.1016/j.plaphy.2011.10.001; Chen L, 2013, MOL BIOL REP, V40, P4759, DOI 10.1007/s11033-013-2572-9; Chen SF, 2011, MAR GENOM, V4, P129, DOI 10.1016/j.margen.2011.03.005; Chen TT, 2012, PLANT CELL REP, V31, P1737, DOI 10.1007/s00299-012-1287-z; Chen XJ, 2014, INT J MOL SCI, V15, P14819, DOI 10.3390/ijms150814819; Childs KL, 2007, NUCLEIC ACIDS RES, P35; Cosentino C, 2010, NEW PHYTOL, V186, P669, DOI 10.1111/j.1469-8137.2010.03208.x; Costa De Oliveira A, 2008, INT J PLANT GENOMICS, V2008; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Dasgupta M, 2008, ORISSA J HORTIC, V35, P27; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Du WM, 2011, PLANT PHYSIOL, V156, P2235, DOI 10.1104/pp.111.173377; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; Fraile-Escanciano A, 2010, NEW PHYTOL, V188, P750, DOI 10.1111/j.1469-8137.2010.03405.x; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Goel D, 2010, PROTOPLASMA, V245, P133, DOI 10.1007/s00709-010-0158-0; Hashimoto K, 2012, J BIOL CHEM, V287, P7956, DOI 10.1074/jbc.M111.279331; Horneck D.A., 2007, 601E PNW OR STAT U, P22; Hu YZ, 2012, PLANT CELL TISS ORG, V108, P63, DOI 10.1007/s11240-011-0013-9; Jarvis DE, 2014, MOL BIOL EVOL, V31, P2094, DOI 10.1093/molbev/msu152; Jha D, 2010, PLANT CELL ENVIRON, V33, P793, DOI 10.1111/j.1365-3040.2009.02105.x; Ji HT, 2013, MOL PLANT, V6, P275, DOI 10.1093/mp/sst017; Kim YH, 2012, J PLANT PHYSIOL, V169, P1112, DOI 10.1016/j.jplph.2012.03.002; Lamesch P, 2012, NUCLEIC ACIDS RES, VD1, P40; LAROSA PC, 1989, PLANT PHYSIOL, V91, P855, DOI 10.1104/pp.91.3.855; Li DF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-517; Li H, 2013, PLANT GROWTH REGUL, V70, P207, DOI 10.1007/s10725-013-9792-9; Lin HX, 2009, PLANT CELL, V21, P1607, DOI 10.1105/tpc.109.066217; Liu DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093935; Liu DG, 2014, PLANT CELL TISS ORG, V117, P1, DOI 10.1007/s11240-013-0415-y; Liu QL, 2013, PLANT PHYSIOL BIOCH, V69, P27, DOI 10.1016/j.plaphy.2013.04.016; Lonard RI, 1999, J COASTAL RES, V15, P645; Maughan PJ, 2009, GENOME, V52, P647, DOI 10.1139/G09-041; Mondini L, 2012, OMICS, V16, P178, DOI 10.1089/omi.2011.0081; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Pasapula V, 2011, PLANT BIOTECHNOL J, V9, P88, DOI 10.1111/j.1467-7652.2010.00535.x; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Rohini G, 2014, DNA RES, V21, P69, DOI 10.1093/dnares/dst042; Roullier C, 2013, PLOS ONE, P8; Roy SJ, 2013, PLANT CELL ENVIRON, V36, P553, DOI 10.1111/j.1365-3040.2012.02595.x; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Schafleitner R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-604; Seo YJ, 2010, MOL CELLS, V30, P271, DOI 10.1007/s10059-010-0114-z; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; SINGH NK, 1987, PLANT PHYSIOL, V85, P529, DOI 10.1104/pp.85.2.529; Solis J, 2014, J AM SOC HORTIC SCI, V139, P317, DOI 10.21273/JASHS.139.3.317; Subramanyam K, 2012, PLANTA, V236, P1909, DOI 10.1007/s00425-012-1733-8; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Trujillo LE, 2008, PLANT CELL PHYSIOL, V49, P512, DOI 10.1093/pcp/pcn025; Tsukagoshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118339; Wang LJ, 2013, J INTEGR AGR, V12, P27, DOI 10.1016/S2095-3119(13)60202-6; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Wu D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-564; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Yao MH, 2012, MOL BIOL REP, V39, P7989, DOI 10.1007/s11033-012-1645-5; Yoshida K, 2005, PLANT CELL PHYSIOL, V46, P407, DOI 10.1093/pcp/pci057; Yu QY, 2014, PLANT CELL REP, V33, P203, DOI 10.1007/s00299-013-1507-1; Yu XX, 2014, J INTEGR AGR, V13, P310, DOI 10.1016/S2095-3119(13)60357-3; Zhang ZJ, 2012, PLANT J, V71, P273, DOI 10.1111/j.1365-313X.2012.04996.x; Zheng Y, 2011, BMC BIOINFORMATICS, P12; Zhou HP, 2014, PLANT CELL, V26, P1166, DOI 10.1105/tpc.113.117069; Zhou SF, 2011, BIOTECHNOL LETT, V33, P375, DOI 10.1007/s10529-010-0418-2	75	13	15	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147398	10.1371/journal.pone.0147398	http://dx.doi.org/10.1371/journal.pone.0147398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848754	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000015
J	Liu, TN; Wang, ZL; Cai, T				Liu, Tiening; Wang, Zhenlin; Cai, Tie			Canopy Apparent Photosynthetic Characteristics and Yield of Two Spike-Type Wheat Cultivars in Response to Row Spacing under High Plant Density	PLOS ONE			English	Article							WINTER-WHEAT; SEEDING-RATE; LIGHT INTERCEPTION; LEAF SENESCENCE; NARROW-ROW; MAIZE; POPULATION; MICROCLIMATE; NITROGEN; FALLOW	In northern China, large-spike wheat (Triticum aestivum L) is considered to have significant potential for increasing yields due to its greater single-plant productivity despite its lower percentage of effective tillers, and increasing the plant density is an effective means of achieving a higher grain yield. However, with increases in plant density, the amount of solar radiation intercepted by lower strata leaves is decreased and the rate of leaf senescence is accelerated. Row spacing can be manipulated to optimize the plant spatial distribution under high plant density, therefore improving light conditions within the canopy. Consequently, field experiments were conducted from 2010 to 2012 to investigate whether changes in row spacing under high plant density led to differences in canopy apparent photosynthesis (CAP), individual leaf photosynthesis and grain yield. Two different spike-type winter wheat cultivars, Jimai22 (a small-spike cultivar as a control cultivar) and Wennong6 (a large-spike cultivar), were grown at a constant plant density of 3,600,000 plants ha(-1) (a relatively higher plant density) over a wide range of row spacing as follows: 5-cm row spacing (R-0), 15-cm row spacing (R-1), 25-cm conventional row spacing (R-2), and 35-cm row spacing (R-3). The two-year investigations revealed that increased row spacing exhibited a significantly higher light transmission ratio (LT), which improved light conditions within the canopy; however, excessive light leakage losses in R-2 and R-3 treatments were not favorable to improved irradiation energy utilization efficiency. Aboveground biomass accumulation was influenced by row spacing. Two spike-type wheat accumulated greater biomass under 15-cm row spacing compared to other row spacing treatments, although a markedly improved photosynthetic rate (P-N), effective quantum yield of photosystem II (Phi(PSII)) and maximal efficiency of photosystem II photochemistry (F-v/F-m) in the penultimate and third leaves were observed in R-2 and R-3 treatments. At the same time, a longer duration of CAP and green leaf area was maintained in R-1 during grain filling. Compared with conventional row spacing, Wennong6 in R-1 treatment obtained 21.0% and 19.1% higher grain yield in 2011 and 2012, respectively, while for Jimai22 it increased by 11.3% and 11.4%, respectively. A close association of yield with CAP and LAI at mid-grain filling was observed. In conclusion, for the tested growing conditions, decreasing the row spacing to an optimal distance (15 cm) maintained a longer duration of LAI and CAP during grain filling, made a better coordination of group and individual leaf photosynthesis, and accumulated higher aboveground biomass, leading to a greater grain yield. In addition, Wennong6 had a more rational canopy architecture than Jimai22 (improved LT and higher LAI) and CAP under 15-cm row spacing, leading to a higher grain yield, which indicated that the large-spike type cultivar has the potential to obtain higher yields by increasing plant density through optimum row spacing allocation (15 cm).	[Liu, Tiening; Cai, Tie] Northwest A&F Univ, Key Lab Crop Physi Ecol & Tillage Sci Northwester, Minist Agr, Coll Agron, Yangling 712100, Shaanxi, Peoples R China; [Liu, Tiening; Cai, Tie] Northwest A&F Univ, Chinese Inst Water Saving Agr, Yangling 712100, Shaanxi, Peoples R China; [Wang, Zhenlin] Shandong Agr Univ, Agron Coll, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China; Shandong Agricultural University	Cai, T (corresponding author), Northwest A&F Univ, Key Lab Crop Physi Ecol & Tillage Sci Northwester, Minist Agr, Coll Agron, Yangling 712100, Shaanxi, Peoples R China.; Cai, T (corresponding author), Northwest A&F Univ, Chinese Inst Water Saving Agr, Yangling 712100, Shaanxi, Peoples R China.	sdauct@126.com		Cai, Tommaso/0000-0002-7234-3526	National Basic Research Program of China (973 Program) [2009CB118602]; Twelfth Five-Year Science and Technology Support Plan of the People's Republic of China [2015BAD22B02]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Twelfth Five-Year Science and Technology Support Plan of the People's Republic of China	This research was supported by the National Basic Research Program of China (973 Program, No. 2009CB118602) and Twelfth Five-Year Science and Technology Support Plan of the People's Republic of China (2015BAD22B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade FH, 2002, CROP SCI, V42, P1173, DOI 10.2135/cropsci2002.1173; Awal MA, 2006, AGR FOREST METEOROL, V139, P74, DOI 10.1016/j.agrformet.2006.06.001; Barbieri PA, 2000, AGRON J, V92, P283, DOI 10.1007/s100870050034; Borras L, 2003, FIELD CROP RES, V82, P13, DOI 10.1016/S0378-4290(03)00002-9; Chen CC, 2008, AGRON J, V100, P1296, DOI 10.2134/agronj2007.0198; Dong S. T., 1993, Biologia Plantarum, V35, P273, DOI 10.1007/BF02925953; EPPLIN FM, 1992, J PROD AGRIC, V5, P427, DOI 10.2134/jpa1992.0427; FREEZE DM, 1990, J PROD AGRIC, V3, P345, DOI 10.2134/jpa1990.0345; Gelang J, 2000, PHYSIOL PLANTARUM, V110, P366, DOI 10.1034/j.1399-3054.2000.1100311.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Guo J., 2005, MAIZE SCI, V13, P55, DOI DOI 10.13597/j.cnki.maize.science.2005.02.019; Guo TC, 2001, ACTA AGRONOMICA SINI, V27, P632; HEICHEL GH, 1970, PLANT PHYSIOL, V46, P359, DOI 10.1104/pp.46.3.359; Hu YJ, 2000, ACTA AGRONOMICA SINI, V26, P905; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Lafond GP, 1996, CAN J PLANT SCI, V76, P791, DOI 10.4141/cjps96-132; Li Na-Na, 2010, Chinese Journal of Plant Ecology, V34, P289, DOI 10.3773/j.issn.1005-264x.2010.03.006; Li NaNa, 2010, Scientia Agricultura Sinica, V43, P2869; Liu TT, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-4; Maddonni G, 2001, FIELD CROP RES, V70, P1, DOI 10.1016/S0378-4290(00)00144-1; Maddonni GA, 2001, FIELD CROP RES, V71, P183, DOI 10.1016/S0378-4290(01)00158-7; Maddonni GA, 2006, AGRON J, V98, P1532, DOI 10.2134/agronj2006.0038; Mattera J, 2013, EUR J AGRON, V45, P87, DOI 10.1016/j.eja.2012.10.008; McLeod JG, 1996, CAN J PLANT SCI, V76, P207, DOI 10.4141/cjps96-039; Porter PM, 1997, J PROD AGRIC, V10, P293, DOI 10.2134/jpa1997.0293; Qiao RQ, 2001, J TRITICEAE CROPS, V21, P84; Reta-Sanchez DG, 2002, AGRON J, V94, P1317, DOI 10.2134/agronj2002.1317; Sharratt BS, 2005, AGRON J, V97, P1129, DOI 10.2134/agronj2004.0292; Singels A, 2009, FIELD CROP RES, V113, P149, DOI 10.1016/j.fcr.2009.04.015; STOSKOPF NC, 1967, CAN J PLANT SCI, V47, P597, DOI 10.4141/cjps67-103; Wang ZF, 2001, SHANDONG AGR SCI, V4, P6; Xu HengYong, 1995, Acta Agronomica Sinica, V21, P204; Xu HY, 1996, SHANDONG AGR SCI, V1, P14; [杨吉顺 Yang Jishun], 2010, [作物学报, Acta Agronomica Sinica], V36, P1226; Yang Wen-Ping, 2008, Zhiwu Shengtai Xuebao, V32, P485, DOI 10.3773/j.issn.1005-264x.2008.02.028; Zheng Ting, 2013, Acta Agronomica Sinica, V39, P885, DOI 10.3724/SP.J.1006.2013.00885; Zhu YJ, 2001, J TRITICEAE CROPS, V21, P62	37	24	26	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148582	10.1371/journal.pone.0148582	http://dx.doi.org/10.1371/journal.pone.0148582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845330	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800074
J	Brown, BM; Stallings, JW; Clay, JS; Rhoads, ML				Brown, Britni M.; Stallings, Jon W.; Clay, John S.; Rhoads, Michelle L.			Periconceptional Heat Stress of Holstein Dams Is Associated with Differences in Daughter Milk Production during Their First Lactation	PLOS ONE			English	Article							SIRE; COWS	The fertility of lactating Holstein cows is severely reduced during periods of heat stress. Despite this reduction in fertility, however, some inseminations conducted during heat stress result in successful pregnancies from which heifer calves are born. Many of these heifer calves are retained and raised to enter the milking herd as replacement animals. Heat stress experienced by these females around the time they were conceived may confer long-lasting effects that alter subsequent milk production capacity. The objective of this study was to examine the relationship between periconceptional heat stress and subsequent milk production of primiparous cows. National Dairy Herd Improvement Association data was obtained from Dairy Records Management Systems. Records included Holstein cows that had completed at least one lactation in one of three states with large populations of dairy cattle and which are known for having hot, humid summers: Georgia, Florida or Texas. Dates of conception were calculated by subtracting 276 d from the recorded birth date of each individual cow. Records for cows conceived within the months of June, July, and August were retained as heat stress-conceived (HSC) cows (n = 94,440); cows conceived within the months of December, January, and February were retained as thermoneutral-conceived (TNC) contemporaries (n = 141,365). In order to account for the effects of environmental conditions on total milk production for a given lactation, cows were blocked by season of calving (winter, spring, summer or fall). Adjusted 305-day mature-equivalent milk production was evaluated with a mixed model ANOVA using SAS, in which random effects were used to account for variability between herds. Of the cows that calved in the summer, fall and winter, TNC cows had higher milk yield than the HSC cows in all states. Interestingly, the cows that calved in the spring presented a unique relationship, with HSC cows producing more milk. Overall however, heat stress at the time of conception is associated with lower milk production during the first lactation. While this association does not prove cause and effect, it does provide justification for additional investigation into whether heat stress around the time of conception results in long-term, detrimental consequences for the conceptus.	[Brown, Britni M.; Rhoads, Michelle L.] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [Stallings, Jon W.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Clay, John S.] N Carolina State Univ, Dept Anim Sci, Box 7621, Raleigh, NC 27695 USA	Virginia Polytechnic Institute & State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Rhoads, ML (corresponding author), Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA.	rhoadsm@vt.edu		Clay, John/0000-0001-7273-225X; Stallrich, Jonathan/0000-0002-0180-9309; Rhoads, Michelle/0000-0003-4652-6430	Virginia Agricultural Experiment Station; National Institute of Food and Agriculture, U.S. Department of Agriculture; Virginia Tech Open Access Subvention Fund	Virginia Agricultural Experiment Station; National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Virginia Tech Open Access Subvention Fund	Funding for this work was provided, in part, by the Virginia Agricultural Experiment Station and the Hatch Program of the National Institute of Food and Agriculture, U.S. Department of Agriculture and the Virginia Tech Open Access Subvention Fund.	Bernabucci U, 2010, ANIMAL, V4, P1167, DOI 10.1017/S175173111000090X; Brown BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133574; COLLIER RJ, 1982, J DAIRY SCI, V65, P2213, DOI 10.3168/jds.S0022-0302(82)82484-3; Cruzen SM, 2014, J ANIM SCI UNPUB; Dhakal K, 2013, J DAIRY SCI, V96, P690, DOI 10.3168/jds.2012-5817; Dikmen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069202; Gaughan J. B., 2012, Environmental physiology of livestock, P243; Hernandez CE, 2010, PHYSIOL BEHAV, V101, P588, DOI 10.1016/j.physbeh.2010.08.020; Li QL, 2011, DNA CELL BIOL, V30, P247, DOI 10.1089/dna.2010.1133; Pegorer MF, 2007, THERIOGENOLOGY, V67, P692, DOI 10.1016/j.theriogenology.2006.09.042; Ravagnolo O, 2000, J DAIRY SCI, V83, P2120, DOI 10.3168/jds.S0022-0302(00)75094-6; Renaudeau D, 2012, ANIMAL, V6, P707, DOI 10.1017/S1751731111002448; Satrapa RA, 2011, THERIOGENOLOGY, V76, P1162, DOI 10.1016/j.theriogenology.2011.05.026; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Zhang S, 2010, FASEB J, V24, P2772, DOI 10.1096/fj.09-154294; Zimbelman R. B., 2009, REEVALUATION IMACT T, P158	16	12	12	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148234	10.1371/journal.pone.0148234	http://dx.doi.org/10.1371/journal.pone.0148234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840076	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200105
J	Hare, JA; Morrison, WE; Nelson, MW; Stachura, MM; Teeters, EJ; Griffis, RB; Alexander, MA; Scott, JD; Alade, L; Bell, RJ; Chute, AS; Curti, KL; Curtis, TH; Kircheis, D; Kocik, JF; Lucey, SM; McCandless, CT; Milke, LM; Richardson, DE; Robillard, E; Walsh, HJ; McManus, MC; Marancik, KE; Griswold, CA				Hare, Jonathan A.; Morrison, Wendy E.; Nelson, Mark W.; Stachura, Megan M.; Teeters, Eric J.; Griffis, Roger B.; Alexander, Michael A.; Scott, James D.; Alade, Larry; Bell, Richard J.; Chute, Antonie S.; Curti, Kiersten L.; Curtis, Tobey H.; Kircheis, Daniel; Kocik, John F.; Lucey, Sean M.; McCandless, Camilla T.; Milke, Lisa M.; Richardson, David E.; Robillard, Eric; Walsh, Harvey J.; McManus, M. Conor; Marancik, Katrin E.; Griswold, Carolyn A.			A Vulnerability Assessment of Fish and Invertebrates to Climate Change on the Northeast US Continental Shelf	PLOS ONE			English	Article							OCEAN ACIDIFICATION; THERMAL TOLERANCE; SPECIES TRAITS; UNITED-STATES; RANGE SHIFTS; MARINE FISH; FISHERIES; IMPACTS; TEMPERATURE; RIVER	Climate change and decadal variability are impacting marine fish and invertebrate species worldwide and these impacts will continue for the foreseeable future. Quantitative approaches have been developed to examine climate impacts on productivity, abundance, and distribution of various marine fish and invertebrate species. However, it is difficult to apply these approaches to large numbers of species owing to the lack of mechanistic understanding sufficient for quantitative analyses, as well as the lack of scientific infrastructure to support these more detailed studies. Vulnerability assessments provide a framework for evaluating climate impacts over a broad range of species with existing information. These methods combine the exposure of a species to a stressor (climate change and decadal variability) and the sensitivity of species to the stressor. These two components are then combined to estimate an overall vulnerability. Quantitative data are used when available, but qualitative information and expert opinion are used when quantitative data is lacking. Here we conduct a climate vulnerability assessment on 82 fish and invertebrate species in the Northeast U.S. Shelf including exploited, forage, and protected species. We define climate vulnerability as the extent to which abundance or productivity of a species in the region could be impacted by climate change and decadal variability. We find that the overall climate vulnerability is high to very high for approximately half the species assessed; diadromous and benthic invertebrate species exhibit the greatest vulnerability. In addition, the majority of species included in the assessment have a high potential for a change in distribution in response to projected changes in climate. Negative effects of climate change are expected for approximately half of the species assessed, but some species are expected to be positively affected (e.g., increase in productivity or move into the region). These results will inform research and management activities related to understanding and adapting marine fisheries management and conservation to climate change and decadal variability.	[Hare, Jonathan A.; Bell, Richard J.; McCandless, Camilla T.; Richardson, David E.; Walsh, Harvey J.; Griswold, Carolyn A.] NOAA, NMFS, Northeast Fisheries Sci Ctr, Narragansett Lab, 28 Tarzwell Dr, Narragansett, RI 02818 USA; [Morrison, Wendy E.; Nelson, Mark W.; Teeters, Eric J.] NOAA, Earth Resources Technol Inc, NMFS, Off Sustainable Fisheries, 1315 East West Highway, Silver Spring, MD 20910 USA; [Stachura, Megan M.] NOAA, NMFS, Off Sustainable Fisheries, 1315 East West Highway, Silver Spring, MD 20910 USA; [Griffis, Roger B.] NOAA, NMFS, Off Sci & Technol, 1315 East West Highway, Silver Spring, MD 20910 USA; [Alexander, Michael A.; Scott, James D.] NOAA, OAR, Earth Syst Res Lab, 325 Broadway, Boulder, CO 80305 USA; [Alade, Larry; Chute, Antonie S.; Curti, Kiersten L.; Lucey, Sean M.; Robillard, Eric] NOAA, NMFS, Northeast Fisheries Sci Ctr, Woods Hole Lab, 166 Water St, Woods Hole, MA 02543 USA; [Curtis, Tobey H.] NOAA, NMFS, Greater Atlantic Reg Fisheries Off, 55 Great Republic Dr, Gloucester, MA 01930 USA; [Kircheis, Daniel; Kocik, John F.] NOAA, NMFS, Northeast Fisheries Sci Ctr, Maine Field Stn, 17 Godfrey Dr,Suite 1, Orono, ME 04473 USA; [Milke, Lisa M.] NOAA, NMFS, Northeast Fisheries Sci Ctr, Milford Lab, 212 Rogers Ave, Milford, CT 06460 USA; [McManus, M. Conor; Marancik, Katrin E.] NOAA, Integrated Stat, NMFS, Northeast Fisheries Sci Ctr,Narragansett Lab, 28 Tarzwell Dr, Narragansett, RI 02818 USA; [Stachura, Megan M.] NOAA, ECS Fed Inc, NMFS, NW Fisheries Sci Ctr, 2725 Montlake Blvd E, Seattle, WA 98112 USA; [Bell, Richard J.] Univ Rhode Isl, Nat Conservancy, Bay Campus, Narragansett, RI 02882 USA; [McManus, M. Conor] Univ Rhode Isl, Grad Sch Oceanog, 215 S Ferry Rd, Narragansett, RI 02882 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Woods Hole Oceanographic Institution; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Nature Conservancy; University of Rhode Island; University of Rhode Island	Hare, JA (corresponding author), NOAA, NMFS, Northeast Fisheries Sci Ctr, Narragansett Lab, 28 Tarzwell Dr, Narragansett, RI 02818 USA.	jon.hare@noaa.gov	Alexander, Michael A/A-7097-2013; Kocik, John/AAV-7558-2021	Alexander, Michael A/0000-0001-9646-6427; Curtis, Tobey/0000-0003-0164-7335; McManus, Conor/0000-0003-3504-0371; Scott, James D/0000-0002-8709-8594; Griffis, Roger/0000-0001-9329-2230	National Oceanic and Atmospheric Administration (NOAA) NMFS Office of Science and Technology; NOAA NMFS Office of Sustainable Fisheries; NOAA OAR Earth System Laboratory; NOAA NMFS Greater Atlantic Regional Fisheries Office; NOAA NMFS Northeast Fisheries Science Center; NOAA Ocean Acidification Program; NOAA NMFS Office of Science and Technology	National Oceanic and Atmospheric Administration (NOAA) NMFS Office of Science and Technology; NOAA NMFS Office of Sustainable Fisheries; NOAA OAR Earth System Laboratory; NOAA NMFS Greater Atlantic Regional Fisheries Office; NOAA NMFS Northeast Fisheries Science Center; NOAA Ocean Acidification Program; NOAA NMFS Office of Science and Technology	Funding for this project was provided by the National Oceanic and Atmospheric Administration (NOAA) NMFS Office of Science and Technology, NOAA NMFS Office of Sustainable Fisheries, NOAA OAR Earth System Laboratory, NOAA NMFS Greater Atlantic Regional Fisheries Office, NOAA NMFS Northeast Fisheries Science Center, and the NOAA Ocean Acidification Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided by the NOAA NMFS Office of Science and Technology, NOAA NMFS Office of Sustainable Fisheries, NOAA OAR Earth System Laboratory, NOAA NMFS Greater Atlantic Regional Fisheries Office, NOAA NMFS Northeast Fisheries Science Center, and the NOAA Ocean Acidification Program. We thank Antonietta Capotondi, Vince Saba, and Charles Stock for contributing to the description of projected changes in ocean currents in the Northwest Atlantic Ocean. We thank Mike Johnson for contributing to the description of projected sea level rise in the region. We thank Richard Balouskus, Diane Borggaard, Edith Carson, Sarah Laporte, Lynn Lankshear, Jessica Pruden, Rory Saunders, and Tara Trinko Lake for completing species profiles in preparation for the assessment. We thank Kim Hare for formatting references here and in the Supplemental Material and we thank Kris Gamble for help with the figures. Finally, we thank Diane Borggaard and Kimberly Damon-Randall for the encouragement and support throughout the project (before the beginning to the end). We also thank Ken Drinkwater, Jeff Hutchings, and Nick Caputi for their thoughtful and constructive advice during a Council of Independent Experts review of the Climate Vulnerability Assessment Methodology and this Northeast fisheries climate vulnerability assessment. Acknowledgment of the above individuals does not imply their endorsement of this work; the authors have sole responsibility for the content of this contribution. The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA or any of its subagencies.	Able K. W., 2010, ECOLOGY ESTUARINE FI; [Anonymous], 2011, SCANNING CONSERVATIO; Atlantic States Marine Fisheries Commission (ASMFC), 2010, ATL CROAK 2010 BENCH; Barbier EB, 2012, REV ENV ECON POLICY, V6, P1, DOI 10.1093/reep/rer017; BAUMGARTNER TR, 1992, CAL COOP OCEAN FISH, V33, P24; Beever EA, 2016, CONSERV LETT, V9, P131, DOI 10.1111/conl.12190; Bell RJ, 2015, ICES J MAR SCI, V72, P1311, DOI 10.1093/icesjms/fsu217; Bell RJ, 2014, ICES J MAR SCI, V71, P2416, DOI 10.1093/icesjms/fsu069; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Busch DS, 2013, ICES J MAR SCI, V70, P823, DOI 10.1093/icesjms/fst061; Chambers RC, 2014, BIOGEOSCIENCES, V11, P1613, DOI 10.5194/bg-11-1613-2014; Cheung WWL, 2015, PROG OCEANOGR, V130, P19, DOI 10.1016/j.pocean.2014.09.003; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; Collette B. B, 2002, BIGELOW SCHROEDERS F, V3rd; Cooley SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124145; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; CRECCO VA, 1985, CAN J FISH AQUAT SCI, V42, P1640, DOI 10.1139/f85-205; Doubleday ZA, 2013, AQUACULT ENV INTERAC, V3, P163, DOI 10.3354/aei00058; Earth Systems Research Laboratory, 2014, NOAAS OC CLIM CHANG; Federal Register, FED REG, V78, P48944; Flato G., 2013, CONTRIBUTION WORKING, DOI DOI 10.1017/CB09781107415324.020; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Fogarty M, 2008, MITIG ADAPT STRAT GL, V13, P453, DOI 10.1007/s11027-007-9131-4; Friedland KD, 2007, CONT SHELF RES, V27, P2313, DOI 10.1016/j.csr.2007.06.001; Gaichas SK, 2014, ICES J MAR SCI, V71, P2323, DOI 10.1093/icesjms/fsu048; Gamito R, 2015, FISH RES, V161, P207, DOI 10.1016/j.fishres.2014.07.014; Garcia RA, 2014, J BIOGEOGR, V41, P724, DOI 10.1111/jbi.12257; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Griffis R., 2015, NMFSOSF3148 NOAA, P48; Hahn ME, 2011, AQUAT TOXICOL, V105, P67, DOI 10.1016/j.aquatox.2011.06.001; Hall CJ, 2011, LANDSCAPE ECOL, V26, P95, DOI 10.1007/s10980-010-9539-1; Hare JA, 2007, FISH OCEANOGR, V16, P31, DOI 10.1111/j.1365-2419.2006.00407.x; Hare JA, 2012, ICES J MAR SCI, V69, P1753, DOI 10.1093/icesjms/fss160; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; HETTLER WF, 1976, J FISH BIOL, V8, P55, DOI 10.1111/j.1095-8649.1976.tb03907.x; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hollowed AB, 2013, ICES J MAR SCI, V70, P1023, DOI 10.1093/icesjms/fst081; Hollowed AB, 2009, ICES J MAR SCI, V66, P1584, DOI 10.1093/icesjms/fsp057; Jepson M., 2013, NOAA TECHNICAL MEMOR, P1; Ji RB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032010; Johnson JE, 2010, REV FISH SCI, V18, P106, DOI 10.1080/10641260903434557; Jones MC, 2015, ICES J MAR SCI, V72, P741, DOI 10.1093/icesjms/fsu172; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Lehodey P, 2010, PROG OCEANOGR, V86, P302, DOI 10.1016/j.pocean.2010.04.021; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Link J. S., 2010, ECOSYSTEM BASED FISH; Link JS, 2011, FISH FISH, V12, P461, DOI 10.1111/j.1467-2979.2010.00398.x; Lovell S, 2011, 2013NMFSFSPO134 NOAA; Lynch PD, 2015, ICES J MAR SCI, V72, P374, DOI 10.1093/icesjms/fsu134; Mahrosh U, 2014, J HAZARD MATER, V280, P331, DOI 10.1016/j.jhazmat.2014.07.076; Mathis JT, 2015, PROG OCEANOGR, V136, P71, DOI 10.1016/j.pocean.2014.07.001; McKibben B, 2014, NEW YORK REV BOOKS, V61, P46; Methot RD, 2009, FISH FISHERIES SERIE, V31, P137, DOI 10.1007/978-1-4020-9210-7_9; Mid-Atlantic Fishery Management Council (MAFMC), PROT UNM FOR SPEC; Mills KE, 2013, OCEANOGRAPHY, V26, P191, DOI 10.5670/oceanog.2013.27; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Murdy EO., 1997, FISHES CHESAPEAKE BA, P324; National Marine Fisheries Service, 2014, COMM FISH STAT; National Marine Fisheries Service, NMFS PROACT CONS PRO; National Marine Fisheries Service, 2010, NMFSFSPO108 NOAA US; National Marine Fisheries Service, END THREAT MAR SPEC; Northeast Fisheries Science Center, 2014, NE REG STOCK ASS WOR; Northeast Fisheries Science Center, 2012, 54 NE REG STOCK ASS, V12-18; Northeast Fisheries Science Center, 2014, EFH SOURC DOC LIF HI; Northeast Fisheries Science Center (NEFSC), 2008, 3 GROUNDF ASS REV M; Nye JA, 2013, ECOL MODEL, V264, P157, DOI 10.1016/j.ecolmodel.2012.08.019; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Patrick WS, 2010, FISH B-NOAA, V108, P305; Pecl GT, 2014, CLIMATIC CHANGE, V127, P505, DOI 10.1007/s10584-014-1284-z; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Perry RI, 2010, J MARINE SYST, V79, P427, DOI 10.1016/j.jmarsys.2008.12.017; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Petitgas P, 2012, MAR ECOL PROG SER, V444, P1, DOI 10.3354/meps09451; Pilgrim JM, 1998, J AM WATER RESOUR AS, V34, P1109, DOI 10.1111/j.1752-1688.1998.tb04158.x; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Saba V, REVIEW; Seney EE, 2013, CONSERV BIOL, V27, P1138, DOI 10.1111/cobi.12167; Shackell NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090662; Signorini SR, 2013, J GEOPHYS RES-OCEANS, V118, P5439, DOI 10.1002/jgrc.20369; Solomon A, 2011, B AM METEOROL SOC, V92, P141, DOI 10.1175/2010BAMS2962.1; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Stortini CH, 2015, ICES J MAR SCI, V72, P1731, DOI 10.1093/icesjms/fsv022; Strayer DL, 2014, BIOSCIENCE, V64, P496, DOI 10.1093/biosci/biu061; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Titus J. G., 2009, Coastal sensitivity to sea-level rise: a focus on the Mid-Atlantic Region; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Veilleux HD, 2015, NAT CLIM CHANGE, V5, P1074, DOI [10.1038/nclimate2724, 10.1038/NCLIMATE2724]; Walsh HJ, 2005, T AM FISH SOC, V134, P910, DOI 10.1577/T04-060.1; Walsh HJ, PLOS ONE IN PRESS; Walther BD, 2008, T AM FISH SOC, V137, P57, DOI 10.1577/T07-029.1; Weinberg JR, 2005, ICES J MAR SCI, V62, P1444, DOI 10.1016/j.icesjms.2005.04.020; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	106	284	292	4	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146756	10.1371/journal.pone.0146756	http://dx.doi.org/10.1371/journal.pone.0146756			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839967	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200013
J	Kim, K; Kim, N; Lee, GR				Kim, Kiwan; Kim, Najung; Lee, Gap Ryol			Transcription Factors Oct-1 and GATA-3 Cooperatively Regulate Th2 Cytokine Gene Expression via the RHS5 within the Th2 Locus Control Region	PLOS ONE			English	Article							RANGE INTRACHROMOSOMAL INTERACTIONS; HELPER TYPE-2 CYTOKINE; CD4 T-CELLS; OCTAMER FACTORS; ETS-DOMAIN; DIFFERENTIATION; BINDING; RESPONSES; PROMOTER; ELEMENTS	The T helper type 2 (Th2) locus control region (LCR) regulates Th2 cell differentiation. Several transcription factors bind to the LCR to modulate the expression of Th2 cytokine genes, but the molecular mechanisms behind Th2 cytokine gene regulation are incompletely understood. Here, we used database analysis and an oligonucleotide competition/electrophoretic mobility shift assays to search for transcription factors binding to RHS5, a DNase I hypersensitive site (DHS) within the Th2 LCR. Consequently, we demonstrated that GATA-binding protein-3 (GATA-3), E26 transformation-specific protein 1 (Ets-1), octamer transcription factor-1 (Oct-1), and Oct-2 selectively associate with RHS5. Furthermore, chromatin immunoprecipitation and luciferase reporter assays showed that Oct-1 and Oct-2 bound within the Il4 promoter region and the Th2 LCR, and that Oct-1 and GATA-3 or Oct-2 synergistically triggered the transactivational activity of the Il4 promoter through RHS5. These results suggest that Oct-1 and GATA-3/Oct-2 direct Th2 cytokine gene expression in a cooperative manner.	[Kim, Kiwan; Kim, Najung; Lee, Gap Ryol] Sogang Univ, Dept Life Sci, Seoul, South Korea	Sogang University	Lee, GR (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	grlee@sogang.ac.kr			National Research Foundation of Korea (NRF) - Korean government, Ministry of Science, ICT & Future Planning, Republic of Korea [2014-052545]	National Research Foundation of Korea (NRF) - Korean government, Ministry of Science, ICT & Future Planning, Republic of Korea	This work was supported by a National Research Foundation of Korea (NRF) grant funded by Korean government (2014-052545), Ministry of Science, ICT & Future Planning, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Brunner C, 2007, EMBO J, V26, P3191, DOI 10.1038/sj.emboj.7601742; dela Paz NG, 2007, J BIOL CHEM, V282, P8424, DOI 10.1074/jbc.M606923200; Deyev IE, 2004, MOL BIOL+, V38, P40, DOI 10.1023/B:MBIL.0000015138.80503.81; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Grenningloh K, 2005, J EXP MED, V201, P615, DOI 10.1084/jem.20041330; Hwang SS, 2013, P NATL ACAD SCI USA, V110, P276, DOI 10.1073/pnas.1214682110; Hwang SS, 2011, BIOCHEM BIOPH RES CO, V410, P866, DOI 10.1016/j.bbrc.2011.06.080; Hwang SS, 2010, IMMUNOLOGY, V131, P50, DOI 10.1111/j.1365-2567.2010.03271.x; Kim LK, 2014, MOL CELL, V54, P56, DOI 10.1016/j.molcel.2014.02.004; Koh BH, 2010, P NATL ACAD SCI USA, V107, P10614, DOI 10.1073/pnas.1005383107; Lee DU, 2004, P NATL ACAD SCI USA, V101, P16010, DOI 10.1073/pnas.0407031101; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Li-Weber M, 1998, J IMMUNOL, V161, P1380; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; PFEUFFER I, 1994, J IMMUNOL, V153, P5572; Salerno MS, 2001, CYTOKINE, V15, P4, DOI 10.1006/cyto.2001.0897; Schwenger GTF, 2001, J BIOL CHEM, V276, P48502, DOI 10.1074/jbc.M107836200; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Strempel JM, 2010, J IMMUNOL, V184, P1309, DOI 10.4049/jimmunol.0804162; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Williams A, 2013, P NATL ACAD SCI USA, V110, P6955, DOI 10.1073/pnas.1304720110; Wu GD, 1997, J BIOL CHEM, V272, P2396; Wurster AL, 2008, MOL CELL BIOL, V28, P7274, DOI 10.1128/MCB.00835-08; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	37	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148576	10.1371/journal.pone.0148576	http://dx.doi.org/10.1371/journal.pone.0148576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840450	Green Submitted, gold, Green Published			2022-12-26	WOS:000369550200149
J	Milano, M; Moraes, MO; Rodenbusch, R; Carvalho, CX; Delcroix, M; Mousquer, G; da Costa, LL; Unis, G; Dalla Costa, ER; Rossetti, MLR				Milano, Mariana; Moraes, Milton Ozorio; Rodenbusch, Rodrigo; Carvalho, Caroline Xavier; Delcroix, Melaine; Mousquer, Gabriel; da Costa, Lucas Laux; Unis, Gisela; Dalla Costa, Elis Regina; Rosa Rossetti, Maria Lucia			Single Nucleotide Polymorphisms in IL17A and IL6 Are Associated with Decreased Risk for Pulmonary Tuberculosis in Southern Brazilian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; T-CELL RESPONSE; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; GENE POLYMORPHISMS; ADAPTIVE IMMUNITY; INTERFERON-GAMMA; IFN-GAMMA; SUSCEPTIBILITY; INNATE	In Mycobacterium tuberculosis (MTB) infection, the complex interaction of host immune system and the mycobacteria is associated with levels of cytokines production that play a major role in determining the outcome of the disease. Several single-nucleotide polymorphisms (SNPs) in cytokine genes have been associated with tuberculosis (TB) outcome. The aim of this study was to evaluate the association between previously reported SNPs IL2-330 T>G (rs2069762); IL4-590 C>T (rs2243250); IL6-174 G>C (rs1800795); IL10-592 A>C (rs1800872); IL10-1082 G>A (rs1800896); IL17A -692 C>T (rs8193036); IL17A -197 G>A (rs2275913); TNF -238 G>A (rs361525); TNF -308 G>A (rs1800629) and IFNG +874 T>A (rs2430561) and pulmonary TB (PTB) susceptibility. We conducted a case-control study in individuals from Southern Brazil who were recruited between February 2012 and October 2013 in a high incidence TB city. We performed a multiplex genotyping assay in 191 patients with PTB and 175 healthy subjects. Our results suggest a decreased risk for PTB development associated with the IL17A -197A allele (OR = 0.29; p = 0.04), AA genotype (OR = 0.12; p = 0.04) and A carrier (AG/AA) (OR = 0.29; p = 0.004) and IL6 -174C carrier (CC/CG) (OR = 0.46; p = 0.04). We could not properly analyze IL17A -692 C>T (rs8193036) and IFNG +874T>A due to genotypic inconsistencies and found no evidence of association for the IL2, IL4, IL10 and TNF polymorphisms and PTB. In conclusion, our results show a protective effect of IL17 and IL6 polymorphisms on PTB outcome in Southern Brazilian population.	[Milano, Mariana; Rosa Rossetti, Maria Lucia] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Milano, Mariana; Rodenbusch, Rodrigo; da Costa, Lucas Laux; Dalla Costa, Elis Regina; Rosa Rossetti, Maria Lucia] Fundacao Estudual Prod & Pesquisa Saude, Ctr Desenvolvimento Cient & Tecnol, Porto Alegre, RS, Brazil; [Moraes, Milton Ozorio; Carvalho, Caroline Xavier] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, RJ, Brazil; [Delcroix, Melaine] Univ Calif Berkeley, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Mousquer, Gabriel] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil; [da Costa, Lucas Laux] Univ Fed Rio de Janeiro, Programa Posgrad Clin Med, Rio De Janeiro, RJ, Brazil; [Unis, Gisela] Hosp Sanatorio Partenon, Porto Alegre, RS, Brazil; [Rosa Rossetti, Maria Lucia] Univ Luterana Brazil, Canoas, RS, Brazil	Universidade Federal do Rio Grande do Sul; Fundacao Oswaldo Cruz; University of California System; University of California Berkeley; Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal do Rio de Janeiro	Milano, M (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil.; Milano, M (corresponding author), Fundacao Estudual Prod & Pesquisa Saude, Ctr Desenvolvimento Cient & Tecnol, Porto Alegre, RS, Brazil.; Moraes, MO (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, RJ, Brazil.	marianamilano@hotmail.com; mmoraes@fiocruz.br	Moraes, Milton Ozório/G-9753-2011; Rossetti, Maria Lucia/ABH-1935-2020; Moraes, Milton/AFF-1842-2022	Moraes, Milton Ozório/0000-0003-2653-0037; Rossetti, Maria Lucia/0000-0002-9672-9394; 				Alcais A, 2005, J EXP MED, V202, P1617, DOI 10.1084/jem.20052302; Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; Alvarado-Arnez LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136282; Ansari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027848; APPELBERG R, 1994, IMMUNOLOGY, V82, P361; Arisawa T, 2008, J CLIN IMMUNOL, V28, P44, DOI 10.1007/s10875-007-9125-8; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bulat-Kardum LJ, 2015, SCAND J IMMUNOL, V82, P63, DOI 10.1111/sji.12300; Cardoso CC, 2011, FUTURE MICROBIOL, V6, P533, DOI [10.2217/FMB.11.39, 10.2217/fmb.11.39]; Chen JH, 2010, J CLIN IMMUNOL, V30, P539, DOI 10.1007/s10875-010-9391-8; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; El Baghdadi J, 2006, J EXP MED, V203, P1679, DOI 10.1084/jem.20060269; Espinoza JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026229; Etna MP, 2014, SEMIN IMMUNOL, V26, P543, DOI 10.1016/j.smim.2014.09.011; Fairfax BP, 2014, CURR OPIN IMMUNOL, V30, P63, DOI 10.1016/j.coi.2014.07.001; Fernando SL, 2006, IMMUNOL CELL BIOL, V84, P125, DOI 10.1111/j.1440-1711.2006.01420.x; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gao X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127496; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Ocejo-Vinyals JG, 2013, CYTOKINE, V64, P58, DOI 10.1016/j.cyto.2013.05.022; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Indrigo J, 2002, MICROBIOL-SGM, V148, P1991, DOI 10.1099/00221287-148-7-1991; Isailovic N, 2015, J AUTOIMMUN, V60, P1, DOI 10.1016/j.jaut.2015.04.006; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; KALLMANN F. J., 1943, American Review of Tuberculosis and Pulmonary Diseases, V47, P549; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Leal IS, 1999, INFECT IMMUN, V67, P5747, DOI 10.1128/IAI.67.11.5747-5754.1999; Li X, 2011, 2011 SECOND ETP/IITA CONFERENCE ON TELECOMMUNICATION AND INFORMATION (TEIN 2011), VOL 1, P1, DOI 10.1109/ICCSN.2011.6014661; Liang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088448; Liu XKK, 2004, J BIOL CHEM, V279, P52762, DOI 10.1074/jbc.M405764200; Mabunda N, 2015, MOL BIOL REP, V42, P71, DOI 10.1007/s11033-014-3741-1; Mao X, 2015, GENE; Ministerio da Saude, 2011, MAN NAC REC CONTR TU; Ministerio da Saude (Brazilian Ministry of Health), B EP; Moller M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-154; Moraes MO, 2013, CAD SAUDE PUBLICA, V29, P2144, DOI 10.1590/0102-311XPE011113; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5; Peng R, 2013, GENE, V515, P229, DOI 10.1016/j.gene.2012.11.017; Puffer R., 1944, FAMILIAL SUSCEPTIBIL; Shi GC, 2015, GENET MOL RES, V14, P8526, DOI 10.4238/2015.July.28.22; Stein CM, 2011, MAMM GENOME, V22, P91, DOI 10.1007/s00335-010-9301-7; Team R. D. C., 2008, R LANG ENV STAT COMP; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tian G, 2015, GENET MOL RES, V14, P5501, DOI 10.4238/2015.May.25.1; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Vidyarani M, 2006, INDIAN J MED RES, V124, P403; Wareham AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088149; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2011, GUID PROGR MAN DRUG; Wu GN, 2014, INFECT GENET EVOL, V24, P82, DOI 10.1016/j.meegid.2014.03.006; Zhang ZJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-328	65	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147814	10.1371/journal.pone.0147814	http://dx.doi.org/10.1371/journal.pone.0147814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840977	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200063
J	Torres, CW; Tsutsui, ND				Torres, Candice W.; Tsutsui, Neil D.			The Effect of Social Parasitism by Polyergus breviceps on the Nestmate Recognition System of Its Host, Formica altipetens	PLOS ONE			English	Article							DIRECT BEHAVIORAL EVIDENCE; CUTICULAR HYDROCARBONS; MICROSATELLITE LOCI; COLONY RECOGNITION; GENETIC DIVERSITY; RAIDING BEHAVIOR; CHEMICAL CUES; ANT; HYMENOPTERA; DISCRIMINATION	Highly social ants, bees and wasps employ sophisticated recognition systems to identify colony members and deny foreign individuals access to their nest. For ants, cuticular hydrocarbons serve as the labels used to ascertain nest membership. Social parasites, however, are capable of breaking the recognition code so that they can thrive unopposed within the colonies of their hosts. Here we examine the influence of the socially parasitic slave-making ant, Polyergus breviceps on the nestmate recognition system of its slaves, Formica altipetens. We compared the chemical, genetic, and behavioral characteristics of colonies of enslaved and free-living F. altipetens. We found that enslaved Formica colonies were more genetically and chemically diverse than their free-living counterparts. These differences are likely caused by the hallmark of slave-making ant ecology: seasonal raids in which pupa are stolen from several adjacent host colonies. The different social environments of enslaved and free-living Formica appear to affect their recognition behaviors: enslaved Formica workers were less aggressive towards non-nestmates than were free-living Formica. Our findings indicate that parasitism by P. breviceps dramatically alters both the chemical and genetic context in which their kidnapped hosts develop, leading to changes in how they recognize nestmates.	[Torres, Candice W.; Tsutsui, Neil D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Torres, CW (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	candicewt@gmail.com			United States Department of Agriculture National Institute of Food and Agriculture, Hatch project [CA-B-INS-0087-H]; Sigma Xi [G2007106132227470]	United States Department of Agriculture National Institute of Food and Agriculture, Hatch project; Sigma Xi	This work was supported by the United States Department of Agriculture National Institute of Food and Agriculture, Hatch project CA-B-INS-0087-H(http://nifa.usda.gov) and the Sigma Xi Grants-in-Aid of Research program (Grant ID:G2007106132227470; https://www.sigmaxi.org/programs/grants-in-aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; Beye M, 1998, BEHAV ECOL SOCIOBIOL, V43, P67, DOI 10.1007/s002650050467; BONAVITACOUGOURDAN A, 1987, J ENTOMOL SCI, V22, P1; Bono JM, 2006, J INSECT BEHAV, V19, P429, DOI 10.1007/s10905-006-9035-2; Brandt M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-71; Breed M.D., 1987, P243; BUSCHINGER A, 1980, Z TIERPSYCHOL, V53, P245; Chapuisat M, 1996, MOL ECOL, V5, P599, DOI 10.1111/j.1365-294X.1996.tb00354.x; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; CUSHMAN JH, 1988, OECOLOGIA, V77, P522, DOI 10.1007/BF00377268; D'Ettorre Patrizia, 2001, Acta Ethologica, V3, P67, DOI 10.1007/s102110100038; Errard C, 2008, INSECT SOC, V55, P115, DOI 10.1007/s00040-008-0979-4; Errard C, 2006, BEHAV ECOL SOCIOBIOL, V59, P353, DOI 10.1007/s00265-005-0058-z; Errard C, 1997, INSECT SOC, V44, P189, DOI 10.1007/s000400050040; Errard C, 2006, CHEMOECOLOGY, V16, P235, DOI 10.1007/s00049-006-0358-4; Esponda F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2838; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Gyllenstrand N, 2002, MOL ECOL NOTES, V2, P67, DOI 10.1046/j.1471-8286.2002.00152.x; HABERSETZER C, 1993, PHYSIOL ENTOMOL, V18, P160, DOI 10.1111/j.1365-3032.1993.tb00463.x; Hasegawa E, 2004, MOL ECOL NOTES, V4, P200, DOI 10.1111/j.1471-8286.2004.00614.x; Hefetz A, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P477, DOI 10.1017/CBO9780511711909.021; Heinze J, 1996, ETHOLOGY, V102, P510; Helantera H, 2011, BEHAV ECOL, V22, P710, DOI 10.1093/beheco/arr037; Holldobler B., 1990, pi; HOWARD RW, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P179; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Johnson BR, 2011, BEHAV ECOL SOCIOBIOL, V65, P935, DOI 10.1007/s00265-010-1094-x; Johnson CA, 2001, J CHEM ECOL, V27, P1787, DOI 10.1023/A:1010456608626; Katzerke A, 2006, BEHAV ECOL SOCIOBIOL, V61, P143, DOI 10.1007/s00265-006-0245-6; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Lalzar I, 2010, CHEMOECOLOGY, V20, P19, DOI 10.1007/s00049-009-0030-x; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; Leonhardt SD, 2007, J COMP PHYSIOL A, V193, P993, DOI 10.1007/s00359-007-0252-8; Liebert AE, 2004, ANN ZOOL FENN, V41, P747; LITT M, 1993, BIOTECHNIQUES, V15, P280; Liu Zhibin, 2003, Entomological Science, V6, P125, DOI 10.1046/j.1343-8786.2003.00014.x; Lorenzi MC, 2003, INSECT SOC, V50, P82, DOI 10.1007/s000400300013; Lucas C, 2005, J INSECT PHYSIOL, V51, P1148, DOI 10.1016/j.jinsphys.2005.06.003; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; Martin SJ, 2008, BIOL J LINN SOC, V95, P131, DOI 10.1111/j.1095-8312.2008.01038.x; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; Michener C.D., 1987, P209; MOREL L, 1990, ANN ENTOMOL SOC AM, V83, P642, DOI 10.1093/aesa/83.3.642; MORI A, 1991, ETHOLOGY, V88, P46; OBIN MS, 1989, ANN ENTOMOL SOC AM, V82, P649, DOI 10.1093/aesa/82.5.649; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Ozaki Mamiko, 2014, Insects, V5, P722, DOI 10.3390/insects5040722; Pamilo P, 1996, EVOLUTION SOCIAL INS, pviii; Pamminger T, 2012, BIOL LETTERS, V8, P748, DOI 10.1098/rsbl.2012.0499; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pirk CWW, 2001, BEHAV ECOL SOCIOBIOL, V49, P366, DOI 10.1007/s002650000315; RATNIEKS FLW, 1991, AM NAT, V137, P202, DOI 10.1086/285154; REEVE HK, 1989, AM NAT, V133, P407, DOI 10.1086/284926; Sharma KR, 2015, CELL REP, V12, P1261, DOI 10.1016/j.celrep.2015.07.031; Sherman Paul W., 1997, P69; Singer TL, 1998, AM ZOOL, V38, P394; Smith BH, 1995, CHEM ECOLOGY INSECTS, V2, P433; SOROKER V, 1994, NATURWISSENSCHAFTEN, V81, P510; SOROKER V, 1995, J CHEM ECOL, V21, P365, DOI 10.1007/BF02036724; Starks PT, 1998, ANIM BEHAV, V56, P449, DOI 10.1006/anbe.1998.0778; Thomas ML, 1999, NATURWISSENSCHAFTEN, V86, P87, DOI 10.1007/s001140050578; TOPOFF H, 1985, SOUTHWEST NAT, V30, P259, DOI 10.2307/3670739; Topoff H, 1982, BIOL SOCIAL INSECTS, V9, P292; Torres CW, 2007, INSECT SOC, V54, P363, DOI 10.1007/s00040-007-0954-5; Trager JC, 2013, ZOOTAXA, V3722, P501; Tsutsui ND, 2004, ANN ZOOL FENN, V41, P713; Tsutsui ND, 2003, P NATL ACAD SCI USA, V100, P1078, DOI 10.1073/pnas.0234412100; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Wagner D, 2000, J CHEM ECOL, V26, P2245, DOI 10.1023/A:1005529224856; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543	72	2	2	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147498	10.1371/journal.pone.0147498	http://dx.doi.org/10.1371/journal.pone.0147498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840394	Green Published, gold			2022-12-26	WOS:000369550200042
J	Vaatainen, S; Cederberg, H; Roine, R; Keinanen-Kiukaanniemi, S; Saramies, J; Uusitalo, H; Tuomilehto, J; Martikainen, J				Vaatainen, Saku; Cederberg, Henna; Roine, Risto; Keinanen-Kiukaanniemi, Sirkka; Saramies, Jouko; Uusitalo, Hannu; Tuomilehto, Jaakko; Martikainen, Janne			Does Future Diabetes Risk Impair Current Quality of Life? A Cross-Sectional Study of Health-Related Quality of Life in Relation to the Finnish Diabetes Risk Score (FINDRISC)	PLOS ONE			English	Article							STYLE; INSTRUMENTS; PREVENTION; OBESITY; MODEL; SF-36	Objectives Present study examines the relationship between the estimated risk of developing type 2 diabetes (T2D) and health-related quality of life (HRQoL). We quantify the association between Finnish Diabetes Risk Score (FINDRISC) and HRQoL, and examine the potential use of FINDRISC as tool to evaluate HRQoL indirectly. Methods We conducted a cross-sectional study comprising 707 Finnish people without a diagnosis of T2D between the ages of 51 and 75 years. The risk of developing T2D was assessed using the validated and widely used FINDRISC (range 0-26 points), and quality of life was measured using two preference-based HRQoL instruments (15D and SF-6D) and one health profile instrument (SF-36). Effects of the individual FINDRISC items and demographic and clinical characteristics, such as co-morbidities, on HRQoL were studied using multivariable Tobit regression models. Results Low HRQoL was significantly and directly associated with the estimated risk of developing T2D. An approximate 4-5 point change in FINDRISC score was observed to be associated with clinically noticeable changes in the preference-based instrument HRQoL index scores. The association between HRQoL and the risk of developing T2D was also observed for most dimensions of HRQoL in all applied HRQoL instruments. Overall, old age, lack of physical activity, obesity, and history of high blood glucose were the FINDRISC factors most prominently associated with lower HRQoL. Conclusions The findings may help the health care professionals to substantiate the possible improvement in glucose metabolism and HRQoL potentially achieved by lifestyle changes, and better convince people at high risk of T2D to take action towards healthier lifestyle habits. FINDRISC may also provide an accurate proxy for HRQoL, and thus by estimating the risk of T2D with the FINDRISC, information about patients' HRQoL may also be obtained indirectly, when it is not feasible to use HRQoL instruments.	[Vaatainen, Saku; Martikainen, Janne] Univ Eastern Finland, Sch Pharm, Pharmacoecon & Outcomes Res Unit PHORU, Kuopio, Finland; [Cederberg, Henna] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Roine, Risto] Univ Eastern Finland, Dept Hlth & Social Management, Res Ctr Comparat Effectiveness & Patient Safety R, Kuopio, Finland; [Roine, Risto] Univ Helsinki, Adm Grp, Helsinki, Finland; [Roine, Risto] Helsinki Univ Hosp, Helsinki, Finland; [Keinanen-Kiukaanniemi, Sirkka] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka] Oulu Univ Hosp, Unit Primary Hlth Care, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland; [Saramies, Jouko] South Karelia Cent Hosp, Lappeenranta, Finland; [Uusitalo, Hannu] Univ Tampere, Sch Med, SILK, Dept Ophthalmol, FIN-33101 Tampere, Finland; [Uusitalo, Hannu] TAUH Eye Ctr, Tampere, Finland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21413, Saudi Arabia; [Tuomilehto, Jaakko] Dasman Diabet Inst, Kuwait, Kuwait	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; University of Oulu; Tampere University; Danube University Krems; Finland National Institute for Health & Welfare; King Abdulaziz University	Vaatainen, S (corresponding author), Univ Eastern Finland, Sch Pharm, Pharmacoecon & Outcomes Res Unit PHORU, Kuopio, Finland.	saku.vaatainen@uef.fi		Cederberg, Henna/0000-0003-2901-9373	Finnish Cultural Foundation (skr.fi)	Finnish Cultural Foundation (skr.fi)	This study was supported by an individual grant to the corresponding author (SV) from the Finnish Cultural Foundation (skr.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanne S, 2014, QUAL LIFE RES, V22, P1; Andersson S, 2013, SCAND J PRIM HEALTH, V31, P111, DOI 10.3109/02813432.2013.784541; Anokye NK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-624; Austin PC, 2000, QUAL LIFE RES, V9, P901, DOI 10.1023/A:1008938326604; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Brown N, 2012, DIABETES RES CLIN PR, V98, P369, DOI 10.1016/j.diabres.2012.09.005; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fayers PM, 2014, QUAL LIFE RES, V23, P1, DOI 10.1007/s11136-013-0443-4; Hawthorne G, 2001, ANN MED, V33, P358, DOI 10.3109/07853890109002090; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Heidemann C, 2009, EUR J EPIDEMIOL, V24, P281, DOI 10.1007/s10654-009-9338-7; Keating CL, 2013, OBESITY, V21, P652, DOI 10.1002/oby.20290; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162; Luo N, 2010, MED CARE, V48, P365, DOI 10.1097/MLR.0b013e3181c162a2; Neumann A, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0150-z; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Sabia S, 2012, CAN MED ASSOC J, V184, P1985, DOI 10.1503/cmaj.121080; Saramies J., 2005, THESIS U KUOPIO FINL; Savolainen J, 2014, SCAND J PUBLIC HEALT, V42, P163, DOI 10.1177/1403494813504837; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Sliventoinen K, 2005, EUR J CARDIOV PREV R, V12, P451, DOI 10.1097/01.hjr.0000174793.31812.21; Tapp R, 2010, DIABETES CARE, V33, P757, DOI 10.2337/dc09-1107; Vaatainen S, 2014, QUAL LIFE RES, V23, P1935, DOI 10.1007/s11136-014-0638-3; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; World Health Organization (WHO), 2009, GLOB HLTH RISK MORT; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097865	32	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147898	10.1371/journal.pone.0147898	http://dx.doi.org/10.1371/journal.pone.0147898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840374	Green Published, gold			2022-12-26	WOS:000369550200068
J	Yanagisawa, T; Takahashi, H; Suzuki, T; Masuda, A; Dohmae, N; Yokoyama, S				Yanagisawa, Tatsuo; Takahashi, Hideyuki; Suzuki, Takehiro; Masuda, Akiko; Dohmae, Naoshi; Yokoyama, Shigeyuki			Neisseria meningitidis Translation Elongation Factor P and Its Active-Site Arginine Residue Are Essential for Cell Viability	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; FACTOR EF-P; COMPLETE GENOME SEQUENCE; PEPTIDE-BOND FORMATION; ESCHERICHIA-COLI; AMINO-ACID; POSTTRANSLATIONAL MODIFICATION; PROMOTES TRANSLATION; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE	Translation elongation factor P (EF-P), a ubiquitous protein over the entire range of bacterial species, rescues ribosomal stalling at consecutive prolines in proteins. In Escherichia coli and Salmonella enterica, the post-translational beta-lysyl modification of Lys34 of EF-P is important for the EF-P activity. The beta-lysyl EF-P modification pathway is conserved among only 26-28% of bacteria. Recently, it was found that the Shewanella oneidensis and Pseudomonas aeruginosa EF-P proteins, containing an Arg residue at position 32, are modified with rhamnose, which is a novel post-translational modification. In these bacteria, EF-P and its Arg modification are both dispensable for cell viability, similar to the E. coli and S. enterica EF-P proteins and their Lys34 modification. However, in the present study, we found that EF-P and Arg32 are essential for the viability of the human pathogen, Neisseria meningitidis. We therefore analyzed the modification of Arg32 in the N. meningitidis EF-P protein, and identified the same rhamnosyl modification as in the S. oneidensis and P. aeruginosa EF-P proteins. N. meningitidis also has the orthologue of the rhamnosyl modification enzyme (EarP) from S. oneidensis and P. aeruginosa. Therefore, EarP should be a promising target for antibacterial drug development specifically against N. meningitidis. The pair of genes encoding N. meningitidis EF-P and EarP suppressed the slow-growth phenotype of the EF-P-deficient mutant of E. coli, indicating that the activity of N. meningitidis rhamnosyl-EF-P for rescuing the stalled ribosomes at proline stretches is similar to that of E. coli beta-lysyl-EF-P. The possible reasons for the unique requirement of rhamnosyl-EF-P for N. meningitidis cells are that more proline stretch-containing proteins are essential and/or the basal ribosomal activity to synthesize proline stretch-containing proteins in the absence of EF-P is lower in this bacterium than in others.	[Yanagisawa, Tatsuo; Yokoyama, Shigeyuki] RIKEN Struct Biol Lab, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Yanagisawa, Tatsuo; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Takahashi, Hideyuki] Natl Inst Infect Dis, Dept Bacteriol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan; [Suzuki, Takehiro; Masuda, Akiko; Dohmae, Naoshi] RIKEN Ctr Sustainable Resource Sci CSRS, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Masuda, Akiko] Natl Maritime Res Inst, 6-38-1 Shinkawa, Mitaka, Tokyo 1810004, Japan	RIKEN; RIKEN; National Institute of Infectious Diseases (NIID); RIKEN; National Maritime Research Institute	Yanagisawa, T; Yokoyama, S (corresponding author), RIKEN Struct Biol Lab, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.; Yanagisawa, T; Yokoyama, S (corresponding author), RIKEN Syst & Struct Biol Ctr, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	tatsuo.yanagisawa@riken.jp; yokoyama@riken.jp	Dohmae, Naoshi/C-2040-2011; Suzuki, Takehiro/B-3210-2013; Yokoyama, Shigeyuki/N-6911-2015	Dohmae, Naoshi/0000-0002-5242-9410; Yokoyama, Shigeyuki/0000-0003-3133-7338	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and development (AMED); Targeted Proteins Research Program (TPRP); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24590545]; Kurata Memorial Hitachi Science and Technology Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); Targeted Proteins Research Program (TPRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kurata Memorial Hitachi Science and Technology Foundation	This work was supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and development (AMED) (to S.Y.); the Targeted Proteins Research Program (TPRP) (to S.Y.); a Grants-in-Aid for Scientific Research (to H.T. grant number 24590545) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; and the Kurata Grant of the Kurata Memorial Hitachi Science and Technology Foundation (to T.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Balibar CJ, 2013, CURR MICROBIOL, V67, P293, DOI 10.1007/s00284-013-0363-0; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Choi S, 2011, PROTEINS, V79, P1688, DOI 10.1002/prot.22992; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Elgamal S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004553; Ganoza MC, 2002, MICROBIOL MOL BIOL R, V66, P460, DOI 10.1128/MMBR.66.3.460-485.2002; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; Iannino F, 2012, MICROB PATHOGENESIS, V52, P31, DOI 10.1016/j.micpath.2011.09.008; Kang YS, 2004, J BACTERIOL, V186, P4921, DOI 10.1128/JB.186.15.4921-4930.2004; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; Katz A, 2014, NUCLEIC ACIDS RES, V42, P3261, DOI 10.1093/nar/gkt1296; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kobayashi K, 2014, NUCLEIC ACIDS RES, V42, P12295, DOI 10.1093/nar/gku898; Lassak J, 2015, NAT CHEM BIOL, V11, P266, DOI [10.1038/nchembio.1751, 10.1038/NCHEMBIO.1751]; Marman HE, 2014, INFECT IMMUN, V82, P3612, DOI 10.1128/IAI.01532-13; MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P44, DOI 10.1016/0005-2744(81)90106-6; Masuda A, 2013, ANAL BIOANAL CHEM, V405, P8073, DOI 10.1007/s00216-013-7056-1; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Ohashi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2245, DOI 10.1271/bbb.67.2245; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; PARK MH, 1982, J BIOL CHEM, V257, P7217; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Peng WT, 2001, J BACTERIOL, V183, P36, DOI 10.1128/JB.183.1.36-45.2001; Rajkovic A, 2015, MBIO, V6, DOI 10.1128/mBio.00823-15; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Starosta AL, 2014, CELL REP, V9, P476, DOI 10.1016/j.celrep.2014.09.008; Starosta AL, 2014, NUCLEIC ACIDS RES, V42, P10711, DOI 10.1093/nar/gku768; Sumida T, 2010, ACTA CRYSTALLOGR F, V66, P1115, DOI 10.1107/S1744309110032008; Takahashi H, 2002, MICROBIOL-SGM, V148, P229, DOI 10.1099/00221287-148-1-229; Takahashi H, 2008, INFECT IMMUN, V76, P5777, DOI 10.1128/IAI.00676-08; Takahashi H, 2008, FEMS IMMUNOL MED MIC, V52, P36, DOI 10.1111/j.1574-695X.2007.00342.x; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Yanagisawa T, 2003, J BIOL CHEM, V278, P25887, DOI 10.1074/jbc.M302633200; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Yanagisawa T, 2008, CHEM BIOL, V15, P1187, DOI 10.1016/j.chembiol.2008.10.004; Yasuno S, 1997, BIOSCI BIOTECH BIOCH, V61, P1944, DOI 10.1271/bbb.61.1944; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	57	28	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147907	10.1371/journal.pone.0147907	http://dx.doi.org/10.1371/journal.pone.0147907			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840407	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200069
J	Zoz, F; Iaconelli, C; Lang, E; Iddir, H; Guyot, S; Grandvalet, C; Gervais, P; Beney, L				Zoz, Fiona; Iaconelli, Cyril; Lang, Emilie; Iddir, Hayet; Guyot, Stephane; Grandvalet, Cosette; Gervais, Patrick; Beney, Laurent			Control of Relative Air Humidity as a Potential Means to Improve Hygiene on Surfaces: A Preliminary Approach with Listeria monocytogenes	PLOS ONE			English	Article							ESCHERICHIA-COLI; DESICCATION SURVIVAL; SODIUM-CHLORIDE; TEMPERATURE; CONTAMINATION; PREVALENCE; TOLERANCE; MEMBRANE; KINETICS; BACTERIA	Relative air humidity fluctuations could potentially affect the development and persistence of pathogenic microorganisms in their environments. This study aimed to characterize the impact of relative air humidity (RH) variations on the survival of Listeria monocytogenes, a bacterium persisting on food processing plant surfaces. To assess conditions leading to the lowest survival rate, four strains of L. monocytogenes (EGDe, CCL500, CCL128, and LO28) were exposed to different RH conditions (75%, 68%, 43% and 11%) with different drying kinetics and then rehydrated either progressively or instantaneously. The main factors that affected the survival of L. monocytogenes were RH level and rehydration kinetics. Lowest survival rates between 1% and 0.001% were obtained after 3 hours of treatment under optimal conditions (68% RH and instantaneous rehydration). The survival rate was decreased under 0.001% after prolonged exposure (16h) of cells under optimal conditions. Application of two successive dehydration and rehydration cycles led to an additional decrease in survival rate. This preliminary study, performed in model conditions with L. monocytogenes, showed that controlled ambient RH fluctuations could offer new possibilities to control foodborne pathogens in food processing environments and improve food safety.	[Zoz, Fiona; Iaconelli, Cyril; Lang, Emilie; Iddir, Hayet; Guyot, Stephane; Grandvalet, Cosette; Gervais, Patrick; Beney, Laurent] UMR PAM Univ Bourgogne Franche Comte AgroSup Dijo, Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne	Beney, L (corresponding author), UMR PAM Univ Bourgogne Franche Comte AgroSup Dijo, Dijon, France.	lbeney@u-bourgogne.fr	Lang, Emilie/U-8120-2019; Guyot, Stéphane/A-3482-2012	Guyot, Stéphane/0000-0002-2316-234X; Laurent, Beney/0000-0002-2757-2506	French Agence Nationale de la Recherche (ANR) under the project "EcoSec"; Agence Nationale de la Recherche (France)	French Agence Nationale de la Recherche (ANR) under the project "EcoSec"(French National Research Agency (ANR)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR))	This work was supported by French Agence Nationale de la Recherche (ANR) under the project "EcoSec". We thank all partners of EcoSec project: Labeyrie-Group, Dessica, MF conseil, IRSTEA, ANSES SBCL Unit: Staphylocoques, Bacillus, Clostridies et Lait, INRA-Theix UR454 Microbiologie.; This work received support from the Agence Nationale de la Recherche (France): Fiona Zoz grant (PhD student), materials, chemicals, equipment.	[Anonymous], 2014, SUNBURST FOODS RECAL; [Anonymous], 2011, ALPINE SLICING CHEES; Autio T, 1999, APPL ENVIRON MICROB, V65, P150; BATEMAN JB, 1962, J GEN MICROBIOL, V29, P207, DOI 10.1099/00221287-29-2-207; Becavin C, 2014, MBIO, V5, DOI 10.1128/mBio.00969-14; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Castro HP, 1995, APPL MICROBIOL BIOT, V44, P172, DOI [10.1007/BF00164498, 10.1007/s002530050537]; Chmielewski R A N, 2003, Compr Rev Food Sci Food Saf, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x; COX L J, 1989, Food Microbiology (London), V6, P49, DOI 10.1016/S0740-0020(89)80037-1; DUNKLIN EW, 1948, J EXP MED, V87, P87, DOI 10.1084/jem.87.2.87; Dupont S, 2014, APPL MICROBIOL BIOT, V98, P8821, DOI 10.1007/s00253-014-6028-5; Dupont S, 2010, BBA-BIOMEMBRANES, V1798, P975, DOI 10.1016/j.bbamem.2010.01.015; FENLON DR, 1985, J APPL BACTERIOL, V59, P537, DOI 10.1111/j.1365-2672.1985.tb03357.x; Gandhi M, 2007, INT J FOOD MICROBIOL, V113, P1, DOI 10.1016/j.ijfoodmicro.2006.07.008; Golowczyc MA, 2011, BIOTECHNOL LETT, V33, P681, DOI 10.1007/s10529-010-0491-6; Hingston PA, 2015, APPL ENV MI IN PRESS; Huang YN, 2015, FOOD MICROBIOL, V46, P443, DOI 10.1016/j.fm.2014.09.007; King And Prince Seafood Corp, 2011, ISS VOL REC NOT NOV; Kramarenko T, 2013, FOOD CONTROL, V30, P24, DOI 10.1016/j.foodcont.2012.06.047; Laksanalamai P, 2012, PLOS ONE, V7; Lambertz ST, 2012, INT J FOOD MICROBIOL, V160, P24, DOI 10.1016/j.ijfoodmicro.2012.09.010; Lemetais G, 2012, APPL MICROBIOL BIOT, V96, P471, DOI 10.1007/s00253-012-4014-3; Lin CM, 2006, J FOOD PROTECT, V69, P71, DOI 10.4315/0362-028X-69.1.71; MCCLURE PJ, 1989, LETT APPL MICROBIOL, V9, P95, DOI 10.1111/j.1472-765X.1989.tb00299.x; MCELDOWNEY S, 1988, LETT APPL MICROBIOL, V7, P83, DOI 10.1111/j.1472-765X.1988.tb01258.x; Miettinen MK, 1999, INT J FOOD MICROBIOL, V46, P187, DOI 10.1016/S0168-1605(98)00185-8; Mille Y, 2003, BIOTECHNOL BIOENG, V83, P578, DOI 10.1002/bit.10706; Morgan CA, 2006, J MICROBIOL METH, V66, P183, DOI 10.1016/j.mimet.2006.02.017; Murray EGD, 1926, J PATHOL BACTERIOL, V29, P407, DOI 10.1002/path.1700290409; Parisi A, 2013, FOOD CONTROL, V29, P91, DOI 10.1016/j.foodcont.2012.05.036; Poirier I, 1998, APPL MICROBIOL BIOT, V50, P704, DOI 10.1007/s002530051354; Pompermayer DMC, 2000, FOOD MICROBIOL, V17, P361, DOI 10.1006/fmic.1999.0291; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Rome Packing Co. Inc., 2014, REC FRESH FROZ CRAB; Sleator RD, 2001, APPL ENVIRON MICROB, V67, P2692, DOI 10.1128/AEM.67.6.2692-2698.2001; STOKES RH, 1949, IND ENG CHEM, V41, P2013, DOI 10.1021/ie50477a041; Takahashi H, 2011, FOOD CONTROL, V22, P633, DOI 10.1016/j.foodcont.2010.09.003; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; VICENTE MF, 1985, FEMS MICROBIOL LETT, V30, P77; Vogel BF, 2010, INT J FOOD MICROBIOL, V140, P192, DOI 10.1016/j.ijfoodmicro.2010.03.035; WALKER SJ, 1990, J APPL BACTERIOL, V68, P157, DOI 10.1111/j.1365-2672.1990.tb02561.x; WATKINS J, 1981, J APPL BACTERIOL, V50, P1, DOI 10.1111/j.1365-2672.1981.tb00865.x; WEIS J, 1975, APPL MICROBIOL, V30, P29, DOI 10.1128/AEM.30.1.29-32.1975; WELSHIMER HJ, 1971, APPL MICROBIOL, V21, P516, DOI 10.1128/AEM.21.3.516-519.1971; Wilks SA, 2006, INT J FOOD MICROBIOL, V111, P93, DOI 10.1016/j.ijfoodmicro.2006.04.037; Wing EJ, 2002, J INFECT DIS, V185, pS18, DOI 10.1086/338465; Wolkers WF, 1998, BBA-GEN SUBJECTS, V1425, P127, DOI 10.1016/S0304-4165(98)00059-2	48	29	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148418	10.1371/journal.pone.0148418	http://dx.doi.org/10.1371/journal.pone.0148418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840373	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200133
J	Li, Z; Zhu, YZ; Huang, TL; Hisatome, I; Yamamoto, T; Cheng, JD				Li Zhi; Zhu Yuzhang; Huang Tianliang; Hisatome, Ichiro; Yamamoto, Tetsuya; Cheng Jidong			High Uric Acid Induces Insulin Resistance in Cardiomyocytes In Vitro and In Vivo	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; GLUCOSE-UPTAKE; HEART-FAILURE; CAUSAL ROLE; RISK-FACTOR; DYSFUNCTION; PATHWAYS; SURVIVAL	Clinical studies have shown hyperuricemia strongly associated with insulin resistance as well as cardiovascular disease. Direct evidence of how high uric acid (HUA) affects insulin resistance in cardiomyocytes, but the pathological mechanism of HUA associated with cardiovascular disease remains to be clarified. We aimed to examine the effect of HUA on insulin sensitivity in cardiomyocytes and on insulin resistance in hyperuricemic mouse model. We exposed primary cardiomyocytes and a rat cardiomyocyte cell line, H9c2 cardiomyocytes, to HUA, then quantified glucose uptake with a fluorescent glucose analog, 2-NBDG, after insulin challenge and detected reactive oxygen species (ROS) production. Western blot analysis was used to examine the levels of insulin receptor (IR), phosphorylated insulin receptor substrate 1 (IRS1, Ser307) and phospho-Akt (Ser473). We monitored the impact of HUA on insulin resistance, insulin signaling and IR, phospho-IRS1 (Ser307) and phospho-Akt levels in myocardial tissue of an acute hyperuricemia mouse model established by potassium oxonate treatment. HUA inhibited insulin-induced glucose uptake in H9c2 and primary cardiomyocytes. It increased ROS production; pretreatment with N-acetyl-L-cysteine (NAC), a ROS scavenger, reversed HUA-inhibited glucose uptake induced by insulin. HUA exposure directly increased the phospho-IRS1 (Ser307) response to insulin and inhibited that of phospho-Akt in H9C2 cardiomyocytes, which was blocked by NAC. Furthermore, the acute hyperuricemic mice model showed impaired glucose tolerance and insulin tolerance accompanied by increased phospho-IRS1 (Ser307) and inhibited phospho-Akt response to insulin in myocardial tissues. HUA inhibited insulin signaling and induced insulin resistance in cardiomyocytes in vitro and in vivo, which is a novel potential mechanism of hyperuricemic-related cardiovascular disease.	[Li Zhi; Huang Tianliang; Cheng Jidong] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, Shantou, Guangdong, Peoples R China; [Li Zhi] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Internal Med, Shantou, Guangdong, Peoples R China; [Li Zhi] Chaozhou Peoples Hosp, Dept Internal Med, Chaozhou, Guangdong, Peoples R China; [Zhu Yuzhang] Second Hosp Jiaxing City, Dept Internal Med, Jiaxing, Zhejiang, Peoples R China; [Hisatome, Ichiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Regenerat Med & Therapeut, Yonago, Tottori, Japan; [Yamamoto, Tetsuya] Hyogo Coll Med, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan	Shantou University; Shantou University; Tottori University; Hyogo College of Medicine	Cheng, JD (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, Shantou, Guangdong, Peoples R China.	jidongcheng36@126.com			National Natural Science Foundation of China [81070673]; Special Foundation of Guangdong Province College Talent Introduction [10027425]; Scientific Research Foundation for Returning Overseas Chinese Scholars, State Education Ministry [20111568]; Natural Science Foundation of Guangdong Province [S2011010005102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation of Guangdong Province College Talent Introduction; Scientific Research Foundation for Returning Overseas Chinese Scholars, State Education Ministry; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Natural Science Foundation of China (81070673), the Special Foundation of Guangdong Province College Talent Introduction (10027425), the Project Sponsored by the Scientific Research Foundation for Returning Overseas Chinese Scholars, State Education Ministry (20111568), and the Natural Science Foundation of Guangdong Province (S2011010005102).	Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Barbu A, 2002, MOL CELL ENDOCRINOL, V190, P75, DOI 10.1016/S0303-7207(02)00009-6; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Doehner W, 2005, J AM COLL CARDIOL, V46, P1019, DOI 10.1016/j.jacc.2005.02.093; Dong F, 2006, DIABETOLOGIA, V49, P1421, DOI 10.1007/s00125-006-0230-7; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Hirofumi H, 2011, AM J PHYSIOL-CELL PH, V301, pC1415; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Ingelsson E, 2005, JAMA-J AM MED ASSOC, V294, P334, DOI 10.1001/jama.294.3.334; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Leyva F, 1997, EUR HEART J, V18, P858; Li JM, 2011, EUR J PHARMACOL, V666, P196, DOI 10.1016/j.ejphar.2011.05.021; Liu Q, 2013, CHINESE MED J-PEKING, V126, P4037, DOI 10.3760/cma.j.issn.0366-6999.20130685; Matsui T, 2005, J MOL CELL CARDIOL, V38, P63, DOI 10.1016/j.yjmcc.2004.11.005; Mellor KM, 2010, CLIN EXP PHARMACOL P, V37, P222, DOI 10.1111/j.1440-1681.2009.05274.x; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Paolisso G, 1999, AM J CARDIOL, V83, P1338, DOI 10.1016/S0002-9149(99)00097-1; Ritchie RH, 2009, HEART LUNG CIRC, V18, P11, DOI 10.1016/j.hlc.2008.11.003; Santos FR, 2012, ARCH PHYSIOL BIOCHEM, V118, P231, DOI 10.3109/13813455.2012.713366; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Wang C, 2013, CARDIOVASC RES, V100, P114, DOI 10.1093/cvr/cvt160; Yang J, 2006, ENDOCRINOLOGY, V147, P2728, DOI 10.1210/en.2005-1433; Yoneyama Y, 2013, MOL CELL BIOL, V33, P1991, DOI 10.1128/MCB.01394-12; Yu B, 1999, AM J PHYSIOL-ENDOC M, V277, pE259, DOI 10.1152/ajpendo.1999.277.2.E259; Yue RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050778; Zhang JX, 2015, ENDOCRINE, V48, P135, DOI 10.1007/s12020-014-0239-5; Zhang YN, 2013, MOL CELL ENDOCRINOL, V375, P89, DOI 10.1016/j.mce.2013.04.027; Zhu Y, 2013, MOL ENDOCRINOL, V27, P172, DOI 10.1210/me.2012-1210; Zhu YZ, 2014, BIOCHEM BIOPH RES CO, V447, P707, DOI 10.1016/j.bbrc.2014.04.080; Zhuang YB, 2014, AM J PHYSIOL-RENAL, V307, pF396, DOI 10.1152/ajprenal.00565.2013	31	28	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0147737	10.1371/journal.pone.0147737	http://dx.doi.org/10.1371/journal.pone.0147737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26836389	gold, Green Published, Green Submitted			2022-12-26	WOS:000369548500003
J	Sagili, KD; Satyanarayana, S; Chadha, SS				Sagili, Karuna D.; Satyanarayana, Srinath; Chadha, Sarabjit S.			Is Knowledge Regarding Tuberculosis Associated with Stigmatising and Discriminating Attitudes of General Population towards Tuberculosis Patients? Findings from a Community Based Survey in 30 Districts of India	PLOS ONE			English	Article							GENDER	Background Stigmatising and discriminating attitudes may discourage tuberculosis (TB) patients from actively seeking medical care, hide their disease status, and discontinue treatment. It is expected that appropriate knowledge regarding TB should remove stigmatising and discriminating attitudes. In this study we assessed the prevalence of stigmatising and discriminating attitudes towards TB patients among general population and their association with knowledge regarding TB. Method A cross-sectional knowledge, attitude and practice survey was conducted in 30 districts of India in January-March 2011. A total of 4562 respondents from general population were interviewed using semi-structured questionnaires which contained items to measure stigma, discrimination and knowledge on TB. Result Of the 4562 interviewed, 3823 were eligible for the current analysis. Of these, 73% (95% CI 71.4-74.2) had stigmatising and 98% (95% CI 97.4-98.3) had discriminating attitude towards TB patients. Only 17% (95% CI 15.6-18.0) of the respondents had appropriate knowledge regarding TB with even lower levels observed amongst females, rural areas and respondents from low income groups. Surprisingly stigmatising (adjusted OR 1.31 (0.782.18) and discriminating (adjusted OR 0.79 (0.43-1.44) attitudes were independent of knowledge regarding TB. Conclusion Stigmatising and discriminating attitudes towards TB patients remain high among the general population in India. Since these attitudes were independent of the knowledge regarding TB, it is possible that the current disseminated knowledge regarding TB which is mainly from a medical perspective may not be adequately addressing the factors that lead to stigma and discrimination towards TB patients. Therefore, there is an urgent need to review the messages and strategies currently used for disseminating knowledge regarding TB among general population and revise them appropriately. The disseminated knowledge should include medical, psycho-social and economic aspects of TB that not only informs people about medical aspects of TB disease, but also removes stigma and discrimination.	[Sagili, Karuna D.; Satyanarayana, Srinath; Chadha, Sarabjit S.] South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India		Sagili, KD (corresponding author), South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India.	drkarunas@gmail.com		Satyanarayana, Srinath/0000-0002-5420-2551	Global Fund [IDA-910-G17-T]; Program Management Unit at the Union South East Asia office	Global Fund; Program Management Unit at the Union South East Asia office	This study analyses the data from a community based KAP survey conducted as part of Project Axshya funded by Global Fund (IDA-910-G17-T). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank the team at GfK MODE, New Delhi for their enthusiastic support in conducting this survey. We acknowledge the support of the Program Management Unit at the Union South East Asia office for their support in conducting the survey. We also thank the Deputy Director General (TB), Central TB Division, Ministry of Health and Family Welfare, Government of India for providing necessary consent to carry out this study, and the district TB officers and their staff of the various surveyed districts for supporting the data collection process. We are also thankful to Dr. Vivek Gupta, former OR Fellow at The Union South East Asia office for his support in statistical analysis.	Ali M, 2014, LANCET, V383, P2195, DOI 10.1016/S0140-6736(14)61063-1; [Anonymous], INF ED COMM MAT; Aryal S, 2012, Kathmandu Univ Med J (KUMJ), V10, P48; Atre SR, 2004, TROP MED INT HEALTH, V9, P1228, DOI 10.1111/j.1365-3156.2004.01321.x; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Central Tuberculosis Division, 2005, HLTH COMM STRAT RNTC; Central Tuberculosis Division, 2003, BAS KAP STUD RNTCP P; Central Tuberculosis Division, 2014, OP HDB ADV COMM SOC; Chang SH, 2014, INT J TUBERC LUNG D, V18, P168, DOI 10.5588/ijtld.13.0181; Courtwright A, 2010, PUBLIC HLTH REPOR S4, V125; Dhingra V K, 2010, Indian J Tuberc, V57, P12; Ganapathy Sudha, 2008, Indian J Tuberc, V55, P9; Global health strategies, 2013, HDB TUB IND; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Jaggarajamma K, 2008, Indian J Tuberc, V55, P179; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Mathew AS, 2007, CLIN INFECT DIS, V45, P1247, DOI 10.1086/522312; Satyanarayana S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024160; Sermrittirong S, 2015, LEPROSY REV, V86, P54; Sharma N, 2007, INT J TROPICAL MED, V4, P2; Somma D, 2008, INT J TUBERC LUNG D, V12, P856; Van Brakel Wim H, 2006, Psychol Health Med, V11, P307, DOI 10.1080/13548500600595160; World Health Organization, 2014, GLOB TUB REP	23	24	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147274	10.1371/journal.pone.0147274	http://dx.doi.org/10.1371/journal.pone.0147274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829713	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200017
J	Wei, J; Lei, GH; Fu, L; Zeng, C; Yang, T; Peng, SF				Wei, Jie; Lei, Guang-hua; Fu, Lei; Zeng, Chao; Yang, Tuo; Peng, Shi-fang			Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults	PLOS ONE			English	Article							MORBIDLY OBESE-PATIENTS; METABOLIC SYNDROME; CHINESE ADULTS; ASCORBIC-ACID; INSULIN-RESISTANCE; ANTIOXIDANT STATUS; OXIDATIVE STRESS; STEATOHEPATITIS; CHILDREN; SERUM	Background Non-alcoholic fatty liver disease (NAFLD) has become one of the most prevalent chronic liver disease all over the world. The objective of this study was to evaluate the association between dietary vitamin C intake and NAFLD. Method Subjects were diagnosed with NAFLD by abdominal ultrasound examination and the consumption of alcohol was less than 40g/day for men or less than 20g/day for women. Vitamin C intake was classified into four categories according to the quartile distribution in the study population: <= 74.80 mg/day, 74.81-110.15 mg/day, 110.16-146.06 mg/day, and >= 146.07 mg/day. The energy and multi-variable adjusted odds ratio (OR), as well as their corresponding 95% confidence interval (CI), were used to determine the relationship between dietary vitamin C intake and NAFLD through logistic regression. Result The present cross-sectional study included 3471 subjects. A significant inverse association between dietary vitamin C intake and NAFLD was observed in the energy-adjusted and the multivariable model. The multivariable adjusted ORs (95% CI) for NAFLD were 0.69 (95% CI: 0.54-0.89), 0.93 (95% CI: 0.72-1.20), and 0.71 (95% CI: 0.53-0.95) in the second, third and fourth dietary vitamin C intake quartiles, respectively, compared with the lowest (first) quartile. The relative odds of NAFLD was decreased by 0.71 times in the fourth quartile of dietary vitamin C intake compared with the lowest quartile. After stratifying data by sex or the status of obesity, the inverse association remained valid in the male population or non-obesity population, but not in the female population or obesity population. Conclusion There might be a moderate inverse association between dietary vitamin C intake and NAFLD in middle-aged and older adults, especially for the male population and non-obesity population.	[Wei, Jie; Peng, Shi-fang] Cent S Univ, Xiangya Hosp, Hlth Management Ctr, Changsha, Hunan, Peoples R China; [Fu, Lei; Peng, Shi-fang] Cent S Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Wei, Jie] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Lei, Guang-hua; Zeng, Chao; Yang, Tuo] Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Peng, SF (corresponding author), Cent S Univ, Xiangya Hosp, Hlth Management Ctr, Changsha, Hunan, Peoples R China.; Peng, SF (corresponding author), Cent S Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China.	sfp1988@hotmail.com	Wei, Jie/ACR-8087-2022	Wei, Jie/0000-0003-3510-8241	Hunan Provincial Innovation Foundation for Postgraduate [CX2014B096]; Fundamental Research Funds for the Central Universities of Central South University [2014zzts070]	Hunan Provincial Innovation Foundation for Postgraduate; Fundamental Research Funds for the Central Universities of Central South University	JW accepted funding support from Hunan Provincial Innovation Foundation for Postgraduate (CX2014B096), the Fundamental Research Funds for the Central Universities of Central South University (2014zzts070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasheim ET, 2008, AM J CLIN NUTR, V87, P362, DOI 10.1093/ajcn/87.2.362; Bian SS, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-106; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Canbakan B, 2007, ACTA GASTRO-ENT BELG, V70, P277; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chan R, 2015, PLOS ONE, V10; Da SH, 2014, J ACAD NUTR DIET, V114, P1181, DOI [10.1016/j.jand.2014.01.009, DOI 10.1016/J.JAND.2014.01.009]; Day CP, 2002, BEST PRACT RES CL GA, V16, P663, DOI 10.1053/bega.2002.0333; Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association, 2006, ZHONGHUA GAN ZANG BI, V14, P161; Ford ES, 2003, DIABETES, V52, P2346, DOI 10.2337/diabetes.52.9.2346; Foster T, 2011, AM J GASTROENTEROL, V106, P71, DOI 10.1038/ajg.2010.299; Gambino R, 2011, ANTIOXID REDOX SIGN, V15, P1325, DOI 10.1089/ars.2009.3058; GINTER E, 1975, ANN NY ACAD SCI, V258, P410, DOI 10.1111/j.1749-6632.1975.tb29299.x; Han JM, 2014, J GASTROEN HEPATOL, V29, P1265, DOI 10.1111/jgh.12520; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1111/j.1572-0241.2003.08699.x; Ipsen DH, 2014, NUTRIENTS, V6, P5473, DOI 10.3390/nu6125473; Jankovic A, 2014, METABOLISM, V63, P661, DOI 10.1016/j.metabol.2014.01.009; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Li YR, 2013, ASIA PAC J CLIN NUTR, V22, P60, DOI 10.6133/apjcn.2013.22.1.06; Li ZZ, 2014, J GASTROEN HEPATOL, V29, P42, DOI 10.1111/jgh.12428; Lirussi F, 2007, COCHRANE DB SYST REV, pD4996; Madan K, 2006, J CLIN GASTROENTEROL, V40, P930, DOI 10.1097/01.mcg.0000212608.59090.08; Mah E, 2011, J AM DIET ASSOC, V111, P737, DOI 10.1016/j.jada.2011.02.003; Motamed Soudabe, 2013, N Am J Med Sci, V5, P377, DOI 10.4103/1947-2714.114171; Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132; NAMBISAN B, 1975, ATHEROSCLEROSIS, V22, P447, DOI 10.1016/0021-9150(75)90024-6; Nobili V, 2006, ALIMENT PHARM THER, V24, P1553, DOI 10.1111/j.1365-2036.2006.03161.x; Nobili V, 2008, HEPATOLOGY, V48, P119, DOI 10.1002/hep.22336; Papandreou D, 2007, CLIN NUTR, V26, P409, DOI 10.1016/j.clnu.2007.02.002; Valdecantos MP, 2010, REDOX REP, V15, P207, DOI 10.1179/135100010X12826446921464; Polimeni L, 2015, WORLD J HEPATOL, V7, P1325, DOI 10.4254/wjh.v7.i10.1325; Rezazadeh A, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-26; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Rose FJ, 2010, DIABETES OBES METAB, V12, P1084, DOI 10.1111/j.1463-1326.2010.01297.x; Sun C, 2013, NUTR FOOD HYGIENE; Sun W, 2015, QJM-INT J MED, V108, P617, DOI 10.1093/qjmed/hcv006; Uzun H, 2004, OBES SURG, V14, P659, DOI 10.1381/096089204323093453; Veena J, 2014, BRIT J NUTR, V112, P1858, DOI 10.1017/S0007114514002591; Wei J, 2015, PLOS ONE, V10; Wei J, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0007-2; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wu SJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000802; Yang CQ, 2015, NUTRIENTS, V7, P4778, DOI 10.3390/nu7064778; Yang YX, 2009, CHINA FOOD COMPOSITI; Zeng C., 2015, PLOS ONE, V10; Zeng C, 2015, J RHEUMATOL, V42, P1231, DOI 10.3899/jrheum.141414; Zhang ZC, 2015, J HEPATOL	48	37	39	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147985	10.1371/journal.pone.0147985	http://dx.doi.org/10.1371/journal.pone.0147985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824361	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528600083
J	Kabir, I; Li, ZQ; Bui, HH; Kuo, MS; Gao, GP; Jiang, XC				Kabir, Inamul; Li, Zhiqiang; Bui, Hai H.; Kuo, Ming-Shang; Gao, Guangping; Jiang, Xian-Cheng			Small Intestine but Not Liver Lysophosphatidylcholine Acyltransferase 3 (Lpcat3) Deficiency Has a Dominant Effect on Plasma Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; PHOSPHOLIPID-TRANSFER PROTEIN; FATTY-ACID; ABSORPTION; IDENTIFICATION; MICE; ATHEROSCLEROSIS; TRANSPORT; GENE; LKB1	Lysophosphatidylcholine acyltransferase 3 (Lpcat3) is involved in phosphatidylcholine remodeling in the small intestine and liver. We investigated lipid metabolism in inducible intestine-specific and liver-specific Lpcat3 gene knock-out mice. We produced Lpcat3-Flox/villin-Cre-ERT2 mice, which were treated with tamoxifen (at days 1, 3, 5, and 7), to delete Lpcat3 specifically in the small intestine. At day 9 after the treatment, we found that Lpcat3 deficiency in enterocytes significantly reduced polyunsaturated phosphatidylcholines in the enterocyte plasma membrane and reduced Niemann-Pick C1-like 1 (NPC1L1), CD36, ATP-binding cassette transporter 1 (ABCA1), and ABCG8 levels on the membrane, thus significantly reducing lipid absorption, cholesterol secretion through apoB-dependent and apoB-independent pathways, and plasma triglyceride, cholesterol, and phospholipid levels, as well as body weight. Moreover, Lpcat3 deficiency does not cause significant lipid accumulation in the small intestine. We also utilized adenovirus-associated virus-Cre to deplete Lpcat3 in the liver. We found that liver deficiency only reduces plasma triglyceride levels but not other lipid levels. Furthermore, there is no significant lipid accumulation in the liver. Importantly, small intestine Lpcat3 deficiency has a much bigger effect on plasma lipid levels than that of liver deficiency. Thus, inhibition of small intestine Lpcat3 might constitute a novel approach for treating hyperlipidemia.	[Kabir, Inamul; Li, Zhiqiang; Jiang, Xian-Cheng] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Li, Zhiqiang; Jiang, Xian-Cheng] Vet Affairs New York Harbor Healthcare Syst, Mol & Cellular Cardiol Program, Brooklyn, NY 11209 USA; [Bui, Hai H.; Kuo, Ming-Shang] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Gao, Guangping] Univ Massachusetts, Sch Med, Horae Gene Therapy Ctr, Worcester, MA 01605 USA; [Gao, Guangping] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Eli Lilly; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Jiang, XC (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.; Jiang, XC (corresponding author), Vet Affairs New York Harbor Healthcare Syst, Mol & Cellular Cardiol Program, Brooklyn, NY 11209 USA.	xjiang@downstate.edu		Kabir, Inamul/0000-0001-6207-1785	Veterans Affairs Merit Grant [000900-01]; National Institutes of Health [R56HL121409]; National Natural Scientific Foundation (NSF) of China [31371190]; American Heart Association [10SDG4040054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL121409] Funding Source: NIH RePORTER	Veterans Affairs Merit Grant(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Scientific Foundation (NSF) of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Veterans Affairs Merit Grant 000900-01 (to X. C. J.), National Institutes of Health Grant R56HL121409 (to X. C. J.), National Natural Scientific Foundation (NSF) of China Grant 31371190 (to X. C. J.), and Scientist Development Grant 10SDG4040054 from the American Heart Association (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; GLICKMAN RM, 1977, P NATL ACAD SCI USA, V74, P2569, DOI 10.1073/pnas.74.6.2569; GLICKMAN RM, 1973, J CLIN INVEST, V52, P2910, DOI 10.1172/JCI107487; GLICKMAN RM, 1978, NEW ENGL J MED, V299, P1424, DOI 10.1056/NEJM197812282992602; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; HAYASHI Y, 1993, MOL ENDOCRINOL, V7, P1049, DOI 10.1210/me.7.8.1049; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; Iqbal J, 2013, J BIOL CHEM, V288, P30432, DOI 10.1074/jbc.M113.501247; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; Kitajima K, 2006, ARTERIOSCL THROM VAS, V26, P1852, DOI 10.1161/01.ATV.0000231520.26490.54; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Li PS, 2014, NAT MED, V20, P80, DOI 10.1038/nm.3417; Li ZQ, 2015, GASTROENTEROLOGY, V149, P1519, DOI 10.1053/j.gastro.2015.07.012; Li ZQ, 2012, J BIOL CHEM, V287, P20122, DOI 10.1074/jbc.M111.334664; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Liu R, 2007, ARTERIOSCL THROM VAS, V27, P2014, DOI 10.1161/ATVBAHA.107.149914; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Pan XY, 2012, BBA-MOL CELL BIOL L, V1821, P727, DOI 10.1016/j.bbalip.2011.09.013; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rong X, 2015, ELIFE, V4, DOI 10.7554/eLife.06557; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Schiller J, 2001, J LIPID RES, V42, P1501; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; STREMMEL W, 1985, J CLIN INVEST, V75, P1068, DOI 10.1172/JCI111769; TALL AR, 1979, J CLIN INVEST, V64, P977, DOI 10.1172/JCI109564; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANCE DE, 2002, PHOSPHOLIPID BIOSYNT; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	37	29	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7651	7660		10.1074/jbc.M115.697011	http://dx.doi.org/10.1074/jbc.M115.697011			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26828064	hybrid, Green Published			2022-12-26	WOS:000383447600036
J	Bi, DX; Xie, YZ; Tai, C; Jiang, XF; Zhang, J; Harrison, EM; Jia, SR; Deng, ZX; Rajakumar, K; Ou, HY				Bi, Dexi; Xie, Yingzhou; Tai, Cui; Jiang, Xiaofei; Zhang, Jie; Harrison, Ewan M.; Jia, Shiru; Deng, Zixin; Rajakumar, Kumar; Ou, Hong-Yu			A Site-Specific Integrative Plasmid Found in Pseudomonas aeruginosa Clinical Isolate HS87 along with A Plasmid Carrying an Aminoglycoside-Resistant Gene	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; METALLO-BETA-LACTAMASE; NUCLEOTIDE-SEQUENCE; IDENTIFICATION; VIRULENCE; INTEGRONS; BACTERIA; ISLANDS	Plasmids play critical roles in bacterial fitness and evolution of Pseudomonas aeruginosa. Here two plasmids found in a drug-resistant P. aeruginosa clinical isolate HS87 were completely sequenced. The pHS87b plasmid (11.2 kb) carries phage-related genes and function-unknown genes. Notably, pHS87b encodes an integrase and has an adjacent tRNA(Thr)-associated attachment site. A corresponding integrated form of pHS87b at the tRNA(Thr) locus was identified on the chromosome of P. aeruginosa, showing that pHS87b is able to site-specifically integrate into the 3'-end of the tRNA(Thr) gene. The pHS87a plasmid (26.8 kb) displays a plastic structure containing a putative replication module, stability factors and a variable region. The RepA of pHS87a shows significant similarity to the replication proteins of pPT23A-family plasmids. pHS87a carries a transposon Tn6049, a truncated insertion sequence Delta IS1071 and a Tn402-like class 1 integron which contains an aacA4 cassette that may confer aminoglycoside resistance. Thus, pHS87b is a site-specific integrative plasmid whereas pHS87a is a plastic antibiotic resistance plasmid. The two native plasmids may promote the fitness and evolution of P. aeruginosa.	[Bi, Dexi; Xie, Yingzhou; Tai, Cui; Deng, Zixin; Ou, Hong-Yu] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Bi, Dexi; Xie, Yingzhou; Tai, Cui; Deng, Zixin; Ou, Hong-Yu] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Jiang, Xiaofei] Fudan Univ, Dept Lab Med, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhang, Jie; Jia, Shiru] Tianjin Univ Sci & Technol, Key Lab Ind Microbiol, Minist Educ, Tianjin, Peoples R China; [Harrison, Ewan M.; Rajakumar, Kumar] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Tianjin University Science & Technology; University of Leicester	Ou, HY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.; Ou, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	hyou@sjtu.edu.cn	jia, shi/HHS-4172-2022; Harrison, Ewan/I-5003-2013	Harrison, Ewan/0000-0003-2720-0507; Bi, Dexi/0000-0001-9325-8868	973 program, Ministry of Science and Technology, China [2015CB554202]; National Natural Science Foundation of China [31170082]; Specialized Research Fund for the Doctoral Program of Higher Education, China [20130073110062]; Sino-UK Higher Education Research Partnership	973 program, Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education, China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Sino-UK Higher Education Research Partnership	The 973 program, Ministry of Science and Technology, China (2015CB554202); National Natural Science Foundation of China (31170082); Specialized Research Fund for the Doctoral Program of Higher Education, China (20130073110062); Sino-UK Higher Education Research Partnership for PhD Studies grant (to HYO and KR).	Borodovsky Mark, 2003, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0405s01; Boyd EF, 2009, TRENDS MICROBIOL, V17, P47, DOI 10.1016/j.tim.2008.11.003; CAMPBELL AM, 1992, J BACTERIOL, V174, P7495, DOI 10.1128/JB.174.23.7495-7499.1992; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Di Pilato V, 2014, J ANTIMICROB CHEMOTH, V69, P67, DOI 10.1093/jac/dkt311; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENGLISH RS, 1995, PLASMID, V33, P1, DOI 10.1006/plas.1995.1001; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Gillings MR, 2014, MICROBIOL MOL BIOL R, V78, P257, DOI 10.1128/MMBR.00056-13; Haines AS, 2007, PLASMID, V58, P76, DOI 10.1016/j.plasmid.2007.01.001; Haines AS, 2005, J BACTERIOL, V187, P4728, DOI 10.1128/JB.187.14.4728-4738.2005; Harrison EM, 2010, INFECT IMMUN, V78, P1437, DOI 10.1128/IAI.00621-09; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jovcic B, 2013, ANTIMICROB AGENTS CH, V57, P3405, DOI 10.1128/AAC.02312-12; Klockgether J, 2004, J BACTERIOL, V186, P518, DOI 10.1128/JB.186.2.518-534.2004; Kobayashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070557; KORFHAGEN TR, 1976, ANTIMICROB AGENTS CH, V9, P810, DOI 10.1128/AAC.9.5.810; Li HY, 2008, ANTIMICROB AGENTS CH, V52, P3099, DOI 10.1128/AAC.01093-07; Naas T, 2013, J ANTIMICROB CHEMOTH, V68, P1757, DOI 10.1093/jac/dkt094; Odumosu BT, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-29; Ou HY, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj005; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Ramirez-Diaz MI, 2011, PLASMID, V66, P7, DOI 10.1016/j.plasmid.2011.03.002; RATHER PN, 1992, J BACTERIOL, V174, P3196, DOI 10.1128/jb.174.10.3196-3203.1992; Ricker N, 2012, GENOMICS, V100, P167, DOI 10.1016/j.ygeno.2012.06.009; Roy PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008842; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Xiong JH, 2013, ANTIMICROB AGENTS CH, V57, P3775, DOI 10.1128/AAC.00423-13; Yeldho D, 2011, B ENVIRON CONTAM TOX, V86, P110, DOI 10.1007/s00128-010-0162-2; Zhao YF, 2005, J BACTERIOL, V187, P2113, DOI 10.1128/JB.187.6.2113-2126.2005	35	3	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148367	10.1371/journal.pone.0148367	http://dx.doi.org/10.1371/journal.pone.0148367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841043	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200128
J	Cheng, YH; Jiang, Y; Wu, Y; Valentine, TA; Li, HX				Cheng, Yanhong; Jiang, Ying; Wu, Yue; Valentine, Tracy A.; Li, Huixin			Soil Nitrogen Status Modifies Rice Root Response to Nematode-Bacteria Interactions in the Rhizosphere	PLOS ONE			English	Article							FEEDING NEMATODES; PLANT-GROWTH; MICROBIAL COMMUNITIES; SYSTEM ARCHITECTURE; ARABIDOPSIS; AVAILABILITY; BIODIVERSITY; PROTOZOA; NITRATE; GENE	It has been hypothesized that faunal activity in the rhizosphere influences root growth via an auxin-dependent pathway. In this study, two methods were used to adjust nematode and bacterial populations within experimental soils. One is "exclusion", where soil mixed with pig manure was placed in two bags with different mesh sizes (1mm and 5 mu m-diameter), and then surrounded by an outer layer of unamended soil resulting in soil with a greater populations of bacterial-feeding nematodes (1mm) and a control treatment (5 mu m). The second method is "inoculation", whereby autoclaved soil was inoculated with bacteria (E. coli and Pseudomonas) and Nematodes (Cephalobus and C. elegans). In order to detect the changes in the rice's perception of auxin under different nutrient and auxin conditions in the presence of soil bacterial-feeding nematodes, responses of soil chemistry (NH4+, NO3- and indole acetic acid (IAA)), rice root growth and the expression of an auxin responsive gene GH3-2 were measured. Results showed that, under low soil nutrient conditions (exclusion), low NO3- correlated with increased root branching and IAA correlated with increased root elongation and GH3-2 expression. However, under high soil nutrient conditions (inoculation), a high NH4+ to NO3- ratio promoted an increase in root surface area and there was an additional influence of NH4+ and NO3- on GH3-2 expression. Thus it was concluded that soil bacterial-feeding nematodes influenced soil nutritional status and soil IAA content, promoting root growth via an auxin dependent pathway that was offset by soil nitrogen status.	[Cheng, Yanhong; Li, Huixin] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China; [Cheng, Yanhong] Jiang Xi Inst Red Soil, Nanchang 330000, Peoples R China; [Jiang, Ying] Henan Agr Univ, Coll Resources & Environm, Zhengzhou 450000, Peoples R China; [Wu, Yue] Soil & Fertilizer Bur Shandong Prov, Jinan 250100, Peoples R China; [Valentine, Tracy A.] James Hutton Inst, Ecol Sci, Dundee DD2 5DA, Scotland	Nanjing Agricultural University; Henan Agricultural University; James Hutton Institute	Li, HX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China.; Valentine, TA (corresponding author), James Hutton Inst, Ecol Sci, Dundee DD2 5DA, Scotland.	tracy.valentine@hutton.ac.uk; huixinli@njau.edu.cn	Valentine, Tracy A/C-2666-2009; Li, huixin/H-5573-2011	Valentine, Tracy A/0000-0002-9064-2896; 	National Science Foundation of China [41401274, 30970537, 41301235]; Royal Society, London, UK; Scottish Government	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society, London, UK(Royal Society of London); Scottish Government	This work was supported by the National Science Foundation of China (grants 41401274, 30970537, and 41301235). The project was assisted by funding from The Royal Society, London, UK, under an International Joint Project grant. The James Hutton Institute (formerly Scottish Crop Research Institute and The Macaulay Land Use Research Institute) is financially supported by the Scottish Government. The funders all had part in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; [Anonymous], 1986, LAB METHODS WORK PLA; Blanc C, 2006, EUR J SOIL BIOL, V42, pS70, DOI 10.1016/j.ejsobi.2006.06.003; Bonkowski M, 2002, SOIL BIOL BIOCHEM, V34, P1709, DOI 10.1016/S0038-0717(02)00157-8; Bonkowski M, 2004, NEW PHYTOL, V162, P617, DOI 10.1111/j.1469-8137.2004.01066.x; BRENNER S, 1974, GENETICS, V77, P71; Cadet P, 2004, APPL SOIL ECOL, V25, P193, DOI 10.1016/j.apsoil.2003.10.001; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Cheng YH, 2011, NEMATOLOGY, V13, P369, DOI 10.1163/138855410X528253; Coleman DC, 2014, HOLISTIC APPROACH SO, P211; Djigal D, 2004, SOIL BIOL BIOCHEM, V36, P323, DOI 10.1016/j.soilbio.2003.10.007; Edwards C, 2000, SOIL INVERTEBRATE CO; Ferris H, 1997, SOIL BIOL BIOCHEM, V29, P1183, DOI 10.1016/S0038-0717(97)00035-7; FRANKENBERGER WT, 1983, SOIL SCI SOC AM J, V47, P237, DOI 10.2136/sssaj1983.03615995004700020012x; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Goodfriend WL, 2000, PLANT SOIL, V223, P23, DOI 10.1023/A:1004756832367; Gray WM, 2004, PLOS BIOL, V2, P1270, DOI 10.1371/journal.pbio.0020311; Griffiths BS, 2001, SOIL BIOL BIOCHEM, V33, P1713, DOI 10.1016/S0038-0717(01)00094-3; Griffiths BS, 2002, NEMATOLOGY, V4, P943, DOI 10.1163/156854102321122566; HERDER GD, 2010, TRENDS PLANT SCI, V0015, P00600, DOI DOI 10.1016/J.TPLANTS.2010.08.009; INGHAM RE, 1985, ECOL MONOGR, V55, P119, DOI 10.2307/1942528; Irshad U, 2011, SOIL BIOL BIOCHEM, V43, P2121, DOI 10.1016/j.soilbio.2011.06.015; Jiang Y, 2012, EUR J SOIL BIOL, V52, P20, DOI 10.1016/j.ejsobi.2012.05.003; Lakzian A, 2007, CASPIAN J ENV SCI, V5, P87; Lambrecht M, 2000, TRENDS MICROBIOL, V8, P298, DOI 10.1016/S0966-842X(00)01732-7; Li Q, 2010, PLANT CELL ENVIRON, V33, P1529, DOI 10.1111/j.1365-3040.2010.02162.x; Linkohr BI, 2002, PLANT J, V29, P751, DOI 10.1046/j.1365-313X.2002.01251.x; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Mao XF, 2007, SOIL BIOL BIOCHEM, V39, P1816, DOI 10.1016/j.soilbio.2007.01.027; Mao XF, 2006, SOIL BIOL BIOCHEM, V38, P1615, DOI 10.1016/j.soilbio.2005.12.002; Phillips DA, 2003, ECOLOGY, V84, P816, DOI 10.1890/0012-9658(2003)084[0816:MCPIRF]2.0.CO;2; Picard C, 2003, FEMS MICROBIOL ECOL, V46, P73, DOI 10.1016/S0168-6496(03)00206-X; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Tu C, 2003, MICROB ECOL, V46, P134, DOI 10.1007/s00248-002-1068-2; Zhang HM, 2000, J EXP BOT, V51, P51, DOI 10.1093/jexbot/51.342.51; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407	38	6	6	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148021	10.1371/journal.pone.0148021	http://dx.doi.org/10.1371/journal.pone.0148021			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841062	gold, Green Submitted, Green Published			2022-12-26	WOS:000369550200077
J	Horl, G; Froehlich, H; Ferstl, U; Ledinski, G; Binder, J; Cvirn, G; Stojakovic, T; Trauner, M; Koidl, C; Tafeit, E; Amrein, K; Scharnagl, H; Jurgens, G; Hallstrom, S				Hoerl, Gerd; Froehlich, Harald; Ferstl, Ulrika; Ledinski, Gerhard; Binder, Josepha; Cvirn, Gerhard; Stojakovic, Tatjana; Trauner, Michael; Koidl, Christoph; Tafeit, Erwin; Amrein, Karin; Scharnagl, Hubert; Juergens, Guenther; Hallstroem, Seth			Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ACUTE CORONARY SYNDROMES; INTIMA-MEDIA THICKNESS; OXIDIZED LDL; GRADIENT ULTRACENTRIFUGATION; SERUM-LIPOPROTEINS; APOLIPOPROTEIN-B; IMMUNOGLOBULIN-M; ARTERY-DISEASE; RISK-FACTORS	We investigated a polyethylene glycol non-precipitable low-density lipoprotein (LDL) subfraction targeted by IgG and the influence of statin therapy on plasma levels of these small LDL-IgG-immune complexes (LDL-IgG-IC). LDL-subfractions were isolated from 6 atherosclerotic subjects and 3 healthy individuals utilizing iodixanol density gradient ultracentrifugation. Cholesterol, apoB and malondialdehyde (MDA) levels were determined in each fraction by enzymatic testing, dissociation-enhanced lanthanide fluorescence immunoassay and high-performance liquid chromatography, respectively. The levels of LDL-IgG-IC were quantified densitometrically following lipid electrophoresis, particle size distribution was assessed with dynamic light scattering and size exclusion chromatography. The influence of simvastatin (40 mg/day for three months) on small LDL-IgG-IC levels and their distribution among LDL-subfractions (salt gradient separation) were investigated in 11 patients with confirmed coronary artery disease (CAD). We demonstrate that the investigated LDL-IgG-IC are small particles present in atherosclerotic patients and healthy subjects. In vitro assembly of LDL-IgG-IC resulted in particle density shifts indicating a composition of one single molecule of IgG per LDL particle. Normalization on cholesterol levels revealed MDA values twice as high for LDL-subfractions rich in small LDL-IgG-IC if compared to dominant LDL-subfractions. Reactivity of affinity purified small LDL-IgG-IC to monoclonal antibody OB/04 indicates a high degree of modified apoB and oxidative modification. Simvastatin therapy studied in the CAD patients significantly lowered LDL levels and to an even higher extent, small LDL-IgG-IC levels without affecting their distribution. In conclusion simvastatin lowers levels of small LDL-IgG-IC more effectively than LDL-cholesterol and LDL-apoB levels in atherosclerotic patients. This antiatherogenic effect may additionally contribute to the known beneficial effects of this drug in the treatment of atherosclerosis.	[Hoerl, Gerd; Ferstl, Ulrika; Ledinski, Gerhard; Cvirn, Gerhard; Tafeit, Erwin; Juergens, Guenther; Hallstroem, Seth] Med Univ Graz, Ctr Physiol Med, Inst Physiol Chem, Graz, Austria; [Froehlich, Harald] Med Univ Graz, Div Angiol, Dept Internal Med, Graz, Austria; [Binder, Josepha] Med Univ Graz, Div Cardiol, Dept Internal Med, Graz, Austria; [Stojakovic, Tatjana; Scharnagl, Hubert] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Trauner, Michael] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Med 3, Vienna, Austria; [Koidl, Christoph] Med Univ Graz, Inst Hyg, Graz, Austria; [Amrein, Karin] Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Vienna; Medical University of Graz; Medical University of Graz	Horl, G (corresponding author), Med Univ Graz, Ctr Physiol Med, Inst Physiol Chem, Graz, Austria.	gerd.hoerl@medunigraz.at		Froehlich, Harald/0000-0003-4415-9809; Hoerl, Gerd/0000-0002-0884-0851; Amrein, Karin/0000-0003-0915-085X; Trauner, Michael/0000-0002-1275-6425				Agar C, 2009, J THROMB HAEMOST, V7, P235, DOI 10.1111/j.1538-7836.2008.03223.x; Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Asciutto G, 2015, ATHEROSCLEROSIS, V239, P289, DOI 10.1016/j.atherosclerosis.2015.01.023; Atchley DH, 2002, DIABETOLOGIA, V45, P1562, DOI 10.1007/s00125-002-0962-y; Bancells C, 2010, J LIPID RES, V51, P3508, DOI 10.1194/jlr.M009258; Bassi N, 2009, AUTOIMMUNITY, V42, P289, DOI 10.1080/08916930902828247; BAUMSTARK MW, 1990, BIOCHIM BIOPHYS ACTA, V1037, P48, DOI 10.1016/0167-4838(90)90100-T; Carmena R, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000131511.50734.44; CARROLL RM, 1983, J LIPID RES, V24, P200; Chait A, 2000, CURR OPIN LIPIDOL, V11, P457, DOI 10.1097/00041433-200010000-00003; Chapman MJ, 1998, EUR HEART J, V19, pA24; CHAPMAN MJ, 1988, J LIPID RES, V29, P442; Chen K, 2012, BLOOD, V120, P4421, DOI 10.1182/blood-2011-12-401133; Chyu Kuang-Yuh, 2014, Ther Adv Vaccines, V2, P56, DOI 10.1177/2051013613514327; Davies IG, 2003, CLIN CHEM, V49, P1865, DOI 10.1373/clinchem.2003.023366; Estruch M, 2015, BBA-MOL CELL BIOL L, V1851, P1442, DOI 10.1016/j.bbalip.2015.08.009; Fagerberg B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120744; Fraley AE, 2009, J AM COLL CARDIOL, V53, P2186, DOI 10.1016/j.jacc.2009.02.041; Frostegard J, 2010, CLIN IMMUNOL, V134, P47, DOI 10.1016/j.clim.2009.08.013; Goncalves I, 2009, AUTOIMMUNITY, V42, P203, DOI 10.1080/08916930802668602; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Gutierrez MM, 1999, BIOCHEMISTRY-US, V38, P1284, DOI 10.1021/bi981424x; HAMMER A, 1995, ARTERIOSCL THROM VAS, V15, P704, DOI 10.1161/01.ATV.15.5.704; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Harmon EY, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001232; Hermansson A, 2011, CIRCULATION, V123, P1083, DOI 10.1161/CIRCULATIONAHA.110.973222; Hunt KJ, 2013, ATHEROSCLEROSIS, V231, P315, DOI 10.1016/j.atherosclerosis.2013.09.027; Itabe H, 2003, BIOL PHARM BULL, V26, P1, DOI 10.1248/bpb.26.1; Itabe H, 2009, CLIN REV ALLERG IMMU, V37, P4, DOI 10.1007/s12016-008-8095-9; Karvonen J, 2003, CIRCULATION, V108, P2107, DOI 10.1161/01.CIR.0000092891.55157.A7; Klein RL, 2011, J DIABETES COMPLICAT, V25, P73, DOI 10.1016/j.jdiacomp.2010.03.001; KLIMOV AN, 1988, ATHEROSCLEROSIS, V74, P41, DOI 10.1016/0021-9150(88)90189-X; Kobayashi K, 2007, LUPUS, V16, P929, DOI 10.1177/0961203307084170; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158; Li SJ, 2013, MOL METAB, V2, P256, DOI 10.1016/j.molmet.2013.06.001; Lopes-Virella MF, 2007, ATHEROSCLEROSIS, V190, P359, DOI 10.1016/j.atherosclerosis.2006.02.007; Lopes-Virella MF, 2010, CLIN IMMUNOL, V134, P55, DOI 10.1016/j.clim.2009.04.001; Lopes-Virella MF, 1999, CLIN IMMUNOL, V90, P165, DOI 10.1006/clim.1998.4631; Lopes-Virella MF, 2004, DIABETES CARE, V27, P908, DOI 10.2337/diacare.27.4.908; Matsuura Eiji, 2002, Autoimmunity Reviews, V1, P348, DOI 10.1016/S1568-9972(02)00084-8; Matsuura Eiji, 2009, Curr Rheumatol Rep, V11, P61; Mironova MA, 2000, DIABETES, V49, P1033, DOI 10.2337/diabetes.49.6.1033; Nilsson J, 2012, CURR OPIN LIPIDOL, V23, P422, DOI 10.1097/MOL.0b013e328356ec7c; Nordestgaard BG, 1996, CURR OPIN LIPIDOL, V7, P269, DOI 10.1097/00041433-199610000-00002; Nowak B, 2012, ADV CLIN EXP MED, V21, P331; Orekhov AN, 2014, INT J MOL SCI, V15, P12807, DOI 10.3390/ijms150712807; Pilz J, 2000, J CHROMATOGR B, V742, P315, DOI 10.1016/S0378-4347(00)00174-2; POLZ E, 1979, FEBS LETT, V102, P183, DOI 10.1016/0014-5793(79)80955-2; Ravandi A, 2011, J LIPID RES, V52, P1829, DOI 10.1194/jlr.M015776; Saad AF, 2006, J LIPID RES, V47, P1975, DOI 10.1194/jlr.M600064-JLR200; SCHUMAKER VN, 1994, ADV PROTEIN CHEM, V45, P205; Shoenfeld Y, 2005, CIRCULATION, V112, P3337, DOI 10.1161/CIRCULATIONAHA.104.507996; Shoenfeld Y, 2004, CIRCULATION, V110, P2552, DOI 10.1161/01.CIR.0000143225.07377.EA; Singh Y, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-47; Sobenin IA, 2013, INT J CARDIOL, V166, P747, DOI 10.1016/j.ijcard.2012.09.175; Soto Yosdel, 2009, Human Antibodies, V18, P109, DOI 10.3233/HAB-2009-0202; SPARROW CP, 1988, J LIPID RES, V29, P745; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Stojakovic T, 2010, EUR J CLIN INVEST, V40, P187, DOI 10.1111/j.1365-2362.2009.02249.x; Su J, 2006, ATHEROSCLEROSIS, V188, P160, DOI 10.1016/j.atherosclerosis.2005.10.017; Tertov VV, 1996, ATHEROSCLEROSIS, V122, P191, DOI 10.1016/0021-9150(95)05737-4; Tertov VV, 1995, EXP MOL PATHOL, V62, P166, DOI 10.1006/exmp.1995.1018; Timar O, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4285; Toshima S, 2000, ARTERIOSCL THROM VAS, V20, P2243, DOI 10.1161/01.ATV.20.10.2243; TRIBBLE DL, 1995, J LIPID RES, V36, P662; Tsimikas S, 2004, CIRCULATION, V110, P1406, DOI 10.1161/01.CIR.0000141728.23033.B5; van Leeuwen M, 2009, AUTOIMMUN REV, V9, P53, DOI 10.1016/j.autrev.2009.03.001; Virella G, 2013, J IMMUNOASS IMMUNOCH, V34, P61, DOI 10.1080/15321819.2012.683500; Wu RH, 1998, ARTERIOSCL THROM VAS, V18, P626, DOI 10.1161/01.ATV.18.4.626; Yee MS, 2008, J LIPID RES, V49, P1364, DOI 10.1194/jlr.D700044-JLR200; Younis NN, 2012, CLIN SCI LOND; Zhang XL, 2014, J ATHEROSCLER THROMB, V21, P1140, DOI 10.5551/jat.24372; Zhu XM, 2014, J IMMUNOL, V193, P2483, DOI 10.4049/jimmunol.1303075	75	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148210	10.1371/journal.pone.0148210	http://dx.doi.org/10.1371/journal.pone.0148210			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840480	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200098
J	Samo, RN; Agha, A; Shah, SA; Altaf, A; Memon, A; Blevins, M; Qian, HZ; Vermund, SH				Samo, Rab Nawaz; Agha, Ajmal; Shah, Sharaf Ali; Altaf, Arshad; Memon, Ashraf; Blevins, Meridith; Qian, Han-Zhu; Vermund, Sten H.			Risk Factors for Loss to Follow-Up among People Who Inject Drugs in a Risk Reduction Program at Karachi, Pakistan. A Case-Cohort Study	PLOS ONE			English	Article							METHADONE-MAINTENANCE THERAPY; QUALITY-OF-LIFE; HIV RISK; ANTIRETROVIRAL THERAPY; SICHUAN PROVINCE; BUPRENORPHINE MAINTENANCE; SOUTHERN CHINA; UNITED-STATES; HEPATITIS-C; USERS	Introduction Retention of male people who inject drugs (PWIDs) is a major challenge for harm reduction programs that include sterile needle/syringe exchange in resource-limited settings like Pakistan. We assessed the risk factors for loss to follow-up among male PWIDs enrolled in a risk reduction program in Karachi, Pakistan. Methods We conducted a prospective cohort study among 636 HIV-uninfected male PWIDs enrolled during March-June 2009 in a harm reduction program for the estimation of incidence rate. At 24 months post-enrollment, clients who had dropped out of the program were defined as lost to follow-up and included as cases for case-cohort study. Results The median age of the participants was 29 years (interquartile range: 23-36). Active outreach accounted for 76% (483/636) of cohort recruits. Loss to follow-up at 24 months was 25.5% (162/636). In multivariable logistic regression, younger age (AOR: 0.97, 95% CI: 0.92-0.99, p = 0.028), clients from other provinces than Sindh (AOR: 1.49, 95% CI: 1.01-2.22, p = 0.046), having no formal education (AOR: 3.44, 95% CI: 2.35-4.90, p<0.001), a history of incarceration (AOR: 1.68, 95% CI: 1.14-2.46, p<0.008), and being homeless (AOR: 1.47, 95% CI: 1.00-2.19, p<0.049) were associated with loss to follow-up. Conclusions Our cohort retained 74.5% of male PWIDs in Karachi for 24 months. Its loss to follow up rate suggested substantial ongoing programmatic challenges. Programmatic enhancements are needed for the highest risk male PWIDs, i.e., younger men, men not from Sindh Province, men who are poorly educated, formerly incarcerated, and/or homeless.	[Samo, Rab Nawaz] World Hlth Org, Polio Eradicat Initiat, Larkana, Pakistan; [Agha, Ajmal] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Shah, Sharaf Ali; Altaf, Arshad] Bridge Consultants Fdn, Karachi, Pakistan; [Memon, Ashraf] Sindh AIDS Control Program, Karachi, Pakistan; [Blevins, Meridith; Qian, Han-Zhu; Vermund, Sten H.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Blevins, Meridith] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	World Health Organization; Aga Khan University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Samo, RN (corresponding author), World Hlth Org, Polio Eradicat Initiat, Larkana, Pakistan.	drsamo1974@yahoo.com	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698	National Institutes of Health Fogarty AIDS International Training and Research Program [D43TW001035]	National Institutes of Health Fogarty AIDS International Training and Research Program	The authors acknowledge support from the National Institutes of Health Fogarty AIDS International Training and Research Program (grant # D43TW001035).	Abdul Mujeeb S, 1988, J Pak Med Assoc, V38, P221; Ahmadi J, 2003, J SUBST ABUSE TREAT, V24, P217, DOI 10.1016/S0740-5472(03)00024-2; Ahmadi J, 2002, J SUBST ABUSE TREAT, V22, P157, DOI 10.1016/S0740-5472(02)00222-2; Ali SA, 2009, INT J INFECT DIS, V13, P9, DOI 10.1016/j.ijid.2008.06.019; Azim T, 2008, SUBST USE MISUSE, V43, P2124, DOI 10.1080/10826080802344583; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Canada Pakistan HIV/AIDS Surveillance Project (CIDA), 2008, HIV 2 GEN SURV SINDH; Celentano DD, 1998, J ACQ IMMUN DEF SYND, V17, P73, DOI 10.1097/00042560-199801010-00011; Chawarski MC, 2011, DRUG ALCOHOL DEPEN, V115, P237, DOI 10.1016/j.drugalcdep.2010.09.024; Chawarski MC, 2012, DRUG ALCOHOL DEPEN, V124, P177, DOI 10.1016/j.drugalcdep.2011.12.024; Che YH, 2011, AM J DRUG ALCOHOL AB, V37, P148, DOI 10.3109/00952990.2010.535578; Choi SYP, 2007, AIDS CARE, V19, P1, DOI 10.1080/09540120600900496; Choi SYP, 2006, SOC SCI MED, V62, P1672, DOI 10.1016/j.socscimed.2005.08.046; Choopanya K, 2003, JAIDS-J ACQ IMM DEF, V33, P88, DOI 10.1097/00126334-200305010-00013; Cohen JE, 2008, PLOS MED, V5, P1682, DOI 10.1371/journal.pmed.0050234; Cook C, 2008, 5 GLOBAL STATE HARM; Dev A, 2004, J GASTROEN HEPATOL, V19, P792, DOI 10.1111/j.1440-1746.2004.03381.x; Emmanuel Faran, 2006, J Pak Med Assoc, V56, P119; Hadland SE, 2012, AIDS PATIENT CARE ST, V26, P274, DOI 10.1089/apc.2011.0196; Hall HI, 2012, JAIDS-J ACQ IMM DEF, V60, P77, DOI 10.1097/QAI.0b013e318249fe90; Hammett TM, 2006, AIDS EDUC PREV, V18, P97, DOI 10.1521/aeap.2006.18.2.97; Hayashi K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-492; Hellard ME, 2006, AUST NZ J PUBL HEAL, V30, P519, DOI 10.1111/j.1467-842X.2006.tb00779.x; Husain S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-11; Hyder AA, 1999, PUBLIC HEALTH, V113, P39, DOI 10.1016/S0033-3506(99)00111-0; Jarlais DCD, 2007, AIDS, V21, pS109, DOI 10.1097/01.aids.0000304705.79541.34; Jordan MR, 2009, INT J STD AIDS, V20, P418, DOI 10.1258/ijsa.2008.008389; Kazi AM, 2010, INT J INFECT DIS, V14, pE60, DOI 10.1016/j.ijid.2009.11.012; Kazi BM, 2000, J PUBLIC HEALTH MED, V22, P43, DOI 10.1093/pubmed/22.1.43; Kerr T, 2010, INT J DRUG POLICY, V21, P255, DOI 10.1016/j.drugpo.2009.08.002; KHANANI RM, 1988, AIDS RES HUM RETROV, V4, P149, DOI 10.1089/aid.1988.4.149; Kheirandish P, 2010, JAIDS-J ACQ IMM DEF, V53, P273, DOI 10.1097/QAI.0b013e3181be6dde; KHEIRANDISH P, 2009, URBAN HLTH, V86, P902, DOI DOI 10.1007/S11524-009-9393-0; Latkin C, 2009, HEALTH PSYCHOL, V28, P323, DOI 10.1037/a0014707; Latkin CA, 2009, SOC SCI MED, V68, P740, DOI 10.1016/j.socscimed.2008.11.019; Lawrinson P, 2008, ADDICTION, V103, P1484, DOI 10.1111/j.1360-0443.2008.02249.x; Li L, 2011, DRUG ALCOHOL DEPEN, V118, P335, DOI 10.1016/j.drugalcdep.2011.04.014; Lin C, 2011, PUBLIC HEALTH, V125, P269, DOI 10.1016/j.puhe.2011.01.009; Lin CQ, 2011, DRUG ALCOHOL DEPEN, V117, P45, DOI 10.1016/j.drugalcdep.2011.01.004; Lin CQ, 2010, J SUBST ABUSE TREAT, V38, P119, DOI 10.1016/j.jsat.2009.09.002; Luksamijarulkul Pipat, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P147; Malhotra S, 2002, Indian J Med Sci, V56, P602; Moore DM, 2010, HIV MED, V11, P299, DOI 10.1111/j.1468-1293.2009.00779.x; National AIDS Control Program, 2006, HIV 2 GEN SURV PAK N; National AIDS Control Program Ministry of Health Government of Pakistan, 2010, UNGASS PAK REP PROGR; National AIDS Control Program Ministry of Health Government of Pakistan; Islamabad, 2006, UNGASS IND COUNTR RE; NEWMAN RG, 1979, LANCET, V2, P485; Nishtar S, 2013, LANCET, V381, P2193, DOI 10.1016/S0140-6736(13)60019-7; Nishtar S, 2011, LANCET, V378, P648, DOI 10.1016/S0140-6736(11)60606-5; Noordin NM, 2008, LANCET, V372, P1149, DOI 10.1016/S0140-6736(08)61479-8; PEAK A, 1995, AIDS, V9, P1067, DOI 10.1097/00002030-199509000-00013; Perngmark P, 2003, ADDICTION, V98, P1153, DOI 10.1046/j.1360-0443.2003.00446.x; Razani N, 2007, ADDICTION, V102, P1472, DOI 10.1111/j.1360-0443.2007.01914.x; Ruan YH, 2005, JAIDS-J ACQ IMM DEF, V39, P459, DOI 10.1097/01.qai.0000152398.47025.0f; Rudolph AE, 2012, AIDS CARE, V24, P239, DOI 10.1080/09540121.2011.596517; Sabin LL, 2008, AIDS CARE, V20, P1242, DOI 10.1080/09540120801918651; Salter ML, 2010, AIDS EDUC PREV, V22, P558, DOI 10.1521/aeap.2010.22.6.558; Samo RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081715; Sarasvita R, 2012, J SUBST ABUSE TREAT, V42, P239, DOI 10.1016/j.jsat.2011.07.009; Sarin E, 2013, SUBST ABUSE TREAT PR, V8, DOI 10.1186/1747-597X-8-2; Sarkar S, 1995, Indian J Public Health, V39, P86; Shah SA, 2004, INT J STD AIDS, V15, P209, DOI 10.1258/095646204322916713; Shah SA, 1998, AIDS IN PAKISTAN; Shrestha I L, 2003, Kathmandu Univ Med J (KUMJ), V1, P101; Sullivan PS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000552; Ti LP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-189; UNODC, UNAIDS PAK COUNTR AD; Vanichseni S, 2004, JAIDS-J ACQ IMM DEF, V37, P1170, DOI 10.1097/01.qai.0000120821.38576.ec; VANICHSENI S, 1993, AIDS, V7, P887, DOI 10.1097/00002030-199306000-00020; Wang HH, 2008, AIDS PATIENT CARE ST, V22, P71, DOI 10.1089/apc.2007.0047; Wang HH, 2010, J CLIN NURS, V19, P380, DOI 10.1111/j.1365-2702.2009.03048.x; Wolfe D, 2007, INT J DRUG POLICY, V18, P246, DOI 10.1016/j.drugpo.2007.01.012; Wong KH, 2003, J SUBST ABUSE TREAT, V24, P233, DOI 10.1016/S0740-5472(03)00029-1; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang WD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-221; Zhang YZ, 2007, INT J INFECT DIS, V11, P318, DOI 10.1016/j.ijid.2006.09.001; Zhao L, 2012, AIDS CARE, V24, P195, DOI 10.1080/09540121.2011.596520	78	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147912	10.1371/journal.pone.0147912	http://dx.doi.org/10.1371/journal.pone.0147912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840414	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200070
J	Kicielinska, J; Szczygiel, A; Rossowska, J; Anger, N; Kempinska, K; Switalska, M; Kaszowska, M; Wietrzyk, J; Boratynski, J; Pajtasz-Piasecka, E				Kicielinska, Jagoda; Szczygiel, Agnieszka; Rossowska, Joanna; Anger, Natalia; Kempinska, Katarzyna; Switalska, Marta; Kaszowska, Marta; Wietrzyk, Joanna; Boratynski, Janusz; Pajtasz-Piasecka, Elzbieta			Oral Administration of Polymyxin B Modulates the Activity of Lipooligosaccharide E. coli B against Lung Metastases in Murine Tumor Models	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-RESPONSE; IFN-GAMMA; ACTIVATION; ACID; MICE	Introduction Polymyxin B (PmB) belongs to the group of cyclic peptide antibiotics, which neutralize the activity of LPS by binding to lipid A. The aim of this study was to analyze the effect of PmB on the biological activity of lipooligosaccharide (LOS E. coli B, rough form of LPS) in vitro and in experimental metastasis models. Results Cultures of murine macrophage J774A. 1 cells and murine bone marrow-derived dendritic cells (BM-DC) stimulated in vitro with LOS and supplemented with PmB demonstrated a decrease in inflammatory cytokine production (IL-6, IL-10, TNF-alpha) and down-regulation of CD40, CD80, CD86 and MHC class II molecule expression. Additionally, PmB suspended in drinking water was given to the C57BL/6 mice seven or five days prior to the intravenous injection of B16 or LLC cells and intraperitoneal application of LOS. This strategy of PmB administration was continued throughout the duration of the experiments (29 or 21 days). In B16 model, statistically significant decrease in the number of metastases in mice treated with PmB and LOS (p<0.01) was found on the 14th day of the experiments, whereas themost intensive changes in surface-antigen expression and ex vivo production of IL-6, IL-1 beta and TNF-alpha by peritoneal cells were observed 7 days earlier. By contrast, antigen expression and ex vivo production of IL-6, IL-10, IFN-gamma by splenocytes remained relatively high and stable. Statistically significant decrease in LLC metastases number was observed after the application of LOS (p<0.01) and in the group of mice preconditioned by PmB and subsequently treated with LOS (LOS + PmB, p<0.01). Conclusions In conclusion, prolonged in vivo application of PmB was not able to neutralize the LOSinduced immune cell activity but its presence in the organism of treated mice was important in modulation of the LOS-mediated response against the development of metastases.	[Kicielinska, Jagoda; Szczygiel, Agnieszka; Rossowska, Joanna; Anger, Natalia; Kempinska, Katarzyna; Switalska, Marta; Kaszowska, Marta; Wietrzyk, Joanna; Boratynski, Janusz; Pajtasz-Piasecka, Elzbieta] Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Pajtasz-Piasecka, E (corresponding author), Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland.	pajtasz@iitd.pan.wroc.pl	Wietrzyk, Joanna/O-4392-2018; Rossowska, Joanna/E-9159-2015; Rossowska, Joanna/Y-6164-2019	Wietrzyk, Joanna/0000-0003-4980-6606; Rossowska, Joanna/0000-0002-3682-7160; Szczygiel, Agnieszka/0000-0003-1516-5636; Mierzejewska, Jagoda/0000-0001-7233-442X; Pajtasz-Piasecka, Elzbieta/0000-0002-0253-970X; Anger-Gora, Natalia/0000-0003-4942-9134; Kaszowska, Marta/0000-0003-4469-5660; Switalska, Marta/0000-0001-7920-2251; Boratynski, Janusz/0000-0001-5072-1162	Wroclaw Centre of Biotechnology, Programme The Leading National Research Centre (KNOW); Polish Ministry of Science-The National Centre for Research and Development [13-0089-06/2010]; Polish Ministry of Science and Higher Education-The National Centre for Research and Development [13-00-89-06/2010]	Wroclaw Centre of Biotechnology, Programme The Leading National Research Centre (KNOW); Polish Ministry of Science-The National Centre for Research and Development; Polish Ministry of Science and Higher Education-The National Centre for Research and Development	This work was supported by Wroclaw Centre of Biotechnology, Programme The Leading National Research Centre (KNOW) for years 2014-2018 and by the Polish Ministry of Science-The National Centre for Research and Development (http://www.ncbir.pl/en/): "Products of the Gram-negative bacteria lysis as potential anti-tumor agents. Determination of their chemical and biochemical properties as well as biological activities. Development of active substance production technology' (grants no. 13-0089-06/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Polish Ministry of Science and Higher Education-The National Centre for Research and Development grants no. 13-00-89-06/2010 and Wroclaw Centre of Biotechnology, Programme The Leading National Research Centre (KNOW) for years 2014-2018.	Abdi K, 2012, J IMMUNOL, V188, P5981, DOI 10.4049/jimmunol.1102868; Bao Y, 2014, CELL RES, V24, P161, DOI 10.1038/cr.2013.155; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Chamberlain LM, 2009, J BIOMED MATER RES A, V88A, P858, DOI 10.1002/jbm.a.31930; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; Ferrari D, 2004, J IMMUNOL, V173, P4652, DOI 10.4049/jimmunol.173.7.4652; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gaston JSH, 2002, CLIN EXP IMMUNOL, V127, P1, DOI 10.1046/j.1365-2249.2002.01759.x; HERSHBERGER C, 1968, J BIOL CHEM, V243, P1585; Kamath AT, 2005, J IMMUNOL, V174, P767, DOI 10.4049/jimmunol.174.2.767; Kaszowska M, 2015, CARBOHYD RES, V413, P51, DOI 10.1016/j.carres.2015.04.023; Malleshappa P, 2011, Indian J Nephrol, V21, P41, DOI 10.4103/0971-4065.78077; Mares J, 2009, J BIOL CHEM, V284, P11498, DOI 10.1074/jbc.M806587200; McCarthy Edward F, 2006, Iowa Orthop J, V26, P154; Miernikiewicz P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071036; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Preston A, 1996, CRIT REV MICROBIOL, V22, P139, DOI 10.3109/10408419609106458; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Rossowska J, 2007, FOLIA HISTOCHEM CYTO, V45, P349; Rossowska J, 2015, IMMUNOBIOLOGY, V220, P389, DOI 10.1016/j.imbio.2014.10.009; Rossowska J, 2009, ONCOL REP, V21, P1539, DOI 10.3892/or_00000386; RUGGIERO V, 1993, MEDIAT INFLAMM, V2, pS43, DOI 10.1155/S0962935193000754; Tzeng YL, 2002, J BACTERIOL, V184, P2379, DOI 10.1128/JB.184.9.2379-2388.2002; Valentinis B, 2005, J BIOL CHEM, V280, P14264, DOI 10.1074/jbc.M410791200; Wolfert MA, 2007, INFECT IMMUN, V75, P706, DOI 10.1128/IAI.01597-06; Yoshino N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061643	28	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148156	10.1371/journal.pone.0148156	http://dx.doi.org/10.1371/journal.pone.0148156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829479	Green Submitted, Green Published, gold			2022-12-26	WOS:000369548200072
J	Viti, F; Landini, M; Mezzelani, A; Petecchia, L; Milanesi, L; Scaglione, S				Viti, Federica; Landini, Martina; Mezzelani, Alessandra; Petecchia, Loredana; Milanesi, Luciano; Scaglione, Silvia			Osteogenic Differentiation of MSC through Calcium Signaling Activation: Transcriptomics and Functional Analysis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; BONE-FORMATION; POROUS HYDROXYAPATITE; PHOSPHATE CERAMICS; MODEL; GENE; BEHAVIOR; TISSUE; SCAFFOLDS	The culture of progenitor mesenchymal stem cells (MSC) onto osteoconductive materials to induce a proper osteogenic differentiation and mineralized matrix regeneration represents a promising and widely diffused experimental approach for tissue-engineering (TE) applications in orthopaedics. Among modern biomaterials, calcium phosphates represent the best bone substitutes, due to their chemical features emulating the mineral phase of bone tissue. Although many studies on stem cells differentiation mechanisms have been performed involving calcium-based scaffolds, results often focus on highlighting production of in vitro bone matrix markers and in vivo tissue ingrowth, while information related to the biomolecular mechanisms involved in the early cellular calcium-mediated differentiation is not well elucidated yet. Genetic programs for osteogenesis have been just partially deciphered, and the description of the different molecules and pathways operative in these differentiations is far from complete, as well as the activity of calcium in this process. The present work aims to shed light on the involvement of extracellular calcium in MSC differentiation: a better understanding of the early stage osteogenic differentiation program of MSC seeded on calcium-based biomaterials is required in order to develop optimal strategies to promote osteogenesis through the use of new generation osteoconductive scaffolds. A wide spectrum of analysis has been performed on time-dependent series: gene expression profiles are obtained from samples (MSC seeded on calcium-based scaffolds), together with related microRNAs expression and in vivo functional validation. On this basis, and relying on literature knowledge, hypotheses are made on the biomolecular players activated by the biomaterial calcium-phosphate component. Interestingly, a key role of miR-138 was highlighted, whose inhibition markedly increases osteogenic differentiation in vitro and enhance ectopic bone formation in vivo. Moreover, there is evidence that Ca-P substrate triggers osteogenic differentiation through genes (SMAD and RAS family) that are typically regulated during dexamethasone (DEX) induced differentiation.	[Viti, Federica; Petecchia, Loredana] CNR, Inst Biophys, Genoa, Italy; [Viti, Federica; Landini, Martina; Mezzelani, Alessandra; Milanesi, Luciano] CNR, Inst Biomed Technol, Segrate, MI, Italy; [Scaglione, Silvia] CNR, Inst Elect Comp & Telecommun Engn, Genoa, Italy; [Scaglione, Silvia] Adv Biotechnol Ctr CBA, Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Elettronica e di Ingegneria dell'Informazione e delle Telecomunicazioni (IEIIT-CNR)	Scaglione, S (corresponding author), CNR, Inst Elect Comp & Telecommun Engn, Genoa, Italy.; Scaglione, S (corresponding author), Adv Biotechnol Ctr CBA, Genoa, Italy.	silvia.scaglione@ieiit.cnr.it	scaglione, silvia/K-5378-2019; Viti, Federica/J-9305-2018; Scaglione, Silvia/B-7124-2014; Milanesi, Luciano/AAE-7230-2019; Mezzelani, Alessandra/B-3355-2014	scaglione, silvia/0000-0002-9464-3554; Scaglione, Silvia/0000-0002-9464-3554; Milanesi, Luciano/0000-0002-1201-3939; MEZZELANI, ALESSANDRA/0000-0001-7563-5869; Viti, Federica/0000-0002-9651-8896	Italian Ministry of Education and Research (MIUR) [PB05, RBFR13V4M2]	Italian Ministry of Education and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by the Italian Ministry of Education and Research (MIUR) through Flagship "InterOmics" (PB05) (received by SS) and through "Futuro in Ricerca 2013" (RBFR13V4M2) (received by FV).	Anselme K, 1999, BONE, V25, p51S, DOI 10.1016/S8756-3282(99)00133-7; Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Carlier A, 2011, ACTA BIOMATER, V7, P3573, DOI 10.1016/j.actbio.2011.06.021; Caterson E J, 2001, MedGenMed, pE1; Chai YC, 2011, TISSUE ENG PT A, V17, P1083, DOI [10.1089/ten.tea.2010.0160, 10.1089/ten.TEA.2010.0160]; Chan WC, 2012, GENOMICS, V100, P141, DOI 10.1016/j.ygeno.2012.06.007; Delaine-Smith RM, 2011, VITAM HORM, V87, P417, DOI 10.1016/B978-0-12-386015-6.00039-1; Deshpande S, 2013, J SURG RES, V185, P278, DOI 10.1016/j.jss.2013.06.063; Dua R, 2014, J BIOMED MATER RES B, V102, P922, DOI 10.1002/jbm.b.33073; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Eyckmans J, 2010, J CELL MOL MED, V14, P1845, DOI 10.1111/j.1582-4934.2009.00807.x; Farina NM, 2008, J MATER SCI-MATER M, V19, P1565, DOI 10.1007/s10856-008-3400-y; Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174; GATTI AM, 1990, BIOMATERIALS, V11, P513, DOI 10.1016/0142-9612(90)90068-2; Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4; Gil-Albarova J, 2004, BIOMATERIALS, V25, P4639, DOI 10.1016/j.biomaterials.2003.12.009; Gosain AK, 2005, PLAST RECONSTR SURG, V116, P1044, DOI 10.1097/01.prs.0000178402.77445.44; GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298; Graneli C, 2014, STEM CELL RES, V12, P153, DOI 10.1016/j.scr.2013.09.009; Guasch G, 2004, M S-MED SCI, V20, P265, DOI 10.1051/medsci/2004203265; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hronik-Tupaj M, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-9; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Johnston N, 2004, DRUG DISCOV TODAY, V9, P994, DOI 10.1016/S1359-6446(04)03271-4; Jung GY, 2010, J MATER SCI-MATER M, V21, P1649, DOI 10.1007/s10856-010-4011-y; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; Kim CH, 1999, J ENDOCRINOL, V162, P371, DOI 10.1677/joe.0.1620371; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Kon E, 2000, J BIOMED MATER RES, V49, P328; Lee MW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/154919; Levi B, 2013, PLAST RECONSTR SURG, V132, P580, DOI 10.1097/PRS.0b013e31829ace13; Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; MARTIN RB, 1993, BIOMATERIALS, V14, P341, DOI 10.1016/0142-9612(93)90052-4; Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031; Mizuno Hiroshi, 2003, Journal of Nippon Medical School, V70, P300; Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X; Nair MB, 2009, J BIOMED MATER RES A, V90A, P533, DOI 10.1002/jbm.a.32114; Noro T, 1999, BIO-MED MATER ENG, V9, P319; Olszewski Waldemar L, 2004, Ann Transplant, V9, P34; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; Parrington J, 2014, ACTA PHYSIOL, V211, P285, DOI 10.1111/apha.12298; Pennesi G, 2011, CURR PHARM BIOTECHNO, V12, P151, DOI 10.2174/138920111794295684; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; R Core Team, 2018, R LANG ENV STAT COMP; Reh TA, 2001, BRAIN BEHAV EVOLUT, V58, P296, DOI 10.1159/000057571; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Ren JQ, 2011, CYTOTHERAPY, V13, P661, DOI 10.3109/14653249.2010.548379; Rezaee F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009690; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Scaglione S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00274; Schellenberg A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094353; SHAH A, 2013, RAVAZI INT J MED, V1, P5, DOI DOI 10.17795/rijm14849; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Song W, 2011, J BIOACT COMPAT POL, V26, P242, DOI 10.1177/0883911511406327; Sun S, 2007, FASEB J, V21, P1472, DOI 10.1096/fj.06-7153com; Teixeira S, 2010, J BIOMED MATER RES A, V93A, P567, DOI 10.1002/jbm.a.32532; Tsuzuki N, 2012, RES VET SCI, V93, P1021, DOI 10.1016/j.rvsc.2011.12.002; von Heydebreck A, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P623; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang YK, 2013, J CELL MOL MED, V17, P823, DOI 10.1111/jcmm.12061; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	79	68	69	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148173	10.1371/journal.pone.0148173	http://dx.doi.org/10.1371/journal.pone.0148173			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828589	Green Submitted, Green Published, gold			2022-12-26	WOS:000369548200078
J	Gong, W; Zhu, LY; Hao, Y				Gong, Wenjing; Zhu, Liyan; Hao, Ya			Lethal and Sublethal Toxicity Comparison of BFRs to Three Marine Planktonic Copepods: Effects on Survival, Metabolism and Ingestion	PLOS ONE			English	Article							BROMINATED FLAME RETARDANTS; TETRABROMOBISPHENOL-A TBBPA; EURYTEMORA-AFFINIS; DIPHENYL ETHERS; HEXABROMOCYCLODODECANE; BIOACCUMULATION; ENVIRONMENT; ORGANISMS; BIOLOGY; TONSA	The estuarine planktonic copepods have a wide geographical distribution and commendable tolerance to various kinds of contaminants. The primary aim of the present study was to contrast the impacts of model POPs (TBBPA and HBCD) on three common estuarine planktonic copepods (Oithona similis, Acartia pacifica and Pseudodiaptomus inopinus) and establish a protocol for the assessment of acute toxicity of marine organic pollutants. We first quantified the 96h-LC50 (0.566, 0.04 and 0.257 mg/L of TBBPA to the three subjects above respectively and 0.314 mg/L of HBCD to P. inopinus; all reported concentrations are nominal values). In the sub-lethal toxicity tests, it was turned out that the effects of copepods exposed to TBBPA could product different influences on the energy ingestion and metabolism. Different type of pollutions, meanwhile, could also bring varying degree effect on the target copepods. In general, the indicators (the rate of oxygen consumption, ammonia excretion, food ingestion and filtration) in higher concentration groups showed marked significant difference compared with controls as well a dose-effect relationship. The study also extended the research on the joint toxicity of TBBPA and HBCD based on the survival rate of P. inopinus. Whether 1:1 concentration or 1:1 toxic level, the research showed synergy effect relative to single exposure conditions. The result indicated that current single ecological testing used for environmental protection activities may underestimate the risk for copepods. It was also demonstrated that short-term sub-lethal experiment could be a standard to evaluate the sensitivity of copepods to POPs.	[Gong, Wenjing; Zhu, Liyan; Hao, Ya] Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China	Ocean University of China	Zhu, LY (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China.	lyzhu@ouc.edu.cn			National Natural Science Foundation of China [31172412]; National key S&T Special Projects [2012ZX07501-003-06]; NSFC [31172412]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National key S&T Special Projects; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Grant No: 31172412, URLs: www.nsfc.gov.cn/, Grant recipient: LZ and the National key S&T Special Projects, Grant No: 2012ZX07501-003-06, URLs: www.nmp.gov.cn/, Grant recipient: LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by the Grants of NSFC (Grant No. 31172412), and also supported by the Grants of the subitem of national key S&T Special Projects (Grant No. 2012ZX07501-003-06). The authors also thank professor Huang J. by the Laboratory of Ecology for hers help with the chemical analyses.	Alaee M, 2003, ENVIRON INT, V29, P683, DOI 10.1016/S0160-4120(03)00121-1; Alaee M, 2002, CHEMOSPHERE, V46, P579, DOI 10.1016/S0045-6535(01)00224-7; [Anonymous], 2004, E231704 ASTM INT; Barata C, 2005, ENVIRON TOXICOL CHEM, V24, P2992, DOI 10.1897/05-189R.1; Barata C, 2002, MAR ECOL PROG SER, V230, P183, DOI 10.3354/meps230183; Birnbaum LS, 2004, ENVIRON HEALTH PERSP, V112, P9, DOI 10.1289/ehp.6559; CAHOON LB, 1981, DEEP-SEA RES, V28, P1215, DOI 10.1016/0198-0149(81)90057-1; Calbet A, 2007, MAR BIOL, V151, P195, DOI 10.1007/s00227-006-0468-0; Canesi L, 2005, AQUAT TOXICOL, V75, P277, DOI 10.1016/j.aquatox.2005.08.010; Covaci A, 2006, ENVIRON SCI TECHNOL, V40, P3679, DOI 10.1021/es0602492; Darnerud PO, 2003, ENVIRON INT, V29, P841, DOI 10.1016/S0160-4120(03)00107-7; de Wit CA, 2002, CHEMOSPHERE, V46, P583, DOI 10.1016/S0045-6535(01)00225-9; de Wit CA, 2006, CHEMOSPHERE, V64, P209, DOI 10.1016/j.chemosphere.2005.12.029; Devreker D, 2010, ESTUAR COAST SHELF S, V89, P245, DOI 10.1016/j.ecss.2010.07.010; Dur G, 2009, ECOL MODEL, V220, P1073, DOI 10.1016/j.ecolmodel.2008.12.013; Eriksson J, 2004, CHEMOSPHERE, V54, P117, DOI 10.1016/S0045-6535(03)00704-5; Esslinger S, 2003, ENVIRON SCI TECHNOL, V45, P3938; Feng AH, 2012, MAR POLLUT BULL, V64, P919, DOI 10.1016/j.marpolbul.2012.03.008; Fonseca VM, 2005, J THERM ANAL CALORIM, V79, P429, DOI 10.1007/s10973-005-0079-x; Fraser J. H., 1936, Journal of the Marine Biological Association Plymouth, V20, P523; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; FRYER G., 1957, PROC ZOOL SOC LONDON, V129, P1; Gaudy R, 2000, J EXP MAR BIOL ECOL, V247, P51, DOI 10.1016/S0022-0981(00)00139-8; Gourmelon A, 2007, ECOTOXICOLOGY, V16, P161, DOI 10.1007/s10646-006-0105-1; HARRIS RP, 1994, MAR BIOL, V119, P431, DOI 10.1007/BF00347540; Harris RP, 1973, J MAR BIOL ASSOC UK, V54, P141; Hornsby PR, 2007, SPRINGER SER MATER S, V97, P3; Huang Y, 2008, THESIS OCEAN U CHINA; HUNTLEY M, 1988, HYDROBIOLOGIA, V167, P83, DOI 10.1007/BF00026296; Hutchinson TH, 2006, AQUAT TOXICOL, V76, P69, DOI 10.1016/j.aquatox.2005.09.008; IPCS (International Program on Chemical Safety), 1995, ENV HLTH CRIT WHO; Kuiper RV, 2007, ECOTOX ENVIRON SAFE, V67, P349, DOI 10.1016/j.ecoenv.2006.12.001; Laurent Seuront, 2011, PLOS ONE, V6, P1; Lavorante BRBO, 2013, ECOTOX ENVIRON SAFE, V95, P52, DOI 10.1016/j.ecoenv.2013.05.010; Lee KW, 2008, CHEMOSPHERE, V72, P1359, DOI 10.1016/j.chemosphere.2008.04.023; Li Chao-Lun, 2002, Acta Ecologica Sinica, V22, P593; Li SJ, 1964, J AMOY U, V11, P93; Li Ya-ning, 2008, Shengtaixue Zazhi, V27, P263; Li YongDong, 2010, Journal of Environment and Health, V27, P933; Liu S.M., 2012, PERIOD OCEAN U CHINA, V42, P49, DOI [10.16441/j.cnki.hdxb.2012.12.007, DOI 10.16441/J.CNKI.HDXB.2012.12.007]; Lu DY, 2003, J HARBIN U COMMERCE, V19, P20; Marking L, 1977, AQUATIC TOXICOLOGY H, P99, DOI DOI 10.1520/STP32392S; Medina M, 2002, ARCH ENVIRON CON TOX, V42, P17, DOI 10.1007/s002440010286; Michalec FG, 2013, AQUAT TOXICOL, V138, P129, DOI 10.1016/j.aquatox.2013.05.007; Nakajima A., 2009, TOXICOL LETT, V05, P003; Niehoff B, 2007, PROG OCEANOGR, V74, P1, DOI 10.1016/j.pocean.2006.05.005; [彭浩 PENG Hao], 2006, [环境与健康杂志, Journal of Environment and Health], V23, P571; Powlik JJ, 1997, CRUSTACEANA, V70, P324, DOI 10.1163/156854097X00609; Remberger M, 2004, CHEMOSPHERE, V54, P9, DOI 10.1016/S0045-6535(03)00758-6; Research Group of Carcinology Institute of Zoology Academia Sinica, 1979, FAUN SIN; Saint-Louis R, 2004, ANALYST, V129, P724, DOI 10.1039/b400743n; Saito H, 1996, MAR BIOL, V125, P97, DOI 10.1007/BF00350764; Sellstrom U, 2003, ENVIRON SCI TECHNOL, V37, P5496, DOI 10.1021/es0300766; [史雅娟 Shi Yajuan], 2003, [世界科技研究与发展, World Sci-Tech R and D], V25, P73; Shi ZX, 2009, THESIS CHINESE CTR D; Sun YY, 2008, CHEMOSPHERE, V70, P1787, DOI 10.1016/j.chemosphere.2007.08.033; ten Dam G, 2012, J CHROMATOGR B, V898, P101, DOI 10.1016/j.jchromb.2012.04.025; The state oceanic administration of China, 2007, SPEC MAR MON; Tomy GT, 2008, ENVIRON SCI TECHNOL, V42, P3634, DOI 10.1021/es703083z; Troitzsch JH, 1998, CHIM OGGI, V16, P18; VOLKMANN-ROCCO B, 1973, Archivio di Oceanografia e Limnologia, V18, P71; Xu Dong-hui, 2010, Asian Journal of Ecotoxicology, V5, P543; Xu Fengfeng, 2013, Asian Journal of Ecotoxicology, V8, P737, DOI 10.7524/AJE.1673-5897.20130322001; Yi AX, 2014, ECOTOXICOLOGY, V23, P1314, DOI 10.1007/s10646-014-1274-y; Zegers BN, 2005, ENVIRON SCI TECHNOL, V39, P2095, DOI 10.1021/es049209t; ZHANG P., 2011, INNER MONGOLIA SCI T, V5, P51; Zheng Xiaoyan, 1989, Oceanologia et Limnologia Sinica, V20, P308; Zheng Z, 1984, MARINE ZOOPLANKTON B; Zhu JW, 2012, ENVIRON SCI TECHNOL, V25, P62; [No title captured]	70	8	8	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147790	10.1371/journal.pone.0147790	http://dx.doi.org/10.1371/journal.pone.0147790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824601	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528600061
J	Kayser, EB; Sedensky, MM; Morgan, PG				Kayser, Ernst-Bernhard; Sedensky, Margaret M.; Morgan, Philip G.			Region-Specific Defects of Respiratory Capacities in the Ndufs4(KO) Mouse Brain	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; MITOCHONDRIAL PHOSPHOENOLPYRUVATE CARBOXYKINASE; LEIGH-LIKE-SYNDROME; AQDQ SUBUNIT; DISEASE; MUTATIONS; GENE; MICE; PROTEIN; MODEL	Background Lack of NDUFS4, a subunit of mitochondrial complex I (NADH: ubiquinone oxidoreductase), causes Leigh syndrome (LS), a progressive encephalomyopathy. Knocking out Ndufs4, either systemically or in brain only, elicits LS in mice. In patients as well as in KO mice distinct regions of the brain degenerate while surrounding tissue survives despite systemic complex I dysfunction. For the understanding of disease etiology and ultimately for the development of rationale treatments for LS, it appears important to uncover the mechanisms that govern focal neurodegeneration. Results Here we used the Ndufs4(KO) mouse to investigate whether regional and temporal differences in respiratory capacity of the brain could be correlated with neurodegeneration. In the KO the respiratory capacity of synaptosomes from the degeneration prone regions olfactory bulb, brainstem and cerebellum was significantly decreased. The difference was measurable even before the onset of neurological symptoms. Furthermore, neither compensating nor exacerbating changes in glycolytic capacity of the synaptosomes were found. By contrast, the KO retained near normal levels of synaptosomal respiration in the degeneration-resistant/resilient "rest" of the brain. We also investigated non-synaptic mitochondria. The KO expectedly had diminished capacity for oxidative phosphorylation (state 3 respiration) with complex I dependent substrate combinations pyruvate/malate and glutamate/malate but surprisingly had normal activity with alpha-ketoglutarate/malate. No correlation between oxidative phosphorylation (pyruvate/malate driven state 3 respiration) and neurodegeneration was found: Notably, state 3 remained constant in the KO while in controls it tended to increase with time leading to significant differences between the genotypes in older mice in both vulnerable and resilient brain regions. Neither regional ROS damage, measured as HNE-modified protein, nor regional complex I stability, assessed by blue native gels, could explain regional neurodegeneration. Conclusion Our data suggests that locally insufficient respiration capacity of the nerve terminals may drive focal neurodegeneration.	[Kayser, Ernst-Bernhard; Sedensky, Margaret M.; Morgan, Philip G.] Seattle Childrens Res Inst, Ctr Dev Therapeut, Seattle, WA USA; [Sedensky, Margaret M.; Morgan, Philip G.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle	Kayser, EB (corresponding author), Seattle Childrens Res Inst, Ctr Dev Therapeut, Seattle, WA USA.	ernstbernhard.kayser@seattlechildrens.org			Seattle Children's Research Institute	Seattle Children's Research Institute	This work was supported by a seed fund from Seattle Children's Research Institute and by a gift from the Northwest Mitochondrial research Guild. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assouline Z, 2012, BBA-MOL BASIS DIS, V1822, P1062, DOI 10.1016/j.bbadis.2012.01.013; Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; CHENG SC, 1972, ARCH BIOCHEM BIOPHYS, V151, P501, DOI 10.1016/0003-9861(72)90527-9; Choi SW, 2011, J NEUROSCI, V31, P4524, DOI 10.1523/JNEUROSCI.5817-10.2011; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188; Cobb CA, 2015, NEUROBIOL DIS, V84, P4, DOI 10.1016/j.nbd.2015.04.020; DRAHOTA Z, 1983, FEBS LETT, V157, P347, DOI 10.1016/0014-5793(83)80573-0; Falk MJ, 2010, CURR OPIN PEDIATR, V22, P711, DOI 10.1097/MOP.0b013e3283402e21; Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068831; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leshinsky-Silver E, 2009, MOL GENET METAB, V97, P185, DOI 10.1016/j.ymgme.2009.03.002; Pathak D, 2015, J BIOL CHEM, V290, P22325, DOI 10.1074/jbc.M115.656405; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Quintana A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042904; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176; Sakai Y, 2006, AM J NEURORADIOL, V27, P1924; Scacco S, 2003, J BIOL CHEM, V278, P44161, DOI 10.1074/jbc.M307615200; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; SCHMOLL D, 1995, EUR J BIOCHEM, V227, P308, DOI 10.1111/j.1432-1033.1995.tb20390.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134; SHANK RP, 1985, BRAIN RES, V329, P364, DOI 10.1016/0006-8993(85)90552-9; Spickett CM, 2013, REDOX BIOL, V1, P145, DOI 10.1016/j.redox.2013.01.007; Tsai L, 1998, P NATL ACAD SCI USA, V95, P7975, DOI 10.1073/pnas.95.14.7975; Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009; Wang XY, 2011, J NEUROCHEM, V119, P1253, DOI 10.1111/j.1471-4159.2011.07525.x; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; WESTERGAARD N, 1994, NEUROSCI LETT, V176, P105, DOI 10.1016/0304-3940(94)90882-6; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200	41	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148219	10.1371/journal.pone.0148219	http://dx.doi.org/10.1371/journal.pone.0148219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824698	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600110
J	Moreno-Arriola, E; El Hafidi, M; Ortega-Cuellar, D; Carvajal, K				Moreno-Arriola, Elizabeth; El Hafidi, Mohammed; Ortega-Cuellar, Daniel; Carvajal, Karla			AMP-Activated Protein Kinase Regulates Oxidative Metabolism in Caenorhabditis elegans through the NHR-49 and MDT-15 Transcriptional Regulators	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; LIFE-SPAN; DIETARY RESTRICTION; C. ELEGANS; PPAR-ALPHA; GLUCOSE; INCREASES; PATHWAY; STRESS; AAK-2	Cellular energy regulation relies on complex signaling pathways that respond to fuel availability and metabolic demands. Dysregulation of these networks is implicated in the development of human metabolic diseases such as obesity and metabolic syndrome. In Caenorhabditis elegans the AMP-activated protein kinase, AAK, has been associated with longevity and stress resistance; nevertheless its precise role in energy metabolism remains elusive. In the present study, we find an evolutionary conserved role of AAK in oxidative metabolism. Similar to mammals, AAK is activated by AICAR and metformin and leads to increased glycolytic and oxidative metabolic fluxes evidenced by an increase in lactate levels and mitochondrial oxygen consumption and a decrease in total fatty acids and lipid storage, whereas augmented glucose availability has the opposite effects. We found that these changes were largely dependent on the catalytic subunit AAK-2, since the aak-2 null strain lost the observed metabolic actions. Further results demonstrate that the effects due to AAK activation are associated to SBP-1 and NHR-49 transcriptional factors and MDT-15 transcriptional co-activator, suggesting a regulatory pathway that controls oxidative metabolism. Our findings establish C. elegans as a tractable model system to dissect the relationship between distinct molecules that play a critical role in the regulation of energy metabolism in human metabolic diseases.	[Moreno-Arriola, Elizabeth; Ortega-Cuellar, Daniel; Carvajal, Karla] Inst Nacl Pediat, Lab Nutr Expt, Mexico City, DF, Mexico; [El Hafidi, Mohammed] Inst Nacl Cardiol, Dept Biomed Cardiovasc, Mexico City, DF, Mexico	National Institute of Cardiology - Mexico	Carvajal, K (corresponding author), Inst Nacl Pediat, Lab Nutr Expt, Mexico City, DF, Mexico.	karla_ca@yahoo.com	El-Hafidi, Mohammed/AAN-4083-2021	Moreno-Arriola, Elizabeth/0000-0003-0160-6429; Ortega-Cuellar, Daniel/0000-0001-7950-4911; CARVAJAL, KARLA/0000-0002-5522-3266	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [239732]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors received no specific funding for this work. The authors thank Consejo Nacional de Ciencia y Tecnologia (CONACyT) for PhD scholarship (239732) given to EMA. EMA is a Ph.D. student at Programa de Doctorado en Ciencias Biomedicas, Facultad de Medicina, Universidad Nacional Autonoma de Mexico (UNAM, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Consejo Nacional de Ciencia y Tecnologia (CONACyT) for PhD scholarship (239732) given to Elizabeth Moreno-Arriola (EMA). EMA is a Ph.D. student at Programa de Doctorado en Ciencias Biomedicas, Facultad de Medicina, Universidad Nacional Autonoma de Mexico (UNAM, Mexico). We greatly thank Reyna Hernandez-Morales and Patricia Zarate-Grajales for technical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, DISSOLVED OXYGEN HDB; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Ashrafi K, 2007, OBESITY REGULATION F; Atherton HJ, 2008, FEBS LETT, V582, P1661, DOI 10.1016/j.febslet.2008.04.020; Beale EG, 2008, EXP BIOL MED, V233, P12, DOI 10.3181/0705-MR-117; Bergmeyer H, 1974, METHOD ENZYMAT AN, P1463; BRENNER S, 1974, GENETICS, V77, P71; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; CARLING D, 1994, J BIOL CHEM, V269, P11442; Coughlan KA, 2014, DIABET METAB SYND OB, V7, P241, DOI 10.2147/DMSO.S43731; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Da Silva D, 2012, IUBMB LIFE, V64, P766, DOI 10.1002/iub.1063; Daignan-Fornier B, 2012, METABOLITES, V2, DOI 10.3390/metabo2020292; De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111; El Hafidi M, 2001, J NUTR BIOCHEM, V12, P396, DOI 10.1016/S0955-2863(01)00154-1; Elle IC, 2008, LIPID INSIGHTS, V1, P13; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIUGLIANO D, 1993, DIABETES CARE, V16, P1387, DOI 10.2337/diacare.16.10.1387; Grad LI, 2005, P NATL ACAD SCI USA, V102, P18367, DOI 10.1073/pnas.0506939102; Grad LI, 2004, HUM MOL GENET, V13, P303, DOI 10.1093/hmg/ddh027; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Haase TN, 2011, AM J PHYSIOL-REG I, V301, pR1501, DOI 10.1152/ajpregu.00775.2010; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hope IA., 1999, C ELEGANS PRACTICAL; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kemp BJ, 2012, CURR BIOL, V22, P2213, DOI 10.1016/j.cub.2012.09.047; Kniazeva M, 2003, GENETICS, V163, P159; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Lee SK, 2012, CELL SIGNAL, V24, P2329, DOI 10.1016/j.cellsig.2012.07.022; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moreno-Arriola E, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/705253; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Nomura T, 2010, GENES NUTR, V5, P17, DOI 10.1007/s12263-009-0157-y; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Ortega-Cuellar D, 2010, J NUTRIGENET NUTRIGE, V3, P18, DOI 10.1159/000318054; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Pino EC, 2013, JOVE-J VIS EXP, DOI 10.3791/50180; Qin Y, 2009, BBA-MOL CELL BIOL L, V1791, P140, DOI 10.1016/j.bbalip.2008.12.003; Ruiz-Ramirez A, 2011, AM J PHYSIOL-ENDOC M, V301, pE1198, DOI 10.1152/ajpendo.00631.2010; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Tateya S, 2013, DIABETES, V62, P1913, DOI 10.2337/db12-0325; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Vazquez Garcia JC, 2000, REV I NAL ENF RESP M, V13, P6; Velazquez-Arellano A, 2011, MOL GENET METAB, V102, P69, DOI 10.1016/j.ymgme.2010.08.021; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; ZBOROWSK.DT, 1967, J APPL PHYSIOL, V22, P746, DOI 10.1152/jappl.1967.22.4.746; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	70	33	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148089	10.1371/journal.pone.0148089	http://dx.doi.org/10.1371/journal.pone.0148089			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824904	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600097
J	Macias-Garcia, A; Heizmann, B; Sellars, M; Marchal, P; Dali, H; Pasquali, JL; Muller, S; Kastner, P; Chan, SS				Macias-Garcia, Alejandra; Heizmann, Beate; Sellars, MacLean; Marchal, Patricia; Dali, Hayet; Pasquali, Jean-Louis; Muller, Sylviane; Kastner, Philippe; Chan, Susan			Ikaros Is a Negative Regulator of B1 Cell Development and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEINS; TUMOR-SUPPRESSOR; B-1; DIFFERENTIATION; EXPRESSION; RECEPTOR; GENE; IDENTIFICATION; ACTIVATION; FETAL	B1 B cells secrete most of the circulating natural antibodies and are considered key effector cells of the innate immune response. However, B1 cell-associated antibodies often cross-react with self-antigens, which leads to autoimmunity, and B1 cells have been implicated in cancer. How B1 cell activity is regulated remains unclear. We show that the Ikaros transcription factor is a major negative regulator of B1 cell development and function. Using conditional knock-out mouse models to delete Ikaros at different locations, we show that Ikaros-deficient mice exhibit specific and significant increases in splenic and bone marrow B1 cell numbers, and that the B1 progenitor cell pool is increased similar to 10-fold in the bone marrow. Ikaros-null B1 cells resemble WT B1 cells at the molecular and cellular levels, but show a down-regulation of signaling components important for inhibiting proliferation and immunoglobulin production. Ikaros-null B1 cells hyper-react to TLR4 stimulation and secrete high amounts of IgM autoantibodies. These results indicate that Ikaros is required to limit B1 cell homeostasis in the adult.	[Macias-Garcia, Alejandra; Heizmann, Beate; Sellars, MacLean; Marchal, Patricia; Pasquali, Jean-Louis; Kastner, Philippe; Chan, Susan] Univ Strasbourg, CNRS UMR 7104, INSERM U964, IGBMC, F-67404 Illkirch Graffenstaden, France; [Dali, Hayet; Pasquali, Jean-Louis; Muller, Sylviane] IBMC, CNRS UPR3572, F-67000 Strasbourg, France; [Pasquali, Jean-Louis] Univ Strasbourg, UFR Med, F-67000 Strasbourg, France; Hop Univ Strasbourg, Dept Clin Immunol, F-67000 Strasbourg, France; [Muller, Sylviane] Univ Strasbourg, Inst Etud Avancees, F-67000 Strasbourg, France; [Kastner, Philippe] Univ Strasbourg, Fac Med, F-67000 Strasbourg, France; [Macias-Garcia, Alejandra] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Heizmann, Beate] IGBMC, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France; [Sellars, MacLean] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Massachusetts Institute of Technology (MIT); Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chan, SS (corresponding author), Univ Strasbourg, CNRS UMR 7104, INSERM U964, IGBMC, F-67404 Illkirch Graffenstaden, France.	scpk@igbmc.fr	Beate, HEIZMANN/G-6157-2017		Agence Nationale de la Recherche [ANR-11-BSV3-018]; Institut National du Cancer (INCa) [2011-144]; Ligue Nationale Contre le Cancer (Equipe labellisee); Fondation Arthritis Courtin; Fondation ARC [PJA20141201922]; Fondation de France [201400047508]; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Hopitaux Universitaires de Strasbourg; Laboratory of Excellence Medalis [ANR-10-LABX-0034]; EquipEx program I2MC [ANR-11-EQPX-022]; Initiative of Excellence (IdEx), University of Strasbourg; Conacyt Association of Mexico; Fondation ARC; Fondation de France; Fondation pour la Recherche Medicale;  [ANR-10-LABX-0030-INRT]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Fondation Arthritis Courtin; Fondation ARC; Fondation de France(Fondation de France); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Hopitaux Universitaires de Strasbourg; Laboratory of Excellence Medalis; EquipEx program I2MC; Initiative of Excellence (IdEx), University of Strasbourg; Conacyt Association of Mexico; Fondation ARC; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); 	This work was supported by the Agence Nationale de la Recherche (ANR-11-BSV3-018), the Institut National du Cancer (INCa #2011-144), the Ligue Nationale Contre le Cancer (Equipe labellisee 2006-2012, 2015-2017, to S. C. and P. K.), Fondation Arthritis Courtin (2013), Fondation ARC (#PJA20141201922), Fondation de France (#201400047508), and institutional funds from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), the Hopitaux Universitaires de Strasbourg, the ANR-10-LABX-0030-INRT, the Laboratory of Excellence Medalis (ANR-10-LABX-0034), the EquipEx program I2MC (ANR-11-EQPX-022), the Initiative of Excellence (IdEx), University of Strasbourg. The authors declare that they have no competing financial interests.r Received predoctoral fellowships from the Conacyt Association of Mexico and the Fondation ARC.r Received post-doctoral fellowships from the Fondation ARC and Fondation de France.r Received a predoctoral fellowship from the Fondation pour la Recherche Medicale.	Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Arita K, 2011, J IMMUNOL, V186, P7050, DOI 10.4049/jimmunol.1001302; Badea TC, 2003, J NEUROSCI, V23, P2314; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Ferreiros-Vidal I, 2013, BLOOD, V121, P1769, DOI 10.1182/blood-2012-08-450114; Geimer Le Lay AS, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004545; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Grandoch M, 2009, CELL SIGNAL, V21, P609, DOI 10.1016/j.cellsig.2009.01.002; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; Hayakawa K, 2015, ANN NY ACAD SCI, V1362, P250, DOI 10.1111/nyas.12768; Heizmann B, 2013, J EXP MED, V210, P2823, DOI 10.1084/jem.20131735; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Holodick NE, 2010, EUR J IMMUNOL, V40, P3007, DOI 10.1002/eji.201040545; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Hwang IY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060139; Johnson EN, 2002, J BIOL CHEM, V277, P16768, DOI 10.1074/jbc.M200751200; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Kastner P, 2013, AM J BLOOD RES, V3, P1; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Kleinmann E, 2008, MOL CELL BIOL, V28, P7465, DOI 10.1128/MCB.00715-08; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kubo T, 2009, J EXP MED, V206, P1971, DOI 10.1084/jem.20082392; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; LEVENSON R, 1982, CELL, V28, P855, DOI 10.1016/0092-8674(82)90064-2; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu Z, 2006, IMMUNITY, V24, P405, DOI 10.1016/j.immuni.2006.02.001; Mabbott NA, 2014, IMMUNOLOGY, V141, P79, DOI 10.1111/imm.12171; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; MANOHAR V, 1982, J IMMUNOL, V129, P532; MCINTYRE TM, 1991, J IMMUNOL, V146, P3639; Milpied P, 2009, EUR J IMMUNOL, V39, P1466, DOI 10.1002/eji.200839040; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Montecino-Rodriguez E, 2014, J IMMUNOL, V192, P5171, DOI 10.4049/jimmunol.1303170; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; MORRIS DL, 1993, J EXP MED, V177, P857, DOI 10.1084/jem.177.3.857; Nakamura A, 2003, J EXP MED, V197, P669, DOI 10.1084/jem.20021824; Nakano-Yokomizo T, 2011, J EXP MED, V208, P1661, DOI 10.1084/jem.20101623; Oliveira VC, 2015, IMMUNOBIOLOGY, V220, P1232, DOI 10.1016/j.imbio.2015.06.010; Oravecz A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9823; PARRY SL, 1994, J IMMUNOL, V152, P2821; Pedersen GK, 2015, ANN NY ACAD SCI, V1362, P39, DOI 10.1111/nyas.12800; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Savitsky D, 2006, J EXP MED, V203, P2305, DOI 10.1084/jem.20060411; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Sellars M, 2009, J EXP MED, V206, P1073, DOI 10.1084/jem.20082311; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Weigelt K, 2007, J LEUKOCYTE BIOL, V82, P1564, DOI 10.1189/jlb.0707447; Wojcik H, 2007, EUR J IMMUNOL, V37, P1022, DOI 10.1002/eji.200637026; Yang Y, 2007, P NATL ACAD SCI USA, V104, P4542, DOI 10.1073/pnas.0700001104; Ye M, 2005, J EXP MED, V202, P1411, DOI 10.1084/jem.20051089; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhou Y., 2015, MOL BIOL B CELLS; Zhou Y, 2015, J EXP MED, V212, P569, DOI 10.1084/jem.20141510; Zuccolo J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00195	66	13	13	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9073	9086		10.1074/jbc.M115.704239	http://dx.doi.org/10.1074/jbc.M115.704239			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26841869	Green Published, hybrid			2022-12-26	WOS:000374849000021
J	Fontenete, S; Leite, M; Cappoen, D; Santos, R; Van Ginneken, C; Figueiredo, C; Wengel, J; Cos, P; Azevedo, NF				Fontenete, Silvia; Leite, Marina; Cappoen, Davie; Santos, Rita; Van Ginneken, Chris; Figueiredo, Ceu; Wengel, Jesper; Cos, Paul; Azevedo, Nuno Filipe			Fluorescence In Vivo Hybridization (FIVH) for Detection of Helicobacter pylori Infection in a C57BL/6 Mouse Model	PLOS ONE			English	Article							CONFOCAL LASER ENDOMICROSCOPY; NUCLEIC-ACID; ANTISENSE OLIGONUCLEOTIDES; MESSENGER-RNA; LIVING CELLS; DIAGNOSIS; EXPRESSION; TRACKING; BACTERIA; STOMACH	Introduction In this study, we applied fluorescence in vivo hybridization (FIVH) using locked nucleic acid (LNA) probes targeting the bacterial rRNA gene for in vivo detection of H. pylori infecting the C57BL/6 mouse model. A previously designed Cy3_HP_LNA/2OMe_PS probe, complementary to a sequence of the H. pylori 16S rRNA gene, was used. First, the potential cytotoxicity and genotoxicity of the probe was assessed by commercial assays. Further, the performance of the probe for detecting H. pylori at different pH conditions was tested in vitro, using fluorescence in situ hybridization (FISH). Finally, the efficiency of FIVH to detect H. pylori SS1 strain in C57BL/6 infectedmice was evaluated ex vivo in mucus samples, in cryosections and paraffin-embedded sections by epifluorescence and confocal microscopy. Results H. pylori SS1 strain infecting C57BL/6 mice was successfully detected by the Cy3_HP_LNA/2OMe_PS probe in the mucus, attached to gastric epithelial cells and colonizing the gastric pits. The specificity of the probe for H. pylori was confirmed by microscopy. Conclusions In the future this methodology can be used in combination with a confocal laser endomicroscope for in vivo diagnosis of H. pylori infection using fluorescent LNA probes, which would be helpful to obtain an immediate diagnosis. Our results proved for the first time that FIVH method is applicable inside the body of a higher-order animal.	[Fontenete, Silvia; Santos, Rita; Azevedo, Nuno Filipe] Univ Porto, Fac Engn, LEPABE, Lab Proc Engn Environm Biotechnol & Energy, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Fontenete, Silvia; Leite, Marina; Santos, Rita; Figueiredo, Ceu] Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Fontenete, Silvia; Leite, Marina; Santos, Rita; Figueiredo, Ceu] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Fontenete, Silvia; Wengel, Jesper] Univ Southern Denmark, Dept Phys Chem & Pharm, Nucle Acid Ctr, Odense M, Denmark; [Fontenete, Silvia] Univ Porto, Inst Biomed Sci Abel Salazar, ICBAS, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Cappoen, Davie; Cos, Paul] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Lab Microbiol Parasitol & Hyg, B-2020 Antwerp, Belgium; [Santos, Rita] Univ Ghent, Lab Gen Biochem & Phys Pharm, B-9000 Ghent, Belgium; [Van Ginneken, Chris] Univ Antwerp, Lab Appl Vet Morphol, Fac Pharmaceut Biomed & Vet Sci, B-2020 Antwerp, Belgium; [Figueiredo, Ceu] Univ Porto, Fac Med, FMUP, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Fontenete, Silvia] Spanish Natl Canc Res Ctr, Epithelial Cell Biol Grp, Canc Cell Biol Program, Madrid, Spain	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; University of Southern Denmark; Universidade do Porto; University of Antwerp; Ghent University; University of Antwerp; Universidade do Porto; Centro Nacional de Investigaciones Oncologicas (CNIO)	Azevedo, NF (corresponding author), Univ Porto, Fac Engn, LEPABE, Lab Proc Engn Environm Biotechnol & Energy, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	nazevedo@fe.up.pt	Fontenete, Sílvia/Q-1936-2018; Figueiredo, Ceu/B-8776-2008; Leite, Carla Marina Gonçalves/J-5976-2013; Van Ginneken, Chris/AAK-2559-2020; cos, paul/AAU-3896-2020; Guimarães, Nuno/J-6879-2013; Cos, Paul/L-9717-2015	Fontenete, Sílvia/0000-0003-1972-6349; Figueiredo, Ceu/0000-0001-5247-840X; Leite, Carla Marina Gonçalves/0000-0003-4286-0247; Van Ginneken, Chris/0000-0002-1622-9120; cos, paul/0000-0003-4361-8911; Guimarães, Nuno/0000-0002-7623-3877; Cos, Paul/0000-0003-4361-8911; Cappoen, Davie/0000-0002-3115-8797; S. Santos, Rita/0000-0002-7174-271X; Wengel, Jesper/0000-0001-9835-1009; Azevedo, Nuno/0000-0001-5864-3250	FCT/MEC; FEDER [NORTE-07-0124-FEDER-000025-RL2_EnvironmentHealth, NORTE-07-0124-FEDER-000022-ML]; FEDER funds through Programa Operacional Factores de Competitividade - COMPETE; Programa Operacional do Norte (ON2) program; FCT-Fundacao para a Ciencia e a Tecnologia [PIC/IC/82815/2007, SFRH/BD/72999/2010, SFRH/BD/84376/2012, SFRH/BPD/33420/2008]; Nucleic Acid Center, University of Southern Denmark; Research Foundation - Flanders (FWO-Vlaanderen) [12N5915N]; FEDER funds through Programa Operacional Factores de Competitividade-COMPETE; Research Foundation-Flanders (FWO-Vlaanderen) [12N5915N];  [UID/EQU/00511/2013-LEPABE]	FCT/MEC; FEDER(European Commission); FEDER funds through Programa Operacional Factores de Competitividade - COMPETE; Programa Operacional do Norte (ON2) program; FCT-Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Nucleic Acid Center, University of Southern Denmark; Research Foundation - Flanders (FWO-Vlaanderen)(FWO); FEDER funds through Programa Operacional Factores de Competitividade-COMPETE; Research Foundation-Flanders (FWO-Vlaanderen)(FWO); 	This work was financially supported by: Project UID/EQU/00511/2013-LEPABE, by the FCT/MEC with national funds and when applicable co-funded by FEDER in the scope of the P2020 Partnership Agreement; Project NORTE-07-0124-FEDER-000025-RL2_Environment&Health, and Project NORTE-07-0124-FEDER-000022-ML, by FEDER funds through Programa Operacional Factores de Competitividade - COMPETE, by the Programa Operacional do Norte (ON2) program and by national funds through FCT-Fundacao para a Ciencia e a Tecnologia; DNA mimics Research Project PIC/IC/82815/2007], PhD grants [SFRH/BD/72999/2010 to SF and SFRH/BD/84376/2012 to RS], Post-Doctoral fellowship [SFRH/BPD/33420/2008 to ML] and by Nucleic Acid Center, University of Southern Denmark. The salary of DC is covered by the Research Foundation - Flanders (FWO-Vlaanderen) under grant 12N5915N.; This work was financially supported by: Project UID/EQU/00511/2013-LEPABE, by the FCT/MEC with national funds and when applicable co-funded by FEDER in the scope of the P2020 Partnership Agreement; Project NORTE-07-0124-FEDER-000025-RL2_Environment&Health, and Project NORTE-07-0124-FEDER-000022-ML, by FEDER funds through Programa Operacional Factores de Competitividade-COMPETE, by the Programa Operacional do Norte (ON2) program and by national funds through FCT-Fundacao para a Ciencia e a Tecnologia; DNA mimics Research Project PIC/IC/82815/2007], PhD grants [SFRH/BD/72999/2010 to SF and SFRH/BD/84376/2012 to RS], Post-Doctoral fellowship [SFRH/BPD/33420/2008 to ML] and by Nucleic Acid Center, University of Southern Denmark. The salary of DC is covered by the Research Foundation-Flanders (FWO-Vlaanderen) under grant 12N5915N.	[Anonymous], [No title captured]; Cappoen D, 2014, J MED CHEM, V57, P2895, DOI 10.1021/jm401735w; Cerqueira L, 2008, INT J MOL SCI, V9, P1944, DOI 10.3390/ijms9101944; Fluiter K, 2003, NUCLEIC ACIDS RES, V31, P953, DOI 10.1093/nar/gkg185; Fontenete S, 2015, APPL MICROBIOL BIOTE; Fontenete S, 2016, CRIT REV BIOTECHNOL, V36, P566, DOI 10.3109/07388551.2014.993589; Fontenete S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125494; Fontenete S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081230; Gheonea DI, 2011, WORLD J GASTROENTERO, V17, P21, DOI 10.3748/wjg.v17.i1.21; Gupta N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010682; Hoerr V, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-63; Hovelmann F, 2014, ANGEW CHEM INT EDIT, V53, P11370, DOI 10.1002/anie.201406022; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Ji R, 2010, J GASTROEN HEPATOL, V25, P700, DOI 10.1111/j.1440-1746.2009.06197.x; Kam Y, 2012, MOL PHARMACEUT, V9, P685, DOI 10.1021/mp200505k; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; KIRSCHNER DE, 1995, J THEOR BIOL, V176, P281, DOI 10.1006/jtbi.1995.0198; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Li LL, 2014, P NATL ACAD SCI USA, V111, P17099, DOI 10.1073/pnas.1420105111; Lopes AI, 2014, WORLD J GASTROENTERO, V20, P9299, DOI 10.3748/wjg.v20.i28.9299; Lorenz U, 2011, EUR J VASC ENDOVASC, V41, P68, DOI 10.1016/j.ejvs.2010.09.007; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; McNulty CAM, 2011, HELICOBACTER, V16, P10, DOI 10.1111/j.1523-5378.2011.00875.x; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Mook Orf, 2010, Artif DNA PNA XNA, V1, P36; Nedosekin DA, 2013, J BIOPHOTONICS, V6, P523, DOI 10.1002/jbio.201200242; Neumann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058753; Paramsothy S, 2010, NAT REV GASTRO HEPAT, V7, P366, DOI 10.1038/nrgastro.2010.83; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Schreiber S, 2004, P NATL ACAD SCI USA, V101, P5024, DOI 10.1073/pnas.0308386101; Shahid Muhammad W, 2011, J Interv Gastroenterol, V1, P166; Shi H, 2014, ANAL CHIM ACTA, V812, P138, DOI 10.1016/j.aca.2013.12.023; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070476; Shi SR, 2008, AM J CLIN PATHOL, V129, P358, DOI 10.1309/7CXUYXT23E5AL8KQ; Sigal M, 2015, GASTROENTEROLOGY; Stanton R, 2012, NUCLEIC ACID THER, V22, P344, DOI 10.1089/nat.2012.0366; Swayze EE, 2007, NUCLEIC ACIDS RES, V35, P687, DOI 10.1093/nar/gkl1071; Testerman TL, 2014, WORLD J GASTROENTERO, V20, P12781, DOI 10.3748/wjg.v20.i36.12781; Verschaeve L, 1999, ENVIRON MOL MUTAGEN, V33, P240, DOI 10.1002/(SICI)1098-2280(1999)33:3<240::AID-EM8>3.3.CO;2-I; Wang YZ, 2013, NUCL MED BIOL, V40, P89, DOI 10.1016/j.nucmedbio.2012.10.001; Weil TT, 2010, TRENDS CELL BIOL, V20, P380, DOI 10.1016/j.tcb.2010.03.006; Westerink WMA, 2009, MUTAT RES-GEN TOX EN, V676, P113, DOI 10.1016/j.mrgentox.2009.04.008; Wiegant J, 2010, METHODS MOL BIOL, V659, P239, DOI 10.1007/978-1-60761-789-1_17; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Zelenka J, 2014, J BIOENERG BIOMEMBR, V46, P147, DOI 10.1007/s10863-014-9543-2; Zhao XM, 2014, J NUCL MED, V55, P1008, DOI 10.2967/jnumed.113.136101	48	14	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148353	10.1371/journal.pone.0148353	http://dx.doi.org/10.1371/journal.pone.0148353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848853	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000076
J	Han, GJ; Xu, J; Liu, Q; Li, CM; Xu, HX; Lu, ZX				Han, Guangjie; Xu, Jian; Liu, Qin; Li, Chuanming; Xu, Hongxing; Lu, Zhongxian			Genome of Cnaphalocrocis medinalis Granulovirus, the First Crambidae-Infecting Betabaculovirus Isolated from Rice Leaffolder to Sequenced	PLOS ONE			English	Article							PROTEIN; BINDING; GENE; TRANSCRIPTION; LEPIDOPTERA; REPEATS; CHITIN; LARVAE; IDENTIFICATION; BACULOVIRUSES	Cnaphalocrocis medinalis is a major pest of rice in South and South-East Asia. Insecticides are the major means farmers use for management. A naturally occurring baculovirus, C. medinalis granulovirus (CnmeGV), has been isolated from the larvae and this has the potential for use as microbial agent. Here, we described the complete genome sequence of CnmeGV and compared it to other baculovirus genomes. The genome of CnmeGV is 112,060 base pairs in length, has a G+C content of 35.2%. It contains 133 putative open reading frames (ORFs) of at least 150 nucleotides. A hundred and one (101) of these ORFs are homologous to other baculovirus genes including 37 baculovirus core genes. Thirty-two (32) ORFs are unique to CnmeGV with no homologues detected in the GeneBank and 53 tandem repeats (TRs) with sequence length from 25 to 551 nt intersperse throughout the genome of CnmeGV. Six (6) homologous regions (hrs) were identified interspersed throughout the genome. Hr2 contains 11 imperfect palindromes and a high content of AT sequence (about 73%). The unique ORF28 contains a coiled-coil region and a zinc finger-like domain of 4-50 residues specialized by two C2C2 zinc finger motifs that putatively bound two atoms of zinc. ORF21 encoding a chit-1 protein suggesting a horizontal gene transfer from alphabaculovirus. The putative protein presents two carbohydrate-binding module family 14 (CBM_14) domains rather than other homologues detected from betabaculovirus that only contains one chit-binding region. Gene synteny maps showed the colinearity of sequenced betabaculovirus. Phylogenetic analysis indicated that CnmeGV grouped in the betabaculovirus, with a close relation to AdorGV. The cladogram obtained in this work grouped the 17 complete GV genomes in one monophyletic clade. CnmeGV represents a new crambidae host-isolated virus species from the genus Betabaculovirus and is most closely relative of AdorGV. The analyses and information derived from this study will provide a better understanding of the pathological symptoms caused by this virus and its potential use as a microbial pesticide.	[Han, Guangjie; Xu, Jian; Liu, Qin; Li, Chuanming] Jiangsu Lixiahe Inst Agr Sci, Dept Biol Pesticides, Yangzhou 225007, Jiangsu, Peoples R China; [Xu, Hongxing; Lu, Zhongxian] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect & Microbiol, Hangzhou 310021, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Xu, J (corresponding author), Jiangsu Lixiahe Inst Agr Sci, Dept Biol Pesticides, Yangzhou 225007, Jiangsu, Peoples R China.; Lu, ZX (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect & Microbiol, Hangzhou 310021, Zhejiang, Peoples R China.	bio-xj@163.com; luzxmh@163.com	Han, Guangjie/AAE-1496-2019	Han, Guangjie/0000-0002-6921-7369; Han, Guangjie/0000-0002-3920-9413	National Natural Science Foundation of China [31071740]; Jiangsu Science Project of China [BK20141283, BE2014361]; Jiangsu Province "333 engineering" Project [BRA2014154]; Jiangsu Province Independent Innovation of Agricultural Science [CX (14)2129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Science Project of China; Jiangsu Province "333 engineering" Project; Jiangsu Province Independent Innovation of Agricultural Science	This work was supported by the National Natural Science Foundation of China (31071740), Jiangsu Science Project of China (BK20141283, BE2014361), Jiangsu Province "333 engineering" Project (BRA2014154), and Jiangsu Province Independent Innovation of Agricultural Science (CX (14)2129).	Araki K, 2003, J NEUROCHEM, V86, P749, DOI 10.1046/j.1471-4159.2003.01875.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Buard J, 1998, EMBO J, V17, P3495, DOI 10.1093/emboj/17.12.3495; Wolff JL, 2008, J GEN VIROL, V89, P1202, DOI 10.1099/vir.0.83581-0; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Casu R, 1997, P NATL ACAD SCI USA, V94, P8939, DOI 10.1073/pnas.94.17.8939; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Cuartas PE, 2015, VIRUSES-BASEL, V7, P394, DOI 10.3390/v7010394; Oliveira JVD, 2006, J GEN VIROL, V87, P3233, DOI 10.1099/vir.0.82161-0; Ehrensberger KM, 2014, J BIOL CHEM, V289, P18087, DOI 10.1074/jbc.M114.551333; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Elvin CM, 1996, J BIOL CHEM, V271, P8925, DOI 10.1074/jbc.271.15.8925; Escasa SR, 2006, J GEN VIROL, V87, P1917, DOI 10.1099/vir.0.81792-0; Federici B.A., 1997, BACULOVIRUSES VIRUSE, P33, DOI [10.1007/978-1-4899-1834-5_3, DOI 10.1007/978-1-4899-1834-5_3]; FEUERSTEIN R, 1994, P NATL ACAD SCI USA, V91, P10655, DOI 10.1073/pnas.91.22.10655; Gaines PJ, 2003, INSECT BIOCHEM MOLEC, V33, P1061, DOI 10.1016/S0965-1748(03)00096-1; Garcia-Maruniak A, 2004, J VIROL, V78, P7036, DOI 10.1128/JVI.78.13.7036-7051.2004; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gilbert C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4348; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Herniou EA., 2011, VIRUS TAXONOMY, P163; Hilton S, 2007, J GEN VIROL, V88, P1496, DOI 10.1099/vir.0.82760-0; Inoue H, 2004, JPN J APPL ENTOMOL Z, V48, P177, DOI 10.1303/jjaez.2004.177; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Kang WY, 1999, J VIROL, V73, P10339, DOI 10.1128/JVI.73.12.10339-10345.1999; Kawazu K, 2001, APPL ENTOMOL ZOOL, V36, P471, DOI 10.1303/aez.2001.471; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lange M, 2003, VIROLOGY, V317, P220, DOI 10.1016/S0042-6822(03)00515-4; Ferrelli ML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-548; Li QJ, 2002, VIROLOGY, V294, P106, DOI 10.1006/viro.2001.1313; Li ZF, 2003, VIRUS RES, V96, P113, DOI 10.1016/S0168-1702(03)00179-5; Liang ZP, 2011, ARCH VIROL, V156, P1185, DOI 10.1007/s00705-011-0977-0; Liu Qin, 2013, Journal of Yangzhou University (Agricultural and Life Science Edition), V34, P89; Liu XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110023; LU A, 1995, J VIROL, V69, P975, DOI 10.1128/JVI.69.2.975-982.1995; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Miele Solange Ana Belen, 2011, Int J Evol Biol, V2011, P379424, DOI 10.4061/2011/379424; Mittelman D, 2010, CELL STRESS CHAPERON, V15, P753, DOI 10.1007/s12192-010-0191-0; Nai YS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-116; Nathan SS, 2004, PHYTOPARASITICA, V32, P433, DOI 10.1007/BF02980437; Oh S, 2013, ARCH VIROL, V158, P1701, DOI 10.1007/s00705-013-1649-z; Peng K, 2010, J VIROL, V84, P9497, DOI 10.1128/JVI.00812-10; Ardisson-Araujo DMP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-856; Pijlman GP, 2003, J GEN VIROL, V84, P2041, DOI 10.1099/vir.0.19133-0; Possee RD, 1997, BACULOVIRUSES, P109; Regier JC, 1998, MOL BIOL EVOL, V15, P1172, DOI 10.1093/oxfordjournals.molbev.a026024; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; ROHRMANN GF, 1992, J GEN VIROL, V73, P749, DOI 10.1099/0022-1317-73-4-749; Shen ZC, 1998, J BIOL CHEM, V273, P17665, DOI 10.1074/jbc.273.28.17665; THEILMANN DA, 2005, VIRUS TAXONOMY, P177; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thumbi DK, 2011, VIRUSES-BASEL, V3, P2301, DOI 10.3390/v3112301; TODD JW, 1995, J VIROL, V69, P968, DOI 10.1128/JVI.69.2.968-974.1995; VanOers MM, 1997, J INVERTEBR PATHOL, V70, P1, DOI 10.1006/jipa.1997.4675; Vega FE, 2012, INSECT PATHOLOGY, 2ND EDITION, P1; Wang D, 2006, VIRUS RES, V117, P237, DOI 10.1016/j.virusres.2005.10.019; Wang Y, 2011, NEURAL REGEN RES, V6, P6, DOI 10.3969/j.issn.1673-5374.2011.01.001; Wang Y, 2008, J MICROBIOL, V46, P704, DOI 10.1007/s12275-008-0133-z; Wierdl M, 1996, GENETICS, V143, P713; WINSTANLEY D, 1993, J GEN VIROL, V74, P1599, DOI 10.1099/0022-1317-74-8-1599; Wormleaton S, 2003, VIROLOGY, V311, P350, DOI 10.1016/S0042-6822(03)00149-1; ZANOTTO PMD, 1993, J INVERTEBR PATHOL, V62, P147, DOI 10.1006/jipa.1993.1090; Zemskov EA, 2000, J VIROL, V74, P6784, DOI 10.1128/JVI.74.15.6784-6789.2000; Zheng XS, 2011, J ECON ENTOMOL, V104, P653, DOI 10.1603/EC10419	66	4	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147882	10.1371/journal.pone.0147882	http://dx.doi.org/10.1371/journal.pone.0147882			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848752	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000027
J	Chandra, S; Singh, D; Pathak, J; Kumari, S; Kumar, M; Poddar, R; Balyan, HS; Gupta, PK; Prabhu, KV; Mukhopadhyay, K				Chandra, Saket; Singh, Dharmendra; Pathak, Jyoti; Kumari, Supriya; Kumar, Manish; Poddar, Raju; Balyan, Harindra Singh; Gupta, Puspendra Kumar; Prabhu, Kumble Vinod; Mukhopadhyay, Kunal			De Novo Assembled Wheat Transcriptomes Delineate Differentially Expressed Host Genes in Response to Leaf Rust Infection	PLOS ONE			English	Article							RNA-SEQ; DEFENSE RESPONSES; SEQUENCING DATA; PLANT DEFENSE; PROTEIN; RESISTANCE; STRESS; ANNOTATION; METABOLISM; DISCOVERY	Pathogens like Puccinia triticina, the causal organism for leaf rust, extensively damages wheat production. The interaction at molecular level between wheat and the pathogen is complex and less explored. The pathogen induced response was characterized using mock-or pathogen inoculated near-isogenic wheat lines (with or without seedling leaf rust resistance gene Lr28). Four Serial Analysis of Gene Expression libraries were prepared from mock-and pathogen inoculated plants and were subjected to Sequencing by Oligonucleotide Ligation and Detection, which generated a total of 165,767,777 reads, each 35 bases long. The reads were processed and multiple k-mers were attempted for de novo transcript assembly; 22 k-mers showed the best results. Altogether 21,345 contigs were generated and functionally characterized by gene ontology annotation, mining for transcription factors and resistance genes. Expression analysis among the four libraries showed extensive alterations in the transcriptome in response to pathogen infection, reflecting reorganizations in major biological processes and metabolic pathways. Role of auxin in determining pathogenesis in susceptible and resistant lines were imperative. The qPCR expression study of four LRR-RLK (Leucine-rich repeat receptor-like protein kinases) genes showed higher expression at 24 hrs after inoculation with pathogen. In summary, the conceptual model of induced resistance in wheat contributes insights on defense responses and imparts knowledge of Puccinia triticina-induced defense transcripts in wheat plants.	[Chandra, Saket; Singh, Dharmendra; Pathak, Jyoti; Kumar, Manish; Poddar, Raju; Mukhopadhyay, Kunal] Birla Inst Technol, Dept Bioengn, Ranchi 835215, Jharkhand, India; [Kumari, Supriya; Balyan, Harindra Singh; Gupta, Puspendra Kumar] Ch Charan Singh Univ, Dept Genet & Plant Breeding, Meerut 200005, Uttar Pradesh, India; [Prabhu, Kumble Vinod] Indian Agr Res Inst, Div Genet, New Delhi 110012, India; [Singh, Dharmendra] Univ Queensland, Ctr Plant Sci, QAAF1, Brisbane, Qld 4072, Australia	Birla Institute of Technology Mesra; Chaudhary Charan Singh University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; University of Queensland	Mukhopadhyay, K (corresponding author), Birla Inst Technol, Dept Bioengn, Ranchi 835215, Jharkhand, India.	kmukhopadhyay@bitmesra.ac.in	Mukhopadhyay, Kunal/L-9577-2017; Balyan, H./AAI-9077-2020; Chandra, Saket/O-6522-2018; Kumar, Manish/O-8149-2017; PODDAR, RAJU/R-1671-2018	Mukhopadhyay, Kunal/0000-0003-2213-8134; Chandra, Saket/0000-0001-5201-5106; Kumar, Manish/0000-0002-3023-9018; Singh, Dharmendra/0000-0002-8325-2726	Department of Biotechnology, Government of India [BT/PR6037/AGR/02/308/05, BT/PR3925/BID/7/384/2011]; Centre of Excellence, Technical Education Quality Improvement Program-II [NPIU/TEQIP II/FIN/31/158]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Centre of Excellence, Technical Education Quality Improvement Program-II	This work was supported by Department of Biotechnology, Government of India (Grant No. BT/PR6037/AGR/02/308/05 and BT/PR3925/BID/7/384/2011) and Centre of Excellence, Technical Education Quality Improvement Program-II, (Grant No. NPIU/TEQIP II/FIN/31/158). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bansal UK, 2008, J APPL GENET, V49, P141, DOI 10.1007/BF03195607; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cantu D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-492; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Catala C, 1997, PLANT J, V12, P417, DOI 10.1046/j.1365-313X.1997.12020417.x; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COSGROVE DJ, 1993, NEW PHYTOL, V124, P1, DOI 10.1111/j.1469-8137.1993.tb03795.x; de Bruijn N.G., 1946, KONINKLIJKE NEDERLAN, V49, P758; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dhariwal R, 2015, FUNCT INTEGR GENOMIC, V15, P233, DOI 10.1007/s10142-014-0416-x; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fofana Bourlaye, 2007, Int J Plant Genomics, V2007, P17542, DOI 10.1155/2007/17542; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Goring DR, 2004, SCIENCE, V303, P1474, DOI 10.1126/science.1095764; Gou XP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-19; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan YF, 2008, PLANT PHYSIOL, V147, P852, DOI 10.1104/pp.108.118026; Haznedaroglu BZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-170; Higaki T, 2011, J PLANT RES, V124, P315, DOI 10.1007/s10265-011-0408-z; Hiltscher H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00475; Hu GG, 1998, MYCOL RES, V102, P391, DOI 10.1017/S0953756297005054; Igawa T, 2004, PLANT CELL PHYSIOL, V45, P1347, DOI 10.1093/pcp/pch195; Jaillais Y, 2011, P NATL ACAD SCI USA, V108, P8503, DOI 10.1073/pnas.1103556108; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Krasileva KV, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r66; Kumar D, 2014, FUNCT PLANT BIOL, V41, P1295, DOI 10.1071/FP14077; Kumar D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117559; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Less H, 2011, PLANT CELL, V23, P1264, DOI 10.1105/tpc.110.082867; Li AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028810; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Manickavelu A, 2012, DNA RES, V19, P165, DOI 10.1093/dnares/dss001; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Melicher D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-188; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Nakasugi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091776; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Pellny TK, 2012, PLANT PHYSIOL, V158, P612, DOI 10.1104/pp.111.189191; Pont C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r119; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Rudd S, 2003, TRENDS PLANT SCI, V8, P321, DOI 10.1016/S1360-1385(03)00131-6; Sanseverino W, 2010, NUCLEIC ACIDS RES, V38, pD814, DOI 10.1093/nar/gkp978; Satapathy L, 2014, MOL GENET GENOMICS, V289, P1289, DOI 10.1007/s00438-014-0890-9; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Schreiber AW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-492; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shah J, 2005, ANNU REV PHYTOPATHOL, V43, P229, DOI 10.1146/annurev.phyto.43.040204.135951; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Singh D, 2012, MOL BIOL REP, V39, P9373, DOI 10.1007/s11033-012-1801-y; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Taj G, 2010, PLANT SIGNAL BEHAV, V5, P1370, DOI 10.4161/psb.5.11.13020; Thurow C, 2005, PLANT J, V44, P100, DOI 10.1111/j.1365-313X.2005.02513.x; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Wan Jinrong, 2002, Funct Integr Genomics, V2, P259, DOI 10.1007/s10142-002-0080-4; Wang CF, 2007, PHYSIOL MOL PLANT P, V71, P230, DOI 10.1016/j.pmpp.2008.02.006; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang XE, 2009, MOL PLANT MICROBE IN, V22, P1227, DOI 10.1094/MPMI-22-10-1227; Wanjugi H, 2009, GENOME, V52, P576, DOI [10.1139/G09-033, 10.1139/g09-033]; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wright CA, 2004, P NATL ACAD SCI USA, V101, P3269, DOI 10.1073/pnas.0400461101; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Xu P, 2013, GENE, V525, P26, DOI 10.1016/j.gene.2013.04.066; Yang AH, 2005, PLANTA, V221, P493, DOI 10.1007/s00425-004-1462-8; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zabala MDT, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.74, 10.1038/nplants.2015.74]; Zhang D, 2004, GENETICS, V168, P595, DOI 10.1534/genetics.104.034785; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	97	28	28	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148453	10.1371/journal.pone.0148453	http://dx.doi.org/10.1371/journal.pone.0148453			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840746	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200138
J	Lane-Donovan, C; Herz, J				Lane-Donovan, Courtney; Herz, Joachim			High-Fat Diet Changes Hippocampal Apolipoprotein E (ApoE) in a Genotype- and Carbohydrate-Dependent Manner in Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; TARGETED REPLACEMENT; MEDITERRANEAN DIET; BETA AMYLOIDOSIS; MOUSE MODEL; CHOLESTEROL; RECEPTOR; BRAIN; GENE	Alzheimer's disease is a currently incurable neurodegenerative disease affecting millions of individuals worldwide. Risk factors for Alzheimer's disease include genetic risk factors, such as possession of e4 allele of apolipoprotein E (ApoE4) over the risk-neutral ApoE3 allele, and lifestyle risk factors, such as diet and exercise. The intersection of these two sources of disease risk is not well understood. We investigated the impact of diet on ApoE levels by feeding wildtype, ApoE3, and ApoE4 targeted replacement (TR) mice with chow, high-fat, or ketogenic (high-fat, very-low-carbohydrate) diets. We found that high-fat diet affected both plasma and hippocampal levels of ApoE in an isoform-dependent manner, with high-fat diet causing a surprising reduction of hippocampal ApoE levels in ApoE3 TR mice. Conversely, the ketogenic diet had no effect on hippocampal ApoE. Our findings suggest that the use of dietary interventions to slow the progression AD should take ApoE genotype into consideration.	[Lane-Donovan, Courtney; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Lane-Donovan, Courtney; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Lane-Donovan, Courtney; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Herz, Joachim] Univ Freiburg, Ctr Neurosci, Dept Neuroanat, Hugstetter Str 55, D-79106 Freiburg, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Freiburg	Lane-Donovan, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.; Lane-Donovan, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.; Lane-Donovan, C (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA.	Courtney.lane@utsouthwestern.edu			NIH [F30 AG047799, R37 HL63762]; American Health Assistance Foundation; Consortium for Frontotemporal Dementia Research; Bright Focus Foundation; Lupe Murchison Foundation; Ted Nash Long Life Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG047799] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Consortium for Frontotemporal Dementia Research; Bright Focus Foundation(BrightFocus Foundation); Lupe Murchison Foundation; Ted Nash Long Life Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant F30 AG047799 (to C.L.D.), NIH grant R37 HL63762 (to J. H.), the American Health Assistance Foundation (to J.H.), the Consortium for Frontotemporal Dementia Research (to J.H.), the Bright Focus Foundation (to J. H.), the Lupe Murchison Foundation (to J.H.), and The Ted Nash Long Life Foundation (to J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braak H, 1998, J NEURAL TRANSM-SUPP, P127; COLE TG, 1983, J CLIN ENDOCR METAB, V56, P1108, DOI 10.1210/jcem-56-6-1108; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Freeman LR, 2014, NUTR NEUROSCI, V17, P241, DOI 10.1179/1476830513Y.0000000092; Grant WB, 2014, J ALZHEIMERS DIS, V38, P611, DOI 10.3233/JAD-130719; GREENWOOD CE, 1990, BEHAV NEURAL BIOL, V53, P74, DOI 10.1016/0163-1047(90)90831-P; Head D, 2012, ARCH NEUROL-CHICAGO, V69, P636, DOI 10.1001/archneurol.2011.845; Heeren J, 2004, J BIOL CHEM, V279, P55483, DOI 10.1074/jbc.M409324200; HERZ J, 1991, J BIOL CHEM, V266, P21232; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Huebbe P, 2015, MOL NUTR FOOD RES, V59, P334, DOI 10.1002/mnfr.201400636; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kim J, 2011, J NEUROSCI, V31, P18007, DOI 10.1523/JNEUROSCI.3773-11.2011; Liao F, 2014, J NEUROSCI, V34, P7281, DOI 10.1523/JNEUROSCI.0646-14.2014; Martinez-Lapiscina EH, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0393-7; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Petanceska SS, 2003, J MOL NEUROSCI, V20, P395, DOI 10.1385/JMN:20:3:395; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Singh B, 2014, J ALZHEIMERS DIS, V39, P271, DOI 10.3233/JAD-130830; Srivastava RAK, 1996, MOL CELL BIOCHEM, V155, P153, DOI 10.1007/BF00229312; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wang CS, 2005, NEUROBIOL DIS, V18, P390, DOI 10.1016/j.nbd.2004.10.013	24	12	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148099	10.1371/journal.pone.0148099	http://dx.doi.org/10.1371/journal.pone.0148099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828652	gold, Green Published, Green Submitted			2022-12-26	WOS:000369548200060
J	Mirvakili, A; Dadgarnia, MH; Baradaranfar, MH; Atighechi, S; Zand, V; Ansari, A				Mirvakili, Abbas; Dadgarnia, Mohammad Hossein; Baradaranfar, Mohammad Hossein; Atighechi, Saeid; Zand, Vahid; Ansari, Abdollah			Role of Platelet Parameters on Sudden Sensorineural Hearing Loss: A Case-Control Study in Iran	PLOS ONE			English	Article							HYPERBARIC-OXYGEN THERAPY; RISK-FACTORS; VOLUME; APHERESIS; SEVERITY	Sudden sensorineural hearing loss (SSNHL) is a common otological disorder characterized by a hearing loss greater than 30 dB over three consecutive frequencies, in less than 72 hours. It has been established that platelet parameters, such as mean platelet volume, are associated with ischemic heart events, whose clinical manifestations are similar to those of SSNHL. Hence, we aimed to determine if the platelet count, mean platelet volume and platelet distribution width are related to the occurrence and severity of sudden sensorineural hearing loss. A case-control prospective study was conducted in a teaching hospital in Iran. One hundred-eight patients with SSNHL and an equal number of healthy, age-and sex-matched controls were enrolled in the study. Peripheral venous blood samples were collected from the subjects, and the platelet count, mean platelet volume and platelet distribution width were measured with an automated blood cell counter. Analysis of the audiometry and hematological test results using SPSS22 software showed no statistical correlation between the platelet parameters and the occurrence of SSNHL, but correlation coefficients showed a significant correlation between PDW and hearing loss severity in patients group. However, further investigation is required to unequivocally establish the absence of correlation between the platelet parameters and occurrence of SSNHL.	[Mirvakili, Abbas; Dadgarnia, Mohammad Hossein; Baradaranfar, Mohammad Hossein; Atighechi, Saeid; Zand, Vahid; Ansari, Abdollah] Shahid Sadoughi Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Otorhinolaryngol Res Ctr, Yazd, Iran		Ansari, A (corresponding author), Shahid Sadoughi Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Otorhinolaryngol Res Ctr, Yazd, Iran.	dr.ansaria6531@gmail.com	baradaranfar, Mohammad hossein/F-6328-2017; zand, vahid/F-6371-2017; atighechi, saeid/F-6352-2017; dadgarnia, mohammad hossein/F-6364-2017	baradaranfar, Mohammad hossein/0000-0002-3995-6822; zand, vahid/0000-0003-0658-7757; atighechi, saeid/0000-0002-9330-5342; dadgarnia, mohammad hossein/0000-0002-2802-9601; Zand, Vahid/0000-0001-6725-5196				Balta S, 2013, EUR ARCH OTO-RHINO-L, V270, P2373, DOI 10.1007/s00405-013-2522-0; Berrettini S, 1999, PEDIATR NEUROL, V20, P130, DOI 10.1016/S0887-8994(98)00123-4; Blaha M, 2014, EUROPEAN ARCH OTORHI, P3384; Bodur Serkan, 2013, Med Glas (Zenica), V10, P59; Capaccio P, 2005, AM J OTOLARYNG, V26, P383, DOI 10.1016/j.amjoto.2005.05.001; Chen YS, 2005, INT J PEDIATR OTORHI, V69, P817, DOI 10.1016/j.ijporl.2005.01.015; Cho SH, 2012, BMC EAR NOSE THROAT, V12, DOI 10.1186/1472-6815-12-5; De Felice C, 2000, LANCET, V356, P1237, DOI 10.1016/S0140-6736(00)02790-2; Finger RP, 2006, J CLIN APHERESIS, V21, P241, DOI 10.1002/jca.20081; Gerceker M, 2011, J INT ADV OTOL, V7, P67; Hato N, 2010, AURIS NASUS LARYNX, V37, P626, DOI 10.1016/j.anl.2010.01.008; Hausch RC, 1998, SEMIN ARTHRITIS RHEU, V28, P206, DOI 10.1016/S0049-0172(98)80038-3; Heigl F, 2009, ATHEROSCLEROSIS SUPP, V10, P95, DOI 10.1016/S1567-5688(09)71820-3; Hong SM, 2008, OTOLARYNG HEAD NECK, V139, P541, DOI 10.1016/j.otohns.2008.07.003; Inci E, 2011, J INT ADV OTOL, V7, P62; Itoh A, 2001, PUBLIC HEALTH, V115, P192; Karli R, 2013, INDIAN J OTOLARYNGOL, V65, P350, DOI 10.1007/s12070-013-0648-4; Klingel R, 2009, ATHEROSCLEROSIS SUPP, V10, P102, DOI 10.1016/S1567-5688(09)71821-5; Lazarini AR, 2006, OTORRINOLARINGOL, V72, P1; Leong AC, 2007, CLIN OTOLARYNGOL, V32, P391, DOI 10.1111/j.1749-4486.2007.01523.x; Massimo F, 2012, INT J AUDIOL, P1; Masuda M, 2013, WORLD J OTORHINOLARY, V28, P42; McRae S., 2008, IMVS NEWSLETTER SUMM, V68, P6; Mokhtari N, 2003, IRANIAN J EAR NOSE T, V35, P14; Nosrati-Zarenoe R., THESIS LINKOPING U; Nosrati-Zarenoe R, 2007, ACTA OTO-LARYNGOL, V127, P1168, DOI 10.1080/00016480701242477; Ohno Kazuchika, 2010, Journal of Medical and Dental Sciences, V57, P127; Ozcan M, BRAZILIAN J OTORHINO; Rudack C, 2004, HEARING RES, V191, P41, DOI 10.1016/j.heares.2004.01.002; Sagit M, 2013, J LARYNGOL OTOL, V127, P972, DOI 10.1017/S002221511300193X; Salahaldin Ahmed Harith, 2004, Int Tinnitus J, V10, P165; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; Seo YJ, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/702807; Shah AR, 2013, NATL J MED RES, V3, P162; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; SUNDEL RP, 1990, J PEDIATR-US, V117, P371, DOI 10.1016/S0022-3476(05)81075-3; Suzuki H, 2008, AURIS NASUS LARYNX, V35, P192, DOI 10.1016/j.anl.2007.06.003; Ulu S, 2013, EUR ARCH OTO-RHINO-L, V270, P2875, DOI 10.1007/s00405-013-2348-9; Wang Yao-Ting, 2007, J Chin Med Assoc, V70, P294, DOI 10.1016/S1726-4901(07)70008-4	39	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148149	10.1371/journal.pone.0148149	http://dx.doi.org/10.1371/journal.pone.0148149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829393	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200071
J	Nguyen, TT; Parat, MO; Shaw, PN; Hewavitharana, AK; Hodson, MP				Nguyen, Thao T.; Parat, Marie-Odile; Shaw, Paul N.; Hewavitharana, Amitha K.; Hodson, Mark P.			Traditional Aboriginal Preparation Alters the Chemical Profile of Carica papaya Leaves and Impacts on Cytotoxicity towards Human Squamous Cell Carcinoma	PLOS ONE			English	Article							LEAF EXTRACT; TOXICITY; CANCER; L.	Carica papaya leaf decoction, an Australian Aboriginal remedy, has been used widely for its healing capabilities against cancer, with numerous anecdotal reports. In this study we investigated its in vitro cytotoxicity on human squamous cell carcinoma cells followed by metabolomic profiling of Carica papaya leaf decoction and leaf juice/brewed leaf juice to determine the effects imparted by the long heating process typical of the Aboriginal remedy preparation. MTT assay results showed that in comparison with the decoction, the leaf juice not only exhibited a stronger cytotoxic effect on SCC25 cancer cells, but also produced a significant cancer-selective effect as shown by tests on non-cancerous human keratinocyte HaCaT cells. Furthermore, evidence from testing brewed leaf juice on these two cell lines suggested that the brewing process markedly reduced the selective effect of Carica papaya leaf on SCC25 cancer cells. To tentatively identify the compounds that contribute to the distinct selective anticancer activity of leaf juice, an untargeted metabolomic approach employing Ultra High Performance Liquid Chromatography-Quadrupole Time of Flight-Mass Spectrometry followed by multivariate data analysis was applied. Some 90 and 104 peaks in positive and negative mode respectively were selected as discriminatory features from the chemical profile of leaf juice and >1500 putative compound IDs were obtained via database searching. Direct comparison of chromatographic and tandem mass spectral data to available reference compounds confirmed one feature as a match with its proposed authentic standard, namely pheophorbide A. However, despite pheophorbide A exhibiting cytotoxic activity on SCC25 cancer cells, it did not prove to be the compound contributing principally to the selective activity of leaf juice. With promising results suggesting stronger and more selective anticancer effects when compared to the Aboriginal remedy, Carica papaya leaf juice warrants further study to explore its activity on other cancer cell lines, as well as investigation to confirm the identity of compounds contributing to its selective effect, particularly those compounds altered by the long heating process applied during the traditional Aboriginal remedy preparation.	[Nguyen, Thao T.; Parat, Marie-Odile; Shaw, Paul N.; Hewavitharana, Amitha K.; Hodson, Mark P.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Hodson, Mark P.] Univ Queensland, Metabol Australia, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Hodson, MP (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.; Hodson, MP (corresponding author), Univ Queensland, Metabol Australia, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.	m.hodson1@uq.edu.au	Hewavitharana, Amitha K/A-5533-2008; Shaw, Paul N/G-4418-2010; Hodson, Mark P/J-7609-2013; Parat, Marie-Odile/G-4410-2010; Shaw, Paul/Q-8454-2019	Hewavitharana, Amitha K/0000-0003-2935-9941; Shaw, Paul N/0000-0001-7154-592X; Hodson, Mark P/0000-0002-5436-1886; Parat, Marie-Odile/0000-0003-4895-7381; Shaw, Paul/0000-0001-7154-592X	Prime Minister's Australia Asia Endeavour Award from the Department of Education and Training [2997_2012]	Prime Minister's Australia Asia Endeavour Award from the Department of Education and Training	TTN was funded by a Prime Minister's Australia Asia Endeavour Award from the Department of Education and Training (2997_2012).	Afzan A, 2012, MOLECULES, V17, P4326, DOI 10.3390/molecules17044326; Ahmad Nisar, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P330, DOI 10.1016/S2221-1691(11)60055-5; Arkhipov A., 2014, Pharmacognosy Communications, V4, P10; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cheng XL, 2011, FOOD CHEM, V129, P1785, DOI 10.1016/j.foodchem.2011.06.026; Dai J, 2010, MOLECULES, V15, P7313, DOI 10.3390/molecules15107313; Emmanuelle Bournay UG-A, 2012, GLOB SOL UV IND; Food and Agriculture Organization, 2013, FAOSTAT PROD DAT; Gammulle A., 2012, ONLINE INT J MED PLA, V1, P21; Halim SZ, 2011, J MED PLANTS RES, V5, P1867; Hewitt H, 2000, W INDIAN MED J, V49, P32; Ismail Z, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/741470; JACKMAN RL, 1987, J FOOD BIOCHEM, V11, P201, DOI 10.1111/j.1745-4514.1987.tb00123.x; Krishna K. L., 2008, Natural Product Radiance, V7, P364; Leiter U, 2013, ADV EXP MED BIOL, V810, P120; Lucas TP, 1914, MOST WONDERFUL TREE; Mangal M, 2013, NUCLEIC ACIDS RES, V41, pD1124, DOI 10.1093/nar/gks1047; Mikhal'chik EV, 2004, B EXP BIOL MED+, V137, P560, DOI 10.1023/B:BEBM.0000042711.31775.f7; Morimoto C., 2008, US Patent, Patent No. 20080069907; Morton J. F., 1987, FRUITS WARM CLIMATES, P336; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nayak BS, 2007, INDIAN J EXP BIOL, V45, P739; Nguyen TTT, 2013, MOL NUTR FOOD RES, V57, P153, DOI 10.1002/mnfr.201200388; Otsuki N, 2010, J ETHNOPHARMACOL, V127, P760, DOI 10.1016/j.jep.2009.11.024; Qi LW, 2010, BIOCHEM PHARMACOL, V80, P947, DOI 10.1016/j.bcp.2010.06.023; Sirdaarta J., 2015, Pharmacognosy Communications, V5, P100, DOI 10.5530/pc.2015.2.2; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2014, ANTI-CANCER AGENT ME, V14, P77, DOI 10.2174/18715206113139990308; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; Subenthiran S., 2013, EVID-BASED COMPL ALT, V2013, P1, DOI [10.1155/2013/616737, DOI 10.1155/2013/616737]; Tietze HW, 2003, PAPAYA THE MED TREE; Vien D.T.H., 2013, ASEAN J CHEM ENG, V12, P43, DOI [10.22146/ajche.49742, DOI 10.22146/AJCHE.49742]; Wang CZ, 2006, J AGR FOOD CHEM, V54, P9936, DOI 10.1021/jf062467k; Xiang F, 2014, JAMA DERMATOL, V150, P1063, DOI 10.1001/jamadermatol.2014.762; Zunjar V, 2015, NAT PROD RES, V29, P2097, DOI 10.1080/14786419.2014.986658	35	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147956	10.1371/journal.pone.0147956	http://dx.doi.org/10.1371/journal.pone.0147956			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829042	gold, Green Submitted, Green Published			2022-12-26	WOS:000369548200047
J	Hedegaard, CJ; Strube, ML; Hansen, MB; Lindved, BK; Lihme, A; Boye, M; Heegaard, PMH				Hedegaard, Chris J.; Strube, Mikael L.; Hansen, Marie B.; Lindved, Bodil K.; Lihme, Allan; Boye, Mette; Heegaard, Peter M. H.			Natural Pig Plasma Immunoglobulins Have Anti-Bacterial Effects: Potential for Use as Feed Supplement for Treatment of Intestinal Infections in Pigs	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; DRIED ANIMAL PLASMA; BLOOD BY-PRODUCTS; ESCHERICHIA-COLI; G AVIDITY; YOUNG CHICKENS; WEANED PIGS; DIAGNOSIS; ANTIBIOTICS; ANTIBODIES	There is an increasing demand for non-antibiotics solutions to control infectious disease in intensive pig production. Here, one such alternative, namely pig antibodies purified from slaughterhouse blood was investigated in order to elucidate its potential usability to control post-weaning diarrhoea (PWD), which is one of the top indications for antibiotics usage in the pig production. A very cost-efficient and rapid one-step expanded bed adsorption (EBA) chromatography procedure was used to purify pig immunoglobulin G from slaughterhouse pig plasma (more than 100 litres), resulting in >85% pure pig IgG (ppIgG). The ppIgG thus comprised natural pig immunoglobulins and was subsequently shown to contain activity towards four pig-relevant bacterial strains (three different types of Escherichia coli and one type of Salmonella enterica) but not towards a fish pathogen (Yersinia ruckeri), and was demonstrated to inhibit the binding of the four pig relevant bacteria to a pig intestinal cell line (IPEC-J2). Finally it was demonstrated in an in vivo weaning piglet model for intestinal colonization with an E. coli F4+ challenge strain that ppIgG given in the feed significantly reduced shedding of the challenge strain, reduced the proportion of the bacterial family Enterobacteriaceae, increased the proportion of families Enterococcoceae and Streptococcaceae and generally increased ileal microbiota diversity. Conclusively, our data support the idea that natural IgG directly purified from pig plasma and given as a feed supplement can be used in modern swine production as an efficient and cost-effective means for reducing both occurrence of PWD and antibiotics usage and with a potential for the prevention and treatment of other intestinal infectious diseases even if the causative agent might not be known.	[Hedegaard, Chris J.; Strube, Mikael L.; Boye, Mette; Heegaard, Peter M. H.] Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark; [Hansen, Marie B.; Lindved, Bodil K.; Lihme, Allan] Upfront Chromatog AS, Copenhagen, Denmark	Technical University of Denmark	Heegaard, PMH (corresponding author), Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark.	pmhh@vet.dtu.dk	Strube, Mikael/G-7949-2016; Heegaard, Peter/E-9794-2015	Strube, Mikael/0000-0003-0905-5705; Heegaard, Peter/0000-0003-4506-4932; Hedegaard, Chris Juul/0000-0003-1333-8687	Green Development and Demonstration Programme (Ministry of Food, Agriculture and Fisheries, The Danish AgriFish Agency) [34009-120471]	Green Development and Demonstration Programme (Ministry of Food, Agriculture and Fisheries, The Danish AgriFish Agency)	The project was supported by Green Development and Demonstration Programme (Ministry of Food, Agriculture and Fisheries, The Danish AgriFish Agency, Journal number: 34009-120471). The funder provided support in the form of salaries for the author CJH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial affiliation did provide purified plasma IgG for this study.	Bhandari SK, 2008, J ANIM SCI, V86, P836, DOI 10.2527/jas.2006-822; Boesen HT, 2005, VET MICROBIOL, V109, P105, DOI 10.1016/j.vetmic.2005.05.004; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Campbell JM, 2006, J ANIM SCI, V84, P2501, DOI 10.2527/jas.2005-722; CDC U, 2013, ANTIBIOTIC RESISTANC; Chan KH, 2007, CLIN VACCINE IMMUNOL, V14, P1433, DOI 10.1128/CVI.00056-07; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; DANMAP, 2014, US ANT AG OCC ANT RE; de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004; ECDC/EMEA, 2009, BACT CHALL TIM REACT, P54; EMEA, 2015, COL F4; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Hermann-Bank ML, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0419-4; HOORFAR J, 1994, CAN J VET RES, V58, P268; Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442; Jamroz D, 2012, J ANIM PHYSIOL AN N, V96, P319, DOI 10.1111/j.1439-0396.2011.01149.x; Jamroz D, 2011, BRIT POULTRY SCI, V52, P589, DOI 10.1080/00071668.2011.610298; Jenum PA, 1997, J CLIN MICROBIOL, V35, P1972, DOI 10.1128/JCM.35.8.1972-1977.1997; Kaveri SV, 2012, AUTOIMMUN REV, V11, P792, DOI 10.1016/j.autrev.2012.02.006; Levast B, 2014, DEV COMP IMMUNOL, V44, P235, DOI 10.1016/j.dci.2013.12.012; Levett PN, 2005, J CLIN MICROBIOL, V43, P5873, DOI 10.1128/JCM.43.12.5873-5875.2005; Lihme A, 2010, ANAL BIOCHEM, V399, P102, DOI 10.1016/j.ab.2009.12.002; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Madi A, 2012, ADV EXP MED BIOL, V750, P198, DOI 10.1007/978-1-4614-3461-0_15; Melkebeek V, 2013, VET IMMUNOL IMMUNOP, V152, P37, DOI 10.1016/j.vetimm.2012.09.024; Niewold TA, 2007, VET MICROBIOL, V124, P362, DOI 10.1016/j.vetmic.2007.04.034; Nollet H, 1999, VET MICROBIOL, V65, P37, DOI 10.1016/S0378-1135(98)00282-X; Opriessnig T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104766; Pierce JL, 2005, J ANIM SCI, V83, P2876; Rhee JH, 2012, CLIN EXP VACCINE RES, V1, P50, DOI 10.7774/cevr.2012.1.1.50; Shen HG, 2011, J ANIM SCI, V89, P1930, DOI 10.2527/jas.2010-3502; Stahl M, 2011, VET MICROBIOL, V151, P307, DOI 10.1016/j.vetmic.2011.03.013; Strube ML, 2015, APPL ENVIRON MICROB, V81, P1668, DOI 10.1128/AEM.03582-14; Torrallardona D, 2010, ASIAN AUSTRAL J ANIM, V23, P131; Viswanathan VK, 2009, NAT REV MICROBIOL, V7, P110, DOI 10.1038/nrmicro2053; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	36	34	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147373	10.1371/journal.pone.0147373	http://dx.doi.org/10.1371/journal.pone.0147373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824607	Green Published, gold			2022-12-26	WOS:000369528600029
J	Jiang, Y; Chen, JD; Wu, Y; Wang, Q; Li, HX				Jiang, Ying; Chen, Jiandong; Wu, Yue; Wang, Qiang; Li, Huixin			Sublethal Toxicity Endpoints of Heavy Metals to the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							BEHAVIORAL DEFECTS; OXIDATIVE DAMAGE; LIFE-SPAN; EXPOSURE; CADMIUM; STRESS; ACETYLCHOLINESTERASE; REPRODUCTION; SOIL; DICHLORVOS	Caenorhabditis elegans, a free-living nematode, is commonly used as a model organism in ecotoxicological studies. The current literatures have provided useful insight into the relative sensitivity of several endpoints, but few direct comparisons of multiple endpoints under a common set of experimental conditions. The objective of this study was to determine appropriate sublethal endpoints to develop an ecotoxicity screening and monitoring system. C. elegans was applied to explore the sublethal toxicity of four heavy metals (copper, zinc, cadmium and chromium). Two physiological endpoints (growth and reproduction), three behavioral endpoints (head thrash frequency, body bend frequency and feeding) and two enzymatic endpoints (acetylcholine esterase [AChE] and superoxide dismutase [SOD]) were selected for the assessment of heavy metal toxicity. The squared correlation coefficients (R-2) between the responses observed and fitted by Logit function were higher than 0.90 and the RMSE were lower than 0.10, indicating a good significance statistically. There was no significant difference among the half effect concentration (EC50) endpoints in physiological and behavioral effects of the four heavy metals, indicating similar sensitivity of physiological and behavioral effects. AChE enzyme was more sensitive to copper, zinc, and cadmium than to other physiological and behavioral effects, and SOD enzyme was most sensitive to chromium. The EC50 of copper, zinc, and cadmium, to the AChE enzyme in the nematodes were 0.68 mg/L, 2.76 mg/L, and 0.92 mg/L respectively and the EC50 of chromium to the SOD enzyme in the nematode was 1.58 mg/L. The results of this study showed that there was a good concentration-response relationship between all four heavy metals and the sublethal toxicity effects to C. elegans. Considering these sublethal endpoints in terms of simplicity, accuracy, repeatability and costs of the experiments, feeding is the relatively ideal sublethal toxicity endpoint of heavy metals to C. elegans.	[Jiang, Ying; Wang, Qiang] Henan Agr Univ, Coll Resources & Environm, Zhengzhou 450000, Peoples R China; [Jiang, Ying; Li, Huixin] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China; [Chen, Jiandong] Guangxi Univ Finance & Econ, Sch Management Sci & Engn, Nanning 530003, Peoples R China; [Wu, Yue] Soil & Fertilizer Bur Shandong Prov, Jinan 250100, Peoples R China	Henan Agricultural University; Nanjing Agricultural University; Guangxi University of Finance & Economics	Wang, Q (corresponding author), Henan Agr Univ, Coll Resources & Environm, Zhengzhou 450000, Peoples R China.; Li, HX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China.	huixinli@njau.edu.cn; wstrong1970@163.com	Li, huixin/H-5573-2011		National Science Foundation of China [41401274]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (grant 41401274). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P2768, DOI 10.1897/02-573; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P1100, DOI 10.1897/1551-5028(2003)022&lt;1100:AOMTTN&gt;2.0.CO;2; BRENNER S, 1974, GENETICS, V77, P71; Cabreiro F, 2011, FREE RADICAL BIO MED, V51, P1575, DOI 10.1016/j.freeradbiomed.2011.07.020; Chen JD, 2013, ECOTOX ENVIRON SAFE, V94, P73, DOI 10.1016/j.ecoenv.2013.04.026; Dhawan R, 1999, J TOXICOL ENV HEAL A, V58, P451, DOI 10.1080/009841099157179; Dhawan R, 2000, ENVIRON TOXICOL CHEM, V19, P3061, DOI [10.1897/1551-5028(2000)019&lt;3061:ACOMIL&gt;2.0.CO;2, 10.1002/etc.5620191228]; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333; Grifman M, 1998, P NATL ACAD SCI USA, V95, P13935, DOI 10.1073/pnas.95.23.13935; Gupta SC, 2005, BBA-GEN SUBJECTS, V1725, P81, DOI 10.1016/j.bbagen.2005.04.033; Harada H, 2007, ECOTOX ENVIRON SAFE, V66, P378, DOI 10.1016/j.ecoenv.2006.02.017; Jadhav KB, 2009, J BIOCHEM MOL TOXIC, V23, P9, DOI 10.1002/jbt.20258; Jones D, 1999, J EXP ZOOL, V284, P147, DOI 10.1002/(SICI)1097-010X(19990701)284:2&lt;147::AID-JEZ4&gt;3.0.CO;2-Z; Kim J, 2004, TOXICOL SCI, V81, P518, DOI 10.1093/toxsci/kfh221; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lehtonen KK, 2003, B ENVIRON CONTAM TOX, V71, P489, DOI 10.1007/s00128-003-8853-6; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Melstrom PC, 2007, BIOCHEM BIOPH RES CO, V357, P200, DOI 10.1016/j.bbrc.2007.03.122; MIDDENDORF PJ, 1993, J NEMATOL, V25, P573; Patrick R, 1988, GROUNDWATER CONTAMIN; RITTER WF, 1990, J ENVIRON SCI HEAL B, V25, P1, DOI 10.1080/03601239009372674; Roh JY, 2008, ECOTOX ENVIRON SAFE, V71, P483, DOI 10.1016/j.ecoenv.2007.11.007; Roh JY, 2007, TOXICOLOGY, V237, P126, DOI 10.1016/j.tox.2007.05.008; Shashikumar S, 2010, ECOTOX ENVIRON SAFE, V73, P1057, DOI 10.1016/j.ecoenv.2010.02.003; Silvestre F, 2006, AQUAT TOXICOL, V76, P46, DOI 10.1016/j.aquatox.2005.09.006; Swain SC, 2004, J MOL BIOL, V341, P951, DOI 10.1016/j.jmb.2004.06.050; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Wang DY, 2008, ARCH ENVIRON CON TOX, V54, P447, DOI 10.1007/s00244-007-9050-0; Wang Da-Yong, 2007, Asian Journal of Ecotoxicology, V2, P297; Wang D, 2007, ENVIRON TOXICOL PHAR, V24, P223, DOI 10.1016/j.etap.2007.05.009; Wang DY, 2009, ENVIRON TOXICOL PHAR, V28, P459, DOI 10.1016/j.etap.2009.07.008; Wang SC, 2008, TOXICOL SCI, V102, P345, DOI 10.1093/toxsci/kfm220; [汪洋 WANG Yang], 2007, [安全与环境学报, Journal of Safety and Environment], V7, P10; WILLIAMS PL, 1990, TOXICOL IND HEALTH, V6, P425, DOI 10.1177/074823379000600306; Wu QL, 2011, ENVIRON TOXICOL PHAR, V32, P175, DOI 10.1016/j.etap.2011.04.009; Yadav A, 2009, ECOTOXICOLOGY, V18, P325, DOI 10.1007/s10646-008-0286-x; Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367	40	22	23	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148014	10.1371/journal.pone.0148014	http://dx.doi.org/10.1371/journal.pone.0148014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824831	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528600088
J	McDonnell, MM; Burkhart, SE; Stoddard, JM; Wright, ZJ; Strader, LC; Bartel, B				McDonnell, Margaret M.; Burkhart, Sarah E.; Stoddard, Jerrad M.; Wright, Zachary J.; Strader, Lucia C.; Bartel, Bonnie			The Early-Acting Peroxin PEX19 Is Redundantly Encoded, Farnesylated, and Essential for Viability in Arabidopsis thaliana	PLOS ONE			English	Article							MATRIX PROTEIN-DEGRADATION; INDOLE-3-BUTYRIC ACID; MEMBRANE-PROTEINS; ENDOPLASMIC-RETICULUM; TARGETING SIGNAL; SACCHAROMYCES-CEREVISIAE; BETA-OXIDATION; ABSCISIC-ACID; BIOGENESIS; RECEPTOR	Peroxisomes are single-membrane bound organelles that are essential for normal development in plants and animals. In mammals and yeast, the peroxin (PEX) proteins PEX3 and PEX19 facilitate the early steps of peroxisome membrane protein (PMP) insertion and pre-peroxisome budding from the endoplasmic reticulum. The PEX3 membrane protein acts as a docking site for PEX19, a cytosolic chaperone for PMPs that delivers PMPs to the endoplasmic reticulum or peroxisomal membrane. PEX19 is farnesylated in yeast and mammals, and we used immunoblotting with prenylation mutants to show that PEX19 also is fully farnesylated in wild-type Arabidopsis thaliana plants. We examined insertional alleles disrupting either of the two Arabidopsis PEX19 isoforms, PEX19A or PEX19B, and detected similar levels of PEX19 protein in the pex19a-1 mutant and wild type; however, PEX19 protein was nearly undetectable in the pex19b-1 mutant. Despite the reduction in PEX19 levels in pex19b-1, both pex19a-1 and pex19b-1 single mutants lacked notable peroxisomal beta-oxidation defects and displayed normal levels and localization of peroxisomal matrix and membrane proteins. The pex19a-1 pex19b-1 double mutant was embryo lethal, indicating a redundantly encoded critical role for PEX19 during embryogenesis. Expressing YFP-tagged versions of either PEX19 isoform rescued this lethality, confirming that PEX19A and PEX19B act redundantly in Arabidopsis. We observed that pex19b-1 enhanced peroxisome-related defects of a subset of peroxin-defective mutants, supporting a role for PEX19 in peroxisome function. Together, our data indicate that Arabidopsis PEX19 promotes peroxisome function and is essential for viability.	[McDonnell, Margaret M.; Burkhart, Sarah E.; Stoddard, Jerrad M.; Wright, Zachary J.; Bartel, Bonnie] Rice Univ, Dept BioSci, Houston, TX USA; [Strader, Lucia C.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [McDonnell, Margaret M.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA; [Burkhart, Sarah E.] Arizona Dept Publ Safety, Phoenix, AZ USA; [Stoddard, Jerrad M.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA	Rice University; Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Texas System; UTMD Anderson Cancer Center	Bartel, B (corresponding author), Rice Univ, Dept BioSci, Houston, TX USA.	bartel@rice.edu	Bartel, Bonnie/O-8119-2019; Bartel, Bonnie/D-3550-2011	Bartel, Bonnie/0000-0002-6367-346X; Bartel, Bonnie/0000-0002-6367-346X; Wright, Zachary J./0000-0002-8335-0203; Strader, Lucia/0000-0002-7600-7204	National Science Foundation [MCB-1244182, MCB-1516966, IOS-1453750]; Robert A. Welch Foundation [C-1309]; National Institutes of Health [S10RR026399-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026399] Funding Source: NIH RePORTER; Direct For Biological Sciences [1516966] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation (MCB-1244182 and MCB-1516966 to BB; IOS-1453750 to LCS) and the Robert A. Welch Foundation (C-1309 to BB). Confocal microscopy was performed on equipment obtained through a Shared Instrumentation Grant from the National Institutes of Health (S10RR026399-01 to BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baerends RJS, 1997, YEAST, V13, P1437; Baker A, 2006, TRENDS PLANT SCI, V11, P124, DOI 10.1016/j.tplants.2006.01.005; Bartel B., 2014, MOL MACHINES INVOLVE, P325, DOI [10.1007/978-3-7091-1788-0_14, 10.1007/978-3-7091-1788-0_14., DOI 10.1007/978-3-7091-1788-0_14]; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Burkhart SE, 2014, PLANT PHYSIOL, V166, P1329, DOI 10.1104/pp.114.247148; Burkhart SE, 2013, GENETICS, V193, P125, DOI 10.1534/genetics.112.146100; Chen YX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6790; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CORPAS FJ, 1994, EUR J CELL BIOL, V65, P280; Crowell DN, 2000, PROG LIPID RES, V39, P393, DOI 10.1016/S0163-7827(00)00010-2; Crowell DN, 2009, TRENDS PLANT SCI, V14, P163, DOI 10.1016/j.tplants.2008.12.001; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; De Rybel B, 2012, NAT CHEM BIOL, V8, P798, DOI [10.1038/NCHEMBIO.1044, 10.1038/nchembio.1044]; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Gotte K, 1998, MOL CELL BIOL, V18, P616; Hadden DA, 2006, MOL MEMBR BIOL, V23, P325, DOI 10.1080/09687860600738221; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Hua R, 2015, TRAFFIC, V16, P832, DOI 10.1111/tra.12292; Johnson CD, 2005, PLANT PHYSIOL, V139, P722, DOI 10.1104/pp.105.065045; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Khan BR, 2010, PLANT PHYSIOL, V154, P1602, DOI 10.1104/pp.110.162479; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Kim PK, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00241; Koncz C., 1992, Methods in Arabidopsis research., P224; Lingard MJ, 2009, P NATL ACAD SCI USA, V106, P4561, DOI 10.1073/pnas.0811329106; Lisenbee CS, 2003, PLANT PHYSIOL, V132, P870, DOI 10.1104/pp.103.019976; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Mayerhofer PU, 2002, BIOCHEM BIOPH RES CO, V291, P1180, DOI 10.1006/bbrc.2002.6568; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Mohamed S, 2010, AM J MED GENET A, V152A, P2318, DOI 10.1002/ajmg.a.33560; Monroe-Augustus M, 2011, PLANT MOL BIOL, V77, P1, DOI 10.1007/s11103-011-9782-0; Mullen RT, 2001, TRENDS PLANT SCI, V6, P256, DOI 10.1016/S1360-1385(01)01951-3; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nito K, 2007, PLANT CELL PHYSIOL, V48, P763, DOI 10.1093/pcp/pcm053; Nyathi Y, 2012, FEBS LETT, V586, P2280, DOI 10.1016/j.febslet.2012.05.065; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Platta HW, 2014, BIOCHIMIE, V98, P16, DOI 10.1016/j.biochi.2013.12.009; Pracharoenwattana I, 2007, PLANT J, V50, P381, DOI 10.1111/j.1365-313X.2007.03055.x; Ramon NM, 2010, MOL BIOL CELL, V21, P1263, DOI 10.1091/mbc.E09-08-0672; Ratzel SE, 2011, TRAFFIC, V12, P121, DOI 10.1111/j.1600-0854.2010.01136.x; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Rucktaschel R, 2009, J BIOL CHEM, V284, P20885, DOI 10.1074/jbc.M109.016584; Running MP, 2004, P NATL ACAD SCI USA, V101, P7815, DOI 10.1073/pnas.0402385101; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Sato Y, 2010, EMBO J, V29, P4083, DOI 10.1038/emboj.2010.293; Schmidt F, 2010, J BIOL CHEM, V285, P25410, DOI 10.1074/jbc.M110.138503; Schueller N, 2010, EMBO J, V29, P2491, DOI 10.1038/emboj.2010.115; Snyder WB, 1999, MOL BIOL CELL, V10, P1745, DOI 10.1091/mbc.10.6.1745; STASINOPOULOS TC, 1990, PLANT PHYSIOL, V93, P1365, DOI 10.1104/pp.93.4.1365; Strader Lucia C, 2010, Plant Physiol, V153, P1577, DOI 10.1104/pp.110.157461; Strader LC, 2011, PLANT CELL, V23, P984, DOI 10.1105/tpc.111.083071; Strader LC, 2011, MOL PLANT, V4, P477, DOI 10.1093/mp/ssr006; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Theodoulou FL, 2013, BIOCHEM J, V451, P345, DOI 10.1042/BJ20130078; Vastiau IMK, 2006, CELL MOL LIFE SCI, V63, P1686, DOI 10.1007/s00018-006-6110-y; Wanders RJA, 2005, CLIN GENET, V67, P107, DOI 10.1111/j.1399-0004.2004.00329.x; Woodward AW, 2014, PLANT MOL BIOL, V86, P201, DOI 10.1007/s11103-014-0223-8; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422; Yagita Y, 2013, J CELL BIOL, V200, P651, DOI 10.1083/jcb.201211077; Zolman BK, 2007, PLANT MOL BIOL, V64, P59, DOI 10.1007/s11103-007-9134-2; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691; Zolman BK, 2004, P NATL ACAD SCI USA, V101, P1786, DOI 10.1073/pnas.0304368101; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550; Zolman BK, 2000, GENETICS, V156, P1323	71	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148335	10.1371/journal.pone.0148335	http://dx.doi.org/10.1371/journal.pone.0148335			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824478	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600116
J	Shah, D; Ali, M; Pasha, Z; Jaboori, AJ; Jassim, SH; Jain, S; Aakalu, VK				Shah, Dhara; Ali, Marwan; Pasha, Zeeshan; Jaboori, Assraa Jassim; Jassim, Sarmad H.; Jain, Sandeep; Aakalu, Vinay K.			Histatin-1 Expression in Human Lacrimal Epithelium	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; ANTIMICROBIAL PEPTIDES; GLAND EPITHELIUM; GENE-EXPRESSION; REGENERATION; PROTEOME; FGF10	Background Study of human lacrimal cell biology is limited by poor access to tissue samples, heterogeneous cell composition of tissue and a lack of established lacrimal epithelial markers. In order to further our understanding of lacrimal cell biology, we sought to find a better marker for human lacrimal epithelial cells, compared to what has been reported in the literature. Methods We utilized human Muller's muscle conjunctival resection (MMCR) specimens containing accessory lacrimal gland (ALG) and cadaveric main lacrimal gland (MLG) as sources of lacrimal tissue. Candidate markers were sought using human ALG tissue from MMCR specimens, isolated by laser capture microdissection (LCM). Affymetrix (R) analysis was performed on total RNA isolated from FFPE samples to profile transcription in ALG. MMCR tissue sections were assessed by immunofluorescence using antibodies for histatin-1, lactoferrin, E-cadherin (E-cad) and alpha-smooth muscle actin (ASMA). Reverse transcriptase polymerase chain reaction (RT-PCR) analysis was performed to analyze the expression of histatin-1, E-cad and lactoferrin from cadaveric MLG. Results Histatin-1 is expressed in ALG and MLG, localizes to lacrimal epithelium, and to a greater degree than do other putative lacrimal epithelial markers. Conclusions Histatin-1 is a good marker for human lacrimal epithelium in ALG and MLG and can be used to identify lacrimal cells in future studies.	[Shah, Dhara; Ali, Marwan; Pasha, Zeeshan; Jaboori, Assraa Jassim; Jassim, Sarmad H.; Jain, Sandeep; Aakalu, Vinay K.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Aakalu, VK (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA.	vaakalu@uic.edu			National Institute of Health-National Eye Institute [K08EY024339]; Illinois Society to Prevent Blindness; Midwest Eye Banks; National Institute of Health-National Eye Institute Core grant [2P30EY001792-36A1]; Research to Prevent Blindness (NY,NY); NATIONAL EYE INSTITUTE [P30EY001792, R01EY024966, K08EY024339, R01EY023656] Funding Source: NIH RePORTER	National Institute of Health-National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Illinois Society to Prevent Blindness; Midwest Eye Banks; National Institute of Health-National Eye Institute Core grant; Research to Prevent Blindness (NY,NY)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institute of Health-National Eye Institute Grant (K08EY024339), a seed grant from Illinois Society to Prevent Blindness, a Research Grant from Midwest Eye Banks, a Grant-in-Aid from Fight for Sight and Departmental Support through an National Institute of Health-National Eye Institute Core grant (2P30EY001792-36A1) and an Unrestricted Grant from Research to Prevent Blindness (NY,NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Brewitt H, 2001, SURV OPHTHALMOL, V45, pS199, DOI 10.1016/S0039-6257(00)00202-2; BUCKMAN G, 1989, OPHTHALMOLOGY, V96, P413; Campese M, 2009, ARCH ORAL BIOL, V54, P345, DOI 10.1016/j.archoralbio.2008.11.010; De Saint Jean M, 2004, EXP EYE RES, V78, P257, DOI 10.1016/j.exer.2003.10.006; Flanagan JL, 2009, BIOCHIMIE, V91, P35, DOI 10.1016/j.biochi.2008.07.007; Grishina IB, 2005, DEV BIOL, V288, P334, DOI 10.1016/j.ydbio.2005.08.018; Gusman H, 2004, ARCH ORAL BIOL, V49, P11, DOI 10.1016/S0003-9969(03)00182-1; Hirayama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3497; Hodges RR, 2003, INT REV CYTOL, V231, P129, DOI 10.1016/S0074-7696(03)31004-6; Huang LC, 2007, CURR EYE RES, V32, P595, DOI 10.1080/02713680701446653; Jumblatt MM, 2006, INFECT IMMUN, V74, P4058, DOI 10.1128/IAI.01951-05; Kavanagh K, 2004, J PHARM PHARMACOL, V56, P285, DOI 10.1211/0022357022971; Kulchaiyawat V, 2010, ARVO 2010; Liu AJ, 2010, AM J SURG PATHOL, V34, P697, DOI 10.1097/PAS.0b013e3181db84aa; Liu XS, 2008, CELL RES, V18, P1177, DOI 10.1038/cr.2008.309; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; Manconi B, 2013, J PROTEOMICS, V91, P536, DOI 10.1016/j.jprot.2013.08.009; Melino S, 2014, FEBS J, V281, P657, DOI 10.1111/febs.12612; Oudhoff MJ, 2010, BIOL CHEM, V391, P541, DOI 10.1515/BC.2010.057; Oudhoff MJ, 2009, FASEB J, V23, P3928, DOI 10.1096/fj.09-137588; Perumal N, 2015, PROTEOMICS, V15, P3370, DOI 10.1002/pmic.201400239; Santagati MG, 2005, OPHTHALMIC RES, V37, P270, DOI 10.1159/000087372; Shatos MA, 2012, INVEST OPHTH VIS SCI, V53, P2749, DOI 10.1167/iovs.11-9025; Si YF, 2013, J OCUL PHARMACOL TH, V29, P310, DOI 10.1089/jop.2012.0137; Spaniol K, 2015, TISSUE ENG PT A, V21, P2605, DOI [10.1089/ten.tea.2014.0694, 10.1089/ten.TEA.2014.0694]; Steele PS, 2004, ARVO 2004; Steele PS, 2002, ARVO 2002; Stoeckelhuber M, 2012, J HISTOCHEM CYTOCHEM, V60, P110, DOI 10.1369/0022155411432785; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tiwari S, 2014, SAUDI J OPHTHALMOL, V28, P12, DOI 10.1016/j.sjopt.2013.09.004; Tiwari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029458; Tsau C, 2011, DEVELOPMENT, V138, P3307, DOI 10.1242/dev.066241; Ubels JL, 2012, INVEST OPHTH VIS SCI, V53, P6738, DOI 10.1167/iovs.12-10750; Voronov D, 2013, INVEST OPHTH VIS SCI, V54, P3115, DOI 10.1167/iovs.13-11791; WILK CM, 1990, GRAEF ARCH CLIN EXP, V228, P65, DOI 10.1007/BF02764294	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148018	10.1371/journal.pone.0148018	http://dx.doi.org/10.1371/journal.pone.0148018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824896	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528600089
J	Coke, CJ; Scarlett, KA; Chetram, MA; Jones, KJ; Sandifer, BJ; Davis, AS; Marcus, AI; Hinton, CV				Coke, Christopher J.; Scarlett, Kisha A.; Chetram, Mahandranauth A.; Jones, Kia J.; Sandifer, Brittney J.; Davis, Ahriea S.; Marcus, Adam I.; Hinton, Cimona V.			Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELL-MIGRATION; ADENYLATE-CYCLASE; HUMAN BREAST; PC-3 CELLS; FACTOR-I; EXPRESSION; PROTEIN; METASTASIS; INHIBITION; LIGAND	The G-protein-coupled chemokine receptor CXCR4 generates signals that lead to cell migration, cell proliferation, and other survival mechanisms that result in the metastatic spread of primary tumor cells to distal organs. Numerous studies have demonstrated that CXCR4 can form homodimers or can heterodimerize with other G-protein-coupled receptors to form receptor complexes that can amplify or decrease the signaling capacity of each individual receptor. Using biophysical and biochemical approaches, we found that CXCR4 can form an induced heterodimer with cannabinoid receptor 2 (CB2) in human breast and prostate cancer cells. Simultaneous, agonist-dependent activation of CXCR4 and CB2 resulted in reduced CXCR4-mediated expression of phosphorylated ERK1/2 and ultimately reduced cancer cell functions such as calcium mobilization and cellular chemotaxis. Given that treatment with cannabinoids has been shown to reduce invasiveness of cancer cells as well as CXCR4-mediated migration of immune cells, it is plausible that CXCR4 signaling can be silenced through a physical heterodimeric association with CB2, thereby inhibiting subsequent functions of CXCR4. Taken together, the data illustrate a mechanism by which the cannabinoid system can negatively modulate CXCR4 receptor function and perhaps tumor progression.	[Coke, Christopher J.; Scarlett, Kisha A.; Jones, Kia J.; Sandifer, Brittney J.; Davis, Ahriea S.; Hinton, Cimona V.] Clark Atlanta Univ, Dept Biol Sci, 223 James P Brawley Dr SW, Atlanta, GA 30314 USA; [Coke, Christopher J.; Scarlett, Kisha A.; Jones, Kia J.; Sandifer, Brittney J.; Davis, Ahriea S.; Hinton, Cimona V.] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, 223 James P Brawley Dr SW, Atlanta, GA 30314 USA; [Chetram, Mahandranauth A.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Mol Oncol Program, Washington, DC USA; [Marcus, Adam I.] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Clark Atlanta University; Clark Atlanta University; Georgetown University; Emory University	Hinton, CV (corresponding author), Clark Atlanta Univ, Dept Biol Sci, 223 James P Brawley Dr SW, Atlanta, GA 30314 USA.; Hinton, CV (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, 223 James P Brawley Dr SW, Atlanta, GA 30314 USA.	chinton@cau.edu		Hinton, Cimona/0000-0002-5724-1804	National Institutes of Health from the NIGMS [1R01GM106020, 3R01GM106020, R25GM060414]; Research Centers in Minority Institutions Program [5G12MD007590]; NATIONAL CANCER INSTITUTE [T32CA009686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060414, R01GM106020] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007590] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research Centers in Minority Institutions Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grants 1R01GM106020, 3R01GM106020, and R25GM060414 from the NIGMS and Grant 5G12MD007590 from the Research Centers in Minority Institutions Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agle KA, 2010, J BIOL CHEM, V285, P16066, DOI 10.1074/jbc.M109.061416; Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Ali H, 1997, MED CLIN N AM, V81, P1, DOI 10.1016/S0025-7125(05)70503-4; Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Benamar K, 2008, J PHARMACOL EXP THER, V325, P641, DOI 10.1124/jpet.107.135053; Blazquez C, 2003, FASEB J, V17, P529, DOI 10.1096/fj.02-0795fje; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; Callen L, 2012, J BIOL CHEM, V287, P20851, DOI 10.1074/jbc.M111.335273; Chen CG, 2004, EUR J PHARMACOL, V483, P175, DOI 10.1016/j.ejphar.2003.10.033; Chetram MA, 2011, BIOCHEM BIOPH RES CO, V410, P195, DOI 10.1016/j.bbrc.2011.05.074; Chetram MA, 2011, MOL CANCER RES, V9, P90, DOI 10.1158/1541-7786.MCR-10-0235; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Chinni SR, 2008, MOL CANCER RES, V6, P446, DOI 10.1158/1541-7786.MCR-07-0117; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Correa F, 2005, BRIT J PHARMACOL, V145, P441, DOI 10.1038/sj.bjp.0706215; Costantino CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033961; Croci T, 1998, BRIT J PHARMACOL, V125, P1393, DOI 10.1038/sj.bjp.0702190; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Dias J, 2014, AM J PHYSIOL-RENAL, V306, pF855, DOI 10.1152/ajprenal.00488.2013; Don-Salu-Hewage AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057194; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Engl T, 2006, NEOPLASIA, V8, P290, DOI 10.1593/neo.05694; Franco Rafael, 2007, ScientificWorldJournal, V7, P48; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; GERARD C, 1994, CURR OPIN IMMUNOL, V6, P140, DOI 10.1016/0952-7915(94)90045-0; Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/j.molimm.2006.01.005; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Guzman M, 2001, J MOL MED-JMM, V78, P613, DOI 10.1007/s001090000177; Haack KKV, 2011, PHARMACEUTICALS, V4, P509, DOI 10.3390/ph4030509; Hamada T, 1996, GENE, V176, P211, DOI 10.1016/0378-1119(96)00251-X; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hereld D, 2008, EUR J IMMUNOL, V38, P334, DOI 10.1002/eji.200738101; HOWLETT AC, 1984, LIFE SCI, V35, P1803, DOI 10.1016/0024-3205(84)90278-9; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; HOWLETT AC, 1985, MOL PHARMACOL, V27, P429; Humblet Valerie, 2005, Mol Imaging, V4, P448; Hurst Dow P., 2009, P235, DOI 10.1007/978-1-59745-503-9_9; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; Jorda MA, 2002, BLOOD, V99, P2786; Joseph J, 2004, CANCER IMMUNOL IMMUN, V53, P723, DOI 10.1007/s00262-004-0509-9; Karnoub Antoine E, 2006, Breast Dis, V26, P75; Kato M, 2003, BREAST CANCER RES, V5, pR144, DOI 10.1186/bcr627; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Lee BC, 2004, MOL CANCER RES, V2, P327; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Munoz LM, 2011, PHARMACOL THERAPEUT, V131, P351, DOI 10.1016/j.pharmthera.2011.05.002; McKallip RJ, 2005, J IMMUNOL, V174, P3281, DOI 10.4049/jimmunol.174.6.3281; Melck D, 2000, ENDOCRINOLOGY, V141, P118, DOI 10.1210/en.141.1.118; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Rodriguez-Frade JM, 2009, METHOD ENZYMOL, V461, P105, DOI 10.1016/S0076-6879(09)05405-6; Misra P, 2008, J NUCL MED, V49, P963, DOI 10.2967/jnumed.107.050054; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nasser MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023901; Ohtani Y, 1998, NEUROSCI LETT, V249, P163, DOI 10.1016/S0304-3940(98)00425-X; Pello OM, 2008, EUR J IMMUNOL, V38, P537, DOI 10.1002/eji.200737630; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Pertwee R. G., 1995, CANNABINOIDS; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 2001, PROG NEUROBIOL, V63, P569, DOI 10.1016/S0301-0082(00)00031-9; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pisanti S, 2009, BEST PRACT RES CL EN, V23, P117, DOI 10.1016/j.beem.2009.02.001; Prasad A, 2007, J LEUKOCYTE BIOL, V82, P465, DOI 10.1189/jlb.1106678; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Qamri Z, 2009, MOL CANCER THER, V8, P3117, DOI 10.1158/1535-7163.MCT-09-0448; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Ruiz L, 1999, FEBS LETT, V458, P400, DOI 10.1016/S0014-5793(99)01073-X; Sarfaraz S, 2008, CANCER RES, V68, P339, DOI 10.1158/0008-5472.CAN-07-2785; Satake H, 2008, PROTEIN PEPTIDE LETT, V15, P300, DOI 10.2174/092986608783744207; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Steele AD, 2002, CYTOKINE GROWTH F R, V13, P209, DOI 10.1016/S1359-6101(02)00007-2; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Szabo B, 2001, J PHARMACOL EXP THER, V297, P819; Taichman RS, 2002, CANCER RES, V62, P1832; Taub D D, 1994, Ther Immunol, V1, P229; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wagner JA, 2001, EUR J PHARMACOL, V423, P203, DOI 10.1016/S0014-2999(01)01112-8; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Wang JH, 2004, J CELL BIOCHEM, V93, P753, DOI 10.1002/jcb.20161; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Wang JH, 2006, MOL CANCER THER, V5, P2474, DOI 10.1158/1535-7163.MCT-05-0261; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	92	62	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9991	10005		10.1074/jbc.M115.712661	http://dx.doi.org/10.1074/jbc.M115.712661			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26841863	hybrid, Green Published			2022-12-26	WOS:000375602800013
J	Hirasawa, M; Takubo, K; Osada, H; Miyake, S; Toda, E; Endo, M; Umezawa, K; Tsubota, K; Oike, Y; Ozawa, Y				Hirasawa, Manabu; Takubo, Keiyo; Osada, Hideto; Miyake, Seiji; Toda, Eriko; Endo, Motoyoshi; Umezawa, Kazuo; Tsubota, Kazuo; Oike, Yuichi; Ozawa, Yoko			Angiopoietin-like Protein 2 Is a Multistep Regulator of Inflammatory Neovascularization in a Murine Model of Age-related Macular Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION; GENERAL JAPANESE POPULATION; INTEGRIN ALPHA-5-BETA-1; INSULIN-RESISTANCE; METABOLIC SYNDROME; IN-VITRO; MACROPHAGE; EXPRESSION; MICE; METASTASIS	Choroidal neovascularization (CNV) is a pathogenic process of age-related macular degeneration, a vision-threatening disease. The retinal pigment epithelium and macrophages both influence CNV development. However, the underlying mechanisms remain obscure. Here, we focus on Angptl2 (angiopoietin-like protein 2), a cytokine involved in age-related systemic diseases. Angptl2 was originally identified as an adipocytokine and is also expressed in the eye. Using a laser-induced CNV model, we found that Angptl2 KO mice exhibited suppressed CNV development with reduced macrophage recruitment and inflammatory mediator induction. The mediators monocyte chemotactic protein-1, interleukin-1 beta (Il-1 beta), Il-6, matrix metalloprotease-9 (Mmp-9), and transforming growth factor-beta 1 (Tgf-beta 1) that were upregulated during CNV development were all suppressed in the retinal pigment epithelium-choroid of CNV models generated in the Angptl2 KO mice. Bone marrow transplantation using wild-type and KO mice suggested that both bone marrow-derived and host-derived Angptl2 were responsible for macrophage recruitment and CNV development. Peritoneal macrophages derived from Angptl2 KO mice expressed lower levels of the inflammatory mediators. In the wild-type peritoneal macrophages and RAW264.7 cells, Angptl2 induced the mediators via integrins alpha 4 and beta 2, followed by the downstream activation of NF-kappa B and ERK. The activation of NF-kappa B and ERK by Angptl2 also promoted macrophage migration. Therefore, Angptl2 from focal tissue might trigger macrophage recruitment, and that from recruited macrophages might promote expression of inflammatory mediators including Angptl2 in an autocrine and/or paracrine fashion to facilitate CNV development. Angptl2 might therefore represent a multistep regulator of CNV pathogenesis and serve as a new therapeutic target for age-related macular degeneration.	[Hirasawa, Manabu; Osada, Hideto; Miyake, Seiji; Toda, Eriko; Ozawa, Yoko] Keio Univ, Sch Med, Lab Retinal Cell Biol, Tokyo 1608582, Japan; [Hirasawa, Manabu; Tsubota, Kazuo; Ozawa, Yoko] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan; [Hirasawa, Manabu] Tokyo Dent Coll, Suidobashi Hosp, Dept Ophthalmol, Tokyo 1010061, Japan; [Endo, Motoyoshi; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8608555, Japan; [Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med Screening, Nagakute, Aichi 4801195, Japan; [Oike, Yuichi] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Tokyo 1000004, Japan; [Takubo, Keiyo] Natl Ctr Global Hlth & Med, Res Inst, Dept Stem Cell Biol, Tokyo 1628655, Japan	Keio University; Keio University; Tokyo Dental College; Kumamoto University; Aichi Medical University; Japan Science & Technology Agency (JST); National Center for Global Health & Medicine - Japan	Ozawa, Y (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Lab Retinal Cell Biol,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	ozawa@a5.keio.jp	Endo, Motoyoshi/T-5840-2019; Ozawa, Yoko/AAH-9888-2020; Takubo, Keiyo/AAX-5546-2020	Takubo, Keiyo/0000-0002-1736-7592; Osada, Hideto/0000-0001-9971-8992	Japan Society for the Promotion of Science KAKENHI [80365345, 25462734]; Grants-in-Aid for Scientific Research [25462734] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 80365345 and 25462734. The authors declare that they have no conflicts of interest with the contents of this article.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178; Aoi J, 2014, MOL CANCER RES, V12, P239, DOI 10.1158/1541-7786.MCR-13-0336; Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Belotti D, 2008, MOL CANCER RES, V6, P525, DOI 10.1158/1541-7786.MCR-07-0366; Campa C, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/546826; Doi Y, 2013, DIABETES CARE, V36, P98, DOI 10.2337/dc12-0166; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Du HJ, 2013, P NATL ACAD SCI USA, V110, P2377, DOI 10.1073/pnas.1221729110; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Espinosa-Heidmann DG, 2013, INVEST OPHTH VIS SCI, V54, P7439, DOI 10.1167/iovs.13-12546; Farhat N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000201; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Fu ZY, 2013, BIOCHEM BIOPH RES CO, V430, P1126, DOI 10.1016/j.bbrc.2012.12.025; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Grossniklaus HE, 2002, MOL VIS, V8, P119; Honda S, 2009, GRAEF ARCH CLIN EXP, V247, P515, DOI 10.1007/s00417-008-1010-5; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Kamizuru H, 2001, INVEST OPHTH VIS SCI, V42, P2664; Kamoshita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103013; Kanda A, 2012, LAB INVEST, V92, P1553, DOI 10.1038/labinvest.2012.111; Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523; Koto T, 2007, INVEST OPHTH VIS SCI, V48, P4328, DOI 10.1167/iovs.06-1148; Lambert V, 2002, AM J PATHOL, V161, P1247, DOI 10.1016/S0002-9440(10)64401-X; Lavalette S, 2011, AM J PATHOL, V178, P2416, DOI 10.1016/j.ajpath.2011.01.013; Lee HJ, 2013, BIOCHEM BIOPH RES CO, V430, P981, DOI 10.1016/j.bbrc.2012.11.127; Mangione CM, 1999, AM J OPHTHALMOL, V128, P45, DOI 10.1016/S0002-9394(99)00169-5; Meng QX, 2013, EXP THER MED, V5, P1631, DOI 10.3892/etm.2013.1045; Nagai N, 2007, INVEST OPHTH VIS SCI, V48, P2321, DOI 10.1167/iovs.06-1296; Nagai T, 2007, INVEST OPHTH VIS SCI, V48, P5716, DOI 10.1167/iovs.07-1023; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Oike Y, 2004, INT J HEMATOL, V80, P21, DOI 10.1532/ijh97.04034; Oike Y, 2009, CIRC J, V73, P2192, DOI 10.1253/circj.CJ-09-0710; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; Ozawa Y, 2012, CURR PHARM DESIGN, V18, P51, DOI 10.2174/138161212798919101; Parmeggiani F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/435607; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Sene A, 2013, CELL METAB, V17, P549, DOI 10.1016/j.cmet.2013.03.009; Suzuki M, 2012, J CELL SCI, V125, P2407, DOI 10.1242/jcs.097683; Suzuki M, 2014, BRIT J OPHTHALMOL, V98, P1186, DOI 10.1136/bjophthalmol-2013-304670; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Tian Z, 2013, J MOL CELL CARDIOL, V57, P1, DOI 10.1016/j.yjmcc.2013.01.004; Toyono T, 2013, INVEST OPHTH VIS SCI, V54, P4278, DOI 10.1167/iovs.12-11497; Usui T, 2013, CIRC J, V77, P2311, DOI 10.1253/circj.CJ-12-1548; Wang WQ, 2011, INVEST OPHTH VIS SCI, V52, P7213, DOI 10.1167/iovs.10-7097; Watanabe M, 2008, BIOCHEM BIOPH RES CO, V376, P310, DOI 10.1016/j.bbrc.2008.08.148; Xu J, 2012, ANGIOGENESIS, V15, P213, DOI 10.1007/s10456-012-9254-4; Yasukawa T, 2004, CURR EYE RES, V28, P359, DOI 10.1076/ceyr.28.5.359.28678; Zarbin Marco A, 2003, Trans Am Ophthalmol Soc, V101, P499; Zarranz-Ventura J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065434	56	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7373	7385		10.1074/jbc.M115.710186	http://dx.doi.org/10.1074/jbc.M115.710186			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26839315	Green Published, hybrid			2022-12-26	WOS:000383447600014
J	Arriagada, RA; Echeverria, CM; Moya, DE				Arriagada, Rodrigo A.; Echeverria, Cristian M.; Moya, Danisa E.			Creating Protected Areas on Public Lands: Is There Room for Additional Conservation?	PLOS ONE			English	Article							MATCHING ESTIMATORS; ENVIRONMENTAL SERVICES; FOREST COVER; DEFORESTATION; LOCATION; PAYMENTS; ROADS; BIAS	Most evaluations of the effectiveness of PAs have relied on indirect estimates based on comparisons between protected and unprotected areas. Such methods can be biased when protection is not randomly assigned. We add to the growing literature on the impact of PAs by answering the following research questions: What is the impact of Chilean PAs on deforestation which occurred between 1986 and 2011? How do estimates of the impact of PAs vary when using only public land as control units? We show that the characteristics of the areas in which protected and unprotected lands are located differ significantly. To satisfactorily estimate the effects of PAs, we use matching methods to define adequate control groups, but not as in previous research. We construct control groups using separately non-protected private areas and non-protected public lands. We find that PAs avoid deforestation when using unprotected private lands as valid controls, however results show no impact when the control group is based only on unprotected public land. Different land management regimes, and higher levels of enforcement inside public lands may reduce the opportunity to add additional conservation benefits when the national systems for PAs are based on the protection of previously unprotected public lands. Given that not all PAs are established to avoid deforestation, results also admit the potential for future studies to include other outcomes including forest degradation (not just deforestation), biodiversity, wildlife, primary forests (not forests in general), among others.	[Arriagada, Rodrigo A.; Echeverria, Cristian M.; Moya, Danisa E.] Millennium Nucleus Ctr Socioecon Impact Environm, Santiago, Chile; [Arriagada, Rodrigo A.] Pontificia Univ Catolica Chile, Dept Ecosyst & Environm, Ctr Appl Ecol & Sustainabil CAPES, Interdisciplinary Ctr Intercultural & Indigenous, Alameda 340, Santiago, Chile; [Echeverria, Cristian M.] Univ Concepcion, Dept Forest Management & Environm, Concepcion, Chile	Pontificia Universidad Catolica de Chile; Universidad de Concepcion	Arriagada, RA (corresponding author), Millennium Nucleus Ctr Socioecon Impact Environm, Santiago, Chile.; Arriagada, RA (corresponding author), Pontificia Univ Catolica Chile, Dept Ecosyst & Environm, Ctr Appl Ecol & Sustainabil CAPES, Interdisciplinary Ctr Intercultural & Indigenous, Alameda 340, Santiago, Chile.	rarriagadac@uc.cl	Echeverria, Cristian/ABD-7286-2020		Fondo Nacional de Investigacion Cientifica y Tecnologica, FONDECYT-CONICYT Chile (Proyecto FONDECYT Iniciacion) [11110271]	Fondo Nacional de Investigacion Cientifica y Tecnologica, FONDECYT-CONICYT Chile (Proyecto FONDECYT Iniciacion)	This work was funded by Fondo Nacional de Investigacion Cientifica y Tecnologica, FONDECYT-CONICYT Chile (Proyecto FONDECYT Iniciacion No 11110271). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2011, J BUS ECON STAT, V29, P1, DOI 10.1198/jbes.2009.07333; Abadie A, 2008, ECONOMETRICA, V76, P1537, DOI 10.3982/ECTA6474; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Armesto J.J., 1992, AMBIENTE DESARROLLO, V8, P19; Arriagada RA, 2012, LAND ECON, V88, P382, DOI 10.3368/le.88.2.382; Basic Z, 2012, AGRON UC, V46, P18; Carmona A, 2012, APPL GEOGR, V32, P904, DOI 10.1016/j.apgeog.2011.09.006; Chomitz KM, 1996, WORLD BANK ECON REV, V10, P487, DOI 10.1093/wber/10.3.487; Cofre H, 1999, BIOL CONSERV, V88, P53, DOI 10.1016/S0006-3207(98)00090-1; CONAF CONAMA BIRF UA CHILE PUC Chile UC Temuco., 1999, CAT EV REC VEG NAT C; Dinerstein E., 1995, CONSERVATION ASSESSM; Donoso C., 1993, ECOLOGIA FORESTAL; Ferraro PJ, 2011, ENVIRON RESOUR ECON, V48, P269, DOI 10.1007/s10640-010-9408-z; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kamal S, 2014, BIODIVERS CONSERV, V23, P2689, DOI 10.1007/s10531-014-0744-0; Lambin E.F., 1999, LAND USE LAND COVER, V1st ed.; Lara A, 2009, FOREST ECOL MANAG, V258, P415, DOI 10.1016/j.foreco.2009.01.004; Miteva DA, 2014, NATURE BALANCE EC BI, P301, DOI [10.1093/acprof, DOI 10.1093/ACPROF]; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Neira Eduardo, 2002, CHILES FRONTIER FORE; Pauchard A, 2002, NAT AREA J, V22, P318; Pfaff A, 2007, J REGIONAL SCI, V47, P109, DOI 10.1111/j.1467-9787.2007.00502.x; Pfaff A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0273; Pfaff A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129460; Pfaff A, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.1990; Pfaff ASP, 1999, J ENVIRON ECON MANAG, V37, P26, DOI 10.1006/jeem.1998.1056; Robalino J., 2014, ENVIRON DEV ECON, V20, P283; Robalino JA, 2007, ENVIRON DEV ECON, V12, P521, DOI 10.1017/S1355770X07003671; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; Rozzi R., 1994, Bosque, V15, P55; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Sims KRE, 2010, J ENVIRON ECON MANAG, V60, P94, DOI 10.1016/j.jeem.2010.05.003; Turner B., 1990, EARTH TRANSFORMED HU; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x	41	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148094	10.1371/journal.pone.0148094	http://dx.doi.org/10.1371/journal.pone.0148094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26848856	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000040
J	Dipnall, JF; Pasco, JA; Berk, M; Williams, LJ; Dodd, S; Jacka, FN; Meyer, D				Dipnall, Joanna F.; Pasco, Julie A.; Berk, Michael; Williams, Lana J.; Dodd, Seetal; Jacka, Felice N.; Meyer, Denny			Fusing Data Mining, Machine Learning and Traditional Statistics to Detect Biomarkers Associated with Depression	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; MULTIPLE IMPUTATION; REGRESSION; CLASSIFICATION; BILIRUBIN; RISK; ANTIOXIDANT; DISEASE; INFLAMMATION; DIAGNOSIS	Background Atheoretical large-scale data mining techniques using machine learning algorithms have promise in the analysis of large epidemiological datasets. This study illustrates the use of a hybrid methodology for variable selection that took account of missing data and complex survey design to identify key biomarkers associated with depression from a large epidemiological study. Methods The study used a three-step methodology amalgamating multiple imputation, a machine learning boosted regression algorithm and logistic regression, to identify key biomarkers associated with depression in the National Health and Nutrition Examination Study (2009-2010). Depression was measured using the Patient Health Questionnaire-9 and 67 biomarkers were analysed. Covariates in this study included gender, age, race, smoking, food security, Poverty Income Ratio, Body Mass Index, physical activity, alcohol use, medical conditions and medications. The final imputed weighted multiple logistic regression model included possible confounders and moderators. Results After the creation of 20 imputation data sets from multiple chained regression sequences, machine learning boosted regression initially identified 21 biomarkers associated with depression. Using traditional logistic regression methods, including controlling for possible confounders and moderators, a final set of three biomarkers were selected. The final three biomarkers from the novel hybrid variable selection methodology were red cell distribution width (OR 1.15; 95% CI 1.01, 1.30), serum glucose (OR 1.01; 95% CI 1.00, 1.01) and total bilirubin (OR 0.12; 95% CI 0.05, 0.28). Significant interactions were found between total bilirubin with Mexican American/Hispanic group (p = 0.016), and current smokers (p<0.001). Conclusion The systematic use of a hybrid methodology for variable selection, fusing data mining techniques using a machine learning algorithm with traditional statistical modelling, accounted for missing data and complex survey sampling methodology and was demonstrated to be a useful tool for detecting three biomarkers associated with depression for future hypothesis generation: red cell distribution width, serum glucose and total bilirubin.	[Dipnall, Joanna F.; Pasco, Julie A.; Berk, Michael; Williams, Lana J.; Dodd, Seetal; Jacka, Felice N.] Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic 3217, Australia; [Dipnall, Joanna F.; Meyer, Denny] Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Melbourne, Vic, Australia; [Pasco, Julie A.] Univ Melbourne, Dept Med, St Albans, Vic, Australia; [Pasco, Julie A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Pasco, Julie A.; Berk, Michael; Dodd, Seetal] Barwon Hlth, Univ Hosp Geelong, Geelong, Vic, Australia; [Berk, Michael; Dodd, Seetal; Jacka, Felice N.] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia; [Berk, Michael] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Berk, Michael] Orygen, Parkville, Vic, Australia; [Jacka, Felice N.] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Jacka, Felice N.] Black Dog Inst, Sydney, NSW, Australia	Deakin University; Swinburne University of Technology; University of Melbourne; Monash University; Geelong Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Orygen, The National Centre of Excellence in Youth Mental Health; Murdoch Children's Research Institute; Black Dog Institute	Dipnall, JF (corresponding author), Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic 3217, Australia.; Dipnall, JF (corresponding author), Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Melbourne, Vic, Australia.	jdipnall@deakin.edu.au	Berk, Michael/M-7891-2013; Berk, Michael/M-3585-2019; Jacka, Felice N/D-9424-2012; Jacka, Felice N/ABE-6322-2020	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946; Jacka, Felice N/0000-0002-9825-0328; Jacka, Felice N/0000-0002-9825-0328; Williams, Lana/0000-0002-1377-1272; Dipnall, Joanna/0000-0001-7543-0687; Dodd, Seetal/0000-0002-7918-4636	NHMRC [1059660, 1064272]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Michael Berk is supported by a NHMRC Senior Principal Research Fellowship 1059660 and Lana J Williams is supported by a NHMRC Career Development Fellowship 1064272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; ANDERSON TW, 1957, J AM STAT ASSOC, V52, P200, DOI 10.2307/2280845; Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024; Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Berry M.J.A., 2011, DATA MINING TECHNIQU; Boksa P, 2013, J PSYCHIATR NEUROSCI, V38, P75, DOI 10.1503/jpn.130018; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Buston PM, 2011, J ANIM ECOL, V80, P528, DOI 10.1111/j.1365-2656.2011.01803.x; (CDC). CfDCaP. National Center for Health Statistics (NCHS), 2009, NHANES LAB PROC MAN; Centers for Disease Control and Prevention National Center for Health Statistics, 1999, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention National Center for Health Statistics, 2014, NAT HLTH NUTR EX SUR; Chaovalitwongse W, 2010, SPRINGER SER OPTIM A, V38, P1, DOI 10.1007/978-0-387-88630-5; Council NR, 2006, FOOD INS HUNG US ASS; Davis J, 2015, MOL PSYCHIATR, V20, P152, DOI 10.1038/mp.2014.139; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Dipnall JF, 2014, METHODS; Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Essau CA, 2010, J AFFECT DISORDERS, V127, P185, DOI 10.1016/j.jad.2010.05.016; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman J, 2001, SPRINGER SERIES STAT, V10; Friedman J, 2009, R PACKAGE VERSION, P1, DOI DOI 10.18637/JSS.V033.I01; Friedman JH, 1997, COMP SCI STAT, V29, P3; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Kenward MG, 2007, STAT METHODS MED RES, V16, P199, DOI 10.1177/0962280206075304; Kirkman MS, 2009, DIABETES CARE, V32, pS1, DOI 10.2337/dc09-S001; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Li C, 2013, STATA J, V13, P795, DOI 10.1177/1536867X1301300407; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Longadge R., 2013, INT J COMPUT NETW IJ; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004; Malandrino N, 2012, DIABETOLOGIA, V55, P226, DOI 10.1007/s00125-011-2331-1; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Mezuk B, 2013, HEALTH PSYCHOL, V32, P254, DOI 10.1037/a0029014; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Opitz D., 1999, J ARTIF INTELL RES, V11, P169, DOI [10.1613/jair.614, DOI 10.1613/JAIR.614]; Ozturk ZA, 2013, ARCH GERONTOL GERIAT, V56, P50, DOI 10.1016/j.archger.2012.10.002; Pandya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020416; Patel P., 2010, DIABETES, V100, P13; Pearce N, 2012, INT J EPIDEMIOL, V41, P393, DOI 10.1093/ije/dys049; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Schaefer RL., 1986, J STAT COMPUT SIM, V25, P75, DOI [10.1080/00949658608810925, DOI 10.1080/00949658608810925]; Schonlau M, 2005, STATA J, V5, P330, DOI 10.1177/1536867X0500500304; Schwertner HA, 1998, ATHEROSCLEROSIS, V136, P383, DOI 10.1016/S0021-9150(97)00232-3; Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776; Seref O, 2007, DATA MINING SYSTEMS; Spell DW, 2004, CANCER DETECT PREV, V28, P37, DOI 10.1016/j.cdp.2003.10.002; StataCorp L, 2015, STAT MULT IMP REF MA; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stewart JC, 2009, BRAIN BEHAV IMMUN, V23, P936, DOI 10.1016/j.bbi.2009.04.011; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tabachnick B. G.., 2012, USING MULTIVARIATE S; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Tovar D, 2012, METHODS MOL BIOL, V829, P593, DOI 10.1007/978-1-61779-458-2_37; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Van Hoydonck PGA, 2001, INT J EPIDEMIOL, V30, P1465; van Kimmenade RRJ, 2010, EUR J HEART FAIL, V12, P129, DOI 10.1093/eurjhf/hfp179; Van Ness PH, 2007, J CLIN EPIDEMIOL, V60, P1239, DOI 10.1016/j.jclinepi.2007.03.006; Van Voorhees BW, 2008, ANN FAM MED, V6, P503, DOI 10.1370/afm.887; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WINOKUR A, 1988, AM J PSYCHIAT, V145, P325; Witten IH, 2011, MOR KAUF D, P1; Wood Angela M, 2004, Clin Trials, V1, P368; World Health Organization, 2006, GLOB DAT BOD MASS IN; Yesil A, 2011, GUT LIVER, V5, P460, DOI 10.5009/gnl.2011.5.4.460; Yoo I, 2012, J MED SYST, V36, P2431, DOI 10.1007/s10916-011-9710-5; Zhang DS, 2004, IEEE T SYST MAN CY C, V34, P513, DOI 10.1109/TSMCC.2004.829279	85	37	38	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148195	10.1371/journal.pone.0148195	http://dx.doi.org/10.1371/journal.pone.0148195			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848571	Green Published, gold			2022-12-26	WOS:000369554000050
J	Leggatt, RA; Sundstrom, LF; Vandersteen, WE; Devlin, RH				Leggatt, Rosalind A.; Sundstrom, L. Fredrik; Vandersteen, Wendy E.; Devlin, Robert H.			Alternate Directed Anthropogenic Shifts in Genotype Result in Different Ecological Outcomes in Coho Salmon Oncorhynchus kisutch Fry	PLOS ONE			English	Article							GROWTH-HORMONE TRANSGENESIS; WILD ATLANTIC SALMON; ANTIPREDATOR BEHAVIOR; BROWN TROUT; RISK-TAKING; DOMESTICATION; SALAR; PREDATION; SIZE; CONSEQUENCES	Domesticated and growth hormone (GH) transgenic salmon provide an interesting model to compare effects of selected versus engineered phenotypic change on relative fitness in an ecological context. Phenotype in domestication is altered via polygenic selection of traits over multiple generations, whereas in transgenesis is altered by a single locus in one generation. These established and emerging technologies both result in elevated growth rates in culture, and are associated with similar secondary effects such as increased foraging, decreased predator avoidance, and similar endocrine and gene expression profiles. As such, there is concern regarding ecological consequences should fish that have been genetically altered escape to natural ecosystems. To determine if the type of genetic change influences fitness components associated with ecological success outside of the culture environments they were produced for, we examined growth and survival of domesticated, transgenic, and wild-type coho salmon fry under different environmental conditions. In simple conditions (i. e. culture) with unlimited food, transgenic fish had the greatest growth, while in naturalized stream tanks (limited natural food, with or without predators) domesticated fish had greatest growth and survival of the three fish groups. As such, the largest growth in culture conditions may not translate to the greatest ecological effects in natural conditions, and shifts in phenotype over multiple rather than one loci may result in greater success in a wider range of conditions. These differences may arise from very different historical opportunities of transgenic and domesticated strains to select for multiple growth pathways or counter-select against negative secondary changes arising from elevated capacity for growth, with domesticated fish potentially obtaining or retaining adaptive responses to multiple environmental conditions not yet acquired in recently generated transgenic strains.	[Leggatt, Rosalind A.; Sundstrom, L. Fredrik; Vandersteen, Wendy E.; Devlin, Robert H.] Fisheries & Oceans Canada, Ctr Aquaculture & Environm Res, 4160 Marine Dr, W Vancouver, BC V7V 1N6, Canada; [Sundstrom, L. Fredrik] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [Vandersteen, Wendy E.] Miracle Springs Inc, 12443 Stave Lake Rd, Mission, BC V2V 0A6, Canada	Fisheries & Oceans Canada; Uppsala University	Leggatt, RA (corresponding author), Fisheries & Oceans Canada, Ctr Aquaculture & Environm Res, 4160 Marine Dr, W Vancouver, BC V7V 1N6, Canada.	rosalind.leggatt@gmail.com	Sundstrom, Fred/E-6736-2011	Sundstrom, Fred/0000-0002-3157-7289	Canadian Regulatory System for Biotechnology program within the Federal Government of Canada [61740]	Canadian Regulatory System for Biotechnology program within the Federal Government of Canada	All funding was provided for by the Canadian Regulatory System for Biotechnology (Grant # 61740), a program within the Federal Government of Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MV, 1999, ANIM BEHAV, V58, P933, DOI 10.1006/anbe.1999.1229; Adriaenssens B, 2011, BEHAV ECOL, V22, P135, DOI 10.1093/beheco/arq185; Berejikian BA, 1995, CAN J FISH AQUAT SCI, V52, P2476, DOI 10.1139/f95-838; BERG S, 1991, J FISH BIOL, V39, P151, DOI 10.1111/j.1095-8649.1991.tb04353.x; Biro PA, 2004, P ROY SOC B-BIOL SCI, V271, P2233, DOI 10.1098/rspb.2004.2861; Blann CA, 2006, J FISH BIOL, V69, P535, DOI 10.1111/j.1095-8649.2006.01124.x; Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; Crossin GT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120173; Debes PV, 2014, CAN J FISH AQUAT SCI, V71, P1371, DOI 10.1139/cjfas-2013-0618; Debes PV, 2014, GENETICS, V196, P1277, DOI 10.1534/genetics.114.161729; Devlin RH, 2013, J ANIM SCI, V91, P5247, DOI 10.2527/jas.2013-6612; Devlin RH, 1999, AQUAC RES, V30, P479, DOI 10.1046/j.1365-2109.1999.00359.x; Devlin RH, 2004, P NATL ACAD SCI USA, V101, P9303, DOI 10.1073/pnas.0400023101; Devlin RH, 2004, AQUACULTURE, V236, P607, DOI 10.1016/j.aquaculture.2004.02.026; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; Devlin RH, 2001, NATURE, V409, P781, DOI 10.1038/35057314; Devlin RH, 2015, BIOSCIENCE, V65, P685, DOI 10.1093/biosci/biv068; Devlin RH, 2010, AQUACULTURE, V304, P66, DOI 10.1016/j.aquaculture.2010.03.023; Devlin RH, 2009, P NATL ACAD SCI USA, V106, P3047, DOI 10.1073/pnas.0809798106; Dieperink C, 2001, ECOL FRESHW FISH, V10, P177, DOI 10.1034/j.1600-0633.2001.100307.x; DILL LM, 1984, BEHAV ECOL SOCIOBIOL, V16, P65, DOI 10.1007/BF00293105; Dionne M, 2002, CAN J ZOOL, V80, P2006, DOI 10.1139/Z02-176; Drew RE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-323; Einum S, 1997, J FISH BIOL, V50, P634, DOI 10.1006/jfbi.1996.0330; Fleming IA, 2002, CAN J FISH AQUAT SCI, V59, P1323, DOI 10.1139/F02-082; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Fox J., 2019, R COMPANION APPL REG, V.; Gjedrem T, 2012, AQUACULTURE, V350, P117, DOI 10.1016/j.aquaculture.2012.04.008; Harwood AJ, 2003, BEHAV ECOL, V14, P902, DOI 10.1093/beheco/arg080; HERSHBERGER WK, 1990, AQUACULTURE, V85, P187, DOI 10.1016/0044-8486(90)90018-I; Houde ALS, 2010, ICES J MAR SCI, V67, P657, DOI 10.1093/icesjms/fsp272; Houde ALS, 2010, CONSERV GENET, V11, P785, DOI 10.1007/s10592-009-9892-2; JOHNSSON JI, 1993, CAN J FISH AQUAT SCI, V50, P480, DOI 10.1139/f93-056; Johnsson JI, 1996, CAN J FISH AQUAT SCI, V53, P1546, DOI 10.1139/cjfas-53-7-1546; Johnsson JI, 2003, J FISH BIOL, V63, P863, DOI 10.1046/j.1095-8649.2003.00187.x; Jonsson E, 1998, HORM BEHAV, V33, P9, DOI 10.1006/hbeh.1997.1426; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Metcalfe NB, 2003, J APPL ECOL, V40, P535, DOI 10.1046/j.1365-2664.2003.00815.x; Moreau DTR, 2011, J FISH BIOL, V78, P726, DOI 10.1111/j.1095-8649.2010.02888.x; Moreau DTR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095853; Morris MRJ, 2008, CAN J FISH AQUAT SCI, V65, P2807, DOI 10.1139/F08-181; Neregard L, 2008, J FISH BIOL, V73, P2341, DOI 10.1111/j.1095-8649.2008.02082.x; Oakes JD, 2007, AQUACULTURE, V265, P309, DOI 10.1016/j.aquaculture.2007.01.015; Overturf K, 2010, AQUACULTURE, V307, P111, DOI 10.1016/j.aquaculture.2010.06.010; R Core Team, 2013, R LANG ENV STAT COMP; Raven PA, 2008, GEN COMP ENDOCR, V159, P26, DOI 10.1016/j.ygcen.2008.07.011; Reinhardt UG, 1999, ANIM BEHAV, V57, P923, DOI 10.1006/anbe.1998.1051; RUZZANTE DE, 1994, AQUACULTURE, V120, P1, DOI 10.1016/0044-8486(94)90217-8; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Skaala O, 2012, CAN J FISH AQUAT SCI, V69, P1994, DOI 10.1139/f2012-118; Sloman KA, 2002, J FISH BIOL, V61, P1, DOI 10.1111/j.1095-8649.2002.tb01733.x; Solberg MF, 2015, APPL ANIM BEHAV SCI, V162, P67, DOI 10.1016/j.applanim.2014.11.012; Solberg MF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-234; Solberg MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054469; Sundstrom LF, 2007, P NATL ACAD SCI USA, V104, P3889, DOI 10.1073/pnas.0608767104; Sundstrom LF, 2007, ETHOLOGY, V113, P403, DOI 10.1111/j.1439-0310.2007.01331.x; Sundstrom LF, 2014, J APPL ECOL, V51, P82, DOI 10.1111/1365-2664.12185; Sundstrom LF, 2011, EVOL ECOL, V25, P447, DOI 10.1007/s10682-010-9406-1; Sundstrom LF, 2010, ECOL APPL, V20, P1372, DOI 10.1890/09-0631.1; Sundstrom LF, 2009, J APPL ECOL, V46, P762, DOI 10.1111/j.1365-2664.2009.01668.x; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; Sundstrom LF, 2004, ETHOLOGY, V110, P381, DOI 10.1111/j.1439-0310.2004.00985.x; Sundstrom LF, 2003, ETHOLOGY, V109, P701, DOI 10.1046/j.1439-0310.2003.00908.x; Sundstrom LF, 2005, EVOLUTION, V59, P1560, DOI 10.1111/j.0014-3820.2005.tb01805.x; Tymchuk WE, 2007, EVOLUTION, V61, P1225, DOI 10.1111/j.1558-5646.2007.00102.x; Tymchuk WE, 2006, T AM FISH SOC, V135, P442, DOI 10.1577/T05-181.1; Tymchuk WE, 2009, ENDOCRINOLOGY, V150, P1809, DOI 10.1210/en.2008-0797; Tymchuk Wendy E., 2006, Canadian Technical Report of Fisheries and Aquatic Sciences, V2450, P1; Vandersteen W, 2012, EVOL APPL, V5, P76, DOI 10.1111/j.1752-4571.2011.00210.x; Wringe BF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-63	70	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148687	10.1371/journal.pone.0148687	http://dx.doi.org/10.1371/journal.pone.0148687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848575	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000158
J	Zhu, SS; Zhang, CY; Wang, J; Wei, L; Quan, R; Yang, JY; Yan, X; Li, ZX; She, RP; Hu, FJ; Liu, J				Zhu, Shanshan; Zhang, Chunyan; Wang, Jing; Wei, Li; Quan, Rong; Yang, Jiayu; Yan, Xu; Li, Zixuan; She, Ruiping; Hu, Fengjiao; Liu, Jue			Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; CELLULAR MECHANISMS; PROTECTIVE IMMUNITY; SYNDROME PMWS; PCV2; PIGS; VIRUS; INFECTION; CELLS; ANTIBODIES	In a recent study, we reported that a recombinant protein from fusion expression of flagellin to porcine circovirus type 2 (PCV2) Cap induced robust humoral and cell-mediated immunity that afforded full protection for PCV2 infection using BALB/c mice. Here, we further evaluated the immunogenicity and protection of the recombinant protein using specific pathogen free (SPF) pigs. Twenty-five 3-week-old piglets without passively acquired immunity were divided into 5 groups. All piglets except negative controls were challenged with a virulent PCV2 at 21 days after booster vaccination and necropsied at 21 days post-challenge. Vaccination of piglets with the recombinant protein without adjuvant induced strong humoral and cellular immune responses as observed by high levels of PCV2-specific IgG antibodies and neutralizing antibodies, as well as frequencies of PCV2-specific IFN-gamma-secreting cells that conferred good protection against PCV2 challenge, with significant reduced PCV2 viremia, mild lesions, low PCV2 antigen-positive cells, as well as improved body weight gain, comparable to piglets vaccinated with a commercial PCV2 subunit vaccine. These results further demonstrated that the recombinant flagellin-Cap fusion protein is capable of inducing solid protective humoral and cellular immunity when administered to pigs, thereby becoming an effective PCV2 vaccine candidate for control of PCV2 infection.	[Zhu, Shanshan; Zhang, Chunyan; Wang, Jing; Wei, Li; Quan, Rong; Yang, Jiayu; Yan, Xu; Li, Zixuan; Liu, Jue] Beijing Acad Agr & Forestry Sci, Beijing Key Lab Prevent & Control Infect Dis Live, Inst Anim Husb & Vet Med, 9 Shuguang Garden Middle Rd, Beijing 100097, Peoples R China; [She, Ruiping; Hu, Fengjiao] China Agr Univ, Coll Vet Med, 2 Yuanmingyuan West Rd, Beijing 100197, Peoples R China	Beijing Academy of Agriculture & Forestry; China Agricultural University	Liu, J (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Key Lab Prevent & Control Infect Dis Live, Inst Anim Husb & Vet Med, 9 Shuguang Garden Middle Rd, Beijing 100097, Peoples R China.	liujue@263.net			National Science Fund for Distinguished Young Scholars [31025028]; Beijing Municipal Science and Technology Contract Project, People's Republic of China [Z07010501780701]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Beijing Municipal Science and Technology Contract Project, People's Republic of China	This work was supported by grants from the National Science Fund for Distinguished Young Scholars (31025028) and the Beijing Municipal Science and Technology Contract Project (Z07010501780701), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan G, 1998, VET REC, V142, P467; Bates JT, 2011, J IMMUNOL, V186, P6255, DOI 10.4049/jimmunol.1001855; Ben-Yedidia T, 1998, IMMUNOL LETT, V64, P9, DOI 10.1016/S0165-2478(98)00073-X; Blanchard P, 2003, VACCINE, V21, P4565, DOI 10.1016/S0264-410X(03)00503-6; Bucarey SA, 2009, VACCINE, V27, P5781, DOI 10.1016/j.vaccine.2009.07.061; Calsamiglia M, 2002, J CLIN MICROBIOL, V40, P1848, DOI 10.1128/JCM.40.5.1848-1850.2002; Carasova P, 2007, RES VET SCI, V83, P274, DOI 10.1016/j.rvsc.2006.11.013; Cheung AK, 2003, VIROLOGY, V305, P168, DOI 10.1006/viro.2002.1733; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; Darwich L, 2003, J GEN VIROL, V84, P3453, DOI 10.1099/vir.0.19364-0; Delaney KN, 2010, VIRAL IMMUNOL, V23, P201, DOI 10.1089/vim.2009.0107; Fan HY, 2008, J VIROL METHODS, V150, P21, DOI 10.1016/j.jviromet.2008.02.011; Fenaux M, 2004, J VIROL, V78, P6297, DOI 10.1128/JVI.78.12.6297-6303.2004; Fort M, 2008, VACCINE, V26, P1063, DOI 10.1016/j.vaccine.2007.12.019; Fort M, 2009, VACCINE, V27, P4031, DOI 10.1016/j.vaccine.2009.04.028; Fort M, 2007, VET MICROBIOL, V125, P244, DOI 10.1016/j.vetmic.2007.06.004; Fort M, 2009, VET IMMUNOL IMMUNOP, V129, P101, DOI 10.1016/j.vetimm.2008.12.024; Gilpin DF, 2003, VET IMMUNOL IMMUNOP, V94, P149, DOI 10.1016/S0165-2427(03)00087-4; Kamstrup S, 2004, VACCINE, V22, P1358, DOI 10.1016/j.vaccine.2004.01.032; Kekarainen T, 2008, J GEN VIROL, V89, P760, DOI 10.1099/vir.0.83354-0; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim T, 2009, VET MICROBIOL, V138, P318, DOI 10.1016/j.vetmic.2009.04.014; Kixmoller M, 2008, VACCINE, V26, P3443, DOI 10.1016/j.vaccine.2008.04.032; Larochelle R, 2003, CAN J VET RES, V67, P114; Letran SE, 2011, EUR J IMMUNOL, V41, P29, DOI 10.1002/eji.201040717; Liu G, 2012, VACCINE, V30, P6833, DOI 10.1016/j.vaccine.2012.09.013; Liu GM, 2011, VACCINE, V29, P8677, DOI 10.1016/j.vaccine.2011.08.118; Liu J, 2005, J VIROL, V79, P8262, DOI 10.1128/JVI.79.13.8262-8274.2005; Martelli P, 2011, VET MICROBIOL, V149, P339, DOI 10.1016/j.vetmic.2010.12.008; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; McIntosh KA, 2006, CAN J VET RES, V70, P58; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Meerts P, 2005, VIRAL IMMUNOL, V18, P333, DOI 10.1089/vim.2005.18.333; MEERTS P, 2006, BMC VET RES, V30, P2; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Mizel SB, 2009, CLIN VACCINE IMMUNOL, V16, P21, DOI 10.1128/CVI.00333-08; Nawagitgul P, 2000, J GEN VIROL, V81, P2281, DOI 10.1099/0022-1317-81-9-2281; Okuda Y, 2003, J VET DIAGN INVEST, V15, P107, DOI 10.1177/104063870301500204; Opriessnig T, 2009, VACCINE, V27, P1002, DOI 10.1016/j.vaccine.2008.11.105; Opriessnig T, 2008, CLIN VACCINE IMMUNOL, V15, P397, DOI 10.1128/CVI.00416-07; Opriessnig T, 2007, J VET DIAGN INVEST, V19, P591, DOI 10.1177/104063870701900601; Perez-Martin E, 2010, VACCINE, V28, P2340, DOI 10.1016/j.vaccine.2009.12.061; Pino O, 2005, INFECT IMMUN, V73, P6763, DOI 10.1128/IAI.73.10.6763-6770.2005; Rodriguez-Arrioja GM, 2000, VET REC, V146, P762, DOI 10.1136/vr.146.26.762; Rosell C, 1999, J COMP PATHOL, V120, P59, DOI 10.1053/jcpa.1998.0258; Segales Joaquim, 2005, Animal Health Research Reviews, V6, P119, DOI 10.1079/AHR2005106; Shen HG, 2008, J GEN VIROL, V89, P1857, DOI 10.1099/vir.0.2008/000125-0; Sibila M, 2004, AM J VET RES, V65, P88, DOI 10.2460/ajvr.2004.65.88; Sorden SD, 1999, J VET DIAGN INVEST, V11, P528, DOI 10.1177/104063879901100607; Stevenson LS, 2006, VIRAL IMMUNOL, V19, P189, DOI 10.1089/vim.2006.19.189; Wang K, 2008, J VIROL METHODS, V150, P1, DOI 10.1016/j.jviromet.2008.02.014; Wang YP, 2013, VACCINE, V31, P833, DOI 10.1016/j.vaccine.2012.11.062; Zhang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129617	54	16	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147432	10.1371/journal.pone.0147432	http://dx.doi.org/10.1371/journal.pone.0147432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848967	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000017
J	Chen, RC; Tang, XQ; Fan, BL; Liu, JF; Jia, XD; Yang, XG				Chen, Rucheng; Tang, Xiaoqiao; Fan, Bolin; Liu, Jiafa; Jia, Xudong; Yang, Xiaoguang			IgG Expression upon Oral Sensitization in Association with Maternal Exposure to Ovalbumin	PLOS ONE			English	Article							BROWN-NORWAY RAT; FOOD ALLERGY; PEANUT ALLERGY; RISK-FACTOR; MODEL; PROTEINS; ASTHMA; ALLERGENICITY; CHILDHOOD; PREGNANCY	The role of maternal allergen exposure in the allergenicity of the offspring remains controversial. Some studies have shown that maternal exposure is a risk factor for allergy in the offspring, whereas other studies have shown that maternal exposure induces immune tolerance and protects offspring from allergy disease. Therefore, we utilized maternal rat allergen exposure model to evaluate the offspring immune reactions to ovalbumin protein and to determine whether the Brown Norway (BN) rat model is a suitable animal model for studying the allergenicity of food proteins. For three generations, rats received an allergens or nonallergens by gavage during the pregnancy and lactation periods. After weaning, the offspring rats were used for oral sensitization experiment. In the sensitization experiment, the control rat, which had maternal exposure to phosphate-buffered saline (PBS), exhibited full response of IgG to oral exposure to OVA. The IgG level was significantly lower in F1 rats that were sensitized by maternal exposure to ovalbumin(OVA). Moreover, the lowest IgG level was found for the F3b sensitized by maternal rats exposed to OVA allergen for three continuous generations. Compared with maternal OVA exposure prior to postnatal sensitization, the sensitization via maternal PBS led to a higher serum level of OVA-specific IgG. However, the OVA-specific IgG levels for the two generations of maternal PBS exposure prior to postnatal sensitization was not higher than that for the one generation of maternal rats exposed to PBS prior to postnatal sensitization. Our studies demonstrate that maternal OVA exposure during the pregnancy and lactation can affect the results of oral sensitization studies using ovalbumin protein. BN rats must be bred in non-allergen conditions for at least one generation to avoid problems in rat models for studying the allergenicity of food proteins.	[Chen, Rucheng; Tang, Xiaoqiao; Fan, Bolin; Liu, Jiafa] Hubei Prov Ctr Dis Control & Prevent, Hubei Prov Key Lab Appl Toxicol, Wuhan 430079, Hubei, Peoples R China; [Chen, Rucheng] Zhejiang Chinese Med Sch, Coll Basic Med Sci, Hangzhou 310053, Zhejiang, Peoples R China; [Jia, Xudong] China Natl Ctr Food Safety Risk Assessment, Beijing 100021, Peoples R China; [Yang, Xiaoguang] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Beijing 100021, Peoples R China	Zhejiang Chinese Medical University; Chinese Center for Disease Control & Prevention	Fan, BL; Liu, JF (corresponding author), Hubei Prov Ctr Dis Control & Prevent, Hubei Prov Key Lab Appl Toxicol, Wuhan 430079, Hubei, Peoples R China.	vanbolin@163.com; jfllionm@sohu.com			Key Program of Transgenic Plant Breeding, National institute for nutrition and food safety, Chinese center for disease control and prevention [2011ZX08011005, 2014ZX08011005]; Hubei Province's Outstanding Medical Academic Leader Program, Hubei Provincial Key Laboratory for Applied Toxicology, Hubei provincial center for disease control and prevention; Scientific Research Project of Zhejiang Chinese Medical University, College of Basic Medical Science, Zhejiang Chinese Medical School [711200E013, 712223A06001/005/015]	Key Program of Transgenic Plant Breeding, National institute for nutrition and food safety, Chinese center for disease control and prevention; Hubei Province's Outstanding Medical Academic Leader Program, Hubei Provincial Key Laboratory for Applied Toxicology, Hubei provincial center for disease control and prevention; Scientific Research Project of Zhejiang Chinese Medical University, College of Basic Medical Science, Zhejiang Chinese Medical School	The funding of Key Program of Transgenic Plant Breeding (2011ZX08011005,2014ZX08011005), affiliating to National institute for nutrition and food safety, Chinese center for disease control and prevention(XY) played a role in study design and data collection. The funding of Hubei Province's Outstanding Medical Academic Leader Program, affiliating to Hubei Provincial Key Laboratory for Applied Toxicology, Hubei provincial center for disease control and prevention (BF JL), played a role in data analysis and decision to publish. The funding of Scientific Research Project of Zhejiang Chinese Medical University (711200E013,712223A06001/005/015), affiliating to College of Basic Medical Science, Zhejiang Chinese Medical School, played a role in preparation of the manuscript.	Alvarez Pedro A, 2012, J Allergy (Cairo), V2012, P746125, DOI 10.1155/2012/746125; Arshad SH, 2007, J ALLERGY CLIN IMMUN, V119, P307, DOI 10.1016/j.jaci.2006.12.621; Astwood JD, 1996, NAT BIOTECHNOL, V14, P1269, DOI 10.1038/nbt1096-1269; ATKINSON HAC, 1994, TOXICOLOGY, V91, P281, DOI 10.1016/0300-483X(94)90015-9; Atkinson HAC, 1996, FOOD CHEM TOXICOL, V34, P27, DOI 10.1016/0278-6915(95)00084-4; Bergmann RL, 2002, CLIN EXP ALLERGY, V32, P205, DOI 10.1046/j.1365-2222.2002.01274.x; DesRoches A, 2010, J INVEST ALLERG CLIN, V20, P289; Flodrova D, 2015, J SCI FOOD AGR, V95, P983, DOI 10.1002/jsfa.6773; Fox AT, 2009, J ALLERGY CLIN IMMUN, V123, P417, DOI 10.1016/j.jaci.2008.12.014; Gendel SM, 1998, ADV FOOD NUTR RES, V42, P63, DOI 10.1016/S1043-4526(08)60093-5; Gupta RS, 2014, PEDIATRICS, V134, P729, DOI 10.1542/peds.2014-0402; Kimber I, 2003, ENVIRON HEALTH PERSP, V111, P227, DOI 10.1289/ehp.5703; Knippels LMJ, 1999, TOXICOL APPL PHARM, V156, P161, DOI 10.1006/taap.1999.8641; Knippels LMJ, 2000, ALLERGY, V55, P251, DOI 10.1034/j.1398-9995.2000.00403.x; Knippels LMJ, 2003, ENVIRON HEALTH PERSP, V111, P233, DOI 10.1289/ehp.5704; Knippels LMJ, 2002, ANN NY ACAD SCI, V964, P151; Knippels LMJ, 1998, J ALLERGY CLIN IMMUN, V101, P815, DOI 10.1016/S0091-6749(98)70309-4; Knippels LMJ, 1998, CLIN EXP ALLERGY, V28, P368, DOI 10.1046/j.1365-2222.1998.00242.x; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Kull I, 2004, J ALLERGY CLIN IMMUN, V114, P755, DOI 10.1016/j.jaci.2004.07.036; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Ladics GS, 2009, REGUL TOXICOL PHARM, V54, pS2, DOI 10.1016/j.yrtph.2008.10.010; Ladics GS, 2003, TOXICOL SCI, V73, P8, DOI 10.1093/toxsci/kfg055; Lavado R, 2004, TOXICOL APPL PHARM, V196, P247, DOI 10.1016/j.taap.2003.12.012; Li XM, 2001, J ALLERGY CLIN IMMUN, V107, P693, DOI 10.1067/mai.2001.114110; Nestle A., 2011, FOOD ALLERGY; Pilegaard K, 2004, TOXICOLOGY, V196, P247, DOI 10.1016/j.tox.2003.11.010; Polte T, 2008, CLIN EXP ALLERGY, V38, P1950, DOI 10.1111/j.1365-2222.2008.03096.x; Prescott Susan, 2011, Ann Nutr Metab, V59 Suppl 1, P28, DOI 10.1159/000334150; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Sears MR, 2002, LANCET, V360, P901, DOI 10.1016/S0140-6736(02)11025-7; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V126, P1191, DOI 10.1016/j.jaci.2010.08.036; WEIL GJ, 1983, J CLIN INVEST, V71, P1124, DOI 10.1172/JCI110862	33	1	1	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148251	10.1371/journal.pone.0148251	http://dx.doi.org/10.1371/journal.pone.0148251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844775	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800040
J	Feiersinger, F; Nolte, E; Wach, S; Rau, TT; Vassos, N; Geppert, C; Konrad, A; Merkel, S; Taubert, H; Sturzl, M; Croner, RS				Feiersinger, Fabian; Nolte, Elke; Wach, Sven; Rau, Tilman T.; Vassos, Nikolaos; Geppert, Carol; Konrad, Andreas; Merkel, Susanne; Taubert, Helge; Sturzl, Michael; Croner, Roland S.			MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma	PLOS ONE			English	Article							MICRORNA EXPRESSION; INVASION; MIR-21; IDENTIFY; GROWTH; GENES; RNA	Objective Metastasis is the major cause of death in colorectal cancer patients. Expression of certain miRNAs in the primary tumors has been shown to be associated with progression of colorectal cancer and the initiation of metastasis. In this study, we compared miRNA expression in primary colorectal cancer and corresponding liver metastases in order to get an idea of the oncogenic importance of the miRNAs in established metastases. Methods We analyzed the expression of miRNA-21, miRNA-31 and miRNA-373 in corresponding formalin-fixed paraffin-embedded (FFPE) tissue samples of primary colorectal cancer, liver metastasis and healthy tissues of 29 patients by quantitative real-time PCR. Results All three miRNAs were significantly up-regulated in the primary tumor tissues as compared to healthy colon mucosa of the respective patients (p < 0.01). MiRNA-21 and miRNA-31 were also higher expressed in liver metastases as compared to healthy liver tissues (p < 0.01). No significant difference of expression of miRNA-31 and miRNA-373 was observed between primary tumors and metastases. Of note, miRNA-21 expression was significantly reduced in liver metastases as compared to the primary colorectal tumors (p < 0.01). Conclusion In the context of previous studies demonstrating increased miRNA-21 expression in metastatic primary tumors, our findings raise the question whether miRNA-21 might be involved in the initiation but not in the perpetuation and growth of metastases.	[Feiersinger, Fabian; Konrad, Andreas; Sturzl, Michael] Univ Erlangen Nurnberg, Surg Clin, Div Mol & Expt Surg, Schwabachanlage 12, D-91054 Erlangen, Germany; [Nolte, Elke; Wach, Sven; Taubert, Helge] Univ Erlangen Nurnberg, Urol Clin, Krankenhausstr 12, D-91054 Erlangen, Germany; [Rau, Tilman T.; Geppert, Carol] Univ Erlangen Nurnberg, Dept Pathol, Krankenhausstr 12, D-91054 Erlangen, Germany; [Vassos, Nikolaos; Merkel, Susanne; Croner, Roland S.] Univ Erlangen Nurnberg, Surg Clin, Krankenhausstr 12, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Feiersinger, F (corresponding author), Univ Erlangen Nurnberg, Surg Clin, Div Mol & Expt Surg, Schwabachanlage 12, D-91054 Erlangen, Germany.	fabian.feiersinger@uk-erlangen.de	Stürzl, Michael/B-3019-2015	Stürzl, Michael/0000-0002-9276-2824; Merkel, Susanne/0000-0003-2676-9486	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, Polyprobe Study); Deutsche Forschungsgemeinschaft [SFB796, KFO257, DFG 136/2]; German Cancer Aid (Deutsche Krebshilfe) [109510]; Interdisciplinary Center for Clinical Research (IZKF) Erlangen	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, Polyprobe Study)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Interdisciplinary Center for Clinical Research (IZKF) Erlangen	This work was supported by grants (to MS) of the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, Polyprobe Study), the Deutsche Forschungsgemeinschaft [SFB796 (sub-project B9), KFO257 (sub-project 4), DFG 136/2] and the German Cancer Aid (Deutsche Krebshilfe, 109510). Additional support was obtained from the Interdisciplinary Center for Clinical Research (IZKF) Erlangen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Choi SH, 2000, INT J CANCER, V85, P523, DOI 10.1002/(SICI)1097-0215(20000215)85:4<523::AID-IJC13>3.0.CO;2-6; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; de Krijger I, 2011, J PATHOL, V224, P438, DOI 10.1002/path.2922; Drusco A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096670; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kulda V, 2010, CANCER GENET CYTOGEN, V200, P154, DOI 10.1016/j.cancergencyto.2010.04.015; Li Xiaohua, 2011, J Cell Mol Med, V15, P1887, DOI 10.1111/j.1582-4934.2010.01194.x; Liu K, 2011, J INT MED RES, V39, P2288, DOI 10.1177/147323001103900626; Nakano H, 2010, INT J CANCER, V127, P1072, DOI 10.1002/ijc.25143; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Ostalecki C, 2013, EXP MOL PATHOL, V95, P1, DOI 10.1016/j.yexmp.2013.03.008; Schee K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-505; Schetter AJ, 2012, CANCER J, V18, P244, DOI 10.1097/PPO.0b013e318258b78f; Shibuya H, 2010, ONCOLOGY-BASEL, V79, P313, DOI 10.1159/000323283; Tanaka T, 2011, ONCOL REP, V26, P1329, DOI 10.3892/or.2011.1401; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vickers MM, 2012, CLIN EXP METASTAS, V29, P123, DOI 10.1007/s10585-011-9435-3; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023	26	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148580	10.1371/journal.pone.0148580	http://dx.doi.org/10.1371/journal.pone.0148580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845148	Green Published, gold			2022-12-26	WOS:000369552800073
J	Liu, Z; Smagghe, G; Lei, ZR; Wang, JJ				Liu, Zhao; Smagghe, Guy; Lei, Zhongren; Wang, Jin-Jun			Identification of Male- and Female-Specific Olfaction Genes in Antennae of the Oriental Fruit Fly (Bactrocera dorsalis)	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; CANDIDATE CHEMOSENSORY GENES; SOUTHERN HOUSE MOSQUITO; EXPRESSION PROFILES; MOLECULAR CHARACTERIZATION; CHILO-SUPPRESSALIS; TRANSCRIPTOME; RECEPTORS; DIPTERA; ATTRACTION	The oriental fruit fly (Bactrocera dorsalis) is a species of tephritid fruit fly, endemic to Southeast Asia but also introduced to many regions of the US, and it is one of the major pest species with a broad host range of cultivated and wild fruits. Although males of B. dorsalis respond strongly to methyl eugenol and this is used for monitoring and estimating populations, the molecular mechanism of the oriental fruit fly olfaction has not been elucidated yet. Therefore, in this project, using next generation sequencing technologies, we sequenced the transcriptome of the antennae of male and female adults of B. dorsalis. We identified a total of 20 candidate odorant binding proteins (OBPs), 5 candidate chemosensory proteins (CSPs), 35 candidate odorant receptors (ORs), 12 candidate ionotropic receptors (IRs) and 4 candidate sensory neuron membrane proteins (SNMPs). The sex-specific expression of these genes was determined and a subset of 9 OR genes was further characterized by qPCR with male and female antenna, head, thorax, abdomen, leg and wing samples. In the male antennae, 595 genes showed a higher expression, while 128 genes demonstrated a higher expression in the female antennae. Interestingly, 2 ORs (BdorOR13 and BdorOR14) were highly and specifically expressed in the antennae of males, and 4 ORs (BdorOR13, BdorOR16, BdorOR18 and BdorOR35) clustered with DmOR677, suggesting pheromone reception. We believe this study with these antennae-enriched OBPs, CSPs, ORs, IRs and SNMPs can play an important role in the detection of pheromones and general odorants, and so in turn our data improve our current understanding of insect olfaction at the molecular level and provide important information for disrupting the behavior of the oriental fruit fly using chemical communication methods.	[Liu, Zhao; Smagghe, Guy; Wang, Jin-Jun] Southwest Univ, Inst Entomol, Coll Plant Protect, Chongqing 400715, Peoples R China; [Lei, Zhongren] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100086, Peoples R China; [Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium	Southwest University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ghent University	Wang, JJ (corresponding author), Southwest Univ, Inst Entomol, Coll Plant Protect, Chongqing 400715, Peoples R China.; Lei, ZR (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100086, Peoples R China.	leizhr@sina.com; jjwang7008@yahoo.com	Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313	National Natural Science Foundation of China [31201515]; China Postdoctoral Science Foundation [2013M531929]; Research Fund for the Doctoral Program of Higher Education of China [SWU111033]; Special Fund for Agro-scientific Research in the Public Interest of China [201303019]; Natural Science Foundation of Chongqing (CSTC) [2013jjB0176]; Foundation Project of Southwest University [SWU114049]; Fundamental Research Funds for the Central Universities [XDJK2012C080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Special Fund for Agro-scientific Research in the Public Interest of China; Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Foundation Project of Southwest University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was funded in part by the National Natural Science Foundation of China (31201515), the China Postdoctoral Science Foundation (2013M531929), the Research Fund for the Doctoral Program of Higher Education of China (SWU111033), the Special Fund for Agro-scientific Research in the Public Interest of China (201303019), the Natural Science Foundation of Chongqing (CSTC, 2013jjB0176), the Foundation Project of Southwest University (SWU114049), and the Fundamental Research Funds for the Central Universities (XDJK2012C080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; CHRISTENSON LD, 1960, ANNU REV ENTOMOL, V5, P171, DOI 10.1146/annurev.en.05.010160.001131; Cornelius ML, 2000, J ECON ENTOMOL, V93, P93, DOI 10.1603/0022-0493-93.1.93; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dippel S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1141; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Feng B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1375-x; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Geib S M, 2014, BMC GENOMICS, P15; Glaser N, 2013, INT J BIOL SCI, V9, P481, DOI 10.7150/ijbs.6109; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103420; He M, 2014, COMP BIOCHEM PHYS B, V174, P1, DOI 10.1016/j.cbpb.2014.04.008; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hsu JC, 2006, J ECON ENTOMOL, V99, P931, DOI 10.1603/0022-0493-99.3.931; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; Jang EB, 1997, J CHEM ECOL, V23, P1389, DOI 10.1023/B:JOEC.0000006471.46161.8d; Jin T, 2011, PEST MANAG SCI, V67, P370, DOI 10.1002/ps.2076; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Leitch O, 2015, BMC GENOMICS, V16, P17, DOI [10.1186/s12864-015-1216-y, DOI 10.1186/S12864-015-1216-Y]; Li ZQ, 2015, COMP BIOCHEM PHYS D, V15, P28, DOI 10.1016/j.cbd.2015.05.002; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Liu S, 2015, COMP BIOCHEM PHYS D, V13, P44, DOI 10.1016/j.cbd.2015.01.004; Liu S, 2015, J ASIA-PAC ENTOMOL, V18, P99, DOI 10.1016/j.aspen.2014.12.006; Liu S, 2013, ANN ENTOMOL SOC AM, V106, P378, DOI 10.1603/AN12099; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Ma L, 2014, J INSECT PHYSIOL, V60, P118, DOI 10.1016/j.jinsphys.2013.11.007; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; OEPP/EPPO, 1983, BULLETIN OEPP EPPO B, P13; Pelletier J, 2011, J INSECT PHYSIOL, V57, P915, DOI 10.1016/j.jinsphys.2011.04.003; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Siderhurst MS, 2006, J CHEM ECOL, V32, P2513, DOI 10.1007/s10886-006-9160-6; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Stengl M, 2013, J COMP PHYSIOL A, V199, P897, DOI 10.1007/s00359-013-0837-3; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Taylor AJ, 2008, CHEMOSENS PERCEPT, V1, P153, DOI 10.1007/s12078-008-9016-2; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Yan SW, 2015, J INSECT PHYSIOL, V79, P36, DOI 10.1016/j.jinsphys.2015.06.002; Yi X, 2014, J CHEM ECOL, V40, P267, DOI 10.1007/s10886-014-0406-4; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077295; Zhang J, 2015, PLOS ONE, V10, P26; Zhang SF, 2014, INSECT BIOCHEM MOLEC, V52, P69, DOI 10.1016/j.ibmb.2014.06.006; Zhang T T, 2015, PLOS ONE, V10, P22; Zheng WW, 2013, INT J MOL SCI, V14, P14936, DOI 10.3390/ijms140714936; Zheng WW, 2012, J INSECT PHYSIOL, V58, P1122, DOI 10.1016/j.jinsphys.2012.05.011; Zhou CX, 2015, COMP BIOCHEM PHYS D, V16, P10, DOI 10.1016/j.cbd.2015.06.003; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007	66	45	51	8	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147783	10.1371/journal.pone.0147783	http://dx.doi.org/10.1371/journal.pone.0147783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845547	Green Published, gold			2022-12-26	WOS:000369552800016
J	Mao, S; Yang, G; Li, W; Zhang, J; Liang, HL; Li, J; Zhang, MZ				Mao, Shuai; Yang, Guang; Li, Winny; Zhang, Jian; Liang, Hailong; Li, Jian; Zhang, Minzhou			Gastroprotective Effects of Astragaloside IV against Acute Gastric Lesion in Rats	PLOS ONE			English	Article							HELICOBACTER-PYLORI; CALCIUM; OVEREXPRESSION; PROSTAGLANDINS; PREVENTION; PROTECTION; APOPTOSIS; ISCHEMIA; EXTRACTS; ETHANOL	Background Protection of the gastric mucosa from acute lesions induced by various irritants is a pertinent issue in the field of critical care medicine. In this study, we investigated the gastroprotective effects of astragaloside IV on acute gastric lesions in rats under stressful conditions. Methods Rats were randomized into six groups. Group 1 and 2 received 10% Tween 80 (vehicle). Group 3 received 20 mg/kg of omeprazole, a proton pump inhibitor. Groups 4, 5 and 6 received astragaloside IV at concentration of 1, 10, and 50 mg/kg, respectively. As a means to induce gastric lesions, Groups 2-6 were subjected to water immersion and restraint stress for 12 hours after treatment. Results Our present studies show that compared to rats in group 2, treatment with 1 to 50 mg/kg astragaloside IV significantly decreased the size of gastric lesions, MDA, TNF alpha and MCP1 levels, in addition to normalizing gastric pH, gastric mucus and SOD levels (P<0.05). Histomorphological examination confirmed that treatment with astragaloside IV elicited a dosage-dependent protective effect on the gastric mucosa. Furthermore, pretreatment with astragaloside IV resulted in significant elevations in HSP70 and reduction in Bax, along with over-expression of PLC. response level, which was further confirmed via immunohistochemical analysis. Conclusions The acute gastric lesions induced are attenuated by pretreatment with astragaloside IV which is possibly due to the enhancing of the expression of HSP70 with concomitant antioxidant, anti-inflammatory and anti-apoptotic capacity.	[Mao, Shuai; Yang, Guang; Zhang, Jian; Liang, Hailong; Li, Jian; Zhang, Minzhou] Guangdong Prov Hosp Chinese Med, Dept Crit Care Med, Rd Dade, Guangzhou 510120, Guangdong, Peoples R China; [Mao, Shuai; Yang, Guang; Zhang, Jian; Liang, Hailong; Li, Jian; Zhang, Minzhou] Guangzhou Univ Chinese Med, Clin Med Coll 2, Rd Jichang, Guangzhou 510405, Guangdong, Peoples R China; [Li, Winny] Univ Toronto, Fac Med, Univ Ave, Toronto, ON M5G 0A4, Canada; [Mao, Shuai] Hosp Sick Children, Physiol & Expt Med, Toronto, ON M5G 0A4, Canada	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Zhang, MZ (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Crit Care Med, Rd Dade, Guangzhou 510120, Guangdong, Peoples R China.	minzhouzhang@yeah.net			Postdoctoral Science Foundation of China [2015M570701]; Science Foundation from Department of Science and Technology of Guangdong Province [S2012010010397, [2013] 137168]	Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Science Foundation from Department of Science and Technology of Guangdong Province	This work was financially supported by Postdoctoral Science Foundation of China (NO. 2015M570701), Science Foundation from Department of Science and Technology of Guangdong Province (NO. S2012010010397 & NO. [2013] 137168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2008, INT J MED MUSHROOMS, V10, P325, DOI 10.1615/IntJMedMushr.v10.i4.40; Abdulla MA, 2010, AFR J PHARM PHARMACO, V4, P226; Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004; AlRashdi AS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/786426; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; Brzozowski T, 1997, J PINEAL RES, V23, P79, DOI 10.1111/j.1600-079X.1997.tb00339.x; Brzozowski T, 2000, EUR J PHARMACOL, V398, P147, DOI 10.1016/S0014-2999(00)00287-9; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601; Gao XH, 2009, J NAT MED-TOKYO, V63, P421, DOI 10.1007/s11418-009-0348-2; Golbabapour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075036; Golbabapour S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/974185; Gui DK, 2013, CYTOKINE, V61, P970, DOI 10.1016/j.cyto.2013.01.008; Huang LF, 2012, FITOTERAPIA, V83, P1514, DOI 10.1016/j.fitote.2012.08.019; Hwang JY, 2008, AM J PATHOL, V173, P1919, DOI 10.2353/ajpath.2008.070875; Ismail IF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/404012; Kang HJ, 2003, MOL PHARMACOL, V64, P228, DOI 10.1124/mol.64.2.228; KAUFFMAN GL, 1978, GASTROENTEROLOGY, V75, P1099; Kwiecien S, 2002, J PHYSIOL PHARMACOL, V53, P39; Matsuda M, 2010, J BIOL CHEM, V285, P5848, DOI 10.1074/jbc.M109.063453; Metz DC, 2005, CURR MED RES OPIN, V21, P11, DOI 10.1185/030079905X16777; Mizushima T, 2014, CURR OPIN PHARMACOL, V19, pR1, DOI 10.1016/j.coph.2014.10.006; Nartey ET, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-65; Nassar NN, 2011, WORLD J GASTROENTERO, V17, P1135, DOI 10.3748/wjg.v17.i9.1135; Navarrete A, 2005, J PHARM PHARMACOL, V57, P1059, DOI 10.1211/0022357056659; Nguelefack TB, 2008, J ETHNOPHARMACOL, V119, P135, DOI 10.1016/j.jep.2008.06.008; Padol S, 2006, AM J GASTROENTEROL, V101, P1467, DOI 10.1111/j.1572-0241.2006.00717.x; Patterson RL, 2005, TRENDS BIOCHEM SCI, V30, P688, DOI 10.1016/j.tibs.2005.10.005; Qiu LH, 2010, BIOL PHARM BULL, V33, P641, DOI 10.1248/bpb.33.641; Shah A. H., 2014, Biology and Medicine, V6, P1000197; Sofidiya MO, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-168; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Targa AC, 2007, GENET MOL RES, V6, P554; Zhou RN, 2012, DRUG METAB PHARMACOK, V27, P586, DOI 10.2133/dmpk.DMPK-11-RG-160	34	7	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148146	10.1371/journal.pone.0148146	http://dx.doi.org/10.1371/journal.pone.0148146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845156	Green Published, Green Submitted, gold			2022-12-26	WOS:000369552800033
J	Cabrita, MA; Vanzyl, EJ; Hamill, JD; Pan, E; Marcellus, KA; Tolls, VJ; Alonzi, RC; Pastic, A; Rambo, TME; Sayed, H; McKay, BC				Cabrita, Miguel A.; Vanzyl, Erin J.; Hamill, Jeff D.; Pan, Elysia; Marcellus, Kristen A.; Tolls, Victoria J.; Alonzi, Rhea C.; Pastic, Alyssa; Rambo, Teeghan M. E.; Sayed, Hadil; McKay, Bruce C.			A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing	PLOS ONE			English	Article							CELL-CYCLE ARREST; TARGETING C-MYC; TUMOR-SUPPRESSOR; DNA-DAMAGE; COLORECTAL-CANCER; TRANSCRIPTIONAL REPRESSION; MIR-34A CONTRIBUTES; APOPTOSIS; PROTEIN; NETWORK	The p53 tumour suppressor is a transcription factor that can regulate the expression of numerous genes including many encoding proteins and microRNAs (miRNAs). The predominant outcomes of a typical p53 response are the initiation of apoptotic cascades and the activation of cell cycle checkpoints. HT29-tsp53 cells express a temperature sensitive variant of p53 and in the absence of exogenous DNA damage, these cells preferentially undergo G(1) phase cell cycle arrest at the permissive temperature that correlates with increased expression of the cyclin-dependent kinase inhibitor p21(WAF1). Recent evidence also suggests that a variety of miRNAs can induce G(1) arrest by inhibiting the expression of proteins like CDK4 and CDK6. Here we used oligonucleotide microarrays to identify p53-regulated miRNAs that are induced in these cells undergoing G(1) arrest. At the permissive temperature, the expression of several miRNAs was increased through a combination of either transcriptional or post-transcriptional regulation. In particular, miR-34a-5p, miR-143-3p and miR-145-5p were strongly induced and they reached levels comparable to that of reference miRNAs (miR-191 and miR-103). Importantly, miR-34a-5p and miR-145-5p are known to silence the Cdk4 and/or Cdk6 G(1) cyclin-dependent kinases (cdks). Surprisingly, there was no p53-dependent decrease in the expression of either of these G(1) cdks. To search for other potential targets of p53-regulated miRNAs, p53-downregulated mRNAs were identified through parallel microarray analysis of mRNA expression. Once again, there was no clear effect of p53 on the repression of mRNAs under these conditions despite a remarkable increase in p53-induced mRNA expression. Therefore, despite a strong p53 transcriptional response, there was no clear evidence that p53-responsive miRNA contributed to gene silencing. Taken together, the changes in cell cycle distribution in this cell line at the permissive temperature is likely attributable to transcriptional upregulation of the CDKN1A mRNA and p21(WAF1) protein and not to the down regulation of CDK4 or CDK6 by p53-regulated miRNAs.	[Cabrita, Miguel A.; Hamill, Jeff D.; Pan, Elysia; Marcellus, Kristen A.; McKay, Bruce C.] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Vanzyl, Erin J.; Tolls, Victoria J.; Pastic, Alyssa; Rambo, Teeghan M. E.; Sayed, Hadil; McKay, Bruce C.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Alonzi, Rhea C.; McKay, Bruce C.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada	University of Ottawa; Ottawa Hospital Research Institute; Carleton University; Carleton University	McKay, BC (corresponding author), Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	bruce_mckay@carleton.ca	McKay, Bruce C/I-4081-2013	McKay, Bruce C/0000-0002-7921-1331	Carleton University Dean's Summer Research Internship Awards; Carleton University I-CUREUS award; Carleton University; Canadian Institutes of Health Research [69031]; National Sciences and Engineering Council of Canada [RGPIN 2014-03645]	Carleton University Dean's Summer Research Internship Awards; Carleton University I-CUREUS award; Carleton University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We would also like to acknowledge the assistance of Microarray Core Facility of StemCore Laboratories at the Ottawa Hospital Research Institute. E.V., T.R. and H.S. were recipients of Carleton University Dean's Summer Research Internship Awards and E.V. was a recipient of a Carleton University I-CUREUS award.; This work was supported with funds from Carleton University to BCM., Canadian Institutes of Health Research to BCM. (Grant# 69031, http://www.cihr-irsc.gc.ca/e/193.html), National Sciences and Engineering Council of Canada (RGPIN 2014-03645, http://www.nserc-crsng.gc.ca/index_eng.asp) to BCM. EJV, TMER and HS were recipients of Carleton University Dean's Summer Research Internship Awards. EJV was a recipient of a Carleton University I-CUREUS award.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Bohlig L, 2011, NUCLEIC ACIDS RES, V39, P440, DOI 10.1093/nar/gkq796; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chen Z, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-151; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; EWEN ME, 1995, GENE DEV, V9, P204, DOI 10.1101/gad.9.2.204; GANNON JV, 1991, NATURE, V349, P802; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hattori H, 2014, CELL CYCLE, V13, P2572, DOI 10.4161/15384101.2015.942209; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; KASTAN MB, 1993, ENVIRON HEALTH PERSP, V101, P55, DOI 10.2307/3431842; KASTAN MB, 1991, CANCER RES, V51, P6304; Kozomara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104286; Krol J, NATURE REV, V11, P597; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552; Li BQ, 2001, J BIOL CHEM, V276, P29729, DOI 10.1074/jbc.M101167200; Mayya VK, 2015, NUCLEIC ACIDS RES, V43, P7556, DOI 10.1093/nar/gkv720; McKay BC, 2000, MOL BIOL CELL, V11, P2543, DOI 10.1091/mbc.11.8.2543; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; Melanson BD, 2011, RNA, V17, P2222, DOI 10.1261/rna.030122.111; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Merchant AK, 1996, ONCOGENE, V13, P2631; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinn JL, 2011, TRENDS CELL BIOL, V21, P344, DOI 10.1016/j.tcb.2011.04.002; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Sanchez-Martinez C, 2015, BIOORG MED CHEM LETT, V25, P3420, DOI 10.1016/j.bmcl.2015.05.100; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shen K, 2014, FEBS J, V281, P3609, DOI 10.1111/febs.12880; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Stubbert LJ, 2007, CELL CYCLE, V6, P1730, DOI 10.4161/cc.6.14.4427; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Villadsen SB, 2012, BRIT J CANCER, V106, P366, DOI 10.1038/bjc.2011.520; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang B, 2010, CELL CYCLE, V9, P870, DOI 10.4161/cc.9.5.10825; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Yamamura S, 2012, CARCINOGENESIS, V33, P294, DOI 10.1093/carcin/bgr286; Younger ST, 2015, NUCLEIC ACIDS RES, V43, P4447, DOI 10.1093/nar/gkv284; Zhang H, ONCOLOGY REPORTS, V24, P1363; Zhang XF, 2015, ONCOTARGET, V6, P4144, DOI 10.18632/oncotarget.2864; Zhao RB, 2000, GENE DEV, V14, P981	62	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148529	10.1371/journal.pone.0148529	http://dx.doi.org/10.1371/journal.pone.0148529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840126	gold, Green Submitted, Green Published			2022-12-26	WOS:000369550200145
J	Gossner, MM; Struwe, JF; Sturm, S; Max, S; McCutcheon, M; Weisser, WW; Zytynska, SE				Gossner, Martin M.; Struwe, Jan-Frederic; Sturm, Sarah; Max, Simeon; McCutcheon, Michelle; Weisser, Wolfgang W.; Zytynska, Sharon E.			Searching for the Optimal Sampling Solution: Variation in Invertebrate Communities, Sample Condition and DNA Quality	PLOS ONE			English	Article							FLIGHT-INTERCEPTION TRAPS; DEAD WOOD; VERTICAL STRATIFICATION; ARTHROPOD COMMUNITIES; BEETLES COLEOPTERA; SPECIES RICHNESS; EUROPEAN BEECH; PITFALL TRAPS; NORWAY SPRUCE; FOREST FLOOR	There is a great demand for standardising biodiversity assessments in order to allow optimal comparison across research groups. For invertebrates, pitfall or flight-interception traps are commonly used, but sampling solution differs widely between studies, which could influence the communities collected and affect sample processing (morphological or genetic). We assessed arthropod communities with flight-interception traps using three commonly used sampling solutions across two forest types and two vertical strata. We first considered the effect of sampling solution and its interaction with forest type, vertical stratum, and position of sampling jar at the trap on sample condition and community composition. We found that samples collected in copper sulphate were more mouldy and fragmented relative to other solutions which might impair morphological identification, but condition depended on forest type, trap type and the position of the jar. Community composition, based on order-level identification, did not differ across sampling solutions and only varied with forest type and vertical stratum. Species richness and species-level community composition, however, differed greatly among sampling solutions. Renner solution was highly attractant for beetles and repellent for true bugs. Secondly, we tested whether sampling solution affects subsequent molecular analyses and found that DNA barcoding success was species-specific. Samples from copper sulphate produced the fewest successful DNA sequences for genetic identification, and since DNA yield or quality was not particularly reduced in these samples additional interactions between the solution and DNA must also be occurring. Our results show that the choice of sampling solution should be an important consideration in biodiversity studies. Due to the potential bias towards or against certain species by Ethanol-containing sampling solution we suggest ethylene glycol as a suitable sampling solution when genetic analysis tools are to be used and copper sulphate when focusing on morphological species identification and facing financial restrictions in biodiversity studies.	[Gossner, Martin M.; Sturm, Sarah; Max, Simeon; McCutcheon, Michelle; Weisser, Wolfgang W.; Zytynska, Sharon E.] Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, Sch Life Sci Weihenstephan, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany; [Struwe, Jan-Frederic] Zool Res Museum Alexander Koenig, Adenauerallee 160-162, D-53113 Bonn, Germany	Technical University of Munich; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Gossner, MM (corresponding author), Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, Sch Life Sci Weihenstephan, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany.	martin.gossner@tum.de	Zytynska, Sharon/C-9089-2011; Gossner, Martin M./J-2730-2015; Weisser, Wolfgang W/B-9718-2014	Zytynska, Sharon/0000-0002-0174-3303; Gossner, Martin M./0000-0003-1516-6364; Weisser, Wolfgang W/0000-0002-2757-8959	DFG [1374, WE 3081/19-1, WE 3081/21-1]; German Research Foundation (DFG); Technische Universitat Munchen	DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	The work has been partly funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (WE 3081/19-1, WE 3081/21-1) (www.exploratories.de). In addition, it was supported by the German Research Foundation (DFG; www.dfg.de) and the Technische Universitat Munchen within the funding programme Open Access Publishing (http://www.ub.tum.de/open-access-publikationsfonds-der-tum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A'Hara S, 1998, J ARACHNOL, V26, P397; AATI, 2012, GDNA AN FRAGM AN AUT, P2; Ammer U, 2003, FAUNISTISCH OKOLOGIS, V8, P297; Ammer Ulrich, 2008, P531; Basset Y., 1997, P27; Bisanti M, 2009, ENTOMOL EXP APPL, V130, P290, DOI 10.1111/j.1570-7458.2008.00821.x; Bouget C, 2009, AGR FOREST ENTOMOL, V11, P143, DOI 10.1111/j.1461-9563.2008.00400.x; Bouget C, 2011, FOREST ECOL MANAG, V261, P211, DOI 10.1016/j.foreco.2010.10.007; Byers JA, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P89; BYERS JA, 1992, J CHEM ECOL, V18, P2385, DOI 10.1007/BF00984957; Cardoso P, 2009, BIODIVERS CONSERV, V18, P3949, DOI 10.1007/s10531-009-9690-7; Cervantes-Cervantes MP, 2005, BIOL TRACE ELEM RES, V103, P229, DOI 10.1385/BTER:103:3:229; Darriet P, 2001, VITIS, V40, P93; Dillon N, 1996, INSECT MOL BIOL, V5, P21, DOI 10.1111/j.1365-2583.1996.tb00036.x; Doledec S, 1996, ENVIRON ECOL STAT, V3, P143, DOI 10.1007/BF02427859; Dorow W, 2010, FORSTARCHIV, V8, P61; Dray S, 2014, ECOLOGY, V95, P14, DOI 10.1890/13-0196.1; Dray S, 2008, ECOLOGY, V89, P3400, DOI 10.1890/08-0349.1; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fountain-Jones NM, 2015, ECOL ENTOMOL, V40, P1, DOI 10.1111/een.12158; Gossner M, 2006, EUR J FOREST RES, V125, P345, DOI 10.1007/s10342-006-0126-6; Gossner M, 2006, EUR J FOREST RES, V125, P221, DOI 10.1007/s10342-006-0113-y; Gossner Martin, 2008, P119; Gossner MM, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00177.1; Gossner MM, 2014, BIODIVERS CONSERV, V23, P945, DOI 10.1007/s10531-014-0644-3; Gossner MM, 2013, FOREST ECOL MANAG, V302, P404, DOI 10.1016/j.foreco.2013.03.039; Gossner MM, 2009, EUR J ENTOMOL, V106, P241, DOI 10.14411/eje.2009.032; Gossner MM, 2009, AM NAT, V173, P599, DOI 10.1086/597603; GRAHAM K, 1968, CAN J ZOOLOG, V46, P905, DOI 10.1139/z68-127; Grimbacher PS, 2007, AUSTRAL ECOL, V32, P77, DOI 10.1111/j.1442-9993.2007.01735.x; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hardy S, 2007, PRIMEFACT, V757, P1; Hendrich L, 2015, MOL ECOL RESOUR, V15, P795, DOI 10.1111/1755-0998.12354; Hessenmoller D., 2011, Forstarchiv, V82, P171; Hill D., 2005, HDB BIODIVERSITY MET, DOI DOI 10.1017/CBO9780511542084; Hoefer Hubert, 2015, Arachnologische Mitteilungen, P30, DOI 10.5431/aramit5005; Holopainen J.K., 1990, P339; HOLOPAINEN JK, 1992, PEDOBIOLOGIA, V36, P257; Hribik M, 2012, J HYDROL HYDROMECH, V60, P319, DOI 10.2478/v10098-012-0028-x; Jose GP, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-9; Jud P, 2008, ENTOMOL EXP APPL, V129, P356, DOI 10.1111/j.1570-7458.2008.00773.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kohler F, 2000, RECKLINGHAUSEN LANDE; Koivula M, 2003, ENTOMOL FENNICA, V14, P1; Kowalski E, 2011, ENTOMOL EXP APPL, V140, P35, DOI 10.1111/j.1570-7458.2011.01134.x; Lamarre GPA, 2012, ZOOKEYS, P43, DOI 10.3897/zookeys.216.3332; Lange M, 2011, METHODS ECOL EVOL, V2, P185, DOI 10.1111/j.2041-210X.2010.00062.x; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lloyd DR, 1999, MUTAT RES-FUND MOL M, V424, P23, DOI 10.1016/S0027-5107(99)00005-6; Maguire DY, 2014, ENVIRON ENTOMOL, V43, P9, DOI 10.1603/EN13056; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; McCravy Kenneth W., 2007, Great Lakes Entomologist, V40, P154; Muller J, 2015, ECOGRAPHY, V38, P499, DOI 10.1111/ecog.00908; Muller J, 2010, BIOL CONSERV, V143, P625, DOI 10.1016/j.biocon.2009.11.027; Obrist MK, 2010, BIODIVERS CONSERV, V19, P2201, DOI 10.1007/s10531-010-9832-y; Oertli B, 2005, AQUAT CONSERV, V15, P665, DOI 10.1002/aqc.744; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Parker Geoffrey G., 1995, P73; Pinheiro J, 2020, R PACKAGE VERSION 31; Plachter H, 2003, ENTWICKLUNG FESTLEGU; Pokluda P, 2014, EUR J ENTOMOL, V111, P175, DOI 10.14411/eje.2014.024; R Core Team, 2021, R LANGUAGE ENV STAT; Ranius T, 2011, BIODIVERS CONSERV, V20, P2903, DOI 10.1007/s10531-011-0124-y; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Renner, 1982, FAUNISTISCH OKOLOGIS, V5, P137; Roder J, 2010, FOREST ECOL MANAG, V259, P1513, DOI 10.1016/j.foreco.2010.01.027; Scherber C, 2014, OECOLOGIA, V174, P1387, DOI 10.1007/s00442-013-2865-7; Schmidl Juergen, 2004, Naturschutz und Landschaftsplanung, V36, P202; Schmidt MH, 2006, J ARACHNOL, V34, P159, DOI 10.1636/T04-95.1; Sereda E, 2014, J ARACHNOL, V42, P44, DOI 10.1636/P13-16.1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Sobek S, 2009, ECOL ENTOMOL, V34, P772, DOI 10.1111/j.1365-2311.2009.01132.x; Sobek S, 2009, DIVERS DISTRIB, V15, P660, DOI 10.1111/j.1472-4642.2009.00570.x; Speight M.C.D., 1989, Council of Europe Nature and Environment Series, P1; Stoeckle BC, 2010, ENTOMOL EXP APPL, V135, P217, DOI 10.1111/j.1570-7458.2010.00977.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Szinwelski N, 2012, ZOOKEYS, P11, DOI 10.3897/zookeys.196.3130; TEVIOTDALE B L, 1989, California Agriculture, V43, P30; TKESHELASHVILI LK, 1991, J BIOL CHEM, V266, P6401; Vialatte A, 2010, P ROY SOC B-BIOL SCI, V277, P2227, DOI 10.1098/rspb.2010.0365; Vink CJ, 2005, INVERTEBR SYST, V19, P99, DOI 10.1071/IS04039; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Weeks RD, 1997, ENTOMOL EXP APPL, V82, P267, DOI 10.1046/j.1570-7458.1997.00140.x; Zehetmair T, 2015, INSECT CONSERV DIVER, V8, P193, DOI 10.1111/icad.12101; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	92	6	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148247	10.1371/journal.pone.0148247	http://dx.doi.org/10.1371/journal.pone.0148247			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840598	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200110
J	Saez, I; Friedlander, MJ				Saez, Ignacio; Friedlander, Michael J.			Role of GABA(A)-Mediated Inhibition and Functional Assortment of Synapses onto Individual Layer 4 Neurons in Regulating Plasticity Expression in Visual Cortex	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DEPENDENT SYNAPTIC PLASTICITY; OCULAR DOMINANCE; MONOCULAR DEPRIVATION; CRITICAL-PERIOD; EXPERIENCE; DEPRESSION; SIGN; CAT; INNERVATION	Layer 4 (L4) of primary visual cortex (V1) is the main recipient of thalamocortical fibers from the dorsal lateral geniculate nucleus (LGN(d)). Thus, it is considered the main entry point of visual information into the neocortex and the first anatomical opportunity for intracortical visual processing before information leaves L4 and reaches supra-and infragranular cortical layers. The strength of monosynaptic connections from individual L4 excitatory cells onto adjacent L4 cells (unitary connections) is highly malleable, demonstrating that the initial stage of intracortical synaptic transmission of thalamocortical information can be altered by previous activity. However, the inhibitory network within L4 of V1 may act as an internal gate for induction of excitatory synaptic plasticity, thus providing either high fidelity throughput to supragranular layers or transmittal of a modified signal subject to recent activitydependent plasticity. To evaluate this possibility, we compared the induction of synaptic plasticity using classical extracellular stimulation protocols that recruit a combination of excitatory and inhibitory synapses with stimulation of a single excitatory neuron onto a L4 cell. In order to induce plasticity, we paired pre-and postsynaptic activity (with the onset of postsynaptic spiking leading the presynaptic activation by 10ms) using extracellular stimulation (ECS) in acute slices of primary visual cortex and comparing the outcomes with our previously published results in which an identical protocol was used to induce synaptic plasticity between individual pre-and postsynaptic L4 excitatory neurons. Our results indicate that pairing of ECS with spiking in a L4 neuron fails to induce plasticity in L4-L4 connections if synaptic inhibition is intact. However, application of a similar pairing protocol under GABA(A)Rs inhibition by bath application of 2 mu M bicuculline does induce robust synaptic plasticity, long term potentiation (LTP) or long term depression (LTD), similar to our results with pairing of pre-and postsynaptic activation between individual excitatory L4 neurons in which inhibitory connections are not activated. These results are consistent with the wellestablished observation that inhibition limits the capacity for induction of plasticity at excitatory synapses and that pre-and postsynaptic activation at a fixed time interval can result in a variable range of plasticity outcomes. However, in the current study by virtue of having two sets of experimental data, we have provided a new insight into these processes. By randomly mixing the assorting of individual L4 neurons according to the frequency distribution of the experimentally determined plasticity outcome distribution based on the calculated convergence of multiple individual L4 neurons onto a single postsynaptic L4 neuron, we were able to compare then actual ECS plasticity outcomes to those predicted by randomly mixing individual pairs of neurons. Interestingly, the observed plasticity profiles with ECS cannot account for the random assortment of plasticity behaviors of synaptic connections between individual cell pairs. These results suggest that connections impinging onto a single postsynaptic cell may be grouped according to plasticity states.	[Saez, Ignacio; Friedlander, Michael J.] Virginia Tech Carill Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA; [Saez, Ignacio] Univ Calif Berkeley, Hellen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Friedlander, MJ (corresponding author), Virginia Tech Carill Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA.	friedlan@vtc.vt.edu		Saez, Ignacio/0000-0003-0651-2069	NIH [EY12782]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH grant EY12782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aton SJ, 2013, P NATL ACAD SCI USA, V110, P3101, DOI 10.1073/pnas.1208093110; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Campanac E, 2008, J PHYSIOL-LONDON, V586, P779, DOI 10.1113/jphysiol.2007.147017; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; DEWS PB, 1970, J PHYSIOL-LONDON, V206, P437, DOI 10.1113/jphysiol.1970.sp009023; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; FRIEDLANDER MJ, 1989, J PHYSIOL-LONDON, V416, P183, DOI 10.1113/jphysiol.1989.sp017756; FRIEDLANDER MJ, 1991, J NEUROSCI, V11, P3268; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Hardingham NR, 2007, J NEUROPHYSIOL, V97, P2965, DOI 10.1152/jn.01352.2006; Hirsch JA, 2006, CURR OPIN NEUROBIOL, V16, P377, DOI 10.1016/j.conb.2006.06.014; Ismailov I, 2004, J NEUROSCI, V24, P9847, DOI 10.1523/JNEUROSCI.0738-04.2004; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; Lefort S, 2013, P NATL ACAD SCI USA, V110, pE4540, DOI 10.1073/pnas.1319571110; Li W, 2008, NEURON, V57, P442, DOI 10.1016/j.neuron.2007.12.011; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Martin KAC, 2002, CURR OPIN NEUROBIOL, V12, P418, DOI 10.1016/S0959-4388(02)00343-4; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Owens DF, 1996, J NEUROSCI, V16, P6414; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Rozas C, 2001, DEV INHIBITORY GATE; Saez I, 2009, J NEUROSCI, V29, P15286, DOI 10.1523/JNEUROSCI.2980-09.2009; Saez I, 2009, J NEUROSCI, V29, P4930, DOI 10.1523/JNEUROSCI.0046-09.2009; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Wang L, 2014, J NEUROSCI, V34, P1083, DOI 10.1523/JNEUROSCI.4711-13.2014; Wang L, 2012, J NEUROSCI, V32, P10562, DOI 10.1523/JNEUROSCI.0622-12.2012	45	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147642	10.1371/journal.pone.0147642	http://dx.doi.org/10.1371/journal.pone.0147642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841221	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200051
J	Zhao, X; Vazquez-Gutierrez, JL; Johansson, DP; Landberg, R; Langton, M				Zhao, Xue; Vazquez-Gutierrez, Jose Luis; Johansson, Daniel P.; Landberg, Rikard; Langton, Maud			Yellow Mealworm Protein for Food Purposes - Extraction and Functional Properties	PLOS ONE			English	Article							NUTRIENT COMPOSITION; GELATION PROPERTIES; OIL; INSECTS; FEED	A protocol for extraction of yellow mealworm larvae proteins was established, conditions were evaluated and the resulting protein extract was characterised. The freeze-dried yellow mealworm larvae contained around 33% fat, 51% crude protein and 43% true protein on a dry matter basis. The true protein content of the protein extract was about 75%, with an extraction rate of 70% under optimised extraction conditions using 0.25 M NaOH, a NaOH solution: ethanol defatted worm ratio of 15: 1 mL/g, 40 degrees C for 1 h and extraction twice. The protein extract was a good source of essential amino acids. The lowest protein solubility in distilled water solution was found between pH 4 and 5, and increased with either increasing or decreasing pH. Lower solubility was observed in 0.5 M NaCl solution compared with distilled water. The rheological tests indicated that temperature, sample concentration, addition of salt and enzyme, incubation time and pH alterations influenced the elastic modulus of yellow mealworm protein extract (YMPE). These results demonstrate that the functional properties of YMPE can be modified for different food applications.	[Zhao, Xue; Vazquez-Gutierrez, Jose Luis; Johansson, Daniel P.; Landberg, Rikard; Langton, Maud] Swedish Univ Agr Sci, Dept Food Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences	Zhao, X (corresponding author), Swedish Univ Agr Sci, Dept Food Sci, Uppsala, Sweden.	xue.zhao@slu.se	Vázquez-Gutiérrez, José L./M-6510-2015; Zhao, Xue/E-7033-2017	Vázquez-Gutiérrez, José L./0000-0003-1493-5539; Zhao, Xue/0000-0002-0211-3549; Langton, Maud/0000-0003-1565-6996; Johansson, Daniel/0000-0002-9677-8233	Swedish University of Agricultural Sciences; Swedish research council Formas; Swedish research council VR	Swedish University of Agricultural Sciences; Swedish research council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish research council VR(Swedish Research Council)	The project was financially supported by Strategic research funding for young research leaders from Swedish University of Agricultural Sciences and salary of RL was funded by grants from the Swedish research council Formas and VR.	Aguilera JM, 2005, J FOOD ENG, V67, P3, DOI 10.1016/j.jfoodeng.2004.05.050; ALKAHTANI HA, 1993, CEREAL CHEM, V70, P619; AOAC, 1990, OFF METH AN ASS AN C; Azadmard-Damirchi S, 2008, J AM OIL CHEM SOC, V85, P13, DOI 10.1007/s11746-007-1170-1; Barker D, 1998, ZOO BIOL, V17, P123, DOI 10.1002/(SICI)1098-2361(1998)17:2&lt;123::AID-ZOO7&gt;3.0.CO;2-B; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Damodaran S., 1997, FOOD PROTEINS THEIR; FAO, 2013, REP FAO EXP CONS, P27; Ferreira-Dias S, 2003, GRASAS ACEITES, V54, P378; Finke MD, 2007, ZOO BIOL, V26, P105, DOI 10.1002/zoo.20123; Finke MD, 2015, ZOO BIOL, V34, P554, DOI 10.1002/zoo.21246; Finke MD, 2002, ZOO BIOL, V21, P269, DOI 10.1002/zoo.10031; FINKEL AJ, 1948, PHYSIOL ZOOL, V21, P111, DOI 10.1086/physzool.21.2.30151989; Gauche C, 2010, LWT-FOOD SCI TECHNOL, V43, P214, DOI 10.1016/j.lwt.2009.08.009; GOULET G, 1978, NUTR REP INT, V18, P11; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Jones LD, 1972, J ZOO ANIM MED, V3, P34, DOI DOI 10.2307/20094161; Kwiatkowski JR, 2002, J AM OIL CHEM SOC, V79, P825, DOI 10.1007/s11746-002-0565-8; L'Hocine L, 2006, J FOOD SCI, V71, pC137, DOI 10.1111/j.1365-2621.2006.tb15609.x; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; LIN MJY, 1974, J FOOD SCI, V39, P368, DOI 10.1111/j.1365-2621.1974.tb02896.x; LIU HJ, 1995, J AOAC INT, V78, P736; Liu LH, 1998, J FOOD SCI, V63, P331; Lopez-Sanchez P, 2011, J SCI FOOD AGR, V91, P207, DOI 10.1002/jsfa.4168; Naik A, 2012, APPL BIOCHEM BIOTECH, V167, P1290, DOI 10.1007/s12010-012-9632-9; OZIMEK L, 1985, J FOOD SCI, V50, P1327, DOI 10.1111/j.1365-2621.1985.tb10469.x; Ramirez-Suarez JC, 2003, MEAT SCI, V65, P899, DOI 10.1016/S0309-1740(02)00297-8; SCHUT J, 1976, FOOD EMULSIONS, P385; Suliman Mashair A., 2006, PAK J NUTR, V5, P589; Sun XD, 2012, FOOD HYDROCOLLOID, V27, P394, DOI 10.1016/j.foodhyd.2011.11.001; Sun XD, 2011, J FOOD ENG, V107, P226, DOI 10.1016/j.jfoodeng.2011.06.019; van Huis A, 2013, ANNU REV ENTOMOL, V58, P563, DOI 10.1146/annurev-ento-120811-153704; Wu LM, 2009, J FOOD COMPOS ANAL, V22, P242, DOI 10.1016/j.jfca.2008.10.022; Yi LY, 2013, FOOD CHEM, V141, P3341, DOI 10.1016/j.foodchem.2013.05.115; Zhang BuNing, 2009, Modern Applied Science, V3, P77	35	105	106	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147791	10.1371/journal.pone.0147791	http://dx.doi.org/10.1371/journal.pone.0147791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840533	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000369550200059
J	Halada, P; Brugger, D; Volc, J; Peterbauer, CK; Leitner, C; Haltrich, D				Halada, Petr; Brugger, Dagmar; Volc, Jindrich; Peterbauer, Clemens K.; Leitner, Christian; Haltrich, Dietmar			Oxidation of Phe454 in the Gating Segment Inactivates Trametes multicolor Pyranose Oxidase during Substrate Turnover	PLOS ONE			English	Article							AMINO-ACID-RESIDUES; PROTEIN PHARMACEUTICALS; ENZYMATIC OXIDATION; CATALYZED REACTIONS; GLUCOSE-OXIDASE; 2-OXIDASE; OXYGEN; SUGARS; PURIFICATION; MECHANISMS	The flavin-dependent enzyme pyranose oxidase catalyses the oxidation of several pyranose sugars at position C-2. In a second reaction step, oxygen is reduced to hydrogen peroxide. POx is of interest for biocatalytic carbohydrate oxidations, yet it was found that the enzyme is rapidly inactivated under turnover conditions. We studied pyranose oxidase from Trametes multicolor (TmPOx) inactivated either during glucose oxidation or by exogenous hydrogen peroxide using mass spectrometry. MALDI-MS experiments of proteolytic fragments of inactivated TmPOx showed several peptides with a mass increase of 16 or 32 Da indicating oxidation of certain amino acids. Most of these fragments contain at least one methionine residue, which most likely is oxidised by hydrogen peroxide. One peptide fragment that did not contain any amino acid residue that is likely to be oxidised by hydrogen peroxide (DAFSYGAVQQSIDSR) was studied in detail by LC-ESI-MS/MS, which showed a +16 Da mass increase for Phe454. We propose that oxidation of Phe454, which is located at the flexible active-site loop of TmPOx, is the first and main step in the inactivation of TmPOx by hydrogen peroxide. Oxidation of methionine residues might then further contribute to the complete inactivation of the enzyme.	[Halada, Petr; Volc, Jindrich] Acad Sci Czech Republic, Inst Microbiol, Vvi, Videnska 1083, Prague, Czech Republic; [Brugger, Dagmar; Peterbauer, Clemens K.; Leitner, Christian; Haltrich, Dietmar] BOKU Univ Nat Resources & Life Sci Vienna, Food Biotechnol Lab, Vienna, Austria; [Brugger, Dagmar; Peterbauer, Clemens K.; Haltrich, Dietmar] BOKU Univ Nat Resources & Life Sci Vienna, Doctoral Programme BioToP Mol Biotechnol Prot, Vienna, Austria	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Haltrich, D (corresponding author), BOKU Univ Nat Resources & Life Sci Vienna, Food Biotechnol Lab, Vienna, Austria.; Haltrich, D (corresponding author), BOKU Univ Nat Resources & Life Sci Vienna, Doctoral Programme BioToP Mol Biotechnol Prot, Vienna, Austria.	dietmar.haltrich@boku.ac.at	Haltrich, Dietmar/N-2624-2019; Halada, Petr/H-3330-2014	Haltrich, Dietmar/0000-0002-8722-8176; Halada, Petr/0000-0002-7229-3450; Peterbauer, Clemens/0000-0002-8033-198X	BOKU University of Natural Resources and Life Sciences; Austrian Science Fund (FWF), Doctoral Programme BioToP-Biomolecular Technology of Proteins [FWF W1224]; programme for Scientific Technical Cooperation KONTAKT Austria-Czech Republic [MEB060910]; Institutional Research Project [RVO61388971]; Ministry of Education, Youth and Sports of the Czech Republic [LO1509]; Operational Program Prague - Competitiveness project [CZ.2.16/3.1.00/24023]; EU;  [FWF P22094]	BOKU University of Natural Resources and Life Sciences; Austrian Science Fund (FWF), Doctoral Programme BioToP-Biomolecular Technology of Proteins(Austrian Science Fund (FWF)); programme for Scientific Technical Cooperation KONTAKT Austria-Czech Republic; Institutional Research Project; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Operational Program Prague - Competitiveness project; EU(European Commission); 	This work was funded by BOKU University of Natural Resources and Life Sciences (BOKU Doc Program), by the Austrian Science Fund (FWF), Doctoral Programme BioToP-Biomolecular Technology of Proteins (FWF W1224), the programme for Scientific Technical Cooperation KONTAKT Austria-Czech Republic (MEB060910), individual project FWF P22094 (to CKP), and by Institutional Research Project RVO61388971 (IMIC). The authors also gratefully acknowledge the support by the project LO1509 of the Ministry of Education, Youth and Sports of the Czech Republic and by Operational Program Prague - Competitiveness project (CZ.2.16/3.1.00/24023) supported by the EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger D, 2014, BIOTECHNOL J, V9, P474, DOI 10.1002/biot.201300336; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Decamps K, 2012, FOOD CHEM, V131, P1485, DOI 10.1016/j.foodchem.2011.10.041; Freinbichler W, 2011, CELL MOL LIFE SCI, V68, P2067, DOI 10.1007/s00018-011-0682-x; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Giffhorn F, 2000, ENZYME MICROB TECH, V27, P734, DOI 10.1016/S0141-0229(00)00293-3; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Halada P, 2003, ANAL BIOCHEM, V314, P235, DOI 10.1016/S0003-2697(02)00661-9; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Kwon KY, 2014, ELECTROANAL, V26, P2075, DOI 10.1002/elan.201400170; Leitner C, 2002, APPL BIOCHEM BIOTECH, V98, P497, DOI 10.1385/ABAB:98-100:1-9:497; Leitner C, 2001, APPL ENVIRON MICROB, V67, P3636, DOI 10.1128/AEM.67.8.3636-3644.2001; Leitner C, 1998, BIOCATAL BIOTRANSFOR, V16, P365, DOI 10.3109/10242429809003629; Leitner C, 1998, APPL BIOCHEM BIOTECH, V70-2, P237, DOI 10.1007/BF02920140; LI SH, 1995, BIOTECHNOL BIOENG, V48, P490, DOI 10.1002/bit.260480511; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Maria G, 2012, J MOL CATAL B-ENZYM, V74, P209, DOI 10.1016/j.molcatb.2011.10.007; Pisanelli I, 2009, J BIOTECHNOL, V142, P97, DOI 10.1016/j.jbiotec.2009.03.019; Prongjit M, 2009, BIOCHEMISTRY-US, V48, P4170, DOI 10.1021/bi802331r; Savige W E, 1977, Methods Enzymol, V47, P453; Schneider K, 2012, BIOTECHNOL BIOENG, V109, P2941, DOI 10.1002/bit.24572; Spadiut O, 2009, FEBS J, V276, P776, DOI 10.1111/j.1742-4658.2008.06823.x; Spadiut O, 2010, FEBS J, V277, P2892, DOI 10.1111/j.1742-4658.2010.07705.x; Spadiut O, 2010, ELECTROANAL, V22, P813, DOI 10.1002/elan.200980015; Spadiut Oliver, 2009, Biotechnology Journal, V4, P525, DOI 10.1002/biot.200800260; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Swoboda M, 2012, ACS NANO, V6, P6364, DOI 10.1021/nn301895c; Tasca F, 2007, ELECTROANAL, V19, P294, DOI 10.1002/elan.200603740; Treitz G, 2001, J BIOTECHNOL, V85, P271, DOI 10.1016/S0168-1656(00)00371-0; Wongnate T, 2013, FEBS J, V280, P3009, DOI 10.1111/febs.12280	33	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148108	10.1371/journal.pone.0148108	http://dx.doi.org/10.1371/journal.pone.0148108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828796	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200062
J	Kiertiburanakul, S; Pinsai, S; Chantratita, W; Pasomsub, E; Leechawengwongs, M; Thipmontree, W; Siriyakorn, N; Sungkanuparph, S				Kiertiburanakul, Sasisopin; Pinsai, Subencha; Chantratita, Wasun; Pasomsub, Ekawat; Leechawengwongs, Manoon; Thipmontree, Wilawan; Siriyakorn, Nirada; Sungkanuparph, Somnuek			Prevalence of Primary HIV Drug Resistance in Thailand Detected by Short Reverse Transcriptase Genotypic Resistance Assay	PLOS ONE			English	Article							ANTIRETROVIRAL-NAIVE INDIVIDUALS; HIV-1-INFECTED PATIENTS; THRESHOLD SURVEY; SCALING-UP; MUTATIONS; THERAPY; IMPACT; EPIDEMIOLOGY; TRANSMISSION; INFECTION	Background HIV drug resistance (HIVDR) is the major cause of treatment failure after scaling up of anti-retroviral therapy (ART). HIVDR testing prior to ART initiation is not routinely performed in resource-limited settings. We aimed to assess the prevalence of primary HIVDR by short reverse transcriptase (RT) genotypic resistance assay and evaluate of the impact of the mutations on the treatment outcomes. Methods A prospective cohort study was conducted in treatment-naive HIV-infected patients. Fourteen major mutations of codon 99-191 on the RT gene were selected (K103N, V106A/M, V108I, Q151M, Y181C/I, M184V/I, Y188C/L/H, and G190S/A) at a cost of testing of 35 USD. The association between the presence of primary HIVDR and undetectable HIV RNA (< 50 copies/mL) after 6 months of ART was determined. Results A total of 265 HIV-infected patients were included, with a median age of 35.2 (range, 16.8-75.2) years; 62.6% were males. The median (interquartile range) CD4 cell count at ART initiation was 216 (77-381) cells/mm(3). The overall prevalence of primary HIVDR was 7.9%. The prevalence of each HIVDR mutation were K103N 6.0%, V106I 1.1%, V108I 0.4%, Y181C 2.3%, Y181I 0.7%, Y181V 0.4%, M184V 3.0%, M184I 1.5%, and G190A 2.3%. No associated factor of having primary HIVDR was determined. By multiple stepwise logistic regression, factors associated with undetectable HIV RNA after 6 months of ART were: having M184V/I (odds ratio [OR] 0.11; 95% confidence interval [CI] 0.02-0.62, p = 0.013), condom use (OR 2.38; 95% CI 1.12-5.06, p = 0.024), and adherence per 5% increase (OR 1.16; 95% CI 1.00-1.35, p = 0.044). Conclusions The prevalence of primary HIVDR is approximately 8%; it is associated with detectable HIV RNA at 6 months after ART initiation. Routine "short RT" genotypic resistance assay should be considered in resource-limited settings to maximize treatment outcome.	[Kiertiburanakul, Sasisopin; Pinsai, Subencha; Sungkanuparph, Somnuek] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand; [Chantratita, Wasun; Pasomsub, Ekawat] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok 10400, Thailand; [Leechawengwongs, Manoon] Vichaiyut Hosp, Bangkok, Thailand; [Thipmontree, Wilawan; Siriyakorn, Nirada] Maharat Nakhon Ratchasima Hosp, Dept Med, Nakhon Ratchasima, Thailand	Mahidol University; Mahidol University	Kiertiburanakul, S (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand.	sasisopin.kie@mahidol.ac.th			Thai AIDS Society	Thai AIDS Society	Source of support: Thai AIDS Society (http://www.thaiaidssociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDS Division Bureau of AIDS TB and STIs, 2014, THAIL NAT GUID HIV A; Apisarnthanarak A, 2008, HIV MED, V9, P322, DOI 10.1111/j.1468-1293.2008.00562.x; Apisarnthanarak A, 2008, CLIN INFECT DIS, V46, P1630, DOI 10.1086/587753; Bansi L, 2010, JAIDS-J ACQ IMM DEF, V53, P633, DOI 10.1097/QAI.0b013e3181c070d2; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Booth C, 2006, ANTIRETROVIRAL RESIS; Charpentier C, 2011, ANTIVIR THER, V16, P429, DOI 10.3851/IMP1754; Chasombat Sanchai, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P704; Dai L, 2014, J ANTIVIR ANTIRETROV, V6; Frentz D, 2012, AIDS REV, V14, P17; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hong Steven Y., 2011, Infectious Disorders - Drug Targets, V11, P124; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Joint United Nations Programme on HIV/AIDS, 2013, UNAIDS REP GLOB AIDS; Jongwutiwes U, 2007, CURR HIV RES, V5, P355, DOI 10.2174/157016207780636551; Kiertiburanakul S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062057; Kiertiburanakul S, 2009, CURR HIV RES, V7, P273, DOI 10.2174/157016209788347976; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Manosuthi W, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0053-z; Manosuthi W, 2013, J MED VIROL, V85, P194, DOI 10.1002/jmv.23452; Margot NA, 2009, JAIDS-J ACQ IMM DEF, V52, P209, DOI 10.1097/QAI.0b013e3181b05f7c; Nguyen HT, 2008, ANTIVIR THER, V13, P115; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Phanuphak P, 2014, JAIDS-J ACQ IMM DEF, V66, P74, DOI 10.1097/QAI.0000000000000108; Public Health Agency of Canada, PRIM HIV ANT DRUG RE; Shafer RW, 2008, ANTIVIR THER, V13, P59; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Sirivichoyaku S, 2008, ANTIVIR THER, V13, P109; Sukasem C, 2007, JPN J INFECT DIS, V60, P284; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Sungkanuparph S, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-12; Sungkanuparph S, 2011, CLIN INFECT DIS, V52, P1053, DOI 10.1093/cid/cir107; Van Vaerenbergh K, 2001, Verh K Acad Geneeskd Belg, V63, P447; Vergne L, 2006, ANTIVIR THER, V11, P575; Wensing Annemarie M. J., 2003, AIDS Reviews, V5, P140; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; World Health Organization, 2014, CONS GUID HIV PREV D; Zhao B, 2011, AIDS RES HUM RETROV, V27, P1047, DOI [10.1089/aid.2010.0119, 10.1089/AID.2010.0119]	40	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147945	10.1371/journal.pone.0147945	http://dx.doi.org/10.1371/journal.pone.0147945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828876	gold, Green Published			2022-12-26	WOS:000369548200044
J	Marques-Neto, SR; Castiglione, RC; Pontes, A; Oliveira, DF; Ferraz, EB; Nascimento, JHM; Bouskela, E				Marques-Neto, Silvio Rodrigues; Castiglione, Raquel Carvalho; Pontes, Aiza; Oliveira, Dahienne Ferreira; Ferraz, Emanuelle Baptista; Matheus Nascimento, Jose Hamilton; Bouskela, Eliete			Effects of Incretin-Based Therapies on Neuro-Cardiovascular Dynamic Changes Induced by High Fat Diet in Rats	PLOS ONE			English	Article							MICROVASCULAR DYSFUNCTION; GLUCOSE; MITOCHONDRIA; INSULIN; OBESITY; LIRAGLUTIDE; SITAGLIPTIN	Background and Aims Obesity promotes cardiac and cerebral microcirculatory dysfunction that could be improved by incretin-based therapies. However, the effects of this class of compounds on neuro-cardiovascular system damage induced by high fat diet remain unclear. The aim of this study was to investigate the effects of incretin-based therapies on neuro-cardiovascular dysfunction induced by high fat diet in Wistar rats. Methods and Results We have evaluated fasting glucose levels and insulin resistance, heart rate variability quantified on time and frequency domains, cerebral microcirculation by intravital microscopy, mean arterial blood pressure, ventricular function and mitochondrial swelling. High fat diet worsened biometric and metabolic parameters and promoted deleterious effects on autonomic, myocardial and haemodynamic parameters, decreased capillary diameters and increased functional capillary density in the brain. Biometric and metabolic parameters were better improved by glucagon like peptide-1 (GLP-1) compared with dipeptdyl peptidase-4 (DPP-4) inhibitor. On the other hand, both GLP-1 agonist and DPP-4 inhibitor reversed the deleterious effects of high fat diet on autonomic, myocardial, haemodynamic and cerebralmicrovascular parameters. GLP-1 agonist and DPP-4 inhibitor therapy also increased mitochondrial permeability transition pore resistance in brain and heart tissues of rats subjected to high fat diet. Conclusion Incretin-based therapies improve deleterious cardiovascular effects induced by high fat diet and may have important contributions on the interplay between neuro-cardiovascular dynamic controls through mitochondrial dysfunction associated to metabolic disorders.	[Marques-Neto, Silvio Rodrigues; Castiglione, Raquel Carvalho; Pontes, Aiza; Bouskela, Eliete] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, RJ, Brazil; [Oliveira, Dahienne Ferreira; Ferraz, Emanuelle Baptista; Matheus Nascimento, Jose Hamilton] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Cardiac Electrophysiol Lab, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Marques-Neto, SR (corresponding author), Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, RJ, Brazil.	marquesilvio@gmail.com	Nascimento, Jose Hamilton/L-3722-2018	Nascimento, Jose Hamilton/0000-0001-7052-254X; Marques-Neto, Silvio/0000-0001-5742-4646; Ferreira de Oliveira, Dahienne/0000-0002-8104-9476	National Research Council (CNPq) [474116/2008-5]; Research Supporting Agency of Rio de Janeiro State (FAPERJ) [E-26/111.732/2011]; Coordination for the Improvement of Higher Education Personnel (CAPES)	National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Supporting Agency of Rio de Janeiro State (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from the National Research Council (CNPq - 474116/2008-5), the Research Supporting Agency of Rio de Janeiro State (FAPERJ - E-26/111.732/2011) and Coordination for the Improvement of Higher Education Personnel (CAPES). Further information concerning those agencies can be found at the following URLs: CNPq: http //www.cnpq.br http://www.cnpq.br/web/guest/, FAPERJ: http://www.faperj.br/, CAPES: http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Burcelin R, 2010, DIABETES METAB, V36, pS54, DOI 10.1016/S1262-3636(10)70468-7; Burcelin R, 2014, PHYSIOLOGY, V29, P108, DOI 10.1152/physiol.00009.2013; De Boer MP, 2012, MICROCIRCULATION, V19, P5, DOI 10.1111/j.1549-8719.2011.00130.x; DeFronzo RA, 2008, CURR MED RES OPIN, V24, P2943, DOI 10.1185/03007990802418851 ; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Li WG, 2013, AM J PHYSIOL-REG I, V304, pR1001, DOI 10.1152/ajpregu.00523.2012; Maranhao PA, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-32; Neto SRM, 2013, ACTA PHYSIOL, V208, P166, DOI 10.1111/apha.12056; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Nakabayashi H, 1996, AM J PHYSIOL-ENDOC M, V271, pE808, DOI 10.1152/ajpendo.1996.271.5.E808; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Pannacciulli P, 2007, NEUROIMAGE, V86, P573; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Rowell LB, 1993, HUMAN CARDIOVASCULAR, P268; Serne EH, 2007, HYPERTENSION, V50, P204, DOI 10.1161/HYPERTENSIONAHA.107.089680; Shah GN, 2013, BIOCHEM BIOPH RES CO, V440, P354, DOI 10.1016/j.bbrc.2013.09.086; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Sivitz WI, 2010, US ENDOCRINOL, V6, P20, DOI [10.17925/USE.2010.06.1.20, DOI 10.17925/USE.2010.06.1.20]; Torekov SS, 2011, OBES REV, V12, P593, DOI 10.1111/j.1467-789X.2011.00860.x; Ussher JR, 2014, CIRC RES, V114, P1788, DOI 10.1161/CIRCRESAHA.114.301958; van Raalte DH, 2013, DIABETOLOGIA, V56, P2383, DOI 10.1007/s00125-013-3016-8	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148402	10.1371/journal.pone.0148402	http://dx.doi.org/10.1371/journal.pone.0148402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828649	gold, Green Submitted, Green Published			2022-12-26	WOS:000369548200098
J	Minick, SG; Stafford, CL; Kertz, BL; Cully, JA; Stanley, MA; Davila, JA; Dang, BN; Rodriguez-Barradas, MC; Giordano, TP				Minick, Sophie G.; Stafford, Crystal L.; Kertz, Barbara L.; Cully, Jeffery A.; Stanley, Melinda A.; Davila, Jessica A.; Dang, Bich N.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.			Veterans' Perspectives on Interventions to Improve Retention in HIV Care	PLOS ONE			English	Article							CASE-MANAGEMENT; ENGAGEMENT; ADHERENCE; CONTINUUM; HIV/AIDS; SERVICES; OUTCOMES; PROGRAM	Poor retention in HIV medical care is associated with increased mortality among patients with HIV/AIDS. Developing new interventions to improve retention in HIV primary care is needed. The Department of Veteran Affairs (VA) is the largest single provider of HIV care in the US. We sought to understand what veterans would want in an intervention to improve retention in VA HIV care. We conducted 18 one-on-one interviews and 15 outpatient focus groups with 46 patients living with HIV infection from the Michael E. DeBakey VAMC (MEDVAMC). Analysis identified three focus areas for improving retention in care: developing an HIV friendly clinic environment, providing mental health and substance use treatment concurrent with HIV care and encouraging peer support from other Veterans with HIV.	[Minick, Sophie G.; Stafford, Crystal L.; Cully, Jeffery A.; Stanley, Melinda A.; Davila, Jessica A.; Dang, Bich N.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.] Baylor Coll Med, Houston Ctr Innovat Qual Safety & Effectiveness, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Kertz, Barbara L.] Michael E DeBakey VA Med Ctr, Infect Dis Sect, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Giordano, TP (corresponding author), Baylor Coll Med, Houston Ctr Innovat Qual Safety & Effectiveness, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA.	tpg@bcm.tcm.edu		Giordano, Thomas/0000-0002-9346-5530	Department of Veterans Affiars Health Services and Development (VA HSRD) [IBB 09-033]; National Institutes of Health [R01 MH085527-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085527] Funding Source: NIH RePORTER	Department of Veterans Affiars Health Services and Development (VA HSRD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Department of Veterans Affiars Health Services and Development (VA HSR&D) grant IBB 09-033 and National Institutes of Health (R01 MH085527-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TP Giordano is a researcher at the Center for Innovations in Quality, Safety and Effectiveness at the Michael E. DeBakey VA Medical Center, Houston, TX.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Braverman J, 2008, COMMUN RES, V35, P666, DOI 10.1177/0093650208321785; Byrd KK, 2015, AIDS CARE, V27, P1387, DOI 10.1080/09540121.2015.1114991; Chinman C, 2012, PEER SPECIALIST TOOL; Chinman M, 2015, J BEHAV HEALTH SER R, V42, P109, DOI 10.1007/s11414-013-9343-1; Clarke G N, 2000, Ment Health Serv Res, V2, P155, DOI 10.1023/A:1010141826867; Cully JA, 2012, AIDS PATIENT CARE ST, V26, P165, DOI 10.1089/apc.2011.0248; Dang BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054729; Dang BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042980; Davila JA, 2013, AIDS CARE, V25, P202, DOI 10.1080/09540121.2012.689811; Department of Veteran Affairs, 2011, DEPARTMENT OF VETERA; Dodds S, 2004, PUBLIC HEALTH REP, V119, P48, DOI 10.1177/003335490411900111; Doshi RK, 2015, CLIN INFECT DIS, V60, P117, DOI 10.1093/cid/ciu722; Gardner LI, 2014, CLIN INFECT DIS, V59, P725, DOI 10.1093/cid/ciu357; Gardner LI, 2012, CLIN INFECT DIS, V55, P1124, DOI 10.1093/cid/cis623; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Kaaya S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001447; Kalichman SC, 1999, J GEN INTERN MED, V14, P267, DOI 10.1046/j.1525-1497.1999.00334.x; Krippendorff K., 1989, INT ENCY COMMUNICATI, V1; Morgan DL, 1997, FOCUS GROUPS QUALITA, P7; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Naar-King S, 2007, AIDS PATIENT CARE ST, V21, pS40, DOI 10.1089/apc.2007.9988; O'Donnell M, 1999, AUST NZ J PSYCHIAT, V33, P684, DOI 10.1046/j.1440-1614.1999.00629.x; Rajabiun S, 2007, AIDS PATIENT CARE ST, V21, pS20, DOI 10.1089/apc.2007.9990; Rivera JJ, 2007, PSYCHIAT SERV, V58, P802, DOI 10.1176/appi.ps.58.6.802; Sells D, 2006, PSYCHIAT SERV, V57, P1179, DOI 10.1176/appi.ps.57.8.1179; Sherer R, 2002, AIDS CARE, V14, pS31, DOI 10.1080/09540120220149975; Simoni JM, 2011, AIDS BEHAV, V15, P376, DOI 10.1007/s10461-010-9836-3; SOLOMON P, 1995, J MENT HEALTH ADMIN, V22, P135, DOI 10.1007/BF02518754; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Tobias C, 2007, AIDS PATIENT CARE ST, V21, pS3, DOI 10.1089/apc.2007.9992; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148163	10.1371/journal.pone.0148163	http://dx.doi.org/10.1371/journal.pone.0148163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26829641	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200074
J	Bach, M; Schafer, K				Bach, Michael; Schaefer, Kerstin			Visual Acuity Testing: Feedback Affects Neither Outcome nor Reproducibility, but Leaves Participants Happier	PLOS ONE			English	Article							TASK	Assessment of visual acuity is a well standardized procedure at least for expert opinions and clinical trials. It is often recommended not giving patients feedback on the correctness of their responses. As this viewpoint has not been quantitatively examined so far, we quantitatively assessed possible effects of feedback on visual acuity testing. In 40 normal participants we presented Landolt Cs in 8 orientations using the automated Freiburg Acuity Test (FrACT, <michaelbach.de/fract. Over a run comprising 24 trials, the acuity threshold was measured with an adaptive staircase procedure. In an ABCDDCBA scheme, trial-by-trial feedback was provided in 2 x 4 conditions: (A) no feedback, (B) acoustic signals indicating correctness, (C) visual indication of correct orientation, and (D) a combination of (B) and (C). After each run the participants judged comfort. Main outcome measures were absolute visual acuity (logMAR), its test-retest agreement (limits of agreement) and participants' comfort estimates on a 5-step symmetric Likert scale. Feedback influenced acuity outcome significantly (p = 0.02), but with a tiny effect size: 0.02 logMAR poorer acuity for (D) compared to (A), even weaker effects for (B) and (C). Test-retest agreement was high (limits of agreement: +/- 1.0 lines) and did not depend on feedback (p>0.5). The comfort ranking clearly differed, by 2 steps on the Likert scale: the condition (A)-no feedback-was on average "slightly uncomfortable", the other three conditions were "slightly comfortable" (p<0.0001). Feedback affected neither reproducibility nor the acuity outcome to any relevant extent. The participants, however, reported markedly greater comfort with any kind of feedback. We conclude that systematic feedback (as implemented in FrACT) offers nothing but advantages for routine use.	[Bach, Michael; Schaefer, Kerstin] Univ Freiburg, Med Ctr, Electrophysiol Eye Ctr, Sect Visual Funct, Killianstr 5, D-79106 Freiburg, Germany	University of Freiburg	Bach, M (corresponding author), Univ Freiburg, Med Ctr, Electrophysiol Eye Ctr, Sect Visual Funct, Killianstr 5, D-79106 Freiburg, Germany.	michael.bach@uni-freiburg.de	Bach, Michael/A-6637-2010	Bach, Michael/0000-0003-2028-535X				American National Standards Institute and Optical Laboratories Association, 2004, AM NAT STAND OPHTH I; ARDITI A, 1993, INVEST OPHTH VIS SCI, V34, P120; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bach M, 2009, HOMEPAGE FREIBURG VI; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; Fahle M, 2002, PERCEPTUAL LEARNING; Goldhacker M, 2014, VISION RES, V99, P99, DOI 10.1016/j.visres.2013.11.010; Heinrich SP, 2011, GRAEF ARCH CLIN EXP, V249, P1319, DOI 10.1007/s00417-011-1675-z; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; International Council of Ophthalmology, 1984, VIS AC MEAS STAND; International Organization for Standardization, 2009, 85962009 ISO; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kingdom FAA, 2009, PSYCHOPHYSICS PRACTI; Li JR, 2015, VISION RES, V114, P161, DOI 10.1016/j.visres.2015.01.017; LIEBERMAN HR, 1982, BEHAV RES METH INSTR, V14, P21, DOI 10.3758/BF03202110; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; R Development Core Team, 2014, R LANG ENV STAT COMP; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; World Medical Association, 2008, DECL HELS ETH PRINC	23	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147803	10.1371/journal.pone.0147803	http://dx.doi.org/10.1371/journal.pone.0147803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824693	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528600062
J	Gerstmeier, J; Newcomer, ME; Dennhardt, S; Romp, E; Fischer, J; Werz, O; Garscha, U				Gerstmeier, Jana; Newcomer, Marcia E.; Dennhardt, Sophie; Romp, Erik; Fischer, Jana; Werz, Oliver; Garscha, Ulrike			5-Lipoxygenase-activating protein rescues activity of 5-lipoxygenase mutations that delay nuclear membrane association and disrupt product formation	FASEB JOURNAL			English	Article						arachidonic acid; HEK293; inflammation; leukotriene A(4); translocation	BETA-BARREL DOMAIN; LEUKOTRIENE BIOSYNTHESIS; FLAP; 11R-LIPOXYGENASE; TRANSLOCATION; LOCALIZATION; LIPOXYGENASE; ORGANIZATION; SPECIFICITY; INHIBITORS	Leukotrienes (LTs) are proinflammatory lipid mediators formed from arachidonic acid in a 2-step reaction catalyzed by 5-lipoxygenase (5-LOX) requiring the formation of 5-HPETE [5(S)-hydroperoxy-6-trans-8,11,14-cis-eicosatetraenoic acid] and its subsequent transformation to LTA(4). 5-LOX is thought to receive arachidonic acid from the nuclear membrane-embedded 5-LOX-activating protein (FLAP). The crystal structure of 5-LOX revealed an active site concealed by F177 and Y181 (FY cork). We examined the influence of the FY cork on 5-LOX activity and membrane binding in HEK293 cells in the absence and presence of FLAP. Uncapping the 5-LOX active site by mutation of F177 and/or Y181 to alanine (5-LOX-F177A, 5-LOX-Y181A, 5-LOX-F177/Y181A) resulted in delayed and diminished 5-LOX membrane association in A23187-stimulated cells. For 5-LOX-F177A and 5-LOX-F177/Y181A, formation of 5-LOX products was dramatically reduced relative to 5-LOX-wild type (wt). Strikingly, coexpression of FLAP in A23187-activated HEK293 cells effectively restored formation of 5-H(p)ETE (5-hydroxy- and 5-peroxy-6-trans-8,11,14-cis-eicosatetraenoic acid) by these same 5-LOX mutants (approximate to 60-70% 5-LOX-wt levels) but not of LTA(4) hydrolysis products. Yet 5-LOX-Y181A generated 5-H(p) ETE at levels comparable to 5-LOX-wt but reduced LTA(4) hydrolysis products. Coexpression of FLAP partially restored LTA(4) hydrolysis product formation by 5-LOX-Y181A. Together, the data suggest that the concealed FY cork impacts membrane association and that FLAP may help shield an uncapped active site.-Gerstmeier, J., Newcomer, M. E., Dennhardt, S., Romp, E., Fischer, J., Werz, O., Garscha, U. 5-Lipoxygenase-activating protein rescues activity of 5-lipoxygenase mutations that delay nuclear membrane association and disrupt product formation. www.fasebj.org	[Gerstmeier, Jana; Dennhardt, Sophie; Romp, Erik; Fischer, Jana; Werz, Oliver; Garscha, Ulrike] Univ Jena, Inst Pharm, Dept Pharmaceut & Med Chem, Philosophenweg 14, D-07743 Jena, Germany; [Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Friedrich Schiller University of Jena; Louisiana State University System; Louisiana State University	Garscha, U (corresponding author), Univ Jena, Inst Pharm, Dept Pharmaceut & Med Chem, Philosophenweg 14, D-07743 Jena, Germany.	ulrike.garscha@uni-jena.de	Garscha, Ulrike/G-3559-2018	Garscha, Ulrike/0000-0002-3645-7833	Deutsche Forschungsgemeinschaft (DFG) within the Collaborative Research Centres: Chemical Mediators in complex Biosystems [SFB 1127]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL 107887]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG) within the Collaborative Research Centres: Chemical Mediators in complex Biosystems; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the Deutsche Forschungsgemeinschaft (DFG) within the Collaborative Research Centres (SFB 1127): Chemical Mediators in complex Biosystems (to O.W.) and the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (HL 107887; to M.E.N.) for financial support.	Bair AM, 2012, MOL BIOL CELL, V23, P4456, DOI 10.1091/mbc.E12-06-0489; Basavarajappa D, 2014, P NATL ACAD SCI USA, V111, P11371, DOI 10.1073/pnas.1410983111; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; Coic YM, 2005, EUR BIOPHYS J BIOPHY, V35, P27, DOI 10.1007/s00249-005-0002-1; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Gerstmeier J, 2016, FASEB J, V30, P276, DOI 10.1096/fj.15-278010; Gerstmeier J, 2014, BBA-GEN SUBJECTS, V1840, P2961, DOI 10.1016/j.bbagen.2014.05.016; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Grauffel C, 2013, J AM CHEM SOC, V135, P5740, DOI 10.1021/ja312656v; Hafner AK, 2011, BIOL CHEM, V392, P1097, DOI [10.1515/BC.2011.200, 10.1515/BC-2011-200]; HILL E, 1992, J BIOL CHEM, V267, P22048; Jarving R, 2012, BIOCHEMISTRY-US, V51, P3310, DOI 10.1021/bi201690z; KARGMAN S, 1992, J CELL BIOL, V119, P1701, DOI 10.1083/jcb.119.6.1701; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Mandal AK, 2004, P NATL ACAD SCI USA, V101, P6587, DOI 10.1073/pnas.0308523101; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; MirAfzali Z, 2006, J BIOL CHEM, V281, P28354, DOI 10.1074/jbc.M605206200; Mitra S, 2015, BIOCHEMISTRY-US, V54, P6333, DOI 10.1021/acs.biochem.5b00930; Newcomer ME, 2015, PROTEIN SCI, V24, P298, DOI 10.1002/pro.2626; NOGUCHI M, 1994, BBA-LIPID LIPID MET, V1215, P300, DOI 10.1016/0005-2760(94)90057-4; PANOSSIAN A, 1982, FEBS LETT, V150, P511, DOI 10.1016/0014-5793(82)80801-6; Pergola C, 2014, BRIT J PHARMACOL, V171, P3051, DOI 10.1111/bph.12625; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Poeckel D, 2010, CARDIOVASC RES, V86, P243, DOI 10.1093/cvr/cvq016; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; SAMUELSSON B, 1983, ADV PROSTAG THROMB L, V11, P1; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Walther M, 2011, ARCH BIOCHEM BIOPHYS, V516, P1, DOI 10.1016/j.abb.2011.09.004; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Werz O, 2005, BIOCHEM PHARMACOL, V70, P327, DOI 10.1016/j.bcp.2005.04.018; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WISEMAN JS, 1987, BIOCHEMISTRY-US, V26, P5684, DOI 10.1021/bi00392a016	35	24	25	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1892	1900		10.1096/fj.201500210R	http://dx.doi.org/10.1096/fj.201500210R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26842853	Green Published, Green Submitted			2022-12-26	WOS:000374879400018
J	Johnson, JJ; Miller, DL; Jiang, R; Liu, YY; Shi, ZG; Tarwater, L; Williams, R; Balsara, R; Sauter, ER; Stack, MS				Johnson, Jeff J.; Miller, Daniel L.; Jiang, Rong; Liu, Yueying; Shi, Zonggao; Tarwater, Laura; Williams, Russell; Balsara, Rashna; Sauter, Edward R.; Stack, M. Sharon			Protease-activated Receptor-2 (PAR-2)-mediated Nf-B Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; kallikrein; microRNA (miRNA); NF-B; protease; serine protease; oral cancer; protease-activated receptor	EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN KERATINOCYTES; UP-REGULATION; KAPPA-B; CANCER; EXPRESSION; HEAD; INVASION; LESIONS; DIFFERENTIATION	Oral cancer is the sixth most common cause of death from cancer with an estimated 400,000 deaths worldwide and a low (50%) 5-year survival rate. The most common form of oral cancer is oral squamous cell carcinoma (OSCC). OSCC is highly inflammatory and invasive, and the degree of inflammation correlates with tumor aggressiveness. The G protein-coupled receptor protease-activated receptor-2 (PAR-2) plays a key role in inflammation. PAR-2 is activated via proteolytic cleavage by trypsin-like serine proteases, including kallikrein-5 (KLK5), or by treatment with activating peptides. PAR-2 activation induces G protein--mediated signaling, mobilizing intracellular calcium and Nf-B signaling, leading to the increased expression of pro-inflammatory mRNAs. Little is known, however, about PAR-2 regulation of inflammation-related microRNAs. Here, we assess PAR-2 expression and function in OSCC cell lines and tissues. Stimulation of PAR-2 activates Nf-B signaling, resulting in RelA nuclear translocation and enhanced expression of pro-inflammatory mRNAs. Concomitantly, suppression of the anti-inflammatory tumor suppressor microRNAs let-7d, miR-23b, and miR-200c was observed following PAR-2 stimulation. Analysis of orthotopic oral tumors generated by cells with reduced KLK5 expression showed smaller, less aggressive lesions with reduced inflammatory infiltrate relative to tumors generated by KLK5-expressing control cells. Together, these data support a model wherein KLK5-mediated PAR-2 activation regulates the expression of inflammation-associated mRNAs and microRNAs, thereby modulating progression of oral tumors.	[Johnson, Jeff J.; Liu, Yueying; Shi, Zonggao; Tarwater, Laura; Stack, M. Sharon] Univ Notre Dame, Harper Canc Res Inst, 1234 Notre Dame Ave,A200E Harper Hall, South Bend, IN 46617 USA; [Johnson, Jeff J.; Liu, Yueying; Shi, Zonggao; Stack, M. Sharon] Univ Notre Dame, Dept Chem & Biochem, 1234 Notre Dame Ave,A200E Harper Hall, South Bend, IN 46617 USA; [Miller, Daniel L.] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Jiang, Rong] Emory Univ, Dept Human Genet, Atlanta, GA USA; [Williams, Russell] Indiana Univ, Dept Biol, South Bend, IN 46634 USA; [Balsara, Rashna] WM Keck Ctr Transgene Res, South Bend, IN 46617 USA; [Sauter, Edward R.] Univ Texas Tyler, Hlth Sci Ctr, Dept Surg, Tyler, TX 75799 USA	University of Notre Dame; University of Notre Dame; University of Missouri System; University of Missouri Columbia; Emory University; Indiana University System; Indiana University South Bend; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Stack, MS (corresponding author), Univ Notre Dame, 1234 Notre Dame Ave,A200E Harper Hall, South Bend, IN 46617 USA.	sstack@nd.edu		Shi, Zonggao/0000-0001-7503-2953	National Institutes of Health NCI Research Grant [RO1CA085870]; NIDCR Grant [F31DE021926]; NATIONAL CANCER INSTITUTE [R01CA085870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE021926] Funding Source: NIH RePORTER	National Institutes of Health NCI Research Grant; NIDCR Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health NCI Research Grant RO1CA085870 (to M. S. S.) and NIDCR Grant F31DE021926 (to D. L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Arwert EN, 2010, P NATL ACAD SCI USA, V107, P19903, DOI 10.1073/pnas.1007404107; Barland CO, 2004, J INVEST DERMATOL, V122, P330, DOI 10.1046/j.0022-202X.2004.22203.x; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Buddenkotte J, 2005, J INVEST DERMATOL, V124, P38, DOI 10.1111/j.0022-202X.2004.23539.x; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Chang CJ, 2011, ONCOL REP, V26, P1003, DOI 10.3892/or.2011.1360; Chang PY, 2013, CLIN CHEM LAB MED, V51, P1291, DOI 10.1515/cclm-2012-0504; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Christofakis EP, 2008, ORAL ONCOL, V44, P920, DOI 10.1016/j.oraloncology.2007.12.002; Chuang TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095370; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Elashoff D, 2012, CANCER EPIDEM BIOMAR, V21, P664, DOI 10.1158/1055-9965.EPI-11-1093; Fujita Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110378; Furio L, 2011, J INVEST DERMATOL, V131, P2169, DOI 10.1038/jid.2011.295; Ghosh S, 2010, MOL CANCER RES, V8, P145, DOI 10.1158/1541-7786.MCR-09-0045; Gonzalez HE, 2003, ARCH OTOLARYNGOL, V129, P754, DOI 10.1001/archotol.129.7.754; Gorenchtein M, 2012, J DENT RES, V91, P440, DOI 10.1177/0022034511431261; Inaba H, 2014, CELL MICROBIOL, V16, P131, DOI 10.1111/cmi.12211; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Jamali Z, 2015, ORAL ONCOL, V51, P321, DOI 10.1016/j.oraloncology.2015.01.008; Jayakumar A, 2005, ARCH BIOCHEM BIOPHYS, V435, P89, DOI 10.1016/j.abb.2004.12.012; Jian SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066133; Jiang R, 2011, J BIOL CHEM, V286, P9127, DOI 10.1074/jbc.M110.191361; Johnson J, 2014, ORAL ONCOL, V50, P468, DOI 10.1016/j.oraloncology.2014.02.004; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; KRAMER I R H, 1978, Oral Surgery Oral Medicine Oral Pathology, V46, P518; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Lee MC, 2008, NEUROGASTROENT MOTIL, V20, P385, DOI 10.1111/j.1365-2982.2007.01041.x; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; LUMERMAN H, 1995, ORAL SURG ORAL MED O, V79, P321, DOI 10.1016/S1079-2104(05)80226-4; Macfarlane SR, 2005, BRIT J PHARMACOL, V145, P535, DOI 10.1038/sj.bjp.0706204; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Myers JN, 2002, CLIN CANCER RES, V8, P293; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Oikonomopoulou K, 2006, BIOL CHEM, V387, P817, DOI 10.1515/BC.2006.104; Ono M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005231; Pellegrino L, 2013, NUCLEIC ACIDS RES, V41, P5400, DOI 10.1093/nar/gkt245; Perez-Sayans M, 2012, J ORAL PATHOL MED, V41, P433, DOI 10.1111/j.1600-0714.2011.01121.x; Pettus JR, 2009, HISTOL HISTOPATHOL, V24, P197, DOI 10.14670/HH-24.197; Rajkumar K, 2014, OR SURG OR MED OR PA, V118, P309, DOI 10.1016/j.oooo.2014.04.008; Rallabhandi P, 2008, J BIOL CHEM, V283, P24314, DOI 10.1074/jbc.M804800200; Ramdas L, 2009, HEAD NECK-J SCI SPEC, V31, P642, DOI 10.1002/hed.21017; Rao SK, 2010, J BIOL CHEM, V285, P32512, DOI 10.1074/jbc.M110.150490; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Sales KU, 2015, ONCOGENE, V34, P288, DOI 10.1038/onc.2013.563; Shi LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078344; Shi ZG, 2015, ARCH ORAL BIOL, V60, P1416, DOI 10.1016/j.archoralbio.2015.06.007; Suen JY, 2014, BRIT J PHARMACOL, V171, P4112, DOI 10.1111/bph.12757; Tanis T, 2014, ARCH ORAL BIOL, V59, P1155, DOI 10.1016/j.archoralbio.2014.07.005; VEDTOFTE P, 1987, INT J ORAL MAX SURG, V16, P656, DOI 10.1016/S0901-5027(87)80049-8; Vergnolle N, 2001, TRENDS PHARMACOL SCI, V22, P146, DOI 10.1016/S0165-6147(00)01634-5; Wagner S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/376326; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Wojtukiewicz MZ, 2015, CANCER METAST REV, V34, P775, DOI 10.1007/s10555-015-9599-4; World Health Organization, 2012, GLOBOCAN 2012 EST CA; Yau MK, 2013, J MED CHEM, V56, P7477, DOI 10.1021/jm400638v; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zidar N, 2011, HUM PATHOL, V42, P482, DOI 10.1016/j.humpath.2010.07.020	67	35	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6936	6945		10.1074/jbc.M115.692640	http://dx.doi.org/10.1074/jbc.M115.692640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26839311	hybrid, Green Published			2022-12-26	WOS:000373299700030
J	Rieger, ME; Zhou, BY; Solomon, N; Sunohara, M; Li, CG; Nguyen, C; Liu, YX; Pan, JH; Minoo, P; Crandall, ED; Brody, SL; Kahn, M; Borok, Z				Rieger, Megan E.; Zhou, Beiyun; Solomon, Nicola; Sunohara, Mitsuhiro; Li, Changgong; Cu Nguyen; Liu, Yixin; Pan, Jie-hong; Minoo, Parviz; Crandall, Edward D.; Brody, Steven L.; Kahn, Michael; Borok, Zea			p300/-Catenin Interactions Regulate Adult Progenitor Cell Differentiation Downstream of WNT5a/Protein Kinase C (PKC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-catenin (-catenin); differentiation; protein kinase C (PKC); protein-protein interaction; Wnt pathway; p300	IDIOPATHIC PULMONARY-FIBROSIS; PROTEIN-KINASE; BETA-CATENIN; EPITHELIAL-CELLS; PRIMARY CULTURE; STEM-CELLS; INHIBITION; P300; ACTIVATION; BINDING	Maintenance of stem/progenitor cell-progeny relationships is required for tissue homeostasis during normal turnover and repair. Wnt signaling is implicated in both maintenance and differentiation of adult stem/progenitor cells, yet how this pathway serves these dichotomous roles remains enigmatic. We previously proposed a model suggesting that specific interaction of -catenin with either of the homologous Kat3 co-activators, p300 or CREB-binding protein, differentially regulates maintenance versus differentiation of embryonic stem cells. Limited knowledge of endogenous mechanisms driving differential -catenin/co-activator interactions and their role in adult somatic stem/progenitor cell maintenance versus differentiation led us to explore this process in defined models of adult progenitor cell differentiation. We focused primarily on alveolar epithelial type II (AT2) cells, progenitors of distal lung epithelium, and identified a novel axis whereby WNT5a/protein kinase C (PKC) signaling regulates specific -catenin/co-activator interactions to promote adult progenitor cell differentiation. p300/-catenin but not CBP/-catenin interaction increases as AT2 cells differentiate to a type I (AT1) cell-like phenotype. Additionally, p300 transcriptionally activates AT1 cell-specific gene Aqp-5. IQ-1, a specific inhibitor of p300/-catenin interaction, prevents differentiation of not only primary AT2 cells, but also tracheal epithelial cells, and C2C12 myoblasts. p300 phosphorylation at Ser-89 enhances p300/-catenin interaction, concurrent with alveolar epithelial cell differentiation. WNT5a, a traditionally non-canonical WNT ligand regulates Ser-89 phosphorylation and p300/-catenin interactions in a PKC-dependent manner, likely involving PKC. These studies identify a novel intersection of canonical and non-canonical Wnt signaling in adult progenitor cell differentiation that has important implications for targeting -catenin to modulate adult progenitor cell behavior in disease.	[Rieger, Megan E.; Zhou, Beiyun; Solomon, Nicola; Sunohara, Mitsuhiro; Liu, Yixin; Crandall, Edward D.; Borok, Zea] Univ So Calif, Pulm Res Ctr, Will Rogers Inst, Div Pulm Crit Care & Sleep Med,Dept Med, Los Angeles, CA 90033 USA; [Li, Changgong; Minoo, Parviz] Univ So Calif, Div Neonatol, Dept Pediat, Los Angeles, CA 90033 USA; [Cu Nguyen; Kahn, Michael; Borok, Zea] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Crandall, Edward D.] Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA; [Kahn, Michael] Univ So Calif, Ctr Mol Pathways & Drug Discovery, Los Angeles, CA 90033 USA; [Zhou, Beiyun; Kahn, Michael; Borok, Zea] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Pan, Jie-hong; Brody, Steven L.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Crandall, Edward D.] Univ So Calif, Dept Chem Engn & Mat Sci, Viterbi Sch Engn, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Washington University (WUSTL); University of Southern California	Borok, Z (corresponding author), Univ So Calif, Will Rogers Inst, Pulm Res Ctr, Div Pulm Critical Care & Sleep Med,Keck Sch Med, IRD 723,M-C 9520, Los Angeles, CA 90089 USA.	zborok@med.usc.edu	CRANDALL, EDWARD/AAD-8382-2020		Hastings Foundation; Whittier Foundation; National Institutes of Health [CA148837, ES017034, HL056244, HL056590, HL062569, HL089445, HL095349, HL108364, HL112638, HL114959, HL122582, NS074392, T32 CA900320]; Children's Discovery Institute; University of Southern California Norris Comprehensive Cancer Center [P30 CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089445, R01HL062569, R29HL056244, R01HL095349, R37HL062569, R01HL056590, R01HL122582, R01HL114959, R01HL112638, R01HL056244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074392] Funding Source: NIH RePORTER	Hastings Foundation; Whittier Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; University of Southern California Norris Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Hastings Foundation, Whittier Foundation, National Institutes of Health Grants CA148837, ES017034, HL056244, HL056590, HL062569, HL089445, HL095349, HL108364, HL112638, HL114959, HL122582, and NS074392, National Institutes of Health postdoctoral fellowship T32 CA900320, Children's Discovery Institute for support of the Pulmonary Epithelial Cell Core at Washington University in St. Louis, and University of Southern California Norris Comprehensive Cancer Center Support Grant P30 CA014089. Content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare that they have no conflicts of interest with the contents of this article.	ADAMSON IYR, 1975, LAB INVEST, V32, P736; ADAMSON IYR, 1974, LAB INVEST, V30, P35; Andersson ER, 2013, P NATL ACAD SCI USA, V110, pE602, DOI 10.1073/pnas.1208524110; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Ballard PL, 2010, AM J PHYSIOL-LUNG C, V299, pL36, DOI 10.1152/ajplung.00427.2009; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Barok Z, 2000, J BIOL CHEM, V275, P26507, DOI 10.1074/jbc.M910007199; BOROK Z, 1994, IN VITRO CELL DEV-AN, V30A, P99; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Cao YX, 2003, J CELL BIOCHEM, V89, P887, DOI 10.1002/jcb.10555; Chilosi M, 2002, LAB INVEST, V82, P1335, DOI 10.1097/01.LAB.0000032380.82232.67; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; DANTO SI, 1992, AM J RESP CELL MOL, V6, P296, DOI 10.1165/ajrcmb/6.3.296; DeMaio L, 2009, AM J PHYSIOL-LUNG C, V296, pL1051, DOI 10.1152/ajplung.00021.2009; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Endo M, 2012, J CELL SCI, V125, P2017, DOI 10.1242/jcs.097782; Flozak AS, 2010, J BIOL CHEM, V285, P3157, DOI 10.1074/jbc.M109.070326; Gang EJ, 2014, ONCOGENE, V33, P2169, DOI 10.1038/onc.2013.169; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Hasegawa K, 2012, STEM CELL TRANSL MED, V1, P18, DOI 10.5966/sctm.2011-0033; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Horani A, 2013, AM J RESP CELL MOL, V49, P341, DOI 10.1165/rcmb.2013-0046TE; Kahn M, 2011, FUTURE MED CHEM, V3, P1745, DOI [10.4155/FMC.11.126, 10.4155/fmc.11.126]; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Komiya Yuko, 2008, Organogenesis, V4, P68; Kung AL, 2000, GENE DEV, V14, P272; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lomas NJ, 2012, INT J CLIN EXP PATHO, V5, P58; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Mavila N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050401; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morrisey EE, 2003, AM J PATHOL, V162, P1393, DOI 10.1016/S0002-9440(10)64271-X; Nemoto E, 2012, BIOCHEM BIOPH RES CO, V422, P627, DOI 10.1016/j.bbrc.2012.05.039; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Nsair A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045603; Palpant NJ, 2007, J MOL CELL CARDIOL, V43, P362, DOI 10.1016/j.yjmcc.2007.06.012; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sasaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075010; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Tanjore H, 2013, AM J RESP CRIT CARE, V187, P630, DOI 10.1164/rccm.201205-0972OC; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Yang DH, 2009, CIRC RES, V104, P372, DOI 10.1161/CIRCRESAHA.108.185405; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; Zemans RL, 2011, P NATL ACAD SCI USA, V108, P15990, DOI 10.1073/pnas.1110144108; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zhou B, 2008, AM J PHYSIOL-CELL PH, V295, pC111, DOI 10.1152/ajpcell.90620.2007; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou BY, 2008, AM J PHYSIOL-CELL PH, V295, pC1141, DOI 10.1152/ajpcell.00120.2008	64	52	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6569	6582		10.1074/jbc.M115.706416	http://dx.doi.org/10.1074/jbc.M115.706416			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26833564	Green Published, hybrid			2022-12-26	WOS:000372894200042
J	Saviolli, JY; Cunha, MPV; Guerra, MFL; Irino, K; Catao-Dias, JL; de Carvalho, VM				Saviolli, Juliana Yuri; Vieira Cunha, Marcos Paulo; Lopes Guerra, Maria Flavia; Irino, Kinue; Catao-Dias, Jose Luiz; de Carvalho, Vania Maria			Free-Ranging Frigates (Fregata magnificens) of the Southeast Coast of Brazil Harbor Extraintestinal Pathogenic Escherichia coli Resistant to Antimicrobials	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ANTIBIOTIC-RESISTANCE; VIRULENCE GENOTYPES; WILD BIRDS; STRAINS; INFECTIONS; BACTERIA; HUMANS; IDENTIFICATION; MENINGITIS	Seabirds may be responsible for the spread of pathogenic/resistant organisms over great distances, playing a relevant role within the context of the One World, One Health concept. Diarrheagenic E. coli strains, known as STEC (shiga toxin-producing E. coli), and the extra-intestinal pathogenic E. coli (ExPEC and the subpathotype APEC), are among the E. coli pathotypes with zoonotic potential associated with the birds. In order to identify health threats carried by frigates and to evaluate the anthropic influence on the southern coast of Brazil, the aim of this work was to characterize E. coli isolated from free-ranging frigates in relation to virulence genotypes, serotypes, phylogenetic groups and antimicrobial resistance. Cloacal and choanal swabs were sampled from 38 Fregata magnificens from two oceanic islands and one rescue center. Forty-three E. coli strains were recovered from 33 out of the 38 birds (86.8%); 88.4% of strains showed some of the virulence genes (VGs) searched, 48.8% contained three or more VGs. None of the strains presented VGs related to EPEC/STEC. Some of the isolates showed virulence genotypes, phylogenetic groups and serotypes of classical human ExPEC or APEC (O2:H7, O1:H6, ONT:H7, O25:H4). Regarding antimicrobial susceptibility, 62.8% showed resistance, and 11.6% (5/43) were multidrug-resistant. The E. coli present in the intestines of the frigates may reflect the environmental human impact on southeast coast of Brazil; they may also represent an unexplored threat for seabird species, especially considering the overlap of pathogenic potential and antimicrobial resistance present in these strains.	[Saviolli, Juliana Yuri; Vieira Cunha, Marcos Paulo; Lopes Guerra, Maria Flavia; Catao-Dias, Jose Luiz; de Carvalho, Vania Maria] Univ Sao Paulo, Fac Med Vet, Dept Pathol, Sao Paulo, SP, Brazil; [Irino, Kinue] Adolfo Lutz Inst, Enterobacteriacea Lab, Sao Paulo, SP, Brazil; [Saviolli, Juliana Yuri] Projeto Albatroz, Santos, SP, Brazil	Universidade de Sao Paulo; Instituto Adolfo Lutz	de Carvalho, VM (corresponding author), Univ Sao Paulo, Fac Med Vet, Dept Pathol, Sao Paulo, SP, Brazil.	vaniamc@uol.com.br	Cunha, Marcos Paulo Vieira/J-4832-2014; CATÃO-DIAS, JOSE LUIZ/C-4897-2012	Cunha, Marcos Paulo Vieira/0000-0002-8545-1518; CATÃO-DIAS, JOSE LUIZ/0000-0003-2999-3395	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; VMC [2010/51943-4]; MPVC [2010/20706-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); VMC; MPVC	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br); VMC, Grant #2010/51943-4; MPVC, Grant # 2010/20706-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Barbieri NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072322; Barbieri NL, 2015, FOODBORNE PATHOG DIS, V12, P74, DOI 10.1089/fpd.2014.1815; Bonnedahl J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005958; Carroll D, 2015, ZOONOSES PUBLIC HLTH, V62, P534, DOI 10.1111/zph.12182; Carvalho VM, 2012, J VET DIAGN INVEST, V24, P1014, DOI 10.1177/1040638712453576; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clinical and Laboratory Standards Institute (CLSI), 2020, PERFORMANCE STANDARD, V5th; CLSI, 2013, VET01S2 CLSI; CLSI, 2013, PERFORMANCE STANDARD; Cunha MPV, 2014, SCI WORLD J, DOI 10.1155/2014/289024; da Costa PM, 2013, INT J ENV RES PUB HE, V10, P278, DOI 10.3390/ijerph10010278; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; GANNON VPJ, 1993, J CLIN MICROBIOL, V31, P1268, DOI 10.1128/JCM.31.5.1268-1274.1993; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; Gordon DM, 2003, MICROBIOL-SGM, V149, P3575, DOI 10.1099/mic.0.26486-0; Iovine R, 2015, BRAZILIAN J IN PRESS; Johnson JR, 2005, INT J MED MICROBIOL, V295, P383, DOI 10.1016/j.ijmm.2005.07.005; Johnson JR, 2003, J CLIN MICROBIOL, V41, P337, DOI 10.1128/JCM.41.1.337-345.2003; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Maluta RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105016; Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; Mora Azucena, 2013, Vet Microbiol, V167, P506, DOI 10.1016/j.vetmic.2013.08.007; Mora A, 2012, APPL ENVIRON MICROB, V78, P2578, DOI 10.1128/AEM.07520-11; Moura A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00419; Muscat Edelcio, 2014, Check List, V10, P729; Olsvik Orjan, 1993, P271; Osugui L, 2014, VET MICROBIOL, V171, P242, DOI 10.1016/j.vetmic.2014.03.027; Pesapane R, 2013, ECOHEALTH, V10, P115, DOI 10.1007/s10393-013-0838-2; POLLARD DR, 1990, J CLIN MICROBIOL, V28, P540, DOI 10.1128/JCM.28.3.540-545.1990; Radhouani H, 2009, VET REC, V165, P138, DOI 10.1136/vr.165.5.138; Radhouani H, 2012, J MED MICROBIOL, V61, P837, DOI 10.1099/jmm.0.038364-0; Riley LW, 2014, CLIN MICROBIOL INFEC, V20, P380, DOI 10.1111/1469-0691.12646; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Schwarz S, 2010, VET MICROBIOL, V141, P1, DOI 10.1016/j.vetmic.2009.12.013; Smith JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/fpd.2007.0087; Smith S, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-8; Steele CM, 2005, J WILDLIFE DIS, V41, P735, DOI 10.7589/0090-3558-41.4.735; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Tsiodras S, 2008, J INFECTION, V56, P83, DOI 10.1016/j.jinf.2007.11.001; YAMAMOTO S, 1995, MICROBIOL IMMUNOL, V39, P401, DOI 10.1111/j.1348-0421.1995.tb02219.x	45	9	10	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148624	10.1371/journal.pone.0148624	http://dx.doi.org/10.1371/journal.pone.0148624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845679	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800077
J	Choi, HJ; Chung, TW; Park, MJ; Lee, KS; Yoon, Y; Kim, HS; Lee, JH; Kwon, SM; Lee, SO; Kim, KJ; Baek, JH; Ha, KT				Choi, Hee-Jung; Chung, Tae-Wook; Park, Mi-Ju; Lee, Kyu Sup; Yoon, Youngjin; Kim, Hyung Sik; Lee, Jun Hee; Kwon, Sang-Mo; Lee, Syng-Ook; Kim, Keuk-Jun; Baek, Jin-Ho; Ha, Ki-Tae			Paeonia lactiflora Enhances the Adhesion of Trophoblast to the Endometrium via Induction of Leukemia Inhibitory Factor Expression	PLOS ONE			English	Article							EMBRYONIC IMPLANTATION DYSFUNCTION; CHINESE HERBAL MEDICINE; UNEXPLAINED INFERTILITY; PREVENTS IMPLANTATION; UTERINE RECEPTIVITY; MENSTRUAL-CYCLE; CELL-ADHESION; FACTOR LIF; KAPPA-B; PAEONIFLORIN	In the present study, we investigated the role of Paeonia lactiflora Pall. extract on embryo implantation in vitro and in vivo. A polysaccharides depleted-water extract of P. lactiflora (PL-PP) increased LIF expression in human endometrial Ishikawa cells at non-cytotoxic doses. PL-PP significantly increased the adhesion of the human trophectoderm-derived JAr spheroids to endometrial Ishikawa cells. PL-PP-induced LIF expression was decreased in the presence of a p38 kinase inhibitor SB203580 and an MEK/ERK inhibitor U0126. Furthermore, endometrial LIF knockdown by shRNA reduced the expression of integrins beta 3 and beta 5 and adhesion of JAr spheroids to Ishikawa cells. In vivo administration of PL-PP restored the implantation of mouse blastocysts in a mifepristone-induced implantation failure mice model. Our results demonstrate that PL-PP increases LIF expression via the p38 and MEK/ERK pathways and favors trophoblast adhesion to endometrial cells.	[Choi, Hee-Jung; Chung, Tae-Wook; Park, Mi-Ju; Ha, Ki-Tae] Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan, Gyeongsangnam D, South Korea; [Choi, Hee-Jung; Chung, Tae-Wook; Park, Mi-Ju; Ha, Ki-Tae] Pusan Natl Univ, Korean Med Res Ctr Hlth Aging, Yangsan, Gyeongsangnam D, South Korea; [Lee, Kyu Sup] Pusan Natl Univ Hosp, Dept Obstet & Gynecol, Pusan, South Korea; [Yoon, Youngjin] Pusan Natl Univ, Sch Korean Med, Dept Korean Obstet & Gynecol, Pusan 609735, South Korea; [Kim, Hyung Sik] Sungkyunkwan Univ, Sch Pharm, Mol Toxicol Lab, Suwon, Gyeonggi Do, South Korea; [Lee, Jun Hee; Kwon, Sang-Mo] Pusan Natl Univ, Sch Med, Med Res Inst, Lab Vasc Med & Stem Cell Biol,Dept Physiol, Yangsan, Gyeongsangnam D, South Korea; [Lee, Syng-Ook] Keimyung Univ, Dept Food Sci & Technol, Daegu, South Korea; [Kim, Keuk-Jun] TaeKyeung Univ, Dept Clin Pathol, Gyongsan, South Korea; [Baek, Jin-Ho] Daechubatbaek Korean Med Clin, Gyeongju, Gyeongsangbuk D, South Korea	Pusan National University; Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Sungkyunkwan University (SKKU); Pusan National University; Pusan National University Hospital; Keimyung University	Ha, KT (corresponding author), Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan, Gyeongsangnam D, South Korea.; Ha, KT (corresponding author), Pusan Natl Univ, Korean Med Res Ctr Hlth Aging, Yangsan, Gyeongsangnam D, South Korea.	hagis@pusan.ac.kr		Chung, Tae-Wook/0000-0001-5243-5020; Lee, Syng-Ook/0000-0002-8958-8634	Traditional Korean Medicine R&D Project, Ministry of Health Welfare [HI13C0502]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MISP), Korea Government [2014R1A5A20009936]	Traditional Korean Medicine R&D Project, Ministry of Health Welfare; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MISP), Korea Government	This study was supported by a grant of the Traditional Korean Medicine R&D Project, Ministry of Health & Welfare (Grant no. HI13C0502), and by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT & Future Planning (MISP), Korea Government (Grant no. 2014R1A5A20009936).	Agca C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.323; Aghajanova L, 2010, CURR OPIN OBSTET GYN, V22, P213, DOI 10.1097/GCO.0b013e32833848e5; ARICI A, 1995, J CLIN ENDOCR METAB, V80, P1908, DOI 10.1210/jc.80.6.1908; Aschenbach LC, 2013, CONTRACEPTION, V87, P813, DOI 10.1016/j.contraception.2012.09.032; Brown JK, 2012, MOL HUM REPROD, V18, P111, DOI 10.1093/molehr/gar068; Cakmak H, 2011, HUM REPROD UPDATE, V17, P242, DOI 10.1093/humupd/dmq037; Castelbaum AJ, 1997, J CLIN ENDOCR METAB, V82, P136, DOI 10.1210/jc.82.1.136; Catalano RD, 2005, P NATL ACAD SCI USA, V102, P8585, DOI 10.1073/pnas.0502343102; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; da Costa SV, 2010, LEUKEMIA RES, V34, P507, DOI 10.1016/j.leukres.2009.10.012; Danielsson KG, 1997, HUM REPROD, V12, P1293; Diedrich K, 2007, HUM REPROD UPDATE, V13, P365, DOI 10.1093/humupd/dmm011; Dimitriadis E, 2010, PLACENTA, V31, pS99, DOI 10.1016/j.placenta.2009.12.027; Fan ZY, 2004, CYTOKINE, V28, P17, DOI 10.1016/j.cyto.2004.06.003; Gao D., 1997, ENCY CHINESE MED; Gao WN, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/678390; Giudice LC, 1999, HUM REPROD, V14, P3, DOI 10.1093/humrep/14.suppl_2.3; Gui J, 2012, AM J REPROD IMMUNOL, V67, P383, DOI 10.1111/j.1600-0897.2011.01097.x; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; He DY, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00010; Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4; Jia W, 2006, PHYTOTHER RES, V20, P819, DOI 10.1002/ptr.1905; Koot YEM, 2013, CURR OPIN OBSTET GYN, V25, P274, DOI 10.1097/GCO.0b013e3283630d94; Laird SM, 2000, MOL HUM REPROD, V6, P34, DOI 10.1093/molehr/6.1.34; Lalitkumar PGL, 2007, HUM REPROD, V22, P3031, DOI 10.1093/humrep/dem297; Lee B, 2008, ARCH PHARM RES, V31, P445, DOI 10.1007/s12272-001-1177-6; Lessey BA, 1998, HUM REPROD, V13, P247, DOI 10.1093/humrep/13.suppl_3.247; LESSEY BA, 1992, J CLIN INVEST, V90, P188, DOI 10.1172/JCI115835; Li QX, 2002, J BIOL CHEM, V277, P46447, DOI 10.1074/jbc.M203555200; Lian F, 2013, J ALTERN COMPLEM MED, V19, P353, DOI 10.1089/acm.2011.0410; Liu DF, 2006, CLIN EXP PHARMACOL P, V33, P332, DOI 10.1111/j.1440-1681.2006.04371.x; Macklon NS, 2006, ENDOCR REV, V27, P170, DOI 10.1210/er.2005-0015; Mao QQ, 2012, PHARM BIOL, V50, P72, DOI 10.3109/13880209.2011.602696; Menkhorst E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019665; Poncelet C, 2002, ACTA OBSTET GYN SCAN, V81, P195, DOI 10.1034/j.1600-0412.2002.810302.x; Ried K, 2011, COMPLEMENT THER MED, V19, P319, DOI 10.1016/j.ctim.2011.09.003; Robertson SA, 2010, J REPROD IMMUNOL, V85, P51, DOI 10.1016/j.jri.2010.01.008; ROBLERO LS, 1987, CONTRACEPTION, V36, P549, DOI 10.1016/0010-7824(87)90007-2; Steck T, 2004, EUR J OBSTET GYN R B, V112, P69, DOI 10.1016/S0301-2115(03)00315-4; Tabibzadeh SRGJDALCGS, 2004, ENDOMETRIUM; Terakawa J, 2011, J REPROD DEVELOP, V57, P700, DOI 10.1262/jrd.11-048H; THIE M, 1995, EUR J CELL BIOL, V66, P180; TOMODA M, 1993, BIOL PHARM BULL, V16, P1207, DOI 10.1248/bpb.16.1207; Tong HB, 2014, CARBOHYD POLYM, V105, P20, DOI 10.1016/j.carbpol.2014.01.039; Vogiagis D, 1996, J ENDOCRINOL, V148, P95, DOI 10.1677/joe.0.1480095; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104; Wu M, 2013, CYTOKINE, V62, P334, DOI 10.1016/j.cyto.2013.03.002; Yu N, 2011, J ETHNOPHARMACOL, V137, P389, DOI 10.1016/j.jep.2011.05.037; Zhang MM, 2008, J HUAZHONG U SCI-MED, V28, P65, DOI 10.1007/s11596-008-0116-7; Zheng YQ, 2007, INFLAMM RES, V56, P182, DOI 10.1007/s00011-006-6002-5	50	17	17	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148232	10.1371/journal.pone.0148232	http://dx.doi.org/10.1371/journal.pone.0148232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839969	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200104
J	Jin, WB; Wu, FL				Jin, Weibo; Wu, Fangli			Proteome-Wide Identification of Lysine Succinylation in the Proteins of Tomato (Solanum lycopersicum)	PLOS ONE			English	Article							NUCLEOSOME; TARGETS	Post-translational modification of proteins through lysine succinylation plays important regulatory roles in living cells. Lysine succinylation was recently identified as a novel post-translational modification in Escherichia coli, yeast, Toxoplasma gondii, HeLa cells, and mouse liver. Interestingly, only a few sites of lysine succinylation have been detected in plants to date. In this study, we identified 347 sites of lysine succinylation in 202 proteins in tomato by using high-resolution mass spectrometry. Succinylated proteins are implicated in the regulation of diverse metabolic processes, including chloroplast and mitochondrial metabolism. Bioinformatic analysis showed that succinylated proteins are evolutionarily conserved and involved in various cellular functions such as metabolism and epigenetic regulation. Moreover, succinylated proteins exhibit diverse subcellular localizations. We also defined six types of definitively conserved succinylation motifs. These results provide the first in-depth analysis of the lysine succinylome and novel insights into the role of succinylation in tomato, thereby elucidating lysine succinylation in the context of cellular physiology and metabolite biosynthesis in plants.	[Jin, Weibo; Wu, Fangli] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Wu, FL (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China.	wfl@zstu.edu.cn			Natural Science Foundation of China [31372075]; Natural Science Foundation of Zhejiang Province [LQ15C140021]; 521 Talent Foundation of Zhejiang Sci-Tech University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); 521 Talent Foundation of Zhejiang Sci-Tech University	This work was supported by the grants of the Natural Science Foundation of China (grant No. 31372075), and the website is (http://isisn.nsfc.gov.en/). This work was supported by the Natural Science Foundation of Zhejiang Province (grant No. LQ15C140021), and the website is (http:/www.zjnsf.gov.cn/). This work was supported by the 521 Talent Foundation of Zhejiang Sci-Tech University, and the website is (http://www.zstu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Fransz P, 2011, PLANT J, V66, P4, DOI 10.1111/j.1365-313X.2011.04526.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li XL, 2014, J PROTEOME RES, V13, P6087, DOI 10.1021/pr500992r; Lin HN, 2012, ACS CHEM BIOL, V7, P947, DOI 10.1021/cb3001793; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Pfluger J, 2007, CURR OPIN PLANT BIOL, V10, P645, DOI 10.1016/j.pbi.2007.07.013; Sadeh R, 2011, CELL, V147, P263, DOI 10.1016/j.cell.2011.09.042; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]	16	54	56	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147586	10.1371/journal.pone.0147586	http://dx.doi.org/10.1371/journal.pone.0147586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828863	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200025
J	Rankinen, T; Fuku, N; Wolfarth, B; Wang, G; Sarzynski, MA; Alexeev, DG; Ahmetov, II; Boulay, MR; Cieszczyk, P; Eynon, N; Filipenko, ML; Garton, FC; Generozov, EV; Govorun, VM; Houweling, PJ; Kawahara, T; Kostryukova, ES; Kulemin, NA; Larin, AK; Maciejewska-Karlowska, A; Miyachi, M; Muniesa, CA; Murakami, H; Ospanova, EA; Padmanabhan, S; Pavlenko, AV; Pyankova, ON; Santiago, C; Sawczuk, M; Scott, RA; Uyba, VV; Yvert, T; Perusse, L; Ghosh, S; Rauramaa, R; North, KN; Lucia, A; Pitsiladis, Y; Bouchard, C				Rankinen, Tuomo; Fuku, Noriyuki; Wolfarth, Bernd; Wang, Guan; Sarzynski, Mark A.; Alexeev, Dmitry G.; Ahmetov, Ildus I.; Boulay, Marcel R.; Cieszczyk, Pawel; Eynon, Nir; Filipenko, Maxim L.; Garton, Fleur C.; Generozov, Edward V.; Govorun, Vadim M.; Houweling, Peter J.; Kawahara, Takashi; Kostryukova, Elena S.; Kulemin, Nickolay A.; Larin, Andrey K.; Maciejewska-Karlowska, Agnieszka; Miyachi, Motohiko; Muniesa, Carlos A.; Murakami, Haruka; Ospanova, Elena A.; Padmanabhan, Sandosh; Pavlenko, Alexander V.; Pyankova, Olga N.; Santiago, Catalina; Sawczuk, Marek; Scott, Robert A.; Uyba, Vladimir V.; Yvert, Thomas; Perusse, Louis; Ghosh, Sujoy; Rauramaa, Rainer; North, Kathryn N.; Lucia, Alejandro; Pitsiladis, Yannis; Bouchard, Claude			No Evidence of a Common DNA Variant Profile Specific to World Class Endurance Athletes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CELL GENETIC-VARIATION; EXERCISE HEART-RATE; HERITAGE FAMILY; AEROBIC POWER; LINKAGE SCAN; POLYMORPHISM; PERFORMANCE; IDENTIFICATION; GENOTYPE	There are strong genetic components to cardiorespiratory fitness and its response to exercise training. It would be useful to understand the differences in the genomic profile of highly trained endurance athletes of world class caliber and sedentary controls. An international consortium (GAMES) was established in order to compare elite endurance athletes and ethnicity-matched controls in a case-control study design. Genome-wide association studies were undertaken on two cohorts of elite endurance athletes and controls (GENATHLETE and Japanese endurance runners), from which a panel of 45 promising markers was identified. These markers were tested for replication in seven additional cohorts of endurance athletes and controls: from Australia, Ethiopia, Japan, Kenya, Poland, Russia and Spain. The study is based on a total of 1520 endurance athletes (835 who took part in endurance events in World Championships and/or Olympic Games) and 2760 controls. We hypothesized that world-class athletes are likely to be characterized by an even higher concentration of endurance performance alleles and we performed separate analyses on this subsample. The meta-analysis of all available studies revealed one statistically significant marker (rs558129 at GALNTL6 locus, p = 0.0002), even after correcting for multiple testing. As shown by the low heterogeneity index (I-2 = 0), all eight cohorts showed the same direction of association with rs558129, even though p-values varied across the individual studies. In summary, this study did not identify a panel of genomic variants common to these elite endurance athlete groups. Since GAMES was underpowered to identify alleles with small effect sizes, some of the suggestive leads identified should be explored in expanded comparisons of world-class endurance athletes and sedentary controls and in tightly controlled exercise training studies. Such studies have the potential to illuminate the biology not only of world class endurance performance but also of compromised cardiac functions and cardiometabolic diseases.	[Rankinen, Tuomo; Sarzynski, Mark A.; Bouchard, Claude] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA USA; [Fuku, Noriyuki] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan; [Wolfarth, Bernd] Humboldt Univ, Dept Sport Med, D-10099 Berlin, Germany; [Wolfarth, Bernd] Charite, Sch Med, D-13353 Berlin, Germany; [Wang, Guan; Pitsiladis, Yannis] Univ Brighton, Ctr Sport & Exercise Sci & Med SESAME, Eastbourne, England; [Alexeev, Dmitry G.; Ahmetov, Ildus I.; Generozov, Edward V.; Govorun, Vadim M.; Kostryukova, Elena S.; Kulemin, Nickolay A.; Larin, Andrey K.; Ospanova, Elena A.; Pavlenko, Alexander V.] Res Inst Physical Chem Med, Moscow, Russia; [Ahmetov, Ildus I.] Volga Reg State Acad Phys Culture Sport & Tourism, Sport Technol Res Ctr, Kazan, Russia; [Boulay, Marcel R.; Perusse, Louis] Univ Laval, Dept Kinesiol, Ste Foy, PQ, Canada; [Cieszczyk, Pawel; Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek] Univ Szczecin, Dept Phys Educ & Hlth Promot, PL-70453 Szczecin, Poland; [Cieszczyk, Pawel] Acad Phys Educ & Sport, Dept Tourism & Recreat, Gdansk, Poland; [Eynon, Nir] Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia; [Filipenko, Maxim L.; Houweling, Peter J.; Pyankova, Olga N.] RAS, Inst Chem Biol & Fundamental Med, Pharmacogen Lab, SB, Novosibirsk, Russia; [Filipenko, Maxim L.; Houweling, Peter J.; Pyankova, Olga N.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Garton, Fleur C.; North, Kathryn N.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic 3010, Australia; [Garton, Fleur C.; North, Kathryn N.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Garton, Fleur C.; North, Kathryn N.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Westmead, NSW, Australia; [Kawahara, Takashi] Japan Inst Sports Sci, Dept Sports Med, Tokyo, Japan; [Miyachi, Motohiko; Murakami, Haruka] Natl Inst Hlth & Nutr, Dept Hlth Promot & Exercise, Tokyo 162, Japan; [Muniesa, Carlos A.; Santiago, Catalina; Yvert, Thomas; Lucia, Alejandro] Univ Europea & Res Inst I 12, Madrid, Spain; [Padmanabhan, Sandosh] Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Scott, Robert A.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge Biomed Campus, Cambridge, England; [Uyba, Vladimir V.] Fed Med Biol Agcy, Moscow, Russia; [Ghosh, Sujoy] Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Ghosh, Sujoy] Duke NUS Grad Med Sch, Ctr Computat Biol, Singapore, Singapore; [Rauramaa, Rainer] Univ Eastern Finland, Kuopio Res Inst Exercise Med, Kuopio, Finland; [Sarzynski, Mark A.] Univ S Carolina, Sch Publ Hlth, Columbia, SC 29208 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Juntendo University; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Brighton; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Volga Region State Academy of Physical Culture, Sport & Tourism; Laval University; University of Szczecin; Gdansk University of Physical Education & Sport; Victoria University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Sydney; National Institute of Health & Nutrition - Japan; University of Glasgow; University of Cambridge; National University of Singapore; National University of Singapore; University of Eastern Finland; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Bouchard, C (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA USA.	claude.bouchard@pbrc.edu	Generozov, Edward V/U-3431-2017; Perusse, Louis/A-3444-2012; Houweling, Peter/B-4157-2016; Cieszczyk, Pawel/AAG-3328-2022; Padmanabhan, Sandosh/S-3963-2016; Bouchard, Claude/A-7637-2009; Bouchard, Claude/AAE-2035-2019; Ghosh, Sujoy/I-3729-2017; North, Kathryn N/K-6476-2012; Wang, Guan/AAN-9249-2020; Govorun, Vadim M/A-9043-2018; Filipenko, Maksim/AAU-9552-2020; Ahmetov, Ildus I/C-6163-2009; Kostryukova, Elena/D-8064-2014; Garton, Fleur/H-7713-2016; Sawczuk, Marek/S-3609-2017; Sarzynski, Mark/A-9798-2014; Garton, Fleur C./D-2744-2017; Kulemin, Nikolay A./F-3571-2017; Alexeev, Dmitry/A-6167-2013; Cieszczyk, Pawel/AFK-4645-2022; Rankinen, Tuomo/N-1984-2017; Santiago, Catalina/P-8177-2019; Miyachi, Motohiko/AAW-3403-2020	Generozov, Edward V/0000-0002-6314-4883; Perusse, Louis/0000-0001-6440-9698; Houweling, Peter/0000-0001-6132-2554; Cieszczyk, Pawel/0000-0002-7735-7580; Bouchard, Claude/0000-0002-0048-491X; Ghosh, Sujoy/0000-0002-7601-165X; North, Kathryn N/0000-0003-0841-8009; Wang, Guan/0000-0002-7432-7933; Filipenko, Maksim/0000-0002-8950-5368; Ahmetov, Ildus I/0000-0002-6335-4020; Kostryukova, Elena/0000-0002-0457-6803; Garton, Fleur/0000-0002-1490-5930; Garton, Fleur C./0000-0002-1490-5930; Kulemin, Nikolay A./0000-0002-8588-3206; Alexeev, Dmitry/0000-0003-0783-1176; Cieszczyk, Pawel/0000-0002-7735-7580; Santiago, Catalina/0000-0003-3852-8217; Miyachi, Motohiko/0000-0002-1146-0905; Eynon, Nir/0000-0003-4046-8276; Yvert, Thomas/0000-0002-9451-9799; Maciejewska-Skrendo, Agnieszka/0000-0003-4587-2411; Lucia, Alejandro/0000-0002-5565-0997; Sawczuk, Marek/0000-0002-5730-5249; Fuku, Noriyuki/0000-0001-7792-5835; Murakami, Haruka/0000-0001-9160-0033; Padmanabhan, Sandosh/0000-0003-3869-5808; Wolfarth, Bernd/0000-0001-6501-3003; Pitsiladis, Yannis/0000-0001-6210-2449	Prince Faisal Prize awarded; John W. Barton Jr Chair in Genetics and Nutrition; Federal Medical-Biological Agency; Fondo de Investigaciones Sanitarias [PI12/00914]; Consejo Superior de Deportes (CSD); Ministry of Education, Culture, Sports, Science and Technology [24650414]	Prince Faisal Prize awarded; John W. Barton Jr Chair in Genetics and Nutrition; Federal Medical-Biological Agency; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Consejo Superior de Deportes (CSD); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Partial funding for the study has been received from the Prince Faisal Prize awarded to Drs. C. Bouchard, T. Rankinen, M. Sarzynski and B. Wolfahrt. CB is partially funded by the John W. Barton Jr Chair in Genetics and Nutrition. The study in Russia was supported by a grant from the Federal Medical-Biological Agency ("Sportgen project"), http://fmbaros.ru/en/fmba/infor/. The Spanish group (AL, CAM, CS, TY) was funded by Fondo de Investigaciones Sanitarias (grant # PI12/00914). Research in sports genetics to A. Lucia in Spain was funded by grants from the Consejo Superior de Deportes (CSD). This work in Japan was supported in part by grants from the programs Grants-in-Aid for Challenging Exploratory Research (24650414 to NF) from the Ministry of Education, Culture, Sports, Science and Technology; and by a grant-in-aid for scientific research from the Ministry of Health, Labor, and Welfare of Japan (to MM). No specific funding for this work was received for the studies performed in Australia, Poland, Kenya and Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmetov II, 2010, BRIT J SPORT MED, V44, P649, DOI 10.1136/bjsm.2008.051540; Argyropoulos G, 2009, PHYSIOL GENOMICS, V36, P79, DOI 10.1152/physiolgenomics.00003.2008; Ash GI, 2011, MED SCI SPORT EXER, V43, P590, DOI 10.1249/MSS.0b013e3181f70bd6; Bouchard C, 1994, Obes Res, V2, P400; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Buxens A, 2011, SCAND J MED SCI SPOR, V21, P570, DOI 10.1111/j.1600-0838.2009.01079.x; Chagnon YC, 1984, J SPORT SCI, V2, P121, DOI 10.1080/02640418408729707; COUTURE L, 1986, CAN J APPL SPORT SCI, V11, P16; de Garay A. L., 1974, GENETIC ANTHR STUDIE; De Moor MHM, 2007, TWIN RES HUM GENET, V10, P812, DOI 10.1375/twin.10.6.812; Eynon N, 2009, EXP PHYSIOL, V94, P1147, DOI 10.1113/expphysiol.2009.049668; GEDDA L, 1960, Acta Genet Med Gemellol (Roma), V9, P387; Ghosh S, 2013, J APPL PHYSIOL, V115, P1343, DOI 10.1152/japplphysiol.01487.2012; HAMEL P, 1986, MED SCI SPORT EXER, V18, P690; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Liekens AML, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r57; LORTIE G, 1982, HUM BIOL, V54, P801; Mikami E, 2013, SCAND J MED SCI SPOR, V23, P593, DOI 10.1111/j.1600-0838.2011.01424.x; Mikami E, 2011, BRIT J SPORT MED, V45, P1179, DOI 10.1136/bjsm.2010.072371; Peng C, 2010, BIOCHEM BIOPH RES CO, V402, P680, DOI 10.1016/j.bbrc.2010.10.084; Pitsiladis Y, 2013, BRIT J SPORT MED, V47, P550, DOI 10.1136/bjsports-2013-092400; PRUDHOMME D, 1984, MED SCI SPORT EXER, V16, P489, DOI 10.1249/00005768-198410000-00012; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rankinen T, 2000, J APPL PHYSIOL, V88, P1571, DOI 10.1152/jappl.2000.88.5.1571; Rankinen T, 2011, ENCY SPORTS MED, P177; Rankinen T, 2012, J APPL PHYSIOL, V112, P892, DOI 10.1152/japplphysiol.01287.2011; Rice TK, 2012, EUR J APPL PHYSIOL, V112, P2969, DOI 10.1007/s00421-011-2274-8; Rivera MA, 1997, MED SCI SPORT EXER, V29, P1311, DOI 10.1097/00005768-199710000-00006; Rivera MA, 1999, INT J OBESITY, V23, P666, DOI 10.1038/sj.ijo.0800900; Scott RA, 2003, MED SCI SPORT EXER, V35, P1727, DOI 10.1249/01.MSS.0000089335.85254.89; Skinner JS, 2001, J APPL PHYSIOL, V90, P1770, DOI 10.1152/jappl.2001.90.5.1770; Spielmann N, 2007, AM J PHYSIOL-HEART C, V293, pH3366, DOI 10.1152/ajpheart.00042.2007; Stutz AM, 2009, EUR J HUM GENET, V17, P1481, DOI 10.1038/ejhg.2009.64; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wolfarth B, 2008, SCAND J MED SCI SPOR, V18, P485, DOI 10.1111/j.1600-0838.2007.00717.x; Wolfarth B, 2000, MED SCI SPORT EXER, V32, P1709, DOI 10.1097/00005768-200010000-00008; Wolfarth B, 2011, ENCY SPORTS MED, VXVIII, P151; Wolfarth B, 2007, METABOLISM, V56, P1649, DOI 10.1016/j.metabol.2007.07.006; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Zarebska A, 2013, J STRENGTH COND RES, V27, P2898, DOI 10.1519/JSC.0b013e31828155b5	46	70	70	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147330	10.1371/journal.pone.0147330	http://dx.doi.org/10.1371/journal.pone.0147330			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824906	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000369528600025
J	Yang, L; Yu, D; Mo, R; Zhang, JR; Hua, H; Hu, L; Feng, Y; Wang, S; Zhang, WY; Yin, N; Mo, XM				Yang, Lei; Yu, Di; Mo, Ran; Zhang, Jiru; Hua, Hu; Hu, Liang; Feng, Yu; Wang, Song; Zhang, Wei-yan; Yin, Ning; Mo, Xu-Ming			The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; PROTEIN-COUPLED RECEPTORS; CHRONIC HYPOXIA; HEART-FAILURE; RATS; MONOCROTALINE; INHIBITION; EXPRESSION; KINASE; CANCER	Background Pulmonary arterial hypertension is characterized by increased pressure overload that leads to right ventricular hypertrophy (RVH). GPR91 is a formerly orphan G-protein-coupled receptor (GPCR) that has been characterized as a receptor for succinate; however, its role in RVH remains unknown. Methods and Results We investigated the role of succinate-GPR91 signaling in a pulmonary arterial banding (PAB) model of RVH induced by pressure overload in SD rats. GPR91 was shown to be located in cardiomyocytes. In the sham and PAB rats, succinate treatment further aggravated RVH, up-regulated RVH-associated genes and increased p-Akt/t-Akt levels in vivo. In vitro, succinate treatment up-regulated the levels of the hypertrophic gene marker anp and p-Akt/t-Akt in cardiomyocytes. All these effects were inhibited by the PI3K antagonist wortmannin both in vivo and in vitro. Finally, we noted that the GPR91-PI3K/Akt axis was also up-regulated compared to that in human RVH. Conclusions Our findings indicate that succinate-GPR91 signaling may be involved in RVH via PI3K/Akt signaling in vivo and in vitro. Therefore, GPR91 may be a novel therapeutic target for treating pressure overload-induced RVH.	[Yang, Lei] Nanjing Med Univ, Dept Gastroenterol, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China; [Yu, Di; Hua, Hu; Hu, Liang; Feng, Yu; Wang, Song; Zhang, Wei-yan; Mo, Xu-Ming] Nanjing Med Univ, Dept Cardiothorac Surg, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China; [Mo, Ran] Nanjing Univ, Sch Med, Dept Cardiothorac Surg, Nanjing Drum Tower Hosp,Affiliated Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Jiru] Jiangnan Univ, Dept Anesthesiol, Affiliated Hosp, Wuxi Peoples Hosp 4, Nanjing, Jiangsu, Peoples R China; [Yin, Ning] Southeast Univ, Dept Anesthesiol, Zhongda Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University; Jiangnan University; Southeast University - China	Mo, XM (corresponding author), Nanjing Med Univ, Dept Cardiothorac Surg, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China.; Yin, N (corresponding author), Southeast Univ, Dept Anesthesiol, Zhongda Hosp, Nanjing, Jiangsu, Peoples R China.	yinning882000@126.com; mohsuming15@sina.com	Yang, Mi/GQA-8758-2022	Hu, Liang/0000-0002-0013-7440	National Natural Science Foundation of China [81370277, 81500243]; National 12th Five-Year technology based plan topic [2011BAI11B22]; Research and Innovation Project for College Graduates of Jiangsu Province [CXLX-0560]; Young talent of Nanjing Children's Hospital Affiliated to Nanjing Medical University; Medical Science and technology development Foundation; Nanjing Department of Health [YKK14116]; Hospital Management Center Project of Wuxi [YGZXY1307]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 12th Five-Year technology based plan topic; Research and Innovation Project for College Graduates of Jiangsu Province; Young talent of Nanjing Children's Hospital Affiliated to Nanjing Medical University; Medical Science and technology development Foundation; Nanjing Department of Health; Hospital Management Center Project of Wuxi	This work was supported by the National Natural Science Foundation of China (81370277, 81500243), the National 12th Five-Year technology based plan topic (2011BAI11B22), was sponsored by the Research and Innovation Project for College Graduates of Jiangsu Province (CXLX-0560), and by Young talent of Nanjing Children's Hospital Affiliated to Nanjing Medical University and Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health (YKK14116) and Hospital Management Center Project of Wuxi (YGZXY1307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli E, 2012, CARDIOTHORAC SURG, V2012, DOI [10.1093/mmcts/mms010, DOI 10.1093/MMCTS/MMS010]; Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; Billard MJ, 2014, AM J CLIN EXP IMMUNO, V3, P97; Blyth Kevin G, 2011, Pulm Circ, V1, P470, DOI 10.4103/2045-8932.93546; Chiarini A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/471790; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cooke CL, 2014, J DEV ORIG HLTH DIS, V5, P36, DOI 10.1017/S2040174413000524; Camberos MD, 2014, J BIOENERG BIOMEMBR, V46, P357, DOI 10.1007/s10863-014-9563-y; Dempsie Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-159; Dunlop K, 2014, FREE RADICAL BIO MED, V69, P35, DOI 10.1016/j.freeradbiomed.2014.01.008; Engi SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105172; Farmer DGS, 2014, PULM PHARMACOL THER, V29, P7, DOI 10.1016/j.pupt.2014.01.002; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hu JY, 2013, EXP EYE RES, V109, P31, DOI 10.1016/j.exer.2013.01.011; Huffman KM, 2014, DIABETOLOGIA, V57, P2282, DOI 10.1007/s00125-014-3343-4; Iftikar FI, 2014, J EXP BIOL, V217, P2348, DOI 10.1242/jeb.098798; Janssen W, 2013, EXP PHYSIOL, V98, P1274, DOI 10.1113/expphysiol.2012.069138; Kim KC, 2012, J KOREAN MED SCI, V27, P605, DOI 10.3346/jkms.2012.27.6.605; Komers R, 2013, CLIN SCI, V124, P553, DOI 10.1042/CS20120468; Kumar S, 2012, AM J PHYSIOL-HEART C, V302, pH1655, DOI 10.1152/ajpheart.00756.2011; Lang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043433; Lee KK, 2015, HEPATOLOGY, V61, P326, DOI 10.1002/hep.27385; Liu CP, 2014, KAOHSIUNG J MED SCI, V30, P267, DOI 10.1016/j.kjms.2014.02.014; Liu XX, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-356; Lyu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101438; Mivelaz Y, 2011, J DEV ORIG HLTH DIS, V2, P184, DOI 10.1017/S2040174411000171; Oudit GY, 2008, CARDIOVASC RES, V78, P505, DOI 10.1093/cvr/cvn041; Palomer X, 2013, INT J CARDIOL, V168, P3160, DOI 10.1016/j.ijcard.2013.07.150; Pecsi I, 2014, MBIO, V5, DOI 10.1128/mBio.01093-14; Peters THF, 2013, CELL BIOCHEM BIOPHYS, V67, P305, DOI 10.1007/s12013-013-9710-9; Piao L, 2013, J MOL MED, V91, P1185, DOI 10.1007/s00109-013-1064-7; Piao L, 2012, CIRCULATION, V126, P2859, DOI 10.1161/CIRCULATIONAHA.112.109868; Piao L, 2010, J MOL MED, V88, P1011, DOI 10.1007/s00109-010-0679-1; Pluznick JL, 2013, AM J PHYSIOL-RENAL, V305, pF439, DOI 10.1152/ajprenal.00252.2013; Prigent A, 2014, SEMIN NUCL MED, V44, P110, DOI 10.1053/j.semnuclmed.2013.10.006; Qazi AK, 2015, CANCER LETT, V359, P47, DOI 10.1016/j.canlet.2014.12.034; Qi D, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0159-1; Rogers NM, 2013, PULM CIRC, V3, P936, DOI 10.1086/674754; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Ruiz-Cano MJ, 2015, INT J CARDIOL, V181, P232, DOI 10.1016/j.ijcard.2014.11.118; Ryan JJ, 2013, HANDB EXP PHARMACOL, V218, P105, DOI 10.1007/978-3-642-38664-0_5; Stuckey DJ, 2014, CIRC-CARDIOVASC IMAG, V7, P240, DOI 10.1161/CIRCIMAGING.113.000993; Sundstrom L, 2013, FEBS LETT, V587, P2399, DOI 10.1016/j.febslet.2013.05.067; Tabima DM, 2012, FREE RADICAL BIO MED, V52, P1970, DOI 10.1016/j.freeradbiomed.2012.02.041; Tautermann CS, 2014, BIOORG MED CHEM LETT, V24, P4073, DOI 10.1016/j.bmcl.2014.07.009; Tigchelaar W, 2015, AM J PHYSIOL-CELL PH, V308, pC155, DOI 10.1152/ajpcell.00227.2014; Wagenaar GTM, 2014, AM J PHYSIOL-LUNG C, V307, pL261, DOI 10.1152/ajplung.00345.2013; Wang YL, 2014, EXP CELL RES, V328, P143, DOI 10.1016/j.yexcr.2014.07.029; Wang YL, 2011, J PHARMACOL EXP THER, V336, P56, DOI 10.1124/jpet.110.172668; Wang ZG, 2015, MED SCI MONITOR, V21, P9, DOI 10.12659/MSM.891063; Waskova-Arnostova P, 2014, CELL PHYSIOL BIOCHEM, V33, P310, DOI 10.1159/000356671; Yavuz T, 2013, PATHOL RES PRACT, V209, P302, DOI 10.1016/j.prp.2013.03.002; Yoshikawa N, 2014, BIOCHEM BIOPH RES CO, V453, P600, DOI 10.1016/j.bbrc.2014.09.135; Yousefi B, 2014, DNA REPAIR, V22, P24, DOI 10.1016/j.dnarep.2014.07.001; Zhang DX, 2014, LIFE SCI, V98, P39, DOI 10.1016/j.lfs.2013.12.208; Zhang LY, 2013, CIRC-HEART FAIL, V6, P1039, DOI 10.1161/CIRCHEARTFAILURE.112.000228; Zheng Y, 2013, EUR J CLIN INVEST, V43, P397, DOI 10.1111/eci.12050	58	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147597	10.1371/journal.pone.0147597	http://dx.doi.org/10.1371/journal.pone.0147597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824665	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600038
J	Stumpf, M; den Hertog, J				Stumpf, Miriam; den Hertog, Jeroen			Differential Requirement for Pten Lipid and Protein Phosphatase Activity during Zebrafish Embryonic Development	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; ENDOTHELIAL GROWTH-FACTOR; HEMATOPOIETIC STEM-CELLS; GLIOMA-CELLS; TYROSINE PHOSPHATASES; GERMLINE MUTATIONS; GLIOBLASTOMA CELLS; SIGNALING PATHWAY; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN	The lipid- and protein phosphatase PTEN is one of the most frequently mutated tumor suppressor genes in human cancers and many mutations found in tumor samples directly affect PTEN phosphatase activity. In order to understand the functional consequences of these mutations in vivo, the aim of our study was to dissect the role of Pten phosphatase activities during zebrafish embryonic development. As in other model organisms, zebrafish mutants lacking functional Pten are embryonically lethal. Zebrafish have two pten genes and pten double homozygous zebrafish embryos develop a severe pleiotropic phenotype around 4 days post fertilization, which can be largely rescued by re-introduction of pten mRNA at the one-cell stage. We used this assay to characterize the rescue-capacity of Pten and variants with mutations that disrupt lipid, protein or both phosphatase activities. The pleiotropic phenotype at 4dpf could only be rescued by wild type Pten, indicating that both phosphatase activities are required for normal zebrafish embryonic development. An earlier aspect of the phenotype, hyperbranching of intersegmental vessels, however, was rescued by Pten that retained lipid phosphatase activity, independent of protein phosphatase activity. Lipid phosphatase activity was also required for moderating pAkt levels at 4 dpf. We propose that the role of Pten during angiogenesis mainly consists of suppressing PI3K signaling via its lipid phosphatase activity, whereas the complex process of embryonic development requires lipid and protein phosphatase of Pten.	[Stumpf, Miriam; den Hertog, Jeroen] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Utrecht, Netherlands; [Stumpf, Miriam; den Hertog, Jeroen] Univ Med Ctr Utrecht, Utrecht, Netherlands; [den Hertog, Jeroen] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University - Excl LUMC	den Hertog, J (corresponding author), Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Utrecht, Netherlands.	j.denhertog@hubrecht.eu						BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; Cheney IW, 1998, CANCER RES, V58, P2331; Chi SG, 1998, GASTROENTEROLOGY, V115, P1084, DOI 10.1016/S0016-5085(98)70078-2; Choorapoikayil S, 2014, BLOOD, V123, P184, DOI 10.1182/blood-2013-05-501544; Choorapoikayil S, 2013, DIS MODEL MECH, V6, P1159, DOI 10.1242/dmm.012377; Choorapoikayil S, 2012, DIS MODEL MECH, V5, P241, DOI 10.1242/dmm.008326; Covassin LD, 2009, DEV BIOL, V329, P212, DOI 10.1016/j.ydbio.2009.02.031; Croushore JA, 2005, DEV DYNAM, V234, P911, DOI 10.1002/dvdy.20576; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; Davies MA, 1998, CANCER RES, V58, P5285; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Errafiy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083318; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Furnari FB, 1998, CANCER RES, V58, P5002; Gildea JJ, 2004, ONCOGENE, V23, P6788, DOI 10.1038/sj.onc.1207599; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Huang JH, 2002, J BIOL CHEM, V277, P10760, DOI 10.1074/jbc.M110219200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kolmodin K, 2001, FEBS LETT, V498, P208, DOI 10.1016/S0014-5793(01)02479-6; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Leslie NR, 2009, ADV ENZYME REGUL, V49, P190, DOI 10.1016/j.advenzreg.2008.12.002; Leslie NR, 2001, BIOCHEM J, V357, P427, DOI 10.1042/0264-6021:3570427; Leslie NR, 2000, BIOCHEM J, V346, P827, DOI 10.1042/0264-6021:3460827; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lyu JW, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0114-1; Ma DD, 2011, BLOOD, V118, P289, DOI 10.1182/blood-2010-12-327403; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Newton RH, 2015, BLOOD, V125, P852, DOI 10.1182/blood-2014-04-571372; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Park MJ, 2002, CANCER RES, V62, P6318; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stumpf M, 2015, METHODS, V77-78, P191, DOI 10.1016/j.ymeth.2014.11.002; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thakker GD, 1999, J BIOL CHEM, V274, P10002, DOI 10.1074/jbc.274.15.10002; Tibarewal P, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002138; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Wang H, 2010, P NATL ACAD SCI USA, V107, P5142, DOI 10.1073/pnas.0912524107; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Zhang XC, 2012, BIOCHEM J, V444, P457, DOI 10.1042/BJ20120098; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; Zhou YJ, 2004, WORLD J GASTROENTERO, V10, P3225	57	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148508	10.1371/journal.pone.0148508	http://dx.doi.org/10.1371/journal.pone.0148508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848951	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000113
J	Chen, GW; Kuo, SM; Yang, SL; Gong, YN; Hsiao, MR; Liu, YC; Shih, SR; Tsao, KC				Chen, Guang-Wu; Kuo, Shu-Ming; Yang, Shu-Li; Gong, Yu-Nong; Hsiao, Mei-Ren; Liu, Yi-Chun; Shih, Shin-Ru; Tsao, Kuo-Chien			Genomic Signatures for Avian H7N9 Viruses Adapting to Humans	PLOS ONE			English	Article							INFLUENZA-A VIRUS; AMINO-ACID; INCREASED VIRULENCE; POLYMERASE-ACTIVITY; POSITION 627; PB2 PROTEIN; PATHOGENICITY; TRANSMISSION; MUTATION; FERRETS	An avian influenza A H7N9 virus emerged in March 2013 and caused a remarkable number of human fatalities. Genome variability in these viruses may provide insights into host adaptability. We scanned over 140 genomes of the H7N9 viruses isolated from humans and identified 104 positions that exhibited seven or more amino acid substitutions. Approximately half of these substitutions were identified in the influenza ribonucleoprotein (RNP) complex. Although PB2 627K of the avian virus promotes replication in humans, 45 of the 147 investigated PB2 sequences retained the E signature at this position, which is an avian characteristic. We discovered 10 PB2 substitutions that covaried with K627E. An RNP activity assay showed that Q591K, D701N, and M535L restored the polymerase activity in human cells when 627K transformed to an avian-like E. Genomic analysis of the human-isolated avian influenza virus is crucial in assessing genome variability, because relationships between position-specific variations can be observed and explored. In this study, we observed alternative positions that can potentially compensate for PB2 627K, a well-known marker for cross-species infection. An RNP assay suggested Q591K, D701N, and M535L as potential markers for an H7N9 virus capable of infecting humans.	[Chen, Guang-Wu] Chang Gung Univ, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Coll Engn, Taoyuan, Taiwan; [Chen, Guang-Wu; Kuo, Shu-Ming; Shih, Shin-Ru; Tsao, Kuo-Chien] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Yang, Shu-Li; Gong, Yu-Nong; Hsiao, Mei-Ren; Liu, Yi-Chun; Shih, Shin-Ru; Tsao, Kuo-Chien] Linkou Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Hsiao, Mei-Ren; Tsao, Kuo-Chien] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, GW (corresponding author), Chang Gung Univ, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Coll Engn, Taoyuan, Taiwan.; Chen, GW; Tsao, KC (corresponding author), Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan.; Tsao, KC (corresponding author), Linkou Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan.; Tsao, KC (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan.	gwchen@mail.cgu.edu.tw; kctsao@cgmh.org.tw	liu, yi/GXE-9662-2022; Shih, Shin-Ru/M-9711-2016; Kuo, Shu-Ming/I-6350-2016; Chen, Guang-Wu/M-6768-2016	Kuo, Shu-Ming/0000-0002-4437-689X; Gong, Yu-Nong/0000-0002-6799-1561; Shih, Shin-Ru/0000-0003-4874-401X; Chen, Guang-Wu/0000-0002-5322-4839	Ministry of Science and Technology, Taipei, Taiwan [MOST 100-2221-E-182-056-MY3, MOST 103-2221-E-182-022, MOST 104-2221-E-182-064, MOST 101-2321-B-182-016-MY2]; Ministry of Health and Welfare, Taipei, Taiwan [MOHW-TD-B-111-D005]; Chang Gung Memorial Hospital, Linkou, Taiwan [BMRP 832, CMRPD1A0083, CLRPG3B0043, CMRPG3C0731-2]	Ministry of Science and Technology, Taipei, Taiwan; Ministry of Health and Welfare, Taipei, Taiwan; Chang Gung Memorial Hospital, Linkou, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants from the Ministry of Science and Technology, Taipei, Taiwan (MOST 100-2221-E-182-056-MY3, MOST 103-2221-E-182-022, MOST 104-2221-E-182-064, MOST 101-2321-B-182-016-MY2, http://www.most.gov.tw/); Ministry of Health and Welfare, Taipei, Taiwan (MOHW-TD-B-111-D005, http://www.mohw.gov.tw/); and Chang Gung Memorial Hospital, Linkou, Taiwan (BMRP 832, CMRPD1A0083, CLRPG3B0043, CMRPG3C0731-2, https://www.cgmh.org.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Bogner P, 2006, NATURE, V442, P981, DOI 10.1038/442981a; Boivin S, 2011, J BIOL CHEM, V286, P10439, DOI 10.1074/jbc.M110.182964; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Carr SM, 2006, VIROLOGY, V344, P492, DOI 10.1016/j.virol.2005.08.041; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen Guang-Wu, 2014, Biomed J, V37, P1, DOI 10.4103/2319-4170.125882; Chen GW, 2013, J FORMOS MED ASSOC, V112, P312, DOI 10.1016/j.jfma.2013.04.015; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Huang CH, 2013, J INFECT DIS, V208, P1898, DOI 10.1093/infdis/jit381; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lam WY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-528; Li JE, 2013, SCI CHINA LIFE SCI, V56, P619, DOI 10.1007/s11427-013-4504-2; Li JW, 2009, VIRUS RES, V144, P123, DOI 10.1016/j.virusres.2009.04.008; Lin PH, 2014, CLIN INFECT DIS, V58, P242, DOI 10.1093/cid/cit638; Lo YC, 2013, EURO SURVEILL, V18; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; Mehle A, 2012, J VIROL, V86, P1750, DOI 10.1128/JVI.06203-11; Min JY, 2013, J VIROL, V87, P10884, DOI 10.1128/JVI.01016-13; Mok CKP, 2014, J VIROL, V88, P3568, DOI 10.1128/JVI.02740-13; Mok CK, 2013, JOURNAL OF MICROBIOL; Moncorge O, 2013, J VIROL, V87, P384, DOI 10.1128/JVI.01633-12; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Song WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6509; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun HL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00073; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Yamamoto N, 2013, VIRUS RES, V178, P404, DOI 10.1016/j.virusres.2013.09.012; Zhang H, 2014, J GEN VIROL, V95, P779, DOI 10.1099/vir.0.061721-0; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhou B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067616; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	53	20	21	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148432	10.1371/journal.pone.0148432	http://dx.doi.org/10.1371/journal.pone.0148432			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845764	Green Published, Green Submitted, gold			2022-12-26	WOS:000369552800058
J	Frydlova, J; Prikryl, P; Truksa, J; Falke, LL; Du, X; Gurieva, I; Vokurka, M; Krijt, J				Frydlova, Jana; Prikryl, Petr; Truksa, Jaroslav; Falke, Lucas L.; Du, Xin; Gurieva, Iuliia; Vokurka, Martin; Krijt, Jan			Effect of Erythropoietin, Iron Deficiency and Iron Overload on Liver Matriptase-2 (TMPRSS6) Protein Content in Mice and Rats	PLOS ONE			English	Article							HEPCIDIN EXPRESSION; SERINE-PROTEASE; GENE-EXPRESSION; DIETARY IRON; ORAL IRON; HEMOJUVELIN; HOMEOSTASIS; REGULATOR; ANEMIA; BMP6	Matriptase-2 (TMPRSS6) is an important negative regulator of hepcidin expression; however, the effects of iron overload or accelerated erythropoiesis on liver TMPRSS6 protein content in vivo are largely unknown. We determined TMPRSS6 protein content in plasma membrane-enriched fractions of liver homogenates by immunoblotting, using a commercial antibody raised against the catalytic domain of TMPRSS6. Plasma membrane-enriched fractions were obtained by centrifugation at 3000 g and washing. TMPRSS6 was detected in the 3000 g fraction as a 120 kDa full-length protein in both mice and rats. Feeding of iron-deficient diet as well as erythropoietin treatment increased TMPRSS6 protein content in rats and mice by a posttranscriptional mechanism; the increase in TMPRSS6 protein by erythropoietin was also observed in Bmp6-mutant mice. Administration of high doses of iron to mice (200, 350 and 700 mg/kg) decreased TMPRSS6 protein content. Hemojuvelin was detected in the plasma membrane-enriched fractions of control animals as a full length protein of approximately 52 kDa; in iron deficient animals, the full length protein was partially cleaved at the N-terminus, resulting in an additional weak band of approximately 47 kDa. In livers from hemojuvelin-mutant mice, TMPRSS6 protein content was strongly decreased, suggesting that intact hemojuvelin is necessary for stable TMPRSS6 expression in the membrane. Overall, the results demonstrate posttranscriptional regulation of liver TMPRSS6 protein by iron status and erythropoietin administration, and provide support for the interaction of TMPRSS6 and hemojuvelin proteins in vivo.	[Frydlova, Jana; Prikryl, Petr; Gurieva, Iuliia; Vokurka, Martin; Krijt, Jan] Charles Univ Prague, Fac Med 1, Inst Pathophysiol, Prague, Czech Republic; [Truksa, Jaroslav] Acad Sci Czech Republic, Inst Biotechnol, Lab Tumour Resistance, Prague, Czech Republic; [Falke, Lucas L.] Univ Med Ctr Utrecht, Dept Pathol, Kidney Grp, Utrecht, Netherlands; [Du, Xin] Univ Calif San Diego, Dept Med, Div Med Genet, La Jolla, CA 92093 USA	Charles University Prague; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Diego	Krijt, J (corresponding author), Charles Univ Prague, Fac Med 1, Inst Pathophysiol, Prague, Czech Republic.	jan.krijt@lf1.cuni.cz	Frydlova, Jana/H-8878-2017; Krijt, Jan/B-2359-2009; Truksa, Jaroslav/G-9454-2014; Falke, Lucas L/D-5288-2017; Truksa, Jaroslav/AAB-5089-2020; Gurieva, Iuliia/I-4575-2017; Prikryl, Petr/B-1359-2008; Vokurka, Martin/F-7533-2017	Frydlova, Jana/0000-0001-9725-9526; Truksa, Jaroslav/0000-0002-8967-7354; Falke, Lucas L/0000-0003-0020-433X; Truksa, Jaroslav/0000-0002-8967-7354; Gurieva, Iuliia/0000-0003-1269-1083; Prikryl, Petr/0000-0001-6167-2853; Vokurka, Martin/0000-0001-5943-5939	Czech Science Foundation [15-16803S, 13-28830S]; Charles University [PRVOUK P24/LF1/3, SVV 260157]; European Regional Development Fund [BIOCEV CZ.1.05/1.1.00/02.0109]; Netherlands Institute for Regenerative Medicine [FES0908]	Czech Science Foundation(Grant Agency of the Czech Republic); Charles University; European Regional Development Fund(European Commission); Netherlands Institute for Regenerative Medicine	The study was supported by the Czech Science Foundation (http://gacr.cz/en/), grants 15-16803S to JK and 13-28830S to JT; by Charles University (https://www.cuni.cz/), grants PRVOUK P24/LF1/3 and SVV 260157, to MV; by the European Regional Development Fund, grant BIOCEV CZ.1.05/1.1.00/02.0109, to JT; and by the Netherlands Institute for Regenerative Medicine (www.nirmresearch.nl), grant FES0908 to LLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Corradini E, 2011, HEPATOLOGY, V54, P273, DOI 10.1002/hep.24359; Daba A, 2013, J MOL MED, V91, P95, DOI 10.1007/s00109-012-0937-5; Dendooven A, 2011, AM J PATHOL, V178, P1069, DOI 10.1016/j.ajpath.2010.12.005; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enns CA, 2012, J BIOL CHEM, V287, P35104, DOI 10.1074/jbc.M112.363937; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2009, SEMIN HEMATOL, V46, P378, DOI 10.1053/j.seminhematol.2009.06.006; FINCH C, 1994, BLOOD, V84, P1697; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Frydlova J, 2013, PHYSIOL RES, V62, P405, DOI 10.33549/physiolres.932455; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; Jiang J, 2014, J BIOL CHEM, V289, P19500, DOI 10.1074/jbc.M114.555110; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Keel SB, 2015, EXP HEMATOL, V43, P469, DOI 10.1016/j.exphem.2015.03.001; Krijt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037391; Krijt J, 2011, BLOOD CELL MOL DIS, V47, P133, DOI 10.1016/j.bcmd.2011.04.009; Krijt J, 2010, BLOOD CELL MOL DIS, V44, P257, DOI 10.1016/j.bcmd.2010.02.012; Lakhal S, 2011, J BIOL CHEM, V286, P4090, DOI 10.1074/jbc.M110.173096; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lee P, 2012, BRIT J HAEMATOL, V156, P415, DOI 10.1111/j.1365-2141.2011.09006.x; Lehmberg K, 2013, ANN HEMATOL, V92, P387, DOI 10.1007/s00277-012-1618-8; Maurer E, 2012, BIOL CHEM, V393, P535, DOI 10.1515/hsz-2011-0221; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; McDonald CJ, 2014, AM J PHYSIOL-GASTR L, V306, pG132, DOI 10.1152/ajpgi.00256.2013; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nai A, 2012, BLOOD, V119, P5021, DOI 10.1182/blood-2012-01-401885; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; Nicolas G, 2011, BRIT J HAEMATOL, V152, P498, DOI 10.1111/j.1365-2141.2010.08473.x; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Nili M, 2010, J BIOL CHEM, V285, P24783, DOI 10.1074/jbc.M110.130286; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Willemetz A, 2014, BLOOD, V124, P441, DOI 10.1182/blood-2014-01-551150; Wisniewski Jacek R., 2009, V528, P127, DOI 10.1007/978-1-60327-310-7_9; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhao NN, 2015, J BIOL CHEM, V290, P4432, DOI 10.1074/jbc.M114.611913	47	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148540	10.1371/journal.pone.0148540	http://dx.doi.org/10.1371/journal.pone.0148540			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845567	Green Submitted, Green Published, gold			2022-12-26	WOS:000369552800066
J	Kohata, Y; Fujiwara, Y; Watanabe, T; Kobayashi, M; Takemoto, Y; Kamata, N; Yamagami, H; Tanigawa, T; Shiba, M; Watanabe, T; Tominaga, K; Shuto, T; Arakawa, T				Kohata, Yukie; Fujiwara, Yasuhiro; Watanabe, Takanori; Kobayashi, Masanori; Takemoto, Yasuhiko; Kamata, Noriko; Yamagami, Hirokazu; Tanigawa, Tetsuya; Shiba, Masatsugu; Watanabe, Toshio; Tominaga, Kazunari; Shuto, Taichi; Arakawa, Tetsuo			Long-Term Benefits of Smoking Cessation on Gastroesophageal Reflux Disease and Health-Related Quality of Life	PLOS ONE			English	Article							CIGARETTE-SMOKING; STYLE MEASURES; RISK-FACTORS; POPULATION; IMPACT; GERD	Objective Smoking is associated with gastroesophageal reflux disease (GERD). Varenicline, a nicotinic receptor partial agonist, is used to aid smoking cessation. The purpose of this study was to prospectively examine the long-term benefits of smoking cessation on GERD and health-related quality of life (HR-QOL). Methods Patients treated with varenicline were asked to fill out a self-report questionnaire about their smoking habits, gastrointestinal symptoms, and HR-QOL before and 1 year after smoking cessation. The prevalence of GERD, frequency of symptoms, and HR-QOL scores were compared. We also investigated associations between clinical factors and newly-developed GERD. Results A total of 141 patients achieved smoking cessation (success group) and 50 did not (failure group) at 1 year after the treatment. The GERD improvement in the success group (43.9%) was significantly higher than that in the failure group (18.2%). The frequency of reflux symptoms significantly decreased only in the success group. There were no significant associations between newly developed GERD and clinical factors including increased body mass index and successful smoking cessation. HR-QOL significantly improved only in the success group. Conclusions Smoking cessation improved both GERD and HR-QOL. Smoking cessation should be recommended for GERD patients.	[Kohata, Yukie; Fujiwara, Yasuhiro; Kamata, Noriko; Yamagami, Hirokazu; Tanigawa, Tetsuya; Shiba, Masatsugu; Watanabe, Toshio; Tominaga, Kazunari; Arakawa, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka 558, Japan; [Watanabe, Takanori] Uehonmachi Watanabe Clin, Osaka, Japan; [Kobayashi, Masanori; Takemoto, Yasuhiko; Shuto, Taichi] Osaka City Univ, Grad Sch Med, Dept Med Educ & Gen Practice, Osaka 558, Japan	Osaka Metropolitan University; Osaka Metropolitan University	Fujiwara, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka 558, Japan.	yasu@med.osaka-cu.ac.jp	Tanigawa, Tetsuya/J-6131-2019	Tanigawa, Tetsuya/0000-0002-9305-1637	Otsuka; Eisai; Astellas; Abbott Japan, Takeda; Dainippon Sumitomo; Daiichi Sankyo	Otsuka(Otsuka Pharmaceutical); Eisai(Eisai Co Ltd); Astellas(Astellas Pharmaceuticals); Abbott Japan, Takeda; Dainippon Sumitomo(Dainippon Sumitomo Pharma Co., Ltd.); Daiichi Sankyo(Daiichi Sankyo Company Limited)	Prof. Arakawa received lecture fees from Otsuka and Eisai and research grants from Otsuka, Eisai, Astellas, Abbott Japan, Takeda, Dainippon Sumitomo, and Daiichi Sankyo. The remaining authors have no conflicts to disclose. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	DENNISH GW, 1971, NEW ENGL J MED, V284, P1136, DOI 10.1056/NEJM197105202842007; DIMENAS E, 1993, SCAND J GASTROENTERO, V28, P18, DOI 10.3109/00365529309098350; Fujiwara Y, 2011, INTERNAL MED, V50, P2443, DOI 10.2169/internalmedicine.50.6012; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Fukuhara S., 2004, MANUAL SF 8 JAPANESE; Hallan A, 2015, AM J GASTROENTEROL, V110, P393, DOI 10.1038/ajg.2015.18; Hays JT, 2012, EUR J PUBLIC HEALTH, V22, P224, DOI 10.1093/eurpub/ckq137; KADAKIA SC, 1995, AM J GASTROENTEROL, V90, P1785; KAHRILAS PJ, 1989, J LAB CLIN MED, V114, P431; KAHRILAS PJ, 1990, GUT, V31, P4, DOI 10.1136/gut.31.1.4; Kaltenbach T, 2006, ARCH INTERN MED, V166, P965, DOI 10.1001/archinte.166.9.965; Kang JHE, 2015, THER ADV CHRONIC DIS, V6, P51, DOI 10.1177/2040622315569501; Kinoshita Y, 2009, AM J GASTROENTEROL, V104, P1106, DOI 10.1038/ajg.2009.77; Kusano M, 2004, J GASTROENTEROL, V39, P888, DOI 10.1007/s00535-004-1417-7; Matsuki N, 2013, J GASTROENTEROL, V48, P340, DOI 10.1007/s00535-012-0649-1; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Ness-Jensen E, 2016, CLIN GASTROENTEROL H, V14, P175, DOI 10.1016/j.cgh.2015.04.176; Ness-Jensen E, 2014, AM J GASTROENTEROL, V109, P171, DOI 10.1038/ajg.2013.414; Nilsson M, 2004, GUT, V53, P1730, DOI 10.1136/gut.2004.043265; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Piper ME, 2012, ANN BEHAV MED, V43, P262, DOI 10.1007/s12160-011-9329-2; SCHINDLBECK NE, 1987, GASTROENTEROLOGY, V92, P1994, DOI 10.1016/0016-5085(87)90634-2; Trudgill NJ, 1998, SCAND J GASTROENTERO, V33, P568; Ware J, 1994, SF 36 PHYS MENTAL SU; WARING JP, 1989, AM J GASTROENTEROL, V84, P1076; Watanabe Y, 2003, SCAND J GASTROENTERO, V38, P807, DOI 10.1080/00365520310004506	26	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147860	10.1371/journal.pone.0147860	http://dx.doi.org/10.1371/journal.pone.0147860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845761	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800018
J	Li, L; Liu, JC; Lai, FN; Liu, HQ; Zhang, XF; Dyce, PW; Shen, W; Chen, H				Li, Lan; Liu, Jing-Cai; Lai, Fang-Nong; Liu, Huan-Qi; Zhang, Xi-Feng; Dyce, Paul W.; Shen, Wei; Chen, Hong			Di (2-ethylhexyl) Phthalate Exposure Impairs Growth of Antral Follicle in Mice	PLOS ONE			English	Article							DI(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL PHTHALATE; OXIDATIVE STRESS; ESTROUS CYCLICITY; HORMONE-RECEPTOR; OVARIAN-FUNCTION; GENE-EXPRESSION; MOUSE; DEHP; OOCYTES	Di (2-ethylhexyl) phthalate (DEHP) is a widely used plastic additive. As an environmental endocrine disruptor, it has been shown to be harmful to the mammalian reproductive system. Previous studies indicated that DEHP inhibited the development of mouse ovarian follicles. However, the mechanisms by which DEHP affects ovarian antral follicle development during the pre-puberty stage are poorly understand. Thus, we investigated the effects of direct DEHP exposure on antral follicle growth in pre-pubescent mice by use of intraperitoneal injection. Our results demonstrated that the percentage of large antral follicles was significantly reduced when mice were exposed to 20 or 40 mu g/kg DEHP every 5 days from postnatal day 0 (0 dpp) to 15 dpp. In 20 dpp, we performed microarray of these ovaries. The microarray results indicated that mRNA levels of apoptosis related genes were increased. The mRNA levels of the apoptosis and cell proliferation (negative) related genes Apoe, Agt, Glo1 and Grina were increased after DEHP exposure. DEHP induced the differential gene expression of Hsp90ab1, Rhoa, Grina and Xdh which may play an important role in this process. In addition, TUNEL staining and immunofluorescence showed that DEHP exposure significantly increased the number of TUNEL, Caspase3 and.H2AX positive ovarian somatic cells within the mouse ovaries. Flow cytometer analyses of redox-sensitive probes showed that DEHP caused the accumulation of reactive oxygen species. Moreover, the mRNA expression of ovarian somatic cell antioxidative enzymes was down-regulated both in vivo and in vitro. In conclusion, our data here demonstrated that DEHP exposure induced oxidative stress and ovarian somatic cell apoptosis, and thus may impact antral follicle enlargement during the pre-pubertal stage in mice.	[Li, Lan; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Liu, Jing-Cai; Lai, Fang-Nong] Qingdao Agr Univ, Coll Life Sci, Qingdao 266109, Peoples R China; [Liu, Jing-Cai; Lai, Fang-Nong; Liu, Huan-Qi; Zhang, Xi-Feng; Shen, Wei] Qingdao Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Reprod & Germplasm Enhancement Univ, Inst Reprod Sci, Qingdao 266109, Peoples R China; [Dyce, Paul W.] Auburn Univ, Dept Anim Sci, Auburn, AL 36849 USA	Northwest A&F University - China; Qingdao Agricultural University; Qingdao Agricultural University; Auburn University System; Auburn University	Chen, H (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China.	chenhong1212@263.net		Dyce, Paul/0000-0002-4574-3321	National Nature Science Foundation of China [31572225, 31471346, 31201120]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Nature Science Foundation of China, Number: 31572225, Recipient: Lan Li; National Nature Science Foundation of China, Number: 31471346, Recipient: Wei Shen; National Nature Science Foundation of China, Number: 31201120, Recipient: Xi-Feng Zhang.	Abd-Ellah MF, 2016, HUM EXP TOXICOL, V35, P232, DOI 10.1177/0960327115580602; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Alvarez-Quilon A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4347; Ambruosi B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027452; Barry JA, 2014, J SEX MED, V11, P1882, DOI 10.1111/jsm.12503; Bauer MJ, 1997, SCI TOTAL ENVIRON, V208, P49, DOI 10.1016/S0048-9697(97)00272-6; Chao HH, 2012, HISTOCHEM CELL BIOL, V137, P249, DOI 10.1007/s00418-011-0894-z; Craig ZR, 2014, REPROD TOXICOL, V45, P45, DOI 10.1016/j.reprotox.2014.01.002; Craig ZR, 2011, REPRODUCTION, V142, P633, DOI 10.1530/REP-11-0136; Dalman A, 2008, BIOFACTORS, V33, P149, DOI 10.1002/biof.5520330207; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Edwards JL, 1997, MOL REPROD DEV, V46, P138, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;138::AID-MRD4&gt;3.0.CO;2-R; Engel SM, 2013, ANNU REV PUBL HEALTH, V34, P139, DOI 10.1146/annurev-publhealth-031811-124556; Forand A, 2004, BIOL REPROD, V71, P643, DOI 10.1095/biolreprod.104.027466; Fridstrom M, 1999, ACTA OBSTET GYN SCAN, V78, P212, DOI 10.1034/j.1600-0412.1999.780308.x; Hai L, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129072; Hannon PR, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.129148; Hannon PR, 2015, TOXICOL APPL PHARM, V284, P42, DOI 10.1016/j.taap.2015.02.010; Hannon PR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.119032; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Hoeger KM, 2014, SEMIN REPROD MED, V32, P157, DOI 10.1055/s-0034-1371086; Kambia K, 2004, INT J ARTIF ORGANS, V27, P971, DOI 10.1177/039139880402701110; Kim SY, 2015, ENDOCRINOLOGY, V156, P1464, DOI 10.1210/en.2014-1926; Li L, 2015, HISTOCHEM CELL BIOL, V144, P389, DOI 10.1007/s00418-015-1348-9; Li L, 2014, MOL BIOL REP, V41, P1227, DOI 10.1007/s11033-013-2967-7; Liu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106412; Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Mu XY, 2015, J HAZARD MATER, V298, P232, DOI 10.1016/j.jhazmat.2015.05.052; Pierre A, 2013, HUM REPROD, V28, P762, DOI 10.1093/humrep/des460; Qin XS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127551; Rockville, 2014, SAF ASS DI 2 ETH PHT; Ruder EH, 2008, HUM REPROD UPDATE, V14, P345, DOI 10.1093/humupd/dmn011; Sampson J, 2011, TRANSFUSION MED, V21, P73, DOI 10.1111/j.1365-3148.2010.01056.x; Sircar D, 2008, J CHROMATOGR SCI, V46, P627, DOI 10.1093/chromsci/46.7.627; Tesfaye D, 2009, REPROD FERT DEVELOP, V21, P451, DOI 10.1071/RD08190; Thomas TA, 2010, REV EXPOSURE DATA AS; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Wang W, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102467; Wang W, 2012, TOXICOL APPL PHARM, V258, P288, DOI 10.1016/j.taap.2011.11.008; Yodoi R, 2009, ENDOCRINOLOGY, V150, P3345, DOI 10.1210/en.2008-1449; Yuan FL, 2015, BONE, V75, P128, DOI 10.1016/j.bone.2015.02.017; Zhang HQ, 2012, MOL BIOL REP, V39, P5651, DOI 10.1007/s11033-011-1372-3; Zhang JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086589; Zhang T, 2014, ENVIRON MOL MUTAGEN, V55, P343, DOI 10.1002/em.21847; Zhang XF, 2015, REPROD FERT DEVELOP, V27, P1213, DOI 10.1071/RD14113; Zhang XF, 2013, ENVIRON MOL MUTAGEN, V54, P354, DOI 10.1002/em.21776	49	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148350	10.1371/journal.pone.0148350	http://dx.doi.org/10.1371/journal.pone.0148350			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845775	Green Published, gold			2022-12-26	WOS:000369552800048
J	Mikkelsen, KB; Bach, LA				Mikkelsen, Kaare B.; Bach, Lars A.			Threshold Games and Cooperation on Multiplayer Graphs	PLOS ONE			English	Article							SNOWDRIFT GAMES; EVOLUTIONARY DYNAMICS; DILEMMA; MODEL; DEFECTION; SIZE	Objective The study investigates the effect on cooperation in multiplayer games, when the population from which all individuals are drawn is structured-i.e. when a given individual is only competing with a small subset of the entire population. Method To optimize the focus on multiplayer effects, a class of games were chosen for which the payoff depends nonlinearly on the number of cooperators-this ensures that the game cannot be represented as a sum of pair-wise interactions, and increases the likelihood of observing behaviour different from that seen in two-player games. The chosen class of games are named "threshold games", and are defined by a threshold, M > 0, which describes the minimal number of cooperators in a given match required for all the participants to receive a benefit. The model was studied primarily through numerical simulations of large populations of individuals, each with interaction neighbourhoods described by various classes of networks. Results When comparing the level of cooperation in a structured population to the mean-field model, we find that most types of structure lead to a decrease in cooperation. This is both interesting and novel, simply due to the generality and breadth of relevance of the model-it is likely that any model with similar payoff structure exhibits related behaviour. More importantly, we find that the details of the behaviour depends to a large extent on the size of the immediate neighbourhoods of the individuals, as dictated by the network structure. In effect, the players behave as if they are part of a much smaller, fully mixed, population, which we suggest an expression for. Highlights Observed behaviour depends on the size of each player's immediate interaction neighbourhood. When the number of players is much larger than the number of required cooperators, average payoff decreases. Most network structures lead to a decrease in cooperation compared to the fully mixed case.	[Mikkelsen, Kaare B.] Aarhus Univ, Interacting Minds Ctr, DK-8000 Aarhus C, Denmark; [Mikkelsen, Kaare B.; Bach, Lars A.] Aarhus Univ, Dept Engn, DK-8000 Aarhus C, Denmark; [Bach, Lars A.] Aarhus Univ, ICOA, DK-8210 Aarhus V, Denmark	Aarhus University; Aarhus University; Aarhus University	Mikkelsen, KB (corresponding author), Aarhus Univ, Interacting Minds Ctr, DK-8000 Aarhus C, Denmark.; Mikkelsen, KB (corresponding author), Aarhus Univ, Dept Engn, DK-8000 Aarhus C, Denmark.	mikkelsen.kaare@gmail.com	Mikkelsen, Kaare/J-2217-2018	Mikkelsen, Kaare/0000-0002-7360-8629	Interacting Minds Centre, Aarhus University	Interacting Minds Centre, Aarhus University	This project has been supported by the seed funding program from the Interacting Minds Centre, Aarhus University.	Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Archetti M, 2009, J THEOR BIOL, V261, P475, DOI 10.1016/j.jtbi.2009.08.018; Bach LA, 2006, J THEOR BIOL, V238, P426, DOI 10.1016/j.jtbi.2005.06.007; Bach LA, 2001, EUR J CANCER, V37, P2116, DOI 10.1016/S0959-8049(01)00246-5; Bastian M., 2009, 3 INT AAAI C WEBL SO; Broom M, 1997, B MATH BIOL, V59, P931; Broom M, 2013, CHAPMAN HALL CRC MAT; Chen XJ, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/38003; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; EWENS WJ, 1982, THEOR POPUL BIOL, V21, P373, DOI 10.1016/0040-5809(82)90024-7; Gillespie JH, 2001, EVOLUTION, V55, P2161; Gokhale CS, 2014, DYN GAMES APPL, V4, P468, DOI 10.1007/s13235-014-0106-2; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Hummert S, 2014, MOL BIOSYST, V10, P3044, DOI 10.1039/c3mb70602h; Latane B, 1972, UNRESPONSIVE BYSTAND, V1; Li AM, 2015, J THEOR BIOL, V377, P57, DOI 10.1016/j.jtbi.2015.04.008; MOTRO U, 1991, J THEOR BIOL, V151, P145, DOI 10.1016/S0022-5193(05)80358-3; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pena J, 2014, J THEOR BIOL, V346, P23, DOI 10.1016/j.jtbi.2013.12.016; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos MD, 2012, J THEOR BIOL, V315, P81, DOI 10.1016/j.jtbi.2012.09.001; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Souza MO, 2009, J THEOR BIOL, V260, P581, DOI 10.1016/j.jtbi.2009.07.010; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Szolnoki A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026104; Toivonen R, 2006, PHYSICA A, V371, P851, DOI 10.1016/j.physa.2006.03.050; Traulsen A, 2007, J THEOR BIOL, V246, P522, DOI 10.1016/j.jtbi.2007.01.002; Wang Z, 2015, PHYS LIFE REV, V14, P1, DOI 10.1016/j.plrev.2015.04.033; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEESIE J, 1993, J CONFLICT RESOLUT, V37, P569, DOI 10.1177/0022002793037003008; WRIGHT S., 1938, Science (Washington), V87, P430; Zhang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09098; Zhang YL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02021; Zheng DF, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/18002	37	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147207	10.1371/journal.pone.0147207	http://dx.doi.org/10.1371/journal.pone.0147207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844547	Green Submitted, Green Published, gold			2022-12-26	WOS:000369552800009
J	Nagasawa, K; Sarropoulou, E; Edvardsen, V; Fernandes, JMO				Nagasawa, Kazue; Sarropoulou, Elena; Edvardsen, Vigdis; Fernandes, Jorge M. O.			Substantial Downregulation of Myogenic Transcripts in Skeletal Muscle of Atlantic Cod during the Spawning Period	PLOS ONE			English	Article							GADUS-MORHUA L; EXTRAOCULAR-MUSCLE; EXPRESSION; GENE; GROWTH; FISH; L.; MATURATION; PROTEASES; PROTEINS	Gonadal maturation is an extremely energy consuming process for batch spawners and it is associated with a significant decrease in growth and seasonal deterioration in flesh quality. Our knowledge about the molecular mechanisms linking sexual maturation and muscle growth is still limited. In the present study, we performed RNA-Seq using 454 GS-FLX pyro-sequencing in fast skeletal muscle sampled from two-year-old Atlantic cod (Gadus morhua) at representative time points throughout the reproductive cycle (August, March and May). In total, 126,937 good quality reads were obtained, with 546 nucleotide length and 52% GC content on average. RNA-Seq analysis using the CLC Genomics Workbench with the Atlantic cod reference UniGene cDNA data revealed 59,581 (46.9%) uniquely annotated reads. Pairwise comparison for expression levels identified 153 differentially expressed UniGenes between time points. Notably, we found a significant suppression of myh13 and myofibrillar gene isoforms in fast skeletal muscle during the spawning season. This study uncovered a large number of differentially expressed genes that may be influenced by gonadal maturation, thus representing a significant contribution to our limited understanding of the molecular mechanisms regulating muscle wasting and regeneration in batch spawners during their reproductive cycle.	[Nagasawa, Kazue; Edvardsen, Vigdis; Fernandes, Jorge M. O.] Nord Univ, Fac Biosci & Aquaculture, Marine Genom Grp, N-8049 Bodo, Norway; [Sarropoulou, Elena] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion 71003, Greece	Nord University; Hellenic Centre for Marine Research	Fernandes, JMO (corresponding author), Nord Univ, Fac Biosci & Aquaculture, Marine Genom Grp, N-8049 Bodo, Norway.	jorge.m.fernandes@nord.no	Fernandes, Jorge/AAC-4632-2022; Fernandes, Jorge MO/A-3526-2013; Nagasawa, Kazue/ABH-6117-2020	Fernandes, Jorge/0000-0002-2550-1640; Fernandes, Jorge MO/0000-0002-2550-1640; Nagasawa, Kazue/0000-0003-2819-3302	Research Council of Norway [190350/S40]	Research Council of Norway(Research Council of Norway)	This work was financed by the Research Council of Norway (grant 190350/S40, http://www.forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolkar DB, 2010, J EXP BIOL, V213, P137, DOI 10.1242/jeb.030759; Bagenal T.B., 1978, P75; Bertola LD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-166; BRADFORD RG, 1993, J FISH BIOL, V43, P811, DOI 10.1111/j.1095-8649.1993.tb01157.x; Briggs MM, 2002, J EXP BIOL, V205, P3133; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de la Serrana DG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-181; Freiburg A, 2000, CIRC RES, V86, P1114; Georgiou S, 2016, CELL TISSUE RES, V363, P541, DOI 10.1007/s00441-015-2254-0; Godo O.R., 1999, Journal of Northwest Atlantic Fishery Science, V25, P115, DOI 10.2960/J.v25.a10; Hagen O, 2008, J AGR FOOD CHEM, V56, P5953, DOI 10.1021/jf801215b; Hansen T, 2001, AQUACULTURE, V203, P51, DOI 10.1016/S0044-8486(01)00610-X; Hemre GI, 2004, AQUAC RES, V35, P683, DOI 10.1111/j.1365-2109.2004.01069.x; Imai JI, 1997, J EXP BIOL, V200, P27; Johnston IA, 2003, J EXP BIOL, V206, P1337, DOI 10.1242/jeb.00262; KARLSEN O, 1995, AQUACULTURE, V133, P159, DOI 10.1016/0044-8486(94)00399-9; Kiessling A, 1995, FISH PHYSIOL BIOCHEM, V14, P439, DOI 10.1007/BF00004344; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; LUQUET P, 1986, FISH PHYSIOL BIOCHEM, V2, P121, DOI 10.1007/BF02264080; Nagasawa K, 2014, J MOL ENDOCRINOL, V52, P357, DOI 10.1530/JME-13-0187; Nagasawa K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036908; Palstra AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053171; Ricker W.E., 1979, BIOENERGETICS GROWTH, VVIII, P677, DOI DOI 10.1016/S1546-5098(08)60034-5; Salem M., 2013, PHYS REP, V1, P1; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sarropoulou E, 2012, MAR BIOTECHNOL, V14, P634, DOI 10.1007/s10126-012-9466-z; Seeley M, 2007, CIRC RES, V100, P238, DOI 10.1161/01.RES.0000255758.69821.b5; Socquet-Juglard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054196; Solberg C, 2008, AQUAC RES, V39, P619, DOI 10.1111/j.1365-2109.2008.01918.x; SPARGO E, 1979, J ROY SOC MED, V72, P921; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; TOYOHARA H, 1991, COMP BIOCHEM PHYS B, V99, P419, DOI 10.1016/0305-0491(91)90064-K; Wang DK, 2011, INT J BIOL SCI, V7, P440, DOI 10.7150/ijbs.7.440; Wang PA, 2009, FOOD CHEM, V115, P1228, DOI 10.1016/j.foodchem.2009.01.031; Winters LM, 1998, GENOMICS, V54, P188, DOI 10.1006/geno.1998.5558	38	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148374	10.1371/journal.pone.0148374	http://dx.doi.org/10.1371/journal.pone.0148374			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844771	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000369552800050
J	Gilbert, AL; Lattanzio, MS				Gilbert, Anthony L.; Lattanzio, Matthew S.			Ontogenetic Variation in the Thermal Biology of Yarrow's Spiny Lizard, Sceloporus jarrovii	PLOS ONE			English	Article							WEST-INDIAN LIZARD; CLIMATE-CHANGE; LOCOMOTOR PERFORMANCE; INTRASPECIFIC COMPETITION; THERMOREGULATORY BEHAVIOR; GROWTH-RATES; WATER-LOSS; FOOD; SIZE; TEMPERATURE	Climate change is rapidly altering the way current species interact with their environment to satisfy life-history demands. In areas anticipated to experience extreme warming, rising temperatures are expected to diminish population growth, due either to environmental degradation, or the inability to tolerate novel temperature regimes. Determining how at risk ectotherms, and lizards in particular, are to changes in climate traditionally emphasizes the thermal ecology and thermal sensitivity of physiology of adult members of a population. In this study, we reveal ontogenetic differences in thermal physiological and ecological traits that have been used to anticipate how ectotherms will respond to climate change. We show that the thermal biological traits of juvenile Yarrow's Spiny Lizards (Sceloporus jarrovii) differ from the published estimates of the same traits for adult lizards. Juvenile S. jarrovii differ in their optimal performance temperature, field field-active body temperature, and critical thermal temperatures compared to adult S. jarrovii. Within juvenile S. jarrovii, males and females exhibit differences in field-active body temperature and desiccation tolerance. Given the observed age-and sex-related variation in thermal physiology, we argue that not including physiological differences in thermal biology throughout ontogeny may lead to misinterpretation of patterns of ecological or evolutionary change due to climate warming. Further characterizing the potential for ontogenetic changes in thermal biology would be useful for a more precise and accurate estimation of the role of thermal physiology in mediating population persistence in warmer environments.	[Gilbert, Anthony L.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Lattanzio, Matthew S.] Christopher Newport Univ, Dept Organismal & Environm Biol, Newport News, VA 23606 USA	University System of Ohio; Ohio University	Gilbert, AL (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	ag499412@ohio.edu			Ohio University Graduate Student Senate Original Work Grant	Ohio University Graduate Student Senate Original Work Grant	Funding for this work was received from the Ohio University Graduate Student Senate Original Work Grant (to ALG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2014, AM NAT, V184, pE50, DOI 10.1086/677386; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; BALLINGER RE, 1973, ECOLOGY, V54, P269, DOI 10.2307/1934336; Beal MS, 2014, ECOL EVOL, V4, P4220, DOI 10.1002/ece3.1297; Bennett A.F., 1990, Oxford Surveys in Evolutionary Biology, V7, P251; Boggs CL, 2012, ECOL LETT, V15, P502, DOI 10.1111/j.1461-0248.2012.01766.x; Bowen KD, 2003, J HERPETOL, V37, P729, DOI 10.1670/46-03N; Brown RP, 2005, J THERM BIOL, V30, P79, DOI 10.1016/j.jtherbio.2004.07.005; Buckley LB, 2015, FUNCT ECOL, V29, P1038, DOI 10.1111/1365-2435.12406; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Carrier DR, 1996, PHYSIOL ZOOL, V69, P467, DOI 10.1086/physzool.69.3.30164211; Clobert J, 2000, FUNCT ECOL, V14, P675, DOI 10.1046/j.1365-2435.2000.00477.x; Clusella-Trullas S, 2011, SCIENCE, V332, DOI 10.1126/science.1195193; Cox RM, 2007, HERPETOLOGICA, V63, P245, DOI 10.1655/0018-0831(2007)63[245:GATTDO]2.0.CO;2; DAWSON WR, 1966, ECOLOGY, V47, P589, DOI 10.2307/1933936; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Durtsche RD, 1997, ECOGRAPHY, V20, P336, DOI 10.1111/j.1600-0587.1997.tb00378.x; Galan P, 2008, ANIM BIOL, V58, P173, DOI 10.1163/157075608X328026; GARLAND T, 1985, J ZOOL, V207, P425; Garland T, 1991, EVOLUTION; Gienapp P, 2014, QUANTITATIVE GENETICS IN THE WILD, P254; Gunderson AR, 2015, AM NAT, V185, P653, DOI 10.1086/680849; Gunderson AR, 2011, J COMP PHYSIOL B, V181, P965, DOI 10.1007/s00360-011-0576-0; Haenel GJ, 2003, COPEIA, P113, DOI 10.1643/0045-8511(2003)003[0113:HRAISU]2.0.CO;2; Haenel GJ, 2003, COPEIA, DOI DOI 10.1643/0045-8511(2003)003%5B0099:HRAISU%5D2.0.CO%3B2; Herczeg G, 2008, OECOLOGIA, V155, P1, DOI 10.1007/s00442-007-0886-9; Herrel A, 2006, BIOL J LINN SOC, V89, P443, DOI 10.1111/j.1095-8312.2006.00685.x; HERTZ PE, 1983, EVOLUTION, V37, P1075, DOI 10.1111/j.1558-5646.1983.tb05634.x; HERTZ PE, 1981, ECOLOGY, V62, P515, DOI 10.2307/1937714; HERTZ PE, 1993, AM NAT, V142, P796, DOI 10.1086/285573; Hertz PE, 1982, ANIM BEHAV, V1982; Huey R.B., 1991, American Naturalist, V137, P91; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; HUEY RB, 1979, AM ZOOL, V19, P357; Huey RB, 1998, AM ZOOL; Husak JF, 2006, EVOLUTION, V60, P2122, DOI 10.1111/j.0014-3820.2006.tb01849.x; Irschick DJ, 2000, FUNCT ECOL, V14, P438, DOI 10.1046/j.1365-2435.2000.00447.x; Jeglinski JWE, 2013, J ANIM ECOL, V82, P694, DOI 10.1111/1365-2656.12019; Kearney MR, 2013, ECOL LETT, V16, P1470, DOI 10.1111/ele.12192; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Leal M, 2012, AM NAT, V180, P815, DOI 10.1086/668077; Logan ML, 2015, FUNCT ECOL, V29, P694, DOI 10.1111/1365-2435.12379; Logan ML, 2014, P NATL ACAD SCI USA, V111, P14165, DOI 10.1073/pnas.1404885111; Lovern MB, 2001, HORM BEHAV, V39, P131, DOI 10.1006/hbeh.2000.1637; MOORE MC, 1987, GEN COMP ENDOCR, V65, P225, DOI 10.1016/0016-6480(87)90170-5; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; POUGH FH, 1983, ECOLOGY, V64, P244, DOI 10.2307/1937072; POUNDS JA, 1988, ECOL MONOGR, V58, P299, DOI 10.2307/1942542; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Robson MA, 2000, FUNCT ECOL, V14, P338, DOI 10.1046/j.1365-2435.2000.00427.x; Rosenblum EB, 2005, COPEIA, P586, DOI 10.1643/CP-04-154R1; RUBY DE, 1978, COPEIA, P430; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; SMITH GR, 1994, FUNCT ECOL, V8, P215, DOI 10.2307/2389904; STAMPS J, 1981, ECOLOGY, V62, P33, DOI 10.2307/1936665; STAMPS JA, 1983, BEHAV ECOL SOCIOBIOL, V12, P19, DOI 10.1007/BF00296929; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; TEMPLETON JAMES R., 1960, PHYSIOL ZOOL, V33, P136; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; VANBERKUM FH, 1989, FUNCT ECOL, V3, P97; Wake DB, 2007, P NATL ACAD SCI USA, V104, P8201, DOI 10.1073/pnas.0702506104; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; West-Eberhard MJ, 2005, J EXP ZOOL PART B, V304B, P610, DOI 10.1002/jez.b.21071; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Williams JB, 1996, AUK, V113, P457, DOI 10.2307/4088912; Wilson D, 2007, BIOL LETT-UK, V3, P40, DOI 10.1098/rsbl.2006.0574; Withers PC, 2000, AUST J ZOOL, V48, P111, DOI 10.1071/ZO99007; Wood SN, 2006, WILEY INTERDISCIPLIN, DOI DOI 10.1002/WICS.10/FULL\; Xu XF, 2006, COMP BIOCHEM PHYS A, V143, P118, DOI 10.1016/j.cbpa.2005.11.004; Zajitschek SRK, 2012, BIOL J LINN SOC, V107, P573, DOI 10.1111/j.1095-8312.2012.01963.x	74	23	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146904	10.1371/journal.pone.0146904	http://dx.doi.org/10.1371/journal.pone.0146904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840620	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200020
J	Pandya, A; Eggman, AA; Kamel, H; Gupta, A; Schackman, BR; Sanelli, PC				Pandya, Ankur; Eggman, Ashley A.; Kamel, Hooman; Gupta, Ajay; Schackman, Bruce R.; Sanelli, Pina C.			Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up Stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INTRAVENOUS THROMBOLYSIS; EARLY MANAGEMENT; SYMPTOM ONSET; UNKNOWN TIME; HEALTH; CARE; ASSOCIATION; VALIDATION	Background Thrombolytic treatment (tissue-type plasminogen activator [tPA]) is only recommended for acute ischemic stroke patients with stroke onset time <4.5 hours. tPA is not recommended when stroke onset time is unknown. Diffusion-weighted MRI (DWI) and fluid attenuated inversion recovery (FLAIR) MRI mismatch information has been found to approximate stroke onset time with some accuracy. Therefore, we developed a micro-simulation model to project health outcomes and costs of MRI-based treatment decisions versus no treatment for acute wake-up stroke patients. Methods and Findings The model assigned simulated patients a true stroke onset time from a specified probability distribution. DWI-FLAIR mismatch estimated stroke onset <4.5 hours with sensitivity and specificity of 0.62 and 0.78, respectively. Modified Rankin Scale (mRS) scores reflected tPA treatment effectiveness accounting for patients' true stroke onset time. Discounted lifetime costs and benefits (quality-adjusted life years [QALYs]) were projected for each strategy. Incremental cost-effectiveness ratios (ICERs) were calculated for the MRI-based strategy in base-case and sensitivity analyses. With no treatment, 45.1% of simulated patients experienced a good stroke outcome (mRS score 0-1). Under the MRI-based strategy, in which 17.0% of all patients received tPA despite stroke onset times >4.5 hours, 46.3% experienced a good stroke outcome. Lifetime discounted QALYs and costs were 5.312 and $88,247 for the no treatment strategy and 5.342 and $90,869 for the MRI-based strategy, resulting in an ICER of $88,000/QALY. Results were sensitive to variations in patient-and provider-specific factors such as sleep duration, hospital travel and door-to-needle times, as well as onset probability distribution, MRI specificity, and mRS utility values. Conclusions Our model-based findings suggest that an MRI-based treatment strategy for this population could be cost-effective and quantifies the impact that patient-and provider-specific factors, such as sleep duration, hospital travel and door-to-needle times, could have on the optimal decision for wake-up stroke patients.	[Pandya, Ankur] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Eggman, Ashley A.; Schackman, Bruce R.; Sanelli, Pina C.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Kamel, Hooman] New York Presbyterian Weill Cornell Med Coll, Dept Neurol, New York, NY USA; [Gupta, Ajay; Sanelli, Pina C.] New York Presbyterian Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Sanelli, Pina C.] North Shore LIJ Hlth Syst, Dept Radiol, Manhasset, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Cornell University; Cornell University; Cornell University; Northwell Health	Pandya, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.	anpandya@hsph.harvard.edu	Kamel, Hooman/AGG-9071-2022; Schackman, Bruce R./J-8208-2019	Schackman, Bruce R./0000-0002-1132-2932	American Heart Association [14CRP18730014]; NIH/NINDS; Michael Goldberg Stroke Research Fund	American Heart Association(American Heart Association); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael Goldberg Stroke Research Fund	Dr. Pandya's effort for this paper was supported by a grant from the American Heart Association (http://www.heart.org/HEARTORG/) (14CRP18730014). Dr. Kamel reports grants from NIH/NINDS and grants from Michael Goldberg Stroke Research Fund during the conduct of the study; and personal fees from Genentech, outside the submitted work. Dr. Gupta reports grants from Foundation of the American Society of Neuroradiology and grants from Association of University Radiologists-GERRAF Award, outside the submitted work. The other authors had no potential conflict of interests to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Albers GW, 2008, CHEST, V133, p630S, DOI 10.1378/chest.08-0720; Breuer L, 2010, INT J STROKE, V5, P68, DOI 10.1111/j.1747-4949.2010.00410.x; Briggs AH, 2003, MED DECIS MAKING, V23, P341, DOI 10.1177/0272989X03255922; Buck D, 2014, STROKE, V45, P1869, DOI 10.1161/STROKEAHA.114.005126; Caro JJ, 1999, STROKE, V30, P2574, DOI 10.1161/01.STR.30.12.2574; Centers for Medicare and Medicaid Services, 2013, PHYS FEE SCHED; Chambers MG, 2002, VALUE HEALTH, V5, P82, DOI 10.1046/j.1524-4733.2002.52011.x; Earnshaw SR, 2009, VALUE HEALTH, V12, P507, DOI 10.1111/j.1524-4733.2008.00467.x; Ebinger M, 2012, EUR J NEUROL, V19, P348, DOI 10.1111/j.1468-1331.2011.03504.x; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; Ehlers L, 2007, STROKE, V38, P85, DOI 10.1161/01.STR.0000251790.19419.a8; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fagan SC, 1998, NEUROLOGY, V50, P883, DOI 10.1212/WNL.50.4.883; Fink JN, 2002, STROKE, V33, P988, DOI 10.1161/01.STR.0000014585.17714.67; Fink JN, 2002, STROKE, V33, P954, DOI 10.1161/01.STR.0000013069.24300.1D; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Gage BF, 1998, STROKE, V29, P1083, DOI 10.1161/01.STR.29.6.1083; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HCUP National Inpatient Sample (NIS), 2012, HEALTHC COST UT PROJ; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Huisa BN, 2013, J STROKE CEREBROVASC, V22, P972, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.004; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kang DW, 2012, INT J STROKE, V7, P311, DOI 10.1111/j.1747-4949.2012.00779.x; Kopec JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-710; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Petkova M, 2010, RADIOLOGY, V257, P782, DOI 10.1148/radiol.10100461; Samsa GP, 1999, J CLIN EPIDEMIOL, V52, P259, DOI 10.1016/S0895-4356(98)00151-6; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Serena J, 2003, CEREBROVASC DIS, V16, P128, DOI 10.1159/000070592; Sheppard JP, 2015, AM J HYPERTENS, V28, P30, DOI 10.1093/ajh/hpu104; SOLOMON NA, 1994, STROKE, V25, P1721, DOI 10.1161/01.STR.25.9.1721; Stahl JE, 2003, RADIOLOGY, V228, P659, DOI 10.1148/radiol.2283021557; Tatlisumak T, 2002, STROKE, V33, P2144, DOI 10.1161/01.STR.0000026862.42440.AA; Thomalla G, 2014, INT J STROKE, V9, P829, DOI 10.1111/ijs.12011; Thomalla G, 2011, LANCET NEUROL, V10, P978, DOI 10.1016/S1474-4422(11)70192-2; Thomalla G, 2009, ANN NEUROL, V65, P724, DOI 10.1002/ana.21651; Tung CE, 2011, STROKE, V42, P2257, DOI 10.1161/STROKEAHA.111.615682; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Young KC, 2010, NEUROLOGY, V75, P1678, DOI 10.1212/WNL.0b013e3181fc2838	42	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148106	10.1371/journal.pone.0148106	http://dx.doi.org/10.1371/journal.pone.0148106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840397	Green Published, gold			2022-12-26	WOS:000369550200081
J	Prudkovsky, AA; Ivanenko, VN; Nikitin, MA; Lukyanov, KA; Belousova, A; Reimer, JD; Berumen, ML				Prudkovsky, Andrey A.; Ivanenko, Viatcheslav N.; Nikitin, Mikhail A.; Lukyanov, Konstantin A.; Belousova, Anna; Reimer, James D.; Berumen, Michael L.			Green Fluorescence of Cytaeis Hydroids Living in Association with Nassarius Gastropods in the Red Sea	PLOS ONE			English	Article							GFP-LIKE PROTEINS; EVOLUTION; BIOLUMINESCENCE; HYDROZOA; FAMILY; DIVERSITY; CNIDARIA; RNA	Green Fluorescent Proteins (GFPs) have been reported from a wide diversity of medusae, but only a few observations of green fluorescence have been reported for hydroid colonies. In this study, we report on fluorescence displayed by hydroid polyps of the genus Cytaeis Eschscholtz, 1829 (Hydrozoa: Anthoathecata: Filifera) found at night time in the southern Red Sea (Saudi Arabia) living on shells of the gastropod Nassarius margaritifer (Dunker, 1847) (Neogastropoda: Buccinoidea: Nassariidae). We examined the fluorescence of these polyps and compare with previously reported data. Intensive green fluorescence with a spectral peak at 518 nm was detected in the hypostome of the Cytaeis polyps, unlike in previous reports that reported fluorescence either in the basal parts of polyps or in other locations on hydroid colonies. These results suggest that fluorescence may be widespread not only in medusae, but also in polyps, and also suggests that the patterns of fluorescence localization can vary in closely related species. The fluorescence of polyps may be potentially useful for field identification of cryptic species and study of geographical distributions of such hydroids and their hosts.	[Prudkovsky, Andrey A.; Ivanenko, Viatcheslav N.; Belousova, Anna] Moscow MV Lomonosov State Univ, Fac Biol, Dept Invertebrate Zool, Moscow, Russia; [Nikitin, Mikhail A.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Lukyanov, Konstantin A.] Inst Bioorgan Chem, Moscow, Russia; [Reimer, James D.] Univ Ryukyus, Dept Biol Chem & Marine Sci, Fac Sci, Mol Invertebrate Systemat & Ecol Lab, Nishihara, Okinawa 90301, Japan; [Reimer, James D.] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 90301, Japan; [Berumen, Michael L.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal, Saudi Arabia	Lomonosov Moscow State University; Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of the Ryukyus; University of the Ryukyus; King Abdullah University of Science & Technology	Ivanenko, VN (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Invertebrate Zool, Moscow, Russia.	ivanenko.slava@gmail.com	Lukyanov, Konstantin A/D-4030-2013; Prudkovsky, Andrey/R-8248-2016; Reimer, James Davis/AAP-1331-2020; Ivanenko, Viatcheslav N/B-8198-2008; Berumen, Michael/F-7745-2011; Nikitin, Mikhail/K-3417-2013	Lukyanov, Konstantin A/0000-0001-9845-2088; Ivanenko, Viatcheslav N/0000-0003-1255-0491; Berumen, Michael/0000-0003-2463-2742; Nikitin, Mikhail/0000-0003-4855-8057	King Abdullah University of Science and Technology Office of Competitive Research Funds [CRG-1-2012-BER-002]; Russian Foundation for Basic Research [15-29-02601]; Russian Scientific Foundation [14-50-00029]	King Abdullah University of Science and Technology Office of Competitive Research Funds; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Scientific Foundation(Russian Science Foundation (RSF))	Fieldwork was supported by the King Abdullah University of Science and Technology Office of Competitive Research Funds under grant number CRG-1-2012-BER-002; molecular laboratory work and data analysis were conducted with support from the Russian Foundation for Basic Research (#15-29-02601); microscopic study and processing of the paper were supported by the Russian Scientific Foundation (#14-50-00029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglyamova GV, 2011, PHOTOCH PHOTOBIO SCI, V10, P1303, DOI 10.1039/c1pp05068k; Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; ANDERSON JM, 1973, J BIOL CHEM, V248, P2937; Bouillon J, 2004, SCI MAR, V68, P5, DOI 10.3989/scimar.2004.68s25; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Cartwright P, 2010, INTEGR COMP BIOL, V50, P456, DOI 10.1093/icb/icq089; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Dougherty JR, 2005, J SHELLFISH RES, V24, P35; Fourrage C, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130206; FREEMAN G, 1987, ROUX ARCH DEV BIOL, V196, P30, DOI 10.1007/BF00376020; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Gravili C, 2013, MAR ECOL-EVOL PERSP, V34, P41, DOI 10.1111/maec.12023; Haddock SHD, 2015, BIOL OPEN, V4, P1094, DOI 10.1242/bio.012138; Hastings JW, 2006, METHOD BIOCHEM ANAL, V47, P15; Hunt ME, 2012, PHOTOCH PHOTOBIO SCI, V11, P637, DOI 10.1039/c1pp05238a; KRAMP P. L., 1965, DANA REP CARLSBERG FOUND, V63, P1; Kubota S, 2011, KUROSHIO BIOSPHERE, V7, P41; Kubota S, 2010, KUROSHIO BIOSPHERE, V6, P11; Kubota Shin, 2011, Biogeography, V13, P9; Kubota S, 2008, J MAR BIOL ASSOC UK, V88, P1743, DOI 10.1017/S0025315408002580; LEVINE LD, 1982, COMP BIOCHEM PHYS B, V72, P77, DOI 10.1016/0305-0491(82)90013-X; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Miglietta MP, 2012, EVOLUTION, V66, P3876, DOI 10.1111/j.1558-5646.2012.01717.x; Millard NAH, 1975, ANN S AFR MUS, V68, P1; MORIN JG, 1974, BIOL BULL-US, V147, P397, DOI 10.2307/1540457; Morse VJ, 2013, THESIS CARDIFF U; NAVAS-PEREIRA D, 1991, Boletim do Instituto Oceanografico, V39, P25; Petrov NB, 2005, MOL BIOL+, V39, P503, DOI 10.1007/s11008-005-0067-z; Puce S, 2004, HYDROBIOLOGIA, V530, P503; Rees W.J., 1962, BR MUS NAT HIST, V8, P381; Rees WJ, 1967, J MOLLUS STUD, V37, P213, DOI DOI 10.1093/OXFORDJOURNALS.MOLLUS.A064991; Ryusaku D, 2012, BULLETIN OF MIYAGI U, V47, P95; Schuchert P, 2007, REV SUISSE ZOOL, V114, P195, DOI 10.5962/bhl.part.80395; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsuji FI, 2010, MICROSC RES TECHNIQ, V73, P785, DOI 10.1002/jemt.20821; VANDERAUWERA G, 1994, FEBS LETT, V338, P133, DOI 10.1016/0014-5793(94)80350-1; Xia NS, 2002, MAR BIOTECHNOL, V4, P155, DOI 10.1007/s10126-001-0081-7; Yanushevich YG, 2005, RUSS J BIOORG CHEM+, V31, P43, DOI 10.1007/s11171-005-0005-9	43	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146861	10.1371/journal.pone.0146861	http://dx.doi.org/10.1371/journal.pone.0146861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840497	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200019
J	Snitz, K; Arzi, A; Jacobson, M; Secundo, L; Weissler, K; Yablonka, A				Snitz, Kobi; Arzi, Anat; Jacobson, Merav; Secundo, Lavi; Weissler, Kineret; Yablonka, Adi			A Cross Modal Performance-Based Measure of Sensory Stimuli Intricacy	PLOS ONE			English	Article							ODOR	We define a new measure of sensory stimuli which has the following properties: It is cross modal, performance based, robust, and well defined. We interpret this measure as the intricacy or complexity of the stimuli, yet its validity is independent of its interpretation. We tested the validity and cross modality of our measure using three olfactory and one visual experiment. In order to test the link between our measure and cognitive performance we also conducted an additional visual experiment. We found that our measure is correlated with the results of the well-established Rapid Serial Visual Presentation masking experiment. Specifically, ranking stimuli according to our measure was correlated at r = 0.75 (p < 0.002) with masking effectiveness. Thus, our novel measure of sensory stimuli provides a new quantitative tool for the study of sensory processing.	[Snitz, Kobi; Arzi, Anat; Jacobson, Merav; Secundo, Lavi; Weissler, Kineret; Yablonka, Adi] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Snitz, K (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	kobi.snitz@weizmann.ac.il		Arzi, Anat/0000-0003-1005-1752	ISF - Israel Science Foundation - India-Israel Joint Academic Research Program in neurobiology [1599/14]	ISF - Israel Science Foundation - India-Israel Joint Academic Research Program in neurobiology	This work was supported by ISF - Israel Science Foundation - India-Israel Joint Academic Research Program in neurobiology, grant number 1599/14.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brodatz P, 1966, TEXTURES PHOTOGRAPHI; Dravnieks A, 1982, ATLAS ODOR CHARACTER; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Golan T, 2014, ATTEN PERCEPT PSYCHO, V76, P391, DOI 10.3758/s13414-013-0562-6; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Kermen F, 2011, SCI REP-UK, V1, DOI 10.1038/srep00206; Kleiner M, 2007, PERCEPTION, V36, P14; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Marr D., 1982, VISION COMPUTATIONAL; Morrison D. F., 1990, MULTIVARIATE STAT ME; Stevenson R, 2010, LEARNING TO SMELL OL; Weissler K, 2016, THESIS TEL AVIV U; Wise PM, 2000, CHEM SENSES, V25, P429, DOI 10.1093/chemse/25.4.429; Yeshurun Y, 2010, ANNU REV PSYCHOL, V61, P219, DOI 10.1146/annurev.psych.60.110707.163639	15	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147449	10.1371/journal.pone.0147449	http://dx.doi.org/10.1371/journal.pone.0147449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840072	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200040
J	Wilk, M; Hessler, R; Mugridge, K; Jolly, C; Fehr, M; Lenarz, T; Scheper, V				Wilk, Maciej; Hessler, Roland; Mugridge, Kenneth; Jolly, Claude; Fehr, Michael; Lenarz, Thomas; Scheper, Verena			Impedance Changes and Fibrous Tissue Growth after Cochlear Implantation Are Correlated and Can Be Reduced Using a Dexamethasone Eluting Electrode	PLOS ONE			English	Article							CHRONIC ELECTRICAL-STIMULATION; GUINEA-PIG MODEL; NECROSIS-FACTOR-ALPHA; AUDITORY-NERVE; POSTOPERATIVE IMPEDANCES; RESIDUAL HEARING; SHORT-TERM; PROTECTION; HYDROGEL; SURFACES	Background The efficiency of cochlear implants (CIs) is affected by postoperative connective tissue growth around the electrode array. This tissue formation is thought to be the cause behind post-operative increases in impedance. Dexamethasone (DEX) eluting CIs may reduce fibrous tissue growth around the electrode array subsequently moderating elevations in impedance of the electrode contacts. Methods For this study, DEX was incorporated into the silicone of the CI electrode arrays at 1% and 10% (w/w) concentration. Electrodes prepared by the same process but without dexamethasone served as controls. All electrodes were implanted into guinea pig cochleae though the round window membrane approach. Potential additive or synergistic effects of electrical stimulation (60 minutes) were investigated by measuring impedances before and after stimulation (days 0, 7, 28, 56 and 91). Acoustically evoked auditory brainstem responses were recorded before and after CI insertion as well as on experimental days 7, 28, 56, and 91. Additionally, histology performed on epoxy embedded samples enabled measurement of the area of scala tympani occupied with fibrous tissue. Results In all experimental groups, the highest levels of fibrous tissue were detected in the basal region of the cochlea in vicinity to the round window niche. Both DEX concentrations, 10% and 1% (w/w), significantly reduced fibrosis around the electrode array of the CI. Following 3 months of implantation impedance levels in both DEX-eluting groups were significantly lower compared to the control group, the 10% group producing a greater effect. The same effects were observed before and after electrical stimulation. Conclusion To our knowledge, this is the first study to demonstrate a correlation between the extent of new tissue growth around the electrode and impedance changes after cochlear implantation. We conclude that DEX-eluting CIs are a means to reduce this tissue reaction and improve the functional benefits of the implant by attenuating electrode impedance.	[Wilk, Maciej; Lenarz, Thomas; Scheper, Verena] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Wilk, Maciej; Fehr, Michael] Univ Vet Med, Clin Exot Pets Reptiles Pet & Feral Birds, Hannover, Germany; [Hessler, Roland; Mugridge, Kenneth; Jolly, Claude] MEDEl GmbH, Innsbruck, Austria; [Lenarz, Thomas; Scheper, Verena] Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School	Scheper, V (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.; Scheper, V (corresponding author), Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany.	scheper.verena@mh-hannover.de	Scheper, Verena/J-4298-2019	Scheper, Verena/0000-0001-8618-8793	MED-EL Hearing Implants GmbH, Innsbruck, Austria	MED-EL Hearing Implants GmbH, Innsbruck, Austria	MW received funding from MED-EL Hearing Implants GmbH, Innsbruck, Austria. RH, KM, and CJ are affiliated with MED-EL and were involved in study design, data analysis, and manuscript preparation.	Abi-Hachem Ralph N, 2010, Recent Pat CNS Drug Discov, V5, P147; Bas E, 2012, ANAT REC, V295, P1944, DOI 10.1002/ar.22585; Bas E, 2012, ANAT REC, V295, P1909, DOI 10.1002/ar.22574; Braun S, 2011, ORL-J OTO-RHIN-LARYN, V73, P219, DOI 10.1159/000329791; Burghard A, 2014, HEARING RES, V312, P21, DOI 10.1016/j.heares.2014.02.002; Connolly TM, 2011, AUDIOL NEURO-OTOL, V16, P137, DOI 10.1159/000314757; De Ceulaer G, 2003, OTOL NEUROTOL, V24, P769, DOI 10.1097/00129492-200309000-00014; deSauvage RC, 1997, HEARING RES, V110, P119, DOI 10.1016/S0378-5955(97)00066-X; Dinh CT, 2009, AUDIOL NEURO-OTOL, V14, P383, DOI 10.1159/000241895; DORMAN MF, 1992, J SPEECH HEAR RES, V35, P1126, DOI 10.1044/jshr.3505.1126; DYMOND AM, 1976, IEEE T BIO-MED ENG, V23, P274, DOI 10.1109/TBME.1976.324585; Eshraghi A A, 2011, Cochlear Implants Int, V12 Suppl 1, pS51, DOI 10.1179/146701011X13001035753254; Eshraghi AA, 2007, OTOL NEUROTOL, V28, P842, DOI 10.1097/MAO.0b013e31805778fc; Eshraghi AA, 2013, LARYNGOSCOPE, V123, pS1, DOI 10.1002/lary.23902; Farhadi Mohammad, 2013, Cochlear Implants Int, V14, P45; Huang Christie Qi, 2007, Cochlear Implants Int, V8, P123, DOI 10.1002/cii.336; Hutten M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104564; Ibrahim H N, 2010, Cochlear Implants Int, V11 Suppl 1, P431, DOI 10.1179/146701010X12671177204345; Ichimiya I, 2000, INT J PEDIATR OTORHI, V56, P45, DOI 10.1016/S0165-5876(00)00408-0; James DP, 2008, AUDIOL NEURO-OTOL, V13, P86, DOI 10.1159/000111780; Joseph J, 2010, J MATER SCI-MATER M, V21, P1665, DOI 10.1007/s10856-010-4015-7; Kamel M, 2001, J BIOMED MATER RES, V58, P88, DOI 10.1002/1097-4636(2001)58:1<88::AID-JBM130>3.0.CO;2-7; Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313; Lee J, 2013, AUDIOL NEURO-OTOL, V18, P392, DOI 10.1159/000353582; Lenarz T, 2015, FREE RADICALS IN ENT; Liu Y., 2015, EUR ARCH OTORHINOL; Maeda K, 2005, HEARING RES, V202, P154, DOI 10.1016/j.heares.2004.08.022; Maini S, 2009, AUDIOL NEURO-OTOL, V14, P402, DOI 10.1159/000241897; Newbold Carrie, 2014, Cochlear Implants Int, V15, P191, DOI 10.1179/1754762813Y.0000000050; NI DF, 1992, HEARING RES, V62, P63, DOI 10.1016/0378-5955(92)90203-Y; O'Leary SJ, 2013, HEARING RES, V298, P27, DOI 10.1016/j.heares.2013.01.012; Paasche G, 2006, OTOL NEUROTOL, V27, P639, DOI 10.1097/01.mao.0000227662.88840.61; Paasche G, 2009, OTOL NEUROTOL, V30, P592, DOI 10.1097/MAO.0b013e3181ab8fba; Piu F, 2011, OTOL NEUROTOL, V32, P171, DOI 10.1097/MAO.0b013e3182009d29; Satoh H, 2002, LARYNGOSCOPE, V112, P1627, DOI 10.1097/00005537-200209000-00019; Seyyedi M, 2014, OTOL NEUROTOL, V35, P1545, DOI 10.1097/MAO.0000000000000540; SHEPHERD RK, 1994, HEARING RES, V81, P150, DOI 10.1016/0378-5955(94)90162-7; Silverman BG, 1996, ANN INTERN MED, V124, P744, DOI 10.7326/0003-4819-124-8-199604150-00008; Stathopoulos Dimitra, 2014, Cochlear Implants Int, V15, P254, DOI 10.1179/1754762813Y.0000000054; Wrzeszcz A, 2015, J BIOMED MATER RES B, V103, P169, DOI 10.1002/jbm.b.33187; Wrzeszcz A, 2014, J BIOMED MATER RES A, V102, P442, DOI 10.1002/jbm.a.34719; Xu J, 1997, HEARING RES, V105, P1, DOI 10.1016/S0378-5955(96)00193-1; Yoshida K, 1999, HEARING RES, V137, P155, DOI 10.1016/S0378-5955(99)00134-3	43	99	101	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147552	10.1371/journal.pone.0147552	http://dx.doi.org/10.1371/journal.pone.0147552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840740	Green Published, gold			2022-12-26	WOS:000369550200046
J	Zheng, H; Dirlam, J				Zheng, Hui; Dirlam, Jonathan			The Body Mass Index-Mortality Link across the Life Course: Two Selection Biases and Their Effects	PLOS ONE			English	Article							OBESITY PARADOX; HEART-FAILURE; WEIGHT CHANGE; RE OBESITY; RISK; AGE; HETEROGENEITY; ASSOCIATION; TIME; EXPECTANCY	In this study, we investigated two selection biases that may affect the obesity-mortality link over the life course: mortality selection and healthy participant effects. If these selection mechanisms are stronger among obese adults than among non-obese adults, they may contribute to the weakening obesity-mortality link over the life course. We used data from the National Health and Nutrition Examination Survey 1988-2010 with linked mortality files from 1988-2011. We employed weighted Cox models to test and adjust for these two selection biases. We also used complementary log-log models, adjusted for a normal distribution of frailty, to test for mortality selection effects; accelerated failure-time models to mitigate the mortality selection effect; and ordinary least squares regression to test for healthy participant effects. The link between class II/III obesity and mortality weakens at older ages. We did not find evidence for significant mortality selection or healthy participant effects. Also, even if the healthy participant effects were stronger among obese adults, they are not strong enough to produce a weakening association between obesity and morbidity at higher ages at the time of the survey. Therefore, neither of these selection biases explains the diminishing effect of class II/III obesity on mortality over the life course.	[Zheng, Hui; Dirlam, Jonathan] Ohio State Univ, Dept Sociol, Inst Populat Res, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Zheng, H (corresponding author), Ohio State Univ, Dept Sociol, Inst Populat Res, Columbus, OH 43210 USA.	zheng.64@osu.edu	Zheng, Hui/K-3735-2012	Zheng, Hui/0000-0003-3085-4560	Institute for Population Research at the Ohio State University, Eunice Kennedy Shriver National Institute for Child Health and Human Development [R24-HD058484]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD058484, R24HD058484] Funding Source: NIH RePORTER	Institute for Population Research at the Ohio State University, Eunice Kennedy Shriver National Institute for Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support for this project is provided by a seed grant from the Institute for Population Research at the Ohio State University which is supported by a grant from the Eunice Kennedy Shriver National Institute for Child Health and Human Development (R24-HD058484).	Abhyankar S, 2012, CRIT CARE, V16, DOI 10.1186/cc11903; Adams KF, 2014, AM J EPIDEMIOL, V179, P135, DOI 10.1093/aje/kwt254; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Casas-Vara A, 2012, NUTRITION, V28, P616, DOI 10.1016/j.nut.2011.10.006; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chapman IM, 2010, INTERD T GERONT GERI, V37, P20, DOI 10.1159/000319992; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x; Flinn C.J., 1982, SOCIOL METHODOL, V13, P99; Fonarow GC, 2007, AM HEART J, V153, P74, DOI 10.1016/j.ahj.2006.09.007; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193; Heckman JJ, 1982, ADV ECONOMETRICS, P39; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; HOUGAARD P, 1994, BIOMETRICS, V50, P1178, DOI 10.2307/2533456; Hutagalung R, 2011, INTENS CARE MED, V37, P1793, DOI 10.1007/s00134-011-2321-2; Keiding N, 1997, STAT MED, V16, P215; Kim BJ, 2012, NEUROLOGY, V79, P856, DOI 10.1212/WNL.0b013e318266fad1; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Kuk JL, 2009, J AM GERIATR SOC, V57, P2077, DOI 10.1111/j.1532-5415.2009.02486.x; Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003; Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325; McAuley PA, 2010, MAYO CLIN PROC, V85, P115, DOI 10.4065/mcp.2009.0562; Mehta NK, 2013, AM J EPIDEMIOL, V178, P320, DOI 10.1093/aje/kwt117; Mehta NK, 2011, POPUL DEV REV, V37, P435, DOI 10.1111/j.1728-4457.2011.00429.x; Mehta NK, 2009, DEMOGRAPHY, V46, P851, DOI 10.1353/dem.0.0077; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Myrskyla M, 2009, EPIDEMIOLOGY, V20, P840, DOI 10.1097/EDE.0b013e3181b5f520; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Preston SH, 2014, EPIDEMIOLOGY, V25, P454, DOI 10.1097/EDE.0000000000000075; Reynolds SL, 2005, GERONTOLOGIST, V45, P438, DOI 10.1093/geront/45.4.438; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Stallard E., 2010, POP ASS AM 2010 ANN; Stevens June, 1998, New England Journal of Medicine, V338, P1, DOI 10.1056/NEJM199801013380101; Stewart Susan T, 2009, N Engl J Med, V361, P2252, DOI 10.1056/NEJMsa0900459; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wang ZQ, 2014, AM J EPIDEMIOL, V179, P529, DOI 10.1093/aje/kwt329; Zheng H, 2013, AM J EPIDEMIOL, V178, P1591, DOI 10.1093/aje/kwt179; Zheng H, 2012, SOC SCI MED, V75, P990, DOI 10.1016/j.socscimed.2012.05.013	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148178	10.1371/journal.pone.0148178	http://dx.doi.org/10.1371/journal.pone.0148178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841215	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200090
J	Bergstrom, I; Kilteni, K; Slater, M				Bergstroem, Ilias; Kilteni, Konstantina; Slater, Mel			First-Person Perspective Virtual Body Posture Influences Stress: A Virtual Reality Body Ownership Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RUBBER-HAND ILLUSION; ILLUSORY OWNERSHIP; SELF-ATTRIBUTION; TOUCH; PART; OBJECTS; THATS; SKIN	In immersive virtual reality (IVR) it is possible to replace a person's real body by a life-sized virtual body that is seen from first person perspective to visually substitute their own. Multisensory feedback from the virtual to the real body (such as the correspondence of touch and also movement) can also be present. Under these conditions participants typically experience a subjective body ownership illusion (BOI) over the virtual body, even though they know that it is not their real one. In most studies and applications the posture of the real and virtual bodies are as similar as possible. Here we were interested in whether the BOI is diminished when there are gross discrepancies between the real and virtual body postures. We also explored whether a comfortable or uncomfortable virtual body posture would induce feelings and physiological responses commensurate with the posture. We carried out an experiment with 31 participants in IVR realized with a wide field-of-view head-mounted display. All participants were comfortably seated. Sixteen of them were embodied in a virtual body designed to be in a comfortable posture, and the remainder in an uncomfortable posture. The results suggest that the uncomfortable body posture led to lesser subjective BOI than the comfortable one, but that participants in the uncomfortable posture experienced greater awareness of their autonomic physiological responses. Moreover their heart rate, heart rate variability, and the number of mistakes in a cognitive task were associated with the strength of their BOI in the uncomfortable posture: greater heart rate, lower heart rate variability and more mistakes were associated with higher levels of the BOI. These findings point in a consistent direction-that the BOI over a body that is in an uncomfortable posture can lead to subjective, physiological and cognitive effects consistent with discomfort that do not occur with the BOI over a body in a comfortable posture.	[Bergstroem, Ilias; Kilteni, Konstantina; Slater, Mel] Univ Barcelona, Fac Psicol, Event Lab, Barcelona, Spain; [Slater, Mel] UCL, Dept Comp Sci, London, England; [Slater, Mel] ICREA, Barcelona, Spain; [Bergstroem, Ilias] Royal Inst Technol, KTH, Mobile Life, Stockholm, Sweden; [Kilteni, Konstantina] Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden	University of Barcelona; University of London; University College London; ICREA; Royal Institute of Technology; Karolinska Institutet	Slater, M (corresponding author), Univ Barcelona, Fac Psicol, Event Lab, Barcelona, Spain.; Slater, M (corresponding author), UCL, Dept Comp Sci, London, England.; Slater, M (corresponding author), ICREA, Barcelona, Spain.	melslater@ub.edu	Slater, Mel/M-5210-2014; Kilteni, Konstantina/J-7754-2015	Slater, Mel/0000-0002-6223-0050; Kilteni, Konstantina/0000-0002-6887-6434	European Union; Aeronautics and Transport; VR-HYPERSPACE project; Framework 7; ICREA Funding Source: Custom	European Union(European Commission); Aeronautics and Transport; VR-HYPERSPACE project; Framework 7; ICREA(ICREA)	This work was supported by the European Union, Framework 7, Aeronautics and Transport, VR-HYPERSPACE project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2005, J BODYW MOV THER, V9, P134, DOI 10.1016/j.jbmt.2004.04.001; Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Banakou D, 2014, P NATL ACAD SCI USA, V111, P17678, DOI 10.1073/pnas.1414936111; Banakou D, 2013, P NATL ACAD SCI USA, V110, P12846, DOI 10.1073/pnas.1306779110; Barnsley N, 2011, CURR BIOL, V21, pR945, DOI 10.1016/j.cub.2011.10.039; Blanke O, 2015, NEURON, V88, P145, DOI 10.1016/j.neuron.2015.09.029; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Blom KJ, 2014, PERCEPTION, V43, P275, DOI 10.1068/p7618; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; Cameron JA, 1996, INT J IND ERGONOM, V18, P389, DOI 10.1016/0169-8141(95)00101-8; Camm AJ, 1996, EUR HEART J, V17, P354; de la Pena N, 2010, PRESENCE-TELEOP VIRT, V19, P291, DOI 10.1162/PRES_a_00005; Dishman RK, 2000, INT J PSYCHOPHYSIOL, V37, P121, DOI 10.1016/S0167-8760(00)00085-4; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Giannopoulos Elias, 2012, International Journal of Virtual Reality, V11, P19; Giummarra MJ, 2010, PERCEPTION, V39, P103, DOI 10.1068/p6519; Gonzalez-Franco M, 2014, EXP BRAIN RES, V232, P875, DOI 10.1007/s00221-013-3800-1; Hohwy J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009416; Ide M, 2013, PERCEPTION, V42, P103, DOI 10.1068/p7322; Ionta S, 2013, COGN AFFECT BEHAV NE, V13, P197, DOI 10.3758/s13415-012-0120-z; Jones JA, 2008, APGV 2008: PROCEEDINGS OF THE SYMPOSIUM ON APPLIED PERCEPTION IN GRAPHICS AND VISUALIZATION, P9; Kalckert A, 2014, CONSCIOUS COGN, V26, P117, DOI 10.1016/j.concog.2014.02.003; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Kilteni K, 2013, IEEE T VIS COMPUT GR, V19, P597, DOI 10.1109/TVCG.2013.29; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Liu WW, 2008, EUR J APPL PHYSIOL, V103, P361, DOI 10.1007/s00421-008-0718-6; Llobera J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0300; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; MANDLER G, 1958, J ABNORM SOC PSYCH, V56, P367, DOI 10.1037/h0048083; Maselli A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00693; Maselli A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00083; Mehler B., 2011, P 6 INT DRIV S HUM F, P590, DOI [10.17077/drivingassessment.1451, DOI 10.17077/DRIVINGASSESSMENT]; MESHKATI N, 1988, P101; Miyatsuji Aya, 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P67, DOI 10.2114/jpa.21.67; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; Peck TC, 2013, CONSCIOUS COGN, V22, P779, DOI 10.1016/j.concog.2013.04.016; Pellecchia GL, 2003, GAIT POSTURE, V18, P29, DOI 10.1016/S0966-6362(02)00138-8; Pellecchia GL, 2001, J MOTOR BEHAV, V33, P9, DOI 10.1080/00222890109601898; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Petkova VI, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00035; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; Slater M, 2006, PRESENCE-VIRTUAL AUG, V15, P553, DOI 10.1162/pres.15.5.553; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Thomas ML, 2011, ASSESSMENT, V18, P291, DOI 10.1177/1073191110374797	54	45	46	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148060	10.1371/journal.pone.0148060	http://dx.doi.org/10.1371/journal.pone.0148060			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828365	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000369548200057
J	Wilczynska, A; Git, A; Argasinska, J; Belloc, E; Standart, N				Wilczynska, Ania; Git, Anna; Argasinska, Joanna; Belloc, Eulalia; Standart, Nancy			CPEB and miR-15/16 Co-Regulate Translation of Cyclin E1 mRNA during Xenopus Oocyte Maturation	PLOS ONE			English	Article							CYTOPLASMIC POLYADENYLATION ELEMENTS; MEIOTIC METAPHASE ARREST; BINDING PROTEINS; MICRORNA REPRESSION; TARGET SITES; CANCER; DEADENYLATION; ROLES; FAMILY; GW182	Cell cycle transitions spanning meioticmaturation of the Xenopus oocyte and early embryogenesis are tightly regulated at the level of stored inactive maternal mRNA. We investigated here the translational control of cyclin E1, required for metaphase II arrest of the unfertilised egg and the initiation of S phase in the early embryo. We show that the cyclin E1 mRNA is regulated by both cytoplasmic polyadenylation elements (CPEs) and two miR-15/16 target sites within its 3'UTR. Moreover, we provide evidence that maternal miR-15/16 microRNAs co-immunoprecipitate with CPE-binding protein (CPEB), and that CPEB interacts with the RISC component Ago2. Experiments using competitor RNA and mutated cyclin E1 3'UTRs suggest cooperation of the regulatory elements to sustain repression of the cyclin E1 mRNA during early stages of maturation when CPEB becomes limiting and cytoplasmic polyadenylation of repressed mRNAs begins. Importantly, injection of anti-miR-15/16 LNA results in the early polyadenylation of endogenous cyclin E1 mRNA during meiotic maturation, and an acceleration of GVBD, altogether strongly suggesting that the proximal CPEB and miRNP complexes act to mutually stabilise each other. We conclude that miR-15/16 and CPEB co-regulate cyclin E1 mRNA. This is the first demonstration of the co-operation of these two pathways.	[Wilczynska, Ania; Argasinska, Joanna; Standart, Nancy] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England; [Git, Anna] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Belloc, Eulalia] Inst Res Biomed, Barcelona, Spain; [Wilczynska, Ania] Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England; [Argasinska, Joanna] EMBL European Bioinformat Inst, Cambridge, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Leicester; European Molecular Biology Laboratory (EMBL)	Standart, N (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	nms23@cam.ac.uk		Wilczynska, Ania/0000-0003-4548-9367; Argasinska, Joanna/0000-0003-2678-2824	Biotechnology and Biological Sciences Research Council [BB/E016316/1]; Cancer Research UK; RATHER consortium; Cambridge Overseas Trust; Parke Davis Bursary (Downing College); BBSRC [BB/E016316/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); RATHER consortium; Cambridge Overseas Trust; Parke Davis Bursary (Downing College); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the Biotechnology and Biological Sciences Research Council (BB/E016316/1). AG was funded by Cancer Research UK and the RATHER consortium, and JA was funded by the Cambridge Overseas Trust and the Parke Davis Bursary (Downing College). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Armisen J, 2009, GENOME RES, V19, P1766, DOI 10.1101/gr.093054.109; Balagopal V, 2012, BBA-GENE REGUL MECH, V1819, P593, DOI 10.1016/j.bbagrm.2012.01.001; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Brook M, 2009, REPRODUCTION, V137, P595, DOI 10.1530/REP-08-0524; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2000, DEV BIOL, V227, P706, DOI 10.1006/dbio.2000.9922; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; Chevalier S, 1996, J CELL SCI, V109, P1173; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fernandez-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Gillian-Daniel DL, 1998, MOL CELL BIOL, V18, P6152, DOI 10.1128/MCB.18.10.6152; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Git A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2109; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213; Kamenska A, 2014, BIOCHEM SOC T, V42, P1238, DOI 10.1042/BST20140063; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kirino Y, 2009, NAT CELL BIOL, V11, P652, DOI 10.1038/ncb1872; Lau NC, 2009, EMBO J, V28, P2945, DOI 10.1038/emboj.2009.237; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lund E, 2011, GENE DEV, V25, P1121, DOI 10.1101/gad.2038811; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Marnef A, 2010, RNA, V16, P2094, DOI 10.1261/rna.2295410; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Miles WO, 2012, GENE DEV, V26, P356, DOI 10.1101/gad.182568.111; Minshall N, 1999, RNA, V5, P27, DOI 10.1017/S1355838299981220; Minshall N, 2004, NUCLEIC ACIDS RES, V32, P1325, DOI 10.1093/nar/gkh303; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Minshall N, 2010, METHODS, V51, P165, DOI 10.1016/j.ymeth.2010.02.018; Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309; Mortensen RD, 2011, PNAS, V108, P8261; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; REMPEL RE, 1995, J BIOL CHEM, V270, P6843, DOI 10.1074/jbc.270.12.6843; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; SIMON R, 1992, GENE DEV, V6, P2580, DOI 10.1101/gad.6.12b.2580; Slevin MK, 2007, NUCLEIC ACIDS RES, V35, P2167, DOI 10.1093/nar/gkm084; Strausfeld UP, 1996, J CELL SCI, V109, P1555; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Sun GH, 2010, NUCLEIC ACIDS RES, V38, P239, DOI 10.1093/nar/gkp870; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tunquist BJ, 2002, CURR BIOL, V12, P1027, DOI 10.1016/S0960-9822(02)00894-1; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Villalba A, 2011, CURR OPIN GENET DEV, V21, P452, DOI 10.1016/j.gde.2011.04.006; Wang F, 2009, BMB REP, V42, P725, DOI 10.5483/BMBRep.2009.42.11.725; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wormington M, 1996, EMBO J, V15, P900, DOI 10.1002/j.1460-2075.1996.tb00424.x; Zhang S, 1999, METHODS, V17, P46, DOI 10.1006/meth.1998.0706; Zhang Y, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-7; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	77	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0146792	10.1371/journal.pone.0146792	http://dx.doi.org/10.1371/journal.pone.0146792			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829217	Green Published, gold			2022-12-26	WOS:000369548200011
J	Fumoto, S; Nishimura, K; Nishida, K; Kawakami, S				Fumoto, Shintaro; Nishimura, Koyo; Nishida, Koyo; Kawakami, Shigeru			Three-Dimensional Imaging of the Intracellular Fate of Plasmid DNA and Transgene Expression: ZsGreen1 and Tissue Clearing Method CUBIC Are an Optimal Combination for Multicolor Deep Imaging in Murine Tissues	PLOS ONE			English	Article							SINGLE-CELL RESOLUTION; NUCLEAR IMPORT; IN-VIVO; FLUORESCENT PROTEINS; GENE TRANSFECTION; EFFICIENT; DELIVERY; LIVER; MICE; SYSTEMS	Evaluation methods for determining the distribution of transgene expression in the body and the in vivo fate of viral and non-viral vectors are necessary for successful development of in vivo gene delivery systems. Here, we evaluated the spatial distribution of transgene expression using tissue clearing methods. After hydrodynamic injection of plasmid DNA into mice, whole tissues were subjected to tissue clearing. Tissue clearing followed by con-focal laser scanning microscopy enabled evaluation of the three-dimensional distribution of transgene expression without preparation of tissue sections. Among the tested clearing methods (Clear(T2), SeeDB, and CUBIC), CUBIC was the most suitable method for determining the spatial distribution of transgene expression in not only the liver but also other tissues such as the kidney and lung. In terms of the type of fluorescent protein, the observable depth for green fluorescent protein ZsGreen1 was slightly greater than that for red fluorescent protein tdTomato. We observed a depth of similar to 1.5 mm for the liver and 500 mu m for other tissues without preparation of tissue sections. Furthermore, we succeeded in multicolor deep imaging of the intracellular fate of plasmid DNA in the murine liver. Thus, tissue clearing would be a powerful approach for determining the spatial distribution of plasmid DNA and transgene expression in various murine tissues.	[Fumoto, Shintaro; Nishimura, Koyo; Nishida, Koyo; Kawakami, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan	Nagasaki University	Fumoto, S; Kawakami, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan.	sfumoto@nagasaki-u.ac.jp; skawakam@nagasaki-u.ac.jp	Kawakami, Shigeru/R-1460-2019; Wilson, Matthew H/K-3193-2013		Japan Society for the Promotion of Science [25350553]; Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grant Number 25350553), and by the Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Dean DA, 1999, EXP CELL RES, V253, P713, DOI 10.1006/excr.1999.4716; Denk W., 1990, NATURE, V248, P73, DOI DOI 10.1126/SCIENCE.2321027; Fumoto S, 2003, PHARM RES-DORDR, V20, P1452, DOI 10.1023/A:1025766429175; Fumoto S, 2012, MOL PHARMACEUT, V9, P1962, DOI 10.1021/mp2006592; Gomme EA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002971; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Hama S, 2006, MOL THER, V13, P786, DOI 10.1016/j.ymthe.2005.10.007; Hu YX, 2013, ACS NANO, V7, P5376, DOI 10.1021/nn4012384; Kawakami S, 2000, PHARMACEUT RES, V17, P306, DOI 10.1023/A:1007501122611; Kawakami S, 2002, BIOCHEM BIOPH RES CO, V294, P46, DOI 10.1016/S0006-291X(02)00432-1; Kawakami S, 2014, J CONTROL RELEASE, V190, P542, DOI 10.1016/j.jconrel.2014.06.001; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Koksharov MI, 2012, BIOTECHNOL J, V2, DOI [10.5936/csbj.201209004, DOI 10.5936/CSBJ.201209004]; Kurosaki T, 2014, J CONTROL RELEASE, V176, P24, DOI 10.1016/j.jconrel.2013.12.023; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Morris LM, 2010, BIOTECH HISTOCHEM, V85, P379, DOI 10.3109/10520290903504753; Mutze J, 2012, BIOPHYS J, V102, P934, DOI 10.1016/j.bpj.2011.12.056; Nomoto T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4545; Picconi JL, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.14; Richard JC, 2003, GENE THER, V10, P2074, DOI 10.1038/sj.gt.3302117; Richards B, 2002, CYTOMETRY, V48, P106, DOI 10.1002/cyto.10117; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shimizu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041319; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Tamaru M, 2014, INT J NANOMED, V9, P4267, DOI 10.2147/IJN.S65402; Un K, 2010, BIOMATERIALS, V31, P7813, DOI 10.1016/j.biomaterials.2010.06.058; Vacik J, 1999, GENE THER, V6, P1006, DOI 10.1038/sj.gt.3300924; Wilson GL, 1999, J BIOL CHEM, V274, P22025, DOI 10.1074/jbc.274.31.22025; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Zhu D, 2013, LASER PHOTONICS REV, V7, P732, DOI 10.1002/lpor.201200056	33	25	27	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148233	10.1371/journal.pone.0148233	http://dx.doi.org/10.1371/journal.pone.0148233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824850	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528600112
J	Geng, XX; Jiang, CH; Yang, J; Wang, LJ; Wu, XM; Wei, WH				Geng, Xinxin; Jiang, Chenghong; Yang, Jie; Wang, Lijun; Wu, Xiaoming; Wei, Wenhui			Rapid Identification of Candidate Genes for Seed Weight Using the SLAF-Seq Method in Brassica napus	PLOS ONE			English	Article							QUANTITATIVE TRAIT ANALYSIS; COMPLEX TRAITS; SILIQUE LENGTH; LARGE GRAIN; YIELD; L.; ARABIDOPSIS; HYBRID; QTL; MAP	Seed weight is a critical and direct trait for oilseed crop seed yield. Understanding its genetic mechanism is of great importance for yield improvement in Brassica napus breeding. Two hundred and fifty doubled haploid lines derived bymicrospore culture were developed from a cross between a large-seed lineG-42 and a small-seed line 7-9. According to the 1000-seed weight (TSW) data, the individual DNA of the heaviest 46 lines and the lightest 47 lines were respectively selected to establish two bulked DNA pools. A new high-throughput sequencing technology, Specific Locus Amplified Fragment Sequencing (SLAF-seq), was used to identify candidate genes of TSWin association analysis combined with bulked segregant analysis (BSA). A total of 1,933 high quality polymorphic SLAF markers were developed and 4 associated markers of TSW were procured. A hot region of similar to 0.58 Mb at nucleotides 25,401,885-25,985,931 on ChrA09 containing 91 candidate genes was identified as tightly associated with the TSW trait. From annotation information, four genes (GSBRNA2T00037136001, GSBRNA2T00037157001, GSBRNA2T00037129001 and GSBRNA2T00069389001) might be interesting candidate genes that are highly related to seed weight.	[Geng, Xinxin; Jiang, Chenghong; Yang, Jie; Wang, Lijun; Wu, Xiaoming; Wei, Wenhui] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan 430062, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wei, WH (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan 430062, Peoples R China.	wuxm@oilcrops.cn; whwei@oilcrops.cn			National Natural Science Foundation of China [31371664, 31470088]; Scientific and Technological Project of Wuhan City [2013020501010174]; National Nonprofit Institute Research Grant [1610172012001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Project of Wuhan City; National Nonprofit Institute Research Grant	This work was supported by the National Natural Science Foundation of China (grant no. 31371664 and 31470088), the Scientific and Technological Project of Wuhan City (grant no. 2013020501010174) and the National Nonprofit Institute Research Grant (grant no. 1610172012001). WHW received all of the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basunanda P, 2010, THEOR APPL GENET, V120, P271, DOI 10.1007/s00122-009-1133-z; Cai GQ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-105; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; Chen W, 2007, THEOR APPL GENET, V115, P849, DOI 10.1007/s00122-007-0613-2; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Deza E, 2009, ENCY DISTANCES, P94, DOI [10.1007/978-3-642-30958-8, DOI 10.1007/978-3-642-30958-8]; Fan CC, 2010, THEOR APPL GENET, V121, P1289, DOI 10.1007/s00122-010-1388-4; Hajduch M, 2006, PLANT PHYSIOL, V141, P32, DOI 10.1104/pp.105.075390; Hu ZJ, 2012, J INTEGR PLANT BIOL, V54, P979, DOI 10.1111/jipb.12008; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Li B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1086; Li F, 2014, PHYS REV APPL, V1, DOI 10.1103/PhysRevApplied.1.051001; Li N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-114; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu J, 2015, P NATL ACAD SCI USA, V112, pE5123, DOI 10.1073/pnas.1502160112; Liu TM, 2009, THEOR APPL GENET, V118, P1509, DOI 10.1007/s00122-009-0999-0; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Nelson MN, 2009, THEOR APPL GENET, V119, P497, DOI 10.1007/s00122-009-1056-8; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Quijada PA, 2006, THEOR APPL GENET, V113, P549, DOI 10.1007/s00122-006-0323-1; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Song GL, 1998, ACTA GOSSYPII SIN, V10, P273; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Udall JA, 2006, THEOR APPL GENET, V113, P597, DOI 10.1007/s00122-006-0324-0; Xia C, 2015, EUPHYTICA, V202, P35, DOI 10.1007/s10681-014-1202-5; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122206; Yang P, 2012, THEOR APPL GENET, V125, P285, DOI 10.1007/s00122-012-1833-7; Zhang LW, 2011, THEOR APPL GENET, V122, P21, DOI 10.1007/s00122-010-1419-1; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; [朱恒星 Zhu Hengxing], 2012, [植物遗传资源学报, Journal of Plant Genetic Resources], V13, P843	47	48	55	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147580	10.1371/journal.pone.0147580	http://dx.doi.org/10.1371/journal.pone.0147580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824525	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528600037
J	Jan, HU; Abbadi, A; Lucke, S; Nichols, RA; Snowdon, RJ				Jan, Habib U.; Abbadi, Amine; Luecke, Sophie; Nichols, Richard A.; Snowdon, Rod J.			Genomic Prediction of Testcross Performance in Canola (Brassica napus)	PLOS ONE			English	Article							HYBRID PERFORMANCE; GENETIC DIVERSITY; RIDGE-REGRESSION; QUANTITATIVE TRAITS; COMBINING ABILITY; BREEDING VALUES; LINKAGE DISEQUILIBRIUM; GENOMEWIDE SELECTION; INBRED LINES; SSR MARKERS	Genomic selection (GS) is a modern breeding approach where genome-wide single-nucleotide polymorphism (SNP) marker profiles are simultaneously used to estimate performance of untested genotypes. In this study, the potential of genomic selection methods to predict testcross performance for hybrid canola breeding was applied for various agronomic traits based on genome-wide marker profiles. A total of 475 genetically diverse spring-type canola pollinator lines were genotyped at 24,403 single-copy, genome-wide SNP loci. In parallel, the 950 F1 testcross combinations between the pollinators and two representative testers were evaluated for a number of important agronomic traits including seedling emergence, days to flowering, lodging, oil yield and seed yield along with essential seed quality characters including seed oil content and seed glucosinolate content. A ridge-regression best linear unbiased prediction (RR-BLUP) model was applied in combination with 500 cross-validations for each trait to predict testcross performance, both across the whole population as well as within individual subpopulations or clusters, based solely on SNP profiles. Subpopulations were determined using multidimensional scaling and K-means clustering. Genomic prediction accuracy across the whole population was highest for seed oil content (0.81) followed by oil yield (0.75) and lowest for seedling emergence (0.29). For seed yield, seed glucosinolate, lodging resistance and days to onset of flowering (DTF), prediction accuracies were 0.45, 0.61, 0.39 and 0.56, respectively. Prediction accuracies could be increased for some traits by treating subpopulations separately; a strategy which only led to moderate improvements for some traits with low heritability, like seedling emergence. No useful or consistent increase in accuracy was obtained by inclusion of a population substructure covariate in the model. Testcross performance prediction using genome-wide SNP markers shows considerable potential for pre-selection of promising hybrid combinations prior to resource-intensive field testing over multiple locations and years.	[Jan, Habib U.; Snowdon, Rod J.] Univ Giessen, IFZ Res Ctr Biosyst Land Use & Nutr, Dept Plant Breeding, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany; [Abbadi, Amine] NPZ Innovat GmbH, D-24363 Hohenlieth, Holtsee, Germany; [Luecke, Sophie] Norddeutsch Pflanzenzucht Hans Georg Lembke KG, D-24363 Hohenlieth, Holtsee, Germany; [Nichols, Richard A.] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England	Justus Liebig University Giessen; University of London; Queen Mary University London	Snowdon, RJ (corresponding author), Univ Giessen, IFZ Res Ctr Biosyst Land Use & Nutr, Dept Plant Breeding, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	rod.snowdon@agrar.uni-giessen.de	Nichols, Richard Alan/T-4773-2019; Jan, Habib/ABE-2476-2021	Jan, Habib/0000-0001-9085-7398; Nichols, Richard Alan/0000-0002-4801-9312	Deutsche Forschungsgemeinschaft (DFG) [SN14/16-1]; European Union FP7 Marie Curie Initial Training Network INTERCROSSING; Norddeutsche Pflanzenzucht Hans-Georg Lembke KG; NPZ Innovation GmbH	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union FP7 Marie Curie Initial Training Network INTERCROSSING; Norddeutsche Pflanzenzucht Hans-Georg Lembke KG; NPZ Innovation GmbH	The work was funded by Deutsche Forschungsgemeinschaft (DFG) grant SN14/16-1 to RS and funding to RN, RS, and HJ from the European Union FP7 Marie Curie Initial Training Network INTERCROSSING. AA is an employee of NPZ Innovation GmbH and SL is an employee of Norddeutsche Pflanzenzucht Hans-Georg Lembke KG. These companies provided support in the form of salaries for AA and SL, but neither they nor the other funding bodies had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Albrecht T, 2011, THEOR APPL GENET, V123, P339, DOI 10.1007/s00122-011-1587-7; Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Badani AG, 2006, GENOME, V49, P1499, DOI 10.1139/G06-091; Basunanda P, 2007, PLANT BREEDING, V126, P581, DOI 10.1111/j.1439-0523.2007.01404.x; Basunanda P, 2010, THEOR APPL GENET, V120, P271, DOI 10.1007/s00122-009-1133-z; BECK DL, 1990, MAYDICA, V35, P279; BECKER HC, 1995, THEOR APPL GENET, V91, P62, DOI 10.1007/BF00220859; Bekele WA, 2014, PLANT CELL ENVIRON, V37, P707, DOI 10.1111/pce.12189; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; BRANDLE JE, 1989, CROP SCI, V29, P1191, DOI 10.2135/cropsci1989.0011183X002900050020x; Bus A, 2011, THEOR APPL GENET, V123, P1413, DOI 10.1007/s00122-011-1676-7; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Cho YI, 2004, BREEDING SCI, V54, P389, DOI 10.1270/jsbbs.54.389; Cowling WA, 2007, FIELD CROP RES, V104, P103, DOI 10.1016/j.fcr.2006.12.014; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de Roos APW, 2009, GENETICS, V183, P1545, DOI 10.1534/genetics.109.104935; Delourme R, 2006, THEOR APPL GENET, V113, P1331, DOI 10.1007/s00122-006-0386-z; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; Duvick J, 2001, ENVIRON HEALTH PERSP, V109, P337, DOI 10.2307/3435028; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Girke A, 2012, THEOR APPL GENET, V124, P1017, DOI 10.1007/s00122-011-1765-7; GRANT I, 1985, CAN J GENET CYTOL, V27, P472, DOI 10.1139/g85-069; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hasan M, 2006, GENET RESOUR CROP EV, V53, P793, DOI 10.1007/s10722-004-5541-2; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Hofheinz N, 2014, G3-GENES GENOM GENET, V4, P539, DOI 10.1534/g3.113.010025; Hofheinz N, 2012, THEOR APPL GENET, V125, P1639, DOI 10.1007/s00122-012-1940-5; Iniguez-Luy FL, 2001, GENETICS GENOMICS BR, P291; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Jonas E, 2013, TRENDS BIOTECHNOL, V31, P497, DOI 10.1016/j.tibtech.2013.06.003; LEFORTBUSON M, 1987, GENOME, V29, P413, DOI 10.1139/g87-072; Li YY, 2006, EUPHYTICA, V152, P25, DOI 10.1007/s10681-006-9173-9; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Mei JQ, 2011, PLANT BREEDING, V130, P333, DOI 10.1111/j.1439-0523.2011.01850.x; Melchinger AE, 1998, CSSA SPEC PUBL, P29; Meuwissen THE, 2001, GENETICS, V157, P1819; Piepho HP, 2009, CROP SCI, V49, P1165, DOI 10.2135/cropsci2008.10.0595; Qian W, 2007, THEOR APPL GENET, V115, P27, DOI 10.1007/s00122-007-0537-x; Qian W, 2005, THEOR APPL GENET, V110, P1187, DOI 10.1007/s00122-005-1932-9; R 3.1.0 Development Core Team R, 2014, LANG ENV STAT COMP; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; Reif JC, 2013, PLANT BREEDING, V132, P107, DOI 10.1111/pbr.12007; Renard M, 1997, GCIRC B, P114; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Riedelsheimer C, 2013, GENETICS, V194, P493, DOI 10.1534/genetics.113.150227; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Rogers J. S., 1972, U TEXAS PUBL, V7213, P145; Saatchi M, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-40; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Schrag TA, 2006, THEOR APPL GENET, V113, P1037, DOI 10.1007/s00122-006-0363-6; SHAHIDI F, 1990, CANOLA RAPESEED PROD, P3; Snowdon R, 2012, NATURE, V490, P37, DOI 10.1038/490037d; Snowdon RJ, 2015, TRENDS PLANT SCI, V20, P410, DOI 10.1016/j.tplants.2015.04.013; Snowdon RJ, 2012, PLANT BREEDING, V131, P351, DOI 10.1111/j.1439-0523.2012.01976.x; Solberg TR, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-29; Technow F, 2012, THEOR APPL GENET, V125, P1181, DOI 10.1007/s00122-012-1905-8; Teklewold A, 2006, THEOR APPL GENET, V112, P752, DOI 10.1007/s00122-005-0180-3; Wang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080569; Wang Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-556; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Windhausen VS, 2012, G3-GENES GENOM GENET, V2, P1427, DOI 10.1534/g3.112.003699; Wu JG, 2006, GENET MOL BIOL, V29, P533, DOI 10.1590/S1415-47572006000300023; Wurschum T, 2014, PLANT BREEDING, V133, P45, DOI 10.1111/pbr.12137; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Zhao YS, 2013, CROP SCI, V53, P802, DOI 10.2135/cropsci2012.08.0463; Zhao YuSheng, 2012, TAG Theoretical and Applied Genetics, V124, P769, DOI 10.1007/s00122-011-1745-y; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277; Zou J, 2010, THEOR APPL GENET, V120, P283, DOI 10.1007/s00122-009-1201-4; [No title captured]	77	46	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147769	10.1371/journal.pone.0147769	http://dx.doi.org/10.1371/journal.pone.0147769			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824924	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528600057
J	Rechner, S; Berger, A				Rechner, Steffen; Berger, Annabell			Marathon: An Open Source Software Library for the Analysis of Markov-Chain Monte Carlo Algorithms	PLOS ONE			English	Article							GRAPHS	We present the software library marathon, which is designed to support the analysis of sampling algorithms that are based on the Markov-Chain Monte Carlo principle. The main application of this library is the computation of properties of so-called state graphs, which represent the structure of Markov chains. We demonstrate applications and the usefulness of marathon by investigating the quality of several bounding methods on four well-known Markov chains for sampling perfect matchings and bipartite graphs. In a set of experiments, we compute the total mixing time and several of its bounds for a large number of input instances. We find that the upper bound gained by the famous canonical path method is often several magnitudes larger than the total mixing time and deteriorates with growing input size. In contrast, the spectral bound is found to be a precise approximation of the total mixing time.	[Rechner, Steffen; Berger, Annabell] Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Saale, Germany; [Berger, Annabell] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg	Rechner, S (corresponding author), Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Saale, Germany.	steffen.rechner@informatik.uni-halle.de						Berger A, 2010, LECT NOTES COMPUT SC, V6410, P220; Bezakova I, 2006, PROCEEDINGS OF THE SEVENTHEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P900, DOI 10.1145/1109557.1109656; Broder A, 1986, P 18 ANN ACM S THEOR, P50, DOI DOI 10.1145/12130.12136; Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313; Diaconis P, 1999, IMS LECT NOTES MONOG, P195; Diaconis P, 2009, B AM MATH SOC, V46, P179; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Greenhill C., 2015, 26 ANN ACM SIAM S DI, P1564, DOI DOI 10.1137/1.9781611973730.103; Jerrum M, 2004, J ACM, V51, P671, DOI 10.1145/1008731.1008738; JERRUM M, 1989, SIAM J COMPUT, V18, P1149, DOI 10.1137/0218077; JERRUM MR, 1986, THEOR COMPUT SCI, V43, P169, DOI 10.1016/0304-3975(86)90174-X; Kannan R, 1999, RANDOM STRUCT ALGOR, V14, P293, DOI 10.1002/(SICI)1098-2418(199907)14:4<293::AID-RSA1>3.0.CO;2-G; Kashtan N, 2005, MFINDER NETWORK MOTI; Lehoucq RB, ARPACK USERS GUIDE S; Levin D. A., 2006, MARKOV CHAINS MIXING; Lovasz L, 1996, BOLYAI MATH STUD, V2, P353; Miklos I., 2013, ELECRON J COMBIN, V20, P1; Nvidia, 2015, CUBLAS; Nvidia, 2015, CUDA TOOLK; Nvidia, 2015, CUBLAS XT; Petersen J., 1891, ACTA MATH, P193, DOI DOI 10.1007/BF02392606; SINCLAIR A, 1992, LECT NOTES COMPUT SC, V583, P474; Sinclair A, 2009, CS294 MARKOV CHAIN M; TUTTE WT, 1952, CAN J MATH, V4, P314, DOI 10.4153/CJM-1952-028-2; Xianyi Z, 2015, OPENBLAS	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147935	10.1371/journal.pone.0147935	http://dx.doi.org/10.1371/journal.pone.0147935			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824442	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600076
J	Flores, AM; Casey, SD; Felix, CM; Phuan, PW; Verkman, AS; Levin, MH				Flores, Alyssa M.; Casey, Scott D.; Felix, Christian M.; Phuan, Puay W.; Verkman, A. S.; Levin, Marc H.			Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease	FASEB JOURNAL			English	Article						ocular surface; chloride channels; cornea; conjunctiva	BASOLATERAL K+ CONDUCTANCE; CYSTIC-FIBROSIS; CHLORIDE TRANSPORT; OCULAR SURFACE; DIQUAFOSOL TETRASODIUM; OPHTHALMIC SOLUTION; RABBIT; CONJUNCTIVAL; MODEL; MICE	Dry eye disorders, including Sjogren's syndrome, constitute a common problem in the aging population, with limited effective therapeutic options available. The cAMP-activated Cl- channel cystic fibrosis transmembrane conductance regulator (CFTR) is a major prosecretory channel at the ocular surface. We investigated whether compounds that target CFTR can correct the abnormal tear film in dry eye. Small-molecule activators of human wild-type CFTR identified by high-throughput screening were evaluated in cell culture and in vivo assays, to select compounds that stimulate Cl--driven fluid secretion across the ocular surface in mice. An aminophenyl-1,3,5-triazine, CFTRact-K089, fully activated CFTR in cell cultures with EC50 similar to 250 nM and produced an similar to 8.5 mV hyperpolarization in ocular surface potential difference. When delivered topically, CFTRact-K089 doubled basal tear volume for 4 h and had no effect in CF mice. CFTRact-K089 showed sustained tear film bio-availability without detectable systemic absorption. In a mouse model of aqueous-deficient dry eye produced by lacrimal ablation, topical administration of 0.1 nmol CFTRact-K089 3 times daily restored tear volume to basal levels, preventing corneal epithelial disruption when initiated at the time of surgery and reversing it when started after development of dry eye. Our results support the potential utility of CFTR-targeted activators as a novel prosecretory treatment for dry eye.-Flores, A. M., Casey, S. D., Felix, C. M., Phuan, P. W., Verkman, A. S., Levin, M. H. Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease.	[Flores, Alyssa M.; Casey, Scott D.; Felix, Christian M.; Phuan, Puay W.; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Flores, Alyssa M.; Casey, Scott D.; Felix, Christian M.; Phuan, Puay W.; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Flores, Alyssa M.; Casey, Scott D.; Felix, Christian M.; Levin, Marc H.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Levin, MH (corresponding author), Univ Calif San Francisco, 10 Koret Way,Room K203, San Francisco, CA 94143 USA.	marc.levin@ucsf.edu		Casey, Scott/0000-0001-6733-2155	U.S. National Institutes of Health (NIH)/National Center for Advancing Translational Sciences-UCSF-Clinical and Translational Science Institute Grant [UL1 TR000004]; Research to Prevent Blindness Career Development Award; NIH National Eye Institute Grant [EY023981, EY13574, EY002162]; National Institute of Biomedical Imaging and Bioengineering Grant [EB00415]; National Institute of Diabetes and Digestive and Kidney Diseases [DK72517, DK35124, DK101373]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013574, P30EY002162, K08EY023981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R37DK035124, P30DK072517, R01DK101373] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Center for Advancing Translational Sciences-UCSF-Clinical and Translational Science Institute Grant; Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); NIH National Eye Institute Grant; National Institute of Biomedical Imaging and Bioengineering Grant; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. N. A. McNamara, Dr. D. N. Stephens, and F.Y.T. Chen [Francis I. Proctor Foundation, UCSF (N.A.M., D.N.S., and F.Y.T.C.); and Departments of Anatomy and Ophthalmology, UCSF, and University of California, Berkeley School of Optometry and Vision Science Graduate Group (N.A.M.)] for expert advice in evaluation of rodent dry eye models and Dr. T. Porco (Frances I. Proctor Foundation and Departments of Ophthalmology and Epidemiology & Biostatistics, UCSF) for statistical assistance. This project was supported by U.S. National Institutes of Health (NIH)/National Center for Advancing Translational Sciences-UCSF-Clinical and Translational Science Institute Grant UL1 TR000004 (to M.H.L. and A.S.V), a Research to Prevent Blindness Career Development Award and NIH National Eye Institute Grant EY023981 (to M.H.L); NIH National Eye Institute Grant EY13574, National Institute of Biomedical Imaging and Bioengineering Grant EB00415, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK72517, DK35124, and DK101373 (to A.S.V.); and NIH National Eye Institute Grant EY002162 (to the UCSF Core Grant for Vision Research). Provisional U.S. patents have been filed on the use of the CFTR activators reported here for dry eye therapy and alternative applications. The authors declare no additional conflicts of interest.	Al-Nakkash L, 2001, INVEST OPHTH VIS SCI, V42, P2364; Alves M, 2013, OCUL SURF, V11, P181, DOI 10.1016/j.jtos.2013.02.002; Ansari EA, 1999, BRIT J OPHTHALMOL, V83, P688, DOI 10.1136/bjo.83.6.688; Asbell PA, 2010, EYE CONTACT LENS, V36, P33, DOI 10.1097/ICL.0b013e3181c739ad; BOTELHO SY, 1973, J PEDIATR-US, V83, P601, DOI 10.1016/S0022-3476(73)80221-5; Chen YT, 2009, MOL VIS, V15, P563; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Esteva-Font C, 2014, FASEB J, V28, P3878, DOI 10.1096/fj.14-253872; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; GILBARD JP, 1984, OPHTHALMOLOGY, V91, P1205; Koh S, 2013, JPN J OPHTHALMOL, V57, P440, DOI 10.1007/s10384-013-0251-y; KOMPELLA UB, 1993, CURR EYE RES, V12, P1041, DOI 10.3109/02713689309033501; Lemp MA, 2007, OCUL SURF, V5, P75; Lemp MA, 2011, AM J OPHTHALMOL, V151, P792, DOI 10.1016/j.ajo.2010.10.032; Levin MH, 2006, INVEST OPHTH VIS SCI, V47, P306, DOI 10.1167/iovs.05-1082; Levin MH, 2005, INVEST OPHTH VIS SCI, V46, P1428, DOI 10.1167/iovs.04-1314; Levin MH, 2004, INVEST OPHTH VIS SCI, V45, P4423, DOI 10.1167/iovs.04-0816; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Lu M, 2012, CURR EYE RES, V37, P671, DOI 10.3109/02713683.2012.675613; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; MORKEBERG JC, 1995, GRAEF ARCH CLIN EXP, V233, P709, DOI 10.1007/BF00164674; Mrugacz M, 2006, J INTERF CYTOK RES, V26, P71, DOI 10.1089/jir.2006.26.71; Nandoskar P, 2012, CORNEA, V31, P273, DOI 10.1097/ICO.0b013e3182254b42; Nichols KK, 2004, EXPERT OPIN INV DRUG, V13, P47, DOI 10.1517/13543784.13.1.47; RALPH RA, 1975, INVEST OPHTH VISUAL, V14, P299; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Sheppard JD, 2014, OPHTHALMOLOGY, V121, P475, DOI 10.1016/j.ophtha.2013.09.015; Shiue MHI, 2002, CAN J PHYSIOL PHARM, V80, P533, DOI 10.1139/Y02-066; Smith JA, 2007, OCUL SURF, V5, P93; Stevenson W, 2014, CORNEA, V33, P1336, DOI 10.1097/ICO.0000000000000264; Sullivan DA, 1999, INVEST OPHTH VIS SCI, V40, P1261; Sung MS, 2015, INVEST OPHTH VIS SCI, V56, P3149, DOI 10.1167/iovs.14-16153; Takamura E, 2012, BRIT J OPHTHALMOL, V96, P1310, DOI 10.1136/bjophthalmol-2011-301448; Tauber J, 2004, CORNEA, V23, P784, DOI 10.1097/01.ico.0000133993.14768.a9; Thelin WR, 2012, J OCUL PHARMACOL TH, V28, P433, DOI 10.1089/jop.2011.0157; Turner HC, 2002, CURR EYE RES, V24, P182, DOI 10.1076/ceyr.24.3.182.8297; Turner HC, 2000, EXP EYE RES, V70, P295, DOI 10.1006/exer.1999.0792; Van Goor F, 2008, TOP MED CHEM SER, V3, P91, DOI 10.1007/7355_2008_022; Vertex Pharmaceuticals, 2012, KAL PROD MON; Villareal Arturo L, 2006, Eye Contact Lens, V32, P272, DOI 10.1097/01.icl.0000224360.10319.b1; WATSKY MA, 1988, CURR EYE RES, V7, P483, DOI 10.3109/02713688809031801; WOLOSIN JM, 1987, AM J PHYSIOL, V253, pC555, DOI 10.1152/ajpcell.1987.253.4.C555; Yao CJ, 2012, J AM SOC NEPHROL, V23, P1210, DOI 10.1681/ASN.2011070751; Yu DF, 2012, AM J PHYSIOL-CELL PH, V303, pC767, DOI 10.1152/ajpcell.00195.2012; Yu JH, 2011, CORNEA, V30, P379, DOI 10.1097/ICO.0b013e3181f7f363	51	21	26	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1789	1797		10.1096/fj.201500180	http://dx.doi.org/10.1096/fj.201500180			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26842854	Green Published			2022-12-26	WOS:000374879400010
J	Shelar, SB; Narasimhan, M; Shanmugam, G; Litovsky, SH; Gounder, SS; Karan, G; Arulvasu, C; Kensler, TW; Hoidal, JR; Darley-Usmar, VM; Rajasekaran, NS				Shelar, Sandeep Balu; Narasimhan, Madhusudhanan; Shanmugam, Gobinath; Litovsky, Silvio Hector; Gounder, Sellamuthu S.; Karan, Goutam; Arulvasu, Cinnasamy; Kensler, Thomas W.; Hoidal, John R.; Darley-Usmar, Victor M.; Rajasekaran, Namakkal S.			Disruption of nuclear factor (erythroid-derived-2)-like 2 antioxidant signaling: a mechanism for impaired activation of stem cells and delayed regeneration of skeletal muscle	FASEB JOURNAL			English	Article						TA muscle; Pax7; Nrf2/ARE; satellite cell; cardiotoxin	ISCHEMIA-REPERFUSION INJURY; SATELLITE CELLS; MYOGENIC DIFFERENTIATION; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; GENE-EXPRESSION; PRECURSOR CELLS; SELF-RENEWAL; AGED MUSCLE; MOUSE MODEL	Recently we have reported that age-dependent decline in antioxidant levels accelerated apoptosis and skeletal muscle degeneration. Here, we demonstrate genetic ablation of the master cytoprotective transcription factor, nuclear factor (erythroid-derived-2)-like 2 (Nrf2), aggravates cardiotoxin (CTX)-induced tibialis anterior (TA) muscle damage. Disruption of Nrf2 signaling sustained the CTX-induced burden of reactive oxygen species together with compromised expression of antioxidant genes and proteins. Transcript/protein expression of phenotypic markers of muscle differentiation, namely paired box 7 (satellite cell) and early myogenic differentiation and terminal differentiation (myogenin and myosin heavy chain 2) were increased on d 2 and 4 postinjury but later returned to baseline levels on d 8 and 15 in wild-type (WT) mice. In contrast, these responses were persistently augmented in Nrf2-null mice suggesting that regulation of the regeneration-related signaling mechanisms require Nrf2 for normal functioning. Furthermore, Nrf2-null mice displayed slower regeneration marked by dysregulation of embryonic myosin heavy chain temporal expression. Histologic observations illustrated that Nrf2-null mice displayed smaller, immature TA muscle fibers compared with WT counterparts on d 15 after CTX injury. Improvement in TA muscle morphology and gain in muscle mass evident in the WT mice was not noticeable in the Nrf2-null animals. Taken together these data show that the satellite cell activation, proliferation, and differentiation requires a functional Nrf2 system for effective healing following injury.-Shelar, S. B., Narasimhan, M., Shanmugam, G., Litovsky, S. H., Gounder, S. S., Karan, G., Arulvasu, C., Kensler, T. W., Hoidal, J. R., Darley-Usmar, V. M., Rajasekaran, N. S. Disruption of nuclear factor (erythroid-derived-2)-like 2 antioxidant signaling: a mechanism for impaired activation of stem cells and delayed regeneration of skeletal muscle. www.fasebj.org	[Shelar, Sandeep Balu; Shanmugam, Gobinath; Rajasekaran, Namakkal S.] Univ Alabama Birmingham, Cardiac Aging & Redox Signaling Lab, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; [Litovsky, Silvio Hector] Univ Alabama Birmingham, Div Anat Pathol, Dept Pathol, Birmingham, AL 35294 USA; [Darley-Usmar, Victor M.; Rajasekaran, Namakkal S.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Narasimhan, Madhusudhanan] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Gounder, Sellamuthu S.; Hoidal, John R.; Rajasekaran, Namakkal S.] Univ Utah, Sch Med, Dept Med, Div Cardiovasc Med Pulm Med, Salt Lake City, UT USA; [Karan, Goutam] Mirx Pharmaceut, Lexington, KY USA; [Arulvasu, Cinnasamy] Univ Madras, Dept Zool, Madras 600025, Tamil Nadu, India; [Kensler, Thomas W.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Utah System of Higher Education; University of Utah; University of Madras; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rajasekaran, NS (corresponding author), Univ Alabama Birmingham, Cardiac Aging & Redox Signaling Lab, Div Mol & Cellular Pathol, Ctr Free Rad Biol,Dept Pathol, BMR2 Room 533,901 19th St South, Birmingham, AL 35294 USA.	rajnsr@uab.edu	Kensler, Thomas W/D-8686-2014; Shanmugam, Gobinath/ACL-0604-2022	Kensler, Thomas W/0000-0002-6676-261X; Darley-Usmar, Victor/0000-0001-8921-7086	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01HL118067]; NIH National Institute on Aging [1R03AG042860-01]; American Heart Association [BGIA-0865015F]; University of Utah Center for Aging; University of Utah; University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE [R35CA197222] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042860, P30AG050886] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); University of Utah Center for Aging; University of Utah; University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by awards/research funds from the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (R01HL118067), NIH National Institute on Aging (1R03AG042860-01), the American Heart Association (BGIA-0865015F), University of Utah Center for Aging (Pilot Grant-2009), the University of Utah, and the University of Alabama at Birmingham startup funds (to N.S.R.). The authors thank Ms. Indira Guevera, Ms. Jennifer Hong, and Ms. Nancy Atieno (University of Utah School of Medicine, Salt Lake City, Utah, USA) for their technical assistance, including animal colony maintenance and genotyping. The authors also thank Dr. Christopher Davidson for his review and critiques to strengthen the manuscript.	Al-Sawaf O, 2014, J PATHOL, V234, P538, DOI 10.1002/path.4418; Al-Sawaf O, 2014, SCI REP-UK, V4, DOI 10.1038/srep03625; Angione AR, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-33; Aoi Wataru, 2011, Curr Aging Sci, V4, P101; Ardite E, 2004, AM J PATHOL, V165, P719, DOI 10.1016/S0002-9440(10)63335-4; Armand AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027283; ARRINGTON ED, 1995, ORTHOP CLIN N AM, V26, P411; Bismuth K, 2010, EXP CELL RES, V316, P3081, DOI 10.1016/j.yexcr.2010.08.018; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Capell BC, 2007, CIRC RES, V101, P13, DOI 10.1161/CIRCRESAHA.107.153692; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen CN, 2008, J GERONTOL A-BIOL, V63, P461, DOI 10.1093/gerona/63.5.461; Chien CM, 2010, TOXICON, V56, P508, DOI 10.1016/j.toxicon.2010.05.007; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Di Stasi SL, 2010, PHYS THER, V90, P1530, DOI 10.2522/ptj.20090251; FUCHTBAUER EM, 1992, DEV DYNAM, V193, P34; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; Hosokawa K, 2007, BIOCHEM BIOPH RES CO, V363, P578, DOI 10.1016/j.bbrc.2007.09.014; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; IRINTCHEV A, 1987, CELL TISSUE RES, V249, P509; Islam KN, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001986; Judson RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059622; Karalaki M, 2009, IN VIVO, V23, P779; Komaravelli N, 2015, FREE RADICAL BIO MED, V88, P391, DOI 10.1016/j.freeradbiomed.2015.05.043; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; LEFAUCHEUR JP, 1995, NEUROMUSCULAR DISORD, V5, P501, DOI 10.1016/0960-8966(95)00012-C; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Narasimhan M, 2014, FREE RADICAL BIO MED, V71, P402, DOI 10.1016/j.freeradbiomed.2014.02.023; ONTELL M, 1993, DEVELOPMENT, V117, P1435; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Pavlath GK, 1998, DEV DYNAM, V212, P495, DOI 10.1002/(SICI)1097-0177(199808)212:4<495::AID-AJA3>3.3.CO;2-I; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Putman CT, 2001, J GERONTOL A-BIOL, V56, pB510, DOI 10.1093/gerona/56.12.B510; Rajasekaran NS, 2011, ANTIOXID REDOX SIGN, V14, P957, DOI 10.1089/ars.2010.3587; Ramadasan-Nair R, 2014, J BIOL CHEM, V289, P485, DOI 10.1074/jbc.M113.493270; RAYNOR RL, 1991, J BIOL CHEM, V266, P2753; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Schultz E, 2006, DEV DYNAM, V235, P3230, DOI 10.1002/dvdy.20976; Sestili P, 2009, MOL NUTR FOOD RES, V53, P1187, DOI 10.1002/mnfr.200800504; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shrier I, 2004, BRIT J SPORT MED, V38, P526, DOI 10.1136/bjsm.2003.011262; SNOW MH, 1983, ANAT REC, V207, P593, DOI 10.1002/ar.1092070407; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; WATT DJ, 1987, ANAT EMBRYOL, V175, P527, DOI 10.1007/BF00309688; Wu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088450; Xiu JH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-215; Yang JCS, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0147-x; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	64	22	24	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1865	1879		10.1096/fj.201500153	http://dx.doi.org/10.1096/fj.201500153			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26839378	Green Published			2022-12-26	WOS:000374879400016
J	Ghosh, U; Adhya, S				Ghosh, Utpalendu; Adhya, Samit			Non-equivalent Roles of AGO1 and AGO2 in mRNA Turnover and Translation of Cyclin D1 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; cyclin D1; microRNA (miRNA); mRNA; myogenesis	COMPLEXES; EXPRESSION; REPRESSION; PROTEINS; PROVIDES; CELLS	Mammalian Argonaute proteins (AGO1-4), in combination with microRNAs (miRs), bind to target mRNAs to initiate degradation and/or translation repression, but the relationships between these two effects is unclear. Although the AGO isoforms of Drosophila and plants perform different functions, mammalian AGO isoforms are considered to be functionally degenerate in terms of miR loading and downstream silencing effects. However, we found that, in quiescent (G0) rat myoblasts transiting to the G1 phase, cyclin D1 (Ccnd1) mRNA was associated with two functionally distinct AGO-miR complexes. While AGO1-miR-1 down-regulated the mRNA level, AGO2-let-7 delayed the timing of translation. Knockdown (KD) of AGO2, or antisense-mediated depletion of Let-7, caused Ccnd1 translation to occur earlier, but had no significant effect on mRNA abundance. Conversely, down-regulation of either AGO1 or miR-1, resulted in elevated Ccnd1 mRNA levels at early times, but failed to affect the timing of translation. These results show that the two miR-mediated silencing effects, viz. mRNA decay and translation repression, are independent processes induced by individual AGO isoforms in association with specific miRs.	[Ghosh, Utpalendu; Adhya, Samit] CSIR, Indian Inst Chem Biol, Genet Engn Lab, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Adhya, S (corresponding author), CSIR, Indian Inst Chem Biol, Genet Engn Lab, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	nilugrandson@gmail.com			Project BEnD of CSIR-IICB [BSC0206]	Project BEnD of CSIR-IICB	This work was supported by Project BEnD (BSC0206) of CSIR-IICB. The authors declare that they have no conflicts of interest with the contents of this article.	Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fu X, 2014, ONCOGENE, V33, P4296, DOI 10.1038/onc.2013.385; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo Y, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-41; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Huang V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003821; Hur JK, 2013, J BIOL CHEM, V288, P7829, DOI 10.1074/jbc.M112.441030; Izaurralde E, 2015, SCIENCE, V349, P380, DOI 10.1126/science.1260969; Jash S, 2014, MOL CELL BIOL, V34, P3594, DOI 10.1128/MCB.00742-14; Jash S, 2012, FASEB J, V26, P4187, DOI 10.1096/fj.11-203232; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Ritchie W, 2014, BIOCHEM BIOPH RES CO, V445, P780, DOI 10.1016/j.bbrc.2014.01.181; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wu PH, 2013, MOL CELL, V52, P113, DOI 10.1016/j.molcel.2013.08.023; Yamakawa N, 2014, NUCLEIC ACIDS RES, V42, P5289, DOI 10.1093/nar/gku137; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Zhang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041478	31	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7119	7127		10.1074/jbc.M115.696377	http://dx.doi.org/10.1074/jbc.M115.696377			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26846850	Green Published, hybrid			2022-12-26	WOS:000373299700045
J	Jones, JW; Singh, P; Govind, CK				Jones, Jeffery W.; Singh, Priyanka; Govind, Chhabi K.			Recruitment of Saccharomyces cerevisiae Cmr1/Ydl156w to Coding Regions Promotes Transcription Genome Wide	PLOS ONE			English	Article							POL II CTD; PAF1 COMPLEX; HISTONE MODIFICATIONS; TERMINAL DOMAIN; RNA; METHYLATION; GCN4P; DEACETYLATION; CHROMATIN; BINDING	Cmr1 (changed mutation rate 1) is a largely uncharacterized nuclear protein that has recently emerged in several global genetic interaction and protein localization studies. It clusters with proteins involved in DNA damage and replication stress response, suggesting a role in maintaining genome integrity. Under conditions of proteasome inhibition or replication stress, this protein localizes to distinct sub-nuclear foci termed as intranuclear quality control (INQ) compartments, which sequester proteins for their subsequent degradation. Interestingly, it also interacts with histones, chromatin remodelers and modifiers, as well as with proteins involved in transcription including subunits of RNA Pol I and Pol III, but not with those of Pol II. It is not known whether Cmr1 plays a role in regulating transcription of Pol II target genes. Here, we show that Cmr1 is recruited to the coding regions of transcribed genes of S. cerevisiae. Cmr1 occupancy correlates with the Pol II occupancy genome-wide, indicating that it is recruited to coding sequences in a transcription-dependent manner. Cmr1-enriched genes include Gcn4 targets and ribosomal protein genes. Furthermore, our results show that Cmr1 recruitment to coding sequences is stimulated by Pol II CTD kinase, Kin28, and the histone deacetylases, Rpd3 and Hos2. Finally, our genome-wide analyses implicate Cmr1 in regulating Pol II occupancy at transcribed coding sequences. However, it is dispensable for maintaining co-transcriptional histone occupancy and histone modification (acetylation and methylation). Collectively, our results show that Cmr1 facilitates transcription by directly engaging with transcribed coding regions.	[Jones, Jeffery W.; Singh, Priyanka; Govind, Chhabi K.] Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA	Oakland University	Govind, CK (corresponding author), Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA.	govind@oakland.edu			National Institutes of Health [GM095514]; Center for Biomedical Sciences, Oakland University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Biomedical Sciences, Oakland University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, GM095514, and Center for Biomedical Sciences, Oakland University.	Abu-Jamous B, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0990; Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Buratowski S, 1994, Genet Eng (N Y), V16, P1; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Burugula BB, 2014, MOL CELL BIOL, V34, P4115, DOI 10.1128/MCB.00695-14; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Choi DH, 2012, J MICROBIOL, V50, P112, DOI 10.1007/s12275-012-1597-4; Coulombe C, 2014, NUCLEIC ACIDS RES, V42, pW485, DOI 10.1093/nar/gku302; Drouin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001173; Dutta A, 2014, GENE DEV, V28, P2314, DOI 10.1101/gad.243584.114; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Gallina I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7533; Ghosh A, 2011, MOL CELL, V43, P299, DOI 10.1016/j.molcel.2011.06.001; Gilmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011544; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2012, METHODS MOL BIOL, V833, P15, DOI 10.1007/978-1-61779-477-3_2; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hellauer K, 2005, MOL PHARMACOL, V68, P1365, DOI 10.1124/mol.105.012963; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jeronimo C, 2014, NAT STRUCT MOL BIOL, V21, P449, DOI 10.1038/nsmb.2810; Joo YJ, 2011, EMBO J, V30, P859, DOI 10.1038/emboj.2010.332; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Patterson AV, 1998, ANTI-CANCER DRUG DES, V13, P541; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Polo SE, 2015, J MOL BIOL, V427, P626, DOI 10.1016/j.jmb.2014.05.025; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schwer B, 2011, MOL CELL, V43, P311, DOI 10.1016/j.molcel.2011.05.024; Spain MM, 2014, MOL CELL, V56, P653, DOI 10.1016/j.molcel.2014.10.002; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Wong CM, 2007, MOL CELL BIOL, V27, P6520, DOI 10.1128/MCB.00733-07; Wong KH, 2014, MOL CELL, V15, P00257; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043005	58	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148897	10.1371/journal.pone.0148897	http://dx.doi.org/10.1371/journal.pone.0148897			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848854	gold, Green Published			2022-12-26	WOS:000369554000184
J	Chen, XJ; Li, WN; Hiett, SC; Obukhov, AG				Chen, Xingjuan; Li, Wennan; Hiett, S. Christopher; Obukhov, Alexander G.			Novel Roles for K(v)7 Channels in Shaping Histamine-Induced Contractions and Bradykinin-Dependent Relaxations in Pig Coronary Arteries	PLOS ONE			English	Article							KCNQ POTASSIUM CHANNELS; SMOOTH-MUSCLE-CELLS; METABOLIC SYNDROME; BLOOD-FLOW; DOWN-REGULATION; KV7 CHANNELS; ACTIVATION; EXPRESSION; VASODILATION; RETIGABINE	Voltage-gated K(v)7 channels are inhibited by agonists of G(q)-protein-coupled receptors, such as histamine. Recent works have provided evidence that inhibition of vascular K(v)7 channels may trigger vessel contractions. In this study, we investigated how K(v)7 activity modulates the histamine-induced contractions in "healthy" and metabolic syndrome (MetS) pig right coronary arteries (CAs). We performed isometric tension and immunohistochemical studies with domestic, lean Ossabaw, and MetS Ossabaw pig CAs. We found that neither the K(v)7.2/K(v)7.4/K(v)7.5 activator ML213 nor the general K(v)7 inhibitor XE991 altered the tension of CA rings under preload, indicating that vascular K(v)7 channels are likely inactive in the preloaded rings. Conversely, ML213 potently dilated histamine-pre-contracted CAs, suggesting that K(v)7 channels are activated during histamine applications and yet partially inhibited by histamine. Immunohistochemistry analysis revealed strong K(v)7.4 immunostaining in the medial and intimal layers of the CA wall, whereas K(v)7.5 immunostaining intensity was strong in the intimal but weak in the medial layers. The medial K(v)7 immunostaining was significantly weaker in MetS Ossabaw CAs as compared to lean Ossabaw or domestic CAs. Consistently, histamine-pre-contracted MetS Ossabaw CAs exhibited attenuated ML213-dependent dilations. In domestic pig CAs, where medial K(v)7 immunostaining intensity was stronger, histamine-induced contractions spontaneously decayed to similar to 31% of the peak amplitude within 4 minutes. Oppositely, in Ossabaw CAs, where K(v)7 immunostaining intensity was weaker, the histamine-induced contractions were more sustained. XE991 pretreatment significantly slowed the decay rate of histamine-induced contractions in domestic CAs, supporting the hypothesis that increased K(v)7 activity correlates with a faster rate of histamine-induced contraction decay. Alternatively, XE991 significantly decreased the amplitude of bradykinin-dependent dilations in pre-contracted CAs. We propose that in CAs, a decreased expression or a loss of function of K(v)7 channels may lead to sustained histamine-induced contractions and reduced endothelium-dependent relaxation, both risk factors for coronary spasm.	[Chen, Xingjuan; Li, Wennan; Hiett, S. Christopher; Obukhov, Alexander G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Obukhov, AG (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA.	aobukhov@iu.edu	Obukhov, Alexander G/C-7246-2008; chen, xingjuan/V-4064-2019	Obukhov, Alexander G/0000-0002-3862-6004; chen, xingjuan/0000-0002-7380-8399	NIH [R01HL115140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by a grant from the NIH (R01HL115140 to AGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alevizos M, 2014, ANN ALLERG ASTHMA IM, V112, P309, DOI 10.1016/j.anai.2013.09.017; Beech DJ, 2013, CIRC J, V77, P570, DOI 10.1253/circj.CJ-13-0154; Berwick ZC, 2012, J MOL CELL CARDIOL, V52, P912, DOI 10.1016/j.yjmcc.2011.07.004; Borbouse L, 2010, AM J PHYSIOL-HEART C, V298, pH966, DOI 10.1152/ajpheart.00876.2009; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Brueggemann LI, 2014, MOL PHARMACOL, V86, P330, DOI 10.1124/mol.114.093799; Bubolz AH, 2005, AM J PHYSIOL-HEART C, V289, pH1873, DOI 10.1152/ajpheart.00357.2005; Chakraborty S, 2011, J PHARMACOL EXP THER, V339, P329, DOI 10.1124/jpet.111.183673; Dupuis DS, 2002, EUR J PHARMACOL, V437, P129, DOI 10.1016/S0014-2999(02)01287-6; Edwards JM, 2010, CARDIOVASC RES, V85, P631, DOI 10.1093/cvr/cvp308; GINSBURG R, 1984, CIRCULATION, V69, P430, DOI 10.1161/01.CIR.69.2.430; Greenwood IA, 2009, BRIT J PHARMACOL, V156, P1196, DOI 10.1111/j.1476-5381.2009.00131.x; Hedegaard ER, 2014, BRIT J PHARMACOL, V171, P69, DOI 10.1111/bph.12424; Hiett SC, 2014, CARDIOVASC RES, V103, P607, DOI 10.1093/cvr/cvu152; Jepps TA, 2011, CIRCULATION, V124, P602, DOI 10.1161/CIRCULATIONAHA.111.032136; Jeziorska M, 1997, J PATHOL, V182, P115, DOI 10.1002/(SICI)1096-9896(199705)182:1<115::AID-PATH806>3.0.CO;2-9; Joshi S, 2009, J PHARMACOL EXP THER, V329, P368, DOI 10.1124/jpet.108.147785; KEITOKU M, 1990, CARDIOVASC RES, V24, P614, DOI 10.1093/cvr/24.8.614; LECLERC G, 1992, CIRCULATION, V85, P543, DOI 10.1161/01.CIR.85.2.543; Liu BY, 2008, AM J PHYSIOL-CELL PH, V295, pC81, DOI 10.1152/ajpcell.00028.2008; Liu YP, 2001, CIRC RES, V89, P146, DOI 10.1161/hh1401.093294; Mackie AR, 2008, J PHARMACOL EXP THER, V325, P475, DOI 10.1124/jpet.107.135764; Milionis HJ, 2007, CORONARY ARTERY DIS, V18, P247, DOI 10.1097/MCA.0b013e328035f8c4; Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6; Morales-Cano D, 2015, CARDIOVASC RES, V106, P98, DOI 10.1093/cvr/cvv020; Ng FL, 2011, BRIT J PHARMACOL, V162, P42, DOI 10.1111/j.1476-5381.2010.01027.x; Ohya S, 2003, CIRC RES, V92, P1016, DOI 10.1161/01.RES.0000070880.20955.F4; Saarinen K, 1998, HUM MUTAT, V11, P158, DOI 10.1002/(SICI)1098-1004(1998)11:2<158::AID-HUMU9>3.0.CO;2-F; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Setty S, 2003, BASIC RES CARDIOL, V98, P416, DOI 10.1007/s00395-003-0418-7; Soh H, 2010, MOL PHARMACOL, V78, P1088, DOI 10.1124/mol.110.066100; Stott JB, 2015, HYPERTENSION, V65, P676, DOI 10.1161/HYPERTENSIONAHA.114.04373; Stott JB, 2014, DRUG DISCOV TODAY, V19, P413, DOI 10.1016/j.drudis.2013.12.003; Su CC, 2006, BIOCHEM BIOPH RES CO, V348, P295, DOI 10.1016/j.bbrc.2006.07.053; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; TODA N, 1987, CIRC RES, V61, P280, DOI 10.1161/01.RES.61.2.280; Turhan H, 2004, AM HEART J, V148, P789, DOI 10.1016/j.ahj.2004.05.016; Van d V, 1994, EUR J PHARMACOL, V271, P17; van Heuven-Nolsen D, 1990, BR J CLIN PHARM S1, V30, p156S; Wang HS, 2000, MOL PHARMACOL, V57, P1218; WOLFF AA, 1986, CIRC RES, V58, P1; Yeung SYM, 2008, BRIT J PHARMACOL, V155, P62, DOI 10.1038/bjp.2008.231; Yeung SYM, 2005, BRIT J PHARMACOL, V146, P585, DOI 10.1038/sj.bjp.0706342; Yu H., 2010, PROBE REPORTS NIH MO; Zdravkovic V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/315709	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148569	10.1371/journal.pone.0148569	http://dx.doi.org/10.1371/journal.pone.0148569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844882	Green Submitted, gold, Green Published			2022-12-26	WOS:000369552800071
J	Gascuel, Q; Bordat, A; Sallet, E; Pouilly, N; Carrere, S; Roux, F; Vincourt, P; Godiard, L				Gascuel, Quentin; Bordat, Amandine; Sallet, Erika; Pouilly, Nicolas; Carrere, Sebastien; Roux, Fabrice; Vincourt, Patrick; Godiard, Laurence			Effector Polymorphisms of the Sunflower Downy Mildew Pathogen Plasmopara halstedii and Their Use to Identify Pathotypes from Field Isolates	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; HELIANTHUS-ANNUUS L; MULTIPLE INTRODUCTIONS; DISEASE RESISTANCE; RXLR EFFECTORS; PHYTOPHTHORA; SEQUENCE; VIRULENCE; EVOLUTION; REVEALS	The obligate biotroph oomycete Plasmopara halstedii causes downy mildew on sunflower crop, Helianthus annuus. The breakdown of several Pl resistance genes used in sunflower hybrids over the last 25 years came along with the appearance of new Pl. halstedii isolates showing modified virulence profiles. In oomycetes, two classes of effector proteins, key players of pathogen virulence, are translocated into the host: RXLR and CRN effectors. We identified 54 putative CRN or RXLR effector genes from transcriptomic data and analyzed their genetic diversity in seven Pl. halstedii pathotypes representative of the species variability. Pl. halstedii effector genes were on average more polymorphic at both the nucleic and protein levels than random non-effector genes, suggesting a potential adaptive dynamics of pathogen virulence over the last 25 years. Twenty-two KASP (Competitive Allele Specific PCR) markers designed on polymorphic effector genes were genotyped on 35 isolates belonging to 14 Pl. halstedii pathotypes. Polymorphism analysis based on eight KASP markers aims at proposing a determination key suitable to classify the eight multi-isolate pathotypes into six groups. This is the first report of a molecular marker set able to discriminate Pl. halstedii pathotypes based on the polymorphism of pathogenicity effectors. Compared to phenotypic tests handling living spores used until now to discriminate Pl. halstedii pathotypes, this set of molecular markers constitutes a first step in faster pathotype diagnosis of Pl. halstedii isolates. Hence, emerging sunflower downy mildew isolates could be more rapidly characterized and thus, assessment of plant resistance breakdown under field conditions should be improved.	[Gascuel, Quentin; Bordat, Amandine; Sallet, Erika; Pouilly, Nicolas; Carrere, Sebastien; Roux, Fabrice; Vincourt, Patrick; Godiard, Laurence] INRA, Lab Interact Plantes Microorganismes LIPM, Unite Mixte Recherches UMR441, F-31326 Castanet Tolosan, France; [Gascuel, Quentin; Bordat, Amandine; Sallet, Erika; Pouilly, Nicolas; Carrere, Sebastien; Roux, Fabrice; Vincourt, Patrick; Godiard, Laurence] CNRS, Lab Interact Plantes Microorganismes LIPM, Unite Mixte Recherches UMR2594, F-31326 Castanet Tolosan, France; [Bordat, Amandine] INRA, Unite Mixte Recherches UMR1332 BFP, Biol Fruit & Pathol, CS20032, F-33882 Villenave Dornon, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Godiard, L (corresponding author), INRA, Lab Interact Plantes Microorganismes LIPM, Unite Mixte Recherches UMR441, F-31326 Castanet Tolosan, France.; Godiard, L (corresponding author), CNRS, Lab Interact Plantes Microorganismes LIPM, Unite Mixte Recherches UMR2594, F-31326 Castanet Tolosan, France.	Laurence.Godiard@toulouse.inra.fr		Sallet, Erika/0000-0003-4637-473X; Carrere, Sebastien/0000-0002-2348-0778; Fabrice, Roux/0000-0001-8059-5638	French INRA Project "Bioressources"; CETIOM; French Laboratory of Excellence project "TULIP" [ANR-10-LABX-41, ANR-11-IDEX-0002-02]	French INRA Project "Bioressources"; CETIOM; French Laboratory of Excellence project "TULIP"	This work was supported by the French INRA Project "Bioressources 2009", the CETIOM, and the French Laboratory of Excellence project "TULIP" (Toward a unified theory of biotic interactions: role of environmental perturbations) (ANR-10-LABX-41; ANR-11-IDEX-0002-02).	Ahmed S, 2012, FUNGAL GENET BIOL, V49, P847, DOI 10.1016/j.fgb.2012.06.012; Allen RL, 2008, MOL PLANT PATHOL, V9, P511, DOI 10.1111/J.1364-3703.2008.00481.X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; As-sadi F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-498; Bailey K, 2011, MOL PLANT MICROBE IN, V24, P827, DOI 10.1094/MPMI-12-10-0278; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birch PRJ, 2009, J EXP BOT, V60, P1133, DOI 10.1093/jxb/ern353; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Caillaud MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001732; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Delmotte F, 2008, INFECT GENET EVOL, V8, P534, DOI 10.1016/j.meegid.2008.02.012; Dillmann C, 1997, THEOR APPL GENET, V95, P92, DOI 10.1007/s001220050536; Fabro G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002348; Gascuel Q, 2015, MOL PLANT PATHOL, V16, P109, DOI 10.1111/mpp.12164; Giedroc DP, 2009, VIRUS RES, V139, P193, DOI 10.1016/j.virusres.2008.06.008; Gilroy EM, 2011, NEW PHYTOL, V191, P763, DOI 10.1111/j.1469-8137.2011.03736.x; Gulya TJ, 1998, ISA: SYMPOSIUM III: SUNFLOWER DOWNY MILDEW, P130; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Links MG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-503; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Mestre P, 2016, PLANT PATHOL, V65, P767, DOI 10.1111/ppa.12469; Michelmore RW, 2013, ANNU REV PHYTOPATHOL, V51, P291, DOI 10.1146/annurev-phyto-082712-102334; MOINARD J, 2006, PHYTOMA DEFENSE VEGE, V589, P34; MOUZEYAR S, 1995, THEOR APPL GENET, V91, P733, DOI 10.1007/BF00220951; MOUZEYAR S, 1993, J PHYTOPATHOL, V139, P289, DOI 10.1111/j.1439-0434.1993.tb01430.x; MOUZEYAR S, 1994, J PHYTOPATHOL, V141, P249, DOI 10.1111/j.1439-0434.1994.tb01468.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NISHIMURA M., 1922, Journal of the College of Agriculture, Hokkaido Imperial University, V11, P185; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Pais M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-211; Pedersen C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-694; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Saunders DGO, 2012, PLANT CELL, V24, P3420, DOI 10.1105/tpc.112.099861; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Sharma V, 2011, MOL BIOL EVOL, V28, P3195, DOI 10.1093/molbev/msr155; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Stassen JHM, 2012, MOL PLANT PATHOL, V13, P719, DOI 10.1111/j.1364-3703.2011.00780.x; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Tourvieille de Labrouhe D, 2012, P 18 INT SUNFL C MAR, P322; van Damme M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002875; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wawra S, 2012, CURR OPIN MICROBIOL, V15, P685, DOI 10.1016/j.mib.2012.10.008; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	51	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148513	10.1371/journal.pone.0148513	http://dx.doi.org/10.1371/journal.pone.0148513			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845339	Green Published, Green Submitted, gold			2022-12-26	WOS:000369552800064
J	Kosulic, O; Michalko, R; Hula, V				Kosulic, Ondrej; Michalko, Radek; Hula, Vladimir			Impact of Canopy Openness on Spider Communities: Implications for Conservation Management of Formerly Coppiced Oak Forests	PLOS ONE			English	Article							SPECIES COMPOSITION; OPEN WOODLANDS; HABITAT; DIVERSITY; BIODIVERSITY; SUCCESSION; ARANEAE; INVERTEBRATES; ASSEMBLAGES; VEGETATION	Traditional woodland management created a mosaic of differently aged patches providing favorable conditions for a variety of arthropods. After abandonment of historical ownership patterns and traditional management and the deliberate transformation to high forest after World War II, large forest areas became darker and more homogeneous. This had significant negative consequences for biodiversity. An important question is whether even small-scale habitat structures maintained by different levels of canopy openness in abandoned coppiced forest may constitute conditions suitable for forest as well as open habitat specialists. We investigated the effect of canopy openness in former traditionally coppiced woodlands on the species richness, functional diversity, activity density, conservation value, and degree of rareness of epigeic spiders. In each of the eight studied locations, 60-m-long transect was established consisting of five pitfall traps placed at regular 15 m intervals along the gradient. Spiders were collected from May to July 2012. We recorded 90 spider species, including high proportions of xeric specialists (40%) and red-listed threatened species (26%). The peaks of conservation indicators, as well as spider community abundance, were shifted toward more open canopies. On the other hand, functional diversity peaked at more closed canopies followed by a rapid decrease with increasing canopy openness. Species richness was highest in the middle of the canopy openness gradient, suggesting an ecotone effect. Ordinations revealed that species of conservation concern tended to be associated with sparse and partly opened canopy. The results show that the various components of biodiversity peaked at different levels of canopy openness. Therefore, the restoration and suitable forest management of such conditions will retain important diversification of habitats in formerly coppiced oak forest stands. We indicate that permanent presence of small-scale improvements could be suitable conservation tools to prevent the general decline of woodland biodiversity in the intensified landscape of Central Europe.	[Kosulic, Ondrej] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Protect & Wildlife Management, Brno, Czech Republic; [Michalko, Radek] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Ecol, Brno, Czech Republic; [Michalko, Radek] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Hula, Vladimir] Mendel Univ Brno, Fac Agron, Dept Zool Fisheries Hydrobiol & Apiculture, Brno, Czech Republic	Mendel University in Brno; Mendel University in Brno; Masaryk University Brno; Mendel University in Brno	Kosulic, O (corresponding author), Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Protect & Wildlife Management, Brno, Czech Republic.	ondra.kosulic@seznam.cz	Ondrej, Kosulic/B-9736-2014; Michalko, Radek/Q-2349-2016; Michalko, Radek/AAT-2529-2021; Hula, Vladimir/B-9726-2014; Hula, Vladimir/ABG-9500-2020	Michalko, Radek/0000-0003-0831-0823; Michalko, Radek/0000-0003-0831-0823; Hula, Vladimir/0000-0001-7023-7087; Kosulic, Ondrej/0000-0003-2199-1694	Internal Grant Agency of Mendel University [LDF_VT_2015012/2015]; Masaryk University [MUNI/A/1484/2014]	Internal Grant Agency of Mendel University; Masaryk University	The study was funded by the Internal Grant Agency of Mendel University (Reg. No. LDF_VT_2015012/2015) as well as by student grant no. MUNI/A/1484/2014 provided by Masaryk University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadjiev S, 2001, ATLAS DISTRIBUTION B; Altman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055770; Auguie B, 2017, GRIDEXTRA MISCELLANE; Ausden M., 2007, HABITAT MANAGEMENT C; Basset Y, 2001, J APPL ECOL, V38, P1045, DOI 10.1046/j.1365-2664.2001.00660.x; Benes J, 2006, FOREST ECOL MANAG, V237, P353, DOI 10.1016/j.foreco.2006.09.058; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Bicknell JE, 2014, CURR BIOL, V24, pR1119, DOI 10.1016/j.cub.2014.10.067; Brunet Jorg, 2010, Ecological Bulletins, V53, P77; Buchar J., 1993, ACTA U CAROLINAE BIO, V36, P383; Buckley G.P., 1992, ECOLOGY MANAGEMENT C; Cardoso P, 2015, METHODS ECOL EVOL, V6, P232, DOI 10.1111/2041-210X.12310; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; Currylow AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040473; Denno R.F., 2005, ECOLOGY PREDATOR PRE; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Fartmann T, 2013, BIOL CONSERV, V159, P396, DOI 10.1016/j.biocon.2012.11.024; Samu F, 2014, J ARACHNOL, V42, P135, DOI 10.1636/CP13-75.1; Frazer GW, 1999, GAP LIGHT ANAL GLA V; FULLER R. J., 1990, COPPICED WOODLANDS T; Gonsamo A, 2013, OIKOS, V122, P1283, DOI 10.1111/j.1600-0706.2013.00369.x; GREENSTONE MH, 1984, OECOLOGIA, V62, P299, DOI 10.1007/BF00384260; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; HANSEN AJ, 1991, BIOSCIENCE, V41, P382, DOI 10.2307/1311745; Hansson L, 2010, BIODIVERS CONSERV, V10, P1865; Hedl R, 2010, DIVERS DISTRIB, V16, P267, DOI 10.1111/j.1472-4642.2010.00637.x; Heimer S., 1991, SPINNEN MITTELEUROPA; Hermy M, 2007, ECOL RES, V22, P361, DOI 10.1007/s11284-007-0354-3; HILL D, 1990, BIOL CONSERV, V51, P167, DOI 10.1016/0006-3207(90)90149-J; Horak J, 2014, FOREST ECOL MANAG, V315, P80, DOI 10.1016/j.foreco.2013.12.018; Horak J, 2013, J INSECT CONSERV, V17, P307, DOI 10.1007/s10841-012-9511-2; Horvath R., 2002, Web Ecology, V3, P43; Jimenez-Valverde A, 2007, ECOL ENTOMOL, V32, P113, DOI 10.1111/j.1365-2311.2006.00848.x; Kasal P, ARACHNOBASE CZECH SP; Klessmann C, 2011, ENERG POLICY, V39, P7637, DOI 10.1016/j.enpol.2011.08.038; Konvicka M., 2004, OHROZENY HMYZ NIZINN; Konvicka M, 2008, J INSECT CONSERV, V12, P549, DOI 10.1007/s10841-007-9087-4; Kosulic O, 2014, ECOL ENG, V68, P133, DOI 10.1016/j.ecoleng.2014.03.030; Krauss J, 2009, J APPL ECOL, V46, P194, DOI 10.1111/j.1365-2664.2008.01582.x; Kurka A, 2015, SPIDERS CZECH REPUBL; Larrivee M, 2008, FOREST ECOL MANAG, V255, P1434, DOI 10.1016/j.foreco.2007.10.062; Mackovcin P, 2007, PROTECTED AREAS CZEC, VIX; MCIVER JD, 1992, CAN J FOREST RES, V22, P984, DOI 10.1139/x92-132; McNett BJ, 2000, ECOL ENTOMOL, V25, P423, DOI 10.1046/j.1365-2311.2000.00279.x; Miklin J, 2014, J NAT CONSERV, V22, P35, DOI 10.1016/j.jnc.2013.08.002; Mullerova J, 2015, FOREST ECOL MANAG, V343, P88, DOI 10.1016/j.foreco.2015.02.003; Mullerova J, 2014, FOREST ECOL MANAG, V331, P104, DOI 10.1016/j.foreco.2014.07.032; Muff P, 2009, INSECT CONSERV DIVER, V2, P36, DOI 10.1111/j.1752-4598.2008.00037.x; Mupepele AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086571; Nentwig W, SPINNEN MITTELEUROPA; New TR., 2009, INSECT CONSERVATION; Niemela J, 1996, ECOGRAPHY, V19, P352, DOI 10.1111/j.1600-0587.1996.tb01264.x; NYFFELER M, 1987, J APPL ENTOMOL, V103, P321, DOI 10.1111/j.1439-0418.1987.tb00992.x; Oxbrough AG, 2005, FOREST ECOL MANAG, V212, P171, DOI 10.1016/j.foreco.2005.03.040; Oxbrough AG, 2006, FOREST ECOL MANAG, V237, P404, DOI 10.1016/j.foreco.2006.09.063; Paletto A, 2009, EUR J FOREST RES, V128, P265, DOI 10.1007/s10342-009-0262-x; Pearce JL, 2006, ECOL INDIC, V6, P780, DOI 10.1016/j.ecolind.2005.03.005; Pearce JL, 2004, BIODIVERS CONSERV, V13, P1305, DOI 10.1023/B:BIOC.0000019403.26948.55; Pekar S, 2012, MODERN ANAL BIOL DAT, P2; Pekar S., 2009, MODERN ANAL BIOL DAT; Purchart L, 2013, FOREST ECOL MANAG, V306, P42, DOI 10.1016/j.foreco.2013.06.012; Quitt E., 1971, STUD GEOGR BRNO, V16, P1; Rancka B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120085; Rezac M, 2015, BIOLOGIA, V70, P645, DOI 10.1515/biolog-2015-0079; Rezac M, 2014, J INSECT CONSERV, V18, P523, DOI 10.1007/s10841-014-9668-y; Roberts M.J., 1995, COLLINS FIELD GUIDE; RUZICKA V., 2008, SBORNIK OBLASTNIHO M, V29, P3; Ruzicka V, 2002, CATALOGUE SPIDERS CZ; Sanders D, 2015, J ANIM ECOL, V84, P134, DOI 10.1111/1365-2656.12271; Schuldt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022905; Sebek P, 2015, FOREST ECOL MANAG, V358, P80, DOI 10.1016/j.foreco.2015.09.008; Sebek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060456; Settele Josef, 2009, P353; Silbernagel J, 2001, FOREST ECOL MANAG, V149, P217, DOI 10.1016/S0378-1127(00)00556-9; SMILAUER P, 2014, MULTIVARIETE ANAL EC; Spitzer L, 2008, BIOL CONSERV, V141, P827, DOI 10.1016/j.biocon.2008.01.005; Swenson N., 2014, PHYLOGENETIC FUNCTIO; TERBRAAK CJF, 2012, CANNOCO 5 SOFTWARE M; Thomas CD, 2000, P ROY SOC B-BIOL SCI, V267, P139, DOI 10.1098/rspb.2000.0978; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tropek R, 2014, ECOL ENG, V73, P45, DOI 10.1016/j.ecoleng.2014.09.011; Tropek R, 2010, J APPL ECOL, V47, P139, DOI 10.1111/j.1365-2664.2009.01746.x; Ugurlu E, 2012, APPL VEG SCI, V15, P590, DOI 10.1111/j.1654-109X.2012.01192.x; Vacik R, 2009, SILVA BALCANICA, V10, P35; Van Calster H, 2008, FOREST ECOL MANAG, V256, P519, DOI 10.1016/j.foreco.2008.04.042; Vera FWM, 2000, GRAZING ECOLOGY FORE; Vodka S, 2013, FOREST ECOL MANAG, V304, P33, DOI 10.1016/j.foreco.2013.04.007; Vodka S, 2009, J INSECT CONSERV, V13, P553, DOI 10.1007/s10841-008-9202-1; VRSKA T., 2006, DYNAMIKA VYVOJE PRAL; Vrska T, 2006, DEV DYNAMICS VIRGIN; Wagner JD, 2003, J ARACHNOL, V31, P28, DOI 10.1636/0161-8202(2003)031[0028:SSILDB]2.0.CO;2; Warren M. S., 1991, The conservation of insects and their habitats., P155; WARREN MS, 1987, J APPL ECOL, V24, P499, DOI 10.2307/2403889; Wise DH, 1999, OECOLOGIA, V121, P129, DOI 10.1007/s004420050914; Wise DH, 1993, SPIDERS ECOLOGICAL W; Ziesche TM, 2008, FOREST ECOL MANAG, V255, P738, DOI 10.1016/j.foreco.2007.09.060	96	53	56	6	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148585	10.1371/journal.pone.0148585	http://dx.doi.org/10.1371/journal.pone.0148585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845431	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800075
J	Calderon-Sanchez, E; Diaz, I; Ordonez, A; Smani, T				Calderon-Sanchez, Eva; Diaz, Ignacio; Ordonez, Antonio; Smani, Tarik			Urocortin-1 Mediated Cardioprotection Involves XIAP and CD40-Ligand Recovery: Role of EPAC2 and ERK1/2	PLOS ONE			English	Article							REPERFUSION INJURY; HEART-FAILURE; SIGNAL-TRANSDUCTION; APOPTOSIS; ACTIVATION; PROTECTS; MECHANISMS; POLYMORPHISM; PKA	Aims Urocortin-1 (Ucn-1) is an endogenous peptide that protects heart from ischemia and reperfusion (I/R) injuries. Ucn-1 is known to prevent cardiac cell death, but its role in the transcription of specific genes related to survival signaling pathway has not been fully defined. The aim of this study was to investigate the molecular signaling implicated in the improvement of cardiac myocytes survival induced by Ucn-1. Methods and Results Ucn-1 administration before ischemia and at the onset of reperfusion, in rat hearts perfused in Langendorff system, fully recovered heart contractility and other hemodynamic parameters. Ucn-1 enhanced cell viability and decreased lactate dehydrogenase (LDH) release in adult cardiac myocytes subjected to simulated I/R. Annexin V-FITC/PI staining indicated that Ucn-1 promoted cell survival and decreased cell necrosis through Epac2 (exchange protein directly activated by cAMP) and ERK1/2 (extracellular signal-regulated kinases 1/2) activation. We determined that Ucn-1 shifted cell death from necrosis to apoptosis and activated caspases 9 and 3/7. Furthermore, mini-array, RT-qPCR and protein analyses of apoptotic genes showed that Ucn-1 upregulated the expression of CD40lg, Xiap and BAD in cells undergoing I/R, involving Epac2 and ERK1/2 activation. Conclusions Our data indicate that Ucn- 1 efficiently protected hearts from I/R damage by increasing the cell survival and stimulated apoptotic genes, CD40lg, Xiap and BAD, overexpression through the activation of Epac2 and ERK1/2.	[Calderon-Sanchez, Eva; Diaz, Ignacio; Ordonez, Antonio; Smani, Tarik] Univ Seville, CSIC, IBiS, Grp Fisiopatol Cardiovasc,HUVR, Seville, Spain; [Smani, Tarik] Univ Seville, Dept Fisiol Med & Biofis, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Sevilla	Ordonez, A; Smani, T (corresponding author), Univ Seville, CSIC, IBiS, Grp Fisiopatol Cardiovasc,HUVR, Seville, Spain.; Smani, T (corresponding author), Univ Seville, Dept Fisiol Med & Biofis, Seville, Spain.	antorfernan@us.es; tasmani@us.es	IBIS, CARDIOVASCULAR/P-3910-2015; Calderón-Sánchez, Eva María/B-5906-2016; Ordoñez, Antonio/G-9195-2018; Hajami, Tarik Smani/D-5372-2016	Calderón-Sánchez, Eva María/0000-0002-9599-3513; Ordoñez, Antonio/0000-0002-4344-8660; Hajami, Tarik Smani/0000-0002-1877-7438	Spanish Ministry of Economy and Competitiveness [BFU-2013-45564-C2-2-P]; Institute of Carlos III and Cardiovascular Network "RIC" [RD12/0042/0041, PI12/00941]; Andalusia Government [PI-0108-2012, P10-CVI-6095]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Institute of Carlos III and Cardiovascular Network "RIC"; Andalusia Government	This study was supported by Spanish Ministry of Economy and Competitiveness [BFU-2013-45564-C2-2-P]; Institute of Carlos III and Cardiovascular Network "RIC" [RD12/0042/0041; PI12/00941]; and from the Andalusia Government [PI-0108-2012; P10-CVI-6095].	Adao R, 2015, DRUG DISCOV TODAY, V20, P906, DOI 10.1016/j.drudis.2015.02.012; Boonprasert P, 2008, INT J CARDIOL, V127, P307, DOI 10.1016/j.ijcard.2007.11.026; Brar BK, 2000, J BIOL CHEM, V275, P8508, DOI 10.1074/jbc.275.12.8508; Brar BK, 2004, ENDOCRINOLOGY, V145, P24, DOI 10.1210/en.2003-0689; Brar BK, 1999, MOL CELL ENDOCRINOL, V158, P55, DOI 10.1016/S0303-7207(99)00183-5; Calderon-Sanchez E, 2009, CARDIOVASC RES, V83, P717, DOI 10.1093/cvr/cvp161; Chambers DJ, 2010, PHARMACOL THERAPEUT, V127, P41, DOI 10.1016/j.pharmthera.2010.04.001; Chen-Scarabelli C, 2004, AM HEART J, V148, P196, DOI 10.1016/j.ahj.2004.03.030; Chen-Scarabelli Carol, 2013, JAKSTAT, V2, pe24812, DOI 10.4161/jkst.24812; Dautzenberg FM, 2002, TRENDS PHARMACOL SCI, V23, P71, DOI 10.1016/S0165-6147(02)01946-6; Diaz I, 2013, CURR VASC PHARMACOL, V11, P457; Gao XF, 2015, MOL CELL BIOCHEM, V398, P135, DOI 10.1007/s11010-014-2213-1; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jiang X, 2015, APOPTOSIS, V20, P1033, DOI 10.1007/s10495-015-1130-4; Keiper M, 2004, J BIOL CHEM, V279, P46497, DOI 10.1074/jbc.M403604200; Kwak HJ, 2008, CELL SIGNAL, V20, P803, DOI 10.1016/j.cellsig.2007.12.011; Lawrence KM, 2005, FASEB J, V19, P831, DOI 10.1096/fj.04-2506fje; Malarstig A, 2006, ARTERIOSCL THROM VAS, V26, P1667, DOI 10.1161/01.ATV.0000222908.78873.36; Calderon-Sanchez EM, 2011, CELL CALCIUM, V50, P84, DOI 10.1016/j.ceca.2011.05.010; Markovic D, 2011, BBA-MOL CELL RES, V1813, P896, DOI 10.1016/j.bbamcr.2011.02.005; Morel E, 2005, CIRC RES, V97, P1296, DOI 10.1161/01.RES.0000194325.31359.86; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Pereira L, 2007, J PHYSIOL-LONDON, V583, P685, DOI 10.1113/jphysiol.2007.133066; Rademaker MT, 2015, INT J CARDIOL, V197, P56, DOI 10.1016/j.ijcard.2015.06.011; Rademaker MT, 2011, HYPERTENSION, V57, P1136, DOI 10.1161/HYPERTENSIONAHA.111.173203; Rehmann H, 2013, SCI REP, P3; Reutenauer-Patte J, 2012, AM J PATHOL, V180, P749, DOI 10.1016/j.ajpath.2011.10.038; Rigaud S, 2011, BLOOD, V118, P252, DOI 10.1182/blood-2011-01-328849; Ruiz-Hurtado G, 2013, J MOL CELL CARDIOL, V58, P162, DOI 10.1016/j.yjmcc.2012.11.021; Ruiz-Hurtado G, 2012, J MOL CELL CARDIOL, V53, P617, DOI 10.1016/j.yjmcc.2012.08.004; Scarabelli TM, 2006, CURR PROB CARDIOLOGY, V31, P181, DOI 10.1016/j.cpcardiol.2005.11.002; Scarabelli TM, 2002, J AM COLL CARDIOL, V40, P155, DOI 10.1016/S0735-1097(02)01930-7; Schulman D, 2002, AM J PHYSIOL-HEART C, V283, pH1481, DOI 10.1152/ajpheart.01089.2001; Smani T, 2011, CLIN EXP PHARMACOL P, V38, P71, DOI 10.1111/j.1440-1681.2010.05466.x; Smani T, 2010, CARDIOVASC RES, V87, P459, DOI 10.1093/cvr/cvq063; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Tsatsanis C, 2005, FEBS LETT, V579, P4259, DOI 10.1016/j.febslet.2005.06.057; Verma S, 2002, CIRCULATION, V105, P2332, DOI 10.1161/01.CIR.0000016602.96363.36; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Zhang XY, 2013, CIRC RES, V112, P498, DOI 10.1161/CIRCRESAHA.112.273896	43	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147375	10.1371/journal.pone.0147375	http://dx.doi.org/10.1371/journal.pone.0147375			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840743	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200034
J	Gainey, MA; Wolfe, R; Pourzia, O; Feldman, DE				Gainey, Melanie A.; Wolfe, Renna; Pourzia, Olivia; Feldman, Daniel E.			Whisker Deprivation Drives Two Phases of Inhibitory Synapse Weakening in Layer 4 of Rat Somatosensory Cortex	PLOS ONE			English	Article							CORTICAL MAP PLASTICITY; MOUSE VISUAL-CORTEX; BARREL CORTEX; CRITICAL PERIOD; IN-VIVO; SENSORY DEPRIVATION; GABAERGIC TRANSMISSION; DEPENDENT MATURATION; EXPERIENCE; NEURONS	Inhibitory synapse development in sensory neocortex is experience-dependent, with sustained sensory deprivation yielding fewer and weaker inhibitory synapses. Whether this represents arrest of synapse maturation, or a more complex set of processes, is unclear. To test this, we measured the dynamics of inhibitory synapse development in layer 4 of rat somatosensory cortex (S1) during continuous whisker deprivation from postnatal day 7, and in age-matched controls. In deprived columns, spontaneous miniature inhibitory postsynaptic currents (mIPSCs) and evoked IPSCs developed normally until P15, when IPSC amplitude transiently decreased, recovering by P16 despite ongoing deprivation. IPSCs remained normal until P22, when a second, sustained phase of weakening began. Delaying deprivation onset by 5 days prevented the P15 weakening. Both early and late phase weakening involved measurable reduction in IPSC amplitude relative to prior time points. Thus, deprivation appears to drive two distinct phases of active IPSC weakening, rather than simple arrest of synapse maturation.	[Feldman, Daniel E.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Feldman, DE (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	dfeldman@berkeley.edu		Gainey, Melanie/0000-0002-4782-9647	National Institute of Health Ruth L. Kirschstein National Research Service Award (NRSA) [1F32NS087893-01A1]; National Science Foundation; National Institute of Health [1R01NS073912]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073912, F32NS087893] Funding Source: NIH RePORTER	National Institute of Health Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: National Institute of Health (http://www.nih.gov/) Ruth L. Kirschstein National Research Service Award (NRSA) 1F32NS087893-01A1 to MG; National Science Foundation (http://www.nsf.gov/) Graduate Research Fellowship to RW; National Institute of Health (http://www.nih.gov/) 1R01NS073912 to DF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chittajallu R, 2010, NAT NEUROSCI, V13, P1240, DOI 10.1038/nn.2639; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; Drew PJ, 2009, CEREB CORTEX, V19, P331, DOI 10.1093/cercor/bhn085; Erzurumlu RS, 2012, EUR J NEUROSCI, V35, P1540, DOI 10.1111/j.1460-9568.2012.08075.x; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1992, J NEUROSCI, V12, P1826; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jiang B, 2010, J NEUROSCI, V30, P14261, DOI 10.1523/JNEUROSCI.2979-10.2010; Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006; Jiao YY, 2011, P NATL ACAD SCI USA, V108, P12131, DOI 10.1073/pnas.1105296108; Kreczko A, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/415135; Landers M, 2006, SOMATOSENS MOT RES, V23, P1, DOI 10.1080/08990220600700768; Lee SH, 2007, J NEUROPHYSIOL, V97, P4380, DOI 10.1152/jn.01217.2006; Lefort S, 2013, P NATL ACAD SCI USA, V110, pE4540, DOI 10.1073/pnas.1319571110; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; LI XR, 1995, J COMP NEUROL, V357, P465, DOI 10.1002/cne.903570310; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Maffei A, 2010, J NEUROSCI, V30, P3304, DOI 10.1523/JNEUROSCI.5340-09.2010; MICHEVA KD, 1995, EUR J NEUROSCI, V7, P419, DOI 10.1111/j.1460-9568.1995.tb00338.x; MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8; Minlebaev M, 2011, SCIENCE, V334, P226, DOI 10.1126/science.1210574; Morales B, 2002, J NEUROSCI, V22, P8084; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Sadaka Y, 2003, J COMP NEUROL, V457, P75, DOI 10.1002/cne.10518; Shoykhet M, 2005, J NEUROPHYSIOL, V94, P3987, DOI 10.1152/jn.00569.2005; SIMONS DJ, 1984, J COMP NEUROL, V230, P119, DOI 10.1002/cne.902300111; Smit-Rigter LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005167; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Stief F, 2007, EUR J NEUROSCI, V25, P519, DOI 10.1111/j.1460-9568.2006.05296.x; Sun QQ, 2009, J NEUROPHYSIOL, V102, P2955, DOI 10.1152/jn.00562.2009; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Zhang Z, 2011, NEUROSCIENCE, V174, P10, DOI 10.1016/j.neuroscience.2010.11.045; Zhang Z, 2011, INT REV NEUROBIOL, V97, P305, DOI 10.1016/B978-0-12-385198-7.00012-6; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	47	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148227	10.1371/journal.pone.0148227	http://dx.doi.org/10.1371/journal.pone.0148227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840956	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200102
J	Jacob, F; Yonis, AY; Cuello, F; Luther, P; Schulze, T; Eder, A; Streichert, T; Mannhardt, I; Hirt, MN; Schaaf, S; Stenzig, J; Force, T; Eschenhagen, T; Hansen, A				Jacob, Fabian; Yonis, Amina Y.; Cuello, Friederike; Luther, Pradeep; Schulze, Thomas; Eder, Alexandra; Streichert, Thomas; Mannhardt, Ingra; Hirt, Marc N.; Schaaf, Sebastian; Stenzig, Justus; Force, Thomas; Eschenhagen, Thomas; Hansen, Arne			Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue	PLOS ONE			English	Article							INDUCED CARDIOTOXICITY; CELL-DEATH; IN-VITRO; IMATINIB; MITOCHONDRIA; MECHANISMS; SUNITINIB; AUTOPHAGY; CARDIOMYOCYTES; SORAFENIB	Introduction Left ventricular dysfunction is a frequent and potentially severe side effect of many tyrosine kinase inhibitors (TKI). The mode of toxicity is not identified, but may include impairment of mitochondrial or sarcomeric function, autophagy or angiogenesis, either as an on-target or off-target mechanism. Methods and Results We studied concentration-response curves and time courses for nine TKIs in three-dimensional, force generating engineered heart tissue (EHT) from neonatal rat heart cells. We detected a concentration-and time-dependent decline in contractile force for gefitinib, lapatinib, sunitinib, imatinib, sorafenib, vandetanib and lestaurtinib and no decline in contractile force for erlotinib and dasatinib after 96 hours of incubation. The decline in contractile force was associated with an impairment of autophagy (LC3 Western blot) and appearance of autophagolysosomes (transmission electron microscopy). Conclusion This study demonstrates the feasibility to study TKI-mediated force effects in EHTs and identifies an association between a decline in contractility and inhibition of autophagic flux.	[Jacob, Fabian; Cuello, Friederike; Schulze, Thomas; Eder, Alexandra; Mannhardt, Ingra; Hirt, Marc N.; Schaaf, Sebastian; Stenzig, Justus; Eschenhagen, Thomas; Hansen, Arne] Univ Med Ctr Hamburg Eppendorf, Cardiovasc Res Ctr, Dept Expt Pharmacol & Toxicol, Hamburg, Germany; [Jacob, Fabian; Cuello, Friederike; Schulze, Thomas; Eder, Alexandra; Mannhardt, Ingra; Hirt, Marc N.; Schaaf, Sebastian; Stenzig, Justus; Eschenhagen, Thomas; Hansen, Arne] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany; [Yonis, Amina Y.; Luther, Pradeep] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Mol Med Sect, London, England; [Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Cent Labs, Hamburg, Germany; [Force, Thomas] Temple Univ, Sch Med, Div Cardiol, Ctr Translat Med, Philadelphia, PA 19140 USA; [Streichert, Thomas] Univ Hosp Cologne, Dept Clin Chem, Cologne, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; Imperial College London; University of Hamburg; University Medical Center Hamburg-Eppendorf; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Cologne	Hansen, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Cardiovasc Res Ctr, Dept Expt Pharmacol & Toxicol, Hamburg, Germany.; Hansen, A (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany.	ar.hansen@uke.de		Force, Thomas/0000-0002-0450-8659; Luther, Pradeep/0000-0002-8841-4368	Deutsche Herzstiftung [F/13/10]; German Research Foundation [DFG Es 88/12-1]; German Ministry of Research and Education (DZHK, German Centre for Cardiovascular Research); European Commission; British Heart Foundation [RG/11/21/29335] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119234] Funding Source: NIH RePORTER	Deutsche Herzstiftung; German Research Foundation(German Research Foundation (DFG)); German Ministry of Research and Education (DZHK, German Centre for Cardiovascular Research); European Commission(European CommissionEuropean Commission Joint Research Centre); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by funds from Deutsche Herzstiftung (F/13/10), the German Research Foundation (DFG Es 88/12-1), the German Ministry of Research and Education (DZHK, German Centre for Cardiovascular Research), the European Commission with FP7 Projects Angioscaff and Biodesign.	Abi-Gerges N, 2013, J MOL CELL CARDIOL, V64, P108, DOI 10.1016/j.yjmcc.2013.09.004; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Cheng H, 2011, CIRC RES, V109, P1401, DOI 10.1161/CIRCRESAHA.111.255695; Cheng H, 2010, CIRC RES, V106, P21, DOI 10.1161/CIRCRESAHA.109.206920; Cross MJ, 2015, BRIT J PHARMACOL, V172, P957, DOI 10.1111/bph.12979; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Eder A, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0436-7; French KJ, 2010, TOXICOL PATHOL, V38, P691, DOI 10.1177/0192623310373775; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Herman EH, 2011, TOXICOL PATHOL, V39, P1091, DOI 10.1177/0192623311419524; Hill JA, 2011, PEDIATR CARDIOL, V32, P282, DOI 10.1007/s00246-010-9883-6; Hirt MN, 2014, J MOL CELL CARDIOL, V74, P151, DOI 10.1016/j.yjmcc.2014.05.009; Hirt MN, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0307-z; HOLEN I, 1995, J BIOL CHEM, V270, P12823, DOI 10.1074/jbc.270.21.12823; Hu WY, 2012, TOXICOL SCI, V129, P188, DOI 10.1093/toxsci/kfs192; Ikeda T, 2013, J PHARMACOL SCI, V121, P67, DOI 10.1254/jphs.12158FP; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Kharaziha P, 2012, CANCER RES, V72, P5348, DOI 10.1158/0008-5472.CAN-12-0658; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Laverty HG, 2011, BRIT J PHARMACOL, V163, P675, DOI 10.1111/j.1476-5381.2011.01255.x; Long XL, 1997, J CLIN INVEST, V99, P2635, DOI 10.1172/JCI119452; Pegram M, 2006, ADV DRUG DELIVER REV, V58, P723, DOI 10.1016/j.addr.2006.05.003; Rana P, 2012, TOXICOL SCI, V130, P117, DOI 10.1093/toxsci/kfs233; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; Shimizu S, 2012, INT J CANCER, V131, P548, DOI 10.1002/ijc.26374; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Will Y, 2008, TOXICOL SCI, V106, P153, DOI 10.1093/toxsci/kfn157; Zhao YQ, 2010, TOXICOL APPL PHARM, V248, P20, DOI 10.1016/j.taap.2010.07.007	29	29	29	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0145937	10.1371/journal.pone.0145937	http://dx.doi.org/10.1371/journal.pone.0145937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840448	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200005
J	Tagliaferri, D; De Angelis, MT; Russo, NA; Marotta, M; Ceccarelli, M; Del Vecchio, L; De Felice, M; Falco, G				Tagliaferri, Daniela; De Angelis, Maria Teresa; Russo, Nicola Antonino; Marotta, Maria; Ceccarelli, Michele; Del Vecchio, Luigi; De Felice, Mario; Falco, Geppino			Retinoic Acid Specifically Enhances Embryonic Stem Cell Metastate Marked by Zscan4	PLOS ONE			English	Article							MOUSE ES CELLS; TELOMERE ELONGATION; DIFFERENTIATION; PLURIPOTENCY; EXPRESSION; IDENTIFICATION; POTENCY; STATE	Pluripotency confers Embryonic Stem Cells (ESCs) the ability to differentiate in ectoderm, endoderm, and mesoderm derivatives, producing the majority of cell types. Although the majority of ESCs divide without losing pluripotency, it has become evident that ESCs culture consists of multiple cell populations with different degrees of potency that are spontaneously induced in regular ESC culture conditions. Zscan4, a key pluripotency factor, marks ESC subpopulation that is referred to as high-level of pluripotency metastate. Here, we report that in ESC cultures treated with retinoic acid (RA), Zscan4 ESCs metastate is strongly enhanced. In particular, we found that induction of Zscan4 metastate is mediated via RA receptors (RAR-alpha, RAR-beta, and RAR-gamma), and it is dependent on phosphoinositide-3-kinase (PI3K) signaling. Remarkably, Zscan4 metastate induced by RA lacks canonical pluripotency genes Oct3/4 and Nanog but retained both self-renewal and pluripotency capabilities. Finally we demonstrated that the conditional ablation of Zscan4 subpopulation is dispensable for both endoderm and mesoderm but is required for ectoderm lineage. In conclusion, our research provides new insights about the role of RA signaling during ESCs high pluripotency metastate fluctuation.	[Tagliaferri, Daniela; De Angelis, Maria Teresa; Russo, Nicola Antonino; Marotta, Maria; De Felice, Mario; Falco, Geppino] Ist Ric Genet Gaetano Salvatore Biogem Scarl, Biogem, Ariano Irpino, Italy; [Ceccarelli, Michele] HBKU, Qatar Comp Res Inst, Doha, Qatar; [Del Vecchio, Luigi; De Felice, Mario] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Falco, Geppino] Univ Sannio, Dept Sci, Benevento, Italy; [Falco, Geppino] Univ Naples Federico II, Dept Biol, Naples, Italy	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute; University of Naples Federico II; Italfarmaco; University of Sannio; University of Naples Federico II	Falco, G (corresponding author), Univ Sannio, Dept Sci, Benevento, Italy.; Falco, G (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	geppino.falco@unina.it	Ceccarelli, Michele/AGP-1739-2022; Russo, Nicola Antonino/AAC-6602-2020	falco, geppino/0000-0001-6193-7233; Ceccarelli, Michele/0000-0002-4702-6617; Russo, Nicola Antonino/0000-0001-5773-0803; De Angelis, Maria Teresa/0000-0003-3926-0611	European International Reintegration Grant Marie Curie FP7th; FIRB MIUR; Biogem Research Institute "Gaetano Salvatore"; InterOmics; IEOS; CNR	European International Reintegration Grant Marie Curie FP7th; FIRB MIUR(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Biogem Research Institute "Gaetano Salvatore"; InterOmics; IEOS; CNR(Consiglio Nazionale delle Ricerche (CNR))	This work was supported by European International Reintegration Grant Marie Curie FP7th; FIRB MIUR and Biogem Research Institute "Gaetano Salvatore", InterOmics, IEOS, CNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2966; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Casanova EA, 2011, STEM CELLS, V29, P474, DOI 10.1002/stem.588; Cerulo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083235; Chen W, 2012, BIOCHEM BIOPH RES CO, V418, P571, DOI 10.1016/j.bbrc.2012.01.078; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; DAiuto L, 2015, ORGANOGENESIS, V28, P0; Dan JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03492; De Angelis MT, 2014, STEM CELL REV REP, V10, P269, DOI 10.1007/s12015-013-9489-5; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Idres N, 2005, BIOCHEM PHARMACOL, V69, P1595, DOI 10.1016/j.bcp.2005.02.024; Laing AF, 2015, DEV BIOL, V397, P56, DOI 10.1016/j.ydbio.2014.10.007; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Redner RL, 2013, CLIN CANCER RES, V19, P2277, DOI 10.1158/1078-0432.CCR-13-0386; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Takahashi M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-87; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882	27	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147683	10.1371/journal.pone.0147683	http://dx.doi.org/10.1371/journal.pone.0147683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840068	gold, Green Submitted, Green Published			2022-12-26	WOS:000369550200053
J	Jasprova, J; Dal Ben, M; Vianello, E; Goncharova, I; Urbanova, M; Vyroubalova, K; Gazzin, S; Tiribelli, C; Sticha, M; Cerna, M; Vitek, L				Jasprova, Jana; Dal Ben, Matteo; Vianello, Eleonora; Goncharova, Iryna; Urbanova, Marie; Vyroubalova, Karolina; Gazzin, Silvia; Tiribelli, Claudio; Sticha, Martin; Cerna, Marcela; Vitek, Libor			The Biological Effects of Bilirubin Photoisomers	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; INDUCED CELL-DEATH; NEONATAL JAUNDICE; IX-ALPHA; CIRCULAR-DICHROISM; PHOTOBILIRUBIN-II; PHOTOTHERAPY; BINDING; LIGHT; HYPERBILIRUBINEMIA	Although phototherapy was introduced as early as 1950's, the potential biological effects of bilirubin photoisomers (PI) generated during phototherapy remain unclear. The aim of our study was to isolate bilirubin PI in their pure forms and to assess their biological effects in vitro. The three major bilirubin PI (ZE- and EZ-bilirubin and Z-lumirubin) were prepared by photo-irradiation of unconjugated bilirubin. The individual photoproducts were chromatographically separated (TLC, HPLC), and their identities verified by mass spectrometry. The role of Z-lumirubin (the principle bilirubin PI) on the dissociation of bilirubin from albumin was tested by several methods: peroxidase, fluorescence quenching, and circular dichroism. The biological effects of major bilirubin PI (cell viability, expression of selected genes, cell cycle progression) were tested on the SH-SY5Y human neuroblastoma cell line. Lumirubin was found to have a binding site on human serum albumin, in the subdomain IB (or at a close distance to it); and thus, different from that of bilirubin. Its binding constant to albumin was much lower when compared with bilirubin, and lumirubin did not affect the level of unbound bilirubin (Bf). Compared to unconjugated bilirubin, bilirubin PI did not have any effect on either SH-SY5Y cell viability, the expression of genes involved in bilirubin metabolism or cell cycle progression, nor in modulation of the cell cycle phase. The principle bilirubin PI do not interfere with bilirubin albumin binding, and do not exert any toxic effect on human neuroblastoma cells.	[Jasprova, Jana; Vyroubalova, Karolina; Vitek, Libor] Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic; [Dal Ben, Matteo; Vianello, Eleonora; Gazzin, Silvia; Tiribelli, Claudio] Italian Liver Fdn, CSF, Trieste, Italy; [Goncharova, Iryna; Urbanova, Marie] Prague Inst Chem Technol, CR-16628 Prague, Czech Republic; [Sticha, Martin] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Cerna, Marcela] Inst Mother & Child Hlth, Prague, Czech Republic; [Vitek, Libor] Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague, Czech Republic	Charles University Prague; University of Chemistry & Technology, Prague; Charles University Prague; Charles University Prague	Vitek, L (corresponding author), Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic.; Vitek, L (corresponding author), Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague, Czech Republic.	vitek@cesnet.cz	Dal Ben, Matteo/N-6658-2015; Vitek, Libor/A-2645-2008; Sticha, Martin/E-6158-2017; Urbanová, Marie/E-4286-2014; Jasprova, Jana/H-7839-2017; Tiribelli, Claudio/A-4716-2014; Vianello, Eleonora/Y-2458-2018	Dal Ben, Matteo/0000-0001-9294-2107; Vitek, Libor/0000-0002-5318-0151; Sticha, Martin/0000-0001-8008-7668; Jasprova, Jana/0000-0002-0579-0895; Tiribelli, Claudio/0000-0001-6596-7595; Urbanova, Marie/0000-0003-3402-9998; Vianello, Eleonora/0000-0003-0342-4055	Czech Ministry of Health [RVO-VFN64165/2015]; Charles University in Prague [SW2665161/2015, 556912, PRVOUK-P25/LF1/2]; Czech Science Foundation [P206/11/0836]; Czech Ministry of Education [KONTAKT LH15097]	Czech Ministry of Health(Ministry of Health, Czech Republic); Charles University in Prague; Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic)	This work was funded by the Czech Ministry of Health, grant RVO-VFN64165/2015 (http://www.mzcr.cz/), the Charles University in Prague, grants SW2665161/2015, GAUK No. 556912, and PRVOUK-P25/LF1/2 (http://www.cuni.cz/), and the Czech Science Foundation, grant P206/11/0836 (http://www.gacr.cz/). This work was also supported in part by the Czech Ministry of Education, grant KONTAKT LH15097 (http://www.msmt.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Ahlfors CE, 2004, SEMIN PERINATOL, V28, P334, DOI 10.1053/j.semperi.2004.09.002; Ahlfors CE, 2000, ANAL BIOCHEM, V279, P130, DOI 10.1006/abio.2000.4485; Arnold C, 2014, SEMIN PERINATOL, V38, P452, DOI 10.1053/j.semperi.2014.08.008; Beken S, 2014, FETAL PEDIATR PATHOL, V33, P151, DOI 10.3109/15513815.2014.883456; BONNETT R, 1984, BIOCHEM J, V219, P1053, DOI 10.1042/bj2191053; BRODERSEN R, 1979, CRC CR REV CL LAB SC, V11, P305; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calligaris SD, 2007, PEDIATR RES, V62, P576, DOI 10.1203/PDR.0b013e3181568c94; CHRISTENSEN T, 1994, ACTA PAEDIATR, V83, P7, DOI 10.1111/j.1651-2227.1994.tb12943.x; CHRISTENSEN T, 1990, J PHOTOCH PHOTOBIO B, V7, P337, DOI 10.1016/1011-1344(90)85166-T; Christensen T, 2000, J PHOTOCH PHOTOBIO B, V58, P170, DOI 10.1016/S1011-1344(00)00126-3; CREMER RJ, 1958, LANCET, V1, P1094; Gazzin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016165; Goncharova I, 2013, BIOPHYS CHEM, V180, P55, DOI 10.1016/j.bpc.2013.06.004; Goncharova I, 2008, ANAL BIOANAL CHEM, V392, P1355, DOI 10.1007/s00216-008-2427-8; KNOBLOCH E, 1991, J CHROMATOGR-BIOMED, V566, P89, DOI 10.1016/0378-4347(91)80113-Q; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V26; LIGHTNER DA, 1984, ACCOUNTS CHEM RES, V17, P417, DOI 10.1021/ar00108a002; MCDONAGH AF, 1972, BIOCHEM J, V129, P797, DOI 10.1042/bj1290797; MCDONAGH AF, 1982, J AM CHEM SOC, V104, P6867, DOI 10.1021/ja00388a104; MCDONAGH AF, 1982, J AM CHEM SOC, V104, P6865, DOI 10.1021/ja00388a103; MCDONAGH AF, 1989, PHOTOCHEM PHOTOBIOL, V50, P305, DOI 10.1111/j.1751-1097.1989.tb04164.x; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Mreihil K, 2010, PEDIATR RES, V67, P656, DOI 10.1203/PDR.0b013e3181dcedc0; ONISHI S, 1980, BIOCHEM J, V190, P533, DOI 10.1042/bj1900533; ONISHI S, 1984, BIOCHEM J, V218, P667, DOI 10.1042/bj2180667; Ostrow JD, 2003, EUR J CLIN INVEST, V33, P988, DOI 10.1046/j.1365-2362.2003.01261.x; Pestell RG, 2013, AM J PATHOL, V183, P3, DOI 10.1016/j.ajpath.2013.03.001; Raghavan K, 2005, J MATERN-FETAL NEO M, V18, P129, DOI 10.1080/14767050500233076; Rigato L, 2004, BIOCHEM J, V383, P335, DOI 10.1042/BJ20040599; Roll EB, 2005, ACTA PAEDIATR, V94, P1437, DOI 10.1080/08035250510032646; Roll EB, 2005, ACTA PAEDIATR, V94, P1443, DOI 10.1080/08035250510032637; Roll EB, 2005, ACTA PAEDIATR, V94, P1448, DOI 10.1080/08035250510032655; ROYER RE, 1983, FEBS LETT, V157, P28, DOI 10.1016/0014-5793(83)81109-0; SILBERBERG D, 1970, Birth Defects Original Article Series, V6, P119; SILBERBERG DH, 1970, J PEDIATR-US, V77, P613, DOI 10.1016/S0022-3476(70)80202-5; STOLL MS, 1979, BIOCHEM J, V183, P139, DOI 10.1042/bj1830139; STOLL MS, 1982, BIOCHEM J, V201, P179, DOI 10.1042/bj2010179; Tatli MM, 2008, MUTAT RES-GEN TOX EN, V654, P93, DOI 10.1016/j.mrgentox.2007.06.013; Tyson JE, 2012, J PERINATOL, V32, P677, DOI 10.1038/jp.2012.64; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vitek L, 2007, ADV CLIN CHEM, V43, P1, DOI 10.1016/S0065-2423(06)43001-8; Vreman HJ, 2005, ANAL BIOCHEM, V341, P280, DOI 10.1016/j.ab.2005.03.019; Xiong T, 2011, EUR J PEDIATR, V170, P1247, DOI 10.1007/s00431-011-1454-1; Zsila F, 2013, MOL PHARMACEUT, V10, P1668, DOI 10.1021/mp400027q	46	22	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148126	10.1371/journal.pone.0148126	http://dx.doi.org/10.1371/journal.pone.0148126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829016	Green Published, gold			2022-12-26	WOS:000369548200067
J	Mauvais, FX; Gonzales, E; Davit-Spraul, A; Jacquemin, E; Brauner, R				Mauvais, Francois-Xavier; Gonzales, Emmanuel; Davit-Spraul, Anne; Jacquemin, Emmanuel; Brauner, Raja			Cholestasis Reveals Severe Cortisol Deficiency in Neonatal Pituitary Stalk Interruption Syndrome	PLOS ONE			English	Article							GROWTH-HORMONE DEFICIENCY; CONGENITAL HYPOPITUITARISM; IDIOPATHIC HYPOPITUITARISM; LIVER DYSFUNCTION; GH THERAPY; LONG-TERM; INFANTS; HYPOGLYCEMIA; HEPATITIS; MORTALITY	Objectives Cholestasis has been reported during the course of congenital hypothalamic-pituitary deficiency, but crucial information is lacking regarding both its origin and prognosis. We aimed to characterize the course of cholestasis and factors contributing to it in patients with deficiency due to pituitary stalk interruption syndrome (PSIS). Methods We conducted a retrospective single-center, case-cohort study including 16 patients with PSIS diagnosed before one year of age. We collected clinical and biological parameters from medical records and compared the characteristics of the endocrine syndrome in PSIS patients with and without cholestasis. Results 5/16 patients had cholestasis, all with a neonatal onset and multiple hypothalamic-pituitary deficiency. Patients with cholestasis presented with lower Apgar score and higher rate of ophthalmic malformations: 3/5 vs 1/11, p = 0.03 and 5/5 vs 4/11, p = 0.02, respectively. The plasma cortisol level was strongly decreased in patients with cholestasis: 12.4 ng/mL (8-15 ng/mL) vs 79.4 ng/mL (10-210 ng/mL), p = 0.04. Cholestasis resolved within 9 months following hormone supplementation. No development of chronic liver disease was observed during a median follow-up of 9.4 years (range, 1.3-13.3 years). Conclusions Cholestasis is a frequent symptom at presentation of PSIS during the neonatal period that may help earlier diagnosis and that indicates a profound cortisol deficiency.	[Mauvais, Francois-Xavier; Gonzales, Emmanuel; Jacquemin, Emmanuel] Hop Bicetre, AP HP, Reference Ctr Pediat Liver Dis DHU Hepatinov, Pediat Hepatol & Liver Transplantat Unit, Le Kremlin Bicetre, France; [Mauvais, Francois-Xavier] INSERM, Unite 1151, Paris, France; [Mauvais, Francois-Xavier] CNRS, UMR8253, Paris, France; [Mauvais, Francois-Xavier; Brauner, Raja] Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France; [Gonzales, Emmanuel; Jacquemin, Emmanuel] Univ Paris 11, INSERM, UMR S 1174, F-91405 Orsay, France; [Gonzales, Emmanuel] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Davit-Spraul, Anne] Hop Bicetre, AP HP, Biochem Lab, Le Kremlin Bicetre, France; [Brauner, Raja] Fdn Ophtalmol Adolphe De Rothschild, Pediat Endocrinol Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Mauvais, FX (corresponding author), Hop Bicetre, AP HP, Reference Ctr Pediat Liver Dis DHU Hepatinov, Pediat Hepatol & Liver Transplantat Unit, Le Kremlin Bicetre, France.; Mauvais, FX (corresponding author), INSERM, Unite 1151, Paris, France.; Mauvais, FX (corresponding author), CNRS, UMR8253, Paris, France.; Mauvais, FX (corresponding author), Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France.	francois-xavier.mauvais@inserm.fr	jacquemin, emmanuel/J-8673-2013; Mauvais, François-Xavier/AAA-4989-2019	Mauvais, François-Xavier/0000-0002-5240-4280; GONZALES, Emmanuel/0000-0002-1546-3193				Al-Hussaini A, 2012, SAUDI J GASTROENTERO, V18, P339, DOI 10.4103/1319-3767.101137; ARGYROPOULOU M, 1992, J PEDIATR-US, V120, P886, DOI 10.1016/S0022-3476(05)81955-9; Arrigo T, 1998, EUR J ENDOCRINOL, V139, P84, DOI 10.1530/eje.0.1390084; BAUMAN JW, 1966, ACTA ENDOCRINOL-COP, V52, P404, DOI 10.1530/acta.0.0520404; Binder G, 2007, J PEDIATR ENDOCR MET, V20, P695; Braslavsky D, 2011, ARQ BRAS ENDOCRINOL, V55, P622, DOI 10.1590/S0004-27302011000800017; DeSalvo D, 2008, J NATL MED ASSOC, V100, P342, DOI 10.1016/S0027-9684(15)31249-9; DROP SLS, 1979, ACTA PAEDIATR SCAND, V68, P277, DOI 10.1111/j.1651-2227.1979.tb05003.x; Dupuis-Girod S, 2001, J PEDIATR-US, V138, P129, DOI 10.1067/mpd.2001.109200; ELLAWAY CJ, 1995, J PAEDIATR CHILD H, V31, P51, DOI 10.1111/j.1440-1754.1995.tb02914.x; GARTNER LM, 1972, AM J PHYSIOL, V222, P1091, DOI 10.1152/ajplegacy.1972.222.5.1091; Gonc EN, 2006, TURKISH J PEDIATR, V48, P376; Grammatikopoulos A, 2006, J PEDIAT GASTROENTER, V42; HERMAN SP, 1975, J PEDIATR-US, V87, P892, DOI 10.1016/S0022-3476(75)80900-0; HODGES S, 1984, ARCH DIS CHILD, V59, P1200, DOI 10.1136/adc.59.12.1200; Huet F, 1999, EUR J ENDOCRINOL, V140, P29, DOI 10.1530/eje.0.1400029; Jacquemin E, 1998, J PEDIATR-US, V133, P563, DOI 10.1016/S0022-3476(98)70070-8; Karnsakul W, 2007, ANN HEPATOL, V6, P97; KAUFMAN FR, 1984, ARCH DIS CHILD, V59, P787, DOI 10.1136/adc.59.8.787; LACY DE, 1993, J PEDIATR GASTR NUTR, V17, P438, DOI 10.1097/00005176-199311000-00018; LANES R, 1978, AM J DIS CHILD, V132, P926, DOI 10.1001/archpedi.1978.02120340102022; LEBLANC A, 1981, J PEDIATR-US, V99, P577, DOI 10.1016/S0022-3476(81)80260-0; Leblanc T, 2003, J PEDIATR-US, V142, P358, DOI 10.1067/mpd.2003.57; LOVINGER RD, 1975, J PEDIATR-US, V87, P1171, DOI 10.1016/S0022-3476(75)80132-6; Lu Y, 2012, GASTROENTEROLOGY, V143, P1630, DOI 10.1053/j.gastro.2012.08.029; Machado MK, 2011, ARCH ARGENT PEDIATR, V109, pE59, DOI 10.1590/S0325-00752011000300014; Mills JL, 2004, J PEDIATR-US, V144, P430, DOI 10.1016/j.jpeds.2003.12.036; Pena-Almazan S, 2001, J CLIN ENDOCR METAB, V86, P5691, DOI 10.1210/jc.86.12.5691; Pham LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053189; Pinto G, 1997, J CLIN ENDOCR METAB, V82, P3450, DOI 10.1210/jc.82.10.3450; Reynaud R, 2006, J CLIN ENDOCR METAB, V91, P3329, DOI 10.1210/jc.2005-2173; Simon FR, 2006, AM J PHYSIOL-GASTR L, V290, pG595, DOI 10.1152/ajpgi.00240.2005; Spray CH, 2000, ACTA PAEDIATR, V89, P951, DOI 10.1080/080352500750043413; Taback SP, 1996, J CLIN ENDOCR METAB, V81, P1693, DOI 10.1210/jc.81.5.1693; Vallette-Kasic S, 2005, J CLIN ENDOCR METAB, V90, P1323, DOI 10.1210/jc.2004-1300	35	9	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147750	10.1371/journal.pone.0147750	http://dx.doi.org/10.1371/journal.pone.0147750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829045	gold, Green Submitted, Green Published			2022-12-26	WOS:000369548200030
J	Ogawa, K; Fukuda, T; Han, J; Kitamura, Y; Shiba, K; Odani, A				Ogawa, Kazuma; Fukuda, Tadahisa; Han, Jaegab; Kitamura, Yoji; Shiba, Kazuhiro; Odani, Akira			Evaluation of Chlorella as a Decorporation Agent to Enhance the Elimination of Radioactive Strontium from Body	PLOS ONE			English	Article							CESIUM; CHERNOBYL; EXCRETION; ALGINATE; SR-90; CONTAMINATION; ABSORPTION; BINDING	Background Release of radionuclides, such as Cs-137 and Sr-90, into the atmosphere and the ocean presents an important problem because internal exposure to Cs-137 and Sr-90 could be very harmful to humans. Chlorella has been reported to be effective in enhancing the excretion of heavy metals; thus, we hypothesized that Chlorella could also enhance the elimination of Cs-137 or Sr-90 from the body. We evaluated the potential of Chlorella as a decorporation agent in vitro and in vivo, using Sr-85 instead of Sr-90. Methods In vitro experiments of adsorption of Cs-137 and Sr-85 to Chlorella were performed under wide pH conditions. The maximum sorption capacity of Chlorella to strontium was estimated using the Langmuir model. A Sr-85 solution was orally administrated to mice pretreated with Chlorella. At 48 h after Sr-85 administration, the biodistribution of radioactivity was determined. Results In the in vitro experiments, although Sr-85 barely adsorbed to Chlorella at low pH, the Sr-85 adsorption ratio to Chlorella increased with increasing pH. The maximum sorption capacity of Chlorella to strontium was 9.06 mg / g. Cs-137 barely adsorbed to Chlorella under any pH conditions. In the biodistribution experiments, bone accumulation of radioactivity after Sr-85 administration was significantly decreased in the Chlorella pretreatment group compared with the non-treatment control group. Conclusions In conclusion, these results indicated that Chlorella could inhibit the absorption of Sr-90 into the blood and enhance the elimination of Sr-90 from the body through adsorption in intestine. Further studies are required to elucidate the mechanism and the components of Chlorella needed for adsorption to strontium and could promote the development of more effective decorporation agents.	[Ogawa, Kazuma; Fukuda, Tadahisa; Odani, Akira] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Ogawa, Kazuma] Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa, Japan; [Han, Jaegab] DAESANG Corp, Seoul, South Korea; [Kitamura, Yoji; Shiba, Kazuhiro] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Ogawa, K (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan.; Ogawa, K (corresponding author), Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa, Japan.	kogawa@p.kanazawa-u.ac.jp	ODANI, Akira/B-3043-2011; Ogawa, Kazuma/D-8406-2015	ODANI, Akira/0000-0003-3786-6740; Ogawa, Kazuma/0000-0002-1691-7302	DAESANG Corporation	DAESANG Corporation	This study was funded by DAESANG Corporation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BARNES DWH, 1970, INT J RADIAT BIOL RE, V18, P531, DOI 10.1080/09553007014551461; Brumfiel G, 2011, NATURE, V474, P135, DOI 10.1038/474135a; Chaalal O, 2001, J ENVIRON MANAGE, V61, P51, DOI 10.1006/jema.2000.0399; Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7; Davis J, 2000, J NUCL MED, V41, P183; DUNGWORTH DL, 1969, BLOOD-J HEMATOL, V34, P610, DOI 10.1182/blood.V34.5.610.610; Evangeliou N, 2014, ENVIRON INT, V64, P17, DOI 10.1016/j.envint.2013.11.020; Faustino PJ, 2008, J PHARMACEUT BIOMED, V47, P114, DOI 10.1016/j.jpba.2007.11.049; Froidevaux P, 2010, CHEMOSPHERE, V80, P519, DOI 10.1016/j.chemosphere.2010.04.049; FRY FA, 1987, LANCET, V2, P160; Haratake M, 2012, CHEM PHARM BULL, V60, P1258, DOI 10.1248/cpb.c12-00430; HESP R, 1965, NATURE, V208, P1341, DOI 10.1038/2081341a0; Idota Y, 2013, BIOL PHARM BULL, V36, P485, DOI 10.1248/bpb.b12-00899; Kanai Y, 2012, J ENVIRON RADIOACTIV, V111, P33, DOI 10.1016/j.jenvrad.2011.10.011; Leggett RW, 2003, SCI TOTAL ENVIRON, V317, P235, DOI 10.1016/S0048-9697(03)00333-4; Leggett RW, 1998, RADIAT PROT DOSIM, V79, P335, DOI 10.1093/oxfordjournals.rpd.a032422; MCKINLEY MK, 1993, FUND APPL TOXICOL, V21, P425, DOI 10.1006/faat.1993.1118; Mercola Joseph, 2001, Journal of Nutritional and Environmental Medicine (Abingdon), V11, P53, DOI 10.1080/13590840020030267; Morita K, 1999, J NUTR, V129, P1731, DOI 10.1093/jn/129.9.1731; NISHIMURA Y, 1991, Radioisotopes, V40, P244; Ogawa K, 2012, CURR MED CHEM, V19, P3290, DOI 10.2174/092986712801215865; Queiroz MLS, 2003, INT IMMUNOPHARMACOL, V3, P889, DOI 10.1016/S1567-5769(03)00082-1; Shim JA, 2009, NUTR RES PRACT, V3, P15, DOI 10.4162/nrp.2009.3.1.15; SUTTON A, 1967, NATURE, V216, P1005, DOI 10.1038/2161005a0; Timchalk C, 2010, HEALTH PHYS, V99, P420, DOI 10.1097/HP.0b013e3181bca9b0; VERZIJL JM, 1992, J TOXICOL-CLIN TOXIC, V30, P215, DOI 10.3109/15563659209038633; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P5, DOI [10.1111/j.1749-6632.2009.04821.x, 10.1111/j.1749-6632.2009.04820.x]	28	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148080	10.1371/journal.pone.0148080	http://dx.doi.org/10.1371/journal.pone.0148080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828430	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200058
J	Banskota, S; Gautam, J; Regmi, SC; Gurung, P; Park, MH; Kim, SJ; Nam, TG; Jeong, BS; Kim, JA				Banskota, Suhrid; Gautam, Jaya; Regmi, Sushil C.; Gurung, Pallavi; Park, Myo-Hyeon; Kim, Seung Joo; Nam, Tae-gyu; Jeong, Byeong-Seon; Kim, Jung-Ae			BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; ANTIANGIOGENIC ACTIVITY; VENOUS THROMBOEMBOLISM; OXIDATIVE STRESS; CARCINOID-TUMORS; ROS GENERATION; CANCER; PHOSPHORYLATION; KINASE; ANTIOXIDANTS	5-Hydroxytryptamine (5-HT) induces proliferation of cancer cells and vascular cells. In addition to 5-HT production by several cancer cells including gastrointestinal and breast cancer, a significant level of 5-HT is released from activated platelets in the thrombotic environment of tumors, suggesting that inhibition of 5-HT signaling may constitute a new target for antiangiogenic anticancer drug discovery. In the current study we clearly demonstrate that 5-HT-induced angiogenesis was mediated through the 5-HT1 receptor-linked G beta gamma/Src/PI3K pathway, but not through the MAPK/ERK/p38 pathway. In addition, 5-HT induced production of NADPH oxidase (NOX)-derived reactive oxygen species (ROS). In an effort to develop new molecularly targeted anticancer agents against 5-HT action in tumor growth, we demonstrate that BJ-1108, a derivative of 6-amino-2,4,5-trimethylpyridin-3-ol, significantly inhibited 5-HT-induced angiogenesis. In addition, BJ-1108 induced a significant reduction in the size and weight of excised tumors in breast cancer cell-inoculated CAM assay, showing proportionate suppression of tumor growth along with inhibition of angiogenesis. In human umbilical vein endothelial cells (HUVECs), BJ-1108 significantly suppressed 5-HT-induced ROS generation and phosphorylation of PI3K/Akt but not of Src. Unlike NOX inhibitors, BJ-1108, which showed better antioxidant activity than vitamin C, barely suppressed superoxide anion induced by mevalonate or geranylgeranyl pyrophosphate which directly activates NOX without help from other signaling molecules in HUVECs, implying that the anti-angiogenic action of BJ-1108 was not mediated through direct action on NOX activation, or free radical scavenging activity. In conclusion, BJ-1108 inhibited 5-HT-induced angiogenesis through PI3K/NOX signaling but not through Src, ERK, or p38.	[Banskota, Suhrid; Gautam, Jaya; Regmi, Sushil C.; Gurung, Pallavi; Park, Myo-Hyeon; Kim, Seung Joo; Jeong, Byeong-Seon; Kim, Jung-Ae] Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea; [Nam, Tae-gyu] Hanyang Univ, Dept Pharm, Ansan 15588, South Korea	Yeungnam University; Hanyang University	Jeong, BS; Kim, JA (corresponding author), Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea.	jeongb@ynu.ac.kr; jakim@yu.ac.kr	Banskota, Suhrid/AAF-2315-2020; Banskota, Suhrid/Q-8485-2016	Banskota, Suhrid/0000-0003-3183-6268; Banskota, Suhrid/0000-0003-3183-6268	Yeungnam University research grant	Yeungnam University research grant	This work was supported by a Yeungnam University research grant.	Ahn MR, 2009, MOL NUTR FOOD RES, V53, P643, DOI 10.1002/mnfr.200800021; Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-88; Asada M, 2009, NEOPLASIA, V11, P408, DOI 10.1593/neo.81630; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Banskota S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0379-0; Bianchi P, 2005, FASEB J, V19, P641, DOI 10.1096/fj.04-2518fje; CATTANEO MG, 1995, EUR J PHARM-MOLEC PH, V291, P209, DOI 10.1016/0014-2999(95)90106-X; Corydon TJ, 2015, HUM GENE THER, V26, P777, DOI 10.1089/hum.2015.064.cxn; Elshabrawy HA, 2015, ANGIOGENESIS, V18, P433, DOI 10.1007/s10456-015-9477-2; EMSON PC, 1984, CANCER, V54, P715, DOI 10.1002/1097-0142(1984)54:4<715::AID-CNCR2820540420>3.0.CO;2-6; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Iwabayashi M, 2012, ATHEROSCLEROSIS, V220, P337, DOI 10.1016/j.atherosclerosis.2011.10.042; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kang Y, 2015, ARCH PHARM RES, V38, P249, DOI 10.1007/s12272-014-0535-x; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kim DG, 2014, EUR J MED CHEM, V78, P126, DOI 10.1016/j.ejmech.2014.03.045; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Lee H, 2014, BIOORG MED CHEM LETT, V24, P3131, DOI 10.1016/j.bmcl.2014.05.005; Lee YM, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0800-7; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; LUSCHER TF, 1990, CLIN PHYSIOL BIOCH, V8, P108; Mao CY, 1998, INT J PANCREATOL, V23, P153, DOI 10.1385/IJGC:23:2:153; Mukhin YV, 2000, BIOCHEM J, V347, P61, DOI 10.1042/0264-6021:3470061; Nakagawa K, 2007, J NUTR, V137, P1938, DOI 10.1093/jn/137.8.1938; NEMECEK GM, 1986, P NATL ACAD SCI USA, V83, P674, DOI 10.1073/pnas.83.3.674; Nishihira K, 2006, J THROMB HAEMOST, V4, P247, DOI 10.1111/j.1538-7836.2005.01702.x; Nocito A, 2008, CANCER RES, V68, P5152, DOI 10.1158/0008-5472.CAN-08-0202; Omata Y, 2010, FREE RADICAL BIO MED, V48, P1358, DOI 10.1016/j.freeradbiomed.2010.02.018; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; PAKALA R, 1994, CIRCULATION, V90, P1919, DOI 10.1161/01.CIR.90.4.1919; Park BC, 2007, EUR J PHARMACOL, V567, P193, DOI 10.1016/j.ejphar.2007.04.014; Park BC, 2009, J PHARMACOL SCI, V111, P1, DOI 10.1254/jphs.08305FP; Park SY, 2008, ARCH PHARM RES, V31, P195, DOI 10.1007/s12272-001-1141-2; Qin LL, 2013, BLOOD, V121, P2154, DOI 10.1182/blood-2012-07-443903; Regmi SC, 2014, FREE RADICAL BIO MED, V69, P377, DOI 10.1016/j.freeradbiomed.2014.02.003; Serwa R, 2010, CHEM-EUR J, V16, P14106, DOI 10.1002/chem.201001382; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Soll C, 2010, HEPATOLOGY, V51, P1244, DOI 10.1002/hep.23441; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Tesselaar MET, 2007, CURR OPIN PULM MED, V13, P362, DOI 10.1097/MCP.0b013e328209413c; Thapa D, 2008, J PHARMACOL EXP THER, V327, P353, DOI 10.1124/jpet.108.141887; TUTTON PJM, 1982, BRIT J CANCER, V46, P260, DOI 10.1038/bjc.1982.191; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Zamani A, 2012, FEBS LETT, V586, P2360, DOI 10.1016/j.febslet.2012.05.047	49	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148133	10.1371/journal.pone.0148133	http://dx.doi.org/10.1371/journal.pone.0148133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824764	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600103
J	Zazo, R; Lozano-Diez, A; Gonzalez-Dominguez, J; Toledano, DT; Gonzalez-Rodriguez, J				Zazo, Ruben; Lozano-Diez, Alicia; Gonzalez-Dominguez, Javier; Toledano, Doroteo T.; Gonzalez-Rodriguez, Joaquin			Language Identification in Short Utterances Using Long Short-Term Memory (LSTM) Recurrent Neural Networks	PLOS ONE			English	Article							SPEAKER	Long Short Term Memory (LSTM) Recurrent Neural Networks (RNNs) have recently outperformed other state-of-the-art approaches, such as i-vector and Deep Neural Networks (DNNs), in automatic Language Identification (LID), particularly when dealing with very short utterances (similar to 3s). In this contribution we present an open-source, end-to-end, LSTM RNN system running on limited computational resources (a single GPU) that outperforms a reference i-vector system on a subset of the NIST Language Recognition Evaluation (8 target languages, 3s task) by up to a 26%. This result is in line with previously published research using proprietary LSTM implementations and huge computational resources, which made these former results hardly reproducible. Further, we extend those previous experiments modeling unseen languages (out of set, OOS, modeling), which is crucial in real applications. Results show that a LSTM RNN with OOS modeling is able to detect these languages and generalizes robustly to unseen OOS languages. Finally, we also analyze the effect of even more limited test data (from 2.25s to 0.1s) proving that with as little as 0.5s an accuracy of over 50% can be achieved.	[Zazo, Ruben; Lozano-Diez, Alicia; Gonzalez-Dominguez, Javier; Toledano, Doroteo T.; Gonzalez-Rodriguez, Joaquin] Univ Autonoma Madrid, ATVS Biometr Recognit Grp, Madrid, Spain	Autonomous University of Madrid	Zazo, R (corresponding author), Univ Autonoma Madrid, ATVS Biometr Recognit Grp, Madrid, Spain.	ruben.zazo@uam.es	Lozano-Diez, Alicia/U-4476-2019; Toledano, Doroteo T/C-7750-2014	Toledano, Doroteo T/0000-0003-1159-6455	project CMC-V2: Caracterizacion, Modelado y Compensacion de Variabilidad en la Sennal de Voz - Ministerio de Economia y Competitividad, Spain [TEC2012-37585-C02-01]	project CMC-V2: Caracterizacion, Modelado y Compensacion de Variabilidad en la Sennal de Voz - Ministerio de Economia y Competitividad, Spain	This work has been supported by project CMC-V2: Caracterizacion, Modelado y Compensacion de Variabilidad en la Sennal de Voz (TEC2012-37585-C02-01), funded by Ministerio de Economia y Competitividad, Spain.	[Anonymous], P OD 2012 SPEAK LANG; Bengio Y, 2013, INT CONF ACOUST SPEE, P8624, DOI 10.1109/ICASSP.2013.6639349; Bishop C. M., 2007, J ELECT IMAGING, V2nd, DOI 10.1117/1.2819119; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; Dehak N., 2011, P INTERSPEECH, V2011, P857; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Frinken V, 2012, INT C PATT RECOG, P701; Ganapathy S, 2014, INTERSPEECH 2014; Gers F., 2001, LONG SHORT TERM MEMO; Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015; Gonzalez-Dominguez J, 2014, FRAME FRAME LANGUAGE; Gonzalez-Dominguez J., 2014, INTERSPEECH, P2155, DOI DOI 10.21437/INTERSPEECH.2014-483; Gonzalez-Dominguez J, 2010, IEEE J-STSP, V4, P1084, DOI 10.1109/JSTSP.2010.2076071; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Graves A, 2013, 2013 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING (ASRU), P273, DOI 10.1109/ASRU.2013.6707742; Greff K., 2016, ARXIV150304069, P2222, DOI [10.1109/TNNLS.2016.2582924, DOI 10.1109/TNNLS.2016.2582924]; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Kenny P, 2008, IEEE T AUDIO SPEECH, V16, P980, DOI 10.1109/TASL.2008.925147; Lei Y, 2014, P OD 2014 SPEAK LANG; Li HZ, 2013, P IEEE, V101, P1136, DOI 10.1109/JPROC.2012.2237151; Lopez-Moreno I, 2014, AC SPEECH S IN PRESS; Lozano-Diez A, 2014, LECT NOTES ARTIF INT, V8854, P79, DOI 10.1007/978-3-319-13623-3_9; Martinez D, 2011, 12TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2011 (INTERSPEECH 2011), VOLS 1-5, P868; Mikolov T, 2011, INT CONF ACOUST SPEE, P5528; Mohamed AR, 2012, INT CONF ACOUST SPEE, P4273, DOI 10.1109/ICASSP.2012.6288863; Muthusamy YK, 1994, IEEE SIGNAL PROC MAG, V11, P33, DOI 10.1109/79.317925; Pascanu R, 2012, ARXIV12115063; Povey Daniel, 2011, P ASRU BIG ISL HI US; REYNOLDS DA, 1995, SPEECH COMMUN, V17, P91, DOI 10.1016/0167-6393(95)00009-D; Richardson F, 2015, IEEE SIGNAL PROC LET, V22, P1671, DOI 10.1109/LSP.2015.2420092; SCHMIDHUBER J, 1992, NEURAL COMPUT, V4, P234, DOI 10.1162/neco.1992.4.2.234; Singer E, 2012, OD 2012 THE SPEAK LA; Song Y, 2013, ELECTRON LETT, V49, P1569, DOI 10.1049/el.2013.1721; Torres-Carrasquillo P. A., 2002, P INT C SPOK LANG PR, P89; Van Segbroeck M, 2015, IEEE-ACM T AUDIO SPE, V23, P1118, DOI 10.1109/TASLP.2015.2419978; Weninger F, 2014, J MACHINE LEARNING R, P15; Weninger Felix, 2013, CUDA ENABLED MACHINE; Yu D, 2011, IEEE SIGNAL PROC MAG, V28, P145, DOI 10.1109/MSP.2010.939038	40	75	78	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0146917	10.1371/journal.pone.0146917	http://dx.doi.org/10.1371/journal.pone.0146917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824467	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600012
J	Heir, P; Srikumar, T; Bikopoulos, G; Bunda, S; Poon, BP; Lee, JE; Raught, B; Ohh, M				Heir, Pardeep; Srikumar, Tharan; Bikopoulos, George; Bunda, Severa; Poon, Betty P.; Lee, Jeffrey E.; Raught, Brian; Ohh, Michael			Oxygen-dependent Regulation of Erythropoietin Receptor Turnover and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-HIPPEL-LINDAU; HYPOXIA-INDUCIBLE FACTOR; DIFFERENTIATED NEUROBLASTOMA SH-SY5Y; PROLYL HYDROXYLASE DOMAIN; TUMOR-SUPPRESSOR PROTEIN; CELL-SURFACE EXPRESSION; CONGENITAL POLYCYTHEMIA; MEDIATES UBIQUITINATION; PROLINE HYDROXYLATION; CHUVASH POLYCYTHEMIA	von Hippel-Lindau (VHL) disease is a rare familial cancer predisposition syndrome caused by a loss or mutation in a single gene, VHL, but it exhibits a wide phenotypic variability that can be categorized into distinct subtypes. The phenotypic variability has been largely argued to be attributable to the extent of deregulation of the alpha subunit of hypoxia-inducible factor alpha, a well established target of VHL E3 ubiquitin ligase, ECV (Elongins/Cul2/VHL). Here, we show that erythropoietin receptor (EPOR) is hydroxylated on proline 419 and 426 via prolyl hydroxylase 3. EPOR hydroxylation is required for binding to the beta domain of VHL and polyubiquitylation via ECV, leading to increased EPOR turnover. In addition, several type-specific VHL disease-causing mutants, including those that have retained proper binding and regulation of hypoxia-inducible factor alpha, showed a severe defect in binding prolyl hydroxylated EPOR peptides. These results identify EPOR as the second bona fide hydroxylation-dependent substrate of VHL that potentially influences oxygen homeostasis and contributes to the complex genotype-phenotype correlation in VHL disease.	[Heir, Pardeep; Bikopoulos, George; Bunda, Severa; Poon, Betty P.; Lee, Jeffrey E.; Ohh, Michael] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Poon, Betty P.; Ohh, Michael] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Srikumar, Tharan; Raught, Brian] Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Ohh, M (corresponding author), Univ Toronto, Dept Biochem, Dept Lab Med & Pathobiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	michael.ohh@utoronto.ca	Srikumar, Tharan/Q-5642-2016		Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from the Canadian Institutes of Health Research. The authors declare that they have no conflicts of interest with the contents of this article.	AKAHANE K, 1989, EXP HEMATOL, V17, P177; Ali N, 2009, BLOOD, V113, P3690, DOI 10.1182/blood-2008-10-176396; Anderson K, 2011, J BIOL CHEM, V286, P42027, DOI 10.1074/jbc.M111.303222; Arsenault PR, 2013, J BIOL CHEM, V288, P33571, DOI 10.1074/jbc.M113.482364; Astuti D, 2011, ENDOCR-RELAT CANCER, V18, P73, DOI 10.1677/ERC-10-0113; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Delhommeau F, 2006, CELL MOL LIFE SCI, V63, P2939, DOI 10.1007/s00018-006-6272-7; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; ERSLEV A, 1953, BLOOD, V8, P349, DOI 10.1182/blood.V8.4.349.349; Furlow PW, 2009, J BIOL CHEM, V284, P9050, DOI 10.1074/jbc.M808737200; Gopalakrishnan T V, 1979, Methods Enzymol, V58, P506; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Komatsu N, 1997, BLOOD, V89, P4021, DOI 10.1182/blood.V89.11.4021; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Motohashi T, 2001, EUR J HAEMATOL, V67, P88, DOI 10.1034/j.1600-0609.2001.t01-1-00446.x; Niu XM, 2009, AM J HEMATOL, V84, P74, DOI 10.1002/ajh.21327; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Pastore Y, 2003, AM J HUM GENET, V73, P412, DOI 10.1086/377108; Perrotta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012015; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Richard S, 2013, SEMIN CANCER BIOL, V23, P26, DOI 10.1016/j.semcancer.2012.05.005; Russell RC, 2011, NAT MED, V17, P845, DOI 10.1038/nm.2370; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shively SB, 2008, J PATHOL, V216, P514, DOI 10.1002/path.2435; STEIN AA, 1960, J NEUROSURG, V17, P751, DOI 10.3171/jns.1960.17.4.0751; Sulahian R, 2009, BLOOD, V113, P5287, DOI 10.1182/blood-2008-09-179572; Supino-Rosin L, 1999, EUR J BIOCHEM, V263, P410, DOI 10.1046/j.1432-1327.1999.00516.x; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Um M, 2006, J BIOL CHEM, V281, P5648, DOI 10.1074/jbc.M510943200; Um M, 2007, CELL SIGNAL, V19, P634, DOI 10.1016/j.cellsig.2006.08.014; Vortmeyer AO, 2003, CANCER RES, V63, P7051; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Zheng XN, 2014, GENE DEV, V28, P1429, DOI 10.1101/gad.242131.114	57	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7357	7372		10.1074/jbc.M115.694562	http://dx.doi.org/10.1074/jbc.M115.694562			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26846855	Green Published, hybrid			2022-12-26	WOS:000383447600013
J	Schultheiss, M; Schnichels, S; Hermann, T; Hurst, J; Feldkaemper, M; Arango-Gonzalez, B; Ueffing, M; Bartz-Schmidt, KU; Zeck, G; Spitzer, MS				Schultheiss, Maximilian; Schnichels, Sven; Hermann, Thoralf; Hurst, Jose; Feldkaemper, Marita; Arango-Gonzalez, Blanca; Ueffing, Marius; Bartz-Schmidt, Karl U.; Zeck, Guenther; Spitzer, Martin S.			Hypothermia Protects and Prolongs the Tolerance Time of Retinal Ganglion Cells against Ischemia	PLOS ONE			English	Article							LOCAL INTRAARTERIAL FIBRINOLYSIS; TISSUE-PLASMINOGEN ACTIVATOR; ARTERY-OCCLUSION; STROKE; RECOVERY; DAMAGE; TRIAL	Purpose Hypothermia has been shown to be neuroprotective in the therapy of ischemic stroke in the brain. To date no studies exist on the level of the inner retina and it is unclear if hypothermia would prolong the ischemic tolerance time of retinal ganglion cells, which are decisive in many ischemic retinopathies. Methods Bovine eyes were enucleated and stored either at 21 degrees C or 37 degrees C for 100 or 340 minutes, respectively. Afterwards the globes were dissected, the retina was prepared and either the spontaneous ganglion cell responses were measured or the retina was incubated as an organotypic culture for additional 24 hours. After incubation the retina was either processed for histology (H& E and DAPI staining) or real-time PCR (Thy-1 expression) was performed. Results Hypothermia prolonged ganglion cell survival up to 340 minutes under ischemic conditions. In contrast to eyes kept at 37 degrees C the eyes stored at 21 degrees C still showed spontaneous ganglion cell spiking (56.8% versus 0%), a 5.8 fold higher Thy-1 mRNA expression (not significant, but a trend) and a preserved retinal structure after 340 minutes of ischemia. Conclusion Hypothermia protects retinal ganglion cells against ischemia and prolongs their ischemic tolerance time.	[Schultheiss, Maximilian; Schnichels, Sven; Hurst, Jose; Bartz-Schmidt, Karl U.; Spitzer, Martin S.] Univ Eye Hosp Tubingen, Ctr Ophthalmol, Tubingen, Germany; [Hermann, Thoralf; Zeck, Guenther] Univ Tubingen, Nat & Med Sci Inst, Reutlingen, Germany; [Feldkaemper, Marita; Arango-Gonzalez, Blanca; Ueffing, Marius] Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schnichels, S (corresponding author), Univ Eye Hosp Tubingen, Ctr Ophthalmol, Tubingen, Germany.	sven.schnichels@med.uni-tuebingen.de	Zeck, Günther/H-7419-2013; Arango-Gonzalez, Blanca/AAR-7427-2021	Zeck, Günther/0000-0003-3998-9883; Arango-Gonzalez, Blanca/0000-0002-9045-182X; Schnichels, Sven/0000-0002-2385-5517; Hurst, Jose/0000-0002-8697-2569; Feldkaemper, Marita Pauline/0000-0001-6938-3714				Aldrich EM, 2008, STROKE, V39, P1746, DOI 10.1161/STROKEAHA.107.505404; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Baltmr A, 2010, EXP EYE RES, V91, P554, DOI 10.1016/j.exer.2010.08.009; Beatty S, 2000, BRIT J OPHTHALMOL, V84, P914, DOI 10.1136/bjo.84.8.914; Brandt SK, 2010, NEUROSCIENCE; Chen CS, 2011, STROKE, V42, P2229, DOI 10.1161/STROKEAHA.111.613653; Gumbinger C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3429; Hattenrach LO, 2008, AM J OPHTHALMOL, V146, P700, DOI 10.1016/j.ajo.2008.06.016; Hayreh SS, 2004, EXP EYE RES, V78, P723, DOI 10.1016/S0014-4835(03)00214-8; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nash MS, 1999, INVEST OPHTH VIS SCI, V40, P1293; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinones-Hinojosa A, 2003, NEUROSURGERY, V52, P1178, DOI 10.1227/01.NEU.0000057836.64972.A0; Salido EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061656; Schumacher M, 2010, OPHTHALMOLOGY, V117, P1367, DOI 10.1016/j.ophtha.2010.03.061; Stevens WD, 2002, STROKE, V33, P1107, DOI 10.1161/01.STR.0000014204.05597.0C; Stutzki H, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00038; Tamai K, 1997, BRIT J OPHTHALMOL, V81, P789, DOI 10.1136/bjo.81.9.789; Terao Y, 2009, NEUROSCI RES, V64, P75, DOI 10.1016/j.neures.2009.01.017; Wang XD, 2002, NEUROL RES, V24, P730, DOI 10.1179/016164102101200663; Wu TC, 2013, LANCET NEUROL, V12, P275, DOI 10.1016/S1474-4422(13)70013-9; Zeitler R, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3672224	23	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148616	10.1371/journal.pone.0148616	http://dx.doi.org/10.1371/journal.pone.0148616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848953	Green Submitted, gold, Green Published			2022-12-26	WOS:000369554000137
J	Macintosh, AA; Pinhasi, R; Stock, JT				Macintosh, Alison A.; Pinhasi, Ron; Stock, Jay T.			Early Life Conditions and Physiological Stress following the Transition to Farming in Central/Southeast Europe: Skeletal Growth Impairment and 6000 Years of Gradual Recovery	PLOS ONE			English	Article							BODY-MASS ESTIMATION; CATCH-UP GROWTH; HUMAN-POPULATIONS; SEX-DIFFERENCES; SECULAR CHANGE; AMERICAN-BORN; LONG BONES; ENVIRONMENTAL-INFLUENCES; SIMILAR-TO-6150 YEARS; NEOLITHIC SETTLEMENT	Early life conditions play an important role in determining adult body size. In particular, childhood malnutrition and disease can elicit growth delays and affect adult body size if severe or prolonged enough. In the earliest stages of farming, skeletal growth impairment and small adult body size are often documented relative to hunter-gatherer groups, though this pattern is regionally variable. In Central/Southeast Europe, it is unclear how early life stress, growth history, and adult body size were impacted by the introduction of agriculture and ensuing long-term demographic, social, and behavioral change. The current study assesses this impact through the reconstruction and analysis of mean stature, body mass, limb proportion indices, and sexual dimorphism among 407 skeletally mature men and women from foraging and farming populations spanning the Late Mesolithic through Early Medieval periods in Central/Southeast Europe (similar to 7100 calBC to 850 AD). Results document significantly reduced mean stature, body mass, and crural index in Neolithic agriculturalists relative both to Late Mesolithic hunter-gatherer-fishers and to later farming populations. This indication of relative growth impairment in the Neolithic, particularly among women, is supported by existing evidence of high developmental stress, intensive physical activity, and variable access to animal protein in these early agricultural populations. Among subsequent agriculturalists, temporal increases in mean stature, body mass, and crural index were more pronounced among Central European women, driving declines in the magnitude of sexual dimorphism through time. Overall, results suggest that the transition to agriculture in Central/Southeast Europe was challenging for early farming populations, but was followed by gradual amelioration across thousands of years, particularly among Central European women. This sex difference may be indicative, in part, of greater temporal variation in the social status afforded to young girls, in their access to resources during growth, and/or in their health status than was experienced by men.	[Macintosh, Alison A.; Stock, Jay T.] Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, PAVE Res Grp, Cambridge, England; [Pinhasi, Ron] Univ Coll Dublin, Earth Inst & Sch Archaeol, Newman Bldg, Dublin 2, Ireland	University of Cambridge; University College Dublin	Macintosh, AA (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, PAVE Res Grp, Cambridge, England.	am2028@cam.ac.uk	Stock, Jay T/B-6453-2011; Pinhasi, Ron/AAT-1531-2020	Stock, Jay T/0000-0003-0147-8631; Pinhasi, Ron/0000-0003-1629-8131; Murray, Alison/0000-0003-2914-5206	Cambridge Commonwealth, European and International Trust; Social Sciences and Humanities Research Council of Canada; European Research Council (ERC) [ERC-2010-StG263441]; Natural Environment Research Council (NERC) [NE/M/S/2003/00069]	Cambridge Commonwealth, European and International Trust; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); European Research Council (ERC)(European Research Council (ERC)European Commission); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by funding from the Cambridge Commonwealth, European and International Trust (AAPM), the Social Sciences and Humanities Research Council of Canada (AAPM), the European Research Council (RP; ERC Starting Grant, ERC-2010-StG263441), and the Natural Environment Research Council (JTS; NERC Grant Number NE/M/S/2003/00069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 1999, J NUTR, V129, P1140, DOI 10.1093/jn/129.6.1140; ALBERMAN E, 1991, ANN HUM BIOL, V18, P127, DOI 10.1080/03014469100001472; Alfonso MP, 2007, ANCIENT HLTH SKELETA, P113; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Ameen S, 2005, SKELETAL RADIOL, V34, P279, DOI 10.1007/s00256-004-0841-3; Angel, 1984, PALEOPATHOLOGY ORIGI, P51; Auerbach BM, 2011, AM J PHYS ANTHROPOL, V144, P382, DOI 10.1002/ajpa.21418; Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; Auerbach BM, 2004, AM J PHYS ANTHROPOL, V125, P331, DOI 10.1002/ajpa.20032; Bakker JA, 1999, ANTIQUITY, V73, P778, DOI 10.1017/S0003598X00065522; Banffy E., 2010, NEOLITHISIERUNG MITT, P255; Banner J, 1956, DIE PECELER KULTUR; Bartelheim Martin, 2009, STUDIES HONOUR BARBA, V169, P3446; Bass S, 2000, J PEDIATR-US, V136, P149, DOI 10.1016/S0022-3476(00)70094-1; Bentley RA, 2012, P NATL ACAD SCI USA, V109, P9326, DOI 10.1073/pnas.1113710109; Bentley RA, 2013, 1 FARMERS CENTRAL EU, P251; Berner M, 2012, AM J PHYS ANTHROPOL, V147, P98; Bickle Penny, 2013, 1 FARMERS CENTRAL EU, P101; Bigoni L, 2013, AM J PHYS ANTHROPOL, V150, P349, DOI 10.1002/ajpa.22210; Bocquet-Appel JP, 2009, J ARCHAEOL SCI, V36, P807, DOI 10.1016/j.jas.2008.11.004; Bogin B, 2003, COMP BIOCHEM PHYS A, V136, P71, DOI 10.1016/S1095-6433(02)00294-5; Bogin B, 2002, AM J HUM BIOL, V14, P753, DOI 10.1002/ajhb.10092; Bonsall C, 2004, RADIOCARBON, V46, P293, DOI 10.1017/S0033822200039606; Bonsall C., 2000, DOC PRAEHIST, V27, P119; Bonsall C., 1997, J EUROPEAN ARCHAEOLO, V5, P50, DOI DOI 10.1179/096576697800703575; Bonsall C, 2015, RADIOCARBON, V57, P33, DOI 10.2458/azu_rc.57.18188; Boric D, 2002, ANTIQUITY, V76, P1026, DOI 10.1017/S0003598X00091833; Boric D., 2004, EUR J ARCHAEOL, V7, P221, DOI DOI 10.1177/1461957104056500; Boric D., 2007, STARINAR, V57, P9; Boric D., 2007, DOCUMENTA PRAEHISTOR, V34, P53, DOI DOI 10.4312/DP.34.5; Boric D, 2006, CULTURAL CONTINUTIES; Boric D., 2011, BEGINNINGS NEW RES A, P157; Boric D, 2014, J FIELD ARCHAEOL, V39, P4, DOI 10.1179/0093469013Z.00000000070; Boric Dusan., 2009, METALS SOC STUDIES H, P191; BOTTEMA S, 1982, J ARCHAEOL SCI, V9, P221, DOI 10.1016/0305-4403(82)90020-6; Buikstra JE, 1994, ARKANSAS ARACHEOLOGI, V44; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; CHAKRABORTY R, 1982, AM J PHYS ANTHROPOL, V59, P295, DOI 10.1002/ajpa.1330590309; Cizmarova J, 2006, DOSSIERS ARAHCEOLOGI, P26; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coles J.M, 1979, BRONZE AGE EUROPE IN; Constantini N. W., 1997, Medicine and Science in Sports and Exercise, V29, pS150; Cook DC, 1984, PALEOPATHOLOGY ORIGI, P235; Cutler GB, 1997, J STEROID BIOCHEM, V61, P3; Dani J, 2001, BRONZEZEITLICHE KULT, P93; Dezso G, 1966, ANTHROPOL HUNG, VVII, P36; Drozdova E, 2011, RESULTS ANTHR SURVEY; Dubois L, 2007, TWIN RES HUM GENET, V10, P479, DOI 10.1375/twin.10.3.479; Dziegielewski K., 2010, MIGRATION BRONZE EAR, V63, P121; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Eveleth PB, 1990, WORLDWIDE VARIATION; Fischl KP., 2013, 1600 KULTURELLER UMB, P355; Frayer D. W., 2004, ANTHROPOLOGIE, V42, P71; Freedman DS, 2000, ARCH PEDIAT ADOL MED, V154, P155, DOI 10.1001/archpedi.154.2.155; Frelat MA, 2011, AM J HUM BIOL, V23, P796, DOI 10.1002/ajhb.21217; Frey Otto-Herman, 2004, P ROY IRISH ACAD, V104C, P104; Friesinger H, 1972, ARCHA, V51, P113; Frisancho A. Roberto, 2001, Acta Medica Auxologica (Milan), V33, P47; Galvani AP, 2005, MICROBES INFECT, V7, P302, DOI 10.1016/j.micinf.2004.12.006; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Garasanin M, 2001, ANTIQUITY, V75, P118, DOI 10.1017/S0003598X00052819; GOLDEN MHN, 1994, EUR J CLIN NUTR, V48, pS58; Greenfield HJ, 2001, ENCY PREHISTORY, V4, P124; GREULICH WW, 1957, AM J PHYS ANTHROPOL, V15, P489, DOI 10.1002/ajpa.1330150403; GREULICH WW, 1976, AM J PHYS ANTHROPOL, V45, P553, DOI 10.1002/ajpa.1330450320; Gronkiewicz L, 2001, PRZEGLAD ATHR ANTHR, V64, P73; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haapasalo H, 1996, J BONE MINER RES, V11, P864; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Harding A, 2002, EUROPEAN PREHISTORY, P271; Havelkova P, 2011, INT J OSTEOARCHAEOL, V21, P487, DOI 10.1002/oa.1164; Herold M, 2008, THESIS U WIEN; Hofmann, 2009, CREATING COMMUNITIES, P142; Holden C, 2009, HUM BIOL, V81, P597, DOI 10.3378/027.081.0609; Holliday TW, 2010, AM J PHYS ANTHROPOL, V142, P287, DOI 10.1002/ajpa.21226; Holliday TW, 1997, AM J PHYS ANTHROPOL, V104, P245, DOI 10.1002/(SICI)1096-8644(199710)104:2<245::AID-AJPA10>3.3.CO;2-8; Holliday TW, 1997, J HUM EVOL, V32, P423, DOI 10.1006/jhev.1996.0111; Holliday TW, 2001, AM J PHYS ANTHROPOL, V116, P26, DOI 10.1002/ajpa.1098; Holliday TW, 1999, J HUM EVOL, V36, P549, DOI 10.1006/jhev.1998.0289; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; JANSSON JO, 1983, AM J PHYSIOL, V244, pE135, DOI 10.1152/ajpendo.1983.244.2.E135; Jantz LM, 1999, AM J PHYS ANTHROPOL, V110, P57, DOI 10.1002/(SICI)1096-8644(199909)110:1<57::AID-AJPA5>3.0.CO;2-1; Jarosova I, 2008, ANTHROPOL-INT J HUM, V46, P175; Jelenkovic A, 2011, AM J HUM BIOL, V23, P764, DOI 10.1002/ajhb.21208; JENKINS CL, 1981, AM J PHYS ANTHROPOL, V56, P169, DOI 10.1002/ajpa.1330560208; Jeunesse C., 1997, PRATIQUES FUNERAIRES; Jochim M, 2002, EUROPEAN PREHISTORY, P115; Kala J, 2008, ACTA ARCHAEOLOGICA O, P61; Kalicz N, 1976, SOV ARCHEOL, V2, P106; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; KUH DL, 1991, INT J EPIDEMIOL, V20, P1001, DOI 10.1093/ije/20.4.1001; Kujanova M, 2008, INT J OSTEOARCHAEOL, V18, P476, DOI 10.1002/oa.958; Kuster H, 1992, BAUERN BAYERN ANFANG, P137; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; Lasker GW, 1946, AM J PHYS ANTHROP-NE, V4, P273, DOI 10.1002/ajpa.1330040310; Le Huray JD, 2005, J ANTHROPOL ARCHAEOL, V24, P135, DOI 10.1016/j.jaa.2004.09.002; Le Huray Jonathan D, 2009, Acta Univ Carol Med Monogr, V156, P145; Leonard WR, 2000, AM J HUM BIOL, V12, P825, DOI 10.1002/1520-6300(200011/12)12:6<825::AID-AJHB10>3.3.CO;2-5; Li L, 2004, AM J CLIN NUTR, V80, P185; Lillie M, 2008, ANTHROPOL-INT J HUM, V46, P135; LINDHOLM C, 1994, ACTA OBSTET GYN SCAN, V73, P269, DOI 10.3109/00016349409023452; Livshits G, 2002, ANN HUM BIOL, V29, P271, DOI 10.1080/03014460110085322; Macintosh AA, 2014, J ARCHAEOL SCI, V52, P376, DOI 10.1016/j.jas.2014.09.001; Macintosh AA, 2015, AM J PHYS ANTHROPOL, V157, P260, DOI 10.1002/ajpa.22710; Macintosh AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112116; Macklin, 2002, FARMING, V3, P1, DOI [10.3828/bfarm.2002.3-4.2, DOI 10.3828/BFARM.2002.3-4.2]; Martin R., 1928, LEHRBUCH ANTHR; Martin R, 1957, LEHBRBUCH ANTHR SYST; MARTORELL R, 1988, HUM BIOL, V60, P205; Mascie-Taylor CGN, 2010, SOC ST HUM, V49, P239; Mathieson I, 2015, BIORXIV; Mauras N, 1996, HORM RES, V45, P74, DOI 10.1159/000184763; MEADOWS L, 1995, J FORENSIC SCI, V40, P762; Meiklejohn C., 1984, PALEOPATHOLOGY ORIGI, P75; Meiklejohn C, 1991, BAR INT SERIES, V567, P129; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Milasinovic L, 2009, REV POSSIBILITY SOCI, P65; Milisauskas S, 2002, EUROPEAN PREHISTORY, P143; Morris DH, 2012, AM J HUM BIOL, V24, P22, DOI 10.1002/ajhb.21230; Muller HH, 1964, HAUSTIERE MITTELDEUT; Mummert A, 2011, ECON HUM BIOL, V9, P284, DOI 10.1016/j.ehb.2011.03.004; Nemejcova-Pavukova V, 1973, S ENTST CHRON BAD KU, P297; NICKENS PR, 1976, J ARCHAEOL SCI, V3, P31, DOI 10.1016/0305-4403(76)90029-7; Nikitovic D, 2014, AM J HUM BIOL, V26, P117, DOI 10.1002/ajhb.22492; Olalde I, 2015, MODERN HUMANS PALEOG, V1; Pankowska A, 2009, ANTHROPOL-INT J HUM, V47, P215; Peng Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-15; Pettitt P, 2008, ANTHROPOL-INT J HUM, V46, P125; Pinhasi R, 2005, AM J HUM BIOL, V17, P470, DOI 10.1002/ajhb.20406; Pinhasi R, 2008, ADV HUMAN PALAEOPATH, P31; Pinhasi R, 2011, HUMAN BIOARCHAEOLOGY OF THE TRANSITION TO AGRICULTURE, P177; Piontek J., 2012, INTERDISCIPLINARIA A, V3, P23, DOI DOI 10.24916/IANSA.2012.1.2; Podborsky V., 1993, PRAVEKE DEJINY MORAV, V3rd; PRADER A, 1963, J PEDIATR-US, V62, P646, DOI 10.1016/S0022-3476(63)80035-9; Price T., 2003, FUNDBERICHTE BADEN W, P23; Raczky P, 2009, INTERACTIONS DIFFERE, P31; Radovanovic I, 1996, ARCHAEOLOGICAL SERIE, V11; Rathbun TA, 1984, PALEOPATHOLOGY ORIGI, P137; RELETHFORD JH, 1985, AM J PHYS ANTHROPOL, V66, P55, DOI 10.1002/ajpa.1330660105; Richards MP, 2008, ANTHROPOL-INT J HUM, V46, P185; Rosch M, 2008, VEG HIST ARCHAEOBOT, V17, pS225, DOI 10.1007/s00334-008-0184-4; Roksandic M, 2012, ADV ANTHR, V2, P117; Rolle R, 1989, WORLD SCYTHIANS; Ruff C, 2002, ANNU REV ANTHROPOL, V31, P211, DOI 10.1146/annurev.anthro.31.040402.085407; RUFF CB, 1991, J HUM EVOL, V21, P81, DOI 10.1016/0047-2484(91)90001-C; RUFF CB, 1984, AM J PHYS ANTHROPOL, V64, P125, DOI 10.1002/ajpa.1330640205; RUFF CB, 1981, HUM BIOL, V53, P69; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Ruff CB, 2012, AM J PHYS ANTHROPOL, V148, P601, DOI 10.1002/ajpa.22087; Scheeres M, 2014, AM J PHYS ANTHROPOL, V155, P496, DOI 10.1002/ajpa.22597; Schutkowski H, 1999, J ARCHAEOL SCI, V26, P675, DOI 10.1006/jasc.1998.0384; Schutkowski H., 1995, FGR HUM EVOL, V10, P119, DOI DOI 10.1007/BF02437535; Sherratt A., 2006, PREMIERS CHARIOTS PR, V29, p329 ; Shin DH, 2012, AM J PHYS ANTHROPOL, V147, P433, DOI 10.1002/ajpa.22011; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Silventoinen K, 2007, TWIN RES HUM GENET, V10, P354, DOI 10.1375/twin.10.2.354; Smrcka V, 2008, STUDIEN BURGWALL MIK, VVIII, P169; Smrcka V, 2007, SLUZBACH ARCHEOLOGIE, V2, P110; Smrcka V, 2006, SLUZBACH ARCHEOLOGIE, V7, P329; Smrcka V, 2005, ANTHROPOL-INT J HUM, V43, P315; Sosna D, 2007, 1621 FLOR STAT U; Larsen CS, 2006, QUATERN INT, V150, P12, DOI 10.1016/j.quaint.2006.01.004; Srejovic D, 1978, SERBIAN ACAD SCI ART, V5; Starling AP, 2007, AM J PHYS ANTHROPOL, V134, P520, DOI 10.1002/ajpa.20700; STINI WA, 1969, AM J PHYS ANTHROPOL, V31, P417, DOI 10.1002/ajpa.1330310316; STINSON S, 1985, YEARB PHYS ANTHROPOL, V28, P123, DOI 10.1002/ajpa.1330280507; Stinson S., 2012, HUMAN BIOL EVOLUTION, P587, DOI [10.1002/9781118108062.ch12, DOI 10.1002/9781118108062.CH12]; Stock JT, 2011, HUMAN BIOARCHAEOLOGY OF THE TRANSITION TO AGRICULTURE, P347; Stranska P, 2015, ARCH ORAL BIOL, V60, P62, DOI 10.1016/j.archoralbio.2014.08.002; TANNER JM, 1982, ANN HUM BIOL, V9, P411, DOI 10.1080/03014468200005951; Tanner JM, 1989, OETUS MAN PHYS GROWT; Tasic N, 2003, STARINAR, V53-54, P25; Tasic N., 1972, ARCHAEOLOGIA IUGOSLA, V13, P27; Tasic N, 2004, BALCANICA, VXXXV, P5; Temple DH, 2011, AM J PHYS ANTHROPOL, V145, P415, DOI 10.1002/ajpa.21515; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Toomay Douglas Michele, 2007, ANCIENT HLTH SKELETA, P300; Trotter M, 1952, AM J PHYS ANTHROP-NE, V10, P463, DOI 10.1002/ajpa.1330100407; Trotter M, 1951, AM J PHYS ANTHROP-NE, V9, P427, DOI 10.1002/ajpa.1330090404; TUPMAN GS, 1962, J BONE JOINT SURG BR, V44, P42, DOI 10.1302/0301-620X.44B1.42; Tveit-Milligan P, 1993, SPORTS MED TRAIN REH, V4, P47; Ubelaker DH, 1998, INT J OSTEOARCHAEOL, V8, P231, DOI 10.1002/(SICI)1099-1212(199807/08)8:4<231::AID-OA423>3.3.CO;2-2; Ubelaker DH, 1996, ANN HIST NAT MUS HUN, V88, P271; VANZEIST W, 1975, J ARCHAEOL SCI, V2, P315, DOI 10.1016/0305-4403(75)90004-7; Vercellotti G, 2012, AM J PHYS ANTHROPOL, V147, P113, DOI 10.1002/ajpa.21636; Vercellotti G, 2011, AM J PHYS ANTHROPOL, V145, P203, DOI 10.1002/ajpa.21486; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Wallduck RJ, 2013, THESIS U CAMBRIDGE; Wells PS, 2002, EUROPEAN PREHISTORY, P335; Welte B, 2010, FUNDBERICHTE BADEN W, V31, P7; Whittle A., 1996, EUROPE NEOLITHIC CRE; Whittle A, 2013, 1 FARMERS CENTRAL EU, P49; Zakrzewski SR, 2007, AM J PHYS ANTHROPOL, V132, P501, DOI 10.1002/ajpa.20569; Zelditch Miriam Leah, 2005, P249, DOI 10.1016/B978-012088777-4/50014-4; Zoffmann ZK, 2011, RAD MUZEJA VOJVODINE, V53, P93; Zvelebil M, 2013, J ANTHROPOL ARCHAEOL, V32, P313, DOI 10.1016/j.jaa.2012.01.011; Zvelebil M, 2008, ANTHROPOL-INT J HUM, V46, P195	202	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148468	10.1371/journal.pone.0148468	http://dx.doi.org/10.1371/journal.pone.0148468			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26844892	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800061
J	Lamichhane, JR; Bartoli, C; Varvaro, L				Lamichhane, Jay Ram; Bartoli, Claudia; Varvaro, Leonardo			Extensive Field Survey, Laboratory and Greenhouse Studies Reveal Complex Nature of Pseudomonas syringae-Associated Hazelnut Decline in Central Italy	PLOS ONE			English	Article							BACTERIUM CAUSING CANKER; PV AVELLANAE; CORYLUS-AVELLANA; LEAF-SPOT; DISEASE; NOV; EVOLUTION; OUTBREAK; TREES	Pseudomonas avellanae (Pav) has been reported as the causal agent of bacterial decline and bacterial canker of hazelnut in Italy and Greece, respectively. Both hazelnut diseases were reported to be similar in terms of symptoms, severity and persistence. In this study, we found that both symptomatic and asymptomatic trees in the field were colonized by Pav. Multilocus Sequence Typing (MLST) analysis showed that Pav strains isolated during this study in Italy belong to the P. syringae phylogroup 1 and they are closely related to Pav strains previously isolated in Greece from hazelnut bacterial canker. On the other hand, strains isolated in earlier studies from hazelnut decline in Italy belong to both phylogroup 1 and 2 of P. syringae. Both phylogroup 1 strains of P. syringae from Greece and Italy are different than strains isolated in this study in terms of their capacity to excrete fluorescent pigments on different media. Despite the same plant genotype and cropping practices adopted, the incidence of hazelnut decline ranged from nearly 0 to 91% across our study sites. No disease developed on plants inoculated with Pav through wounding while leaf scar inoculations produced only mild disease symptoms. Based on our results and the previously reported correlation between pedo-climatic conditions and hazelnut decline, we conclude that hazelnut decline in central Italy could be incited by a combination of predisposing (adverse pedo-climatic conditions) and contributing factors (Pav). Because this is a true decline different from "bacterial canker" described in Greece, we refer to it as hazelnut decline (HD).	[Lamichhane, Jay Ram; Bartoli, Claudia; Varvaro, Leonardo] Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy; [Lamichhane, Jay Ram; Varvaro, Leonardo] Hazelnut Res Ctr, Viterbo, Italy; [Lamichhane, Jay Ram] INRA, UAR Ecoinnov 1240, BP 01, F-78850 Thiverval Grignon, France; [Bartoli, Claudia] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Bartoli, Claudia] CNRS, LIPM, UMR2594, Castanet Tolosan, France	Tuscia University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse	Lamichhane, JR (corresponding author), Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy.; Lamichhane, JR (corresponding author), Hazelnut Res Ctr, Viterbo, Italy.; Lamichhane, JR (corresponding author), INRA, UAR Ecoinnov 1240, BP 01, F-78850 Thiverval Grignon, France.	jayram.lamichhane@gmail.com	Bartoli, Claudia/F-4961-2017	Bartoli, Claudia/0000-0003-1461-2983; Lamichhane, Jay Ram/0000-0001-9780-0941				Aloj B, 1987, INF AGRARIO, V26, P55; Aloj B., 1994, INFORM AGRARIO, V10, P65; Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002; Bartoli C, 2015, MOL PLANT PATHOL, V16, P137, DOI 10.1111/mpp.12167; Berge O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105547; CROSSE JE, 1966, ANN APPL BIOL, V58, P31, DOI 10.1111/j.1744-7348.1966.tb05068.x; Destefano SAL, 2010, PLANT PATHOL, V59, P1162, DOI 10.1111/j.1365-3059.2010.02357.x; Fabi A, 2005, ACTA HORTIC, P427, DOI 10.17660/ActaHortic.2005.686.59; Fabi A, 2009, ACTA HORTIC, V845, P507, DOI 10.17660/ActaHortic.2009.845.78; Fabi A, 2003, J PLANT PATHOL, V85, P282; GOTO M, 1983, INT J SYST BACTERIOL, V33, P546, DOI 10.1099/00207713-33-3-546; HUTCHINSON P. B., 1949, NEW ZEALAND JOUR SCI AND TECHNOL, V30, P274; Janse JD, 1996, SYST APPL MICROBIOL, V19, P589, DOI 10.1016/S0723-2020(96)80030-0; KING EO, 1954, J LAB CLIN MED, V44, P301; KOVACS N, 1956, NATURE, V178, P703, DOI 10.1038/178703a0; Lamichhane JR, 2013, PLANT PATHOL, V62, P624, DOI 10.1111/j.1365-3059.2012.02670.x; Lamichhane JR, 2014, ADV AGRON, V126, P235, DOI 10.1016/B978-0-12-800132-5.00004-3; Lamichhane JR, 2014, PHYTOPATHOLOGY, V104, P387, DOI 10.1094/PHYTO-05-13-0136-R; Lamichhane JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056298; Lelliot R.A., 1987, METHODS PLANT PATHOL, V2; Lindow S.E, 1990, METHODS PHYTOBACTERI, P428; Loreti S, 2009, J PLANT PATHOL, V91, P365; LUISETTI J, 1972, Annales de Phytopathologie, V4, P295; Marcelletti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131112; Me G, 2006, PETRIA, V16, P7; Mertelik J, 2013, FOREST PATHOL, V43, P165, DOI 10.1111/efp.12021; Mirik M, 2005, PLANT PATHOL, V54, P238, DOI 10.1111/j.1365-3059.2005.01134.x; O'Brien HE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-141; PSALLIDAS PG, 1979, PHYTOPATHOL Z, V94, P103; PSALLIDAS PG, 1993, PLANT PATHOL, V42, P358, DOI 10.1111/j.1365-3059.1993.tb01512.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakamoto Y., 1999, J FOR RES, V4, P281; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Scortichini M., 1999, Journal of Plant Pathology, V81, P55; Scortichini M, 1996, J PHYTOPATHOL, V144, P215, DOI 10.1111/j.1439-0434.1996.tb01517.x; SCORTICHINI M, 1994, J PHYTOPATHOL, V140, P65, DOI 10.1111/j.1439-0434.1994.tb00177.x; Scortichini M, 2012, MOL PLANT PATHOL, V13, P631, DOI 10.1111/j.1364-3703.2012.00788.x; SEEM RC, 1984, ANNU REV PHYTOPATHOL, V22, P133, DOI 10.1146/annurev.py.22.090184.001025; Tacconi R, 1991, FRUTTICOLTURA, V7, P41; Varvaro L., 1994, Acta Horticulturae, P559; Varvaro L, 1993, INF FITOPATOL, V2, P54; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Wang PW, 2007, MICROBIOL-SGM, V153, P2067, DOI 10.1099/mic.0.2006/001545-0; WHITBREAD R, 1967, ANN APPL BIOL, V59, P123, DOI 10.1111/j.1744-7348.1967.tb04423.x; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	45	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147584	10.1371/journal.pone.0147584	http://dx.doi.org/10.1371/journal.pone.0147584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840951	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200048
J	Novoa, A; Talley, TS; Talley, DM; Crooks, JA; Reyns, NB				Novoa, Anai; Talley, Theresa S.; Talley, Drew M.; Crooks, Jeffrey A.; Reyns, Nathalie B.			Spatial and Temporal Examination of Bivalve Communities in Several Estuaries of Southern California and Northern Baja California, MX	PLOS ONE			English	Article							LAND-USE; PATTERNS; COASTAL; BAY; ASSEMBLAGES; PREDATION; ABUNDANCE; DECLINES; IMPACTS; MUSSEL	A combination of historical bivalve surveys spanning 30-50 years and contemporary sampling were used to document the changes in bivalve community structure over time at four southern California and one northern Baja California estuaries. While there are limitations to the interpretation of historic data, we observed generally similar trends of reduced total bivalve species richness, losses of relatively large and/or deeper-dwelling natives, and gains of relatively small, surface dwelling introduced species across the southern California estuaries, despite fairly distinct bivalve communities. A nearly 50-year absence of bivalves from two wetlands surveyed in a Baja California estuary continued. A combination of site history and current characteristics (e.g., location, depth) likely contributes to maintenance of distinct communities, and both episodic and gradual environmental changes likely contribute to within-estuary temporal shifts (or absences). We highlight future research needed to determine mechanisms underlying patterns so that we can better predict responses of bivalve communities to future scenarios, including climate change and restoration.	[Novoa, Anai; Talley, Drew M.; Reyns, Nathalie B.] Univ San Diego, Dept Environm & Ocean Sci, San Diego, CA 92110 USA; [Talley, Theresa S.] Univ Calif San Diego, Scripps Inst Oceanog, Dept Calif Sea Grant Extens Program, La Jolla, CA 92093 USA; [Crooks, Jeffrey A.] Dept Tijuana River Natl Estuarine Res Reserve, Imperial Beach, CA USA	University of San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Novoa, A (corresponding author), Univ San Diego, Dept Environm & Ocean Sci, San Diego, CA 92110 USA.	anovoa@sandiego.edu	Reyns, Nathalie/P-1242-2016; Talley, Drew/M-7872-2019	Reyns, Nathalie/0000-0002-9967-0199; 	California Sea Grant [A/EA-AR-37]	California Sea Grant	No external funding was received for this study. Some resources (supplies and research assistance) were donated by T.S. Talley through California Sea Grant Project A/EA-AR-37, and D.M. Talley and N. Reyns through Environmental and Ocean Sciences at University of San Diego. The statements, findings, conclusions and recommendations are those of the researchers and do not necessarily reflect the views of the aforementioned organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Beller E.E., 2014, SFEI PUBLICATION, V#722; Bendell LI, 2014, ESTUAR COAST, V37, P369, DOI 10.1007/s12237-013-9677-1; Boesch DF, 2000, BIOLOGICAL RESOURCE MANAGEMENT: CONNECTING SCIENCE AND POLICY, P93; BOURNE N, 1982, Journal of Shellfish Research, V2, P47; Bradshaw J, 1968, REPORT ECOLOGICAL RE; Byers JE, 2005, ECOLOGY, V86, P487, DOI 10.1890/03-0580; Calabretta CJ, 2008, MAR POLLUT BULL, V56, P1680, DOI 10.1016/j.marpolbul.2008.07.012; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coan EV, 2000, SANTA BARBARA MUSEUM; Colwell RK, 2013, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Corbin JD, 2012, INVAS PLANT SCI MANA, V5, P117, DOI 10.1614/IPSM-D-11-00005.1; Crooks JA, 1999, J EXP MAR BIOL ECOL, V240, P53, DOI 10.1016/S0022-0981(99)00041-6; Crooks Jeffrey A., 2001, Biological Invasions, V3, P23, DOI 10.1023/A:1011404914338; Dauer DM, 2000, ESTUARIES, V23, P80, DOI 10.2307/1353227; Desmond JS, 2002, ESTUARIES, V25, P552, DOI 10.1007/BF02804890; Dexter Deborah M., 2000, Bulletin Southern California Academy of Sciences, V99, P128; Dudas SE, 2005, J EXP MAR BIOL ECOL, V325, P8, DOI 10.1016/j.jembe.2005.04.015; Duggan RM, 1989, THESIS SAN DIEGO STA; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Hechinger R. F., 2011, Ecology, V92, P791, DOI 10.1890/10-1383.1; Herring ML, 1991, KENDALL FROST MISSIO; HOFFMAN EJ, 1984, ENVIRON SCI TECHNOL, V18, P580, DOI 10.1021/es00126a003; Hosmer SC, 1977, THESIS SAN DIEGO STA; Houlahan JE, 2006, WETLANDS, V26, P79, DOI 10.1672/0277-5212(2006)26[79:TEOALU]2.0.CO;2; Kittinger J.N., 2014, MARINE HIST ECOLOGY; Kramer GW, 1976, THESIS HUMBOLDT STAT; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; Leet WS, 2001, UC D ANR PUB, P435; LEVIN LA, 1984, ECOLOGY, V65, P1185, DOI 10.2307/1938326; Lewis TL, 2007, MAR ECOL PROG SER, V329, P131, DOI 10.3354/meps329131; Ma AP, 1987, 821178 US FISH WILDL, V82; MACDONALD KB, 1969, ECOL MONOGR, V39, P33, DOI 10.2307/1948564; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; MARCUS L, 1989, COASTAL WETLANDS SAN; Melillo JM, 2014, CLIMATE CHANGE IMPAC, V841, DOI DOI 10.7930/J0Z31WJ2; Miller J.N., 1966, THESIS U CALIFORNIA; MORRISON R, 1930, THESIS U SO CALIFORN; Morrison RL, 1952, ANN REPORT, P32; NORDBY CS, 1991, ESTUARIES, V14, P80, DOI 10.2307/1351985; Nordby CS, 1986, 8575 US FISH WILDL S, V85; Novoa A, 2014, THESIS U SAN DIEGO; Onuf CP, 1987, 85715 US FISH WILDL, V85; PETERSON CH, 1985, PALEOBIOLOGY, V11, P139; PETERSON CH, 1975, ECOLOGY, V56, P958, DOI 10.2307/1936306; Phleger FB, 1969, LAGUNAS COSTERAS S, P319; Pranovi F, 2006, BIOL INVASIONS, V8, P595, DOI 10.1007/s10530-005-1602-5; R Core Team, 2021, R LANGUAGE ENV STAT; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; SAS Institute Inc, 1989, JMP VERS 12 0 1; Schiff K, 2004, ENVIRON TOXICOL CHEM, V23, P1815, DOI 10.1897/03-401; Seitz RD, 2011, INTEGR COMP BIOL, V51, P598, DOI 10.1093/icb/icr098; Smith JR, 2006, ECOLOGY, V87, P1153, DOI 10.1890/0012-9658(2006)87[1153:DDIMBC]2.0.CO;2; Stein ED, 2014, 826 SO CAL COAST WAT; Strayer DL, 1999, BIOSCIENCE, V49, P19, DOI 10.2307/1313490; Talley DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118891; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Tuskes Paul M., 2012, Festivus, V44, P13; van der Zee EM, 2012, ECOSYSTEMS, V15, P664, DOI 10.1007/s10021-012-9538-y; Vellend M, 2013, AM J BOT, V100, P1294, DOI 10.3732/ajb.1200503; Vinagre C, 2008, J APPL ICHTHYOL, V24, P238, DOI 10.1111/j.1439-0426.2008.01055.x; Walling DE, 2006, GEOMORPHOLOGY, V79, P192, DOI 10.1016/j.geomorph.2006.06.019; Ward DH, 2003, ESTUARIES, V26, P1529, DOI 10.1007/BF02803661; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wing SR, 2011, MAR ECOL PROG SER, V422, P201, DOI 10.3354/meps08911; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; Zar J. H, 2009, BIOSTAT ANAL, P960; Zedler JB, 2001, HDB RESTORING TIDAL, P1; Zhou Y, 2006, MAR ECOL PROG SER, V317, P127, DOI 10.3354/meps317127	70	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148220	10.1371/journal.pone.0148220	http://dx.doi.org/10.1371/journal.pone.0148220			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840744	Green Published, gold			2022-12-26	WOS:000369550200100
J	Syme, RA; Tan, KC; Hane, JK; Dodhia, K; Stoll, T; Hastie, M; Furuki, E; Ellwood, SR; Williams, AH; Tan, YF; Testa, AC; Gorman, JJ; Oliver, RP				Syme, Robert A.; Tan, Kar-Chun; Hane, James K.; Dodhia, Kejal; Stoll, Thomas; Hastie, Marcus; Furuki, Eiko; Ellwood, Simon R.; Williams, Angela H.; Tan, Yew-Foon; Testa, Alison C.; Gorman, Jeffrey J.; Oliver, Richard P.			Comprehensive Annotation of the Parastagonospora nodorum Reference Genome Using Next-Generation Genomics, Transcriptomics and Proteogenomics	PLOS ONE			English	Article							STAGONOSPORA-NODORUM; NECROTROPHIC EFFECTORS; PEPTIDE IDENTIFICATION; G-ALPHA; WHEAT; PATHOGENICITY; SPORULATION; METABOLISM; DISEASE; SENSITIVITY	Parastagonospora nodorum, the causal agent of Septoria nodorum blotch (SNB), is an economically important pathogen of wheat (Triticum spp.), and a model for the study of necrotrophic pathology and genome evolution. The reference P. nodorum strain SN15 was the first Dothideomycete with a published genome sequence, and has been used as the basis for comparison within and between species. Here we present an updated reference genome assembly with corrections of SNP and indel errors in the underlying genome assembly from deep resequencing data as well as extensive manual annotation of gene models using transcriptomic and proteomic sources of evidence (https://github.com/robsyme/Parastagonospora_nodorum_SN15). The updated assembly and annotation includes 8,366 genes with modified protein sequence and 866 new genes. This study shows the benefits of using a wide variety of experimental methods allied to expert curation to generate a reliable set of gene models.	[Syme, Robert A.; Tan, Kar-Chun; Hane, James K.; Dodhia, Kejal; Furuki, Eiko; Ellwood, Simon R.; Williams, Angela H.; Testa, Alison C.; Oliver, Richard P.] Curtin Univ, Dept Environm & Agr, Ctr Crop & Dis Management, Bentley, WA, Australia; [Hane, James K.] Curtin Univ, Curtin Inst Computat, Bentley, WA, Australia; [Stoll, Thomas; Hastie, Marcus; Gorman, Jeffrey J.] QIMR Berghofer Med Res Inst, Prot Discovery Ctr, Herston, Qld, Australia; [Tan, Yew-Foon] Telethon Kids Inst, Subiaco, WA, Australia	Curtin University; Curtin University; QIMR Berghofer Medical Research Institute; Telethon Kids Institute	Oliver, RP (corresponding author), Curtin Univ, Dept Environm & Agr, Ctr Crop & Dis Management, Bentley, WA, Australia.	Richard.Oliver@curtin.edu.au	Tan, Kar-Chun/AAQ-4674-2021; Ellwood, Simon/K-2023-2013; Hane, James/A-7062-2011; Hastie, Marcus L/L-4366-2016; Williams, Angela/M-5256-2015	Tan, Kar-Chun/0000-0001-6094-823X; Ellwood, Simon/0000-0002-2673-0816; Hane, James/0000-0002-7651-0977; Hastie, Marcus L/0000-0002-8386-5549; Syme, Robert/0000-0002-8721-2350; Williams, Angela/0000-0003-0196-0022; Dodhia, Kejal/0000-0002-7891-1088; Stoll, Thomas/0000-0002-6275-3433	Australian Government National Collaborative Research Infrastructure Strategy; Education Investment Fund Super Science Initiative; Grains Research and Development Corporation [CUR00012]; Australian Government; GRDC [GRS10061]; Curtin University	Australian Government National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Education Investment Fund Super Science Initiative; Grains Research and Development Corporation(Grains R&D Corp); Australian Government(Australian GovernmentCGIAR); GRDC; Curtin University	This work was supported through access to facilities managed by BioPlatforms Australia (http://www.bioplatforms.com) and funded by the Australian Government National Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative and Grains Research and Development Corporation (http://www.grdc.com.au) research grant CUR00012. This research was undertaken with the assistance of resources provided at the NCI Specialised Facility in Bioinformatics at The University of Queensland through the National Computational Merit Allocation Scheme supported by the Australian Government and by iVEC through the use of advanced computing resources located at the Pawsey Supercomputing Centre. RAS received funding through scholarships from GRDC (GRS10061) and Curtin University (http://www.curtin.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bonnal RJ, 2012, BIOINFORMATICS; Bringans S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-301; Casey T, 2010, PROTEOMICS, V10, P38, DOI 10.1002/pmic.200900474; Chain P, 2009, SCIENCE, V326; Chevreux B, 1999, GERM C BIOINF; Chooi Yit-Heng, 2014, Mycology, V5, P192, DOI 10.1080/21501203.2014.928386; Clarke JD., 2009, COLD SPRING HARBOR P, V2009, ppdbprot5177, DOI [10.1101/pdb.prot5177, DOI 10.1101/PDB.PROT5177]; COOLEY RN, 1991, MOL GEN GENET, V228, P17; Crook AD, 2012, PHYTOPATHOLOGY, V102, P498, DOI 10.1094/PHYTO-08-11-0238; Diament BJ, 2011, J PROTEOME RES, V10, P3871, DOI 10.1021/pr101196n; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Goto N., 2010, BIOINFORMATICS; Grandaubert J, 2015, G3 GENESGENOMESGENET; Gummer JPA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-131; Haibao Tang BP, 2015, GOA TOOLS 2015; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Hane JK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004281; Hane JK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r45; Hane JK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-655; Hastie ML, 2012, MOL CELL PROTEOMICS, V11, P108, DOI 10.1074/mcp.M111.015909; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Ipcho SVS, 2012, MOL PLANT PATHOL, V13, P531, DOI 10.1111/j.1364-3703.2011.00770.x; Ipcho SVS, 2010, EUKARYOT CELL, V9, P1100, DOI 10.1128/EC.00064-10; Jin YJ, 1997, J BIOL CHEM, V272, P7352, DOI 10.1074/jbc.272.11.7352; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93; Lees JG, 2014, NUCLEIC ACIDS RES, V42, pD240, DOI 10.1093/nar/gkt1205; Liu ZH, 2004, PHYTOPATHOLOGY, V94, P1056, DOI 10.1094/PHYTO.2004.94.10.1056; Liu ZH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000581; Lowe RGT, 2009, FUNGAL GENET BIOL, V46, P381, DOI 10.1016/j.fgb.2009.02.002; Manning VA, 2013, G3-GENES GENOM GENET, V3, P41, DOI 10.1534/g3.112.004044; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Park CY, 2008, J PROTEOME RES, V7, P3022, DOI 10.1021/pr800127y; Quaedvlieg W, 2013, STUD MYCOL, P307, DOI 10.3114/sim0017; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Solomon PS, 2006, BIOCHEM J, V399, P231, DOI 10.1042/BJ20060891; Solomon PS, 2006, MOL MICROBIOL, V62, P367, DOI 10.1111/j.1365-2958.2006.05380.x; Solomon PS, 2005, CURR GENET, V48, P60, DOI 10.1007/s00294-005-0588-y; Solomon PS, 2004, MOL PLANT MICROBE IN, V17, P456, DOI 10.1094/MPMI.2004.17.5.456; Solomon PS, 2004, MOL MICROBIOL, V53, P1065, DOI 10.1111/j.1365-2958.2004.04178.x; Solomon PS, 2006, MICROBIOL-SGM, V152, P1533, DOI 10.1099/mic.0.28556-0; Solomon PS, 2005, MOL PLANT MICROBE IN, V18, P110, DOI 10.1094/MPMI-18-0110; Stergiopoulos I, 2013, FEMS MICROBIOL REV, V37, P67, DOI 10.1111/j.1574-6976.2012.00349.x; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Syme RA, 2013, G3-GENES GENOM GENET, V3, P959, DOI 10.1534/g3.112.004994; Tan KC, 2008, EUKARYOT CELL, V7, P1916, DOI 10.1128/EC.00237-08; Tan KC, 2014, CROP PASTURE SCI, V65, P150, DOI 10.1071/CP13443; Tan KC, 2010, FUNCT PLANT BIOL, V37, P907, DOI 10.1071/FP10067; Tan KC, 2009, METABOLOMICS, P1; Tange O., 2018, USENIX MAGAZINE, V36, P42; Testa AC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1344-4; Urban M, 2014, NUCL ACIDS RES; Vincent D, 2012, METHODS MOL BIOL, V835, P75, DOI 10.1007/978-1-61779-501-5_5; Vleeshouwers VGAA, 2014, MOL PLANT MICROBE IN, V27, P196, DOI 10.1094/MPMI-10-13-0313-IA; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003	69	24	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147221	10.1371/journal.pone.0147221	http://dx.doi.org/10.1371/journal.pone.0147221			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840125	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200028
J	Yong, HS; Song, SL; Lim, PE; Eamsobhana, P; Suana, IW				Yong, Hoi-Sen; Song, Sze-Looi; Lim, Phaik-Eem; Eamsobhana, Praphathip; Suana, I. Wayan			Complete Mitochondrial Genome of Three Bactrocera Fruit Flies of Subgenus Bactrocera (Diptera: Tephritidae) and Their Phylogenetic Implications	PLOS ONE			English	Article							SPECIES DIPTERA; TRANSFER-RNA; MOLECULAR PHYLOGENY; COI; SEQUENCES; MODEL; LOOP	Bactrocera latifrons is a serious pest of solanaceous fruits and Bactrocera umbrosa is a pest of Artocarpus fruits, while Bactrocera melastomatos infests the fruit of Melastomataceae. They are members of the subgenus Bactrocera. We report here the complete mitochondrial genome of these fruit flies determined by next-generation sequencing and their phylogeny with other taxa of the subgenus Bactrocera. The whole mitogenomes of these three species possessed 37 genes namely, 13 protein-coding genes (PCGs), 2 rRNA and 22 tRNA genes. The mitogenome of B. latifrons (15,977 bp) was longer than those of B. melastomatos (15,954 bp) and B. umbrosa (15,898 bp). This difference can be attributed to the size of the intergenic spacers (283 bp in B. latifrons, 261 bp in B. melastomatos, and 211 bp in B. umbrosa). Most of the PCGs in the three species have an identical start codon, except for atp8 (adenosine triphosphate synthase protein 8), which had an ATG instead of GTG in B. umbrosa, whilst the nad3 (NADH dehydrogenase subunit 3) and nad6 (NADH dehydrogenase subunit 6) genes were characterized by an ATC instead of ATT in B. melastomatos. The three species had identical stop codon for the respective PCGs. In B. latifrons and B. melastomatos, the T.C (thymidine-pseudouridine-cytidine)-loop was absent in trnF (phenylalanine) and DHU (dihydrouracil)-loop was absent in trnS1 (serine S1). In B. umbrosa, trnN (asparagine), trnC (cysteine) and trnF lacked the T.C-loop, while trnS1 lacked the DHU-stem. Molecular phylogeny based on 13 PCGs was in general concordant with 15 mitochondrial genes (13 PCGs and 2 rRNA genes), with B. latifrons and B. umbrosa forming a sister group basal to the other species of the subgenus Bactrocera which was monophyletic. The whole mitogenomes will serve as a useful dataset for studying the genetics, systematics and phylogenetic relationships of the many species of Bactrocera genus in particular, and tephritid fruit flies in general.	[Yong, Hoi-Sen] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Yong, Hoi-Sen; Song, Sze-Looi] Univ Malaya, Chancellory High Impact Res, Kuala Lumpur, Malaysia; [Lim, Phaik-Eem] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Eamsobhana, Praphathip] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok 10700, Thailand; [Suana, I. Wayan] Mataram Univ, Fac Sci & Math, Mataram, Indonesia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Mahidol University; Universitas Mataram	Yong, HS (corresponding author), Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia.; Yong, HS; Song, SL (corresponding author), Univ Malaya, Chancellory High Impact Res, Kuala Lumpur, Malaysia.; Lim, PE (corresponding author), Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia.	yong@um.edu.my; looi511@hotmail.com; phaikeem@um.edu.my	LIM, Phaik Eem/B-5331-2010; Yong, Hoi Sen/C-1548-2010; Suana, I Wayan/J-2665-2012; Eamsobhana, Praphathip/H-3343-2012; Song, Sze-Looi/E-7939-2015; song, sl/GRS-1884-2022	LIM, Phaik Eem/0000-0001-9186-1487; Yong, Hoi Sen/0000-0002-9832-8826; Suana, I Wayan/0000-0003-1443-9017; Song, Sze Looi/0000-0002-1188-9728	Ministry of Higher Education High Impact Research Grant [H-50001-00-A000025]; University of Malaya [H-5620009]	Ministry of Higher Education High Impact Research Grant; University of Malaya(Universiti Malaya)	This study was funded in part by Ministry of Higher Education High Impact Research Grant (H-50001-00-A000025) and the University of Malaya (H-5620009).	Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 1992, FRUIT FLIES EC SIGNI; Asokan R, 2011, FLA ENTOMOL, V94, P1026, DOI 10.1653/024.094.0441; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boykin LM, 2014, J APPL ENTOMOL, V138, P235, DOI 10.1111/jen.12047; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Chan CW, 2013, WIRES RNA, V4, P507, DOI 10.1002/wrna.1175; Choudhary JS, 2015, GENE, V569, P191, DOI 10.1016/j.gene.2015.05.066; De Meyer M, 2011, INVASIVE FRUIT FLY P; Drew R.A.I., 2013, TROPICAL FRUIT FLIES; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hendrickson TL, 2001, P NATL ACAD SCI USA, V98, P13473, DOI 10.1073/pnas.251549298; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishida Tatsuaki, 2005, Research Bulletin of the Plant Protection Service Japan, V41, P39; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Krosch MN, 2012, MOL PHYLOGENET EVOL, V64, P513, DOI 10.1016/j.ympev.2012.05.006; Li H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08527; Liu Shen-Si, 2014, Acta Entomologica Sinica, V57, P343; McQuate Grant T., 2013, Insecta Mundi, V289, P1; Mwatawala Maulid, 2010, Journal of Afrotropical Zoology, V6, P83; Nakahara Shigehito, 2008, Research Bulletin of the Plant Protection Service Japan, P1; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Rambaut A., 2012, FIGTREE VERSION 1 4; Schutze MK, 2015, SYST ENTOMOL, V40, P456, DOI 10.1111/syen.12113; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith PT, 2003, MOL PHYLOGENET EVOL, V26, P8, DOI 10.1016/S1055-7903(02)00293-2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vargas RI, 2015, INSECTS, V6, P297, DOI 10.3390/insects6020297; Virgilio M, 2015, MOL PHYLOGENET EVOL, V85, P171, DOI 10.1016/j.ympev.2015.01.007; White P. Scott, 1992, P29; Yong HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15155; Yong HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129455; YONG HS, 1995, B ENTOMOL RES, V85, P431, DOI 10.1017/S0007485300036166; Yong HS, 2013, J SCI TECHNOL TROP, V9, P127; Zhang B, 2010, FLA ENTOMOL, V93, P369, DOI 10.1653/024.093.0308	43	23	23	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148201	10.1371/journal.pone.0148201	http://dx.doi.org/10.1371/journal.pone.0148201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840430	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200097
J	D'Souza, CA; Zhao, FLD; Li, XJ; Xu, Y; Dunn, SE; Zhang, L				D'Souza, Cheryl A.; Zhao, Fei Linda; Li, Xujian; Xu, Yan; Dunn, Shannon E.; Zhang, Li			OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages	PLOS ONE			English	Article							EXTRACELLULAR ACIDIFICATION; IFN-GAMMA; OGR1; EAE; INFLAMMATION; RECEPTORS; PH; PROLIFERATION; SUPEROXIDE; INHIBITION	Ovarian cancer G protein-coupled receptor 1 (OGR1) is a proton-sensing molecule that can detect decreases in extracellular pH that occur during inflammation. Although OGR1 has been shown to have pro-inflammatory functions in various diseases, its role in autoimmunity has not been examined. We therefore sought to determine whether OGR1 has a role in the development of T cell autoimmunity by contrasting the development of experimental autoimmune encephalomyelitis between wild type and OGR1-knockout mice. OGR1-knockout mice showed a drastically attenuated clinical course of disease that was associated with a profound reduction in the expansion of myelin oligodendrocyte glycoprotein 35-55-reactive T helper 1 (Th1) and Th17 cells in the periphery and a reduced accumulation of Th1 and Th17 effectors in the central nervous system. We determined that these impaired T cell responses in OGR1-knockout mice associated with a reduced frequency and number of dendritic cells in draining lymph nodes during EAE and a higher production of nitric oxide by macrophages. Our studies suggest that OGR1 plays a key role in regulating T cell responses during autoimmunity.	[D'Souza, Cheryl A.; Li, Xujian; Dunn, Shannon E.; Zhang, Li] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Zhao, Fei Linda; Dunn, Shannon E.; Zhang, Li] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Xu, Yan] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Dunn, Shannon E.] Womens Coll Res Inst, Toronto, ON, Canada; [Zhang, Li] Univ Toronto, Dept Lab Med & Pathobiol & Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Indiana University System; Indiana University Bloomington; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto	Dunn, SE; Zhang, L (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.; Dunn, SE; Zhang, L (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Dunn, SE (corresponding author), Womens Coll Res Inst, Toronto, ON, Canada.; Zhang, L (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol & Immunol, Toronto, ON, Canada.	sdunn@uhnresearch.ca; lzhang@uhnresearch.ca			Canadian Institutes of Health Research [MOP341319]; NIH [5R01CA155145]; Ralph C. Wilson, Sr. and Ralph C. Wilson, Jr. Medical Research Foundation; NATIONAL CANCER INSTITUTE [R01CA155145] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph C. Wilson, Sr. and Ralph C. Wilson, Jr. Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Canadian Institutes of Health Research grant (Grant number MOP341319) to LZ, NIH 5R01CA155145 (to YX and LZ) and Ralph C. Wilson, Sr. and Ralph C. Wilson, Jr. Medical Research Foundation grant (to YX). LZ is the Maria H. Bacardi Chair in Transplantation at the University Health Network. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aoki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079985; Bingisser RM, 1998, J IMMUNOL, V160, P5729; Bogdan C, 1998, J EXP MED, V187, P1361, DOI 10.1084/jem.187.9.1361; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Boullerne AI, 1999, J NEUROCHEM, V72, P1050, DOI 10.1046/j.1471-4159.1999.0721050.x; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Dalton DK, 2005, J NEUROIMMUNOL, V160, P110, DOI 10.1016/j.jneuroim.2004.11.004; de Valliere C, 2015, INFLAMM BOWEL DIS, V21, P1269, DOI 10.1097/MIB.0000000000000375; FARR M, 1985, CLIN EXP RHEUMATOL, V3, P99; Fenyk-Melody JE, 1998, J IMMUNOL, V160, P2940; Figueiredo CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101947; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Fujii W, 2015, ARTHRITIS RHEUMATOLO; Garthwaite G, 2002, NEUROSCIENCE, V109, P145, DOI 10.1016/S0306-4522(01)00447-X; Gold DP, 1997, EUR J IMMUNOL, V27, P2863, DOI 10.1002/eji.1830271118; Hoey S, 1997, J IMMUNOL, V159, P5132; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Ichimonji I, 2010, AM J PHYSIOL-LUNG C, V299, pL567, DOI 10.1152/ajplung.00415.2009; Jiang ZL, 2014, IMMUNOL LETT, V160, P17, DOI 10.1016/j.imlet.2014.03.006; Juedes AE, 2001, J IMMUNOL, V166, P5168, DOI 10.4049/jimmunol.166.8.5168; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lassmann H, 2011, FEBS LETT, V585, P3715, DOI 10.1016/j.febslet.2011.08.004; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005705; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Mayhan WG, 2000, BRAIN RES, V866, P101, DOI 10.1016/S0006-8993(00)02254-X; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Murata N, 2009, CELL IMMUNOL, V259, P21, DOI 10.1016/j.cellimm.2009.05.008; Niedbala W, 2002, P NATL ACAD SCI USA, V99, P16186, DOI 10.1073/pnas.252464599; Niedbala W, 2011, P NATL ACAD SCI USA, V108, P9220, DOI 10.1073/pnas.1100667108; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Pahan K, 2012, J CLIN CELLULAR IMMU, V3; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Prat E, 2002, J REHABIL RES DEV, V39, P187; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Rao Praveen, 2012, Methods Mol Biol, V900, P363, DOI 10.1007/978-1-60761-720-4_18; Rawji KS, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/948976; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Seuwen K, 2006, J RECEPT SIG TRANSD, V26, P599, DOI 10.1080/10799890600932220; Singh LS, 2007, JNCI-J NATL CANCER I, V99, P1313, DOI 10.1093/jnci/djm107; Tomura H, 2005, J BIOL CHEM, V280, P34458, DOI 10.1074/jbc.M505287200; van der Veen RC, 1999, CELL IMMUNOL, V193, P194, DOI 10.1006/cimm.1999.1471; van der Veen RC, 2000, CELL IMMUNOL, V199, P43, DOI 10.1006/cimm.1999.1597; Wei WC, 2015, P NATL ACAD SCI USA, V112, P10738, DOI 10.1073/pnas.1506085112; Willenborg DO, 1999, J IMMUNOL, V163, P5278; Wu GF, 2011, J AUTOIMMUN, V36, P56, DOI 10.1016/j.jaut.2010.10.006; Yamazaki H, 2005, J IMMUNOL, V175, P1586, DOI 10.4049/jimmunol.175.3.1586; Yan L, 2014, ONCOGENE, V33, P157, DOI 10.1038/onc.2012.566; Yang JJ, 2013, J EXP MED, V210, P1447, DOI 10.1084/jem.20122494; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	52	12	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148439	10.1371/journal.pone.0148439	http://dx.doi.org/10.1371/journal.pone.0148439			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828924	gold, Green Published, Green Submitted			2022-12-26	WOS:000369548200102
J	de Vos, P; Smink, AM; Paredes, G; Lakey, JRT; Kuipers, J; Giepmans, BNG; de Haan, BJ; Faas, MM				de Vos, Paul; Smink, Alexandra M.; Paredes, Genaro; Lakey, Jonathan R. T.; Kuipers, Jeroen; Giepmans, Ben N. G.; de Haan, Bart J.; Faas, Marijke M.			Enzymes for Pancreatic Islet Isolation Impact Chemokine-Production and Polarization of Insulin-Producing beta-Cells with Reduced Functional Survival of Immunoisolated Rat Islet-Allografts as a Consequence	PLOS ONE			English	Article							ALGINATE-PLL CAPSULES; INFLAMMATORY RESPONSES; INDUCIBLE PROTEIN-10; BIOCOMPATIBILITY; TRANSPLANTATION; GRAFTS; MICROENCAPSULATION; ENCAPSULATION; PURIFICATION; COLLAGENASE	The primary aim of this study was to determine whether normal variations in enzyme-activities of collagenases applied for rat-islet isolation impact longevity of encapsulated islet grafts. Also we studied the functional and immunological properties of rat islets isolated with different enzyme preparations to determine whether this impacts these parameters. Rat-islets were isolated from the pancreas with two different collagenases with commonly accepted collagenase, neutral protease, and clostripain activities. Islets had a similar and acceptable glucose-induced insulin-release profile but a profound statistical significant difference in production of the chemokines IP-10 and Gro-alpha. The islets were studied with nanotomy which is an EM-based technology for unbiased study of ultrastructural features of islets such as cell-cell contacts, endocrine-cell condition, ER stress, mitochondrial conditions, and cell polarization. The islet-batch with higher chemokine-production had a lower amount of polarized insulin-producing beta-cells. All islets had more intercellular spaces and less interconnected areas with tight cell-cell junctions when compared to islets in the pancreas. Islet-graft function was studied by implanting encapsulated and free islet grafts in rat recipients. Alginate-based encapsulated grafts isolated with the enzymelot inducing higher chemokine production and lower polarization survived for a two-fold shorter period of time. The lower survival-time of the encapsulated grafts was correlated with a higher influx of inflammatory cells at 7 days after implantation. Islets from the same two batches transplanted as free unencapsulated-graft, did not show any difference in survival or function in vivo. Lack of insight in factors contributing to the current lab-to-lab variation in longevity of encapsulated islet-grafts is considered to be a threat for clinical application. Our data suggest that seemingly minor variations in activity of enzymes applied for islet-isolation might contribute to longevity-variations of immunoisolated isletgrafts.	[de Vos, Paul; Smink, Alexandra M.; Paredes, Genaro; de Haan, Bart J.; Faas, Marijke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Immunoendocrinol, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [Lakey, Jonathan R. T.] Univ Calif Irvine, Dept Surg & Biomed Engn, Orange, CA 92868 USA; [Kuipers, Jeroen; Giepmans, Ben N. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, POB 196, NL-9700 AD Groningen, Netherlands	University of Groningen; University of California System; University of California Irvine; University of Groningen	de Vos, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Immunoendocrinol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	p.de.vos@umcg.nl	Smink, Alexandra/AAP-5285-2021; de Vos, Paul/A-3170-2013; Giepmans, Ben N.G./R-4564-2016; Paredes, Genaro A/R-6633-2016	Smink, Alexandra/0000-0002-9714-1779; Giepmans, Ben N.G./0000-0001-5105-5915; Paredes, Genaro A/0000-0002-6621-7830; de vos, paul/0000-0001-9618-2408	Juvenile Diabetes Research Foundation [17-2013288]; ZonM grant [91111.006]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); ZonM grant	This research was supported by the Juvenile Diabetes Research Foundation (17-2013288) and ZonM grant 91111.006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Barkai U, 2013, CELL TRANSPLANT, V22, P1463, DOI 10.3727/096368912X657341; Basta G, 2004, TRANSPL IMMUNOL, V13, P289, DOI 10.1016/j.trim.2004.10.003; Basta G, 2011, CURR DIABETES REP, V11, P384, DOI 10.1007/s11892-011-0219-6; Bunger CM, 2003, J BIOMED MATER RES A, V67A, P1219, DOI 10.1002/jbm.a.10094; Calafiore R, 2004, BIOTECHNOL APPL BIOC, V39, P159, DOI 10.1042/BA20030151; Cowley MJ, 2012, CELL TRANSPLANT, V21, P2063, DOI 10.3727/096368911X627372; de Haan BJ, 2004, PANCREAS, V29, pE15, DOI 10.1097/00006676-200407000-00063; de Haan BJ, 2003, CELL TRANSPLANT, V12, P617, DOI 10.3727/000000003108747226; De Haan BJ, 2002, BIOTECHNIQUES, V32, P612, DOI 10.2144/02323rr03; De Vos P, 1999, DIABETES, V48, P1381, DOI 10.2337/diabetes.48.7.1381; de Vos P, 2002, J BIOMED MATER RES, V62, P430, DOI 10.1002/jbm.10345; de Vos P, 2003, DIABETOLOGIA, V46, P666, DOI 10.1007/s00125-003-1087-7; de Vos P, 2003, BIOMATERIALS, V24, P305, DOI 10.1016/S0142-9612(02)00319-8; de Vos P, 2007, J BIOMED MATER RES A, V80A, P813, DOI 10.1002/jbm.a.30979; de Vos P, 2004, CELL TRANSPLANT, V13, P515, DOI 10.3727/000000004783983738; de Vos P, 2014, ADV DRUG DELIVER REV, V67-68, P15, DOI 10.1016/j.addr.2013.11.005; de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039; de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014; de Vos Paul, 2006, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V6, P139; DeVos P, 1997, BIOMATERIALS, V18, P1085, DOI 10.1016/S0142-9612(97)00040-9; DeVos P, 1996, TRANSPLANTATION, V62, P888, DOI 10.1097/00007890-199610150-00003; DeVos P, 1996, TRANSPLANTATION, V62, P893, DOI 10.1097/00007890-199610150-00004; DeVos P, 1997, DIABETOLOGIA, V40, P262; deVos P, 1997, TRANSPL P, V29, P756, DOI 10.1016/S0041-1345(96)00456-3; DeVos P, 1997, TRANSPLANTATION, V63, P824, DOI 10.1097/00007890-199703270-00006; Dominguez-Bendala J, 2012, EXPERT OPIN BIOL TH, V12, P731, DOI 10.1517/14712598.2012.679654; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Dufrane D, 2006, TRANSPLANTATION, V81, P1345, DOI 10.1097/01.tp.0000208610.75997.20; Dusseault J, 2006, J BIOMED MATER RES A, V76A, P243, DOI 10.1002/jbm.a.30541; Eldor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056924; FRITSCHY WM, 1991, TRANSPLANTATION, V52, P777, DOI 10.1097/00007890-199111000-00004; FRITSCHY WM, 1994, TRANSPLANT INT, V7, P264, DOI 10.1111/j.1432-2277.1994.tb01572.x; Gibly RF, 2011, DIABETOLOGIA, V54, P2494, DOI 10.1007/s00125-011-2243-0; Houwing H, 1996, CELL TRANSPLANT, V5, P21, DOI 10.1016/0963-6897(95)02019-5; IIDA N, 1990, MOL CELL BIOL, V10, P5596, DOI 10.1128/MCB.10.10.5596; Juhl K, 2010, CURR OPIN ORGAN TRAN, V15, P79, DOI 10.1097/MOT.0b013e3283344932; Jun HS, 2010, ADV EXP MED BIOL, V654, P627, DOI 10.1007/978-90-481-3271-3_27; Kin T, 2007, AM J TRANSPLANT, V7, P1233, DOI 10.1111/j.1600-6143.2007.01760.x; Kin T, 2007, TRANSPLANTATION, V83, P7, DOI 10.1097/01.tp.0000243169.09644.e6; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; Lacik I, 2006, AUST J CHEM, V59, P508, DOI 10.1071/CH06197; Lakey JRT, 2003, TRANSPL INT, V16, P613, DOI 10.1007/s00147-003-0651-x; Ludwig B, 2012, P NATL ACAD SCI USA, V109, P5022, DOI 10.1073/pnas.1201868109; McCarthy RC, 2011, TRANSPLANTATION, V91, P137, DOI 10.1097/TP.0b013e3181ffff7d; Melzi R, 2010, CELL TRANSPLANT, V19, P1031, DOI 10.3727/096368910X514639; Nano R, 2005, DIABETOLOGIA, V48, P906, DOI 10.1007/s00125-005-1725-3; Omer A, 2003, XENOTRANSPLANTATION, V10, P240, DOI 10.1034/j.1399-3089.2003.01150.x; Orive G, 2015, TRENDS PHARMACOL SCI, V36, P537, DOI 10.1016/j.tips.2015.05.003; Orive G, 2014, NAT MED, V20, P233, DOI 10.1038/nm.3486; Paredes Juarez Genaro Alberto, 2014, Front Bioeng Biotechnol, V2, P26, DOI 10.3389/fbioe.2014.00026; Paredes-Juarez GA, 2014, MATERIALS, V7, P2087, DOI 10.3390/ma7032087; Paredes-Juarez GA, 2013, J CONTROL RELEASE, V172, P983, DOI 10.1016/j.jconrel.2013.09.009; Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014; Ravelli RBG, 2013, SCI REP-UK, V3, DOI 10.1038/srep01804; Rheinheimer J, 2014, ISLETS, V6, DOI 10.4161/19382014.2014.977118; Rokstad AMA, 2014, ADV DRUG DELIVER REV, V67-68, P111, DOI 10.1016/j.addr.2013.07.010; Santos E, 2010, ADV EXP MED BIOL, V670, P5; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Shimoda M, 2012, CELL TRANSPLANT, V21, P501, DOI 10.3727/096368911X605411; Shimoda M, 2012, CELL TRANSPLANT, V21, P465, DOI 10.3727/096368911X605376; Spasojevic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109837; Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929; Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006; Tam SK, 2009, J BIOMED MATER RES A, V89A, P609, DOI 10.1002/jbm.a.32002; Tatarkiewicz K, 2001, DIABETOLOGIA, V44, P646, DOI 10.1007/s001250051672; Vaithilingam V, 2011, J MICROENCAPSUL, V28, P499, DOI 10.3109/02652048.2011.586067; VANSUYLICHEM PTR, 1992, J SURG RES, V53, P502, DOI 10.1016/0022-4804(92)90097-J; VANSUYLICHEM PTR, 1994, TRANSPLANTATION, V57, P1010, DOI 10.1097/00007890-199404150-00005; VANSUYLICHEM PTR, 1992, DIABETOLOGIA, V35, P917, DOI 10.1007/BF00401419; VOSSCHEPERKEUTER GH, 1994, TRANSPLANT P, V26, P641	72	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147992	10.1371/journal.pone.0147992	http://dx.doi.org/10.1371/journal.pone.0147992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824526	Green Published, gold			2022-12-26	WOS:000369528600085
J	Komac, B; Esteban, P; Trapero, L; Caritg, R				Komac, Benjamin; Esteban, Pere; Trapero, Laura; Caritg, Roger			Modelization of the Current and Future Habitat Suitability of Rhododendron ferrugineum Using Potential Snow Accumulation	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ADAPTIVE REGRESSION SPLINES; ALPINE PLANT-DISTRIBUTION; CLIMATE-CHANGE; SPATIAL AUTOCORRELATION; CENTRAL PYRENEES; ACCURACY ASSESSMENT; ECOLOGICAL MODELS; PRESENCE-ABSENCE; DISTRIBUTIONS	Mountain areas are particularly sensitive to climate change. Species distribution models predict important extinctions in these areas whose magnitude will depend on a number of different factors. Here we examine the possible impact of climate change on the Rhododendron ferrugineum (alpenrose) niche in Andorra (Pyrenees). This species currently occupies 14.6 km(2) of this country and relies on the protection afforded by snow cover in winter. We used high-resolution climatic data, potential snow accumulation and a combined forecasting method to obtain the realized niche model of this species. Subsequently, we used data from the high-resolution Scampei project climate change projection for the A2, A1B and B1 scenarios to model its future realized niche model. The modelization performed well when predicting the species's distribution, which improved when we considered the potential snow accumulation, the most important variable influencing its distribution. We thus obtained a potential extent of about 70.7 km(2) or 15.1% of the country. We observed an elevation lag distribution between the current and potential distribution of the species, probably due to its slow colonization rate and the small-scale survey of seedlings. Under the three climatic scenarios, the realized niche model of the species will be reduced by 37.9-70.1 km(2) by the end of the century and it will become confined to what are today screes and rocky hillside habitats. The particular effects of climate change on seedling establishment, as well as on the species' plasticity and sensitivity in the event of a reduction of the snow cover, could worsen these predictions.	[Komac, Benjamin; Trapero, Laura; Caritg, Roger] IEA, CENMA, AD-600 St Julia De Loria, Andorra; [Esteban, Pere] Univ Barcelona, Fac Geog & Hist, Dept Geog Fis & Anal Geog Reg, Barcelona 08001, Spain	University of Barcelona	Komac, B (corresponding author), IEA, CENMA, Avinguda Rocafort 21-23, AD-600 St Julia De Loria, Andorra.	bkomac.cenma@iea.ad		Esteban, Pere/0000-0001-5095-1187				Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2012, PIRINEOS, DOI DOI 10.3989/Pirineos.2012.167005; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Batalla M., 2011, ATLES CLIMATIC DIGIT; Binaghi E, 1999, PATTERN RECOGN LETT, V20, P935, DOI 10.1016/S0167-8655(99)00061-6; Black J.T, 1992, MULTIVARIATE DATA AN; Brieman L, 1984, CLASSIFICATION REGRE; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Buisson L, 2010, AM FISH S S, V73, P327; Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P885, DOI 10.1016/S0895-4356(99)00075-X; Carreras J, 2013, MAPA DIGITAL DELS HA; Castroviejo S, 1993, FLORA IBERICA PLANTA; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Cliff A. D., 1981, SPATIAL PROCESSES MO; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Comes Hans Peter, 2004, New Phytol, V164, P11, DOI 10.1111/j.1469-8137.2004.01194.x; CONGALTON RG, 1993, PHOTOGRAMM ENG REM S, V59, P641; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Deque M, 2011, RES ATMOSPHERIC OCEA, V41, P11; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Diniz JAF, 2005, GLOBAL ECOL BIOGEOGR, V14, P177, DOI 10.1111/j.1466-822X.2005.00147.x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dullinger S, 2003, ARCT ANTARCT ALP RES, V35, P434, DOI 10.1657/1523-0430(2003)035[0434:POSIIH]2.0.CO;2; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Escaravage N, 2001, AM J BOT, V88, P68, DOI 10.2307/2657128; Escaravage N, 1998, MOL ECOL, V7, P975, DOI 10.1046/j.1365-294x.1998.00415.x; Esteban P, 2005, INT J CLIMATOL, V25, P319, DOI 10.1002/joc.1103; Falk W, 2013, J CLIMATOL, DOI 10.1155/2013/787250; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; FORTIN MJ, 1989, VEGETATIO, V83, P209, DOI 10.1007/BF00031693; Friedel H., 1961, MITTEILUNGEN FORSTLI, V59, P317; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Gracia M, 2007, FOREST ECOL MANAG, V242, P391, DOI 10.1016/j.foreco.2007.01.056; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Gray LK, 2013, CLIMATIC CHANGE, V117, P289, DOI 10.1007/s10584-012-0548-8; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2000, PHYTOCOENOLOGIA, V30, P353; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Habel JC, 2011, GLOBAL CHANGE BIOL, V17, P194, DOI 10.1111/j.1365-2486.2010.02233.x; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Jay F, 2012, MOL ECOL, V21, P2354, DOI 10.1111/j.1365-294X.2012.05541.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Jump AS, 2006, GLOBAL CHANGE BIOL, V12, P2163, DOI 10.1111/j.1365-2486.2006.01250.x; Kirtman B., 2013, IPCC 2013 CLIMATE CH, P953; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Komac B, 2014, J NAT CONSERV, V22, P247, DOI 10.1016/j.jnc.2014.01.005; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Korner C., 2005, ADV GLOB CHANGE RES, P367; Kreyling J, 2011, RESTOR ECOL, V19, P433, DOI 10.1111/j.1526-100X.2011.00777.x; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P L, 2000, NUMERICAL ECOLOGY; Lischke H, 1998, POLIT SCI ENVIRONM, P309; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Lopez-Moreno JI, 2008, INT J CLIMATOL, V28, P1535, DOI 10.1002/joc.1645; Lopez-Moreno JI, 2014, THEOR APPL CLIMATOL, V117, P207, DOI 10.1007/s00704-013-0991-0; Lopez-Moreno JI, 2007, CLIM RES, V33, P257, DOI 10.3354/cr033257; Louis A, 2010, PLANTA MED, V76, P1550, DOI 10.1055/s-0029-1241016; Lutz C, 2005, PHYTON-ANN REI BOT A, V45, P139; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martinez I, 2012, GLOBAL CHANGE BIOL, V18, P1714, DOI 10.1111/j.1365-2486.2012.02660.x; Mayr S, 2010, OECOLOGIA, V164, P321, DOI 10.1007/s00442-010-1648-7; Montgomery D. C., 2021, INTRO LINEAR REGRESS, P12; Neuner G, 1999, TREE PHYSIOL, V19, P725; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; OPCC PCCO, 2013, MAIN CLIM REG PYR; Pasche F, 2004, BIOL CONSERV, V118, P101, DOI 10.1016/j.biocon.2003.07.012; Pauli H, 2001, ADV GLOB CHANGE RES, V9, P45; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Pornon A, 2000, MOL ECOL, V9, P1099, DOI 10.1046/j.1365-294x.2000.00976.x; Pornon A, 1997, PLANT ECOL, V130, P1, DOI 10.1023/A:1009724216796; Randin CF, 2014, ECOHYDROLOGY, pn/a; Randin CF, 2009, ARCT ANTARCT ALP RES, V41, P347, DOI 10.1657/1938-4246-41.3.347; Reichert P, 1997, ECOL MODEL, V95, P289, DOI 10.1016/S0304-3800(96)00043-9; Ridgeway G., 1999, COMPUT SCI STAT, P172; Ripley B. D., 1996, PATTERN RECOGNITION; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Ruiz-Labourdette D, 2012, J BIOGEOGR, V39, P162, DOI 10.1111/j.1365-2699.2011.02592.x; Sillero N, 2011, ECOL MODEL, V222, P1343, DOI 10.1016/j.ecolmodel.2011.01.018; Szczypta C, 2015, J HYDROL, V521, P84, DOI 10.1016/j.jhydrol.2014.11.060; Tardif J, 2003, ECOL MONOGR, V73, P241, DOI 10.1890/0012-9615(2003)073[0241:SVITGI]2.0.CO;2; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W., 2013, BIOMOD2 ENSEMBLE PLA; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; Vetaas OR, 2002, J BIOGEOGR, V29, P545, DOI 10.1046/j.1365-2699.2002.00694.x; Vittoz P, 2009, GLOBAL CHANGE BIOL, V15, P209, DOI 10.1111/j.1365-2486.2008.01707.x; Williams-Tripp M, 2012, SCI WORLD J, DOI 10.1100/2012/612965; Wintle BA, 2003, CONSERV BIOL, V17, P1579, DOI 10.1111/j.1523-1739.2003.00614.x; Wintle BA, 2005, AUSTRAL ECOL, V30, P719, DOI 10.1111/j.1442-9993.2005.01514.x; Zaghi D, 2008, MANAGEMENT NATURA 20; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	111	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147324	10.1371/journal.pone.0147324	http://dx.doi.org/10.1371/journal.pone.0147324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824847	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528600024
J	Liu, XH; Berry, CT; Ruthel, G; Madara, JJ; MacGillivray, K; Gray, CM; Madge, LA; McCorkell, KA; Beiting, DP; Hershberg, U; May, MJ; Freedman, BD				Liu, Xiaohong; Berry, Corbett T.; Ruthel, Gordon; Madara, Jonathan J.; MacGillivray, Katelyn; Gray, Carolyn M.; Madge, Lisa A.; McCorkell, Kelly A.; Beiting, Daniel P.; Hershberg, Uri; May, Michael J.; Freedman, Bruce D.			T Cell Receptor-induced Nuclear Factor kappa B (NF-kappa B) Signaling and Transcriptional Activation Are Regulated by STIM1-and Orai1-mediated Calcium Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FALSE DISCOVERY RATE; P65 PHOSPHORYLATION; GENE-EXPRESSION; DIFFERENTIAL REQUIREMENT; CA2+ SENSOR; PKC-THETA; LYMPHOCYTES; SUBUNIT; ALPHA	T cell activation following antigen binding to the T cell receptor (TCR) involves the mobilization of intracellular Ca2+ to activate the key transcription factors nuclear factor of activated T lymphocytes (NFAT) and NF-kappa B. The mechanism of NFAT activation by Ca2+ has been determined. However, the role of Ca2+ in controlling NF-kappa B signaling is poorly understood, and the source of Ca2+ required for NF-kappa B activation is unknown. We demonstrate that TCR- but not TNF-induced NF-kappa B signaling upstream of I kappa B kinase activation absolutely requires the influx of extracellular Ca2+ via STIM1-dependent Ca2+ release-activated Ca2+/Orai channels. We further show that Ca2+ influx controls phosphorylation of the NF-kappa B protein p65 on Ser-536 and that this posttranslational modification controls its nuclear localization and transcriptional activation. Notably, our data reveal that this role for Ca2+ is entirely separate from its upstream control of IB degradation, thereby identifying a novel Ca2+-dependent distal step in TCR-induced NF-kappa B activation. Finally, we demonstrate that this control of distal signaling occurs via Ca2+-dependent PKC-mediated phosphorylation of p65. Thus, we establish the source of Ca2+ required for TCR-induced NF-kappa B activation and define a new distal Ca2+-dependent checkpoint in TCR-induced NF-kappa B signaling that has broad implications for the control of immune cell development and T cell functional specificity.	[Liu, Xiaohong; Berry, Corbett T.; Ruthel, Gordon; Madara, Jonathan J.; MacGillivray, Katelyn; Beiting, Daniel P.; Freedman, Bruce D.] Univ Penn, Sch Vet Med, Dept Pathobiol, 3800 Spruce St, Philadelphia, PA 19104 USA; [Gray, Carolyn M.; Madge, Lisa A.; McCorkell, Kelly A.; May, Michael J.] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Berry, Corbett T.; Hershberg, Uri] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Drexel University	Freedman, BD (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, 3800 Spruce St, Philadelphia, PA 19104 USA.	bruce@vet.upenn.edu	Ruthel, Gordon/GYU-9133-2022; Hershberg, Uri/AAQ-6255-2020; Beiting, Daniel/AAG-6275-2019	Hershberg, Uri/0000-0002-6425-5980; Berry, Corbett/0000-0001-9348-2034; May, Michael/0000-0002-2485-3716	National Institutes of Health [RO1AI060921, RO1HL096642]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096642, R56HL096642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI125415, T32AI070077, R01AI060921] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD010919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by National Institutes of Health Grants RO1AI060921 (to B. F.) and RO1HL096642 (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTMAN A, 1992, IMMUNOLOGY, V76, P465; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Barouch-Bentov R, 2006, ADV EXP MED BIOL, V584, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Buss H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051847; Campbell KJ, 2006, BIOCHEM SOC SYMP, V73, P165, DOI 10.1042/bss0730165; Campbell KJ, 2004, BIOCHEM SOC T, V32, P1087, DOI 10.1042/BST0321087; Clavijo PE, 2012, J IMMUNOL, V188, P1213, DOI 10.4049/jimmunol.1100793; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Coutinho A, 2005, CURR TOP MICROBIOL, V293, P43, DOI 10.1007/3-540-27702-1_3; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; DOLMETSCH RE, 1994, J GEN PHYSIOL, V103, P365, DOI 10.1085/jgp.103.3.365; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Frischbutter S, 2011, EUR J IMMUNOL, V41, P2349, DOI 10.1002/eji.201041052; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Gentleman R, 2005, LIMMA LINEAR MODELS; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Gilmore F., 2015, NF B TRANSCRIPTION F; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Healy JI, 1998, CIBA F SYMP, V215, P137; Hochrainer K, 2013, J BIOL CHEM, V288, P285, DOI 10.1074/jbc.M112.385625; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hori S, 2010, EUR J IMMUNOL, V40, P664, DOI 10.1002/eji.201040372; Hu J, 2005, MOL CARCINOGEN, V44, P274, DOI 10.1002/mc.20142; Hu J, 2004, CARCINOGENESIS, V25, P1991, DOI 10.1093/carcin/bgh198; Ishiguro K, 2007, MOL IMMUNOL, V44, P2095, DOI 10.1016/j.molimm.2006.09.012; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Itatsu K, 2009, LIVER INT, V29, P291, DOI 10.1111/j.1478-3231.2008.01858.x; Jana S, 2009, EUR J IMMUNOL, V39, P2571, DOI 10.1002/eji.200939201; Jang MK, 2001, J BIOL CHEM, V276, P20005, DOI 10.1074/jbc.M010211200; Lee HM, 2011, ADV IMMUNOL, V112, P25, DOI 10.1016/B978-0-12-387827-4.00002-4; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Lio CWJ, 2011, CURR OPIN IMMUNOL, V23, P213, DOI 10.1016/j.coi.2010.11.010; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; Medoff BD, 2009, EUR J IMMUNOL, V39, P78, DOI 10.1002/eji.200838734; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oruganti SR, 2011, MOL IMMUNOL, V48, P1448, DOI 10.1016/j.molimm.2011.03.020; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Podtschaske M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000935; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sanchez-Valdepenas C, 2007, CELL SIGNAL, V19, P528, DOI 10.1016/j.cellsig.2006.08.002; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Schmidt AM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004411; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Takeuchi H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003326; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang BL, 2015, J BIOL CHEM, V290, P20336, DOI 10.1074/jbc.M115.639849; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028081; Wittwer T, 2008, BIOCHEM BIOPH RES CO, V371, P294, DOI 10.1016/j.bbrc.2008.04.069; Xing DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024021; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	81	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8440	8452		10.1074/jbc.M115.713008	http://dx.doi.org/10.1074/jbc.M115.713008			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26826124	Green Published, hybrid			2022-12-26	WOS:000374773200011
J	Rizvi, S; Yamada, D; Hirsova, P; Bronk, SF; Werneburg, NW; Krishnan, A; Salim, W; Zhang, L; Trushina, E; Truty, MJ; Gores, GJ				Rizvi, Sumera; Yamada, Daisaku; Hirsova, Petra; Bronk, Steven F.; Werneburg, Nathan W.; Krishnan, Anuradha; Salim, Warda; Zhang, Liang; Trushina, Eugenia; Truty, Mark J.; Gores, Gregory J.			A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; cancer biology; fibroblast growth factor receptor (FGFR); Hippo pathway; Yes-associated protein (YAP); BGJ398; mcl-1	YAP; LIVER; EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; HOMEOSTASIS; ACTIVATION; GENERATION; DIAGNOSIS; ONCOGENE	Herein, we have identified cross-talk between the Hippo and fibroblast growth factor receptor (FGFR) oncogenic signaling pathways in cholangiocarcinoma (CCA). Yes-associated protein (YAP) nuclear localization and up-regulation of canonical target genes was observed in CCA cell lines and a patient-derived xenograft (PDX). Expression of FGFR1, -2, and -4 was identified in human CCA cell lines, driven, in part, by YAP coactivation of TBX5. In turn, FGFR signaling in a cell line with minimal basal YAP expression induced its cellular protein expression and nuclear localization. Treatment of YAP-positive CCA cell lines with BGJ398, a pan-FGFR inhibitor, resulted in a decrease in YAP activation. FGFR activation of YAP appears to be driven largely by FGF5 activation of FGFR2, as siRNA silencing of this ligand or receptor, respectively, inhibited YAP nuclear localization. BGJ398 treatment of YAP-expressing cells induced cell death due to Mcl-1 depletion. In a YAP-associated mouse model of CCA, expression of FGFR 1, 2, and 4 was also significantly increased. Accordingly, BGJ398 treatment was tumor-suppressive in this model and in a YAP-positive PDX model. These preclinical data suggest not only that the YAP and Hippo signaling pathways culminate in an Mcl-1-regulated tumor survival pathway but also that nuclear YAP expression may be a biomarker to employ in FGFR-directed therapy.	[Rizvi, Sumera; Yamada, Daisaku; Hirsova, Petra; Bronk, Steven F.; Werneburg, Nathan W.; Krishnan, Anuradha; Salim, Warda; Gores, Gregory J.] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St S-W, Rochester, MN 55905 USA; [Zhang, Liang; Trushina, Eugenia] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Trushina, Eugenia] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Truty, Mark J.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Gores, GJ (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 First St S-W, Rochester, MN 55905 USA.	gores.gregory@mayo.edu	Hirsova, Petra/B-8943-2018	Hirsova, Petra/0000-0003-0494-0924	National Institutes of Health [DK59427, T32DK007198, DK84567, ES020715]; Mayo Foundation; American Liver Foundation; International Liver Cancer Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007198, P30DK084567, R01DK059427, R56DK059427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; American Liver Foundation; International Liver Cancer Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants DK59427 (to G. J. G.), T32DK007198 (to S. R.), DK84567 (Optical Microscopy Core for the Mayo Center for Cell Signaling in Gastroenterology), and ES020715 (to E. T.) and by the Mayo Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the American Liver Foundation.; Supported by the International Liver Cancer Association.	Anan A, 2006, HEPATOLOGY, V43, P335, DOI 10.1002/hep.21036; Arai Y, 2014, HEPATOLOGY, V59, P1427, DOI 10.1002/hep.26890; Bae SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7314; Borad MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004135; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Ertel F, 2013, EMBO REP, V14, P328, DOI 10.1038/embor.2013.20; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Gores GJ, 2012, GENE DEV, V26, P305, DOI 10.1101/gad.186189.111; Gradilone SA, 2013, CANCER RES, V73, P2259, DOI 10.1158/0008-5472.CAN-12-2938; Graham RP, 2014, HUM PATHOL, V45, P1630, DOI 10.1016/j.humpath.2014.03.014; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011; He C, 2015, ONCOGENE, V34, P6040, DOI 10.1038/onc.2015.52; Ishimura N, 2006, AM J PHYSIOL-GASTR L, V290, pG129, DOI 10.1152/ajpgi.00242.2005; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; Kim MP, 2012, ANN SURG ONCOL, V19, pS395, DOI 10.1245/s10434-011-1839-4; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Lange Miranda, 2012, Front Neurol, V3, P175, DOI 10.3389/fneur.2012.00175; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Li H, 2012, LIVER INT, V32, P38, DOI 10.1111/j.1478-3231.2011.02646.x; Li J, 2014, J CLIN INVEST, V124, P3241, DOI 10.1172/JCI73742; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Marti P, 2015, HEPATOLOGY, V62, P1497, DOI 10.1002/hep.27992; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Mott JL, 2008, MOL CANCER THER, V7, P2339, DOI 10.1158/1535-7163.MCT-08-0285; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Pei TM, 2015, ONCOTARGET, V6, P17206, DOI 10.18632/oncotarget.4043; Perra A, 2014, J HEPATOL, V61, P1088, DOI 10.1016/j.jhep.2014.06.033; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Rizvi S, 2014, SEMIN LIVER DIS, V34, P456, DOI 10.1055/s-0034-1394144; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Sandhu DS, 2014, HEPATOLOGY, V59, P1166, DOI 10.1002/hep.26679; Schmidt C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv024; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Xu YF, 2014, BIOCHEM BIOPH RES CO, V446, P54, DOI 10.1016/j.bbrc.2014.02.050; Yamada D, 2015, HEPATOLOGY, V61, P1627, DOI 10.1002/hep.27687; YANO H, 1992, CANCER, V69, P1664, DOI 10.1002/1097-0142(19920401)69:7<1664::AID-CNCR2820690705>3.0.CO;2-P; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	49	66	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8031	8047		10.1074/jbc.M115.698472	http://dx.doi.org/10.1074/jbc.M115.698472			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26826125	hybrid, Green Published			2022-12-26	WOS:000374056700023
J	Mair, JL; Nevill, AM; De Vito, G; Boreham, CA				Mair, Jacqueline L.; Nevill, Alan M.; De Vito, Giuseppe; Boreham, Colin A.			Personalised Prescription of Scalable High Intensity Interval Training to Inactive Female Adults of Different Ages	PLOS ONE			English	Article							RESTING METABOLIC-RATE; PHYSICAL-ACTIVITY; HEART-RATE; ENERGY-COST; EXERCISE; YOUNG; INTERVENTION; MORTALITY; MODERATE; PROGRAM	Stepping is a convenient form of scalable high-intensity interval training (HIIT) that may lead to health benefits. However, the accurate personalised prescription of stepping is hampered by a lack of evidence on optimal stepping cadences and step heights for various populations. This study examined the acute physiological responses to stepping exercise at various heights and cadences in young (n = 14) and middle-aged (n = 14) females in order to develop an equation that facilitates prescription of stepping at targeted intensities. Participants completed a step test protocol consisting of randomised three-minute bouts at different step cadences (80, 90, 100, 110 steps.min(-1)) and step heights (17, 25, 30, 34 cm). Aerobic demand and heart rate values were measured throughout. Resting metabolic rate was measured in order to develop female specific metabolic equivalents (METs) for stepping. Results revealed significant differences between age groups for METs and heart rate reserve, and within-group differences for METs, heart rate, and metabolic cost, at different step heights and cadences. At a given step height and cadence, middle-aged females were required to work at an intensity on average 1.9 +/- 0.26 METs greater than the younger females. A prescriptive equation was developed to assess energy cost in METs using multilevel regression analysis with factors of step height, step cadence and age. Considering recent evidence supporting accumulated bouts of HIIT exercise for health benefits, this equation, which allows HIIT to be personally prescribed to inactive and sedentary women, has potential impact as a public health exercise prescription tool.	[Mair, Jacqueline L.; De Vito, Giuseppe; Boreham, Colin A.] Univ Coll Dublin, UCD Inst Sport & Hlth, Newstead, Dublin 2, Dublin, Ireland; [Nevill, Alan M.] Wolverhampton Univ, Sch Sport Performing Arts & Leisure, Wolverhampton WV1 1DJ, W Midlands, England; [Mair, Jacqueline L.] Univ Ulster, Sch Sport, Shore Rd, Newtownabbey, Antrim, North Ireland	University College Dublin; University of Wolverhampton; Ulster University	Mair, JL (corresponding author), Univ Coll Dublin, UCD Inst Sport & Hlth, Newstead, Dublin 2, Dublin, Ireland.	j.mair@ulster.ac.uk	Nevill, Alan/Q-1010-2019; Mair, Jacqueline Louise/D-3829-2013; De Vito, Giuseppe/J-4499-2012	Nevill, Alan/0000-0003-0506-3652; Mair, Jacqueline Louise/0000-0002-1466-8680; De Vito, Giuseppe/0000-0002-6855-9180				Adams J., 2002, HLTH ED J, V61, DOI [10.1177/001789690206100308, DOI 10.1177/001789690206100308]; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; American College., 2006, ACSMS GUID EX TEST P; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Balke B, 1960, MED PHYS, P50; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; Bassett DR, 1997, MED SCI SPORT EXER, V29, P1250, DOI 10.1097/00005768-199709000-00019; Betik AC, 2008, APPL PHYSIOL NUTR ME, V33, P130, DOI 10.1139/H07-174; Boreham CAG, 2000, PREV MED, V30, P277, DOI 10.1006/pmed.2000.0634; Bouchard C., 1990, EXERCISE FITNESS HLT; Buford TW, 2013, SPORTS MED, V43, P157, DOI 10.1007/s40279-013-0018-0; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Cohen J.E., 1988, STAT POWER ANAL BEHA; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; Department of Health, 2011, START ACT STAY ACT R; Doheny EP, 2013, ANN BIOMED ENG, V41, P1748, DOI 10.1007/s10439-013-0804-8; Engbers LH, 2007, PREV MED, V44, P356, DOI 10.1016/j.ypmed.2006.11.005; FARDY PS, 1975, MED SCI SPORT EXER, V7, P91; GREIG CA, 1994, AGE AGEING, V23, P185, DOI 10.1093/ageing/23.3.185; Grier TD, 2002, J STRENGTH COND RES, V16, P242; Gulati M, 2010, CIRCULATION, V122, P130, DOI 10.1161/CIRCULATIONAHA.110.939249; Hall EE, 2002, BRIT J HEALTH PSYCH, V7, P47, DOI 10.1348/135910702169358; HEMENWAY D, 1994, ACCIDENT ANAL PREV, V26, P675, DOI 10.1016/0001-4575(94)90029-9; Higgins TP, 2015, CLIN HEMORHEOL MICRO, V59, P365, DOI 10.3233/CH-141857; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Horner NK, 2001, J NUTR, V131, P2215, DOI 10.1093/jn/131.8.2215; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Jung ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114541; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Kennedy RA, 2007, J SPORT SCI MED, V6, P448; LAKATTA EG, 1990, EUR HEART J, V11, P22, DOI 10.1093/eurheartj/11.suppl_C.22; Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Mair JL, 2014, CLIN PHYSIOL FUNCT I, V34, P10, DOI 10.1111/cpf.12056; Mair JL, 2014, EUR J APPL PHYSIOL, V114, P983, DOI 10.1007/s00421-014-2826-9; Myers J, 2004, AM J MED, V117, P912, DOI 10.1016/j.amjmed.2004.06.047; Nevill AM, 1998, J APPL PHYSIOL, V84, P963, DOI 10.1152/jappl.1998.84.3.963; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; ScharffOlson MR, 1996, RES Q EXERCISE SPORT, V67, P465, DOI 10.1080/02701367.1996.10607979; Sergi G, 2010, CLIN NUTR, V29, P84, DOI 10.1016/j.clnu.2009.07.010; Shenassa ED, 2008, INT J OBESITY, V32, P490, DOI 10.1038/sj.ijo.0803755; STUDENSKI S, 1994, J AM GERIATR SOC, V42, P297, DOI 10.1111/j.1532-5415.1994.tb01755.x; Teh KC, 2002, MED SCI SPORT EXER, V34, P695, DOI 10.1097/00005768-200204000-00021; Yu S, 2003, HEART, V89, P502, DOI 10.1136/heart.89.5.502; Zaletel P, 2009, KINESIOLOGY, V41, P97	45	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148702	10.1371/journal.pone.0148702	http://dx.doi.org/10.1371/journal.pone.0148702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848956	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000161
J	Li, HY; Lin, HA; Nien, FJ; Wu, VC; Jiang, YD; Chang, TJ; Kao, HL; Lin, MS; Wei, JN; Lin, CH; Shih, SR; Hung, CS; Chuang, LM				Li, Hung-Yuan; Lin, Hung-An; Nien, Feng-Jung; Wu, Vin-Cent; Jiang, Yi-Der; Chang, Tien-Jyun; Kao, Hsien-Li; Lin, Mao-Shin; Wei, Jung-Nan; Lin, Cheng-Hsin; Shih, Shyang-Rong; Hung, Chi-Sheng; Chuang, Lee-Ming			Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes	PLOS ONE			English	Article							SENSITIVE AMINE OXIDASE; CHRONIC KIDNEY-DISEASE; RISK-FACTORS; COMPLICATIONS; MORTALITY; INFLAMMATION; DIALYSIS; MARKERS; PEOPLE; TAIWAN	Background Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the deamination of primary amines into aldehydes, hydrogen peroxide, and ammonia, both of which are involved in the pathogenesis of diabetic complications. We have shown that serum VAP-1 is higher in patients with diabetes and in patients with chronic kidney disease (CKD), and can predict cardiovascular mortality in subjects with diabetes. In this study, we investigated if serum VAP-1 can predict ESRD in diabetic subjects. Methods In this prospective cohort study, a total of 604 type 2 diabetic subjects were enrolled between 1996 to 2003 at National Taiwan University Hospital, Taiwan, and were followed for a median of 12.36 years. The development of ESRD was ascertained by linking our database with the nationally comprehensive Taiwan Society Nephrology registry. Serum VAP-1 concentrations at enrollment were measured by time-resolved immunofluorometric assay. Results Subjects with serum VAP-1 in the highest tertile had the highest incidence of ESRD (p<0.001). Every 1-SD increase in serum VAP-1 was associated with a hazard ratio of 1.55 (95% CI 1.12-2.14, p<0.01) for the risk of ESRD, adjusted for smoking, history of cardiovascular disease, body mass index, hypertension, HbA1c, duration of diabetes, total cholesterol, use of statins, ankle-brachial index, estimated GFR, and proteinuria. We developed a risk score comprising serum VAP-1, HbA1c, estimated GFR, and proteinuria, which could predict ESRD with good performance (area under the ROC curve = 0.9406, 95% CI 0.8871-0.9941, sensitivity = 77.3%, and specificity = 92.8%). We also developed an algorithm based on the stage of CKD and a risk score including serum VAP-1, which can stratify these subjects into 3 categories with an ESRD risk of 0.101%/year, 0.131%/year, and 2.427%/year, respectively. Conclusions In conclusion, serum VAP-1 can predict ESRD and is a useful biomarker to improve risk stratification in type 2 diabetic subjects.	[Li, Hung-Yuan; Wu, Vin-Cent; Jiang, Yi-Der; Chang, Tien-Jyun; Kao, Hsien-Li; Lin, Mao-Shin; Shih, Shyang-Rong; Hung, Chi-Sheng; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lin, Hung-An] Minist Hlth & Welf, Lo Sheng Sanat & Hosp, Taipei, Taiwan; [Nien, Feng-Jung] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan; [Lin, Mao-Shin; Chuang, Lee-Ming] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Wei, Jung-Nan] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Lin, Cheng-Hsin] Taipei Med Univ, Wan Fang Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Sch Publ Hlth, Grad Inst Prevent Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chia Nan University of Pharmacy & Science; Taipei Medical University; Taipei Municipal WanFang Hospital; National Taiwan University	Chuang, LM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.; Chuang, LM (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan.; Chuang, LM (corresponding author), Natl Taiwan Univ, Sch Publ Hlth, Grad Inst Prevent Med, Taipei 10764, Taiwan.	leeming@ntu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019	Li, Hung-Yuan/0000-0001-9644-2855; WU, VIN-CENT/0000-0001-7935-0991; SHIH, SHYANG-RONG/0000-0001-7424-1358; KAO, HSIEN-LI/0000-0002-5278-3540; CHUANG, LEE-MING/0000-0003-0978-2662; JIANG, YI-DER/0000-0002-4276-5461; CHANG, TIEN-JYUN/0000-0001-9437-5847	National Science Council, Taiwan [NSC 101-2314-B-002-069-MY3]; Diabetes Research Fund of National Taiwan University Hospital, Taipei, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Diabetes Research Fund of National Taiwan University Hospital, Taipei, Taiwan	This work is supported in part by a grant (NSC 101-2314-B-002-069-MY3) from the National Science Council, Taiwan, and by the Diabetes Research Fund (to LMC) of National Taiwan University Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto K, 2012, ARTERIOSCL THROM VAS, V32, P523, DOI 10.1161/ATVBAHA.111.238030; Abella A, 2004, DIABETOLOGIA, V47, P429, DOI 10.1007/s00125-004-1346-2; Boomsma F, 2003, BBA-PROTEINS PROTEOM, V1647, P48, DOI 10.1016/S1570-9639(03)00047-5; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Clark N, 2003, DIABETES CARE, V26, P3333; Dalla Vestra M, 2005, J AM SOC NEPHROL, V16, pS78, DOI 10.1681/ASN.2004110961; Dunkel P, 2008, CURR MED CHEM, V15, P1827, DOI 10.2174/092986708785133022; Fernandes-Freitas I, 2015, CURR OPIN PHARMACOL, V25, P30, DOI 10.1016/j.coph.2015.09.014; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Guariguata L, 2012, DIABETES RES CLIN PR, V98, P524, DOI 10.1016/j.diabres.2012.11.006; Huang YY, 2012, J FORMOS MED ASSOC, V111, P637, DOI 10.1016/j.jfma.2012.09.006; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Kohavi R, 1995, P 14 INT JOINT C ART, V2, P1137; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Lee MJ, 2015, DIABETES METAB J, V39, P230, DOI 10.4093/dmj.2015.39.3.230; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LEWINSOHN R, 1981, J PHARM PHARMACOL, V33, P569, DOI 10.1111/j.2042-7158.1981.tb13868.x; Li HY, 2012, J FORMOS MED ASSOC, V111, P645, DOI 10.1016/j.jfma.2012.09.013; Li HY, 2011, DIABETES, V60, P993, DOI 10.2337/db10-0607; Li HY, 2009, CLIN CHIM ACTA, V404, P149, DOI 10.1016/j.cca.2009.03.041; Li HY, 2009, CLIN CHIM ACTA, V403, P97, DOI 10.1016/j.cca.2009.01.027; Lin MS, 2008, CLIN BIOCHEM, V41, P1362, DOI 10.1016/j.clinbiochem.2008.06.019; Murata M, 2012, INVEST OPHTH VIS SCI, V53, P4055, DOI 10.1167/iovs.12-9857; Narita T, 2006, DIABETES CARE, V29, P142, DOI 10.2337/diacare.29.1.142; Pannecoeck R, 2015, CRIT REV CL LAB SCI, V52, P284, DOI 10.3109/10408363.2015.1050714; Sallisalmi M, 2012, ACTA ANAESTH SCAND, V56, P316, DOI 10.1111/j.1399-6576.2011.02578.x; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Schnedl C, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/358086; Stolen CM, 2004, FASEB J, V18, P702, DOI 10.1096/fj.03-0562fje; Stolen CM, 2004, CIRC RES, V95, P50, DOI 10.1161/01.RES.0000134630.68877.2F; Streja D, 2003, J DIABETES COMPLICAT, V17, P120, DOI 10.1016/S1056-8727(02)00204-0; Taal MW, 2014, CURR OPIN NEPHROL HY, V23, P519, DOI 10.1097/MNH.0000000000000072; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F9; Wang C, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-9; Wu VC, 2011, KIDNEY INT, V80, P1222, DOI 10.1038/ki.2011.259; Yu PH, 1998, ATHEROSCLEROSIS, V140, P357, DOI 10.1016/S0021-9150(98)00142-7; Yu PH, 1997, DIABETOLOGIA, V40, P1243, DOI 10.1007/s001250050816	40	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147981	10.1371/journal.pone.0147981	http://dx.doi.org/10.1371/journal.pone.0147981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845338	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800024
J	Maiden, SL; Petrova, YI; Gumbiner, BM				Maiden, Stephanie L.; Petrova, Yuliya I.; Gumbiner, Barry M.			Microtubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; ARMADILLO REPEAT REGION; TYROSINE KINASE FER; ALPHA-CATENIN; BETA-CATENIN; CYTOPLASMIC DOMAIN; MOLECULE UVOMORULIN; P120 CATENIN; C-CADHERIN; F-ACTIN	Tight regulation of cadherin-mediated intercellular adhesions is critical to both tissue morphogenesis during development and tissue homeostasis in adults. Cell surface expression of the cadherin-catenin complex is often directly correlated with the level of adhesion, however, examples exist where cadherin appears to be inactive and cells are completely non-adhesive. The state of p120-catenin phosphorylation has been implicated in regulating the adhesive activity of E-cadherin but the mechanism is currently unclear. We have found that destabilization of the microtubule cytoskeleton, independent of microtubule plus-end dynamics, dephosphorylates p120-catenin and activates E-cadherin adhesion in Colo 205 cells. Through chemical screening, we have also identified several kinases as potential regulators of E-cadherin adhesive activity. Analysis of several p120-catenin phosphomutants suggests that gross dephosphorylation of p120-catenin rather than that of specific amino acids may trigger E-cadherin adhesion. Uncoupling p120-catenin binding to E-cadherin at the membrane causes constitutive adhesion in Colo 205 cells, further supporting an inhibitory role of phosphorylated p120-catenin on E-cadherin activity.	[Maiden, Stephanie L.; Petrova, Yuliya I.; Gumbiner, Barry M.] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Maiden, Stephanie L.] Truman State Univ, Dept Biol, Kirksville, MO USA; [Gumbiner, Barry M.] Seattle Childrens Res Inst, Seattle, WA USA; [Gumbiner, Barry M.] Univ Washington, Sch Med, Seattle, WA USA	University of Virginia; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Gumbiner, BM (corresponding author), Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA.; Gumbiner, BM (corresponding author), Seattle Childrens Res Inst, Seattle, WA USA.; Gumbiner, BM (corresponding author), Univ Washington, Sch Med, Seattle, WA USA.	gumbiner@uw.edu		Maiden, Stephanie/0000-0002-5144-386X	National Institutes of Health [R01GM106659, 5T32DK007769]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (http://www.nih.gov/) grant R01GM106659 to BMG. National Institutes of Health (http://www.nih.gov/) postdoctoral training grant 5T32DK007769 to SLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERLE H, 1994, J CELL SCI, V107, P3655; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cheung PY, 2004, J BIOL CHEM, V279, P45308, DOI 10.1074/jbc.C400333200; Ferrarese A, 2007, BIOCHEMISTRY-US, V46, P11902, DOI 10.1021/bi701674z; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber O, 1997, J CELL SCI, V110, P1759; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikeda K, 2011, MOL BIOL CELL, V22, P1321, DOI 10.1091/mbc.E10-09-0741; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Kaufmann U, 2000, J CELL SCI, V113, P4121; KIM L, 1995, MOL CELL BIOL, V15, P4553; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Koeberle SC, 2012, NAT CHEM BIOL, V8, P141, DOI 10.1038/nchembio.761; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; LEE CH, 1995, DEV BIOL, V171, P363, DOI 10.1006/dbio.1995.1288; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Nieset JE, 1997, J CELL SCI, V110, P1013; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Pappas DJ, 2006, CELL COMMUN ADHES, V13, P151, DOI 10.1080/15419060600726142; Petrova YI, 2012, MOL BIOL CELL, V23, P2092, DOI 10.1091/mbc.E11-12-1060; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; REYNOLDS AB, 1992, ONCOGENE, V7, P2439; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Risco Ana, 2012, J Signal Transduct, V2012, P520289, DOI 10.1155/2012/520289; Rosato R, 1998, MOL CELL BIOL, V18, P5762, DOI 10.1128/MCB.18.10.5762; Seldin DC, 2005, MOL CELL BIOCHEM, V274, P63, DOI 10.1007/s11010-005-3078-0; Shanware NP, 2009, BMB REP, V42, P142, DOI 10.5483/BMBRep.2009.42.3.142; Shashikanth N, 2015, J BIOL CHEM, V290, P21749, DOI 10.1074/jbc.M115.657098; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; VESTWEBER D, 1987, DEV BIOL, V124, P451, DOI 10.1016/0012-1606(87)90498-2; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Xia XB, 2003, BIOCHEMISTRY-US, V42, P9195, DOI 10.1021/bi034597h; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Zhong Y, 1999, J CELL BIOL, V144, P351, DOI 10.1083/jcb.144.2.351	61	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148574	10.1371/journal.pone.0148574	http://dx.doi.org/10.1371/journal.pone.0148574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845024	Green Published, gold			2022-12-26	WOS:000369552800072
J	Owen, HE; Halberstadt, J; Carr, EW; Winkielman, P				Owen, Helen E.; Halberstadt, Jamin; Carr, Evan W.; Winkielman, Piotr			Johnny Depp, Reconsidered: How Category-Relative Processing Fluency Determines the Appeal of Gender Ambiguity	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; PERCEPTUAL FLUENCY; FACES; ATTRACTIVENESS; TYPICALITY; EVOLUTION; DOMINANCE; ATTENTION; MEMORY; EYES	Individuals that combine features of both genders-gender blends-are sometimes appealing and sometimes not. Heretofore, this difference was explained entirely in terms of sexual selection. In contrast, we propose that part of individuals' preference for gender blends is due to the cognitive effort required to classify them, and that such effort depends on the context in which a blend is judged. In two studies, participants judged the attractiveness of male-female morphs. Participants did so after classifying each face in terms of its gender, which was selectively more effortful for gender blends, or classifying faces on a gender-irrelevant dimension, which was equally effortful for gender blends. In both studies, gender blends were disliked when, and only when, the faces were first classified by gender, despite an overall preference for feminine features in all conditions. Critically, the preferences were mediated by the effort of stimulus classification. The results suggest that the variation in attractiveness of gender-ambiguous faces may derive from context-dependent requirements to determine gender membership. More generally, the results show that the difficulty of resolving social category membership-not just attitudes toward a social category-feed into perceivers' overall evaluations toward category members.	[Owen, Helen E.; Halberstadt, Jamin] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Carr, Evan W.; Winkielman, Piotr] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Winkielman, Piotr] Univ Warwick, Warwick Business Sch, Behav Sci Grp, Coventry CV4 7AL, W Midlands, England; [Winkielman, Piotr] Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland	University of Otago; University of California System; University of California San Diego; University of Warwick; SWPS University of Social Sciences & Humanities	Halberstadt, J (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.; Winkielman, P (corresponding author), Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA.; Winkielman, P (corresponding author), Univ Warwick, Warwick Business Sch, Behav Sci Grp, Coventry CV4 7AL, W Midlands, England.; Winkielman, P (corresponding author), Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland.	jhalbers@psy.otago.ac.pz; pwinkielman@ucsd.edu	Winkielman, Piotr/AAT-6275-2020	Winkielman, Piotr/0000-0003-2330-1802				Allan K, 2012, EVOL HUM BEHAV, V33, P193, DOI 10.1016/j.evolhumbehav.2011.09.002; Alter AL, 2006, P NATL ACAD SCI USA, V103, P9369, DOI 10.1073/pnas.0601071103; Anderson US, 2010, J EXP SOC PSYCHOL, V46, P804, DOI 10.1016/j.jesp.2010.04.015; [Anonymous], 2003, POP COMMUN, DOI DOI 10.1207/S15405710PC0102_2; [Anonymous], 2009, MORPH PHOT SUIT; ARMSTRONG SL, 1983, COGNITION, V13, P263, DOI 10.1016/0010-0277(83)90012-4; BARSALOU LW, 1985, J EXP PSYCHOL LEARN, V11, P629, DOI 10.1037/0278-7393.11.1-4.629; Budgeon S, 2014, SOCIOLOGY, V48, P317, DOI 10.1177/0038038513490358; Causey K., 2009, JOHNNY DEPP EFFECT E; Cunningham M. R., 1997, EVOLUTIONARY SOCIAL, P109; DeBruine L. M., 2010, P ROYAL SOC B; DUNKLE JH, 1990, SEX ROLES, V23, P157, DOI 10.1007/BF00289863; Eagly AH, 2002, PSYCHOL REV, V109, P573, DOI 10.1037//0033-295X.109.3.573; Fiske S. T., 1982, AFFECT COGNITION, P55; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Garber Marjorie, 1997, VESTED INTERESTS CRO; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Halberstadt J., 2013, PSYCHOL SCI; Halberstadt J, 2014, J EXP SOC PSYCHOL, V50, P175, DOI 10.1016/j.jesp.2013.08.004; Halberstadt J, 2013, EXPERIENCE OF THINKING: HOW THE FLUENCY OF MENTAL PROCESSES INFLUENCES COGNITION AND BEHAVIOR, P133; Hayes A. F., 2012, PROCESS VERSATILE CO; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Lee AY, 2004, J MARKETING RES, V41, P151, DOI 10.1509/jmkr.41.2.151.28665; Meadow T, 2010, GENDER SOC, V24, P814, DOI 10.1177/0891243210385918; Meyer DA, 1999, NATURE, V397, P661, DOI 10.1038/17720; Oppenheimer DM, 2006, APPL COGNITIVE PSYCH, V20, P139, DOI 10.1002/acp.1178; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P355, DOI 10.1016/j.evolhumbehav.2004.06.002; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; POSNER MI, 1968, J EXP PSYCHOL, V77, P353, DOI 10.1037/h0025953; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Reber R, 1998, PSYCHOL SCI, V9, P45, DOI 10.1111/1467-9280.00008; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2005, SOC COGNITION, V23, P205, DOI 10.1521/soco.2005.23.3.205; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rhodes G, 2000, BRIT J PSYCHOL, V91, P125, DOI 10.1348/000712600161718; Sczesny S, 2006, SWISS J PSYCHOL, V65, P15, DOI 10.1024/1421-0185.65.1.15; Smith D, 2013, MEM COGNITION, V41, P850, DOI 10.3758/s13421-013-0301-1; STANGOR C, 1992, J PERS SOC PSYCHOL, V62, P207, DOI 10.1037/0022-3514.62.2.207; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; von Stockhausen L, 2013, EXP PSYCHOL, V60, P444, DOI 10.1027/1618-3169/a000217; Watkins CD, 2012, EUR J PERSONALITY, V26, P79, DOI 10.1002/per.837; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006; Watkins CD, 2010, BEHAV ECOL, V21, P943, DOI 10.1093/beheco/arq091; Weber P., 2014, CONFUSED ALL NEW FAC; Winkielman P, 2003, PSYCHOLOGY OF EVALUATION, P189; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; Winkielman P, 2006, PSYCHOL SCI, V17, P799, DOI 10.1111/j.1467-9280.2006.01785.x; Winkielman P, 2015, EMOTION, V15, P232, DOI 10.1037/emo0000036	50	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0146328	10.1371/journal.pone.0146328	http://dx.doi.org/10.1371/journal.pone.0146328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845341	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800004
J	Sako, H; Yada, K; Suzuki, K				Sako, Hiroaki; Yada, Koichi; Suzuki, Katsuhiko			Genome-Wide Analysis of Acute Endurance Exercise-Induced Translational Regulation in Mouse Skeletal Muscle	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; PROTEIN-SYNTHESIS; RESISTANCE EXERCISE; IN-VIVO; MECHANISMS; BREAKDOWN; TARGET	Exercise dynamically changes skeletal muscle protein synthesis to respond and adapt to the external and internal stimuli. Many studies have focused on overall protein synthesis to understand how exercise regulates the muscular adaptation. However, despite the probability that each gene transcript may have its own unique translational characteristics and would be differentially regulated at translational level, little attention has been paid to how exercise affects translational regulation of individual genes at a genome-wide scale. Here, we conducted a genome-wide translational analysis using ribosome profiling to investigate the effect of a single bout of treadmill running (20 m/min for 60 min) on mouse gastrocnemius. Global translational profiles largely differed from those in transcription even at a basal resting condition as well as immediately after exercise. As for individual gene, Slc25a25 (Solute carrier family 25, member 25), localized in mitochondrial inner membrane and maintaining ATP homeostasis and endurance performance, showed significant up-regulation at translational level. However, multiple regression analysis suggests that Slc25a25 protein degradation may also have a role in mediating Slc25a25 protein abundance in the basal and early stages after acute endurance exercise.	[Sako, Hiroaki] Waseda Univ, Grad Sch Sport Sci, Saitama 3591192, Japan; [Yada, Koichi; Suzuki, Katsuhiko] Waseda Univ, Fac Sport Sci, Saitama 3591192, Japan	Waseda University; Waseda University	Sako, H (corresponding author), Waseda Univ, Grad Sch Sport Sci, Saitama 3591192, Japan.	h.sako@kurenai.waseda.jp	Suzuki, Katsuhiko/AAI-2197-2019	Suzuki, Katsuhiko/0000-0002-6572-5809; SAKO, Hiroaki/0000-0002-5812-655X	Ministry of Education, Culture, Sports Science and Technology of Japan [26560370]; Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan [S1511017]; Grants-in-Aid for Scientific Research [15H01833] Funding Source: KAKEN	Ministry of Education, Culture, Sports Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Education, Culture, Sports Science and Technology of Japan, a Grant-in-Aid for the Global COE Program "Sport Science for the Promotion of Active Life", Challenging Exploratory Research 26560370, and the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (S1511017) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; Carmeli E, 2005, EXP PHYSIOL, V90, P613, DOI 10.1113/expphysiol.2004.029462; Chinkes D, 1996, AM J PHYSIOL-ENDOC M, V270, pE67, DOI 10.1152/ajpendo.1996.270.1.E67; Freeberg MA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r13; Fyfe JJ, 2014, SPORTS MED, V44, P743, DOI 10.1007/s40279-014-0162-1; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gautsch TA, 1998, AM J PHYSIOL-CELL PH, V274, pC406, DOI 10.1152/ajpcell.1998.274.2.C406; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jobling RK, 2015, BRAIN, V138, P1505, DOI 10.1093/brain/awv057; Jung T, 2014, REDOX BIOL, V2, P388, DOI 10.1016/j.redox.2013.12.029; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Kumar V, 2009, J APPL PHYSIOL, V106, P2026, DOI 10.1152/japplphysiol.91481.2008; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Lu B, 2008, BIOL REPROD, V78, P601, DOI 10.1095/biolreprod.107.065987; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Miller BF, 2015, J APPL PHYSIOL, V118, P655, DOI 10.1152/japplphysiol.00987.2014; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Ogasawara R, 2014, AM J PHYSIOL-ENDOC M, V306, pE1155, DOI 10.1152/ajpendo.00647.2013; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145; RENNIE MJ, 1982, CLIN SCI, V63, P519, DOI 10.1042/cs0630519; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sako H, 2014, EXERC IMMUNOL REV, V20, P55; Scalzo RL, 2014, FASEB J, V28, P2705, DOI 10.1096/fj.13-246595; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Williamson DL, 2006, J PHYSIOL-LONDON, V573, P497, DOI 10.1113/jphysiol.2005.103481	36	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148311	10.1371/journal.pone.0148311	http://dx.doi.org/10.1371/journal.pone.0148311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845575	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800046
J	Ho, J; Theg, SM				Ho, Jonathan; Theg, Steven M.			The Formation of Stromules In Vitro from Chloroplasts Isolated from Nicotiana benthamiana	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; PLASTID STROMULES; MEMBRANE; MOVEMENT; MICROFILAMENTS; PROTRUSIONS; EXPRESSION; TUBULATION; MORPHOLOGY; INDUCTION	Stromules are stroma-containing tubules that have been observed to emanate from the main plastidic body in vivo. These structures have been shown to require cytoskeletal components for movement. Though numerous studies have shown a close association with the endoplasmic reticulum, nucleus, mitochondria, and other plastids, the mechanism of formation and their overall function remain unknown. A limiting factor in studying these structures has been the lack of a reconstituted system for in vitro stromule formation. In this study, stromule formation was induced in vitro by adding a plant extract fraction that is greater than 100 kDa to a population of isolated chloroplasts. Kinetic measurements show that stromule formation occurs within similar to 10 seconds after the addition of the plant extract fraction. Heat inactivation and apyrase treatment reveal that the stromule stimulating compound found in the extract fraction is a protein or protein complex 100 kDa or greater. The formation of the stromules in vitro with isolated chloroplasts and a concentrated fraction of cell extract opens an avenue for the biochemical dissection of this process that has heretofore been studied only in vivo.	[Ho, Jonathan; Theg, Steven M.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Theg, SM (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	smtheg@ucdavis.edu			National Science Foundation [MCB-1330321]	National Science Foundation(National Science Foundation (NSF))	This work was supported by MCB-1330321 from the National Science Foundation (http://www.nsf.gov/bio/mcb/about.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2007, J BIOL CHEM, V282, P1170, DOI 10.1074/jbc.M608124200; Arimura S, 2004, PLANT CELL PHYSIOL, V45, P236, DOI 10.1093/pcp/pch024; Breuers FKH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00007; Brunkard JO, 2015, P NATL ACAD SCI USA, V112, P10044, DOI 10.1073/pnas.1511570112; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Caplan JL, 2015, DEV CELL, V34, P45, DOI 10.1016/j.devcel.2015.05.011; Gray JC, 2001, PLANT BIOLOGY, V3, P223, DOI 10.1055/s-2001-15204; Gray JC, 2012, PLANT J, V69, P387, DOI 10.1111/j.1365-313X.2011.04800.x; Gunning BES, 2005, PROTOPLASMA, V225, P33, DOI 10.1007/s00709-004-0073-3; Hanson MR, 2011, PLANT PHYSIOL, V155, P1486, DOI 10.1104/pp.110.170852; Hayward A, 2011, METHODS MOL BIOL, V678, P55, DOI 10.1007/978-1-60761-682-5_5; Holzinger A, 2007, PROTOPLASMA, V230, P23, DOI 10.1007/s00709-006-0222-y; Kohler RH, 1997, SCIENCE, V276, P2039, DOI 10.1126/science.276.5321.2039; Kohler RH, 2000, J CELL SCI, V113, P81; Krenz B, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00291; Kwok Ernest Y., 2004, BMC Plant Biology, V4, P2, DOI 10.1186/1471-2229-4-2; Kwok EY, 2003, PLANT J, V35, P16, DOI 10.1046/j.1365-313X.2003.01777.x; Kwok EY, 2004, PLANT CELL REP, V23, P188, DOI 10.1007/s00299-004-0824-9; Lo SM, 2011, METHODS MOL BIOL, V684, P139, DOI [10.1007/978.1.60761.925.3_13, 10.1007/978-1-60761-925-3_13]; Machettira AB, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00118; MENZEL D, 1994, PROTOPLASMA, V179, P166, DOI 10.1007/BF01403955; Natesan SKA, 2009, MOL PLANT, V2, P1262, DOI 10.1093/mp/ssp078; Oikawa K, 2008, PLANT PHYSIOL, V148, P829, DOI 10.1104/pp.108.123075; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Pyke KA, 2002, ANN BOT-LONDON, V90, P559, DOI 10.1093/aob/mcf235; Schattat M, 2011, PLANT PHYSIOL, V155, P1667, DOI 10.1104/pp.110.170480; Schattat MH, 2015, PROTOPLASMA, V252, P359, DOI 10.1007/s00709-014-0666-4; Senn G., 1908, GESTALTS UND LAGEVER; Singh ND, 2008, PLANT CELL, V20, P3405, DOI 10.1105/tpc.108.063172; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Stachowiak JC, 2010, P NATL ACAD SCI USA, V107, P7781, DOI 10.1073/pnas.0913306107; Tominaga M, 2003, EMBO J, V22, P1263, DOI 10.1093/emboj/cdg130; Usami H, 2012, PLANTA, V236, P1889, DOI 10.1007/s00425-012-1735-6; Wada M, 2003, ANNU REV PLANT BIOL, V54, P455, DOI 10.1016/j.plantsci.2013.05.016; Walley J, 2015, P NATL ACAD SCI USA, V112, P6212, DOI 10.1073/pnas.1504828112; Wang WM, 2013, PLANT CELL, V25, P4242, DOI 10.1105/tpc.113.117226; Waters MT, 2004, PLANT J, V39, P655, DOI 10.1111/j.1365-313X.2004.02164.x; Xiao YM, 2012, CELL, V149, P1525, DOI 10.1016/j.cell.2012.04.038	39	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146489	10.1371/journal.pone.0146489	http://dx.doi.org/10.1371/journal.pone.0146489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840974	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200010
J	Nair, ADS; Cheng, C; Ganta, CK; Sanderson, MW; Alleman, AR; Munderloh, UG; Ganta, RR				Nair, Arathy D. S.; Cheng, Chuanmin; Ganta, Chanran K.; Sanderson, Michael W.; Alleman, Arthur R.; Munderloh, Ulrike G.; Ganta, Roman R.			Comparative Experimental Infection Study in Dogs with Ehrlichia canis, E. chaffeensis, Anaplasma platys and A. phagocytophilum	PLOS ONE			English	Article							SERUM ANTIPLATELET ANTIBODIES; MONOCYTIC EHRLICHIOSIS; CYCLIC THROMBOCYTOPENIA; HUMORAL IMMUNITY; NESTED PCR; DISEASES; ASSAY; LYMPHOCYTOSIS; COINFECTION; DIAGNOSIS	Dogs acquire infections with the Anaplasmataceae family pathogens, E. canis, E. chaffeensis, E. ewingii, A. platys and A. phagocytophilum mostly during summer months when ticks are actively feeding on animals. These pathogens are also identified as causing diseases in people. Despite the long history of tick-borne diseases in dogs, much remains to be defined pertaining to the clinical and pathological outcomes of infections with these pathogens. In the current study, we performed experimental infections in dogs with E. canis, E. chaffeensis, A. platys and A. phagocytophilum. Animals were monitored for 42 days to evaluate infection-specific clinical, hematological and pathological differences. All four pathogens caused systemic persistent infections detectible throughout the 6 weeks of infection assessment. Fever was frequently detected in animals infected with E. canis, E. chaffeensis, and A. platys, but not in dogs infected with A. phagocytophilum. Hematological differences were evident in all four infected groups, although significant overlap existed between the groups. A marked reduction in packed cell volume that correlated with reduced erythrocytes and hemoglobin was observed only in E. canis infected animals. A decline in platelet numbers was common with E. canis, A. platys and A. phagocytophilum infections. Histopathological lesions in lung, liver and spleen were observed in all four groups of infected dogs; infection with E. canis had the highest pathological scores, followed by E. chaffeensis, then A. platys and A. phagocytophilum. All four pathogens induced IgG responses starting on day 7 post infection, which was predominantly comprised of IgG2 subclass antibodies. This is the first detailed investigation comparing the infection progression and host responses in dogs after inoculation with four pathogens belonging to the Anaplasmataceae family. The study revealed a significant overlap in clinical, hematological and pathological changes resulting from the infections.	[Nair, Arathy D. S.; Cheng, Chuanmin; Sanderson, Michael W.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Excellence Vector Borne Dis, Manhattan, KS 66506 USA; [Ganta, Chanran K.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA; [Alleman, Arthur R.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN USA	Kansas State University; Kansas State University; State University System of Florida; University of Florida; University of Minnesota System; University of Minnesota Twin Cities	Ganta, RR (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Excellence Vector Borne Dis, Manhattan, KS 66506 USA.	rganta@vet.ksu.edu			PHS from the National Institute of Allergy and Infectious Diseases [AI070908]; Abaxis Inc., Union City, CA; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER	PHS from the National Institute of Allergy and Infectious Diseases; Abaxis Inc., Union City, CA; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by PHS grant # AI070908 from the National Institute of Allergy and Infectious Diseases, https://projectreporter.nih.gov/project_info_details.cfm?aid=8900898&icde=27122417&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC. The project also received funding from the Abaxis Inc., Union City, CA; http://www.abaxis.com/. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The authors declare that the funder had no role in guiding or evaluating their research or preparing this manuscript.	Beall MJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-29; Chang WL, 1996, J CLIN MICROBIOL, V34, P3142, DOI 10.1128/JCM.34.12.3142-3146.1996; Chang WL, 1997, J VET MED SCI, V59, P849, DOI 10.1292/jvms.59.849; Dawson JE, 1996, J PARASITOL, V82, P52, DOI 10.2307/3284115; de Castro MB, 2004, VET PARASITOL, V119, P73, DOI 10.1016/j.vetpar.2003.10.012; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; DUMLER JS, 1991, NEW ENGL J MED, V325, P1109, DOI 10.1056/NEJM199110103251517; Eberts MD, 2011, J AM ANIM HOSP ASSOC, V47, pE86, DOI 10.5326/JAAHA-MS-5578; FRENCH TW, 1983, AM J VET RES, V44, P2407; Ganta RR, 2002, INFECT IMMUN, V70, P380, DOI 10.1128/IAI.70.1.380-388.2002; Gaunt SD, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-33; Greene C.E., 2006, INFECT DIS DOG CAT; Guo XY, 2009, INFECT IMMUN, V77, P2320, DOI 10.1128/IAI.01507-08; Harrus S, 1996, VET IMMUNOL IMMUNOP, V51, P13, DOI 10.1016/0165-2427(95)05516-9; HARVEY JW, 1978, J INFECT DIS, V137, P182, DOI 10.1093/infdis/137.2.182; Heeb HL, 2003, J AM ANIM HOSP ASSOC, V39, P379, DOI 10.5326/0390379; Hess PR, 2006, VET IMMUNOL IMMUNOP, V109, P117, DOI 10.1016/j.vetimm.2005.07.027; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Jouret-Gourjault S, 2006, ANN NY ACAD SCI, V89, P470; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Little SE, 2014, PARASITE VECTOR, V7, P1756; Little SE, 2010, VET CLIN N AM-SMALL, V40, P1121, DOI 10.1016/j.cvsm.2010.07.004; Maggi RG, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-103; Massung RF, 1998, J CLIN MICROBIOL, V36, P1090, DOI 10.1128/JCM.36.4.1090-1095.1998; Nair AD, 2015, INFECT IMMUN, V27, P00487; Nair ADS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109056; Nicholson WL, 2010, TRENDS PARASITOL, V26, P205, DOI 10.1016/j.pt.2010.01.007; O'Connor TP, 2006, AM J VET RES, V67, P206, DOI 10.2460/ajvr.67.2.206; Paddock CD, 1997, J CLIN MICROBIOL, V35, P2496, DOI 10.1128/JCM.35.10.2496-2502.1997; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Perez M, 2006, ANN NY ACAD SCI, V1078, P110, DOI 10.1196/annals.1374.016; Rar V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/j.meegid.2011.09.019; RIKIHISA Y, 1994, J CLIN MICROBIOL, V32, P2107, DOI 10.1128/JCM.32.9.2107-2112.1994; Rotondano TE, 2012, SCI WORLD J, P22; Saito TB, 2015, J INFECT DIS, V211, P452, DOI 10.1093/infdis/jiu372; SAMBROOK J, 2000, MOL CLONING LAB MANU; Scorpio DG, 2011, VECTOR-BORNE ZOONOT, V11, P223, DOI 10.1089/vbz.2009.0262; Sehdev AES, 2003, AM J CLIN PATHOL, V119, P859, DOI 10.1309/F7EAB5P7321716LJ; Shaw SE, 2001, TRENDS PARASITOL, V17, P74, DOI 10.1016/S1471-4922(00)01856-0; Starkey LA, 2015, J VET INTERN MED, V29, P552, DOI 10.1111/jvim.12567; Unver A, 2009, CLIN MICROBIOL INFEC, V15, P59, DOI 10.1111/j.1469-0691.2008.02634.x; WANER T, 1995, VET IMMUNOL IMMUNOP, V48, P177, DOI 10.1016/0165-2427(95)05420-B; Waner T, 2001, VET PARASITOL, V95, P1, DOI 10.1016/S0304-4017(00)00407-6; WEISER MG, 1991, J AM ANIM HOSP ASSOC, V27, P84; Wen BH, 1997, J CLIN MICROBIOL, V35, P1852, DOI 10.1128/JCM.35.7.1852-1855.1997; Winslow GM, 2003, ANN NY ACAD SCI, V990, P435, DOI 10.1111/j.1749-6632.2003.tb07408.x; Winslow GM, 2000, INFECT IMMUN, V68, P2187, DOI 10.1128/IAI.68.4.2187-2195.2000; WOODY BJ, 1991, VET CLIN N AM-SMALL, V21, P75, DOI 10.1016/S0195-5616(91)50009-7; Yabsley MJ, 2010, VET PARASITOL, V167, P136, DOI 10.1016/j.vetpar.2009.09.015; Yager E, 2005, INFECT IMMUN, V73, P8009, DOI 10.1128/IAI.73.12.8009-8016.2005; Zhang XF, 2003, J MED MICROBIOL, V52, P1021, DOI 10.1099/jmm.0.05234-0	51	33	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148239	10.1371/journal.pone.0148239	http://dx.doi.org/10.1371/journal.pone.0148239			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840398	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200107
J	Sahraoui, A; Dewachter, C; de Medina, G; Naeije, R; Bouguerra, SA; Dewachter, L				Sahraoui, Abdelhamid; Dewachter, Celine; de Medina, Geoffrey; Naeije, Robert; Bouguerra, Souhila Aouichat; Dewachter, Laurence			Myocardial Structural and Biological Anomalies Induced by High Fat Diet in Psammomys obesus Gerbils	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HEART-FAILURE; DIABETIC CARDIOMYOPATHY; MOUSE MODEL; RAT-HEART; OBESITY; CHOLESTEROL; EXPRESSION; INFARCTION; DISEASE	Background Psammomys obesus gerbils are particularly prone to develop diabetes and obesity after brief period of abundant food intake. A hypercaloric high fat diet has been shown to affect cardiac function. Here, we sought to determine whether a short period of high fat feeding might alter myocardial structure and expression of calcium handling proteins in this particular strain of gerbils. Methods Twenty Psammomys obesus gerbils were randomly assigned to receive a normal plant diet (controls) or a high fat diet. At baseline and 16-week later, body weight, plasma biochemical parameters (including lipid and carbohydrate levels) were evaluated. Myocardial samples were collected for pathobiological evaluation. Results Sixteen-week high fat dieting resulted in body weight gain and hyperlipidemia, while levels of carbohydrates remained unchanged. At myocardial level, high fat diet induced structural disorganization, including cardiomyocyte hypertrophy, lipid accumulation, interstitial and perivascular fibrosis and increased number of infiltrating neutrophils. Myocardial expressions of pro-apoptotic Bax-to-Bcl-2 ratio, pro-inflammatory cytokines [interleukin (IL)-1 beta and tumor necrosis factor (TNF)-alpha], intercellular (ICAM1) and vascular adhesion molecules (VCAM1) increased, while gene encoding cardiac muscle protein, the alpha myosin heavy polypeptide (MYH6), was downregulated. Myocardial expressions of sarco(endo)plasmic calcium-ATPase (SERCA2) and voltage-dependent calcium channel (Cacna1c) decreased, while protein kinase A (PKA) and calcium-calmodulin-dependent protein kinase (CaMK2D) expressions increased. Myocardial expressions of ryanodine receptor, phospholamban and sodium/calcium exchanger (Slc8a1) did not change. Conclusions We conclude that a relative short period of high fat diet in Psammomys obesus results in severe alterations of cardiac structure, activation of inflammatory and apoptotic processes, and altered expression of calcium-cycling determinants.	[Sahraoui, Abdelhamid; Dewachter, Celine; de Medina, Geoffrey; Naeije, Robert; Dewachter, Laurence] Univ Libre Bruxelles, Fac Med, Lab Physiol & Pharmacol, Brussels, Belgium; [Sahraoui, Abdelhamid; Bouguerra, Souhila Aouichat] Houari Boumediene Univ Sci & Technol, Fac Biol Sci, Team Cellular & Mol Physiopathol, Algiers, Algeria	Universite Libre de Bruxelles; University Science & Technology Houari Boumediene	Dewachter, L (corresponding author), Univ Libre Bruxelles, Fac Med, Lab Physiol & Pharmacol, Brussels, Belgium.	ldewacht@ulb.ac.be		Aouichat, Souhila/0000-0002-1079-6722	Fonds de la Recherche Scientifique Medicale [3.4637.09]; Belgian Foundation for Cardiac Surgery; "Fonds National de la Recherche Scientifique" (FNRS); FNRS	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Belgian Foundation for Cardiac Surgery; "Fonds National de la Recherche Scientifique" (FNRS)(Fonds de la Recherche Scientifique - FNRS); FNRS(Fonds de la Recherche Scientifique - FNRS)	The present work was supported by grants from the "Fonds de la Recherche Scientifique Medicale" (grant number 3.4637.09), the Belgian Foundation for Cardiac Surgery. CD was supported by the "Fonds National de la Recherche Scientifique" (FNRS) as a doctoral fellow ("Aspirant FNRS"; Belgium). LD was supported by a FNRS postdoctoral fellow ("Chargee de Recherches"; Belgium).	Akasaka Y, 2006, MODERN PATHOL, V19, P588, DOI 10.1038/modpathol.3800568; Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Begieneman MPV, 2008, HEART, V94, P450, DOI 10.1136/hrt.2007.118638; Bouguerra S A, 2001, Int J Exp Diabetes Res, V2, P37, DOI 10.1155/EDR.2001.37; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Clark C, 2011, PHYSIOL RES, V60, P291, DOI 10.33549/physiolres.931999; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; CLEUTJENS JPM, 1995, AM J PATHOL, V147, P325; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Dewachter L, 2009, EUR RESPIR J, V34, P1100, DOI 10.1183/09031936.00183008; DILLMANN WH, 1984, MOL CELL ENDOCRINOL, V34, P169, DOI 10.1016/0303-7207(84)90173-4; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Flagg TP, 2009, CIRC RES, V104, P95, DOI 10.1161/CIRCRESAHA.108.186809; Gorski PA, 2015, CELL METAB, V21, P183, DOI 10.1016/j.cmet.2015.01.005; Herron TJ, 2001, CIRC RES, V89, P1184, DOI 10.1161/hh2401.101908; Howell WH, 1997, AM J CLIN NUTR, V65, P1747, DOI 10.1093/ajcn/65.6.1747; KALDERON B, 1986, DIABETES, V35, P717, DOI 10.2337/diabetes.35.6.717; KAWAKAMI K, 1989, CLIN CHIM ACTA, V185, P147, DOI 10.1016/0009-8981(89)90037-5; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kiang JG, 2006, CHINESE J PHYSIOL, V49, P223; KINOSIAN B, 1995, J INVEST MED, V43, P443; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Lebeche D, 2008, NAT CLIN PRACT CARD, V5, P715, DOI 10.1038/ncpcardio1347; Leopoldo AS, 2010, CAN J CARDIOL, V26, P423, DOI 10.1016/S0828-282X(10)70440-2; Lin JHC, 1996, ATHEROSCLEROSIS, V127, P185, DOI 10.1016/S0021-9150(96)05951-5; Liu HR, 2009, CARDIOVASC RES, V81, P344, DOI 10.1093/cvr/cvn308; Lopaschuk GD, 2007, CIRC RES, V101, P335, DOI 10.1161/CIRCRESAHA.107.150417; MacLennan DH, 1998, ANN NY ACAD SCI, V853, P31, DOI 10.1111/j.1749-6632.1998.tb08254.x; Maier LS, 2005, BRAZ J MED BIOL RES, V38, P1293, DOI 10.1590/S0100-879X2005000900002; Mandavia CH, 2012, METABOLISM, V61, P1205, DOI 10.1016/j.metabol.2012.02.013; MARQUIE G, 1984, DIABETES, V33, P438, DOI 10.2337/diabetes.33.5.438; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; NEELY J R, 1972, Progress in Cardiovascular Diseases, V15, P289, DOI 10.1016/0033-0620(72)90029-1; Osborn S, 1860, CELLULAR PATHOLOGY B; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; PRITCHARD KA, 1991, ARTERIOSCLER THROMB, V11, P1175, DOI 10.1161/01.ATV.11.5.1175; Rider OJ, 2013, INT J OBESITY, V37, P972, DOI 10.1038/ijo.2012.170; Rondelet B, 2012, EUR HEART J, V33, P1017, DOI 10.1093/eurheartj/ehr111; Shafrir E, 2006, ILAR J, V47, P212, DOI 10.1093/ilar.47.3.212; Slater-Jefferies JL, 2010, PROSTAG LEUKOTR ESS, V83, P219, DOI 10.1016/j.plefa.2010.07.006; Slim RM, 1996, J AM COLL NUTR, V15, P289; Staiano RL, 2009, EUR J IMMUNOL, V39, P1405, DOI 10.1002/eji.200838792; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Sun YO, 1998, J MOL CELL CARDIOL, V30, P1559, DOI 10.1006/jmcc.1998.0721; Tsuji T, 2001, J CARDIOVASC PHARM, V38, P868, DOI 10.1097/00005344-200112000-00008; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Walder K, 2002, INT J OBESITY, V26, P605, DOI 10.1038/sj.ijo.0801965; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; Wu CK, 2011, CRIT CARE MED, V39, P984, DOI 10.1097/CCM.0b013e31820a91b9; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	56	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148117	10.1371/journal.pone.0148117	http://dx.doi.org/10.1371/journal.pone.0148117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840416	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200082
J	Yang, QY; Wang, R; Xiao, WF; Sun, FY; Yuan, H; Pan, QH				Yang, Qingyuan; Wang, Rui; Xiao, Weifan; Sun, Fenyong; Yuan, Hong; Pan, Qiuhui			Cellular Retinoic Acid Binding Protein 2 Is Strikingly Downregulated in Human Esophageal Squamous Cell Carcinoma and Functions as a Tumor Suppressor	PLOS ONE			English	Article							EXPRESSION; CRABP2; CANCER; PROLIFERATION; METASTASIS; GROWTH	Esophageal squamous cell carcinoma (ESCC) is the predominant pathotype of esophageal carcinoma (EC) in China, especially in Henan province, with poor prognosis and limited 5-year survival rate. Cellular retinoic acid binding protein 2 (CRABP2) is a member of the retinoic acid (RA) and lipocalin/cytosolic fatty-acid binding protein family and plays a completely contrary role in tumorigenesis through the retinoid signaling pathway, depending on the nuclear RA receptors (RAR) and PPARbeta/delta receptors. Presently, the biological role of CRABP2 in the development of ESCC has never been reported. Here, we firstly evaluated the expression of CRABP2 at both mRNA and protein levels and showed that it was remarkably downregulated in clinical ESCC tissues and closely correlated with the occurrence position, pathology, TNM stage, size, infiltration depth and cell differentiation of the tumor. Additionally, the biological function assays demonstrated that CRABP2 acted as a tumor suppressor in esophageal squamous carcinogenesis by significantly inhibiting cell growth, inducing cell apoptosis and blocking cell metastasis both in vitro and in vivo. All in all, our finding simplicate that CRABP2 is possibly an efficient molecular marker for diagnosing and predicting the development of ESCC.	[Yang, Qingyuan; Wang, Rui; Sun, Fenyong] Tongji Univ, Peoples Hosp 10, Dept Clin Lab Med, Shanghai 200072, Peoples R China; [Xiao, Weifan; Pan, Qiuhui] Tongji Univ, Peoples Hosp 10, Cent Lab, Shanghai 200072, Peoples R China; [Yuan, Hong] Dalian Med Univ, Affiliated Hosp 1, Dept Clin Lab Med, Tianjin 300070, Peoples R China	Tongji University; Tongji University; Dalian Medical University	Pan, QH (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Clin Lab Med, Tianjin 300070, Peoples R China.	yuanhonglab@163.com; sloganmore@163.com			National natural science foundation of China [81272292, 81371913, 81472624, 81472124, 81502425]; Shanghai Young Science and Technology Talents Sailing Program [15YF1409300]	National natural science foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Young Science and Technology Talents Sailing Program	Funding for this work came from National natural science foundation of China http://www.nsfc.gov.cn/ to Fenyong Sun and Qiuhui Pan, 81272292, 81371913, 81472624, 81472124, 81502425; and Shanghai Young Science and Technology Talents Sailing Program, to Qingyuan Yang, http://www.stcsm.gov.cn/, 15YF1409300.	Calmon MF, 2009, NEOPLASIA, V11, P1329, DOI 10.1593/neo.91110; Campos B, 2012, INT J CANCER, V131, P1963, DOI 10.1002/ijc.27446; Delva L, 1999, MOL CELL BIOL, V19, P7158; Favorskaya I, 2014, TUMOR BIOL, V35, P10295, DOI 10.1007/s13277-014-2348-4; Geiger T, 2012, CANCER RES, V72, P2428, DOI 10.1158/0008-5472.CAN-11-3711; Gupta S, 2012, CLIN CANCER RES, V18, P280, DOI 10.1158/1078-0432.CCR-11-2165; Mallikarjuna K, 2010, PROTEOM CLIN APPL, V4, P449, DOI 10.1002/prca.200900069; McEwan J, 2011, DEV DYNAM, V240, P1259, DOI 10.1002/dvdy.22555; Nakajima M, 2013, EXPERT OPIN PHARMACO, V14, P1345, DOI 10.1517/14656566.2013.801454; Okuducu AF, 2005, INT J ONCOL, V27, P1273; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Stachurska E, 2011, ACTA BIOCHIM POL, V58, P19; Takahashi M, 2002, CANCER RES, V62, P6598; Tang YL, 2015, INT J CLIN EXP PATHO, V8, P11224; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Uchikado Y, 2006, INT J ONCOL, V29, P1337; Vreeland AC, 2014, J BIOL CHEM, V289, P34065, DOI 10.1074/jbc.M114.604041; Vreeland AC, 2014, MOL CELL BIOL, V34, P2135, DOI 10.1128/MCB.00281-14; Wang JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042281; Xiao WB, 2014, HUM PATHOL, V45, P1177, DOI 10.1016/j.humpath.2014.01.014; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang QY, 2014, CARCINOGENESIS, V35, P1643, DOI 10.1093/carcin/bgu084; Yang QY, 2014, J CHEMOTHERAPY, V26, P235, DOI 10.1179/1973947813Y.0000000138; Yuan J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055479, 10.4161/psb.25026]; Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598	27	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148381	10.1371/journal.pone.0148381	http://dx.doi.org/10.1371/journal.pone.0148381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839961	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200130
J	Ceolin, L; Romitti, M; Siqueira, DR; Ferreira, CV; Scapineli, JO; Assis-Brazil, B; Maximiano, RV; Amarante, TD; Nunes, MCD; Weber, G; Maia, AL				Ceolin, Lucieli; Romitti, Mirian; Siqueira, Debora Rodrigues; Ferreira, Carla Vaz; Scapineli, Jessica Oliboni; Assis-Brazil, Beatriz; Maximiano, Rodolfo Vieira; Amarante, Tauanne Dias; de Souza Nunes, Miriam Celi; Weber, Gerald; Maia, Ana Luiza			Effect of 3 ' UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma	PLOS ONE			English	Article							HIRSCHSPRUNG-DISEASE; SOMATIC MUTATIONS; SEQUENCE VARIANT; FOLLOW-UP; PROTOONCOGENE; POLYMORPHISMS; CANCER; GENE; HAPLOTYPES; S836S	Background The RET S836S variant has been associated with early onset and increased risk for metastatic disease in medullary thyroid carcinoma (MTC). However, the mechanism by which this variant modulates MTC pathogenesis is still open to discuss. Of interest, strong linkage disequilibrium (LD) between RET S836S and 3'UTR variants has been reported in Hirschsprung's disease patients. Objective To evaluate the frequency of the RET 3' UTR variants (rs76759170 and rs3026785) in MTC patients and to determine whether these variants are in LD with S836S polymorphism. Methods Our sample comprised 152 patients with sporadic MTC. The RET S836S and 3' UTR (rs76759170 and rs3026785) variants were genotyped using Custom TaqMan Genotyping Assays. Haplotypes were inferred using the phase 2.1 program. RET mRNA structure was assessed by Vienna Package. Results The mean age of MTC diagnosis was 48.5+/-15.5 years and 57.9% were women. The minor allele frequencies of RET polymorphisms were as follows: S836S, 5.6%; rs76759170, 5.6%; rs3026785, 6.2%. We observed a strong LD among S836S and 3' UTR variants (|D'| = -1, r(2) = 1 and |D'| = -1, r2 = 0,967). Patients harboring the S836S/3' UTR variants presented a higher percentage of lymph node and distant metastasis (P = 0.013 and P<0.001, respectively). Accordingly, RNA folding analyses demonstrated different RNA secondary structure predictions for WT(TCCGT), S836S(TTCGT) or 3' UTR(GTCAC) haplotypes. The S836S/3' UTR haplotype presented a greater number of double helices sections and lower levels of minimal free energy when compared to the wild-type haplotype, suggesting that these variants provides the most thermodynamically stable mRNA structure, which may have functional consequences on the rate of mRNA degradation. Conclusion The RET S836S polymorphism is in LD with 3' UTR variants. In silico analysis indicate that the 3' UTR variants may affect the secondary structure of RET mRNA, suggesting that these variants might play a role in posttranscriptional control of the RET transcripts.	[Ceolin, Lucieli; Romitti, Mirian; Siqueira, Debora Rodrigues; Ferreira, Carla Vaz; Scapineli, Jessica Oliboni; Maia, Ana Luiza] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrine, Thyroid Sect, Porto Alegre, RS, Brazil; [Assis-Brazil, Beatriz] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Dept Pathol, Porto Alegre, RS, Brazil; [Maximiano, Rodolfo Vieira; Amarante, Tauanne Dias; de Souza Nunes, Miriam Celi; Weber, Gerald] Univ Fed Minas Gerais, Computat Biophys Grp, Dept Phys, Belo Horizonte, MG, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal de Minas Gerais	Maia, AL (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrine, Thyroid Sect, Porto Alegre, RS, Brazil.	almaia@ufrgs.br	Weber, Gerald/A-8669-2010; Maia, Ana Luiza/F-9201-2012; CEOLIN, LUCIELI/U-5261-2019	Weber, Gerald/0000-0002-2935-1571; Maia, Ana Luiza/0000-0002-4186-5532; Ceolin, Lucieli/0000-0001-6794-6042; Dias Amarante, Tauanne/0000-0002-1999-9753	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Apoio a Pesquisa do Rio Grande do Sul (FAPERGS); Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE), Brazil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE), Brazil	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Apoio a Pesquisa do Rio Grande do Sul (FAPERGS), and Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE), Brazil.	Asai N, 2006, PATHOL INT, V56, P164, DOI 10.1111/j.1440-1827.2006.01942.x; Attie Tania, 1994, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V188, P499; Berard I, 2004, CLIN GENET, V65, P150, DOI 10.1111/j.0009-9163.2004.00172.x; Borrego S, 2003, AM J HUM GENET, V72, P88, DOI 10.1086/345466; Borrego S, 1999, J MED GENET, V36, P771, DOI 10.1136/jmg.36.10.771; Brondani LA, 2012, INVEST OPHTH VIS SCI, V53, P7449, DOI 10.1167/iovs.12-10660; Ceolin L, 2012, EUR J ENDOCRINOL, V166, P847, DOI 10.1530/EJE-11-1060; Ceolin L, 2012, INT J MOL SCI, V13, P221, DOI 10.3390/ijms13010221; Clark JR, 2005, LARYNGOSCOPE, V115, P1445, DOI 10.1097/01.mlg.0000168114.90852.a6; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; de Silanes IL, 2007, CELL ONCOL, V29, P1; Ding Y, 2006, RNA, V12, P323, DOI 10.1261/rna.2274106; Elisei R, 2004, J CLIN ENDOCR METAB, V89, P3579, DOI 10.1210/jc.2003-031898; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P682, DOI 10.1210/jc.2007-1714; Eng C, 1998, J CLIN ENDOCR METAB, V83, P4310, DOI 10.1210/jc.83.12.4310; ENG C, 1995, GENE CHROMOSOME CANC, V12, P209, DOI 10.1002/gcc.2870120308; Fernandez RM, 2006, THYROID, V16, P411, DOI 10.1089/thy.2006.16.411; Figlioli G, 2013, MUTAT RES-REV MUTAT, V752, P36, DOI 10.1016/j.mrrev.2012.09.002; Fitze G, 2003, HUM MOL GENET, V12, P3207, DOI 10.1093/hmg/ddg354; Fitze G, 2002, LANCET, V359, P1200, DOI 10.1016/S0140-6736(02)08218-1; Gimm O, 1999, ONCOGENE, V18, P1369, DOI 10.1038/sj.onc.1202418; Griseri P, 2005, HUM MUTAT, V25, P189, DOI 10.1002/humu.20135; Griseri P, 2000, EUR J HUM GENET, V8, P721, DOI 10.1038/sj.ejhg.5200521; Griseri P, 2002, AM J HUM GENET, V71, P969, DOI 10.1086/342774; Griseri P, 2007, HUM MUTAT, V28, P168, DOI 10.1002/humu.20397; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; HEDRICK PW, 1987, J HERED, V78, P204, DOI 10.1093/oxfordjournals.jhered.a110358; Lantieri F, 2006, ANN HUM GENET, V70, P12, DOI 10.1111/j.1529-8817.2005.00196.x; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lou F, 2010, BIOINFORMATICS, V26, pi278, DOI 10.1093/bioinformatics/btq218; LYONNET S, 1994, CR ACAD SCI III-VIE, V317, P358; Maia AL, 2014, ARQ BRAS ENDOCRINOL, V58, P667, DOI 10.1590/0004-2730000003427; Marsh DJ, 1996, CLIN ENDOCRINOL, V44, P249, DOI 10.1046/j.1365-2265.1996.681503.x; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; MYERS SM, 1995, ONCOGENE, V11, P2039; O'Sullivan Brian, 2003, Semin Surg Oncol, V21, P30, DOI 10.1002/ssu.10019; Pelizzo MR, 2007, EJSO-EUR J SURG ONC, V33, P493, DOI 10.1016/j.ejso.2006.10.021; Richardson DS, 2012, MOL BIOL CELL, V23, P3838, DOI 10.1091/mbc.E12-02-0114; Romei C, 1996, J CLIN ENDOCR METAB, V81, P1619, DOI 10.1210/jc.81.4.1619; Ruiz A, 2001, CLIN ENDOCRINOL, V55, P399, DOI 10.1046/j.1365-2265.2001.01328.x; SANTORO M, 1990, ONCOGENE, V5, P1595; Sharma BP, 2011, J BIOSCIENCES, V36, P603, DOI 10.1007/s12038-011-9095-0; Siqueira DR, 2010, ENDOCR-RELAT CANCER, V17, P953, DOI 10.1677/ERC-09-0312; Siqueira DR, 2014, EUR J ENDOCRINOL, V170, P821, DOI 10.1530/EJE-14-0084; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamanaha R, 2009, CLIN ENDOCRINOL, V71, P56, DOI 10.1111/j.1365-2265.2008.03491.x; Wells Jr SA, 2015, THYROID; Wohllk N, 2005, REV MED CHILE, V133	48	6	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147840	10.1371/journal.pone.0147840	http://dx.doi.org/10.1371/journal.pone.0147840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829565	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200036
J	Juhl, K; Christensen, A; Persson, M; Ploug, M; Kjaer, A				Juhl, Karina; Christensen, Anders; Persson, Morten; Ploug, Michael; Kjaer, Andreas			Peptide-Based Optical uPAR Imaging for Surgery: In Vivo Testing of ICG-Glu-Glu-AE105	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; UROKINASE RECEPTOR; SURGICAL MARGINS; CANCER; PET; LOCALIZATION; EXPRESSION; ANTIBODIES	Near infrared intra-operative optical imaging is an emerging technique with clear implications for improved cancer surgery by enabling a more distinct delineation of the tumor margins during resection. This modality has the potential to increase the number of patients having a curative radical tumor resection. In the present study, a new uPAR-targeted fluorescent probe was developed and the in vivo applicability was evaluated in a human xenograft mouse model. Most human carcinomas express high level of uPAR in the tumor-stromal interface of invasive lesions and uPAR is therefore considered an ideal target for intra-operative imaging. Conjugation of the flourophor indocyanine green (ICG) to the uPAR agonist (AE105) provides an optical imaging ligand with sufficiently high receptor affinity to allow for a specific receptor targeting in vivo. For in vivo testing, human glioblastoma xenograft mice were subjected to optical imaging after i.v. injection of ICG-AE105, which provided an optimal contrast in the time window 6-24 h post injection. Specificity of the uPAR-targeting probe ICG-AE105 was demonstrated in vivo by 1) no uptake of unconjugated ICG after 15 hours, 2) inhibition of ICG-AE105 tumor uptake by a bolus injection of the natural uPAR ligand pro-uPA, and finally 3) the histological colocalization of ICG-AE105 fluorescence and immunohistochemical detected human uPAR on resected tumor slides. Taken together, our data supports the potential use of this probe for intra-operative optical guidance in cancer surgery to ensure complete removal of tumors while preserving adjacent, healthy tissue.	[Juhl, Karina; Christensen, Anders; Persson, Morten; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Juhl, Karina; Christensen, Anders; Persson, Morten; Kjaer, Andreas] Rigshosp, Cluster Mol Imaging, DK-2100 Copenhagen, Denmark; [Juhl, Karina; Christensen, Anders; Persson, Morten; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Christensen, Anders] Rigshosp, Dept Otolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark; [Ploug, Michael] Rigshosp, Finsen Lab, Strandboulevarden 49, DK-2100 Copenhagen, Denmark; [Ploug, Michael] Univ Copenhagen, BRIC, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Kjaer, A (corresponding author), Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark.; Kjaer, A (corresponding author), Rigshosp, Cluster Mol Imaging, DK-2100 Copenhagen, Denmark.; Kjaer, A (corresponding author), Univ Copenhagen, Copenhagen, Denmark.	akjaer@sund.ku.dk	; Kjaer, Andreas/E-8932-2015	Ploug, Michael/0000-0003-2215-4265; Kjaer, Andreas/0000-0002-2706-5547	Lundbeck Foundation [R198-2015-1107] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0007149] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)		Alander JT, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/940585; Atallah I, 2015, HEAD NECK; Atkins J, 2012, J SURG RES, V177, P109, DOI 10.1016/j.jss.2012.03.045; Becker A, 2001, NAT BIOTECHNOL, V19, P327, DOI 10.1038/86707; Boonstra MC, 2015, ONCOTARGET; Cozzi PJ, 2006, HUM PATHOL, V37, P1442, DOI 10.1016/j.humpath.2006.05.002; Crane LMA, 2011, GYNECOL ONCOL, V120, P291, DOI 10.1016/j.ygyno.2010.10.009; Day KE, 2013, MOL IMAGING BIOL; Dullin C, 2009, MOL IMAGING, V8, P2, DOI 10.2310/7290.2009.00001; Eldeeb Hany, 2012, Cancer Biology Medicine, V9, P29, DOI 10.3969/j.issn.2095-3941.2012.01.005; Foekens JA, 2000, CANCER RES, V60, P636; Gardsvoll H, 2004, PROTEIN EXPRES PURIF, V34, P284, DOI 10.1016/j.pep.2003.12.002; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Hansen L, 2013, NANOSCALE, V5, P8192, DOI 10.1039/c3nr32922d; Hutteman M, 2011, EJSO-EUR J SURG ONC, V37, P252, DOI 10.1016/j.ejso.2010.12.014; Keereweer S, 2013, CLIN CANCER RES, V19, P3745, DOI 10.1158/1078-0432.CCR-12-3598; Keereweer S, 2011, MOL IMAGING BIOL, V13, P199, DOI 10.1007/s11307-010-0373-2; LeBeau AM, 2014, THERANOSTICS, V4, P267, DOI 10.7150/thno.7323; LeBeau AM, 2015, IMAGING ACTIVE UROKI; Li ZB, 2008, CLIN CANCER RES, V14, P4758, DOI 10.1158/1078-0432.CCR-07-4434; Liu DJ, 2009, BIOCONJUGATE CHEM, V20, P888, DOI 10.1021/bc800433y; Marshall Milton V, 2010, Open Surg Oncol J, V2, P12; Metildi CA, 2012, J AM COLL SURGEONS, V215, P126, DOI 10.1016/j.jamcollsurg.2012.02.021; Nguyen QT, 2013, FLUORESCENCE GUIDED, P1; Noh H, 2013, THERANOSTICS, V3, P487, DOI 10.7150/thno.4218; Ogawa M, 2009, BIOCONJUGATE CHEM, V20, P2177, DOI 10.1021/bc900362k; Ogawa M, 2009, CANCER RES, V69, P1268, DOI 10.1158/0008-5472.CAN-08-3116; Persson M, 2015, THERANOSTICS; Persson M, 2013, CLIN PHYSIOL FUNCT I, V33, P329, DOI 10.1111/cpf.12037; Persson M, 2013, NUCL MED BIOL, V40, P618, DOI 10.1016/j.nucmedbio.2013.03.001; Persson M, 2012, NUCL MED BIOL, V39, P560, DOI 10.1016/j.nucmedbio.2011.10.011; Persson M, 2012, J NUCL MED, V53, P138, DOI 10.2967/jnumed.110.083386; Ploug M, 2001, BIOCHEMISTRY-US, V40, P12157, DOI 10.1021/bi010662g; Ploug M, 2013, THERANOSTICS, V3, P467, DOI 10.7150/thno.3791; Pogue BW, 2010, IEEE J SEL TOP QUANT, V16, P493, DOI 10.1109/JSTQE.2009.2034541; RONNE E, 1995, BREAST CANCER RES TR, V33, P199, DOI 10.1007/BF00665944; Rosenthal EL, 2015, ANN SURG, V261, P46, DOI 10.1097/SLA.0000000000000622; Rosenthal EL, 2015, CLIN CANC RES; Sano K, 2013, BIOCONJUGATE CHEM, V24, P811, DOI 10.1021/bc400050k; Sun CL, 2014, BIOTECHNOL LETT, V36, P1203, DOI 10.1007/s10529-014-1478-5; Swindle P, 2005, J UROLOGY, V174, P903, DOI 10.1097/01.ju.0000169475.00949.78; Vahrmeijer AL, 2013, NAT REV CLIN ONCOL, V10, P507, DOI 10.1038/nrclinonc.2013.123; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; van Driel PBAA, 2014, INT J CANCER, V134, P2663, DOI 10.1002/ijc.28601; YAMAMOTO M, 1994, CANCER RES, V54, P5016; Yang LL, 2014, THERANOSTICS, V4, P106, DOI 10.7150/thno.7409	47	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147428	10.1371/journal.pone.0147428	http://dx.doi.org/10.1371/journal.pone.0147428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828431	Green Submitted, Green Published, gold			2022-12-26	WOS:000369548200020
J	Kamma-Lorger, CS; Pinali, C; Martinez, JC; Harris, J; Young, RD; Bredrup, C; Crosas, E; Malfois, M; Rodahl, E; Meek, KM; Knupp, C				Kamma-Lorger, Christina S.; Pinali, Christian; Carlos Martinez, Juan; Harris, Jon; Young, Robert D.; Bredrup, Cecilie; Crosas, Eva; Malfois, Marc; Rodahl, Eyvind; Meek, Keith M.; Knupp, Carlo			Role of Decorin Core Protein in Collagen Organisation in Congenital Stromal Corneal Dystrophy (CSCD)	PLOS ONE			English	Article							BINDING FORCE; FAMILY; MUTATION; TOMOGRAPHY; PROTEOGLYCANS	The role of Decorin in organising the extracellular matrix was examined in normal human corneas and in corneas from patients with Congenital Stromal Corneal Dystrophy (CSCD). In CSCD, corneal clouding occurs due to a truncating mutation (c.967delT) in the decorin (DCN) gene. Normal human Decorin protein and the truncated one were reconstructed in silico using homology modelling techniques to explore structural changes in the diseased protein. Corneal CSCD specimens were also examined using 3-D electron tomography and Small Angle X-ray diffraction (SAXS), to image the collagen-proteoglycan arrangement and to quantify fibrillar diameters, respectively. Homology modelling showed that truncated Decorin had a different spatial geometry to the normal one, with the truncation removing a major part of the site that interacts with collagen, compromising its ability to bind effectively. Electron tomography showed regions of abnormal stroma, where collagen fibrils came together to form thicker fibrillar structures, showing that Decorin plays a key role in the maintenance of the order in the normal corneal extracellular matrix. Average diameter of individual fibrils throughout the thickness of the cornea however remained normal.	[Kamma-Lorger, Christina S.; Carlos Martinez, Juan; Crosas, Eva; Malfois, Marc] ALBA Synchrotron Light Source, NCD BL11, Barcelona 08290, Spain; [Kamma-Lorger, Christina S.; Pinali, Christian; Harris, Jon; Young, Robert D.; Meek, Keith M.; Knupp, Carlo] Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Res Grp, Cardiff CF24 4HQ, S Glam, Wales; [Bredrup, Cecilie; Rodahl, Eyvind] Haukeland Hosp, Dept Ophthalmol, N-5021 Bergen, Norway; [Rodahl, Eyvind] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway	Cardiff University; University of Bergen; Haukeland University Hospital; University of Bergen	Kamma-Lorger, CS (corresponding author), ALBA Synchrotron Light Source, NCD BL11, Barcelona 08290, Spain.; Kamma-Lorger, CS (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Res Grp, Cardiff CF24 4HQ, S Glam, Wales.	ckamma@cells.es	Bredrup, Cecilie/GPK-4303-2022; Malfois, Marc/L-2974-2014; Martinez Guil, Juan Carlos/R-6601-2018	Malfois, Marc/0000-0001-5231-1896; Martinez Guil, Juan Carlos/0000-0003-2411-5446; Pinali, Christian/0000-0001-9815-6940; Young, Robert D./0000-0002-1452-6682	Medical Research Council [G0600755, MR/K000837/1]; Biotechnology and Biological Sciences Research Council [BB/F022077]; MRC [MR/K000837/1, G0600755] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The project was supported by Medical Research Council 5-year programme grants G0600755 and MR/K000837/1 (www.mrc.ac.uk) and a Biotechnology and Biological Sciences Research Council research grant BB/F022077 (www.bbsrc.ac.uk) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, CURRENT PROTOCOLS BI, DOI DOI 10.1002/0471250953.BI0506S15; Banerjee-Basu S, 2001, Methods Biochem Anal, V43, P253; Boote C, 2011, BIOPHYS J, V101, P33, DOI 10.1016/j.bpj.2011.05.029; Bredrup C, 2005, INVEST OPHTH VIS SCI, V46, P420, DOI 10.1167/iovs.04-0804; Bredrup C, 2010, INVEST OPHTH VIS SCI, V51, P5578, DOI 10.1167/iovs.09-4933; Chaudhari MI, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3521484; Chen S, 2014, MATRIX BIOL, V35, P103, DOI 10.1016/j.matbio.2014.01.004; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Cousins KR, 2011, J AM CHEM SOC, V133, P8388, DOI 10.1021/ja204075s; D'Alfonso G, 2001, J STRUCT BIOL, V134, P246, DOI 10.1006/jsbi.2001.4351; Dalton JAR, 2007, BIOINFORMATICS, V23, P1901, DOI 10.1093/bioinformatics/btm262; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hocking AM, 1998, MATRIX BIOL, V17, P1; Islam M, 2014, J BIOL CHEM, V288, P35526; Jing Y, 2014, CORNEA, V33, P288, DOI 10.1097/ICO.0000000000000055; Jolles P., 1994, PROTEOGLYCANS; Kamma-Lorger CS, 2009, EXP EYE RES, V88, P953, DOI 10.1016/j.exer.2008.12.005; Kim JH, 2011, CORNEA, V30, P1473, DOI 10.1097/ICO.0b013e3182137788; KRANTZ DD, 1991, J BIOL CHEM, V266, P16801; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lewis PN, 2010, STRUCTURE, V18, P239, DOI 10.1016/j.str.2009.11.013; Maurice DM., 1957, J PHYSL, V136, P263; McEvoy FJ, 2007, VET RADIOL ULTRASOUN, V48, P528, DOI 10.1111/j.1740-8261.2007.00290.x; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; MEEK KM, 1986, COLLAGEN REL RES, V6, P203; Meek KM, 2001, PROG RETIN EYE RES, V20, P95, DOI 10.1016/S1350-9462(00)00016-1; Molecular Operating Environment (MOE), 2005, MOE US MAN; Nareyeck G, 2004, EUR J BIOCHEM, V271, P3389, DOI 10.1111/j.1432-1033.2004.04273.x; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Parfitt GJ, 2010, J STRUCT BIOL, V170, P392, DOI 10.1016/j.jsb.2010.01.019; Ress DB, 2004, STRUCTURE, V12, P1763, DOI 10.1016/j.str.2004.07.022; Rodahl E, 2006, AM J OPHTHALMOL, V142, P520, DOI 10.1016/j.ajo.2006.03.064; SCHONHERR E, 1995, J BIOL CHEM, V270, P8877, DOI 10.1074/jbc.270.15.8877; SCOTT JE, 1988, BIOCHEM J, V253, P607, DOI 10.1042/bj2530607; Scott PG, 2006, J BIOMECH, V39, P1159, DOI 10.1016/j.jbiomech.2006.01.011; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Van Ginderdeuren R, 2002, CORNEA, V21, P118, DOI 10.1097/00003226-200201000-00025; Vesentini S, 2006, J BIOMECH, V39, P1160, DOI 10.1016/j.jbiomech.2006.01.013; Vesentini S, 2005, J BIOMECH, V38, P433, DOI 10.1016/j.jbiomech.2004.04.032; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; Zubay G, 1998, BIOCHEMISTRY	44	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147948	10.1371/journal.pone.0147948	http://dx.doi.org/10.1371/journal.pone.0147948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828927	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200045
J	Lu, L; Pandey, AK; Houseal, MT; Mulligan, MK				Lu, Lu; Pandey, Ashutosh K.; Houseal, M. Trevor; Mulligan, Megan K.			The Genetic Architecture of Murine Glutathione Transferases	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; OPEN-ANGLE GLAUCOMA; HIPPOCAMPAL THETA RHYTHM; GENOME-WIDE ASSOCIATION; AGE-AT-ONSET; S-TRANSFERASE; OXIDATIVE STRESS; ELEVATED EXPRESSION; CELL-PROLIFERATION; SIGNALING PATHWAY	Glutathione S-transferase (GST) genes play a protective role against oxidative stress and may influence disease risk and drug pharmacokinetics. In this study, massive multiscalar trait profiling across a large population of mice derived from a cross between C57BL/6J (B6) and DBA2/J (D2)-the BXD family-was combined with linkage and bioinformatic analyses to characterize mechanisms controlling GST expression and to identify downstream consequences of this variation. Similar to humans, mice show a wide range in expression of GST family members. Variation in the expression of Gsta4, Gstt2, Gstz1, Gsto1, and Mgst3 is modulated by local expression QTLs (eQTLs) in several tissues. Higher expression of Gsto1 in brain and liver of BXD strains is strongly associated (P < 0.01) with inheritance of the B6 parental allele whereas higher expression of Gsta4 and Mgst3 in brain and liver, and Gstt2 and Gstz1 in brain is strongly associated with inheritance of the D2 parental allele. Allele-specific assays confirmed that expression of Gsto1, Gsta4, and Mgst3 are modulated by sequence variants within or near each gene locus. We exploited this endogenous variation to identify coexpression networks and downstream targets in mouse and human. Through a combined systems genetics approach, we provide new insight into the biological role of naturally occurring variants in GST genes.	[Lu, Lu; Pandey, Ashutosh K.; Houseal, M. Trevor; Mulligan, Megan K.] Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38106 USA; [Lu, Lu] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; Nantong University	Mulligan, MK (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38106 USA.	mulliganmk@gmail.com		Mulligan, Megan/0000-0003-4909-635X	NIH [R01AA023774, R01ES022614]; Natural Science Foundation of China [30971591]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants R01AA023774 and R01ES022614, and a grant from the Natural Science Foundation of China (30971591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Nimer F, 2013, ANTIOXID REDOX SIGN, V18, P784, DOI 10.1089/ars.2011.4440; Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Alcivar A, 2003, ONCOGENE, V22, P291, DOI 10.1038/sj.onc.1206099; Aleksunes LM, 2012, DRUG METAB DISPOS, V40, P1366, DOI 10.1124/dmd.112.045112; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Amarillo IE, 2014, AM J MED GENET A, V164, P958, DOI 10.1002/ajmg.a.36393; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Ashbrook DG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-850; Ashton KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072278; Atkinson HJ, 2009, BIOCHEMISTRY-US, V48, P11108, DOI 10.1021/bi901180v; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; BAMMLER TK, 1994, BIOCHEM J, V298, P385, DOI 10.1042/bj2980385; Bayer AU, 2002, EUR NEUROL, V47, P165, DOI 10.1159/000047976; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Bernardini S, 2005, CLIN CHEM, V51, P944, DOI 10.1373/clinchem.2004.045955; Beunders G, 2013, AM J HUM GENET, V92, P210, DOI 10.1016/j.ajhg.2012.12.011; BOARD PG, 1981, FEBS LETT, V124, P163, DOI 10.1016/0014-5793(81)80127-5; Board PG, 2008, ANAL BIOCHEM, V374, P25, DOI 10.1016/j.ab.2007.09.029; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Cai QL, 2014, TUMOR BIOL, V35, P247, DOI 10.1007/s13277-013-1030-6; Capurso C, 2010, REJUV RES, V13, P645, DOI 10.1089/rej.2010.1052; CHENEVIXTRENCH G, 1995, CARCINOGENESIS, V16, P1655, DOI 10.1093/carcin/16.7.1655; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Ching GY, 1999, J NEUROSCI, V19, P2974; Chowdhury UK, 2006, TOXICOL APPL PHARM, V216, P446, DOI 10.1016/j.taap.2006.06.014; Ciobanu DC, 2010, GENETICS, V184, P119, DOI 10.1534/genetics.109.107474; Coggan M, 1998, BIOCHEM J, V334, P617, DOI 10.1042/bj3340617; Coggan M, 2002, BIOCHEM J, V366, P323, DOI 10.1042/bj20011878; Coles BF, 2001, PHARMACOGENETICS, V11, P663, DOI 10.1097/00008571-200111000-00004; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Dasgupta S, 2013, CLIN CANCER RES, V19, P4621, DOI 10.1158/1078-0432.CCR-13-0585; Davalieva K, 2015, PROSTATE, V75, P1586, DOI 10.1002/pros.23034; Pinhel MAD, 2013, ARQ NEURO-PSIQUIAT, V71, P527, DOI 10.1590/0004-282X20130076; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Di Curzio DL, 2011, MAMM GENOME, V22, P209, DOI 10.1007/s00335-011-9315-9; Dickson TC, 2005, NEUROBIOL DIS, V18, P286, DOI 10.1016/j.nbd.2004.10.001; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Dreyer J, 2004, J NEUROSCI, V24, P10454, DOI 10.1523/JNEUROSCI.2265-04.2004; Dumont M, 2009, FREE RADICAL BIO MED, V47, P1019, DOI 10.1016/j.freeradbiomed.2009.07.008; Dwivedi S, 2006, TOXICOLOGY, V218, P58, DOI 10.1016/j.tox.2005.10.012; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Engle MR, 2004, TOXICOL APPL PHARM, V194, P296, DOI 10.1016/j.taap.2003.10.001; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Fernandez-Canon JM, 2002, MOL CELL BIOL, V22, P4943, DOI 10.1128/MCB.22.13.4943-4951.2002; Fernandez-Canon JM, 1999, GENOMICS, V58, P263, DOI 10.1006/geno.1999.5832; Fu ZD, 2014, TOXICOL APPL PHARM, V274, P137, DOI 10.1016/j.taap.2013.11.003; Gaier ED, 2014, ANN NY ACAD SCI, V1314, P15, DOI 10.1111/nyas.12378; Ghosh T, 2012, ASIAN J PSYCHIATR, V5, P160, DOI 10.1016/j.ajp.2012.02.023; Giffen PS, 2002, TOXICOL PATHOL, V30, P365, DOI 10.1080/01926230252929945; Goldman SM, 2012, MOVEMENT DISORD, V27, P1652, DOI 10.1002/mds.25216; GRAY JA, 1970, SCIENCE, V168, P1246, DOI 10.1126/science.168.3936.1246; Guan M, 2015, TUMOR BIOL, V36, P2973, DOI 10.1007/s13277-014-2930-9; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; Hirose K, 2013, ANIM SCI J, V84, P213, DOI 10.1111/j.1740-0929.2012.01066.x; Homayouni R, 2005, BIOINFORMATICS, V21, P104, DOI 10.1093/bioinformatics/bth464; Isaacs AM, 2011, CURR ALZHEIMER RES, V8, P246; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; Jaras M, 2014, J EXP MED, V211, P605, DOI 10.1084/jem.20131033; Jang SG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-16; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kegelman TP, 2015, EXPERT OPIN THER TAR, V19, P97, DOI 10.1517/14728222.2014.959495; Kegelman TP, 2014, NEURO-ONCOLOGY, V16, P50, DOI 10.1093/neuonc/not157; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kim WY, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.1; Kolsch H, 2004, NEUROLOGY, V63, P2255, DOI 10.1212/01.WNL.0000147294.29309.47; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Ladner JE, 2004, BIOCHEMISTRY-US, V43, P352, DOI 10.1021/bi035832z; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Lee YM, 2013, MOL GENET METAB, V110, P275, DOI 10.1016/j.ymgme.2013.06.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li K, 2014, INT J CLIN EXP PATHO, V7, P6486; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Lim CEL, 2004, AM J PATHOL, V165, P679, DOI 10.1016/S0002-9440(10)63332-9; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu XM, 2014, ONCOL REP, V32, P2810, DOI 10.3892/or.2014.3498; Liu Y, 2015, AM J MED GENET A, V167, P1381, DOI 10.1002/ajmg.a.37050; Loh YN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-174; Longo GS, 2013, ARQ NEURO-PSIQUIAT, V71, P446, DOI 10.1590/0004-282X20130060; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Matejcic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029366; Mazzetti AP, 2015, NEUROCHEM INT, V82, P10, DOI 10.1016/j.neuint.2015.01.008; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meng XH, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-122; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nishimura M, 2004, NEUROSCI LETT, V368, P140, DOI 10.1016/j.neulet.2004.06.076; Osawa T, 2011, NEUROPATHOLOGY, V31, P569, DOI 10.1111/j.1440-1789.2011.01199.x; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Ozturk A, 2005, NEUROBIOL AGING, V26, P1161, DOI 10.1016/j.neurobiolaging.2004.11.001; Pandey AK, 2014, INT REV NEUROBIOL, V116, P195, DOI 10.1016/B978-0-12-801105-8.00008-4; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Piacentini S, 2012, J NEUROL SCI, V317, P137, DOI 10.1016/j.jns.2012.01.026; Piacentini S, 2012, NEUROSCI LETT, V506, P203, DOI 10.1016/j.neulet.2011.11.005; Pinhel MAS, 2008, CLIN CHEM LAB MED, V46, P439, DOI 10.1515/CCLM.2008.102; Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Rakhshandehroo M, 2012, AM J PHYSIOL-ENDOC M, V302, pE595, DOI 10.1152/ajpendo.00299.2011; Regard JB, 2004, J NEUROSCI, V24, P4092, DOI 10.1523/JNEUROSCI.4252-03.2004; Reitz C, 2009, ANN NY ACAD SCI, V1180, P75, DOI 10.1111/j.1749-6632.2009.04945.x; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Robinson A, 2004, BIOCHEM J, V379, P541, DOI 10.1042/BJ20031656; Ronis MJJ, 2015, AM J PHYSIOL-GASTR L, V308, pG403, DOI 10.1152/ajpgi.00154.2014; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Sarasqueta AF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-277; Schmuck E, 2008, INT J BIOCHEM CELL B, V40, P2553, DOI 10.1016/j.biocel.2008.04.017; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Shroads AL, 2015, J CLIN PHARMACOL, V55, P50, DOI 10.1002/jcph.371; Singh M, 2008, MOL CELL BIOCHEM, V312, P131, DOI 10.1007/s11010-008-9728-2; Singh SP, 2010, J GERONTOL A-BIOL, V65, P14, DOI 10.1093/gerona/glp165; Smeyne M, 2007, P NATL ACAD SCI USA, V104, P1977, DOI 10.1073/pnas.0610978104; Smith KT, 2012, MOL CELL PROTEOMICS, V11, P1815, DOI 10.1074/mcp.M112.020255; Soutourina J, 2000, J BIOL CHEM, V275, P11626, DOI 10.1074/jbc.275.16.11626; Spalletta G, 2007, AM J GERIAT PSYCHIAT, V15, P879, DOI 10.1097/JGP.0b013e3180547076; Speed D, 2014, HUM MOL GENET, V23, P247, DOI 10.1093/hmg/ddt403; Sprenger R, 2000, PHARMACOGENETICS, V10, P557, DOI 10.1097/00008571-200008000-00009; Suga K, 2015, NEUROSCI LETT, V604, P30, DOI 10.1016/j.neulet.2015.07.017; Sun MK, 2001, J NEUROPHYSIOL, V85, P269, DOI 10.1152/jn.2001.85.1.269; Tamura H, 2006, J NEUROL SCI, V246, P79, DOI 10.1016/j.jns.2006.02.009; TAYLOR BA, 1973, P SOC EXP BIOL MED, V143, P629, DOI 10.3181/00379727-143-37380; Tew KD, 2012, ANTIOXID REDOX SIGN, V17, P1728, DOI 10.1089/ars.2012.4640; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Tzeng HF, 2000, CHEM RES TOXICOL, V13, P231, DOI 10.1021/tx990175q; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Wolen AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033575; Xiao Q, 2014, ANN HEMATOL, V93, P1381, DOI 10.1007/s00277-014-2050-z; Xu PT, 2006, NEUROBIOL DIS, V21, P256, DOI 10.1016/j.nbd.2005.07.004; Yang LT, 2002, J BIOL CHEM, V277, P17406, DOI 10.1074/jbc.M111902200; Yang Y, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3442; Ye R, 2014, GENES BRAIN BEHAV, V13, P247, DOI 10.1111/gbb.12092; Yochim BP, 2012, J GLAUCOMA, V21, P250, DOI 10.1097/IJG.0b013e3182071b7e; Zarrindast MR, 2012, BEHAV BRAIN RES, V229, P68, DOI 10.1016/j.bbr.2011.12.033; Zhao YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000472; Zhou TB, 2014, AM J EPIDEMIOL, V180, P1, DOI 10.1093/aje/kwu112	149	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148230	10.1371/journal.pone.0148230	http://dx.doi.org/10.1371/journal.pone.0148230			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829228	gold, Green Published			2022-12-26	WOS:000369548200088
J	Maksimchuk, KR; Alser, KA; Mou, R; Valdivia, RH; McCafferty, DG				Maksimchuk, Kenneth R.; Alser, Katherine A.; Mou, Rui; Valdivia, Raphael H.; McCafferty, Dewey G.			The Chlamydia trachomatis Protease CPAF Contains a Cryptic PDZ-Like Domain with Similarity to Human Cell Polarity and Tight Junction PDZ-Containing Proteins	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FUNCTIONAL-ANALYSIS; LIGAND RECOGNITION; HOST; SPECIFICITY; HOMEOSTASIS; ACTIVATION; GENERATION; PLASTICITY	The need for more effective anti-chlamydial therapeutics has sparked research efforts geared toward further understanding chlamydial pathogenesis mechanisms. Recent studies have implicated the secreted chlamydial serine protease, chlamydial protease-like activity factor (CPAF) as potentially important for chlamydial pathogenesis. By mechanisms that remain to be elucidated, CPAF is directed to a discrete group of substrates, which are subsequently cleaved or degraded. While inspecting the previously solved CPAF crystal structure, we discovered that CPAF contains a cryptic N-terminal PSD95 Dlg ZO-1 (PDZ) domain spanning residues 106-212 (CPAF106-212). This PDZ domain is unique in that it bears minimal sequence similarity to canonical PDZ-forming sequences and displays little sequence and structural similarity to known chlamydial PDZ domains. We show that the CPAF106-212 sequence is homologous to PDZ domains of human tight junction proteins.	[Maksimchuk, Kenneth R.; McCafferty, Dewey G.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Alser, Katherine A.; Mou, Rui; McCafferty, Dewey G.] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Valdivia, Raphael H.] Duke Univ, Mol Genet & Microbiol, Durham, NC USA; [Maksimchuk, Kenneth R.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	Duke University; Duke University; Duke University; University of North Carolina; North Carolina State University	McCafferty, DG (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.; McCafferty, DG (corresponding author), Duke Univ, Dept Chem, Durham, NC 27706 USA.	dewey.mccafferty@duke.edu	Valdivia, Raphael/R-5377-2019	Valdivia, Raphael/0000-0003-0961-073X	National Institutes of Health Allergy and Infectious Diseases Institute [R01 AI107951]; Duke University; National Science Foundation Predoctoral Graduate Research Fellowship (NSF) [GRFP 2011121201]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107951] Funding Source: NIH RePORTER	National Institutes of Health Allergy and Infectious Diseases Institute; Duke University; National Science Foundation Predoctoral Graduate Research Fellowship (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was generously supported by research grant R01 AI107951 from the National Institutes of Health Allergy and Infectious Diseases Institute (to DGM and RV) and by support from Duke University. KRM was kindly supported by a National Science Foundation Predoctoral Graduate Research Fellowship (NSF GRFP 2011121201).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bednar MM, 2011, BIOCHEMISTRY-US, V50, P7441, DOI 10.1021/bi201098r; Beebe KD, 2000, BIOCHEMISTRY-US, V39, P3149, DOI 10.1021/bi992709s; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betts HJ, 2008, J BACTERIOL, V190, P1680, DOI 10.1128/JB.01671-07; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Bohl J, 2007, J BIOL CHEM, V282, P9392, DOI 10.1074/jbc.M610002200; Brown HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100763; Brown HM, 2012, CELL MICROBIOL, V14, P1554, DOI 10.1111/j.1462-5822.2012.01820.x; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Centers for Disease Control and Prevention, 2014, SEX TRANSM DIS SURV; Chen D, 2010, MICROBIOL-SGM, V156, P3031, DOI 10.1099/mic.0.040527-0; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Endo H, SOLUTION STRUCTURE P; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Fujiwara Y, 2015, PROTEIN SCI, V24, P376, DOI 10.1002/pro.2628; Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Harris BZ, 2003, BIOCHEMISTRY-US, V42, P2797, DOI 10.1021/bi027061p; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holmes K, 2007, CHLAMYDIA TRACHOMATI, P575; Hozjan V, CRYSTAL STRUCTURE 1; Huang ZW, 2008, CELL HOST MICROBE, V4, P529, DOI 10.1016/j.chom.2008.10.005; Hultqvist G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050055; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huston WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024547; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Jorgensen I, 2011, CELL HOST MICROBE, V10, P21, DOI 10.1016/j.chom.2011.06.008; Joshi M, 2006, ANGEW CHEM INT EDIT, V45, P3790, DOI 10.1002/anie.200503965; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kessler M, 2012, AM J PATHOL, V180, P186, DOI 10.1016/j.ajpath.2011.09.015; Kohlmann F, 2015, J BACTERIOL, V197, P211, DOI 10.1128/JB.02140-14; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; Kusunoki H, 2006, PROTEINS, V64, P804, DOI 10.1002/prot.21028; Lad SP, 2007, J BACTERIOL, V189, P6619, DOI 10.1128/JB.00429-07; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Monteiro AC, 2013, MOL BIOL CELL, V24, P2849, DOI 10.1091/mbc.E13-06-0298; Nedyalkova L, CRYSTAL STRUCTURE PD; Papagrigoriou E, CRYSTAL STRUCTURE 1; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodriguez-Tirado C, 2012, MICROBES INFECT, V14, P290, DOI 10.1016/j.micinf.2011.11.002; Rowley J, 2012, GLOBAL INCIDENCE PRE; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Saro D, HIGHER RESOLUTION CR; Savijoki K, 2008, FEMS IMMUNOL MED MIC, V54, P375, DOI 10.1111/j.1574-695X.2008.00488.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slep KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050097; Snavely EA, 2014, PATHOG DIS, V71, P336, DOI 10.1111/2049-632X.12179; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stucke VM, 2007, MOL BIOL CELL, V18, P1744, DOI 10.1091/mbc.E06-11-0980; Sun JR, 2009, MICROBES INFECT, V11, P12, DOI 10.1016/j.micinf.2008.10.001; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Ugochukwu E, CRYSTAL STRUCTURE C1; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Vallenius T, 2004, EXP CELL RES, V293, P117, DOI 10.1016/j.yexcr.2003.09.004; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Zhang YN, 2007, PROTEIN SCI, V16, P1738, DOI 10.1110/ps.072833207	75	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147233	10.1371/journal.pone.0147233	http://dx.doi.org/10.1371/journal.pone.0147233			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829550	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200015
J	Vinit, S; Keomani, E; Deramaudt, TB; Bonay, M; Petitjean, M				Vinit, Stephane; Keomani, Emilie; Deramaudt, Therese B.; Bonay, Marcel; Petitjean, Michel			Reorganization of Respiratory Descending Pathways following Cervical Spinal Partial Section Investigated by Transcranial Magnetic Stimulation in the Rat	PLOS ONE			English	Article							CROSSED-PHRENIC PHENOMENON; MOTOR CORTICAL REPRESENTATION; CORD-INJURY; HUMAN DIAPHRAGM; TIDAL VOLUME; RECOVERY; HEMISECTION; MOTONEURONS; PLASTICITY; FACILITATION	High cervical spinal cord injuries lead to permanent respiratory deficits. One preclinical model of respiratory insufficiency in adult rats is the C2 partial injury which causes unilateral diaphragm paralysis. This model allows the investigation of a particular population of respiratory bulbospinal axons which cross the midline at C3-C6 spinal segment, namely the crossed phrenic pathway. Transcranial magnetic stimulation (TMS) is a non-invasive technique that can be used to study supraspinal descending respiratory pathways in the rat. Interestingly, a lateral C2 injury does not affect the amplitude and latency of the largest motor-evoked potential recorded from the diaphragm (MEPdia) ipsilateral to the injury in response to a single TMS pulse, compared to a sham animal. Although the rhythmic respiratory activity on the contralateral diaphragm is preserved at 7 days post-injury, no diaphragm activity can be recorded on the injured side. However, a profound reorganization of the MEPdia evoked by TMS can be observed. The MEPdia is reduced on the non-injured rather than the injured side. This suggests an increase in ipsilateral phrenic motoneurons excitability. Moreover, correlations between MEPdia amplitude and spontaneous contralateral diaphragmatic activity were observed. The larger diaphragm activity correlated with a larger MEPdia on the injured side, and a smaller MEPdia on the non-injured side. This suggests, for the first time, the occurrence of a functional neuroplasticity process involving changes in motoneuron excitability balance between the injured and non-injured sides at a short post-lesional delay.	[Vinit, Stephane; Keomani, Emilie; Deramaudt, Therese B.; Bonay, Marcel; Petitjean, Michel] Univ Versailles St Quentin En Yvelines, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France; [Vinit, Stephane; Keomani, Emilie; Deramaudt, Therese B.; Bonay, Marcel; Petitjean, Michel] Inserm U1179, Lab Physiol TITAN, End Icap, Montigny Le Bretonneux, France; [Deramaudt, Therese B.; Bonay, Marcel] CSM, LIA BAHN, 8 Quai Antoine Ier, MC-98000 Monaco, Monaco; [Bonay, Marcel; Petitjean, Michel] Grp Hosp Paris Ile de France Ouest, Hop Ambroise Pare, AP HP, Serv Physiol Explorat Fonctionnelles, Boulogne Billancourt, France	UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Petitjean, M (corresponding author), Univ Versailles St Quentin En Yvelines, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France.; Petitjean, M (corresponding author), Inserm U1179, Lab Physiol TITAN, End Icap, Montigny Le Bretonneux, France.; Petitjean, M (corresponding author), Grp Hosp Paris Ile de France Ouest, Hop Ambroise Pare, AP HP, Serv Physiol Explorat Fonctionnelles, Boulogne Billancourt, France.	michel.petitjean134@gmail.com	Bonay, Marcel/ABG-2039-2020	Bonay, Marcel/0000-0003-1446-7456; vinit, stephane/0000-0001-7013-1741	European Union [246556]	European Union(European Commission)	This work was supported by funding from the European Union Seventh framework Programme (FP7/2007-2013) under grant agreement No. 246556 (European project RBUCE-UP), HandiMedEx allocated by the French Public Investment Board, the Chancellerie des Universites de Paris (Legs Poix), the "Centre d'Assistance Respiratoire a Domicile d'Ile de France (CARDIF)", the "Fonds de Dotation de Recherche en Sante Respiratoire", LVL Medical, and Universite de Versailles Saint-Quentin-en-Yvelines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov VG, 2007, J PHYSIOL PHARMACOL, V58, P17; Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Bonay M, 2014, NEURAL REGEN RES, V9, P1949, DOI 10.4103/1673-5374.145367; Boulenguez P, 2007, BRAIN RES, V1148, P96, DOI 10.1016/j.brainres.2007.02.060; Buttry JL, 2015, J NEUROSCI METH, V241, P137, DOI 10.1016/j.jneumeth.2014.12.013; Corfield DR, 1998, RESP PHYSIOL, V114, P109, DOI 10.1016/S0034-5687(98)00083-8; Darlot F, 2012, EXP NEUROL, V236, P88, DOI 10.1016/j.expneurol.2012.04.004; Davey NJ, 1996, RESP PHYSIOL, V106, P127, DOI 10.1016/S0034-5687(96)00069-2; Dougherty BJ, 2012, J APPL PHYSIOL, V112, P96, DOI 10.1152/japplphysiol.00690.2011; Ferrini F, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/429815; Fuller DD, 2009, RESP PHYSIOL NEUROBI, V165, P245, DOI 10.1016/j.resp.2008.12.010; Fuller DD, 2006, J APPL PHYSIOL, V100, P800, DOI 10.1152/japplphysiol.00960.2005; GANDEVIA SC, 1987, J PHYSIOL-LONDON, V384, P109, DOI 10.1113/jphysiol.1987.sp016445; Golder FJ, 2005, J NEUROSCI, V25, P2925, DOI 10.1523/JNEUROSCI.0148-05.2005; Golder FJ, 2003, J NEUROSCI, V23, P2494; Goshgarian HG, 2009, RESP PHYSIOL NEUROBI, V169, P85, DOI 10.1016/j.resp.2009.06.005; Goshgarian HG, 2003, J APPL PHYSIOL, V94, P795, DOI 10.1152/japplphysiol.00847.2002; Keomani E, 2014, JOVE-J VIS EXP, DOI 10.3791/51235; Khedr EM, 2001, EUR J APPL PHYSIOL, V85, P560, DOI 10.1007/s004210100504; Lane MA, 2011, RESP PHYSIOL NEUROBI, V179, P3, DOI 10.1016/j.resp.2011.07.004; Lane MA, 2009, RESP PHYSIOL NEUROBI, V169, P123, DOI 10.1016/j.resp.2009.08.007; LIPSKI J, 1986, EXP BRAIN RES, V61, P280; LISSENS MA, 1994, J NEUROL SCI, V124, P204, DOI 10.1016/0022-510X(94)90327-1; Lovett-Barr MR, 2012, J NEUROSCI, V32, P3591, DOI 10.1523/JNEUROSCI.2908-11.2012; Luft AR, 2001, EXP BRAIN RES, V140, P112, DOI 10.1007/s002210100805; Mantilla CB, 2014, EXP NEUROL, V261, P190, DOI 10.1016/j.expneurol.2014.05.027; MASKILL D, 1991, J PHYSIOL-LONDON, V443, P105, DOI 10.1113/jphysiol.1991.sp018825; Minor KH, 2006, EXP NEUROL, V200, P486, DOI 10.1016/j.expneurol.2006.02.125; Navarrete-Opazo A, 2015, EXP NEUROL, V266, P1, DOI 10.1016/j.expneurol.2015.02.007; Polentes J, 2004, NEUROBIOL DIS, V16, P638, DOI 10.1016/j.nbd.2004.04.009; Sharshar T, 2003, J APPL PHYSIOL, V95, P26, DOI 10.1152/japplphysiol.00918.2002; Shionoya K, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00128; SPERRY MA, 1993, EXP NEUROL, V120, P233, DOI 10.1006/exnr.1993.1058; Vinit S, 2006, J NEUROTRAUM, V23, P1137, DOI 10.1089/neu.2006.23.1137; Vinit S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113251; Vinit S, 2011, RESP PHYSIOL NEUROBI, V176, P130, DOI 10.1016/j.resp.2011.02.008; Vinit S, 2009, RESP PHYSIOL NEUROBI, V169, P115, DOI 10.1016/j.resp.2009.08.004; Vinit S, 2009, RESP PHYSIOL NEUROBI, V169, P210, DOI 10.1016/j.resp.2009.07.023; Windelborn JA, 2012, RESP PHYSIOL NEUROBI, V180, P61, DOI 10.1016/j.resp.2011.10.011; Winslow C, 2003, AM J PHYS MED REHAB, V82, P803, DOI 10.1097/01.PHM.0000078184.08835.01; Zimmer MB, 2015, J SPINAL CORD MED, V38, P224, DOI 10.1179/2045772314Y.0000000220	41	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148180	10.1371/journal.pone.0148180	http://dx.doi.org/10.1371/journal.pone.0148180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828648	gold, Green Published, Green Submitted			2022-12-26	WOS:000369548200079
J	Follin, C; Gabery, S; Petersen, A; Sundgren, PC; Bjorkman-Burtcher, I; Latt, J; Mannfolk, P; Erfurth, EM				Follin, Cecilia; Gabery, Sanaz; Petersen, Asa; Sundgren, Pia C.; Bjorkman-Burtcher, Isabella; Latt, Jimmy; Mannfolk, Peter; Erfurth, Eva Marie			Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CARDIOVASCULAR RISK; CIRCULATING GHRELIN; ADULT SURVIVORS; HORMONE; OBESITY; BRAIN; PREVALENCE; RESISTANCE; NUCLEUS	Metabolic complications are prevalent in individuals treated with cranial radiotherapy (CRT) for childhood acute lymphoblastic leukemia (ALL). The hypothalamus is a master regulator of endocrine and metabolic control. The aim of this study was to investigate whether the hypothalamic volume would be associated to metabolic parameters in ALL survivors. Thirty-eight (21 women) survivors participated in this study 34 years after diagnosis and with a median age of 38 (27-46) years. All were treated with a median CRT dose of 24 Gy and 11 years (3-13) of complete hormone supplementation. Comparisons were made to 31 matched controls. We performed analyses of fat mass, fat free mass, plasma (p)-glucose, p-insulin, Homa-Index (a measure of insulin resistance), serum (s)-leptin, s-ghrelin and of the hypothalamic volume in scans obtained by magnetic resonance imaging (MRI) at 3 Tesla. Serum leptin/kg fat mass (r = -0.4, P = 0.04) and fat mass (r = -0.4, P = 0.01) were negatively correlated with the HT volume among ALL survivors, but not among controls. We also detected significantly higher BMI, waist, fat mass, p-insulin, Homa-Index, leptin/kg fat mass and s-ghrelin and significantly lower fat free mass specifically among female ALL survivors (all P<0.01). Interestingly, s-ghrelin levels increased with time since diagnosis and with low age at diagnosis for childhood ALL. Our results showed that leptin/kg fat mass and fat mass were associated with a reduced HT volume 34 years after ALL diagnosis and that women treated with CRT after ALL are at high risk of metabolic abnormalities. Taken together our data suggest that the hypothalamus is involved in the metabolic consequences after CRT in ALL survivors.	[Follin, Cecilia; Erfurth, Eva Marie] Lund Univ, Dept Endocrinol, Skane Univ Hosp, Lund, Sweden; [Follin, Cecilia; Sundgren, Pia C.; Bjorkman-Burtcher, Isabella; Latt, Jimmy; Mannfolk, Peter; Erfurth, Eva Marie] Lund Univ, IKVL, Lund, Sweden; [Gabery, Sanaz; Petersen, Asa] Lund Univ, Translat Neuroendocrine Res Unit, Dept Expt Med Sci, Lund, Sweden; [Sundgren, Pia C.; Bjorkman-Burtcher, Isabella; Latt, Jimmy; Mannfolk, Peter] Lund Univ, Dept Diagnost Radiol, Skane Univ Hosp, Lund, Sweden; [Bjorkman-Burtcher, Isabella] Lund Univ, Lund Univ Bioimaging Ctr LBIC, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Lund University; Skane University Hospital; Lund University	Follin, C (corresponding author), Lund Univ, Dept Endocrinol, Skane Univ Hosp, Lund, Sweden.; Follin, C (corresponding author), Lund Univ, IKVL, Lund, Sweden.	Cecilia.follin@med.lu.se		Sundgren, Pia/0000-0001-9237-1236	Swedish Childhood Cancer Foundation	Swedish Childhood Cancer Foundation(European Commission)	This study was supported by the Swedish Childhood Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao AM, 2005, BRAIN, V128, P1301, DOI 10.1093/brain/awh448; Brennan B, 1999, CLIN ENDOCRINOL, V61, P683; Briggs DI, 2014, ENDOCRINOLOGY, V155, P2411, DOI 10.1210/en.2013-1861; Date Y, 2002, DIABETES, V51, P124, DOI 10.2337/diabetes.51.1.124; DelPparigi A, 2002, J CLIN ENDOCR METAB, V87, P5461, DOI 10.1210/jc.2002-020871; Eden Engstrom B, 2003, J CLIN ENDOCR METAB, V88, P5093; Egido EM, 2002, EUR J ENDOCRINOL, V146, P241, DOI 10.1530/eje.0.1460241; Filippi BM, 2013, REV ENDOCR METAB DIS, V14, P365, DOI 10.1007/s11154-013-9258-4; Flanagan DE, 2003, AM J PHYSIOL-ENDOC M, V284, pE313, DOI 10.1152/ajpendo.00569.2001; Follin C, 2006, J CLIN ENDOCR METAB, V91, P1872, DOI 10.1210/jc.2005-2298; Follin C, 2010, J CLIN ENDOCR METAB, V95, P3726, DOI 10.1210/jc.2010-0117; Gabery S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117593; Gordon-Dseagu V, 2015, PLOS ONE, V18, P1; GUSTAFSSON G, 1981, ACTA PAEDIATR SCAND, V70, P609, DOI 10.1111/j.1651-2227.1981.tb05754.x; Ha J, 2013, DIS MARKERS, V2013, P249, DOI 10.1155/2013/531736; Hempel R, 2012, DIABETES-METAB RES, V28, P76, DOI 10.1002/dmrr.1230; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Holmer H, 2010, J CLIN ENDOCR METAB, V95, P5395, DOI 10.1210/jc.2010-0993; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Howlader N, 2011, SEER CANC STAT REV 1; Kamegai J, 2000, ENDOCRINOLOGY, V141, P4797, DOI 10.1210/en.141.12.4797; Kohno D, 2007, ENDOCRINOLOGY, V148, P2251, DOI 10.1210/en.2006-1240; Link K, 2004, J CLIN ENDOCR METAB, V89, P5003, DOI 10.1210/jc.2004-0126; Lustig RH, 2003, J CLIN ENDOCR METAB, V88, P611, DOI 10.1210/jc.2002-021180; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Maison P, J CLIN ENDOCRINOL ME, V89, P2192; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; O'Brien LM, 2006, HARVARD REV PSYCHIAT, V14, P141, DOI 10.1080/10673220600784119; Peper JS, 2010, PSYCHONEUROENDOCRINO, V35, P133, DOI 10.1016/j.psyneuen.2009.05.025; Saad MF, 2002, J CLIN ENDOCR METAB, V87, P3997, DOI 10.1210/jc.87.8.3997; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Schneeberger M, 2014, J ENDOCRINOL, V220, pT25, DOI 10.1530/JOE-13-0398; Sklar CA, 2000, MED PEDIATR ONCOL, V35, P91, DOI 10.1002/1096-911X(200008)35:2<91::AID-MPO1>3.0.CO;2-G; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Stahl R, 2007, RADIOLOGY, V243, P483, DOI 10.1148/radiol.2432051714; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Vestergaard ET, 2007, J CLIN ENDOCR METAB, V92, P297, DOI 10.1210/jc.2006-1435	37	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147575	10.1371/journal.pone.0147575	http://dx.doi.org/10.1371/journal.pone.0147575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824435	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528600036
J	Padroni, M; Bernardoni, A; Tamborino, C; Roversi, G; Borrelli, M; Saletti, A; De Vito, A; Azzini, C; Borgatti, L; Marcello, O; d'Esterre, C; Ceruti, S; Casetta, I; Lee, TY; Fainardi, E				Padroni, Marina; Bernardoni, Andrea; Tamborino, Carmine; Roversi, Gloria; Borrelli, Massimo; Saletti, Andrea; De Vito, Alessandro; Azzini, Cristiano; Borgatti, Luca; Marcello, Onofrio; d'Esterre, Christopher; Ceruti, Stefano; Casetta, Ilaria; Lee, Ting-Yim; Fainardi, Enrico			Cerebral Blood Volume ASPECTS Is the Best Predictor of Clinical Outcome in Acute Ischemic Stroke: A Retrospective, Combined Semi-Quantitative and Quantitative Assessment	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY PERFUSION; CT PERFUSION; INFARCT CORE; HEMORRHAGIC TRANSFORMATION; THROMBOLYTIC THERAPY; IMAGING SELECTION; PENUMBRA; RECANALIZATION; TRIAL; SCORE	Introduction The capability of CT perfusion (CTP) Alberta Stroke Program Early CT Score (ASPECTS) to predict outcome and identify ischemia severity in acute ischemic stroke (AIS) patients is still questioned. Methods 62 patients with AIS were imaged within 8 hours of symptom onset by non-contrast CT, CT angiography and CTP scans at admission and 24 hours. CTP ASPECTS was calculated on the affected hemisphere using cerebral blood flow (CBF), cerebral blood volume (CBV) and mean transit time (MTT) maps by subtracting 1 point for any abnormalities visually detected or measured within multiple cortical circular regions of interest according to previously established thresholds. MTT-CBV ASPECTS was considered as CTP ASPECTS mismatch. Hemorrhagic transformation (HT), recanalization status and reperfusion grade at 24 hours, final infarct volume at 7 days andmodified Rankin scale (mRS) at 3 months after onset were recorded. Results Semi-quantitative and quantitative CTP ASPECTS were highly correlated (p<0.00001). CBF, CBV and MTT ASPECTS were higher in patients with no HT and mRS <= 2 and inversely associated with final infarct volume and mRS (p values: from p<0.05 to p<0.00001). CTP ASPECTS mismatch was slightly associated with radiological and clinical outcomes (p values: from p<0.05 to p<0.02) only if evaluated quantitatively. A CBV ASPECTS of 9 was the optimal semi-quantitative value for predicting outcome. Conclusions Our findings suggest that visual inspection of CTP ASPECTS recognizes infarct and ischemic absolute values. Semi-quantitative CBV ASPECTS, but not CTP ASPECTS mismatch, represents a strong prognostic indicator, implying that core extent is the main determinant of outcome, irrespective of penumbra size.	[Padroni, Marina; Tamborino, Carmine; Roversi, Gloria; Casetta, Ilaria] Univ Ferrara, Dept Biol Psychiat & Psychol Sci, Neurol Sect, I-44100 Ferrara, Italy; [Bernardoni, Andrea] Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Diagnost Imaging, I-44100 Ferrara, Italy; [Borrelli, Massimo; Saletti, Andrea; Borgatti, Luca; Marcello, Onofrio; Ceruti, Stefano; Fainardi, Enrico] Azienda Osped Univ, Dept Neurosci & Rehabil, Neuroradiol Unit, Ferrara, Italy; [De Vito, Alessandro; Azzini, Cristiano] Azienda Osped Univ, Dept Neurosci & Rehabil, Neurol Unit, Ferrara, Italy; [d'Esterre, Christopher] Univ Calgary, Dept Clin Neurosci, Calgary Stroke Program, Calgary, AB, Canada; [d'Esterre, Christopher; Lee, Ting-Yim] Univ Western Ontario, Robarts Res Inst, Imaging Res Lab, London, ON, Canada; [Lee, Ting-Yim] Univ Western Ontario, Lawson Hlth Res Inst, Imaging program, London, ON, Canada	University of Ferrara; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Arcispedale Sant'Anna; University of Calgary; Western University (University of Western Ontario); Western University (University of Western Ontario)	Fainardi, E (corresponding author), Azienda Osped Univ, Dept Neurosci & Rehabil, Neuroradiol Unit, Ferrara, Italy.	henryfai@tin.it	Lee, Ting-Yim/M-1721-2013; Casetta, Ilaria/K-5289-2016	Casetta, Ilaria/0000-0003-4099-8875; Padroni, Marina/0000-0001-8410-3039; SALETTI, ANDREA/0000-0001-6984-113X; De Vito, Alessandro/0000-0002-7572-819X	Italian National Health System-Research Program entitled "Nuove conoscenze e problematiche assistenziali nell'ictus cerebrale: un Programma Strategico di Ricerca e Sviluppo" [502/92, PG/2007/0293184]; Canadian Stroke Network and European Stroke Network; Canadian Institutes of Health Research; Ontario Research Fund and GE Healthcare	Italian National Health System-Research Program entitled "Nuove conoscenze e problematiche assistenziali nell'ictus cerebrale: un Programma Strategico di Ricerca e Sviluppo"; Canadian Stroke Network and European Stroke Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund and GE Healthcare(General Electric)	This work has been supported by Italian National Health System-Research Program entitled "Nuove conoscenze e problematiche assistenziali nell'ictus cerebrale: un Programma Strategico di Ricerca e Sviluppo" ex art. 12-12bis/D.Lgs n. 502/92, PG/2007/0293184. The authors would also like to thank the Canadian Stroke Network and European Stroke Network, Canadian Institutes of Health Research, Ontario Research Fund and GE Healthcare for partial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermaier A, 2015, J STROKE CEREBROVASC, V24, P2306, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.025; Aviv RI, 2007, AM J NEURORADIOL, V28, P1975, DOI 10.3174/ajnr.A0689; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2011, STROKE, V42, P3435, DOI 10.1161/STROKEAHA.111.618355; d'Esterre CD, 2015, NEUROL SCI, V36, P1777, DOI 10.1007/s10072-015-2244-8; Eilaghi A, 2013, RADIOLOGY, V269, P240, DOI 10.1148/radiol.13122327; Finlayson O, 2013, STROKE, V44, P234, DOI 10.1161/STROKEAHA.112.665208; Goyal M, 2010, NEURORADIOLOGY, V52, P341, DOI 10.1007/s00234-009-0636-2; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Hacke W, 2009, LANCET NEUROL, V8, P141, DOI 10.1016/S1474-4422(08)70267-9; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Jain AR, 2013, AM J NEURORADIOL, V34, P1895, DOI 10.3174/ajnr.A3502; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jovin TG, 2003, STROKE, V34, P2426, DOI 10.1161/01.STR.0000091232.81947.C9; Kamalian S, 2012, AM J NEURORADIOL, V33, P545, DOI 10.3174/ajnr.A2809; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Lin K, 2009, NEURORADIOLOGY, V51, P17, DOI 10.1007/s00234-008-0454-y; Lum C, 2014, STROKE, V45, P2683, DOI 10.1161/STROKEAHA.114.006163; Murphy BD, 2006, STROKE, V37, P1771, DOI 10.1161/01.STR.0000227243.96808.53; Nagar VA, 2009, AM J ROENTGENOL, V193, P1629, DOI 10.2214/AJR.09.2664; Parsons MW, 2005, ANN NEUROL, V58, P672, DOI 10.1002/ana.20638; Psychogios MN, 2013, STROKE, V44, P2188, DOI 10.1161/STROKEAHA.113.001068; Puetz V, 2009, INT J STROKE, V4, P354, DOI 10.1111/j.1747-4949.2009.00337.x; Sanelli PC, 2014, AM J NEURORADIOL, V35, P1045, DOI 10.3174/ajnr.A3518; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Sillanpaa N, 2011, CEREBROVASC DIS EXTR, V1, P6, DOI 10.1159/000324324; Soares BP, 2010, STROKE, V41, pE34, DOI 10.1161/STROKEAHA.109.568766; Souza LCS, 2012, CEREBROVASC DIS, V33, P8, DOI 10.1159/000331914; The Thrombolysis In Myocardial Infarction (TIMI) trial, 1985, N ENGL J MED, V312, P932; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Yoo AJ, 2012, STROKE, V43, P1323, DOI 10.1161/STROKEAHA.111.639401	33	34	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147910	10.1371/journal.pone.0147910	http://dx.doi.org/10.1371/journal.pone.0147910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824672	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528600070
J	Jean-Charles, PY; Zhang, LS; Wu, JH; Han, SO; Brian, L; Freedman, NJ; Shenoy, SK				Jean-Charles, Pierre-Yves; Zhang, Lisheng; Wu, Jiao-Hui; Han, Sang-oh; Brian, Leigh; Freedman, Neil J.; Shenoy, Sudha K.			Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of beta-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor kappa B (NF kappa B) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; DOMAIN-CONTAINING PROTEINS; RAT SM22-ALPHA GENE; BETA-ARRESTIN 2; 7-TRANSMEMBRANE RECEPTORS; NEOINTIMAL HYPERPLASIA; DEUBIQUITINATING ENZYMES; APOLIPOPROTEIN-E; DEFICIENT MICE; EXPRESSION	Toll-like receptor 4 (TLR4) promotes vascular inflammatory disorders such as neointimal hyperplasia and atherosclerosis. TLR4 triggers NF kappa B signaling through the ubiquitin ligase TRAF6 (tumor necrosis factor receptor-associated factor 6). TRAF6 activity can be impeded by deubiquitinating enzymes like ubiquitin-specific protease 20 (USP20), which can reverse TRAF6 autoubiquitination, and by association with the multifunctional adaptor protein beta-arrestin2. Although beta-arrestin2 effects on TRAF6 suggest an anti-inflammatory role, physiologic beta-arrestin2 promotes inflammation in atherosclerosis and neointimal hyperplasia. We hypothesized that anti-and proinflammatory dimensions of beta-arrestin2 activity could be dictated by beta-arrestin2's ubiquitination status, which has been linked with its ability to scaffold and localize activated ERK1/2 to signalosomes. With purified proteins and in intact cells, our protein interaction studies showed that TRAF6/USP20 association and subsequent USP20-mediated TRAF6 deubiquitination were beta-arrestin2-dependent. Generation of transgenic mice with smooth muscle cell-specific expression of either USP20 or its catalytically inactive mutant revealed anti-inflammatory effects of USP20 in vivo and in vitro. Carotid endothelial denudation showed that antagonizing smooth muscle cell USP20 activity increased NF kappa B activation and neointimal hyperplasia. We found that beta-arrestin2 ubiquitination was promoted by TLR4 and reversed by USP20. The association of USP20 with beta-arrestin2 was augmented when beta-arrestin2 ubiquitination was prevented and reduced when beta-arrestin2 ubiquitination was rendered constitutive. Constitutive beta-arrestin2 ubiquitination also augmented NF kappa B activation. We infer that pro-and anti-inflammatory activities of beta-arrestin2 are determined by beta-arrestin2 ubiquitination and that changes in USP20 expression and/or activity can therefore regulate inflammatory responses, at least in part, by defining the ubiquitination status of beta-arrestin2.	[Jean-Charles, Pierre-Yves; Zhang, Lisheng; Wu, Jiao-Hui; Han, Sang-oh; Brian, Leigh; Freedman, Neil J.; Shenoy, Sudha K.] Duke Univ, Med Ctr, Dept Med Cardiol, Durham, NC 27710 USA; [Freedman, Neil J.; Shenoy, Sudha K.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Freedman, NJ (corresponding author), Duke Univ, Med Ctr, Box 3187, Durham, NC 27710 USA.; Shenoy, SK (corresponding author), Duke Univ, Med Ctr, Box 103204, Durham, NC 27710 USA.	neil.freedman@dm.duke.edu; skshenoy@dm.duke.edu	Shenoy, Sudha/AAN-4075-2021	Shenoy, Sudha/0000-0002-2565-4663	National Institutes of Health [HL080525, HL118369, T32 HL00710]; American Heart Association [25550051]; Edna and Fred L. Mandel Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080525, R01HL118369, R01HL121689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Edna and Fred L. Mandel Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL080525 (to S. K. S.) and HL118369 (to S. K. S. and N. J. F.) and Grant 25550051 from the American Heart Association (to S. K. S.). We also acknowledge funding support from the Edna and Fred L. Mandel Jr. Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Training Grant T32 HL00710.	Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Cai XJ, 2009, MOL PHARMACOL, V75, P626, DOI 10.1124/mol.108.050278; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fan HK, 2007, MOL IMMUNOL, V44, P3092, DOI 10.1016/j.molimm.2007.02.009; Fan HK, 2010, IMMUNOLOGY, V130, P344, DOI 10.1111/j.1365-2567.2009.03185.x; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Hou BD, 2004, J BIOL CHEM, V279, P18127, DOI 10.1074/jbc.M310438200; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; KEMP PR, 1995, BIOCHEM J, V310, P1037, DOI 10.1042/bj3101037; Keys JR, 2005, CIRCULATION, V112, P1145, DOI 10.1161/CIRCULATIONAHA.104.531657; Kim J, 2008, CIRC RES, V103, P70, DOI 10.1161/CIRCRESAHA.108.172338; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kommaddi RP, 2015, J BIOL CHEM, V290, P8888, DOI 10.1074/jbc.M114.630541; Kommaddi RP, 2013, PROG MOL BIOL TRANSL, V118, P175, DOI 10.1016/B978-0-12-394440-5.00007-3; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Li PF, 2011, MOL IMMUNOL, V49, P64, DOI 10.1016/j.molimm.2011.07.021; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lokeshwar VB, 2008, J BIOL CHEM, V283, P29215, DOI 10.1074/jbc.M801101200; Lovgren AK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001564; Luttrell LM, 2013, PROG MOL BIOL TRANSL, V118, P115, DOI 10.1016/B978-0-12-394440-5.00005-X; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; OSBOURN JK, 1995, GENE, V154, P249, DOI 10.1016/0378-1119(94)00847-L; Poole E, 2006, EMBO J, V25, P4390, DOI 10.1038/sj.emboj.7601287; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Squadrito F, 2003, ATHEROSCLEROSIS, V166, P233, DOI 10.1016/S0021-9150(02)00336-2; Stoll LL, 2006, CURR PHARM DESIGN, V12, P4229, DOI 10.2174/138161206778743501; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wang XW, 2006, MED SCI MONITOR, V12, pRA177; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Wolfrum S, 2007, P NATL ACAD SCI USA, V104, P18601, DOI 10.1073/pnas.0709011104; Wu JH, 2003, J BIOL CHEM, V278, P44238, DOI 10.1074/jbc.M309450200; Wu JH, 2012, ARTERIOSCL THROM VAS, V32, P308, DOI 10.1161/ATVBAHA.111.239608; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yasunaga J, 2011, J VIROL, V85, P6212, DOI 10.1128/JVI.00079-11; Zernecke A, 2005, BASIC RES CARDIOL, V100, P93, DOI 10.1007/s00395-005-0511-6; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhang LL, 2011, CARDIOVASC RES, V92, P484, DOI 10.1093/cvr/cvr238; Zhang LS, 2007, ARTERIOSCL THROM VAS, V27, P1087, DOI 10.1161/01.ATV.0000261548.49790.63	69	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7450	7464		10.1074/jbc.M115.687129	http://dx.doi.org/10.1074/jbc.M115.687129			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26839314	Green Published, hybrid			2022-12-26	WOS:000383447600021
J	Yun, B; Lee, H; Jayaraja, S; Suram, S; Murphy, RC; Leslie, CC				Yun, Bogeon; Lee, HeeJung; Jayaraja, Sabarirajan; Suram, Saritha; Murphy, Robert C.; Leslie, Christina C.			Prostaglandins from Cytosolic Phospholipase A(2)/Cyclooxygenase-1 Pathway and Mitogen-activated Protein Kinases Regulate Gene Expression in Candida albicans-infected Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal kinase (JNK); cAMP-response element-binding protein (CREB); Candida albicans; cyclic AMP (cAMP); extracellular signal-regulated kinase (ERK); mitogen-activated protein kinase (MAPK); p38 MAPK; phospholipase A; prostaglandin	RESIDENT PERITONEAL-MACROPHAGES; ARACHIDONIC-ACID RELEASE; AMP RESPONSE ELEMENT; CYCLIC-AMP; CYCLOOXYGENASE-2 EXPRESSION; EICOSANOID PRODUCTION; CELL-DIFFERENTIATION; SIGNALING PATHWAY; NUCLEAR RECEPTORS; LIPID MEDIATORS	In Candida albicans-infected resident peritoneal macrophages, activation of group IVA cytosolic phospholipase A(2) (cPLA(2)) by calcium- and mitogen-activated protein kinases triggers the rapid production of prostaglandins I-2 and E-2 through cyclooxygenase (COX)-1 and regulates gene expression by increasing cAMP. In C. albicans-infected cPLA(2)(-/-) or COX-1(-/-) macrophages, expression of Il10, Nr4a2, and Ptgs2 was lower, and expression of Tnf was higher, than in wild type macrophages. Expression was reconstituted with 8-bromo-cAMP, the PKA activator 6-benzoyl-cAMP, and agonists for prostaglandin receptors IP, EP2, and EP4 in infected but not uninfected cPLA(2)(-/-) or COX-1(-/-) macrophages. In C. albicans-infected cPLA(2)(+/+) macrophages, COX-2 expression was blocked by IP, EP2, and EP4 receptor antagonists, indicating a role for both prostaglandin I-2 and E-2. Activation of ERKs and p38, but not JNKs, by C. albicans acted synergistically with prostaglandins to induce expression of Il10, Nr4a2, and Ptgs2. Tnf expression required activation of ERKs and p38 but was suppressed by cAMP. Results using cAMP analogues that activate PKA or Epacs suggested that cAMP regulates gene expression through PKA. However, phosphorylation of cAMP-response element-binding protein (CREB), the cAMP-regulated transcription factor involved in Il10, Nr4a2, Ptgs2, and Tnf expression, was not mediated by cAMP/PKA because it was similar in C. albicans-infected wild type and cPLA(2)(-/-) or COX-1(-/-) macrophages. CREB phosphorylation was blocked by p38 inhibitors and induced by the p38 activator anisomycin but not by the PKA activator 6-benzoyl-cAMP. Therefore, MAPK activation in C. albicans-infected macrophages plays a dual role by promoting the cPLA(2)/prostaglandin/cAMP/PKA pathway and CREB phosphorylation that coordinately regulate immediate early gene expression.	[Yun, Bogeon; Lee, HeeJung; Jayaraja, Sabarirajan; Suram, Saritha; Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA; [Murphy, Robert C.; Leslie, Christina C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Leslie, CC (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	lesliec@njhealth.org	Jayaraja, Sabarirajan/AAC-8653-2022; Murphy, Robert/AAO-5349-2020	Jayaraja, Sabarirajan/0000-0002-2852-4258; Murphy, Robert/0000-0002-9430-6515	National Institutes of Health [HL34303]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL34303 (to C. C. L. and R. C. M.). The authors declare that they have no conflicts of interest with the contents of the article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Alvarez Y, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/201929; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Back M, 2014, BRIT J PHARMACOL, V171, P3551, DOI 10.1111/bph.12665; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; BONNEY RJ, 1978, BIOCHEM J, V176, P433, DOI 10.1042/bj1760433; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bradbury DA, 2003, J BIOL CHEM, V278, P49954, DOI 10.1074/jbc.M307964200; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Casas J, 2009, J IMMUNOL, V183, P2767, DOI 10.4049/jimmunol.0901530; Chinen T, 1999, CLIN EXP IMMUNOL, V115, P491; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DECARVALHO MS, 1993, ARCH BIOCHEM BIOPHYS, V306, P534, DOI 10.1006/abbi.1993.1549; Diaz-Munoz MD, 2012, BIOCHEM J, V443, P451, DOI 10.1042/BJ20111052; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Ermert D, 2013, J LEUKOCYTE BIOL, V94, P223, DOI 10.1189/jlb.0213063; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Girotti M, 2004, J BIOL CHEM, V279, P19113, DOI 10.1074/jbc.M313867200; Grewal S, 2003, J CELL SCI, V116, P2303, DOI 10.1242/jcs.00446; Gubern A, 2009, J BIOL CHEM, V284, P32359, DOI 10.1074/jbc.M109.061515; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Haeggstrom JZ, 2002, CELL MOL LIFE SCI, V59, P742, DOI 10.1007/s00018-002-8463-1; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Healy S, 2013, PHARMACOL THERAPEUT, V137, P64, DOI 10.1016/j.pharmthera.2012.09.001; Ishikawa T, 2009, BIOCHEM BIOPH RES CO, V378, P534, DOI 10.1016/j.bbrc.2008.11.099; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Klein T, 2007, BBA-MOL CELL RES, V1773, P1605, DOI 10.1016/j.bbamcr.2007.09.001; Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006; Leslie CC, 2015, J LIPID RES, V56, P1386, DOI 10.1194/jlr.R057588; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahajan S, 2015, J BIOL CHEM, V290, P18304, DOI 10.1074/jbc.M115.638064; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McEvoy AN, 2002, J IMMUNOL, V168, P2979, DOI 10.4049/jimmunol.168.6.2979; Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018; Naqvi S, 2014, BIOCHEM J, V458, P469, DOI 10.1042/BJ20131115; Norris PC, 2011, J LEUKOCYTE BIOL, V90, P563, DOI 10.1189/jlb.0311153; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Platzer C, 1999, EUR J IMMUNOL, V29, P3098, DOI 10.1002/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; QIU ZH, 1993, J BIOL CHEM, V268, P24506; QIU ZH, 1994, J BIOL CHEM, V269, P19480; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Rodriguez M, 2014, MOL PHARMACOL, V85, P187, DOI 10.1124/mol.113.089573; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Rouzer CA, 2004, J BIOL CHEM, V279, P34256, DOI 10.1074/jbc.M402594200; Rouzer CA, 2006, BIOCHEM J, V399, P91, DOI 10.1042/BJ20060615; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Sales KJ, 2008, MOL CELL ENDOCRINOL, V285, P51, DOI 10.1016/j.mce.2008.01.016; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schroppel K, 2001, INT J MED MICROBIOL, V290, P659, DOI 10.1016/S1438-4221(01)80003-5; SCOTT WA, 1980, J EXP MED, V152, P324, DOI 10.1084/jem.152.2.324; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Suram S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069002; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; Tam VC, 2013, SEMIN IMMUNOL, V25, P240, DOI 10.1016/j.smim.2013.08.006; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Tang FM, 2009, J EXP MED, V206, P707, DOI 10.1084/jem.20071887; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200; Volakakis N, 2010, P NATL ACAD SCI USA, V107, P12317, DOI 10.1073/pnas.1007088107; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yin F, 2006, J MOL CELL CARDIOL, V40, P384, DOI 10.1016/j.yjmcc.2005.12.005; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517; Zhang JY, 2002, PROSTAG OTH LIPID M, V67, P121, DOI 10.1016/S0090-6980(01)00177-0; Zhong J, 2007, J BIOL CHEM, V282, P24246, DOI 10.1074/jbc.M703422200	96	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7070	7086		10.1074/jbc.M116.714873	http://dx.doi.org/10.1074/jbc.M116.714873			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26841868	hybrid, Green Published			2022-12-26	WOS:000373299700041
J	Choudhry, P				Choudhry, Priya			High-Throughput Method for Automated Colony and Cell Counting by Digital Image Analysis Based on Edge Detection	PLOS ONE			English	Article							IN-VITRO; HEART MORPHOLOGY; EPITHELIAL-CELLS; LEAF MORPHOLOGY; STEM-CELLS; CULTURE; TOXICITY; LEUKEMIA; MODELS; GENE	Counting cells and colonies is an integral part of high-throughput screens and quantitative cellular assays. Due to its subjective and time-intensive nature, manual counting has hindered the adoption of cellular assays such as tumor spheroid formation in high-throughput screens. The objective of this study was to develop an automated method for quick and reliable counting of cells and colonies from digital images. For this purpose, I developed an ImageJ macro Cell Colony Edge and a CellProfiler Pipeline Cell Colony Counting, and compared them to other open-source digital methods and manual counts. The ImageJ macro Cell Colony Edge is valuable in counting cells and colonies, and measuring their area, volume, morphology, and intensity. In this study, I demonstrate that Cell Colony Edge is superior to other open-source methods, in speed, accuracy and applicability to diverse cellular assays. It can fulfill the need to automate colony/cell counting in high-throughput screens, colony forming assays, and cellular assays.	[Choudhry, Priya] CALTECH, Dept Chem, Pasadena, CA 91125 USA	California Institute of Technology	Choudhry, P (corresponding author), CALTECH, Dept Chem, Pasadena, CA 91125 USA.	docpriya21@gmail.com	Choudhry, Priya/F-7576-2014	Choudhry, Priya/0000-0002-4438-1576				Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; ALVESGOMES JA, 1995, MOL BIOL EVOL, V12, P298; Anderson Melisa, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P205, DOI 10.1016/S2221-1691(11)60028-2; Azari H, 2011, JOVE-J VIS EXP, DOI 10.3791/2639; Bewes JM, 2008, PHYS MED BIOL, V53, P5991, DOI 10.1088/0031-9155/53/21/007; Brugger SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033695; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Arroyo ECJ, 2013, NAT REV MICROBIOL, V11, P648, DOI 10.1038/nrmicro3090; Cai ZL, 2011, INT J RADIAT BIOL, V87, P1135, DOI 10.3109/09553002.2011.622033; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chang EH, 2015, SCI REP-UK, V5, DOI 10.1038/srep07695; Cheng CM, 2011, MOL CELL BIOL, V31, P983, DOI 10.1128/MCB.00137-10; Choudhry P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058145; Choudhry P, 2011, DEV BIOL, V349, P483, DOI 10.1016/j.ydbio.2010.11.006; Clarke ML, 2010, CYTOM PART A, V77A, P790, DOI 10.1002/cyto.a.20864; Eskiocak U, 2010, RADIAT RES, V174, P27, DOI 10.1667/RR2155.1; Fidanza V, 1996, CANCER RES, V56, P1179; Galli Rossella, 2013, Methods Mol Biol, V986, P267, DOI 10.1007/978-1-62703-311-4_17; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; GRAY TE, 1983, IN VITRO CELL DEV B, V19, P559; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Hebert EM, 2010, INT J RADIAT BIOL, V86, P692, DOI 10.3109/09553001003746067; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Ho WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044640; Horie M, 2010, J BIOCHEM, V148, P289, DOI 10.1093/jb/mvq068; Ivanov DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103817; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kim S, 2014, BIOTECHNOL LETT, V36, P481, DOI 10.1007/s10529-013-1393-1; KOTOURA Y, 1985, ARCH ORTHOP TRAUM SU, V104, P15, DOI 10.1007/BF00449950; Krastev DB, 2011, NAT CELL BIOL, V13, P809, DOI 10.1038/ncb2264; LI Y, 1994, BRIT J HAEMATOL, V87, P471, DOI 10.1111/j.1365-2141.1994.tb08300.x; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Lopez V, 2008, BIOL TRACE ELEM RES, V122, P238, DOI 10.1007/s12011-007-8079-2; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Neame PB, 1997, AM J HEMATOL, V56, P131, DOI 10.1002/(SICI)1096-8652(199711)56:3<131::AID-AJH1>3.0.CO;2-Z; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Park SK, 2010, BREAST CANCER RES TR, V124, P361, DOI 10.1007/s10549-010-0786-2; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Rac M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08882; Ridges S, 2012, BLOOD, V119, P5621, DOI 10.1182/blood-2011-12-398818; RUDIN M, 1991, BASIC RES CARDIOL, V86, P165, DOI 10.1007/BF02190549; Ruusuvuori P, 2014, BIOTECHNIQUES, V56, P18, DOI 10.2144/000114123; Sieuwerts S, 2008, LETT APPL MICROBIOL, V47, P275, DOI 10.1111/j.1472-765X.2008.02417.x; So JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107616; Treloar KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067389; Vieira FCS, 2005, MICROBIOL RES, V160, P197, DOI 10.1016/j.micres.2005.01.004; Vokes Martha S, 2008, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1417s82; Wang Yue J, 2013, Methods Mol Biol, V980, P281, DOI 10.1007/978-1-62703-287-2_15; Williams TF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01317; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhang F, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0368-4; Zhang G, 2012, MOL MED REP, V6, P519, DOI 10.3892/mmr.2012.939	57	70	73	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148469	10.1371/journal.pone.0148469	http://dx.doi.org/10.1371/journal.pone.0148469			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848849	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000369554000100
J	Juge, L; Pong, AC; Bongers, A; Sinkus, R; Bilston, LE; Cheng, S				Juge, Lauriane; Pong, Alice C.; Bongers, Andre; Sinkus, Ralph; Bilston, Lynne E.; Cheng, Shaokoon			Changes in Rat Brain Tissue Microstructure and Stiffness during the Development of Experimental Obstructive Hydrocephalus	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; KAOLIN-INDUCED HYDROCEPHALUS; CEREBRAL WHITE-MATTER; MR ELASTOGRAPHY; IN-VIVO; INFANTILE HYDROCEPHALUS; VISCOELASTIC PROPERTIES; BREAST-LESIONS; IMMATURE RATS; DIFFUSION	Understanding neural injury in hydrocephalus and how the brain changes during the course of the disease in-vivo remain unclear. This study describes brain deformation, microstructural and mechanical properties changes during obstructive hydrocephalus development in a rat model using multimodal magnetic resonance (MR) imaging. Hydrocephalus was induced in eight Sprague-Dawley rats (4 weeks old) by injecting a kaolin suspension into the cisterna magna. Six sham-injected rats were used as controls. MR imaging (9.4T, Bruker) was performed 1 day before, and at 3, 7 and 16 days post injection. T2-weighted MR images were collected to quantify brain deformation. MR elastography was used to measure brain stiffness, and diffusion tensor imaging (DTI) was conducted to observe brain tissue microstructure. Results showed that the enlargement of the ventricular system was associated with a decrease in the cortical gray matter thickness and caudate-putamen cross-sectional area (P < 0.001, for both), an alteration of the corpus callosum and periventricular white matter microstructure (CC+ PVWM) and rearrangement of the cortical gray matter microstructure (P < 0.001, for both), while compression without gross microstructural alteration was evident in the caudate-putamen and ventral internal capsule (P < 0.001, for both). During hydrocephalus development, increased space between the white matter tracts was observed in the CC+ PVWM (P < 0.001), while a decrease in space was observed for the ventral internal capsule (P < 0.001). For the cortical gray matter, an increase in extracellular tissue water was significantly associated with a decrease in tissue stiffness (P = 0.001). To conclude, this study characterizes the temporal changes in tissue microstructure, water content and stiffness in different brain regions and their association with ventricular enlargement. In summary, whilst diffusion changes were larger and statistically significant for majority of the brain regions studied, the changes in mechanical properties were modest. Moreover, the effect of ventricular enlargement is not limited to the CC+ PVWM and ventral internal capsule, the extent of microstructural changes vary between brain regions, and there is regional and temporal variation in brain tissue stiffness during hydrocephalus development.	[Juge, Lauriane; Pong, Alice C.; Bilston, Lynne E.; Cheng, Shaokoon] Neurosci Res Australia, Margarete Ainsworth Bldg, Randwick, NSW, Australia; [Juge, Lauriane] Univ New S Wales, Sch Med Sci, Wallace Wurth Bldg, Kensington, NSW, Australia; [Bongers, Andre] Univ New S Wales, Biol Resources Imaging Lab, Lowy Canc Res Ctr, POB 1, Kensington, NSW 2033, Australia; [Sinkus, Ralph] Kings Coll London, Imaging Sci & Biomed Engn Div Kings Coll, St Thomas Hosp, Biomed Engn, London WC2R 2LS, England; [Bilston, Lynne E.] Univ New S Wales, Prince Wales Clin Sch, Edmund Blacket Bldg, Kensington, NSW 2033, Australia; [Cheng, Shaokoon] Macquarie Univ, Fac Sci, Dept Engn, Sydney, NSW 2109, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of New South Wales Sydney; Macquarie University	Cheng, S (corresponding author), Neurosci Res Australia, Margarete Ainsworth Bldg, Randwick, NSW, Australia.; Cheng, S (corresponding author), Macquarie Univ, Fac Sci, Dept Engn, Sydney, NSW 2109, Australia.	shaokoon.cheng@mq.edu.au	Jugé, Lauriane/F-7085-2014; Bilston, Lynne/C-9665-2011	Jugé, Lauriane/0000-0002-4136-8069; Sinkus, Ralph/0000-0002-6093-1654; Cheng, Shaokoon/0000-0002-2057-4605; Bilston, Lynne/0000-0001-8250-9019	National Health and Medical Research Council of Australia [APP1027684, 568610]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London(General Electric); King's College Hospital NHS Foundation Trust	This project was supported by a project grant (APP1027684) from the National Health and Medical Research Council of Australia [https://www.nhmrc.gov.au/]. L.E. Bilston was supported by a Senior Research Fellowship (#568610) from the National Health and Medical Research Council of Australia [https://www.nhmrc.gov.au/]. The authors also acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish.	Assaf Y, 2006, AM J NEURORADIOL, V27, P1717; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bilston LE, 2011, STUD MECHANOBIOL TIS, V3, P1, DOI 10.1007/978-3-642-13890-4; Bilston LE, 2014, 7 WORLD C BIOM BOST; Bourne RM, 2014, MAGN RESON MED, V72, P1418, DOI 10.1002/mrm.25032; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; CLARK RG, 1970, J NEUROSURG, V32, P400, DOI 10.3171/jns.1970.32.4.0400; Clarke EC, 2011, J BIOMECH, V44, P2461, DOI 10.1016/j.jbiomech.2011.06.023; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; DE SN, 1950, J PATHOL BACTERIOL, V62, P197, DOI 10.1002/path.1700620207; Del Bigio MR, 2003, ANN NEUROL, V53, P337, DOI 10.1002/ana.10453; Del Bigio MR, 1998, EXP NEUROL, V154, P157, DOI 10.1006/exnr.1998.6922; DelBigio MR, 1997, J NEUROPATH EXP NEUR, V56, P1053, DOI 10.1097/00005072-199709000-00010; DelBigio MR, 1997, EXP NEUROL, V148, P256, DOI 10.1006/exnr.1997.6644; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; DIGGS J, 1986, INVEST RADIOL, V21, P118, DOI 10.1097/00004424-198602000-00006; Diguet E, 2009, P INT SOC MAG RESON, P17; ELGAMMAL T, 1987, AM J ROENTGENOL, V149, P807, DOI 10.2214/ajr.149.4.807; EPSTEIN F, 1974, DEV MED CHILD NEUROL, V16, P49; Eskandari R, 2014, CHILD NERV SYST, V30, P1651, DOI 10.1007/s00381-014-2500-x; FLETCHER JM, 1992, ARCH NEUROL-CHICAGO, V49, P818, DOI 10.1001/archneur.1992.00530320042010; Fletcher JM, 1996, ARCH NEUROL-CHICAGO, V53, P549, DOI 10.1001/archneur.1996.00550060093022; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Hakim S, 1976, Surg Neurol, V5, P187; HANIGAN WC, 1991, NEUROSURGERY, V29, P701, DOI 10.1227/00006123-199111000-00010; Harris NG, 1996, EXP NEUROL, V141, P269, DOI 10.1006/exnr.1996.0161; Herring Susan W., 2008, V12, P41, DOI 10.1159/000115031; Ho ML, 2012, AM J ROENTGENOL, V199, pW258, DOI 10.2214/AJR.11.8081; HOCHWALD GM, 1981, Z KINDERCHIR, V34, P403; HOCHWALD GM, 1972, ARCH NEUROL-CHICAGO, V26, P120, DOI 10.1001/archneur.1972.00490080038003; Hoehn-Berlage M, 1999, NMR BIOMED, V12, P45, DOI 10.1002/(SICI)1099-1492(199902)12:1<45::AID-NBM545>3.0.CO;2-6; Hwang YS, 2011, J NEUROSURG-PEDIATR, V7, P401, DOI 10.3171/2011.1.PEDS10182; Juge L, 2012, RADIOLOGY, V264, P436, DOI 10.1148/radiol.12111548; Klatt D, 2006, INVEST RADIOL, V41, P841, DOI 10.1097/01.rli.0000244341.16372.08; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Mcalexander J. H., 2015, J NEUROSURG, P1; MILHORAT TH, 1970, ARCH NEUROL-CHICAGO, V22, P397, DOI 10.1001/archneur.1970.00480230015002; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Olopade FE, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-19; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; PAGE RB, 1975, J NEUROSURG, V42, P646, DOI 10.3171/jns.1975.42.6.0646; PANG DL, 1994, NEUROSURGERY, V35, P643, DOI 10.1227/00006123-199410000-00010; Pena A, 2002, ACT NEUR S, V81, P59; PENN RD, 1984, NEUROSURGERY, V14, P670, DOI 10.1227/00006123-198406000-00004; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pong AC, 2014, 7 WORLD C BIOM BOST; Qin EC, 2014, RADIOLOGY, V273, P726, DOI 10.1148/radiol.14132661; RUBIN RC, 1972, DEV MED CHILD NEUROL, V14, P117; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; SAHAR A, 1969, ARCH NEUROL-CHICAGO, V21, P638, DOI 10.1001/archneur.1969.00480180094009; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; SCHURR PH, 1953, J NEUROSURG, V10, P515, DOI 10.3171/jns.1953.10.5.0515; Shulyakov AV, 2012, NEUROSURGERY, V71, P1032, DOI 10.1227/NEU.0b013e3182690a0c; Sinkus R, 2000, PHYS MED BIOL, V45, P1649, DOI 10.1088/0031-9155/45/6/317; Sinkus R, 2005, MAGN RESON IMAGING, V23, P159, DOI 10.1016/j.mri.2004.11.060; Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404; SKLAR FH, 1980, J NEUROSURG, V53, P173, DOI 10.3171/jns.1980.53.2.0173; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Tan K, 2013, J BIOMECH, V46, P1060, DOI 10.1016/j.jbiomech.2013.01.028; Tu TW, 2014, J NEUROPATH EXP NEUR, V73, P1152, DOI 10.1097/NEN.0000000000000140; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; Vinchon M, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-18; WELLER RO, 1972, J NEUROSURG, V36, P255, DOI 10.3171/jns.1972.36.3.0255; Williams MA, 2007, J NEUROSURG, V107, P345, DOI 10.3171/PED-07/11/345; Williams MA, 2007, J NEUROSURG, V107, P21, DOI 10.3171/JNS-07/07/0021; WILLS KE, 1993, J CLIN CHILD PSYCHOL, V22, P247, DOI 10.1207/s15374424jccp2202_11; YAMADA H, 1992, J NEUROSURG, V76, P856, DOI 10.3171/jns.1992.76.5.0856; Yuan W, 2009, AM J NEURORADIOL, V30, P1792, DOI 10.3174/ajnr.A1663; Yuan WH, 2012, CHILD NERV SYST, V28, P47, DOI 10.1007/s00381-011-1590-y; Yuan WH, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-19	78	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148652	10.1371/journal.pone.0148652	http://dx.doi.org/10.1371/journal.pone.0148652			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848844	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000148
J	Lampert, A; Tlusty, T				Lampert, Adam; Tlusty, Tsvi			Where Two Are Fighting, the Third Wins: Stronger Selection Facilitates Greater Polymorphism in Traits Conferring Competition-Dispersal Tradeoffs	PLOS ONE			English	Article							EVOLUTION; COOPERATION; DYNAMICS; SIZE; GERMINATION; STRATEGIES; STABILITY; RESOURCE; GROWTH	A major conundrum in evolution is that, despite natural selection, polymorphism is still omnipresent in nature: Numerous species exhibit multiple morphs, namely several abundant values of an important trait. Polymorphism is particularly prevalent in asymmetric traits, which are beneficial to their carrier in disruptive competitive interference but at the same time bear disadvantages in other aspects, such as greater mortality or lower fecundity. Here we focus on asymmetric traits in which a better competitor disperses fewer offspring in the absence of competition. We report a general pattern in which polymorphic populations emerge when disruptive selection increases: The stronger the selection, the greater the number of morphs that evolve. This pattern is general and is insensitive to the form of the fitness function. The pattern is somewhat counterintuitive since directional selection is excepted to sharpen the trait distribution and thereby reduce its diversity (but note that similar patterns were suggested in studies that demonstrated increased biodiversity as local selection increases in ecological communities). We explain the underlying mechanism in which stronger selection drives the population towards more competitive values of the trait, which in turn reduces the population density, thereby enabling lesser competitors to stably persist with reduced need to directly compete. Thus, we believe that the pattern is more general and may apply to asymmetric traits more broadly. This robust pattern suggests a comparative, unified explanation to a variety of polymorphic traits in nature.	[Lampert, Adam] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Lampert, Adam] Arizona State Univ, Math Computat & Modeling Sci Ctr, Tempe, AZ 85287 USA; [Tlusty, Tsvi] Inst Adv Study, Simons Ctr Syst Biol, Olden Lane, Princeton, NJ 08540 USA; [Tlusty, Tsvi] Inst Adv Study, Sch Nat Sci, Olden Lane, Princeton, NJ 08540 USA; [Tlusty, Tsvi] UNIST, IBS, Dept Phys, UNIST Gil 50, Ulsan 689798, South Korea; [Tlusty, Tsvi] UNIST, IBS, Ctr Soft & Living Matter, UNIST Gil 50, Ulsan 689798, South Korea	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Institute for Advanced Study - USA; Institute for Advanced Study - USA; Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST); Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST)	Lampert, A (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.; Lampert, A (corresponding author), Arizona State Univ, Math Computat & Modeling Sci Ctr, Tempe, AZ 85287 USA.	adam.lampert@asu.edu	Tlusty, Tsvi/A-9880-2008	Tlusty, Tsvi/0000-0002-9662-3725	School of Human Evolution and Social Change, Arizona State University; Institute for Basic Science [IBS-R020-D1]; Simons Center for Systems Biology at the Institute for Advanced Study	School of Human Evolution and Social Change, Arizona State University; Institute for Basic Science; Simons Center for Systems Biology at the Institute for Advanced Study	We thank Jon Wilkins, Tamar Fridlander, Rami Pugatch, Gyuri Barabas and another (anonymous) reviewer for helpful comments on the manuscript. A.L. is supported by the School of Human Evolution and Social Change, Arizona State University. T.T. has been partly supported by the Institute for Basic Science (IBS-R020-D1) and the Simons Center for Systems Biology at the Institute for Advanced Study.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; ATKINSON WD, 1981, J ANIM ECOL, V50, P461, DOI 10.2307/4067; Barabas G, 2013, THEOR ECOL-NETH, V6, P1, DOI 10.1007/s12080-011-0151-z; Burger R, 2010, THEOR POPUL BIOL, V78, P123, DOI 10.1016/j.tpb.2010.06.002; Burger R, 2005, J MATH BIOL, V50, P355, DOI 10.1007/s00285-004-0294-2; CHRISTIANSEN FB, 1980, THEOR POPUL BIOL, V18, P297, DOI 10.1016/0040-5809(80)90056-8; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Emlen DJ, 2000, BIOSCIENCE, V50, P403, DOI 10.1641/0006-3568(2000)050[0403:IDWEAC]2.0.CO;2; Eshel I, 1996, J MATH BIOL, V34, P485; FLINT SD, 1978, OECOLOGIA, V36, P33, DOI 10.1007/BF00344569; Gavrilets S, 2003, EVOLUTION, V57, P2197; Gavrilets S, 2004, FITNESS LANDSCAPES O; Geritz SAH, 2000, P ROY SOC B-BIOL SCI, V267, P1671, DOI 10.1098/rspb.2000.1194; Geritz SAH, 1999, THEOR POPUL BIOL, V55, P324, DOI 10.1006/tpbi.1998.1409; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hanski I., 1999, METAPOPULATION ECOLO; HASTINGS A, 1980, THEOR POPUL BIOL, V18, P363, DOI 10.1016/0040-5809(80)90059-3; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jansen VAA, 1999, ECOL LETT, V2, P379; Johnson C.G., 1969, MIGRATION DISPERSAL; Johnson TC, 1996, SCIENCE, V273, P1091, DOI 10.1126/science.273.5278.1091; KHAN MA, 1984, AM J BOT, V71, P481, DOI 10.2307/2443323; Kinzig AP, 1999, AM NAT, V153, P371, DOI 10.1086/303182; Kisdi E, 1999, J THEOR BIOL, V197, P149, DOI 10.1006/jtbi.1998.0864; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; Lampert A, 2014, ECOL COMPLEX, V19, P80, DOI 10.1016/j.ecocom.2014.05.002; Lampert A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0559; Lampert A, 2013, P NATL ACAD SCI USA, V110, P205, DOI 10.1073/pnas.1211761110; Lampert A, 2011, EVOLUTION, V65, P2750, DOI 10.1111/j.1558-5646.2011.01364.x; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; MAY RM, 1994, J THEOR BIOL, V170, P95, DOI 10.1006/jtbi.1994.1171; Maynard Smith J., 1982, pi; Nagylaki T, 2007, THEOR POPUL BIOL, V72, P21, DOI 10.1016/j.tpb.2007.02.005; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pillai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033566; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Ross-Gillespie A, 2009, EVOLUTION, V63, P2315, DOI 10.1111/j.1558-5646.2009.00723.x; Rowland JM, 2009, SCIENCE, V323, P773, DOI 10.1126/science.1167345; RYAN MJ, 1992, AM NAT, V139, P21, DOI 10.1086/285311; Schliewen UK, 1994, NATURE, V400, P351; Schneider KA, 2007, THEOR POPUL BIOL, V71, P342, DOI 10.1016/j.tpb.2006.11.003; SHORROCKS B, 1979, J ANIM ECOL, V48, P899, DOI 10.2307/4202; SHUSTER SM, 1991, NATURE, V350, P608, DOI 10.1038/350608a0; TAYLOR LR, 1975, J ANIM ECOL, V44, P135, DOI 10.2307/3855; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143	52	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147970	10.1371/journal.pone.0147970	http://dx.doi.org/10.1371/journal.pone.0147970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845157	Green Submitted, Green Published, gold			2022-12-26	WOS:000369552800023
J	Cassmann, E; White, R; Atherly, T; Wang, C; Sun, YX; Khoda, S; Mosher, C; Ackermann, M; Jergens, A				Cassmann, Eric; White, Robin; Atherly, Todd; Wang, Chong; Sun, Yaxuan; Khoda, Samir; Mosher, Curtis; Ackermann, Mark; Jergens, Albert			Alterations of the Ileal and Colonic Mucosal Microbiota in Canine Chronic Enteropathies	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INVASIVE ESCHERICHIA-COLI; IN-SITU HYBRIDIZATION; MOLECULAR-PHYLOGENETIC CHARACTERIZATION; TARGETED OLIGONUCLEOTIDE PROBES; CROHNS-DISEASE; GRANULOMATOUS COLITIS; E. COLI; DOGS; BACTERIA	Background The intestinal microbiota is increasingly linked to the pathogenesis of chronic enteropathies (CE) in dogs. While imbalances in duodenal and fecal microbial communities have been associated with mucosal inflammation, relatively little is known about alterations in mucosal bacteria seen with CE involving the ileum and colon. Aim To investigate the composition and spatial organization of mucosal microbiota in dogs with CE and controls. Methods Tissue sections from endoscopic biopsies of the ileum and colon from 19 dogs with inflammatory bowel disease (IBD), 6 dogs with granulomatous colitis (GC), 12 dogs with intestinal neoplasia, and 15 controls were studied by fluorescence in situ hybridization (FISH) on a quantifiable basis. Results The ileal and colonic mucosa of healthy dogs and dogs with CE is predominantly colonized by bacteria localized to free and adherent mucus compartments. CE dogs harbored more (P < 0.05) mucosal bacteria belonging to the Clostridium-coccoides/Eubacterium rectale group, Bacteroides, Enterobacteriaceae, and Escherichia coli versus controls. Within the CE group, IBD dogs had increased (P < 0.05) Enterobacteriaceae and E. coli bacteria attached onto surface epithelia or invading within the intestinal mucosa. Bacterial invasion with E. coli was observed in the ileal and colonic mucosa of dogs with GC (P < 0.05). Dogs with intestinal neoplasia had increased (P < 0.05) adherent (total bacteria, Enterobacteriaceae, E. coli) and invasive (Enterobacteriaceae, E. coli, and Bacteroides) bacteria in biopsy specimens. Increased numbers of total bacteria adherent to the colonic mucosa were associated with clinical disease severity in IBD dogs (P < 0.05). Conclusion Pathogenic events in canine CE are associated with different populations of the ileal and colonic mucosal microbiota.	[Cassmann, Eric; White, Robin; Khoda, Samir; Jergens, Albert] Iowa State Univ, Dept Vet Clin Sci, Coll Vet Med, Ames, IA USA; [Atherly, Todd] ARS, USDA, Ames, IA USA; [Wang, Chong; Sun, Yaxuan] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, Ames, IA USA; [Mosher, Curtis] Iowa State Univ, Coll Liberal Arts & Sci, Dept Genet Dev & Cell Biol, Ames, IA USA; [Ackermann, Mark] Iowa State Univ, Dept Vet Pathol, Coll Vet Med, Ames, IA USA	Iowa State University; United States Department of Agriculture (USDA); Iowa State University; Iowa State University; Iowa State University	Jergens, A (corresponding author), Iowa State Univ, Dept Vet Clin Sci, Coll Vet Med, Ames, IA USA.	ajergens@iastate.edu	Wang, Chong/AAI-3796-2020; Cassmann, Eric D/B-2749-2016	Wang, Chong/0000-0003-4489-4344; Cassmann, Eric D/0000-0002-7130-2650; White, Robin/0000-0003-4811-2573				Allenspach K, 2007, J VET INTERN MED, V21, P700, DOI 10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2; Allenspach K, 2010, VET MICROBIOL, V146, P326, DOI 10.1016/j.vetmic.2010.05.025; Allenspach K, 2011, VET CLIN N AM-SMALL, V41, P345, DOI 10.1016/j.cvsm.2011.01.004; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Casamian-Sorrosal D, 2010, J VET INTERN MED, V24, P80, DOI 10.1111/j.1939-1676.2009.0427.x; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Glanemann B, 2008, J VET INTERN MED, V22, P1090, DOI 10.1111/j.1939-1676.2008.0147.x; Janeczko S, 2008, VET MICROBIOL, V128, P178, DOI 10.1016/j.vetmic.2007.10.014; Jergens AE, 2014, VET PATHOL, V51, P946, DOI 10.1177/0300985813511123; Jergens AE, 2009, J VET INTERN MED, V23, P16, DOI 10.1111/j.1939-1676.2008.0211.x; Jergens AE, 2003, J VET INTERN MED, V17, P291, DOI 10.1892/0891-6640(2003)017&lt;0291:ASIFDA&gt;2.3.CO;2; JERGENS AE, 1992, J AM VET MED ASSOC, V201, P1603; Jergens Albert E, 2012, Front Biosci (Elite Ed), V4, P1404; Kleessen B, 2002, SCAND J GASTROENTERO, V37, P1034, DOI 10.1080/003655202320378220; Kopp ZA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00017; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kuhbacher T, 2006, GUT, V55, P833, DOI 10.1136/gut.2005.078303; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Manchester AC, 2013, J VET INTERN MED, V27, P56, DOI 10.1111/jvim.12020; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Martinez-Medina M, 2011, APPL ENVIRON MICROB, V77, P5813, DOI 10.1128/AEM.02614-10; McGregor DP, 1996, BIOTECHNIQUES, V21, P463; Minamoto Y, 2015, GUT MICROBES, V6, P33, DOI 10.1080/19490976.2014.997612; Mira- Pascual L, 2014, J GASTROENTEROL; Packey CD, 2008, J INTERN MED, V263, P597, DOI 10.1111/j.1365-2796.2008.01962.x; POULSEN LK, 1994, INFECT IMMUN, V62, P5191, DOI 10.1128/IAI.62.11.5191-5194.1994; Priestnall SL, 2004, J CLIN MICROBIOL, V42, P2144, DOI 10.1128/JCM.42.5.2144-2151.2004; Procoli F, 2013, J VET INTERN MED, V27, P268, DOI 10.1111/jvim.12041; Sartor R Balfour, 2007, Curr Gastroenterol Rep, V9, P497; Simpson KW, 2006, INFECT IMMUN, V74, P4778, DOI 10.1128/IAI.00067-06; Simpson KW, 2011, VET CLIN N AM-SMALL, V41, P381, DOI 10.1016/j.cvsm.2011.02.003; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Vasquez N, 2007, INFLAMM BOWEL DIS, V13, P684, DOI 10.1002/ibd.20084; Willard MD, 2002, J AM VET MED ASSOC, V220, P1177, DOI 10.2460/javma.2002.220.1177; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x; Zhu QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090849	49	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147321	10.1371/journal.pone.0147321	http://dx.doi.org/10.1371/journal.pone.0147321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840462	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200032
J	Jurets, A; Le Bras, M; Staffler, G; Stein, G; Leitner, L; Neuhofer, A; Tardelli, M; Turkof, E; Zeyda, M; Stulnig, TM				Juerets, Alexander; Le Bras, Marie; Staffler, Guenther; Stein, Gesine; Leitner, Lukas; Neuhofer, Angelika; Tardelli, Matteo; Turkof, Edvin; Zeyda, Maximilian; Stulnig, Thomas M.			Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage	PLOS ONE			English	Article							CRYPTIC EPITOPE SLAYGLR; RHEUMATOID-ARTHRITIS; ADIPOSE-TISSUE; LIGAND INTERACTION; PROTEOLYTIC FRAGMENTS; INSULIN-RESISTANCE; TERMINAL FRAGMENT; INTEGRIN; EXPRESSION; OBESITY	Osteopontin (OPN), a secreted protein involved in inflammatory processes and cancer, induces cell adhesion, migration, and activation of inflammatory pathways in various cell types. Cells bind OPN via integrins at a canonical RGD region in the full length form as well as to a contiguous cryptic site that some have shown is unmasked upon thrombin or matrix metalloproteinase cleavage. Thus, the adhesive capacity of osteopontin is enhanced by proteolytic cleavage that may occur in inflammatory conditions such as obesity, atherosclerosis, rheumatoid arthritis, tumor growth and metastasis. Our aim was to inhibit cellular adhesion to recombinant truncated proteins that correspond to the N-terminal cleavage products of thrombin-or matrix metalloproteinase-cleaved OPN in vitro. We specifically targeted the cryptic integrin binding site with monoclonal antibodies and antisera induced by peptide immunization of mice. HEK 293 cells adhered markedly stronger to truncated OPN proteins than to full length OPN. Without affecting cell binding to the full length form, the raised monoclonal antibodies specifically impeded cellular adhesion to the OPN fragments. Moreover, we show that the peptides used for immunization were able to induce antisera, which impeded adhesion either to all OPN forms, including the full-length form, or selectively to the corresponding truncated recombinant proteins. In conclusion, we developed immunological tools to selectively target functional properties of protease-cleaved OPN forms, which could find applications in treatment and prevention of various inflammatory diseases and cancers.	[Juerets, Alexander; Stein, Gesine; Leitner, Lukas; Neuhofer, Angelika; Tardelli, Matteo; Zeyda, Maximilian; Stulnig, Thomas M.] Med Univ Vienna, Christian Doppler Lab Cardiometab Immunotherapy, Vienna, Austria; [Juerets, Alexander; Stein, Gesine; Leitner, Lukas; Neuhofer, Angelika; Tardelli, Matteo; Zeyda, Maximilian; Stulnig, Thomas M.] Med Univ Vienna, Dept Med 3, Clin Div Endocrinol & Metab, Vienna, Austria; [Le Bras, Marie; Staffler, Guenther] AFFiRiS AG, A-1030 Vienna, Austria; [Turkof, Edvin] Med Univ Vienna, Dept Plast & Reconstruct Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Stulnig, TM (corresponding author), Med Univ Vienna, Christian Doppler Lab Cardiometab Immunotherapy, Vienna, Austria.	thomas.stulnig@meduniwien.ac.at	Tardelli, Matteo/U-3834-2019; Jürets, Alexander/K-3469-2019	Tardelli, Matteo/0000-0003-2232-7779; Neuhofer, Angelika/0000-0002-8989-6207; Stulnig, Thomas/0000-0003-3300-6161; Zeyda, Maximilian/0000-0001-5000-1974	Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology and Development; AFFiRiS AG	Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology and Development; AFFiRiS AG	This study was funded by the Austrian Federal Ministry of Science, Research and Economy and the National Foundation for Research, Technology and Development (to TMS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AFFiRiS AG provided support in the form of salaries for authors MLB and GS, but did not have any additional role in the study design, data collection and analysis, or decision to publish.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Bachmann MF, 2013, VACCINE, V31, P1777, DOI 10.1016/j.vaccine.2013.02.001; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; Barry ST, 2000, BIOCHEM BIOPH RES CO, V267, P764, DOI 10.1006/bbrc.1999.2032; Bayless KJ, 1998, J CELL SCI, V111, P1165; Boumans MJH, 2012, ANN RHEUM DIS, V71, P180, DOI 10.1136/annrheumdis-2011-200298; Breyne J, 2010, ATHEROSCLEROSIS, V213, P369, DOI 10.1016/j.atherosclerosis.2010.07.047; BROWN LF, 1994, AM J PATHOL, V145, P610; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Christensen B, 2014, J DAIRY SCI, V97, P136, DOI 10.3168/jds.2013-7223; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Gabazza EC, 1999, LUNG, V177, P253, DOI 10.1007/PL00007645; Galabova G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114469; Gao YA, 2004, MATRIX BIOL, V23, P457, DOI 10.1016/j.matbio.2004.09.003; GIACHELLI CM, 1995, ANN NY ACAD SCI, V760, P109, DOI 10.1111/j.1749-6632.1995.tb44624.x; Gravallese EM, 2003, J CLIN INVEST, V112, P147, DOI 10.1172/JCI200310109; Hamamoto S, 2011, J BONE MINER RES, V26, P2967, DOI 10.1002/jbmr.495; Hasegawa M, 2009, J RHEUMATOL, V36, P240, DOI 10.3899/jrheum.080753; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hoshino M, 1998, J ALLERGY CLIN IMMUN, V102, P783, DOI 10.1016/S0091-6749(98)70018-1; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Hui T, 2015, MATRIX BIOL, V41, P19, DOI 10.1016/j.matbio.2014.11.005; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kessenbrock K, 2015, MATRIX BIOL, V44-46, P184, DOI 10.1016/j.matbio.2015.01.022; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Kon S, 2002, J CELL BIOCHEM, V84, P420, DOI 10.1002/jcb.10039; Konno S, 2011, CLIN EXP ALLERGY, V41, P1360, DOI 10.1111/j.1365-2222.2011.03775.x; Leitner L, 2015, OBESITY, V23, P779, DOI 10.1002/oby.21024; Madden HL, 2000, AM J RESP CRIT CARE, V162, P1553, DOI 10.1164/ajrccm.162.4.2001015; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Mas-Moruno C, 2010, ANTI-CANCER AGENT ME, V10, P753, DOI 10.2174/187152010794728639; Megaptche AP, 2014, IMMUNOL CELL BIOL, V92, P709, DOI 10.1038/icb.2014.47; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Petrow PK, 2000, ARTHRITIS RHEUM, V43, P1597, DOI 10.1002/1529-0131(200007)43:7<1597::AID-ANR25>3.0.CO;2-0; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Platzer G, 2011, BIOCHEMISTRY-US, V50, P6113, DOI 10.1021/bi200291e; Schack L, 2009, J IMMUNOL, V182, P6943, DOI 10.4049/jimmunol.0900065; SENGER DR, 1989, BIOCHIM BIOPHYS ACTA, V996, P43, DOI 10.1016/0167-4838(89)90092-7; Shao ZF, 2014, J BIOL CHEM, V289, P27146, DOI 10.1074/jbc.M114.572172; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Smith LL, 1999, J CELL BIOCHEM, V73, P20, DOI 10.1002/(SICI)1097-4644(19990401)73:1<20::AID-JCB3>3.0.CO;2-3; Vacek TP, 2015, VASC HEALTH RISK MAN, V11, P173, DOI 10.2147/VHRM.S68415; Wang MY, 2015, P NATL ACAD SCI USA, V112, P2503, DOI 10.1073/pnas.1424934112; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Weetall M, 2001, ANAL BIOCHEM, V293, P277, DOI 10.1006/abio.2001.5140; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Yamamoto N, 2007, INT IMMUNOPHARMACOL, V7, P1460, DOI 10.1016/j.intimp.2007.06.009; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zeyda M, 2011, ENDOCRINOLOGY, V152, P2219, DOI 10.1210/en.2010-1328; Zhang FJ, 2015, RHEUMATOL INT, V35, P589, DOI 10.1007/s00296-014-3122-z	57	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148333	10.1371/journal.pone.0148333	http://dx.doi.org/10.1371/journal.pone.0148333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840958	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200127
J	Ramos, A; Petit, O; Longour, P; Pasquaretta, C; Sueur, C				Ramos, Amandine; Petit, Odile; Longour, Patrice; Pasquaretta, Cristian; Sueur, Cedric			Space Use and Movement Patterns in a Semi-Free-Ranging Herd of European Bison (Bison bonasus)	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; FLIGHT SEARCH PATTERNS; SEXUAL SEGREGATION; ACTIVITY BUDGETS; DECISION-MAKING; HOME-RANGE; LEVY; CONSERVATION; DENSITY; BEHAVIOR	The successful reintroduction and restocking of the European Bison demands a reliable knowledge of the biology of this species. Yet little is known to date about the European bison, and empirical data remains insufficient to set up a reliable plan ensuring the reintroduction, maintenance and survival of populations in habitats that have been largely modified by human activity. Studies of the ecology, social behaviour and management of bison are therefore crucial to the conservation of this species and its cohabitation with humans. To meet these challenges, we focused on movement patterns and space use in a semi-free-ranging herd of European bison living in the Reserve Biologique des Monts-d'Azur (France). Bison spend over 80% of their time foraging and resting; foraging mainly occurs around the artificial feeding sites (i.e., hay racks) or in meadows. The time of day and the presence of snow have no influence on the time budget allocated to each activity. Animals, however, spend more time at the food racks in winter. Bison also spend most of their time in small groups of individuals, confirming the occurrence of both fission-fusion dynamics and sexual segregation in this species. Bison seem to follow a Levy walk pattern of movement, which is probably related to the geographical distribution and size of food patches in the reserve. The conclusions of this study provide a better understanding of the sociality, life habits and habitat use of bison, and also describe how the provision of hay affects all these behaviours. These results could be useful in the development of tools to select the most suitable habitats for the reintroduction, management and conservation of bison populations.	[Ramos, Amandine; Petit, Odile; Pasquaretta, Cristian; Sueur, Cedric] Ctr Natl Rech Sci, Dept Ecol Physiol & Ethol, Strasbourg, France; [Ramos, Amandine; Petit, Odile; Pasquaretta, Cristian; Sueur, Cedric] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Longour, Patrice] Domaine Haut Thorenc, Reserve Biol Monts dAzur, Thorenc, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sueur, C (corresponding author), Ctr Natl Rech Sci, Dept Ecol Physiol & Ethol, Strasbourg, France.; Sueur, C (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France.	cedric.sueur@iphc.cnrs.fr	Pasquaretta, Cristian/AAA-3364-2021; Sueur, Cédric/A-4020-2011	Pasquaretta, Cristian/0000-0001-8308-9968; Sueur, Cédric/0000-0001-8206-2739	Fyssen Foundation	Fyssen Foundation	The authors thank Baptiste Vivinus for his help during bison observations. C.S. gratefully acknowledges the support of the Fyssen Foundation.	Aldezabal A, 2010, PIRINEOS, V153, P145; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Balciauskas Linas, 1999, Acta Zoologica Lituanica, V9, P3; Benecke N, 2015, ANTROPOLOGIA ARKEOLO, V57, P421; Bocherens H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115090; Bon R, 1996, BEHAV PROCESS, V38, P131, DOI 10.1016/S0376-6357(96)00029-0; Bowyer RT, 2004, J MAMMAL, V85, P1039, DOI 10.1644/BBL-002.1; CABONRACZYNSKA K, 1983, ACTA THERIOL, V28, P273, DOI 10.4098/AT.arch.83-22; CABONRACZYNSKA K, 1987, ACTA THERIOL, V32, P335, DOI 10.4098/AT.arch.87-24; Caro T, 2013, ANIM BEHAV, V85, P305, DOI 10.1016/j.anbehav.2012.11.007; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Couzin ID, 2009, CURR BIOL, V19, pR633, DOI 10.1016/j.cub.2009.05.034; DANELL K, 1994, J MAMMAL, V75, P833, DOI 10.2307/1382465; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; ERRIKSSON LO, 1981, OECOLOGIA, V48, P64, DOI 10.1007/BF00346989; Fersterer P, 2001, URSUS-SERIES, V12, P51; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; Focardi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006587; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Hoffman TS, 2012, ECOL SOC, V17, DOI 10.5751/ES-04882-170313; Hofman-Kaminska E, 2012, ENVIRON MANAGE, V50, P530, DOI 10.1007/s00267-012-9913-7; HOLM S, 1979, SCAND J STAT, V6, P65; Hudson RJ, 2006, J RANGE MANAGEMENT A, V54, P218; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Jacobs A, 2010, BEHAV PROCESS, V84, P678, DOI 10.1016/j.beproc.2010.03.004; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kaplan BS, 2011, INT J PRIMATOL, V32, P1397, DOI 10.1007/s10764-011-9541-8; Kerley GIH, 2012, ECOGRAPHY, V35, P519, DOI 10.1111/j.1600-0587.2011.07146.x; Kowalczyk R, 2013, ACTA THERIOL, V58, P391, DOI 10.1007/s13364-013-0136-y; Kozlo P, 2011, EUROPEAN BISON CONSE, V4, P37; KRASINSKA M, 1995, ACTA THERIOL, V40, P1; Krasinska M, 2000, ACTA THERIOL, V45, P321, DOI 10.4098/AT.arch.00-32; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Kuemmerle T, 2010, BIOL CONSERV, V143, P908, DOI 10.1016/j.biocon.2009.12.038; Kuijper DPJ, 2010, J VEG SCI, V21, P1082, DOI 10.1111/j.1654-1103.2010.01217.x; Landman M, 2014, BIOTROPICA, V46, P42, DOI 10.1111/btp.12066; McHugh T, 1958, SOCIAL BEHAV AM BUFF; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; Merkle JA, 2015, ECOL LETT, V18, P799, DOI 10.1111/ele.12457; Merkle JA, 2015, ECOLOGY, V96, P1793, DOI 10.1890/14-0805.1; Mooring MS, 2005, BEHAVIOUR, V142, P897, DOI 10.1163/1568539055010110; Mysterud A, 2007, ANIM CONSERV, V10, P77, DOI 10.1111/j.1469-1795.2006.00075.x; Neuhaus P, 2002, CAN J ZOOL, V80, P1437, DOI 10.1139/Z02-126; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Parnikoza I., 2009, EUROPEAN BISON CONSE, V2, P5; Pays O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034678; Perzanowski K, 2007, WILDLIFE BIOL, V13, P108, DOI 10.2981/0909-6396(2007)13[108:AFFEBB]2.0.CO;2; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Pyziel AM, 2011, J PARASITOL, V97, P737, DOI 10.1645/GE-2567.1; Radwan J, 2010, BIOL CONSERV, V143, P2049, DOI 10.1016/j.biocon.2010.05.012; Ramseyer A, 2009, ANIMAL, V3, P1319, DOI 10.1017/S1751731109004790; ROBITAILLE JF, 1993, ZOO BIOL, V12, P367, DOI 10.1002/zoo.1430120407; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Sahlsten J, 2010, WILDLIFE BIOL, V16, P85, DOI 10.2981/08-085; Selva N, 2003, ECOSCIENCE, V10, P303, DOI 10.1080/11956860.2003.11682778; Shakun V, 2012, EUROPEAN BISON CONSE, V5, P95; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; Sueur C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026788; Sueur C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016131; Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896; Tokarska M, 2011, MAMMAL REV, V41, P151, DOI 10.1111/j.1365-2907.2010.00178.x; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Zdzislaw Pucek, 2004, EUROPEAN BISON BISON; Ziolkowska E, 2012, BIOL CONSERV, V146, P188, DOI 10.1016/j.biocon.2011.12.017	67	12	13	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147404	10.1371/journal.pone.0147404	http://dx.doi.org/10.1371/journal.pone.0147404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841107	Green Published, gold			2022-12-26	WOS:000369550200038
J	Muntion, S; Ramos, TL; Diez-Campelo, M; Roson, B; Sanchez-Abarca, LI; Misiewicz-Krzeminska, I; Preciado, S; Sarasquete, ME; de las Rivas, J; Gonzalez, M; Sanchez-Guijo, F; del Canizo, MC				Muntion, Sandra; Ramos, Teresa L.; Diez-Campelo, Maria; Roson, Beatriz; Ignacio Sanchez-Abarca, Luis; Misiewicz-Krzeminska, Irena; Preciado, Silvia; Sarasquete, Maria-Eugenia; de las Rivas, Javier; Gonzalez, Marcos; Sanchez-Guijo, Fermin; del Canizo, Maria-Consuelo			Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients	PLOS ONE			English	Article							BONE-MARROW; STEM-CELLS; EXTRACELLULAR VESICLES; MICRORNAS; EXPRESSION; MECHANISM; MDM2; HEMATOPOIESIS; COMMUNICATION; PATHOGENESIS	Exosomes/microvesicles (MVs) provide a mechanism of intercellular communication. Our hypothesis was that mesenchymal stromal cells (MSC) from myelodysplastic syndrome (MDS) patients could modify CD34(+) cells properties by MVs. They were isolated from MSC from MDS patients and healthy donors (HD). MVs from 30 low-risk MDS patients and 27 HD were purified by ExoQuick-TC (TM) or ultracentrifugation and identified by transmission electron microscopy, flow cytometry (FC) and western blot for CD63. Incorporation of MVs into CD34(+) cells was analyzed by FC, and confocal and fluorescence microscopy. Changes in hematopoietic progenitor cell (HPC) properties were assessed from modifications in microRNAs and gene expression in CD34(+) cells as well as viability and clonogenic assays of CD34(+) cells after MVs incorporation. Some microRNAs were overexpressed in MVs from patients MSC and two of them, miR-10a and miR-15a, were confirmed by RT-PCR. These microRNAs were transferred to CD34(+) cells, modifying the expression of MDM2 and P53 genes, which was evaluated by RT-PCR and western blot. Finally, examining CD34(+) cells properties after incorporation, higher cell viability (p = 0.025) and clonogenic capacity (p = 0.037) were observed when MVs from MDS patients were incorporated. In summary, we show that BM-MSC release MVs with a different cargo in MDS patients compared with HD. These structures are incorporated into HPC and modify their properties.	[Muntion, Sandra; Ramos, Teresa L.; Diez-Campelo, Maria; Ignacio Sanchez-Abarca, Luis; Misiewicz-Krzeminska, Irena; Preciado, Silvia; Sarasquete, Maria-Eugenia; Gonzalez, Marcos; Sanchez-Guijo, Fermin; del Canizo, Maria-Consuelo] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain; [Muntion, Sandra; Diez-Campelo, Maria; Ignacio Sanchez-Abarca, Luis; Preciado, Silvia; Sanchez-Guijo, Fermin; del Canizo, Maria-Consuelo] Ctr Red Med Regenerat & Terapia Celular Castilla, Salamanca, Spain; [Muntion, Sandra; Diez-Campelo, Maria; Roson, Beatriz; Ignacio Sanchez-Abarca, Luis; Preciado, Silvia; de las Rivas, Javier; Sanchez-Guijo, Fermin; del Canizo, Maria-Consuelo] Inst Nacl Salud Carlos III, Red Nacl Terapia Celular TerCel, Madrid, Spain; [Ignacio Sanchez-Abarca, Luis; Misiewicz-Krzeminska, Irena; Preciado, Silvia; Gonzalez, Marcos; Sanchez-Guijo, Fermin; del Canizo, Maria-Consuelo] Univ Salamanca, CSIC, IBMCC, Ctr Invest Canc, E-37008 Salamanca, Spain; [Muntion, Sandra; Ramos, Teresa L.; Diez-Campelo, Maria; Ignacio Sanchez-Abarca, Luis; Preciado, Silvia; Sarasquete, Maria-Eugenia; Gonzalez, Marcos; Sanchez-Guijo, Fermin; del Canizo, Maria-Consuelo] Hosp Univ Salamanca, IBSAL, Salamanca, Spain; [Misiewicz-Krzeminska, Irena] Natl Med Inst, Warsaw, Poland	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; National Medicines Institute Lekow (NIL)	del Canizo, MC (corresponding author), Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain.	concarol@usal.es	De Las Rivas, Javier/G-5936-2014; Garcia-Sanz, Ramon/B-7986-2017; Roson Burgo, Beatriz/ABA-6235-2021; Sanchez-Guijo, Fermin/D-8542-2018; Preciado, silvia/AAV-7364-2021; Ramos, Teresa/GXG-4223-2022; Misiewicz-Krzeminska, Irena/M-4629-2015; sarasquete, Maria E/U-8063-2018	De Las Rivas, Javier/0000-0002-0984-9946; Garcia-Sanz, Ramon/0000-0003-4120-2787; Roson Burgo, Beatriz/0000-0002-9851-2025; Sanchez-Guijo, Fermin/0000-0002-7076-7739; Ramos, Teresa/0000-0002-0696-7197; Misiewicz-Krzeminska, Irena/0000-0002-4206-8586; sarasquete, Maria E/0000-0001-7335-3657; Diez Campelo, Maria/0000-0002-1467-6779; Muntion Olave, Sandra/0000-0001-7164-0767; Diez Campelo, Maria/0000-0003-0386-4835; PRECIADO, SILVIA/0000-0002-7811-4679; Gonzalez Diaz, Marcos/0000-0001-6637-1072	Gerencia Regional de Salud de Castilla y Leon [GRS 873/A/13]; Fondo de Investigaciones Sanitarias [PS09/01530]; Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica [CEI10-1-0010)]; Portuguese Fundacao para a Ciencia e Tecnologia [SFRH/BD/86451/2012]	Gerencia Regional de Salud de Castilla y Leon; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica(Ministry of Science and Innovation, Spain (MICINN)); Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Gerencia Regional de Salud de Castilla y Leon (GRS 873/A/13) MCC, Fondo de Investigaciones Sanitarias (PS09/01530) MCC, Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, 2008-2011 (CEI10-1-0010) MCC. A fellowship from the Portuguese Fundacao para a Ciencia e Tecnologia (SFRH/BD/86451/2012) TLR.	Abbas HA, 2011, CELL CYCLE, V10, P3257, DOI 10.4161/cc.10.19.17721; Abbas HA, 2010, CELL STEM CELL, V7, P606, DOI 10.1016/j.stem.2010.09.013; Aliotta JM, 2007, STEM CELLS, V25, P2245, DOI 10.1634/stemcells.2007-0128; Blau O, 2011, BLOOD, V118, P5583, DOI 10.1182/blood-2011-03-343467; Bruno S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0304; Chen LH, 1997, J BIOL CHEM, V272, P22966, DOI 10.1074/jbc.272.36.22966; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Corrado C, 2014, CANCER LETT, V348, P71, DOI 10.1016/j.canlet.2014.03.009; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Fang J, 2012, CURR PHARM DESIGN, V18, P3170, DOI 10.2174/1381612811209023170; Flores-Figueroa E, 2008, LEUKEMIA RES, V32, P1407, DOI 10.1016/j.leukres.2008.02.013; Gajos-Michniewicz A, 2014, CANCER LETT, V347, P29, DOI 10.1016/j.canlet.2014.02.004; Gelderman MP, 2008, METHODS MOL BIOL, V484, P79, DOI 10.1007/978-1-59745-398-1_6; Gentalen ET, 2015, METHODS MOL BIOL, V1219, P139, DOI 10.1007/978-1-4939-1661-0_11; Geyh S, 2013, LEUKEMIA, V27, P1841, DOI 10.1038/leu.2013.193; Grange C, 2014, INT J MOL MED, V33, P1055, DOI 10.3892/ijmm.2014.1663; Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240; Havelange V, 2010, AM J HEMATOL, V85, P935, DOI 10.1002/ajh.21863; Issa JPJ, 2013, BLOOD, V121, P3811, DOI 10.1182/blood-2013-02-451757; Li X, 2013, HAEMATOLOGICA, V98, P414, DOI 10.3324/haematol.2012.071753; Lopez-Villar O, 2009, LEUKEMIA, V23, P664, DOI 10.1038/leu.2008.361; Maetens M, 2007, BLOOD, V109, P2630, DOI 10.1182/blood-2006-03-013656; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Pereira JKN, 2012, LEUKEMIA RES, V36, P1300, DOI 10.1016/j.leukres.2012.06.010; Pons A, 2009, LEUKEMIA LYMPHOMA, V50, P1854, DOI 10.3109/10428190903147645; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Ramos TL, 2015, CELL COMMUNICATIONS; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Rustandi Richard R, 2013, Methods Mol Biol, V988, P181, DOI 10.1007/978-1-62703-327-5_11; Sanchez MBH, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt514; Santamaria C, 2012, HAEMATOL-HEMATOL J, V97, P1218, DOI 10.3324/haematol.2011.054437; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Tauro S, 2001, HAEMATOLOGICA, V86, P1038; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasilatou D, 2013, EPIGENETICS-US, V8, P561, DOI 10.4161/epi.24897; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Villaron EM, 2007, TRANSFUS APHER SCI, V37, P145, DOI 10.1016/j.transci.2007.05.001; Wang JH, 2014, BLOOD, V124, P555, DOI 10.1182/blood-2014-03-562439; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Yuana Y, 2013, BLOOD REV, V27, P31, DOI 10.1016/j.blre.2012.12.002; Zhao ZG, 2012, CANCER LETT, V317, P136, DOI 10.1016/j.canlet.2011.08.030	46	60	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0146722	10.1371/journal.pone.0146722	http://dx.doi.org/10.1371/journal.pone.0146722			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26836120	gold, Green Submitted, Green Published			2022-12-26	WOS:000369548500001
J	Royal, W; Cherner, M; Burdo, TH; Umlauf, A; Letendre, SL; Jumare, J; Abimiku, A; Alabi, P; Alkali, N; Bwala, S; Okwuasaba, K; Eyzaguirre, LM; Akolo, C; Guo, M; Williams, KC; Blattner, WA				Royal, Walter, III; Cherner, Mariana; Burdo, Tricia H.; Umlauf, Anya; Letendre, Scott L.; Jumare, Jibreel; Abimiku, Alash'le; Alabi, Peter; Alkali, Nura; Bwala, Sunday; Okwuasaba, Kanayo; Eyzaguirre, Lindsay M.; Akolo, Christopher; Guo, Ming; Williams, Kenneth C.; Blattner, William A.			Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria	PLOS ONE			English	Article							HEMOGLOBIN SCAVENGER RECEPTOR; IMMUNODEFICIENCY-VIRUS-INFECTION; NEUROCOGNITIVE IMPAIRMENT; ANTIRETROVIRAL THERAPY; SOLUBLE CD163; NEUROPSYCHOLOGICAL PERFORMANCE; MICROBIAL TRANSLOCATION; MONONUCLEAR PHAGOCYTES; DISEASE PROGRESSION; IMMUNE ACTIVATION	The potential role of gender in the occurrence of HIV-related neurocognitive impairment (NCI) and associations with markers of HIV-related immune activity has not been previously examined. In this study 149 antiretroviral-naive seropositive subjects in Nigeria (SP, 92 women and 57 men) and 58 seronegative (SN, 38 women and 20 men) were administered neuropsychological testing that assessed 7 ability domains. From the neuropsychological test scores was calculated a global deficit score (GDS), a measure of overall NCI. Percentages of circulating monocytes and plasma HIV RNA, soluble CD163 and soluble CD14 levels were also assessed. HIV SP women were found to be younger, more educated and had higher CD4+ T cell counts and borderline higher viral load measures than SP men. On the neuropsychological testing, SP women were more impaired in speed of information processing and verbal fluency and had a higher mean GDS than SN women. Compared to SP men, SP women were also more impaired in speed of information processing and verbal fluency as well as on tests of learning and memory. Numbers of circulating monocytes and plasma sCD14 and sCD163 levels were significantly higher for all SP versus all SN individuals and were also higher for SP women and for SP men versus their SN counterparts. Among SP women, soluble CD14 levels were slightly higher than for SP men, and SP women had higher viral load measurements and were more likely to have detectable virus than SP men. Higher sCD14 levels among SP women correlated with more severe global impairment, and higher viral load measurements correlated with higher monocyte numbers and sCD14 and sCD14 levels, associations that were not observed for SP men. These studies suggest that the risk of developing NCI differ for HIV infected women and men in Nigeria and, for women, may be linked to effects from higher plasma levels of HIV driving activation of circulating monocytes.	[Royal, Walter, III; Guo, Ming] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Cherner, Mariana; Umlauf, Anya] Univ Calif San Diego, Sch Med, HIV Neurobehav Res Ctr, San Diego, CA 92103 USA; [Burdo, Tricia H.; Letendre, Scott L.; Williams, Kenneth C.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Jumare, Jibreel; Abimiku, Alash'le; Okwuasaba, Kanayo; Akolo, Christopher; Blattner, William A.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Jumare, Jibreel; Abimiku, Alash'le; Okwuasaba, Kanayo; Eyzaguirre, Lindsay M.; Akolo, Christopher] Inst Human Virol Nigeria, Abuja, Nigeria; [Alabi, Peter] Univ Abuja, Teaching Hosp, Gwagwalada, Abuja, Nigeria; [Alkali, Nura] Abubakar Tafawa Balewa Univ, Teaching Hosp, Bauchi, Nigeria; [Bwala, Sunday] Natl Hosp, Abuja, Nigeria	University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego; Boston College; University System of Maryland; University of Maryland Baltimore	Royal, W (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA.	wroyal@som.umaryland.edu	Alkali, Nura/AAH-6357-2020; Letendre, Scott L./GLU-6874-2022; cherner, mariana/N-4810-2015	cherner, mariana/0000-0002-5479-7401; Okwuasaba, Kanayo/0000-0001-8625-528X	National Institute of Mental Health, NIH [R01 MH086356]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, R01MH086356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA040550] Funding Source: NIH RePORTER	National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work received grant support from the National Institute of Mental Health, NIH Grant #R01 MH086356. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolo C, 2014, J NEUROVIROL, V20, P380, DOI 10.1007/s13365-014-0254-6; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anderson E, 2002, JAIDS-J ACQ IMM DEF, V31, pS43, DOI 10.1097/00126334-200210012-00004; BACKE E, 1991, J CLIN PATHOL, V44, P936, DOI 10.1136/jcp.44.11.936; Beck AT, 1996, PSYCHOL ASSESS; Bergmann S, 1998, RESP PHYSIOL, V114, P269, DOI 10.1016/S0034-5687(98)00098-X; Brauer KB, 2000, HANDBOOD CROSS CULTU, P73; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Burdo TH, 2013, AIDS, V27, P1387, DOI 10.1097/QAD.0b013e32836010bd; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Cherner M, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200401001-00005; Denton ML, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.110501; Durvasula RS, 2001, J CLIN EXP NEUROPSYC, V23, P149, DOI 10.1076/jcen.23.2.149.1211; Ellis RJ, 1997, ARCH NEUROL-CHICAGO, V54, P416, DOI 10.1001/archneur.1997.00550160054016; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Fitch KV, 2013, J INFECT DIS, V208, P1737, DOI 10.1093/infdis/jit508; Goodwin GM, 1996, AIDS, V10, P431, DOI 10.1097/00002030-199604000-00012; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hestad KA, 2012, J NERV MENT DIS, V200, P336, DOI 10.1097/NMD.0b013e31824cc225; Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711; Hogger P, 2001, BIOCHEM BIOPH RES CO, V288, P841, DOI 10.1006/bbrc.2001.5845; Huang ZS, 1996, ARTERIOSCL THROM VAS, V16, P256, DOI 10.1161/01.ATV.16.2.256; Jarrin I, 2008, AM J EPIDEMIOL, V168, P532, DOI 10.1093/aje/kwn179; Jaworowski A, 2007, J INFECT DIS, V196, P38, DOI 10.1086/518443; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lien E, 1998, BLOOD, V92, P2084, DOI 10.1182/blood.V92.6.2084.418k26_2084_2092; Lopez OL, 1999, EUR J NEUROL, V6, P205, DOI 10.1111/j.1468-1331.1999.tb00014.x; Lyons JL, 2011, JAIDS-J ACQ IMM DEF, V57, P371, DOI 10.1097/QAI.0b013e3182237e54; MARDER K, 1995, ARCH NEUROL-CHICAGO, V52, P1174, DOI 10.1001/archneur.1995.00540360052016; MELTZER MS, 1990, ANNU REV IMMUNOL, V8, P169, DOI 10.1146/annurev.iy.08.040190.001125; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Naranbhai V, 2014, J INFECT DIS, V209, P500, DOI 10.1093/infdis/jit494; Odiase F, 2006, J NATL MED ASSOC, V98, P1260; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Robertson KR, 2004, JAIDS-J ACQ IMM DEF, V36, P817, DOI 10.1097/00126334-200407010-00008; Royal W, 2012, J NEUROVIROL, V18, P191, DOI 10.1007/s13365-012-0097-y; Ryan LA, 2001, J INFECT DIS, V184, P699, DOI 10.1086/323036; Sacktor NC, 1996, J NEUROVIROL, V2, P404, DOI 10.3109/13550289609146906; Salawu FK, 2008, J NEUROL SCI, V267, P142, DOI 10.1016/j.jns.2007.10.013; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Stern RA, 1998, J INT NEUROPSYCH SOC, V4, P172, DOI 10.1017/S1355617798001726; Timmerman KL, 2008, J LEUKOCYTE BIOL, V84, P1271, DOI 10.1189/jlb.0408244; Weaver LK, 2006, J LEUKOCYTE BIOL, V80, P26, DOI 10.1189/jlb.1205756; World Health Organisation, 2007, WHO CAS DEF HIV SURV	51	59	60	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147182	10.1371/journal.pone.0147182	http://dx.doi.org/10.1371/journal.pone.0147182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829391	Green Submitted, Green Published, gold			2022-12-26	WOS:000369548200013
J	Kaucsar, T; Godo, M; Revesz, C; Kovacs, M; Mocsai, A; Kiss, N; Albert, M; Krenacs, T; Szenasi, G; Hamar, P				Kaucsar, Tamas; Godo, Maria; Revesz, Csaba; Kovacs, Miklos; Mocsai, Attila; Kiss, Norbert; Albert, Mihaly; Krenacs, Tibor; Szenasi, Gabor; Hamar, Peter			Urine/Plasma Neutrophil Gelatinase Associated Lipocalin Ratio Is a Sensitive and Specific Marker of Subclinical Acute Kidney Injury in Mice	PLOS ONE			English	Article							EPITHELIAL-CELLS; PROTECTS MICE; NGAL; CREATININE; BIOMARKER; ACTIVATION; IDENTIFICATION; SURGERY; URINE; RNA	Background Detection of acute kidney injury (AKI) is still a challenge if conventional markers of kidney function are within reference range. We studied the sensitivity and specificity of NGAL as an AKI marker at different degrees of renal ischemia. Methods Male C57BL/6J mice were subjected to 10-, 20- or 30-min unilateral renal ischemia, to control operation or no operation, and AKI was evaluated 1 day later by histology, immunohistochemistry, BUN, creatinine, NGAL (plasma and urine) and renal NGAL mRNA expression. Results A short (10-min) ischemia did not alter BUN or kidney histology, but elevated plasma and urinary NGAL level and renal NGAL mRNA expression although to a much smaller extent than longer ischemia. Surprisingly, control operation elevated plasma NGAL and renal NGAL mRNA expression to a similar extent as 10-min ischemia. Further, the ratio of urine to plasma NGAL was the best parameter to differentiate a 10-min ischemic injury from control operation, while it was similar in the non and control-operated groups. Conclusions These results suggest that urinary NGAL excretion and especially ratio of urine to plasma NGAL are sensitive and specific markers of subclinical acute kidney injury in mice.	[Kaucsar, Tamas; Godo, Maria; Revesz, Csaba; Kiss, Norbert; Szenasi, Gabor; Hamar, Peter] Semmelweis Univ, Inst Pathophysiol, H-1085 Budapest, Hungary; [Kovacs, Miklos; Mocsai, Attila] Semmelweis Univ, Dept Physiol, MTA SE Lendlet Inflammat Physiol Res Grp, H-1085 Budapest, Hungary; [Albert, Mihaly] CEVA Phylaxia Ltd, Budapest, Hungary; [Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, MTA SE Tumor Progress Res Grp, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Ceva Sante Animale; Semmelweis University	Hamar, P (corresponding author), Semmelweis Univ, Inst Pathophysiol, H-1085 Budapest, Hungary.	hamar.peter@med.semmelweis-univ.hu	Szénási, Gábor/K-3136-2017; Kiss, Norbert/O-5821-2016; Szenasi, Gabor/ABH-2591-2021; Hamar, Peter/A-8996-2010; Revesz, Csaba/AAA-5722-2022; Kaucsár, Tamás/H-4904-2016	Szénási, Gábor/0000-0002-7350-6091; Kiss, Norbert/0000-0002-9947-1755; Hamar, Peter/0000-0002-1095-3564; Kaucsár, Tamás/0000-0003-4460-1265	Hungarian Research Fund [OTKA ANN-110810, SNN-114619, ETT 07-011/2009]; Bolyai Research Scholarship of the Hungarian Academy of Sciences and Merit Award of Semmelweis University; Lendulet program of the Hungarian Academy of Sciences [LP2013-66]	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Research Scholarship of the Hungarian Academy of Sciences and Merit Award of Semmelweis University; Lendulet program of the Hungarian Academy of Sciences	Support was provided to PH from the Hungarian Research Fund: OTKA ANN-110810, SNN-114619, ETT 07-011/2009 and Bolyai Research Scholarship of the Hungarian Academy of Sciences and Merit Award of Semmelweis University (to PH), as well as by the Lendulet program of the Hungarian Academy of Sciences (LP2013-66 to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON L, 1995, SCAND J CLIN LAB INV, V55, P577, DOI 10.3109/00365519509110257; Bagshaw SM, 2010, INTENS CARE MED, V36, P452, DOI 10.1007/s00134-009-1724-9; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2; Cai LJ, 2010, CLIN J AM SOC NEPHRO, V5, P2229, DOI 10.2215/CJN.00980110; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Clerico A, 2012, CLIN CHEM LAB MED, V50, P1505, DOI 10.1515/cclm-2011-0814; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Efrati S, 2012, NEPHROLOGY, V17, P591, DOI 10.1111/j.1440-1797.2012.01638.x; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Haase-Fielitz A, 2014, ANN CLIN BIOCHEM, V51, P335, DOI 10.1177/0004563214521795; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.0406421101; Helmersson-Karlqvist J, 2013, CLIN BIOCHEM, V46, P70, DOI 10.1016/j.clinbiochem.2012.09.022; Hjortrup PB, 2013, CRIT CARE, V17, DOI 10.1186/cc11855; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Jakus Z, 2010, ARTHRITIS RHEUM-US, V62, P1899, DOI 10.1002/art.27438; Kaucsar T, 2013, NUCLEIC ACID THER, V23, P344, DOI 10.1089/nat.2013.0438; Krenacs T, 2010, METHODS MOL BIOL, V664, P163, DOI 10.1007/978-1-60761-806-5_16; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; Lacquaniti A, 2013, RADIOLOGY, V267, P86, DOI 10.1148/radiol.12120578; Leelahavanichkul A, 2014, AM J PHYSIOL-RENAL, V307, pF939, DOI 10.1152/ajprenal.00025.2013; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCullough PA, 2013, CONTRIB NEPHROL, V182, P13, DOI 10.1159/000349963; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Munshi R, 2011, J AM SOC NEPHROL, V22, P165, DOI 10.1681/ASN.2010060641; Murray PT, 2014, KIDNEY INT, V85, P513, DOI 10.1038/ki.2013.374; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Nielsen SE, 2010, DIABETIC MED, V27, P1144, DOI 10.1111/j.1464-5491.2010.03083.x; Paragas N, 2012, BBA-MOL CELL RES, V1823, P1451, DOI 10.1016/j.bbamcr.2012.06.014; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; Pera M, 2003, J GASTROINTEST SURG, V7, P783, DOI 10.1016/S1091-255X(03)00111-2; ROSEN SM, 1972, BRIT J ANAESTH, V44, P252, DOI 10.1093/bja/44.3.252; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Schock-Kusch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071519; Sear JW, 2005, BRIT J ANAESTH, V95, P20, DOI 10.1093/bja/aei018; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Singer E, 2013, ACTA PHYSIOL, V207, P663, DOI 10.1111/apha.12054; Steinhauser ML, 1999, J IMMUNOL, V162, P5437; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Tsai WH, 2013, J CHIN MED ASSOC, V76, P486, DOI 10.1016/j.jcma.2013.05.004; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Weber FC, 2015, J EXP MED, V212, P15, DOI 10.1084/jem.20130062; Yang C, 2008, CELL DEATH DIFFER, V15, P530, DOI 10.1038/sj.cdd.4402287	48	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148043	10.1371/journal.pone.0148043	http://dx.doi.org/10.1371/journal.pone.0148043			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824608	Green Published, gold, Green Accepted			2022-12-26	WOS:000369528600093
J	Stacchiotti, A; Favero, G; Lavazza, A; Golic, I; Aleksic, M; Korac, A; Rodella, LF; Rezzani, R				Stacchiotti, Alessandra; Favero, Gaia; Lavazza, Antonio; Golic, Igor; Aleksic, Marija; Korac, Aleksandra; Rodella, Luigi Fabrizio; Rezzani, Rita			Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL DYSFUNCTION; PROTECTIVE ROLE; ADIPOSE-TISSUE; DIABETIC MICE; MOUSE-LIVER; OBESITY; METABOLISM; ZONATION	Background Obesity is a common risk factor for non-alcoholic fatty liver disease (NAFLD). Currently, there are no specific treatments against NAFLD. Thus, examining any molecule with potential benefits against this condition emerged melatonin as a molecule that influences metabolic dysfunctions. The aim of this study was to determine whether melatonin would function against NAFDL, studying morphological, ultrastuctural and metabolic markers that characterize the liver of ob/ob mice. Methods Lean and ob/ob mice were supplemented with melatonin in the drinking water for 8 weeks. Histology and stereology were performed to assess hepatic steatosis and glycogen deposition. Ultrastructural features of mitochondria, endoplasmic reticulum (ER) and their juxtapositions were evaluated in livers of all experimental groups. Furthermore, hepatic distribution and expression of markers of ER and mitochondria (calnexin, ATP sintase beta, GRP78 and CHOP) and metabolic dysfunction (RPB4, beta-catenin) and cellular longevity (SIRT1) were analyzed. Results Melatonin significantly reduced glycemia, identified also by a decrease of hepatic RBP4 expression, reversed macrosteatosis in microsteatosis at the hepatic pericentral zone, enlarged ER-mitochondrial distance and ameliorated the morphology and organization of these organelles in ob/ob mouse liver. Furthermore, in ob/ob mice, calnexin and ATP synthase beta were partially restored, GRP78 and CHOP decreased in periportal and midzonal hepatocytes and beta-catenin expression was, in part, restored in peripheral membranes of hepatocytes. Melatonin supplementation to ob/ob mice improves hepatic morphological, ultrastructural and metabolic damage that occurs as a result of NAFLD. Conclusions Melatonin may be a potential adjuvant treatment to limit NAFLD and its progression into irreversible complications.	[Stacchiotti, Alessandra; Favero, Gaia; Rodella, Luigi Fabrizio; Rezzani, Rita] Univ Brescia, Dept Clin & Expt Sci, Anat & Physiopathol Div, Viale Europa 11, I-25123 Brescia, Italy; [Stacchiotti, Alessandra; Rodella, Luigi Fabrizio; Rezzani, Rita] Univ Brescia, Interdipartimental Univ Ctr Res Adapt & Regenerat, I-25121 Brescia, Italy; [Lavazza, Antonio] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Via Bianchi 7-9, I-25124 Brescia, Italy; [Golic, Igor; Aleksic, Marija; Korac, Aleksandra] Univ Belgrade, Fac Biol, Ctr Electron Microscopy, Belgrade, Serbia	University of Brescia; University of Brescia; IZS Lombardia e Emilia; University of Belgrade	Rezzani, R (corresponding author), Univ Brescia, Dept Clin & Expt Sci, Anat & Physiopathol Div, Viale Europa 11, I-25123 Brescia, Italy.; Rezzani, R (corresponding author), Univ Brescia, Interdipartimental Univ Ctr Res Adapt & Regenerat, I-25121 Brescia, Italy.	rita.rezzani@unibs.it	Golic, Igor/B-4492-2009; Stacchiotti, Alessandra/AAA-2193-2019; Stacchiotti, Alessandra/AAL-7239-2021; lavazza, antonio/G-8182-2011	Golic, Igor/0000-0001-5944-5053; lavazza, antonio/0000-0002-7646-3592	New Petfood Italia S.r.l.; Fondazione Cariplo e Regione Lombardia [2014-2256]	New Petfood Italia S.r.l.; Fondazione Cariplo e Regione Lombardia	Sincere thanks to New Petfood Italia S.r.l. and Fondazione Cariplo e Regione Lombardia, "New opportunities and ways towards ERC" (Project 2014-2256) for grants donation.	Acuna Castroviejo Dario, 2002, Curr Top Med Chem, V2, P133; Agabiti-Rosei C, 2014, J HYPERTENS, V32, P1264, DOI 10.1097/HJH.0000000000000178; Agil A, 2015, J PINEAL RES, V59, P70, DOI 10.1111/jpi.12241; Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Berasain C, 2014, HEPATOLOGY, V59, P2080, DOI 10.1002/hep.27000; Bousette N, 2014, J CELL PHYSIOL, V229, P374, DOI 10.1002/jcp.24459; Carloni S, 2014, J PINEAL RES, V57, P192, DOI 10.1111/jpi.12156; Chalasani N, 2008, J HEPATOL, V48, P829, DOI 10.1016/j.jhep.2008.01.016; Christou GA, 2012, HORM METAB RES, V44, P6, DOI 10.1055/s-0031-1295491; Cipolla-Neto J, 2014, J PINEAL RES, V56, P371, DOI 10.1111/jpi.12137; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Codenotti S, 2015, ONCOL REP, V34, P279, DOI 10.3892/or.2015.3987; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dara L, 2011, HEPATOLOGY, V53, P1752, DOI 10.1002/hep.24279; de Luxan-Delgado B, 2014, J PINEAL RES, V56, P126, DOI 10.1111/jpi.12104; den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e; El-Badry AM, 2007, HEPATOLOGY, V45, P855, DOI 10.1002/hep.21625; Favero G, 2015, NUTR RES, V35, P891, DOI 10.1016/j.nutres.2015.07.001; Favero G, 2015, AGE, V37, DOI 10.1007/s11357-015-9804-y; Favero G, 2014, ACTA HISTOCHEM, V116, P272, DOI 10.1016/j.acthis.2013.08.006; Favero G, 2013, ACTA HISTOCHEM, V115, P783, DOI 10.1016/j.acthis.2013.02.014; Garcia JJ, 2014, J PINEAL RES, V56, P225, DOI 10.1111/jpi.12128; Garcia-Ruiz I, 2007, HEPATOLOGY, V46, P414, DOI 10.1002/hep.21687; Ge YX, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/945076; Gebhardt R, 2014, WORLD J GASTROENTERO, V20, P8491, DOI 10.3748/wjg.v20.i26.8491; Giorgi C, 2015, ANTIOXID REDOX SIGN, V22, P995, DOI 10.1089/ars.2014.6223; Govender J, 2014, J PINEAL RES, V57, P367, DOI 10.1111/jpi.12176; Hempel M, 2015, CELL MOL LIFE SCI, V72, P2599, DOI 10.1007/s00018-015-1861-y; Hijmans BS, 2014, BIOCHIMIE, V96, P121, DOI 10.1016/j.biochi.2013.06.007; Ikura Y, 2014, WORLD J HEPATOL, V6, P894, DOI 10.4254/wjh.v6.i12.894; Lee D, 2015, J BIOL CHEM, V290, P5725, DOI 10.1074/jbc.M114.635474; Leon J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x; Liu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07973; Macias M, 2003, EUR J BIOCHEM, V270, P832, DOI 10.1046/j.1432-1033.2003.03430.x; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Mansouri M, 2014, J DIABETES INVEST, V5, P484, DOI 10.1111/jdi.12186; Marseglia L, 2013, J PEDIATR-US, V162, P357, DOI 10.1016/j.jpeds.2012.07.019; Martin M, 2002, INT J BIOCHEM CELL B, V34, P348, DOI 10.1016/S1357-2725(01)00138-8; Martin M, 2000, J PINEAL RES, V28, P242, DOI 10.1034/j.1600-079X.2000.280407.x; Masarone M, 2014, REV RECENT CLIN TRIA, V9, P126, DOI 10.2174/1574887109666141216111143; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Monga SP, 2015, GASTROENTEROLOGY, V148, P1294, DOI 10.1053/j.gastro.2015.02.056; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Mozdzan M, 2014, ARCH MED SCI, V10, P669, DOI 10.5114/aoms.2014.44858; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Purushotham A, 2009, AGING-US, V1, P669, DOI 10.18632/aging.100076; Radogna F, 2008, J PINEAL RES, V44, P316, DOI 10.1111/j.1600-079X.2007.00532.x; Reiter RJ, 2012, ANN MED, V44, P564, DOI 10.3109/07853890.2011.586365; Rios-Lugo MJ, 2010, J PINEAL RES, V49, P342, DOI 10.1111/j.1600-079X.2010.00798.x; Rodella LF, 2013, AGE, V35, P103, DOI 10.1007/s11357-011-9336-z; Rodella LF, 2012, CELLS TISSUES ORGANS, V195, P252, DOI 10.1159/000324919; Sartori C, 2009, ENDOCRINOLOGY, V150, P5311, DOI 10.1210/en.2009-0425; Sodhi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128648; Solis-Munoz P, 2011, J PINEAL RES, V51, P113, DOI 10.1111/j.1600-079X.2011.00868.x; Stacchiotti A, 2009, FOOD CHEM TOXICOL, V47, P2834, DOI 10.1016/j.fct.2009.09.003; Tan DX, 2011, OBES REV, V12, P167, DOI 10.1111/j.1467-789X.2010.00756.x; Tetri LH, 2008, AM J PHYSIOL-GASTR L, V295, pG987, DOI 10.1152/ajpgi.90272.2008; Torre C, 2011, INT J BIOCHEM CELL B, V43, P271, DOI 10.1016/j.biocel.2009.11.004; Tsutsumi A, 2015, INT J OCCUP MED ENV, V28, P4, DOI 10.2478/s13382-014-0319-z; Venegas C, 2013, J PINEAL RES, V54, P313, DOI 10.1111/jpi.12019; Wang CJ, 2014, DIABETES, V63, P947, DOI 10.2337/db13-1096; Wolf G, 2007, NUTR REV, V65, P251, DOI 10.1111/j.1753-4887.2007.tb00302.x	65	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148115	10.1371/journal.pone.0148115	http://dx.doi.org/10.1371/journal.pone.0148115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824477	Green Published, gold			2022-12-26	WOS:000369528600100
J	Tewfik, A; Bell, SS; McCann, KS; Morrow, K				Tewfik, Alexander; Bell, Susan S.; McCann, Kevin S.; Morrow, Kristina			Predator Diet and Trophic Position Modified with Altered Habitat Morphology	PLOS ONE			English	Article							EXPOSED SANDY BEACHES; CRABS OCYPODE-QUADRATA; FOOD-WEB COMPLEXITY; GHOST CRABS; COMMUNITY STRUCTURE; MARINE SUBSIDIES; STABLE-ISOTOPES; CHAIN LENGTH; OCEAN BEACH; MACROFAUNA	Empirical patterns that emerge from an examination of food webs over gradients of environmental variation can help to predict the implications of anthropogenic disturbance on ecosystems. This "dynamic food web approach" is rarely applied at the coastal margin where aquatic and terrestrial systems are coupled and human development activities are often concentrated. We propose a simple model of ghost crab (Ocypode quadrata) feeding that predicts changing dominant prey (Emerita talpoida, Talorchestia sp., Donax variablis) along a gradient of beach morphology and test this model using a suite of 16 beaches along the Florida, USA coast. Assessment of beaches included quantification of morphological features (width, sediments, slope), macrophyte wrack, macro-invertebrate prey and active ghost crab burrows. Stable isotope analysis of carbon (C-13/C-12) and nitrogen (N-15/N-14) and the SIAR mixing model were used to determine dietary composition of ghost crabs at each beach. The variation in habitat conditions displayed with increasing beach width was accompanied by quantifiable shifts in ghost crab diet and trophic position. Patterns of ghost crab diet were consistent with differences recorded across the beach width gradient with respect to the availability of preferred micro-habitats of principal macro-invertebrate prey. Values obtained for trophic position also suggests that the generalist ghost crab assembles and augments its diet in fundamentally different ways as habitat morphology varies across a highly dynamic ecosystem. Our results offer support for a functional response in the trophic architecture of a common food web compartment (ghost crabs, macro-invertebrate prey) across well-known beach morphologies. More importantly, our "dynamic food web approach" serves as a basis for evaluating how globally wide-spread sandy beach ecosystems should respond to a variety of anthropogenic impacts including beach grooming, beach re-nourishment, introduction of non-native or feral predators and human traffic on beaches.	[Tewfik, Alexander; Bell, Susan S.; Morrow, Kristina] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA; [McCann, Kevin S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	State University System of Florida; University of South Florida; University of Guelph	Tewfik, A (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA.	atewfik@wcs.org			National Science Foundation [043180]; Biological Oceanography Program; Natural Sciences and Engineering Research Council of Canada Discovery	National Science Foundation(National Science Foundation (NSF)); Biological Oceanography Program; Natural Sciences and Engineering Research Council of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Science Foundation grant 043180, Biological Oceanography Program to SSB, and Natural Sciences and Engineering Research Council of Canada Discovery Grant to KSM.	Adams TS, 2000, LIMNOL OCEANOGR, V45, P601, DOI 10.4319/lo.2000.45.3.0601; Adin R, 2003, ESTUAR COAST SHELF S, V56, P91, DOI 10.1016/S0272-7714(02)00124-5; Barrett K, 2005, OIKOS, V109, P145, DOI 10.1111/j.0030-1299.2005.13728.x; Barros F, 2001, BIOL CONSERV, V97, P399, DOI 10.1016/S0006-3207(00)00116-6; Barton BT, 2008, BIOL CONSERV, V141, P2139, DOI 10.1016/j.biocon.2008.06.013; Bergamino L, 2011, ESTUAR COAST SHELF S, V91, P536, DOI 10.1016/j.ecss.2010.12.007; Britton J. C., 1989, SHORE ECOLOGY GULF M; BRITTON JC, 1994, OCEANOGR MAR BIOL, V32, P369; Chan BKK, 2006, HYDROBIOLOGIA, V560, P43, DOI 10.1007/s10750-005-1088-2; Christoffers EWI, 1986, ECOLOGY GHOST CRAB O; COHEN JE, 1985, PROC R SOC SER B-BIO, V224, P449, DOI 10.1098/rspb.1985.0043; Colombini I, 2000, MAR BIOL, V136, P531, DOI 10.1007/s002270050713; Coupland GT, 2007, ECOSYSTEMS, V10, P1341, DOI 10.1007/s10021-007-9102-3; de la Huz R, 2005, ESTUAR COAST SHELF S, V65, P19, DOI 10.1016/j.ecss.2005.03.024; de la Huz R, 2002, J SEA RES, V47, P85, DOI 10.1016/S1385-1101(02)00108-9; Defeo O, 2005, MAR ECOL PROG SER, V295, P1, DOI 10.3354/meps295001; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Degraer S, 1999, ESTUARIES, V22, P742, DOI 10.2307/1353107; DELANCEY LB, 1989, J COASTAL RES, V5, P477; Doi H, 2009, OIKOS, V118, P138, DOI 10.1111/j.1600-0706.2008.17171.x; Dolson R, 2009, OIKOS, V118, P1230, DOI 10.1111/j.1600-0706.2009.17351.x; Dugan JE, 2003, ESTUAR COAST SHELF S, V58, P25, DOI 10.1016/S0272-7714(03)00045-3; Dugan JE, 2013, GEOMORPHOLOGY, V199, P95, DOI 10.1016/j.geomorph.2013.04.043; FALES R R, 1976, Chesapeake Science, V17, P65, DOI 10.2307/1350581; Foster CR, 2009, ESTUAR COAST, V32, P1079, DOI 10.1007/s12237-009-9224-2; France RL, 1997, CAN J FISH AQUAT SCI, V54, P1255, DOI 10.1139/f97-044; Fry B., 2006, STABLE ISOTOPE ECOLO; GRIFFITHS CL, 1981, ESTUAR COAST SHELF S, V12, P645, DOI 10.1016/S0302-3524(81)80062-X; HALEY S R, 1972, Crustaceana (Leiden), V23, P1, DOI 10.1163/156854072X00011; Hobbs CH, 2008, J COASTAL RES, V24, P1450, DOI 10.2112/07-0856.1; Holmes C.W., 2011, GULF MEXICO ORIGIN W, V3, P89; Horwith MJ, 2005, INTEGR COMP BIOL, V45, P1147; Huijbers CM, 2013, LANDSCAPE URBAN PLAN, V119, P1, DOI 10.1016/j.landurbplan.2013.06.004; Hussey NE, 2014, ECOL LETT, V17, P239, DOI 10.1111/ele.12226; Huxel GR, 1998, AM NAT, V152, P460, DOI 10.1086/286182; Ince R, 2007, ESTUAR COAST SHELF S, V74, P77, DOI 10.1016/j.ecss.2007.03.029; Jackson DA, 1997, ECOLOGY, V78, P929; James RJ, 1996, ESTUAR COAST SHELF S, V43, P81, DOI 10.1006/ecss.1996.0058; Jaramillo E, 2001, MAR ECOL-P S Z N I, V22, P323, DOI 10.1046/j.1439-0485.2001.01752.x; JARAMILLO E, 1993, ESTUAR COAST SHELF S, V37, P615, DOI 10.1006/ecss.1993.1077; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; LEBER KM, 1982, B MAR SCI, V32, P86; Little C, 2000, BIOL SOFT SHORES EST, P35; Lucrezi S, 2014, OCEANOGR MAR BIOL, V52, P201; Manning LM, 2014, MAR ECOL PROG SER, V508, P1, DOI 10.3354/meps10870; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; MASSELINK G, 1993, J COASTAL RES, V9, P785; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McLachlan A, 1995, OCEANOGR MAR BIOL, V33, P305; McLachlan A, 2005, J COASTAL RES, V21, P674, DOI 10.2112/03-0114.1; McLachlan A, 2006, ECOLOGY SANDY SHORES; Mellbrand K, 2011, ECOSYSTEMS, V14, P732, DOI 10.1007/s10021-011-9442-x; Morrow K, 2014, MAR ECOL PROG SER, V502, P197, DOI 10.3354/meps10728; NELSON WG, 1986, OPHELIA, V26, P305, DOI 10.1080/00785326.1986.10421996; Olabarria C, 2007, MAR ENVIRON RES, V63, P19, DOI 10.1016/j.marenvres.2006.06.001; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Parnell A., 2008, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pavesi L, 2013, J COAST CONSERV, V17, P841, DOI 10.1007/s11852-013-0285-9; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Peterson CH, 2000, J COASTAL RES, V16, P368; Peterson CH, 2006, J EXP MAR BIOL ECOL, V338, P205, DOI 10.1016/j.jembe.2006.06.021; PIMM SL, 1980, J ANIM ECOL, V49, P879, DOI 10.2307/4233; Pinotti RM, 2014, BIOTA NEOTROP, V14, DOI 10.1590/1676-06032014006914; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Pombo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083792; Poore AGB, 2013, HYDROBIOLOGIA, V701, P117, DOI 10.1007/s10750-012-1263-1; Porri F, 2011, MAR ECOL PROG SER, V426, P253, DOI 10.3354/meps08951; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Quijon P, 2001, CRUSTACEANA, V74, P91, DOI 10.1163/156854001505460; Rakocinski CF, 1996, J COASTAL RES, V12, P326; Fernandes RSR, 2006, MAR ECOL-EVOL PERSP, V27, P160, DOI 10.1111/j.1439-0485.2006.00093.x; ROBERTSON JR, 1982, J EXP MAR BIOL ECOL, V59, P1, DOI 10.1016/0022-0981(82)90102-2; Schlacher TA, 2015, ESTUAR COAST SHELF S, V157, P1, DOI 10.1016/j.ecss.2015.02.002; Schlacher TA, 2013, ACTA OECOL, V48, P7, DOI 10.1016/j.actao.2013.01.007; Schlacher TA, 2011, ECOL INDIC, V11, P284, DOI 10.1016/j.ecolind.2010.05.006; Schlacher TA, 2009, ECOSYSTEMS, V12, P311, DOI 10.1007/s10021-008-9224-2; SHORT AD, 1979, J GEOL, V87, P553, DOI 10.1086/628445; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Stapp P, 2003, OECOLOGIA, V134, P496, DOI 10.1007/s00442-002-1146-7; STEINER AJ, 1981, BIOL CONSERV, V20, P111, DOI 10.1016/0006-3207(81)90022-7; Stenroth P, 2008, OECOLOGIA, V156, P681, DOI 10.1007/s00442-008-1019-9; Strachan PH, 1999, SCI MAR, V63, P51, DOI 10.3989/scimar.1999.63n151; Tewfik A, 2005, ECOLOGY, V86, P2726, DOI 10.1890/04-1537; Tewfik A, 2007, CAN J FISH AQUAT SCI, V64, P956, DOI 10.1139/F07-071; Tunney TD, 2014, P NATL ACAD SCI USA, V111, P8077, DOI 10.1073/pnas.1319618111; Tunney TD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2098; Turra A, 2005, J NAT HIST, V39, P2163, DOI 10.1080/00222930500060165; Valero-Pacheco E, 2007, CRUSTACEANA, V80, P313, DOI 10.1163/156854007780162479; van der Zee EM, 2012, ECOSYSTEMS, V15, P664, DOI 10.1007/s10021-012-9538-y; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; WADE BA, 1967, B MAR SCI, V17, P149; WILLIAMS JA, 1982, MAR BIOL, V69, P65, DOI 10.1007/BF00396962; WOLCOTT TG, 1978, J EXP MAR BIOL ECOL, V31, P67, DOI 10.1016/0022-0981(78)90137-5; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; WRIGHT LD, 1984, MAR GEOL, V56, P93, DOI 10.1016/0025-3227(84)90008-2; Zar J.H., 2010, BIOSTAT ANAL	100	33	33	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147759	10.1371/journal.pone.0147759	http://dx.doi.org/10.1371/journal.pone.0147759			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824766	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600055
J	Niu, YB; Zhang, LH; Yu, JJ; Wang, CC; Wang, L				Niu, Yingbo; Zhang, Lihui; Yu, Jiaojiao; Wang, Chih-chen; Wang, Lei			Novel Roles of the Non-catalytic Elements of Yeast Protein-disulfide Isomerase in Its Interplay with Endoplasmic Reticulum Oxidoreductin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						disulfide; endoplasmic reticulum (ER); protein-disulfide isomerase; protein-protein interaction; redox regulation; Ero1; oxidative protein folding; regulatory disulfide	BOND FORMATION; OXIDATIVE ACTIVITY; REDOX ENVIRONMENT; FOLDING CATALYST; ERO1-ALPHA; ERO1P; SUBSTRATE; INACTIVATION; SITE; CELL	The formation of disulfide bonds in the endoplasmic reticulum (ER) of eukaryotic cells is catalyzed by the sulfhydryl oxidase, ER oxidoreductin 1 (Ero1), and protein-disulfide isomerase (PDI). PDI is oxidized by Ero1 to continuously introduce disulfides into substrates, and feedback regulates Ero1 activity by manipulating the regulatory disulfides of Ero1. In this study we find that yeast Ero1p is enzymatically active even with its regulatory disulfides intact, and further activation of Ero1p by reduction of the regulatory disulfides requires the reduction of non-catalytic Cys(90)-Cys(97) disulfide in Pdi1p. The principal client-binding site in the Pdi1p b domain is necessary not only for the functional Ero1p-Pdi1p disulfide relay but also for the activation of Ero1p. We also demonstrate by complementary activation assays that the regulatory disulfides in Ero1p are much more stable than those in human Ero1. These new findings on yeast Ero1p-Pdi1p interplay reveal significant differences from our previously identified mode of human Ero1-PDI interplay and provide insights into the evolution of the eukaryotic oxidative protein folding pathway.	[Niu, Yingbo; Zhang, Lihui; Yu, Jiaojiao; Wang, Chih-chen; Wang, Lei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China; [Niu, Yingbo; Zhang, Lihui; Yu, Jiaojiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, CC; Wang, L (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	chihwang@sun5.ibp.ac.cn; wanglei@moon.ibp.ac.cn		Wang, Lei/0000-0002-5071-5800	Chinese Ministry of Science and Technology [2011CB910303, 2012CB911002]; National Natural Science Foundation of China [31370775, 31571163]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Ministry of Science and Technology Grants 2011CB910303 and 2012CB911002 (to C. C. W.) and National Natural Science Foundation of China Grants 31370775 and 31571163 (to L. W.). The authors declare that they have no conflict of interest with the contents of this article.	Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Delic M, 2010, FEMS MICROBIOL LETT, V306, P61, DOI 10.1111/j.1574-6968.2010.01935.x; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Frand AR, 2000, MOL BIOL CELL, V11, P2833, DOI 10.1091/mbc.11.9.2833; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Heldman N, 2010, PROTEIN SCI, V19, P1863, DOI 10.1002/pro.473; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kim S, 2012, J CELL BIOL, V196, P713, DOI 10.1083/jcb.201110090; Kojer K, 2014, BBA-PROTEINS PROTEOM, V1844, P1383, DOI 10.1016/j.bbapap.2014.02.004; Luz JM, 1998, BIOCHEM BIOPH RES CO, V248, P621, DOI 10.1006/bbrc.1998.8992; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Mares RE, 2011, INT J MOL SCI, V12, P4625, DOI 10.3390/ijms12074625; Oka OBV, 2013, BBA-MOL CELL RES, V1833, P2425, DOI 10.1016/j.bbamcr.2013.02.007; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Ramming T, 2015, FREE RADICAL BIO MED, V83, P361, DOI 10.1016/j.freeradbiomed.2015.02.011; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2006, MOL BIOL CELL, V17, P2256, DOI 10.1091/mbc.E05-05-0417; Shepherd C, 2014, BIOCHEM J, V461, P107, DOI 10.1042/BJ20140234; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; Wang L, 2015, FREE RADICAL BIO MED, V83, P305, DOI 10.1016/j.freeradbiomed.2015.02.007; Wang L, 2011, BIOCHEM J, V434, P113, DOI 10.1042/BJ20101357; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200; Zhang LH, 2014, J BIOL CHEM, V289, P31188, DOI 10.1074/jbc.M114.602961	37	13	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8283	8294		10.1074/jbc.M115.694257	http://dx.doi.org/10.1074/jbc.M115.694257			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26846856	Green Published, hybrid			2022-12-26	WOS:000374056700043
J	van Meel, E; Lee, WS; Liu, L; Qian, Y; Doray, B; Kornfeld, S				van Meel, Eline; Lee, Wang-Sik; Liu, Lin; Qian, Yi; Doray, Balraj; Kornfeld, Stuart			Multiple Domains of GlcNAc-1-phosphotransferase Mediate Recognition of Lysosomal Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lysosomal glycoprotein; lysosomal storage disease; lysosome; mannose 6-phosphate (Man-6-P); phosphorylation	MANNOSE 6-PHOSPHATE RECEPTOR; SITE-DIRECTED MUTAGENESIS; UDP-N-ACETYLGLUCOSAMINE; CATHEPSIN-D; MRH DOMAIN; BETA-GLUCURONIDASE; ALPHA-SUBUNIT; PHOSPHORYLATION; OLIGOSACCHARIDES; GLYCOSYLATION	The Golgi enzyme UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase (GlcNAc-1-phosphotransferase), an (222) hexamer, mediates the initial step in the addition of the mannose 6-phosphate targeting signal on newly synthesized lysosomal enzymes. This tag serves to direct the lysosomal enzymes to lysosomes. A key property of GlcNAc-1-phosphotransferase is its unique ability to distinguish the 60 or so lysosomal enzymes from the numerous non-lysosomal glycoproteins with identical Asn-linked glycans. In this study, we demonstrate that the two Notch repeat modules and the DNA methyltransferase-associated protein interaction domain of the subunit are key components of this recognition process. Importantly, different combinations of these domains are involved in binding to individual lysosomal enzymes. This study also identifies the -binding site on the subunit and demonstrates that in the majority of instances the mannose 6-phosphate receptor homology domain of the subunit is required for optimal phosphorylation. These findings serve to explain how GlcNAc-1-phosphotransferase recognizes a large number of proteins that lack a common structural motif.	[van Meel, Eline; Lee, Wang-Sik; Liu, Lin; Qian, Yi; Doray, Balraj; Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, Campus Box 8125,660 South Euclid Ave, St Louis, MO 63110 USA; [van Meel, Eline] Leiden Univ, Leiden Inst Chem, Dept Med Biochem, POB 9502, NL-2300 RA Leiden, Netherlands; [Qian, Yi] Shanghai Tech Univ, Shanghai Inst Adv Immunochem Studies, Bldg 6,99 Haike Rd, Shanghai 201210, Peoples R China	Washington University (WUSTL); Leiden University; Leiden University - Excl LUMC; ShanghaiTech University	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Hematol, Campus Box 8125,660 South Euclid Ave, St Louis, MO 63110 USA.	skornfel@dom.wustl.edu		Doray, Balraj/0000-0003-3347-5013; Liu, Lin/0000-0003-4363-1411	National Institutes of Health [CA-008759]; Yash Gandhi Foundation; NATIONAL CANCER INSTITUTE [P30CA091842, R37CA008759, R01CA008759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yash Gandhi Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA-008759 and the Yash Gandhi Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Boldt HB, 2004, J BIOL CHEM, V279, P38525, DOI 10.1074/jbc.M405222200; Canduri F, 1998, BIOCHEM MOL BIOL INT, V45, P797, DOI 10.1080/15216549800203222; CANTOR AB, 1992, J BIOL CHEM, V267, P23357; Castonguay AC, 2011, BBA-GEN SUBJECTS, V1810, P815, DOI 10.1016/j.bbagen.2011.06.016; CUNNINGHAM M, 1976, J BIOL CHEM, V251, P4528; De Pace R, 2015, HUM MOL GENET, V24, P6826, DOI 10.1093/hmg/ddv387; DUSTIN ML, 1995, J BIOL CHEM, V270, P170, DOI 10.1074/jbc.270.1.170; GIESELMANN V, 1992, J BIOL CHEM, V267, P13262; GOLDBERG DE, 1981, J BIOL CHEM, V256, P3060; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Hancock MK, 2002, J BIOL CHEM, V277, P11255, DOI 10.1074/jbc.M109855200; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hu D, 2009, GLYCOBIOLOGY, V19, P1127, DOI 10.1093/glycob/cwp104; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Qian Y, 2015, J BIOL CHEM, V290, P3045, DOI 10.1074/jbc.M114.612507; Qian Y, 2013, P NATL ACAD SCI USA, V110, P10246, DOI 10.1073/pnas.1308453110; Qian Y, 2010, J BIOL CHEM, V285, P3360, DOI 10.1074/jbc.M109.068650; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; REITMAN ML, 1981, J BIOL CHEM, V256, P1977; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; SHIPLEY JM, 1993, J BIOL CHEM, V268, P12193; SONDERFELDFRESKO S, 1989, J BIOL CHEM, V264, P7692; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; TONG PY, 1989, J BIOL CHEM, V264, P7962; VALENZANO KJ, 1995, J BIOL CHEM, V270, P16441, DOI 10.1074/jbc.270.27.16441; VARKI A, 1980, J BIOL CHEM, V255, P8398; Warner JB, 2002, J BIOL CHEM, V277, P41897, DOI 10.1074/jbc.M203097200; WEITZ G, 1992, J BIOL CHEM, V267, P10039; Weyer K, 2007, J BIOL CHEM, V282, P10988, DOI 10.1074/jbc.M607903200	35	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8295	8307		10.1074/jbc.M116.714568	http://dx.doi.org/10.1074/jbc.M116.714568			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26833567	Green Published, hybrid			2022-12-26	WOS:000374056700044
J	Vershinin, Z; Feldman, M; Chen, A; Levy, D				Vershinin, Zlata; Feldman, Michal; Chen, Ayelet; Levy, Dan			PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/-Catenin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-catenin (-catenin); chromatin; gene transcription; post-translational modification (PTM); S-adenosylmethionine (SAM); Wnt pathway; Wnt signaling; PAK4; SETD6; methylation	LYSINE METHYLATION; HISTONE METHYLATION; STEM-CELLS; CHROMATIN; IDENTIFICATION; MAINTENANCE; MECHANISMS; ENRICHMENT; PROTEINS	Lysine methylation of non-histone proteins has emerged as a key regulator of many cellular functions. Although less studied than other post-translational modifications such as phosphorylation and acetylation, the number of known methylated non-histone proteins is rapidly expanding. We have identified the p21-activated kinase 4 (PAK4) as a new substrate for methylation by the protein lysine methyltransferase SETD6. Our data demonstrate that SETD6 methylates PAK4 both in vitro and at chromatin in cells. Interestingly, depletion of SETD6 in various cellular systems significantly hinders the activation of the Wnt/-catenin target genes. PAK4 was recently shown to regulate -catenin signaling, and we show that SETD6 is a key mediator of this pathway. In the presence of SETD6, the physical interaction between PAK4 and -catenin is dramatically increased, leading to a significant increase in the transcription of -catenin target genes. Taken together, our results uncover a new regulatory layer of the Wnt/-catenin signaling cascade and provide new insight into SETD6 biology.	[Vershinin, Zlata; Feldman, Michal; Chen, Ayelet; Levy, Dan] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel; [Vershinin, Zlata; Feldman, Michal; Chen, Ayelet; Levy, Dan] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Levy, D (corresponding author), Ben Gurion Univ Negev, Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel.	ledan@post.bgu.ac.il	Levy, Dan/A-3226-2013	Levy, Dan/0000-0003-0719-0305; Vershinin, Zlata/0000-0002-0060-693X	Israel Science Foundation [285/14]; Research Career Development Award from the Israel Cancer Research Fund; Marie Curie Career Integration Grant [PCIG12-GA-2012-333242]	Israel Science Foundation(Israel Science Foundation); Research Career Development Award from the Israel Cancer Research Fund; Marie Curie Career Integration Grant	This work was supported by grants (to D. L.) from The Israel Science Foundation (285/14), The Research Career Development Award from the Israel Cancer Research Fund, and a Marie Curie Career Integration Grant (PCIG12-GA-2012-333242). The authors declare that they have no conflicts of interest with the contents of this article.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Alam H, 2015, CELL MOL LIFE SCI, V72, P4577, DOI 10.1007/s00018-015-2023-y; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baskaran Y, 2012, EMBO REP, V13, P653, DOI 10.1038/embor.2012.75; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Binda O, 2013, EPIGENETICS-US, V8, P177, DOI 10.4161/epi.23416; Bremang M, 2013, MOL BIOSYST, V9, P2231, DOI 10.1039/c3mb00009e; Carlson SM, 2014, NAT PROTOC, V9, P37, DOI 10.1038/nprot.2013.164; Chang YQ, 2011, NUCLEIC ACIDS RES, V39, P6380, DOI 10.1093/nar/gkr256; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Ha BH, 2012, P NATL ACAD SCI USA, V109, P16107, DOI 10.1073/pnas.1214447109; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Herbst A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-74; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Levy D, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-19; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Li Y, 2012, BBA-MOL CELL RES, V1823, P465, DOI 10.1016/j.bbamcr.2011.11.013; Lien WH, 2014, GENE DEV, V28, P1517, DOI 10.1101/gad.244772.114; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; O'Neill DJ, 2014, EPIGENETICS-US, V9, P942, DOI 10.4161/epi.28864; Park MH, 2013, ONCOGENE, V32, P2475, DOI 10.1038/onc.2012.255; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Selamat W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129634; Shen CC, 2015, FASEB J, V29, P4313, DOI 10.1096/fj.15-273540; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Whale A, 2011, FRONT BIOSCI-LANDMRK, V16, P849, DOI 10.2741/3724; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Zhang X, 2013, P NATL ACAD SCI USA, V110, P17284, DOI 10.1073/pnas.1307959110	39	46	51	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6786	6795		10.1074/jbc.M115.697292	http://dx.doi.org/10.1074/jbc.M115.697292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26841865	Green Published, hybrid			2022-12-26	WOS:000373299700019
J	Mathot, S; Melmi, JB; van der Linden, L; van der Stigchel, S				Mathot, Sebastiaan; Melmi, Jean-Baptiste; van der Linden, Lotje; van der Stigchel, Stefan			The Mind-Writing Pupil: A Human-Computer Interface Based on Decoding of Covert Attention through Pupillometry	PLOS ONE			English	Article							LIGHT RESPONSE; BRAIN; COMMUNICATION; BCI; EYE	We present a new human-computer interface that is based on decoding of attention through pupillometry. Our method builds on the recent finding that covert visual attention affects the pupillary light response: Your pupil constricts when you covertly (without looking at it) attend to a bright, compared to a dark, stimulus. In our method, participants covertly attend to one of several letters with oscillating brightness. Pupil size reflects the brightness of the selected letter, which allows us-with high accuracy and in real time-to determine which letter the participant intends to select. The performance of our method is comparable to the best covert-attention brain-computer interfaces to date, and has several advantages: no movement other than pupil-size change is required; no physical contact is required (i.e. no electrodes); it is easy to use; and it is reliable. Potential applications include: communication with totally locked-in patients, training of sustained attention, and ultra-secure password input.	[Mathot, Sebastiaan; Melmi, Jean-Baptiste; van der Linden, Lotje] Aix Marseille Univ, CNRS, LPC UMR 7290, Marseille, France; [van der Stigchel, Stefan] Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, Utrecht, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Utrecht University	Mathot, S (corresponding author), Aix Marseille Univ, CNRS, LPC UMR 7290, Marseille, France.	s.mathot@cogsci.nl		Mathot, Sebastiaan/0000-0003-3379-8584; van der Stigchel, Stefan/0000-0002-5918-3521	People Programme (Marie Curie Actions) of European Union's Seventh Framework Programme under REA [622738]; VIDI Grant from Netherlands Organization for Scientific Research [452-13-008]	People Programme (Marie Curie Actions) of European Union's Seventh Framework Programme under REA; VIDI Grant from Netherlands Organization for Scientific Research	The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no 622738 awarded to Sebastiaan Mathot (http://cordis.europa.eu/project/rcn/187709_en.html). In addition, this research was funded by a VIDI Grant 452-13-008 from the Netherlands Organization for Scientific Research to Stefan Van der Stigchel (http://www.nwo.nl/en/research-andresults/programmes/Talent+Scheme/awards/vidi+awards/vidi+awards+2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no 622738 awarded to Sebastiaan Mathot (http://cordis.europa.eu/project/rcn/187709_en.html). In addition, this research was funded by a VIDI Grant 452-13-008 from the Netherlands Organization for Scientific Research to Stefan Van der Stigchel (http://www.nwo.nl/en/research-and-results/programmes/Talent+Scheme/awards/vidi+awards/vidi+awards+2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acqualagna L, 2013, CLIN NEUROPHYSIOL, V124, P901, DOI 10.1016/j.clinph.2012.12.050; Astrand E, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00144; Bates D., 2015, LME4 LINEAR MIXED EF; BAUER G, 1979, J NEUROL, V221, P77, DOI 10.1007/BF00313105; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Blankertz B., 2006, P 3 INT BRAIN COMP I; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Dalmaijer E., 2014, PEERJ PREPRINTS, DOI DOI 10.7287/PEERJ.PREPRINTS.585V1; Dalmaijer ES, 2014, BEHAV RES METHODS, V46, P913, DOI 10.3758/s13428-013-0422-2; Donoghue JP, 2008, NEURON, V60, P511, DOI 10.1016/j.neuron.2008.10.037; Duvinage M, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-56; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazel-Rezai Reza, 2012, Front Neuroeng, V5, P14, DOI 10.3389/fneng.2012.00014; Feinberg Richard, 1965, LATENCY PUPILLARY RE; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Gilja V, 2015, NAT MED, V21, P1142, DOI 10.1038/nm.3953; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kuznetsova A., 2015, LMERTEST TESTS LINEA; Laeng B, 2014, PSYCHOL SCI, V25, P188, DOI 10.1177/0956797613503556; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Majaranta Paivi, 2006, UNIVERSAL ACCESS INF, V5, P199, DOI [10.1007/s10209-006-0034-z, DOI 10.1007/S10209-006-0034-Z]; Marchetti M, 2013, NEUROREHAB NEURAL RE, V27, P430, DOI 10.1177/1545968312471903; Mathot S, 2015, CURR DIR PSYCHOL SCI, V24, P374, DOI 10.1177/0963721415593725; Mathot S, 2015, PEERJ, V3, DOI 10.7717/peerj.1150; Mathot S, 2014, J VISION, V14, DOI 10.1167/14.14.7; Mathot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078168; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Naber M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00919; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; R Core Team, 2014, LANG ENV STAT COMP; Riccio A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045001; SLOOTER J, 1980, INVEST OPHTH VIS SCI, V19, P105; Stoll J, 2013, CURR BIOL, V23, pR647, DOI 10.1016/j.cub.2013.06.011; Treder MS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066003; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; UKAI K, 1985, J OPT SOC AM A, V2, P1094, DOI 10.1364/JOSAA.2.001094; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yuan P, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026014	41	28	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148805	10.1371/journal.pone.0148805	http://dx.doi.org/10.1371/journal.pone.0148805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848745	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000171
J	Fiorentino, M; Sophonneary, P; Laillou, A; Whitney, S; de Groot, R; Perignon, M; Kuong, K; Berger, J; Wieringa, FT				Fiorentino, Marion; Sophonneary, Prak; Laillou, Arnaud; Whitney, Sophie; de Groot, Richard; Perignon, Marlene; Kuong, Khov; Berger, Jacques; Wieringa, Frank T.			Current MUAC Cut-Offs to Screen for Acute Malnutrition Need to Be Adapted to Gender and Age: The Example of Cambodia	PLOS ONE			English	Article							UPPER-ARM CIRCUMFERENCE; WEIGHT-FOR-HEIGHT; NUTRITIONAL-STATUS; LOW-INCOME; HIGH-RISK; Z SCORES; CHILDREN; MORTALITY; FAT	Background Early identification of children <5 yrs with acute malnutrition is a priority. Acute malnutrition is defined by the World Health Organization as a mid-upper-arm circumference (MUAC) <12.5 cm or a weight-for-height Z-score (WHZ) <-2. MUAC is a simple and low-cost indicator to screen for acute malnutrition in communities, but MUAC cut-offs currently recommended by WHO do not identify the majority of children with weight-for-height Z-score (<-2 (moderate malnourished) or r<-3 (severe malnourished). Also, no cut-offs for MUAC are established for children >5 yrs. Therefore, this study aimed at defining gender and age-specific cut-offs to improve sensitivity of MUAC as an indicator of acute malnutrition. Methods To establish new age and gender-specific MUAC cut-offs, pooled data was obtained for 14,173 children from 5 surveys in Cambodia (2011-2013). Sensitivity, false positive rates, and areas under receiver-operator characteristic curves (AUC) were calculated using wasting for children <5yrs and thinness for children >= 5yrs as gold standards. Among the highest values of AUC, the cut-off with the highest sensitivity and a false positive rate <= 33% was selected as the optimal cut-off. Results Optimal cut-off values increased with age. Boys had higher cut-offs than girls, except in the 8-10.9 yrs age range. In children <2yrs, the cut-off was lower for stunted children compared to non stunted children. Sensitivity of MUAC to identify WHZ<-2 and <-3 z-scores increased from 24.3% and 8.1% to >80% with the new cut-offs in comparison with the current WHO cut-offs. Conclusion Gender and age specific MUAC cut-offs drastically increased sensitivity to identify children with WHZ-score <-2 z-scores. International reference of MUAC cut-offs by age group and gender should be established to screen for acute malnutrition at the community level.	[Fiorentino, Marion; Perignon, Marlene; Berger, Jacques; Wieringa, Frank T.] Inst Rech Dev, IRD SupAgro Nutripass Montpellier1 Montpellier2, UMR 204, Montpellier, France; [Sophonneary, Prak] Maternal & Child Hlth Ctr, Natl Nutr Program, Phnom Penh, Cambodia; [Laillou, Arnaud] UNICEF, Maternal Child Hlth & Nutr Sect, Phnom Penh, Cambodia; [Whitney, Sophie] World Food Program, Phnom Penh, Cambodia; [Kuong, Khov] FiA Adm DFPTQ, Minist Agr Forestry & Fisheries, Phnom Penh, Cambodia	Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Fiorentino, M (corresponding author), Inst Rech Dev, IRD SupAgro Nutripass Montpellier1 Montpellier2, UMR 204, Montpellier, France.	marionfiorentino@hotmail.com	Wieringa, Frank Tammo/K-7565-2017	Wieringa, Frank Tammo/0000-0002-6010-355X; fiorentino, marion/0000-0002-1615-4579; PERIGNON, Marlene/0000-0003-2862-9030	UNICEF; WHO; WFP; World Vision; International Relief and Development; Institut de Recherche pour le Developpement	UNICEF; WHO(World Health Organization); WFP; World Vision; International Relief and Development; Institut de Recherche pour le Developpement	Data were obtained from studies funded by UNICEF, WHO, WFP, World Vision, International Relief and Development, and Institut de Recherche pour le Developpement.	Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; BRIEND A, 1987, LANCET, V2, P725; Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Cogill B, 2003, ANTHROPOMETRIC INDIC; De Onis M, 1997, WHO B OMS, V75, P11; Fernandez MAL, 2010, PEDIATRICS, V126, pE195, DOI 10.1542/peds.2009-2175; Clemente APG, 2011, J PEDIAT-BRAZIL, V87, P138, DOI 10.2223/JPED.2071; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; HALL G, 1993, LANCET, V341, P1481, DOI 10.1016/0140-6736(93)90927-9; Hop le T, 1998, Asia Pac J Clin Nutr, V7, P65; Jelliffe D B, 1966, Monogr Ser World Health Organ, V53, P3; Laillou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101159; Malina R., 1999, HLTH WEIGHT J, V13; Martins PA, 2004, BRIT J NUTR, V92, P819, DOI 10.1079/BJN20041274; MCLAREN DS, 1974, AM J CLIN NUTR, V27, P105, DOI 10.1093/ajcn/27.2.105-a; Mwangome MK, 2014, MATERN CHILD NUTR, V10, P474, DOI 10.1111/mcn.12124; Myatt M, 2009, ANN HUM BIOL, V36, P5, DOI 10.1080/03014460802471205; National Institute of Statistics, 2011, CAMB DEM HLTH SURV 2; VANDENBROECK J, 1993, LANCET, V341, P1491, DOI 10.1016/0140-6736(93)90632-Q; VELLA V, 1993, AM J PUBLIC HEALTH, V83, P1616, DOI 10.2105/AJPH.83.11.1616; WHO, 2013, GUID UPD MAN SEV AC; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 1995, PHYS STAT US INT ANT; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	27	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146442	10.1371/journal.pone.0146442	http://dx.doi.org/10.1371/journal.pone.0146442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840899	Green Submitted, gold, Green Published			2022-12-26	WOS:000369550200009
J	Cai, BL; Li, Y; Shen, LL; Zhao, JL; Liu, Y; Wu, JZ; Liu, YP; Yu, B				Cai, Bo-Lei; Li, Yan; Shen, Liang-Liang; Zhao, Jin-Long; Liu, Yuan; Wu, Jun-Zheng; Liu, Yan-Pu; Yu, Bo			Nuclear Multidrug Resistance-Related Protein 1 Is Highly Associated with Better Prognosis of Human Mucoepidermoid Carcinoma through the Suppression of Cell Proliferation, Migration and Invasion	PLOS ONE			English	Article							SALIVARY-GLAND TUMORS; LUNG-CANCER; PAROTID-GLAND; EXPRESSION; GENE; GLUTATHIONE; MRP1/ABCC1; TRANSPORT; SURVIVAL; MRP1	Objectives Multidrug resistance-related protein 1 (MRP1) overexpression is a well acknowledged predictor of poor response to chemotherapy, but MRP1 also correlated to better prognosis in some reports, especially for patients not pretreated with chemotherapy. In our previous study, we found nuclear translocation of MRP1 in mucoepidermoid carcinoma (MEC) for the first time. The purpose of this study was to further investigate the function of nuclear MRP1 in MEC. Materials and Methods Human MEC tissue samples of 125 patients were selected and stained using immunohistochemistry. The expression level of total MRP1/nuclear MRP1 of each sample was evaluated by expression index (EI) which was scored using both qualitative and quantitative analysis. The correlations between the clinicopathologic parameters and the EI of nuclear MRP1 were analyzed using Spearman's rank correlation analysis, respectively. The effects of RNAi-mediated downregulation of nuclear MRP1 on MEC cells were assessed using flow cytometric analysis, MTT assay, plate colony formation assay, transwell invasion assay and monolayer wound healing assay. Results In this study, we found the EI of nuclear MRP1 was negatively correlated to the pathologic grading (r = -0.498, P<0.01) /clinical staging (r = -0.41, P<0.01) /tumor stage (r = -0.28, P = 0.02) /nodal stage (r = -0.29, P<0.01) of MEC patients. The RNAi-mediated downregulation of nuclear MRP1 further proved that the downregulation of nuclear MRP1 could increase the cell replication, growth speed, colony formation efficiency, migration and invasion ability of MEC cells. Conclusion Our results suggested that nuclear MRP1 is highly associated with better prognosis of human mucoepidermoid carcinoma and further study of its function mechanism would provide clues in developing new treatment modalities of MEC.	[Cai, Bo-Lei; Zhao, Jin-Long; Liu, Yan-Pu; Yu, Bo] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Peoples R China; [Li, Yan] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Prosthodont, Xian 710032, Peoples R China; [Shen, Liang-Liang] Fourth Mil Med Univ, State Lab Canc Biol, Dept Biochem & Mol Biol, Xian 710032, Peoples R China; [Liu, Yuan] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Oral Histol & Pathol, Xian 710032, Peoples R China; [Wu, Jun-Zheng] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Oral Biol, 145 Chang Le Xi Rd, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Liu, YP; Yu, B (corresponding author), Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Peoples R China.	liuyanpu@fmmu.edu.cn; yubofmmu@163.com			National Natural Science Research Program of China [81502338, 31501036]; China Scholarship Council; Shaanxi Provincial Science & Technology Foundation [S2011SF1279]	National Natural Science Research Program of China; China Scholarship Council(China Scholarship Council); Shaanxi Provincial Science & Technology Foundation	This work was supported by National Natural Science Research Program of China (81502338) to Dr. Bo-Lei Cai; and National Natural Science Research Program of China (31501036) to Dr. Yan Li. The authors also gratefully acknowledge the financial support from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Natural Science Research Program of China (81502338) to Dr. Bo-Lei Cai; National Natural Science Research Program of China (31501036) to Dr. Yan Li; Shaanxi Provincial Science & Technology Foundation (S2011SF1279) to Prof. Bo Yu. The authors also gratefully acknowledge the financial support from China Scholarship Council.	Bell RB, 2005, J ORAL MAXIL SURG, V63, P917, DOI 10.1016/j.joms.2005.03.006; Berger W, 2005, J CANCER RES CLIN, V131, P355, DOI 10.1007/s00432-004-0653-9; Cai BL, 2011, ORAL ONCOL, V47, P1134, DOI 10.1016/j.oraloncology.2011.08.005; Cai BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069611; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2014, ANNU REV PHARMACOL, V54, P95, DOI 10.1146/annurev-pharmtox-011613-135959; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Goode RK, 1998, CANCER, V82, P1217, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1217::AID-CNCR2>3.0.CO;2-C; Guzzo M, 2002, ANN SURG ONCOL, V9, P688, DOI 10.1007/BF02574486; He SM, 2011, CURR MED CHEM, V18, P439, DOI 10.2174/092986711794839197; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; HICKS MJ, 1995, HEAD NECK-J SCI SPEC, V17, P89, DOI 10.1002/hed.2880170203; Hong BX, 2015, INT J CANCER, V136, P34, DOI 10.1002/ijc.28958; Hosokawa Y, 1999, ORAL ONCOL, V35, P105, DOI 10.1016/S1368-8375(98)00053-0; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Leverstein H, 1998, BRIT J SURG, V85, P1267; Liu ZG, 2015, MOL MED REP, V12, P248, DOI 10.3892/mmr.2015.3366; Lopes MA, 1999, J ORAL PATHOL MED, V28, P264; Garcia-Gimenez JL, 2013, BBA-GEN SUBJECTS, V1830, P3304, DOI 10.1016/j.bbagen.2012.10.005; Monoo Katsumi, 2003, Nihon Jibiinkoka Gakkai Kaiho, V106, P192; Nance MA, 2008, CANCER, V113, P2082, DOI 10.1002/cncr.23825; Nooter K, 1996, ANN ONCOL, V7, P75; Rapidis AD, 2007, ORAL ONCOL, V43, P130, DOI 10.1016/j.oraloncology.2006.03.001; SKALOVA A, 1994, HUM PATHOL, V25, P929, DOI 10.1016/0046-8177(94)90014-0; SPIRO RH, 1991, AM J SURG, V162, P330, DOI 10.1016/0002-9610(91)90142-Z; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Tew KD, 2011, FREE RADICAL BIO MED, V51, P299, DOI 10.1016/j.freeradbiomed.2011.04.013; Vattemi E, 2008, EXPERT REV ANTICANC, V8, P393, DOI 10.1586/14737140.8.3.393; Wen Y, 2001, Hua Xi Kou Qiang Yi Xue Za Zhi, V19, P296; Zhang YF, 2010, CANCER LETT, V292, P1, DOI 10.1016/j.canlet.2009.11.003; Zhu QR, 1999, ANAL QUANT CYTOL, V21, P336	32	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148223	10.1371/journal.pone.0148223	http://dx.doi.org/10.1371/journal.pone.0148223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829120	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200087
J	Chen, YA; Wang, TT; Fang, LC; Li, XP; Yin, TM				Chen, Yingnan; Wang, Tiantian; Fang, Lecheng; Li, Xiaoping; Yin, Tongming			Confirmation of Single-Locus Sex Determination and Female Heterogamety in Willow Based on Linkage Analysis	PLOS ONE			English	Article							PRIMITIVE Y-CHROMOSOME; MALE-SPECIFIC REGION; POPULUS-TREMULA; GENETIC-MAP; SALIX; MARKERS; GENOME; AFLP; EVOLUTION; DIOECY	In this study, we constructed high-density genetic maps of Salix suchowensis and mapped the gender locus with an F1 pedigree. Genetic maps were separately constructed for the maternal and paternal parents by using amplified fragment length polymorphism (AFLP) markers and the pseudo-testcross strategy. The maternal map consisted of 20 linkage groups that spanned a genetic distance of 2333.3 cM; whereas the paternal map contained 21 linkage groups that covered 2260 cM. Based on the established genetic maps, it was found that the gender of willow was determined by a single locus on linkage group LG_03, and the female was the heterogametic gender. Aligned with mapped SSR markers, linkage group LG_03 was found to be associated with chromosome XV in willow. It is noteworthy that marker density in the vicinity of the gender locus was significantly higher than that expected by chance alone, which indicates severe recombination suppression around the gender locus. In conclusion, this study confirmed the findings on the single-locus sex determination and female heterogamety in willow. It also provided additional evidence that validated the previous studies, which found that different autosomes evolved into sex chromosomes between the sister genera of Salix (willow) and Populus (poplar).	[Chen, Yingnan; Fang, Lecheng; Li, Xiaoping; Yin, Tongming] Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Wang, Tiantian] Forestry Res Inst Jingdezhen, Jingdezhen, Jiangxi, Peoples R China	Nanjing Forestry University	Yin, TM (corresponding author), Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.	tmyin@njfu.com.cn			National Basic Research Project [2012CB114505]; Natural Science Foundation of China [31125008, 31400564]; Jiangsu Province [BK20130968]	National Basic Research Project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province	This work was supported by the National Basic Research Project (2012CB114505, http://www.forestry.gov.cn/), the Natural Science Foundation of China (31125008, 31400564, http://isisn.nsfc.gov.cn/egrantweb/) and Jiangsu Province (BK20130968, http://www.jstd.gov.cn/). It was also enabled by the Innovative Research Team of the Educational Department of China (http://www.moe.gov.cn/), the Innovative Research Team of the Universities of Jiangsu Province (http://www.jsrcgz.gov.cn), and the PAPD (Priority Academic Program Development) program at Nanjing Forestry University (http://www.njfu.edu.en/index.php).	Akagi T, 2014, SCIENCE, V346, P646, DOI 10.1126/science.1257225; AlstromRapaport C, 1997, THEOR APPL GENET, V94, P493, DOI 10.1007/s001220050442; Barcaccia G, 2003, HEREDITY, V90, P169, DOI 10.1038/sj.hdy.6800213; Berlin S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-129; Blackburn KB, 1924, BR J EXP BIOL, V1, P413; BRADSHAW HD, 1993, THEOR APPL GENET, V86, P301, DOI 10.1007/BF00222092; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Dai XG, 2014, CELL RES, V24, P1274, DOI 10.1038/cr.2014.83; Dorken ME, 2004, P ROY SOC B-BIOL SCI, V271, P213, DOI 10.1098/rspb.2003.2580; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; EINSPAHR D. W., 1963, SILVAE GENET, V12, P51; Erlanson EW, 1927, MICH ACAD SCI ARTS, V8, P97; Filatov DA, 2005, GENETICS, V170, P975, DOI 10.1534/genetics.104.037069; Fraser LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-102; Fu HH, 2002, P NATL ACAD SCI USA, V99, P1082, DOI 10.1073/pnas.022635499; Gaudet M, 2008, TREE GENET GENOMES, V4, P25, DOI 10.1007/s11295-007-0085-1; Geraldes A, 2015, MOL ECOL, V24, P3243, DOI 10.1111/mec.13126; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Gunter LE, 2003, J HERED, V94, P185, DOI 10.1093/jhered/esg023; Hanley S, 2002, THEOR APPL GENET, V105, P1087, DOI 10.1007/s00122-002-0979-0; Hanley SJ, 2007, TREE GENET GENOMES, V3, P35, DOI 10.1007/s11295-006-0049-x; Hou J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09076; Islam-Faridi MN, 2009, CYTOGENET GENOME RES, V125, P74, DOI 10.1159/000218749; Johnsson H, 1940, HEREDITAS, V26, P321; Lan T, 2006, CYTOGENET GENOME RES, V114, P175, DOI 10.1159/000093335; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060181; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Ma H, 2004, GENETICS, V166, P419, DOI 10.1534/genetics.166.1.419; Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; Markussen T, 2007, SILVAE GENET, V56, P180, DOI 10.1515/sg-2007-0027; Ming R, 2007, AM J BOT, V94, P141, DOI 10.3732/ajb.94.2.141; Muller HJ, 1914, J EXP ZOOL, V17, P325, DOI 10.1002/jez.1400170303; Muntzing A, 1935, HEREDITAS, V21, P383; NAKAJIMA G., 1937, Cytologia, VFujii Jubilee VoL, P282, DOI 10.1508/cytologia.FujiiJubilaei.282; NEI M, 1969, GENETICS, V63, P681; Ohno S., 1967, SEX CHROMOSOMES SEX; Pakull B, 2011, CAN J FOREST RES, V41, P245, DOI 10.1139/X10-206; Pakull B, 2009, TREE GENET GENOMES, V5, P505, DOI 10.1007/s11295-009-0204-2; Paolucci I, 2010, TREE GENET GENOMES, V6, P863, DOI 10.1007/s11295-010-0297-7; Parker JS., 1990, CHROMOSOMES TODAY, V10, P187; Peichel CL, 2004, DEV CELL, V7, P327; PETO F. H., 1938, CANADIAN JOUR RES SECT C BOT SCI, V16, P445; Pucholt P, 2015, HEREDITY, V114, P575, DOI 10.1038/hdy.2014.125; RECHINGER KH, 1992, P ROY SOC EDINB B, V98, P1, DOI 10.1017/S0269727000007417; Remington DL, 1999, THEOR APPL GENET, V98, P1279, DOI 10.1007/s001220051194; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Ronnberg-Wastljung A. C., 2003, Forest Genetics, V10, P185; Rottenberg A, 2000, CAN J FOREST RES, V30, P482, DOI 10.1139/cjfr-30-3-482; Semerikov V, 2003, HEREDITY, V91, P293, DOI 10.1038/sj.hdy.6800327; SiljakYakovlev S, 1996, SEX PLANT REPROD, V9, P127, DOI 10.1007/BF02221391; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Spigler RB, 2008, HEREDITY, V101, P507, DOI 10.1038/hdy.2008.100; TANKSLEY SD, 1992, GENETICS, V132, P1141; Telgmann-Rauber A, 2007, MOL GENET GENOMICS, V278, P221, DOI 10.1007/s00438-007-0235-z; Tsarouhas V, 2002, THEOR APPL GENET, V105, P277, DOI 10.1007/s00122-002-0918-0; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tuskan GA, 2012, TREE GENET GENOMES, V8, P559, DOI 10.1007/s11295-012-0495-6; VAN BUUTENEN J. P., 1959, BOT GAZETTE, V121, P60, DOI 10.1086/336044; van DILLEWIJN C., 1940, GENETICA, V22, P131, DOI 10.1007/BF01984285; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Vyskot B, 2004, TRENDS GENET, V20, P432, DOI 10.1016/j.tig.2004.06.006; WESTERGAARD M, 1958, ADV GENET, V9, P217, DOI 10.1016/S0065-2660(08)60163-7; Wolf DE, 2001, GENETICS, V159, P1243; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308; Yu QY, 2007, MOL GENET GENOMICS, V278, P177, DOI 10.1007/s00438-007-0243-z; Zhang WL, 2008, GENOME RES, V18, P1938, DOI 10.1101/gr.078808.108; Zhou WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126077	72	17	20	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147671	10.1371/journal.pone.0147671	http://dx.doi.org/10.1371/journal.pone.0147671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828940	Green Published, gold			2022-12-26	WOS:000369548200028
J	Kuwae, A; Momose, F; Nagamatsu, K; Suyama, Y; Abe, A				Kuwae, Asaomi; Momose, Fumitaka; Nagamatsu, Kanna; Suyama, Yasuharu; Abe, Akio			BteA Secreted from the Bordetella bronchiseptica Type III Secetion System Induces Necrosis through an Actin Cytoskeleton Signaling Pathway and Inhibits Phagocytosis by Macrophages	PLOS ONE			English	Article							HOST PLASMA-MEMBRANE; PERTUSSIS; EFFECTOR; PROTEIN; INFECTIONS; REQUIRES; CELLS; BOPB; IPAC	BteA is one of the effectors secreted from the Bordetella bronchiseptica type III secretion system. It has been reported that BteA induces necrosis in mammalian cells; however, the roles of BteA during the infection process are largely unknown. In order to investigate the BteA functions, morphological changes of the cells infected with the wild-type B. bronchiseptica were examined by time-lapse microscopy. L2 cells, a rat lung epithelial cell line, spread at 1.6 hours after B. bronchiseptica infection. Membrane ruffles were observed at peripheral parts of infected cells during the cell spreading. BteA-dependent cytotoxicity and cell detachment were inhibited by addition of cytochalasin D, an actin polymerization inhibitor. Domain analyses of BteA suggested that two separate amino acid regions, 200312 and 400-658, were required for the necrosis induction. In order to examine the intra/intermolecular interactions of BteA, the amino-and the carboxyl-terminal moieties were purified as recombinant proteins from Escherichia coli. The amino-terminal moiety of BteA appeared to interact with the carboxyl-terminal moiety in the pull-down assay in vitro. When we measured the amounts of bacteria phagocytosed by J774A. 1, a macrophage-like cell line, the phagocytosed amounts of B. bronchiseptica strains that deliver BteA into the host cell cytoplasm were significantly lower than those of strains that lost the ability to translocate BteA into the host cell cytoplasm. These results suggest that B. bronchiseptica induce necrosis by exploiting the actin polymerization signaling pathway and inhibit macrophage phagocytosis.	[Kuwae, Asaomi; Nagamatsu, Kanna; Suyama, Yasuharu; Abe, Akio] Kitasato Univ, Grad Sch Infect Control Sci, Lab Bacterial Infect, Tokyo 1088641, Japan; [Momose, Fumitaka] Kitasato Univ, Grad Sch Infect Control Sci, Lab Viral Infect 2, Tokyo 1088641, Japan; [Nagamatsu, Kanna] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA	Kitasato University; Kitasato University; Washington University (WUSTL)	Kuwae, A (corresponding author), Kitasato Univ, Grad Sch Infect Control Sci, Lab Bacterial Infect, Tokyo 1088641, Japan.	kuwae@lisci.kitasato-u.ac.jp	Abe, Akio/AAQ-2464-2020		MEXT/JSPS KAKENHI [24390108, 25670215, 23790484, 26460535]; Kitasato University; Oyama Health Foundation; Naito Foundation	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kitasato University; Oyama Health Foundation; Naito Foundation(Naito Memorial Foundation)	This work was supported in part by MEXT/JSPS KAKENHI (www.jsps.go.jp) grant number 24390108 (AA), 25670215 (AA), 23790484 (AK), and 26460535 (AK), by a Grant-in-Aid from the Kitasato University Research Grant (www.kitasato-u.ac.jp) for Young Researchers in 2005 (AK) and 2006 (AK), by a research grant from the Oyama Health Foundation (http://www.disclo-koeki.org/10a/01044/index.html) in 2011 (AK), and by a research grant from The Naito Foundation (www.naito-f.or.jp/en/) in 2012 (AK). The funders had no role in the study design, data collection or analysis, the decision to publish, or the preparation of the manuscript.	Bibova I, 2015, RNA BIOL, V12, P175, DOI 10.1080/15476286.2015.1017237; Chaigne-Delalande B, 2008, J IMMUNOL, V181, P7630, DOI 10.4049/jimmunol.181.11.7630; Francois M, 2000, INFECT IMMUN, V68, P1289, DOI 10.1128/IAI.68.3.1289-1296.2000; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Kurushima J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038925; Kuwae A, 2006, J BIOL CHEM, V281, P6589, DOI 10.1074/jbc.M512711200; Kuwae A, 2001, J BIOL CHEM, V276, P32230, DOI 10.1074/jbc.M103831200; Kuwae A, 2003, CELL MICROBIOL, V5, P973, DOI 10.1046/j.1462-5822.2003.00341.x; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; Nogawa H, 2004, J BACTERIOL, V186, P3806, DOI 10.1128/JB.186.12.3806-3813.2004; Nonaka T, 2003, MICROBIOL-SGM, V149, P2513, DOI 10.1099/mic.0.26341-0; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Tang YW, 1998, CLIN INFECT DIS, V26, P389, DOI 10.1086/516323; WEISS AA, 1984, INFECT IMMUN, V43, P263, DOI 10.1128/IAI.43.1.263-269.1984; WOOLFREY BF, 1991, CLIN MICROBIOL REV, V4, P243, DOI 10.1128/CMR.4.3.243-255.1991; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x	23	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148387	10.1371/journal.pone.0148387	http://dx.doi.org/10.1371/journal.pone.0148387			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828590	gold, Green Published, Green Submitted			2022-12-26	WOS:000369548200097
J	Pinnell, RC; Almajidy, RK; Kirch, RD; Cassel, JC; Hofmann, UG				Pinnell, Richard C.; Almajidy, Rand K.; Kirch, Robert D.; Cassel, Jean C.; Hofmann, Ulrich G.			A Wireless EEG Recording Method for Rat Use inside the Water Maze	PLOS ONE			English	Article							THETA-RHYTHMS; SMALL ANIMALS; PLACE FIELDS; MEMORY TASK; OSCILLATIONS; HIPPOCAMPUS; ACQUISITION; MULTICHANNEL; COORDINATION; SYSTEM	With the continued miniaturisation of portable embedded systems, wireless EEG recording techniques are becoming increasingly prevalent in animal behavioural research. However, in spite of their versatility and portability, they have seldom been used inside water-maze tasks designed for rats. As such, a novel 3D printed implant and waterproof connector is presented, which can facilitate wireless water-maze EEG recordings in freely-moving rats, using a commercial wireless recording system (W32; Multichannel Systems). As well as waterproofing the wireless system, battery, and electrode connector, the implant serves to reduce movement-related artefacts by redistributing movement-related forces away from the electrode connector. This implant/connector was able to successfully record high-quality LFP in the hippocampo-striatal brain regions of rats as they undertook a procedurallearning variant of the double-H water-maze task. Notably, there were no significant performance deficits through its use when compared with a control group across a number of metrics including number of errors and speed of task completion. Taken together, this method can expand the range of measurements that are currently possible in this diverse area of behavioural neuroscience, whilst paving the way for integration with more complex behaviours.	[Pinnell, Richard C.; Almajidy, Rand K.; Kirch, Robert D.; Hofmann, Ulrich G.] Univ Med Ctr Freiburg, Dept Neurosurg, Neuroelect Syst, Freiburg, Germany; [Almajidy, Rand K.] Univ Lubeck, Inst Signal Proc, Lubeck, Germany; [Almajidy, Rand K.] Univ Diyala, Coll Med, Diyala, Iraq; [Cassel, Jean C.] Univ Strasbourg, LNCA, F-67000 Strasbourg, France; [Cassel, Jean C.] CNRS, LNCA UMR 7364, F-67000 Strasbourg, France	University of Freiburg; University of Lubeck; University of Diyala; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Pinnell, RC (corresponding author), Univ Med Ctr Freiburg, Dept Neurosurg, Neuroelect Syst, Freiburg, Germany.	rpinne@gmail.com	Hofmann, Ulrich/D-7107-2013	Hofmann, Ulrich/0000-0002-6264-3701; Pinnell, Richard/0000-0002-2102-2028	University of Strasbourg; Neurex-Neuroscience Upper Rhine Network; BrainLinks-BrainTools Cluster of Excellence - German Research Foundation (DFG) [EXC 1086]	University of Strasbourg; Neurex-Neuroscience Upper Rhine Network; BrainLinks-BrainTools Cluster of Excellence - German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by University of Strasbourg and Neurex-Neuroscience Upper Rhine Network (post-doc fellowship awarded to RCP), and BrainLinks-BrainTools Cluster of Excellence funded by the German Research Foundation (DFG, grant number EXC 1086).	Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; BRAGIN A, 1995, J NEUROSCI, V15, P47; Cassel R, 2012, BEHAV BRAIN RES, V230, P333, DOI 10.1016/j.bbr.2012.02.021; Chang PS, 2011, J NEUROSCI METH, V201, P106, DOI 10.1016/j.jneumeth.2011.07.018; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Hollup SA, 2001, EUR J NEUROSCI, V13, P1197, DOI 10.1046/j.0953-816x.2001.01487.x; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Hurtado JM, 2004, J NEUROPHYSIOL, V91, P1883, DOI 10.1152/jn.00853.2003; Igarashi KM, 2014, NATURE, V510, P143, DOI 10.1038/nature13162; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kirch RD, 2015, JOVE-J VIS EXP, DOI 10.3791/52667; Korshunov VA, 2007, J NEUROSCI METH, V165, P244, DOI 10.1016/j.jneumeth.2007.06.014; Korshunov VA, 2012, J NEUROSCI METH, V206, P15, DOI 10.1016/j.jneumeth.2012.02.007; Lapray D, 2008, J NEUROSCI METH, V168, P119, DOI 10.1016/j.jneumeth.2007.09.029; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Liu CC, 2006, IEEE SENS J, V6, P187, DOI 10.1109/JSEN.2005.860358; Pinnell R C, 2015, J NEUROSCI METHODS I; Pol-Bodetto S, 2011, BEHAV BRAIN RES, V218, P138, DOI 10.1016/j.bbr.2010.11.043; Richter Anja, 2013, Front Neuroeng, V6, P6, DOI 10.3389/fneng.2013.00006; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3	24	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147730	10.1371/journal.pone.0147730	http://dx.doi.org/10.1371/journal.pone.0147730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828947	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200029
J	Herve, V; Ketter, E; Pierrat, JC; Gelhaye, E; Frey-Klett, P				Herve, Vincent; Ketter, Elodie; Pierrat, Jean-Claude; Gelhaye, Eric; Frey-Klett, Pascale			Impact of Phanerochaete chrysosporium on the Functional Diversity of Bacterial Communities Associated with Decaying Wood	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; FUNGI; SOIL; LIGNIN; BIODEGRADATION; DECOMPOSITION; DYNAMICS; QUALITY; GROWTH; LOGS	Bacteria and fungi naturally coexist in various environments including forest ecosystems. While the role of saprotrophic basidiomycetes in wood decomposition is well established, the influence of these fungi on the functional diversity of the wood-associated bacterial communities has received much less attention. Based on a microcosm experiment, we tested the hypothesis that both the presence of the white-rot fungus Phanerochaete chrysosporium and the wood, as a growth substrate, impacted the functional diversity of these bacterial communities. Microcosms containing sterile sawdust were inoculated with a microbial inoculum extracted from a forest soil, in presence or in absence of P. chrysosporium and subsequently, three enrichment steps were performed. First, bacterial strains were isolated from different microcosms previously analyzed by 16S rRNA gene-based pyrosequencing. Strains isolated from P. chrysosporium mycosphere showed less antagonism against this fungus compared to the strains isolated from the initial forest soil inoculum, suggesting a selection by the fungus of less inhibitory bacterial communities. Moreover, the presence of the fungus in wood resulted in a selection of cellulolytic and xylanolytic bacterial strains, highlighting the role of mycospheric bacteria in wood decomposition. Additionally, the proportion of siderophore-producing bacteria increased along the enrichment steps, suggesting an important role of bacteria in iron mobilization in decaying-wood. Finally, taxonomic identification of 311 bacterial isolates revealed, at the family level, strong similarities with the high-throughput sequencing data as well as with other studies in terms of taxonomic composition of the wood-associated bacterial community, highlighting that the isolated strains are representative of the wood-associated bacterial communities.	[Herve, Vincent; Ketter, Elodie; Gelhaye, Eric; Frey-Klett, Pascale] INRA, Interact Arbres Microorganismes, UMR1136, F-54280 Champenoux, France; [Herve, Vincent; Ketter, Elodie; Gelhaye, Eric; Frey-Klett, Pascale] Univ Lorraine, Interact Arbres Microorganismes, UMR1136, F-54500 Vandoeuvre Les Nancy, France; [Pierrat, Jean-Claude] INRA, UMR LERFOB 1092, F-54280 Champenoux, France; [Pierrat, Jean-Claude] AgroParisTech, UMR LERFOB 1092, F-54000 Nancy, France	INRAE; Universite de Lorraine; Universite de Lorraine; INRAE; AgroParisTech	Herve, V (corresponding author), INRA, Interact Arbres Microorganismes, UMR1136, F-54280 Champenoux, France.; Herve, V (corresponding author), Univ Lorraine, Interact Arbres Microorganismes, UMR1136, F-54500 Vandoeuvre Les Nancy, France.	vincent.herve8@gmail.com		Herve, Vincent/0000-0002-3495-561X	French National Research Agency (ANR), "Investissements d'Avenir" program (Lab of Excellence ARBRE) [ANR-11-LABX-0002-01]; Agence Nationale de la Recherche [ANR-09-BLAN-0012]	French National Research Agency (ANR), "Investissements d'Avenir" program (Lab of Excellence ARBRE)(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR))	The UMR IaM is supported by a grant overseen by the French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE). Agence Nationale de la Recherche ANR-09-BLAN-0012 http://www.agence-nationalerecherche.fr/. Funding was received by VH EK EG PFK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; Antony-Babu S, 2014, ENVIRON MICROBIOL, V16, P2831, DOI 10.1111/1462-2920.12294; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baldrian P, 2008, BR MYCOL SY, V28, P19; Berlemont R, 2013, APPL ENVIRON MICROB, V79, P1545, DOI 10.1128/AEM.03305-12; BLANCHETTE RA, 1991, ANNU REV PHYTOPATHOL, V29, P381, DOI 10.1146/annurev.py.29.090191.002121; Blomqvist J, 2014, BIOTECHNOL APPL BIOC, V61, P58, DOI 10.1002/bab.1153; Brown ME, 2014, CURR OPIN CHEM BIOL, V19, P1, DOI 10.1016/j.cbpa.2013.11.015; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Clausen CA, 1996, INT BIODETER BIODEGR, V37, P101, DOI 10.1016/0964-8305(95)00109-3; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; FEKETE FA, 1989, APPL ENVIRON MICROB, V55, P2720, DOI 10.1128/AEM.55.10.2720-2722.1989; Folman LB, 2008, FEMS MICROBIOL ECOL, V63, P181, DOI 10.1111/j.1574-6941.2007.00425.x; Frey P, 1997, APPL ENVIRON MICROB, V63, P1852, DOI 10.1128/AEM.63.5.1852-1860.1997; Frey-Klett P, 2005, NEW PHYTOL, V165, P317, DOI 10.1111/j.1469-8137.2004.01212.x; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; Fukasawa Y, 2015, FOREST ECOL MANAG, V349, P29, DOI 10.1016/j.foreco.2015.04.010; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Herve V, 2014, ENVIRON MICROBIOL, V16, P2238, DOI 10.1111/1462-2920.12347; Hoppe B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09456; Hoppe B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088141; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CS, 2010, INT J SYST EVOL MICR, V60, P281, DOI 10.1099/ijs.0.013367-0; Leonowicz A, 1999, FUNGAL GENET BIOL, V27, P175, DOI 10.1006/fgbi.1999.1150; Lequy E, 2014, SCI TOTAL ENVIRON, V487, P206, DOI 10.1016/j.scitotenv.2014.04.028; Leveau JHJ, 2010, ENVIRON MICROBIOL, V12, P281, DOI 10.1111/j.1462-2920.2009.02010.x; LINDAHL V, 1995, FEMS MICROBIOL ECOL, V16, P135, DOI 10.1111/j.1574-6941.1995.tb00277.x; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Murray AC, 2007, FOREST PATHOL, V37, P217, DOI 10.1111/j.1439-0329.2007.00490.x; Pion M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2242; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; RADTKE C, 1994, APPL MICROBIOL BIOT, V41, P274, DOI 10.1007/BF00186972; Rajala T, 2012, FEMS MICROBIOL ECOL, V81, P494, DOI 10.1111/j.1574-6941.2012.01376.x; Schilling JS, 2015, SOIL BIOL BIOCHEM, V88, P58, DOI 10.1016/j.soilbio.2015.05.002; Schilling JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120679; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stopnisek N, 2014, ENVIRON MICROBIOL, V16, P1503, DOI 10.1111/1462-2920.12211; Sun H, 2014, GEOMICROBIOL J, V31, P315, DOI 10.1080/01490451.2013.827763; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Tornberg K, 2003, BIOL FERT SOILS, V37, P190, DOI 10.1007/s00374-002-0574-1; Ulrich A, 2008, MICROB ECOL, V55, P512, DOI 10.1007/s00248-007-9296-0; Uroz S, 2011, CENT EUR J BIOL, V6, P817, DOI 10.2478/s11535-011-0053-5; Valaskova V, 2009, ISME J, V3, P1218, DOI 10.1038/ismej.2009.64; VanInsberghe D, 2013, APPL ENVIRON MICROB, V79, P2096, DOI 10.1128/AEM.03112-12; Vetrovsky T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089108; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warmink JA, 2009, ENVIRON MICROBIOL, V11, P300, DOI 10.1111/j.1462-2920.2008.01767.x; Watts Joy E.M., 2013, Diversity-Basel, V5, P641, DOI 10.3390/d5030641; Weisshaupt P, 2013, MYCOL PROG, V12, P283, DOI 10.1007/s11557-012-0834-x; Woo HL, 2014, SYST APPL MICROBIOL, V37, P60, DOI 10.1016/j.syapm.2013.10.001; ZAK JC, 1994, SOIL BIOL BIOCHEM, V26, P1101, DOI 10.1016/0038-0717(94)90131-7; Zhang HB, 2008, INT BIODETER BIODEGR, V62, P471, DOI 10.1016/j.ibiod.2008.06.001	60	27	27	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147100	10.1371/journal.pone.0147100	http://dx.doi.org/10.1371/journal.pone.0147100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824755	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528600015
J	Yin, Y; Liu, LR; Yang, CY; Lin, CX; Veith, GM; Wang, CH; Sutovsky, P; Zhou, PB; Ma, L				Yin, Yan; Liu, Liren; Yang, Chenyi; Lin, Congxing; Veith, George Michael; Wang, Caihong; Sutovsky, Peter; Zhou, Pengbo; Ma, Liang			Cell Autonomous and Nonautonomous Function of CUL4B in Mouse Spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mouse genetics; protein degradation; spermatogenesis; ubiquitin; ubiquitin ligase	SPERMATOGONIAL STEM-CELLS; UBIQUITIN LIGASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BULL SPERMATOZOA; SPERM MOTILITY; FLOW-CYTOMETRY; FIBROUS SHEATH; TESTIS; MACROPHAGES; NICHE	CUL4B ubiquitin ligase belongs to the cullin-RING ubiquitin ligase family. Although sharing many sequence and structural similarities, CUL4B plays distinct roles in spermatogenesis from its homologous protein CUL4A. We previously reported that genetic ablation of Cul4a in mice led to male infertility because of aberrant meiotic progression. In the present study, we generated Cul4b germ cell-specific conditional knock-out (Cul4b(Vasa)),as well as Cul4b global knock-out (Cul4b(Sox2)) mouse, to investigate its roles in spermatogenesis. Germ cell-specific deletion of Cul4b led to male infertility, despite normal testicular morphology and comparable numbers of spermatozoa. Notably, significantly impaired sperm mobility caused by reduced mitochondrial activity and glycolysis level were observed in the majority of the mutant spermatozoa, manifested by low, if any, sperm ATP production. Furthermore, Cul4b(Vasa) spermatozoa exhibited defective arrangement of axonemal microtubules and flagella outer dense fibers. Our mass spectrometry analysis identified INSL6 as a novel CUL4B substrate in male germ cells, evidenced by its direct polyubiquination and degradation by CUL4B E3 ligase. Nevertheless, Cul4b global knock-out males lost their germ cells in an age-dependent manner, implying failure of maintaining the spermatogonial stem cell niche in somatic cells. Taken together, our results show that CUL4B is indispensable to spermatogenesis, and it functions cell autonomously in male germ cells to ensure spermatozoa motility, whereas it functions non-cell-autonomously in somatic cells to maintain spermatogonial stemness. Thus, CUL4B links two distinct spermatogenetic processes to a single E3 ligase, highlighting the significance of ubiquitin modification during spermatogenesis.	[Yin, Yan; Lin, Congxing; Veith, George Michael; Ma, Liang] Washington Univ, Sch Med, Dept Med, Div Dermatol, Box 8123,660 S Euclid Ave, St Louis, MO 63110 USA; [Wang, Caihong] Washington Univ, Sch Med, Dept Obstet & Gynecol, Box 8123,660 S Euclid Ave, St Louis, MO 63110 USA; [Liu, Liren; Yang, Chenyi; Zhou, Pengbo] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Liu, Liren; Yang, Chenyi; Zhou, Pengbo] Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA; [Sutovsky, Peter] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Sutovsky, Peter] Univ Missouri, Dept Obstet Gynecol, Columbia, MO 65211 USA; [Sutovsky, Peter] Univ Missouri, Dept Womens Hlth, Columbia, MO 65211 USA	Washington University (WUSTL); Washington University (WUSTL); Cornell University; Cornell University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ma, L (corresponding author), Washington Univ, Dept Med, Box 8123,660 S Euclid Ave, St Louis, MO 63110 USA.	lima@dom.wustl.edu	liu, liren/ABH-6459-2020; Liu, Liren/AAX-8645-2021	liu, liren/0000-0001-7786-7874; Liu, Liren/0000-0001-7786-7874; Sutovsky, Peter/0000-0002-9231-2823	NCI Cancer Center Support Grant [P30 CA91842]; National Institutes of Health [ES016597, 1R01 CA 159925, 1R01 CA098210]; U.S. Department of Agriculture National Institute of Food and Agriculture [2011-67015-20025, 2013-67015-20961]; Food for the 21st Century Program of the University of Missouri; NATIONAL CANCER INSTITUTE [R01CA159925, P30CA091842, R01CA098210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016597] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Food for the 21st Century Program of the University of Missouri; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by NCI Cancer Center Support Grant P30 CA91842 (to the Siteman Cancer Center). This work was supported by National Institutes of Health Grants ES016597 (to L. M.) and 1R01 CA 159925 and 1R01 CA098210 (to P. Z.) and by U.S. Department of Agriculture National Institute of Food and Agriculture Awards 2011-67015-20025 and 2013-67015-20961 and seed funding from the Food for the 21st Century Program of the University of Missouri (to P. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Brugh VM, 2004, MED CLIN N AM, V88, P367, DOI 10.1016/S0025-7125(03)00150-0; Burnicka-Turek O, 2009, ENDOCRINOLOGY, V150, P4348, DOI 10.1210/en.2009-0201; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 1999, BIOL REPROD, V61, P842, DOI 10.1095/biolreprod61.3.842; DeFalco T, 2015, CELL REP, V12, P1107, DOI 10.1016/j.celrep.2015.07.015; EVENSON DP, 1982, J HISTOCHEM CYTOCHEM, V30, P279, DOI 10.1177/30.3.6174566; Frungieri MB, 2002, FERTIL STERIL, V78, P298, DOI 10.1016/S0015-0282(02)03206-5; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Giannessi F, 2005, J MORPHOL, V263, P39, DOI 10.1002/jmor.10287; Goriely A, 2005, P NATL ACAD SCI USA, V102, P6051, DOI 10.1073/pnas.0500267102; Gravance CG, 2000, THERIOGENOLOGY, V53, P1691, DOI 10.1016/S0093-691X(00)00308-3; HALANGK W, 1990, BIOCHIM BIOPHYS ACTA, V1015, P243, DOI 10.1016/0005-2728(90)90026-Z; Hirsh A, 2003, BMJ-BRIT MED J, V327, P669, DOI 10.1136/bmj.327.7416.669; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Hsu SY, 1999, MOL ENDOCRINOL, V13, P2163, DOI 10.1210/me.13.12.2163; Ion R, 1998, HUM GENET, V102, P151, DOI 10.1007/s004390050669; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Krisfalusi M, 2006, BIOL REPROD, V75, P270, DOI 10.1095/biolreprod.105.049684; Lee J, 2013, BLOOD, V121, P4082, DOI 10.1182/blood-2012-09-455204; Lee J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00021; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Lok S, 2000, BIOL REPROD, V62, P1593, DOI 10.1095/biolreprod62.6.1593; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miyazaki S, 2007, J IMMUNOL, V179, P5407, DOI 10.4049/jimmunol.179.8.5407; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; NIEMI M, 1986, CELL TISSUE RES, V243, P337; Oatley MJ, 2011, BIOL REPROD, V84, P639, DOI 10.1095/biolreprod.110.087320; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Perrin RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064314; Pfeiffer JR, 2012, J IMMUNOL, V188, P1828, DOI 10.4049/jimmunol.1102837; Ruiz-Pesini E, 1998, CLIN CHEM, V44, P1616; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Shetty G, 2007, CELL STEM CELL, V1, P361, DOI 10.1016/j.stem.2007.09.013; STOREY BT, 1977, BIOL REPROD, V16, P549; STOREY BT, 1980, J EXP ZOOL, V211, P361, DOI 10.1002/jez.1402110313; STOREY BT, 1980, J EXP ZOOL, V212, P61, DOI 10.1002/jez.1402120109; Sugasawa K, 2009, MOL CELL, V34, P403, DOI 10.1016/j.molcel.2009.05.009; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Westhoff D, 1997, J CELL SCI, V110, P1821; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	47	17	19	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6923	6935		10.1074/jbc.M115.699660	http://dx.doi.org/10.1074/jbc.M115.699660			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26846852	Green Published, hybrid			2022-12-26	WOS:000373299700029
J	Chu, C; Bottaro, DP; Betenbaugh, MJ; Shiloach, J				Chu, Chia; Bottaro, Donald P.; Betenbaugh, Michael J.; Shiloach, Joseph			Stable Ectopic Expression of ST6GALNAC5 Induces Autocrine MET Activation and Anchorage-Independence in MDCK Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN-FREE CULTURE; SCATTER FACTOR; CANCER PROGRESSION; CHO-CELLS; C-MET; MATRIX METALLOPROTEINASES; KINASE ACTIVATION; SIGNALING PATHWAY	The epithelial-mesenchymal transition (EMT) is a complex cancer progression that can boost the metastatic potential of transformed cells by inducing migration, loss of cell adhesion, and promoting proliferation under anchorage-independent conditions. A DNA microarray analysis was performed comparing parental anchorage-dependent MDCK cells and anchorage-independent MDCK cells that were engineered to express human siat7e (ST6GALNAC5). The comparison identified several genes involved in the EMT process that were differentially expressed between the anchorage-dependent and the anchorage-independent MDCK cell lines. The hepatocyte growth factor gene (hgf) was found to be over-expressed in the engineered MDCK-siat7e cells at both transcription and protein expression levels. Phosphorylation analysis of the MET receptor tyrosine kinase confirmed the activation of an autocrine loop of the HGF/MET signaling pathway in the MDCK-siat7e cells. When MET activities were suppressed by using the small-molecular inhibitor drug PF-02341066 (Crizotinib), the anchorage-independent MDCK-siat7e cells reverted to the cellular morphology of the parental anchorage-dependent MDCK cells. These observations indicate that the MET receptor plays a central role in the growth properties of the MDCK cells and its phosphorylation status is likely dependent on sialylation. Further investigation of the downstream signaling targets in the MET network showed that the degree of MDCK cell adhesion correlated with secretion levels of a matrix metalloproteinase, MMP1, suggesting a role of metalloproteinases in the EMT process. These results demonstrate that in addition to its application in biotechnology processes, MDCK-siat7e may serve as a model cell for metastasis studies to decipher the sequence of events leading up to the activation of EMT.	[Chu, Chia; Shiloach, Joseph] NIDDK, Biotechnol Core Lab, NIH, Bethesda, MD 20892 USA; [Chu, Chia; Betenbaugh, Michael J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Bottaro, Donald P.] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Chu, Chia] Pfizer Inc, Bioproc Res & Dev, Chesterfield, MO USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pfizer	Shiloach, J (corresponding author), NIDDK, Biotechnol Core Lab, NIH, Bethesda, MD 20892 USA.	Josephs@niddk.nih.gov	Bottaro, Donald P/AAF-3853-2020; Bottaro, Donald P/F-8550-2010	Bottaro, Donald P/0000-0002-5057-5334; Bottaro, Donald P/0000-0002-5057-5334	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075080] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the Intramural program at the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.	Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Astley K, 2008, APPL MICROBIOL BIOT, V78, P391, DOI 10.1007/s00253-007-1320-2; Astley K, 2007, J BIOTECHNOL, V130, P282, DOI 10.1016/j.jbiotec.2007.04.012; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cecchi F, 2010, EUR J CANCER, V46, P1260, DOI 10.1016/j.ejca.2010.02.028; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chacon-Heszele MF, 2014, AM J PHYSIOL-RENAL, V306, pF1047, DOI 10.1152/ajprenal.00589.2013; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Christiansen MN, 2014, PROTEOMICS, V14, P525, DOI 10.1002/pmic.201300387; Chu C, VACCINE; Chu C, 2009, P NATL ACAD SCI USA, V106, P14802, DOI 10.1073/pnas.0905912106; Chu SH, 2007, J NEURO-ONCOL, V85, P33, DOI 10.1007/s11060-007-9387-2; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fukuta K, 2005, BIOCHEM J, V388, P555, DOI 10.1042/BJ20041698; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; Gomes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066737; GRAZIANI A, 1991, J BIOL CHEM, V266, P22087; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hellman NE, 2008, J BIOL CHEM, V283, P4272, DOI 10.1074/jbc.M708027200; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Hu WS, 1997, CURR OPIN BIOTECH, V8, P148, DOI 10.1016/S0958-1669(97)80093-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikehara Y, 1999, FEBS LETT, V463, P92, DOI 10.1016/S0014-5793(99)01605-1; Jaluria P, 2007, METAB ENG, V9, P241, DOI 10.1016/j.ymben.2006.12.001; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Kurcon T, 2015, P NATL ACAD SCI USA, V112, P7327, DOI 10.1073/pnas.1502076112; Kuystermans D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-25; Lau KM, 2011, EXP CELL RES, V317, P539, DOI 10.1016/j.yexcr.2010.12.005; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mathias RA, 2009, J PROTEOME RES, V8, P2827, DOI 10.1021/pr8010974; Moon SK, 2004, J BIOL CHEM, V279, P33063, DOI 10.1074/jbc.M313462200; Nakashiro K, 2004, AM J PATHOL, V165, P533, DOI 10.1016/S0002-9440(10)63318-4; Okajima T, 1999, J BIOL CHEM, V274, P30557, DOI 10.1074/jbc.274.43.30557; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Parrott JA, 2000, ENDOCRINOLOGY, V141, P2532, DOI 10.1210/en.141.7.2532; Qian J, 2009, ACTA PHARMACOL SIN, V30, P1039, DOI 10.1038/aps.2009.84; RENNER WA, 1995, BIOTECHNOL BIOENG, V47, P476, DOI 10.1002/bit.260470409; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; STOKER M, 1989, J CELL PHYSIOL, V139, P565, DOI 10.1002/jcp.1041390316; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; UEHARA Y, 1992, J CELL BIOL, V117, P889, DOI 10.1083/jcb.117.4.889; Vadnais J, 2002, J BIOL CHEM, V277, P48342, DOI 10.1074/jbc.M209481200; Yamazaki S, 2008, DRUG METAB DISPOS, V36, P1267, DOI 10.1124/dmd.107.019711; Yang JW, 2005, J AM SOC NEPHROL, V16, P68, DOI 10.1681/ASN.2003090795; Ye M, 2008, INVEST OPHTH VIS SCI, V49, P497, DOI 10.1167/iovs.07-0975; YOGEESWARAN G, 1981, SCIENCE, V212, P1514, DOI 10.1126/science.7233237; Zhang AH, 2006, AM J PHYSIOL-RENAL, V291, pF1323, DOI 10.1152/ajprenal.00480.2005; Zhao XH, 2011, BIOTECHNOL LETT, V33, P1293, DOI 10.1007/s10529-011-0577-9; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	64	3	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148075	10.1371/journal.pone.0148075	http://dx.doi.org/10.1371/journal.pone.0148075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848584	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000038
J	Desmarais, MJ; Beauregard, F; Cabana, T; Pflieger, JF				Desmarais, Marie-Josee; Beauregard, France; Cabana, Therese; Pflieger, Jean-Francois			Facial Mechanosensory Influence on Forelimb Movement in Newborn Opossums, Monodelphis domestica	PLOS ONE			English	Article							MERKEL CELLS; SPINAL-CORD; DEVELOPMENTAL ORIGINS; NERVOUS-SYSTEM; BRAIN-STEM; LOCOMOTION; RAT; NEURONS; GRAY; DIFFERENTIATION	The opossum, Monodelphis domestica, is born very immature but crawls, unaided, with its forelimbs (FL) from the mother's birth canal to a nipple where it attaches to pursue its development. What sensory cues guide the newborn to the nipple and trigger its attachment to it? Previous experiments showed that low intensity electrical stimulation of the trigeminal ganglion induces FL movement in in vitro preparations and that trigeminal innervation of the facial skin is well developed in the newborn. The skin does not contain Vater-Pacini or Meissner touch corpuscles at this age, but it contains cells which appear to be Merkel cells (MC). We sought to determine if touch perceived by MC could exert an influence on FL movements. Application of the fluorescent dye AM1-43, which labels sensory cells such as MC, revealed the presence of a large number of labeled cells in the facial epidermis, especially in the snout skin, in newborn opossums. Moreover, calibrated pressure applied to the snout induced bilateral and simultaneous electromyographic responses of the triceps muscle in in vitro preparations of the neuraxis and FL from newborn. These responses increase with stimulation intensity and tend to decrease over time. Removing the facial skin nearly abolished these responses. Metabotropic glutamate 1 receptors being involved in MC neurotransmission, an antagonist of these receptors was applied to the bath, which decreased the EMG responses in a reversible manner. Likewise, bath application of the purinergic type 2 receptors, used by AM1-43 to penetrate sensory cells, also decreased the triceps EMG responses. The combined results support a strong influence of facial mechanosensation on FL movement in newborn opossums, and suggest that this influence could be exerted via MC.	[Desmarais, Marie-Josee; Beauregard, France; Cabana, Therese; Pflieger, Jean-Francois] Univ Montreal, Dept Sci Biol, CP 6128, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Pflieger, JF (corresponding author), Univ Montreal, Dept Sci Biol, CP 6128, Montreal, PQ H3C 3J7, Canada.	jf.pflieger@umontreal.ca		Pflieger, Jean-Francois/0000-0002-6533-6416	Natural Sciences and Engineering Research Council of Canada [3595, 312015]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada, Discovery Grants #3595 (TC) and #312015 (JFP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adadja T, 2013, NEUROSCIENCE, V228, P259, DOI 10.1016/j.neuroscience.2012.10.029; AOKI M, 1981, BRAIN RES, V214, P424, DOI 10.1016/0006-8993(81)91206-3; Ashwell KW, 2015, SOMATOSENS MOT RES, V3, P1; Beiriger A, 2014, J EXP ZOOL PART B, V322, P221, DOI 10.1002/jez.b.22556; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Boulais N, 2007, J AM ACAD DERMATOL, V57, P147, DOI 10.1016/j.jaad.2007.02.009; Burnstock G, 2000, BRIT J ANAESTH, V84, P476, DOI 10.1093/oxfordjournals.bja.a013473; Burnstock G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00227; Cahusac PMB, 2009, NEUROSCIENCE, V163, P933, DOI 10.1016/j.neuroscience.2009.07.015; CASSIDY G, 1994, BRAIN BEHAV EVOLUT, V43, P244, DOI 10.1159/000113638; Crumling MA, 2009, NEUROSCIENCE, V161, P1144, DOI 10.1016/j.neuroscience.2009.02.076; Di Prisco GV, 2000, J NEUROSCI, V20, P8169; DiPrisco GV, 1997, SCIENCE, V278, P1122, DOI 10.1126/science.278.5340.1122; ERZURUMLU RS, 1992, J NEUROSCI, V12, P3946; FADEM BH, 1982, LAB ANIM SCI, V32, P405; Frappell PB, 2006, RESP PHYSIOL NEUROBI, V154, P252, DOI 10.1016/j.resp.2006.05.001; GEMMELL RT, 1988, ANAT EMBRYOL, V177, P403, DOI 10.1007/BF00304737; HUGHES RL, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P377; JONES TE, 1985, SOMATOSENS MOT RES, V3, P169, DOI 10.3109/07367228509144582; Keyte AL, 2010, DEVELOPMENT, V137, P4283, DOI 10.1242/dev.049445; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; KRAUS DB, 1987, LAB ANIM SCI, V37, P478; Lavallee A, 2009, BRAIN RES, V1282, P1, DOI 10.1016/j.brainres.2009.05.068; Liu Xue Jun, 2005, Curr Opin Investig Drugs, V6, P65; Lucarz A, 2007, EUR J CELL BIOL, V86, P243, DOI 10.1016/j.ejcb.2007.02.001; Marasco PD, 2006, P NATL ACAD SCI USA, V103, P9339, DOI 10.1073/pnas.0603229103; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Meyers JR, 2003, J NEUROSCI, V23, P4054; Nagarajan R, 2010, NEUROINFORMATICS, V8, P201, DOI 10.1007/s12021-010-9081-y; Nakatsuka T, 2001, J NEUROSCI, V21, P6522, DOI 10.1523/JNEUROSCI.21-17-06522.2001; NICHOLLS JG, 1990, J EXP BIOL, V152, P1; NOGA BR, 1988, J NEUROSCI, V8, P2074; NOGA BR, 1991, J NEUROSCI, V11, P1691; Petruska JC, 2000, J CHEM NEUROANAT, V20, P141, DOI 10.1016/S0891-0618(00)00080-6; Pflieger JF, 1996, BEHAV BRAIN RES, V80, P137, DOI 10.1016/0166-4328(96)00028-9; Puzzolo E, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-8; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Ruan HZ, 2004, HISTOCHEM CELL BIOL, V122, P539, DOI 10.1007/s00418-004-0714-9; Smith KK, 2006, DEV DYNAM, V235, P1181, DOI 10.1002/dvdy.20676; Staikopoulos V, 2007, NEUROSCIENCE, V144, P208, DOI 10.1016/j.neuroscience.2006.09.035; STEWART RR, 1991, J EXP BIOL, V161, P25; Tachibana Tamiko, 2002, Anatomical Science International, V77, P26, DOI 10.1046/j.0022-7722.2002.00008.x; Vandeberg J. L., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P246, DOI 10.1002/9781444318777.ch19; VINAY L, 1995, EUR J NEUROSCI, V7, P143, DOI 10.1111/j.1460-9568.1995.tb01028.x; Waite PME, 2000, EUR J NEUROSCI, V12, P2781, DOI 10.1046/j.1460-9568.2000.00161.x; WAITE PME, 1994, J COMP NEUROL, V350, P75, DOI 10.1002/cne.903500106; Woo SH, 2015, TRENDS CELL BIOL, V25, P74, DOI 10.1016/j.tcb.2014.10.003	47	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148352	10.1371/journal.pone.0148352	http://dx.doi.org/10.1371/journal.pone.0148352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848758	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000075
J	Hirooka, M; Koizumi, Y; Imai, Y; Miyake, T; Watanabe, T; Yoshida, O; Takeshita, E; Tokumoto, Y; Abe, M; Hiasa, Y				Hirooka, Masashi; Koizumi, Yohei; Imai, Yusuke; Miyake, Teruki; Watanabe, Takao; Yoshida, Osamu; Takeshita, Eiji; Tokumoto, Yoshio; Abe, Masanori; Hiasa, Yoichi			Usefulness of a New Three-Dimensional Simulator System for Radiofrequency Ablation	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; THERMAL ABLATION; EX-VIVO; IN-VIVO; LIVER; PROGRESSION; ELECTRODES; MONOPOLAR; RESECTION; BIOPSY	Multipuncture radiofrequency ablation is expected to produce a large ablated area and reduce intrahepatic recurrence of hepatocellular carcinoma; however, it requires considerable skill. This study evaluated the utility of a new simulator system for multipuncture radiofrequency ablation. To understand positioning of multipuncture electrodes on three-dimensional images, we developed a new technology by expanding real-time virtual ultrasonography. We performed 21 experimental punctures in phantoms. Electrode insertion directions and positions were confirmed on computed tomography, and accuracy and utility of the simulator system were evaluated by measuring angles and intersections for each electrode. Moreover, to appropriately assess placement of the three electrodes, puncture procedures with or without the simulator were performed by experts and non-experts. Technical success was defined as maximum angle and distance ratio, as calculated by maximum and minimum distances between electrodes. In punctures using 2 electrodes, correlations between angles on each imaging modality were strong (ultrasound vs. simulator: r = 0.991, p<0.001, simulator vs. computed tomography: r = 0.991, p<0.001, ultrasound vs. computed tomography: r = 0.999, p<0.001). Correlations between distances in each imaging modality were also strong (ultrasound vs. simulator: r = 0.993, p<0.001; simulator vs. computed tomography: r = 0.994, p<0.001; ultrasound vs. computed tomography: r = 0.994, p<0.001). In cases with 3 electrodes, distances between each electrode correlated strongly (yellow-labeled vs. red-labeled: r = 0.980, p<0.001; red-labeled vs. blue-labeled: r = 0.953, p<0.001; yellow-labeled vs. blue-labeled: r = 0.953, p<0.001). Both angle and distance ratio (expert with simulator vs. without simulator; p = 0.03, p = 0.02) were significantly smaller in procedures performed by experts using the simulator system. The new simulator system appears to accurately guide electrode positioning. This simulator system could allow multipuncture radiofrequency ablation to be performed more effectively and comfortably.	[Hirooka, Masashi; Koizumi, Yohei; Imai, Yusuke; Miyake, Teruki; Watanabe, Takao; Yoshida, Osamu; Takeshita, Eiji; Tokumoto, Yoshio; Abe, Masanori; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan	Ehime University	Hiasa, Y (corresponding author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan.	hiasa@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021	Hiasa, Yoichi/0000-0003-4117-339X; Miyake, Teruki/0000-0002-9905-5356	Japanese Ministry of Education, Culture, Sports, Science and Technology [JSPS KAKENHI 15K09006, JSPS KAKENHI 15K09960]; Japanese Ministry of Health, Labor and Welfare	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in the role of data collection by a Grant-in-Aid for Scientific Research (JSPS KAKENHI 15K09006 to YH and JSPS KAKENHI 15K09960 to MH) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, as well as a Grant-in-Aid for Scientific Research and Development from the Japanese Ministry of Health, Labor and Welfare (to YH) (https://www.jsps.go.jp/j-grantsinaid/).	Cady B, 1998, ANN SURG, V227, P566, DOI 10.1097/00000658-199804000-00019; Chapoutot C, 1999, GASTROEN CLIN BIOL, V23, P552; Clasen S, 2006, RADIOLOGY, V238, P881, DOI 10.1148/radiol.2382050571; Dodd GD, 2001, AM J ROENTGENOL, V177, P777, DOI 10.2214/ajr.177.4.1770777; Elias D, 1998, EUR J SURG ONCOL, V24, P174, DOI 10.1016/S0748-7983(98)92878-5; Frericks BB, 2005, RADIOLOGY, V237, P1056, DOI 10.1148/radiol.2373041104; Hirooka M, 2009, AM J ROENTGENOL, V193, pW149, DOI 10.2214/AJR.08.1817; Kang TW, 2015, INVEST RADIOL, V50, P81, DOI 10.1097/RLI.0000000000000103; Lencioni R, 2001, ABDOM IMAGING, V26, P345, DOI 10.1007/s002610000194; Matsuda M, 2014, JPN J RADIOL, V32, P405, DOI 10.1007/s11604-014-0323-z; Nakazawa T, 2007, AM J ROENTGENOL, V188, P480, DOI 10.2214/AJR.05.2079; Osaki Y, 2013, J GASTROENTEROL, V48, P874, DOI 10.1007/s00535-012-0685-x; Seror O, 2008, RADIOLOGY, V248, P288, DOI 10.1148/radiol.2481071101; Seror O, 2014, J VASC INTERV RADIOL, V25, P599, DOI 10.1016/j.jvir.2013.11.025; Takamori R, 2000, LIVER TRANSPLANT, V6, P67, DOI 10.1002/lt.500060103; Woo S, 2013, RADIOLOGY, V268, P589, DOI 10.1148/radiol.13121736; Yu SCH, 2004, AM J ROENTGENOL, V183, P383, DOI 10.2214/ajr.183.2.1830383	17	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148298	10.1371/journal.pone.0148298	http://dx.doi.org/10.1371/journal.pone.0148298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845038	gold, Green Published			2022-12-26	WOS:000369552800042
J	Jamalian, S; Davis, MJ; Zawieja, DC; Moore, JE				Jamalian, Samira; Davis, Michael J.; Zawieja, David C.; Moore, James E., Jr.			Network Scale Modeling of Lymph Transport and Its Effective Pumping Parameters	PLOS ONE			English	Article							CONTRACTILE ACTIVITY; VESSELS; COORDINATION; FLOW; PRESSURE; ANATOMY; SYSTEM	The lymphatic system is an open-ended network of vessels that run in parallel to the blood circulation system. These vessels are present in almost all of the tissues of the body to remove excess fluid. Similar to blood vessels, lymphatic vessels are found in branched arrangements. Due to the complexity of experiments on lymphatic networks and the difficulty to control the important functional parameters in these setups, computational modeling becomes an effective and essential means of understanding lymphatic network pumping dynamics. Here we aimed to determine the effect of pumping coordination in branched network structures on the regulation of lymph flow. Lymphatic vessel networks were created by building upon our previous lumped-parameter model of lymphangions in series. In our network model, each vessel is itself divided into multiple lymphangions by lymphatic valves that help maintain forward flow. Vessel junctions are modeled by equating the pressures and balancing mass flows. Our results demonstrated that a 1.5 s rest-period between contractions optimizes the flow rate. A time delay between contractions of lymphangions at the junction of branches provided an advantage over synchronous pumping, but additional time delays within individual vessels only increased the flow rate for adverse pressure differences greater than 10.5 cmH(2)O. Additionally, we quantified the pumping capability of the system under increasing levels of steady transmural pressure and outflow pressure for different network sizes. We observed that peak flow rates normally occurred under transmural pressures between 2 to 4 cmH(2)O (for multiple pressure differences and network sizes). Networks with 10 lymphangions per vessel had the highest pumping capability under a wide range of adverse pressure differences. For favorable pressure differences, pumping was more efficient with fewer lymphangions. These findings are valuable for translating experimental measurements from the single lymphangion level to tissue and organ scales.	[Jamalian, Samira; Moore, James E., Jr.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, S Kensington Campus, London, England; [Davis, Michael J.] Univ Missouri, Sch Med, Dept Physiol & Pharmacol, Columbia, MO USA; [Zawieja, David C.] Texas A&M Hlth Sci Ctr, Dept Syst Biol & Translat Med, Temple, TX USA	Imperial College London; University of Missouri System; University of Missouri Columbia; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Moore, JE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, S Kensington Campus, London, England.	james.moore.jr@imperial.ac.uk	Jamalian, Samira/N-1259-2013; Moore, James/D-1326-2013	Jamalian, Samira/0000-0003-2265-5502; Moore, James/0000-0003-1604-158X; Zawieja, David/0000-0002-2644-6524	National Institutes of Health [U01 HL-123420, R01 HL-120867]; Royal Society; Royal Academy of Engineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120867, R01HL125608, U01HL123420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); Royal Academy of Engineering(Royal Academy of Engineering - UK); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by National Institutes of Health U01 HL-123420 (DCZ, JEM) and R01 HL-120867 (MJD). JEM gratefully acknowledges the support of The Royal Society and The Royal Academy of Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram CD, 2014, COMPUT METHOD BIOMEC, V17, P1519, DOI 10.1080/10255842.2012.753066; Bertram CD, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002799; Bertram CD, 2015, AM J PHYSL IN PRESS; Bertram CD, 2013, BIOMECH MODEL MECHAN, P1, DOI 10.1007/s10237-013-0505-0; Crowe MJ, 1997, J PHYSIOL-LONDON, V500, P235, DOI 10.1113/jphysiol.1997.sp022013; Davis Michael J., 2006, Lymphatic Research and Biology, V4, P3, DOI 10.1089/lrb.2006.4.3; Davis MJ, 2011, AM J PHYSIOL-HEART C, V301, pH48, DOI 10.1152/ajpheart.00133.2011; Dixon JB, 2006, MICROCIRCULATION, V13, P597, DOI 10.1080/10739680600893909; EISENHOFFER J, 1995, MICROVASC RES, V49, P97, DOI 10.1006/mvre.1995.1008; Gashev AA, 2004, MICROCIRCULATION, V11, P477, DOI 10.1080/10739680490476033; Gashev AA, 2002, ANN NY ACAD SCI, V979, P178, DOI 10.1111/j.1749-6632.2002.tb04878.x; Jamalian S, 2013, PARAMETER SENSITIVIT; Jamalian S, 2015, P SB3C 2015 SUMM BIO; Macdonald AJ, 2008, AM J PHYSIOL-HEART C, V295, pH305, DOI 10.1152/ajpheart.00004.2008; Margaris KN, 2012, J R SOC INTERFACE, V9, P601, DOI 10.1098/rsif.2011.0751; MCHALE NG, 1992, J PHYSIOL-LONDON, V450, P503, DOI 10.1113/jphysiol.1992.sp019139; MCHALE NG, 1976, J PHYSIOL-LONDON, V261, P255, DOI 10.1113/jphysiol.1976.sp011557; Mislin H., 1966, PROGR LYMPH P INT S, P87; Munn LL, 2015, SEMIN CELL DEV BIOL, V38, P67, DOI 10.1016/j.semcdb.2015.01.010; REDDY NP, 1977, COMPUT BIOL MED, V7, P181, DOI 10.1016/0010-4825(77)90023-3; SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987, DOI 10.1152/physrev.1990.70.4.987; STAPLES LD, 1982, J REPROD FERTIL, V64, P409; Suami H, 2008, ANN SURG ONCOL, V15, P863, DOI 10.1245/s10434-007-9709-9; Venugopal AM, 2007, AM J PHYSIOL-HEART C, V293, pH1183, DOI 10.1152/ajpheart.01340.2006; ZAWIEJA DC, 1993, AM J PHYSIOL, V264, pH1283, DOI 10.1152/ajpheart.1993.264.4.H1283	25	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148384	10.1371/journal.pone.0148384	http://dx.doi.org/10.1371/journal.pone.0148384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845031	Green Published, Green Submitted, gold			2022-12-26	WOS:000369552800052
J	Katz, ML; Viney, TJ; Nikolic, K				Katz, Matthew L.; Viney, Tim J.; Nikolic, Konstantin			Receptive Field Vectors of Genetically-Identified Retinal Ganglion Cells Reveal Cell-Type-Dependent Visual Functions	PLOS ONE			English	Article							MORPHOLOGICAL CLASSIFICATION; NEURAL RESPONSES; NATURAL SCENES; MOUSE; ORGANIZATION; MELANOPSIN; DIVERSITY; POPULATIONS; STATISTICS; PARALLEL	Sensory stimuli are encoded by diverse kinds of neurons but the identities of the recorded neurons that are studied are often unknown. We explored in detail the firing patterns of eight previously defined genetically-identified retinal ganglion cell (RGC) types from a single transgenic mouse line. We first introduce a new technique of deriving receptive field vectors (RFVs) which utilises a modified form of mutual information ("Quadratic Mutual Information"). We analysed the firing patterns of RGCs during presentation of short duration (similar to 10 second) complex visual scenes (natural movies). We probed the high dimensional space formed by the visual input for a much smaller dimensional subspace of RFVs that give the most information about the response of each cell. The new technique is very efficient and fast and the derivation of novel types of RFVs formed by the natural scene visual input was possible even with limited numbers of spikes per cell. This approach enabled us to estimate the 'visual memory' of each cell type and the corresponding receptive field area by calculating Mutual Information as a function of the number of frames and radius. Finally, we made predictions of biologically relevant functions based on the RFVs of each cell type. RGC class analysis was complemented with results for the cells' response to simple visual input in the form of black and white spot stimulation, and their classification on several key physiological metrics. Thus RFVs lead to predictions of biological roles based on limited data and facilitate analysis of sensory-evoked spiking data from defined cell types.	[Katz, Matthew L.; Nikolic, Konstantin] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, Dept Elect & Elect Engn, Ctr Bioinspired Technol, Bessemer Bldg, London SW7 2AZ, England; [Viney, Tim J.] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland; [Viney, Tim J.] Univ Basel, CH-4003 Basel, Switzerland; [Viney, Tim J.] Univ Oxford, Dept Pharmacol, MRC Brain Network Dynam Unit, Mansfield Rd, Oxford OX1 3TH, England	Imperial College London; Friedrich Miescher Institute for Biomedical Research; University of Basel; University of Oxford	Nikolic, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, Dept Elect & Elect Engn, Ctr Bioinspired Technol, Bessemer Bldg, London SW7 2AZ, England.	k.nikolic@imperial.ac.uk		Viney, Tim/0000-0001-6444-1188; Nikolic, Konstantin/0000-0002-6551-2977	European Union [270324]; UK Biotechnology and Biological Sciences Research Council [BB/L018268/1]; UK Engineering and Physical Sciences Research Council [EP/N002474/1]; Biotechnology and Biological Sciences Research Council [BB/L018268/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H024581/1, EP/N002474/1] Funding Source: researchfish; BBSRC [BB/L018268/1] Funding Source: UKRI; EPSRC [EP/N002474/1, EP/H024581/1] Funding Source: UKRI	European Union(European Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Union Framework Programme 7 project "SeeBetter" (270324), http://fp7-pp.publicdata.eu/page/resource/project/270324 to MLK and KN; UK Biotechnology and Biological Sciences Research Council (BB/L018268/1) http://www.bbsrc.ac.uk/home/home.aspx to KN; and UK Engineering and Physical Sciences Research Council (EP/N002474/1) http://www.epsrc.ac.uk to KN.	BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Betsch BY, 2004, BIOL CYBERN, V90, P41, DOI 10.1007/s00422-003-0434-6; Bomash I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053363; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Chan YC, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.13; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; da Silveira RA, 2011, CURR OPIN NEUROBIOL, V21, P664, DOI 10.1016/j.conb.2011.05.007; Dayan P, 2001, COMPUTATIONAL NEUROS; Dimitrov AG, 2011, J COMPUT NEUROSCI, V30, P1, DOI 10.1007/s10827-011-0314-3; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Elstrott J, 2009, CURR OPIN NEUROBIOL, V19, P293, DOI 10.1016/j.conb.2009.03.004; Famiglietti EV, 2005, J COMP NEUROL, V484, P357, DOI 10.1002/cne.20433; Farrow K, 2013, NEURON, V78, P325, DOI 10.1016/j.neuron.2013.02.014; Farrow K, 2011, J NEUROPHYSIOL, V105, P1516, DOI 10.1152/jn.00331.2010; Fitzgerald JD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002249; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Greschner M, 2011, J PHYSIOL-LONDON, V589, P75, DOI 10.1113/jphysiol.2010.193888; Grimes WN, 2014, NEURON, V82, P460, DOI 10.1016/j.neuron.2014.02.037; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kapur J. N., 1994, MEASURES INFORM THEI; Kayser C, 2003, J NEUROPHYSIOL, V90, P1910, DOI 10.1152/jn.00195.2003; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim TJ, 2006, INVEST OPHTH VIS SCI, V47, P2757, DOI 10.1167/iovs.05-1442; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Kouh M, 2009, NETWORK-COMP NEURAL, V20, P49, DOI 10.1080/09548980902950891; Lee ES, 2010, NEUROSCI RES, V66, P141, DOI 10.1016/j.neures.2009.10.008; MacKay D. J. C., 2003, INFORM THEORY INFERE; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Nirenberg S, 2012, P NATL ACAD SCI USA, V109, P15012, DOI 10.1073/pnas.1207035109; Nishimori Y, 2005, NEUROCOMPUTING, V67, P106, DOI 10.1016/j.neucom.2004.11.035; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Paninski L, 2003, NETWORK-COMP NEURAL, V14, P437, DOI 10.1088/0954-898X/14/3/304; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Pillow JW, 2006, J VISION, V6; Principe J.C., 2000, UNSUPERVISED ADAPTIV, P265; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rajan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071959; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Renyi A., 1961, MEASURES ENTROPY INF, VVolume 1; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Roska B, 2003, NAT NEUROSCI, V6, P600, DOI 10.1038/nn1061; Rowekamp RJ, 2011, NETWORK-COMP NEURAL, V22, P45, DOI 10.3109/0954898X.2011.566303; Schmidt TM, 2014, NEURON, V82, P781, DOI 10.1016/j.neuron.2014.03.022; Schwartz G, 2011, J GEN PHYSIOL, V138, P283, DOI 10.1085/jgp.201110629; Schwartz GW, 2012, NAT NEUROSCI, V15, P1572, DOI 10.1038/nn.3225; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smyth D, 2003, J NEUROSCI, V23, P4746; Soo FS, 2011, J NEUROSCI, V31, P2145, DOI 10.1523/JNEUROSCI.5129-10.2011; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; VANSTEVENINCK RD, 1995, PHILOS T R SOC B, V348, P321; Victor JD, 2005, NAT NEUROSCI, V8, P1651, DOI 10.1038/nn1607; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wen Z, 2010, FEASIBLE METHOD OPTI, P1; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Xu DX, 2010, INFORM SCI STAT, P47, DOI 10.1007/978-1-4419-1570-2_2; Yonehara K, 2013, NEURON, V79, P1078, DOI 10.1016/j.neuron.2013.08.005; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x; Zhang Y, 2012, P NATL ACAD SCI; Zhu YL, 2014, J NEUROSCI, V34, P7845, DOI 10.1523/JNEUROSCI.2960-13.2014	78	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147738	10.1371/journal.pone.0147738	http://dx.doi.org/10.1371/journal.pone.0147738			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845435	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800015
J	Asadzadeh, J; Neligan, N; Kramer, SG; Labrador, JP				Asadzadeh, Jamshid; Neligan, Niamh; Kramer, Sunita G.; Labrador, Juan-Pablo			Tinman Regulates NetrinB in the Cardioblasts of the Drosophila Dorsal Vessel	PLOS ONE			English	Article							COMMISSURAL AXONS; TUBE FORMATION; HEART; SLIT; GUIDANCE; GENES; DIVERSIFICATION; MORPHOGENESIS; REPULSION; ADHESION	Morphogenesis of the Drosophila dorsal vessel (DV) shares similarities with that of the vertebrate heart. Precursors line up at both sides of the embryo, migrate towards the midline and fuse to form a tubular structure. Guidance receptors and their ligands have been implicated in this process in vertebrates and invertebrates, as have been a series of evolutionarily conserved cardiogenic transcriptional regulators including Tinman, the Drosophila homolog of the transcription factor Nkx-2.5. NetrinB (NetB), a repulsive ligand for the Unc-5 receptor is required to preserve the dorsal vessel hollow. It localizes to the luminal space of the dorsal vessel but its source and its regulation is unknown. Here, using genetics together with in situ hybridization with single cell resolution, we show how tin is required for NetrinB expression in cardioblasts during DV tubulogenesis and sufficient to promote NetB transcription ectopically. We further identify a dorsal vessel-specific NetB enhancer and show that it is also regulated by tin in a similar fashion to NetB.	[Asadzadeh, Jamshid; Neligan, Niamh; Labrador, Juan-Pablo] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Asadzadeh, Jamshid; Labrador, Juan-Pablo] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Kramer, Sunita G.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA	Trinity College Dublin; Trinity College Dublin; Rutgers State University New Brunswick; Rutgers State University Medical Center	Labrador, JP (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.; Labrador, JP (corresponding author), Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland.	labradoj@tcd.ie	Labrador, Juan Pablo/C-3018-2014	Labrador, Juan Pablo/0000-0003-3671-848X; Kramer, Sunita/0000-0001-8372-5928	SFI [07/IN.1/B913, 08/ RFP/NSC1617]; IRC; Trinity research award; Science Foundation Ireland (SFI) [07/IN.1/B913, 08/ RFP/NSC1617]; Irish Research Council (IRC) New Foundations Award; Trinity College Dublin	SFI(Science Foundation Ireland); IRC; Trinity research award; Science Foundation Ireland (SFI)(Science Foundation Ireland); Irish Research Council (IRC) New Foundations Award(Irish Research Council for Science, Engineering and Technology); Trinity College Dublin	Brian McCabe, Jim Skeath, Hanh Nguyen, Manfred Frasch and Matthew Wolf kindly provided us with stocks, antibodies and other various reagents. Funding sources of this work were as follows: SFI grants 07/IN.1/B913 and 08/ RFP/NSC1617 and a New Foundations Award from the IRC to JPL and a Trinity research award to JA.; This work was supported by the Science Foundation Ireland (SFI) awards 07/IN.1/B913 and 08/ RFP/NSC1617 (http://www.sfi.ie), the Irish Research Council (IRC) New Foundations Award 2012 to JPL (http://research.ie), and the Trinity Research Award 2009 from Trinity College Dublin (http://www.tcd.ie) to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht S, 2011, DEV BIOL, V350, P89, DOI 10.1016/j.ydbio.2010.11.016; Asadzadeh J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137688; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BODMER R, 1993, DEVELOPMENT, V118, P719; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Fish JE, 2011, DEVELOPMENT, V138, P1409, DOI 10.1242/dev.060046; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Lee HK, 2009, JOVE-J VIS EXP, DOI [10.3791/1647, DOI 10.3791/1647]; Lo PCH, 2001, MECH DEVELOP, V104, P49, DOI 10.1016/S0925-4773(01)00361-6; Macabenta FD, 2013, DEV BIOL, V380, P233, DOI 10.1016/j.ydbio.2013.05.007; Medioni C, 2008, J CELL BIOL, V182, P249, DOI 10.1083/jcb.200801100; Medioni C, 2010, DEV DYNAM, V239, P3303, DOI 10.1002/dvdy.22449; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Mommersteeg MTM, 2013, CIRC RES, V112, P465, DOI 10.1161/CIRCRESAHA.112.277426; Qian L, 2005, CURR BIOL, V15, P2271, DOI 10.1016/j.cub.2005.10.037; Santiago C, 2014, CELL REP, V7, P153, DOI 10.1016/j.celrep.2014.02.037; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Ward EJ, 2000, DEVELOPMENT, V127, P4959; Zaffran S, 2006, DEVELOPMENT, V133, P4073, DOI 10.1242/dev.02586; Zarin AA, 2014, NEURON, V81, P1297, DOI 10.1016/j.neuron.2014.01.038; Zarin AA, 2014, CELL MOL LIFE SCI, V71, P419, DOI 10.1007/s00018-013-1434-x; Zarin AA, 2012, DEVELOPMENT, V139, P1798, DOI 10.1242/dev.070656	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148526	10.1371/journal.pone.0148526	http://dx.doi.org/10.1371/journal.pone.0148526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840059	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200144
J	Connolly, NMC; D'Orsi, B; Monsefi, N; Huber, HJ; Prehn, JHM				Connolly, Niamh M. C.; D'Orsi, Beatrice; Monsefi, Naser; Huber, Heinrich J.; Prehn, Jochen H. M.			Computational Analysis of AMPK-Mediated Neuroprotection Suggests Acute Excitotoxic Bioenergetics and Glucose Dynamics Are Regulated by a Minimal Set of Critical Reactions	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENERGY-METABOLISM; NEURONAL SURVIVAL; MITOCHONDRIAL BIOENERGETICS; GLUTAMATE EXCITOTOXICITY; CALCIUM-CONCENTRATION; ATP CONCENTRATION; INDUCED APOPTOSIS; CULTURED NEURONS; MEMBRANE	Loss of ionic homeostasis during excitotoxic stress depletes ATP levels and activates the AMP-activated protein kinase (AMPK), re-establishing energy production by increased expression of glucose transporters on the plasma membrane. Here, we develop a computational model to test whether this AMPK-mediated glucose import can rapidly restore ATP levels following a transient excitotoxic insult. We demonstrate that a highly compact model, comprising a minimal set of critical reactions, can closely resemble the rapid dynamics and cell-to-cell heterogeneity of ATP levels and AMPK activity, as confirmed by single-cell fluorescence microscopy in rat primary cerebellar neurons exposed to glutamate excitotoxicity. The model further correctly predicted an excitotoxicity-induced elevation of intracellular glucose, and well resembled the delayed recovery and cell-to-cell heterogeneity of experimentally measured glucose dynamics. The model also predicted necrotic bioenergetic collapse and altered calcium dynamics following more severe excitotoxic insults. In conclusion, our data suggest that a minimal set of critical reactions may determine the acute bioenergetic response to transient excitotoxicity and that an AMPK-mediated increase in intracellular glucose may be sufficient to rapidly recover ATP levels following an excitotoxic insult.	[Connolly, Niamh M. C.; Monsefi, Naser; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Syst Med, Dublin 2, Ireland; [Connolly, Niamh M. C.; D'Orsi, Beatrice; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Study Neurol Disorders, Dublin 2, Ireland; [Huber, Heinrich J.] Katholieke Univ Leuven, Dept Cardiovasc Sci, B-3000 Leuven, Belgium	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; KU Leuven	Prehn, JHM (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Sci, B-3000 Leuven, Belgium.	Heinrich.Huber@med.kuleuven.be; prehn@rcsi.ie	Connolly, Niamh M. C./U-6083-2019; Prehn, Jochen HM/A-3928-2010; D'Orsi, Beatrice/AAC-8990-2021	Connolly, Niamh M. C./0000-0002-6005-1307; Prehn, Jochen HM/0000-0003-3479-7794; D'Orsi, Beatrice/0000-0002-4335-3995	Science Foundation Ireland [08/IN.1/B1949, 14/JPND/B3077]; Health Research Board in Ireland [PhD/2007/11]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board in Ireland	The authors acknowledge funding from Science Foundation Ireland (08/IN.1/B1949 and 14/JPND/B3077; www.sfi.ie) and the Health Research Board in Ireland (PhD/2007/11; www.hrb.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2010, BBA-GEN SUBJECTS, V1800, P297, DOI 10.1016/j.bbagen.2009.08.002; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Berndt N, 2013, FEBS J, V280, P5080, DOI 10.1111/febs.12480; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bouzier-Sore AK, 2006, EUR J NEUROSCI, V24, P1687, DOI 10.1111/j.1460-9568.2006.05056.x; Brennan-Minnella AM, 2015, ANTIOXID REDOX SIGN, V22, P161, DOI 10.1089/ars.2013.5767; Castaldo P, 2009, PROG NEUROBIOL, V87, P58, DOI 10.1016/j.pneurobio.2008.09.017; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; Concannon CG, 2008, J NEUROCHEM, V105, P891, DOI 10.1111/j.1471-4159.2007.05187.x; Concannon CG, 2010, J CELL BIOL, V189, P83, DOI 10.1083/jcb.200909166; Connolly NMC, 2015, J BIOENERG BIOMEMBR, V47, P75, DOI 10.1007/s10863-014-9578-4; Connolly NMC, 2014, J NEUROSCI, V34, P10192, DOI 10.1523/JNEUROSCI.3127-13.2014; CREMER JE, 1981, BRAIN RES, V221, P331, DOI 10.1016/0006-8993(81)90782-4; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; D'Orsi B, 2015, J NEUROSCI, V35, P1706, DOI 10.1523/JNEUROSCI.2453-14.2015; D'Orsi B, 2012, J NEUROSCI, V32, P1847, DOI 10.1523/JNEUROSCI.2345-11.2012; Davila D, 2012, CELL DEATH DIFFER, V19, P1677, DOI 10.1038/cdd.2012.49; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; GARTHWAITE G, 1986, NEUROSCI LETT, V66, P193, DOI 10.1016/0304-3940(86)90189-8; GEAR CW, 1971, COMMUN ACM, V14, P176, DOI 10.1145/362566.362571; Gerencser AA, 2005, BIOPHYS J, V88, P698, DOI 10.1529/biophysj.104.050062; Gleichmann M, 2009, J NEUROCHEM, V109, P644, DOI 10.1111/j.1471-4159.2009.05997.x; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; Khayat ZA, 1998, BIOCHEM J, V333, P713, DOI 10.1042/bj3330713; Kushnareva YE, 2005, J BIOL CHEM, V280, P28894, DOI 10.1074/jbc.M503090200; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Liu HB, 2006, J MECH DESIGN, V128, P326, DOI 10.1115/1.2159025; Liu XL, 2008, J BIOSCI BIOENG, V105, P106, DOI 10.1263/jbb.105.106; Loewer A, 2011, CURR OPIN GENET DEV, V21, P753, DOI 10.1016/j.gde.2011.09.010; MAHER F, 1994, BIOCHEM J, V301, P379, DOI 10.1042/bj3010379; MARCAIDA G, 1995, BRAIN RES, V695, P146, DOI 10.1016/0006-8993(95)00703-S; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Nicholls DG, 2015, J BIOENERG BIOMEMBR, V47, P63, DOI 10.1007/s10863-014-9573-9; Nicholls DG, 1999, ANN NY ACAD SCI, V893, P1, DOI 10.1111/j.1749-6632.1999.tb07813.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; RAICHLE ME, 1983, ANN NEUROL, V13, P2, DOI 10.1002/ana.410130103; Rodriguez-Rodriguez P, 2012, CELL DEATH DIFFER, V19, P1582, DOI 10.1038/cdd.2012.33; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Sonntag AG, 2012, FEBS J, V279, P3314, DOI 10.1111/j.1742-4658.2012.08582.x; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tabernero A, 1996, NEUROSCI RES, V26, P369, DOI 10.1016/S0168-0102(96)01121-2; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Ward MW, 2005, J NEUROCHEM, V92, P1081, DOI 10.1111/j.1471-4159.2004.02928.x; Ward MW, 2000, J NEUROSCI, V20, P7208; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241	71	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148326	10.1371/journal.pone.0148326	http://dx.doi.org/10.1371/journal.pone.0148326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840769	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200125
J	Kim, JH; Choi, SC; Park, CY; Park, JH; Choi, JH; Joo, HJ; Hong, SJ; Lim, DS				Kim, Jong-Ho; Choi, Seung-Cheol; Park, Chi-Yeon; Park, Jae-Hyoung; Choi, Ji-Hyun; Joo, Hyung-Joon; Hong, Soon-Jun; Lim, Do-Sun			Transplantation of Immortalized CD34+and CD34-Adipose-Derived Stem Cells Improve Cardiac Function and Mitigate Systemic Pro-Inflammatory Responses	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ADIPOSE STROMAL CELLS; MYOCARDIAL-INFARCTION; POSTNATAL NEOVASCULARIZATION; CARDIOVASCULAR-DISEASE; TELOMERASE EXPRESSION; HINDLIMB ISCHEMIA; BONE-MARROW; LIFE-SPAN; TISSUE	Adipose-derived stem cells (ADSCs) have the potential to differentiate into various cell lineages and they are easily obtainable from patients, which makes them a promising candidate for cell therapy. However, a drawback is their limited life span during in vitro culture. Therefore, hTERT-immortalized CD34+ and CD34-mouse ADSC lines (mADSCs(hTERT)) tagged with GFP were established. We evaluated the proliferation capacity, multi-differentiation potential, and secretory profiles of CD34+ and CD34-mADSCs(hTERT) in vitro, as well as their effects on cardiac function and systemic inflammation following transplantation into a rat model of acute myocardial infarction (AMI) to assess whether these cells could be used as a novel cell source for regeneration therapy in the cardiovascular field. CD34+ and CD34- mADSCs(hTERT) demonstrated phenotypic characteristics andmulti-differentiation potentials similar to those of primary mADSCs. CD34+ mADSCs(hTERT) exhibited a higher proliferation ability compared to CD34-mADSCs(hTERT), whereas CD34-mADSCs(hTERT) showed a higher osteogenic differentiation potential compared to CD34+ mADSCs(hTERT). Primary mADSCs, CD34+, and CD34-mADSCs(hTERT) primarily secreted EGF, TGF-beta 1, IGF-1, IGF-2, MCP-1, and HGFR. CD34+ mADSCs(hTERT) had higher secretion of VEGF and SDF-1 compared to CD34-mADSCs(hTERT). IL-6 secretion was severely reduced in both CD34+ and CD34-mADSCs(hTERT) compared to primary mADSCs. Transplantation of CD34+ and CD34-mADSCs(hTERT) significantly improved the left ventricular ejection fraction and reduced infarct size compared to AMI-induced rats after 28 days. At 28 days after transplantation, engraftment of CD34+ and CD34-mADSCs(hTERT) was confirmed by positive Y chromosome staining, and differentiation of CD34+ and CD34-mADSCs(hTERT) into endothelial cells was found in the infarcted myocardium. Significant decreases were observed in circulating IL-6 levels in CD34+ and CD34-mADSCs(hTERT) groups compared to the AMI-induced control group. Transplantation of CD34-mADSCs(hTERT) significantly reduced circulating MCP-1 levels compared to the AMI control and CD34+ mADSCs(hTERT) groups. GFP-tagged CD34+ and CD34-mADSCs(hTERT) are valuable resources for cell differentiation studies in vitro as well as for regeneration therapy in vivo.	[Kim, Jong-Ho; Choi, Seung-Cheol; Park, Chi-Yeon; Park, Jae-Hyoung; Choi, Ji-Hyun; Joo, Hyung-Joon; Hong, Soon-Jun; Lim, Do-Sun] Korea Univ, Anam Hosp, Dept Cardiol, Cardiovasc Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Lim, DS (corresponding author), Korea Univ, Anam Hosp, Dept Cardiol, Cardiovasc Ctr, Seoul, South Korea.	dslmd@kumc.or.kr	Park, Chi-Yeon/ABH-9980-2020; Joo, Hyung Joon/Q-4875-2016	Joo, Hyung Joon/0000-0003-1846-8464; Kim, Jong-Ho/0000-0002-1309-0821; Park, Chi-Yeon/0000-0002-9400-9078	Ministry of Health & Welfare, Republic of Korea [A120275]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120275).	Anastassiadis K, 2010, GENESIS, V48, P220, DOI 10.1002/dvg.20605; Balducci L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt452; Banas A, 2008, STEM CELLS, V26, P2705, DOI 10.1634/stemcells.2008-0034; Bayes-Genis A, 2010, J MOL CELL CARDIOL, V49, P771, DOI 10.1016/j.yjmcc.2010.08.010; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Carceller MC, 2015, CYTOTHERAPY, V17, P1230, DOI 10.1016/j.jcyt.2015.06.001; Cho HH, 2009, CELL PHYSIOL BIOCHEM, V24, P511, DOI 10.1159/000257495; Choi SC, 2015, J CELL PHYSIOL, V230, P1807, DOI 10.1002/jcp.24892; Choi YS, 2010, J CELL MOL MED, V14, P878, DOI 10.1111/j.1582-4934.2010.01009.x; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; DelaRosa O, 2009, TISSUE ENG PT A, V15, P2795, DOI [10.1089/ten.tea.2008.0630, 10.1089/ten.TEA.2008.0630]; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; Dong ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080364; Dredge K, 2002, J IMMUNOL, V168, P4914, DOI 10.4049/jimmunol.168.10.4914; Frangogiannis NG, 1998, CIRCULATION, V98, P699, DOI 10.1161/01.CIR.98.7.699; Frangogiannis NG, 1998, J MOL CELL CARDIOL, V30, P2567, DOI 10.1006/jmcc.1998.0829; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gu YP, 2006, EXP CELL RES, V312, P831, DOI 10.1016/j.yexcr.2005.11.029; He J, 2013, MOL MED REP, V7, P1111, DOI 10.3892/mmr.2013.1307; Kang SK, 2004, STEM CELLS, V22, P1356, DOI 10.1634/stemcells.2004-0023; Kim JM, 2007, BRAIN RES, V1183, P43, DOI 10.1016/j.brainres.2007.09.005; Lee SC, 2015, SURGERY, V157, P934, DOI 10.1016/j.surg.2014.12.016; Li N, 2014, REGEN MED RES, V2, DOI 10.1186/2050-490X-2-6; Mazo M, 2012, CELL TRANSPLANT, V21, P1023, DOI 10.3727/096368911X623862; Mert T, 2015, INFLAMMATION, V38, P1302, DOI 10.1007/s10753-014-0101-1; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Moon MH, 2006, CELL PHYSIOL BIOCHEM, V17, P279, DOI 10.1159/000094140; Nagai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001272; Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pizzolato MC, 2003, TRANSPLANTATION, V75, P542, DOI 10.1097/01.TP.0000048492.91165.FC; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Scherberich Arnaud, 2013, World J Stem Cells, V5, P1, DOI 10.4252/wjsc.v5.i1.1; Shin S, 2013, INT J MED SCI, V10, P8, DOI 10.7150/ijms.5385; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Suga H, 2009, STEM CELLS DEV, V18, P1201, DOI 10.1089/scd.2009.0003; Sun CK, 2012, CRIT CARE MED, V40, P1279, DOI 10.1097/CCM.0b013e31823dae23; Suzuki E, 2015, WORLD J CARDIOL, V7, P454, DOI 10.4330/wjc.v7.i8.454; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Vandervelde S, 2007, CARDIOVASC RES, V73, P783, DOI 10.1016/j.cardiores.2006.11.030; Varma MJO, 2007, STEM CELLS DEV, V16, P91, DOI 10.1089/scd.2006.0026; Weng NP, 2000, J CLIN IMMUNOL, V20, P257; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Zhang SJ, 2014, STEM CELLS, V32, P1616, DOI 10.1002/stem.1632; Zhang XH, 2006, BIOCHEM BIOPH RES CO, V351, P853, DOI 10.1016/j.bbrc.2006.10.125	49	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147853	10.1371/journal.pone.0147853	http://dx.doi.org/10.1371/journal.pone.0147853			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840069	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200066
J	Matsumoto, YK; Okanoya, K				Matsumoto, Yui K.; Okanoya, Kazuo			Phase-Specific Vocalizations of Male Mice at the Initial Encounter during the Courtship Sequence	PLOS ONE			English	Article							ULTRASONIC VOCALIZATIONS; HOUSE MICE; UNUSUAL REPERTOIRE; MUS-MUSCULUS; BEHAVIOR; URINE; SEX; EXPERIENCE	Mice produce ultrasonic vocalizations featuring a variety of syllables. Vocalizations are observed during social interactions. In particular, males produce numerous syllables during courtship. Previous studies have shown that vocalizations change according to sexual behavior, suggesting that males vary their vocalizations depending on the phase of the courtship sequence. To examine this process, we recorded large sets of mouse vocalizations during male-female interactions and acoustically categorized these sounds into 12 vocal types. We found that males emitted predominantly short syllables during the first minute of interaction, more long syllables in the later phases, and mainly harmonic sounds during mounting. These context-and time-dependent changes in vocalization indicate that vocal communication during courtship in mice consists of at least three stages and imply that each vocalization type has a specific role in a phase of the courtship sequence. Our findings suggest that recording for a sufficiently long time and taking the phase of courtship into consideration could provide more insights into the role of vocalization in mouse courtship behavior in future study.	[Matsumoto, Yui K.; Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan	University of Tokyo	Okanoya, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	cokanoya@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science Research Fellowships for Young Scientists [259181]; Ministry of Education, Culture, Sports, Science and Technology of Japan [3118003]; Japan Science and Technology Agency, ERATO, Okanoya Emotional Information Project; Grants-in-Aid for Scientific Research [13J09181] Funding Source: KAKEN	Japan Society for the Promotion of Science Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, ERATO, Okanoya Emotional Information Project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Japan Society for the Promotion of Science Research Fellowships for Young Scientists (259181; DC1) to YM and Grant-in-Aid for Scientific Research on Innovative Areas (3118003; Adolescent Mind & Self-Regulation) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Japan Science and Technology Agency, ERATO, Okanoya Emotional Information Project to KO.	Asaba A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00231; Asaba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087186; Chabout J, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00076, 10.3389/fnbh.2015.00076]; Chabout J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029401; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Hammerschmidt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041133; Hanson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040782; Holfoth DP, 2014, J ACOUST SOC AM, V136, P3401, DOI 10.1121/1.4900564; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; Mahrt EJ, 2013, J NEUROSCI, V33, P5573, DOI 10.1523/JNEUROSCI.5054-12.2013; Matsumoto YK, 2012, NEUROREPORT, V23, P676, DOI 10.1097/WNR.0b013e3283557eea; Neilans EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085405; Neunuebel JP, 2015, ELIFE, V4, DOI 10.7554/eLife.06203; NYBY J, 1983, BEHAV NEURAL BIOL, V39, P128, DOI 10.1016/S0163-1047(83)90722-7; NYBY J, 1980, PHYSIOL BEHAV, V24, P737, DOI 10.1016/0031-9384(80)90405-9; POMERANTZ SM, 1983, PHYSIOL BEHAV, V31, P91, DOI 10.1016/0031-9384(83)90101-4; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Roullet FI, 2011, BEHAV BRAIN RES, V216, P19, DOI 10.1016/j.bbr.2010.06.004; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; SIPOS ML, 1992, BEHAV NEURAL BIOL, V58, P138, DOI 10.1016/0163-1047(92)90375-E; Sugimoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022093; Wang HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001893; White NR, 1998, PHYSIOL BEHAV, V63, P467, DOI 10.1016/S0031-9384(97)00484-8	26	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147102	10.1371/journal.pone.0147102	http://dx.doi.org/10.1371/journal.pone.0147102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841117	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200025
J	Xu, YS; Gao, ZH; Tao, JM; Jiang, WH; Zhang, SJ; Wang, QN; Qu, SC				Xu, Yanshuai; Gao, Zhihong; Tao, Jianmin; Jiang, Weihua; Zhang, Shijie; Wang, Qiunan; Qu, Shenchun			Genome-Wide Detection of SNP and SV Variations to Reveal Early Ripening-Related Genes in Grape	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHETIC-PATHWAY; VINIFERA CV SHIRAZ; ABSCISIC-ACID; BERRY DEVELOPMENT; FRUIT MATURATION; ETHYLENE; EXPRESSION; POLYMORPHISM; GROWTH; COLOR	Early ripening in grape (Vitis vinifera L.) is a crucial agronomic trait. The fruits of the grape line 'Summer Black' (SBBM), which contains a bud mutation, can be harvested approximately one week earlier than the 'Summer Black' (SBC) control. To investigate the molecular mechanism of the bud mutation related to early ripening, we detected genome-wide genetic variations based on re-sequencing. In total, 3,692,777 single nucleotide polymorphisms (SNPs) and 81,223 structure variations (SVs) in the SBC genome and 3,823,464 SNPs and 85,801 SVs in the SBBM genome were detected compared with the reference grape sequence. Of these, 635 SBC-specific genes and 665 SBBM-specific genes were screened. Ripening and colour-associated unigenes with non-synonymous mutations (NS), SVs or frame-shift mutations (F) were analysed. The results showed that 90 unigenes in SBC, 76 unigenes in SBBM and 13 genes that mapped to large fragment indels were filtered. The expression patterns of eight genes were confirmed using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The re-sequencing data showed that 635 SBC-specific genes and 665 SBBM-specific genes associated with early ripening were screened. Among these, NCED6 expression appears to be related to NCED1 and is involved in ABA biosynthesis in grape, which might play a role in the onset of anthocyanin accumulation. The SEP and ERF genes probably play roles in ethylene response.	[Xu, Yanshuai; Gao, Zhihong; Tao, Jianmin; Zhang, Shijie; Qu, Shenchun] Nanjing Agr Univ, Coll Hort, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China; [Jiang, Weihua; Wang, Qiunan] Agr Bur & Forestry Workstn, Wujin Dist 213000, Changzhou, Peoples R China; [Xu, Yanshuai] Jiangsu Key Lab Hort Crop Genet Improvement, 50 Zhongling St, Nanjing 210014, Jiangsu, Peoples R China	Nanjing Agricultural University	Qu, SC (corresponding author), Nanjing Agr Univ, Coll Hort, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China.	qscnj@njau.edu.cn	zhang, shijie/HGF-0836-2022		Key Projects in the Science & Technology Pillar Program of the Agricultural Bureau of Forestry Workstation Changzhou Wujin District [CE20132009]; Qinglan Project of Jiangsu Province	Key Projects in the Science & Technology Pillar Program of the Agricultural Bureau of Forestry Workstation Changzhou Wujin District; Qinglan Project of Jiangsu Province	This study was funded by Key Projects in the Science & Technology Pillar Program of the Agricultural Bureau of Forestry Workstation Changzhou Wujin District (CE20132009) and the Qinglan Project of Jiangsu Province.	Ageorges A, 2006, PLANT SCI, V170, P372, DOI 10.1016/j.plantsci.2005.09.007; Aradhya MK, 2003, GENET RES, V81, P179, DOI 10.1017/S0016672303006177; Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Ban T, 2003, J HORTIC SCI BIOTECH, V78, P586, DOI 10.1080/14620316.2003.11511668; Blair MW, 2013, THEOR APPL GENET, V126, P535, DOI 10.1007/s00122-012-1999-z; Bottcher C, 2013, AM J ENOL VITICULT, V64, P527, DOI 10.5344/ajev.2013.13053; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Castellarin SD, 2011, J EXP BOT, V62, P4345, DOI 10.1093/jxb/err150; CAWTHON DL, 1982, HORTSCIENCE, V17, P490; Cazzonelli CI, 1998, AUST J PLANT PHYSIOL, V25, P513, DOI 10.1071/PP98013; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chervin C, 2004, PLANT SCI, V167, P1301, DOI 10.1016/j.plantsci.2004.06.026; COOMBE BG, 1973, PLANT PHYSIOL, V51, P629, DOI 10.1104/pp.51.4.629; Cota-Sanchez JH, 2006, PLANT MOL BIOL REP, V24, P161, DOI 10.1007/BF02914055; Davies C, 1997, PLANT PHYSIOL, V115, P1155, DOI 10.1104/pp.115.3.1155; Dong TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095559; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Galeano CH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-629; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Hu H, 2001, CHEM PHYS LETT, V345, P25, DOI 10.1016/S0009-2614(01)00851-X; Iannetta PPM, 2006, PHYSIOL PLANTARUM, V127, P247, DOI 10.1111/j.1399-3054.2006.00656.x; INABA A, 1976, J JPN SOC HORTIC SCI, V45, P245, DOI 10.2503/jjshs.45.245; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Ji K, 2014, J EXP BOT, V65, P5243, DOI 10.1093/jxb/eru288; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lijavetzky D, 2006, MOL GENET GENOMICS, V276, P427, DOI 10.1007/s00438-006-0149-1; Liu MC, 2014, NEW PHYTOL, V203, P206, DOI 10.1111/nph.12771; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Mazza G, 1999, J AGR FOOD CHEM, V47, P4009, DOI 10.1021/jf990449f; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Moschou PN, 2010, METHODOLOGIES AND RESULTS IN GRAPEVINE RESEARCH, P193, DOI 10.1007/978-90-481-9283-0_13; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Bicudo MOP, 2014, PLANT FOOD HUM NUTR, V69, P142, DOI 10.1007/s11130-014-0406-0; Schaffer RJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls047; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI DOI 10.1016/S1360-1385(01)02187-2; Seymour GB, 2011, J EXP BOT, V62, P1179, DOI 10.1093/jxb/erq360; Shan HY, 2007, AGR TECHNICAL SERVIC, V24, P95; Soar CJ, 2004, FUNCT PLANT BIOL, V31, P659, DOI 10.1071/FP03238; Sun JH, 2013, J PLANT GROWTH REGUL, V32, P461, DOI 10.1007/s00344-012-9312-6; Suzuki H, 2002, PLANT PHYSIOL, V130, P2142, DOI 10.1104/pp.010447; Symons GM, 2006, PLANT PHYSIOL, V140, P150, DOI 10.1104/pp.105.070706; Tucker GA, 2013, BIOCH PLANTS, V12, P265; Wang B., 2013, THESIS SHANGHAI JIAO; Wang HC, 2007, PLANT GROWTH REGUL, V52, P189, DOI 10.1007/s10725-007-9189-8; Wang ZW, 2014, GENE, V538, P1, DOI 10.1016/j.gene.2014.01.035; WEAVER RJ, 1978, AM J ENOL VITICULT, V29, P282; Wheeler S, 2009, AUST J GRAPE WINE R, V15, P195, DOI 10.1111/j.1755-0238.2008.00045.x; Yan LL, 2014, DECIDUOUS FRUITS, V46, P42; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zarei A, 2011, PLANT MOL BIOL, V75, P321, DOI 10.1007/s11103-010-9728-y; Zhang M, 2009, J PLANT PHYSIOL, V166, P1241, DOI 10.1016/j.jplph.2009.01.013; Zhang SJ, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.45; Zhang XD, 2011, PLANT MOL BIOL REP, V29, P305, DOI 10.1007/s11105-010-0231-z; Zhang XR, 2003, J AM SOC HORTIC SCI, V128, P316, DOI 10.21273/JASHS.128.3.0316; Zhao J, 2006, ANAL CHIM ACTA, V571, P79, DOI 10.1016/j.aca.2006.04.060; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114; Zhu CF, 2007, J PLANT PHYSIOL, V164, P195, DOI 10.1016/j.jplph.2006.02.010; Zou XL, 2014, MOL BREEDING, V33, P769, DOI 10.1007/s11032-013-9997-7	63	16	21	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147749	10.1371/journal.pone.0147749	http://dx.doi.org/10.1371/journal.pone.0147749			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840449	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200058
J	Doyard, M; Chappard, D; Leroyer, P; Roth, MP; Loreal, O; Guggenbuhl, P				Doyard, Mathilde; Chappard, Daniel; Leroyer, Patricia; Roth, Marie-Paule; Loreal, Olivier; Guggenbuhl, Pascal			Decreased Bone Formation Explains Osteoporosis in a Genetic Mouse Model of Hemochromatosiss	PLOS ONE			English	Article							BETA-THALASSEMIA MAJOR; MESENCHYMAL STEM-CELLS; MINERAL DENSITY; IRON OVERLOAD; HEREDITARY HEMOCHROMATOSIS; RECEPTOR ACTIVATOR; TEXTURE ANALYSIS; ADOLESCENTS; DISEASE; OSTEOPROTEGERIN	Osteoporosis may complicate iron overload diseases such as genetic hemochromatosis. However, molecular mechanisms involved in the iron-related osteoporosis remains poorly understood. Recent in vitro studies support a role of osteoblast impairment in iron-related osteoporosis. Our aim was to analyse the impact of excess iron in Hfe(-/-) mice on osteoblast activity and on bone microarchitecture. We studied the bone formation rate, a dynamic parameter reflecting osteoblast activity, and the bone phenotype of Hfe(-/-) male mice, a mouse model of human hemochromatosis, by using histomorphometry. Hfe(-/-) animals were sacrificed at 6 months and compared to controls. We found that bone contains excess iron associated with increased hepatic iron concentration in Hfe(-/-) mice. We have shown that animals with iron overload have decreased bone formation rate, suggesting a direct impact of iron excess on active osteoblasts number. For bone mass parameters, we showed that iron deposition was associated with bone loss by producing microarchitectural impairment with a decreased tendency in bone trabecular volume and trabecular number. A disorganization of trabecular network was found with marrow spaces increased, which was confirmed by enhanced trabecular separation and star volume of marrow spaces. These microarchitectural changes led to a loss of connectivity and complexity in the trabecular network, which was confirmed by decreased interconnectivity index and increased Minkowski's fractal dimension. Our results suggest for the first time in a genetic hemochromatosis mouse model, that iron overload decreases bone formation and leads to alterations in bone mass and microarchitecture. These observations support a negative effect of iron on osteoblast recruitment and/or function, which may contribute to iron-related osteoporosis.	[Doyard, Mathilde; Leroyer, Patricia; Loreal, Olivier; Guggenbuhl, Pascal] INSERM, UMR U991, F-35033 Rennes, France; [Doyard, Mathilde; Leroyer, Patricia; Loreal, Olivier; Guggenbuhl, Pascal] Univ Rennes 1, IFR 140, F-35043 Rennes, France; [Chappard, Daniel] CHU Angers, IRIS IBM, Inst Biol Sante, GEROM LHEA, F-49933 Angers, France; [Roth, Marie-Paule] INSERM, U1043, F-31300 Toulouse, France; [Loreal, Olivier] Hop Pontchaillou, CHU, Serv Malad Foie, F-35033 Rennes, France; [Guggenbuhl, Pascal] CHU, Hop Sud, Serv Rhumatol, F-35033 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; CHU Rennes	Guggenbuhl, P (corresponding author), INSERM, UMR U991, F-35033 Rennes, France.; Guggenbuhl, P (corresponding author), Univ Rennes 1, IFR 140, F-35043 Rennes, France.; Guggenbuhl, P (corresponding author), CHU, Hop Sud, Serv Rhumatol, F-35033 Rennes, France.	pascal.guggenbuhl@chu-rennes.fr	Loreal, Olivier/G-3366-2013; Roth, Marie-Paule/Q-2866-2018	Loreal, Olivier/0000-0002-7428-3766; Roth, Marie-Paule/0000-0001-9691-4234; Guggenbuhl, Pascal/0000-0002-8260-1824	Region Bretagne; "Societe Francaise de Rhumatologie" Paris, France	Region Bretagne(Region Bretagne); "Societe Francaise de Rhumatologie" Paris, France	This work was supported by grants from Region Bretagne (MD) and the "Societe Francaise de Rhumatologie" Paris, France.; We thank Mrs. Guenaelle Brossard and Nadine Gaborit for their skilful technical assistance with histomorphometry study. This work was supported by grants from Region Bretagne (MD) and the "Societe Francaise de Rhumatologie" Paris, France.	Angelopoulos NG, 2007, J BONE MINER METAB, V25, P60, DOI 10.1007/s00774-006-0728-6; BARRY M, 1971, LANCET, V1, P100; Brissot P, 2005, TRANSFUS CLIN BIOL, V12, P77, DOI 10.1016/j.tracli.2005.04.040; Brissot P, 2010, PATHOL BIOL, V58, P316, DOI 10.1016/j.patbio.2009.10.011; Chappard D, 1999, MICROSC RES TECHNIQ, V45, P303, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<303::AID-JEMT14>3.3.CO;2-#; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; CONTE D, 1989, AM J GASTROENTEROL, V84, P1231; DEVERNEJOUL MC, 1984, AM J PATHOL, V116, P377; Doyard M, 2012, OSTEOPOROSIS INT, V23, P2435, DOI 10.1007/s00198-011-1871-z; Guggenbuhl P, 2011, OSTEOPOROSIS INT, V22, P2313, DOI 10.1007/s00198-010-1456-2; Guggenbuhl P, 2008, METABOLISM, V57, P903, DOI 10.1016/j.metabol.2008.02.004; Guggenbuhl P, 2011, BEST PRACT RES CL RH, V25, P649, DOI 10.1016/j.berh.2011.10.014; Guggenbuhl P, 2009, JOINT BONE SPINE, V76, P595, DOI 10.1016/j.jbspin.2009.10.001; Jensen CE, 1998, J PEDIATR ENDOCR MET, V11, P975; Jensen CE, 1998, BRIT J HAEMATOL, V103, P911; Jian JL, 2009, ANTIOXID REDOX SIGN, V11, P2939, DOI [10.1089/ars.2009.2576, 10.1089/ARS.2009.2576]; Karimi M, 2007, INDIAN PEDIATR, V44, P29; Kudo H, 2008, TOXICOLOGY, V246, P143, DOI 10.1016/j.tox.2008.01.004; Lespessailles E, 2007, CALCIFIED TISSUE INT, V80, P97, DOI 10.1007/s00223-006-0216-y; Mahachoklertwattana P, 2003, J CLIN ENDOCR METAB, V88, P3966, DOI 10.1210/jc.2002-021548; Mahachoklertwattana P, 2003, CLIN ENDOCRINOL, V58, P273, DOI 10.1046/j.1365-2265.2003.01707.x; Matsushima S, 2001, TOXICOL PATHOL, V29, P623, DOI 10.1080/019262301753385951; McDermott JH, 2005, J CLIN ENDOCR METAB, V90, P2451, DOI 10.1210/jc.2004-0980; Messer JG, 2009, BONE, V45, P972, DOI 10.1016/j.bone.2009.07.073; Morabito N, 2004, J BONE MINER RES, V19, P722, DOI 10.1359/JBMR.040113; Oliveira FS, 2012, J CELL BIOCHEM, V113, P204, DOI 10.1002/jcb.23345; Pawlotsky Y, 1989, REV RHUM MAL OSTEO, V46, P91; PECK WA, 1993, AM J MED, V94, P646; Pictrangelo A, 2004, NAT CLIN PRACT GASTR, V1, P39, DOI 10.1038/ncpgasthep0019; Plaisant M, 2009, STEM CELLS, V27, P703, DOI 10.1634/stemcells.2008-0888; Rachidi M, 2008, SKELETAL RADIOL, V37, P541, DOI 10.1007/s00256-008-0463-2; Shamshirseliz AA, 2007, PEDIATR HEMAT ONCOL, V24, P469, DOI 10.1080/08880010701533702; Sinigaglia L, 1997, J RHEUMATOL, V24, P1809; Skordis Nicos, 2008, Pediatr Endocrinol Rev, V6 Suppl 1, P107; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; Valenti L, 2009, OSTEOPOROSIS INT, V20, P549, DOI 10.1007/s00198-008-0701-4; Vichinsky EP, 1998, ANN NY ACAD SCI, V850, P344, DOI 10.1111/j.1749-6632.1998.tb10491.x; Vogiatzi MG, 2009, J BONE MINER RES, V24, P543, DOI [10.1359/jbmr.080505, 10.1359/JBMR.080505]; Vogiatzi MG, 2005, ANN NY ACAD SCI, V1054, P462, DOI 10.1196/annals.1345.063; Vogiatzi MG, 2006, BONE, V38, P571, DOI 10.1016/j.bone.2005.10.001; Voskaridou E, 2005, EUR J HAEMATOL, V74, P359, DOI 10.1111/j.1600-0609.2004.00395.x; Yamasaki K, 2009, TOXICOL LETT, V191, P211, DOI 10.1016/j.toxlet.2009.08.023; Yang Q, 2011, J BONE MINER RES, V26, P1188, DOI 10.1002/jbmr.337	43	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148292	10.1371/journal.pone.0148292	http://dx.doi.org/10.1371/journal.pone.0148292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829642	Green Submitted, Green Published, gold			2022-12-26	WOS:000369548200093
J	Volckmar, AL; Han, CT; Putter, C; Haas, S; Vogel, CIG; Knoll, N; Struve, C; Gobel, M; Haas, K; Herrfurth, N; Jarick, I; Grallert, H; Schurmann, A; Al-Hasani, H; Hebebrand, J; Sauer, S; Hinney, A				Volckmar, Anna-Lena; Han, Chung Ting; Puetter, Carolin; Haas, Stefan; Vogel, Carla I. G.; Knoll, Nadja; Struve, Christoph; Goebel, Maria; Haas, Katharina; Herrfurth, Nikolas; Jarick, Ivonne; Grallert, Harald; Schuermann, Annette; Al-Hasani, Hadi; Hebebrand, Johannes; Sauer, Sascha; Hinney, Anke			Analysis of Genes Involved in Body Weight Regulation by Targeted Re-Sequencing	PLOS ONE			English	Article							MELANOCORTIN-4 RECEPTOR GENE; STIMULATED GLUCOSE-UPTAKE; LIFE-STYLE INTERVENTION; ONSET EXTREME OBESITY; GENOME-WIDE ANALYSIS; MASS INDEX; FTO GENE; FAT MASS; OVERWEIGHT CHILDREN; DIABETES-MELLITUS	Introduction Genes involved in body weight regulation that were previously investigated in genome-wide association studies (GWAS) and in animal models were target-enriched followed by massive parallel next generation sequencing. Methods We enriched and re-sequenced continuous genomic regions comprising FTO, MC4R, TMEM18, SDCCAG8, TKNS, MSRA and TBC1D1 in a screening sample of 196 extremely obese children and adolescents with age and sex specific body mass index (BMI) >= 99th percentile and 176 lean adults (BMI <= 15th percentile). 22 variants were confirmed by Sanger sequencing. Genotyping was performed in up to 705 independent obesity trios (extremely obese child and both parents), 243 extremely obese cases and 261 lean adults. Results and Conclusion We detected 20 different non-synonymous variants, one frame shift and one nonsense mutation in the 7 continuous genomic regions in study groups of different weight extremes. For SNP Arg695Cys (rs58983546) in TBC1D1 we detected nominal association with obesity (p(TDT) = 0.03 in 705 trios). Eleven of the variants were rare, thus were only detected heterozygously in up to ten individual(s) of the complete screening sample of 372 individuals. Two of them (in FTO and MSRA) were found in lean individuals, nine in extremely obese. In silico analyses of the 11 variants did not reveal functional implications for the mutations. Concordant with our hypothesis we detected a rare variant that potentially leads to loss of FTO function in a lean individual. For TBC1D1, in contrary to our hypothesis, the loss of function variant (Arg443Stop) was found in an obese individual. Functional in vitro studies are warranted.	[Volckmar, Anna-Lena; Knoll, Nadja; Struve, Christoph; Goebel, Maria; Haas, Katharina; Herrfurth, Nikolas; Hebebrand, Johannes; Hinney, Anke] Univ Hosp Essen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Essen, Germany; [Han, Chung Ting; Haas, Stefan; Sauer, Sascha] Max Planck Inst Mol Genet, Nutrigen & Gene Regulat, Ihnestr 73, D-14195 Berlin, Germany; [Han, Chung Ting] Inst Mol Biol IMB, Core Facil & Technol, Genom, Mainz, Germany; [Puetter, Carolin] Univ Hosp Essen, IMIBE, Essen, Germany; [Vogel, Carla I. G.] Santa Catarina State Univ, Dept Anim & Food Prod, Lages, Brazil; [Jarick, Ivonne] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Grallert, Harald] Helmholtz Zentrum Munich, Inst Epidemiol, Munich, Germany; [Schuermann, Annette] German Inst Human Nutr Potsdam Rehbrucke, Inst Expt Diabetol, Nuthetal, Germany; [Schuermann, Annette; Al-Hasani, Hadi] German Ctr Diabet Res DZD, Munich, Germany; [Al-Hasani, Hadi] German Diabet Ctr, Inst Pathobiochem, Dusseldorf, Germany; [Al-Hasani, Hadi] German Ctr Diabet Res, Dusseldorf, Germany; [Sauer, Sascha] Univ Wurzburg, CU Syst Med, Wurzburg, Germany	University of Duisburg Essen; Max Planck Society; Institute of Molecular Biology (IMB); University of Duisburg Essen; Universidade do Estado de Santa Catarina; Philipps University Marburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Diabetes-Zentrum (DDZ); University of Wurzburg	Hinney, A (corresponding author), Univ Hosp Essen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Essen, Germany.	anke.hinney@uni-due.de	Hinney, Anke/D-6953-2011; Vogel, Carla Ivane/X-3419-2019; Grallert, Harald/B-3424-2013; Volckmar, Anna-Lena/ABE-3676-2021	Hinney, Anke/0000-0001-5659-0706; Schurmann, Annette/0000-0002-4113-4377; Haas, Stefan/0000-0003-3418-3688; Han, Chung-Ting/0000-0003-1916-0314; Vogel, Carla/0000-0003-1715-2556	Deutsche Forschungsgemeinschaft (DFG); Deutsche Forschungsgesellschaft [HI865/2-1]; Bundesministerium fur Bildung and Forschung [01KU0903, 0315082/01EA1303, NGFNplus: 01GS0820]; IFORES program of the University of Duisburg-Essen	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung and Forschung(Federal Ministry of Education & Research (BMBF)); IFORES program of the University of Duisburg-Essen	The ascertainment of study groups belonging to different weight extremes was supported by the Deutsche Forschungsgemeinschaft (DFG). All other analyses were supported by the Deutsche Forschungsgesellschaft (HI865/2-1, AH) and the Bundesministerium fur Bildung and Forschung (01KU0903, AH; 0315082/01EA1303, SS; NGFNplus: 01GS0820, JH) and the IFORES program of the University of Duisburg-Essen (AH, JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Billingsley G, 2012, OPHTHALMIC GENET, V33, P150, DOI 10.3109/13816810.2012.689411; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Busch AM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-211; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chadt A, 2015, DIABETES, V64, P746, DOI 10.2337/db14-0368; Chang S, 2010, AGING-US, V2, P639, DOI 10.18632/aging.100221; Cheng KKY, 2014, DIABETES, V63, P3748, DOI 10.2337/db14-0337; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Dokas J, 2013, ENDOCRINOLOGY, V154, P3502, DOI 10.1210/en.2012-2147; Dusatkova L, 2013, FOLIA BIOL-PRAGUE, V59, P123; Fall T, 2014, MOL CELL ENDOCRINOL, V382, P740, DOI 10.1016/j.mce.2012.08.018; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao JB, 2011, PATHOL ONCOL RES, V17, P685, DOI 10.1007/s12253-011-9369-8; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Graff M, 2013, HUM MOL GENET, V22, P3597, DOI 10.1093/hmg/ddt205; Hebebrand J, 2013, DTSCH ARZTEBL INT, V110, P338, DOI 10.3238/arztebl.2013.0338; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hinney A, 2013, J PEDIATR ENDOCR MET, V26, P1209, DOI 10.1515/jpem-2013-0179; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Ikels K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105349; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jurvansuu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025317; Kim MK, 2012, EMBO REP, V13, P724, DOI 10.1038/embor.2012.86; Knuppel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068941; Livingstone KM, 2015, OBES REV, V16, P666, DOI 10.1111/obr.12290; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Mullhaus J, 2012, HORM RES PAEDIAT, V77, P358, DOI 10.1159/000338999; Mumby HS, 2011, J OBES, V2011, DOI 10.1155/2011/180729; Pellatt AJ, 2013, GENE CHROMOSOME CANC, V52, P595, DOI 10.1002/gcc.22056; Pellatt AJ, 2012, INT J MOL EPIDEMIOL, V3, P184; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Putter C, 2011, HUM HERED, V72, P173, DOI 10.1159/000332824; Quail M. A., 2009, CURRENT PROTOCOLS HU, V18, P18, DOI DOI 10.1002/0471142905.HG1802S62; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rask-Andersen M, 2012, EUR J HUM GENET, V20, P192, DOI 10.1038/ejhg.2011.176; Rohde K, 2014, J MOL MED, V92, P881, DOI 10.1007/s00109-014-1154-1; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Schaefer E, 2010, MOL SYNDROMOL, V1, P273, DOI 10.1159/000331268; Scherag A, 2012, OBESITY, V20, P466, DOI 10.1038/oby.2011.339; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Styskal J, 2013, FREE RADICAL BIO MED, V56, P123, DOI 10.1016/j.freeradbiomed.2012.10.544; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; WHO, 2011, OB AND OV; Zee RYL, 2011, ATHEROSCLEROSIS, V218, P144, DOI 10.1016/j.atherosclerosis.2011.05.013; Zheng ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067039	63	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147904	10.1371/journal.pone.0147904	http://dx.doi.org/10.1371/journal.pone.0147904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828654	Green Published, gold, Green Accepted			2022-12-26	WOS:000369548200041
J	Bar, RJ; DeSouza, JFX				Bar, Rachel J.; DeSouza, Joseph F. X.			Tracking Plasticity: Effects of Long-Term Rehearsal in Expert Dancers Encoding Music to Movement	PLOS ONE			English	Article							BRAIN STRUCTURE CHANGES; CORTICAL MOTOR AREAS; BASAL GANGLIA; LEARNING-TASK; CHUNKING; CORTEX; PERCEPTION; IMAGERY; PERFORMANCE; MECHANISMS	Our knowledge of neural plasticity suggests that neural networks show adaptation to environmental and intrinsic change. In particular, studies investigating the neuroplastic changes associated with learning and practicing motor tasks have shown that practicing such tasks results in an increase in neural activation in several specific brain regions. However, studies comparing experts and non-experts suggest that experts employ less neuronal activation than non-experts when performing a familiar motor task. Here, we aimed to determine the long-term changes in neural networks associated with learning a new dance in professional ballet dancers over 34 weeks. Subjects visualized dance movements to music while undergoing fMRI scanning at four time points over 34-weeks. Results demonstrated that initial learning and performance at seven weeks led to increases in activation in cortical regions during visualization compared to the first week. However, at 34 weeks, the cortical networks showed reduced activation compared to week seven. Specifically, motor learning and performance over the 34 weeks showed the typical inverted-U-shaped function of learning. Further, our result demonstrate that learning of a motor sequence of dance movements to music in the real world can be visualized by expert dancers using fMRI and capture highly significant modeled fits of the brain network variance of BOLD signals from early learning to expert level performance.	[Bar, Rachel J.] York Univ, Dept Psychol, Toronto, ON M3J 2R7, Canada; [DeSouza, Joseph F. X.] York Univ, Canadian Act & Percept Network CAPnet, Grad Program Interdisciplinary Studies, Ctr Vis Res,Dept Psychol,Dept Biol,Neurosci Grad, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	DeSouza, JFX (corresponding author), York Univ, Canadian Act & Percept Network CAPnet, Grad Program Interdisciplinary Studies, Ctr Vis Res,Dept Psychol,Dept Biol,Neurosci Grad, Toronto, ON M3J 2R7, Canada.	desouza@yorku.ca	DeSouza, Joseph FX/B-5615-2009	DeSouza, Joseph FX/0000-0001-6931-0849	National Science and Engineering Research Council (NSERC) Discovery [RGPIN/346135-2012]; Faculty of Health Minor Research Grant at York University; Irpinia Club of Toronto; NSERC USRA; RAY programs	National Science and Engineering Research Council (NSERC) Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Faculty of Health Minor Research Grant at York University; Irpinia Club of Toronto; NSERC USRA(Natural Sciences and Engineering Research Council of Canada (NSERC)); RAY programs	A National Science and Engineering Research Council (NSERC) Discovery grant to JFXD (RGPIN/346135-2012), Faculty of Health Minor Research Grant at York University, and a generous donation from the Irpinia Club of Toronto helped fund this project. RJB was supported by the NSERC USRA and the RAY programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna DE, 2014, J NEUROPHYSIOL, V112, P1849, DOI 10.1152/jn.00028.2014; Andrieux M, 2013, EXP BRAIN RES, V229, P125, DOI 10.1007/s00221-013-3598-x; ANNETT J, 1995, NEUROPSYCHOLOGIA, V33, P1395, DOI 10.1016/0028-3932(95)00072-B; Bach J, CONCERTO IN C MAJOR; Bar RJ, 2012, SEEING PERCEIVING, V25, P45; BATTIG K, 1960, J COMP PHYSIOL PSYCH, V53, P400, DOI 10.1037/h0047392; Bidhan L, 2015, BRAIN CONNECTIVITY; Blasing B, 2012, ACTA PSYCHOL, V139, P300, DOI 10.1016/j.actpsy.2011.12.005; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; BRINKMAN C, 1979, J NEUROPHYSIOL, V42, P681, DOI 10.1152/jn.1979.42.3.681; Brown S, 2006, CEREB CORTEX, V16, P1157, DOI 10.1093/cercor/bhj057; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Cameron IGM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00022; CHOROVER SL, 1963, SCIENCE, V141, P826, DOI 10.1126/science.141.3583.826; Churchland MM, 2014, COLD SH Q B, V79, P67, DOI 10.1101/sqb.2014.79.024703; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cruz-Garza JG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00188; DeSouza JFX, 2002, CEREB CORTEX, V12, P991, DOI 10.1093/cercor/12.9.991; DeSouza JFX, 2000, J NEUROSCI, V20, P5835, DOI 10.1523/JNEUROSCI.20-15-05835.2000; Dhami P, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01478; Di Noto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059244; Diedrichsen J, 2015, TRENDS COGN SCI, V19, P227, DOI 10.1016/j.tics.2015.02.003; DIVAC I, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P461; Dorris MC, 2000, J NEUROSCI, V20; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Fink A, 2009, NEUROIMAGE, V46, P854, DOI 10.1016/j.neuroimage.2009.02.036; Foster PP, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00004; Gobet F, 2001, TRENDS COGN SCI, V5, P236, DOI 10.1016/S1364-6613(00)01662-4; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Houston S, 2013, ARTS HEALTH, V5, P103, DOI 10.1080/17533015.2012.745580; Howe MW, 2011, P NATL ACAD SCI USA, V108, P16801, DOI 10.1073/pnas.1113158108; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Kao JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8759; KARNI A, 1995, NATURE, V377, P155; Karpati FJ, 2015, ANN NY ACAD SCI, V1337, P140, DOI 10.1111/nyas.12632; Kirsch LP, 2015, ANN NY ACAD SCI, V1337, P130, DOI 10.1111/nyas.12634; Kleber B, 2010, CEREB CORTEX, V20, P1144, DOI 10.1093/cercor/bhp177; Kropff E, 2015, NATURE, V523, P419, DOI 10.1038/nature14622; Leonardo M, 1995, HUM BRAIN MAPP, V3, P83, DOI 10.1002/hbm.460030205; Medee B, 2010, NEUROPSYCHOL REHABIL, V20, P854, DOI 10.1080/09602011.2010.499309; Merchant H, 2015, PHILOS T R SOC B, V370, P91, DOI 10.1098/rstb.2014.0093; Moody TD, 2004, BEHAV NEUROSCI, V118, P438, DOI 10.1037/0735-7044.118.2.438; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Olshansky MP, 2015, NEUROCASE, V21, P607, DOI 10.1080/13554794.2014.960428; Olsson C-J, 2008, Open Neuroimag J, V2, P5, DOI 10.2174/1874440000802010005; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Page SJ, 2009, NEUROREHAB NEURAL RE, V23, P382, DOI 10.1177/1545968308326427; Penhune VB, 2012, BEHAV BRAIN RES, V226, P579, DOI 10.1016/j.bbr.2011.09.044; Picard N, 1997, J NEUROPHYSIOL, V77, P2197, DOI 10.1152/jn.1997.77.4.2197; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Roberts R, 2008, J SPORT EXERCISE PSY, V30, P200, DOI 10.1123/jsep.30.2.200; Sack AT, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00214; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Sevdalis V, 2011, BRAIN COGNITION, V77, P231, DOI 10.1016/j.bandc.2011.08.005; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Shenoy K, 2015, 2015 NEUR M PLANN WA; TANJI J, 1982, J NEUROPHYSIOL, V48, P633, DOI 10.1152/jn.1982.48.3.633; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; TERRACE HS, 1987, NATURE, V325, P149, DOI 10.1038/325149a0; Tremblay PL, 2010, EXP BRAIN RES, V205, P375, DOI 10.1007/s00221-010-2372-6; TYSZKA JM, 1994, ANN NEUROL, V35, P746, DOI 10.1002/ana.410350617; Van Nostrand Kirby K., 1993, ADV DATA ANAL SYSTAT; Weis T, 2013, J NEUROPHYSIOL, V110, P1860, DOI 10.1152/jn.00128.2013; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	71	29	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147731	10.1371/journal.pone.0147731	http://dx.doi.org/10.1371/journal.pone.0147731			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824475	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600052
J	Castells-Roca, L; Pijuan, J; Ferrezuelo, F; Belli, G; Herrero, E				Castells-Roca, Laia; Pijuan, Jordi; Ferrezuelo, Francisco; Belli, Gemma; Herrero, Enrique			Cth2 Protein Mediates Early Adaptation of Yeast Cells to Oxidative Stress Conditions	PLOS ONE			English	Article							VACUOLAR IRON STORAGE; RNA-BINDING-PROTEINS; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; DEFICIENCY; STABILITY; DIOXYGEN; OXYGEN	Cth2 is an mRNA-binding protein that participates in remodeling yeast cell metabolism in iron starvation conditions by promoting decay of the targeted molecules, in order to avoid excess iron consumption. This study shows that in the absence of Cth2 immediate upregulation of expression of several of the iron regulon genes (involved in high affinity iron uptake and intracellular iron redistribution) upon oxidative stress by hydroperoxide is more intense than in wild type conditions where Cth2 is present. The oxidative stress provokes a temporary increase in the levels of Cth2 (itself a member of the iron regulon). In such conditions Cth2 molecules accumulate at P bodies-like structures when the constitutive mRNA decay machinery is compromised. In addition, a null.cth2 mutant shows defects, in comparison to CTH2 wild type cells, in exit from a factor-induced arrest at the G1 stage of the cell cycle when hydroperoxide treatment is applied. The cell cycle defects are rescued in conditions that compromise uptake of external iron into the cytosol. The observations support a role of Cth2 in modulating expression of diverse iron regulon genes, excluding those specifically involved in the reductive branch of the high-affinity transport. This would result in immediate adaptation of the yeast cells to an oxidative stress, by controlling uptake of oxidant-promoting iron cations.	[Castells-Roca, Laia; Pijuan, Jordi; Ferrezuelo, Francisco; Belli, Gemma; Herrero, Enrique] Univ Lleida, IRBLleida, Dept Ciencies Med Basiques, Lleida, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Herrero, E (corresponding author), Univ Lleida, IRBLleida, Dept Ciencies Med Basiques, Lleida, Spain.	enric.herrero@cmb.udl.cat	Pijuan, Jordi/P-9651-2015; Bellí, Gemma/AAD-5325-2019; Castells-Roca, Laia/I-1227-2015; Ferrezuelo, Francisco/E-7511-2010; belli, gemma/A-7424-2011; Herrero, Enrique/B-5592-2009	Pijuan, Jordi/0000-0003-0350-6376; Bellí, Gemma/0000-0002-4161-3204; Castells-Roca, Laia/0000-0002-4604-9999; Ferrezuelo, Francisco/0000-0001-9403-0355; belli, gemma/0000-0002-4161-3204; Herrero, Enrique/0000-0002-6763-111X	Spanish Ministerio de Economia y Competitividad [BFU2010-17656]; Ministerio de Economia y Competitividad	Spanish Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Economia y Competitividad(Spanish Government)	This study was supported by grant BFU2010-17656 from Spanish Ministerio de Economia y Competitividad (www.mineco.gob.es). JP was the recipient of a predoctoral grant from Ministerio de Economia y Competitividad. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic N, 2001, MOL BIOL CELL, V12, P1801, DOI 10.1091/mbc.12.6.1801; Batista-Nascimento L, 2013, BBA-MOL CELL RES, V1833, P997, DOI 10.1016/j.bbamcr.2012.12.018; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Castells-Roca L, 2011, MOL MICROBIOL, V81, P232, DOI 10.1111/j.1365-2958.2011.07689.x; Castells-Roca L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017272; Collinson EJ, 2011, J BIOL CHEM, V286, P2205, DOI 10.1074/jbc.M110.187062; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dix D, 1997, J BIOL CHEM, V272, P11770, DOI 10.1074/jbc.272.18.11770; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Ferrezuelo F, 2009, CELL CYCLE, V8, P239, DOI 10.4161/cc.8.2.7543; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Halliwell B., 2007, FREE RADICALS BIOL M; Hassett RF, 1998, J BIOL CHEM, V273, P7628, DOI 10.1074/jbc.273.13.7628; Holmes-Hampton GP, 2013, BIOCHEMISTRY-US, V52, P105, DOI 10.1021/bi3015339; Jensen LT, 2002, J MOL BIOL, V318, P251, DOI 10.1016/S0022-2836(02)00093-1; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; Lee JW, 1996, J BIOL CHEM, V271, P24885, DOI 10.1074/jbc.271.40.24885; Lesuisse E, 2001, MICROBIOL-UK, V147, P289, DOI 10.1099/00221287-147-2-289; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Marques M, 2006, MICROBIOL-SGM, V152, P3595, DOI 10.1099/mic.0.29040-0; Martinez-Pastor M, 2013, MOL CELL BIOL, V33, P2178, DOI 10.1128/MCB.01458-12; Molina-Navarro MM, 2008, J BIOL CHEM, V283, P17908, DOI 10.1074/jbc.M800295200; Moreno-Cermeno A, 2013, BBA-MOL CELL RES, V1833, P3326, DOI 10.1016/j.bbamcr.2013.09.019; Outten CE, 2013, CURR OPIN MICROBIOL, V16, P662, DOI 10.1016/j.mib.2013.07.020; Pedro-Segura E, 2008, J BIOL CHEM, V283, P28527, DOI 10.1074/jbc.M804910200; Perez-Ortin JE, 2013, J MOL BIOL, V425, P3750, DOI 10.1016/j.jmb.2013.02.029; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Pimentel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037434; Protchenko O, 2001, J BIOL CHEM, V276, P49244, DOI 10.1074/jbc.M109220200; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Sanvisens N, 2011, MOL CELL, V44, P759, DOI 10.1016/j.molcel.2011.09.021; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Tamarit J, 2006, ANAL BIOCHEM, V351, P149, DOI 10.1016/j.ab.2005.12.001; Wanke V, 1999, MOL MICROBIOL, V32, P753, DOI 10.1046/j.1365-2958.1999.01391.x; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200	45	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148204	10.1371/journal.pone.0148204	http://dx.doi.org/10.1371/journal.pone.0148204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824473	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528600108
J	Kumar, R; Kumar, A; Sharma, NK; Kaur, N; Chunduri, V; Chawla, M; Sharma, S; Singh, K; Garg, M				Kumar, Rohit; Kumar, Aman; Sharma, Nand Kishor; Kaur, Navneet; Chunduri, Venkatesh; Chawla, Meenakshi; Sharma, Saloni; Singh, Kashmir; Garg, Monika			Soft and Hard Textured Wheat Differ in Starch Properties as Indicated by Trimodal Distribution, Morphology, Thermal and Crystalline Properties	PLOS ONE			English	Article							GRANULE SIZE DISTRIBUTION; IN-VITRO DIGESTIBILITY; FINE-STRUCTURE; PHYSICOCHEMICAL CHARACTERISTICS; DEVELOPING ENDOSPERM; A-TYPE; AMYLOSE; WAXY; RETROGRADATION; GELATINIZATION	Starch and proteins are major components in the wheat endosperm that affect its end product quality. Between the two textural classes of wheat i.e. hard and soft, starch granules are loosely bound with the lipids and proteins in soft wheat due to higher expression of interfering grain softness proteins. It might have impact on starch granules properties. In this work for the first time the physiochemical and structural properties of different sized starch granules (A-, B-and C-granules) were studied to understand the differences in starches with respect to soft and hard wheat. A-, B- and C-type granules were separated with >95% purity. Average number and proportion of A-, B-, and C-type granules was 18%, 56%, 26% and 76%, 19%, 5% respectively. All had symmetrical birefringence pattern with varied intensity. All displayed typical A-type crystallites. A-type granules also showed V-type crystallinity that is indicative of starch complexes with lipids and proteins. Granules differing in gelatinization temperature (Delta H) and transition temperature (Delta T), showed different enthalpy changes during heating. Substitution analysis indicated differences in relative substitution pattern of different starch granules. Birefringence, percentage crystallinity, transmittance, gelatinization enthalpy and substitution decreased in order of A>B>C being higher in hard wheat than soft wheat. Amylose content decreased in order of A>B>C being higher in soft wheat than hard wheat. Reconstitution experiment showed that starch properties could be manipulated by changing the composition of starch granules. Addition of A-granules to total starch significantly affected its thermal properties. Effect of A-granule addition was higher than B-and C-granules. Transmittance of the starch granules paste showed that starch granules of hard wheat formed clear paste. These results suggested that in addition to differences in protein concentration, hard and soft wheat lines have differences in starch composition also.	[Kumar, Rohit; Kumar, Aman; Sharma, Nand Kishor; Kaur, Navneet; Chunduri, Venkatesh; Chawla, Meenakshi; Sharma, Saloni; Garg, Monika] Natl Agri Food Biotechnol Inst, Mohali, Punjab, India; [Singh, Kashmir] Panjab Univ, Chandigarh 160014, Punjab, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Panjab University	Garg, M (corresponding author), Natl Agri Food Biotechnol Inst, Mohali, Punjab, India.	mgarg100@yahoo.com	Singh, Kashmir/ABA-3329-2020; Kumar, Aman/AAY-3202-2020	Singh, Kashmir/0000-0002-9646-9043; Venkatesh, Chunduri/0000-0002-1909-8867; Kumar, Aman/0000-0002-0904-0792; Garg, Monika/0000-0002-2297-1137; Sharma, Saloni/0000-0003-4221-3277	NABI's core grant for agricultural biotechnology for the research project "Improvement of processing and nutritional quality in wheat"; Department of Biotechnology, Govt. of India	NABI's core grant for agricultural biotechnology for the research project "Improvement of processing and nutritional quality in wheat"; Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	The project was funded by NABI's core grant for agricultural biotechnology for the research project "Improvement of processing and nutritional quality in wheat". The authors thank Department of Biotechnology, Govt. of India for fellowship provided to RK.	Ao ZH, 2007, CARBOHYD POLYM, V67, P46, DOI 10.1016/j.carbpol.2006.04.013; Bechtel DB, 2003, CEREAL CHEM, V80, P175, DOI 10.1094/CCHEM.2003.80.2.175; Benmoussa M, 2007, J AGR FOOD CHEM, V55, P1475, DOI 10.1021/jf062349x; Bertolini AC, 2003, CEREAL CHEM, V80, P544, DOI 10.1094/CCHEM.2003.80.5.544; Blazek J, 2008, CARBOHYD POLYM, V71, P380, DOI 10.1016/j.carbpol.2007.06.010; BRIARTY LG, 1979, ANN BOT-LONDON, V44, P641, DOI 10.1093/oxfordjournals.aob.a085779; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Chung HJ, 2006, J CEREAL SCI, V43, P353, DOI 10.1016/j.jcs.2005.12.001; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Copeland L, 2009, FOOD HYDROCOLLOID, V23, P1527, DOI 10.1016/j.foodhyd.2008.09.016; Davis JP, 2003, STARCH-STARKE, V55, P107, DOI 10.1002/star.200390036; Dey P.M., 1990, METHODS PLANT BIOCH, V2, P323; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; GERNAT C, 1990, STARCH-STARKE, V42, P175, DOI 10.1002/star.19900420504; Hermansson AM, 1996, TRENDS FOOD SCI TECH, V7, P345, DOI 10.1016/S0924-2244(96)10036-4; HUGHES CE, 1976, STARKE, V28, P336, DOI 10.1002/star.19760281003; JANE JL, 1994, STARCH-STARKE, V46, P121, DOI 10.1002/star.19940460402; Kim HS, 2010, J CEREAL SCI, V51, P256, DOI 10.1016/j.jcs.2009.11.015; KLUCINEC JD, 2005, FOOD BIOTECHNOL, P675; Langeveld SMJ, 2000, J EXP BOT, V51, P1357, DOI 10.1093/jexbot/51.349.1357; Li JZ, 2014, MICROENCAPSULATION IN THE FOOD INDUSTRY: A PRACTICAL IMPLEMENTATION GUIDE, P195, DOI 10.1016/B978-0-12-404568-2.00018-2; Li WH, 2013, J AGR FOOD CHEM, V61, P6477, DOI 10.1021/jf400943h; Li WenYang, 2008, Agricultural Sciences in China, V7, P907, DOI 10.1016/S1671-2927(08)60129-7; Mischnick P, 1996, CARBOHYD RES, V290, P199, DOI 10.1016/0008-6215(96)00141-3; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Myllarinen P, 2002, CARBOHYD POLYM, V48, P41, DOI 10.1016/S0144-8617(01)00208-9; NARA S, 1983, STARKE, V35, P407, DOI 10.1002/star.19830351202; Oates CG, 1997, TRENDS FOOD SCI TECH, V8, P375, DOI 10.1016/S0924-2244(97)01090-X; PARKER ML, 1985, J CEREAL SCI, V3, P271, DOI 10.1016/S0733-5210(85)80001-1; Paul C, 1997, NATURE, V389, P338; Peng M, 1999, CEREAL CHEM, V76, P375, DOI 10.1094/CCHEM.1999.76.3.375; Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013; Sahlstrom S, 1998, J CEREAL SCI, V28, P157, DOI 10.1006/jcrs.1998.0192; SARKO A, 1978, STARKE, V30, P73, DOI 10.1002/star.19780300302; Sasaki T, 2000, CEREAL CHEM, V77, P58, DOI 10.1094/CCHEM.2000.77.1.58; Sasaki T, 2009, FOOD CHEM, V116, P137, DOI 10.1016/j.foodchem.2009.02.024; Singh N, 2007, STARCH-STARKE, V59, P10, DOI 10.1002/star.200600527; Syahariza ZA, 2013, FOOD CHEM, V136, P742, DOI 10.1016/j.foodchem.2012.08.053; Takeda Y, 1999, CARBOHYD POLYM, V38, P109, DOI 10.1016/S0144-8617(98)00105-2; Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Wickramasinghe HAM, 2008, FOOD SCI TECHNOL RES, V14, P49, DOI 10.3136/fstr.14.49; Wilson JD, 2006, CEREAL CHEM, V83, P259, DOI 10.1094/CC-83-0259; Xie XJ, 2008, FOOD RES INT, V41, P882, DOI 10.1016/j.foodres.2008.07.016; Yonemoto PG, 2007, CIENCIA TECNOL ALIME, V27, P761, DOI 10.1590/S0101-20612007000400015; You SY, 2014, CARBOHYD POLYM, V112, P729, DOI 10.1016/j.carbpol.2014.06.065; Zhao YS, 2011, J AGR FOOD CHEM, V59, P9700, DOI 10.1021/jf202002c	48	20	22	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147622	10.1371/journal.pone.0147622	http://dx.doi.org/10.1371/journal.pone.0147622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824830	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600040
J	Schenk, JJ				Schenk, John J.			Consequences of Secondary Calibrations on Divergence Time Estimates	PLOS ONE			English	Article							MOLECULAR EVOLUTION; ABSOLUTE RATES; DIVERSIFICATION; LIKELIHOOD; SPECIATION; MODEL; PHYLOGEOGRAPHY; UNCERTAINTY; HISTORY; FOSSILS	Secondary calibrations (calibrations based on the results of previous molecular dating studies) are commonly applied in divergence time analyses in groups that lack fossil data; however, the consequences of applying secondary calibrations in a relaxed-clock approach are not fully understood. I tested whether applying the posterior estimate from a primary study as a prior distribution in a secondary study results in consistent age and uncertainty estimates. I compared age estimates from simulations with 100 randomly replicated secondary trees. On average, the 95% credible intervals of node ages for secondary estimates were significantly younger and narrower than primary estimates. The primary and secondary age estimates were significantly different in 97% of the replicates after Bonferroni corrections. Greater error in magnitude was associated with deeper than shallower nodes, but the opposite was found when standardized by median node age, and a significant positive relationship was determined between the number of tips/age of secondary trees and the total amount of error. When two secondary calibrated nodes were analyzed, estimates remained significantly different, and although the minimum and median estimates were associated with less error, maximum age estimates and credible interval widths had greater error. The shape of the prior also influenced error, in which applying a normal, rather than uniform, prior distribution resulted in greater error. Secondary calibrations, in summary, lead to a false impression of precision and the distribution of age estimates shift away from those that would be inferred by the primary analysis. These results suggest that secondary calibrations should not be applied as the only source of calibration in divergence time analyses that test time-dependent hypotheses until the additional error associated with secondary calibrations is more properly modeled to take into account increased uncertainty in age estimates.	[Schenk, John J.] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA	University System of Georgia; Georgia Southern University	Schenk, JJ (corresponding author), Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA.	jschenk@georgiasouthern.edu						Andujar C, 2014, METHODS ECOL EVOL, V5, P226, DOI 10.1111/2041-210X.12151; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Dos Reis M, 2013, J SYST EVOL, V51, P30, DOI 10.1111/j.1759-6831.2012.00236.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duchene D, 2015, NELSI; Duchene S, 2014, MOL PHYLOGENET EVOL, V78, P277, DOI 10.1016/j.ympev.2014.05.032; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HASEGAWA M, 1989, J HUM EVOL, V18, P461, DOI 10.1016/0047-2484(89)90075-4; Hedges SB, 2004, TRENDS GENET, V20, P242, DOI 10.1016/j.tig.2004.03.004; Hipsley CA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00138; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Kornilios P, 2013, MOL PHYLOGENET EVOL, V68, P35, DOI 10.1016/j.ympev.2013.03.009; Kuriyama T, 2011, J BIOGEOGR, V38, P259, DOI 10.1111/j.1365-2699.2010.02403.x; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Maddison WP, 2019, MESQUITE MODULAR SYS; Magallon SA, 2004, INT J PLANT SCI, V165, pS7, DOI 10.1086/383336; Magallon S, 2010, SYST BIOL, V59, P384, DOI 10.1093/sysbio/syq027; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; Miller M.A., 2010, P GAT COMP ENV WORKS; Morrison DA, 2010, 10013586 ARXIV; Near TJ, 2004, PHILOS T R SOC B, V359, P1477, DOI 10.1098/rstb.2004.1523; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Phillips MJ, 2009, GENE, V441, P132, DOI 10.1016/j.gene.2008.08.017; R Development Core Team, 2005, R LANG ENV STAT COMP; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ruiz-Sanchez E, 2013, J BIOGEOGR, V40, P1336, DOI 10.1111/jbi.12073; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Ryberg M, 2011, EVOLUTION, V65, P1862, DOI 10.1111/j.1558-5646.2011.01251.x; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Schenk JJ, 2010, SYSTEMATIC BOT, V35, P1; Schenk JJ, 2013, SYST BIOL, V62, P837, DOI 10.1093/sysbio/syt050; Schenk JJ, 2013, J BIOGEOGR, V40, P455, DOI 10.1111/jbi.12018; Shaul S, 2002, GENE, V300, P59, DOI 10.1016/S0378-1119(02)00851-X; Siler CD, 2012, J BIOGEOGR, V39, P1217, DOI 10.1111/j.1365-2699.2011.02680.x; Swofford DL, 2012, PAUP PHYLOGENETIC AN; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Welch JJ, 2005, TRENDS ECOL EVOL, V20, P320, DOI 10.1016/j.tree.2005.02.007; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhao YP, 2013, MOL PHYLOGENET EVOL, V68, P300, DOI 10.1016/j.ympev.2013.03.025; Zheng YC, 2011, MOL BIOL EVOL, V28, P2521, DOI 10.1093/molbev/msr072; Zuckerkandl E, 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	56	40	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148228	10.1371/journal.pone.0148228	http://dx.doi.org/10.1371/journal.pone.0148228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824760	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600111
J	Spagnol, G; Kieken, F; Kopanic, JL; Li, HJ; Zach, S; Stauch, KL; Grosely, R; Sorgen, PL				Spagnol, Gaelle; Kieken, Fabien; Kopanic, Jennifer L.; Li, Hanjun; Zach, Sydney; Stauch, Kelly L.; Grosely, Rosslyn; Sorgen, Paul L.			Structural Studies of the Nedd4 WW Domains and Their Selectivity for the Connexin43 (Cx43) Carboxyl Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; SECONDARY STRUCTURE ANALYSES; CIRCULAR-DICHROISM; INTERCELLULAR COMMUNICATION; KINETIC-ANALYSIS; C-SRC; PHOSPHORYLATION; INTERNALIZATION; UBIQUITIN; DEGRADATION	Neuronal precursor cell-expressed developmentally downregulated 4 (Nedd4) was the first ubiquitin protein ligase identified to interact with connexin43 (Cx43), and its suppressed expression results in accumulation of gap junction plaques at the plasma membrane. Nedd4-mediated ubiquitination of Cx43 is required to recruit Eps15 and target Cx43 to the endocytic pathway. Although the Cx43 residues that undergo ubiquitination are still unknown, in this study we address other unresolved questions pertaining to the molecular mechanisms mediating the direct interaction between Nedd4 (WW1-3 domains) and Cx43 (carboxyl terminus (CT)). All three WW domains display a similar three antiparallel beta-strand structure and interact with the same Cx43CT (PPXY286)-P-283 sequence. Although Tyr(286) is essential for the interaction, MAPK phosphorylation of the preceding serine residues (Ser(P)(279) and Ser(P)(282)) increases the binding affinity by 2-fold for the WW domains (WW2 > WW3 >> WW1). The structure of the WW2.Cx43CT(276-289)(Ser(P)(279), Ser(P)(282)) complex reveals that coordination of Ser(P)(282) with the end of beta-strand 3 enables Ser(P)(279) to interact with the back face of beta-strand 3 (Tyr(286) is on the front face) and loop 2, forming a horseshoe-shaped arrangement. The close sequence identity of WW2 with WW1 and WW3 residues that interact with the Cx43CT PPXY motif and Ser(P)(279)/Ser(P)(282) strongly suggests that the significantly lower binding affinity of WW1 is the result of a more rigid structure. This study presents the first structure illustrating how phosphorylation of the Cx43CT domain helps mediate the interaction with a molecular partner involved in gap junction regulation.	[Spagnol, Gaelle; Kieken, Fabien; Kopanic, Jennifer L.; Li, Hanjun; Zach, Sydney; Stauch, Kelly L.; Grosely, Rosslyn; Sorgen, Paul L.] Univ Nebraska Med Ctr, Omaha, NE 68105 USA	University of Nebraska System; University of Nebraska Medical Center	Sorgen, PL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68105 USA.	psorgen@unmc.edu		Spagnol, Gaelle/0000-0002-3201-4840	National Institutes of Health [GM072631, P30CA036727]; American Heart Association [0560050Z]; Nebraska Research Initiative; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Nebraska Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM072631 and P30CA036727, American Heart Association Grant 0560050Z, and the Nebraska Research Initiative funding for the Nebraska Center for Structural Biology. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; AUER HE, 1973, J AM CHEM SOC, V95, P3003, DOI 10.1021/ja00790a046; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bouvier D, 2008, CELL COMMUN ADHES, V15, P107, DOI 10.1080/15419060802014347; Bouvier D, 2009, J BIOL CHEM, V284, P34257, DOI 10.1074/jbc.M109.039594; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Catarino S, 2011, BIOCHEM J, V437, P255, DOI 10.1042/BJ20102059; Cochrane K, 2013, CELL COMMUN ADHES, V20, P53, DOI 10.3109/15419061.2013.784745; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Falk MM, 2012, J MEMBRANE BIOL, V245, P465, DOI 10.1007/s00232-012-9464-0; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Fischer MWF, 1998, P NATL ACAD SCI USA, V95, P8016, DOI 10.1073/pnas.95.14.8016; Fong JT, 2012, AUTOPHAGY, V8, P794, DOI 10.4161/auto.19390; GHOSHROY S, 1995, J MEMBRANE BIOL, V146, P15; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Grosely R, 2013, J BIOL CHEM, V288, P24857, DOI 10.1074/jbc.M113.454389; Gumpert AM, 2008, FEBS LETT, V582, P2887, DOI 10.1016/j.febslet.2008.07.024; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Hirst-Jensen BJ, 2007, J BIOL CHEM, V282, P5801, DOI 10.1074/jbc.M605233200; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jager M, 2009, PROTEIN SCI, V18, P1806, DOI 10.1002/pro.172; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnstone SR, 2012, CIRC RES, V111, P201, DOI 10.1161/CIRCRESAHA.112.272302; Jordan K, 2001, J CELL SCI, V114, P763; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kieken F, 2010, J BIOMOL NMR, V46, P245, DOI 10.1007/s10858-010-9397-9; Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005; Kopanic JL, 2015, BIOCHEM J, V466, P571, DOI 10.1042/BJ20141042; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Martins-Marques T, 2015, BIOCHIMIE, V112, P196, DOI 10.1016/j.biochi.2015.02.020; Martins-Marques T, 2015, BIOCHEM J, V467, P231, DOI 10.1042/BJ20141370; Moreno AP, 2002, CIRC RES, V90, P450, DOI 10.1161/hh0402.105667; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Myszka DG, 1997, BIOPHYS CHEM, V64, P127, DOI 10.1016/S0301-4622(96)02230-2; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Nimlamool W, 2015, MOL BIOL CELL, V26, P2755, DOI 10.1091/mbc.E14-06-1105; Oshima A, 2014, FEBS LETT, V588, P1230, DOI 10.1016/j.febslet.2014.01.042; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Salah Z, 2012, FRONT BIOSCI-LANDMRK, V17, P331, DOI 10.2741/3930; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Smith TD, 2012, J MEMBRANE BIOL, V245, P221, DOI 10.1007/s00232-012-9443-5; Smyth JW, 2014, TRAFFIC, V15, P684, DOI 10.1111/tra.12169; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Thevenin AF, 2013, PHYSIOLOGY, V28, P93, DOI 10.1152/physiol.00038.2012; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	68	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7637	7650		10.1074/jbc.M115.701417	http://dx.doi.org/10.1074/jbc.M115.701417			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26841867	hybrid, Green Published			2022-12-26	WOS:000383447600035
J	Contreras, M; Riveros, ME; Quispe, M; Sanchez, C; Perdomo, G; Torrealba, F; Valdes, JL				Contreras, Marco; Riveros, Maria E.; Quispe, Maricel; Sanchez, Cristian; Perdomo, Guayec; Torrealba, Fernando; Valdes, Jose L.			The Histaminergic Tuberomamillary Nucleus Is Involved in Appetite for Sex, Water and Amphetamine	PLOS ONE			English	Article							TUBEROMAMMILLARY NUCLEUS; HYPOTHALAMIC NEURONS; HISTIDINE-DECARBOXYLASE; NERVOUS-SYSTEM; MECHANISMS; BEHAVIOR; MICE; H-1; RESPONSES; INSIGHTS	The histaminergic system is one component of the ascending arousal system which is involved in wakefulness, neuroendocrine control, cognition, psychiatric disorders and motivation. During the appetitive phase of motivated behaviors the arousal state rises to an optimal level, thus giving proper intensity to the behavior. Previous studies have demonstrated that the histaminergic neurons show an earlier activation during the appetitive phase of feeding, compared to other ascending arousal system nuclei, paralleled with a high increase in arousal state. Lesions restricted to the histaminergic neurons in rats reduced their motivation to get food even after 24h of food deprivation, compared with intact or sham lesioned rats. Taken together, these findings indicate that the histaminergic system is important for appetitive behavior related to feeding. However, its role in other goal-directed behaviors remains unexplored. In the present work, male rats rendered motivated to obtain water, sex, or amphetamine showed an increase in Fos-ir of histaminergic neurons in appetitive behaviors directed to get those reinforcers. However, during appetitive tests to obtain sex, or drug in amphetamine-conditioned rats, Fos expression increased in most other ascending arousal system nuclei, including the orexin neurons in the lateral hypothalamus, dorsal raphe, locus coeruleus and laterodorsal tegmental neurons, but not in the ventral tegmental area, which showed no Fos-ir increase in any of the 3 conditions. Importantly, all these appetitive behaviors were drastically reduced after histaminergic cell-specific lesion, suggesting a critical contribution of histamine on the intensity component of several appetitive behaviors.	[Contreras, Marco; Riveros, Maria E.; Quispe, Maricel; Perdomo, Guayec; Torrealba, Fernando] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ciencias Fisiol, Alameda 340, Santiago, Chile; [Sanchez, Cristian; Valdes, Jose L.] Univ Chile, Fac Med, Programa Disciplinario Fisiol & Biofis, BNI,Biomedical Neurosci Inst,ICBM, Independencia 1027, Santiago 7, Chile; [Riveros, Maria E.] Clin Alemana Univ Desarrollo, Fac Med, Ctr Fisiol Celular Integrat, Santiago, Chile; [Valdes, Jose L.] Univ Chile, Fac Med, ICBM, Programa Disciplinario Fisiol & Biofis, Independencia 1027, Santiago 7, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad del Desarrollo; Universidad de Chile	Valdes, JL (corresponding author), Univ Chile, Fac Med, Programa Disciplinario Fisiol & Biofis, BNI,Biomedical Neurosci Inst,ICBM, Independencia 1027, Santiago 7, Chile.; Valdes, JL (corresponding author), Univ Chile, Fac Med, ICBM, Programa Disciplinario Fisiol & Biofis, Independencia 1027, Santiago 7, Chile.	jlvaldes@med.uchile.cl		Perdomo Martin, Guayec/0000-0001-7783-9160; Valdes, Jose L/0000-0002-9178-2743; riveros, maria/0000-0002-0926-8535	Fondecyt [1130042]; Programa de Investigacion Asociativa, Anillos [ACT_66]; Iniciativa Cientifica Milenio, Ministerio de Economia [ICM-P10-063-F, ICM-P10-001-F]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Investigacion Asociativa, Anillos; Iniciativa Cientifica Milenio, Ministerio de Economia	This work was supported by: Fondecyt grant number 1130042, http://www.conicyt.cl/fondecyt/ (FT); Programa de Investigacion Asociativa, Anillos grant number ACT_66 (JLV, FT), http://www.conicyt.cl/pia/; Iniciativa Cientifica Milenio, Ministerio de Economia, grant number ICM-P10-063-F & ICM-P10-001-F, http://www.iniciativamilenio.cl/ (FT & JLV respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston-Jones G, 2000, PROG BRAIN RES, V126, P165; ASTONJONES G, 1986, SCIENCE, V234, P734, DOI 10.1126/science.3775363; Ball GF, 2008, HORM BEHAV, V53, P307, DOI 10.1016/j.yhbeh.2007.09.023; Berlucchi G, 1997, ARCH ITAL BIOL, V135, P5; Brabant C, 2010, PROG NEUROBIOL, V92, P421, DOI 10.1016/j.pneurobio.2010.07.002; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; Craig W, 1917, P NATL ACAD SCI USA, V3, P685, DOI 10.1073/pnas.3.12.685; Dere E, 2004, REV NEUROSCIENCE, V15, P231; DONOSO AO, 1979, PSYCHOPHARMACOLOGY, V66, P251, DOI 10.1007/BF00428315; DUFORT RH, 1966, PSYCHOL REP, V18, P148, DOI 10.2466/pr0.1966.18.1.148; Dupre C, 2010, P NATL ACAD SCI USA, V107, P12311, DOI 10.1073/pnas.1006049107; Gerashchenko D, 2004, SLEEP, V27, P1275, DOI 10.1093/sleep/27.7.1275; HEBB DO, 1955, PSYCHOL REV, V62, P243, DOI 10.1037/h0041823; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; Inzunza O, 2000, NEUROSCI LETT, V293, P139, DOI 10.1016/S0304-3940(00)01516-0; LEIBOWITZ SF, 1973, BRAIN RES, V63, P440; LEPETIT P, 1988, NEUROENDOCRINOLOGY, V48, P271, DOI 10.1159/000125022; Valdes JL, 2010, EUR J NEUROSCI, V31, P2073, DOI 10.1111/j.1460-9568.2010.07241.x; Magrani J, 2005, PHYSIOL BEHAV, V84, P233, DOI 10.1016/j.physbeh.2004.11.010; Magrani J, 2004, PHARMACOL BIOCHEM BE, V79, P189, DOI 10.1016/j.pbb.2004.07.004; Mahia J, 2006, EUR J NEUROSCI, V23, P1321, DOI 10.1111/j.1460-9568.2006.04644.x; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Nielsen BL, 2013, PHYSIOL BEHAV, V120, P150, DOI 10.1016/j.physbeh.2013.07.012; Orihuela PA, 1999, BIOL REPROD, V60, P908, DOI 10.1095/biolreprod60.4.908; Panula P, 2011, J PHARMACOL EXP THER, V336, P9, DOI 10.1124/jpet.110.170928; Parmentier R, 2002, J NEUROSCI, V22, P7695; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pfaff D, 2008, ANN NY ACAD SCI, V1129, P11, DOI 10.1196/annals.1417.019; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Robbins Trevor W., 1995, P703; Rowland NE, 1998, NEUROSCI BIOBEHAV R, V23, P49, DOI 10.1016/S0149-7634(97)00068-7; SENBA E, 1985, J NEUROSCI, V5, P3393; Sherrington C.S., 1906, INTEGRATIVE ACTION N, Vfirst, DOI 10.1037/13798-000; Toth LA, 2000, CONTEMP TOP LAB ANIM, V39, P9; Valdes JL, 2005, EUR J NEUROSCI, V21, P1931, DOI 10.1111/j.1460-9568.2005.04013.x; Zhou J, 2007, J NEUROPHYSIOL, V98, P3143, DOI 10.1152/jn.00337.2007	36	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148484	10.1371/journal.pone.0148484	http://dx.doi.org/10.1371/journal.pone.0148484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845170	Green Published, gold			2022-12-26	WOS:000369552800063
J	Morgenstern, M; Erichsen, C; Hackl, S; Mily, J; Militz, M; Friederichs, J; Hungerer, S; Buhren, V; Moriarty, TF; Post, V; Richards, RG; Kates, SL				Morgenstern, Mario; Erichsen, Christoph; Hackl, Simon; Mily, Julia; Militz, Matthias; Friederichs, Jan; Hungerer, Sven; Buehren, Volker; Moriarty, T. Fintan; Post, Virginia; Richards, R. Geoff; Kates, Stephen L.			Antibiotic Resistance of Commensal Staphylococcus aureus and Coagulase-Negative Staphylococci in an International Cohort of Surgeons: A Prospective Point-Prevalence Study	PLOS ONE			English	Article							HEALTH-CARE WORKERS; CASSETTE CHROMOSOME MEC; NASAL CARRIAGE; UNITED-STATES; ANTIMICROBIAL SUSCEPTIBILITY; COLONIZATION; MRSA; EPIDEMIOLOGY; INFECTION; MICROBIOLOGY	Nasal colonization with antibiotic resistant bacteria represents both a risk factor for the colonized individual and their immediate contacts. Despite the fact that healthcare workers such as orthopedic surgeons are at a critical interface between the healthcare environment and an at-risk patient population, the prevalence of antibiotic resistant bacteria within the surgical profession remains unclear. This study offers a snapshot of the rate of nasal colonization of orthopedic surgeons with multi-resistant staphylococci including methicillin-resistant S. aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MRCoNS). We performed a prospective, observational study obtained at a single time point in late 2013. The participants were active orthopedic, spine and head & neck surgeons from 75 countries. The prevalence of nasal carriage of the different bacteria and the corresponding 95% confidence interval were calculated. From a cohort of 1,166 surgeons, we found an average S. aureus nasal colonization rate of 28.0% (CI 25.4; 30.6) and MRSA rate of 2.0% (CI 1.3; 2.9), although significant regional variations were observed. The highest rates of MRSA colonization were found in Asia (6.1%), Africa (5.1%) and Central America (4.8%). There was no MRSA carriage detected within our population of 79 surgeons working in North America, and a low (0.6%) MRSA rate in 657 surgeons working in Europe. High rates of MRCoNS nasal carriage were also observed (21.4% overall), with a similar geographic distribution. Recent use of systemic antibiotics was associated with higher rates of carriage of resistant staphylococci. In conclusion, orthopedic surgeons are colonized by S. aureus and MRSA at broadly equivalent rates to the general population. Crucially, geographic differences were observed, which may be partially accounted for by varying antimicrobial stewardship practices between the regions. The elevated rates of resistance within the coagulase-negative staphylococci are of concern, due to the increasing awareness of their importance in hospital acquired and device-associated infection.	[Morgenstern, Mario; Erichsen, Christoph; Hackl, Simon; Mily, Julia; Militz, Matthias; Friederichs, Jan; Hungerer, Sven; Buehren, Volker] Trauma Ctr Murnau, Dept Trauma Surg, Murnau, Germany; [Morgenstern, Mario; Erichsen, Christoph; Hackl, Simon; Moriarty, T. Fintan; Post, Virginia; Richards, R. Geoff] AO Res Inst, Davos, Switzerland; [Kates, Stephen L.] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA; [Hungerer, Sven] Paracelsus Med Univ, Salzburg, Austria	Virginia Commonwealth University; Paracelsus Private Medical University	Morgenstern, M (corresponding author), Trauma Ctr Murnau, Dept Trauma Surg, Murnau, Germany.	morgenstern.mario@gmail.com	Hungerer, med Sven/T-7329-2019; Morgenstern, Mario/L-8153-2019; Morgenstern, Mario/AAL-8268-2020; Richards, Robert G/I-8235-2015	Morgenstern, Mario/0000-0001-5108-0731; Richards, Robert G/0000-0002-7778-2480; Moriarty, Fintan/0000-0003-2307-0397	AO Trauma, AO Foundation, Davos Switzerland	AO Trauma, AO Foundation, Davos Switzerland	This project was funded by AO Trauma, AO Foundation, Davos Switzerland, https://aotrauma.aofoundation.org (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; ALY R, 1970, APPL MICROBIOL, V20, P240, DOI 10.1128/AEM.20.2.240-244.1970; ARMSTRONGESTHER CA, 1976, ANN HUM BIOL, V3, P221, DOI 10.1080/03014467600001381; Askarian M, 2009, INT J INFECT DIS, V13, pE241, DOI 10.1016/j.ijid.2008.11.026; Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483; Berglund C, 2008, CLIN MICROBIOL INFEC, V14, P1048, DOI 10.1111/j.1469-0691.2008.02090.x; Blok HEM, 2003, INFECT CONT HOSP EP, V24, P679, DOI 10.1086/502275; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Brady RRW, 2009, EUR J CLIN MICROBIOL, V28, P991, DOI 10.1007/s10096-009-0718-4; Brown DFJ, 2016, J ANTIMICROB CHEMOTH, V71, P3, DOI 10.1093/jac/dkv287; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; CDC, 2013, ANTIBIOTIC RESISTANC; Cespedes C, 2002, J CLIN MICROBIOL, V40, P2594, DOI 10.1128/JCM.40.7.2594-2597.2002; Cole AM, 2001, CLIN DIAGN LAB IMMUN, V8, P1064, DOI 10.1128/CDLI.8.6.1064-1069.2001; Conceicao T, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.010; Conceicao T, 2014, MICROB DRUG RESIST, V20, P57, DOI 10.1089/mdr.2013.0136; Cox RA, 1997, J HOSP INFECT, V35, P117, DOI 10.1016/S0195-6701(97)90100-6; Dalstrom DJ, 2008, J BONE JOINT SURG AM, V90A, P1022, DOI 10.2106/JBJS.G.00689; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Danzmann L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-98; Dawson SJ, 1997, J HOSP INFECT, V37, P75, DOI 10.1016/S0195-6701(97)90078-5; De Sousa MA, 2000, MICROB DRUG RESIST, V6, P133, DOI 10.1089/107662900419447; Diekema D, 2001, CLIN INFECT DIS   S2, V32, P114; EUCAST The European Committee on Antimicrobial Susceptibility Testing, 2021, BREAKP TABL INT MICS; European Centre for Disease Prevention and Control, 2013, ANN REP EUR ANT RES; Gamblin J, 2013, J MED MICROBIOL, V62, P437, DOI 10.1099/jmm.0.051854-0; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Haddadin AS, 2002, POSTGRAD MED J, V78, P385, DOI 10.1136/pmj.78.921.385; Hanssen AM, 2004, ANTIMICROB AGENTS CH, V48, P285, DOI 10.1128/AAC.48.1.285-296.2004; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hawkins G, 2011, J HOSP INFECT, V77, P285, DOI 10.1016/j.jhin.2010.09.038; Iyer A, 2014, J INFECT DEV COUNTR, V8, P372, DOI 10.3855/jidc.3589; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Johnston CP, 2007, INFECT CONT HOSP EP, V28, P1404, DOI 10.1086/523865; Kalenic S, 2010, INT J INFECT CONTROL, V6, P1, DOI [10.3396/ijic.v6i2.5138, DOI 10.3396/IJIC.V6I2.5138]; Kateete David P, 2011, BMC Res Notes, V4, P326, DOI 10.1186/1756-0500-4-326; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mihailescu R, 2014, ANTIMICROB AGENTS CH, V58, P2547, DOI 10.1128/AAC.02420-12; MULLIGAN ME, 1993, AM J MED, V94, P313, DOI 10.1016/0002-9343(93)90063-U; NOBLE WC, 1967, J HYG-CAMB, V65, P567, DOI 10.1017/S002217240004609X; NOBLE WC, 1964, J CLIN PATHOL, V17, P79, DOI 10.1136/jcp.17.1.79; NOBLE WC, 1974, ACTA DERM-VENEREOL, V54, P403; Nulens E, 2005, EUR J CLIN MICROBIOL, V24, P145, DOI 10.1007/s10096-004-1258-6; Olsen K, 2013, EPIDEMIOL INFECT, V141, P143, DOI 10.1017/S0950268812000465; Parnaby RM, 1996, J HOSP INFECT, V33, P201, DOI 10.1016/S0195-6701(96)90003-1; Schwarzkopf R, 2010, J BONE JOINT SURG AM, V92A, P1815, DOI 10.2106/JBJS.I.00991; Solberg CO, 2000, SCAND J INFECT DIS, V32, P587, DOI 10.1080/003655400459478; Tacconelli E, 2008, J ANTIMICROB CHEMOTH, V61, P26, DOI 10.1093/jac/dkm416; Tenover FC, 2008, J CLIN MICROBIOL, V46, P2837, DOI 10.1128/JCM.00480-08; Treesirichod A, 2013, J INFECT PUBLIC HEAL, V6, P196, DOI 10.1016/j.jiph.2012.12.004; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; von Eiff C, 2001, POSTGRAD MED, V110, P63, DOI 10.3810/pgm.2001.10.1046; Vonberg RP, 2006, INFECT CONT HOSP EP, V27, P1123, DOI 10.1086/507922; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111627; WENZEL RP, 1995, J HOSP INFECT, V31, P13, DOI 10.1016/0195-6701(95)90079-9; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Wertheim HFL, 2004, ANN INTERN MED, V140, P419, DOI 10.7326/0003-4819-140-6-200403160-00007; WHO-World Health Organization, 2014, ANTIMICROBIAL RESIST; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Zinn CS, 2004, MICROB DRUG RESIST, V10, P160, DOI 10.1089/1076629041310055	67	49	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148437	10.1371/journal.pone.0148437	http://dx.doi.org/10.1371/journal.pone.0148437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840492	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200136
J	Salazar, RD; Montgomery, RA; Thresher, SE; Macdonald, DW				Salazar, Rosie D.; Montgomery, Robert A.; Thresher, Sarah E.; Macdonald, David W.			Mapping the Relative Probability of Common Toad Occurrence in Terrestrial Lowland Farm Habitat in the United Kingdom	PLOS ONE			English	Article							RESOURCE SELECTION FUNCTIONS; BUFO-BUFO; BODY CONDITION; LANDSCAPE CHARACTERISTICS; AMPHIBIAN POPULATIONS; GENETIC DIVERSITY; HIBERNATION SITES; SPECIES RICHNESS; ANAXYRUS-BOREAS; POND OCCUPANCY	Introduction The common toad (Bufo bufo) is of increasing conservation concern in the United Kingdom (UK) due to dramatic population declines occurring in the past century. Many of these population declines coincided with reductions in both terrestrial and aquatic habitat availability and quality and have been primarily attributed to the effect of agricultural land conversion (of natural and semi-natural habitats to arable and pasture fields) and pond drainage. However, there is little evidence available to link habitat availability with common toad population declines, especially when examined at a broad landscape scale. Assessing such patterns of population declines at the landscape scale, for instance, require an understanding of how this species uses terrestrial habitat. Methods We intensively studied the terrestrial resource selection of a large population of common toads in Oxfordshire, England, UK. Adult common toads were fitted with passive integrated transponder (PIT) tags to allow detection in the terrestrial environment using a portable PIT antenna once toads left the pond and before going into hibernation (April/May-October 2012 and 2013). We developed a population-level resource selection function (RSF) to assess the relative probability of toad occurrence in the terrestrial environment by collecting location data for 90 recaptured toads. Results The predicted relative probability of toad occurrence for this population was greatest in wooded habitat near to water bodies; relative probability of occurrence declined dramatically >50 m from these habitats. Toads also tended to select habitat near to their breeding pond and toad occurrence was negatively related to urban environments.	[Salazar, Rosie D.; Montgomery, Robert A.; Thresher, Sarah E.; Macdonald, David W.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit WildCRU, Tubney House,Abingdon Rd, Tubney OX13 5QL, Oxon, England; [Montgomery, Robert A.] Michigan State Univ, Dept Fisheries & Wildlife, 480 Wilson Rd,Room 13,Nat Resources Bldg, E Lansing, MI 48824 USA	University of Oxford; Michigan State University	Salazar, RD (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit WildCRU, Tubney House,Abingdon Rd, Tubney OX13 5QL, Oxon, England.	rosie.salazar@zoo.ox.ac.uk	Montgomery, Robert A./C-5541-2019	Montgomery, Robert A./0000-0001-5894-0589	Patsy Wood Trust	Patsy Wood Trust	RDS received funding for tuition fees, stipend, employment costs, and college fees from Ms. Sarianne Durie (individual donor). Operational costs for fieldwork were met by the Patsy Wood Trust (www.patsywoodtrust.com). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews Kimberly M., 2008, P121; Atauri JA, 2001, LANDSCAPE ECOL, V16, P147, DOI 10.1023/A:1011115921050; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Baker J., 2011, AMPHIBIAN HABITAT MA; Bancila RI, 2010, AMPHIBIA-REPTILIA, V31, P558, DOI 10.1163/017353710X518405; BEEBEE TJC, 1981, BIOL CONSERV, V21, P127, DOI 10.1016/0006-3207(81)90075-6; Beebee TJC., 1985, FROGS TOADS; Beebee TJC, 2014, J HERPETOL, V48, P2, DOI 10.1670/12-263; Blaxter K., 1995, DEARTH PLENTY MODERN; Bonardi A, 2011, BIOL CONSERV, V144, P2328, DOI 10.1016/j.biocon.2011.06.011; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Brown LJ, 1997, J HERPETOL, V31, P410, DOI 10.2307/1565670; Browne CL, 2010, HERPETOL CONSERV BIO, V5, P49; Browne CL, 2010, HERPETOLOGICA, V66, P250, DOI 10.1655/08-071.1; Carrier JA, 2003, BIOL CONSERV, V111, P395, DOI 10.1016/S0006-3207(02)00308-7; Connette GM, 2012, WILDLIFE RES, V39, P1, DOI 10.1071/WR11055; Cucherousset J, 2005, N AM J FISH MANAGE, V25, P270, DOI 10.1577/M04-053.1; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Daversa DR, 2012, J HERPETOL, V46, P658, DOI 10.1670/11-012; Denton Jonathan S., 1992, Amphibia-Reptilia, V13, P365, DOI 10.1163/156853892X00067; DENTON JS, 1994, OECOLOGIA, V97, P390, DOI 10.1007/BF00317330; Dzialak MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026273; Elzanowski A, 2009, EUR J WILDLIFE RES, V55, P33, DOI 10.1007/s10344-008-0211-x; Findlay CS, 1997, CONSERV BIOL, V11, P1000, DOI 10.1046/j.1523-1739.1997.96144.x; Gervasi V, 2013, ECOL APPL, V23, P1722, DOI 10.1890/12-1615.1; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hartel T, 2008, APPL HERPETOL, V5, P1, DOI 10.1163/157075408783489248; Hebblewhite M, 2011, BIOL CONSERV, V144, P2403, DOI 10.1016/j.biocon.2011.03.020; HEUSSER H, 1969, Revue Suisse de Zoologie, V76, P443; HEUSSER H, 1968, Revue Suisse de Zoologie, V75, P927; Heusser H., 1958, Behaviour, V13, P208; Hitchings SP, 1998, J EVOLUTION BIOL, V11, P269, DOI 10.1046/j.1420-9101.1998.11030269.x; Hof AR, 2010, AGR ECOSYST ENVIRON, V139, P280, DOI 10.1016/j.agee.2010.08.014; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Houlahan JE, 2004, LANDSCAPE ECOL, V19, P677, DOI 10.1023/B:LAND.0000042912.87067.35; Indermaur L, 2009, ECOLOGY, V90, P3430, DOI 10.1890/08-0886.1; Janin A, 2011, BIOL CONSERV, V144, P1008, DOI 10.1016/j.biocon.2010.12.009; Janin A, 2009, J APPL ECOL, V46, P833, DOI 10.1111/j.1365-2664.2009.01665.x; Jehle R, 1998, HERPETOL J, V8, P181; Kovar R, 2009, AMPHIBIA-REPTILIA, V30, P367, DOI 10.1163/156853809788795236; Latham DM, 1997, TERRESTRIAL HABITAT; Long RA, 2009, WILDLIFE BIOL, V15, P288, DOI 10.2981/09-003; Macdonald D.W., 2000, P357; Madison DM, 2010, AMPHIBIAN ECOLOGY CO; Manly BF, 1992, RESOURCE SELECTION A; Marczak LB, 2010, ECOL APPL, V20, P126, DOI 10.1890/08-2064.1; Mazerolle MJ, 2005, ECOL APPL, V15, P824, DOI 10.1890/04-0502; Meatherby A., 2010, 707 NERC CTR EC HYDR; Millspaugh JJ, POPULATION IN PRESS; Muths E, 2014, BIOL CONSERV, V172, P200, DOI 10.1016/j.biocon.2014.02.034; Piha H, 2007, ECOL APPL, V17, P2298, DOI 10.1890/06-1509.1; Pyke Graham H., 2005, Herpetological Review, V36, P281; READING CJ, 1991, J ZOOL, V225, P201, DOI 10.1111/j.1469-7998.1991.tb03811.x; Romero J, 1996, ECOGRAPHY, V19, P305, DOI 10.1111/j.1600-0587.1996.tb01258.x; Salazar RD, 2014, DISTRIBUTION DISPERS; Scribner KT, 2001, BIOL CONSERV, V98, P201, DOI 10.1016/S0006-3207(00)00155-5; SINSCH U, 1988, OECOLOGIA, V76, P390, DOI 10.1007/BF00377034; Smith MA, 2005, ECOGRAPHY, V28, P110; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sztatecsny M, 2005, CAN J ZOOL, V83, P788, DOI [10.1139/Z05-071, 10.1139/z05-071]; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Zanini F, 2008, CAN J ZOOL, V86, P692, DOI 10.1139/Z08-048	67	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148269	10.1371/journal.pone.0148269	http://dx.doi.org/10.1371/journal.pone.0148269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841108	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200115
J	Anderwald, P; Haller, RM; Filli, F				Anderwald, Pia; Haller, Rudolf M.; Filli, Flurin			Heterogeneity in Primary Productivity Influences Competitive Interactions between Red Deer and Alpine Chamois	PLOS ONE			English	Article							CAPREOLUS-CAPREOLUS DEER; HORN GROWTH; CERVUS-ELAPHUS; HABITAT; POPULATION; VEGETATION; MIGRATION; COEXISTENCE; DENSITIES; RESPONSES	Habitat heterogeneity can promote coexistence between herbivores of different body size limited to different extents by resource quantity and quality. Red deer (Cervus elaphus) are known as superior competitors to smaller species with similar diets. We compared competitive interactions and habitat use between red deer and Alpine chamois (Rupicapra rupicapra) in two adjacent valleys in a strictly protected area in the Central Alps. Red deer density was higher in the valley with higher primary productivity. Only here was horn growth in kid and yearling chamois (as a measure for body condition) negatively correlated with red deer population size, suggesting interspecific competition, and chamois selected meadows with steeper slopes and lower productivity than available on average. Conversely, red deer selected meadows of high productivity, particularly in the poorer area. As these were located mainly at lower elevations, this led to strong altitudinal segregation between the two species here. Local differences in interspecific competition thus coincided with differences in habitat preference and-segregation between areas. This suggests that spatial habitat and resource heterogeneity at the scale of adjacent valleys can provide competition refuges for competitively inferior mountain ungulates which differ from their superior competitor in their metabolic requirements.	[Anderwald, Pia; Haller, Rudolf M.; Filli, Flurin] Chaste Planta Wildenberg, Swiss Natl Pk, CH-7530 Zernez, Switzerland		Anderwald, P (corresponding author), Chaste Planta Wildenberg, Swiss Natl Pk, CH-7530 Zernez, Switzerland.	pia.anderwald@nationalpark.ch						Anderwald P, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00365.1; Begon M., 1996, ECOLOGY; BELOVSKY GE, 1986, AM ZOOL, V26, P51; Bertolino S, 2009, J ZOOL, V277, P63, DOI 10.1111/j.1469-7998.2008.00512.x; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Chander G, 2009, REMOTE SENS ENVIRON, V113, P893, DOI 10.1016/j.rse.2009.01.007; Chirichella R, 2013, EVOL ECOL, V27, P145, DOI 10.1007/s10682-012-9583-1; Cook RC, 2013, WILDLIFE MONOGR, V184, DOI 10.1002/wmon.1008; Cote SD, 2001, OECOLOGIA, V127, P230, DOI 10.1007/s004420000584; Cote SD, 1998, J MAMMAL, V79, P406, DOI 10.2307/1382971; Danilkin A, 1995, BEHAV ECOLOGY SIBERI; Darmon G, 2012, ECOGRAPHY, V35, P44, DOI 10.1111/j.1600-0587.2011.06664.x; DEBOER WF, 1990, OECOLOGIA, V82, P264, DOI 10.1007/BF00323544; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Ferretti F, 2015, BEHAV ECOL, V26, P550, DOI 10.1093/beheco/aru226; Festa-Bianchet M, 2004, BEHAV ECOL, V15, P305, DOI 10.1093/beheco/arh014; Frank Douglas A., 2006, Conservation Biology Series (Cambridge), V11, P326; Giacometti M, 2002, J MAMMAL, V83, P245, DOI 10.1644/1545-1542(2002)083<0245:ATISAH>2.0.CO;2; Gordon IJ, 1988, FUNCT ECOL, V2, P15, DOI 10.2307/2389455; GORDON IJ, 1989, OECOLOGIA, V79, P383, DOI 10.1007/BF00384318; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Haller Ruedi, 2006, Nationalpark-Forschung in der Schweiz, V93, P45; Herfindal I, 2006, J ANIM ECOL, V75, P1110, DOI 10.1111/j.1365-2656.2006.01138.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hobbs N. T., 2010, DYNAMICS LARGE HERBI, P141; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Jenny H., 2014, NATIONALPARK FORSCHU, P235; Jorgenson JT, 1998, J WILDLIFE MANAGE, V62, P1011, DOI 10.2307/3802554; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Latham J, 1997, J ZOOL, V242, P681, DOI 10.1111/j.1469-7998.1997.tb05820.x; Latham J, 1996, J ZOOL, V240, P285, DOI 10.1111/j.1469-7998.1996.tb05285.x; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; Lone K, 2015, ANIM BEHAV, V102, P127, DOI 10.1016/j.anbehav.2015.01.012; Lovari S, 2014, ANIM CONSERV, V17, P359, DOI 10.1111/acv.12103; Macandza VA, 2012, OIKOS, V121, P891, DOI 10.1111/j.1600-0706.2012.20250.x; Mazerolle M. J., 2014, AICCMODAVG MODEL SEL; Mbora DNM, 2009, AM J PHYS ANTHROPOL, V140, P562, DOI 10.1002/ajpa.21113; MeteoSwiss, 2015, IDAWEB DAT PORT TEAC; Mysterud A, 1999, J ZOOL, V247, P479, DOI 10.1111/j.1469-7998.1999.tb01011.x; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Nagy L, 2009, BIOL ALPINE HABITATS; Nahlik Andras, 2009, Acta Silvatica & Lignaria Hungarica, V5, P109; OOSENBRUG SM, 1980, ARCTIC, V33, P59; Owen-Smith RN., 2002, ADAPTIVE HERBIVORE E, VStudent; Perez-Barberia FJ, 2001, EVOL ECOL RES, V3, P221; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; R Core Team, 2021, R LANGUAGE ENV STAT; Rammig A, 2010, BIOGEOSCIENCES, V7, P2013, DOI 10.5194/bg-7-2013-2010; Richard E, 2010, OECOLOGIA, V163, P91, DOI 10.1007/s00442-009-1538-z; Rughetti M, 2011, J ANIM ECOL, V80, P438, DOI 10.1111/j.1365-2656.2010.01773.x; Rughetti M, 2010, J WILDLIFE MANAGE, V74, P1024, DOI 10.2193/2009-335; Saether BE, 2002, ECOLOGY, V83, P3457, DOI 10.2307/3072094; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SCHIMEL D, 1985, ECOLOGY, V66, P276, DOI 10.2307/1941328; Schroder J., 1984, ACTA ZOOL FENN, V172, P85; Schweiger AK, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0033-x; Schweiger AK, 2015, J VEG SCI, V26, P175, DOI 10.1111/jvs.12214; Toigo C, 1999, J MAMMAL, V80, P1021, DOI 10.2307/1383272; Vladyshevsky D. V., 1968, Zoologicheskii Zhurnal, V47, P438; White PJ, 2010, J MAMMAL, V91, P827, DOI 10.1644/08-MAMM-A-252.1; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1; ZOLLER H, 1995, NATIONALPARK FORSCHU, V85, P1	65	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0146458	10.1371/journal.pone.0146458	http://dx.doi.org/10.1371/journal.pone.0146458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824867	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600008
J	Fosu-Nyarko, J; Nicol, P; Naz, F; Gill, R; Jones, MGK				Fosu-Nyarko, John; Nicol, Paul; Naz, Fareeha; Gill, Reetinder; Jones, Michael G. K.			Analysis of the Transcriptome of the Infective Stage of the Beet Cyst Nematode, H-schachtii	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; ESOPHAGEAL GLAND-CELLS; CELLULOSE-BINDING PROTEIN; CHORISMATE MUTASE; GLOBODERA-PALLIDA; EFFECTOR PROTEIN; FUNCTIONAL-CHARACTERIZATION; DEVELOPMENTAL EXPRESSION; DISEASE RESISTANCE; PRATYLENCHUS SPP.	The beet cyst nematode, Heterodera schachtii, is a major root pest that significantly impacts the yield of sugar beet, brassicas and related species. There has been limited molecular characterisation of this important plant pathogen: to identify target genes for its control the transcriptome of the pre-parasitic J2 stage of H. schachtii was sequenced using Roche GS FLX. Ninety seven percent of reads (i.e., 387,668) with an average PHRED score > 22 were assembled with CAP3 and CLC Genomics Workbench into 37,345 and 47,263 contigs, respectively. The transcripts were annotated by comparing with gene and genomic sequences of other nematodes and annotated proteins on public databases. The annotated transcripts were much more similar to sequences of Heterodera glycines than to those of Globodera pallida and root knot nematodes (Meloidogyne spp.). Analysis of these transcripts showed that a subset of 2,918 transcripts was common to free-living and plant parasitic nematodes suggesting that this subset is involved in general nematode metabolism and development. A set of 148 contigs and 183 singletons encoding putative homologues of effectors previously characterised for plant parasitic nematodes were also identified: these are known to be important for parasitism of host plants during migration through tissues or feeding from cells or are thought to be involved in evasion or modulation of host defences. In addition, the presence of sequences from a nematode virus is suggested. The sequencing and annotation of this transcriptome significantly adds to the genetic data available for H. schachtii, and identifies genes primed to undertake required roles in the critical pre-parasitic and early post-parasitic J2 stages. These data provide new information for identifying potential gene targets for future protection of susceptible crops against H. schachtii.	[Fosu-Nyarko, John; Nicol, Paul; Naz, Fareeha; Gill, Reetinder; Jones, Michael G. K.] Murdoch Univ, Sch Vet & Life Sci, Western Australian State Agr Biotechnol Ctr, Plant Biotechnol Res Grp, Perth, WA, Australia; [Fosu-Nyarko, John] Murdoch Univ, Western Australian State Agr Biotechnol Ctr, NemGenix Pty Ltd, Perth, WA, Australia	Murdoch University; Murdoch University	Jones, MGK (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Western Australian State Agr Biotechnol Ctr, Plant Biotechnol Res Grp, Perth, WA, Australia.	J.Fosu-Nyarko@murdoch.edu.au; M.Jones@murdoch.edu.au	Jones, Michael G.K./M-5932-2013; Fosu-Nyarko, John/E-5533-2018	Jones, Michael G.K./0000-0001-5002-0227; Fosu-Nyarko, John/0000-0002-2997-7881	Murdoch University; Australian India Strategic Research Fund Grant [BF030027]; Nemgenix Pty. Ltd.	Murdoch University; Australian India Strategic Research Fund Grant; Nemgenix Pty. Ltd.	Murdoch University provided PhD studentship for PN; RG was supported by an Australian India Strategic Research Fund Grant (BF030027); Nemgenix Pty. Ltd. contributed funds for consumables and support in the form of salaries for JFN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the "author contributions" section.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; ABAWI GS, 1980, PHYTOPATHOLOGY, V70, P481, DOI 10.1094/Phyto-70-481; Adam MAM, 2008, PHYSIOL MOL PLANT P, V72, P21, DOI 10.1016/j.pmpp.2008.05.002; Ali S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115042; Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Behm CA, 1997, INT J PARASITOL, V27, P215, DOI 10.1016/S0020-7519(96)00151-8; Bekal S, 2003, MOL PLANT MICROBE IN, V16, P439, DOI 10.1094/MPMI.2003.16.5.439; Bekal S, 2011, J GEN VIROL, V92, P1870, DOI 10.1099/vir.0.030585-0; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; Burke M, 2015, NEMATOLOGY, V17, P621, DOI 10.1163/15685411-00002901; Burt OR, 1996, J NEMATOL, V28, P457; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carpentier J, 2012, MOL PLANT PATHOL, V13, P546, DOI 10.1111/j.1364-3703.2011.00769.x; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; De Boer JM, 2002, MOL PLANT PATHOL, V3, P261, DOI 10.1046/j.1364-3703.2002.00122.x; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Eves-van den Akker S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004391; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Fosu-Nyarko J, 2016, MOL PLANT PATHOL, V17, P532, DOI 10.1111/mpp.12301; Fosu-Nyarko J, 2015, ADV BOT RES, V73, P339, DOI 10.1016/bs.abr.2014.12.012; Fuller VL, 2008, NEW PHYTOL, V180, P27, DOI 10.1111/j.1469-8137.2008.02508.x; Gao BL, 2003, MOL PLANT MICROBE IN, V16, P720, DOI 10.1094/MPMI.2003.16.8.720; Gao BL, 2002, INT J PARASITOL, V32, P1293, DOI 10.1016/S0020-7519(02)00110-8; Gao BL, 2001, MOL PLANT MICROBE IN, V14, P1247, DOI 10.1094/MPMI.2001.14.10.1247; Guiliano DB, 2006, PLOS GENET, V2, P1871, DOI 10.1371/journal.pgen.0020198; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamamouch N, 2012, J EXP BOT, V63, P3683, DOI 10.1093/jxb/ers058; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hewezi T, 2010, PLANT PHYSIOL, V152, P968, DOI 10.1104/pp.109.150557; Hewezi T, 2008, PLANT CELL, V20, P3080, DOI 10.1105/tpc.108.063065; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacob J, 2007, GENE, V402, P9, DOI 10.1016/j.gene.2007.07.015; Jaouannet M, 2013, MOL PLANT MICROBE IN, V26, P97, DOI 10.1094/MPMI-05-12-0130-R; Jaouannet M, 2012, NEW PHYTOL, V194, P924, DOI 10.1111/j.1469-8137.2012.04164.x; Jaubert S, 2004, INT J PARASITOL, V34, P873, DOI 10.1016/j.ijpara.2004.02.008; Jaubert S, 2002, FEBS LETT, V522, P109, DOI 10.1016/S0014-5793(02)02906-X; Jones JT, 2009, MOL PLANT PATHOL, V10, P815, DOI 10.1111/j.1364-3703.2009.00585.x; Jones JT, 2004, GENE, V324, P47, DOI 10.1016/j.gene.2003.09.051; Jones JT, 2003, MOL PLANT PATHOL, V4, P43, DOI 10.1046/j.1364-3703.2003.00140.x; Jones JT, 2000, NEMATOLOGY, V2, P887, DOI 10.1163/156854100750112833; Jones MGK, 2014, ANN APPL BIOL, V164, P163, DOI 10.1111/aab.12105; JONES MGK, 1972, J CELL SCI, V10, P789; JONES MGK, 1981, ANN APPL BIOL, V97, P353, DOI 10.1111/j.1744-7348.1981.tb05122.x; JONES MGK, 1975, PHYSIOL PLANT PATHOL, V5, P119, DOI 10.1016/0048-4059(75)90015-6; Kikuchi T, 2005, BIOCHEM J, V389, P117, DOI 10.1042/BJ20042042; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kumar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096311; Lee C, 2011, PLANT PHYSIOL, V155, P866, DOI 10.1104/pp.110.167197; Lee KZ, 2003, MOL BIOL EVOL, V20, P2097, DOI 10.1093/molbev/msg225; Lozano-Torres JL, 2012, P NATL ACAD SCI USA, V109, P10119, DOI 10.1073/pnas.1202867109; Lu SW, 2008, MOL BIOCHEM PARASIT, V162, P1, DOI 10.1016/j.molbiopara.2008.06.002; Mitreva-Dautova M, 2006, MOL PLANT MICROBE IN, V19, P521, DOI 10.1094/MPMI-19-0521; Muller J, 1999, HELMINTHOLOGIA, V36, P205; Neveu C, 2003, PHYSIOL MOL PLANT P, V63, P159, DOI 10.1016/j.pmpp.2003.10.005; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Noon JB, 2015, PHYTOPATHOLOGY, V105, P1362, DOI 10.1094/PHYTO-02-15-0049-R; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Postma WJ, 2012, PLANT PHYSIOL, V160, P944, DOI 10.1104/pp.112.200188; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; Qin L, 2004, NATURE, V427, P30, DOI 10.1038/427030a; Robertson L, 2000, MOL BIOCHEM PARASIT, V111, P41, DOI 10.1016/S0166-6851(00)00295-4; Semblat JP, 2001, MOL PLANT MICROBE IN, V14, P72, DOI 10.1094/MPMI.2001.14.1.72; SIJMONS PC, 1991, PLANT J, V1, P245, DOI 10.1111/j.1365-313X.1991.00245.x; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Tan JACH, 2013, EXP PARASITOL, V133, P166, DOI 10.1016/j.exppara.2012.11.011; Thorpe P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-923; Torto-Alalibo T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S1; Vanholme B, 2006, PARASITOL RES, V98, P414, DOI 10.1007/s00436-005-0029-3; Vanholme B, 2007, MOL PLANT PATHOL, V8, P267, DOI 10.1111/J.1364-3703.2007.00392.X; Vanholme B, 2009, NEMATOLOGY, V11, P739, DOI 10.1163/156854109X404599; Wang JY, 2011, MOL PLANT PATHOL, V12, P177, DOI 10.1111/j.1364-3703.2010.00660.x; Wang XH, 2001, MOL PLANT MICROBE IN, V14, P536, DOI 10.1094/MPMI.2001.14.4.536; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x	81	17	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147511	10.1371/journal.pone.0147511	http://dx.doi.org/10.1371/journal.pone.0147511			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824923	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528600033
J	Singla, DK; Singla, R; Wang, J				Singla, Dinender K.; Singla, Reetu; Wang, Jing			BMP-7 Treatment Increases M2 Macrophage Differentiation and Reduces Inflammation and Plaque Formation in Apo E-/- Mice	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; MONOCYTE ADHESION; CELLS; ATHEROSCLEROSIS; POLARIZATION; ACTIVATION; MOUSE; MODEL; PROLIFERATION; EXPRESSION	Inflammation plays a fundamental role in the inception and development of atherosclerosis (ATH). Mechanisms of inflammation include the infiltration of monocytes into the injured area and subsequent differentiation into either pro-inflammatory M1 macrophages or anti-inflammatory M2 macrophages. We have previously published data suggesting bone morphogenetic protein-7 (BMP-7) enhances M2 macrophage differentiation and anti-inflammatory cytokine secretion in vitro. In this regard, we hypothesized BMP-7 would inhibit plaque formation in an animal model of ATH through monocytic plasticity mediation. ATH was generated in male and female Apo E-/- mice via partial left carotid artery (PLCA) ligation and mice were divided into 3 groups: Sham, PLCA, and PLCA+BMP-7 (200ug/kg; i.v.). Our data suggest that BMP-7 inhibits plaque formation and increases arterial systolic velocity. Furthermore, we report inhibition of monocyte infiltration and a decrease in associated pro-inflammatory cytokines (MCP-1, TNF-alpha, and IL-6) in the PLCA+BMP-7 mice. In contrast, our data suggest a significant (p<0.05) increase in M2 macrophage populations with consequential enhanced anti-inflammatory cytokine (IL-1RA, IL-10, and Arginase 1) expression following BMP-7 treatment. We have also observed that mechanisms promoting monocyte into M2 macrophage differentiation by BMP-7 involve the upregulation and activation of the BMP-7 receptor (BMP-7RII). In conclusion, we report that BMP-7 has the potential to mediate cellular plasticity and mitigate the inflammatory immune response, which results in decreased plaque formation and improved blood velocity.	[Singla, Dinender K.; Singla, Reetu; Wang, Jing] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Div Metab & Cardiovasc Sci,Biomol Sci Ctr, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Singla, DK (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Div Metab & Cardiovasc Sci,Biomol Sci Ctr, Orlando, FL 32816 USA.	dsingla@ucf.edu			National Institutes of Health [R01HL117241]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institutes of Health [R01HL117241 to DKS].	Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Boon MR, 2011, CYTOKINE GROWTH F R, V22, P221, DOI 10.1016/j.cytogfr.2011.08.001; Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; den Hartigh LJ, 2014, AM J PHYSIOL-HEART C, V306, pH109, DOI 10.1152/ajpheart.00137.2013; Dorai H, 2000, J CELL PHYSIOL, V184, P37, DOI 10.1002/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M; Fadini GP, 2013, ACTA DIABETOL, V50, P977, DOI 10.1007/s00592-013-0517-3; Grenon SM, 2012, J SURG RES, V177, pE35, DOI 10.1016/j.jss.2012.04.010; Guedj K, 2014, CARDIOVASC RES, V101, P434, DOI 10.1093/cvr/cvt263; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; Lee MJ, 2003, J IMMUNOL, V170, P2557, DOI 10.4049/jimmunol.170.5.2557; Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7; Mahmood DFD, 2013, J CELL PHYSIOL, V228, P1577, DOI 10.1002/jcp.24319; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Maric I, 2003, J CELL PHYSIOL, V196, P258, DOI 10.1002/jcp.10275; Merino H, 2013, MOL CELL BIOCHEM, V372, P267, DOI 10.1007/s11010-012-1468-7; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Papadopoulou C, 2008, CYTOKINE, V43, P181, DOI 10.1016/j.cyto.2008.05.009; Pendse AA, 2009, J LIPID RES, V50, pS178, DOI 10.1194/jlr.R800070-JLR200; Perron JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008198; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rocher C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084009; Rocher C, 2012, CAN J PHYSIOL PHARM, V90, P947, DOI [10.1139/Y2012-102, 10.1139/y2012-102]; Saika S, 2005, LAB INVEST, V85, P474, DOI 10.1038/labinvest.3700247; Shimizu T, 2012, BIOCHEM BIOPH RES CO, V417, P869, DOI 10.1016/j.bbrc.2011.12.064; Takahashi T, 2011, CELL TISSUE RES, V344, P321, DOI 10.1007/s00441-011-1154-1; Torroella-Kouri M, 2013, IMMUNOL RES, V57, P86, DOI 10.1007/s12026-013-8438-3; Urbina P, 2014, AM J PHYSIOL-HEART C, V307, pH762, DOI 10.1152/ajpheart.00367.2014; Zhang XL, 2005, J AM SOC NEPHROL, V16, P79, DOI 10.1681/ASN.2004050395	35	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147897	10.1371/journal.pone.0147897	http://dx.doi.org/10.1371/journal.pone.0147897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824441	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528600068
J	Frank, DJ; Zhao, Y; Wong, SH; Basudhar, D; De Voss, JJ; de Montellano, PRO				Frank, Daniel J.; Zhao, Yan; Wong, Siew Hoon; Basudhar, Debashree; De Voss, James J.; de Montellano, Paul R. Ortiz			Cholesterol Analogs with Degradation-resistant Alkyl Side Chains Are Effective Mycobacterium tuberculosis Growth Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-P450 ENZYMES; LIVER-MICROSOMES; MACROPHAGES; CYP125A1; GENES	Cholest-4-en-3-one, whether added exogenously or generated intracellularly from cholesterol, inhibits the growth of Mycobacterium tuberculosis when CYP125A1 and CYP142A1, the cytochrome P450 enzymes that initiate degradation of the sterol side chain, are disabled. Here we demonstrate that a 16-hydroxy derivative of cholesterol, which was previously reported to inhibit growth of M. tuberculosis, acts by preventing the oxidation of the sterol side chain even in the presence of the relevant cytochrome P450 enzymes. The finding that (25R)-cholest-5-en-3 beta,16 beta,26-triol (1) (and its 3-keto metabolite) inhibit growth suggests that cholesterol analogs with non-degradable side chains represent a novel class of anti-mycobacterial agents. In accord with this, two cholesterol analogs with truncated, fluorinated side chains have been synthesized and shown to similarly block the growth in culture of M. tuberculosis.	[Frank, Daniel J.; Zhao, Yan; Basudhar, Debashree; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wong, Siew Hoon; De Voss, James J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia	University of California System; University of California San Francisco; University of Queensland	de Montellano, PRO (corresponding author), 600 16th St,N576D, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu	Frank, Daniel/G-5821-2010	Frank, Daniel/0000-0003-0063-7557; Frank, Daniel/0000-0002-9774-5580	National Institutes of Health [AI074824]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074824. The authors have no conflict of interest.	Alessandrini L, 2004, STEROIDS, V69, P789, DOI 10.1016/j.steroids.2004.09.009; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; HALPERT JR, 1991, METHOD ENZYMOL, V206, P540; Johnston JB, 2012, BIOORGAN MED CHEM, V20, P4064, DOI 10.1016/j.bmc.2012.05.003; Johnston JB, 2010, J BIOL CHEM, V285, P36352, DOI 10.1074/jbc.M110.161117; Klink M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073333; Lal GS, 1999, J ORG CHEM, V64, P7048, DOI 10.1021/jo990566+; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Martin R, 2009, EUR J ORG CHEM, V2009, P3703, DOI 10.1002/ejoc.200900443; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; OMURA T, 1964, J BIOL CHEM, V239, P2379; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Sadhukhan S, 2010, J AM CHEM SOC, V132, P6309, DOI 10.1021/ja100399m; SCHENKMAN JB, 1972, BIOCHEMISTRY-US, V11, P4243, DOI 10.1021/bi00773a008; Schmidt AW, 2013, BIOORG MED CHEM LETT, V23, P6111, DOI 10.1016/j.bmcl.2013.09.013; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x	27	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7325	7333		10.1074/jbc.M115.708172	http://dx.doi.org/10.1074/jbc.M115.708172			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26833565	Green Published, hybrid			2022-12-26	WOS:000383447600010
J	Murase, R; Sato, H; Yamamoto, K; Ushida, A; Nishito, Y; Ikeda, K; Kobayashi, T; Yamamoto, T; Taketomi, Y; Murakami, M				Murase, Remi; Sato, Hiroyasu; Yamamoto, Kei; Ushida, Ayako; Nishito, Yasumasa; Ikeda, Kazutaka; Kobayashi, Tetsuyuki; Yamamoto, Toshinori; Taketomi, Yoshitaka; Murakami, Makoto			Group X Secreted Phospholipase A(2) Releases 3 Polyunsaturated Fatty Acids, Suppresses Colitis, and Promotes Sperm Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arachidonic acid (AA) (ARA); colitis; inflammation; lipid metabolism; membrane; Phospholipase A; polyunsaturated fatty acid (PUFA); prostaglandin; sperm	INFLAMMATORY-BOWEL-DISEASE; PROSTAGLANDIN-E SYNTHASE-1; GROUP-V; DOCOSAHEXAENOIC ACID; LIPID MEDIATORS; GROUP-III; HUMAN MACROPHAGES; ARACHIDONIC-ACID; TRANSGENIC MICE; RESOLVIN D1	Within the secreted phospholipase A(2) (sPLA(2)) family, group X sPLA(2) (sPLA(2)-X) has the highest capacity to hydrolyze cellular membranes and has long been thought to promote inflammation by releasing arachidonic acid, a precursor of pro-inflammatory eicosanoids. Unexpectedly, we found that transgenic mice globally overexpressing human sPLA(2)-X (PLA2G10-Tg) displayed striking immunosuppressive and lean phenotypes with lymphopenia and increased M2-like macrophages, accompanied by marked elevation of free 3 polyunsaturated fatty acids (PUFAs) and their metabolites. Studies using Pla2g10-deficient mice revealed that endogenous sPLA(2)-X, which is highly expressed in the colon epithelium and spermatozoa, mobilized 3 PUFAs or their metabolites to protect against dextran sulfate-induced colitis and to promote fertilization, respectively. In colitis, sPLA(2)-X deficiency increased colorectal expression of Th17 cytokines, and 3 PUFAs attenuated their production by lamina propria cells partly through the fatty acid receptor GPR120. In comparison, cytosolic phospholipase A(2) (cPLA(2)) protects from colitis by mobilizing 6 arachidonic acid metabolites, including prostaglandin E-2. Thus, our results underscore a previously unrecognized role of sPLA(2)-X as an 3 PUFA mobilizer in vivo, segregated mobilization of 3 and 6 PUFA metabolites by sPLA(2)-X and cPLA(2), respectively, in protection against colitis, and the novel role of a particular sPLA(2)-X-driven PUFA in fertilization.	[Murase, Remi; Sato, Hiroyasu; Yamamoto, Kei; Ushida, Ayako; Taketomi, Yoshitaka; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Murase, Remi; Yamamoto, Toshinori] Showa Univ, Sch Pharm, Tokyo 1428555, Japan; [Ushida, Ayako; Kobayashi, Tetsuyuki] Ochanomizu Univ, Fac Sci, Dept Biol, Tokyo 1128610, Japan; [Ikeda, Kazutaka] RIKEN, Ctr Integrat Med Sci, Lab Metabol, Yokohama, Kanagawa 2300045, Japan; [Yamamoto, Kei] PRIME, Tokyo 1000004, Japan; [Murakami, Makoto] Japan Agcy Med Res & Dev, AMED CREST, Tokyo 1000004, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Showa University; Ochanomizu University; RIKEN	Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp	Kobayashi, Tetsuyuki/AAH-2985-2020	Kobayashi, Tetsuyuki/0000-0002-9285-0859	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K14957, 15H05905, 15K07959, 25860059, 23591665, 26461671, 24117724, 25460087]; PRIME, Japan Agency for Medical Research and Development; AMED-CREST, Japan Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [16H02613, 15K07959, 16K15122, 26461671] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRIME, Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); AMED-CREST, Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan 15K14957 and 15H05905 (to M. M.), 15K07959 and 25860059 (to H. S.), 23591665 and 26461671 (to K. Y.), and 24117724 and 25460087 (to Y. T.) and by PRIME (to K. Y.) and AMED-CREST (to M. M.), Japan Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Ait-Oufella H, 2013, ARTERIOSCL THROM VAS, V33, P466, DOI 10.1161/ATVBAHA.112.300309; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Calviello G, 2000, J LIPID RES, V41, P182; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Curfs DMJ, 2008, J BIOL CHEM, V283, P21640, DOI 10.1074/jbc.M710584200; Cyster JG, 2009, J EXP MED, V206, P731, DOI 10.1084/jem.20090458; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Diep QN, 2000, HYPERTENSION, V36, P851, DOI 10.1161/01.HYP.36.5.851; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Furimsky A, 2005, BIOL REPROD, V72, P574, DOI 10.1095/biolreprod.104.036095; Hallstrand TS, 2013, AM J RESP CRIT CARE, V188, P42, DOI 10.1164/rccm.201301-0084OC; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kamei D, 2004, J BIOL CHEM, V279, P33684, DOI 10.1074/jbc.M400199200; Kapoor M, 2006, FASEB J, V20, P2387, DOI 10.1096/fj.06-6366fje; Kaur G, 2011, PROG LIPID RES, V50, P28, DOI 10.1016/j.plipres.2010.07.004; Kelvin AA, 2014, VIROLOGY, V454, P78, DOI 10.1016/j.virol.2014.01.030; Kim W, 2010, PROG LIPID RES, V49, P250, DOI 10.1016/j.plipres.2010.01.002; Kunisawa J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09750; Lai Y, 2010, J BIOL CHEM, V285, P41491, DOI 10.1074/jbc.M110.153338; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lenzi A, 2000, MOL HUM REPROD, V6, P226, DOI 10.1093/molehr/6.3.226; Li X, 2010, FASEB J, V24, P4313, DOI 10.1096/fj.10-154716; Logan RFA, 1998, GUT, V42, P309, DOI 10.1136/gut.42.3.309; Masuda S, 2004, BBA-MOL CELL BIOL L, V1686, P61, DOI 10.1016/j.bbalip.2004.08.017; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Mitsuishi M, 2007, BBA-MOL CELL BIOL L, V1771, P1389, DOI 10.1016/j.bbalip.2007.09.006; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ohta S, 2013, J IMMUNOL, V190, P5927, DOI 10.4049/jimmunol.1203202; Pernet E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6105; Ramon S, 2012, J IMMUNOL, V189, P1036, DOI 10.4049/jimmunol.1103483; Rubio JM, 2015, J IMMUNOL, V194, P3327, DOI 10.4049/jimmunol.1401026; Saleh M, 2011, IMMUNITY, V34, P293, DOI 10.1016/j.immuni.2011.03.008; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Sato H, 2011, J BIOL CHEM, V286, P11632, DOI 10.1074/jbc.M110.206755; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Surrel F, 2009, MOL PHARMACOL, V76, P778, DOI 10.1124/mol.108.053371; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Taylor N, 2010, BLOOD, V115, P1861, DOI 10.1182/blood-2010-01-258848; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Vijay R, 2015, J EXP MED, V212, P1851, DOI 10.1084/jem.20150632; Watanabe K, 2012, AM J PHYSIOL-HEART C, V302, pH95, DOI 10.1152/ajpheart.00695.2011; Yamamoto K, 2015, J EXP MED, V212, P1901, DOI 10.1084/jem.20141904; Yamamoto K, 2011, J BIOL CHEM, V286, P11616, DOI 10.1074/jbc.M110.206714; Zaldumbide A, 2002, J IMMUNOL, V169, P4873, DOI 10.4049/jimmunol.169.9.4873	72	48	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6895	6911		10.1074/jbc.M116.715672	http://dx.doi.org/10.1074/jbc.M116.715672			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26828067	hybrid, Green Published			2022-12-26	WOS:000373299700027
J	Kim, MB; Shim, HY; Jin, SH; Kang, S; Woo, J; Han, JC; Lee, JY; Kim, M; Cho, YS; Moon, IJ; Hong, SH				Kim, Min-Beom; Shim, Hyun-Yong; Jin, Sun Hwa; Kang, Soojin; Woo, Jihwan; Han, Jong Chul; Lee, Ji Young; Kim, Martha; Cho, Yang-Sun; Moon, Il Joon; Hong, Sung Hwa			Cross-Modal and Intra-Modal Characteristics of Visual Function and Speech Perception Performance in Postlingually Deafened, Cochlear Implant Users	PLOS ONE			English	Article							ACTIVATE AUDITORY-CORTEX; PUPILLARY RESPONSES; CONGENITALLY DEAF; SPATIAL-DISTRIBUTION; PLASTICITY; ATTENTION; HEARING; LANGUAGE; NEUROPLASTICITY; DEPRIVATION	Evidence of visual-auditory cross-modal plasticity in deaf individuals has been widely reported. Superior visual abilities of deaf individuals have been shown to result in enhanced reactivity to visual events and/or enhanced peripheral spatial attention. The goal of this study was to investigate the association between visual-auditory cross-modal plasticity and speech perception in post-lingually deafened, adult cochlear implant (CI) users. Post-lingually deafened adults with CIs (N = 14) and a group of normal hearing, adult controls (N = 12) participated in this study. The CI participants were divided into a good performer group (good CI, N = 7) and a poor performer group (poor CI, N = 7) based on word recognition scores. Visual evoked potentials (VEP) were recorded from the temporal and occipital cortex to assess reactivity. Visual field (VF) testing was used to assess spatial attention and Goldmann perimetry measures were analyzed to identify differences across groups in the VF. The association of the amplitude of the P1 VEP response over the right temporal or occipital cortex among three groups (control, good CI, poor CI) was analyzed. In addition, the association between VF by different stimuli and word perception score was evaluated. The P1 VEP amplitude recorded from the right temporal cortex was larger in the group of poorly performing CI users than the group of good performers. The P1 amplitude recorded from electrodes near the occipital cortex was smaller for the poor performing group. P1 VEP amplitude in right temporal lobe was negatively correlated with speech perception outcomes for the CI participants (r = -0.736, P = 0.003). However, P1 VEP amplitude measures recorded from near the occipital cortex had a positive correlation with speech perception outcome in the CI participants (r = 0.775, P = 0.001). In VF analysis, CI users showed narrowed central VF (VF to low intensity stimuli). However, their far peripheral VF (VF to high intensity stimuli) was not different from the controls. In addition, the extent of their central VF was positively correlated with speech perception outcome (r = 0.669, P = 0.009). Persistent visual activation in right temporal cortex even after CI causes negative effect on outcome in post-lingual deaf adults. We interpret these results to suggest that insufficient intra-modal (visual) compensation by the occipital cortex may cause negative effects on outcome. Based on our results, it appears that a narrowed central VF could help identify CI users with poor outcomes with their device.	[Kim, Min-Beom] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Shim, Hyun-Yong; Jin, Sun Hwa; Kang, Soojin; Cho, Yang-Sun; Moon, Il Joon; Hong, Sung Hwa] Samsung Med Ctr, Hearing Lab, Seoul, South Korea; [Woo, Jihwan] Univ Ulsan, Sch Elect Engn, Biomed Engn, Ulsan 680749, South Korea; [Han, Jong Chul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Lee, Ji Young] Catholic Univ Daegu, Dept Audiol & Speech Language Pathol, Daegu, South Korea; [Kim, Martha] Dongguk Univ, Coll Med, Dept Ophthalmol, Ilsan Hosp, Goyang, South Korea; [Cho, Yang-Sun; Moon, Il Joon; Hong, Sung Hwa] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Daegu; Dongguk University; NHIS Ilsan Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Moon, IJ; Hong, SH (corresponding author), Samsung Med Ctr, Hearing Lab, Seoul, South Korea.; Moon, IJ; Hong, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	moonij@skku.edu; hongsh@skku.edu	Cho, Yang Sun/F-4611-2014		IN-SUNG Foundation [CB14011]	IN-SUNG Foundation	This work was supported by the IN-SUNG Foundation, grant number CB14011 (SHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERN S, 1979, SCIENCE, V205, P1289, DOI 10.1126/science.472746; Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Auer ET, 2007, NEUROREPORT, V18, P645, DOI 10.1097/WNR.0b013e3280d943b9; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; BLAMEY PJ, 1992, ANN OTO RHINOL LARYN, V101, P342, DOI 10.1177/000348949210100410; BLUMHARDT LD, 1982, ANN NY ACAD SCI, V388, P264, DOI 10.1111/j.1749-6632.1982.tb50796.x; Bosworth RG, 2002, BRAIN COGNITION, V49, P152, DOI 10.1006/brcg.2001.1497; BRYDEN MP, 1983, BRAIN LANG, V18, P236, DOI 10.1016/0093-934X(83)90018-4; Buckley D, 2010, VISION RES, V50, P548, DOI 10.1016/j.visres.2009.11.018; Buckley KA, 2011, EAR HEARING, V32, P2, DOI 10.1097/AUD.0b013e3181fa41bb; Cammann R, 1985, Zentralbl Neurochir, V46, P52; Campbell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090594; Capek CM, 2008, NEUROPSYCHOLOGIA, V46, P1233, DOI 10.1016/j.neuropsychologia.2007.11.026; Chen Q, 2006, BRAIN RES, V1109, P117, DOI 10.1016/j.brainres.2006.06.043; Codina C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020417; Codina C, 2011, DEVELOPMENTAL SCI, V14, P725, DOI 10.1111/j.1467-7687.2010.01017.x; Dewey RS, 2015, HEARING RES, V325, P55, DOI 10.1016/j.heares.2015.03.007; Doucet ME, 2006, BRAIN, V129, P3376, DOI 10.1093/brain/awl264; Dye MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005640; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Finney EM, 2003, NEUROREPORT, V14, P1425, DOI 10.1097/00001756-200308060-00004; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; GANTZ BJ, 1993, ANN OTO RHINOL LARYN, V102, P909, DOI 10.1177/000348949310201201; Giraud AL, 2001, NEURON, V30, P657, DOI 10.1016/S0896-6273(01)00318-X; Granholm E, 1996, PSYCHOPHYSIOLOGY, V33, P457, DOI 10.1111/j.1469-8986.1996.tb01071.x; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; Holden LK, 2013, EAR HEARING, V34, P342, DOI 10.1097/AUD.0b013e3182741aa7; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Koelewijn T, 2014, HEARING RES, V312, P114, DOI 10.1016/j.heares.2014.03.010; Kral A, 2001, AUDIOL NEURO-OTOL, V6, P346, DOI 10.1159/000046845; Kral A, 2002, CEREB CORTEX, V12, P797, DOI 10.1093/cercor/12.8.797; Lambertz N, 2005, COGNITIVE BRAIN RES, V25, P884, DOI 10.1016/j.cogbrainres.2005.09.010; Lazard DS, 2010, ACTA OTO-LARYNGOL, V130, P1267, DOI 10.3109/00016481003769972; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; Lee JS, 2003, J NUCL MED, V44, P1435; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; McIntosh AR, 1999, SCIENCE, V284, P1531, DOI 10.1126/science.284.5419.1531; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; Neville H, 2002, PROG BRAIN RES, V138, P177, DOI 10.1016/S0079-6123(02)38078-6; PARASNIS I, 1985, BRAIN COGNITION, V4, P313, DOI 10.1016/0278-2626(85)90024-7; Pavani F., 2011, NEURAL BASES MULTISE; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; Proksch J, 2002, J COGNITIVE NEUROSCI, V14, P687, DOI 10.1162/08989290260138591; Rauschecker JP, 2002, SCIENCE, V295, P1025, DOI 10.1126/science.1067796; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Sandmann P, 2012, BRAIN, V135, P555, DOI 10.1093/brain/awr329; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Stevens C, 2006, J COGNITIVE NEUROSCI, V18, P701, DOI 10.1162/jocn.2006.18.5.701; Strelnikov K, 2013, BRAIN, V136, P3682, DOI 10.1093/brain/awt274; Tyler RS, 1997, J ACOUST SOC AM, V102, P508, DOI 10.1121/1.419724; Valimaa TT, 2000, SCAND AUDIOL, V29, P276, DOI 10.1080/010503900750022916; Verney SP, 2004, INT J PSYCHOPHYSIOL, V52, P23, DOI 10.1016/j.ijpsycho.2003.12.003; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	61	82	85	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148466	10.1371/journal.pone.0148466	http://dx.doi.org/10.1371/journal.pone.0148466			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848755	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000099
J	Debelak, R; Tran, US				Debelak, Rudolf; Tran, Ulrich S.			Comparing the Effects of Different Smoothing Algorithms on the Assessment of Dimensionality of Ordered Categorical Items with Parallel Analysis	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; CORRELATION MATRIX; DETERMINING NUMBER; COMPONENTS; CRITERION; VARIANCE; ACCURACY; RULES	The analysis of polychoric correlations via principal component analysis and exploratory factor analysis are well-known approaches to determine the dimensionality of ordered categorical items. However, the application of these approaches has been considered as critical due to the possible indefiniteness of the polychoric correlation matrix. A possible solution to this problem is the application of smoothing algorithms. This study compared the effects of three smoothing algorithms, based on the Frobenius norm, the adaption of the eigenvalues and eigenvectors, and on minimum-trace factor analysis, on the accuracy of various variations of parallel analysis by the means of a simulation study. We simulated different datasets which varied with respect to the size of the respondent sample, the size of the item set, the underlying factor model, the skewness of the response distributions and the number of response categories in each item. We found that a parallel analysis and principal component analysis of smoothed polychoric and Pearson correlations led to the most accurate results in detecting the number of major factors in simulated datasets when compared to the other methods we investigated. Of the methods used for smoothing polychoric correlation matrices, we recommend the algorithm based on minimum trace factor analysis.	[Debelak, Rudolf] SCHUHFRIED GmbH, Modling, Austria; [Debelak, Rudolf] Univ Zurich, Zurich, Switzerland; [Tran, Ulrich S.] Univ Vienna, Vienna, Austria	University of Zurich; University of Vienna	Tran, US (corresponding author), Univ Vienna, Vienna, Austria.	ulrich.tran@univie.ac.at		Debelak, Rudolf/0000-0001-8900-2106; Tran, Ulrich/0000-0002-6589-3167	Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; BABAKUS E, 1987, J MARKETING RES, V24, P222, DOI 10.2307/3151512; Bates D, 2011, MATRIX SPARSE DENSE; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Bentler PM, 2011, PSYCHOMETRIKA, V76, P119, DOI 10.1007/s11336-010-9191-3; Bravo HC, 2010, RCSDP R INTERFACE CS; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cho SJ, 2009, EDUC PSYCHOL MEAS, V69, P748, DOI 10.1177/0013164409332229; Crawford AV, 2010, EDUC PSYCHOL MEAS, V70, P885, DOI 10.1177/0013164410379332; Debelak R, 2013, EDUC PSYCHOL MEAS, V73, P63, DOI 10.1177/0013164412457366; Garrido LE, 2013, PSYCHOL METHODS, V18, P454, DOI 10.1037/a0030005; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; GLORFELD LW, 1995, EDUC PSYCHOL MEAS, V55, P377, DOI 10.1177/0013164495055003002; Gorsuch R., 1983, FACTOR ANAL; Green SB, 2015, EDUC PSYCHOL MEAS, V75, P428, DOI 10.1177/0013164414546566; Green SB, 2012, EDUC PSYCHOL MEAS, V72, P357, DOI 10.1177/0013164411422252; Green SB, 2015, ED PSYCHOL MEAS; Harlow LL, 2013, MULTIVAR BEHAV RES, V48, P749, DOI 10.1080/00273171.2013.822784; Higham NJ, 2002, IMA J NUMER ANAL, V22, P329, DOI 10.1093/imanum/22.3.329; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; HUMPHREY.LG, 1969, EDUC PSYCHOL MEAS, V29, P571, DOI 10.1177/001316446902900303; HUMPHREYS LG, 1975, MULTIVAR BEHAV RES, V10, P193, DOI 10.1207/s15327906mbr1002_5; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KNOL DL, 1989, PSYCHOMETRIKA, V54, P53, DOI 10.1007/BF02294448; KNOL DL, 1991, MULTIVAR BEHAV RES, V26, P457, DOI 10.1207/s15327906mbr2603_5; Ledesma RD, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [https://doi.org/10.7275/wjnc-nm63, DOI 10.7275/WJNC-NM63]; Lord F.M., 1980, APPL ITEM RESPONSE T; Lord F. M., 1968, STAT THEORIES MENTAL; Lorenzo-Seva U, 2015, FACTOR VERS 10 3 01; Lorenzo-Seva U, 2011, MULTIVAR BEHAV RES, V46, P340, DOI 10.1080/00273171.2011.564527; Maechler M, 2014, SFSMISC UT SEM FUER; Mulaik S., 2010, FDN FACTOR ANAL, V2nd; OLSSON U, 1979, MULTIVAR BEHAV RES, V14, P485, DOI 10.1207/s15327906mbr1404_7; OLSSON U, 1979, PSYCHOMETRIKA, V44, P443, DOI 10.1007/BF02296207; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reckase MD, 2009, THEORY; Revelle W., 2014, PSYCH PROCEDURES PER; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Steger MF, 2006, J PERS ASSESS, V86, P263, DOI 10.1207/s15327752jpa8603_03; TENBERGE JMF, 1977, PSYCHOMETRIKA, V42, P593, DOI 10.1007/BF02295981; Timmerman ME, 2011, PSYCHOL METHODS, V16, P209, DOI 10.1037/a0023353; Tran US, 2009, EDUC PSYCHOL MEAS, V69, P50, DOI 10.1177/0013164408318761; TUCKER LR, 1969, PSYCHOMETRIKA, V34, P421, DOI 10.1007/BF02290601; Turner NE, 1998, EDUC PSYCHOL MEAS, V58, P541, DOI 10.1177/0013164498058004001; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; Weng LJ, 2005, EDUC PSYCHOL MEAS, V65, P791, DOI 10.1177/0013164404273941; Yuan KH, 2011, BRIT J MATH STAT PSY, V64, P107, DOI 10.1348/000711010X497442; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	50	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148143	10.1371/journal.pone.0148143	http://dx.doi.org/10.1371/journal.pone.0148143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845032	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800032
J	Han, B; Liu, HB; Zhai, GJ; Wang, Q; Liang, J; Zhang, MC; Cui, K; Shen, FH; Yi, HB; Li, YT; Zhai, YH; Sheng, Y; Chen, J				Han, Bing; Liu, Hongbo; Zhai, Guojiang; Wang, Qun; Liang, Jie; Zhang, Mengcang; Cui, Kai; Shen, Fuhai; Yi, Hongbo; Li, Yuting; Zhai, Yuhan; Sheng, Yang; Chen, Jie			Estimates and Predictions of Coal Workers' Pneumoconiosis Cases among Redeployed Coal Workers of the Fuxin Mining Industry Group in China: A Historical Cohort Study	PLOS ONE			English	Article							REGION	This research was aimed at estimating possible Coal workers' pneumoconiosis (CWP) cases as of 2012, and predicting future CWP cases among redeployed coal workers from the Fuxin Mining Industry Group. This study provided the scientific basis for regulations on CWP screening and diagnosis and labor insurance policies for redeployed coal workers of resource-exhausted mines. The study cohort included 19,116 coal workers. The cumulative incidence of CWP was calculated by the life-table method. Possible CWP cases by occupational category were estimated through the average annual incidence rate of CWP and males' life expectancy. It was estimated that 141 redeployed coal workers might have suffered from CWP as of 2012, and 221 redeployed coal workers could suffer from CWP in the future. It is crucial to establish a set of feasible and affordable regulations on CWP screening and diagnosis as well as labor insurance policies for redeployed coal workers of resource-exhausted coal mines in China.	[Han, Bing; Liu, Hongbo; Cui, Kai; Shen, Fuhai; Chen, Jie] China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang 110122, Liaoning, Peoples R China; [Han, Bing; Liu, Hongbo; Li, Yuting; Zhai, Yuhan; Sheng, Yang] China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang 110122, Liaoning, Peoples R China; [Zhai, Guojiang; Wang, Qun; Yi, Hongbo] Fuxin Min Area Social Secur Adm Ctr, Fuxing 123000, Liaoning, Peoples R China; [Liang, Jie; Zhang, Mengcang] Inst Occupat Dis Prevent & Treatment, Fuxin Min Ind Grp, Fuxing 123000, Liaoning, Peoples R China	China Medical University; China Medical University	Chen, J (corresponding author), China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang 110122, Liaoning, Peoples R China.	chenjie@mail.cmu.edu.cn			National Natural Science Foundation of China [71073176]; Program for Liaoning Innovative Research Team in University [LT2015028]; General Program of Scientific Research of the Educational Department of Liaoning Province [L2015573]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Liaoning Innovative Research Team in University; General Program of Scientific Research of the Educational Department of Liaoning Province	This study was funded by the National Natural Science Foundation of China (no. 71073176) to HL; the Program for Liaoning Innovative Research Team in University (no. LT2015028) to Jie Chen; and the General Program of Scientific Research of the Educational Department of Liaoning Province (no. L2015573) to Bing Han. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaan MR, 1998, OCCUPATIONAL ENV MED, P435; BRADBURY J, 1984, INT J URBAN REGIONAL, V8, P311, DOI 10.1111/j.1468-2427.1984.tb00613.x; Bradbury J., 1988, RESOURCE COMMUNITIES, P3; Chinese Center for disease control and prevention, NAT OCC DIS CONTR PR; Chong S, 2006, RADIOGRAPHICS, V26, P59, DOI 10.1148/rg.261055070; De Vuyst P, 2000, Curr Opin Pulm Med, V6, P151, DOI 10.1097/00063198-200003000-00012; Farzaneh MR, 2010, INT J OCCUP ENV MED, V1, P11; Han XW, 2005, OCCUP HLTH EMERG RES, V23, P110; LANE E, 1977, SOUTHERN MED J, V70, P53, DOI 10.1097/00007611-197701000-00023; Laney AS, 2014, AM J PUBLIC HEALTH, V104, P165, DOI 10.2105/AJPH.2012.301051; Laney AS, 2012, CLIN CHEST MED, V33, P745, DOI 10.1016/j.ccm.2012.08.005; Laney AS, 2010, OCCUP ENVIRON MED, V67, P652, DOI 10.1136/oem.2009.047126; Leng YJ, 2011, J LIAONING TU SOCIAL, V13, P169; Liu FD, 2007, HEALTH PHYS, V93, P127, DOI 10.1097/01.HP.0000261600.29366.b4; LOU JZ, 1989, AM J PUBLIC HEALTH, V79, P1613, DOI 10.2105/AJPH.79.12.1613; Lou JZ, 1998, CHINESE J HLTH STAT, V15, P22; National Health and Family Planning Commission of the People's Republic of China, 702009 GBZ NAT HLTH; National Health and Family Planning Commission of the People's Republic of China, NAT OCC DIS REP 2012; National Institute for Occupational Safety and Health Division of Respiratory Disease Studies, 2008, WORKR LUNG DIS SURV, P27; Ringshausen FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082005; Scarisbrick DA., 2002, ANN OCCUP HYG     S1, V46, P254; Shen FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130958; Shen FH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082181; Sun YF, 2010, HLJ FOREIGN EC RELAT, V187, P109, DOI DOI 10.3969/J.ISSN.2095-3283.2010.01.041; The Central People's Government of the People's Republic of China, NAT RES BAS CIT SUST; Thomas CR, 2010, ENVIRON HEALTH INSIG, V4, P21; Xie ZY, 2014, ADV MATER RES-SWITZ, V869-870, P226, DOI 10.4028/www.scientific.net/AMR.869-870.226; Ying Hua, 2014, Applied Mechanics and Materials, V448-453, P4215, DOI 10.4028/www.scientific.net/AMM.448-453.4215; Zhao G, 2011, ANAL SOCIAL EC IMPAC, P55	29	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148179	10.1371/journal.pone.0148179	http://dx.doi.org/10.1371/journal.pone.0148179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845337	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800034
J	Nguyen, A; Hulleman, JD				Nguyen, Annie; Hulleman, John D.			Evidence of Alternative Cystatin C Signal Sequence Cleavage Which Is Influenced by the A25T Polymorphism	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; GENE G73A POLYMORPHISM; AMYLOID ANGIOPATHY; CEREBRAL-HEMORRHAGE; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; CST3 GENE; ASSOCIATION; VARIANT; PROTEIN	Cystatin C (Cys C) is a small, potent, cysteine protease inhibitor. An Ala25Thr (A25T) polymorphism in Cys C has been associated with both macular degeneration and late-onset Alzheimer's disease. Previously, studies have suggested that this polymorphism may compromise the secretion of Cys C. Interestingly, we found that untagged A25T, A25T tagged C-terminally with FLAG, or A25T FLAG followed by green fluorescent protein (GFP), were all secreted as efficiently from immortalized human cells as their wild-type (WT) counterparts (e.g., 112%, 100%, and 88% of WT levels from HEK-293T cells, respectively). Supporting these observations, WT and A25T Cys C variants also showed similar intracellular steady state levels. Furthermore, A25T Cys C did not activate the unfolded protein response and followed the same canonical endoplasmic reticulum (ER)-Golgi trafficking pathway as WT Cys C. WT Cys C has been shown to undergo signal sequence cleavage between residues Gly26 and Ser27. While the A25T polymorphism did not affect Cys C secretion, we hypothesized that it may alter where the Cys C signal sequence is preferentially cleaved. Under normal conditions, WT and A25T Cys C have the same signal sequence cleavage site after Gly26 (referred to as 'site 2' cleavage). However, in particular circumstances when the residues around site 2 are modified (such as by the presence of an N-terminal FLAG tag immediately after Gly26, or by a Gly26Lys (G26K) mutation), A25T has a significantly higher likelihood than WT Cys C of alternative signal sequence cleavage after Ala20 ('site 1') or even earlier in the Cys C sequence. Overall, our results indicate that the A25T polymorphism does not cause a significant reduction in Cys C secretion, but instead predisposes the protein to be cleaved at an alternative signal sequence cleavage site if site 2 is hindered. Additional N-terminal amino acids resulting from alternative signal sequence cleavage may, in turn, affect the protease inhibition function of Cys C.	[Nguyen, Annie; Hulleman, John D.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA; [Hulleman, John D.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hulleman, JD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA.; Hulleman, JD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	John.Hulleman@UTSouthwestern.edu	Hulleman, John D./AAV-8242-2020	Hulleman, John/0000-0001-8149-656X	Roger and Dorothy Hirl Research Fund; National Eye Institute Visual Science Core Grant [EY020799]; Research to Prevent Blindness; Career Development Award from Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY020799] Funding Source: NIH RePORTER	Roger and Dorothy Hirl Research Fund; National Eye Institute Visual Science Core Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Career Development Award from Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded in part by an endowment from the Roger and Dorothy Hirl Research Fund (JDH), a National Eye Institute Visual Science Core Grant (EY020799), an unrestricted grant from Research to Prevent Blindness, and a Career Development Award from Research to Prevent Blindness (JDH).	ABRAHAMSON M, 1991, BIOCHEM J, V273, P621, DOI 10.1042/bj2730621; ABRAHAMSON M, 1990, BIOCHEM J, V268, P287, DOI 10.1042/bj2680287; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; ALDRED AR, 1995, COMP BIOCHEM PHYS B, V111, P1, DOI 10.1016/0305-0491(94)00229-N; Nguyen A, 2015, EXP EYE RES, V130, P66, DOI 10.1016/j.exer.2014.12.002; Bai G, 2011, NEURON, V72, P9, DOI 10.1016/j.neuron.2011.09.012; BARRETT AJ, 1984, BIOCHEM BIOPH RES CO, V120, P631, DOI 10.1016/0006-291X(84)91302-0; Benussi L, 2003, NEUROBIOL DIS, V13, P15, DOI 10.1016/S0969-9961(03)00012-3; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bjarnadottir M, 1998, J CLIN PATHOL-MOL PA, V51, P317, DOI 10.1136/mp.51.6.317; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; Butler JM, 2015, HUM GENET, V134, P705, DOI 10.1007/s00439-015-1552-7; Chuo LJ, 2007, DEMENT GERIATR COGN, V23, P251, DOI 10.1159/000100021; Crawford FC, 2000, NEUROLOGY, V55, P763, DOI 10.1212/WNL.55.6.763; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Finckh U, 2000, ARCH NEUROL-CHICAGO, V57, P1579, DOI 10.1001/archneur.57.11.1579; HARRIS RJ, 1995, J CHROMATOGR A, V705, P129, DOI 10.1016/0021-9673(94)01255-D; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Helisalmi S, 2009, DEMENT GERIATR COGN, V27, P318, DOI 10.1159/000209278; Hua Y, 2012, INT J NEUROSCI, V122, P431, DOI 10.3109/00207454.2012.672502; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; Hulleman JD, 2015, FASEB J, V29, P565, DOI 10.1096/fj.14-255414; Hulleman JD, 2013, J BIOMOL SCREEN, V18, P647, DOI 10.1177/1087057112469405; Hulleman JD, 2011, MOL BIOL CELL, V22, P4765, DOI 10.1091/mbc.E11-08-0695; JENSSON O, 1987, ACTA NEUROL SCAND, V76, P102, DOI 10.1111/j.1600-0404.1987.tb03553.x; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; LEVY E, 1989, J EXP MED, V169, P1771, DOI 10.1084/jem.169.5.1771; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Maetzler W, 2010, J ALZHEIMERS DIS, V19, P937, DOI 10.3233/JAD-2010-1289; Maruyama H, 2001, NEUROLOGY, V57, P337, DOI 10.1212/WNL.57.2.337; Monastero R, 2005, J ALZHEIMERS DIS, V7, P291; Nacmias B, 2006, NEUROSCI LETT, V392, P110, DOI 10.1016/j.neulet.2005.09.006; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Noto D, 2005, INT J CARDIOL, V101, P213, DOI 10.1016/j.ijcard.2004.03.018; Palsdottir A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000099; Paraoan L, 2004, TRAFFIC, V5, P884, DOI 10.1111/j.1600-0854.2004.00230.x; Paraoan L, 2000, INT J BIOCHEM CELL B, V32, P417, DOI 10.1016/S1357-2725(99)00143-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ratnayaka A, 2007, EXP EYE RES, V84, P1135, DOI 10.1016/j.exer.2006.01.030; Roks G, 2001, NEUROLOGY, V57, P366, DOI 10.1212/WNL.57.2.366-a; Ryan CM, 2010, J AM SOC MASS SPECTR, V21, P908, DOI 10.1016/j.jasms.2010.01.025; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; SUN Q, 1989, EXP CELL RES, V180, P150, DOI 10.1016/0014-4827(89)90219-X; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; VONHEIJNE G, 1982, J MOL BIOL, V159, P537, DOI 10.1016/0022-2836(82)90300-X; Wallin H, 2013, J BIOL CHEM, V288, P17019, DOI 10.1074/jbc.M113.453449; Wang BB, 2008, DEMENT GERIATR COGN, V25, P461, DOI 10.1159/000125670; Wei LH, 1998, J BIOL CHEM, V273, P11806, DOI 10.1074/jbc.273.19.11806; Yamamoto-Watanabe Y, 2010, BRAIN RES, V1361, P140, DOI 10.1016/j.brainres.2010.09.033; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015; Zurdel J, 2002, BRIT J OPHTHALMOL, V86, P214, DOI 10.1136/bjo.86.2.214	61	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147684	10.1371/journal.pone.0147684	http://dx.doi.org/10.1371/journal.pone.0147684			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845025	Green Submitted, gold, Green Published			2022-12-26	WOS:000369552800012
J	Scheffer, HJ; Vogel, JA; van den Bos, W; Neal, RE; van Lienden, KP; Besselink, MGH; van Gemert, MJC; van der Geld, CWM; Meijerink, MR; Klaessens, JH; Verdaasdonk, RM				Scheffer, Hester J.; Vogel, Jantien A.; van den Bos, Willemien; Neal, Robert E., II; van Lienden, Krijn P.; Besselink, Marc G. H.; van Gemert, Martin J. C.; van der Geld, Cees W. M.; Meijerink, Martijn R.; Klaessens, John H.; Verdaasdonk, Rudolf M.			The Influence of a Metal Stent on the Distribution of Thermal Energy during Irreversible Electroporation	PLOS ONE			English	Article							TISSUE ABLATION; LIVER	Purpose Irreversible electroporation (IRE) uses short duration, high-voltage electrical pulses to induce cell death via nanoscale defects resulting from altered transmembrane potential. The technique is gaining interest for ablations in unresectable pancreatic and hepatobiliary cancer. Metal stents are often used for palliative biliary drainage in these patients, but are currently seen as an absolute contraindication for IRE due to the perceived risk of direct heating of the metal and its surroundings. This study investigates the thermal and tissue viability changes due to a metal stent during IRE. Methods IRE was performed in a homogeneous tissue model (polyacrylamide gel), without and with a metal stent placed perpendicular and parallel to the electrodes, delivering 90 and 270 pulses (15-35 A, 90 mu sec, 1.5 cm active tip exposure, 1.5 cm interelectrode distance, 1000-1500 V/cm, 90 pulses/min), and in-vivo in a porcine liver (4 ablations). Temperature changes were measured with an infrared thermal camera and with fiber-optic probes. Tissue viability after in-vivo IRE was investigated macroscopically using 5-triphenyltetrazolium chloride (TTC) vitality staining. Results In the gel, direct stent-heating was not observed. Contrarily, the presence of a stent between the electrodes caused a higher increase in median temperature near the electrodes (23.2 vs 13.3 degrees C [90 pulses]; p = 0.021, and 33.1 vs 24.8 degrees C [270 pulses]; p = 0.242). In-vivo, no temperature difference was observed for ablations with and without a stent. Tissue examination showed white coagulation 1mm around the electrodes only. A rim of vital tissue remained around the stent, whereas ablation without stent resulted in complete tissue avitality. Conclusion IRE in the vicinity of a metal stent does not cause notable direct heating of the metal, but results in higher temperatures around the electrodes and remnant viable tissue. Future studies should determine for which clinical indications IRE in the presence of metal stents is safe and effective.	[Scheffer, Hester J.; Meijerink, Martijn R.] Vrije Univ Amsterdam, Dept Radiol & Nucl Med, Med Ctr, Amsterdam, Netherlands; [Vogel, Jantien A.; Besselink, Marc G. H.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [van den Bos, Willemien] Univ Amsterdam, Acad Med Ctr, Dept Urol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Neal, Robert E., II] Monash Univ, Alfred Hosp, Dept Radiol, Melbourne, Vic 3181, Australia; [van Lienden, Krijn P.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van Gemert, Martin J. C.; Verdaasdonk, Rudolf M.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van der Geld, Cees W. M.] Eindhoven Univ Technol, Dept Mech Engn, NL-5600 MB Eindhoven, Netherlands; [Klaessens, John H.] Vrije Univ Amsterdam, Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Florey Institute of Neuroscience & Mental Health; Monash University; University of Amsterdam; University of Amsterdam; Eindhoven University of Technology; Vrije Universiteit Amsterdam	Scheffer, HJ (corresponding author), Vrije Univ Amsterdam, Dept Radiol & Nucl Med, Med Ctr, Amsterdam, Netherlands.	hj.scheffer@vumc.nl	Besselink, Marc/H-3294-2019; Besselink, Marc G/R-4268-2019	Besselink, Marc G/0000-0003-2650-9350; Klaessens, John/0000-0002-2798-2206; Meijerink, Martijn/0000-0002-1500-7294; Verdaasdonk, Rudolf/0000-0002-3115-637X	AngioDynamics	AngioDynamics	Robert E Neal recently began employment with AngioDynamics. Martijn R Meijerink and Krijn P van Lienden are paid consultants for AngioDynamics.	Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Ben-David E, 2013, RADIOLOGY, V269, P738, DOI 10.1148/radiol.13122590; Davalos RV, 2008, INT J HEAT MASS TRAN, V51, P5617, DOI 10.1016/j.ijheatmasstransfer.2008.04.046; Davalos RV, 2015, PROSTATE, V75, P1114, DOI 10.1002/pros.22986; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Dunki-Jacobs EM, 2014, BRIT J SURG, V101, P1113, DOI 10.1002/bjs.9536; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Faroja M, 2013, RADIOLOGY, V266, P462, DOI 10.1148/radiol.12120609; FISHBEIN MC, 1981, AM HEART J, V101, P593, DOI 10.1016/0002-8703(81)90226-X; Garcia PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103083; Kamalski DMA, 2014, EUR ARCH OTO-RHINO-L, V271, P1477, DOI 10.1007/s00405-013-2624-8; Lee EW, 2012, J VASC INTERV RADIOL, V23, P107, DOI 10.1016/j.jvir.2011.09.020; Lee EW, 2010, GUT LIVER, V4, pS99, DOI 10.5009/gnl.2010.4.S1.S99; Lee YJ, 2012, INVEST RADIOL, V47, P671, DOI 10.1097/RLI.0b013e318274b0df; Mansson C, 2014, ACTA RADIOL OPEN, V3, DOI 10.1177/2047981614556409; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Melenhorst MCAM, 2016, CARDIOVASC INTER RAD, V39, P117, DOI 10.1007/s00270-015-1126-z; Miller L, 2005, TECHNOL CANCER RES T, V4, P699, DOI 10.1177/153303460500400615; Narayanan G, 2014, CARDIOVASC INTER RAD, V37, P1523, DOI 10.1007/s00270-014-0988-9; Neal RE, 2013, CARDIOVASC INTER RAD, V36, P1638, DOI 10.1007/s00270-013-0704-1; Pavlin M, 2005, BIOPHYS J, V88, P4378, DOI 10.1529/biophysj.104.048975; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Sawas T, 2015, GASTROINTEST ENDOSC, V82, P256, DOI 10.1016/j.gie.2015.03.1980; Scheffer HJ, 2014, EUR RADIOL, V24, P2467, DOI 10.1007/s00330-014-3259-x; Scheffer HJ, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2058460115584111; Tol JA, 2015, GUT; van den Bos W, 2016, J VASC INTERV RADIOL, V27, P433, DOI 10.1016/j.jvir.2015.10.020; van Gemert MJC, 2015, PROSTATE, V75, P332, DOI 10.1002/pros.22913; Verdaasdonk RM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2338817; Wagstaff PGK, 2015, UROL ONCOL, V33, p168e1	30	20	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148457	10.1371/journal.pone.0148457	http://dx.doi.org/10.1371/journal.pone.0148457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844550	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800059
J	De Jesus, AM; Aghvami, M; Sander, EA				De Jesus, Aribet M.; Aghvami, Maziar; Sander, Edward A.			A Combined In Vitro Imaging and Multi-Scale Modeling System for Studying the Role of Cell Matrix Interactions in Cutaneous Wound Healing	PLOS ONE			English	Article							MECHANICAL BOUNDARY-CONDITIONS; HYPERTROPHIC SCAR FORMATION; CONTACT GUIDANCE; AVERAGING THEORY; COLLAGEN; FIBRIN; MANAGEMENT; ALIGNMENT; MECHANOTRANSDUCTION; MECHANOBIOLOGY	Many cell types remodel the extracellular matrix of the tissues they inhabit in response to a wide range of environmental stimuli, including mechanical cues. Such is the case in dermal wound healing, where fibroblast migrate into and remodel the provisional fibrin matrix in a complex manner that depends in part on the local mechanical environment and the evolving multi-scale mechanical interactions of the system. In this study, we report on the development of an image-based multi-scale mechanical model that predicts the short-term (24 hours), structural reorganization of a fibrin gel by fibroblasts. These predictive models are based on an in vitro experimental system where clusters of fibroblasts (i.e., explants) were spatially arranged into a triangular geometry onto the surface of fibrin gels that were subjected to either Fixed or Free in-plane mechanical constraints. Experimentally, regional differences in short-term structural remodeling and cell migration were observed for the two gel boundary conditions. A pilot experiment indicated that these small differences in the short-term remodeling of the fibrin gel translate into substantial differences in long-term (4 weeks) remodeling, particularly in terms of collagen production. The multi-scale models were able to predict some regional differences in remodeling and qualitatively similar reorganization patterns for the two boundary conditions. However, other aspects of the model, such as the magnitudes and rates of deformation of gel, did not match the experiments. These discrepancies between model and experiment provide fertile ground for challenging model assumptions and devising new experiments to enhance our understanding of how this multi-scale system functions. These efforts will ultimately improve the predictions of the remodeling process, particularly as it relates to dermal wound healing and the reduction of patient scarring. Such models could be used to recommend patient-specific mechanical-based treatment dependent on parameters such as wound geometry, location, age, and health.	[De Jesus, Aribet M.; Aghvami, Maziar; Sander, Edward A.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA	University of Iowa	Sander, EA (corresponding author), Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA.	edward-sander@uiowa.edu			National Institutes of Health [R03-AR063967]; National Science Foundation (CAREER) [1452728]; Carver Charitable Trust [14-4384]; U.S. Department of Education Graduate Assistance in Areas of National Need Fellowship (GAANN) [P200A120071]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR063967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (CAREER)(National Science Foundation (NSF)); Carver Charitable Trust; U.S. Department of Education Graduate Assistance in Areas of National Need Fellowship (GAANN); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Support for the work was provided by the National Institutes of Health (R03-AR063967), the National Science Foundation (CAREER 1452728), and the Carver Charitable Trust (#14-4384) to ES. A U.S. Department of Education Graduate Assistance in Areas of National Need Fellowship (GAANN P200A120071) supported AD.	Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Abhilash AS, 2014, BIOPHYS J, V107, P1829, DOI 10.1016/j.bpj.2014.08.029; Achterberg VF, 2014, J INVEST DERMATOL, V134, P1862, DOI 10.1038/jid.2014.90; Aghvami M, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024460; Akaishi S, 2010, PLAST RECONSTR SURG, V126, p109E, DOI 10.1097/PRS.0b013e3181df7073; Atkinson JAM, 2005, PLAST RECONSTR SURG, V116, P1648, DOI 10.1097/01.prs.0000187147.73963.a5; Baum BJ, 2006, BBA-BIOMEMBRANES, V1758, P1071, DOI 10.1016/j.bbamem.2005.11.006; Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P327, DOI 10.1115/1.1287158; Blackstone BN, 2012, ADV WOUND CARE, V1, P69, DOI 10.1089/wound.2011.0345; Bonet J., 1997, NONLINEAR CONTINUUM; CARR ME, 1988, THROMB HAEMOSTASIS, V59, P535; Chandran PL, 2007, J BIOMECH ENG-T ASME, V129, P137, DOI 10.1115/1.2472369; Chaubaroux C, 2015, TISSUE ENG C; Chen Margaret A, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P242, DOI 10.1097/01.moo.0000170525.74264.f8; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; De Jesus AM, 2014, JOVE-J VIS EXP, DOI 10.3791/50918; Derderian CA, 2005, ANN PLAS SURG, V55, P69, DOI 10.1097/01.sap.0000168160.86221.e9; Deshpande VS, 2006, P NATL ACAD SCI USA, V103, P14015, DOI 10.1073/pnas.0605837103; DICKINSON RB, 1994, ANN BIOMED ENG, V22, P342, DOI 10.1007/BF02368241; Duscher D, 2014, J BIOMECH, V47, P1997, DOI 10.1016/j.jbiomech.2014.03.031; Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G; Eming SA., 2012, DERMATOLOGY; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Evans ND, 2013, J MECH BEHAV BIOMED, V28, P397, DOI 10.1016/j.jmbbm.2013.04.023; Fernandez P, 2009, INTEGR BIOL-UK, V1, P252, DOI 10.1039/b822897c; Gaudet C, 2003, BIOPHYS J, V85, P3329, DOI 10.1016/S0006-3495(03)74752-3; Gauglitz GG, 2013, CLIN COSMET INV DERM, V6, P103, DOI 10.2147/CCID.S35252; Gold MH, 2014, DERMATOL SURG, V40, P817, DOI 10.1111/dsu.0000000000000049; Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107; Gurtner GC, 2011, ANN SURG, V254, P217, DOI 10.1097/SLA.0b013e318220b159; Hadi MF, 2012, MECH MATER, V44, P72, DOI 10.1016/j.mechmat.2011.07.003; Hadi MF, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007097; Hartmann A, 2006, BLOOD CELL MOL DIS, V36, P191, DOI 10.1016/j.bcmd.2005.12.033; Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587; John J, 2010, ANN BIOMED ENG, V38, P658, DOI 10.1007/s10439-009-9856-1; Kamath S, 2003, QJM-INT J MED, V96, P711, DOI 10.1093/qjmed/hcg129; Kessler-Becker D, 2004, BIOCHEM J, V379, P351, DOI 10.1042/BJ20031371; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Krishnan L, 2008, CARDIOVASC RES, V78, P324, DOI 10.1093/cvr/cvn055; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; Levinson H, 2013, ADV WOUND CARE, V2, P149, DOI 10.1089/wound.2012.0389; Lu F, 2011, ANN PLAS SURG, V66, P296, DOI 10.1097/SAP.0b013e3181ea1e9b; Manwaring ME, 2004, BIOMATERIALS, V25, P3631, DOI 10.1016/j.biomaterials.2003.10.043; Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064; Ogawa R, 2011, WOUND REPAIR REGEN, V19, pS2, DOI 10.1111/j.1524-475X.2011.00707.x; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Raghupathy R, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005170; Reinhardt JW, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024463; Robinson PS, 2009, TISSUE ENG PT A, V15, P2763, DOI 10.1089/ten.tea.2008.0426; Rouillard AD, 2014, BIOPHYS J, V106, P932, DOI 10.1016/j.bpj.2013.12.002; Sander EA, 2011, ANN BIOMED ENG, V39, P714, DOI 10.1007/s10439-010-0192-2; Sander EA, 2009, J BIOMED MATER RES A, V88A, P322, DOI 10.1002/jbm.a.31847; Sander EA, 2014, BIOMATERIALS AND REGENERATIVE MEDICINE, P295; Sander EA, 2009, P NATL ACAD SCI USA, V106, P17675, DOI 10.1073/pnas.0903716106; Sander EA, 2009, IEEE ENG MED BIOL, V28, P10, DOI 10.1109/MEMB.2009.932486; Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332; Stylianopoulos T, 2007, J BIOMECH ENG-T ASME, V129, P611, DOI 10.1115/1.2746387; Stylianopoulos T, 2007, COMPUT METHOD APPL M, V196, P2981, DOI 10.1016/j.cma.2006.06.019; Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105; Thomopoulos S, 2005, J BIOMECH ENG-T ASME, V127, P742, DOI 10.1115/1.1992525; Tranquillo Robert T., 1999, P27; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; Wang HL, 2013, P NATL ACAD SCI USA, V110, P20923, DOI 10.1073/pnas.1313662110; Weinbaum JS, 2013, CELL MOL BIOENG, V6, P279, DOI 10.1007/s12195-013-0289-4; Wong VW, 2013, ADV WOUND CARE, V2, P185, DOI 10.1089/wound.2012.0396; Wong VW, 2011, J INVEST DERMATOL, V131, P2186, DOI 10.1038/jid.2011.212; Yagmur C, 2010, PLAST RECONSTR SURG, V126, P426, DOI 10.1097/PRS.0b013e3181df715d; Yuan Ye K, 2011, J VIS EXP; Zarkoob H, 2015, CELL MOL BIOENG, V8, P32, DOI 10.1007/s12195-015-0377-8	72	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148254	10.1371/journal.pone.0148254	http://dx.doi.org/10.1371/journal.pone.0148254			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840835	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200112
J	Hummler, HD; Banke, K; Wolfson, MR; Buonocore, G; Ebsen, M; Bernhard, W; Tsikas, D; Fuchs, H				Hummler, Helmut D.; Banke, Katharina; Wolfson, Marla R.; Buonocore, Giuseppe; Ebsen, Michael; Bernhard, Wolfgang; Tsikas, Dimitrios; Fuchs, Hans			The Effects of Lung Protective Ventilation or Hypercapnic Acidosis on Gas Exchange and Lung Injury in Surfactant Deficient Rabbits	PLOS ONE			English	Article							OXIDATION PROTEIN PRODUCTS; PARTIAL LIQUID VENTILATION; PERMISSIVE HYPERCAPNIA; THERAPEUTIC HYPERCAPNIA; MECHANICAL VENTILATION; PULMONARY; BIRTH; INFLAMMATION; MORTALITY; VOLUME	Background Permissive hypercapnia has been shown to reduce lung injury in subjects with surfactant deficiency. Experimental studies suggest that hypercapnic acidosis by itself rather than decreased tidal volume may be a key protective factor. Objectives To study the differential effects of a lung protective ventilatory strategy or hypercapnic acidosis on gas exchange, hemodynamics and lung injury in an animal model of surfactant deficiency. Methods 30 anesthetized, surfactant-depleted rabbits were mechanically ventilated (FiO(2) = 0.8, PEEP = 7cmH(2)O) and randomized into three groups: Normoventilation-Normocapnia (NN)-group: tidal volume (Vt) = 7.5 ml/kg, target PaCO2 = 40 mmHg; Normoventilation-Hypercapnia (NH)-group: Vt = 7.5 ml/kg, target PaCO2 = 80 mmHg by increasing FiCO(2); and a Hypoventilation-Hypercapnia (HH)-group: Vt = 4.5 ml/kg, target PaCO2 = 80 mmHg. Plasma lactate and interleukin (IL)-8 were measured every 2 h. Animals were sacrificed after 6 h to perform bronchoalveolar lavage (BAL), to measure lung wet-to-dry weight, lung tissue IL-8, and to obtain lung histology. Results PaO2 was significantly higher in the HH-group compared to the NN-group (p<0.05), with values of the NH-group between the HH- and NN-groups. Other markers of lung injury (wet-dry-weight, BAL-Protein, histology-score, plasma-IL-8 and lung tissue IL-8) resulted in significantly lower values for the HH-group compared to the NN-group and trends for the NH-group towards lower values compared to the NN-group. Lactate was significantly lower in both hypercapnia groups compared to the NN-group. Conclusion Whereas hypercapnic acidosis may have some beneficial effects, a significant effect on lung injury and systemic inflammatory response is dependent upon a lower tidal volume rather than resultant arterial CO2 tensions and pH alone.	[Hummler, Helmut D.; Banke, Katharina; Fuchs, Hans] Univ Ulm, Dept Pediat, Childrens Hosp, Div Neonatol & Pediat Crit Care, D-89070 Ulm, Germany; [Wolfson, Marla R.] CENTRe Collaborat Environm & Neonatal Therapeut R, Dept Physiol, Philadelphia, PA USA; [Wolfson, Marla R.] CENTRe Collaborat Environm & Neonatal Therapeut R, Dept Med, Philadelphia, PA USA; [Wolfson, Marla R.] CENTRe Collaborat Environm & Neonatal Therapeut R, Dept Pediat, Philadelphia, PA USA; [Wolfson, Marla R.] Temple Lung Ctr, Philadelphia, PA USA; [Wolfson, Marla R.] Temple Univ, Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA; [Buonocore, Giuseppe] Univ Hosp Siena, Dept Mol & Dev Med, Pediat Neonatol Unit, Siena, Italy; [Ebsen, Michael] Staedt Krankenhaus Kiel, Med Versorgungszentrum, Inst Pathol, Kiel, Germany; [Bernhard, Wolfgang] Univ Tubingen, Childrens Hosp, Dept Neonatol, Tubingen, Germany; [Tsikas, Dimitrios] Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany	Ulm University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Siena; University Hospital of Siena; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Hannover Medical School	Hummler, HD (corresponding author), Univ Ulm, Dept Pediat, Childrens Hosp, Div Neonatol & Pediat Crit Care, D-89070 Ulm, Germany.	helmut.hummler@uni-ulm.de	Hummler, Helmut/AAN-7297-2021; Bernhard, Wolfgang/AAT-1393-2021; Buonocore, Giuseppe/U-3873-2019	Buonocore, Giuseppe/0000-0002-7921-7485; Bernhard, Wolfgang/0000-0003-0307-223X	Department of Defense/Office of Naval Research [N000141210597, N000141210810]	Department of Defense/Office of Naval Research(Office of Naval ResearchUnited States Department of Defense)	Work performed in this study was supported in part by the Department of Defense/Office of Naval Research N000141210597 and N000141210810 (MRW).	Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Bernhard W, 2007, PEDIATR PULM, V42, P794, DOI 10.1002/ppul.20657; Broccard AF, 2001, AM J RESP CRIT CARE, V164, P802, DOI 10.1164/ajrccm.164.5.2007060; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Buonocore G, 2000, PEDIATR RES, V47, P221, DOI 10.1203/00006450-200002000-00012; Carlo WA, 2002, J PEDIATR-US, V141, P370, DOI 10.1067/mpd.2002.127507; Clark RH, 2001, J PEDIATR-US, V139, P478, DOI 10.1067/mpd.2001.118201; COATES AL, 1991, PEDIATR PULM, V11, P350, DOI 10.1002/ppul.1950110413; Contreras M, 2012, CRIT CARE MED, V40, P2622, DOI 10.1097/CCM.0b013e318258f8b4; Doerr CH, 2005, AM J RESP CRIT CARE, V171, P1371, DOI 10.1164/rccm.200309-1223OC; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Feihl F, 2000, AM J RESP CRIT CARE, V162, P209, DOI 10.1164/ajrccm.162.1.9907119; Fritz KI, 2005, PEDIATR RES, V57, P299, DOI 10.1203/01.PDR.0000148718.47137.9B; Fuchs H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023816; Haitsma JJ, 2000, INTENS CARE MED, V26, P1515, DOI 10.1007/s001340000648; HICKLING KG, 1994, CRIT CARE MED, V22, P1568, DOI 10.1097/00003246-199422100-00011; HILLERED L, 1984, J CEREBR BLOOD F MET, V4, P430, DOI 10.1038/jcbfm.1984.62; HOOD VL, 1988, AM J PHYSIOL, V255, pF479, DOI 10.1152/ajprenal.1988.255.3.F479; Hood VL, 1998, NEW ENGL J MED, V339, P819, DOI 10.1056/NEJM199809173391207; Hummler HD, 2001, PEDIATR RES, V49, P572, DOI 10.1203/00006450-200104000-00021; Kantores C, 2006, AM J PHYSIOL-LUNG C, V291, pL912, DOI 10.1152/ajplung.00480.2005; LACHMANN B, 1980, ACTA ANAESTH SCAND, V24, P231, DOI 10.1111/j.1399-6576.1980.tb01541.x; Laffey JG, 2000, AM J RESP CRIT CARE, V162, P2287, DOI 10.1164/ajrccm.162.6.2003066; Lee WL, 2001, SEMIN RESP CRIT CARE, V22, P269, DOI 10.1055/s-2001-15784; Mariani G, 1999, PEDIATRICS, V104, P1082, DOI 10.1542/peds.104.5.1082; Masood A, 2009, AM J PHYSIOL-LUNG C, V297, pL920, DOI 10.1152/ajplung.00139.2009; NETO GS, 1992, PEDIATR PULM, V12, P146, DOI 10.1002/ppul.1950120304; Paffetti P, 2006, BIOL TRACE ELEM RES, V112, P221, DOI 10.1385/BTER:112:3:221; Rai S, 2004, PEDIATR RES, V55, P42, DOI 10.1203/01.PDR.0000098502.72182.55; Raith M, 2012, J APPL PHYSIOL, V112, P1317, DOI 10.1152/japplphysiol.00887.2011; Sinclair SE, 2002, AM J RESP CRIT CARE, V166, P403, DOI 10.1164/rccm.200112-117OC; STEINHART CR, 1983, AM J PHYSIOL, V244, pH46, DOI 10.1152/ajpheart.1983.244.1.H46; Strand M, 2003, PEDIATR RES, V53, P468, DOI 10.1203/01.PDR.0000049463.76133.8F; Subramanian Siva, 2011, Matern Child Health J, V15 Suppl 1, pS17, DOI 10.1007/s10995-011-0863-0; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; Thome UH, 2001, CRIT CARE MED, V29, P1175, DOI 10.1097/00003246-200106000-00018; Thome UH, 2006, BIOL NEONATE, V90, P218, DOI 10.1159/000092723; Thome UH, 2015, LANCET RESP MED, V3, P534, DOI 10.1016/S2213-2600(15)00204-0; Tomimatsu T, 2006, PEDIATR RES, V60, P711, DOI 10.1203/01.pdr.0000246308.37154.ce; Tsikas D, 2003, J CHROMATOGR B, V794, P237, DOI 10.1016/S1570-0232(03)00457-4; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Witko-Sarsat V, 1998, J IMMUNOL, V161, P2524; Wolthuis EK, 2008, ANESTHESIOLOGY, V108, P46, DOI 10.1097/01.anes.0000296068.80921.10; Yamamoto Y, 2001, J APPL PHYSIOL, V91, P1121, DOI 10.1152/jappl.2001.91.3.1121	44	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147807	10.1371/journal.pone.0147807	http://dx.doi.org/10.1371/journal.pone.0147807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840779	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200061
J	Jelen, V; de Jonge, R; Van de Peer, Y; Javornik, B; Jakse, J				Jelen, Vid; de Jonge, Ronnie; Van de Peer, Yves; Javornik, Branka; Jakse, Jernej			Complete mitochondrial genome of the Verticillium-wilt causing plant pathogen Verticillium nonalfalfae	PLOS ONE			English	Article							OPEN SOFTWARE; REVEALS; ORGANIZATION; EXPRESSION; EVOLUTION; VIRULENCE; ALIGNMENT; TOOL	Verticillium nonalfalfae is a fungal plant pathogen that causes wilt disease by colonizing the vascular tissues of host plants. The disease induced by hop isolates of V. nonalfalfae manifests in two different forms, ranging from mild symptoms to complete plant dieback, caused by mild and lethal pathotypes, respectively. Pathogenicity variations between the causal strains have been attributed to differences in genomic sequences and perhaps also to differences in their mitochondrial genomes. We used data from our recent Illumina NGS-based project of genome sequencing V. nonalfalfae to study the mitochondrial genomes of its different strains. The aim of the research was to prepare a V. nonalfalfae reference mitochondrial genome and to determine its phylogenetic placement in the fungal kingdom. The resulting 26,139 bp circular DNA molecule contains a full complement of the 14 "standard" fungal mitochondrial protein-coding genes of the electron transport chain and ATP synthase subunits, together with a small rRNA subunit, a large rRNA subunit, which contains ribosomal protein S3 encoded within a type IA-intron and 26 tRNAs. Phylogenetic analysis of this mitochondrial genome placed it in the Verticillium spp. lineage in the Glomerellales group, which is also supported by previous phylogenetic studies based on nuclear markers. The clustering with the closely related Verticillium dahliae mitochondrial genome showed a very conserved synteny and a high sequence similarity. Two distinguishing mitochondrial genome features were also found-a potential long non-coding RNA (orf414) contained only in the Verticillium spp. of the fungal kingdom, and a specific fragment length polymorphism observed only in V. dahliae and V. nubilum of all the Verticillium spp., thus showing potential as a species specific biomarker.	[Jelen, Vid; Javornik, Branka; Jakse, Jernej] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [de Jonge, Ronnie; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, Ghent, Belgium; [de Jonge, Ronnie; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Van de Peer, Yves] Bioinformat Inst Ghent, Technol Pk 927, B-9052 Ghent, Belgium; [Van de Peer, Yves] Univ Pretoria, Dept Genet, Genom Res Inst, ZA-0002 Pretoria, South Africa	University of Ljubljana; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Pretoria	Jelen, V (corresponding author), Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia.	vid.jelen1@gmail.com	de Jonge, Ronnie/I-3260-2016; Van de Peer, Yves/D-4388-2009; Van de Peer, Yves/AAE-7666-2019	de Jonge, Ronnie/0000-0001-5065-8538; Van de Peer, Yves/0000-0003-4327-3730; Van de Peer, Yves/0000-0003-4327-3730; Jakse, Jernej/0000-0002-8907-1627	grant - Javni sklad Republike Slovenije za razvoj kadrov in stipendije [163]; grant - Javna agencija za raziskovalno dejavnost Republike Slovenije [P4-0077]	grant - Javni sklad Republike Slovenije za razvoj kadrov in stipendije; grant - Javna agencija za raziskovalno dejavnost Republike Slovenije	VJ received the grant - Javni sklad Republike Slovenije za razvoj kadrov in stipendije - 163. JR (http://www.sklad-kadri.si) BJ received the grant - Javna agencija za raziskovalno dejavnost Republike Slovenije - P4-0077 (www.arrs.gov.si). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2014, GENOME BIOL EVOL, V6, P451, DOI 10.1093/gbe/evu028; Al-Reedy RM, 2012, FUNGAL GENET BIOL, V49, P2, DOI 10.1016/j.fgb.2011.11.008; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Broad Institute, 2014, VERT GROUP DAT; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cardoso MAG, 2007, YEAST, V24, P607, DOI 10.1002/yea.1500; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; de Jonge R, 2013, GENOME RES, V23, P1271, DOI 10.1101/gr.152660.112; Duressa D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-607; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Haas, 2015, TRANSDECODER; Hausner G, 2003, APPLIED MYCOLOGY AND BIOTECHNOLOGY, VOL 3, P101; Hegedusova E, 2014, CURR GENET, V60, P49, DOI 10.1007/s00294-013-0410-1; Himmelstrand K, 2014, CURR GENET, V60, P303, DOI 10.1007/s00294-014-0436-z; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Inderbitzin P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065990; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028341; Jung PP, 2012, G3-GENES GENOM GENET, V2, P1103, DOI 10.1534/g3.112.003152; Keyworth WG, 1942, ANN APPL BIOL, V29, P346, DOI 10.1111/j.1744-7348.1942.tb06138.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93; Li J, 2013, MICRO NANO LETT, V8, P8, DOI 10.1049/mnl.2012.0578; LI KN, 1994, APPL ENVIRON MICROB, V60, P4324, DOI 10.1128/AEM.60.12.4324-4331.1994; Litter J, 2005, ANTON LEEUW INT J G, V88, P249, DOI 10.1007/s10482-005-8544-x; LOWE TM, 1997, NUCL ACIDS RES, V25; Mandelc S, 2009, EUR J PLANT PATHOL, V125, P159, DOI 10.1007/s10658-009-9467-6; Mardanov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107536; Martin FN, 2010, PHYTOPATHOLOGY, V100, P1231, DOI 10.1094/PHYTO-12-09-0352; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Morgenstern I, 2012, FUNGAL BIOL-UK, V116, P489, DOI 10.1016/j.funbio.2012.01.010; NCBI, 2014, ORG GEN RES DAT; Pantou MP, 2006, CURR GENET, V50, P125, DOI 10.1007/s00294-006-0079-9; Pantou MP, 2005, FEMS MICROBIOL LETT, V245, P213, DOI 10.1016/j.femsle.2005.03.011; Radisek S, 2003, PLANT DIS, V87, P633, DOI 10.1094/PDIS.2003.87.6.633; Radisek S, 2006, EUR J PLANT PATHOL, V116, P301, DOI 10.1007/s10658-006-9061-0; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Seefelder S., 2009, CICH IHB IHGC INT HO, P67; Seidl MF, 2015, MOL PLANT MICROBE IN, V28, P362, DOI 10.1094/MPMI-06-14-0173-R; Sethuraman J, 2009, J MOL EVOL, V69, P372, DOI 10.1007/s00239-009-9291-9; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stone CL, 2010, MYCOLOGIA, V102, P887, DOI 10.3852/09-198; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Torriani SFF, 2014, FUNGAL GENET BIOL, V62, P34, DOI 10.1016/j.fgb.2013.11.001; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; [Universite de Montreal Centre Robert-Cedergren Bio-informatique et Genomique], 2014, RNA WEAS; van de Sande WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038654; Yoon H, 2012, J GEN APPL MICROBIOL, V58, P331; Youssar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074792; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao XQ, 2013, MICROBIOLOGYOPEN, V2, P308, DOI 10.1002/mbo3.74; 2007, EPPO B, V37, P528, DOI DOI 10.1111/J.1365-2338.2007.01160.X	64	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148525	10.1371/journal.pone.0148525	http://dx.doi.org/10.1371/journal.pone.0148525			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839950	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200143
J	Lin, LZ; Guo, LL; Zhang, WX; Cai, XB; Chen, DF; Wan, XJ				Lin, Lizhou; Guo, Lili; Zhang, Weixing; Cai, Xiaobo; Chen, Dafan; Wan, Xinjian			Novel Silicone-Coated I-125 Seeds for the Treatment of Extrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							MALIGNANT BILIARY OBSTRUCTION; BRUSH CYTOLOGY; METALLIC STENT; CANCER; MANAGEMENT; PATTERNS; QUALITY; GEL	I-125 seeds coated with titanium are considered a safe and effective interstitial brachytherapy for tumors, while the cost of I-125 seeds is a major problem for the patients implanting lots of seeds. The aim of this paper was to develop a novel silicone coating for I-125 seeds with a lower cost. In order to show the radionuclide utilization ratio, the silicone was coated onto the seeds using the electro-spinning method and the radioactivity was evaluated, then the anti-tumor efficacy of silicone I-125 seeds was compared with titanium I-125 seeds. The seeds were divided into four groups: A (control), B (pure silicone), C (silicone I-125), D (titanium I-125) at 2 Gy or 4 Gy. Their anti-tumour activity and mechanism were assessed in vitro and in vivo using a human extrahepatic cholangiocarcinoma cell line FRH-0201 and tumor-bearing BALB/c nude mice. The silicone I-125 seeds showed higher radioactivity; the rate of cell apoptosis in vitro and the histopathology in vivo demonstrated that the silicone I-125 seeds shared similar anti-tumor efficacy with the titanium I-125 seeds for the treatment of extrahepatic cholangiocarcinoma, while they have a much lower cost.	[Lin, Lizhou; Guo, Lili; Zhang, Weixing; Cai, Xiaobo; Chen, Dafan; Wan, Xinjian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Gastroenterol, Shanghai 200080, Peoples R China	Shanghai Jiao Tong University	Wan, XJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Gastroenterol, Shanghai 200080, Peoples R China.	wanxj_sh@163.com		Wan, Xinjian/0000-0002-4201-633X	Doctoral Fund of Education Administration for New Teacher [070162]	Doctoral Fund of Education Administration for New Teacher	This work was supported by Doctoral Fund of Education Administration for New Teacher (project code: 070162). The funding receiver was Xinjian Wan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2012, CANCER BIOTHER RADIO, V27, P317, DOI 10.1089/cbr.2011.0999; Chun HJ, 2010, J GASTROEN HEPATOL, V25, P234, DOI 10.1111/j.1440-1746.2009.06152.x; Daramwar PP, 2012, ANALYST, V137, P4564, DOI 10.1039/c2an35575b; Davila Jessica A., 2002, American Journal of Gastroenterology, V97, P3199; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Fanelli F, 2008, EUR RADIOL, V18, P911, DOI 10.1007/s00330-008-0852-x; Fung LCT, 1996, PERITON DIALYSIS INT, V16, P398; Han YH, 2006, ABDOM IMAGING, V31, P433, DOI 10.1007/s00261-005-8017-8; Hejna M, 1998, EUR J CANCER, V34, P977, DOI 10.1016/S0959-8049(97)10166-6; Kawada N, 2011, J GASTROEN HEPATOL, V26, P1247, DOI 10.1111/j.1440-1746.2011.06725.x; Khan SA, 2002, J HEPATOL, V37, P806, DOI 10.1016/S0168-8278(02)00297-0; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; Kim HS, 2002, GASTROINTEST ENDOSC, V55, P359, DOI 10.1067/mge.2002.121603; Kumar R, 2004, J GASTROEN HEPATOL, V19, P994, DOI 10.1111/j.1440-1746.2004.03415.x; Li G, 2013, BIOMATERIALS, V34, P9451, DOI 10.1016/j.biomaterials.2013.08.055; Liu Y, 2009, GASTROINTEST ENDOSC, V69, P1067, DOI 10.1016/j.gie.2008.08.033; Luman W, 1997, EUR J GASTROEN HEPAT, V9, P481, DOI 10.1097/00042737-199705000-00013; Ma JX, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-35; Miura Y, 2001, J Hepatobiliary Pancreat Surg, V8, P113, DOI 10.1007/s005340170032; Mulhonen V, 2009, ACTA BIOMATER, V5, P785, DOI 10.1016/j.actbio.2008.08.023; Naitoh I, 2009, J GASTROEN HEPATOL, V24, P552, DOI 10.1111/j.1440-1746.2008.05750.x; Ortner MA, 2004, PHOTODIAGN PHOTODYN, V1, P85, DOI 10.1016/S1572-1000(04)00013-4; Park SW, 2004, HEPATO-GASTROENTEROL, V51, P1612; Radin S, 2001, J BIOMED MATER RES, V57, P313, DOI 10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO;2-E; Rumalla A, 2001, MAYO CLIN PROC, V76, P29, DOI 10.4065/76.1.29; Shinchi H, 2000, J SURG ONCOL, V75, P89, DOI 10.1002/1096-9098(200010)75:2<89::AID-JSO3>3.3.CO;2-M; Shinohara ET, 2009, INT J RADIAT ONCOL, V74, P1191, DOI 10.1016/j.ijrobp.2008.09.017; Takahashi Yutaka, 2006, Radiat Med, V24, P675, DOI 10.1007/s11604-006-0088-0; Trombetta MG, 2008, BRACHYTHERAPY, V7, P50, DOI 10.1016/j.brachy.2007.11.003; Wang JJ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-88; Wang ZM, 2010, EUR RADIOL, V20, P1786, DOI 10.1007/s00330-009-1703-0	31	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147701	10.1371/journal.pone.0147701	http://dx.doi.org/10.1371/journal.pone.0147701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840346	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200055
J	de-Magistris, T; Gracia, A				de-Magistris, Tiziana; Gracia, Azucena			Assessing Projection Bias in Consumers' Food Preferences	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; APPETITE; AUCTION; MARKETS; FUTURE; CHOICE; WOMEN	The aim of this study is to test whether projection bias exists in consumers' purchasing decisions for food products. To achieve our aim, we used a non-hypothetical experiment (i.e., experimental auction), where hungry and non-hungry participants were incentivized to reveal their willingness to pay (WTP). The results confirm the existence of projection bias when consumers made their decisions on food products. In particular, projection bias existed because currently hungry participants were willing to pay a higher price premium for cheeses than satiated ones, both in hungry and satiated future states. Moreover, participants overvalued the food product more when they were delivered in the future hungry condition than in the satiated one. Our study provides clear, quantitative and meaningful evidence of projection bias because our findings are based on economic valuation of food preferences. Indeed, the strength of this study is that findings are expressed in terms of willingness to pay which is an interpretable amount of money.	[de-Magistris, Tiziana; Gracia, Azucena] Ctr Invest & Tecnol Agroalimentaria Aragon Zarago, Unidad Econ Agroalimentaria, Zaragoza, Spain; [de-Magistris, Tiziana; Gracia, Azucena] Univ Zaragoza, CITA, Inst Agroalimentario Aragon IA2, Zaragoza, Spain	University of Zaragoza	de-Magistris, T (corresponding author), Ctr Invest & Tecnol Agroalimentaria Aragon Zarago, Unidad Econ Agroalimentaria, Zaragoza, Spain.; de-Magistris, T (corresponding author), Univ Zaragoza, CITA, Inst Agroalimentario Aragon IA2, Zaragoza, Spain.	tmagistris@aragon.es	, Azucena/N-6263-2019	de Magistris, Tiziana/0000-0001-5480-183X	EU Marie Curie Project [FOODLABELS_PIOF-GA-2009-253323]	EU Marie Curie Project(European Commission)	This study has been funded by the EU Marie Curie Project, FOODLABELS_PIOF-GA-2009-253323, entitled "Do consumers value food labels? An assessment of the impact of information and personality traits on the demand for food labels."	Alfnes F, 2003, AM J AGR ECON, V85, P396, DOI 10.1111/1467-8276.t01-1-00128; Alfnes F, 2009, EUR REV AGRIC ECON, V36, P133, DOI 10.1093/erae/jbp013; Becker G., 1964, BEHAV SCI, V9, P22; Bernard John C., 2010, AGR RESOURCE EC REV, V39, P275; Bolles R.C., 1967, THEORY OF MOTIVATION; Briz T., 2015, AGR FOOD AND EC, V3, P22; Cox JC, 1996, ECON THEORY, V7, P381, DOI 10.1007/BF01213657; De Magistris T, 2015, J CONSUM AFF, V49, P457, DOI 10.1111/joca.12046; Gilbert DT, 2002, ORGAN BEHAV HUM DEC, V88, P430, DOI 10.1006/obhd.2001.2982; Hellyer NE, 2012, FOOD POLICY, V37, P232, DOI 10.1016/j.foodpol.2012.02.005; Keim NL, 1998, AM J CLIN NUTR, V68, P794, DOI 10.1093/ajcn/68.4.794; Loewenstein G, 2005, HEALTH PSYCHOL, V24, pS49, DOI 10.1037/0278-6133.24.4.S49; Loewenstein G, 2003, Q J ECON, V118, P1209, DOI 10.1162/003355303322552784; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; Lusk J.L., 2005, EXPT METHODS ENV RES; Lusk JL, 2007, QUANT METH APPL ECON; Noussair C, 2004, J ECON PSYCHOL, V25, P725, DOI 10.1016/j.joep.2003.06.004; Poppitt SD, 1998, PHYSIOL BEHAV, V64, P279, DOI 10.1016/S0031-9384(98)00061-4; Read D, 1998, ORGAN BEHAV HUM DEC, V76, P189, DOI 10.1006/obhd.1998.2803; Shogren JF, 2006, ENVIRON RESOUR ECON, V34, P163, DOI 10.1007/s10640-005-3785-8; Shogren JF, 2001, J ECON BEHAV ORGAN, V46, P409, DOI 10.1016/S0167-2681(01)00165-2	21	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0146308	10.1371/journal.pone.0146308	http://dx.doi.org/10.1371/journal.pone.0146308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828930	Green Published, gold			2022-12-26	WOS:000369548200007
J	Norback, D; Hashim, JH; Cai, GH; Hashim, Z; Ali, F; Bloom, E; Larsson, L				Norback, Dan; Hashim, Jamal Hisham; Cai, Gui-Hong; Hashim, Zailina; Ali, Faridah; Bloom, Erica; Larsson, Lennart			Rhinitis, Ocular, Throat and Dermal Symptoms, Headache and Tiredness among Students in Schools from Johor Bahru, Malaysia: Associations with Fungal DNA and Mycotoxins in Classroom Dust	PLOS ONE			English	Article							SICK BUILDING SYNDROME; STACHYBOTRYS-CHARTARUM; RESPIRATORY HEALTH; MASS-SPECTROMETRY; PUPILS; MOLDS; AIR; ASPERGILLUS; COMPONENTS; ALLERGENS	There are few studies on rhinitis and sick building syndrome (SBS) among students in tropical countries. We studied associations between levels of five fungal DNA sequences, two mycotoxins (sterigmatocystin and verrucarol) and cat allergen (Fel d 1) levels in schools and rhinitis and other weekly SBS symptoms in the students. Fungal DNA was measured by quantitative PCR and cat allergen by ELISA. Pupils (N = 462) from eight randomly selected schools in Johor Bahru, Malaysia participated (96%). Dust samples were collected by cotton swabs and Petri dishes exposed for one week. None of the schools had a mechanical ventilation system, but all classrooms had openable windows that were kept open during lectures and indoor CO2 levels were low (mean 492 ppm; range 380-690 ppm). Weekly nasal symptoms (rhinitis) (18.8%), ocular (11.6%), throat (11.1%), dermal symptoms, headache (20.6%) and tiredness (22.1%) were common. Total fungal DNA in swab samples was associated with rhinitis (p = 0.02), ocular symptoms (p = 0.009) and tiredness (p = 0.001). There were positive associations between Aspergillus versicolor DNA in Petri dish samples, ocular symptoms (p = 0.02) and tiredness (p = 0.001). The level of the mycotoxin verrucarol (produced by Stachybotrys chartarum) in swab samples was positively associated with tiredness (p = 0.04). Streptomyces DNA in swab samples (p = 0.03) and Petri dish samples (p = 0.03) were negatively associated with tiredness. In conclusion, total fungal contamination, measured as total fungal DNA) in the classrooms, Aspergillus versicolor and verrucarol can be risk factors for rhinitis and SBS symptoms among students in the tropical country Malaysia.	[Norback, Dan; Cai, Gui-Hong] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden; [Hashim, Jamal Hisham] United Nations Univ, Int Inst Global Hlth, Kuala Lumpur, Malaysia; [Hashim, Jamal Hisham] Natl Univ Malaysia, Dept Community Hlth, Kuala Lumpur, Malaysia; [Hashim, Zailina] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Environm & Occupat Hlth, Serdang 43400, Selangor, Malaysia; [Ali, Faridah] Johor State Hlth Dept, Primary Care Unit, Johor Baharu, Malaysia; [Bloom, Erica] IVL Swedish Environm Res Inst Ltd, Stockholm, Sweden; [Bloom, Erica; Larsson, Lennart] Lund Univ, Dept Lab Med, Div Med Microbiol, Lund, Sweden	Uppsala University; Universiti Kebangsaan Malaysia; Universiti Putra Malaysia; IVL Swedish Environmental Research Institute; Lund University	Norback, D (corresponding author), Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden.	dan.norback@medci.uu.se		Bloom, Erica/0000-0001-7893-6042	Swedish Council for Environmental and Agricultural Science and Spatial Planning (FORMAS) [244-2008-68]; Swedish Asthma and Allergy Association's Research Foundation [2013020-K]; Swedish International Development Agency (SIDA) [348-2004-5596]; Swedish Research Council (VR) [348-2013-6762]; Swedish Foundation for Health Care Sciences and Allergy research; IVL Swedish Environmental Research Institute Ltd	Swedish Council for Environmental and Agricultural Science and Spatial Planning (FORMAS); Swedish Asthma and Allergy Association's Research Foundation; Swedish International Development Agency (SIDA); Swedish Research Council (VR)(Swedish Research Council); Swedish Foundation for Health Care Sciences and Allergy research; IVL Swedish Environmental Research Institute Ltd(IVL Swedish Environmental Research Institute)	This study was supported by grants from the Swedish Council for Environmental and Agricultural Science and Spatial Planning (FORMAS) (grant nr 244-2008-68), the Swedish Asthma and Allergy Association's Research Foundation and (grant nr 2013020-K), Swedish International Development Agency (SIDA) (grant 348-2004-5596), Swedish Research Council (VR)/grant nr 348-2013-6762), and the Swedish Foundation for Health Care Sciences and Allergy research. The corresponding author was the recipient of all funding. The funders supported the project financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IVL Swedish Environmental Research Institute Ltd provided support in the form of salaries for authors [EB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0112-7; APTER A, 1994, J ALLERGY CLIN IMMUN, V94, P277, DOI 10.1016/0091-6749(94)90087-6; ASHRAE, 1999, VENT ACC IND AIR QUA; Bholah R, 2002, INT J ENVIRON HEAL R, V12, P93, DOI 10.1080/09603120120110095; Bloom E, 2007, APPL ENVIRON MICROB, V73, P4211, DOI 10.1128/AEM.00343-07; Bloom E, 2009, J OCCUP ENVIRON HYG, V6, P671, DOI 10.1080/15459620903252053; Brewer JH, 2013, TOXINS, V5, P605, DOI 10.3390/toxins5040605; Cai GH, 2011, PEDIAT ALLERG IMM-UK, V22, P290, DOI 10.1111/j.1399-3038.2010.01127.x; Daisey JM, 2003, INDOOR AIR, V13, P53, DOI 10.1034/j.1600-0668.2003.00153.x; Fox A, 2005, J ENVIRON MONITOR, V7, P450, DOI 10.1039/b418038k; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Haugland RA, 2004, SYST APPL MICROBIOL, V27, P198, DOI 10.1078/072320204322881826; Hirvonen MR, 2005, INDOOR AIR, V15, P65, DOI 10.1111/j.1600-0668.2005.00345.x; HODGSON M, 1995, OCCUP MED, V10, P167; Jarvis BB, 2005, APPL MICROBIOL BIOT, V66, P367, DOI 10.1007/s00253-004-1753-9; Jarvis BB, 2003, PHYTOCHEMISTRY, V64, P53, DOI 10.1016/S0031-9422(03)00275-9; Jarvis Bruce B., 1995, Natural Toxins, V3, P10, DOI 10.1002/nt.2620030104; Johansson E, 2011, INDOOR AIR, V21, P300, DOI 10.1111/j.1600-0668.2010.00702.x; Karlsson AS, 2002, ALLERGY, V57, P164, DOI 10.1034/j.1398-9995.2002.1s3297.x; Kim JL, 2011, J KOREAN MED SCI, V26, P166, DOI 10.3346/jkms.2011.26.2.166; Kim JL, 2005, INDOOR AIR, V15, P170, DOI 10.1111/j.1600-0668.2005.00334.x; Larsson L, 2008, J ENVIRON MONITOR, V10, P301, DOI 10.1039/b718584g; Mendell MJ, 2005, INDOOR AIR, V15, P27, DOI 10.1111/j.1600-0668.2004.00320.x; Meyer HW, 2005, INDOOR AIR, V15, P17, DOI 10.1111/j.1600-0668.2005.00356.x; Mi YH, 2006, INDOOR AIR, V16, P454, DOI 10.1111/j.1600-0668.2006.00439.x; Miller JD, 2010, CHEM-BIOL INTERACT, V183, P113, DOI 10.1016/j.cbi.2009.09.023; Miller JD, 2003, MED MYCOL, V41, P271, DOI 10.1080/1369378031000137350; Norback D, 2011, J ENVIRON MONITOR, V13, P2895, DOI 10.1039/c1em10439j; Norback D, 2009, CURR OPIN ALLERGY CL, V9, P55, DOI 10.1097/ACI.0b013e32831f8f08; Peitzsch M, 2012, J ENVIRON MONITOR, V14, P2044, DOI 10.1039/c2em30195d; Raja S, 2010, ENVIRON INT, V36, P8, DOI 10.1016/j.envint.2009.09.001; Rand TG, 2011, CHEM-BIOL INTERACT, V190, P139, DOI 10.1016/j.cbi.2011.02.017; Redlich CA, 1997, LANCET, V349, P1013, DOI 10.1016/S0140-6736(96)07220-0; Roussel S, 2012, INDOOR AIR, V22, P514, DOI 10.1111/j.1600-0668.2012.00781.x; Sahlberg B, 2010, SCAND J PUBLIC HEALT, V38, P232, DOI 10.1177/1403494809350517; Sahlberg B, 2009, INT ARCH OCC ENV HEA, V82, P1211, DOI 10.1007/s00420-009-0444-3; Sahlberg B, 2012, INDOOR AIR, V129, P420; Saijo Yasuaki, 2010, Environmental Health and Preventive Medicine, V15, P276, DOI 10.1007/s12199-010-0139-0; Salo PM, 2009, J ALLERGY CLIN IMMUN, V124, P185, DOI 10.1016/j.jaci.2009.05.012; Scheepers PTJ, 2003, ANN OCCUP HYG, V47, P379, DOI 10.1093/annhyg/meg036; Simoni M, 2011, PEDIAT ALLERG IMM-UK, V22, P843, DOI 10.1111/j.1399-3038.2011.01208.x; Sudakin DL, 1998, AM J IND MED, V34, P183, DOI 10.1002/(SICI)1097-0274(199808)34:2&lt;183::AID-AJIM12&gt;3.0.CO;2-R; Takaoka Motoko, 2015, Glob J Health Sci, V8, P165, DOI 10.5539/gjhs.v8n2p165; Tischer C, 2011, EUR RESPIR J, V38, P812, DOI 10.1183/09031936.00184010; Vesper SJ, 2005, LETT APPL MICROBIOL, V41, P367, DOI 10.1111/j.1472-765X.2005.01764.x; Wan GH, 1999, ARCH ENVIRON HEALTH, V54, P58, DOI 10.1080/00039899909602238; WHO Regional Office for Europe, WHO GUID IND AIR QUA; World Health Organization, 1983, WHO REG OFF EUR EURO, V78, P1; Zhang X, 2011, INDOOR AIR, V21, P462, DOI 10.1111/j.1600-0668.2011.00726.x; Zhang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112933; Zhang X, 2011, SCI TOTAL ENVIRON, V409, P5253, DOI 10.1016/j.scitotenv.2011.08.059	51	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147996	10.1371/journal.pone.0147996	http://dx.doi.org/10.1371/journal.pone.0147996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829324	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000369548200050
J	Pich, C; Teiti, I; Sarrabayrouse, G; Gallardo, F; Gence, R; Tilkin-Mariame, AF				Pich, Christine; Teiti, Iotefa; Sarrabayrouse, Guillaume; Gallardo, Franck; Gence, Remi; Tilkin-Mariame, Anne-Francoise			Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity	PLOS ONE			English	Article							METASTATIC MELANOMA; CD70 EXPRESSION; CELLS; BRAF; CANCER; MIGRATION; INHIBITION; INVASION; IMMUNITY; GTPASES	CD70 is a costimulatory molecule member of the Tumor Necrosis Factor family that is expressed on activated immune cells. Its ectopic expression has been described in several types of cancer cells including lymphomas, renal cell carcinomas and glioblastomas. We have recently described its expression in a part of tumor cells from the vast majority of melanoma biopsies and human melanoma cell lines, and found that CD70 expression decreased over time as the disease progressed. Here, we show that RhoA, BRAF and Mitogen Activating Protein Kinase pathways are involved in the positive transcriptional regulation of CD70 expression in melanomas. Interestingly, the clinical inhibitor of the common BRAF V600E/D variants, Vemurafenib (PLX-4032), which is currently used to treat melanoma patients with BRAF V600E/D-mutated metastatic melanomas, decreased CD70 expression in human CD70+ melanoma cell lines. This decrease was seen in melanoma cells both with and without the BRAFV600E/D mutation, although was less efficient in those lacking the mutation. But interestingly, by silencing CD70 in CD70+ melanoma cell lines we show that PLX-4032-induced melanoma cell killing and its inhibitory effect on MAPK pathway activation are unaffected by CD70 expression. Consequently, our work demonstrates that CD70 ectopic expression in melanomas is not a valuable biomarker to predict tumor cells sensitivity to BRAF V600 inhibitors.	[Pich, Christine; Teiti, Iotefa; Sarrabayrouse, Guillaume; Gence, Remi] CRCT, INSERM, UMR 1037, FR-31037 Toulouse, France; [Pich, Christine; Teiti, Iotefa; Sarrabayrouse, Guillaume; Gence, Remi; Tilkin-Mariame, Anne-Francoise] Univ Toulouse 3, FR-31062 Toulouse, France; [Gallardo, Franck] NeoVirTech, Inst Sci Vivant, FR-31106 Toulouse, France; [Tilkin-Mariame, Anne-Francoise] INSERM, IRSD, U1220, FR-31024 Toulouse, France; [Pich, Christine] Univ Lausanne, CIG, CH-1015 Lausanne, Switzerland; [Sarrabayrouse, Guillaume] Univ Hosp Vall Hebron, Digest Syst Res Unit, Passeig Vall Hebron 119-129, E-08035 Barcelona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Lausanne; Hospital Universitari Vall d'Hebron	Tilkin-Mariame, AF (corresponding author), Univ Toulouse 3, FR-31062 Toulouse, France.; Tilkin-Mariame, AF (corresponding author), INSERM, IRSD, U1220, FR-31024 Toulouse, France.	anne-francoise.tilkin@inserm.fr	Gence, Rémi/O-8961-2014	Gence, Rémi/0000-0003-0747-3540; Pich-Bavastro, Christine/0000-0002-6526-749X	Institut National de la Sante et de la Recherche Medicale; La Ligue contre le Cancer; Association pour la Recherche contre le Cancer; Ministere de l'Enseignement Superieur et de la Recherche; Institut Claudius Regaud	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); La Ligue contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ministere de l'Enseignement Superieur et de la Recherche; Institut Claudius Regaud	This work was supported by the Institut National de la Sante et de la Recherche Medicale, La Ligue contre le Cancer, Association pour la Recherche contre le Cancer, Ministere de l'Enseignement Superieur et de la Recherche, and Institut Claudius Regaud. The funder NeoVirTech provided support in the form of salaries for F Gallardo, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ades F, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/259170; Brown M, 2014, BRIT J CANCER, V110, P2099, DOI 10.1038/bjc.2014.99; Brozyna AA, 2013, HUM PATHOL, V44, P374, DOI 10.1016/j.humpath.2012.03.031; Chahlavi A, 2005, CANCER RES, V65, P5428, DOI 10.1158/0008-5472.CAN-04-4395; Chinestra P, 2012, METHODS MOL BIOL, V827, P283, DOI 10.1007/978-1-61779-442-1_19; Cormary C, 2005, CANCER GENE THER, V12, P963, DOI 10.1038/sj.cgt.7700861; Denoeud J, 2011, J LEUKOCYTE BIOL, V89, P195, DOI 10.1189/jlb.0610351; Dua P, 2008, EUR J CANCER, V44, P1587, DOI 10.1016/j.ejca.2008.04.009; Flaherty L, 2014, CANCER J, V20, P18, DOI 10.1097/PPO.0000000000000024; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Gampel A, 2002, BIOCHEM J, V366, P393, DOI 10.1042/BJ20020844; Garcia P, 2004, J LEUKOCYTE BIOL, V76, P263, DOI 10.1189/jlb.1003508; Grewal IS, 2008, EXPERT OPIN THER TAR, V12, P341, DOI 10.1517/14728222.12.3.341; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Jang S, 2014, CLIN PHARMACOL THER, V95, P24, DOI 10.1038/clpt.2013.197; Janjetovic Z, 2011, BRIT J CANCER, V105, P1874, DOI 10.1038/bjc.2011.458; Jilaveanu LB, 2012, HUM PATHOL, V43, P1394, DOI 10.1016/j.humpath.2011.10.014; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Lu QJ, 2005, J IMMUNOL, V174, P6212, DOI 10.4049/jimmunol.174.10.6212; Makrodouli E, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-118; Mehnert JM, 2012, CURR ONCOL REP, V14, P449, DOI 10.1007/s11912-012-0249-5; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; Pereira AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101963; Pich CS G, 2015, BRIT J CANC IN PRESS; Ridley AJ, 2012, METHODS MOL BIOL, V827, P3, DOI 10.1007/978-1-61779-442-1_1; Ruth MC, 2006, J INVEST DERMATOL, V126, P862, DOI 10.1038/sj.jid.5700211; Saldanha G, 2006, CLIN CANCER RES, V12, P4499, DOI 10.1158/1078-0432.CCR-05-2447; Sapkota B, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22890; Sarrabayrouse G, 2007, NEOPLASIA, V9, P1078, DOI 10.1593/neo.07727; Sarrabayrouse G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009043; Tilkin-Mariame AF, 2005, FASEB J, V19, P1513, DOI 10.1096/fj.04-3482fje; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039	32	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148095	10.1371/journal.pone.0148095	http://dx.doi.org/10.1371/journal.pone.0148095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828592	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200059
J	Uribe-Convers, S; Settles, ML; Tank, DC				Uribe-Convers, Simon; Settles, Matthew L.; Tank, David C.			A Phylogenomic Approach Based on PCR Target Enrichment and High Throughput Sequencing: Resolving the Diversity within the South American Species of Bartsia L. (Orobanchaceae)	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; PARTITIONING SCHEMES; MICROBIAL COMMUNITY; GENE-EXPRESSION; PLASTID GENOME; EVOLUTIONARY; CHLOROPLAST; DNA; UTILITY; PLANTS	Advances in high-throughput sequencing (HTS) have allowed researchers to obtain large amounts of biological sequence information at speeds and costs unimaginable only a decade ago. Phylogenetics, and the study of evolution in general, is quickly migrating towards using HTS to generate larger and more complex molecular datasets. In this paper, we present a method that utilizes microfluidic PCR and HTS to generate large amounts of sequence data suitable for phylogenetic analyses. The approach uses the Fluidigm Access Array System (Fluidigm, San Francisco, CA, USA) and two sets of PCR primers to simultaneously amplify 48 target regions across 48 samples, incorporating sample-specific barcodes and HTS adapters (2,304 unique amplicons per Access Array). The final product is a pooled set of amplicons ready to be sequenced, and thus, there is no need to construct separate, costly genomic libraries for each sample. Further, we present a bioinformatics pipeline to process the raw HTS reads to either generate consensus sequences (with or without ambiguities) for every locus in every sample or-more importantly-recover the separate alleles from heterozygous target regions in each sample. This is important because it adds allelic information that is well suited for coalescent-based phylogenetic analyses that are becoming very common in conservation and evolutionary biology. To test our approach and bioinformatics pipeline, we sequenced 576 samples across 96 target regions belonging to the South American clade of the genus Bartsia L. in the plant family Orobanchaceae. After sequencing cleanup and alignment, the experiment resulted in similar to 25,300bp across 486 samples for a set of 48 primer pairs targeting the plastome, and similar to 13,500bp for 363 samples for a set of primers targeting regions in the nuclear genome. Finally, we constructed a combined concatenated matrix from all 96 primer combinations, resulting in a combined aligned length of similar to 40,500bp for 349 samples.	[Uribe-Convers, Simon; Settles, Matthew L.; Tank, David C.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Uribe-Convers, Simon; Settles, Matthew L.; Tank, David C.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Uribe-Convers, Simon; Tank, David C.] Univ Idaho, Stillinger Herbarium, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Uribe-Convers, S (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.; Uribe-Convers, S (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA.; Uribe-Convers, S (corresponding author), Univ Idaho, Stillinger Herbarium, Moscow, ID 83843 USA.	uribe.convers@gmail.com	Settles, Matthew L/F-2031-2011	Settles, Matthew L/0000-0002-3424-1086	National Science Foundation [DEB-1210895, DEB-1253463]; University of Idaho; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448, P20RR016454] Funding Source: NIH RePORTER; Direct For Biological Sciences [1253463] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Idaho; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by the National Science Foundation (DEB-1210895, http://www.nsf.gov/awardsearch/showAward?AWD_ID= 1210895&HistoricalAwards=false to DCT for SUC, and DEB-1253463, http://www.nsf.gov/awardsearch/showAward?AWD_ID=1253463, to DCT) and the University of Idaho Student Grant Program to SUC. Fieldwork was supported in part by the University of Idaho Graduate Student Research Awards to SUC, by the Society of Systematic Biologists (SSB) to SUC, the Botanical Society of America (BSA) to SUC, the American Society of Plant Taxonomists (ASPT) to SUC, and the University of Idaho Stillinger Herbarium Expedition Funds to SUC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Baldwin BG, 1992, MOL PHYLOGENET EVOL, V1, P3, DOI 10.1016/1055-7903(92)90030-K; Bao SY, 2011, J HUM GENET, V56, P687, DOI [10.1038/jhg.2011.91, 10.1038/jhg.2011.62]; Bhat S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039181; Bi K, 2013, MOL ECOL, V22, P6018, DOI 10.1111/mec.12516; Bi K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-403; Bivand R., 2015, MAPTOOLS TOOLS READI; Bogart J.P., 1980, Basic Life Sciences, V13, P341; Bombarely A, 2011, NUCLEIC ACIDS RES, V39, pD1149, DOI 10.1093/nar/gkq866; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; CANNATELLA DC, 1993, SYST BIOL, V42, P476, DOI 10.2307/2992485; Carrothers JM, 2015, J NUTR, V145, P2379, DOI 10.3945/jn.115.211110; Chamala S, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400115; Chase MW, 1993, JSTOR, P528; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Crowl AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094199; Cruaud A, 2014, MOL BIOL EVOL, V31, P1272, DOI 10.1093/molbev/msu063; Curk F, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0152-1; Dai J, 2015, BIORESOURCE TECHNOL, V175, P23, DOI 10.1016/j.biortech.2014.10.049; Deckmyn M, MAPS DRAW GEOGRAPHIC; Dominguez MH, 2013, J IMMUNOL METHODS, V391, P133, DOI 10.1016/j.jim.2013.03.002; Downie S, 1992, MOL SYSTEMATICS PLAN, P14, DOI DOI 10.1007/978-1-4615-3276-7_2; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Gaedcke J, 2012, CLIN CANCER RES, V18, P4919, DOI 10.1158/1078-0432.CCR-12-0016; Genome 10K Community of Scientists, 2009, J Hered, V100, P659, DOI 10.1093/jhered/esp086; Godden GT, 2012, PLANT ECOL DIVERS, V5, P427, DOI 10.1080/17550874.2012.745909; Gostel MR, 2015, J SYST EVOL, V53, P411, DOI 10.1111/jse.12173; Graham SW, 2000, AM J BOT, V87, P1712, DOI 10.2307/2656749; Hermann-Bank ML, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-788; Hijmans RJ, RASTER GEOGRAPHIC DA; Ilut DC, 2012, SYST BOT, V37, P7, DOI 10.1600/036364412X616576; Jones JC, 2013, MOL ECOL, V22, P2986, DOI 10.1111/mec.12269; Judd WS, 2007, BRITTONIA, V59, P217, DOI 10.1663/0007-196X(2007)59[217:TDANSF]2.0.CO;2; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knowles LL, 2010, ESTIMATING SPECIES T; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leggatt RA, 2003, REV FISH BIOL FISHER, V13, P237, DOI 10.1023/B:RFBF.0000033049.00668.fe; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Li MG, 2008, CLADISTICS, V24, P727, DOI 10.1111/j.1096-0031.2008.00207.x; Liang S, 2015, BIORESOURCE TECHNOL, V179, P268, DOI 10.1016/j.biortech.2014.12.032; Linnen CR, 2008, SYST BIOL, V57, P876, DOI 10.1080/10635150802580949; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Lokki J., 1980, Basic Life Sciences, V13, P277; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Male PJG, 2014, MOL ECOL RESOUR, V14, P966, DOI 10.1111/1755-0998.12246; Mandel JR, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300085; Marx HE, 2010, AM J BOT, V97, P1647, DOI 10.3732/ajb.1000144; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; McCormack JE, 2012, GENOME RES, V22, P746, DOI 10.1101/gr.125864.111; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Molau U., 1990, OPERA BOT, V102, P1; Moonsamy PV, 2013, TISSUE ANTIGENS, V81, P141, DOI 10.1111/tan.12071; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2011, INT J PLANT SCI, V172, P541, DOI 10.1086/658923; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; O'Neill EM, 2013, MOL ECOL, V22, P111, DOI 10.1111/mec.12049; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; R Development Core Team RDC, 2013, R A LANGUAGE AND ENV; Rambaut A., 2004, TRACER; Rannala B, 2003, GENETICS, V164, P1645; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Salamone I, 2013, AM J BOT, V100, P939, DOI 10.3732/ajb.1200624; Schmickl R, 2016, MOL ECOL RESOUR, V16, P1124, DOI 10.1111/1755-0998.12487; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Smith BT, 2014, SYST BIOL, V63, P83, DOI 10.1093/sysbio/syt061; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Straub SCK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-211; Straub SCK, 2013, GENOME BIOL EVOL, V5, P1872, DOI 10.1093/gbe/evt140; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Stull GW, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200497; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tennessen JA, 2013, G3-GENES GENOM GENET, V3, P1341, DOI 10.1534/g3.113.006288; Tepe EJ, 2011, AM J BOT, V98, P1356, DOI 10.3732/ajb.1000516; Thiers B., INDEX HERBARIORUM GL; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Uribe-Convers S., 2014, THESIS U IDAHO; Uribe-Convers S, 2015, AM J BOT, V102, P1854, DOI 10.3732/ajb.1500229; Uribe-Convers S, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300063; Walter K, 2012, CLIN CANCER RES, V18, P2360, DOI 10.1158/1078-0432.CCR-11-2635-T; Weitemier K, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400042; WOLFE KH, 1989, J MOL EVOL, V29, P208, DOI 10.1007/BF02100204; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Xi ZX, 2012, P NATL ACAD SCI USA, V109, P17519, DOI 10.1073/pnas.1205818109; Yuan YW, 2008, AM J BOT, V95, P1166, DOI 10.3732/ajb.0800133; Yuan YW, 2010, MOL PHYLOGENET EVOL, V54, P23, DOI 10.1016/j.ympev.2009.08.029; Yuan YW, 2009, NEW PHYTOL, V182, P272, DOI 10.1111/j.1469-8137.2008.02739.x; Zwickl D. J, 2006, GENETIC ALGORITHM AP	106	57	57	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148203	10.1371/journal.pone.0148203	http://dx.doi.org/10.1371/journal.pone.0148203			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828929	gold, Green Submitted, Green Published			2022-12-26	WOS:000369548200083
J	Coudray-Meunier, C; Fraisse, A; Martin-Latil, S; Delannoy, S; Fach, P; Perelle, S				Coudray-Meunier, Coralie; Fraisse, Audrey; Martin-Latil, Sandra; Delannoy, Sabine; Fach, Patrick; Perelle, Sylvie			A Novel High-Throughput Method for Molecular Detection of Human Pathogenic Viruses Using a Nanofluidic Real-Time PCR System	PLOS ONE			English	Article							HEPATITIS-A-VIRUS; REVERSE-TRANSCRIPTION-PCR; TICK-BORNE ENCEPHALITIS; DROPLET DIGITAL PCR; DUPLEX RT-QPCR; MURINE NOROVIRUS; STOOL SPECIMENS; WATER SAMPLES; QUANTIFICATION; ASSAY	Human enteric viruses are recognized as the main causes of food-and waterborne diseases worldwide. Sensitive and quantitative detection of human enteric viruses is typically achieved through quantitative RT-PCR (RT-qPCR). A nanofluidic real-time PCR system was used to develop novel high-throughput methods for qualitative molecular detection (RT-qPCR array) and quantification of human pathogenic viruses by digital RT-PCR (RT-dPCR). The performance of high-throughput PCR methods was investigated for detecting 19 human pathogenic viruses and two main process controls used in food virology. The conventional real-time PCR system was compared to the RT-dPCR and RT-qPCR array. Based on the number of genome copies calculated by spectrophotometry, sensitivity was found to be slightly better with RT-qPCR than with RT-dPCR for 14 viruses by a factor range of from 0.3 to 1.6 log(10). Conversely, sensitivity was better with RT-dPCR than with RT-qPCR for seven viruses by a factor range of from 0.10 to 1.40 log(10). Interestingly, the number of genome copies determined by RT-dPCR was always from 1 to 2 log(10) lower than the expected copy number calculated by RT-qPCR standard curve. The sensitivity of the RT-qPCR and RT-qPCR array assays was found to be similar for two viruses, and better with RT-qPCR than with RT-qPCR array for eighteen viruses by a factor range of from 0.7 to 3.0 log(10). Conversely, sensitivity was only 0.30 log(10) better with the RT-qPCR array than with conventional RT-qPCR assays for norovirus GIV detection. Finally, the RT-qPCR array and RT-dPCR assays were successfully used together to screen clinical samples and quantify pathogenic viruses. Additionally, this method made it possible to identify co-infection in clinical samples. In conclusion, given the rapidity and potential for large numbers of viral targets, this nanofluidic RT-qPCR assay should have a major impact on human pathogenic virus surveillance and outbreak investigations and is likely to be of benefit to public health.	[Coudray-Meunier, Coralie; Fraisse, Audrey; Martin-Latil, Sandra; Perelle, Sylvie] Univ Paris Est, ANSES, Food Safety Lab, Enter Viruses Unit, 14 Rue Pierre & Marie Curie, F-94701 Maisons Alfort, France; [Delannoy, Sabine; Fach, Patrick] Univ Paris Est, ANSES, Food Safety Lab, 14 Rue Pierre & Marie Curie, F-94701 Maisons Alfort, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Perelle, S (corresponding author), Univ Paris Est, ANSES, Food Safety Lab, Enter Viruses Unit, 14 Rue Pierre & Marie Curie, F-94701 Maisons Alfort, France.	sylvie.perelle@anses.fr	Delannoy, Sabine/J-1045-2019; Martin-Latil, Sandra/GRN-8326-2022	Delannoy, Sabine/0000-0002-9208-5659; Fraisse, Audrey/0000-0001-9567-6270	ANSES	ANSES	Coralie Coudray-Meunier was a PhD student who received financial support from ANSES (Agence Nationale de Securite, Sanitaire de l'alimentation, de l'environnement et du travail).; We thank AM Roque (NRC for hepatitis A virus, France) and P Pothier (NRC for Enteric Viruses, France) for providing contaminated stools. This work is part of the thesis by Coralie Coudray-Meunier, a PhD student who received financial support from ANSES.	[Anonymous], 2013, 152161 ISOTS; [Anonymous], 2013, 152162 ISOTS; Atmar RL, 2001, CLIN MICROBIOL REV, V14, P15, DOI 10.1128/CMR.14.1.15-37.2001; Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Chan MCW, 2006, J VIROL METHODS, V134, P146, DOI 10.1016/j.jviromet.2005.12.013; Costafreda MI, 2006, APPL ENVIRON MICROB, V72, P3846, DOI 10.1128/AEM.02660-05; Coudray-Meunier C, 2015, INT J FOOD MICROBIOL, V201, P17, DOI 10.1016/j.ijfoodmicro.2015.02.006; Coudray-Meunier C, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-216; CROMEANS T, 1987, J MED VIROL, V22, P45, DOI 10.1002/jmv.1890220107; da Silva AK, 2007, APPL ENVIRON MICROB, V73, P7891, DOI 10.1128/AEM.01428-07; Drexler JF, 2011, EMERG INFECT DIS, V17, P1544, DOI 10.3201/eid1708.101556; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Dubois E, 2006, INT J FOOD MICROBIOL, V108, P164, DOI 10.1016/j.ijfoodmicro.2005.11.007; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gibson KE, 2014, CURR OPIN VIROL, V4, P50, DOI 10.1016/j.coviro.2013.12.005; Griffin DW, 2003, CLIN MICROBIOL REV, V16, P129, DOI 10.1128/CMR.16.1.129-143.2003; Henrich TJ, 2012, J VIROL METHODS, V186, P68, DOI 10.1016/j.jviromet.2012.08.019; Ishii S, 2014, APPL ENVIRON MICROB, V80, P7505, DOI 10.1128/AEM.02578-14; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kaida A, 2012, JPN J INFECT DIS, V65, P430, DOI 10.7883/yoken.65.430; Kocwa-Haluch R, 2001, POL J ENVIRON STUD, V10, P485; Koo HL, 2010, DISCOV MED, V10, P61; Koopmans M, 2004, INT J FOOD MICROBIOL, V90, P23, DOI 10.1016/S0168-1605(03)00169-7; Kotwal G, 2014, CURR OPIN VIROL, V4, P37, DOI 10.1016/j.coviro.2013.12.003; Lees D, 2010, FOOD ENVIRON VIROL, V2, P146, DOI 10.1007/s12560-010-9042-5; LEMON SM, 1991, J VIROL, V65, P2056, DOI 10.1128/JVI.65.4.2056-2065.1991; Lindquist L, 2014, HAND CLINIC, V123, P531, DOI 10.1016/B978-0-444-53488-0.00025-0; Loisy F, 2005, J VIROL METHODS, V123, P1, DOI 10.1016/j.jviromet.2004.08.023; Malik YS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/780752; Martin-Latil S, 2012, INT J FOOD MICROBIOL, V157, P167, DOI 10.1016/j.ijfoodmicro.2012.05.001; Martin-Latil S, 2012, FOOD MICROBIOL, V31, P246, DOI 10.1016/j.fm.2012.03.007; Matthews JE, 2012, EPIDEMIOL INFECT, V140, P1161, DOI 10.1017/S0950268812000234; Mohamed N, 2004, J CLIN VIROL, V30, P150, DOI 10.1016/j.jcv.2003.08.016; Monpoeho S, 2000, BIOTECHNIQUES, V29, P88, DOI 10.2144/00291st03; Morisset D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062583; Nainan OV, 2006, CLIN MICROBIOL REV, V19, P63, DOI 10.1128/CMR.19.1.63-79.2006; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; Pang XL, 2011, J VIROL METHODS, V172, P85, DOI 10.1016/j.jviromet.2010.12.013; Pang XLL, 2004, J MED VIROL, V72, P496, DOI 10.1002/jmv.20009; Pinto RM, 2009, APPL ENVIRON MICROB, V75, P7350, DOI 10.1128/AEM.01177-09; Racki N, 2014, ANAL BIOANAL CHEM, V406, P661, DOI 10.1007/s00216-013-7476-y; Sanchez G, 2007, LETT APPL MICROBIOL, V45, P1, DOI 10.1111/j.1472-765X.2007.02140.x; Sanders R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075296; Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3; Stocker A, 2012, EMERG INFECT DIS, V18, P656, DOI 10.3201/eid1804.111415; Svraka S, 2007, J CLIN MICROBIOL, V45, P1389, DOI 10.1128/JCM.02305-06; Trujillo AA, 2006, J CLIN MICROBIOL, V44, P1405, DOI 10.1128/JCM.44.4.1405-1412.2006; Van der Poel WHM, 2014, CURR OPIN VIROL, V4, P91, DOI 10.1016/j.coviro.2014.01.006; van Maarseveen NM, 2010, J CLIN VIROL, V49, P205, DOI 10.1016/j.jcv.2010.07.019; Vaughan G, 2014, INFECT GENET EVOL, V21, P227, DOI 10.1016/j.meegid.2013.10.023; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Xu ZQ, 2011, J CLIN MICROBIOL, V49, P1537, DOI 10.1128/JCM.00196-10; Zlateva KT, 2011, J VIROL METHODS, V177, P174, DOI 10.1016/j.jviromet.2011.08.005	55	20	23	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147832	10.1371/journal.pone.0147832	http://dx.doi.org/10.1371/journal.pone.0147832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824897	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600065
J	Schmidt, CE; Shringi, S; Besser, TE				Schmidt, Carrie E.; Shringi, Smriti; Besser, Thomas E.			Protozoan Predation of Escherichia coli O157:H7 Is Unaffected by the Carriage of Shiga Toxin-Encoding Bacteriophages	PLOS ONE			English	Article							HEMOLYTIC UREMIC SYNDROME; O157-H7; INFECTION; O157/H7; CATTLE; CALVES; VIRULENCE; DEFENSE	Escherichia coli O157:H7 is a food-borne bacterium that causes hemorrhagic diarrhea and hemolytic uremic syndrome in humans. While cattle are a known source of E. coli O157:H7 exposure resulting in human infection, environmental reservoirs may also be important sources of infection for both cattle and humans. Bacteriophage-encoded Shiga toxins (Stx) carried by E. coli O157:H7 may provide a selective advantage for survival of these bacteria in the environment, possibly through their toxic effects on grazing protozoa. To determine Stx effects on protozoan grazing, we co-cultured Paramecium caudatum, a common ciliate protozoon in cattle water sources, with multiple strains of Shiga-toxigenic E. coli O157:H7 and non-Shiga toxigenic cattle commensal E. coli. Over three days at ambient laboratory temperature, P. caudatum consistently reduced both E. coli O157:H7 and non-Shiga toxigenic E. coli populations by 1-3 log cfu. Furthermore, a wild-type strain of Shiga-toxigenic E. coli O157:H7 (EDL933) and isogenic mutants lacking the A subunit of Stx 2a, the entire Stx 2a-encoding bacteriophage, and/or the entire Stx 1-encoding bacteriophage were grazed with similar efficacy by both P. caudatum and Tetrahymena pyriformis (another ciliate protozoon). Therefore, our data provided no evidence of a protective effect of either Stx or the products of other bacteriophage genes on protozoan predation of E. coli. Further research is necessary to determine if the grazing activity of naturally-occurring protozoa in cattle water troughs can serve to decrease cattle exposure to E. coli O157:H7 and other Shiga-toxigenic E. coli.	[Schmidt, Carrie E.; Shringi, Smriti; Besser, Thomas E.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Washington State University	Schmidt, CE (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	cellis@vetmed.wsu.edu	Shringi, Smriti/AAC-9789-2020	Shringi, Smriti/0000-0001-9212-9175	USDA National Institute of Food and Agriculture [2010-04487]; ARCS Foundation; NIH Training Grant [T32]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); ARCS Foundation; NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Agriculture and Food Research Initiative competitive grant no. 2010-04487, from the USDA National Institute of Food and Agriculture, an NIH T32 Training Grant, and the ARCS Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 1996, EPIDEMOL REV, V18, P24; Arnold JW, 2014, ENVIRON MICROBIOL, V16, P454, DOI 10.1111/1462-2920.12232; Besser TE, 2001, EPIDEMIOL INFECT, V127, P555, DOI 10.1017/S095026880100615X; Brown CA, 1997, APPL ENVIRON MICROB, V63, P27, DOI 10.1128/AEM.63.1.27-32.1997; CRAY WC, 1995, APPL ENVIRON MICROB, V61, P1586, DOI 10.1128/AEM.61.4.1586-1590.1995; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eberhart LJ, 2012, APPL ENVIRON MICROB, V78, P6592, DOI 10.1128/AEM.01067-12; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Ho NK, 2012, INFECT IMMUN, V80, P2307, DOI 10.1128/IAI.00255-12; Irino K, 2002, EMERG INFECT DIS, V8, P446, DOI 10.3201/eid0804.010490; Karnati SKR, 2003, J ANIM SCI, V81, P812; KELLY J, 1990, AM J SURG PATHOL, V14, P87, DOI 10.1097/00000478-199001000-00010; Lainhart W, 2009, J BACTERIOL, V191, P5116, DOI 10.1128/JB.00508-09; LeJeune JT, 2001, J DAIRY SCI, V84, P1856, DOI 10.3168/jds.S0022-0302(01)74626-7; Mechie SC, 1997, EPIDEMIOL INFECT, V118, P17, DOI 10.1017/S0950268896007194; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Pruimboom-Brees IM, 2000, P NATL ACAD SCI USA, V97, P10325, DOI 10.1073/pnas.190329997; Ravva SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054782; Ravva SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015671; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; Sargeant JM, 2007, ZOONOSES PUBLIC HLTH, V54, P260, DOI 10.1111/j.1863-2378.2007.01059.x; Sawant AA, 2011, APPL ENVIRON MICROB, V77, P2345, DOI 10.1128/AEM.03150-09; Sheng HQ, 2006, INFECT IMMUN, V74, P4685, DOI 10.1128/IAI.00406-06; Shringi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051572; Shringi S, 2012, INFECT IMMUN, V80, P369, DOI 10.1128/IAI.05470-11; Stolfa G, 2013, MBIO, V4, DOI 10.1128/mBio.00416-12; Zoja C, 2010, PEDIATR NEPHROL, V25, P2231, DOI 10.1007/s00467-010-1522-1	28	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147270	10.1371/journal.pone.0147270	http://dx.doi.org/10.1371/journal.pone.0147270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824472	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600020
J	Tatewaki, N; Konishi, T; Nakajima, Y; Nishida, M; Saito, M; Eitsuka, T; Sakamaki, T; Ikekawa, N; Nishida, H				Tatewaki, Naoto; Konishi, Tetsuya; Nakajima, Yuki; Nishida, Miyako; Saito, Masafumi; Eitsuka, Takahiro; Sakamaki, Toshiyuki; Ikekawa, Nobuo; Nishida, Hiroshi			Squalene Inhibits ATM-Dependent Signaling in gamma IR-Induced DNA Damage Response through Induction of Wip1 Phosphatase	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; KINASE-ACTIVITY; SCHISANDRIN B; ACTIVATES ATM; HUMAN CANCER; CHK2 KINASE; G(2) DELAY; CHECKPOINT; P53	Ataxia telangiectasia mutated (ATM) kinase plays a crucial role as a master controller in the cellular DNA damage response. Inhibition of ATM leads to inhibition of the checkpoint signaling pathway. Hence, addition of checkpoint inhibitors to anticancer therapies may be an effective targeting strategy. A recent study reported that Wip1, a protein phosphatase, dephosphorylates serine 1981 of ATM during the DNA damage response. Squalene has been proposed to complement anticancer therapies such as chemotherapy and radiotherapy; however, there is little mechanistic information supporting this idea. Here, we report the inhibitory effect of squalene on ATM-dependent DNA damage signals. Squalene itself did not affect cell viability and the cell cycle of A549 cells, but it enhanced the cytotoxicity of gamma-irradiation (gamma IR). The in vitro kinase activity of ATM was not altered by squalene. However, squalene increased Wip1 expression in cells and suppressed ATM activation in gamma IR-treated cells. Consistent with the potential inhibition of ATM by squalene, IR-induced phosphorylation of ATM effectors such as p53 (Ser15) and Chk1 (Ser317) was inhibited by cell treatment with squalene. Thus, squalene inhibits the ATM-dependent signaling pathway following DNA damage through intracellular induction of Wip1 expression.	[Tatewaki, Naoto; Konishi, Tetsuya; Nakajima, Yuki; Nishida, Miyako; Saito, Masafumi; Eitsuka, Takahiro; Nishida, Hiroshi] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan; [Sakamaki, Toshiyuki] Niigata Univ Pharm & Appl Life Sci, Dept Pharmaceut Sci, Niigata, Japan; [Ikekawa, Nobuo] Niigata Bio Res Ctr, Niigata, Japan	Niigata University; Niigata University	Nishida, H (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan.	wm7h-nsd@asahi-net.or.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24580203]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities [S1001030]; JSPS KAKENHI [25293029]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant No. 24580203) to HN, Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities (Grant No. S1001030) to HN and TK, and JSPS KAKENHI (Grant No. 25293029) to HN and Masaji Ishiguro, Niigata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Batey MA, 2013, MOL CANCER THER, V12, P959, DOI 10.1158/1535-7163.MCT-12-0707; Bracey TS, 1997, CLIN CANCER RES, V3, P1371; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Caporali S, MOL PHARM, V66, P478; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Collis SJ, 2003, CANCER RES, V63, P1550; Desai KN, 1996, CANCER LETT, V101, P93, DOI 10.1016/0304-3835(96)04122-5; Dunkern TR, 2002, MOL BIOL CELL, V13, P348, DOI 10.1091/mbc.01-05-0225; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; EIDINOFF ML, 1958, J CLIN INVEST, V37, P655, DOI 10.1172/JCI103650; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kawabe T, 2004, MOL CANCER THER, V3, P513; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; LIU GCK, 1976, J LIPID RES, V17, P38; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Luo Y, 2001, ANTICANCER RES, V21, P23; MURAKOSHI M, 1992, INT J CANCER, V52, P950, DOI 10.1002/ijc.2910520620; NAKAGAWA M, 1985, JPN J CANCER RES, V76, P315; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Nishida H, 2009, NUCLEIC ACIDS RES, V37, P5678, DOI 10.1093/nar/gkp593; On KF, 2011, MOL CANCER THER, V10, P784, DOI 10.1158/1535-7163.MCT-10-0809; POWELL SN, 1995, CANCER RES, V55, P1643; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shackelford RE, 2001, J BIOL CHEM, V276, P21951, DOI 10.1074/jbc.M011303200; Shigeta T, 1999, CANCER RES, V59, P2602; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Sturgeon CM, 2007, CELL CYCLE, V6, P572, DOI 10.4161/cc.6.5.3926; Tatewaki N, 2013, J PHARMACOL SCI, V122, P138, DOI 10.1254/jphs.13048FP; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036; Yamamoto K, 2012, J CELL BIOL, V198, P305, DOI 10.1083/jcb.201204098; Yao SL, 1996, NAT MED, V2, P1140, DOI 10.1038/nm1096-1140; Yoda A, 2006, J BIOL CHEM, V281, P24847, DOI 10.1074/jbc.M600403200; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	51	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147570	10.1371/journal.pone.0147570	http://dx.doi.org/10.1371/journal.pone.0147570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824362	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528600035
J	Schneider, K; Valdez, J; Nguyen, J; Vawter, M; Galke, B; Kurtz, TW; Chan, JY				Schneider, Kevin; Valdez, Joshua; Nguyen, Janice; Vawter, Marquis; Galke, Brandi; Kurtz, Theodore W.; Chan, Jefferson Y.			Increased Energy Expenditure, Ucp1 Expression, and Resistance to Diet-induced Obesity in Mice Lacking Nuclear Factor-Erythroid-2-related Transcription Factor-2 (Nrf2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; ERYTHROID 2-RELATED FACTOR-2; GAMMA PPAR-GAMMA; INSULIN-RESISTANCE; GENE-EXPRESSION; UNCOUPLING PROTEIN-2; OXIDATIVE STRESS; SKELETAL-MUSCLE; INDUCED THERMOGENESIS; FAT	The NRF2 (also known as NFE2L2) transcription factor is a critical regulator of genes involved in defense against oxidative stress. Previous studies suggest that Nrf2 plays a role in adipogenesis in vitro, and deletion of the Nrf2 gene protects against diet-induced obesity in mice. Here, we demonstrate that resistance to diet-induced obesity in Nrf2(-/-) mice is associated with a 20-30% increase in energy expenditure. Analysis of bioenergetics revealed that Nrf2(-/-) white adipose tissues exhibit greater oxygen consumption. White adipose tissue showed a > 2-fold increase in Ucp1 gene expression. Oxygen consumption is also increased nearly 2.5-fold in Nrf2-deficient fibroblasts. Oxidative stress induced by glucose oxidase resulted in increased Ucp1 expression. Conversely, antioxidant chemicals (such as N-acetylcysteine and Mn(III)tetrakis(4-benzoic acid) porphyrin chloride) and SB203580 (a known suppressor of Ucp1 expression) decreased Ucp1 and oxygen consumption in Nrf2-deficient fibroblasts. These findings suggest that increasing oxidative stress by limiting Nrf2 function in white adipocytes may be a novel means to modulate energy balance as a treatment of obesity and related clinical disorders.	[Schneider, Kevin; Valdez, Joshua; Nguyen, Janice; Chan, Jefferson Y.] Univ Calif Irvine, Dept Lab Med & Pathol, D440 Med Sci 1, Irvine, CA 92697 USA; [Vawter, Marquis; Galke, Brandi] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Francisco	Chan, JY (corresponding author), Univ Calif Irvine, Dept Lab Med & Pathol, D440 Med Sci 1, Irvine, CA 92697 USA.	jchan@uci.edu			National Institute of Health [CA091907]; NATIONAL CANCER INSTITUTE [R01CA091907, R56CA091907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085801] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institute of Health Research Grant CA091907 to J. Y. C. The authors declare that they have no conflicts of interest with the contents of this article.	Anedda A, 2013, FREE RADICAL BIO MED, V61, P395, DOI 10.1016/j.freeradbiomed.2013.04.007; Auffret J, 2012, FASEB J, V26, P3728, DOI 10.1096/fj.12-204958; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; Chutkow WA, 2010, DIABETES, V59, P1424, DOI 10.2337/db09-1212; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Cohade C, 2003, J NUCL MED, V44, P170; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dunham-Snary KJ, 2014, REDOX BIOL, V2, P656, DOI 10.1016/j.redox.2014.04.005; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Garcia-Alonso V, 2013, J BIOL CHEM, V288, P28230, DOI 10.1074/jbc.M113.468603; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; He XQ, 2008, CHEM RES TOXICOL, V21, P1375, DOI 10.1021/tx800019a; He XQ, 2007, TOXICOL SCI, V98, P298, DOI 10.1093/toxsci/kfm081; He XQ, 2012, MOL PHARMACOL, V82, P887, DOI 10.1124/mol.112.081133; Hou YY, 2012, FREE RADICAL BIO MED, V52, P462, DOI 10.1016/j.freeradbiomed.2011.10.453; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kendig EL, 2011, TOXICOL APPL PHARM, V257, P338, DOI 10.1016/j.taap.2011.09.017; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kozak Leslie P, 2011, Front Endocrinol (Lausanne), V2, P64, DOI 10.3389/fendo.2011.00064; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee P., 2013, INT J OBES LOND, V38, P170; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Ma Q, 2006, AM J PATHOL, V168, P1960, DOI 10.2353/ajpath.2006.051113; Mahadik SR, 2012, ADIPOCYTE, V1, P101, DOI 10.4161/adip.19671; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Mexitalia M, 2013, J PEDIATR ENDOCR MET, V26, P441, DOI 10.1515/jpem-2012-0311; More VR, 2013, FREE RADICAL BIO MED, V61, P85, DOI 10.1016/j.freeradbiomed.2013.03.007; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213; Qian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058939; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Ringholm S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064123; Ro SH, 2014, P NATL ACAD SCI USA, V111, P7849, DOI 10.1073/pnas.1401787111; Rolfe DFS, 1999, AM J PHYSIOL-CELL PH, V276, pC692, DOI 10.1152/ajpcell.1999.276.3.C692; Rolo AP, 2009, ANAL BIOCHEM, V385, P176, DOI 10.1016/j.ab.2008.10.002; ROTHWELL NJ, 1983, CLIN SCI, V64, P19, DOI 10.1042/cs0640019; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang H, 2008, MOL CELL BIOL, V28, P2187, DOI 10.1128/MCB.01479-07; Wang LP, 2013, ARCH BIOCHEM BIOPHYS, V537, P31, DOI 10.1016/j.abb.2013.06.001; Whittle A, 2013, TRENDS PHARMACOL SCI, V34, P347, DOI 10.1016/j.tips.2013.04.004; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584; Zafrir B, 2013, HORM METAB RES, V45, P774, DOI 10.1055/s-0033-1348264; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	82	51	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7754	7766		10.1074/jbc.M115.673756	http://dx.doi.org/10.1074/jbc.M115.673756			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26841864	Green Published, hybrid			2022-12-26	WOS:000383447600044
J	Chaw, L; Kamigaki, T; Burmaa, A; Urtnasan, C; Od, I; Nyamaa, G; Nymadawa, P; Oshitani, H				Chaw, Liling; Kamigaki, Taro; Burmaa, Alexanderyn; Urtnasan, Chuluunbatiin; Od, Ishiin; Nyamaa, Gunregjaviin; Nymadawa, Pagbajabyn; Oshitani, Hitoshi			Burden of Influenza and Respiratory Syncytial Virus Infection in Pregnant Women and Infants Under 6 Months in Mongolia: A Prospective Cohort Study	PLOS ONE			English	Article							ANTIBODY-RESPONSES; TRACT INFECTIONS; ILLNESS; HOSPITALIZATIONS; VACCINE; IMMUNIZATION; CHILDREN; PROTECTION; IMPACT; RECOMMENDATIONS	Background Pregnant women and infants under 6 months are at risk of influenza-related complications. Limited information exists on their community burden of respiratory viruses. Methods and Findings This prospective, observational open cohort study was conducted in Baganuur district, Ulaanbaatar, Mongolia during 2013/14 and 2014/15 influenza seasons. Influenza-like illness (ILI) and severe acute respiratory infection (sARI) were identified by follow-up calls twice a week. For those identified, influenza and respiratory syncytical virus (RSV) were tested by point-of-care test kits. We calculated overall and stratified (by trimester or age group) incidence rates (IR) and used Cox proportional hazard regression for risk factor analyses. Among 1260 unvaccinated pregnant women enrolled, overall IRs for ILI, sARI and influenza A were 11.8 (95% confidence interval (C.I): 11.2-12.4), 0.1 (95% C.I: 0.0-0.4), and 1.7 (95% C.I: 1.5-1.9) per 1,000person-days, respectively. One sARI case was influenza A positive. IRs and adjusted hazard ratios (Adj.HR) for ILI and influenza A were lowest in the third trimester. Those with co-morbidity were 1.4 times more likely to develop ILI [Adj.HR: 1.4 (95% C.I: 1.1-1.9)]. Among 1304 infants enrolled, overall ILI and sARI IRs were 15.2 (95% C.I: 14.5-15.8) and 20.5 (95% C.I: 19.7-21.3) per 1,000person-days, respectively. From the tested ILI (77.6%) and sARI (30.6%) cases, the overall positivity rates were 6.3% (influenza A), 1.1% (influenza B) and 9.3% (RSV). Positivity rates of influenza A and RSV tend to increase with age. sARI cases were 1.4 times more likely to be male [Adj.HR: 1.4 (95% C.I: 1.1-1.8)]. Among all influenza A and RSV positive infants, 11.8% and 68.0% were respectively identified among sARI hospitalized cases. Conclusion We observed low overall influenza A burden in both groups, though underestimation was likely due to point-of-care tests used. For infants, RSV burden was more significant than influenza A. These findings would be useful for establishing control strategies for both viruses in Mongolia.	[Chaw, Liling; Kamigaki, Taro; Oshitani, Hitoshi] Tohoku Univ, Dept Virol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Burmaa, Alexanderyn; Urtnasan, Chuluunbatiin; Nyamaa, Gunregjaviin; Nymadawa, Pagbajabyn] Natl Ctr Communicable Dis, Natl Influenza Ctr, Ulaanbaatar, Mongolia; [Nymadawa, Pagbajabyn] Mongolian Acad Med Sci, Ulaanbaatar, Mongolia	Tohoku University; National Center for Communicable Diseases of Mongolia; Mongolian Academy of Sciences	Kamigaki, T (corresponding author), Tohoku Univ, Dept Virol, Grad Sch Med, Sendai, Miyagi 980, Japan.	kamigakit@med.tohoku.ac.jp	Nymadawa, Pagbajab/AAE-7344-2019; Oshitani, Hitoshi/AAE-4349-2019; Chaw, Liling/R-1591-2019	Nymadawa, Pagbajab/0000-0002-3189-2772; Chaw, Liling/0000-0003-3301-7565	Japan Society for the Promotion of Science (KAKENHI) [24249041]; MEXT Monbukagakusho scholarship program	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT Monbukagakusho scholarship program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) [Grant no. 24249041]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to express their gratitude to the following for their valuable support in this study: All personnel involved in the primary healthcare clinics and district hospital in Baganuur; personnel in National Influenza Center (NIC) and National Center for Communicable Diseases (NCCD) in Ulanbataar, Mongolia; Denka Seiken Co. Ltd, Japan who kindly donated point-of- care test kits in the 2014/15 season; and Dr. Mayuko Saito for her useful advice on the risk factor analyses. LC would also like to thank the MEXT Monbukagakusho scholarship program for financial support during her graduate study in Japan.	Anderson LJ, 2013, VACCINE S2, V31; [Anonymous], 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.1.009, 10.5365/WPSAR.2013.4.1.009]; [Anonymous], 2013, Obstet Gynecol, V122, P1139, DOI 10.1097/01.AOG.0000437385.88715.4a; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2015, SOC EC SIT MONG PREL; [Anonymous], 2014, R LANG ENV STAT COMP; Baigalmaa J, 2012, WEST PAC SURVEILL RE, V3, DOI [10.5365/wpsar.2010.1.1.006, 10.5365/WPSAR.2010.1.1.006]; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Black SB, 2004, AM J PERINAT, V21, P333, DOI 10.1055/s-2004-831888; Blanchard-Rohner G, 2011, VACCINE, V29, P7542, DOI 10.1016/j.vaccine.2011.08.013; Brandenburg AH, 1997, J MED VIROL, V52, P97, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;97::AID-JMV16&gt;3.0.CO;2-Y; Burmaa A, 2014, INFLUENZA OTHER RESP, V8, P530, DOI 10.1111/irv.12268; Central Intelligence Agency (CIA), WORLD FACTB MONG; Chartrand C, 2012, ANN INTERN MED, V156, P500, DOI 10.7326/0003-4819-156-7-201204030-00403; Chu HY, 2014, J INFECT DIS, V210, P1582, DOI 10.1093/infdis/jiu316; Chu HY, 2014, CLIN INFECT DIS, V59, P560, DOI 10.1093/cid/ciu327; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Eick A, 2008, PEDIATR INFECT DIS J, V27, P207, DOI 10.1097/INF.0b013e31815ac585; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; ENGLUND JA, 1993, J INFECT DIS, V168, P647, DOI 10.1093/infdis/168.3.647; Evenson KR, 2010, PREV MED, V50, P123, DOI 10.1016/j.ypmed.2009.12.015; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Goodnight William H, 2005, Crit Care Med, V33, pS390, DOI 10.1097/01.CCM.0000182483.24836.66; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3; Hasan R, 2014, PEDIATR INFECT DIS J, V33, pE45, DOI 10.1097/INF.0000000000000062; Hoo AF, 2002, AM J RESP CRIT CARE, V165, P1084, DOI 10.1164/ajrccm.165.8.2103035; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jedrychowski W, 2005, EUR J EPIDEMIOL, V20, P775, DOI 10.1007/s10654-005-1048-1; Jones M, 2000, AM J RESP CRIT CARE, V161, P353, DOI 10.1164/ajrccm.161.2.9903026; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; Kraus TA, 2012, J CLIN IMMUNOL, V32, P300, DOI 10.1007/s10875-011-9627-2; Lindsay L, 2006, AM J EPIDEMIOL, V163, P838, DOI 10.1093/aje/kwj095; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; MACFARLANE JT, 1993, LANCET, V341, P511, DOI 10.1016/0140-6736(93)90275-L; Martin A, 2013, MATERN CHILD HLTH J, V17, P1325, DOI 10.1007/s10995-012-1135-3; Meng J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004016; MULLOOLY JP, 1986, PUBLIC HEALTH REP, V101, P205; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; National Statistical Office of Mongolia, 2014, SOC EC SIT MONG PREL; Nethery E, 2009, J EXPO SCI ENV EPID, V19, P317, DOI 10.1038/jes.2008.24; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nolan T, 2015, CLIN INFECT DIS, V60, pE80, DOI 10.1093/cid/civ065; Nukiwa N, 2011, WEST PAC SURVEILL RE, V2, P16, DOI [10.5365/wpsar.2010.1.1.004, 10.5365/WPSAR.2010.1.1.004]; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Ortiz JR, 2011, VACCINE, V29, P4439, DOI 10.1016/j.vaccine.2011.04.048; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; PUCK JM, 1980, J INFECT DIS, V142, P844, DOI 10.1093/infdis/142.6.844; Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068; REUMAN PD, 1987, PEDIATR INFECT DIS J, V6, P398, DOI 10.1097/00006454-198704000-00011; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Sande CJ, 2014, VACCINE, V32, P4726, DOI 10.1016/j.vaccine.2014.05.038; Schanzer DL, 2007, J OBSTET GYNAECOL CA, V29, P622, DOI 10.1016/S1701-2163(16)32559-2; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235; Steinhoff MC, 2014, LANCET, V383, P1611, DOI 10.1016/S0140-6736(14)60583-3; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; *WHO, 2005, MOD IMCI HDB INT MAN; World Health Organization, 2015, WHO REC COMP INFL VI; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	69	25	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148421	10.1371/journal.pone.0148421	http://dx.doi.org/10.1371/journal.pone.0148421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849042	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000090
J	Mezzenga, E; D'Errico, V; Sarnelli, A; Strigari, L; Menghi, E; Marcocci, F; Bianchini, D; Benassi, M				Mezzenga, Emilio; D'Errico, Vincenzo; Sarnelli, Anna; Strigari, Lidia; Menghi, Enrico; Marcocci, Francesco; Bianchini, David; Benassi, Marcello			Preliminary Retrospective Analysis of Daily Tomotherapy Output Constancy Checks Using Statistical Process Control	PLOS ONE			English	Article							CONTROL CHARTS; BREAST-CANCER; QA; RADIOTHERAPY	The purpose of this study was to retrospectively evaluate the results from a Helical TomoTherapy Hi-Art treatment system relating to quality controls based on daily static and dynamic output checks using statistical process control methods. Individual value X-charts, exponentially weighted moving average charts, and process capability and acceptability indices were used to monitor the treatment system performance. Daily output values measured from January 2014 to January 2015 were considered. The results obtained showed that, although the process was in control, there was an out-of-control situation in the principal maintenance intervention for the treatment system. In particular, process capability indices showed a decreasing percentage of points in control which was, however, acceptable according to AAPM TG148 guidelines. Our findings underline the importance of restricting the acceptable range of daily output checks and suggest a future line of investigation for a detailed process control of daily output checks for the Helical TomoTherapy Hi-Art treatment system.	[Mezzenga, Emilio; D'Errico, Vincenzo; Sarnelli, Anna; Menghi, Enrico; Marcocci, Francesco; Bianchini, David; Benassi, Marcello] IRCCS, Dept Med Phys, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, FC, Italy; [Strigari, Lidia] Regina Elena Inst Canc Res, Lab Med Phys & Expert Syst, Rome, Italy	IRCCS Meldola (IRST); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Mezzenga, E (corresponding author), IRCCS, Dept Med Phys, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, FC, Italy.	emilio.mezzenga@irst.emr.it	Bianchini, David/K-7205-2016; Strigari, Lidia/B-9352-2017; Sarnelli, Anna/V-4284-2018; Strigari, Lidia/J-3541-2012; Mezzenga, Emilio/Q-1018-2018	Bianchini, David/0000-0001-5927-7483; Strigari, Lidia/0000-0003-4293-2298; Sarnelli, Anna/0000-0001-5986-3845; Mezzenga, Emilio/0000-0002-0150-7757				Abbas N, 2011, QUAL RELIAB ENG INT, V27, P821, DOI 10.1002/qre.1175; [Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Breen SL, 2008, MED PHYS, V35, P4417, DOI 10.1118/1.2975144; Carey R.G., 2003, IMPROVING HEALTHCARE; CHAMP CW, 1987, TECHNOMETRICS, V29, P393, DOI 10.2307/1269449; Cisar P, 2011, ACTA POLYTECH HUNG, V8, P73; DAVIS RB, 1988, J QUAL TECHNOL, V20, P260, DOI 10.1080/00224065.1988.11979118; Dettmer H. W., 1997, GOLDRATTS THEORY CON; Gerard K, 2009, MED PHYS, V36, P1275, DOI 10.1118/1.3089793; Holli K, 1999, INT J RADIAT ONCOL, V44, P827, DOI 10.1016/S0360-3016(99)00078-4; KANE VE, 1986, J QUAL TECHNOL, V18, P41, DOI 10.1080/00224065.1986.11978984; Kelly DL, 1999, USE CONTROL CHARTS H; Langen KM, 2010, MED PHYS, V37, P4817, DOI 10.1118/1.3462971; Montgomery DC, 2009, INTRO STAT QUALITY C, P179; Palaniswaamy G, 2012, MED PHYS, V39, P7560, DOI 10.1118/1.4768161; Pawlicki T, 2008, RADIOTHER ONCOL, V89, P330, DOI 10.1016/j.radonc.2008.07.002; Pitkanen MA, 2001, ACTA ONCOL, V40, P50; RYAN T, 2000, STAT METHODS QUALITY; Sanghangthum T, 2013, J APPL CLIN MED PHYS, V14, P147, DOI 10.1120/jacmp.v14i1.4032; Wheeler DJ, 1992, UNDERSTANDING STAT P, V2nd; Woodall WH, 2000, J QUAL TECHNOL, V32, P341	21	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147936	10.1371/journal.pone.0147936	http://dx.doi.org/10.1371/journal.pone.0147936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848962	Green Submitted, gold, Green Published			2022-12-26	WOS:000369554000029
J	Werbowy, O; Kaczorowski, T				Werbowy, Olesia; Kaczorowski, Tadeusz			Plasmid pEC156, a Naturally Occurring Escherichia coli Genetic Element That Carries Genes of the EcoVIII Restriction-Modification System, Is Mobilizable among Enterobacteria	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; CLONING VEHICLES; F-PLASMID; TRANSFORMATION; DNA; BACTERIAL; EVOLUTION; MAINTENANCE; REGION; CER	Type II restriction-modification systems are ubiquitous in prokaryotes. Some of them are present in naturally occurring plasmids, which may facilitate the spread of these systems in bacterial populations by horizontal gene transfer. However, little is known about the routes of their dissemination. As a model to study this, we have chosen an Escherichia coli natural plasmid pEC156 that carries the EcoVIII restriction modification system. The presence of this system as well as the cis-acting cer site involved in resolution of plasmid multimers determines the stable maintenance of pEC156 not only in Escherichia coli but also in other enterobacteria. We have shown that due to the presence of oriT-type F and oriT-type R64 loci it is possible to mobilize pEC156 by conjugative plasmids (F and R64, respectively). The highest mobilization frequency was observed when pEC156-derivatives were transferred between Escherichia coli strains, Enterobacter cloacae and Citrobacter freundii representing coliform bacteria. We found that a pEC156-derivative with a functional EcoVIII restriction-modification system was mobilized in enterobacteria at a frequency lower than a plasmid lacking this system. In addition, we found that bacteria that possess the EcoVIII restriction-modification system can efficiently release plasmid content to the environment. We have shown that E. coli cells can be naturally transformed with pEC156-derivatives, however, with low efficiency. The transformation protocol employed neither involved chemical agents (e.g. CaCl2) nor temperature shift which could induce plasmid DNA uptake.	[Werbowy, Olesia; Kaczorowski, Tadeusz] Univ Gdansk, Dept Microbiol, Wita Stwosza 59, PL-80952 Gdansk, Poland	Fahrenheit Universities; University of Gdansk	Kaczorowski, T (corresponding author), Univ Gdansk, Dept Microbiol, Wita Stwosza 59, PL-80952 Gdansk, Poland.	tadeusz.kaczorowski@biol.ug.edu.pl	Kaczorowski, Tadeusz/AAX-2027-2020	Werbowy, Olesia/0000-0002-0194-0673	National Science Centre [N302 654240]	National Science Centre(National Science Centre, Poland)	This work was supported by grant N302 654240 from the National Science Centre.	Aas FE, 2002, MOL MICROBIOL, V46, P749, DOI 10.1046/j.1365-2958.2002.03193.x; Ahmer BMM, 1999, J BACTERIOL, V181, P1364, DOI 10.1128/JB.181.4.1364-1368.1999; Bartosik D, 2002, MICROBIOL-SGM, V148, P2847, DOI 10.1099/00221287-148-9-2847; Baur B, 1996, APPL ENVIRON MICROB, V62, P3673, DOI 10.1128/AEM.62.10.3673-3678.1996; BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; BOYD AC, 1989, MOL GEN GENET, V217, P488; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Claus H, 2000, J BACTERIOL, V182, P1296, DOI 10.1128/JB.182.5.1296-1303.2000; COLLOMS SD, 1990, J BACTERIOL, V172, P6973, DOI 10.1128/jb.172.12.6973-6980.1990; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Das T, 2013, ENV MICROBIOL REP, V5, P778, DOI 10.1111/1758-2229.12085; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; Dziewit L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00596; ENGLEBERG NC, 1988, PLASMID, V20, P83, DOI 10.1016/0147-619X(88)90010-8; Ershova AS, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1373, DOI 10.1134/S0006297915100193; Eutsey RA, 2015, MBIO, V6, DOI 10.1128/mBio.00173-15; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; Furuya N, 1997, J BACTERIOL, V179, P7291, DOI 10.1128/jb.179.23.7291-7297.1997; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Handa N, 2000, J BACTERIOL, V182, P2218, DOI 10.1128/JB.182.8.2218-2229.2000; Handa N, 1999, BIOCHIMIE, V81, P931; HANISH J, 1988, GENE ANAL TECH, V5, P105, DOI 10.1016/0735-0651(88)90005-2; Harr B, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-80; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Ichige A, 2005, J BACTERIOL, V187, P6612, DOI 10.1128/JB.187.19.6612-6621.2005; ISHIAI M, 1994, P NATL ACAD SCI USA, V91, P3839, DOI 10.1073/pnas.91.9.3839; Jeltsch A, 1996, J MOL EVOL, V42, P91, DOI 10.1007/BF02198833; Jeltsch A, 2003, GENE, V317, P13, DOI 10.1016/S0378-1119(03)00652-8; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; KACZOROWSKI T, 1993, BIOTECHNIQUES, V14, P900; Kong HM, 2000, NUCLEIC ACIDS RES, V28, P3216, DOI 10.1093/nar/28.17.3216; Kong Y, 2013, GENOME BIOL EVOL, V5, P1611, DOI 10.1093/gbe/evt116; KUES U, 1989, MICROBIOL REV, V53, P491; Lawley T, 2004, PLASMID BIOLOGY, P203; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; LORENZ MG, 1991, ARCH MICROBIOL, V156, P319, DOI 10.1007/BF00263005; Maeda S, 2004, FEMS MICROBIOL LETT, V236, P61, DOI 10.1111/j.1574-6968.2004.tb09627.x; MCKANE M, 1995, GENETICS, V139, P35; Mell JC, 2014, J BACTERIOL, V196, P1471, DOI 10.1128/JB.01293-13; Milewska K, 2015, PLASMID, V81, P42, DOI 10.1016/j.plasmid.2015.07.001; Milkman R, 1999, GENETICS, V153, P539; Mruk I, 2003, MICROBIOL-SGM, V149, P3331, DOI 10.1099/mic.0.26562-0; Mruk I, 2003, APPL ENVIRON MICROB, V69, P2638, DOI 10.1128/AEM.69.5.2638-2650.2003; Mruk I, 2001, PLASMID, V46, P128, DOI 10.1006/plas.2001.1534; Mruk I, 2014, NUCLEIC ACIDS RES, V42, P70, DOI 10.1093/nar/gkt711; Oliveira PH, 2014, NUCLEIC ACIDS RES, V42, P10618, DOI 10.1093/nar/gku734; ORSKOV I, 1973, ACTA PATH MICRO IM B, VB 81, P59; Paradis S, 2005, INT J SYST EVOL MICR, V55, P2013, DOI 10.1099/ijs.0.63539-0; Pleska M, 2016, CURR BIOL, V26, P404, DOI 10.1016/j.cub.2015.12.041; Podgorska B, 2012, ACTA BIOCHIM POL, V59, P669; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; Rehel N, 1996, PLASMID, V36, P183, DOI 10.1006/plas.1996.0045; Roer L, 2015, J BACTERIOL, V197, P337, DOI 10.1128/JB.02418-14; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCOTT JR, 1984, MICROBIOL REV, V48, P1; Seitz P, 2013, P NATL ACAD SCI USA, V110, P17987, DOI 10.1073/pnas.1315647110; SHAPIRO JA, 1977, DNA INSERTION ELEMEN, P601; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Stanisich V.A., 1988, METHOD MICROBIOL, V21, P11; STIRLING CJ, 1989, EMBO J, V8, P1623, DOI 10.1002/j.1460-2075.1989.tb03547.x; STIRLING CJ, 1988, EMBO J, V7, P4389, DOI 10.1002/j.1460-2075.1988.tb03338.x; STIRLING CJ, 1988, MOL GEN GENET, V214, P80, DOI 10.1007/BF00340183; SUMMERS DK, 1984, CELL, V36, P1097, DOI 10.1016/0092-8674(84)90060-6; Sun DC, 2006, FEMS MICROBIOL LETT, V265, P249, DOI 10.1111/j.1574-6968.2006.00503.x; Suzuki H, 2010, J BACTERIOL, V192, P6045, DOI 10.1128/JB.00277-10; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; TWIGG AJ, 1980, NATURE, V283, P216, DOI 10.1038/283216a0; van Elsas JD, 2002, FEMS MICROBIOL ECOL, V42, P187, DOI 10.1111/j.1574-6941.2002.tb01008.x; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Veiga H, 2009, APPL ENVIRON MICROB, V75, P3034, DOI 10.1128/AEM.01862-08; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Werbowy O, 2015, PLASMID, V77, P39, DOI 10.1016/j.plasmid.2014.12.002; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; WILLETTS N, 1980, MOL GEN GENET, V180, P213, DOI 10.1007/BF00267372; Woegerbauer M, 2002, APPL ENVIRON MICROB, V68, P440, DOI 10.1128/AEM.68.1.440-443.2002; Zakharova MV, 2002, MOL GENET GENOMICS, V267, P171, DOI 10.1007/s00438-002-0644-y; Zhong ZP, 2005, PLASMID, V54, P48, DOI 10.1016/j.plasmid.2004.11.001	82	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148355	10.1371/journal.pone.0148355	http://dx.doi.org/10.1371/journal.pone.0148355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848973	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000077
J	Ballesta, S; Reymond, G; Pozzobon, M; Duhamel, JR				Ballesta, Sebastien; Reymond, Gilles; Pozzobon, Matthieu; Duhamel, Jean-Rene			Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis)	PLOS ONE			English	Article							3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; OXYTOCIN CONCENTRATIONS; RHESUS-MONKEYS; ECSTASY; RELEASE; AMPHETAMINE; SEROTONIN; (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE; NOREPINEPHRINE; STEREOISOMERS	3,4-methylenedioxy-N-methyl amphetamine (MDMA) is one of the few known molecules to increase human and rodent prosocial behaviors. However, this effect has never been assessed on the social behavior of non-human primates. In our study, we subcutaneously injected three different doses of MDMA (1.0, 1.5 or 2.0mg/kg) to a group of three, socially housed, young male long-tailed macaques. More than 200 hours of behavioral data were recorded, during 68 behavioral sessions, by an automatic color-based video device that tracked the 3D positions of each animal and of a toy. This data was then categorized into 5 exclusive behaviors (resting, locomotion, foraging, social contact and object play). In addition, received and given social grooming was manually scored. Results show several significant dose-dependent behavioral effects. At 1.5mg/kg only, MDMA induces a significant increase in social grooming behavior, thus confirming the prosocial effect of MDMA in macaques. Additionally, at 1.5 and 2.0 mg/kg MDMA injection substantially decreases foraging behavior, which is consistent with the known anorexigenic effect of this compound. Furthermore, at 2.0 mg/kg MDMA injection induces an increase in locomotor behavior, which is also in accordance with its known stimulant property. Interestingly, MDMA injected at 1.0mg/kg increases the rate of object play, which might be interpreted as a decrease of the inhibition to manipulate a unique object in presence of others, or, as an increase of the intrinsic motivation to manipulate this object. Together, our results support the effectiveness of MDMA to study the complex neurobiology of primates' social behaviors.	[Ballesta, Sebastien; Reymond, Gilles; Pozzobon, Matthieu; Duhamel, Jean-Rene] Ctr Natl Rech Sci, Ctr Neurosci Cognit, F-69675 Bron, France; [Ballesta, Sebastien; Reymond, Gilles; Pozzobon, Matthieu; Duhamel, Jean-Rene] Univ Lyon 1, Dept Biol Humaine, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Ballesta, S (corresponding author), Ctr Natl Rech Sci, Ctr Neurosci Cognit, F-69675 Bron, France.; Ballesta, S (corresponding author), Univ Lyon 1, Dept Biol Humaine, F-69622 Villeurbanne, France.	sebastien.ballesta@gmail.com	Duhamel, Jean-René/M-4723-2017; Ballesta, Sebastien/AAC-7617-2022	Duhamel, Jean-René/0000-0003-0210-1027; Ballesta, Sebastien/0000-0002-7854-5735	LABEX of University de Lyon within the program "Investissement d'Avenir" [ANR-11-IDEX-0007]; Rhone-Alpes Region; Agence Nationale de la Recherche [BLAN-SVSE4-023-01, BS4-0010-01]	LABEX of University de Lyon within the program "Investissement d'Avenir"(French National Research Agency (ANR)); Rhone-Alpes Region(Region Auvergne-Rhone-Alpes); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the LABEX (ANR-11-IDEX-0007) of University de Lyon within the program "Investissement d'Avenir" and by grants from the Rhone-Alpes Region and from the Agence Nationale de la Recherche (BLAN-SVSE4-023-01, BS4-0010-01) to JRD.	ALI SF, 1993, NEUROTOXICOL TERATOL, V15, P91, DOI 10.1016/0892-0362(93)90067-X; Azmitia E C, 1986, Adv Neurol, V43, P407; Ballesta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115965; Ballestaa S, 2014, J NEUROSCI METH, V234, P147, DOI 10.1016/j.jneumeth.2014.05.022; Bartz JA, 2010, PSYCHOL SCI, V21, P1426, DOI 10.1177/0956797610383439; BATTAGLIA G, 1988, EUR J PHARMACOL, V149, P159, DOI 10.1016/0014-2999(88)90056-8; Beaudoin-Gobert M, 2015, BRAIN, V138, P2632, DOI 10.1093/brain/awv183; BELLAROSA A, 1980, PHARMACOL BIOCHEM BE, V13, P221, DOI 10.1016/0091-3057(80)90077-5; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Brody S, 2006, BIOL PSYCHOL, V71, P312, DOI 10.1016/j.biopsycho.2005.06.008; CHAMOVE AS, 1983, MOTIV EMOTION, V7, P213, DOI 10.1007/BF00992904; CHENEY DL, 1990, COGNITION, V37, P167, DOI 10.1016/0010-0277(90)90022-C; Churchland PS, 2012, HORM BEHAV, V61, P392, DOI 10.1016/j.yhbeh.2011.12.003; Crean RD, 2006, NEUROSCIENCE, V142, P515, DOI 10.1016/j.neuroscience.2006.06.033; Dumont GJH, 2009, SOC NEUROSCI-UK, V4, P359, DOI 10.1080/17470910802649470; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Emanuele E, 2006, MED HYPOTHESES, V67, P1250, DOI 10.1016/j.mehy.2006.05.021; Fantegrossi WE, 2002, PSYCHOPHARMACOLOGY, V161, P356, DOI 10.1007/s00213-002-1021-6; Fantegrossi WE, 2008, BIOCHEM PHARMACOL, V75, P17, DOI 10.1016/j.bcp.2007.07.018; Fantegrossi WE, 2007, PSYCHOPHARMACOLOGY, V189, P471, DOI 10.1007/s00213-006-0320-8; Fone KCF, 2002, PSYCHOPHARMACOLOGY, V159, P437, DOI 10.1007/s00213-001-0931-z; Gouzoulis-Mayfrank E, 2001, HEFFTER REV PSYCHEDE, V2, P64; HABER S, 1981, J PSYCHIAT RES, V16, P23, DOI 10.1016/0022-3956(81)90010-8; Harris DS, 2002, PSYCHOPHARMACOLOGY, V162, P396, DOI 10.1007/s00213-002-1131-1; Hunt GE, 2011, BRAIN RES BULL, V86, P65, DOI 10.1016/j.brainresbull.2011.06.011; Hysek CM, 2011, CLIN PHARMACOL THER, V90, P246, DOI 10.1038/clpt.2011.78; Hysek CM, 2013, J CLIN PSYCHOPHARM, V33, P658, DOI 10.1097/JCP.0b013e3182979d32; Hysek CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036476; Hysek CM, 2013, SOC COGN AFFECT NEUR; JOHNSON MP, 1986, EUR J PHARMACOL, V132, P269, DOI 10.1016/0014-2999(86)90615-1; Kamilar-Britt P, 2015, NEUROSCI BIOBEHAV R, V57, P433, DOI 10.1016/j.neubiorev.2015.08.016; Kirkpatrick MG, 2014, PSYCHONEUROENDOCRINO, V46, P23, DOI 10.1016/j.psyneuen.2014.04.006; KUMMER H, 1991, ANIM BEHAV, V42, P529, DOI 10.1016/S0003-3472(05)80238-6; Liechti ME, 2000, NEUROPSYCHOPHARMACOL, V22, P513, DOI 10.1016/S0893-133X(99)00148-7; Liechti ME, 2001, PSYCHOPHARMACOLOGY, V154, P161, DOI 10.1007/s002130000648; Maldonado R, 2014, EUR NEUROPSYCHOPHARM; MARTEL FL, 1995, DEV PSYCHOBIOL, V28, P71, DOI 10.1002/dev.420280202; Meyer JS, 2004, DRUGS BRAIN BEHAV; Morley KC, 2000, EUR J PHARMACOL, V408, P41, DOI 10.1016/S0014-2999(00)00749-4; MOSER R, 1991, INT J PRIMATOL, V12, P217, DOI 10.1007/BF02547585; Murnane KS, 2012, HORM BEHAV, V61, P181, DOI 10.1016/j.yhbeh.2011.10.012; Murnane KS, 2010, J PHARMACOL EXP THER, V334, P642, DOI 10.1124/jpet.110.166595; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; NICHOLS DE, 1982, J MED CHEM, V25, P530, DOI 10.1021/jm00347a010; NICHOLS DE, 1986, J PSYCHOACTIVE DRUGS, V18, P305, DOI 10.1080/02791072.1986.10472362; Parrott AC, 2009, NEUROPSYCHOBIOLOGY, V60, P148, DOI 10.1159/000253551; RICAURTE GA, 1988, JAMA-J AM MED ASSOC, V260, P51, DOI 10.1001/jama.260.1.51; Rothman RB, 2001, SYNAPSE, V39, P32, DOI 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; SCHMIDT CJ, 1987, BIOCHEM PHARMACOL, V36, P747, DOI 10.1016/0006-2952(87)90729-5; Seibert J, 2014, NEUROENDOCRINOLOGY, V100, P17, DOI 10.1159/000364879; Shively CA, 2013, PSYCHOPHARMACOLOGY B; SHULGIN AT, 1986, J PSYCHOACTIVE DRUGS, V18, P291, DOI 10.1080/02791072.1986.10472361; Simmler LD, 2013, BRIT J PHARMACOL, V168, P458, DOI 10.1111/j.1476-5381.2012.02145.x; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Taffe MA, 2006, DRUG ALCOHOL DEPEN, V82, P276, DOI 10.1016/j.drugalcdep.2005.09.013; Thompson MR, 2009, SOC NEUROSCI-UK, V4, P60, DOI 10.1080/17470910802045042; Young SN, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0375	58	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147136	10.1371/journal.pone.0147136	http://dx.doi.org/10.1371/journal.pone.0147136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840064	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200027
J	Harari, S; Madotto, F; Caminati, A; Conti, S; Cesana, G				Harari, Sergio; Madotto, Fabiana; Caminati, Antonella; Conti, Sara; Cesana, Giancarlo			Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASES; MORTALITY; PREVALENCE; DIAGNOSIS; IPF	Background Idiopathic pulmonary fibrosis (IPF) is the most common and severe form of idiopathic interstitial pneumonia. Despite its clinical relevance, few studies have examined the epidemiology of IPF and temporal variation in disease incidence and prevalence. Aim of the study was to investigate the prevalence, incidence and trends of IPF in Lombardy, a region with nearly 10 million inhabitants, during 2005-2010. Methods For the identification of IPF patients, we used healthcare administrative databases of Lombardy Healthcare System and adopted three algorithms: generic, broad and narrow case definition (GCD, BCD, NCD). IPF cases were identified according to diagnoses reported in inpatient and outpatient claims occurred during 2000-2010. We estimated age-and sex-adjusted annual prevalence and incidence rates from 2005 to 2010, thus allowing for a 5-year washout period. Results The mean annual incidence rate was estimated at 2.3 and 5.3 per 100,000 person-years using NCD and GCD, respectively. IPF incidence was higher among males, and increased with age. Trend remained stable over the years. The estimated annual prevalence rate was 35.5, 22.4, and 12.6 per 100,000 person-years using GCD, BCD and NCD, respectively, and increased with age. Moreover, we observed a positive trend over the years. Using BCD and NCD, prevalence was higher among males. Conclusions The results of this study, which is one of the largest population-based survey ever conducted according to strict criteria, indicated that prevalence of IPF increased across the years while incidence remained stable, thus suggesting that survival with IPF has improved.	[Harari, Sergio; Caminati, Antonella] Osped San Giuseppe MultiMed IRCCS, Serv Fisiopatol Resp & Emodinam Polmonare, Unita Operat Pneumol & Terapia Semiintens Resp, Milan, Italy; [Madotto, Fabiana; Conti, Sara] Univ Milano Bicocca, Dept Med & Surg, Res Ctr Publ Hlth, Milan, Italy	University of Milano-Bicocca	Harari, S (corresponding author), Osped San Giuseppe MultiMed IRCCS, Serv Fisiopatol Resp & Emodinam Polmonare, Unita Operat Pneumol & Terapia Semiintens Resp, Milan, Italy.	sharari@hotmail.it	Madotto, Fabiana/AAA-9802-2019; Caminati, Antonella/L-8743-2019; Conti, Sara/J-4891-2019	Madotto, Fabiana/0000-0002-8829-9160; Conti, Sara/0000-0002-5774-3740; Harari, Sergio/0000-0001-8629-7391	InterMune s.r.l.	InterMune s.r.l.	This study was funded by InterMune s.r.l. The sponsor approved the study design but played no role in development of the research and manuscript.	Agabiti N, 2014, SARCOIDOSIS VASC DIF, V31, P191; Agostini C, 2001, Monaldi Arch Chest Dis, V56, P364; Caminati A, 2015, EUR RESPIR REV, V24, P436, DOI 10.1183/16000617.0040-2015; Caminati A, 2010, RESP MED, V104, pS2, DOI 10.1016/j.rmed.2010.03.012; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; COULTAS DB, 2004, IDIOPATHIC PULMONARY, P1; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Fernandez-Perez ER, 2010, CHEST, V137, P242, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; Fornari C, 2008, EPIDEMIOL PREV, V32, P79; Gordis L., 2004, EPIDEMIOLOGY; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Harari S, 2005, ALLERGY, V60, P421, DOI 10.1111/j.1398-9995.2005.00719.x; Hubbard R, 1996, THORAX, V51, P711, DOI 10.1136/thx.51.7.711; Hutchinson John P, 2014, Ann Am Thorac Soc, V11, P1176, DOI 10.1513/AnnalsATS.201404-145OC; Hyldgaard C, 2014, RESP MED, V108, P793, DOI 10.1016/j.rmed.2013.09.002; JOHNSTON I, 1990, BRIT MED J, V301, P1017, DOI 10.1136/bmj.301.6759.1017; Karakatsani A, 2009, RESP MED, V103, P1122, DOI 10.1016/j.rmed.2009.03.001; Kaunisto J, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-53; Lai CC, 2012, RESP MED, V106, P1566, DOI 10.1016/j.rmed.2012.07.012; Ley Brett, 2013, Clin Epidemiol, V5, P483, DOI 10.2147/CLEP.S54815; Lumley T., 2004, BIOSTATISTICS METHOD, V519; Madotto F, 2013, EPIDEMIOL BIOSTAT PU, V10, DOI 10.2427/8840; Mannino DM, 1996, AM J RESP CRIT CARE, V153, P1548, DOI 10.1164/ajrccm.153.5.8630600; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Nalysnyk L, 2012, EUR RESPIR REV, V21, P355, DOI 10.1183/09059180.00002512; Natsuizaka M, 2014, AM J RESP CRIT CARE, V190, P773, DOI 10.1164/rccm.201403-0566OC; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; Ohno S, 2008, RESPIROLOGY, V13, P926, DOI 10.1111/j.1440-1843.2008.01349.x; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; PANOS RJ, 1990, AM J MED, V88, P396, DOI 10.1016/0002-9343(90)90495-Y; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Tinelli C, 2005, SARCOIDOSIS VASC DIF, V22, pS4	34	49	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147072	10.1371/journal.pone.0147072	http://dx.doi.org/10.1371/journal.pone.0147072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841042	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200024
J	Kato, H; Ikeguchi, T				Kato, Hideyuki; Ikeguchi, Tohru			Oscillation, Conduction Delays, and Learning Cooperate to Establish Neural Competition in Recurrent Networks	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; MODEL; CONNECTIVITY; CIRCUITS; INTEGRATION; SYNCHRONY; SELECTION; PATTERNS; NEURONS; SPARSE	Specific memory might be stored in a subnetwork consisting of a small population of neurons. To select neurons involved in memory formation, neural competition might be essential. In this paper, we show that excitable neurons are competitive and organize into two assemblies in a recurrent network with spike timing-dependent synaptic plasticity (STDP) and axonal conduction delays. Neural competition is established by the cooperation of spontaneously induced neural oscillation, axonal conduction delays, and STDP. We also suggest that the competition mechanism in this paper is one of the basic functions required to organize memory-storing subnetworks into fine-scale cortical networks.	[Kato, Hideyuki] Tokyo Univ Technol, Sch Engn, Tokyo, Japan; [Ikeguchi, Tohru] Tokyo Univ Sci, Fac Engn Div 1, Tokyo 162, Japan	Tokyo University of Technology; Tokyo University of Science	Kato, H (corresponding author), Tokyo Univ Technol, Sch Engn, Tokyo, Japan.	katohdyk@stf.teu.ac.jp			Japan Society for the Promotion of Science [22-8144, 24650116, 15KT0112]; JSPS [22.8144]; Grants-in-Aid for Scientific Research [24650116] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Research Fellowships of Japan Society for the Promotion of Science (No. 22-8144) (HK), Grant-in-Aids for Challenging Exploratory Research (No. 24650116) and Grant-in-Aids for Scientific Research (C) (Generative Research Fields) (No. 15KT0112) (TI), http://www.jsps.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is partially supported by Research Fellowships of JSPS (No. 22.8144) for HK, and Grant-in-Aids for Challenging Exploratory Research (No. 24650116) and Grant-in-Aids for Scientific Research (C) (Generative Research Fields) (No. 15KT0112) for TI.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bhattacharya J, 2005, HUM BRAIN MAPP, V26, P1, DOI 10.1002/hbm.20104; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cateau H, 2003, NEURAL COMPUT, V15, P597, DOI 10.1162/089976603321192095; Cateau H, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051909; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; DAWKINS R, 1971, NATURE, V229, P118, DOI 10.1038/229118a0; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gilson M, 2010, FRONT COMPUT NEUROSC, V4, P1, DOI DOI 10.3389/FNCOM.2010.00023; Gutig R, 2003, J NEUROSCI, V23, P3697; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Iglesias J, 2005, LECT NOTES COMPUT SC, V3704, P59, DOI 10.1007/11565123_6; Iglesias J, 2007, LECT NOTES COMPUT SC, V4668, P579; Iglesias J, 2010, J PHYSIOL-PARIS, V104, P137, DOI 10.1016/j.jphysparis.2009.11.016; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Kandel E., 2000, PRINCIPLES NEURAL SC; Kato H, 2008, LECT NOTES COMPUT SC, V5163, P623, DOI 10.1007/978-3-540-87536-9_64; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Kozloski J, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00007; Lee S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000602; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Levy N, 2001, NEURAL NETWORKS, V14, P815, DOI 10.1016/S0893-6080(01)00044-2; LILEY DTJ, 1994, NETWORK-COMP NEURAL, V5, P175, DOI 10.1088/0954-898X/5/2/004; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Masuda N, 2004, NEURAL COMPUT, V16, P627, DOI 10.1162/089976604772744938; McAssey MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086526; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Mountcastle VB, 1982, THE MINDFUL BRAIN CO; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shin CW, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.045101; Shinomoto S, 2003, NEURAL COMPUT, V15, P2823, DOI 10.1162/089976603322518759; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Takahashi YK, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051904; Tesche CD, 2013, FRONT NEURAL CIRCUIT, V7, P1; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Yasuda M, 2011, NEURON, V70, P1128, DOI 10.1016/j.neuron.2011.04.027	58	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146044	10.1371/journal.pone.0146044	http://dx.doi.org/10.1371/journal.pone.0146044			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840529	gold, Green Submitted, Green Published			2022-12-26	WOS:000369550200006
J	Kraus, AK; Chen, J; Edenhofer, I; Ravens, I; Gaspert, A; Cippa, PE; Mueller, S; Wuthrich, RP; Segerer, S; Bernhardt, G; Fehr, T				Kraus, Anna K.; Chen, Jin; Edenhofer, Ilka; Ravens, Inga; Gaspert, Ariana; Cippa, Pietro E.; Mueller, Steffen; Wuthrich, Rudolf P.; Segerer, Stephan; Bernhardt, Guenter; Fehr, Thomas			The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation	PLOS ONE			English	Article							TUBULAR EPITHELIAL-CELLS; POLIOVIRUS RECEPTOR; IMMUNE-RESPONSES; DENDRITIC CELLS; NECTIN-2 CD112; CD226; EXPRESSION; ADHESION; MOLECULE; LIGANDS	DNAX accessory protein-1 (DNAM-1, CD226) is a co-stimulatory and adhesion molecule expressed mainly by natural killer cells and T cells. DNAM-1 and its two ligands CD112 and CD155 are important in graft-versus-host disease, but their role in solid organ transplantation is largely unknown. We investigated the relevance of this pathway in a mouse kidney transplantation model. CD112 and CD155 are constitutively expressed on renal tubular cells and strongly upregulated in acutely rejected renal allografts. In vitro DNAM-1 blockade during allogeneic priming reduced the allospecific T cell response but not the allospecific cytotoxicity against renal tubular epithelial cells. Accordingly, absence of DNAM-1 in recipient mice or absence of CD112 or CD155 in the kidney allograft did not significantly influence renal function and severity of rejection after transplantation, but led to a higher incidence of infarcts in CD112 and CD155 deficient kidney allografts. Thus, DNAM-1 blockade is not effective in preventing transplant rejection. Despite of being highly expressed, CD112 and CD155 do not appear to play a major immunogenic role in kidney transplantation. Considering the high incidence of renal infarcts in CD112 and CD155 deficient grafts, blocking these molecules might be detrimental.	[Kraus, Anna K.; Chen, Jin; Edenhofer, Ilka; Wuthrich, Rudolf P.; Segerer, Stephan; Fehr, Thomas] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Kraus, Anna K.; Chen, Jin; Edenhofer, Ilka; Cippa, Pietro E.; Wuthrich, Rudolf P.; Segerer, Stephan; Fehr, Thomas] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Ravens, Inga; Bernhardt, Guenter] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Gaspert, Ariana] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Mueller, Steffen] SUNY Stony Brook, Dept Mol Genet & Microbiol, New York, NY USA	University of Zurich; University of Zurich; University Zurich Hospital; Hannover Medical School; University of Zurich; University Zurich Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Fehr, T (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.; Fehr, T (corresponding author), Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.	thomas.fehr@uzh.ch	Mueller, Steffen/HGE-0738-2022; Bernhardt, Günter/F-6946-2012	Bernhardt, Günter/0000-0002-0510-2853; Cippa, Pietro/0000-0002-9507-0057; Segerer, Stephan/0000-0002-1936-9719; Mueller, Steffen/0000-0003-2660-258X	Swiss National Science Foundation [310000-121979]; Research Foundation of the University of Zurich [34171706]; Nierenstiftung Switzerland; EMDO Foundation Zurich; Else Kroener-Fresenius Foundation; Pesquisa e Desenvolvimento Humanitario Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Research Foundation of the University of Zurich; Nierenstiftung Switzerland; EMDO Foundation Zurich; Else Kroener-Fresenius Foundation; Pesquisa e Desenvolvimento Humanitario Foundation	This study was supported by the Swiss National Science Foundation (grant no. 310000-121979 to T. Fehr), the Research Foundation of the University of Zurich (grant No 34171706 to T. Fehr), the Nierenstiftung Switzerland, the EMDO Foundation Zurich, the Else Kroener-Fresenius Foundation, and the Pesquisa e Desenvolvimento Humanitario Foundation. The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 1997, EXP CELL RES, V235, P374, DOI 10.1006/excr.1997.3685; Bernhardt G, 2014, NAT IMMUNOL, V15, P406, DOI 10.1038/ni.2855; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Cippa PE, 2011, TRANSPL INT, V24, P722, DOI 10.1111/j.1432-2277.2011.01272.x; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Escalante NK, 2011, ARTERIOSCL THROM VAS, V31, P1177, DOI 10.1161/ATVBAHA.111.224162; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Harris AG, 1996, AM J PHYSIOL-HEART C, V271, pH2388, DOI 10.1152/ajpheart.1996.271.6.H2388; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Kinnear G, 2013, TRANSPLANTATION, V95, P527, DOI 10.1097/TP.0b013e31826d4672; Kojima H, 2003, J BIOL CHEM, V278, P36748, DOI 10.1074/jbc.M300702200; Koyama M, 2013, BLOOD, V121, P3511, DOI 10.1182/blood-2012-07-444026; Kraus AK, 2013, TRANSPL INT, V26, P535, DOI 10.1111/tri.12070; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; Pende D, 2006, BLOOD, V107, P2030, DOI 10.1182/blood-2005-07-2696; Pilat N, 2011, SEMIN IMMUNOL, V23, P293, DOI 10.1016/j.smim.2011.04.002; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; SCHULZE DH, 1983, P NATL ACAD SCI-BIOL, V80, P2007, DOI 10.1073/pnas.80.7.2007; Seth S, 2009, J LEUKOCYTE BIOL, V86, P91, DOI [10.1189/JLB.1208745, 10.1189/jlb.1208745]; Seth S, 2011, P NATL ACAD SCI USA, V108, pE32, DOI 10.1073/pnas.1017969108; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Starke A, 2007, NEPHRON EXP NEPHROL, V107, pE22, DOI 10.1159/000106506; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tian YH, 2010, J SURG RES, V163, pE91, DOI 10.1016/j.jss.2010.04.019; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; Welsh-Bacic D, 2011, NEPHROL DIAL TRANSPL, V26, P1211, DOI 10.1093/ndt/gfq560; WUTHRICH RP, 1990, KIDNEY INT, V37, P783, DOI 10.1038/ki.1990.46; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147951	10.1371/journal.pone.0147951	http://dx.doi.org/10.1371/journal.pone.0147951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840537	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000369550200072
J	Yu, Q; Xiong, YH; Liu, JL; Wen, DL; Wu, XH; Yin, HQ				Yu, Qian; Xiong, Youhua; Liu, Jianliang; Wen, Dongling; Wu, Xiaohui; Yin, Hanqi			Transcriptome Analysis of the SL221 Cells at the Early Stage during Spodoptera litura Nucleopolyhedrovirus Infection	PLOS ONE			English	Article							IN-FIELD POPULATIONS; BIOLOGICAL-CONTROL; GENOME SEQUENCE; VIRAL TRANSPORT; PLANT-EXTRACTS; COMMON CUTWORM; APOPTOSIS; VIRUSES; BACULOVIRUSES; ANTIFEEDANT	Spodoptera litura (S. litura) is one of the most destructive agricultural pests worldwide. There is urgent need for a nuclear polyhedrosis virus that is specific to S. litura. To date, there have been no reports regarding the responses of S. litura cells to early Spodoptera litura nucleopolyhedrovirus (SpltNPV) infection due to the lack of a reference genome and transcriptome for S. litura. In this study, a cell transcriptome fromthe host S. litura was assembled and used for Illumina strand-specific RNA sequencing (RNA-seq) to generate 99180 unigenes, representing the 18 hour infection cycle. More than 2000 S. litura genes were significant differentially regulated throughout the infection. The levels of viral mRNAs began to increase dramatically at 6 hpi, and this increase continued throughout the remainder of the infection. We focused on the expression of genes related to stress responses, apoptosis, metabolic enzymes and host cell innate immune system. A small subset of genes related to host stress response, especially for 62 ones being able to annotated as enzyme, ligand and receptor genes, were observed to be specifically differentially expressed at 6 hpi. At 18 hpi, 104 unigenes were continuously significantly changing from 0 hpi to 18 hpi, considered to be viral multiplication related genes, including 3 annotated SL221 unigenes and 81 viral genes, such as tetraspanin and iap gene. This information and further studies on the regulation of host gene expression by baculovirus infection at early stage will provide the tools needed to enhance the utility of this virus as an effective insecticide.	[Yu, Qian; Xiong, Youhua; Liu, Jianliang; Wen, Dongling] Zhongkai Univ Agr & Engn, Coll Food Sci & Technol, Guangzhou 510225, Guangdong, Peoples R China; [Yin, Hanqi] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Xiaohui] Shanghai Biotechnol Corp, Shanghai 201203, Peoples R China	Zhongkai University of Agriculture & Engineering; Sun Yat Sen University	Yin, HQ (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	hanqiyincn@126.com			National Natural Science Foundation of China [31201575]; Project of outstanding young teachers in Higher Education Institutions of Guangdong Province [Yq2013096]; Deciduous fruit trees technology research institute of Guangdong Province [2015B090903082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of outstanding young teachers in Higher Education Institutions of Guangdong Province; Deciduous fruit trees technology research institute of Guangdong Province	This research was supported by the National Natural Science Foundation of China (No. 31201575), the Project of outstanding young teachers in Higher Education Institutions of Guangdong Province (No. Yq2013096) and Deciduous fruit trees technology research institute of Guangdong Province (2015B090903082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2001, J VIROL, V75, P11157, DOI 10.1128/JVI.75.22.11157-11165.2001; Ahmad M, 2007, CROP PROT, V26, P809, DOI 10.1016/j.cropro.2006.07.006; Ahrnad M, 2007, PEST MANAG SCI, V63, P1002, DOI 10.1002/ps.1430; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Baskar K., 2011, International Journal of Agricultural Technology, V7, P123; Ben-Dov IZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086856; Bernhardt R, 1996, REV PHYSIOL BIOCH P, V127, P137, DOI 10.1007/BFb0048267; Blissard GW, 2002, INSECT CELL CULTURE, P73; Bulach DM, 1999, J INVERTEBR PATHOL, V73, P59, DOI 10.1006/jipa.1998.4797; Cave Ronald D., 2000, Biocontrol News and Information, V21, p21N; Chen JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110623; Chen YR, 2014, J VIROL, V88, P13781, DOI 10.1128/JVI.02243-14; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; Clem RJ, 2001, CELL DEATH DIFFER, V8, P137, DOI 10.1038/sj.cdd.4400821; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Dong SB, 2014, GENE, V544, P220, DOI 10.1016/j.gene.2014.04.031; Hawkins CJ, 1996, P NATL ACAD SCI USA, V93, P13786, DOI 10.1073/pnas.93.24.13786; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Huang SJ, 2007, PESTIC BIOCHEM PHYS, V87, P14, DOI 10.1016/j.pestbp.2006.05.002; Hummelbrunner LA, 2001, J AGR FOOD CHEM, V49, P715, DOI 10.1021/jf000749t; Kamaraj C, 2008, PARASITOL RES, V103, P325, DOI 10.1007/s00436-008-0974-8; Kamiya K, 2004, BIOL CONTROL, V31, P38, DOI 10.1016/j.biocontrol.2004.04.003; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Koyama AH, 2000, MICROBES INFECT, V2, P1111, DOI 10.1016/S1286-4579(00)01265-X; Lacey LA, 2001, BIOL CONTROL, V21, P230, DOI 10.1006/bcon.2001.0938; LIANG Q, 2008, GUANGDONG AGR SCI, V8, P028; Mallikarjuna N, 2004, J APPL ENTOMOL, V128, P321, DOI 10.1111/j.1439-0418.2004.00834.x; Maramorosch K, 2012, VIRAL INSECTICIDES B; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pan LJ, 2005, VIRUS RES, V110, P73, DOI 10.1016/j.virusres.2005.01.008; Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Priyanka Bhatt, 2014, Journal of Applied and Natural Science, V6, P139; Ramakrishnan N, 1984, PESTICIDES, P18; Rhodes D, 1993, FORMULATION BIOL CON, P411; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; SMITH GE, 1978, VIROLOGY, V89, P517, DOI 10.1016/0042-6822(78)90193-9; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Sun Xiu-lian, 2007, Virologica Sinica, V22, P158; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wittmann C, 2002, APPL ENVIRON MICROB, V68, P5843, DOI 10.1128/AEM.68.12.5843-5859.2002; Xiao CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094250; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu Q, 2008, J GEN VIROL, V89, P1873, DOI 10.1099/vir.0.2008/001008-0; Zhang G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks196	54	10	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147873	10.1371/journal.pone.0147873	http://dx.doi.org/10.1371/journal.pone.0147873			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840182	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200067
J	Das, S; Sahoo, GC; Das, P; Singh, UK; Jaiswal, AK; Singh, P; Kumar, R; Kumar, R				Das, Sushmita; Sahoo, Ganesh Chandra; Das, Pradeep; Singh, Utpal Kant; Jaiswal, Anil Kumar; Singh, Prachi; Kumar, Ranjeet; Kumar, Rishikesh			Evaluating the Impact of Breastfeeding on Rotavirus Antigenemia and Disease Severity in Indian Children	PLOS ONE			English	Article							GROUP-A ROTAVIRUSES; HUMAN-MILK GLYCANS; ACUTE GASTROENTERITIS; INFECTION; DIARRHEA; PROTECTION; INFANTS; ANTIBODIES; VACCINE; LACTADHERIN	Objectives To evaluate the contribution of breastfeeding to Rotavirus (RV)-induced antigenemia and/or RNAemia and disease severity in Indian children (<2 yrs age). Methods Paired stool and serum samples were collected from (a) hospitalized infants with diarrhea (n = 145) and (b) healthy control infants without diarrhea (n = 28). Stool RV-antigen was screened in both groups by commercial rapid-test and enzyme immunoassay. The disease severity was scored and real-time-PCR was used for viral-load estimation. Serum was evaluated for RV-antigenemia by EIA and RV-RNAemia by RT-PCR. Data was stratified by age-group and breastfeeding status and compared. Results Presence of RV-antigenemia and RV-RNAemia was positively related with presence of RV in stool. Disease severity and stool viral-load was significantly associated with RV-antigenemia[(r = 0.74; CI: 0.66 to 0.84; P<0.0001, R-2 = 0.59) and (r = -0.55; CI:-0.68 to -0.39; P<0.0001, R-2 = 0.31) respectively], but not with RV-RNAemia. There was significant reduction in RV-antigenemiarate in the breast-fed group compared to non-breastfed infants, especially in 0-6 month age group (P<0.001). Non-breastfed infants were at risk for RV-antigenemia with severe disease manifestations in form of high Vesikari scores correlating with high fever, more vomiting episodes and dehydration. Conclusion RV-antigenemia was common in nonbreastfed children with severe RV-diarrhea and correlated with stool RV-load and disease severity.	[Das, Sushmita] AIIMS, Dept Microbiol, Patna, Bihar, India; [Sahoo, Ganesh Chandra; Das, Pradeep; Kumar, Ranjeet; Kumar, Rishikesh] Rajendra Mem Res Inst Med Sci ICMR, Virol Unit, Patna, Bihar, India; [Singh, Utpal Kant; Jaiswal, Anil Kumar; Singh, Prachi] Nalanda Med Coll & Hosp, Dept Paediat, Patna, Bihar, India; [Jaiswal, Anil Kumar] Patna Med Coll & Hosp, Dept Paediat, Patna, Bihar, India	All India Institute of Medical Sciences (AIIMS) Patna; Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Das, S (corresponding author), AIIMS, Dept Microbiol, Patna, Bihar, India.	sushmita.de2008@gmail.com		Kumar, Rishikesh/0000-0001-8993-4683				Asensi MT, 2006, J PEDIATR GASTR NUTR, V42, P560, DOI 10.1097/01.mpg.0000221892.59371.b3; Blutt SE, 2007, CURR OPIN GASTROEN, V23, P39, DOI 10.1097/MOG.0b013e328011829d; Blutt SE, 2007, PLOS MED, V4, P660, DOI 10.1371/journal.pmed.0040121; Blutt SE, 2003, LANCET, V362, P1445, DOI 10.1016/S0140-6736(03)14687-9; BRUSSOW H, 1993, J CLIN MICROBIOL, V31, P593; Civra A, 2015, J BIOL CHEM, V290, P12403, DOI 10.1074/jbc.M114.620500; Clarke E, 2015, MUCOSAL IMMUNOL, V8, P1, DOI 10.1038/mi.2014.114; CLEMENS J, 1993, PEDIATRICS, V92, P680; Fischer TK, 2005, J INFECT DIS, V192, P913, DOI 10.1086/432549; Fujita Y, 2010, JPN J INFECT DIS, V63, P83; GLASS RI, 1986, ACTA PAEDIATR SCAND, V75, P713, DOI 10.1111/j.1651-2227.1986.tb10279.x; Gomara MI, 2002, J VIROL, V76, P6596, DOI 10.1128/JVI.76.13.6596-6601.2002; Heatona PM, 2007, CLIN INFECT DIS, V45, P1618, DOI 10.1086/522997; Iturriza-Gomara M, 1999, J VIROL METHODS, V78, P93, DOI 10.1016/S0166-0934(98)00168-2; JAYASHREE S, 1988, SCAND J INFECT DIS, V20, P249, DOI 10.3109/00365548809032447; Jiang BM, 2002, CLIN INFECT DIS, V34, P1351, DOI 10.1086/340103; Kvistgaard AS, 2004, J DAIRY SCI, V87, P4088, DOI 10.3168/jds.S0022-0302(04)73551-1; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Moon SS, 2013, PEDIATR INFECT DIS J, V32, P863, DOI 10.1097/INF.0b013e318290646d; Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea; MORRIS SS, 1994, INT J EPIDEMIOL, V23, P617, DOI 10.1093/ije/23.3.617; Morrow AL, 2005, J NUTR, V135, P1304, DOI 10.1093/jn/135.5.1304; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Morrow Ardythe L, 2004, Semin Pediatr Infect Dis, V15, P221, DOI 10.1053/j.spid.2004.07.002; Nelson EAS, 2010, LANCET, V376, P568, DOI 10.1016/S0140-6736(10)60896-3; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Newburg DS, 1998, LANCET, V351, P1160, DOI 10.1016/S0140-6736(97)10322-1; Phadke SM, 2005, J NUTR, V135, P1289, DOI 10.1093/jn/135.5.1289; Phan TG, 2007, J VIROL, V81, P4645, DOI 10.1128/JVI.02342-06; Prameela K K, 2012, Malays J Nutr, V18, P103; Ramani S, 2010, CLIN INFECT DIS, V51, P1284, DOI 10.1086/657069; Ray P, 2006, J INFECT DIS, V194, P588, DOI 10.1086/505878; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Sugata K, 2008, PEDIATRICS, V122, P392, DOI 10.1542/peds.2007-2290; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Velazquez FR, 2000, J INFECT DIS, V182, P1602, DOI 10.1086/317619; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664	39	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0146243	10.1371/journal.pone.0146243	http://dx.doi.org/10.1371/journal.pone.0146243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828823	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200005
J	Guerrero, CA; Guerrero, RA; Silva, E; Acosta, O; Barreto, E				Guerrero, Carlos A.; Guerrero, Rafael A.; Silva, Elver; Acosta, Orlando; Barreto, Emiliano			Experimental Adaptation of Rotaviruses to Tumor Cell Lines	PLOS ONE			English	Article							ONCOLYTIC VIRUS THERAPY; DNA-DAMAGE RESPONSE; HEAT-SHOCK PROTEINS; IN-VITRO; POLY(ADP-RIBOSE) POLYMERASE; N-ACETYLCYSTEINE; CANCER; INFECTION; EXPRESSION; SURFACE	A number of viruses show a naturally extended tropism for tumor cells whereas other viruses have been genetically modified or adapted to infect tumor cells. Oncolytic viruses have become a promising tool for treating some cancers by inducing cell lysis or immune response to tumor cells. In the present work, rotavirus strains TRF-41 (G5) (porcine), RRV (G3) (simian), UK (G6-P5) (bovine), Ym (G11-P9) (porcine), ECwt (murine), Wa (G1-P8), Wi61 (G9) and M69 (G8) (human), and five wild-type human rotavirus isolates were passaged multiple times in different human tumor cell lines and then combined in five different ways before additional multiple passages in tumor cell lines. Cell death caused by the tumor cell-adapted isolates was characterized using Hoechst, propidium iodide, 7-AAD, Annexin V, TUNEL, and anti-poly-(ADP ribose) polymerase (PARP) and -phospho-histone H2A. X antibodies. Multiple passages of the combined rotaviruses in tumor cell lines led to a successful infection of these cells, suggesting a gain-of-function by the acquisition of greater infectious capacity as compared with that of the parental rotaviruses. The electropherotype profiles suggest that unique tumor cell-adapted isolates were derived from reassortment of parental rotaviruses. Infection produced by such rotavirus isolates induced chromatin modifications compatible with apoptotic cell death.	[Guerrero, Carlos A.; Guerrero, Rafael A.; Silva, Elver; Acosta, Orlando] Univ Nacl Colombia, Fac Med, Dept Physiol Sci, Bogota, DC, Colombia; [Barreto, Emiliano] Univ Nacl Colombia, Inst Biotechnol, Bogota, DC, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia	Guerrero, CA (corresponding author), Univ Nacl Colombia, Fac Med, Dept Physiol Sci, Bogota, DC, Colombia.	caguerrerof@unal.edu.co	Barreto, Emiliano/AAB-9009-2020	Barreto, Emiliano/0000-0002-5968-6794; Guerrero Rojas, Rafael Antonio/0000-0001-8755-3385	Departamento Administrativo de Ciencia, Tecnologia e Investigacion - COLCIENCIAS [110165843297, 658-2014]; Departamento Administrativo de Ciencia, Tecnologia e Investigacion-COLCIENCIAS through Patrimonio Autonomo Fondo Nacional de Financiamiento para la Ciencia, la Tecnologia y la Innovacion, Francisco Jose de Caldas [110165843297, 658-2014]	Departamento Administrativo de Ciencia, Tecnologia e Investigacion - COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Departamento Administrativo de Ciencia, Tecnologia e Investigacion-COLCIENCIAS through Patrimonio Autonomo Fondo Nacional de Financiamiento para la Ciencia, la Tecnologia y la Innovacion, Francisco Jose de Caldas	This study was supported by a grant (No. 110165843297, 658-2014) awarded by Departamento Administrativo de Ciencia, Tecnologia e Investigacion - COLCIENCIAS to C.A. Guerrero through Patrimonio Autonomo Fondo Nacional de Financiamiento para la Ciencia, la Tecnologia y la Innovacion, Francisco Jose de Caldas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant (No. 110165843297, 658-2014) awarded by Departamento Administrativo de Ciencia, Tecnologia e Investigacion-COLCIENCIAS to CAG through Patrimonio Autonomo Fondo Nacional de Financiamiento para la Ciencia, la Tecnologia y la Innovacion, Francisco Jose de Caldas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angarita FA, 2013, TRENDS MOL MED, V19, P378, DOI 10.1016/j.molmed.2013.02.008; Arnold MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003064; Arnold MM, 2011, J VIROL, V85, P1970, DOI 10.1128/JVI.01801-10; Guerrero CA, 2013, MEM I OSWALDO CRUZ, V108, P741, DOI 10.1590/0074-0276108062013011; Baker M, 2010, CURR TOP MICROBIOL, V343, P121, DOI 10.1007/82_2010_34; Ballarini F., 2010, J NUCL ACIDS, V2010, P8, DOI 350608; BASS DM, 1992, J CLIN INVEST, V90, P2313, DOI 10.1172/JCI116119; Boshuizen JA, 2003, J VIROL, V77, P13005, DOI 10.1128/JVI.77.24.13005-13016.2003; BROOME RL, 1993, J VIROL, V67, P2448, DOI 10.1128/JVI.67.5.2448-2455.1993; Calderon MN, 2012, INTERVIROLOGY, V55, P451, DOI 10.1159/000335262; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chaibi C, 2005, VIROLOGY, V332, P480, DOI 10.1016/j.virol.2004.11.039; CHEN D, 1993, VIROLOGY, V194, P743, DOI 10.1006/viro.1993.1315; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Cuadras MA, 2003, VIROLOGY, V313, P308, DOI 10.1016/S0042-6822(03)00326-X; DELCASTILLO JR, 1991, J GEN VIROL, V72, P541, DOI 10.1099/0022-1317-72-3-541; Desselberger U, 2013, VIRUS RES, V178, P252, DOI 10.1016/j.virusres.2013.09.034; Feng N, 2009, J VIROL, V83, P6987, DOI 10.1128/JVI.00585-09; Fleming FE, 2011, J BIOL CHEM, V286, P6165, DOI 10.1074/jbc.M110.142992; Gao S, 2015, EUR J NUCL MED MOL I; GINEVSKAYA VA, 1994, ARCH VIROL, V137, P199, DOI 10.1007/BF01311188; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Goldufsky J, 2013, ONCOLYTIC VIROTHER, V2, P31, DOI 10.2147/OV.S38901; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Graner MW, 2007, J NEUROSCI, V27, P11214, DOI 10.1523/JNEUROSCI.3588-07.2007; Guerrero CA, 2002, J VIROL, V76, P4096, DOI 10.1128/JVI.76.8.4096-4102.2002; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; Guerrero CA, 2014, PHARMACOTHERAPY, V34, pE333, DOI 10.1002/phar.1489; Guerrero CA, 2010, J VIROL METHODS, V168, P22, DOI 10.1016/j.jviromet.2010.04.010; Halasz P, 2010, J GEN VIROL, V91, P2007, DOI 10.1099/vir.0.018275-0; Harrington KJ, 2010, CYTOKINE GROWTH F R, V21, P91, DOI 10.1016/j.cytogfr.2010.02.006; Hemminki A, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/862925; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Isa P, 2004, VIROLOGY, V322, P370, DOI 10.1016/j.virol.2004.02.018; Jourdan N, 1997, J VIROL, V71, P8268, DOI 10.1128/JVI.71.11.8268-8278.1997; Kapikian AZ, FIELDS VIROLOGY, P1787; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Khan HA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00070; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Lee HH, 2012, INT J BIOL SCI, V8, P353, DOI 10.7150/ijbs.3157; Levine AJ, FIELDS VIROLOGY, P3; Liu RY, 2013, BIOCHEM BIOPH RES CO, V442, P171, DOI 10.1016/j.bbrc.2013.11.047; Liu TC, 2008, GENE THER, V15, P877, DOI 10.1038/gt.2008.72; Liu ZF, 2008, DRUG DEVELOP RES, V69, P329, DOI 10.1002/ddr.20265; Lokody I, 2014, NAT REV GENET, V15, DOI 10.1038/nrg3676; McClelland CM, 2007, BRIT J CANCER, V96, P284, DOI 10.1038/sj.bjc.6603544; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; Miest TS, 2014, NAT REV MICROBIOL, V12, P23, DOI 10.1038/nrmicro3140; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Newton K, 1997, J VIROL, V71, P9458, DOI 10.1128/JVI.71.12.9458-9465.1997; Nomaguchi M, 2012, FRONT MICROBIOL, V3, P1; Patel MR, 2013, TRANSL RES, V161, P355, DOI 10.1016/j.trsl.2012.12.010; Perez JF, 1998, VIROLOGY, V252, P17, DOI 10.1006/viro.1998.9433; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Podhorecka M., 2010, J NUCL ACIDS, V2010, P1, DOI DOI 10.4061/2010/920161; Ralhan R, 1995, CLIN CANCER RES, V1, P1217; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Ruiz MC, 2005, VIROLOGY, V333, P54, DOI 10.1016/j.virol.2004.12.032; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Santana AY, 2013, ARCH VIROL, V158, P1323, DOI 10.1007/s00705-013-1626-6; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Shinderman-Maman E, 2015, ONCOGENE; Stucci S, 2015, CRIT REV ONCOL HEMAT; Takashima M, 2003, PROTEOMICS, V3, P2487, DOI 10.1002/pmic.200300621; Tanaka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096785; Teimoori A, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.10375; Trask SD, 2012, NAT REV MICROBIOL, V10, P165, DOI 10.1038/nrmicro2673; VANDENBROECKE C, 1984, ANN RECH VET, V15, P29; Virgin S, FIELDS VIROLOGY, P329; Woller N, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00188; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	75	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147666	10.1371/journal.pone.0147666	http://dx.doi.org/10.1371/journal.pone.0147666			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828934	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200027
J	Kotani, O; Naeem, A; Suzuki, T; Iwata-Yoshikawa, N; Sato, Y; Nakajima, N; Hosomi, T; Tsukagoshi, H; Kozawa, K; Hasegawa, H; Taguchi, F; Shimizu, H; Nagata, N				Kotani, Osamu; Naeem, Asif; Suzuki, Tadaki; Iwata-Yoshikawa, Naoko; Sato, Yuko; Nakajima, Noriko; Hosomi, Takushi; Tsukagoshi, Hiroyuki; Kozawa, Kunihisa; Hasegawa, Hideki; Taguchi, Fumihiro; Shimizu, Hiroyuki; Nagata, Noriyo			Neuropathogenicity of Two Saffold Virus Type 3 Isolates in Mouse Models	PLOS ONE			English	Article							THEILERS MURINE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; SAFV GENOTYPE 3; ENCEPHALOMYOCARDITIS VIRUS; DIABETES-MELLITUS; LEADER PROTEIN; INFECTION; CHILDREN; CARDIOVIRUS; DISEASE	Objective Saffold virus (SAFV), a picornavirus, is occasionally detected in children with acute flaccid paralysis, meningitis, and cerebellitis; however, the neuropathogenicity of SAFV remains undetermined. Methods The virulence of two clinical isolates of SAFV type 3 (SAFV-3) obtained from a patient with aseptic meningitis (AM strain) and acute upper respiratory inflammation (UR strain) was analyzed in neonatal and young mice utilizing virological, pathological, and immunological methods. Results The polyproteins of the strains differed in eight amino acids. Both clinical isolates were infective, exhibited neurotropism, and were mildly neurovirulent in neonatal ddY mice. Both strains pathologically infected neural progenitor cells and glial cells, but not large neurons, with the UR strain also infecting epithelial cells. UR infection resulted in longer inflammation in the brain and spinal cord because of demyelination, while the AM strain showed more infectivity in the cerebellum in neonatal ddY mice. Additionally, young BALB/c mice sero-converted following mucosal inoculation with the UR, but not the AM, strain. Conclusions Both SAFV-3 isolates had neurotropism and mild neurovirulence but showed different cell tropisms in both neonatal and young mouse models. This animal model has the potential to recapitulate the potential neuropathogenicity of SAFV-3.	[Kotani, Osamu; Suzuki, Tadaki; Iwata-Yoshikawa, Naoko; Sato, Yuko; Nakajima, Noriko; Hasegawa, Hideki; Nagata, Noriyo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Kotani, Osamu; Taguchi, Fumihiro] Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Virol & Viral Infect, Tokyo, Japan; [Naeem, Asif; Shimizu, Hiroyuki] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Hosomi, Takushi] Publ Hlth Inst Kochi Prefecture, Kochi, Japan; [Tsukagoshi, Hiroyuki; Kozawa, Kunihisa] Gunma Prefectural Inst Publ Hlth & Environm Sci, Gunma, Japan; [Kotani, Osamu] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Hosomi, Takushi] Meat Inspect Ctr Kochi Prefecture, Kochi, Japan	National Institute of Infectious Diseases (NIID); Nippon Veterinary & Life Science University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Nagata, N (corresponding author), Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan.	nnagata@nih.go.jp	Hasegawa, Hideki/C-7978-2014; Suzuki, Tadaki/ABH-2661-2020; Shimizu, Hiroyuki/AAU-9621-2020; Naeem, Asif/ABC-7448-2021	Shimizu, Hiroyuki/0000-0002-2987-2377; Naeem, Asif/0000-0002-2088-0629	Ministry of Education, Culture, Sports, Science, and Technology in Japan [23590554, 15K08511]; Ministry of Health, Labor, and Welfare in Japan [H23-Shinko-Ippan-007, H25-Shinko-Ippan-012]	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology in Japan (grant-in-aid for scientific research no. 23590554 and 15K08511) and the Ministry of Health, Labor, and Welfare in Japan (grant-in-aid for research on emerging and re-emerging infectious diseases, research nos. H23-Shinko-Ippan-007 and H25-Shinko-Ippan-012).	Agamanolis DP, 2003, ANN NEUROL, V54, P547, DOI 10.1002/ana.10731; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Branas P, 2015, J INFECTION, V70, P679, DOI 10.1016/j.jinf.2014.11.006; Buckwalter MR, 2011, J VIROL, V85, P6893, DOI 10.1128/JVI.00274-11; CALENOFF MA, 1990, P NATL ACAD SCI USA, V87, P978, DOI 10.1073/pnas.87.3.978; Canelli E, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-64; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Chiu CY, 2010, J VIROL, V84, P4407, DOI 10.1128/JVI.02536-09; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Chua KB, 2011, EMERG INFECT DIS, V17, P1562, DOI 10.3201/eid1708.101380; CRAIGHEAD JE, 1968, SCIENCE, V162, P913, DOI 10.1126/science.162.3856.913; Cushing MM, 2004, AM J CLIN PATHOL, V121, P26, DOI 10.1309/G23CP54DAR1BCY8L; Czechowicz J, 2011, VECTOR-BORNE ZOONOT, V11, P367, DOI 10.1089/vbz.2010.0029; Dai XQ, 2011, J CLIN VIROL, V50, P186, DOI 10.1016/j.jcv.2010.11.004; Dal Canto Mauro C., 1996, Methods (Orlando), V10, P453, DOI 10.1006/meth.1996.0123; DALCANTO MC, 1977, AM J PATHOL, V88, P497; Delhaye S, 2004, J VIROL, V78, P4357, DOI 10.1128/JVI.78.8.4357-4362.2004; DICKINSON L, 1966, BRIT J EXP PATHOL, V47, P35; Drexler JF, 2008, EMERG INFECT DIS, V14, P1398, DOI 10.3201/eid1409.080570; Feuer R, 2003, AM J PATHOL, V163, P1379, DOI 10.1016/S0002-9440(10)63496-7; Galama J, 2011, EMERG INFECT DIS, V17, P1572, DOI 10.3201/eid1708.101953; Galama JMD, 2014, ANN CLIN TRANSL NEUR, V1, P618, DOI 10.1002/acn3.82; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Hertzler S, 2011, J VIROL, V85, P7411, DOI 10.1128/JVI.00265-11; Himeda T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-110; HUBBARD GB, 1992, LAB ANIM SCI, V42, P233; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Itagaki T, 2011, PEDIATR INFECT DIS J, V30, P680, DOI 10.1097/INF.0b013e31821608a8; Iwata-Yoshikawa N, 2014, J VIROL, V88, P8597, DOI 10.1128/JVI.00983-14; Jnaoui K, 1998, VIROLOGY, V244, P397, DOI 10.1006/viro.1998.9134; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Katano H, 2011, J MED VIROL, V83, P322, DOI 10.1002/jmv.21962; Khamrin P, 2013, INFECT GENET EVOL, V13, P339, DOI 10.1016/j.meegid.2012.11.004; Khamrin P, 2011, EMERG INFECT DIS, V17, P1150, DOI [10.3201/eid1706.101983, 10.3201/eid/1706.101983]; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Kim BS, 2001, IMMUNOL RES, V24, P121, DOI 10.1385/IR:24:2:121; Kobayashi M, 2013, J INFECTION, V66, P191, DOI 10.1016/j.jinf.2012.10.022; Kotani O, 2015, NEUROPATHOLOGY, V35, P107, DOI 10.1111/neup.12171; Kuribayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068375; Li TC, 2013, EMERG INFECT DIS, V19, P115, DOI 10.3201/eid1901.121007; Masek-Hammerman K, 2012, VET PATHOL, V49, P386, DOI 10.1177/0300985811409254; Naeem A, 2014, J GEN VIROL, V95, P1945, DOI 10.1099/vir.0.066498-0; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; Nielsen ACY, 2012, EMERG INFECT DIS, V18, P7, DOI 10.3201/eid1801.110725; Nix WA, 2013, J GEN VIROL, V94, P2017, DOI 10.1099/vir.0.053827-0; Oberste MS, 2009, EMERG INFECT DIS, V15, P640, DOI 10.3201/eid1504.081428; Okuwa T, 2010, MICROBIOL IMMUNOL, V54, P639, DOI 10.1111/j.1348-0421.2010.00260.x; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Onishi T, 2000, ANAT REC, V258, P384, DOI 10.1002/(SICI)1097-0185(20000401)258:4<384::AID-AR6>3.0.CO;2-U; Pallansch M, 2013, FIELDS VIROLOGY, P490; Reddacliff LA, 1997, J ZOO WILDLIFE MED, V28, P153; Ren LL, 2010, EMERG INFECT DIS, V16, P1158, DOI 10.3201/eid1607.091682; Ren LL, 2009, EMERG INFECT DIS, V15, P1509, DOI 10.3201/eid1509.081531; RODRIGUEZ M, 1983, ANN NEUROL, V13, P426, DOI 10.1002/ana.410130409; RODRIGUEZ M, 1987, CRIT REV IMMUNOL, V7, P325; RODRIGUEZ M, 1992, J VIROL, V66, P217, DOI 10.1128/JVI.66.1.217-225.1992; Stavrou S, 2011, J VIROL, V85, P7177, DOI 10.1128/JVI.00009-11; Theiler M, 1937, J EXP MED, V65, P705, DOI 10.1084/jem.65.5.705; Tsukagoshi H, 2010, JPN J INFECT DIS, V63, P378; van Pesch V, 2001, J VIROL, V75, P7811, DOI 10.1128/JVI.75.17.7811-7817.2001; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Villarreal D, 2006, MICROB PATHOGENESIS, V41, P149, DOI 10.1016/j.micpath.2006.01.009; Wang LL, 2014, INT J CLIN EXP PATHO, V7, P858; Wong KT, 2012, NEUROPATH APPL NEURO, V38, P443, DOI 10.1111/j.1365-2990.2011.01247.x; Xu ZQ, 2009, EMERG INFECT DIS, V15, P993, DOI 10.3201/eid1506.090109; Yamazaki T, 2012, J LIPID RES, V53, P2024, DOI 10.1194/jlr.M023713; Yodmeeklin A, 2015, J MED VIROL, V87, P702, DOI 10.1002/jmv.24114; YOON JW, 1980, J EXP MED, V152, P878, DOI 10.1084/jem.152.4.878; Zhang X. A., 2015, SCI REP, V5, P7704, DOI DOI 10.1038/SREP07704; Zhou L, 2000, J VIROL, V74, P1477, DOI 10.1128/JVI.74.3.1477-1485.2000; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	72	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148184	10.1371/journal.pone.0148184	http://dx.doi.org/10.1371/journal.pone.0148184			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828718	Green Published, gold			2022-12-26	WOS:000369548200080
J	Lyon, R; Correll, J; Feng, C; Bluhm, B; Shrestha, S; Shi, A; Lamour, K				Lyon, Rebecca; Correll, James; Feng, Chunda; Bluhm, Burt; Shrestha, Sandesh; Shi, Ainong; Lamour, Kurt			Population Structure of Peronospora effusa in the Southwestern United States	PLOS ONE			English	Article							DOWNY MILDEW PATHOGEN; F-SP SPINACIAE; RACE RACE-4; IDENTIFICATION	Peronospora effusa is an obligate pathogen that causes downy mildew on spinach and is considered the most economically important disease of spinach. The objective of the current research was to assess genetic diversity of known historical races and isolates collected in 2014 from production fields in Yuma, Arizona and Salinas Valley, California. Candidate neutral single nucleotide polymorphisms (SNPs) were identified by comparing sequence data from reference isolates of known races of the pathogen collected in 2009 and 2010. Genotypes were assessed using targeted sequencing on genomic DNA extracted directly from infected plant tissue. Genotyping 26 historical and 167 contemporary samples at 46 SNP loci revealed 82 unique multi-locus genotypes. The unique genotypes clustered into five groups and the majority of isolates collected in 2014 were genetically closely related, regardless of source location. The historical samples, representing several races, showed greater genetic differentiation. Overall, the SNP data indicate much of the genotypic variation found within fields was produced during asexual development, whereas overall genetic diversity may be influenced by sexual recombination on broader geographical and temporal scales.	[Lyon, Rebecca; Shrestha, Sandesh; Lamour, Kurt] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Correll, James; Feng, Chunda; Bluhm, Burt] Univ Arkansas, Dept Plant Pathol, Fayetteville, AR 72701 USA; [Shi, Ainong] Univ Arkansas, Dept Hort, Fayetteville, AR 72701 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Lamour, K (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	klamour@utk.edu	Shi, Ainong/L-6384-2017	Shi, Ainong/0000-0002-1066-7920; Lamour, Kurt/0000-0001-6407-8825	United States Department of Agriculture-Specialty Crop Research Initiative	United States Department of Agriculture-Specialty Crop Research Initiative	Work was completed using funds from a United States Department of Agriculture-Specialty Crop Research Initiative grant (http://nifa.usda.gov/funding-opportunity/specialty-crop-research-initiative-scri) to JC, BB, and KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANDENBERGER LP, 1992, HORTSCIENCE, V27, P1118, DOI 10.21273/HORTSCI.27.10.1118; BRANDENBERGER LP, 1991, PLANT DIS, V75, P630, DOI 10.1094/PD-75-0630; Choi YJ, 2007, MYCOL RES, V111, P381, DOI 10.1016/j.mycres.2007.02.003; Choi YJ, 2011, J MICROBIOL, V49, P1039, DOI 10.1007/s12275-011-1069-2; Corell J. C., 1990, California Agriculture, V44, P14; Correll JC, 2011, EUR J PLANT PATHOL, V129, P193, DOI 10.1007/s10658-010-9713-y; CORRELL JC, 1994, PLANT DIS, V78, P653, DOI 10.1094/PD-78-0831C; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eenink A, 1976, INT J PLANT BREEDING, V25, P713; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO , 2013, FAOSTAT FAO UN; Feng C, 2014, J APPL MICROBIOLOGY; Feng CD, 2014, PLANT DIS, V98, P145, DOI 10.1094/PDIS-04-13-0435-RE; Foss C. R, 2005, CROP PROFILE SPINACH; Hu J., 2013, PLOS ONE, V8; INABA T, 1983, PLANT DIS, V67, P1139, DOI 10.1094/PD-67-1139; Irish BM, 2007, PLANT DIS, V91, P1392, DOI 10.1094/PDIS-91-11-1392; Irish BM, 2003, PLANT DIS, V87, P567, DOI 10.1094/PDIS.2003.87.5.567; Lamour K, 2006, MYCOLOGIA, V98, P514, DOI 10.3852/mycologia.98.3.514; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lucier G, 2004, ELECT OUTLOOK REPORT; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Satou Mamoru, 2006, Journal of General Plant Pathology, V72, P193, DOI 10.1007/s10327-005-0266-4; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157	28	25	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148385	10.1371/journal.pone.0148385	http://dx.doi.org/10.1371/journal.pone.0148385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828428	gold, Green Published, Green Submitted			2022-12-26	WOS:000369548200096
J	Mitra, P; Gupta, ED; Sahar, T; Pandey, AK; Dangi, P; Reddy, KS; Chauhan, VS; Gaur, D				Mitra, Pallabi; Gupta, Enna Dogra; Sahar, Tajali; Pandey, Alok K.; Dangi, Poonam; Reddy, K. Sony; Chauhan, Virander Singh; Gaur, Deepak			Evidence for the Nucleo-Apical Shuttling of a Beta-Catenin Like Plasmodium falciparum Armadillo Repeat Containing Protein	PLOS ONE			English	Article							PARASITE-NEUTRALIZING ANTIBODIES; MALARIA PARASITE; EXPORT SIGNALS; ERYTHROCYTE INVASION; LEPTOMYCIN-B; BINDING; LOCALIZATION; SEQUENCE; RECEPTOR; STRAIN	Eukaryotic Armadillo (ARM) repeat proteins are multifaceted with prominent roles in cell-cell adhesion, cytoskeletal regulation and intracellular signaling among many others. One such ARM repeat containing protein, ARM Repeats Only (ARO), has recently been demonstrated in both Toxoplasma (TgARO) and Plasmodium (PfARO) parasites to be targeted to the rhoptries during the late asexual stages. TgARO has been implicated to play an important role in rhoptry positioning i.e. directing the rhoptry towards the apical end of the parasite. Here, we report for the first time that PfARO exhibits a DNA binding property and a dynamic sub-cellular localization between the nucleus (early schizont) and rhoptry (late schizont) during the different stages of the asexual blood-stage life cycle. PfARO possesses a putative nuclear export signal (NES) and the nucleo-apical shuttling was sensitive to Leptomycin B (LMB) suggesting that the nuclear export was mediated by CRM1. Importantly, PfARO specifically bound an A-T rich DNA sequence of the P. falciparum Gyrase A (PfgyrA) gene, suggesting that the DNA binding specificity of PfARO is likely due to the AT-richness of the probe. This is a novel functional characteristic that has not been reported previously for any P. falciparum ARM containing protein and suggests a putative role for PfARO in gene regulation. This study describes for the first time a conserved P. falciparum ARM repeat protein with a high degree of functional versatility.	[Mitra, Pallabi; Gupta, Enna Dogra; Sahar, Tajali; Pandey, Alok K.; Dangi, Poonam; Reddy, K. Sony; Chauhan, Virander Singh] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India; [Gaur, Deepak] Jawaharlal Nehru Univ, Sch Biotechnol, Lab Malaria & Vaccine Res, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Jawaharlal Nehru University, New Delhi	Chauhan, VS (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India.; Gaur, D (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, Lab Malaria & Vaccine Res, New Delhi 110067, India.	viranderschauhan@gmail.com; deepakgaur189@gmail.com	Gaur, Deepak/AAF-4379-2019; Chauhan, Virander S./K-5276-2019; Sahar, Tajali/AAI-5707-2020; Reddy, K Sony/AAR-6285-2020; Pandey, Alok Kumar/ABD-9897-2021	Gupta, Enna Dogra/0000-0003-1777-833X; Mitra, Pallabi/0000-0003-4609-3006; Reddy, K. Sony/0000-0002-8437-5250	Department of Biotechnology (DBT), Government of India; Department of Biotechnology, Ministry of Science and Technology, Government of India; Ramalingaswami fellowship contingency grant; UPEII grant from Jawaharlal Nehru University (JNU)	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Ramalingaswami fellowship contingency grant; UPEII grant from Jawaharlal Nehru University (JNU)	We thank Dr Pushkar Sharma (National Institute of Immunology, New Delhi) and Prof. Suman Dhar (Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi) for providing the antibodies against PfBip and GAPDH, respectively. We thank Dr Inderjeet Kaur at the mass spectrometry facility of the malaria group, ICGEB for technical help with the LC-MS study. We appreciate Ms Surbhi Dabral at the malaria microscopy facility for technical help in our imaging study. The assistance of Dr Alka Galav, Rakesh Kumar Singh and Ashok Das from the ICGEB animal facility is deeply appreciated. D.G is the recipient of the Ramalingaswami Fellowship from the Department of Biotechnology (DBT), Government of India.; This work was supported by the following grants of the Department of Biotechnology, Ministry of Science and Technology, Government of India: Program Support Grant to D.G. and V.S.C.; Ramalingaswami fellowship contingency grant to D.G.; as well as the UPEII grant from Jawaharlal Nehru University (JNU) to D.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Beck JR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003162; Cabrera A, 2012, TRAFFIC, V13, P1335, DOI 10.1111/j.1600-0854.2012.01394.x; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chene A, 2012, NUCLEIC ACIDS RES, V40, P3066, DOI 10.1093/nar/gkr1215; Choi HJ, 2005, J MOL BIOL, V346, P367, DOI 10.1016/j.jmb.2004.11.048; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Daubenberger CA, 2000, GENE, V246, P255, DOI 10.1016/S0378-1119(00)00069-X; Deka J, 1999, ONCOGENE, V18, P5654, DOI 10.1038/sj.onc.1202944; Deshmukh AS, 2012, NUCLEIC ACIDS RES, V40, P5313, DOI 10.1093/nar/gks202; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Gaur D, 2011, CURR OPIN MICROBIOL, V14, P422, DOI 10.1016/j.mib.2011.07.018; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Gupta A, 2009, EUKARYOT CELL, V8, P1341, DOI 10.1128/EC.00170-09; HAMAMOTO T, 1983, J ANTIBIOT, V36, P639, DOI 10.7164/antibiotics.36.639; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Masuda HP, 2008, EMBO J, V27, P2746, DOI 10.1038/emboj.2008.191; Mohmmed A, 2003, MOL BIOCHEM PARASIT, V127, P199, DOI 10.1016/S0166-6851(02)00331-6; Mueller C, 2013, CELL HOST MICROBE, V13, P289, DOI 10.1016/j.chom.2013.02.001; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Neufeld KL, 2000, P NATL ACAD SCI USA, V97, P12085, DOI 10.1073/pnas.220401797; Panchal M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.521; Pandey AK, 2013, INFECT IMMUN, V81, P441, DOI 10.1128/IAI.01107-12; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Reddy KS, 2015, P NATL ACAD SCI USA, V112, P1179, DOI 10.1073/pnas.1415466112; Reddy KS, 2014, INFECT IMMUN, V82, P152, DOI 10.1128/IAI.00970-13; REED RG, 1975, BIOCHEMISTRY-US, V14, P4578, DOI 10.1021/bi00692a004; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Sahar T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017102; Straschil U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012901; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771	48	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148446	10.1371/journal.pone.0148446	http://dx.doi.org/10.1371/journal.pone.0148446			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828945	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200104
J	Sales, MAF; Lacerda, MB; Horn, BLD; de Oliveira, IAP; Schultz, CL				Sales, Marcos A. F.; Lacerda, Marcel B.; Horn, Bruno L. D.; de Oliveira, Isabel A. P.; Schultz, Cesar L.			The "chi" of the Matter: Testing the Relationship between Paleoenvironments and Three Theropod Clades	PLOS ONE			English	Article							ALCANTARA FORMATION; ISOTOPE EVIDENCE; DINOSAUR; EVOLUTION; SPINOSAURIDAE; PHYLOGENY; THAILAND; AFRICA; HABITS	The view of spinosaurs as dinosaurs of semi-aquatic habits and strongly associated with marginal and coastal habitats are deeply rooted in both scientific and popular knowledge, but it was never statistically tested. Inspired by a previous analysis of other dinosaur clades and major paleoenvironmental categories, here we present our own statistical evaluation of the association between coastal and terrestrial paleoenvironments and spinosaurids, along with other two theropod taxa: abelisaurids and carcharodontosaurids. We also included a taphonomic perspective and classified the occurrences in categories related to potential biases in order to better address our interpretations. Our main results can be summarized as follows: 1) the taxon with the largest amount of statistical evidence showing it positively associated to coastal paleoenvironments is Spinosauridae; 2) abelisaurids and carcharodontosaurids had more statistical evidence showing them positively associated with terrestrial paleoenvironments; 3) it is likely that spinosaurids also occupied spatially inland areas in a way somehow comparable at least to carcharodontosaurids; 4) abelisaurids may have been more common than the other two taxa in inland habitats.	[Sales, Marcos A. F.; Lacerda, Marcel B.; Horn, Bruno L. D.; Schultz, Cesar L.] Univ Fed Rio Grande do Sul, Dept Paleontol & Estratig, Inst Geociencias, Porto Alegre, RS, Brazil; [Horn, Bruno L. D.] Serv Geol Brasil CPRM, Superintendencia Reg Recife, Pernambuco, Brazil; [de Oliveira, Isabel A. P.] INPA, Manaus, Amazonas, Brazil	Universidade Federal do Rio Grande do Sul; Institute Nacional de Pesquisas da Amazonia	Sales, MAF (corresponding author), Univ Fed Rio Grande do Sul, Dept Paleontol & Estratig, Inst Geociencias, Porto Alegre, RS, Brazil.	marcos.paleo@yahoo.com.br	Schultz, Cesar/I-4127-2013	Schultz, Cesar/0000-0001-7121-0409	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [141268/2013-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Ph.D. scholarship, grant number 141268/2013-1 MAFS.	Allain R, 2012, NATURWISSENSCHAFTEN, V99, P369, DOI 10.1007/s00114-012-0911-7; Amiot R, 2006, EARTH PLANET SC LETT, V246, P41, DOI 10.1016/j.epsl.2006.04.018; Amiot R, 2010, GEOLOGY, V38, P139, DOI 10.1130/G30402.1; Astibia H, 1990, TERRA NOVA, V2, P460, DOI 10.1111/j.1365-3121.1990.tb00103.x; Bakker RT., 1986, DINOSAUR HERESIES; Behrensmeyer A.K., 1990, P232; Behrensmeyer A.K., 1991, Topics in Geobiology, V9, P291; Behrensmeyer Anna K., 2002, P297; Benton MJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000321; Benyoucef M, 2015, CRETACEOUS RES, V55, P44, DOI 10.1016/j.cretres.2015.02.002; Bittencourt JS., 2004, ARQ MUS NAC, V62, P309; Buffetaut E, 2004, NATURE, V430, P33, DOI 10.1038/430033a; BUFFETAUT E, 1989, PALAEOGEOGR PALAEOCL, V73, P77, DOI 10.1016/0031-0182(89)90046-1; Buffetaut E, 1999, PALAEOGEOGR PALAEOCL, V150, P13, DOI 10.1016/S0031-0182(99)00004-8; Buffetaut E., 2005, P INT C GEOL GEOT MI, p575 ; Buffetaut E, 2011, ORYCTOS, V10, P1; Buffetaut E, 2005, 3 ANN M EUR ASS VERT, P3; Buffetaut Eric, 2005, Acta Palaeontologica Romaniae, V5, P39; Butler RJ, 2008, NATURWISSENSCHAFTEN, V95, P1027, DOI 10.1007/s00114-008-0417-5; Canudo J.I., 2003, Ciencias de la Tierra Instituto de Estudios Riojanos, V26, P347; Canudo JI, 2009, 4 JORN INT PAL DIN E, P321; Carbone C, 2011, P ROY SOC B-BIOL SCI, V278, P2682, DOI 10.1098/rspb.2010.2497; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Churcher CS, 2001, PALAEONTOLOGY, V44, P305, DOI 10.1111/1475-4983.00181; CHURCHIER C S, 1992, Journal of Vertebrate Paleontology, V12, p23A; COOMBS WP, 1975, PALAEOGEOGR PALAEOCL, V17, P1, DOI 10.1016/0031-0182(75)90027-9; Currie PJ, 2010, CAN J EARTH SCI, V47, P1277, DOI 10.1139/E10-072; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; Dalla-Vecchia FM, 1995, NATURA NASCOSTA, V11, P16; [David W.E.HONE 洪大卫], 2010, [古脊椎动物学报, Vertebrata Palasiatica], V48, P19; Farlow James O., 2002, Paleontological Society Papers, V8, P251; Farlow JO, 2002, HIST BIOL, V16, P21, DOI DOI 10.1080/0891296031000154687; Fricke HC, 2008, PALEOBIOLOGY, V34, P534, DOI 10.1666/08020.1; Gates TA, 2005, PALAIOS, V20, P363, DOI 10.2110/palo.2003.p03-22; Gianechini FA, 2015, CRETACEOUS RES, V54, P1, DOI 10.1016/j.cretres.2014.11.009; Gotelli N.J., 2010, PRINCIPIOS ESTATISTI; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; Hendrickx C, 2014, ZOOTAXA, V 3759, P1, DOI 10.11646/zootaxa.3759.1.1; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Horner JR, 1979, J PALEONTOL, V53; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Kellner AWA, 2011, AN ACAD BRAS CIENC, V83, P99, DOI 10.1590/S0001-37652011000100006; Kellner Alexander W.A., 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V199, P151; LEHMAN TM, 1987, PALAEOGEOGR PALAEOCL, V60, P189, DOI 10.1016/0031-0182(87)90032-0; Machado E. B., 2007, PALEONTOLOGIA CENARI, V1, P291; Machado E, 2008, J VERTEBR PALEONTOL, V28, p109A; Medeiros MA, 2014, J S AM EARTH SCI, V53, P50, DOI 10.1016/j.jsames.2014.04.002; Medeiros Manuel Alfredo, 2007, P413; Mo JY, 2014, ACTA GEOL SIN-ENGL, V88, P6, DOI 10.1111/1755-6724.12177; Novas F. E., 2007, PALEONTOLOGIA CENARI, P333; Novas FE, 2005, NATURWISSENSCHAFTEN, V92, P226, DOI 10.1007/s00114-005-0623-3; Novas FE, 2013, CRETACEOUS RES, V45, P174, DOI 10.1016/j.cretres.2013.04.001; Patefield W. M., 1981, APPL STAT, V30, P91, DOI DOI 10.2307/2346669; Paterson N, 2011, PLANET DINOSAUR; Porfiri JD, 2014, CRETACEOUS RES, V51, P35, DOI 10.1016/j.cretres.2014.04.007; R Core Team, 2018, R LANG ENV STAT COMP; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Robert PC, 2010, INTRO MONTE CARLO ME; Scotese C.R., 2013, MAP FOLIO 73 LATE SI, V5; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Serrano-Martinez A, 2015, P GEOLOGIST ASSOC, V126, P107, DOI 10.1016/j.pgeola.2014.10.005; Smith JB, 2006, NATURWISSENSCHAFTEN, V93, P242, DOI 10.1007/s00114-006-0092-3; STERNBERG C. M., 1933, ANN AND MAG NAT HIST, V11, P231; Sues HD, 2002, J VERTEBR PALEONTOL, V22, P535, DOI 10.1671/0272-4634(2002)022[0535:ICASDT]2.0.CO;2; Therrien F, 2005, LIFE O PAST, P179; Tortosa T, 2014, ANN PALEONTOL, V100, P63, DOI 10.1016/j.annpal.2013.10.003; Weishampel DB., 2004, DINOSAURIA; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827	74	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147031	10.1371/journal.pone.0147031	http://dx.doi.org/10.1371/journal.pone.0147031			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829315	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200012
J	Vasudevan, EV; Patrick, SK; Yang, JF				Vasudevan, Erin V.; Patrick, Susan K.; Yang, Jaynie F.			Gait Transitions in Human Infants: Coping with Extremes of Treadmill Speed	PLOS ONE			English	Article							LOW SPINAL CAT; RHYTHMIC LEG MOVEMENTS; SPLIT-BELT TREADMILL; CENTER-OF-MASS; WALK-TO-RUN; INTERLIMB COORDINATION; HUMAN LOCOMOTION; BILATERAL COORDINATION; CHANGING SPEED; ADAPTATION	Spinal pattern generators in quadrupedal animals can coordinate different forms of locomotion, like trotting or galloping, by altering coordination between the limbs (interlimb coordination). In the human system, infants have been used to study the subcortical control of gait, since the cerebral cortex and corticospinal tract are immature early in life. Like other animals, human infants can modify interlimb coordination to jump or step. Do human infants possess functional neuronal circuitry necessary to modify coordination within a limb (intra-limb coordination) in order to generate distinct forms of alternating bipedal gait, such as walking and running? We monitored twenty-eight infants (7-12 months) stepping on a treadmill at speeds ranging between 0.06-2.36 m/s, and seventeen adults (22-47 years) walking or running at speeds spanning the walk-to-run transition. Six of the adults were tested with body weight support to mimic the conditions of infant stepping. We found that infants could accommodate a wide range of speeds by altering stride length and frequency, similar to adults. Moreover, as the treadmill speed increased, we observed periods of flight during which neither foot was in ground contact in infants and in adults. However, while adults modified other aspects of intralimb coordination and the mechanics of progression to transition to a running gait, infants did not make comparable changes. The lack of evidence for distinct walking and running patterns in infants suggests that the expression of different functional, alternating gait patterns in humans may require neuromuscular maturation and a period of learning post-independent walking.	[Vasudevan, Erin V.] SUNY Stony Brook, Sch Hlth Technol & Management, Rehabil Res & Movement Performance RRAMP Lab, Hlth & Rehabil Sci, Stony Brook, NY 11794 USA; [Patrick, Susan K.; Yang, Jaynie F.] Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada; [Yang, Jaynie F.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Patrick, Susan K.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Div Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Alberta; University of Alberta; University of Alberta	Vasudevan, EV (corresponding author), SUNY Stony Brook, Sch Hlth Technol & Management, Rehabil Res & Movement Performance RRAMP Lab, Hlth & Rehabil Sci, Stony Brook, NY 11794 USA.	erin.vasudevan@stonybrook.edu	; Vasudevan, Erin/F-7081-2017	Yang, Jaynie/0000-0002-7507-8924; Vasudevan, Erin/0000-0003-1129-3489	National Sciences and Engineering Research Council [33125006, 138181-2011]; Canadian Institutes of Health Research [MOP15130]	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Support was provided by National Sciences and Engineering Research Council 33125006 & 138181-2011 [http://www.nserc-crsng.gc.cal/] and Canadian Institutes of Health Research MOP15130 [http://www.cihr-irsc.gc.ca/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER R. M., 1995, APPL MECH REV, V48, P461, DOI [10.1115/1.3005107, DOI 10.1115/1.3005107]; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Altman J, 2001, DEV HUMAN SPINAL COR; Beres-Jones JA, 2004, BRAIN, V127, P2232, DOI 10.1093/brain/awh252; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; CAVAGNA GA, 1963, J APPL PHYSIOL, V18, P1, DOI 10.1152/jappl.1963.18.1.1; CAVAGNA GA, 1964, J APPL PHYSIOL, V19, P249, DOI 10.1152/jappl.1964.19.2.249; CHUGANI HT, 1986, SCIENCE, V231, P840, DOI 10.1126/science.3945811; Connolly KJ, 1997, CLIN DEV MED; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; ENGLISH AW, 1982, BRAIN RES, V245, P353, DOI 10.1016/0006-8993(82)90818-6; Eyre JA, 2000, BRAIN, V123, P51, DOI 10.1093/brain/123.1.51; Fady JC, 1998, DEV BRAIN RES, V108, P111, DOI 10.1016/S0165-3806(98)00040-6; Farley CT, 1998, EXERCISE SPORT SCI R, V26, P253; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P283, DOI 10.1111/j.1748-1716.1980.tb06534.x; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P269, DOI 10.1111/j.1748-1716.1980.tb06533.x; FORSSBERG H, 1977, BRAIN RES, V132, P121, DOI 10.1016/0006-8993(77)90710-7; FORSSBERG H, 1985, EXP BRAIN RES, V57, P480; Fredriks AM, 2005, ARCH DIS CHILD, V90, P807, DOI 10.1136/adc.2004.050799; GRAMSBERGEN A, 1970, Developmental Psychobiology, V3, P267, DOI 10.1002/dev.420030407; GRILLNER S, 1979, BRAIN RES, V165, P177, DOI 10.1016/0006-8993(79)90059-3; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; HALBERTSMA JM, 1983, ACTA PHYSIOL SCAND, P1; Heng C, 2007, J NEUROSCI, V27, P8558, DOI 10.1523/JNEUROSCI.1635-07.2007; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Ivanenko YP, 2011, J APPL PHYSIOL, V110, P781, DOI 10.1152/japplphysiol.00799.2010; Labini FS, 2011, J NEUROPHYSIOL, V106, P1525, DOI 10.1152/jn.00160.2011; Lam T, 2000, J NEUROPHYSIOL, V83, P2814, DOI 10.1152/jn.2000.83.5.2814; Lam T, 2003, J PHYSIOL-LONDON, V553, P319, DOI 10.1113/jphysiol.2003.043984; MARGARIA R, 1963, J APPL PHYSIOL, V18, P367, DOI 10.1152/jappl.1963.18.2.367; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Minetti AE, 2001, ACTA ASTRONAUT, V49, P191, DOI 10.1016/S0094-5765(01)00098-4; MINETTI AE, 1994, ACTA PHYSIOL SCAND, V150, P315, DOI 10.1111/j.1748-1716.1994.tb09692.x; MINETTI AE, 1994, EUR J APPL PHYSIOL O, V68, P285, DOI 10.1007/BF00571444; Muir GD, 1996, J PHYSIOL-LONDON, V493, P589, DOI 10.1113/jphysiol.1996.sp021406; Musselman KE, 2008, J NEUROPHYSIOL, V100, P2225, DOI 10.1152/jn.90532.2008; Musselman KE, 2007, J NEUROPHYSIOL, V97, P1247, DOI 10.1152/jn.00891.2006; Musselman KE, 2011, J NEUROPHYSIOL, V105, P2195, DOI 10.1152/jn.01002.2010; NILSSON J, 1985, ACTA PHYSIOL SCAND, V123, P457, DOI 10.1111/j.1748-1716.1985.tb07612.x; Ogawa T, 2015, J EXP BIOL, V218, P3192, DOI 10.1242/jeb.120865; Ogawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121951; Pang MYC, 2003, J NEUROPHYSIOL, V90, P2731, DOI 10.1152/jn.00407.2003; Pang MYC, 2001, J PHYSIOL-LONDON, V533, P617, DOI 10.1111/j.1469-7793.2001.0617a.x; Pearson KG, 2000, ANNU REV PHYSIOL, V62, P723, DOI 10.1146/annurev.physiol.62.1.723; Peiper A., 1963, CEREBRAL FUNCTION IN; PIEK JP, 1994, EARLY HUM DEV, V39, P109, DOI 10.1016/0378-3782(94)90160-0; Richardson EPJ., 1982, HISTOLOGY HISTOPATHO; Rossignol S, 1996, ACTA NEUROBIOL EXP, V56, P449; Saibene F, 2003, EUR J APPL PHYSIOL, V88, P297, DOI 10.1007/s00421-002-0654-9; Segers V, 2006, GAIT POSTURE, V24, P247, DOI 10.1016/j.gaitpost.2005.09.006; Segers V, 2007, J EXP BIOL, V210, P578, DOI 10.1242/jeb.02693; Segers V, 2013, J EXP BIOL, V216, P3047, DOI 10.1242/jeb.087015; SMITH JL, 1983, BIRTH DEFECTS-ORIG, V19, P357; Stein PSG, 2005, J COMP PHYSIOL A, V191, P213, DOI 10.1007/s00359-004-0568-6; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P336, DOI 10.2106/00004623-198062030-00004; THELEN E, 1983, DEV PSYCHOBIOL, V16, P29, DOI 10.1002/dev.420160105; THELEN E, 1987, J EXP PSYCHOL HUMAN, V13, P405, DOI 10.1037/0096-1523.13.3.405; THORSTENSSON A, 1987, ACTA PHYSIOL SCAND, V131, P211, DOI 10.1111/j.1748-1716.1987.tb08228.x; Timoszyk WK, 2002, J NEUROPHYSIOL, V88, P3108, DOI 10.1152/jn.01050.2001; Van Caekenberghe I, 2010, GAIT POSTURE, V31, P52, DOI 10.1016/j.gaitpost.2009.08.244; VANHARTESVELDT C, 1991, DEV BRAIN RES, V58, P251, DOI 10.1016/0165-3806(91)90012-8; VILLABLANCA JR, 1979, DEV PSYCHOBIOL, V12, P101, DOI 10.1002/dev.420120204; Watson RR, 2011, P ROY SOC B-BIOL SCI, V278, P2040, DOI 10.1098/rspb.2010.2022; WHITALL J, 1995, CHILD DEV, V66, P1541, DOI 10.1111/j.1467-8624.1995.tb00951.x; Yakovenko S, 2005, J NEUROPHYSIOL, V94, P1057, DOI 10.1152/jn.00991.2004; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Yang JF, 2005, J NEUROSCI, V25, P6869, DOI 10.1523/JNEUROSCI.1765-05.2005; Yang JF, 2004, CAN J PHYSIOL PHARM, V82, P662, DOI 10.1139/Y04-070; Yang JF, 1998, J PHYSIOL-LONDON, V507, P927, DOI 10.1111/j.1469-7793.1998.927bs.x; Yang JF, DEVELOPMENTAL PSYCHO; ZELAZO PR, 1983, J MOTOR BEHAV, V15, P99; Zhong H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00112	73	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148124	10.1371/journal.pone.0148124	http://dx.doi.org/10.1371/journal.pone.0148124			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828941	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200066
J	Kockott, D; Herzog, B; Reichrath, J; Keane, K; Holick, MF				Kockott, Dieter; Herzog, Bernd; Reichrath, Joerg; Keane, Kevin; Holick, Michael F.			New Approach to Develop Optimized Sunscreens that Enable Cutaneous Vitamin D Formation with Minimal Erythema Risk	PLOS ONE			English	Article							PREVENTION; SUNLIGHT	Sunscreens protect the skin against erythemal radiation (E-er). But at the same time they reduce the effective radiation dose (E-VD) responsible for the formation of previtamin D in the skin. The paper describes a calculation method for optimizing the ratio E-VD/E-er behind sunscreens e.g. with SPF 5, 15 and 30 respectively. Taking into account that a majority of people in industrialized countries suffer from a shortage in vitamin D even in summer time, the ratio E-vd/E-er is a new and important criterion for the quality of sunscreens. Furthermore the exposure time t(vd) needed per day for forming the equivalent of the recommended amount of 2000 IU of vitamin D per day for skin type 2 is estimated when sunscreens with different filter compositions are used. In vitro experiments show a significant increase of the conversion of 7-dehydrocholesterol (7-DHC) to previtamin D when exposed to artificial solar radiation behind an experimental sunscreen optimized for previtamin D production compared to a commercial sunscreen having the same SPF.	[Kockott, Dieter] UV Tech, Hanau, Germany; [Herzog, Bernd] BASF Grenzach GmbH, Grenzach Wyhlen, Germany; [Reichrath, Joerg] Univ Klinikum Saarlandes, Homburg, Germany; [Keane, Kevin; Holick, Michael F.] Boston Univ, Med Ctr, Dept Med, Endocrinol Diabet & Nutr, Boston, MA 02215 USA	BASF; Universitatsklinikum des Saarlandes; Boston University	Holick, MF (corresponding author), Boston Univ, Med Ctr, Dept Med, Endocrinol Diabet & Nutr, Boston, MA 02215 USA.	mfholick@bu.edu			Nexidus, Pty Ltd of Sydney, Australia; UVTechnik Hanau; BASF Grenzach GmbH	Nexidus, Pty Ltd of Sydney, Australia; UVTechnik Hanau; BASF Grenzach GmbH(BASF)	This project was sponsored by Nexidus, Pty Ltd of Sydney, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. UVTechnik Hanau and BASF Grenzach GmbH provided support in the form of salaries for authors DK and BH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2006, OFFICIAL J EUROPEA L, V265, P39; Commission Internationale de l'Eclairage (CIE), 2006, 174 CIE, V174; Dabai NS, 2012, PHOTODERMATOL PHOTO, V28, P307, DOI 10.1111/phpp.12000; Diffey B. L., 1994, International Journal of Cosmetic Science, V16, P47, DOI 10.1111/j.1467-2494.1994.tb00082.x; Herzog B., 2008, COLLOIDS COSMETICS P, V4, P275; Herzog B, 2011, COSMET SCI TECHNOL, V62, P1; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Mason RS, 2013, ANTI-CANCER AGENT ME, V13, P83; MATSUOKA LY, 1987, J CLIN ENDOCR METAB, V64, P1165, DOI 10.1210/jcem-64-6-1165; McKinlay AF., 1987, CIE J, P83; Reichrath J, 2009, BRIT J DERMATOL, V161, P54, DOI 10.1111/j.1365-2133.2009.09450.x; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]	14	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0145509	10.1371/journal.pone.0145509	http://dx.doi.org/10.1371/journal.pone.0145509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824688	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600006
J	Messias, CV; Santana-Van-Vliet, E; Lemos, JP; Moreira, OC; Cotta-de-Almeida, V; Savino, W; Mendes-da-Cruz, DA				Messias, Carolina V.; Santana-Van-Vliet, Eliane; Lemos, Julia P.; Moreira, Otacilio C.; Cotta-de-Almeida, Vinicius; Savino, Wilson; Mendes-da-Cruz, Daniella Areas			Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 Activation	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; LYMPHOCYTE EGRESS; CELL-MIGRATION; PROMOTES PROLIFERATION; PERIPHERAL-BLOOD; ACTIVE MOVEMENT; IN-VITRO; KINASE 1; INVASION	Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid involved in several physiological processes including cell migration and differentiation. S1P signaling is mediated through five G protein-coupled receptors (S1P1-S1P5). S1P1 is crucial to the exit of T-lymphocytes from the thymus and peripheral lymphoid organs through a gradient of S1P. We have previously observed that T-ALL and T-LBL blasts express S1P1. Herein we analyzed the role of S1P receptors in the migratory pattern of human T-cell neoplastic blasts. S1P-triggered cell migration was directly related to S1P1 expression. T-ALL blasts expressing low levels of S1P1 mRNA (HPB-ALL) did not migrate toward S1P, whereas those expressing higher levels of S1P1 (MOLT-4, JURKAT and CEM) did migrate. The S1P ligand induced T-ALL cells chemotaxis in concentrations up to 500 nM and induced fugetaxis in higher concentrations (1000-10000 nM) through interactions with S1P1. When S1P1 was specifically blocked by the W146 compound, S1P-induced migration at lower concentrations was reduced, whereas higher concentrations induced cell migration. Furthermore, we observed that S1P/S1P1 interactions induced ERK and AKT phosphorylation, and modulation of Rac1 activity. Responding T-ALL blasts also expressed S1P3 mRNA but blockage of this receptor did not modify migratory responses. Our results indicate that S1P is involved in the migration of TALL/LBL blasts, which is dependent on S1P1 expression. Moreover, S1P concentrations in the given microenvironment might induce dose-dependent chemotaxis or fugetaxis of TALL blasts.	[Messias, Carolina V.; Santana-Van-Vliet, Eliane; Lemos, Julia P.; Cotta-de-Almeida, Vinicius; Savino, Wilson; Mendes-da-Cruz, Daniella Areas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil; [Moreira, Otacilio C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mol Biol & Endem Dis, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Mendes-da-Cruz, DA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.	daniella@ioc.fiocruz.br	Cotta-de-Almeida, Vinicius/AAC-3721-2019; Mendes-da-Cruz, Daniella A/E-7875-2016; Cotta-de-Almeida, Vinicius/G-3939-2012; Mendes-da-Cruz, Daniella/AAN-6644-2020; Moreira, Otacilio/AAS-5839-2020	Cotta-de-Almeida, Vinicius/0000-0002-6753-3480; Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Moreira, Otacilio/0000-0002-5340-8697	CNPq; Faperj; Fiocruz; FOCEM-Mercosur	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fiocruz; FOCEM-Mercosur	This work was supported by CNPq, Faperj, Fiocruz, and FOCEM-Mercosur.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Bayerl MG, 2008, LEUKEMIA LYMPHOMA, V49, P948, DOI 10.1080/10428190801911654; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brocklyn James R Van, 2010, World J Biol Chem, V1, P307, DOI 10.4331/wjbc.v1.i10.307; Cuvillier O, 2012, M S-MED SCI, V28, P951, DOI 10.1051/medsci/20122811013; Di JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12363; EPSTEIN AL, 1974, CANCER-AM CANCER SOC, V34, P1851, DOI 10.1002/1097-0142(197412)34:6<1851::AID-CNCR2820340602>3.0.CO;2-4; Evangelisti C, 2014, ONCOTARGET, V5, P7886, DOI 10.18632/oncotarget.2318; Feng H, 2010, CANCER CELL, V18, P353, DOI 10.1016/j.ccr.2010.09.009; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Forbes EM, 2012, NEURON, V74, P490, DOI 10.1016/j.neuron.2012.02.035; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Gao P, 2011, MOL CANCER RES, V9, P1509, DOI 10.1158/1541-7786.MCR-11-0336; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Gonzalez-Cabrera PJ, 2007, J BIOL CHEM, V282, P7254, DOI 10.1074/jbc.M610581200; Grahler MH, 2005, J IMMUNOL, V174, P1997; Guan HY, 2011, MOL ENDOCRINOL, V25, P1858, DOI 10.1210/me.2011-1048; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; He SQ, 2015, INT J CLIN EXP PATHO, V8, P5175; Iino J, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-150; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Le Scolan E, 2005, BLOOD, V106, P1808, DOI 10.1182/blood-2004-12-4832; Lee CJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1580-7; Li MH, 2009, CANCER LETT, V276, P171, DOI 10.1016/j.canlet.2008.11.025; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Malet-Engra G, 2015, CURR BIOL, V25, P242, DOI 10.1016/j.cub.2014.11.030; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuyuki H, 2006, CELL MOL IMMUNOL, V3, P429; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Mendes-da-Cruz DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103405; MINOWADA J, 1972, J NATL CANCER I, V49, P891; MORIKAWA S, 1978, INT J CANCER, V21, P166, DOI 10.1002/ijc.2910210207; Nunes J, 2012, BRIT J CANCER, V106, P909, DOI 10.1038/bjc.2012.14; Onciu M, 2009, HEMATOL ONCOL CLIN N, V23, P655, DOI 10.1016/j.hoc.2009.04.009; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Park KS, 2007, BIOCHEM BIOPH RES CO, V356, P239, DOI 10.1016/j.bbrc.2007.02.112; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI200213853; Pyne Nigel J., 2015, Advances in Biological Regulation, V60, P151, DOI 10.1016/j.jbior.2015.09.001; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Sattler KJE, 2010, BASIC RES CARDIOL, V105, P821, DOI 10.1007/s00395-010-0112-5; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Sekine Y, 2011, PROSTATE, V71, P690, DOI 10.1002/pros.21285; Shikata Y, 2003, J APPL PHYSIOL, V94, P1193, DOI 10.1152/japplphysiol.00690.2002; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Sukocheva O, 2009, ENDOCRINOLOGY, V150, P4484, DOI 10.1210/en.2009-0391; Tabasinezhad M, 2013, J CANCER RES THER, V9, P556, DOI 10.4103/0973-1482.126446; Tarrason G, 2011, INT IMMUNOPHARMACOL, V11, P1773, DOI 10.1016/j.intimp.2011.07.004; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; Watterson K, 2003, PROG LIPID RES, V42, P344, DOI 10.1016/S0163-7827(03)00015-8; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	62	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148137	10.1371/journal.pone.0148137	http://dx.doi.org/10.1371/journal.pone.0148137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824863	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528600104
J	Owino, S; Contreras-Alcantara, S; Baba, K; Tosini, G				Owino, Sharon; Contreras-Alcantara, Susana; Baba, Kenkichi; Tosini, Gianluca			Melatonin Signaling Controls the Daily Rhythm in Blood Glucose Levels Independent of Peripheral Clocks	PLOS ONE			English	Article							INSULIN-SECRETION; PLASMA-GLUCOSE; MEDIATED INFLUENCE; CIRCADIAN-RHYTHMS; FOOD-INTAKE; RECEPTORS; PINEALECTOMY; METABOLISM; IDENTIFICATION; PHARMACOLOGY	Melatonin is rhythmically secreted by both the pineal gland and retina in a circadian fashion, with its peak synthesis occurring during the night. Once synthesized, melatonin exerts its effects by binding to two specific G-protein coupled receptors-melatonin receptor type 1 (MT1) and melatonin receptor type 2(MT2). Recent studies suggest the involvement of MT1 and MT2 in the regulation of glucose homeostasis; however the ability of melatonin signaling to impart timing cues on glucose metabolism remains poorly understood. Here we report that the removal of MT1 or MT2 in mice abolishes the daily rhythm in blood glucose levels. Interestingly, removal of melatonin receptors produced small effects on the rhythmic expression patterns of clock genes within skeletal muscle, liver, and adipose tissue. Taken together, our data suggest that the loss of the daily rhythm in blood glucose observed in MT1-/- and MT2-/- mice does not occur as a consequence of 'disrupted' clocks within insulin sensitive tissues. Finally our results highlight a diurnal contribution of melatonin receptor signaling in the daily regulation of blood glucose levels.	[Baba, Kenkichi; Tosini, Gianluca] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA; Morehouse Sch Med, Dept Pharmacol & Toxicol, Atlanta, GA 30310 USA	Morehouse School of Medicine; Morehouse School of Medicine	Baba, K; Tosini, G (corresponding author), Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA.	bkenkichi@msm.edu; gtosini@msm.edu		tosini, gianluca/0000-0003-3645-4533	NIH; NATIONAL EYE INSTITUTE [P30EY006360] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH supported the research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Baba K, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004302; Baba K, 2009, P NATL ACAD SCI USA, V106, P15043, DOI 10.1073/pnas.0904400106; Bahr I, 2012, J PINEAL RES, V53, P390, DOI 10.1111/j.1600-079X.2012.01009.x; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; BOLLI GB, 1984, DIABETES, V33, P1150, DOI 10.2337/diabetes.33.12.1150; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Brydon L, 1999, MOL ENDOCRINOL, V13, P2025, DOI 10.1210/me.13.12.2025; Cailotto C, 2005, EUR J NEUROSCI, V22, P2531, DOI 10.1111/j.1460-9568.2005.04439.x; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Contreras-Alcantara S, 2010, OBESITY, V18, P1861, DOI 10.1038/oby.2010.24; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; Faria JA, 2013, AM J PHYSIOL-ENDOC M, V305, pE230, DOI 10.1152/ajpendo.00094.2013; Ha E, 2006, J PINEAL RES, V41, P67, DOI 10.1111/j.1600-079X.2006.00334.x; Johnston JD, 2006, ENDOCRINOLOGY, V147, P959, DOI 10.1210/en.2005-1100; JOLIN T, 1973, HORM RES, V4, P153, DOI 10.1159/000178303; Kalsbeek A, 2014, MOL METAB, V3, P372, DOI 10.1016/j.molmet.2014.03.002; Kalsbeek A, 2010, TRENDS ENDOCRIN MET, V21, P402, DOI 10.1016/j.tem.2010.02.005; Kemp DM, 2002, MOL CELL ENDOCRINOL, V191, P157, DOI 10.1016/S0303-7207(02)00064-3; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; la Fleur SE, 2003, J NEUROENDOCRINOL, V15, P315, DOI 10.1046/j.1365-2826.2003.01019.x; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; la Fleur SE, 2001, J NEUROENDOCRINOL, V13, P1025, DOI 10.1046/j.1365-2826.2001.00717.x; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee J, 2013, MOL CELL BIOL, V33, P2327, DOI 10.1128/MCB.01421-12; Li C, 2011, GYNECOL OBSTET INVES, V72, P130, DOI 10.1159/000323542; LIMA FB, 1994, BRAZ J MED BIOL RES, V27, P995; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; de Farias TDM, 2015, J PINEAL RES, V58, P251, DOI 10.1111/jpi.12211; Nogueira TC, 2011, ENDOCRINOLOGY, V152, P1253, DOI 10.1210/en.2010-1088; Park EJ, 2014, J PINEAL RES, V56, P97, DOI 10.1111/jpi.12102; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; PAULY JE, 1967, AM J ANAT, V120, P627, DOI 10.1002/aja.1001200312; PERET J, 1973, J NUTR, V103, P866, DOI 10.1093/jn/103.6.866; Peschke E, 2002, J PINEAL RES, V33, P63, DOI 10.1034/j.1600-079X.2002.02919.x; Picinato MC, 2002, J PINEAL RES, V33, P156, DOI 10.1034/j.1600-079X.2002.02903.x; Reppert SM, 2002, NATURE, P418; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Saini C, 2011, COLD SH Q B, V76, P39, DOI 10.1101/sqb.2011.76.010918; Stumpf I, 2008, J PINEAL RES, V45, P318, DOI 10.1111/j.1600-079X.2008.00593.x; TAKAHASHI K, 1976, ENDOCRINOL JAPON, V23, P417; Tosini G, 2014, BIOESSAYS, V36, P778, DOI 10.1002/bies.201400017; VANCAUTER E, 1990, HORM RES, V34, P45, DOI 10.1159/000181794; von Gall C, 2002, NAT NEUROSCI, V5, P234, DOI 10.1038/nn806; Von Gall C, 2005, ANN NY ACAD SCI, V1040, P508, DOI 10.1196/annals.1327.105; Vriend J, 2014, LIFE SCI, V115, P8, DOI 10.1016/j.lfs.2014.08.024; Wuehlbauer E, 2009, EUR J PHARMACOL, V606, P61, DOI 10.1016/j.ejphar.2009.01.029; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhao Y, 2012, FEBS LETT, V586, P1306, DOI 10.1016/j.febslet.2012.03.034; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	55	35	37	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148214	10.1371/journal.pone.0148214	http://dx.doi.org/10.1371/journal.pone.0148214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824606	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600109
J	Ramakrishnan, SK; Khuder, SS; Al-Share, QY; Russo, L; Abdallah, SL; Patel, PR; Heinrich, G; Muturi, HT; Mopidevi, BR; Oyarce, AM; Shah, YM; Sanchez, ER; Najjar, SM				Ramakrishnan, Sadeesh K.; Khuder, Saja S.; Al-Share, Qusai Y.; Russo, Lucia; Abdallah, Simon L.; Patel, Payal R.; Heinrich, Garrett; Muturi, Harrison T.; Mopidevi, Brahma R.; Oyarce, Ana Maria; Shah, Yatrik M.; Sanchez, Edwin R.; Najjar, Sonia M.			PPAR (Peroxisome Proliferator-activated Receptor ) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid metabolism; fatty acid synthase (FAS); gene expression; insulin secretion; peroxisome proliferator-activated receptor (PPAR); CEACAM1; insulin clearance; PPAR response element	CELL-ADHESION MOLECULE-1; INSULIN-CLEARANCE; GENE-EXPRESSION; TYROSINE KINASE; IN-VIVO; ALPHA; METABOLISM; LIVER; SUBSTRATE; DIET	Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is expressed at high levels in the hepatocyte, consistent with its role in promoting insulin clearance in liver. CEACAM1 also mediates a negative acute effect of insulin on fatty acid synthase activity. Western blot analysis reveals lower hepatic CEACAM1 expression during fasting. Treating of rat hepatoma FAO cells with Wy14,643, an agonist of peroxisome proliferator-activated receptor (PPAR), rapidly reduces Ceacam1 mRNA and CEACAM1 protein levels within 1 and 2 h, respectively. Luciferase reporter assay shows a decrease in the promoter activity of both rat and mouse genes by Ppar activation, and 5-deletion and block substitution analyses reveal that the Ppar response element between nucleotides -557 and -543 is required for regulation of the mouse promoter activity. Chromatin immunoprecipitation analysis demonstrates binding of liganded Ppar to Ceacam1 promoter in liver lysates of Ppar(+/+), but not Ppar(-/-) mice fed a Wy14,643-supplemented chow diet. Consequently, Wy14,643 feeding reduces hepatic Ceacam1 mRNA and CEACAM1 protein levels, thus decreasing insulin clearance to compensate for compromised insulin secretion and maintain glucose homeostasis and insulin sensitivity in wild-type mice. Together, the data show that the low hepatic CEACAM1 expression at fasting is mediated by Ppar-dependent mechanisms. Changes in CEACAM1 expression contribute to the coordination of fatty acid oxidation and insulin action in the fasting-refeeding transition.	[Ramakrishnan, Sadeesh K.; Khuder, Saja S.; Al-Share, Qusai Y.; Russo, Lucia; Abdallah, Simon L.; Patel, Payal R.; Heinrich, Garrett; Muturi, Harrison T.; Oyarce, Ana Maria; Sanchez, Edwin R.; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res, Hlth Sci Campus, Toledo, OH 43614 USA; [Ramakrishnan, Sadeesh K.; Khuder, Saja S.; Al-Share, Qusai Y.; Russo, Lucia; Abdallah, Simon L.; Patel, Payal R.; Heinrich, Garrett; Muturi, Harrison T.; Mopidevi, Brahma R.; Oyarce, Ana Maria; Sanchez, Edwin R.; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Hlth Sci Campus, Toledo, OH 43614 USA; [Shah, Yatrik M.] Univ Michigan, Div Gastroenterol & Mol & Integrat Physiol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Najjar, Sonia M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University of Michigan System; University of Michigan; University System of Ohio; Ohio University	Najjar, SM (corresponding author), Univ Toledo, Coll Med & Life Sci, Hlth Sci Campus,3000 Arlington Ave,Mail Stop 10, Toledo, OH 43614 USA.	sonia.najjar@utoledo.edu	Mopidevi, Brahmaraju/D-6003-2015; Najjar, Sonia M/GXW-2217-2022	Mopidevi, Brahmaraju/0000-0003-1231-7796; Al-Share, Qusai/0000-0002-2306-6198; Khuder, Saja/0000-0001-9101-3744	NIH [R01 DK054254, R01 DK083850, R01 HL112248, R01 DK70127]; American Heart Association; Wolfe Innovation Fund (University of Toledo Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070127, R01DK054254, R01DK083850] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Wolfe Innovation Fund (University of Toledo Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH Grants R01 DK054254, R01 DK083850, and R01 HL112248 (to S. M. N.) and R01 DK70127 (to E. R. S.). The authors declare that they have no conflict of interest associated with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a post-doctoral fellowship from the American Heart Association and by the Wolfe Innovation Fund (University of Toledo Foundation).	Ader M, 2014, OBESITY, V22, P1238, DOI 10.1002/oby.20625; Al-Share QY, 2015, DIABETES, V64, P2780, DOI 10.2337/db14-1772; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Cariello NF, 2005, TOXICOL SCI, V88, P250, DOI 10.1093/toxsci/kfi273; DeAngelis AM, 2008, DIABETES, V57, P2296, DOI 10.2337/db08-0379; Durgan DJ, 2006, AM J PHYSIOL-HEART C, V290, pH2480, DOI 10.1152/ajpheart.01344.2005; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; Goodarzi MO, 2011, AM J PHYSIOL-ENDOC M, V301, pE402, DOI 10.1152/ajpendo.00013.2011; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Gremlich S, 2005, ENDOCRINOLOGY, V146, P375, DOI 10.1210/en.2004-0667; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; IRITANI N, 1992, EUR J BIOCHEM, V205, P433, DOI 10.1111/j.1432-1033.1992.tb16797.x; Kamiya A, 2004, FEBS LETT, V578, P63, DOI 10.1016/j.febslet.2004.10.070; Kane CD, 2009, MOL PHARMACOL, V75, P296, DOI 10.1124/mol.108.051656; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Matveyenko AV, 2012, DIABETES, V61, P2269, DOI 10.2337/db11-1462; MOIR AMB, 1993, BIOCHEM J, V289, P49, DOI 10.1042/bj2890049; Najjar SM, 2005, CELL METAB, V2, P43, DOI 10.1016/j.cmet.2005.06.001; NAJJAR SM, 1995, BIOCHEMISTRY-US, V34, P9341, DOI 10.1021/bi00029a009; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Najjar SM, 1996, J BIOL CHEM, V271, P8809, DOI 10.1074/jbc.271.15.8809; Park SY, 2006, AM J PHYSIOL-ENDOC M, V291, pE517, DOI 10.1152/ajpendo.00077.2006; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Roden M, 1999, ANNU REV MED, V50, P277, DOI 10.1146/annurev.med.50.1.277; Rubi B, 2002, BIOCHEM J, V364, P219, DOI 10.1042/bj3640219; Shah YA, 2007, MOL CELL BIOL, V27, P4238, DOI 10.1128/MCB.00317-07; Sugden MC, 2002, BIOCHEM J, V364, P361, DOI 10.1042/BJ20011699; WARD GM, 1990, DIABETES, V39, P501, DOI 10.2337/diabetes.39.4.501; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Xu E, 2009, ENDOCRINOLOGY, V150, P3503, DOI 10.1210/en.2008-1439; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200	35	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8121	8129		10.1074/jbc.M116.714014	http://dx.doi.org/10.1074/jbc.M116.714014			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26846848	hybrid, Green Published			2022-12-26	WOS:000374056700029
J	Zielonka, J; Zielonka, M; VerPlank, L; Cheng, G; Hardy, M; Ouari, O; Ayhan, MM; Podsiadly, R; Sikora, A; Lambeth, JD; Kalyanaraman, B				Zielonka, Jacek; Zielonka, Monika; VerPlank, Lynn; Cheng, Gang; Hardy, Micael; Ouari, Olivier; Ayhan, Mehmet Menaf; Podsiadly, Radoslaw; Sikora, Adam; Lambeth, J. David; Kalyanaraman, Balaraman			Mitigation of NADPH Oxidase 2 Activity as a Strategy to Inhibit Peroxynitrite Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						high throughput screening (HTS); NADPH oxidase; reactive nitrogen species (RNS); reactive oxygen species (ROS); superoxide ion; NADPH oxidase inhibitors; fluorescence probes	REACTIVE OXYGEN; NITRIC-OXIDE; EXTRACELLULAR-SUPEROXIDE; THERAPEUTIC TARGETS; NOX INHIBITORS; IN-VIVO; CELLS; DISEASE; BIOLOGY; CANCER	Using high throughput screening-compatible assays for superoxide and hydrogen peroxide, we identified potential inhibitors of the NADPH oxidase (Nox2) isoform from a small library of bioactive compounds. By using multiple probes (hydroethidine, hydropropidine, Amplex Red, and coumarin boronate) with well defined redox chemistry that form highly diagnostic marker products upon reaction with superoxide (O2 arrange=stack.), hydrogen peroxide (H2O2), and peroxynitrite (ONOO-), the number of false positives was greatly decreased. Selected hits for Nox2 were further screened for their ability to inhibit ONOO- formation in activated macrophages. A new diagnostic marker product for ONOO- is reported. We conclude that the newly developed high throughput screening/reactive oxygen species assays could also be used to identify potential inhibitors of ONOO- formed from Nox2-derived O2. and nitric oxide synthase-derived nitric oxide.	[Zielonka, Jacek; Zielonka, Monika; Cheng, Gang; Podsiadly, Radoslaw; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Zielonka, Jacek; Zielonka, Monika; Cheng, Gang; Podsiadly, Radoslaw; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [VerPlank, Lynn] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Hardy, Micael; Ouari, Olivier; Ayhan, Mehmet Menaf] Aix Marseille Univ, CNRS, ICR UMR 7273, F-13397 Marseille, France; [Sikora, Adam] Lodz Univ Technol, Fac Chem, Inst Appl Radiat Chem, Zeromskiego 116, PL-90924 Lodz, Poland; [Lambeth, J. David] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Podsiadly, Radoslaw] Lodz Univ Technol, Fac Chem, Inst Polymer & Dye Technol, Stefanowskiego 12-16, PL-90924 Lodz, Poland	Medical College of Wisconsin; Medical College of Wisconsin; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Aix-Marseille Universite; Lodz University of Technology; Emory University; Lodz University of Technology	Zielonka, J; Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jzielonk@mcw.edu; balarama@mcw.edu	AYHAN, MEHMET MENAF/AAY-3312-2020; Podsiadly, Radoslaw/P-1732-2019; Hardy, micael/ABF-3357-2020; Zielonka, Jacek/N-9546-2014; Sikora, Adam B/I-2756-2014	AYHAN, MEHMET MENAF/0000-0001-5367-2220; Podsiadly, Radoslaw/0000-0002-7822-8182; Hardy, micael/0000-0003-2976-7785; Zielonka, Jacek/0000-0002-2524-0145; Sikora, Adam B/0000-0002-4962-8945; Ouari, Olivier/0000-0003-4320-4313	National Institutes of Health [R01 HL073056]; Molecular Libraries Probe Development Network [U54 HG005032]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073056] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI102197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Libraries Probe Development Network; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 HL073056 (to B. K.) and in part by Molecular Libraries Probe Development Network Grant U54 HG005032. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Altenhofer S, 2015, ANTIOXID REDOX SIGN, V23, P406, DOI 10.1089/ars.2013.5814; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Beckman JS, 2009, ARCH BIOCHEM BIOPHYS, V484, P114, DOI 10.1016/j.abb.2009.03.013; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Bonner MY, 2012, CELL MOL LIFE SCI, V69, P2435, DOI 10.1007/s00018-012-1017-2; Borbely G, 2010, J MED CHEM, V53, P6758, DOI 10.1021/jm1004368; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Burkhart RA, 2013, MOL CANCER RES, V11, P901, DOI 10.1158/1541-7786.MCR-12-0699; Cifuentes-Pagano E, 2014, ANTIOXID REDOX SIGN, V20, P2741, DOI 10.1089/ars.2013.5620; COHEN HJ, 1980, BLOOD, V56, P23; COOKSON EA, 1966, J CHEM SOC C, P2003, DOI 10.1039/j39660002003; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Daiber A, 2004, FREE RADICAL BIO MED, V36, P101, DOI 10.1016/j.freeradbiomed.2003.10.012; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Goy R, 2013, EUR J INORG CHEM, V2013, P4466, DOI 10.1002/ejic.201300537; Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003; Hecker L, 2012, CELL MOL LIFE SCI, V69, P2365, DOI 10.1007/s00018-012-1012-7; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hirano K, 2015, ANTIOXID REDOX SIGN, V23, P358, DOI 10.1089/ars.2014.6202; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Khan M, 2016, BRAIN RES, V1630, P159, DOI 10.1016/j.brainres.2015.11.015; KUMAR K, 1987, INORG CHEM, V26, P2706, DOI 10.1021/ic00263a030; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Li Y, 2015, ACS MED CHEM LETT, V6, P1047, DOI 10.1021/acsmedchemlett.5b00287; Michalski R, 2013, FREE RADICAL BIO MED, V54, P135, DOI 10.1016/j.freeradbiomed.2012.09.018; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nisimoto Y, 2014, BIOCHEMISTRY-US, V53, P5111, DOI 10.1021/bi500331y; Oba M, 2001, ORGANOMETALLICS, V20, P4287, DOI 10.1021/om010337p; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; RADI R, 1991, J BIOL CHEM, V266, P4244; Seitz PM, 2010, J BIOMOL SCREEN, V15, P388, DOI 10.1177/1087057109359687; Seredenina T, 2015, FREE RADICAL BIO MED, V86, P239, DOI 10.1016/j.freeradbiomed.2015.05.023; Sikora A, 2013, CHEM RES TOXICOL, V26, P856, DOI 10.1021/tx300499c; Sikora A, 2011, CHEM RES TOXICOL, V24, P687, DOI 10.1021/tx100439a; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Streeter J, 2013, CARDIOVASC THER, V31, P125, DOI 10.1111/j.1755-5922.2011.00310.x; Teufelhofer O, 2003, TOXICOL SCI, V76, P376, DOI 10.1093/toxsci/kfg234; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; Wind S, 2010, BRIT J PHARMACOL, V161, P885, DOI 10.1111/j.1476-5381.2010.00920.x; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Ximenes VF, 2015, J INORG BIOCHEM, V146, P61, DOI 10.1016/j.jinorgbio.2015.02.014; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka Jacek, 2015, Methods Mol Biol, V1264, P171, DOI 10.1007/978-1-4939-2257-4_16; Zielonka J, 2014, J BIOL CHEM, V289, P16176, DOI 10.1074/jbc.M114.548693; Zielonka J, 2013, FREE RADICAL BIO MED, V65, P1310, DOI 10.1016/j.freeradbiomed.2013.09.017; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080	64	48	48	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7029	7044		10.1074/jbc.M115.702787	http://dx.doi.org/10.1074/jbc.M115.702787			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26839313	Green Published, hybrid			2022-12-26	WOS:000373299700038
J	Lasda, E; Parker, R				Lasda, Erika; Parker, Roy			Circular RNAs Co-Precipitate with Extracellular Vesicles: A Possible Mechanism for circRNA Clearance	PLOS ONE			English	Article							EXOSOMES; ABUNDANT	Backspliced circular RNAs (circRNAs) are prevalent in many eukaryotic systems and are spliced from thousands of different genes. Where examined, circRNAs are often highly stable and the mechanisms by which cells degrade and/or clear circRNAs from the cells are unknown. Here we investigated the possibility that cells can eliminate circRNAs into extracellular space, possibly within released vesicles such as exosomes and microvesicles. From three different cell lines and examining multiple circRNAs, we show that extracellular vesicle (EVs) preparations recovered from cell culture conditioned media contain established circRNAs. Moreover, these circRNAs are enriched over their linear counterparts within EV preparations when compared to the producing cells. This supports the idea that expulsion from cells into extracellular space, as by EVs release, can be a mechanism by which cells clear circRNAs. Moreover, since EVs can be taken up by other cells, excreted circRNAs could contribute to cell to cell communication.	[Lasda, Erika] Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA; Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Lasda, E (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	erika.lasda@colorado.edu			Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by funds from the Howard Hughes Medical Institute.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Ghosh S, 2010, WIRES RNA, V1, P351, DOI 10.1002/wrna.25; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jeppesen DK, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25011; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Taylor DD, 2015, METHODS, V87, P3, DOI 10.1016/j.ymeth.2015.02.019; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Van Deun J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24858; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062	24	255	277	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148407	10.1371/journal.pone.0148407	http://dx.doi.org/10.1371/journal.pone.0148407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848835	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000088
J	Mir, RA; Weppelmann, TA; Elzo, M; Ahn, S; Driver, JD; Jeong, KC				Mir, Raies A.; Weppelmann, Thomas A.; Elzo, Mauricio; Ahn, Soohyoun; Driver, J. Danny; Jeong, KwangCheol Casey			Colonization of Beef Cattle by Shiga Toxin-Producing Escherichia coli during the First Year of Life: A Cohort Study	PLOS ONE			English	Article							O157H7 STRAINS; UNITED-STATES; INFECTIONS; PREVALENCE; DIVERSITY; CALVES; GENES	Each year Shiga toxin-producing Escherichia coli (STEC) are responsible for 2.8 million acute illnesses around the world and > 250,000 cases in the US. Lowering the prevalence of this pathogen in animal reservoirs has the potential to reduce STEC outbreaks in humans by controlling its entrance into the food chain. However, factors that modulate the colonization and persistence of STEC in beef cattle remain largely unidentified. This study evaluated if animal physiological factors such as age, breed, sex, and weight gain influenced the shedding of STEC in beef cattle. A cohort of beef calves (n = 260) from a multi-breed beef calf population was sampled every three months after birth to measure prevalence and concentration of STEC during the first year of life. Metagenomic analysis was also used to understand the association between the STEC colonization and the composition of gut microflora. This study identified that beef calves were more likely to shed STEC during the first 6 months and that STEC shedding decreased as the animal matured. Animal breed group, sex of the calf, and average weight gain were not significantly associated with STEC colonization. The meta-genomic analysis revealed for the first time that STEC colonization was correlated with a lower diversity of gut microflora, which increases as the cattle matured. Given these findings, intervention strategies that segregate younger animals, more likely to be colonized by STEC from older animals that are ready to be harvested, could be investigated as a method to reduce zoonotic transmission of STEC from cattle to humans.	[Mir, Raies A.; Elzo, Mauricio; Driver, J. Danny; Jeong, KwangCheol Casey] Univ Florida, Inst Food & Agr Sci, Dept Anim Sci, Gainesville, FL 32611 USA; [Mir, Raies A.; Weppelmann, Thomas A.; Jeong, KwangCheol Casey] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Weppelmann, Thomas A.] Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Ahn, Soohyoun] Univ Florida, Inst Food & Agr Sci, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jeong, KC (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Anim Sci, Gainesville, FL 32611 USA.; Jeong, KC (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.	kcjeong@ufl.edu			National Institute of Food and Agriculture, U.S. Department of Agriculture [2014-67021-21597, 2015-68003-22971]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under awad number 2014-67021-21597 and 2015-68003-22971 to KCJ.	[Anonymous], 2010, R LANG ENV STAT COMP; Bai JF, 2010, J MICROBIOL METH, V82, P85, DOI 10.1016/j.mimet.2010.05.003; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Cobbold R, 2000, VET MICROBIOL, V71, P125, DOI 10.1016/S0378-1135(99)00173-X; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Farfan MJ, 2012, INFECT IMMUN, V80, P903, DOI 10.1128/IAI.05907-11; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Frohlich J, 2009, APPL ENVIRON MICROB, V75, P3695, DOI 10.1128/AEM.02869-08; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jeon SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055728; LeJeune JT, 2007, J ANIM SCI, V85, pE73, DOI 10.2527/jas.2006-612; Li K, 2012, PLOS ONE, V7; Lima FS, 2015, APPL ENVIRON MICROB, V81, P1327, DOI 10.1128/AEM.03138-14; Majowicz SE, 2014, FOODBORNE PATHOG DIS, V11, P447, DOI 10.1089/fpd.2013.1704; Matthews L, 2013, P NATL ACAD SCI USA, V110, P16265, DOI 10.1073/pnas.1304978110; Mir RA, 2014, VET MICROBIOL; Monaghan I, 2011, APPL ENVIRON MICROB, V77, P8662, DOI 10.1128/AEM.06190-11; Park D, 2013, APPL ENVIRON MICROB, V79, P1563, DOI 10.1128/AEM.03158-12; Rantsiou K, 2012, INT J FOOD MICROBIOL, V154, P37, DOI 10.1016/j.ijfoodmicro.2011.12.010; Reiland HA, 2014, ADV MICROBIOL, V4, P390, DOI DOI 10.4236/aim.2014.47046; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Slanec T, 2009, APPL ENVIRON MICROB, V75, P6187, DOI 10.1128/AEM.00874-09; Stanton E, 2014, MICROBIOL-SGM, V160, P502, DOI 10.1099/mic.0.073437-0; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Zhang YX, 2010, APPL ENVIRON MICROB, V76, P474, DOI 10.1128/AEM.01288-09; Zhao L, 2014, FOODBORNE PATHOG DIS, V11, P55, DOI 10.1089/fpd.2013.1587	32	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148518	10.1371/journal.pone.0148518	http://dx.doi.org/10.1371/journal.pone.0148518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849041	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000114
J	Ramo, A; Quilez, J; Monteagudo, L; Del Cacho, E; Sanchez-Acedo, C				Ramo, Ana; Quilez, Joaquin; Monteagudo, Luis; Del Cacho, Emilio; Sanchez-Acedo, Caridad			Intra-Species Diversity and Panmictic Structure of Cryptosporidium parvum Populations in Cattle Farms in Northern Spain	PLOS ONE			English	Article							INFECTING DOMESTIC RUMINANTS; GENETIC DIVERSITY; UNITED-STATES; DAIRY CALVES; HOMINIS; SUBTYPE; GENOTYPES; RECOMBINATION; PREVALENCE; CHILDREN	The intra-herd and intra-host genetic variability of 123 Cryptosporidium parvum isolates was investigated using a multilocus fragment typing approach with eleven variable-number tandem-repeat (VNTR) loci and the GP60 gene. Isolates were collected from intensively farmed diarrheic pre-weaned calves originating from 31 dairy farms in three adjoining regions in northern Spain (Pais Vasco, Cantabria and Asturias). The multilocus tool demonstrated an acceptable typeability, with 104/123 samples amplifying at all twelve loci. The ML2, TP14, GP60 and the previously un-described minisatellite at locus cgd2_3850 were the most discriminatory markers, while others may be dismissed as monomorphic (MSB) or less informative (CP47, ML1 and the novel minisatellites at loci Cgd1_3670 and Cgd6_3940). The 12-satellite typing tool provided a Hunter-Gaston index (HGDI) of 0.987 (95% CI, 0.982-0.992), and differentiated a total of 70 multilocus subtypes (MLTs). The inclusion of only the four most discriminatory markers dramatically reduced the number of MLTs (n: 44) but hardly reduced the HGDI value. A total of 54 MLTs were distinctive for individual farms, indicating that cryptosporidiosis is an endemic condition on most cattle farms. However, a high rate of mixed infections was detected, suggesting frequent meiotic recombination. Namely, multiple MLTs were seen in most farms where several specimens were analyzed (90.5%), with up to 9 MLTs being found on one farm, and individual specimens with mixed populations being reported on 11/29 farms. Bayesian Structure analysis showed that over 35% of isolates had mixed ancestry and analysis of evolutionary descent using the eBURST algorithm detected a high rate (21.4%) of MLTs appearing as singletons, indicating a high degree of genetic divergence. Linkage analysis found evidence of linkage equilibrium and an overall panmictic structure within the C. parvum population in this discrete geographical area.	[Ramo, Ana; Quilez, Joaquin; Del Cacho, Emilio; Sanchez-Acedo, Caridad] Univ Zaragoza, Fac Vet Sci, Dept Anim Pathol, Zaragoza, Spain; [Monteagudo, Luis] Univ Zaragoza, Fac Vet Sci, Dept Anat Embriol & Genet, Zaragoza, Spain	University of Zaragoza; University of Zaragoza	Quilez, J (corresponding author), Univ Zaragoza, Fac Vet Sci, Dept Anim Pathol, Zaragoza, Spain.	jquilez@unizar.es	; Quilez Cinca, Joaquin/Q-7194-2017	Ramo, Ana/0000-0002-0308-1390; Quilez Cinca, Joaquin/0000-0001-7831-2483	European Social Fund; Spanish and regional research programs [AGL2012-32138, DGA-B82]	European Social Fund(European Social Fund (ESF)); Spanish and regional research programs	This work was supported by funds from Spanish (AGL2012-32138) and regional (DGA-B82) research programs, and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Caccio SM, 2015, INFECT GENET EVOL, V31, P245, DOI 10.1016/j.meegid.2015.02.008; Castro-Hermida JA, 2002, VET PARASITOL, V106, P1, DOI 10.1016/S0304-4017(02)00036-5; Castro-Hermida JA, 2002, VET PARASITOL, V106, P11, DOI 10.1016/S0304-4017(02)00038-9; Chalmers RM, 2013, TRENDS PARASITOL, V29, P237, DOI 10.1016/j.pt.2013.03.001; Chalmers RM, 2005, INT J PARASITOL, V35, P397, DOI 10.1016/j.ijpara.2005.01.001; COCKERHAM CC, 1993, EVOLUTION, V47, P855, DOI 10.1111/j.1558-5646.1993.tb01239.x; De Waele V, 2013, APPL ENVIRON MICROB, V79, P2534, DOI 10.1128/AEM.03613-12; Diaz P, 2012, VET PARASITOL, V186, P188, DOI 10.1016/j.vetpar.2011.11.039; Drumo R, 2012, APPL ENVIRON MICROB, V78, P3523, DOI 10.1128/AEM.07686-11; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feng YY, 2014, J CLIN MICROBIOL, V52, P524, DOI 10.1128/JCM.02973-13; Feng YY, 2013, INT J PARASITOL, V43, P1141, DOI 10.1016/j.ijpara.2013.09.002; Garcia A, 2000, COMP IMMUNOL MICROB, V23, P175, DOI 10.1016/S0147-9571(99)00071-5; Gatei W, 2007, INFECT GENET EVOL, V7, P197, DOI 10.1016/j.meegid.2006.08.006; Grinberg A, 2013, INFECT GENET EVOL, V15, P18, DOI 10.1016/j.meegid.2012.08.017; Guo YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1517-1; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Herges GR, 2012, APPL ENVIRON MICROB, V78, P8096, DOI 10.1128/AEM.02105-12; Hotchkiss EJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1107-8; Hunter PR, 2007, EMERG INFECT DIS, V13, P82, DOI 10.3201/eid1301.060481; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Li N, 2013, EMERG INFECT DIS, V19, P1573, DOI 10.3201/eid1910.121361; Mallon M, 2003, J MOL EVOL, V56, P407, DOI 10.1007/s00239-002-2412-3; Mallon ME, 2003, INFECT GENET EVOL, V3, P207, DOI 10.1016/S1567-1348(03)00089-3; Mercado R, 2015, PARASITOL RES, V114, P1985, DOI 10.1007/s00436-015-4364-8; Morrison LJ, 2008, INFECT GENET EVOL, V8, P121, DOI 10.1016/j.meegid.2007.10.010; Ng J, 2010, EXP PARASITOL, V125, P348, DOI 10.1016/j.exppara.2010.02.017; Peng MM, 2003, PARASITOL RES, V90, P175, DOI 10.1007/s00436-003-0834-5; Pritchard JK, 2000, GENETICS, V155, P945; Quilez J, 2008, PARASITOLOGY, V135, P1613, DOI 10.1017/S0031182008005088; Quilez J, 2014, PARASITOL RES, V113, P1821, DOI 10.1007/s00436-014-3828-6; Quilez J, 2013, APPL ENVIRON MICROB, V79, P5363, DOI 10.1128/AEM.01168-13; Quilez J, 2011, APPL ENVIRON MICROB, V77, P7779, DOI 10.1128/AEM.00751-11; Ramo A, 2015, INFECT GENET EVOL, V31, P190, DOI 10.1016/j.meegid.2015.01.023; Ramo A, 2014, VET PARASITOL, V205, P466, DOI 10.1016/j.vetpar.2014.08.025; Robinson G, 2012, EXP PARASITOL, V132, P200, DOI 10.1016/j.exppara.2012.06.016; Ryan U, 2014, PARASITOLOGY, V141, P1667, DOI 10.1017/S0031182014001085; Tanriverdi S, 2006, APPL ENVIRON MICROB, V72, P2507, DOI 10.1128/AEM.72.4.2507-2513.2006; Tanriverdi S, 2006, INFECT GENET EVOL, V6, P113, DOI 10.1016/j.meegid.2005.02.002; Tanriverdi S, 2008, APPL ENVIRON MICROB, V74, P7227, DOI 10.1128/AEM.01576-08; Tanriverdi S, 2007, MOL MICROBIOL, V63, P1432, DOI 10.1111/j.1365-2958.2007.05594.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Waldron LS, 2011, INFECT GENET EVOL, V11, P1388, DOI 10.1016/j.meegid.2011.05.008; Wang RJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04208; Widmer G, 2012, PARASITE IMMUNOL, V34, P61, DOI 10.1111/j.1365-3024.2011.01301.x	46	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148811	10.1371/journal.pone.0148811	http://dx.doi.org/10.1371/journal.pone.0148811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848837	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000172
J	Takayama, Y; Kida, YS				Takayama, Yuzo; Kida, Yasuyuki S.			In Vitro Reconstruction of Neuronal Networks Derived from Human iPS Cells Using Microfabricated Devices	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DIRECTED DIFFERENTIATION; HUMAN FIBROBLASTS; NERVOUS-SYSTEM; GENERATION; INDUCTION	Morphology and function of the nervous system is maintained via well-coordinated processes both in central and peripheral nervous tissues, which govern the homeostasis of organs/tissues. Impairments of the nervous system induce neuronal disorders such as peripheral neuropathy or cardiac arrhythmia. Although further investigation is warranted to reveal the molecular mechanisms of progression in such diseases, appropriate model systems mimicking the patient-specific communication between neurons and organs are not established yet. In this study, we reconstructed the neuronal network in vitro either between neurons of the human induced pluripotent stem(iPS) cell derived peripheral nervous system (PNS) and central nervous system (CNS), or between PNS neurons and cardiac cells in a morphologically and functionally compartmentalized manner. Networks were constructed in photolithographically microfabricated devices with two culture compartments connected by 20 microtunnels. We confirmed that PNS and CNS neurons connected via synapses and formed a network. Additionally, calcium-imaging experiments showed that the bundles originating from the PNS neurons were functionally active and responded reproducibly to external stimuli. Next, we confirmed that CNS neurons showed an increase in calcium activity during electrical stimulation of networked bundles from PNS neurons in order to demonstrate the formation of functional cell-cell interactions. We also confirmed the formation of synapses between PNS neurons and mature cardiac cells. These results indicate that compartmentalized culture devices are promising tools for reconstructing network-wide connections between PNS neurons and various organs, and might help to understand patient-specific molecular and functional mechanisms under normal and pathological conditions.	[Takayama, Yuzo; Kida, Yasuyuki S.] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Takayama, Y; Kida, YS (corresponding author), Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan.	yuzo-takayama@aist.go.jp; y-kida@aist.go.jp	kida, yasuyuki S/J-1718-2018; Takayama, Yuzo/L-5072-2018	kida, yasuyuki S/0000-0002-9972-293X; Takayama, Yuzo/0000-0002-6382-8767	Japan Society for the Promotion of Science (JSPS) [26702015]; Uehara Memorial Foundation; Ono Medical Research Foundation; Grants-in-Aid for Scientific Research [26702015] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Ono Medical Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by a Grant-in-Aid for Young Scientists (A) (#26702015) from Japan Society for the Promotion of Science (JSPS) to YT. Funding was also provided by the Uehara Memorial Foundation and the Ono Medical Research Foundation to YSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard JW, 2015, NAT NEUROSCI, V18, P25, DOI 10.1038/nn.3887; Bloch J, 2001, EXP NEUROL, V172, P425, DOI 10.1006/exnr.2001.7778; Buckner RL, 2013, TRENDS COGN SCI, V17, P648, DOI 10.1016/j.tics.2013.09.017; Burnett Mark G, 2004, Neurosurg Focus, V16, pE1, DOI 10.3171/foc.2004.16.5.2; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Downes JH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002522; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Kanagasabapathi TT, 2013, J NEUROSCI METH, V214, P1, DOI 10.1016/j.jneumeth.2012.12.019; Kempf H, 2014, STEM CELL REP, V3, P1132, DOI 10.1016/j.stemcr.2014.09.017; Kim Ju-Yeon, 2012, World J Stem Cells, V4, P110, DOI 10.4252/wjsc.v4.i11.110; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Liu QY, 2012, STEM CELL TRANSL MED, V1, P266, DOI 10.5966/sctm.2011-0042; Mata A, 2005, BIOMED MICRODEVICES, V7, P281, DOI 10.1007/s10544-005-6070-2; Menendez L, 2013, NAT PROTOC, V8, P203, DOI 10.1038/nprot.2012.156; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Millet Larry J., 2012, Yale Journal of Biology and Medicine, V85, P501; Mooren OL, 2014, MOL BIOL CELL, V25, P4115, DOI 10.1091/mbc.E14-05-0976; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Pfister Bryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P81, DOI 10.1615/CritRevBiomedEng.v39.i2.20; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Qu QH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4449; Slaugenhaupt SA, 2002, CURR OPIN GENET DEV, V12, P307, DOI 10.1016/S0959-437X(02)00303-9; Takayama Y, 2012, BIOSYSTEMS, V107, P1, DOI 10.1016/j.biosystems.2011.08.001; Takeuchi A, 2011, LAB CHIP, V11, P2268, DOI 10.1039/c0lc00327a; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Van Dam PS, 2013, EUR J PHARMACOL, V719, P180, DOI 10.1016/j.ejphar.2013.07.017; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002	37	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148559	10.1371/journal.pone.0148559	http://dx.doi.org/10.1371/journal.pone.0148559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848955	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000125
J	Bonaventura, P; Lamboux, A; Albarede, F; Miossec, P				Bonaventura, Paola; Lamboux, Aline; Albarede, Francis; Miossec, Pierre			A Feedback Loop between Inflammation and Zn Uptake	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ZINC; HOMEOSTASIS; CONTRIBUTES; JOINT; BONE	Objective Zinc (Zn) has major effects on the immune system and inflammation is associated with systemic Zn deficiency. The aim of this work was to investigate how inflammation modifies Zn metabolism at the cellular level. Rheumatoid arthritis (RA) synoviocytes exposed to cytokines were used as a model of chronic inflammation. Osteoarthritis (OA) synoviocytes were used as control. Methods Zn levels were measured in medium and inside cells by Induced Coupled Plasma-Mass Spectrometry (ICP-MS), in the presence of minute quantities of stable spike Zn-70 isotope and the addition or not of the pro-inflammatory cytokines interleukin-17 (IL-17) and tumor necrosis factor alpha (TNF-alpha). Gene expression of ZIP-8 importer, ZnT1 exporter and the homeostasis regulators metallothioneins (MTs) was evaluated after pre-exposure to cytokines, with or without exogenous Zn addition at increasing concentrations. IL-6 production was used as a marker of inflammation and measured by ELISA. Results Exposure to IL-17 and TNF-alpha enhanced expression of the Zn-importer ZIP-8, regardless of the concentration of Zn in the culture medium. In contrast, the expression of the Zn-exporter ZnT1 and of the MTs was primarily dependent on Zn levels. Addition of Zn also increased the production of IL-6, thus further stimulating the inflammatory response. Conclusion IL-17/TNF-mediated inflammation enhanced the intracellular Zn uptake by synoviocytes, further increasing inflammation. These observations document the existence of a feedback loop between inflammation and Zn uptake. Based on these results, a mathematical model was developed to represent the cytokine-mediated Zn homeostasis alterations.	[Bonaventura, Paola; Miossec, Pierre] Univ Lyon, Edouard Herriot Hosp, Dept Immunol & Rheumatol, Dept Immunol & Rheumatol,Immunogen & Inflammat Re, F-69437 Lyon, France; [Lamboux, Aline; Albarede, Francis] Ecole Normale Super Lyon, Geol Lab, Dept Earth Sci, F-69364 Lyon, France; [Lamboux, Aline; Albarede, Francis] CNRS Lyon, F-69364 Lyon, France	CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS)	Miossec, P (corresponding author), Univ Lyon, Edouard Herriot Hosp, Dept Immunol & Rheumatol, Dept Immunol & Rheumatol,Immunogen & Inflammat Re, F-69437 Lyon, France.	pierre.miossec@univ-lyon1.fr	Albarede, Francis/A-8871-2011	Albarede, Francis/0000-0003-1994-1428	7th Framework program of the EU, SP3-People, support for training and career development for researchers (Marie Curie), Network for Initial Training (ITN), FP7-PEOPLE-ITN, under the Marie Sklodowska-Curie grant [289903]; IHU prometteur OPERA; "Cluster 1 region Rhone-Alpes"; "Institut universitaire de France"	7th Framework program of the EU, SP3-People, support for training and career development for researchers (Marie Curie), Network for Initial Training (ITN), FP7-PEOPLE-ITN, under the Marie Sklodowska-Curie grant; IHU prometteur OPERA; "Cluster 1 region Rhone-Alpes"(Region Auvergne-Rhone-Alpes); "Institut universitaire de France"	This project and PB have received funding from the 7th Framework program of the EU, SP3-People, support for training and career development for researchers (Marie Curie), Network for Initial Training (ITN), FP7-PEOPLE-2011-ITN, under the Marie Sklodowska-Curie grant agreement No 289903. This work has been supported in part by grants from the IHU prometteur OPERA and the "Cluster 1 region Rhone-Alpes." PM is a senior member of and supported by the "Institut universitaire de France."	Afridi HI, 2012, CLIN LAB, V58, P705, DOI 10.7754/Clin.Lab.2011.110525; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bonaventura P, 2015, AUTOIMMUN REV, V14, P277, DOI 10.1016/j.autrev.2014.11.008; Chabaud M, 2001, ARTHRITIS RES, V3, P168, DOI 10.1186/ar294; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; Eljaafari A, 2012, ARTHRITIS RHEUM-US, V64, P2147, DOI 10.1002/art.34391; Flavell SJ, 2008, BRIT J PHARMACOL, V153, pS241, DOI 10.1038/sj.bjp.0707487; Gumulec J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085346; JORDANA M, 1994, EUR RESPIR J, V7, P2212, DOI 10.1183/09031936.94.07122212; Kim JH, 2014, CELL, V156, P730, DOI 10.1016/j.cell.2014.01.007; Kim MH, 2014, EUR J PHARMACOL, V738, P31, DOI 10.1016/j.ejphar.2014.05.030; Krebs NF, 2001, BIOMETALS, V14, P397, DOI 10.1023/A:1012942409274; Li S, 2015, J BIOL CHEM, V290, P2368, DOI 10.1074/jbc.M114.618454; Li YX, 2015, MEDCHEMCOMM, V6, P613, DOI 10.1039/c4md00401a; LIGNERE GC, 1984, J INT MED RES, V12, P193, DOI 10.1177/030006058401200311; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Menghini R, 2013, ATHEROSCLEROSIS, V228, P12, DOI 10.1016/j.atherosclerosis.2013.01.024; Mertens K, 2015, BR J ANAESTH; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; PRASAD AS, 1995, NUTRITION, V11, P93; Simpkins CO, 2000, CELL MOL BIOL, V46, P465; Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868; Sutherland DEK, 2011, METALLOMICS, V3, P444, DOI 10.1039/c0mt00102c; Thevenod F, 2010, BIOMETALS, V23, P857, DOI 10.1007/s10534-010-9309-1; Yoshida Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698313; Zrioual S, 2008, J IMMUNOL, V180, P655, DOI 10.4049/jimmunol.180.1.655; Zrioual S, 2009, J IMMUNOL, V182, P3112, DOI 10.4049/jimmunol.0801967	31	20	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147146	10.1371/journal.pone.0147146	http://dx.doi.org/10.1371/journal.pone.0147146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845700	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800007
J	Kahl, P; Baroni, P; Noirez, L				Kahl, Philipp; Baroni, Patrick; Noirez, Laurence			Bringing to Light Hidden Elasticity in the Liquid State Using In-Situ Pretransitional Liquid Crystal Swarms	PLOS ONE			English	Article							ISOTROPIC-PHASE; TRANSITION	The present work reveals that at the sub-millimeter length-scale, molecules in the liquid state are not dynamically free but elastically correlated. It is possible to "visualize" these hidden elastic correlations by using the birefringent properties of pretransitional swarms persistent in liquids presenting a weak first order transition. The strategy consists in observing the optical response of the isotropic phase of mesogenic fluids to a weak (low energy) mechanical excitation. We show that a synchronized optical response is observable at frequencies as low as 0.01Hz and at temperatures far away from any phase transition (up to at least 15 degrees C above the transition). The observation of a synchronized optical signal at very low frequencies points out a collective response and supports the existence of long-range elastic (solid-like) correlations existing at the sub-millimeter length-scale in agreement to weak solid-like responses already identified in various liquids including liquid water. This concept of elastically linked molecules differs deeply with the academic view of molecules moving freely in the liquid state and has profound consequences on the mechanisms governing collective effects as glass formation, gelation and transport, or synchronized processes in physiological media.	[Kahl, Philipp; Baroni, Patrick; Noirez, Laurence] CEA Saclay, Lab Leon Brillouin CEA CNRS, F-91191 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Noirez, L (corresponding author), CEA Saclay, Lab Leon Brillouin CEA CNRS, F-91191 Gif Sur Yvette, France.	laurence.noirez@cea.fr						ASTARITA G, 1974, POLYM ENG SCI, V14, P730, DOI 10.1002/pen.760141012; Bailey C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.237803; Baroni P, 2005, Patent PCT, Patent No. 0510988; Dabrowski R, 2013, CRYSTALS, V3, P443, DOI 10.3390/cryst3030443; Droulias S, 2010, LIQ CRYST, V37, P969, DOI 10.1080/02678292.2010.488819; Farrand L.D., 2008, Merck Patent GmbH, Patent No. [EP1690917 B1, 1690917]; GALLANI JL, 1994, PHYS REV LETT, V72, P2109, DOI 10.1103/PhysRevLett.72.2109; Granato AV, 2009, MAT SCI ENG A-STRUCT, V521-22, P6, DOI 10.1016/j.msea.2008.09.147; Guenza M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.025901; HESS S, 1976, Z NATURFORSCH A, V31, P1507; Humbert C, 1998, COLLOID POLYM SCI, V276, P160, DOI 10.1007/s003960050224; Ibar JP, 2013, J MACROMOLECULAR S B, V52, P1; Kahl P, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050501; Marrucci G., 1993, ADV CHEM PHYS, V86, P331; Mendil H, 2006, EUR PHYS J E, V19, P77, DOI 10.1140/epje/e2006-00011-x; Mendil H, 2005, EUROPHYS LETT, V72, P983, DOI 10.1209/epl/i2004-10552-3; Mukherjee PK, 2001, EUR PHYS J E, V4, P293, DOI 10.1007/s101890170111; Noirez L, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051701; Noirez L, 2010, J MOL STRUCT, V972, P16, DOI 10.1016/j.molstruc.2010.02.013; Noirez L, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/37/372101; OLMSTED PD, 1990, PHYS REV A, V41, P4578, DOI 10.1103/PhysRevA.41.4578; Prost J., 1993, PHYS LIQUID CRYSTALS; Pujolle-Robic C, 2001, NATURE, V409, P167, DOI 10.1038/35051537; REITER G, 1994, J CHEM PHYS, V101, P2606, DOI 10.1063/1.467633; REYS V, 1988, PHYS REV LETT, V61, P2340, DOI 10.1103/PhysRevLett.61.2340; Rzoska SJ, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/24/245105; Sadron C, 1936, J PHYS-PARIS, V7, P263, DOI 10.1051/jphysrad:0193600706026300; SCHOEN M, 1995, PHYS REV E, V52, P2587, DOI 10.1103/PhysRevE.52.2587; Volino F, 1997, ANN PHYS, V22, P18; Zvetkov V, 1944, ACTA PHYSICOCHIM URS, V19, P86	30	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147914	10.1371/journal.pone.0147914	http://dx.doi.org/10.1371/journal.pone.0147914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844881	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800021
J	Aggarwal, G; Prajapati, R; Tripathy, RK; Bajaj, P; Iyengar, ARS; Sangamwar, AT; Pande, AH				Aggarwal, Geetika; Prajapati, Rameshwar; Tripathy, Rajan K.; Bajaj, Priyanka; Iyengar, A. R. Satvik; Sangamwar, Abhay T.; Pande, Abhay H.			Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192	PLOS ONE			English	Article							LACTONASE ACTIVITY; BINDING; RESIDUES	Human paraoxonase 1 (h-PON1) is a serum enzyme that can hydrolyze a variety of substrates. The enzyme exhibits anti-inflammatory, anti-oxidative, anti-atherogenic, anti-diabetic, anti-microbial and organophosphate-hydrolyzing activities. Thus, h-PON1 is a strong candidate for the development of therapeutic intervention against a variety conditions in human. However, the crystal structure of h-PON1 is not solved and the molecular details of how the enzyme hydrolyzes different substrates are not clear yet. Understanding the catalytic mechanism(s) of h-PON1 is important in developing the enzyme for therapeutic use. Literature suggests that R/Q polymorphism at position 192 in h-PON1 dramatically modulates the substrate specificity of the enzyme. In order to understand the role of the amino acid residue at position 192 of h-PON1 in its various hydrolytic activities, site-specific mutagenesis at position 192 was done in this study. The mutant enzymes were produced using Escherichia coli expression system and their hydrolytic activities were compared against a panel of substrates. Molecular dynamics simulation studies were employed on selected recombinant h-PON1 (rh-PON1) mutants to understand the effect of amino acid substitutions at position 192 on the structural features of the active site of the enzyme. Our results suggest that, depending on the type of substrate, presence of a particular amino acid residue at position 192 differentially alters the micro-environment of the active site of the enzyme resulting in the engagement of different subsets of amino acid residues in the binding and the processing of substrates. The result advances our understanding of the catalytic mechanism of h-PON1.	[Aggarwal, Geetika; Tripathy, Rajan K.; Bajaj, Priyanka; Iyengar, A. R. Satvik; Pande, Abhay H.] Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Sect 67, Sas Nagar Mohali 160062, Punjab, India; [Prajapati, Rameshwar; Sangamwar, Abhay T.] Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat, Sect 67, Sas Nagar Mohali 160062, Punjab, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali); National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Pande, AH (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Sect 67, Sas Nagar Mohali 160062, Punjab, India.	apande@niper.ac.in	sangamwar, abhay/AAI-2200-2020; Aggarwal, Geetika/ABD-8696-2021	Aggarwal, Geetika/0000-0002-1848-5056; Iyengar, A.R. Satvik/0000-0002-7117-349X; Bajaj, Priyanka/0000-0001-7813-3709	National Institute of Pharmaceutical Education and Research, SAS Nagar [NPLC-AHP, C0412-AHP, C0312-AHP]; CSIR, New Delhi	National Institute of Pharmaceutical Education and Research, SAS Nagar; CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the National Institute of Pharmaceutical Education and Research, SAS Nagar (NPLC-AHP and C0412-AHP and C0312-AHP). PB (CSIR-SPM-SRF) and GA (CSIR-SRF) were also supported by CSIR, New Delhi in the form of CSIR Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2002, BIOCHEM BIOPH RES CO, V290, P391, DOI 10.1006/bbrc.2001.6150; Ahn JM, 2014, MOL CELL PROTEOMICS, V13, P30, DOI 10.1074/mcp.M113.028621; Bajaj P, 2015, PROTEIN EXP IN PRESS, V2015; Bajaj P, 2014, BIOCHIMIE, V22, P210; Bajaj P, 2014, APPL BIOCHEM BIOTECH, V172, P3798, DOI 10.1007/s12010-014-0806-5; Bajaj P, 2013, PROTEIN SCI, V22, P1799, DOI 10.1002/pro.2380; Bayrak A, 2011, J CHROMATOGR B, V879, P49, DOI 10.1016/j.jchromb.2010.11.006; Ben-David M, 2015, J MOL BIOL, V427, P1359, DOI 10.1016/j.jmb.2015.01.013; Ben-David M, 2013, J MOL BIOL, V425, P1028, DOI 10.1016/j.jmb.2013.01.009; Ben-David M, 2012, J MOL BIOL, V418, P181, DOI 10.1016/j.jmb.2012.02.042; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Camps J, 2007, CLIN CHIM ACTA, V386, P114, DOI 10.1016/j.cca.2007.07.016; Camps J, 2011, ANTIMICROB AGENTS CH, V55, P1325, DOI 10.1128/AAC.01502-10; Carr RL, 2015, J TOXICOL-US, V2015, DOI 10.1155/2015/470189; Costa LG, 2003, ANNU REV MED, V54, P371, DOI 10.1146/annurev.med.54.101601.152421; Duysen EG, 2011, GENE THER, V18, P250, DOI 10.1038/gt.2010.136; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; Ferretti G, 2010, OBESITY, V18, P1079, DOI 10.1038/oby.2009.338; Gaidukov Leonid, 2009, BMC Clin Pharmacol, V9, P18, DOI 10.1186/1472-6904-9-18; Gorl J, 2012, CHEMBIOCHEM, V13, P149, DOI 10.1002/cbic.201100576; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Hu X, 2009, PROTEINS, V75, P486, DOI 10.1002/prot.22264; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Khersonsky O, 2006, CHEMBIOCHEM, V7, P49, DOI 10.1002/cbic.200500334; Koren-Gluzer M, 2011, ATHEROSCLEROSIS, V219, P510, DOI 10.1016/j.atherosclerosis.2011.07.119; LADU BN, 1993, CHEM-BIOL INTERACT, V87, P25, DOI 10.1016/0009-2797(93)90022-Q; Mackness B, 2010, ADV EXP MED BIOL, V660, P143, DOI 10.1007/978-1-60761-350-3_13; Mackness MI, 1996, CURR OPIN LIPIDOL, V7, P69, DOI 10.1097/00041433-199604000-00004; Nachon F, 2013, CHEM-BIOL INTERACT, V206, P536, DOI 10.1016/j.cbi.2013.06.012; Olga K, 2005, BIOCHEMISTRY-US, V44, P6371; Otto TC, 2009, BIOCHEMISTRY-US, V48, P10416, DOI 10.1021/bi901161b; Pajeva IK, 2013, CHEMMEDCHEM, V8, P748, DOI 10.1002/cmdc.201200491; Prajapati R, 2014, BBA-BIOMEMBRANES, V1838, P2882, DOI 10.1016/j.bbamem.2014.07.018; Prajapati R, 2013, J COMPUT AID MOL DES, V27, P347, DOI 10.1007/s10822-013-9650-x; Rozenberg O, 2008, FREE RADICAL BIO MED, V44, P1951, DOI 10.1016/j.freeradbiomed.2008.02.012; Saeed SA, 2008, HEMODIAL INT, V12, P471, DOI 10.1111/j.1542-4758.2008.00311.x; Sanan TT, 2010, J PHYS ORG CHEM, V23, P357, DOI 10.1002/poc.1678; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Steven ZF, 2009, J MOL MODEL, V17, P97; Stevens RC, 2008, P NATL ACAD SCI USA, V105, P12780, DOI 10.1073/pnas.0805865105; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Valabhji J, 2001, CLIN SCI, V101, P659, DOI 10.1042/CS20010111; Valiyaveettil M, 2011, BIOCHEM PHARMACOL, V81, P800, DOI 10.1016/j.bcp.2010.12.024; Yamashita J, 2013, J IMMUNOL, V191, P949, DOI 10.4049/jimmunol.1201828; Yeung DT, 2005, FEBS J, V272, P2225, DOI 10.1111/j.1742-4658.2005.04646.x; Yeung DT, 2004, BBA-PROTEINS PROTEOM, V1702, P67, DOI 10.1016/j.bbapap.2004.08.002	46	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147999	10.1371/journal.pone.0147999	http://dx.doi.org/10.1371/journal.pone.0147999			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829396	Green Submitted, Green Published, gold			2022-12-26	WOS:000369548200051
J	Garza, MTG; Perez, DB; Rodriguez, AV; Garcia-Gutierrez, DI; Zarate, X; Cardenas, MEC; Urraca-Botello, LI; Lopez-Chuken, UJ; Trevino-Torres, AL; Cerino-Cordoba, FD; Medina-Ruiz, P; Villarreal-Chiu, JF; Morones-Ramirez, JR				Gonzalez Garza, Maria Teresa; Barboza Perez, Daniel; Vazquez Rodriguez, Augusto; Ixcoatl Garcia-Gutierrez, Domingo; Zarate, Xristo; Cantu Cardenas, Maria Elena; Ilytch Urraca-Botello, Ludwing; Javier Lopez-Chuken, Ulrico; Ludovico Trevino-Torres, Alberto; de Jesus Cerino-Cordoba, Felipe; Medina-Ruiz, Pavel; Francisco Villarreal-Chiu, Juan; Ruben Morones-Ramirez, Jose			Metal-Induced Production of a Novel Bioadsorbent Exopolysaccharide in a Native Rhodotorula mucilaginosa from the Mexican Northeastern Region	PLOS ONE			English	Article							DYE METHYLENE-BLUE; WASTE-WATER; BASIC DYE; AQUEOUS-SOLUTION; ACTIVATED CARBON; LOW-COST; REMOVAL; ADSORPTION; BIOSORPTION; IDENTIFICATION	There is a current need to develop low-cost strategies to degrade and eliminate industrially used colorants discharged into the environment. Colorants discharged into natural water streams pose various threats, including: toxicity, degradation of aesthetics and inhibiting sunlight penetration into aquatic ecosystems. Dyes and colorants usually have complex aromatic molecular structures, which make them very stable and difficult to degrade and eliminate by conventional water treatment systems. The results in this work demonstrated that heavy metal-resistant Rhodotorula mucilaginosa strain UANL-001L isolated from the northeast region of Mexico produce an exopolysaccharide (EPS), during growth, which has colorant adsorption potential. The EPS produced was purified by precipitation and dialysis and was then physically and chemically characterized by Scanning Electron Microscopy, Fourier Transform Infrared Spectroscopy, and chemical elemental analysis. Here, the ability of the purified EPS produced to adsorb methylene blue (MB), which served as a model colorant, is studied. MB adsorption by the EPS is found to follow Langmuir Adsorption Isotherm kinetics at 25 degrees C. Further, by calculating the Langmuir constant the adsorption capabilities of the EPS produced by the Rhodotorula mucilaginosa strain UANL-001L is compared to that of other adsorbents, both, microbially produced and from agroindustrial waste. The total adsorption capacity of the EPS, from the Rhodotorula mucilaginosa strain UANL-001L, was found to be two-fold greater than the best bioadsorbents reported in the literature. Finally, apart from determining which heavy metals stimulated EPS production in the strain, the optimal conditions of pH, heavy metal concentration, and rate of agitation of the growing culture for EPS production, was determined. The EPS reported here has the potential of aiding in the efficient removal of colorants both in water treatment plants and in situ in natural water streams.	[Gonzalez Garza, Maria Teresa; Barboza Perez, Daniel; Vazquez Rodriguez, Augusto; Zarate, Xristo; Cantu Cardenas, Maria Elena; Javier Lopez-Chuken, Ulrico; Ludovico Trevino-Torres, Alberto; de Jesus Cerino-Cordoba, Felipe; Francisco Villarreal-Chiu, Juan; Ruben Morones-Ramirez, Jose] Univ Autonoma Nuevo Leon, Fac Ciencias Quim, Pedro De Alba S-N, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Ixcoatl Garcia-Gutierrez, Domingo] Univ Autonoma Nuevo Leon, Fac Ingn Mecan & Elect, Pedro De Alba S-N, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Ilytch Urraca-Botello, Ludwing; Medina-Ruiz, Pavel] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Pedro De Alba S-N, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Vazquez Rodriguez, Augusto; Ruben Morones-Ramirez, Jose] Univ Autonoma Nuevo Leon, Fac Ciencias Quim, Ctr Invest Biotecnol & Nanotoxicol, Parque Invest & Innovac Tecnol, Apodaca 66629, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon	Morones-Ramirez, JR (corresponding author), Univ Autonoma Nuevo Leon, Fac Ciencias Quim, Pedro De Alba S-N, San Nicolas De Los Garza, Nuevo Leon, Mexico.; Morones-Ramirez, JR (corresponding author), Univ Autonoma Nuevo Leon, Fac Ciencias Quim, Ctr Invest Biotecnol & Nanotoxicol, Parque Invest & Innovac Tecnol, Apodaca 66629, Nuevo Leon, Mexico.	morones.ruben@gmail.com	Cantú-Cárdenas, María Elena/G-8127-2018; Garcia-Gutierrez, Domingo/GVS-9431-2022; Lopez-Chuken, Ulrico/EEX-2001-2022; Villarreal-Chiu, Juan Francisco/AAH-7054-2020; Zarate, Xristo/AAH-1463-2020	Cantú-Cárdenas, María Elena/0000-0002-8898-3077; Garcia-Gutierrez, Domingo/0000-0001-6350-2161; Villarreal-Chiu, Juan Francisco/0000-0002-0419-9294; Zarate, Xristo/0000-0002-9824-3961; Lopez-Chuken, Ulrico J/0000-0002-2100-9982; Morones-Ramirez, Jose Ruben/0000-0001-7009-686X	Paicyt from the Universidad Autonoma de Nuevo Leon; PROMEP [UANL-PTC-102848]; CONACyT [221332]	Paicyt from the Universidad Autonoma de Nuevo Leon; PROMEP; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Paicyt from the Universidad Autonoma de Nuevo Leon, PROMEP grant number UANL-PTC-102848, and CONACyT basic science grant 221332 financially supported this work.	Al-Ghouti MA, 2003, J ENVIRON MANAGE, V69, P229, DOI 10.1016/j.jenvman.2003.09.005; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Campbell CK, 1999, J CLIN MICROBIOL, V37, P821, DOI 10.1128/JCM.37.3.821-823.1999; Cheng HR, 2006, BIOTECHNOL LETT, V28, P55, DOI 10.1007/s10529-005-4688-z; Chi Z, 2007, BIORESOURCE TECHNOL, V98, P1329, DOI 10.1016/j.biortech.2006.05.001; Chu W, 2000, WATER RES, V34, P3153, DOI 10.1016/S0043-1354(00)00043-9; da Silva LJ, 2014, DESALIN WATER TREAT, V52, P7878, DOI 10.1080/19443994.2013.833871; De Philippis R, 2011, APPL MICROBIOL BIOT, V92, P697, DOI 10.1007/s00253-011-3601-z; Delgado-Vargas F, 2000, CRIT REV FOOD SCI, V40, P173, DOI 10.1080/10408690091189257; Demirbas A, 2009, J HAZARD MATER, V167, P1, DOI 10.1016/j.jhazmat.2008.12.114; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Garg VK, 2004, DYES PIGMENTS, V63, P243, DOI 10.1016/j.dyepig.2004.03.005; Hameed BH, 2008, COLLOID SURFACE A, V316, P78, DOI 10.1016/j.colsurfa.2007.08.033; Hameed BH, 2007, DYES PIGMENTS, V75, P143, DOI 10.1016/j.dyepig.2006.05.039; Hameed BH, 2009, J HAZARD MATER, V162, P344, DOI 10.1016/j.jhazmat.2008.05.045; Khan TA, 2015, APPL CLAY SCI, V107, P70, DOI 10.1016/j.clay.2015.01.005; Kiran B, 2008, BIOCHEM ENG J, V38, P47, DOI 10.1016/j.bej.2007.06.007; KRIZ J, 1994, J CHROMATOGR A, V663, P151; LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P649, DOI 10.1128/AEM.54.3.649-654.1988; Lee JW, 2006, DYES PIGMENTS, V69, P196, DOI 10.1016/j.dyepig.2005.03.008; Lei LC, 1998, WATER RES, V32, P2753, DOI 10.1016/S0043-1354(98)00025-6; McGuire G, 2000, BIOINFORMATICS, V16, P130, DOI 10.1093/bioinformatics/16.2.130; Mohan D, 2014, BIORESOURCE TECHNOL, V160, P191, DOI 10.1016/j.biortech.2014.01.120; Perez JAM, 2008, WORLD J MICROB BIOT, V24, P2699, DOI 10.1007/s11274-008-9800-9; Ngah WSW, 2011, CARBOHYD POLYM, V83, P1446, DOI 10.1016/j.carbpol.2010.11.004; Nogueira PFM, 2005, FRESHWATER BIOL, V50, P1560, DOI 10.1111/j.1365-2427.2005.01406.x; Nunes JM, 2013, ANTIMICROB AGENTS CH, V57, P382, DOI 10.1128/AAC.01647-12; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Praveen PS., 2010, INT J RES PHARM SCI, V3, P317; Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8; Rosas-Castor JM, 2014, ENVIRON TECHNOL, V35, P1077, DOI 10.1080/09593330.2013.861022; Schnider-Keel U, 2001, APPL ENVIRON MICROB, V67, P5683, DOI 10.1128/AEM.67.12.5683-5693.2001; Shah I, 2014, BIORESOURCE TECHNOL, V160, P52, DOI 10.1016/j.biortech.2014.02.047; Sharma KP, 2007, CHEMOSPHERE, V69, P48, DOI 10.1016/j.chemosphere.2007.04.086; Srinivasan A, 2010, J ENVIRON MANAGE, V91, P1915, DOI 10.1016/j.jenvman.2010.05.003; Talarposhti AM, 2001, WATER RES, V35, P425, DOI 10.1016/S0043-1354(00)00280-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsai F-C, 2013, ADSORPTION METHYLENE; Tucker S H, 1945, J CHEM EDUC, V22, P212; Verhoef R, 2005, BIOTECHNOL BIOENG, V91, P91, DOI 10.1002/bit.20494; Verma AK, 2012, J ENVIRON MANAGE, V93, P154, DOI 10.1016/j.jenvman.2011.09.012; Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zheivot VI, 2015, MICROPOR MESOPOR MAT, V202, P57, DOI 10.1016/j.micromeso.2014.09.027; Zhou WZ, 2010, SEP PURIF TECHNOL, V76, P215, DOI 10.1016/j.seppur.2010.10.011	45	13	14	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148430	10.1371/journal.pone.0148430	http://dx.doi.org/10.1371/journal.pone.0148430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828867	gold, Green Published, Green Accepted			2022-12-26	WOS:000369548200101
J	Mizuguchi, M; Sasaki, Y; Hara, T; Higuchi, M; Tanaka, Y; Funato, N; Tanaka, N; Fujii, M; Nakamura, M				Mizuguchi, Mariko; Sasaki, Yuka; Hara, Toshifumi; Higuchi, Masaya; Tanaka, Yuetsu; Funato, Noriko; Tanaka, Nobuyuki; Fujii, Masahiro; Nakamura, Masataka			Induction of Cell Death in Growing Human T-Cells and Cell Survival in Resting Cells in Response to the Human T-Cell Leukemia Virus Type 1 Tax	PLOS ONE			English	Article							NF-KAPPA-B; ONCOGENE PRODUCT TAX; HTLV-I TAX; CYCLE PROGRESSION; GENE-EXPRESSION; TRANSACTIVATOR GENE; SECRETORY PHENOTYPE; NUCLEAR-FACTOR; PROTEIN; ACTIVATION	Tax1 encoded by the human T-cell leukemia virus type 1 (HTLV-1) has been believed to dysregulate the expression of cellular genes involved in cell survival and mortality, leading to the development of adult T-cell leukemia (ATL). The function of Tax1 in ATL development however is still controversial, primarily because Tax1 induces cell cycle progression and apoptosis. To systemically understand cell growth phase-dependent induction of cell survival or cell death by Tax1, we established a single experimental system using an interleukin 2 (IL-2)-dependent human T-cell line Kit 225 that can be forced into resting phase by IL-2 deprivation. Introduction of Tax1 and HTLV-2 Tax (Tax2B) decreased mitochondrial activity alongside apoptosis in growing cells but not in resting cells. Cell cycle profile analysis indicated that Tax1 and Tax2B were likely to perturb the S phase in growing cells. Studies with Tax1 mutants and siRNA for NF-kappa B/RelA revealed that Tax1-mediated cell growth inhibition and apoptosis in growing Kit 225 cells depend on RelA. Interestingly, inactivation of the non-canonical NF-kappa B and p38 MAPK pathways relieved Tax1-mediated apoptosis, suggesting that the Tax1-NF-kappa B-p38 MAPK axis may be associated with apoptosis in growing cells. Inflammatory mediators such as CCL3 and CCL4, which are involved in oncogene-induced senescence (OIS), were induced by Tax1 and Tax2B in growing cells. In contrast, RelA silencing in resting cells reduced mitochondrial activity, indicating that NF-kappa B/RelA is also critical for Tax1-mediated cell survival. These findings suggest that Tax1-mediated cell survival and death depend on the cell growth phase. Both effects of Tax1 may be implicated in the long latency of HTLV-1 infection.	[Mizuguchi, Mariko; Sasaki, Yuka; Funato, Noriko; Nakamura, Masataka] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Tokyo, Japan; [Hara, Toshifumi; Higuchi, Masaya; Fujii, Masahiro] Niigata Univ, Div Virol, Grad Sch Med & Dent Sci, Niigata, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Dept Immunol, Grad Sch, Okinawa, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Fac Med, Okinawa, Japan; [Tanaka, Nobuyuki] Miyagi Canc Ctr, Res Inst, Div Canc Biol & Therapeut, Natori, Miyagi, Japan	Tokyo Medical & Dental University (TMDU); Niigata University; University of the Ryukyus; University of the Ryukyus; Miyagi Cancer Center	Nakamura, M (corresponding author), Tokyo Med & Dent Univ, Human Gene Sci Ctr, Tokyo, Japan.	naka.gene@tmd.ac.jp	Higuchi, Masaya/L-2111-2019; Funato, Noriko/AAY-5113-2020	Funato, Noriko/0000-0002-1320-3304	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arainga M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-275; Azimi N, 1998, P NATL ACAD SCI USA, V95, P2452, DOI 10.1073/pnas.95.5.2452; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chen XL, 1997, J GEN VIROL, V78, P3277, DOI 10.1099/0022-1317-78-12-3277; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Chlichlia K, 1997, ONCOGENE, V14, P2265, DOI 10.1038/sj.onc.1201070; CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9; De La Fuente C, 2000, J VIROL, V74, P7270, DOI 10.1128/JVI.74.16.7270-7283.2000; de la Fuente C, 2003, MOL CELL BIOCHEM, V245, P99, DOI 10.1023/A:1022866027585; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; GESSAIN A, 1985, LANCET, V2, P407; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Hara T, 2008, CANCER SCI, V99, P1155, DOI 10.1111/j.1349-7006.2008.00798.x; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; HIRAI H, 1992, ONCOGENE, V7, P1737; Ho YK, 2012, J VIROL, V86, P9474, DOI 10.1128/JVI.00158-12; HORI T, 1987, BLOOD, V70, P1069; Iwanaga R, 2008, ONCOGENE, V27, P5635, DOI 10.1038/onc.2008.174; Iwanaga R, 2001, ONCOGENE, V20, P2055, DOI 10.1038/sj.onc.1204304; JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; KANNAGI M, 1991, INT IMMUNOL, V3, P761, DOI 10.1093/intimm/3.8.761; KAPLAN J, 1976, AM J HEMATOL, V1, P219, DOI 10.1002/ajh.2830010206; Kawakami A, 1999, BLOOD, V94, P3847, DOI 10.1182/blood.V94.11.3847.423a24_3847_3854; Kawakami H, 2005, INT J CANCER, V115, P967, DOI 10.1002/ijc.20954; Kawata S, 2003, J VIROL, V77, P7291, DOI 10.1128/JVI.77.13.7291-7299.2003; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuo YL, 2006, EMBO J, V25, P1741, DOI 10.1038/sj.emboj.7601054; LEE B, 1989, TOHOKU J EXP MED, V157, P1, DOI 10.1620/tjem.157.1; Lewis MJ, 2000, VIROLOGY, V271, P142, DOI 10.1006/viro.2000.0284; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liang MH, 2002, J VIROL, V76, P4022, DOI 10.1128/JVI.76.8.4022-4033.2002; Macaire H, 2012, J BIOL CHEM, V287, P21357, DOI 10.1074/jbc.M112.340992; Mahieux R, 2000, J VIROL, V74, P6866, DOI 10.1128/JVI.74.15.6866-6874.2000; Mariner JM, 2001, J IMMUNOL, V166, P2602, DOI 10.4049/jimmunol.166.4.2602; Matsumoto K, 1997, J VIROL, V71, P4445, DOI 10.1128/JVI.71.6.4445-4451.1997; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; Mizuguchi M, 2009, J BIOL CHEM, V284, P25501, DOI 10.1074/jbc.M109.010959; Nevins JR, 1997, J CELL PHYSIOL, V173, P233, DOI 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Niinuma A, 2005, J VIROL, V79, P11925, DOI 10.1128/JVI.79.18.11925-11934.2005; Ohtani K, 2000, J BIOL CHEM, V275, P11154, DOI 10.1074/jbc.275.15.11154; OHTANI K, 1987, EMBO J, V6, P389, DOI 10.1002/j.1460-2075.1987.tb04767.x; OHTANI K, 1989, NUCLEIC ACIDS RES, V17, P1589, DOI 10.1093/nar/17.4.1589; OSAME M, 1986, LANCET, V1, P1031; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rivera-Walsh I, 2001, J BIOL CHEM, V276, P40385, DOI 10.1074/jbc.C100501200; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Schmitt I, 1998, J VIROL, V72, P633, DOI 10.1128/JVI.72.1.633-640.1998; Shoji T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-83; Sieburg M, 2004, J VIROL, V78, P10399, DOI 10.1128/JVI.78.19.10399-10409.2004; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; TANAKA Y, 1991, INT J CANCER, V48, P623, DOI 10.1002/ijc.2910480423; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsukahara T, 1999, J VIROL, V73, P7981, DOI 10.1128/JVI.73.10.7981-7987.1999; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Waldele K, 2006, BLOOD, V107, P4491, DOI 10.1182/blood-2005-08-3138; Wang JX, 2009, EMBO REP, V10, P1272, DOI 10.1038/embor.2009.197; Wu XW, 2013, J BIOL CHEM, V288, P36094, DOI 10.1074/jbc.M113.485029; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zhi HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002025; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	72	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148217	10.1371/journal.pone.0148217	http://dx.doi.org/10.1371/journal.pone.0148217			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829041	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200086
J	Pellkofer, S; van der Heijden, MGA; Schmid, B; Wagg, C				Pellkofer, Sarah; van der Heijden, Marcel G. A.; Schmid, Bernhard; Wagg, Cameron			Soil Communities Promote Temporal Stability and Species Asynchrony in Experimental Grassland Communities	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; ECOSYSTEM STABILITY; PLANT DIVERSITY; STATISTICAL INEVITABILITY; BIODIVERSITY LOSS; PRODUCTIVITY; VARIABILITY; POPULATION; MECHANISMS; MICROBES	Background Over the past two decades many studies have demonstrated that plant species diversity promotes primary productivity and stability in grassland ecosystems. Additionally, soil community characteristics have also been shown to influence the productivity and composition of plant communities, yet little is known about whether soil communities also play a role in stabilizing the productivity of an ecosystem. Methodology/Principal Findings Here we use microcosms to assess the effects of the presence of soil communities on plant community dynamics and stability over a one-year time span. Microcosms were filled with sterilized soil and inoculated with either unaltered field soil or field soil sterilized to eliminate the naturally occurring soil biota. Eliminating the naturally occurring soil biota not only resulted in lower plant productivity, and reduced plant species diversity, and evenness, but also destabilized the net aboveground productivity of the plant communities over time, which was largely driven by changes in abundance of the dominant grass Lolium perenne. In contrast, the grass and legumes contributedmore to net aboveground productivity of the plant communities in microcosms where soil biota had been inoculated. Additionally, the forbs exhibited compensatory dynamics with grasses and legumes, thus lowering temporal variation in productivity in microcosms that received the unaltered soil inocula. Overall, asynchrony among plant species was higher inmicrocosms where an unaltered soil community had been inoculated, which lead to higher temporal stability in community productivity. Conclusions/Significance Our results suggest that soil communities increase plant species asynchrony and stabilize plant community productivity by equalizing the performance among competing plant species through potential antagonistic and facilitative effects on individual plant species.	[Pellkofer, Sarah; van der Heijden, Marcel G. A.; Schmid, Bernhard; Wagg, Cameron] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Pellkofer, Sarah; van der Heijden, Marcel G. A.] Inst Sustainabil Sci, Agroscope, Plant Soil Interact, Zurich, Switzerland; [van der Heijden, Marcel G. A.] Univ Utrecht, Fac Sci, Inst Environm Biol, Plant Microbe Interact, Utrecht, Netherlands	University of Zurich; Swiss Federal Research Station Agroscope; Utrecht University	Wagg, C (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland.	cameron.wagg@ieu.uzh.ch	Wagg, Cameron/O-4318-2019; Schmid, Bernhard/C-8625-2009; van der Heijden, Marcel/AAY-1593-2021; van der Heijden, Marcel G.A./H-5243-2011	Wagg, Cameron/0000-0002-9738-6901; Schmid, Bernhard/0000-0002-8430-3214; van der Heijden, Marcel/0000-0001-7040-1924	Swiss National Science Foundation [PDFMP3_137136, GAO: 6570295]; Jena Experiment (German Science Foundation (DFG)) [FOR456/1451]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Jena Experiment (German Science Foundation (DFG))(German Research Foundation (DFG))	Sarah Pellkofer was supported by the Swiss National Science Foundation grant, Project number: PDFMP3_137136, Internal Number GAO: 6570295 awarded to Marcel van der Heijden and Bernhard Schmid. Cameron Wagg was supported by the Jena Experiment (German Science Foundation (DFG) grant FOR456/1451).	Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carter DO, 2007, PEDOBIOLOGIA, V51, P295, DOI 10.1016/j.pedobi.2007.05.002; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chesson P., 2003, MECH MAINTENANCE SPE; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; de Mazancourt C, 2013, ECOL LETT, V16, P617, DOI 10.1111/ele.12088; De Vries FT, 2015, J ECOL, V103, P629, DOI 10.1111/1365-2745.12383; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Eisenhauer N, 2013, P NATL ACAD SCI USA, V110, P6889, DOI 10.1073/pnas.1217382110; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; FRANCIS R, 1994, PLANT SOIL, V159, P11, DOI 10.1007/BF00000091; Gross K, 2014, AM NAT, V183, P1, DOI 10.1086/673915; HARTNETT DC, 1993, J ECOL, V81, P787, DOI 10.2307/2261676; Hautier Y, 2015, SCIENCE, V348, P336, DOI 10.1126/science.aaa1788; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hendriks M, 2013, J ECOL, V101, P287, DOI 10.1111/1365-2745.12032; HETRICK BAD, 1994, ENVIRON POLLUT, V86, P171, DOI 10.1016/0269-7491(94)90188-0; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Isbell FI, 2009, ECOL LETT, V12, P443, DOI 10.1111/j.1461-0248.2009.01299.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Lau JA, 2011, NEW PHYTOL, V192, P215, DOI 10.1111/j.1469-8137.2011.03790.x; Lauber K., 2018, FLORA HELVETICA; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; Loreau M, 2013, ECOL LETT, V16, P106, DOI 10.1111/ele.12073; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; Luescher A., 2008, BIODIVERSITY-OTTAWA, V9, P29; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; Moora M, 2014, FEMS MICROBIOL ECOL, V90, P609, DOI 10.1111/1574-6941.12420; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Nyfeler D., 2008, Biodiversity and animal feed: future challenges for grassland production. Proceedings of the 22nd General Meeting of the European Grassland Federation, Uppsala, Sweden, 9-12 June 2008, P197; Polley HW, 2013, OIKOS, V122, P1275, DOI 10.1111/j.1600-0706.2013.00338.x; Poorter H, 2012, FUNCT PLANT BIOL, V39, P839, DOI 10.1071/FP12049; Postma-Blaauw MB, 2010, ECOLOGY, V91, P460, DOI 10.1890/09-0666.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roscher C, 2011, J ECOL, V99, P1460, DOI 10.1111/j.1365-2745.2011.01875.x; Scheublin TR, 2007, J ECOL, V95, P631, DOI 10.1111/j.1365-2745.2007.01244.x; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Thibaut LM, 2013, ECOL LETT, V16, P140, DOI 10.1111/ele.12019; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; TIWARI SC, 1988, SOIL BIOL BIOCHEM, V20, P583, DOI 10.1016/0038-0717(88)90079-X; Tsiafouli MA, 2015, GLOBAL CHANGE BIOL, V21, P973, DOI 10.1111/gcb.12752; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; VanderPutten WH, 1997, ECOLOGY, V78, P1785, DOI 10.1890/0012-9658(1997)078[1785:HSBPMA]2.0.CO;2; Verbruggen E, 2010, NEW PHYTOL, V186, P968, DOI 10.1111/j.1469-8137.2010.03230.x; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wagg C, 2011, ECOL LETT, V14, P1001, DOI 10.1111/j.1461-0248.2011.01666.x; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Yang GW, 2014, J ECOL, V102, P1072, DOI 10.1111/1365-2745.12249; ZOBEL M, 1995, FOLIA GEOBOT PHYTOTX, V30, P223, DOI 10.1007/BF02812100	65	14	15	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148015	10.1371/journal.pone.0148015	http://dx.doi.org/10.1371/journal.pone.0148015			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829481	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000369548200052
J	Doran, CM; Ling, R; Byrnes, J; Crane, M; Shakeshaft, AP; Searles, A; Perez, D				Doran, Christopher M.; Ling, Rod; Byrnes, Joshua; Crane, Melanie; Shakeshaft, Anthony P.; Searles, Andrew; Perez, Donna			Benefit Cost Analysis of Three Skin Cancer Public Education Mass-Media Campaigns Implemented in New South Wales, Australia	PLOS ONE			English	Article							PREVENTION	Public education mass media campaigns are an important intervention for influencing behaviour modifications. However, evidence on the effectiveness of such campaigns to encourage the population to reduce sun exposure is limited. This study investigates the benefits and costs of three skin cancer campaigns implemented in New South Wales from 2006-2013. This analysis uses Australian dollars (AUD) and 2010-11 as the currency and base year, respectively. Historical data on skin cancer were used to project skin cancer rates for the period 2006-2020. The expected number of skin cancer cases is derived by combining skin cancer rates, sunburn rates and relative risk of skin cancers due to sun exposure. Counterfactual estimates are based on sunburn exposure in the absence of the campaigns. Monetary values are attached to direct (treatment) and indirect (productivity) costs saved due to fewer skin cancer cases. Monetary benefits are compared with the cost of implementing the campaigns and are presented in the form of a benefit-cost ratio. Relative to the counterfactual (i.e., no campaigns) there are an estimated 13,174 fewer skin cancers and 112 averted deaths over the period 2006-2013. The net present value of these benefits is $60.17 million and the campaign cost is $15.63 million. The benefit cost ratio is 3.85, suggesting that for every $1 invested a return of $3.85 is achieved. Skin cancer public education mass media campaigns are a good investment given the likely extent to which they reduce the morbidity, mortality and economic burden of skin cancer.	[Doran, Christopher M.] Cent Queensland Univ, Sch Human Hlth & Social Sci, Brisbane, Qld, Australia; [Doran, Christopher M.; Ling, Rod; Searles, Andrew] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Byrnes, Joshua] Griffith Univ, Ctr Appl Hlth Econ, Brisbane, Qld 4111, Australia; [Crane, Melanie; Perez, Donna] Canc Inst New South Wales, Sydney, NSW, Australia; [Crane, Melanie] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Shakeshaft, Anthony P.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia	Central Queensland University; Hunter Medical Research Institute; University of Newcastle; Griffith University; University of Sydney; University of New South Wales Sydney	Doran, CM (corresponding author), Cent Queensland Univ, Sch Human Hlth & Social Sci, Brisbane, Qld, Australia.; Doran, CM (corresponding author), Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia.	c.doran@cqu.edu.au	Byrnes, Josh/AAA-4387-2021; Shakeshaft, Anthony/U-4637-2017	Shakeshaft, Anthony/0000-0002-5472-0930; Searles, Andrew/0000-0002-9452-9735; Byrnes, Joshua/0000-0001-6562-711X; Crane, Melanie/0000-0002-3058-2211; ling, rod/0000-0002-6862-6363	CINSW [C12/0042]	CINSW	The research team would like to acknowledge the support and funding received from CINSW to conduct the study, Grant number C12/0042. The funder enabled access to appropriate data, assisted with the ethics application and provided comment on the final manuscript.	American Cancer Society, CANC FACTS FIG 2013; [Anonymous], 2014, WORLD CANC REP 2014; Armstrong BK, 2004, CANC PREV CANC CAUSE, V3, P89; Australian Bureau of Statistics, 2013, EST RES POP AG SEX; Australian Institute of Health and Welfare, 2012, AUSTR HLTH 2012; Australian Institute of Health and Welfare & Australasian Association of Cancer Registries, 2012, CANC AUSTR OV 2012; Cancer Council Australia, 2012, SKIN CANC FACTS FIG; Cancer Institute New South Wales, 2013, NSW CENTR CANC REG D; Dobbinson SJ, 2008, AM J PREV MED, V34, P94, DOI 10.1016/j.amepre.2007.09.024; Doran CM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2267-3; Ferlay J, 2010, GLOBOCAN 2008 CANC I; Gordon LG, 2009, J INVEST DERMATOL, V129, P2766, DOI 10.1038/jid.2009.141; Hirst NG, 2012, VALUE HEALTH, V15, P261, DOI 10.1016/j.jval.2011.10.009; Kyle JW, 2008, PEDIATRICS, V121, pE1074, DOI 10.1542/peds.2007-1400; National Cancer Control Initiative Skin Cancer Working Group, 2003, 2002 NAT NONM SKIN C; Pollay RW, 1996, J MARKETING, V60, P1, DOI 10.2307/1251927; Reserve Bank of Australia, 2014, CASH RAT TARG; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Shih STF, 2009, PREV MED, V49, P449, DOI 10.1016/j.ypmed.2009.09.008; Tracey E, 2008, CANC NSW INCIDENCE M; Veerman L., 2010, ASSESSING COST EFFEC	21	34	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147665	10.1371/journal.pone.0147665	http://dx.doi.org/10.1371/journal.pone.0147665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824695	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600046
J	Gan, Q; Dai, J; Zhou, HX; Wollmuth, LP				Gan, Quan; Dai, Jian; Zhou, Huan-Xiang; Wollmuth, Lonnie P.			The Transmembrane Domain Mediates Tetramerization of -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); ion channel; ionotropic glutamate receptor; protein assembly; synapse; amino-terminal domain; ligand-binding domain; native PAGE	LIGAND-BINDING DOMAIN; IONOTROPIC GLUTAMATE-RECEPTOR; RETICULUM QUALITY-CONTROL; N-TERMINAL DOMAIN; ENDOPLASMIC-RETICULUM; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ION CHANNELS; DESENSITIZATION; ACTIVATION	AMPA receptors (AMPARs) mediate fast excitatory neurotransmission in the central nervous system. Functional AMPARs are tetrameric complexes with a highly modular structure, consisting of four evolutionarily distinct structural domains: an amino-terminal domain (ATD), a ligand-binding domain (LBD), a channel-forming transmembrane domain (TMD), and a carboxyl-terminal domain (CTD). Here we show that the isolated TMD of the GluA1 AMPAR is fully capable of tetramerization. Additionally, removal of the extracellular domains from the receptor did not affect membrane topology or surface delivery. Furthermore, whereas the ATD and CTD contribute positively to tetramerization, the LBD presents a barrier to the process by reducing the stability of the receptor complex. These experiments pinpoint the TMD as the tetramerization domain for AMPARs, with other domains playing modulatory roles. They also raise intriguing questions about the evolution of iGluRs as well as the mechanisms regulating the biogenesis of AMPAR complexes.	[Gan, Quan; Wollmuth, Lonnie P.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Gan, Quan] SUNY Stony Brook, Grad Program Neurosci, Stony Brook, NY 11794 USA; [Wollmuth, Lonnie P.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Wollmuth, Lonnie P.] SUNY Stony Brook, Ctr Nervous Syst Disorders, Stony Brook, NY 11794 USA; [Dai, Jian; Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Dai, Jian; Zhou, Huan-Xiang] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Wollmuth, LP (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Ctr Nervous Syst Disorders, Stony Brook, NY 11794 USA.; Wollmuth, LP (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Nervous Syst Disorders, Stony Brook, NY 11794 USA.	lonnie.wollmuth@stonybrook.edu	Gan, Quan/P-1902-2015; zhou, huan/GYJ-4398-2022; Zhou, Huan-Xiang/M-5170-2016	Gan, Quan/0000-0003-4234-7785; Zhou, Huan-Xiang/0000-0001-9020-0302	American Heart Association; National Institutes of Health [NS088479]; NINDS; NIGMS [GM0581879]; Thomas Hartman Center for Parkinson's Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088479] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Thomas Hartman Center for Parkinson's Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an American Heart Association Predoctoral Fellowship (to Q. G.), National Institutes of Health RO1 Grants NS088479 (to L. P. W.) from the NINDS and GM0581879 (to H. Y. Z.) from the NIGMS, and a grant from the Thomas Hartman Center for Parkinson's Research (to L. P. W.). The authors declare no conflict of interest.	Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Dai J, 2013, BIOPHYS J, V104, P2170, DOI 10.1016/j.bpj.2013.04.013; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1362; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Gan Q, 2015, J PHYSIOL-LONDON, V593, P39, DOI 10.1113/jphysiol.2014.273755; Gonzalez J, 2010, P NATL ACAD SCI USA, V107, P9891, DOI 10.1073/pnas.0911854107; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Haering SC, 2014, MEMBRANES, V4, P469, DOI 10.3390/membranes4030469; Herring BE, 2013, NEURON, V77, P1083, DOI 10.1016/j.neuron.2013.01.017; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isacoff EY, 2013, NEURON, V80, P658, DOI 10.1016/j.neuron.2013.10.040; Janovjak H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1231; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; Kazi R, 2013, J NEUROSCI, V33, P12052, DOI 10.1523/JNEUROSCI.5780-12.2013; Kim KS, 2010, J NEUROSCI, V30, P1064, DOI 10.1523/JNEUROSCI.3909-09.2010; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2011, CURR OPIN NEUROBIOL, V21, P283, DOI 10.1016/j.conb.2011.02.001; MEEKER RB, 1989, NEUROSCIENCE, V33, P157, DOI 10.1016/0306-4522(89)90318-7; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Molina ML, 2004, BIOCHEMISTRY-US, V43, P14924, DOI 10.1021/bi048889+; Ojemalm K, 2013, J MOL BIOL, V425, P2813, DOI 10.1016/j.jmb.2013.04.025; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Penn AC, 2012, NEURON, V76, P503, DOI 10.1016/j.neuron.2012.08.010; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Salussolia CL, 2016, NEUROMETHODS, V106, P3, DOI 10.1007/978-1-4939-2812-5_1; Salussolia CL, 2013, J NEUROSCI, V33, P9840, DOI 10.1523/JNEUROSCI.2626-12.2013; Salussolia CL, 2011, J BIOL CHEM, V286, P40205, DOI 10.1074/jbc.M111.268839; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sukumaran M, 2012, ADV EXP MED BIOL, V970, P241, DOI 10.1007/978-3-7091-0932-8_11; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tulumello DV, 2009, BIOCHEMISTRY-US, V48, P12096, DOI 10.1021/bi9013819; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004	55	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6595	6606		10.1074/jbc.M115.686246	http://dx.doi.org/10.1074/jbc.M115.686246			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26839312	hybrid, Green Published			2022-12-26	WOS:000372894200044
J	Higuchi, T; Nagami, T; Nakata, H; Watanabe, M; Isaka, T; Kanosue, K				Higuchi, Takatoshi; Nagami, Tomoyuki; Nakata, Hiroki; Watanabe, Masakazu; Isaka, Tadao; Kanosue, Kazuyuki			Contribution of Visual Information about Ball Trajectory to Baseball Hitting Accuracy	PLOS ONE			English	Article							TARGET POSITION; MOVEMENTS; PLAYERS; SPIN; BAT; TRACKING; BATTERS	The contribution of visual information about a pitched ball to the accuracy of baseball-bat contact may vary depending on the part of trajectory seen. The purpose of the present study was to examine the relationship between hitting accuracy and the segment of the trajectory of the flying ball that can be seen by the batter. Ten college baseball field players participated in the study. The systematic error and standardized variability of ball-bat contact on the bat coordinate system and pitcher-to-catcher direction when hitting a ball launched from a pitching machine were measured with or without visual occlusion and analyzed using analysis of variance. The visual occlusion timing included occlusion from 150 milliseconds (ms) after the ball release (R+150), occlusion from 150 ms before the expected arrival of the launched ball at the home plate (A-150), and a condition with no occlusion (NO). Twelve trials in each condition were performed using two ball speeds (31.9 m.s(-1) and 40.3 m.s(-1)). Visual occlusion did not affect the mean location of ball-bat contact in the bat's long axis, short axis, and pitcher-to-catcher directions. Although the magnitude of standardized variability was significantly smaller in the bat's short axis direction than in the bat's long axis and pitcher-to-catcher directions (p < 0.001), additional visible time from the R+150 condition to the A-150 and NO conditions resulted in a further decrease in standardized variability only in the bat's short axis direction (p < 0.05). The results suggested that there is directional specificity in the magnitude of standardized variability with different visible time. The present study also confirmed the limitation to visual information is the later part of the ball trajectory for improving hitting accuracy, which is likely due to visuo-motor delay.	[Higuchi, Takatoshi; Nagami, Tomoyuki; Kanosue, Kazuyuki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Higuchi, Takatoshi] Ritsumeikan Univ, Res Org Sci & Engn, Kusatsu, Japan; [Nakata, Hiroki] Nara Womens Univ, Fac Human Life & Environm, Nara 630, Japan; [Watanabe, Masakazu] Fukuoka Univ, Fac Sports Sci, Fukuoka 81401, Japan; [Isaka, Tadao] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Japan	Waseda University; Ritsumeikan University; Nara Womens University; Fukuoka University; Ritsumeikan University	Higuchi, T (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.; Higuchi, T (corresponding author), Ritsumeikan Univ, Res Org Sci & Engn, Kusatsu, Japan.	t-higuchi@fuji.waseda.jp			Japan Society for the Promotion of Science [0026969]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by Japan Society for the Promotion of Science under Grant-in-Aid for JSPS Fellows (grant number: 0026969) (URL: https://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair R. K., 2002, PHYS BASEBALL, P121; Alaways LW, 2001, J SPORT SCI, V19, P349, DOI 10.1080/02640410152006126; Bahill A. T., 2008, APPL BIOMEDICAL ENG, P445; BAHILL AT, 1984, AM SCI, V72, P249; Bahill AT, 1979, AM SCI, V240, P249, DOI [10.1038/scientificamerican0179-108, DOI 10.1038/SCIENTIFICAMERICAN0179-108]; Bosco G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049381; Brenner E, 1997, J MOTOR BEHAV, V29, P297, DOI 10.1080/00222899709600017; Brenner E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00342; Cross R, 1998, AM J PHYS, V66, P772, DOI 10.1119/1.19030; Cross R, 2011, PHYSICS OF BASEBALL & SOFTBALL, P235, DOI 10.1007/978-1-4419-8113-4_14; Day BL, 2000, EXP BRAIN RES, V130, P159, DOI 10.1007/s002219900218; DELUCIA PR, 1985, PERCEPT MOTOR SKILL, V61, P143, DOI 10.2466/pms.1985.61.1.143; DeRenne C, 2007, SCI APPROACH HITTING, P1; Engel KC, 2000, J NEUROPHYSIOL, V83, P3483, DOI 10.1152/jn.2000.83.6.3483; Fadde PJ, 2006, TECHNOLOGY INSTRUCT, V4, P265; Fogt NF, 2014, OPTOMETRY VISION SCI, V91, P200, DOI 10.1097/OPX.0000000000000148; Gray R, 2002, J EXP PSYCHOL HUMAN, V28, P1131, DOI 10.1037//0096-1523.28.5.1131; Gray R, 2013, J EXP PSYCHOL HUMAN, V39, P1124, DOI 10.1037/a0030729; Gray R, 2009, J EXP PSYCHOL-APPL, V15, P91, DOI 10.1037/a0015591; Higuchi T, 2013, PERCEPT MOTOR SKILL, V116, P627, DOI 10.2466/30.23.25.PMS.116.2.627-639; Higuchi T, 2013, J APPL BIOMECH, V29, P279, DOI 10.1123/jab.29.3.279; Jinji T, 2006, SPORT BIOMECH, V5, P197, DOI 10.1080/14763140608522874; MCLEOD P, 1987, PERCEPTION, V16, P49, DOI 10.1068/p160049; Muller S, 2006, J SCI MED SPORT, V9, P446, DOI 10.1016/j.jsams.2006.03.029; Nagami T, 2011, MED SCI SPORT EXER, V43, P2321, DOI 10.1249/MSS.0b013e318220e728; Nathan AM, 2000, AM J PHYS, V68, P979, DOI 10.1119/1.1286119; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; Radlo SJ, 2001, RES Q EXERCISE SPORT, V72, P22, DOI 10.1080/02701367.2001.10608928; Renshaw I, 2000, J SPORT SCI, V18, P951, DOI 10.1080/026404100446757; SHAFFER B, 1993, CLIN ORTHOP RELAT R, P285; Szymanski DJ, 2009, J STRENGTH COND RES, V23, P1338, DOI 10.1519/JSC.0b013e318194e09c; Uchida Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031530; WELCH CM, 1995, J ORTHOP SPORT PHYS, V22, P193, DOI 10.2519/jospt.1995.22.5.193	33	21	21	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148498	10.1371/journal.pone.0148498	http://dx.doi.org/10.1371/journal.pone.0148498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26848742	Green Submitted, Green Published, gold			2022-12-26	WOS:000369554000111
J	Stein, C; Notzold, RR; Riedl, S; Bouchard, C; Bauer, UM				Stein, Claudia; Noetzold, Rene Reiner; Riedl, Stefanie; Bouchard, Caroline; Bauer, Uta-Maria			The Arginine Methyltransferase PRMT6 Cooperates with Polycomb Proteins in Regulating HOXA Gene Expression	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HISTONE H3; RETINOIC ACID; HUMAN GENOME; TRANSCRIPTIONAL REPRESSION; DEVELOPMENTAL REGULATORS; TUMOR-SUPPRESSOR; TARGET GENES; METHYLATION; CHROMATIN	Protein arginine methyltransferase 6 (PRMT6) catalyses asymmetric dimethylation of histone H3 at arginine 2 (H3R2me2a), which has been shown to impede the deposition of histone H3 lysine 4 trimethylation (H3K4me3) by blocking the binding and activity of the MLL1 complex. Importantly, the genomic occurrence of H3R2me2a has been found to coincide with histone H3 lysine 27 trimethylation (H3K27me3), a repressive histone mark generated by the Polycomb repressive complex 2 (PRC2). Therefore, we investigate here a putative crosstalk between PRMT6-and PRC-mediated repression in a cellular model of neuronal differentiation. We show that PRMT6 and subunits of PRC2 as well as PRC1 are bound to the same regulatory regions of rostral HOXA genes and that they control the differentiation-associated activation of these genes. Furthermore, we find that PRMT6 interacts with subunits of PRC1 and PRC2 and that depletion of PRMT6 results in diminished PRC1/PRC2 and H3K27me3 occupancy and in increased H3K4me3 levels at these target genes. Taken together, our data uncover a novel, additional mechanism of how PRMT6 contributes to gene repression by cooperating with Polycomb proteins.	[Stein, Claudia; Noetzold, Rene Reiner; Riedl, Stefanie; Bouchard, Caroline; Bauer, Uta-Maria] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany	Philipps University Marburg	Bauer, UM (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany.	bauer@imt.uni-marburg.de			German Research Foundation/ Deutsche Forschungsgemeinschaft (DFG) [TRR81, BA2292/1-3]	German Research Foundation/ Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation/ Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de), grant no. TRR81 (project 3), BA2292/1-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Casadio F, 2013, P NATL ACAD SCI USA, V110, P14894, DOI 10.1073/pnas.1312925110; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gayatri S, 2014, BBA-GENE REGUL MECH, V1839, P702, DOI 10.1016/j.bbagrm.2014.02.015; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Herglotz J, 2013, ONCOGENE, V32, P2565, DOI 10.1038/onc.2012.274; Houldsworth J, 2002, CELL GROWTH DIFFER, V13, P257; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Kleinschmidt MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041446; Kuvardina ON, 2015, BLOOD, V125, P3570, DOI 10.1182/blood-2014-11-610519; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee YH, 2012, STEM CELLS DEV, V21, P2613, DOI 10.1089/scd.2011.0330; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Michaud-Levesque J, 2009, J BIOL CHEM, V284, P21338, DOI 10.1074/jbc.M109.005322; Miranda TB, 2005, BIOCHEM BIOPH RES CO, V336, P831, DOI 10.1016/j.bbrc.2005.08.179; Miyagishima H, 2003, HISTOCHEM CELL BIOL, V120, P111, DOI 10.1007/s00418-003-0551-2; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Neault M, 2012, NUCLEIC ACIDS RES, V40, P9513, DOI 10.1093/nar/gks764; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Phalke S, 2012, NUCLEIC ACIDS RES, V40, P9534, DOI 10.1093/nar/gks858; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Scaramuzzino C, 2015, NEURON, V85, P88, DOI 10.1016/j.neuron.2014.12.031; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Sgarra R, 2006, J BIOL CHEM, V281, P3764, DOI 10.1074/jbc.M510231200; Singhroy DN, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-73; Stein C, 2012, NUCLEIC ACIDS RES, V40, P9522, DOI 10.1093/nar/gks767; Suzuki M, 2002, DEVELOPMENT, V129, P4171; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Waldmann T, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-11; Xu M, 2014, MOL CELL BIOL, V34, P3867, DOI 10.1128/MCB.00567-14	54	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148892	10.1371/journal.pone.0148892	http://dx.doi.org/10.1371/journal.pone.0148892			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848759	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000183
J	Jurado-Parras, MT; Delgado-Garcia, JM; Sanchez-Campusano, R; Gassmann, M; Bettler, B; Gruart, A				Teresa Jurado-Parras, M.; Delgado-Garcia, Jose M.; Sanchez-Campusano, Raudel; Gassmann, Martin; Bettler, Bernhard; Gruart, Agnes			Presynaptic GABA(B) Receptors Regulate Hippocampal Synapses during Associative Learning in Behaving Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SUBUNITS GABA(B1A/B); SYNAPTIC PLASTICITY; CA3-CA1 SYNAPSE; ACQUISITION; CHANNELS; ROLES; LTP	GABA(B) receptors are the G-protein-coupled receptors for GABA, the main inhibitory neurotransmitter in the central nervous system. Pharmacological activation of GABAB receptors regulates neurotransmission and neuronal excitability at pre- and postsynaptic sites. Electrophysiological activation of GABA(B) receptors in brain slices generally requires strong stimulus intensities. This raises the question as to whether behavioral stimuli are strong enough to activate GABA(B) receptors. Here we show that GABA(B1a)(-/-) mice, which constitutively lack presynaptic GABA(B) receptors at glutamatergic synapses, are impaired in their ability to acquire an operant learning task. In vivo recordings during the operant conditioning reveal a deficit in learning-dependent increases in synaptic strength at CA3-CA1 synapses. Moreover, GABA(B1a)(-/-) mice fail to synchronize neuronal activity in the CA1 area during the acquisition process. Our results support that activation of presynaptic hippocampal GABA(B) receptors is important for acquisition of a learning task and for learning-associated synaptic changes and network dynamics.	[Teresa Jurado-Parras, M.; Delgado-Garcia, Jose M.; Sanchez-Campusano, Raudel; Gruart, Agnes] Pablo de Olavide Univ, Div Neurosci, Seville 41013, Spain; [Gassmann, Martin; Bettler, Bernhard] Univ Basel, Dept Biomed, CH-4056 Basel, Switzerland	Universidad Pablo de Olavide; University of Basel	Gruart, A (corresponding author), Pablo de Olavide Univ, Div Neurosci, Seville 41013, Spain.; Bettler, B (corresponding author), Univ Basel, Dept Biomed, CH-4056 Basel, Switzerland.	bernhard.bettler@unibas.ch; agrumas@upo.es	bettler, bernhard/AAO-8018-2020; Sánchez-Campusano, Raudel/K-9254-2014; Delgado-Garcia, Jose M./V-1567-2019	Sánchez-Campusano, Raudel/0000-0003-3132-2769; Bettler, Bernhard/0000-0003-0842-8207	Spanish Ministry of Economy and Competitiveness [BFU2014-56692-R]; Swiss National Science Foundation [3100A0-117816]; European Community's Seventh Framework Program (DEVANX) [201714]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community's Seventh Framework Program (DEVANX)	This study was supported by grants from the Spanish Ministry of Economy and Competitiveness (BFU2014-56692-R) to AG and JMD-G, and from the Swiss National Science Foundation (3100A0-117816) to BB, and a grant from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement No 201714 (DEVANX) to AG, JMD-G, and BB.	Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; Craig MT, 2013, J PHYSIOL-LONDON, V591, P835, DOI 10.1113/jphysiol.2012.248088; Davies CH, 1996, J PHYSIOL-LONDON, V496, P451, DOI 10.1113/jphysiol.1996.sp021698; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; Gottlieb M, 2006, NEUROBIOL DIS, V23, P374, DOI 10.1016/j.nbd.2006.03.017; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gruart A, 2012, J NEUROSCI, V32, P17431, DOI 10.1523/JNEUROSCI.4339-12.2012; Guetg N, 2009, J NEUROSCI, V29, P1414, DOI 10.1523/JNEUROSCI.3697-08.2009; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Hasan MT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3258; Jacobson LH, 2006, J NEUROSCI, V26, P8800, DOI 10.1523/JNEUROSCI.2076-06.2006; Johnson JM, 2010, BEHAV PROCESS, V84, P705, DOI 10.1016/j.beproc.2010.04.008; Kohl MM, 2010, ADV PHARMACOL, V58, P205, DOI 10.1016/S1054-3589(10)58009-8; Kulik A, 2003, J NEUROSCI, V23, P11026; Lopez-Bendito G, 2004, HIPPOCAMPUS, V14, P836, DOI 10.1002/hipo.10221; Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007; Madronal N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011130; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Palmer LM, 2012, SCIENCE, V335, P989, DOI 10.1126/science.1217276; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Sahun I, 2007, J NEUROSCI, V27, P2253, DOI 10.1523/JNEUROSCI.4055-06.2007; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Jurado-Parras MT, 2013, J NEUROSCI, V33, P2293, DOI 10.1523/JNEUROSCI.1013-12.2013; Turecek R, 2014, NEURON, V82, P1032, DOI 10.1016/j.neuron.2014.04.015; Valles-Ortega J, 2011, EMBO MOL MED, V3, P667, DOI 10.1002/emmm.201100174; Vertkin I, 2015, P NATL ACAD SCI USA, V112, pE3291, DOI 10.1073/pnas.1424810112; Vienne J, 2010, J NEUROSCI, V30, P14194, DOI 10.1523/JNEUROSCI.3145-10.2010; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	35	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148800	10.1371/journal.pone.0148800	http://dx.doi.org/10.1371/journal.pone.0148800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848590	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000170
J	Yuan, T; Zhang, JY; Zhao, GY; Zhou, YQ; Zhang, CQ; Wang, JHC				Yuan, Ting; Zhang, Jianying; Zhao, Guangyi; Zhou, Yiqin; Zhang, Chang-Qing; Wang, James H-C.			Creating an Animal Model of Tendinopathy by Inducing Chondrogenic Differentiation with Kartogenin	PLOS ONE			English	Article							TENDON STEM-CELLS; EXTRACELLULAR-MATRIX; ACHILLES-TENDON; TENDINOSIS; PATHOGENESIS; EXPRESSION	Previous animal studies have shown that long term rat treadmill running induces over-use tendinopathy, which manifests as proteoglycan accumulation and chondrocytes-like cells within the affected tendons. Creating this animal model of tendinopathy by long term treadmill running is however time-consuming, costly and may vary among animals. In this study, we used a new approach to develop an animal model of tendinopathy using kartogenin (KGN), a bio-compound that can stimulate endogenous stem/progenitor cells to differentiate into chondrocytes. KGN-beads were fabricated and implanted into rat Achilles tendons. Five weeks after implantation, chondrocytes and proteoglycan accumulation were found at the KGN implanted site. Vascularity as well as disorganization in collagen fibers were also present in the same site along with increased expression of the chondrocyte specific marker, collagen type II (Col. II). In vitro studies confirmed that KGN was released continuously from KGN-alginate in vivo beads and induced chondrogenic differentiation of tendon stem/progenitor cells (TSCs) suggesting that chondrogenesis after KGN-bead implantation into the rat tendons is likely due to the aberrant differentiation of TSCs into chondrocytes. Taken together, our results showed that KGN-alginate beads can be used to create a rat model of tendinopathy, which, at least in part, reproduces the features of over-use tendinopathy model created by long term treadmill running. This model is mechanistic (stem cell differentiation), highly reproducible and precise in creating localized tendinopathic lesions. It is expected that this model will be useful to evaluate the effects of various topical treatments such as NSAIDs and platelet-rich plasma (PRP) for the treatment of tendinopathy.	[Yuan, Ting; Zhang, Jianying; Zhao, Guangyi; Zhou, Yiqin; Wang, James H-C.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15261 USA; [Yuan, Ting; Zhang, Chang-Qing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthopaed Surg, Shanghai 200030, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shanghai Jiao Tong University	Wang, JHC (corresponding author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15261 USA.	wanghc@pitt.edu		zhang, changqing/0000-0002-7408-4126	National Institutes of Health [AR061395, AR065949, AR060920]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060920, R01AR065949, R01AR061395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health AR061395, AR065949, and AR060920 (JHW).; This work was supported by NIH AR061395, AR065949, and AR060920 (JHW). We thank Dr. Nirmala Xavier for assistance in preparing the manuscript.	Abraham T, 2011, BMC MUSCULOSKEL DIS, V12, P1471; Archambault JM, 2007, J ORTHOP RES, V25, P617, DOI 10.1002/jor.20347; ASTROM M, 1995, CLIN ORTHOP RELAT R, P151; Bell R, 2013, J BIOMECH, V46, P498, DOI 10.1016/j.jbiomech.2012.10.020; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Buck FM, 2009, AM J ROENTGENOL, V193, P1367, DOI 10.2214/AJR.09.2738; Cetti R, 2003, ACTA ORTHOP SCAND, V74, P78, DOI 10.1080/00016470310013707; Corps AN, 2006, RHEUMATOLOGY, V45, P291, DOI 10.1093/rheumatology/kei152; Da Violante G, 2002, BIOL PHARM BULL, V25, P1600, DOI 10.1248/bpb.25.1600; Fu SC, 2007, CLIN J SPORT MED, V17, P129, DOI 10.1097/JSM.0b013e318037998f; Fung DT, 2010, J BIOMECH, V43, P274, DOI 10.1016/j.jbiomech.2009.08.039; Glazebrook MA, 2008, J ORTHOP RES, V26, P840, DOI 10.1002/jor.20546; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hsu RWW, 2004, J ORTHOP RES, V22, P221, DOI 10.1016/S0736-0266(03)00138-4; Jiang DP, 2013, HISTOL HISTOPATHOL, V28, P1537, DOI 10.14670/HH-28.1537; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Kearney R, 2010, FOOT ANKLE INT, V31, P689, DOI 10.3113/FAI.2010.0689; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Khan MH, 2005, CLIN J SPORT MED, V15, P27, DOI 10.1097/00042752-200501000-00006; Krishna Sayana Murali, 2005, Foot Ankle Clin, V10, P309; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marsolais D, 2001, J ORTHOPAED RES, V19, P1203, DOI 10.1016/S0736-0266(01)00031-6; Mishra A, 2006, AM J SPORT MED, V34, P1774, DOI 10.1177/0363546506288850; Ng GYF, 2011, CONNECT TISSUE RES, V52, P466, DOI 10.3109/03008207.2011.562334; Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027; Parkinson J, 2010, ARTHRITIS RHEUM-US, V62, P3028, DOI 10.1002/art.27587; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Samiric T, 2009, MATRIX BIOL, V28, P230, DOI 10.1016/j.matbio.2009.04.001; Scott A, 2007, ARTHRITIS RHEUM-US, V56, P871, DOI 10.1002/art.22426; Silva RD, 2011, INT J CLIN EXP PATHO, V4, P683; Stone D, 1999, J ORTHOP RES, V17, P168, DOI 10.1002/jor.1100170204; Sullo A, 2001, J Orthop Sci, V6, P349, DOI 10.1007/s007760100031; Wang JHC, 2006, CLIN ORTHOP RELAT R, P320, DOI 10.1097/01.blo.0000195927.81845.46; Wang James H-C, 2014, Muscles Ligaments Tendons J, V4, P35; Wang YJ, 2005, J BONE MINER RES, V20, P1624, DOI 10.1359/JBMR.050516; Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4; Yuan Ting, 2013, Muscles Ligaments Tendons J, V3, P139; Zhang JY, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.8; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071740; Zhang JY, 2010, J ORTHOP RES, V28, P639, DOI 10.1002/jor.21046; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10	43	18	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148557	10.1371/journal.pone.0148557	http://dx.doi.org/10.1371/journal.pone.0148557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848746	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000369554000123
J	Bonnier, G; Kober, T; Schluep, M; Du Pasquier, R; Krueger, G; Meuli, R; Granziera, C; Roche, A				Bonnier, Guillaume; Kober, Tobias; Schluep, Myriam; Du Pasquier, Renaud; Krueger, Gunnar; Meuli, Reto; Granziera, Cristina; Roche, Alexis			A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; T2-WEIGHTED MRI; MYELIN; BRAIN; NEURODEGENERATION; HISTOLOGY	Introduction The existence of partial volume effects in brain MR images makes it challenging to understand physio-pathological alterations underlying signal changes due to pathology across groups of healthy subjects and patients. In this study, we implement a new approach to disentangle gray and white matter alterations in the thalamus and the basal ganglia. The proposed method was applied to a cohort of early multiple sclerosis (MS) patients and healthy subjects to evaluate tissue-specific alterations related to diffuse inflammatory or neurode-generative processes. Method Forty-three relapsing-remitting MS patients and nineteen healthy controls underwent 3T MRI including: (i) fluid-attenuated inversion recovery, double inversion recovery, magnetizationprepared gradient echo for lesion count, and (ii) T1 relaxometry. We applied a partial volume estimation algorithm to T1 relaxometry maps to gray and white matter local concentrations as well as T1 values characteristic of gray and white matter in the thalamus and the basal ganglia. Statistical tests were performed to compare groups in terms of both global T1 values, tissue characteristic T1 values, and tissue concentrations. Results Significant increases in global T1 values were observed in the thalamus (p = 0.038) and the putamen (p = 0.026) in RRMS patients compared to HC. In the Thalamus, the T1 increase was associated with a significant increase in gray matter characteristic T1 (p = 0.0016) with no significant effect in white matter. Conclusion The presented methodology provides additional information to standard MR signal averaging approaches that holds promise to identify the presence and nature of diffuse pathology in neuro-inflammatory and neurodegenerative diseases.	[Bonnier, Guillaume; Kober, Tobias; Granziera, Cristina] Siemens Healthcare IM BM PI, Adv Clin Imaging Technol, Lausanne, Switzerland; [Bonnier, Guillaume; Kober, Tobias; Granziera, Cristina; Roche, Alexis] Ecole Polytech Fed Lausanne, LTS5, Lausanne, Switzerland; [Bonnier, Guillaume; Schluep, Myriam; Du Pasquier, Renaud; Granziera, Cristina] CHU Vaudois, Dept Clin Neurosci, LREN & Neuroimmunol Lab, Lausanne, Switzerland; [Kober, Tobias; Meuli, Reto; Roche, Alexis] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Krueger, Gunnar] Siemens Med Solut USA IM MR COL NEZ, Burlington, MA USA	Siemens AG; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Siemens AG	Bonnier, G (corresponding author), Siemens Healthcare IM BM PI, Adv Clin Imaging Technol, Lausanne, Switzerland.; Bonnier, G (corresponding author), Ecole Polytech Fed Lausanne, LTS5, Lausanne, Switzerland.; Bonnier, G (corresponding author), CHU Vaudois, Dept Clin Neurosci, LREN & Neuroimmunol Lab, Lausanne, Switzerland.	guillaume.bonnier@unil.ch	Du Pasquier, Renaud/O-8588-2016	Du Pasquier, Renaud/0000-0002-2786-3434; Roche, Alexis/0000-0002-4821-6893; Granziera, Cristina/0000-0002-4917-8761	Swiss National Science Foundation [PZ00P3_131914/11]; Swiss MS Society; Societe Academique Vaudoise; Siemens Healthcare; Siemens Medical Solutions	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss MS Society; Societe Academique Vaudoise; Siemens Healthcare(Siemens AG); Siemens Medical Solutions(Siemens AG)	This work was supported by The Swiss National Science Foundation under grant PZ00P3_131914/11, and The Swiss MS Society and the Societe Academique Vaudoise. The funding sources had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. The funder Siemens Healthcare and Siemens Medical Solutions provided support in the form of salaries for authors GK, TK, and AR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Accolla EA, 2014, HUM BRAIN MAPP, V35, P5083, DOI 10.1002/hbm.22533; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Chakravarty MM, 2006, NEUROIMAGE, V30, P359, DOI 10.1016/j.neuroimage.2005.09.041; Cifelli A, 2002, ANN NEUROL, V52, P650, DOI 10.1002/ana.10326; Deistung A, 2013, NEUROIMAGE, V65, P299, DOI 10.1016/j.neuroimage.2012.09.055; Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Grydeland H, 2013, J NEUROSCI, V33, P18618, DOI 10.1523/JNEUROSCI.2811-13.2013; Harrison TJ., 1975, J ANAT 3, V119, P626; Klaver R, 2013, PRION, V7, P66, DOI 10.4161/pri.23499; Kober T, 2012, INVEST RADIOL, V47, P346, DOI 10.1097/RLI.0b013e31824600e9; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Minagar A, 2013, NEUROLOGY, V80, P210, DOI 10.1212/WNL.0b013e31827b910b; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Papadopoulos D, 2009, BRAIN PATHOL, V19, P238, DOI 10.1111/j.1750-3639.2008.00177.x; Roche A, 2011, MED IMAGE ANAL, V15, P830, DOI 10.1016/j.media.2011.05.002; Sadikot AF, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00071; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Schmitter D, 2015, NEUROIMAGE-CLIN, V7, P7, DOI 10.1016/j.nicl.2014.11.001; van Landeghem FKH, 2007, REGUL PEPTIDES, V142, P52, DOI 10.1016/j.regpep.2007.01.008; Vercellino M, 2009, J NEUROPATH EXP NEUR, V68, P489, DOI 10.1097/NEN.0b013e3181a19a5a; Walhovd KB, 2014, NEUROSCIENCE, V276, P2, DOI 10.1016/j.neuroscience.2014.06.058	22	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148631	10.1371/journal.pone.0148631	http://dx.doi.org/10.1371/journal.pone.0148631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845760	Green Published, Green Submitted, gold			2022-12-26	WOS:000369552800078
J	Hurlburt, RT; Alderson-Day, B; Kuhn, S; Fernyhough, C				Hurlburt, Russell T.; Alderson-Day, Ben; Kuehn, Simone; Fernyhough, Charles			Exploring the Ecological Validity of Thinking on Demand: Neural Correlates of Elicited vs. Spontaneously Occurring Inner Speech	PLOS ONE			English	Article							AUDITORY VERBAL HALLUCINATIONS; IMAGERY; EXPERIENCE; CORTEX; FMRI; SCHIZOPHRENIA; LANGUAGE; BRAIN; ACTIVATIONS; PERCEPTION	Psychology and cognitive neuroscience often use standardized tasks to elicit particular experiences. We explore whether elicited experiences are similar to spontaneous experiences. In an MRI scanner, five participants performed tasks designed to elicit inner speech (covertly repeating experimenter-supplied words), inner seeing, inner hearing, feeling, and sensing. Then, in their natural environments, participants were trained in four days of random-beep-triggered Descriptive Experience Sampling (DES). They subsequently returned to the scanner for nine 25-min resting-state sessions; during each they received four DES beeps and described those moments (9 x 4 = 36 moments per participant) of spontaneously occurring experience. Enough of those moments included spontaneous inner speech to allow us to compare brain activation during spontaneous inner speech with what we had found in task-elicited inner speech. ROI analysis was used to compare activation in two relevant areas (Heschl's gyrus and left inferior frontal gyrus). Task-elicited inner speech was associated with decreased activation in Heschl's gyrus and increased activation in left inferior frontal gyrus. However, spontaneous inner speech had the opposite effect in Heschl's gyrus and no significant effect in left inferior frontal gyrus. This study demonstrates how spontaneous phenomena can be investigated in MRI and calls into question the assumption that task-created phenomena are often neurophysiologically and psychologically similar to spontaneously occurring phenomena.	[Hurlburt, Russell T.] Univ Nevada, Psychol, Las Vegas, NV 89154 USA; [Alderson-Day, Ben; Fernyhough, Charles] Univ Durham, Psychol, Durham, England; [Kuehn, Simone] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Kuehn, Simone] Univ Clin Hamburg Eppendorf, Clin & Policlin Psychiat & Psychotherapy, Hamburg, Germany	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Durham University; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hurlburt, RT (corresponding author), Univ Nevada, Psychol, Las Vegas, NV 89154 USA.	russ@unlv.nevada.edu	Kuehn, Simone/P-6145-2014; Fernyhough, Charles/A-1057-2010; Hurlburt, Russell/O-6949-2017	Fernyhough, Charles/0000-0002-3822-710X; Hurlburt, Russell/0000-0003-4672-2562; Alderson-Day, Ben/0000-0003-0546-8043; Kuhn, Simone/0000-0001-6823-7969	Max Planck Institute; Wellcome Trust [WT098455, WT103817]	Max Planck Institute(Foundation CELLEX); Wellcome Trust(Wellcome TrustEuropean Commission)	This project was supported by the Max Planck Institute and funded by Wellcome Trust (http://www.wellcome.ac.uk/) grants WT098455 and WT103817 to CF. These institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew ZK, 2013, NEUROIMAGE, V73, P191, DOI 10.1016/j.neuroimage.2012.08.020; Alderson-Day B, 2015, SOC COGN AF IN PRESS; Aleman A, 2005, CEREB CORTEX, V15, P221, DOI 10.1093/cercor/bhh124; Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; Baciu MV, 1999, NMR BIOMED, V12, P293, DOI 10.1002/(SICI)1099-1492(199908)12:5<293::AID-NBM573>3.0.CO;2-6; Belardinelli MO, 2009, ACTA PSYCHOL, V132, P190, DOI 10.1016/j.actpsy.2009.06.009; Brett MA, 2002, 2002 8 INT C FUNCT M; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; Delamillieure P, 2010, BRAIN RES BULL, V81, P565, DOI 10.1016/j.brainresbull.2009.11.014; Diaz BA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00271; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Fegen D, 2015, NEUROIMAGE, V105, P120, DOI 10.1016/j.neuroimage.2014.10.034; Fernyhough C, 2004, NEW IDEAS PSYCHOL, V22, P49, DOI 10.1016/j.newideapsych.2004.09.001; Fernyhough C, 2013, HALLUCINATION: PHILOSOPHY AND PSYCHOLOGY, P87; Fitch WT, 2014, ANN NY ACAD SCI, V1316, P87, DOI 10.1111/nyas.12406; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Geva S, 2011, BRAIN, V134, P3071, DOI 10.1093/brain/awr232; Gorgolewski KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097176; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Heavey CL, 2008, CONSCIOUS COGN, V17, P798, DOI 10.1016/j.concog.2007.12.006; Hoffman RE, 2011, BIOL PSYCHIAT, V69, P407, DOI 10.1016/j.biopsych.2010.09.050; Hurlburt R., 1993, SAMPLING INNER EXPER; Hurlburt R. T., 2007, PROPONENT MEETS SKEP; Hurlburt R. T., 2011, INVESTIGATING PRISTI, P117; Hurlburt R. T., 2006, PHENOMENOL COGN SCI, V5, P271, DOI [10.1075/aicr.64, DOI 10.1007/s11097-006-9024-0, DOI 10.1007/S11097-006-9024-0]; Hurlburt R. T., 1990, SAMPLING NORMAL SCHI; Hurlburt R. T., 2006, EXPLORING INNER EXPE; Hurlburt RT, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01535; Hurlburt RT, 2015, CONSCIOUS COGN, V31, P148, DOI 10.1016/j.concog.2014.11.002; Hurlburt RT, 2013, CONSCIOUS COGN, V22, P1477, DOI 10.1016/j.concog.2013.10.003; Hurlburt RT, 2011, J CONSCIOUSNESS STUD, V18, P206; Hurlburt RT, 2009, J CONSCIOUSNESS STUD, V16, P156; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; Jones SR, 2007, CLIN PSYCHOL REV, V27, P140, DOI 10.1016/j.cpr.2006.10.001; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Kuhn S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01393; Kuhn S, 2012, SCHIZOPHRENIA BULL, V38, P779, DOI 10.1093/schbul/sbq152; Matthews PM, 2004, J NEUROL NEUROSUR PS, V75, P6; McGuire PK, 1996, PSYCHOL MED, V26, P29, DOI 10.1017/S0033291700033699; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Schwitzgebel E, 2011, J CONSCIOUSNESS STUD, V18, P288; Shergill SS, 2002, HUM BRAIN MAPP, V16, P219, DOI 10.1002/hbm.10046; Shergill SS, 2001, PSYCHOL MED, V31, P241, DOI 10.1017/S003329170100335X; Shergill SS, 2000, ARCH GEN PSYCHIAT, V57, P1033, DOI 10.1001/archpsyc.57.11.1033; Simons CJP, 2010, BIOL PSYCHIAT, V67, P232, DOI 10.1016/j.biopsych.2009.09.007; Tian X, 2013, J COGNITIVE NEUROSCI, V25, P1020, DOI 10.1162/jocn_a_00381; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Zatorre RJ, 2005, NEURON, V47, P9, DOI 10.1016/j.neuron.2005.06.013	54	44	46	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147932	10.1371/journal.pone.0147932	http://dx.doi.org/10.1371/journal.pone.0147932			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845028	Green Published, Green Accepted, gold			2022-12-26	WOS:000369552800022
J	McShane, A; Hok, E; Tomberlin, J; Eriani, G; Geslain, R				McShane, Ariel; Hok, Eveline; Tomberlin, Jensen; Eriani, Gilbert; Geslain, Renaud			The Enzymatic Paradox of Yeast Arginyl-tRNA Synthetase: Exclusive Arginine Transfer Controlled by a Flexible Mechanism of tRNA Recognition	PLOS ONE			English	Article							AMINOACYL-TRANSFER-RNAS; IDENTITY ELEMENTS; ANTICODON LOOP; GENETIC-CODE; IN-VIVO; DETERMINANTS; TRANSCRIPTS; PROMOTER; ACCEPTOR; BINDING	Identity determinants are essential for the accurate recognition of transfer RNAs by aminoacyl-tRNA synthetases. To date, arginine determinants in the yeast Saccharomyces cerevisiae have been identified exclusively in vitro and only on a limited number of tRNA Arginine isoacceptors. In the current study, we favor a full cellular approach and expand the investigation of arginine determinants to all four tRNA Arg isoacceptors. More precisely, this work scrutinizes the relevance of the tRNA nucleotides at position 20, 35 and 36 in the yeast arginylation reaction. We built 21 mutants by site-directed mutagenesis and tested their functionality in YAL5, a previously engineered yeast knockout deficient for the expression of tRNA Arg CCG. Arginylation levels were also monitored using Northern blot. Our data collected in vivo correlate with previous observations. C35 is the prominent arginine determinant followed by G36 or U36 (G/U36). In addition, although there is no major arginine determinant in the D loop, the recognition of tRNA Arg ICG relies to some extent on the nucleotide at position 20. This work refines the existing model for tRNA Arg recognition. Our observations indicate that yeast Arginyl-tRNA synthetase (yArgRS) relies on distinct mechanisms to aminoacylate the four isoacceptors. Finally, according to our refined model, yArgRS is able to accommodate tRNA Arg scaffolds presenting N34, C/G35 and G/A/U36 anticodons while maintaining specificity. We discuss the mechanistic and potential physiological implications of these findings.	[McShane, Ariel; Hok, Eveline; Tomberlin, Jensen; Geslain, Renaud] Coll Charleston, Dept Biol, Lab tRNA Biol, Charleston, SC 29424 USA; [Eriani, Gilbert] Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, Architecture & Reactivite ARN, 15 Rue Rene Descartes, F-67084 Strasbourg, France	College of Charleston; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Geslain, R (corresponding author), Coll Charleston, Dept Biol, Lab tRNA Biol, Charleston, SC 29424 USA.	geslainr@cofc.edu		Eriani, Gilbert/0000-0002-8518-4675; McShane, Ariel/0000-0003-3281-1302	SC INBRE grant from the National Institute of General Medical Science - NIH [P20GM103499]; Centre National de la Recherche Scientifique [ANR11SVSE8-025-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	SC INBRE grant from the National Institute of General Medical Science - NIH; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a SC INBRE grant from the National Institute of General Medical Science - NIH (P20GM103499 to Renaud Geslain) and a grant from the Centre National de la Recherche Scientifique (ANR11SVSE8-025-01 to Gilbert Eriani).	ACHSEL T, 1993, EMBO J, V12, P3333, DOI 10.1002/j.1460-2075.1993.tb06003.x; ASAHARA H, 1994, J MOL BIOL, V236, P738, DOI 10.1006/jmbi.1994.1186; Cantara WA, 2012, J MOL BIOL, V416, P579, DOI 10.1016/j.jmb.2011.12.054; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; Eriani G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130042; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Fender A, 2004, NUCLEIC ACIDS RES, V32, P5076, DOI 10.1093/nar/gkh843; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; GALLI G, 1981, NATURE, V294, P626, DOI 10.1038/294626a0; Geslain R, 2003, NUCLEIC ACIDS RES, V31, P4729, DOI 10.1093/nar/gkg685; Geslain R, 2000, RNA, V6, P434, DOI 10.1017/S1355838200992331; Geslain R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1083; Geslain R, 2010, J MOL BIOL, V396, P821, DOI 10.1016/j.jmb.2009.12.018; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Giege R, 2012, WIRES RNA, V3, P37, DOI 10.1002/wrna.103; Guigou L, 2005, BIOCHEMISTRY-US, V44, P16540, DOI 10.1021/bi051575h; Hendrickson TL, 2001, P NATL ACAD SCI USA, V98, P13473, DOI 10.1073/pnas.251549298; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Khatter H, 2015, NATURE, V520, P640, DOI 10.1038/nature14427; Kiga D, 2001, EUR J BIOCHEM, V268, P6207, DOI 10.1046/j.0014-2956.2001.02570.x; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MCCLAIN WH, 1988, SCIENCE, V241, P1804, DOI 10.1126/science.2459773; NAMEKI N, 1995, NUCLEIC ACIDS RES, V23, P2831, DOI 10.1093/nar/23.15.2831; SCHULMAN LH, 1989, SCIENCE, V246, P1595, DOI 10.1126/science.2688091; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Sissler M, 1996, EMBO J, V15, P5069, DOI 10.1002/j.1460-2075.1996.tb00887.x; Soma A, 1999, J MOL BIOL, V293, P1029, DOI 10.1006/jmbi.1999.3219; TAMURA K, 1992, NUCLEIC ACIDS RES, V20, P2335, DOI 10.1093/nar/20.9.2335; Tamura T, 1992, Nucleic Acids Symp Ser, P143; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Yao YN, 2004, BIOCHEM BIOPH RES CO, V313, P129, DOI 10.1016/j.bbrc.2003.11.107; YESLAND KD, 1993, NUCLEIC ACIDS RES, V21, P5079, DOI 10.1093/nar/21.22.5079	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148460	10.1371/journal.pone.0148460	http://dx.doi.org/10.1371/journal.pone.0148460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844776	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800060
J	Sonakowska, L; Wlodarczyk, A; Wilczek, G; Wilczek, P; Student, S; Rost-Roszkowska, MM				Sonakowska, Lidia; Wlodarczyk, Agnieszka; Wilczek, Grazyna; Wilczek, Piotr; Student, Sebastian; Rost-Roszkowska, Magdalena Maria			Cell Death in the Epithelia of the Intestine and Hepatopancreas in Neocaridina heteropoda (Crustacea, Malacostraca)	PLOS ONE			English	Article							PALAEMONETES-ARGENTINUS CRUSTACEA; PENAEUS-SEMISULCATUS CRUSTACEA; MIDGUT EPITHELIUM; FUNCTIONAL CYTOLOGY; AUTOPHAGY; APOPTOSIS; MITOCHONDRIAL; DECAPODA; HISTOLOGY; CARIDEA	The endodermal region of the digestive system in the freshwater shrimp Neocaridina heteropoda (Crustacea, Malacostraca) consists of a tube-shaped intestine and large hepatopancreas, which is formed by numerous blind-ended tubules. The precise structure and ultrastructure of these regions were presented in our previous studies, while here we focused on the cell death processes and their effect on the functioning of the midgut. We used transmission electron microscopy, light and confocal microscopes to describe and detect cell death, while a quantitative assessment of cells with depolarized mitochondria helped us to establish whether there is the relationship between cell death and the inactivation of mitochondria. Three types of the cell death were observed in the intestine and hepatopancreas-apoptosis, necrosis and autophagy. No differences were observed in the course of these processes in males and females and or in the intestine and hepatopancreas of the shrimp that were examined. Our studies revealed that apoptosis, necrosis and autophagy only involves the fully developed cells of the midgut epithelium that have contact with the midgut lumen-D-cells in the intestine and B-and F-cells in hepatopancreas, while E-cells (midgut stem cells) did not die. A distinct correlation between the accumulation of E-cells and the activation of apoptosis was detected in the anterior region of the intestine, while necrosis was an accidental process. Degenerating organelles, mainly mitochondria were neutralized and eventually, the activation of cell death was prevented in the entire epithelium due to autophagy. Therefore, we state that autophagy plays a role of the survival factor.	[Sonakowska, Lidia; Wlodarczyk, Agnieszka; Rost-Roszkowska, Magdalena Maria] Univ Silesia, Dept Anim Histol & Embryol, Bankowa 9, PL-40007 Katowice, Poland; [Wilczek, Grazyna] Univ Silesia, Dept Anim Physiol & Ecotoxicol, Bankowa 9, PL-40007 Katowice, Poland; [Wilczek, Piotr] Heart Prosthesis Inst, Bioengn Lab, Wolnosci 345a, PL-41800 Zabrze, Poland; [Student, Sebastian] Silesian Tech Univ, Fac Automat Control Elect & Comp Sci, Akad 16, PL-44100 Gliwice, Poland	University of Silesia in Katowice; University of Silesia in Katowice; Silesian University of Technology	Rost-Roszkowska, MM (corresponding author), Univ Silesia, Dept Anim Histol & Embryol, Bankowa 9, PL-40007 Katowice, Poland.	magdalena.rost-roszkowska@us.edu.pl	Student, Sebastian/H-7895-2013; Rost-Roszkowska, Magdalena/AAM-7005-2020	Student, Sebastian/0000-0003-1812-5496; Wilczek, Piotr/0000-0002-4968-6512; Wilczek, Grazyna/0000-0002-3276-0333; Wlodarczyk, Agnieszka/0000-0002-2374-4892; Rost-Roszkowska, Magdalena/0000-0001-7124-8423	GCONiI-Upper-Silesian Center for Scientific Computation [POIG.02.03.01-24-099/13]	GCONiI-Upper-Silesian Center for Scientific Computation	This work was performed using the infrastructure supported by POIG.02.03.01-24-099/13 grant: "GCONiI-Upper-Silesian Center for Scientific Computation".	ALMOHANNA SY, 1989, MAR BIOL, V101, P535, DOI 10.1007/BF00541656; ALMOHANNA SY, 1986, J MAR BIOL ASSOC UK, V66, P403, DOI 10.1017/S0025315400043034; ARNAUD J, 1978, CELL TISSUE RES, V187, P333; Ceccaldi H.J., 1989, AQUACULTURE, V9, P243, DOI DOI 10.1007/S00248-011-9936-2; Diaz AC, 2010, BRAZ ARCH BIOL TECHN, V53, P599, DOI 10.1590/S1516-89132010000300013; Cuartas Elena Irene, 2003, Biociencias (Porto Alegre), V11, P53; Fernandez-Checa JC, 2003, BIOCHEM BIOPH RES CO, V304, P471, DOI 10.1016/S0006-291X(03)00619-3; Franzetti E, 2012, APOPTOSIS, V17, P305, DOI 10.1007/s10495-011-0675-0; Garcia JJ, 2001, IN VITRO CELL DEV-AN, V37, P353, DOI 10.1290/1071-2690(2001)037<0353:PACMCC>2.0.CO;2; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; LIGHTNER DV, 1994, AQUACULTURE, V122, P9, DOI 10.1016/0044-8486(94)90329-8; Lipovsek S, 2016, PROTOPLASMA, V253, P457, DOI 10.1007/s00709-015-0824-3; Lipovsek S, 2015, ARTHROPOD STRUCT DEV, V44, P131, DOI 10.1016/j.asd.2014.12.002; Lipovsek S, 2014, ARTHROPOD STRUCT DEV, V43, P493, DOI 10.1016/j.asd.2014.06.001; Lockshin RA, 2002, CURR OPIN CELL BIOL, V14, P727, DOI 10.1016/S0955-0674(02)00383-6; Maghsoudi N., 2012, Experimental Oncology, V34, P146; MAJNO G, 1995, AM J PATHOL, V146, P3; Malagoli D, 2010, AUTOPHAGY, V6, P575, DOI 10.4161/auto.6.5.11962; Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839; Masson I., 2001, THESIS; Menze MA, 2010, APOPTOSIS, V15, P293, DOI 10.1007/s10495-009-0443-6; Mijaljica D, 2012, INT J MOL SCI, V13, P3618, DOI 10.3390/ijms13033618; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Nicholls DG, 2002, INT J BIOCHEM CELL B, V34, P1372, DOI 10.1016/S1357-2725(02)00077-8; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Rost MM, 2006, ARTHROPOD STRUCT DEV, V35, P69, DOI 10.1016/j.asd.2005.10.001; Rost-Roszkowska MM, 2015, MICRON, V68, P130, DOI 10.1016/j.micron.2014.10.003; Rost-Roszkowska MM, 2012, ARTHROPOD STRUCT DEV, V41, P271, DOI 10.1016/j.asd.2012.01.001; Rost-Roszkowska MM, 2010, TISSUE CELL, V42, P24, DOI 10.1016/j.tice.2009.06.003; Rost-Roszkowska MM, 2008, CAN J ZOOL, V86, P1179, DOI 10.1139/Z08-096; Saleh AM, 2003, TOXICOL APPL PHARM, V190, P47, DOI 10.1016/S0041-008X(03)00126-1; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Sonakowska L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126900; Sousa LG, 2007, REV BIOL TROP, V55, P79; Sousa LG, 2001, BIOCELL, V25, P275; Sousa LG, 2000, BIOCELL, V24, P189; Sousa L, 2006, BIOCELL, V30, P287; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Teixeira AD, 2013, ARTHROPOD STRUCT DEV, V42, P237, DOI 10.1016/j.asd.2013.02.004; TRUMP BF, 1981, CELL DEATH BIOL PATH, P209; Urbanek A, 2015, MICRON, V69, P25, DOI 10.1016/j.micron.2014.11.003; Vaidyanathan R, 2006, APOPTOSIS, V11, P1643, DOI 10.1007/s10495-006-8783-y; VOGT G, 1994, AQUAT TOXICOL, V28, P223, DOI 10.1016/0166-445X(94)90035-3; VOGT G, 1990, DIS AQUAT ORGAN, V9, P45, DOI 10.3354/dao009045; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; Wertz IE, 1996, TRENDS BIOCHEM SCI, V21, P359, DOI 10.1016/0968-0004(96)40002-0; Wilczek G, 2014, ECOTOX ENVIRON SAFE, V101, P157, DOI 10.1016/j.ecoenv.2013.09.034; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zakeri Z, 2002, J IMMUNOL METHODS, V265, P3, DOI 10.1016/S0022-1759(02)00067-4	59	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147582	10.1371/journal.pone.0147582	http://dx.doi.org/10.1371/journal.pone.0147582			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844766	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800010
J	Carneiro, PP; Conceicao, J; Macedo, M; Magalhaes, V; Carvalho, EM; Bacellar, O				Carneiro, Pedro Paulo; Conceicao, Jacilara; Macedo, Michael; Magalhaes, Viviane; Carvalho, Edgar M.; Bacellar, Olivia			The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis	PLOS ONE			English	Article							MUCOSAL LEISHMANIASIS; PERITONEAL-MACROPHAGES; SUPEROXIDE-DISMUTASE; INNATE IMMUNITY; LESION SIZE; T-CELLS; RESPONSES; EXPRESSION; INFECTION; SYNTHASE	Human cutaneous leishmaniasis (CL) caused by Leishmania braziliensis, presents an exaggerated Th1 response that is associated with ulcer development. Macrophages are the primary cells infected by Leishmania parasites and both reactive oxygen species (ROS) and nitric oxide (NO) are important in the control of Leishmania by these cells. The mechanism involved in the killing of L. braziliensis is not well established. In this study, we evaluate the role of ROS and NO in the control of L. braziliensis infection by monocytes from CL patients. After in vitro infection with L. braziliensis, the oxidative burst by monocytes from CL patients was higher when compared to monocytes from healthy subjects (HS). Inhibition of the ROS pathway caused a significant decrease in the oxidative burst in L. braziliensis infected monocytes from both groups. In addition, we evaluated the intracellular expression of ROS and NO in L. braziliensis-infected monocytes. Monocytes from CL patients presented high expression of ROS after infection with L. braziliensis. The expression of NO was higher in monocytes from CL patients as compared to expression in monocytes from HS. A strong positive correlation between NO production and lesion size of CL patients was observed. The inhibition of ROS production in leishmania-infected monocytes from CL patients allowed the growth of viable promastigotes in culture supernatants. Thus, we demonstrate that while production of ROS is involved in L. braziliensis killing, NO alone is not sufficient to control infection and may contribute to the tissue damage observed in human CL.	[Carneiro, Pedro Paulo; Conceicao, Jacilara; Macedo, Michael; Magalhaes, Viviane; Carvalho, Edgar M.; Bacellar, Olivia] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil; [Carvalho, Edgar M.; Bacellar, Olivia] CNPq MCT, INCT DT, Salvador, BA, Brazil	Universidade Federal da Bahia	Bacellar, O (corresponding author), Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil.; Bacellar, O (corresponding author), CNPq MCT, INCT DT, Salvador, BA, Brazil.	olivinhaufba@gmail.com			National Institute of Health (NIH) [AI30639-20]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI030639] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health (NIH) grant AI30639-20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RP, 2005, AM J TROP MED HYG, V73, P79, DOI 10.4269/ajtmh.2005.73.79; Almeida TF, 2012, PARASITE IMMUNOL, V34, P492, DOI 10.1111/j.1365-3024.2012.01384.x; Antonelli LRV, 2005, IMMUNOL LETT, V101, P226, DOI 10.1016/j.imlet.2005.06.004; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; Bacellar O, 2009, J INFECT DIS, V200, P75, DOI 10.1086/599380; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; BITTENCOURT AL, 1991, MEM I OSWALDO CRUZ, V86, P51, DOI 10.1590/S0074-02761991000100009; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Cardoso TM, 2015, INFECT IMMUN, V83, P898, DOI 10.1128/IAI.02404-14; Chang HK, 2007, INFECT IMMUN, V75, P1017, DOI 10.1128/IAI.00914-06; CHANNON JY, 1984, IMMUNOLOGY, V53, P345; CUPOLILLO E, 1994, AM J TROP MED HYG, V50, P296, DOI 10.4269/ajtmh.1994.50.296; Nogueira NPD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025935; Faria DR, 2005, INFECT IMMUN, V73, P7853, DOI 10.1128/IAI.73.12.7853-7859.2005; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Giudice A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-75; Gonzalez-Lombana C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003243; Katara GK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001703; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Khouri R, 2014, J INFECT DIS, V210, P306, DOI 10.1093/infdis/jiu087; Khouri R, 2009, J IMMUNOL, V182, P2525, DOI 10.4049/jimmunol.0802860; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Kumar R, 2010, IMMUNOLOGY, V130, P193, DOI 10.1111/j.1365-2567.2009.03223.x; LIEW FY, 1990, J IMMUNOL, V145, P4306; Little JW, 2012, AMINO ACIDS, V42, P75, DOI 10.1007/s00726-010-0633-0; Machado PRL, 2007, CLIN INFECT DIS, V44, P788, DOI 10.1086/511643; Matoshvili M, 2014, Georgian Med News, P61; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Morgado FN, 2010, PARASITE IMMUNOL, V32, P285, DOI 10.1111/j.1365-3024.2009.01188.x; Novais FO, 2014, J INFECT DIS, V209, P1288, DOI 10.1093/infdis/jiu013; Novais FO, 2009, J IMMUNOL, V183, P8088, DOI 10.4049/jimmunol.0803720; Olekhnovitch R, 2014, J CLIN INVEST, V124, P1711, DOI 10.1172/JCI72058; Passos S, 2015, J INFECT DIS, V211, P274, DOI 10.1093/infdis/jiu439; Qadoumi M, 2002, INFECT IMMUN, V70, P4638, DOI 10.1128/IAI.70.8.4638-4642.2002; Ribeiro-de-Jesus A, 1998, BRAZ J MED BIOL RES, V31, P143, DOI 10.1590/S0100-879X1998000100020; Roy S, 2015, J CLIN IMMUNOL, V35, P56, DOI 10.1007/s10875-014-0115-3; Santos DM, 2013, NANOMED-NANOTECHNOL, V9, P985, DOI 10.1016/j.nano.2013.04.003; SASADA M, 1983, J BIOL CHEM, V258, P9631; Serarslan G, 2005, MOL CELL BIOCHEM, V280, P147, DOI 10.1007/s11010-005-8542-3; SMITH MT, 1984, BIOCHEM PHARMACOL, V33, P3109, DOI 10.1016/0006-2952(84)90619-1; Srivastava A, 2012, MOL CELL BIOCHEM, V359, P359, DOI 10.1007/s11010-011-1029-5; Srivastava S, 2013, CLIN EXP IMMUNOL, V172, P403, DOI 10.1111/cei.12074; Vieira ELM, 2013, PARASITE IMMUNOL, V35, P65, DOI 10.1111/pim.12012; Vieira MGS, 2002, MEM I OSWALDO CRUZ, V97, P979, DOI 10.1590/S0074-02762002000700009; Weinkopff T, 2013, INFECT IMMUN, V81, P1575, DOI 10.1128/IAI.01401-12; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023	47	99	98	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148084	10.1371/journal.pone.0148084	http://dx.doi.org/10.1371/journal.pone.0148084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840253	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200080
J	Chang, PJ; Lin, L; Zheng, Q; Yu, F; Yu, XY; Zhao, YY; Ding, XX; Zhu, WG; Li, J; Zhao, YE				Chang, Pingjun; Lin, Lei; Zheng, Qian; Yu, Fang; Yu, Xiaoyu; Zhao, Yinying; Ding, Xixia; Zhu, Weigen; Li, Jin; Zhao, Yun-e			An Optical Section-Assisted In Vivo Rabbit Model for Capsular Bend and Posterior Capsule Opacification Investigation	PLOS ONE			English	Article							INTRAOCULAR-LENS IMPLANTATION; CATARACT-SURGERY; COHERENCE TOMOGRAPHY; EPITHELIAL-CELLS; POLY(METHYL METHACRYLATE); EDGE DESIGN; INHIBITION; SILICONE; SHARP; EYES	Purpose To establish an optical section-assisted in vivo rabbit model for capsular bend and posterior capsule opacification (PCO) investigation. Methods A total of 10 rabbits underwent phacoemulsification surgery and intraocular lens (IOL) implantation. On the basis of the relationship between the anterior capsule and IOL, the rabbits were divided into complete overlap and incomplete overlap groups, in which six and four rabbits were included, respectively. The capsular bend optical sections were assessed using ultra-long scan depth optical coherence tomography (UL-OCT), and posterior capsule opacification was evaluated with slit lamp on postoperative day 3, 7, 14, and 28. In addition, histopathological section was used to verify the accuracy of capsular bend type captured by OCT in three rabbits. Results Based on the special animalmodel, six capsular bend types were observed, namely, anterior (A), middle (M), posterior (P), detachment (D), funnel (Fun) and furcate adhesion (Fur). On day 3, capsular bend began to form. On 14 days, the capsular bends were comprised of A, M and D types, which were almostmaintained until day 28. Histopathological section findings were consistent with optical sectioning results. In the incomplete and complete groups, the earliest PCO within the optical zone were on day 7 and 28, respectively. The incomplete group exhibited higher incidence and faster PCO on day 7 (p = 0.038) and 14 (p = 0.002). Conclusions This animal model not only mimics capsular bend evolution and PCO processes but also produces OCT optical section images equivalent to and more repeatable than histopathology, thereby providing a promising method for the further investigations of PCO.	[Chang, Pingjun; Lin, Lei; Zheng, Qian; Yu, Fang; Yu, Xiaoyu; Zhao, Yinying; Ding, Xixia; Zhu, Weigen; Li, Jin; Zhao, Yun-e] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University	Li, J; Zhao, YE (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	lijingerry@163.com; zye@mail.eye.ac.cn			National Natural Science Foundation of China [81170869]; Zhejiang Provincial Natural Science Foundation of China [LY13H120005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by National Natural Science Foundation of China (Grant No. 81170869 to YEZ, website: http://www.nsfc.gov.cn/) and Zhejiang Provincial Natural Science Foundation of China (Grant No. LY13H120005 to JL, website: http://www.zjnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P1141, DOI 10.1016/S0886-3350(02)01425-6; Dawes LJ, 2008, INVEST OPHTH VIS SCI, V49, P650, DOI 10.1167/iovs.07-0586; Dawes LJ, 2013, INVEST OPHTH VIS SCI, V54, P333, DOI 10.1167/iovs.12-10425; Dick HB, 2013, J CATARACT REFR SURG, V39, P1286, DOI 10.1016/j.jcrs.2013.07.014; Hayashi H, 2002, OPHTHALMOLOGY, V109, P1427, DOI 10.1016/S0161-6420(02)01112-0; Hayashi K, 2005, OPHTHALMOLOGY, V112, P1550, DOI 10.1016/j.ophtha.2005.03.024; Hayashi K, 2001, J CATARACT REFR SURG, V27, P817, DOI 10.1016/S0886-3350(01)00787-8; KnightNanan D, 1996, J CATARACT REFR SURG, V22, P730, DOI 10.1016/S0886-3350(96)80312-9; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077864; Nagamoto T, 2003, J CATARACT REFR SURG, V29, P1605, DOI 10.1016/S0886-3350(03)00050-6; Nishi O, 1998, OPHTHALMIC SURG LAS, V29, P587; Nishi O, 2004, J CATARACT REFR SURG, V30, P2170, DOI 10.1016/j.jcrs.2004.05.022; Nishi O, 1999, J CATARACT REFR SURG, V25, P521, DOI 10.1016/S0886-3350(99)80049-2; Nishi O, 2002, J CATARACT REFR SURG, V28, P431, DOI 10.1016/S0886-3350(01)01094-X; Nishi O, 2007, J CATARACT REFR SURG, V33, P1065, DOI 10.1016/j.jcrs.2007.02.022; Sacu S, 2005, J CATARACT REFR SURG, V31, P1888, DOI 10.1016/j.jcrs.2005.03.072; Sacu S, 2005, J CATARACT REFR SURG, V31, P330, DOI 10.1016/j.jcrs.2004.04.057; Saika S, 2002, BRIT J OPHTHALMOL, V86, P1428, DOI 10.1136/bjo.86.12.1428; Shen MX, 2011, INVEST OPHTH VIS SCI, V52, P4091, DOI 10.1167/iovs.10-6507; Shen MX, 2010, EYE CONTACT LENS, V36, P73, DOI 10.1097/ICL.0b013e3181d0423e; Smith SR, 2004, AM J OPHTHALMOL, V138, P521, DOI 10.1016/j.ajo.2004.04.028; Sponer U, 2005, J CATARACT REFR SURG, V31, P595, DOI 10.1016/j.jcrs.2004.05.058; Tassignon MJ, 2007, J CATARACT REFR SURG, V33, P611, DOI 10.1016/j.jcrs.2006.12.016; Tassignon MJBR, 2002, J CATARACT REFR SURG, V28, P1182, DOI 10.1016/S0886-3350(02)01375-5; Zhao YY, 2013, AM J OPHTHALMOL, V155, P484, DOI 10.1016/j.ajo.2012.08.019	25	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148553	10.1371/journal.pone.0148553	http://dx.doi.org/10.1371/journal.pone.0148553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840405	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200147
J	Mitchell, MD; Rice, GE; Vaswani, K; Kvaskoff, D; Peiris, HN				Mitchell, M. D.; Rice, G. E.; Vaswani, K.; Kvaskoff, D.; Peiris, H. N.			Differential Regulation of Eicosanoid and Endocannabinoid Production by Inflammatory Mediators in Human Choriodecidua	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; ANANDAMIDE LEVELS; PRETERM BIRTH; PREGNANCY; WOMEN; MORTALITY; LABOR	An increase in intrauterine prostaglandin production is critical for the onset and progression of labor in women and indeed all mammalian species studied. Endocannabinoids can act as substrates for enzymes of the prostaglandin biosynthetic pathways and can be utilized to generate other related compounds such as prostamides. The end products are indistinguishable by radioimmunoassay. We have separated such compounds by mass spectrometry. We now show that inflammatory stimuli such as LPS and proinflammatory cytokines act differentially on these pathways in human choriodecidua and preferentially create drive through to prostaglandin end products. These findings create doubt about the interpretation of data on prostaglandin biosynthesis in intrauterine tissues from pregnant women especially in the presence of an infection. The possibility is raised that separation of these products might reduce variability in results and lead to potential uses for their measurement in the diagnosis of preterm labor.	[Mitchell, M. D.; Rice, G. E.; Vaswani, K.; Kvaskoff, D.; Peiris, H. N.] Univ Queensland, Clin Res Ctr, Ctr Clin Diagnost, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Kvaskoff, D.] Care of Brugger AG, Univ Heidelberg, Biochem Ctr BZH Neuenheimer Feld, Heidelberg, Germany	Royal Brisbane & Women's Hospital; University of Queensland; Ruprecht Karls University Heidelberg	Mitchell, MD (corresponding author), Univ Queensland, Clin Res Ctr, Ctr Clin Diagnost, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia.	murray.mitchell@uq.edu.au	Peiris, Hassendrini (Nel)/HCH-0058-2022; Kvaskoff, David/F-1010-2017; RICE, GREGORY/F-2412-2010; Peiris, Hassendrini/B-9928-2016; Mitchell, Murray/A-8639-2010	Kvaskoff, David/0000-0002-5569-7226; RICE, GREGORY/0000-0001-7177-0246; Peiris, Hassendrini/0000-0002-4685-2722; Mitchell, Murray/0000-0002-6167-7176	Therapeutics Innovation Australia-Queensland Node; National Collaborative Research Infrastructure Strategy; SmartFutures; Lalor Foundation	Therapeutics Innovation Australia-Queensland Node; National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); SmartFutures; Lalor Foundation	MDM received funding from Therapeutics Innovation Australia-Queensland Node, the National Collaborative Research Infrastructure Strategy and SmartFutures. HNP was supported by The Lalor Foundation Postdoctoral Fellowship.	Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chan HW, 2013, REPRODUCTION, V146, pR101, DOI 10.1530/REP-12-0508; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; Glass M, 2005, J LIPID RES, V46, P1364, DOI 10.1194/jlr.C500006-JLR200; Habayeb OMH, 2004, J CLIN ENDOCR METAB, V89, P5482, DOI 10.1210/jc.2004-0681; Habayeb OMH, 2008, JAMA-J AM MED ASSOC, V299, P1135, DOI 10.1001/jama.299.10.1135; Keelan JA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.031; Lam PMW, 2008, ANAL BIOCHEM, V380, P195, DOI 10.1016/j.ab.2008.05.033; Li Z, 2012, AUSTR MOTHERS BABIES; Liggins G C, 1973, Recent Prog Horm Res, V29, P111; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Maccarrone M, 2002, MOL HUM REPROD, V8, P188, DOI 10.1093/molehr/8.2.188; Maccarrone M, 2000, LANCET, V355, P1326, DOI 10.1016/S0140-6736(00)02115-2; Maccarrone M, 2001, ARCH BIOCHEM BIOPHYS, V393, P321, DOI 10.1006/abbi.2001.2500; Mitchell MD, 2008, AM J PHYSIOL-ENDOC M, V294, pE352, DOI 10.1152/ajpendo.00495.2007; ROMERO R, 1994, SEMIN REPROD ENDOCR, V12, P227, DOI 10.1055/s-2007-1016404; ROMERO R, 1994, PROSTAG LEUKOTR ESS, V50, P97, DOI 10.1016/0952-3278(94)90154-6; Romero R, 1996, PROSTAG LEUKOTR ESS, V54, P187, DOI 10.1016/S0952-3278(96)90015-0; Sergi M, 2013, ANAL BIOANAL CHEM, V405, P785, DOI 10.1007/s00216-012-6273-3; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; TURNBULL AC, 1981, REV PERINATAL MED, V4, P273; Wagner JA, 1997, NATURE, V390, P518, DOI 10.1038/37371	23	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148306	10.1371/journal.pone.0148306	http://dx.doi.org/10.1371/journal.pone.0148306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840435	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200122
J	Newcombe, G; Campbell, J; Griffith, D; Baynes, M; Launchbaugh, K; Pendleton, R				Newcombe, George; Campbell, Jason; Griffith, David; Baynes, Melissa; Launchbaugh, Karen; Pendleton, Rosemary			Revisiting the Life Cycle of Dung Fungi, Including Sordaria fimicola	PLOS ONE			English	Article							ENDOPHYTES; LEAVES; FREQUENCIES; DIVERSITY	Dung fungi, such as Sordaria fimicola, generally reproduce sexually with ascospores discharged from mammalian dung after passage through herbivores. Their life cycle is thought to be obligate to dung, and thus their ascospores in Quaternary sediments have been interpreted as evidence of past mammalian herbivore activity. Reports of dung fungi as endophytes would seem to challenge the view that they are obligate to dung. However, endophyte status is controversial because surface-sterilization protocols could fail to kill dung fungus ascospores stuck to the plant surface. Thus, we first tested the ability of representative isolates of three common genera of dung fungi to affect plant growth and fecundity given that significant effects on plant fitness could not result from ascospores merely stuck to the plant surface. Isolates of S. fimicola, Preussia sp., and Sporormiella sp. reduced growth and fecundity of two of three populations of Bromus tectorum, the host from which they had been isolated. In further work with S. fimicola we showed that inoculations of roots of B. tectorum led to some colonization of above ground tissues. The same isolate of S. fimicola reproduced sexually on inoculated host plant tissues as well as in dung after passage through sheep, thus demonstrating a facultative rather than an obligate life cycle. Finally, plants inoculated with S. fimicola were not preferred by sheep; preference had been expected if the fungus were obligate to dung. Overall, these findings make us question the assumption that these fungi are obligate to dung.	[Newcombe, George; Campbell, Jason; Launchbaugh, Karen] Univ Idaho, Dept Forest Rangelands & Fire Sci, Moscow, ID 83843 USA; [Griffith, David; Baynes, Melissa] Univ Idaho, Environm Sci Program, Moscow, ID 83843 USA; [Campbell, Jason] Univ Idaho, Palouse Res Educ & Extens Ctr, Moscow, ID 83843 USA; [Griffith, David] Univ Idaho, Ctr Resilient Communities, Moscow, ID 83843 USA; [Pendleton, Rosemary] US Forest Serv, Rocky Mt Res Stn, Albuquerque, NM USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; United States Department of Agriculture (USDA); United States Forest Service	Newcombe, G (corresponding author), Univ Idaho, Dept Forest Rangelands & Fire Sci, Moscow, ID 83843 USA.	georgen@uidaho.edu	Newcombe, George/N-1650-2019	Griffith, David/0000-0001-6702-6764	U.S. Forest Service Rocky Mountain Research Station [RMRS 10-CR-11221632-182]	U.S. Forest Service Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service)	Support was provided to GN by the U.S. Forest Service Rocky Mountain Research Station in the form of grant RMRS 10-CR-11221632-182. Their website is www.fs.fed.us/rmrs. RP of the RMRS collaborated fully in all aspects of the project.	AHRENS WH, 1990, WEED SCI, V38, P452, DOI 10.1017/S0043174500056824; ANGEL K, 1975, MYCOLOGIA, V67, P63, DOI 10.2307/3758228; Baker AG, 2013, QUATERNARY SCI REV, V62, P21, DOI 10.1016/j.quascirev.2012.11.018; Baynes M, 2012, FUNGAL BIOL-UK, V116, P133, DOI 10.1016/j.funbio.2011.10.008; Bell A, 1983, DUNG FUNGI ILLUSTRAT; Botella L, 2011, FUNGAL DIVERS, V47, P9, DOI 10.1007/s13225-010-0061-1; CAIN RF, 1948, CAN J RES C, V26, P486, DOI 10.1139/cjr48c-032; CARROLL G, 1988, ECOLOGY, V69, P2, DOI 10.2307/1943154; Chambers JC, 2007, ECOL MONOGR, V77, P117, DOI 10.1890/05-1991; CHAMBERS KR, 1987, J PHYTOPATHOL, V120, P369, DOI 10.1111/j.1439-0434.1987.tb00501.x; Chen XM, 2009, J NAT PROD, V72, P1712, DOI 10.1021/np900302w; Collado J, 1996, NOVA HEDWIGIA, V63, P347; Cugny C, 2010, VEG HIST ARCHAEOBOT, V19, P391, DOI 10.1007/s00334-010-0242-6; Dewan MM, 1994, APPL SOIL ECOL, V1, P45, DOI 10.1016/0929-1393(94)90022-1; Dix NJ, 1994, FUNGAL ECOLOGY; Engh I, 2010, EUR J CELL BIOL, V89, P864, DOI 10.1016/j.ejcb.2010.07.002; Farr DF, FUNGAL DATABASES SYS; Herrera J, 2011, MICROB ECOL, V61, P239, DOI 10.1007/s00248-010-9744-0; Horie Yoshikazu, 1997, Mycoscience, V38, P287, DOI 10.1007/BF02464086; Lamb BC, 1998, GENETICS, V149, P87; Li WC, 2007, FUNGAL DIVERS, V25, P69; Luginbuhl M., 1980, Sydowia, V33, P185; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; MADRAZO GM, 1979, AM BIOL TEACH, V41, P530; Marquez SS, 2007, FUNGAL DIVERS, V27, P171; Medd RW, 2005, BIOCONTROL SCI TECHN, V15, P21, DOI 10.1080/09583150410001720635; Mosley J. C., 1996, Sheep & Goat Research Journal, V12, P74; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; PARKER AD, 1979, MYCOLOGIA, V71, P1206, DOI 10.2307/3759107; Petrini O., 1992, Sydowia, V44, P282; Petrini O, 1988, SYDOWIA, V40, P46; Popp M, 1996, J EXP BOT, V47, P1469, DOI 10.1093/jxb/47.10.1469; Preszler RW, 1996, OECOLOGIA, V108, P159, DOI 10.1007/BF00333227; Raper D, 2009, QUATERNARY RES, V71, P490, DOI 10.1016/j.yqres.2009.01.010; Richardson MJ, 2001, MYCOL RES, V105, P387, DOI 10.1017/S0953756201003884; Marquez SS, 2010, FUNGAL DIVERS, V41, P115, DOI 10.1007/s13225-009-0015-7; SCHULZ B, 1993, MYCOL RES, V97, P1447, DOI 10.1016/S0953-7562(09)80215-3; Suryanarayanan TS, 1998, CAN J MICROBIOL, V44, P1003, DOI 10.1139/cjm-44-10-1003; WICKLOW DT, 1980, MYCOLOGIA, V72, P1015, DOI 10.2307/3759740; Wood JR, 2011, QUATERNARY SCI REV, V30, P915, DOI 10.1016/j.quascirev.2011.01.007; ZAK JC, 1978, CAN J BOT, V56, P2313, DOI 10.1139/b78-279	41	18	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147425	10.1371/journal.pone.0147425	http://dx.doi.org/10.1371/journal.pone.0147425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839959	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200039
J	Tenga, A; Beard, JA; Takwi, A; Wang, YM; Chen, TS				Tenga, Alexa; Beard, Jordan A.; Takwi, Apana; Wang, Yue-Ming; Chen, Taosheng			Regulation of Nuclear Receptor Nur77 by miR-124	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; CANCER CELL; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; ORPHAN RECEPTOR; STEM-CELLS; EXPRESSION; MICRORNAS; MEDULLOBLASTOMA; APOPTOSIS	The nuclear receptor Nur77 is commonly upregulated in adult cancers and has oncogenic functions. Nur77 is an immediate-early response gene that acts as a transcription factor to promote proliferation and protect cells from apoptosis. Conversely, Nur77 can translocate to the mitochondria and induce apoptosis upon treatment with various cytotoxic agents. Because Nur77 is upregulated in cancer and may have a role in cancer progression, it is of interest to understand the mechanism controlling its expression. MicroRNAs (miRNAs) are responsible for inhibiting translation of their target genes by binding to the 3'UTR and either degrading the mRNA or preventing it from being translated into protein, thereby making these non-coding endogenous RNAs vital regulators of every cellular process. Several miRNAs have been predicted to target Nur77; however, strong evidence showing the regulation of Nur77 by any miRNA is lacking. In this study, we used a luciferase reporter assay containing the 3'UTR of Nur77 to screen 296 miRNAs and found that miR-124, which is the most abundant miRNA in the brain and has a role in promoting neuronal differentiation, caused the greatest reduction in luciferase activity. Interestingly, we discovered an inverse relationship in Daoy medulloblastoma cells and undifferentiated granule neuron precursors in which Nur77 is upregulated and miR-124 is downregulated. Exogenous expression to further elevate Nur77 levels in Daoy cells increased proliferation and viability, but knocking down Nur77 via siRNA resulted in the opposite phenotype. Importantly, exogenous expression of miR-124 reduced Nur77 expression, cell viability, proliferation, and tumor spheroid size in 3D culture. In all, we have discovered miR-124 to be downregulated in instances of medulloblastoma in which Nur77 is upregulated, resulting in a proliferative state that abets cancer progression. This study provides evidence for increasing miR-124 expression as a potential therapy for cancers with elevated levels of Nur77.	[Tenga, Alexa; Beard, Jordan A.; Takwi, Apana; Wang, Yue-Ming; Chen, Taosheng] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Tenga, Alexa; Beard, Jordan A.; Chen, Taosheng] Univ Tennessee, Ctr Hlth Sci, Integrated Biomed Sci Program, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Chen, TS (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA.	taosheng.chen@stjude.org	Chen, Taosheng/I-6351-2013	Chen, Taosheng/0000-0001-6420-3809; Beard, Jordan/0000-0003-0281-1432	American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; National Institutes of Health [RO1GM086415, RO1GM110034, P30-CA21765]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086415, R01GM110034] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Lebanese Syrian Associated Charities (TC), St. Jude Children's Research Hospital (TC), and the National Institutes of Health (TC), grants RO1GM086415, RO1GM110034, & P30-CA21765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Alexopoulou AN, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2610; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anwar SL, 2013, INT J CANCER, V133, P660, DOI 10.1002/ijc.28068; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beard JA, 2015, CELL SIGNAL, V27, P257, DOI 10.1016/j.cellsig.2014.11.009; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Bras A, 2000, CELL DEATH DIFFER, V7, P262, DOI 10.1038/sj.cdd.4400653; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Chen C, ENDOGENOUS CONTROLS; Chen HZ, 2012, GUT, V61, P714, DOI 10.1136/gutjnl-2011-300783; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Cho SD, 2007, CANCER RES, V67, P674, DOI 10.1158/0008-5472.CAN-06-2907; Cho SD, 2010, MOL PHARMACOL, V77, P396, DOI 10.1124/mol.109.061143; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gokhale A, 2010, J CANCER RES THER, V6, P521, DOI 10.4103/0973-1482.77072; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Holbeck S, 2010, MOL ENDOCRINOL, V24, P1287, DOI 10.1210/me.2010-0040; Hu LH, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0054-z; Hu Y, 2015, MOL CANCER RES, V13, P281, DOI 10.1158/1541-7786.MCR-14-0230; JACOBSEN PF, 1985, J NEUROPATH EXP NEUR, V44, P472, DOI 10.1097/00005072-198509000-00003; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kotchetkov R, 2005, INT J ONCOL, V27, P1029; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee SO, 2012, ONCOGENE, V31, P3265, DOI 10.1038/onc.2011.504; Lee SO, 2014, MOL CANCER RES, V12, P527, DOI 10.1158/1541-7786.MCR-13-0567; Lee SO, 2011, EXPERT OPIN THER TAR, V15, P195, DOI 10.1517/14728222.2011.547481; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Li XJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.270; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lin PC, 2008, J NEUROCHEM, V106, P1017, DOI 10.1111/j.1471-4159.2008.05432.x; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Maruoka H, 2010, J BIOCHEM, V148, P93, DOI 10.1093/jb/mvq036; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Mazuy C, 2013, FEBS LETT, V587, P3883, DOI 10.1016/j.febslet.2013.10.024; Mohan HM, 2012, CLIN CANCER RES, V18, P3223, DOI 10.1158/1078-0432.CCR-11-2953; Mondanizadeh M, 2015, J CELL BIOCHEM, V116, P943, DOI 10.1002/jcb.25045; Mu XM, 2003, J BIOL CHEM, V278, P42840, DOI 10.1074/jbc.M305594200; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Murray MJ, 2015, CANCER EPIDEM BIOMAR, V24, P350, DOI 10.1158/1055-9965.EPI-14-0669; Packer RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1419, DOI 10.1001/archneur.65.11.1419; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Sato A, 2008, NEURAL NETWORKS, V21, P1056, DOI 10.1016/j.neunet.2008.05.004; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Silber J, 2013, NEURO-ONCOLOGY, V15, P83, DOI 10.1093/neuonc/nos281; Smoll NR, 2012, CANCER-AM CANCER SOC, V118, P1313, DOI 10.1002/cncr.26387; Stephen Safe KK, 2011, NUCL RECEPT SIGNAL, V9; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; To SKY, 2012, EXPERT OPIN THER TAR, V16, P573, DOI 10.1517/14728222.2012.680958; Tomioka T, 2014, NEUROSCI RES, V88, P39, DOI 10.1016/j.neures.2014.07.009; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Tricoli James V, 2007, Cancer Res, V67, P4553, DOI 10.1158/0008-5472.CAN-07-0563; Ueda Y, 1999, AM J RESP CELL MOL, V20, P1319, DOI 10.1165/ajrcmb.20.6.3577; Uemura H, 1998, ENDOCRINOLOGY, V139, P2329, DOI 10.1210/en.139.5.2329; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Wang P, 2014, ONCOGENE, V33, P514, DOI 10.1038/onc.2012.598; [Washington University St. Jude Childrens Research Hospital], 2014, PED CANC GEN PROJ; Wu H, 2011, FASEB J, V25, P192, DOI 10.1096/fj.10-166462; Wu Q, 2002, CARCINOGENESIS, V23, P1583, DOI 10.1093/carcin/23.10.1583; Xu WW, 2012, NEUROSCI LETT, V529, P12, DOI 10.1016/j.neulet.2012.09.025; Yoo YG, 2007, ONCOGENE, V26, P3823, DOI 10.1038/sj.onc.1210149; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng FY, 2009, CANCER LETT, V284, P157, DOI 10.1016/j.canlet.2009.04.016; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	77	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148433	10.1371/journal.pone.0148433	http://dx.doi.org/10.1371/journal.pone.0148433			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840408	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200134
J	Duarte, DA; Papadimitriou, A; Gilbert, RE; Thai, K; Zhang, YL; Rosales, MAB; de Faria, JBL; de Faria, JML				Duarte, Diego A.; Papadimitriou, Alexandros; Gilbert, Richard E.; Thai, Kerri; Zhang, Yanling; Rosales, Mariana A. B.; Lopes de Faria, Jose B.; Lopes de Faria, Jacqueline M.			Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; SIRT1; DEGENERATION; MECHANISMS; TARGET; GROWTH; DAMAGE	Bone marrow-derived cells were demonstrated to improve organ function, but the lack of cell retention within injured organs suggests that the protective effects are due to factors released by the cells. Herein, we tested cell therapy using early outgrowth cells (EOCs) or their conditioned media (CM) to protect the retina of diabetic animal models (type 1 and type 2) and assessed the mechanisms by in vitro study. Control and diabetic (db/db) mice (8 weeks of age) were randomized to receive a unique intravenous injection of 5x10(5)EOCs or 0.25 ml thrice weekly tail-vein injections of 10x concentrated CM and Wystar Kyoto rats rendered diabetic were randomized to receive 0.50 ml thrice weekly tail-vein injections of 10x concentrated CM. Four weeks later, the animals were euthanized and the eyes were enucleated. Rat retinal Muller cells (rMCs) were exposed for 24 h to high glucose (HG), combined or not with EOC-conditioned medium (EOC-CM) from db/m EOC cultures. Diabetic animals showed increase in diabetic retinopathy (DR) and oxidative damage markers; the treatment with EOCs or CM infusions significantly reduced this damage and re-established the retinal function. In rMCs exposed to diabetic milieu conditions (HG), the presence of EOC-CM reduced reactive oxygen species production by modulating the NADPH-oxidase 4 system, thus upregulating SIRT1 activity and deacetylating Lys-310-p65-NF.B, decreasing GFAP and VEGF expressions. The antioxidant capacity of EOC-CM led to the prevention of carbonylation and nitrosylation posttranslational modifications on the SIRT1 molecule, preserving its activity. The pivotal role of SIRT1 on the mode of action of EOCs or their CM was also demonstrated on diabetic retina. These findings suggest that EOCs are effective as a form of systemic delivery for preventing the early molecular markers of DR and its conditioned medium is equally protective revealing a novel possibility for cell-free therapy for the treatment of DR.	[Duarte, Diego A.; Papadimitriou, Alexandros; Rosales, Mariana A. B.; Lopes de Faria, Jose B.; Lopes de Faria, Jacqueline M.] State Univ Campinas UNICAMP, Fac Med Sci, Renal Pathophysiol Lab, Invest Diabet Complicat, Campinas, SP, Brazil; [Gilbert, Richard E.; Thai, Kerri; Zhang, Yanling] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li KaShing Knowledge Inst, Toronto, ON, Canada	Universidade Estadual de Campinas; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	de Faria, JML (corresponding author), State Univ Campinas UNICAMP, Fac Med Sci, Renal Pathophysiol Lab, Invest Diabet Complicat, Campinas, SP, Brazil.	jmlfaria@fcm.unicamp.br	de faria, jose b lopes/C-2752-2012; de Faria, Jose B. Lopes/M-7198-2019; de Faria, Jacqueline M Lopes/B-3851-2013; Rosales, Mariana A B/K-7965-2014	de faria, jose b lopes/0000-0003-2373-5539; de Faria, Jose B. Lopes/0000-0003-2373-5539; de Faria, Jacqueline M Lopes/0000-0002-4783-4665; Rosales, Mariana A B/0000-0001-8042-0483	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57560-0, 2010/11514-7, 2013/04331-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grants 2008/57560-0, 2010/11514-7, J.B.L. F.; 2013/04331-1, J.M.L.F.) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). D.A.D. and A.P. received a scholarship from FAPESP, and M.A.M.R from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio M, 2008, CURR PHARM DESIGN, V14, P2651, DOI 10.2174/138161208786264052; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Duarte DA, 2015, J NUTR BIOCHEM, V26, P64, DOI 10.1016/j.jnutbio.2014.09.003; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Kawamoto Atsuhiko, 2002, Cardiovasc Radiat Med, V3, P221, DOI 10.1016/S1522-1865(03)00082-9; Kitada M, 2010, J DIABETES INVEST, V1, P77, DOI 10.1111/j.2040-1124.2010.00018.x; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mund JA, 2009, CYTOTHERAPY, V11, P103, DOI 10.1080/14653240802714827; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Papadimitriou A, 2014, CELL PHYSIOL BIOCHEM, V34, P1260, DOI 10.1159/000366336; Rahman I, 2012, PREV MED, V54, pS20, DOI 10.1016/j.ypmed.2011.11.014; REICHENBACH A, 1986, NEUROSCI LETT, V71, P125, DOI 10.1016/0304-3940(86)90545-8; Santos JM, 2011, CURR PHARM BIOTECHNO, V12, P352; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Siqueira RC, 2011, RETINA-J RET VIT DIS, V31, P1207, DOI 10.1097/IAE.0b013e3181f9c242; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; TOUT S, 1993, NEUROSCIENCE, V55, P291, DOI 10.1016/0306-4522(93)90473-S; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Wei XF, 2009, AM J PHYSIOL-RENAL, V296, pF427, DOI 10.1152/ajprenal.90536.2008; Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028; Yang HH, 2012, SCI WORLD J, P1, DOI 10.1100/2012/149132; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yuen DA, 2013, STEM CELLS, V31, P2408, DOI 10.1002/stem.1502; Yuen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009543; Zhang YL, 2012, DIABETES, V61, P2114, DOI 10.2337/db11-1365; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b; Zheng Y, 1922, INDIAN J OPHTHALMOL, V60, P428	40	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0147978	10.1371/journal.pone.0147978	http://dx.doi.org/10.1371/journal.pone.0147978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26836609	Green Submitted, Green Published, gold			2022-12-26	WOS:000369548500005
J	Wanlapakorn, N; Ngaovithunvong, V; Thongmee, T; Vichaiwattana, P; Vongpunsawad, S; Poovorawan, Y				Wanlapakorn, Nasamon; Ngaovithunvong, Varisara; Thongmee, Thanunrat; Vichaiwattana, Preeyaporn; Vongpunsawad, Sompong; Poovorawan, Yong			Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; DIPHTHERIA; SEROEPIDEMIOLOGY; IMMUNIZATION; ADULTS	Despite the high coverage of prophylactic vaccine against Bordetella pertussis infection in many countries for more than three decades, pertussis remains a common vaccine-preventable disease. Infections have been detected more commonly in countries using acellular pertussis vaccine in their Expanded Program of Immunization. Thailand implemented a routine infant immunization program with whole-cell pertussis vaccine in 1977, and since 1992, the national vaccine policy has offered a five-dose whole-cell pertussis vaccine for children given at the ages of 2, 4, 6, 18, and 48 months. This study aimed to investigate the seroprevalence of antibodies to pertussis toxin among healthy people across all ages to determine the level of whole-cell vaccine-induced immunity in the population, and to identify which age group should be targeted for a booster dose. The lowest seronegative rate and highest geometric mean concentrations were found in the 0-10 years age group, corresponding to their recent pertussis vaccination. The proportion of people with undetectable IgG level was prominent, starting after 11 years of age onwards. Now that a reduced-dose pertussis vaccine with fewer adverse effects is available, a booster dose during adolescence should be considered in order to reduce the incidence of pertussis disease. Further studies exploring how long the reduced-dose pertussis vaccine can provide protective immunity against pertussis disease when administered to adults and adolescents should also be performed.	[Wanlapakorn, Nasamon; Ngaovithunvong, Varisara; Thongmee, Thanunrat; Vichaiwattana, Preeyaporn; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok 10330, Thailand	Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807; vongpunsawad, sompong/0000-0001-7520-8728	National Research University Project; Office of Higher Education Commission [WCU001-HR-57, WCU007-HR-57, WCU-58-006-HR]; National Research Council of Thailand (NRCT); Research Chair Grant from the National Science and Technology Development Agency; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of Thailand Research Fund [DPG5480002]; Siam Cement Group; MK Restaurant Company Limited	National Research University Project; Office of Higher Education Commission(Office of Higher Education Commission (OHEC)); National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Research Chair Grant from the National Science and Technology Development Agency; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of Thailand Research Fund; Siam Cement Group; MK Restaurant Company Limited	This work was supported by The National Research University Project, Office of Higher Education Commission (WCU001-HR-57, WCU007-HR-57, and WCU-58-006-HR), the National Research Council of Thailand (NRCT), the Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project (CU56-HR01), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093), the Outstanding Professor of Thailand Research Fund (DPG5480002), Siam Cement Group, and MK Restaurant Company Limited. All grants were given to Professor Yong Poovorawan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NATIONAL DISEASE SUR; Bureau of Epidemiology Department of Disease Control Ministry of Public Health Thailand, ANNUAL EPIDEMIOLOGIC; Centers for Disease Control and Prevention, 2014 PROVISIONAL PER; Centers for Disease Control and Prevention, MMWR; Cherry JD, 1996, J INFECT DIS, V174, pS259, DOI 10.1093/infdis/174.Supplement_3.S259; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x; Kretzschmar M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000291; Lugauer S, 2002, EUR J PEDIATR, V161, P142, DOI 10.1007/s00431-001-0893-5; McGirr A, 2015, PEDIATRICS, V135, P331, DOI 10.1542/peds.2014-1729; Rendi-Wagner P, 2010, VACCINE, V28, P3285, DOI 10.1016/j.vaccine.2010.02.104; Riolo MA, 2015, P NATL ACAD SCI USA, V112, pE472, DOI 10.1073/pnas.1415573112; Ronn PF, 2014, EPIDEMIOL INFECT, V142, P729, DOI 10.1017/S0950268813002446; Shamsizadeh A, 2014, E MEDITERR HEALTH J, V20, P623, DOI 10.26719/2014.20.10.623; Snapp Barbara, 2013, Adv Neonatal Care, V13, P103, DOI 10.1097/ANC.0b013e318285f918; Syed MA, 2012, JCPSP-J COLL PHYSICI, V22, P677, DOI 10.2012/JCPSP.677678; Tharmaphornpilas P, 2001, J INFECT DIS, V184, P1035, DOI 10.1086/323453; Urwyler P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-397; Wanlapakorn N, 2014, SE ASIAN J TROP MED, V45, P1132; World Health Organization, IMMUNIZATION VACCINE; World Health Organization, WHO GLOBAL AND REGIO; Zhang Q, 2011, J INFECTION, V63, P441, DOI 10.1016/j.jinf.2011.07.018	22	20	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0148338	10.1371/journal.pone.0148338	http://dx.doi.org/10.1371/journal.pone.0148338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26837004	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548500007
J	Markus, NM; Hasel, P; Qiu, J; Bell, KFS; Heron, S; Kind, PC; Dando, O; Simpson, TI; Hardingham, GE				Markus, Nora M.; Hasel, Philip; Qiu, Jing; Bell, Karen F. S.; Heron, Samuel; Kind, Peter C.; Dando, Owen; Simpson, T. Ian; Hardingham, Giles E.			Expression of mRNA Encoding Mcu and Other Mitochondrial Calcium Regulatory Genes Depends on Cell Type, Neuronal Subtype, and Ca2+ Signaling	PLOS ONE			English	Article							NMDA RECEPTOR-ACTIVITY; ESSENTIAL COMPONENT; NUCLEAR CA2+; GENOME-WIDE; MICU1; UNIPORTER; PROTEIN; TRANSCRIPTION; MEMBRANE; STRESS	Uptake of Ca2+ into the mitochondrial matrix controls cellular metabolism and survival-death pathways. Several genes are implicated in controlling mitochondrial Ca2+ uptake (mitochondrial calcium regulatory genes, MCRGs), however, less is known about the factors which influence their expression level. Here we have compared MCRG mRNA expression, in neural cells of differing type (cortical neurons vs. astrocytes), differing neuronal subtype (CA3 vs. CA1 hippocampus) and in response to Ca2+ influx, using a combination of qPCR and RNA-seq analysis. Of note, we find that the Mcu-regulating Micu gene family profile differs substantially between neurons and astrocytes, while expression of Mcu itself is markedly different between CA3 and CA1 regions in the adult hippocampus. Moreover, dynamic control of MCRG mRNA expression in response to membrane depolarization-induced Ca2+ influx is also apparent, resulting in repression of Letm1, as well as Mcu. Thus, the mRNA expression profile of MCRGs is not fixed, which may cause differences in the coupling between cytoplasmic and mitochondrial Ca2+, as well as diversity of mitochondrial Ca2+ uptake mechanisms.	[Markus, Nora M.; Hasel, Philip; Qiu, Jing; Bell, Karen F. S.; Heron, Samuel; Kind, Peter C.; Hardingham, Giles E.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Heron, Samuel; Simpson, T. Ian] Univ Edinburgh, Sch Informat, Edinburgh EH8 9AB, Midlothian, Scotland; [Kind, Peter C.; Dando, Owen] Natl Ctr Biol Sci, Inst Stem Cell Biol & Regenerat Med, Ctr Brain Dev & Repair, Bangalore 560065, Karnataka, India	University of Edinburgh; University of Edinburgh; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Hardingham, GE (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	Giles.Hardingham@ed.ac.uk	Qiu, Jing/GQH-8027-2022; Simpson, Ian/AAG-8830-2021	Simpson, Ian/0000-0003-0495-7187; Hasel, Philip/0000-0003-4378-3685; Dando, Owen/0000-0002-6269-6408; Hardingham, Giles/0000-0002-7629-5314; Kind, Peter/0000-0002-4256-9639	Medical Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council; MRC [G0902044] Funding Source: UKRI; Medical Research Council [1292847, G0902044] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, the Wellcome Trust, and the Biotechnology and Biological Sciences Research Council.	Alam MR, 2012, J BIOL CHEM, V287, P34445, DOI 10.1074/jbc.M112.392084; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Baxter PS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7761; Baxter PS, 2011, J NEUROCHEM, V118, P365, DOI 10.1111/j.1471-4159.2011.07330.x; Bell KF, 2011, P NATL ACAD SCI USA, V108, pE1, DOI 10.1073/pnas.1015229108; Bell KFS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8066; Bell KFS, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/689524; Bell KFS, 2011, ANTIOXID REDOX SIGN, V14, P1467, DOI 10.1089/ars.2010.3567; Bell KFS, 2011, CURR OPIN NEUROBIOL, V21, P299, DOI 10.1016/j.conb.2011.01.002; Bilican B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085932; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Chen M, 2011, ACTA BIOCH BIOPH SIN, V43, P822, DOI 10.1093/abbs/gmr075; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; Csordas G, 2012, MOL CELL ENDOCRINOL, V353, P109, DOI 10.1016/j.mce.2011.11.011; De Stefani D, 2015, BIOCH BIOPHYS ACTA; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drago I, 2011, EMBO J, V30, P4119, DOI 10.1038/emboj.2011.337; Duchen MR, 2012, PFLUG ARCH EUR J PHY, V464, P111, DOI 10.1007/s00424-012-1112-0; Feng SJ, 2013, P NATL ACAD SCI USA, V110, P11011, DOI 10.1073/pnas.1309531110; Gupta K, 2012, CELL DEATH DIFFER, V19, P779, DOI 10.1038/cdd.2011.154; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2011, ANTIOXID REDOX SIGN, V14, P1421, DOI 10.1089/ars.2010.3573; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hardingham NR, 2007, J NEUROPHYSIOL, V97, P2965, DOI 10.1152/jn.01352.2006; Hasel P, 2014, BIOCH BIOPHYS ACTA; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hoffman NE, 2014, MOL BIOL CELL, V25, P936, DOI 10.1091/mbc.E13-08-0502; Jakob R, 2014, NEUROSCI LETT, V575, P7, DOI 10.1016/j.neulet.2014.05.026; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kamer KJ, 2014, EMBO REP, V15, P299, DOI 10.1002/embr.201337946; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Mallilankaraman K, 2015, NAT CELL BIOL, V17, P953, DOI 10.1038/ncb3202; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Mckenzie GJ, 2005, J NEUROCHEM, V93, P171, DOI 10.1111/j.1471-4159.2005.03010.x; Newrzella D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-370; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Puddifoot C, 2012, J NEUROSCI, V32, P6995, DOI 10.1523/JNEUROSCI.6407-11.2012; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Vais H, 2015, CELL METAB, V22, P533, DOI 10.1016/j.cmet.2015.09.015; Wahl AS, 2009, NEUROSCIENCE, V158, P344, DOI 10.1016/j.neuroscience.2008.06.018; Waldeck-Weiermair M, 2011, J BIOL CHEM, V286, P28444, DOI 10.1074/jbc.M111.244517; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Wilde GJC, 1997, J NEUROCHEM, V69, P883; Wyllie DJA, 2013, NEUROPHARMACOLOGY, V74, P4, DOI 10.1016/j.neuropharm.2013.01.016; Yang G, 2000, BRAIN RES, V870, P195, DOI 10.1016/S0006-8993(00)02319-2; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	68	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148164	10.1371/journal.pone.0148164	http://dx.doi.org/10.1371/journal.pone.0148164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828201	gold, Green Published, Green Submitted			2022-12-26	WOS:000369548200075
J	McHaffie, SL; Hastie, ND; Chau, YY				McHaffie, Sophie L.; Hastie, Nicholas D.; Chau, You-Ying			Effects of CreER(T2), 4-OH Tamoxifen, and Gender on CFU-F Assays	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; CRE RECOMBINASE; MESENCHYMAL PROGENITORS; ALKALINE-PHOSPHATASE; DIFFERENTIATION; POPULATIONS; RALOXIFENE; STRAINS; SURFACE	Gene function in stem cell maintenance is often tested by inducing deletion via the Cre-loxP system. However, controls for Cre and other variables are frequently not included. Here we show that when cultured in the presence of 4-OH tamoxifen, bone and marrow cells containing the CreER(T2) construct have a reduced colony forming ability. Inactive CreER(T2) recombinase, however, has the opposite effect. Young female marrow cells containing the inactive CreER(T2) construct grew more colonies than cells lacking the construct altogether. Young female control marrow cells (i.e., negative for CreER(T2)) also produced significantly greater colony numbers when cultured with 4-OH tamoxifen, compared with the ethanol vehicle control. In conclusion, we report that the use of the Cre-loxP system is inadvisable in combination with CFU-F assays, and that appropriate controls should be in place to extend the future use of Cre-loxP in alternate assays.	[McHaffie, Sophie L.; Hastie, Nicholas D.; Chau, You-Ying] Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Chau, You-Ying] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Chau, YY (corresponding author), Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh, Midlothian, Scotland.; Chau, YY (corresponding author), Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	You-Ying.Chau@igmm.ed.ac.uk		McHaffie, Sophie/0000-0002-9088-2646	Medical Research Council; MRC [MC_PC_U127527180] Funding Source: UKRI; Medical Research Council [MC_PC_U127527180] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is funded by a Medical Research Council core grant.	Antoniou ES, 2004, SHOCK, V22, P415, DOI 10.1097/01.shk.0000142185.88094.88; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Brake Rachael L, 2004, Genet Mol Res, V3, P456; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; Delneri D, 2000, GENE, V252, P127, DOI 10.1016/S0378-1119(00)00217-1; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; Feil Susanne, 2009, V530, P343, DOI 10.1007/978-1-59745-471-1_18; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Grcevic D, 2012, STEM CELLS, V30, P187, DOI 10.1002/stem.780; ISHIKAWA Y, 1988, EUR J HAEMATOL, V40, P126; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Liu SG, 2014, J BONE MINER RES, V29, P1141, DOI 10.1002/jbmr.2120; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305; Michael H, 2007, BRIT J PHARMACOL, V151, P384, DOI 10.1038/sj.bjp.0707232; Miki Y, 2009, J STEROID BIOCHEM, V113, P281, DOI 10.1016/j.jsbmb.2009.01.010; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Ohishi M, 2012, AM J PATHOL, V180, P811, DOI 10.1016/j.ajpath.2011.10.028; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Penfornis P, 2011, METHODS MOL BIOL, V698, P11, DOI 10.1007/978-1-60761-999-4_2; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Ratajczak MZ, 2004, FOLIA HISTOCHEM CYTO, V42, P139; Ray R, 2008, MOL MED, V14, P493, DOI 10.2119/2008-00004.Ray; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Siclari VA, 2013, BONE, V53, P575, DOI 10.1016/j.bone.2012.12.013; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Solchaga LA, 2011, METHODS MOL BIOL, V698, P253, DOI 10.1007/978-1-60761-999-4_20; Sreekala C, 2005, PLANT CELL REP, V24, P86, DOI 10.1007/s00299-004-0909-5; Srivastava V, 2003, PLANT MOL BIOL, V52, P661, DOI 10.1023/A:1024839617490; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; VANSTRAALEN JP, 1991, CLIN CHIM ACTA, V201, P27, DOI 10.1016/0009-8981(91)90021-4; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064	37	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148105	10.1371/journal.pone.0148105	http://dx.doi.org/10.1371/journal.pone.0148105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828722	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200061
J	Wu, ML; Liu, CZ; Joiner, WJ				Wu, Meilin; Liu, Clifford Z.; Joiner, William J.			Structural Analysis and Deletion Mutagenesis Define Regions of QUIVER/SLEEPLESS that Are Responsible for Interactions with Shaker-Type Potassium Channels and Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PHARMACOLOGICAL CHAPERONE; ALPHA-BUNGAROTOXIN; PROTEINS; NEUROTOXINS; ACTIVATION; MECHANISMS; FAMILY; DOMAIN; CELLS	Ly6 proteins are endogenous prototoxins found in most animals. They show striking structural and functional parallels to snake a-neurotoxins, including regulation of ion channels and cholinergic signaling. However, the structural contributions of Ly6 proteins to regulation of effector molecules is poorly understood. This question is particularly relevant to the Ly6 protein QUIVER/SLEEPLESS (QVR/SSS), which has previously been shown to suppress excitability and synaptic transmission by upregulating potassium (K) channels and downregulating nicotinic acetylcholine receptors (nAChRs) in wake-promoting neurons to facilitate sleep in Drosophila. Using deletion mutagenesis, co-immunoprecipitations, ion flux assays, surface labeling and confocal microscopy, we demonstrate that only loop 2 is required for many of the previously described properties of SSS in transfected cells, including interactions with K channels and nAChRs. Collectively our data suggest that QVR/SSS, and by extension perhaps other Ly6 proteins, target effector molecules using limited protein motifs. Mapping these motifs may be useful in rational design of drugs that mimic or suppress Ly6-effector interactions to modulate nervous system function.	[Wu, Meilin; Joiner, William J.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Liu, Clifford Z.] Univ Calif San Diego, Marshall Coll, UCSD Undergrad Program, La Jolla, CA 92093 USA; [Joiner, William J.] Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Joiner, WJ (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Joiner, WJ (corresponding author), Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA.	wjoiner@ucsd.edu		Liu, Clifford/0000-0003-1783-299X	National Institute of Neurological Disorders and Stroke/National Institutes of Health [NS072431]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072431] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by National Institute of Neurological Disorders and Stroke/National Institutes of Health grant # NS072431 to WJJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbitt KB, 2009, J LEUKOCYTE BIOL, V85, P55, DOI 10.1189/jlb.0507305; Adeyo O, 2015, BR J DERMATOL; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Bresson-Mazet C, 2008, CELL PROLIFERAT, V41, P726, DOI 10.1111/j.1365-2184.2008.00554.x; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Dean T, 2011, J NEUROSCI, V31, P11387, DOI 10.1523/JNEUROSCI.0502-11.2011; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; FLEMING TJ, 1993, J IMMUNOL, V150, P5379; Galat A, 2008, CELL MOL LIFE SCI, V65, P3481, DOI 10.1007/s00018-008-8473-8; Govind AP, 2012, J NEUROSCI, V32, P2227, DOI 10.1523/JNEUROSCI.5438-11.2012; Holmes RS, 2012, 3 BIOTECH, V2, P37, DOI 10.1007/s13205-011-0026-4; Kiguchi N, 2012, NEUROCHEM INT, V61, P1212, DOI 10.1016/j.neuint.2012.09.001; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Loertscher R, 2002, TRANSPL IMMUNOL, V9, P93, DOI 10.1016/S0966-3274(02)00013-8; Long KK, 2011, FASEB J, V25, P1156, DOI 10.1096/fj.10-170308; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lyukmanova EN, 2013, J BIOL CHEM, V288, P15888, DOI 10.1074/jbc.M112.436576; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; Mallya M, 2006, PROTEIN SCI, V15, P2244, DOI 10.1110/ps.062242606; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Plengpanich W, 2014, J BIOL CHEM, V289, P19491, DOI 10.1074/jbc.M114.558528; Puddifoot CA, 2015, J NEUROSCI, V35, P3420, DOI 10.1523/JNEUROSCI.3630-14.2015; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Tirosh Y, 2013, TOXINS, V5, P1314, DOI 10.3390/toxins5071314; Tsetlin VI, 2015, TRENDS PHARMACOL SCI, V36, P109, DOI 10.1016/j.tips.2014.11.003; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang JW, 2010, J NEUROGENET, V24, P67, DOI 10.3109/01677061003746341; Wang JW, 2000, J NEUROSCI, V20, P5958, DOI 10.1523/JNEUROSCI.20-16-05958.2000; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Wu ML, 2015, J BIOL CHEM, V290, P24509, DOI 10.1074/jbc.M115.647248; Wu ML, 2014, CURR BIOL, V24, P621, DOI 10.1016/j.cub.2014.02.026	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148215	10.1371/journal.pone.0148215	http://dx.doi.org/10.1371/journal.pone.0148215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828958	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200085
J	Raoufy, MR; Ghafari, T; Darooei, R; Nazari, M; Mahdaviani, SA; Eslaminejad, AR; Almasnia, M; Gharibzadeh, S; Mani, AR; Hajizadeh, S				Raoufy, Mohammad Reza; Ghafari, Tara; Darooei, Reza; Nazari, Milad; Mahdaviani, Seyed Alireza; Eslaminejad, Ali Reza; Almasnia, Mehdi; Gharibzadeh, Shahriar; Mani, Ali R.; Hajizadeh, Sohrab			Classification of Asthma Based on Nonlinear Analysis of Breathing Pattern	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; AIRWAY-OBSTRUCTION; FACE RECOGNITION; ALLERGIC-ASTHMA; RESPIRATORY IMPEDANCE; SPARSE REPRESENTATION; FLUCTUATION ANALYSIS; APPROXIMATE ENTROPY; NONATOPIC ASTHMA; SAMPLE ENTROPY	Normal human breathing exhibits complex variability in both respiratory rhythm and volume. Analyzing such nonlinear fluctuations may provide clinically relevant information in patients with complex illnesses such as asthma. We compared the cycle-by-cycle fluctuations of inter-breath interval (IBI) and lung volume (LV) among healthy volunteers and patients with various types of asthma. Continuous respiratory datasets were collected from forty age-matched men including 10 healthy volunteers, 10 patients with controlled atopic asthma, 10 patients with uncontrolled atopic asthma, and 10 patients with uncontrolled non-atopic asthma during 60 min spontaneous breathing. Complexity of breathing pattern was quantified by calculating detrended fluctuation analysis, largest Lyapunov exponents, sample entropy, and cross-sample entropy. The IBI as well as LV fluctuations showed decreased long-range correlation, increased regularity and reduced sensitivity to initial conditions in patients with asthma, particularly in uncontrolled state. Our results also showed a strong synchronization between the IBI and LV in patients with uncontrolled asthma. Receiver operating characteristic (ROC) curve analysis showed that nonlinear analysis of breathing pattern has a diagnostic value in asthma and can be used in differentiating uncontrolled from controlled and non-atopic from atopic asthma. We suggest that complexity analysis of breathing dynamics may represent a novel physiologic marker to facilitate diagnosis and management of patients with asthma. However, future studies are needed to increase the validity of the study and to improve these novel methods for better patient management.	[Raoufy, Mohammad Reza; Hajizadeh, Sohrab] Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran; [Ghafari, Tara] Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran; [Darooei, Reza] Tarbiat Modares Univ, Fac Elect & Comp Engn, Dept Biomed Engn, Tehran, Iran; [Nazari, Milad] Sharif Univ Technol, Fac Elect Engn, Tehran, Iran; [Mahdaviani, Seyed Alireza] Shahid Beheshti Univ Med Sci, NRITLD, Pediat Resp Dis Res Ctr, Tehran, Iran; [Eslaminejad, Ali Reza] Shahid Beheshti Univ Med Sci, NRITLD, Tracheal Dis Res Ctr, Tehran, Iran; [Almasnia, Mehdi] Shahid Beheshti Univ Med Sci, NRITLD, Chron Resp Dis Res Ctr, Tehran, Iran; [Gharibzadeh, Shahriar] Amirkabir Univ Technol, Fac Biomed Engn, Dept Bioelect, Tehran, Iran; [Mani, Ali R.] UCL, Div Med, London, England	Tarbiat Modares University; Shahid Beheshti University Medical Sciences; Tarbiat Modares University; Sharif University of Technology; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Amirkabir University of Technology; University of London; University College London	Raoufy, MR; Hajizadeh, S (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran.	raoufy@modares.ac.ir; hajezads@modares.ac.ir	mahdaviani, alireza/G-3256-2017; Darooei, Reza/CAF-6976-2022; eslaminejad, alireza/G-3239-2017; Mani, Alireza/H-3236-2015; Raoufy, Mohammad Reza/M-7809-2017	mahdaviani, alireza/0000-0001-6224-4797; eslaminejad, alireza/0000-0002-8788-4544; Mani, Alireza/0000-0003-0830-2022; gharibzadeh, shahriar/0000-0002-9604-8433; hajizadeh, sohrab/0000-0001-7920-6949; Raoufy, Mohammad Reza/0000-0002-9292-8564; Nazari, Milad/0000-0002-5008-5159; Ghafari, Tara/0000-0002-5178-8702	Tarbiat Modares University	Tarbiat Modares University	This work was supported by grants from the Tarbiat Modares University to M.R. Raoufy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARBANEL HDI, 1993, REV MOD PHYS, V65, P1331, DOI 10.1103/RevModPhys.65.1331; Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Basyigit I, 2004, MEDIAT INFLAMM, V13, P285, DOI 10.1080/09629350400003118; Bonham AC, 2001, ENVIRON HEALTH PERSP, V109, P573, DOI 10.2307/3454672; Cernelc M, 2002, J APPL PHYSIOL, V92, P1817, DOI 10.1152/japplphysiol.00675.2001; Chen CY, 2001, J ALLERGY CLIN IMMUN, V108, P557; Chen SD, 2008, NEUROSCI LETT, V440, P87, DOI 10.1016/j.neulet.2008.03.092; Cowan DC, 2010, THORAX, V65, P384, DOI 10.1136/thx.2009.126722; Dames KK, 2014, RESP PHYSIOL NEUROBI, V192, P39, DOI 10.1016/j.resp.2013.12.004; Deng WH, 2012, IEEE T PATTERN ANAL, V34, P1864, DOI 10.1109/TPAMI.2012.30; Engoren M, 1998, CRIT CARE MED, V26, P1817, DOI 10.1097/00003246-199811000-00021; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Frey U, 2008, LANCET, V372, P1088, DOI 10.1016/S0140-6736(08)61450-6; Frey U, 2011, J APPL PHYSIOL, V110, P1723, DOI 10.1152/japplphysiol.01297.2010; Gonem S, 2012, EUR RESPIR J, V40, P1156, DOI 10.1183/09031936.00228611; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Irvin CG, 2003, EUR RESPIR J, V22, P3, DOI 10.1183/09031936.03.00035703; Jain A, 1997, IEEE T PATTERN ANAL, V19, P153, DOI 10.1109/34.574797; Jain M, 2011, CURR SCI INDIA, V101, P1435; Kaminsky DA, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0505-x; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kohlboeck G, 2013, PEDIAT ALLERG IMM-UK, V24, P230, DOI 10.1111/pai.12056; Kuusela TA, 2002, AM J PHYSIOL-HEART C, V282, pH773, DOI 10.1152/ajpheart.00559.2001; Lefevre GR, 1996, AM J RESP CRIT CARE, V154, P1567, DOI 10.1164/ajrccm.154.5.8912782; Lin MJ, 2014, NEUROSCI LETT, V563, P22, DOI 10.1016/j.neulet.2014.01.023; Lu CY, 2013, J VIS COMMUN IMAGE R, V24, P111, DOI 10.1016/j.jvcir.2012.05.003; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; Murphy DM, 2010, CHEST, V137, P1417, DOI 10.1378/chest.09-1895; Muskulus M, 2010, J APPL PHYSIOL, V109, P1582, DOI 10.1152/japplphysiol.01414.2009; Nhlbi. and Prevention Program Expert Panel, 2007, CHILDREN, V120, pS94, DOI [10.1016/j.jaci.2007.09.029, DOI 10.1016/J.JACI.2007.09.029]; Peng CK, 2002, ANN BIOMED ENG, V30, P683, DOI 10.1114/1.1481053; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PINCUS SM, 1994, MATH BIOSCI, V122, P161, DOI 10.1016/0025-5564(94)90056-6; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; RACKEMANN FM, 1947, AM J MED, V3, P601, DOI 10.1016/0002-9343(47)90204-0; Raoufy MR, 2013, RESPIROLOGY, V18, P108, DOI 10.1111/j.1440-1843.2012.02251.x; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Seely AJE, 2014, CRIT CARE, V18, DOI 10.1186/cc13822; Shim E, 2015, ALLERGY ASTHMA IMMUN, V7, P339, DOI 10.4168/aair.2015.7.4.339; Shirazi AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072854; Suki B, 2002, AM J RESP CRIT CARE, V166, P133, DOI 10.1164/rccm.200202-152PP; Suki B, 2010, J APPL PHYSIOL, V109, P1571, DOI 10.1152/japplphysiol.01102.2010; Thamrin C, 2009, J APPL PHYSIOL, V106, P753, DOI 10.1152/japplphysiol.91588.2008; Valenza Gaetano, 2012, Front Neuroeng, V5, P3, DOI 10.3389/fneng.2012.00003; Veiga J, 2012, MED BIOL ENG COMPUT, V50, P1249, DOI 10.1007/s11517-012-0957-x; Veiga J, 2011, J APPL PHYSIOL, V111, P412, DOI 10.1152/japplphysiol.00267.2011; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Walsh GM, 2003, J ENDOCRINOL, V178, P37, DOI 10.1677/joe.0.1780037; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wu HT, 2014, IEEE T BIO-MED ENG, V61, P736, DOI 10.1109/TBME.2013.2288497; Yeragani VK, 2002, NEUROPSYCHOBIOLOGY, V46, P111, DOI 10.1159/000066388; Yin J, 2012, NEUROCOMPUTING, V77, P120, DOI 10.1016/j.neucom.2011.08.018; Zhang T, 2007, EXP PHYSIOL, V92, P659, DOI 10.1113/expphysiol.2007.037150	58	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147976	10.1371/journal.pone.0147976	http://dx.doi.org/10.1371/journal.pone.0147976			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824900	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600081
J	Roussis, IM; Guille, M; Myers, FA; Scarlett, GP				Roussis, Ioannis M.; Guille, Matthew; Myers, Fiona A.; Scarlett, Garry P.			RNA Whole-Mount In situ Hybridisation Proximity Ligation Assay (rISH-PLA), an Assay for Detecting RNA-Protein Complexes in Intact Cells	PLOS ONE			English	Article							LOCKED NUCLEIC-ACID; BINDING PROTEINS; MESSENGER-RNA; XENOPUS; LOCALIZATION; MICRORNAS; LNA; TRANSCRIPTION; RECOGNITION; ELEMENT	Techniques for studying RNA-protein interactions have lagged behind those for DNA-protein complexes as a consequence of the complexities associated with working with RNA. Here we present a method for the modification of the existing In Situ Hybridisation-Proximity Ligation Assay (ISH-PLA) protocol to adapt it to the study of RNA regulation (rISH-PLA). As proof of principle we used the well-characterised interaction of the Xenopus laevis Staufen RNA binding protein with Vg1 mRNA, the complex of which co-localises to the vegetal pole of Xenopus oocytes. The applicability of both the Stau1 antibody and the Locked Nucleic Acid probe (LNA) recognising Vg1 mRNA were independently validated by whole-mount Immunohistochemistry and whole-mount in situ hybridisation assays respectively prior to combining them in the rISH-PLA assay. The rISH-PLA assay allows the identification of a given RNA-protein complex at subcellular and single cell resolution, thus avoiding the lack of spatial resolution and sensitivity associated with assaying heterogenous cell populations from which conventional RNA-protein interaction detection techniques suffer. This technique will be particularly usefully for studying the activity of RNA binding proteins (RBPs) in complex mixtures of cells, for example tissue sections or whole embryos.	[Roussis, Ioannis M.; Guille, Matthew; Myers, Fiona A.; Scarlett, Garry P.] Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DT, Hants, England	University of Portsmouth	Myers, FA; Scarlett, GP (corresponding author), Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DT, Hants, England.	fiona.myers@port.ac.uk; garry.scarlett@port.ac.uk		Myers, Fiona/0000-0001-5568-1817; Guille, Matthew/0000-0001-6865-4519; Scarlett, Garry/0000-0001-8338-2398	Biochemical Society: Eric Reid Fund Methodology grant; University of Portsmouth; Biotechnology and Biological Sciences Research Council [BB/K019988/1] Funding Source: researchfish; BBSRC [BB/K019988/1] Funding Source: UKRI	Biochemical Society: Eric Reid Fund Methodology grant; University of Portsmouth; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biochemical Society: Eric Reid Fund Methodology grant and the University of Portsmouth: Internal funding.	Allison R, 2004, RNA, V10, P1751, DOI 10.1261/rna.7450204; Bheda P, 2014, TRENDS CELL BIOL, V24, P712, DOI 10.1016/j.tcb.2014.08.010; Bilinski SM, 2010, METHODS, V51, P11, DOI 10.1016/j.ymeth.2009.12.003; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; DALE L, 1993, EMBO J, V12, P4471, DOI 10.1002/j.1460-2075.1993.tb06136.x; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Goljanek-Whysall K, 2014, DEVELOPMENT, V141, P3378, DOI 10.1242/dev.108787; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; Guille M, 1999, ZEBRAFISH; Joseph EM, 1998, DEVELOPMENT, V125, P2677; Kechavarzi B, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r14; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Koos B, 2014, CURR TOP MICROBIOL, V377, P111, DOI 10.1007/82_2013_334; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Lewis RA, 2004, MECH DEVELOP, V121, P101, DOI 10.1016/j.mod.2003.09.009; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Llewellyn KJ, 2009, BBA-GENE REGUL MECH, V1789, P675, DOI 10.1016/j.bbagrm.2009.07.007; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; MOWRY KL, 1992, SCIENCE, V255, P991, DOI 10.1126/science.1546297; Myers FA, 2001, J BIOL CHEM, V276, P20197, DOI 10.1074/jbc.M009472200; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Rosa A, 2015, LONG NONCODING RNA R; Scarlett GP, 2004, J BIOL CHEM, V279, P52447, DOI 10.1074/jbc.M406107200; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Szabo L, 2015, GENOME BIOL, V16, DOI [10.1186/s13059-015-0690-5, 10.1186/s13059-016-1123-9]; Tallafuss A, 2014, CURR GENOMICS, V15, P278, DOI 10.2174/1389202915666140602230106; THOMSEN GH, 1993, CELL, V74, P433, DOI 10.1016/0092-8674(93)80045-G; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Van Assche E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00141; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wang Z, 2009, METHODS, V48, P287, DOI 10.1016/j.ymeth.2009.02.021; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; Yoon YJ, 2004, DEVELOPMENT, V131, P3035, DOI 10.1242/dev.01170; Zhao WM, 2001, EMBO J, V20, P2315, DOI 10.1093/emboj/20.9.2315	40	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147967	10.1371/journal.pone.0147967	http://dx.doi.org/10.1371/journal.pone.0147967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824753	Green Published, gold			2022-12-26	WOS:000369528600079
J	Wu, YH; Yu, YQ; Zhao, TC; Wang, SB; Fu, YL; Qi, Y; Yang, G; Yao, WW; Su, YY; Ma, Y; Shi, JP; Jiang, J; Kou, CG				Wu, Yanhua; Yu, Yaqin; Zhao, Tiancheng; Wang, Shibin; Fu, Yingli; Qi, Yue; Yang, Guang; Yao, Wenwang; Su, Yingying; Ma, Yue; Shi, Jieping; Jiang, Jing; Kou, Changgui			Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome	PLOS ONE			English	Article							APOLIPOPROTEIN A1/C3/A5 HAPLOTYPES; PLASMA-LIPID LEVELS; ALCOHOL-CONSUMPTION; TRIGLYCERIDE LEVELS; DAIRY CONSUMPTION; A5 GENE; PREVALENCE; RISK; ASSOCIATION; DISEASE	Objective The present study investigated the prevalence and risk factors for Metabolic syndrome. We evaluated the association between single nucleotide polymorphisms (SNPs) in the apolipoprotein APOA1/C3/A4/A5 gene cluster and the MetS risk and analyzed the interactions of environmental factors and APOA1/C3/A4/A5 gene cluster polymorphisms with MetS. Methods A study on the prevalence and risk factors for MetS was conducted using data from a large cross-sectional survey representative of the population of Jilin Province situated in northeastern China. A total of 16,831 participations were randomly chosen by multistage stratified cluster sampling of residents aged from 18 to 79 years in all nine administrative areas of the province. Environmental factors associated with MetS were examined using univariate and multivariate logistic regression analyses based on the weighted sample data. A subsample of 1813 survey subjects who met the criteria for MetS patients and 2037 controls from this case-control study were used to evaluate the association between SNPs and MetS risk. Genomic DNA was extracted from peripheral blood lymphocytes, and SNP genotyping was determined by MALDI-TOF-MS. The associations between SNPs and MetS were examined using a case-control study design. The interactions of environmental factors and APOA1/C3/A4/A5 gene cluster polymorphisms with MetS were assessed using multivariate logistic regression analysis. Results The overall adjusted prevalence of MetS was 32.86% in Jilin province. The prevalence of MetS in men was 36.64%, which was significantly higher than the prevalence in women (29.66%). MetS was more common in urban areas (33.86%) than in rural areas (31.80%). The prevalence of MetS significantly increased with age (OR = 8.621, 95% CI = 6.594-11.272). Mental labor (OR = 1.098, 95% CI = 1.008-1.195), current smoking (OR = 1.259, 95% CI = 1.108-1.429), excess salt intake (OR = 1.252, 95% CI = 1.149-1.363), and a fruit and dairy intake less than 2 servings a week were positively associated with MetS (P<0.05). A family history of diabetes (OR = 1.630, 95% CI = 1.484-1.791), cardiovascular disease or cerebral diseases (OR = 1.297, 95% CI = 1.211-1.389) was associated with MetS. APOA1 rs670, APOA5 rs662799 and rs651821 revealed significant differences in genotype distributions between the MetS patients and control subjects. The minor alleles of APOA1 rs670, APOA5 rs662799 and rs651821, and APOA5 rs2075291 were associated with MetS (P<0.0016). APOA1 rs5072 and APOC3 rs5128, APOA5 rs651821 and rs662799 were in strong linkage disequilibrium to each other with r(2) greater than 0.8. Five haplotypes were associated with an increased risk of MetS (OR = 1.23, 1.58, 1.80, 1.90, and 1.98). When we investigated the interactions of environmental factors and APOA1/C3/A4/A5 gene cluster gene polymorphisms, we found that APOA5 rs662799 had interactions with tobacco use and alcohol consumption (P-GE<0.05). Conclusions There was a high prevalence of MetS in the northeast of China. Male gender, increasing age, mental labor, family history of diabetes, cardiovascular disease or cerebral diseases, current smoking, excess salt intake, fruit and dairy intake less than 2 servings a week, and drinking were associated with MetS. The APOA1/C3/A4/A5 gene cluster was associated with MetS in the Han Chinese. APOA5 rs662799 had interactions with the environmental factors associated with MetS.	[Wu, Yanhua; Yu, Yaqin; Wang, Shibin; Fu, Yingli; Qi, Yue; Yang, Guang; Yao, Wenwang; Su, Yingying; Ma, Yue; Shi, Jieping; Kou, Changgui] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1163 Xinmin St, Changchun 130021, Jilin Province, Peoples R China; [Wu, Yanhua; Jiang, Jing] Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130021, Jilin, Peoples R China; [Zhao, Tiancheng] Jilin Univ, China Japan Union Hosp, Dept Endoscopy Ctr, Changchun 130021, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Kou, CG (corresponding author), Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1163 Xinmin St, Changchun 130021, Jilin Province, Peoples R China.; Jiang, J (corresponding author), Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130021, Jilin, Peoples R China.	jiangjing19702000@jlu.edu.cn; koucg@jlu.edu.cn	SHI, JIE/GXG-3394-2022	Yang, Guang/0000-0002-4335-2618; Rao, Wenwang/0000-0002-3514-3082; Wu, Yanhua/0000-0002-9920-3486	scientific research foundation of Jilin Provincial Health Department, China [2011Z116]; Jilin Provincial Health Department; Chinese Jilin Provincial Center for Disease Control and Prevention	scientific research foundation of Jilin Provincial Health Department, China; Jilin Provincial Health Department; Chinese Jilin Provincial Center for Disease Control and Prevention	This research was supported by grant 2011Z116 from the scientific research foundation of Jilin Provincial Health Department, China.; We are grateful to the Jilin Provincial Health Department and the Chinese Jilin Provincial Center for Disease Control and Prevention for supporting our project.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; BAI H, 1995, HUM GENET, V95, P102; Chen BD, 2010, CLIN CHIM ACTA, V411, P705, DOI 10.1016/j.cca.2010.01.038; CHEN M, 1994, J LIPID RES, V35, P1918; Cheng TO, 2007, INT J CARDIOL, V116, P257, DOI 10.1016/j.ijcard.2006.04.050; Chhabra S, 2005, DIS MARKERS, V21, P169, DOI 10.1155/2005/195078; Chhabra S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-9; Chien KL, 2008, CLIN CHIM ACTA, V390, P56, DOI 10.1016/j.cca.2007.12.014; Coban N, 2014, CLIN CHIM ACTA, V431, P244, DOI 10.1016/j.cca.2014.01.017; De Franca E, 2005, BRAZ J MED BIOL RES, V38, P535, DOI 10.1590/S0100-879X2005000400006; DECODA Study Grp, 2007, DIABETES RES CLIN PR, V76, P57, DOI 10.1016/j.diabres.2006.07.020; Ding Y.C., 2012, MATH PROBL ENG, V2012, P1, DOI DOI 10.1155/2012/509420; Dodani S, 2012, DIS MARKERS, V32, P9, DOI [10.3233/DMA-2012-0856, 10.1155/2012/868029]; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Fumeron F, 2011, DIABETES CARE, V34, P813, DOI 10.2337/dc10-1772; Garelnabi M, 2013, CLIN BIOCHEM, V46, P12, DOI 10.1016/j.clinbiochem.2012.09.007; GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266; Gu YL, 2014, ENDOCRINE, V45, P454, DOI 10.1007/s12020-013-0020-1; Heng CK, 2001, PEDIATR RES, V49, P514, DOI 10.1203/00006450-200104000-00013; Hosseini-Esfahani F, 2015, BRIT J NUTR, V113, P644, DOI 10.1017/S0007114514003687; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Janczura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133750; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kao JT, 2003, HUM MOL GENET, V12, P2533, DOI 10.1093/hmg/ddg255; Kazlauskiene L, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0096-2; Komurcu-Bayrak E, 2008, CLIN CHEM LAB MED, V46, P778, DOI 10.1515/CCLM.2008.161; Korea Health Industry Development Institute, 2005, 3 KOR NAT HLTH NUTR; Lai CQ, 2005, CURR OPIN LIPIDOL, V16, P153, DOI 10.1097/01.mol.0000162320.54795.68; Li JB, 2010, J INT MED RES, V38, P1142, DOI 10.1177/147323001003800343; Liu L, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0080-8; Liu ZK, 2010, ATHEROSCLEROSIS, V208, P427, DOI 10.1016/j.atherosclerosis.2009.08.013; Ma X, 2013, EUR J CLIN NUTR, V67, P518, DOI 10.1038/ejcn.2013.24; Mar R, 2004, CIRC RES, V94, P993, DOI 10.1161/01.RES.0000124922.61830.F0; Mattei J, 2011, NUTR METAB CARDIOVAS, V21, P862, DOI 10.1016/j.numecd.2010.02.024; Mohammadi SG, 2015, INT J ENDOCRINOL MET, V13, DOI 10.5812/ijem.25201v2; Moreno R, 2006, ATHEROSCLEROSIS, V189, P163, DOI 10.1016/j.atherosclerosis.2005.11.029; Mosley M.A., 2013, FOOD NUTR SCI, V4, P56, DOI [10.4236/fns.2013.41009, DOI 10.4236/FNS.2013.41009]; Office for the Sixth Population Census of Jilin Province Jilin Provincial Bureau of Statistics, 2012, TABULATION ON THE 20; Olivieri O, 2003, J LIPID RES, V44, P2374, DOI 10.1194/jlr.M300253-JLR200; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Povel CM, 2011, OBES REV, V12, P952, DOI 10.1111/j.1467-789X.2011.00907.x; Qi L, 2007, ATHEROSCLEROSIS, V192, P204, DOI 10.1016/j.atherosclerosis.2006.05.006; Qiao Q, 2006, DIABETOLOGIA, V49, P2837, DOI 10.1007/s00125-006-0438-6; Rudkowska I, 2013, BRIT J NUTR, V109, P953, DOI 10.1017/S0007114512002231; Ruidavets J.-B., 2002, Journal of Epidemiology and Community Health, V56, P24, DOI 10.1136/jech.56.1.24; Salamone F, 2010, NEW ENGL J MED, V363, P194; Shim Unjin, 2014, Genomics & Informatics, V12, P195, DOI 10.5808/GI.2014.12.4.195; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Son KY, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0111-5; Song KH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/585134; STEINMETZ A, 1985, J BIOL CHEM, V260, P2258; Steuenson JE, 2012, METABOLISM, V61, P1582, DOI 10.1016/j.metabol.2012.04.010; van der Vliet HN, 2001, J BIOL CHEM, V276, P44512, DOI 10.1074/jbc.M106888200; Volcik KA, 2008, ANN EPIDEMIOL, V18, P101, DOI 10.1016/j.annepidem.2007.07.103; Wang SB, 2015, ASIA-PAC J PUBLIC HE, V27, P394, DOI 10.1177/1010539514551200; Wang W, 2010, J INT MED RES, V38, P150, DOI 10.1177/147323001003800117; Xu CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056216; Yamada Y, 2007, ATHEROSCLEROSIS, V191, P298, DOI 10.1016/j.atherosclerosis.2006.05.035; Yin JH, 2012, CLIN ENDOCRINOL, V76, P802, DOI 10.1111/j.1365-2265.2011.04198.x; Yin RX, 2013, ALCOHOL CLIN EXP RES, V37, P234, DOI 10.1111/j.1530-0277.2012.01918.x; Yin RX, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-140; Zuo H, 2009, METABOLISM, V58, P1102, DOI 10.1016/j.metabol.2009.04.008	65	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147946	10.1371/journal.pone.0147946	http://dx.doi.org/10.1371/journal.pone.0147946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824674	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600078
J	Podmirseg, SR; Jakel, H; Ranches, GD; Kullmann, MK; Sohm, B; Villunger, A; Lindner, H; Hengst, L				Podmirseg, S. R.; Jaekel, H.; Ranches, G. D.; Kullmann, M. K.; Sohm, B.; Villunger, A.; Lindner, H.; Hengst, L.			Caspases uncouple p27(Kip1) from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion	ONCOGENE			English	Article							DEPENDENT KINASE INHIBITOR; GROWTH-FACTOR-BETA; CDK-INHIBITORS; NEURONAL DIFFERENTIATION; MOLECULAR-MECHANISMS; UP-REGULATION; IN-VITRO; APOPTOSIS; PHOSPHORYLATION; P27	In addition to their role in programmed cell death, caspases exert non-lethal functions in diverse developmental processes including cell differentiation or tissue remodeling. Terminal cell cycle exit and differentiation can be promoted by increased level of the CDK inhibitor p27(Kip1). Activated caspases cause proteolytic processing of p27, and we identified a novel caspase cleavage site in human p27 that removes a C-terminal fragment of 22 amino acids from the CDK inhibitor, including a phosphodegron. Thereby, caspases protect the inhibitor from SCF-Skp2-mediated degradation in S, G2 and M phases of the cell cycle. As a consequence, p27 becomes stabilized and remains an efficient nuclear inhibitor of cell cycle progression. Besides controlling cyclin/CDK kinase activity, p27 also regulates cytoskeletal dynamics, cell motility and cell invasion. Following processing by caspases, p27 fails to bind to RhoA and to inhibit its activation, and thereby abolishes the ability of p27 to stimulate cell migration and invasion. We propose that the stabilization of the CDK inhibitor and elimination of RhoA-induced cytoskeletal remodeling upon caspase processing could contribute to cell cycle exit and cytoskeletal remodeling during non-lethal caspase controlled differentiation processes.	[Podmirseg, S. R.; Jaekel, H.; Ranches, G. D.; Kullmann, M. K.; Hengst, L.] Med Univ Innsbruck, Bioctr, Div Med Biochem, Innsbruck, Austria; [Sohm, B.] Univ Lorraine, LIEC, UMR 7360, Metz, France; [Sohm, B.] CNRS, LIEC, UMR 7360, Metz, France; [Villunger, A.] Med Univ Innsbruck, Bioctr, Div Dev Immunol, Innsbruck, Austria; [Villunger, A.] Tyrolean Canc Res Inst, Innsbruck, Austria; [Lindner, H.] Med Univ Innsbruck, Bioctr, Div Clin Biochem, Innsbruck, Austria	Medical University of Innsbruck; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; Medical University of Innsbruck; Medical University of Innsbruck	Hengst, L (corresponding author), Bioctr, Div Med Biochem, Innrain 80-82, A-6020 Innsbruck, Austria.	ludger.hengst@i-med.ac.at	Kullmann, Michael Keith/AGY-4711-2022	Hengst, Ludger/0000-0002-0605-0223; Ranches, Glory/0000-0002-3623-1746; Kullmann, Michael Keith/0000-0003-3567-3806; SOHM, Benedicte/0000-0002-7204-5414	FWF [P24031, P26856]; Tiroler Krebshilfe; Austrian Science Fund (FWF) [P 24031] Funding Source: researchfish	FWF(Austrian Science Fund (FWF)); Tiroler Krebshilfe; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We acknowledge Stephan Geley for providing plasmids and cell lines, Jan Wiegers for useful advice with mouse experiments and all members of the Hengst lab for their help and stimulating discussions. Work was funded by the FWF-grant P24031 to Ludger Hengst, the FWF-grant P26856 to Andreas Villunger and the Tiroler Krebshilfe.	Ashkenazi A, 2014, ANNU REV CELL DEV BI, V30, P337, DOI 10.1146/annurev-cellbio-100913-013226; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bryja V, 2004, CELL MOL LIFE SCI, V61, P1384, DOI 10.1007/s00018-004-4081-4; Chen P, 1999, DEVELOPMENT, V126, P1581; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Coleman ML, 2002, CELL DEATH DIFFER, V9, P493, DOI 10.1038/sj.cdd.4400987; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Crawford ED, 2013, MOL CELL PROTEOMICS, V12, P813, DOI 10.1074/mcp.O112.024372; Cremisi F, 2003, CURR OPIN NEUROBIOL, V13, P26, DOI 10.1016/S0959-4388(03)00005-9; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; De Vita F, 2012, CELL CYCLE, V11, P1583, DOI 10.4161/cc.20003; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Durand B, 2000, BIOESSAYS, V22, P64; Eymin B, 1999, ONCOGENE, V18, P4839, DOI 10.1038/sj.onc.1202860; Eymin B, 1999, ONCOGENE, V18, P1411, DOI 10.1038/sj.onc.1202437; Fan XM, 2004, J GASTROEN HEPATOL, V19, P31, DOI 10.1111/j.1440-1746.2004.03194.x; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Godin JD, 2012, DEV CELL, V23, P729, DOI 10.1016/j.devcel.2012.08.006; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Harvey KJ, 2000, J CELL BIOL, V148, P59, DOI 10.1083/jcb.148.1.59; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Hiromura K, 1999, J CLIN INVEST, V103, P597, DOI 10.1172/JCI5461; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Jakel H, 2011, ONCOGENE, V30, P3502, DOI 10.1038/onc.2011.68; Jakel H, 2012, CELL CYCLE, V11, P1910, DOI 10.4161/cc.19957; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Kalejta RF, 1999, EXP CELL RES, V248, P322, DOI 10.1006/excr.1999.4427; Katayose Y, 1997, CANCER RES, V57, P5441; Kossatz U, 2006, EMBO J, V25, P5159, DOI 10.1038/sj.emboj.7601388; Kullmann MK, 2013, CELL CYCLE, V12, P2625, DOI 10.4161/cc.25622; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Loubat A, 1999, ONCOGENE, V18, P3324, DOI 10.1038/sj.onc.1202668; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mazumder S, 2002, MOL CELL BIOL, V22, P2398, DOI 10.1128/MCB.22.7.2398-2409.2002; Medina-Palazon C, 2004, EUR J BIOCHEM, V271, P2716, DOI 10.1111/j.1432-1033.2004.04200.x; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nguyen L, 2006, CELL CYCLE, V5, P2314, DOI 10.4161/cc.5.20.3381; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; PERANDONES CE, 1993, J IMMUNOL, V151, P3521; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rots NY, 1999, BLOOD, V93, P2721, DOI 10.1182/blood.V93.8.2721.408k28_2721_2729; Schiappacassi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017673; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; See WL, 2010, CELL CYCLE, V9, P1562, DOI 10.4161/cc.9.8.11259; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; Starostina NG, 2012, TRENDS CELL BIOL, V22, P33, DOI 10.1016/j.tcb.2011.10.004; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Tambyrajah WS, 2007, ARCH BIOCHEM BIOPHYS, V466, P186, DOI 10.1016/j.abb.2007.07.019; Taniguchi T, 1999, BLOOD, V93, P4167, DOI 10.1182/blood.V93.12.4167.412k05_4167_4178; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tozser J, 2003, BIOCHEM J, V372, P137, DOI 10.1042/BJ20021901; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Vosper J, 2015, ONCOTARGET, V6, P2889, DOI 10.18632/oncotarget.3068; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Woltman AM, 2003, BLOOD, V101, P1439, DOI 10.1182/blood-2002-06-1688; Yaroslavskiy B, 1999, BLOOD, V93, P2907; Zhang R, 2008, CANCER CHEMOTH PHARM, V62, P407, DOI 10.1007/s00280-007-0619-0; Zhao D, 2015, ONCOGENE, V34, P5447, DOI 10.1038/onc.2014.473; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	82	19	19	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 1	2016	35	35					4580	4590		10.1038/onc.2015.524	http://dx.doi.org/10.1038/onc.2015.524			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU6PE	26829051	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000382336300004
J	Davis, KN; Tao, R; Li, C; Gao, Y; Gondre-Lewis, MC; Lipska, BK; Shin, JH; Xie, B; Ye, TZ; Weinberger, DR; Kleinman, JE; Hyde, TM				Davis, Kasey N.; Tao, Ran; Li, Chao; Gao, Yuan; Gondre-Lewis, Marjorie C.; Lipska, Barbara K.; Shin, Joo Heon; Xie, Bin; Ye, Tianzhang; Weinberger, Daniel R.; Kleinman, Joel E.; Hyde, Thomas M.			GAD2 Alternative Transcripts in the Human Prefrontal Cortex, and in Schizophrenia and Affective Disorders	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; BIPOLAR DISORDER; MESSENGER-RNA; MICE LACKING; GABA; EXPRESSION; BRAIN; REELIN; DEPRESSION	Genetic variation and early adverse environmental events work together to increase risk for schizophrenia. gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in adult mammalian brain, plays a major role in normal brain development, and has been strongly implicated in the pathobiology of schizophrenia. GABA synthesis is controlled by two glutamic acid decarboxylase (GAD) genes, GAD1 and GAD2, both of which produce a number of alternative transcripts. Genetic variants in the GAD1 gene are associated with increased risk for schizophrenia, and reduced expression of its major transcript in the human dorsolateral prefrontal cortex (DLPFC). No consistent changes in GAD2 expression have been found in brains from patients with schizophrenia. In this work, with the use of RNA sequencing and PCR technologies, we confirmed and tracked the expression of an alternative truncated transcript of GAD2 (ENST00000428517) in human control DLPFC homogenates across lifespan besides the well-known full length transcript of GAD2. In addition, using quantitative RT-PCR, expression of GAD2 full length and truncated transcripts were measured in the DLPFC of patients with schizophrenia, bipolar disorder and major depression. The expression of GAD2 full length transcript is decreased in the DLPFC of schizophrenia and bipolar disorder patients, while GAD2 truncated transcript is increased in bipolar disorder patients but decreased in schizophrenia patients. Moreover, the patients with schizophrenia with completed suicide or positive nicotine exposure showed significantly higher expression of GAD2 full length transcript. Alternative transcripts of GAD2 may be important in the growth and development of GABA-synthesizing neurons as well as abnormal GABA signaling in the DLPFC of patients with schizophrenia and affective disorders.	[Davis, Kasey N.; Lipska, Barbara K.] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, Intramural Res Program,NIH, Bethesda, MD 20892 USA; [Davis, Kasey N.; Tao, Ran; Li, Chao; Gao, Yuan; Shin, Joo Heon; Xie, Bin; Ye, Tianzhang; Weinberger, Daniel R.; Kleinman, Joel E.; Hyde, Thomas M.] Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Weinberger, Daniel R.; Hyde, Thomas M.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Johns Hopkins Univ Med Campus, Baltimore, MD 21205 USA; [Weinberger, Daniel R.; Hyde, Thomas M.] Johns Hopkins Univ, Sch Med, Neurol, Johns Hopkins Univ Med Campus, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Davis, Kasey N.; Gondre-Lewis, Marjorie C.] Howard Univ, Coll Med, Dept Anat, Lab Neurodev, Washington, DC 20059 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Howard University	Hyde, TM (corresponding author), Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD 21205 USA.	thomas.hyde@libd.org	Gondre-Lewis, Marjorie/M-8055-2017; Lipska, Barbara K/E-4569-2017		NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002903] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Battaglioli G, 2003, J NEUROCHEM, V86, P879, DOI 10.1046/j.1471-4159.2003.01910.x; Bernstein HG, 2013, CNS NEUROL DISORD-DR, V12, P900, DOI 10.2174/18715273113129990091; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Chan SO, 1997, MOL BRAIN RES, V46, P318, DOI 10.1016/S0169-328X(97)00031-4; Choi SY, 2002, J NEUROSCI, V22, P5271; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Costa E., 2004, Critical Reviews in Neurobiology, V16, P1, DOI 10.1615/CritRevNeurobiol.v16.i12.10; Dracheva S, 2004, J NEUROSCI RES, V76, P581, DOI 10.1002/jnr.20122; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Fatemi SH, 2009, SCHIZOPHR RES, V111, P138, DOI 10.1016/j.schres.2009.03.002; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Fatemi SH, 2000, MOL PSYCHIATR, V5, P571, DOI 10.1038/sj.mp.4000794; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Glausier JR, 2015, BIOL PSYCHIAT, V77, P167, DOI 10.1016/j.biopsych.2014.05.010; Gos T, 2009, J AFFECT DISORDERS, V113, P45, DOI 10.1016/j.jad.2008.04.021; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; GREIF KF, 1991, NEUROCHEM RES, V16, P235, DOI 10.1007/BF00966086; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Heckers S, 2002, ARCH GEN PSYCHIAT, V59, P521, DOI 10.1001/archpsyc.59.6.521; Heldt SA, 2004, NEUROPSYCHOPHARMACOL, V29, P1610, DOI 10.1038/sj.npp.1300468; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; Kanaani J, 2010, J CELL BIOL, V190, P911, DOI 10.1083/jcb.200912101; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Kelly DL, 2011, SCHIZOPHRENIA BULL, V37, P832, DOI 10.1093/schbul/sbp152; Laeng P, 2004, J NEUROCHEM, V91, P238, DOI 10.1111/j.1471-4159.2004.02725.x; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lujan R, 2005, NEUROSCIENCE, V130, P567, DOI 10.1016/j.neuroscience.2004.09.042; Manent JB, 2007, NEUROSCIENTIST, V13, P268, DOI 10.1177/1073858406298918; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; Moyer CE, 2012, BIOL PSYCHIAT, V72, P734, DOI 10.1016/j.biopsych.2012.04.010; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004371; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Tao R, 2012, J NEUROSCI, V32, P5216, DOI 10.1523/JNEUROSCI.4626-11.2012; Taylor SF, 2015, SCHIZOPHR RES, V167, P84, DOI 10.1016/j.schres.2014.10.011; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Walls AB, 2010, J NEUROCHEM, V115, P1398, DOI 10.1111/j.1471-4159.2010.07043.x; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5	49	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148558	10.1371/journal.pone.0148558	http://dx.doi.org/10.1371/journal.pone.0148558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848839	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000124
J	Pasa, MK; Alom, KR; Bashri, Z; Vermund, SH				Pasa, M. Kamal; Alom, Kazi Robiul; Bashri, Zubaida; Vermund, Sten H.			Sharing of Needles and Syringes among Men Who Inject Drugs: HIV Risk in Northwest Bangladesh	PLOS ONE			English	Article							USERS; INDIA; AIDS	Introduction Injection drug use is prevalent in northwestern Bangladesh. We sought to explore the context of needle/syringe sharing among persons who inject drugs (PWID), examining risk exposures to blood-borne infections like the human immunodeficiency virus (HIV) and hepatitis in a region where these dual epidemics are likely to expand. Methods We used a qualitative research approach to learn about injection practices, conducting 60 in-depth interviews among PWID. We then conducted 12 focus group discussions (FGDs) that generated a checklist of salient issues, and followed up with personal observations of typical days at the drug-use venues. Content and interpretative frameworks were used to analyze qualitative information and socio-demographic information, using SPSS software. Results We found that needle/syringe-sharing behaviours were integrated into the overall social and cultural lives of drug users. Sharing behaviours were an central component of PWID social organization. Sharing was perceived as an inherent element within reciprocal relationships, and sharing was tied to beliefs about drug effects, economic adversity, and harassment due to their drug user status. Carrying used needles/syringes to drug-use venues was deemed essential since user-unfriendly needle-syringe distribution schedules of harm reduction programmes made it difficult to access clean needles/syringes in off-hours. PWID had low self-esteem. Unequal power relationships were reported between the field workers of harm reduction programmes and PWID. Field workers expressed anti-PWID bias and judgmental attitudes, and also had had misconceptions about HIV and hepatitis transmission. PWID were especially disturbed that no assistance was forthcoming from risk reduction programme staff when drug users manifested withdrawal symptoms. Conclusion Interventions must take social context into account when scaling up programmes in diverse settings. The social organization of PWID include values that foster needle-syringe sharing. Utilization and impact of risk reduction programmes might be improved with expanded clean needle/syringe distribution at times and venues convenient for PWID, better trained and non-judgmental staff, and medical assistance for health problems, including drug withdrawal symptoms.	[Pasa, M. Kamal; Alom, Kazi Robiul] Rajshahi Univ, Dept Anthropol, Rajshani, Bangladesh; [Bashri, Zubaida] Rajshahi Univ, Inst Environm Sci, Rajshani, Bangladesh; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	University of Rajshahi; University of Rajshahi; Vanderbilt University; Vanderbilt University	Pasa, MK (corresponding author), Rajshahi Univ, Dept Anthropol, Rajshani, Bangladesh.	kamal_pasa@yahoo.com	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698	Bangladesh University Grants Commission	Bangladesh University Grants Commission	Bangladesh University Grants Commission provided funding for the study.	Azim T, 2008, SUBSTANCE USE MISUSE, V43; Azim T, 2008, J HEALTH POPUL NUTR, V26, P311; Azim Tasnim, 2006, Harm Reduct J, V3, P33, DOI 10.1186/1477-7517-3-33; Azim T, 2015, INT J DRUG POLICY, V26, pS16, DOI 10.1016/j.drugpo.2014.09.003; Battjes RJ, 1994, CONTEXT HIV RISK DRU; Brown B. S., 1993, HDB RISK AIDS INJECT; Chakrapani V, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-9; Des Jarlais CD, 1986, SOCIAL DIMENSION AID; Fernando D., 1991, AIDS and Public Policy Journal, V6, P116; Grace CW, 1994, CONTEXT HIV RISK DRU; Haider Muhiuddin, 2008, Bangladesh Med Res Counc Bull, V34, P54; Hossain K J, 2012, Int J STD AIDS, V23, pe1, DOI 10.1258/ijsa.2009.009168; Howard J, 1972, ITS GOOD DONT EVEN T; Kane SA, 1992, THE TIME OF AIDS; Koester SK, 1994, CONTEXT RISK ETHNOGR; Koester SK, 1992, ANN M COLL PROBL DRU; Larance B, 2011, DRUG ALCOHOL REV, V30, P246, DOI 10.1111/j.1465-3362.2011.00304.x; MAGURA S, 1989, AM J PUBLIC HEALTH, V79, P459, DOI 10.2105/AJPH.79.4.459; Malow R. M., 1992, PSYCHOL ADDICT BEHAV, V6, P131, DOI [DOI 10.1037/H0080614, 10.1037/h0080614]; Ministry of Health and Family Welfare (MoHFW) Bangladesh, 2011, NAT HIV SER SURV 201; Murphy S., 1987, CONTEMP DRUG PROBL, V14, P373; Needle RH, 1994, CONTEXT HIV RISK DRU; PAGE JB, 1990, MED ANTHROPOL Q, V4, P56, DOI 10.1525/maq.1990.4.1.02a00050; POWER R, 1988, BRIT J ADDICT, V83, P649; Rafiey H, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-21; Reddy A, 2008, INT J DRUG POLICY, V19, pS37, DOI 10.1016/j.drugpo.2007.11.015; Samo RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081715; Sarkar K, 2006, SUBST USE MISUSE, V41, P341, DOI 10.1080/10826080500410991; Shariful Islam SM, 2015, J ADDICT, V2015; Stephens RC, 1994, CONTEXT HIV RISK DRU; Uddin MJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1151; Waldorf D, 1989, AIDS DRUGS PROSTITUT; WATTERS JK, 1988, J PSYCHOACTIVE DRUGS, V20, P173, DOI 10.1080/02791072.1988.10524491	33	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148276	10.1371/journal.pone.0148276	http://dx.doi.org/10.1371/journal.pone.0148276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26848756	Green Published, gold			2022-12-26	WOS:000369554000063
J	Eriksson, H; Milberg, A; Hjelm, K; Friedrichsen, M				Eriksson, Helene; Milberg, Anna; Hjelm, Katarina; Friedrichsen, Maria			End of Life Care for Patients Dying of Stroke: A Comparative Registry Study of Stroke and Cancer	PLOS ONE			English	Article							PALLIATIVE CARE; TEAM; PROFESSIONALS; PREFERENCES; DEMENTIA; FAMILY; DEATH; NEEDS; PAIN	Background Although stroke is a significant public health challenge and the need for palliative care has been emphasized for these patients, there is limited data on end-of-life care for patients dying from stroke. Objective To study the end-of-life care during the last week of life for patients who had died of stroke in terms of registered symptom, symptom management, and communication, in comparison with patients who had died of cancer. Design This study is a retrospective, comparative registry study. Methods A retrospective comparative registry study was performed using data from a Swedish national quality register for end-of-life care based on WHO's definition of Palliative care. Data from 1626 patients who had died of stroke were compared with data from 1626 patients who had died of cancer. Binary logistic analyses were used to calculate odds ratios, with 95% CI. Results Compared to patients who was dying of cancer, the patients who was dying of stroke had a significantly higher prevalence of having death rattles registered, but a significantly lower prevalence of, nausea, confusion, dyspnea, anxiety, and pain. In addition, the stroke group had significantly lower odds ratios for health care staff not to know whether all these six symptoms were present or not. Patients who was dying of stroke had significantly lower odds ratio of having informative communication from a physician about the transition to end-of-life care and of their family members being offered bereavement follow-up. Conclusions The results indicate on differences in end-of-life care between patients dying of stroke and those dying from cancer. To improve the end-of-life care in clinical practice and ensure it has consistent quality, irrespective of diagnosis, education and implementation of palliative care principles are necessary.	[Eriksson, Helene; Milberg, Anna; Hjelm, Katarina; Friedrichsen, Maria] Linkoping Univ, Dept Social & Welf Studies, Norrkoping, Sweden; [Milberg, Anna; Friedrichsen, Maria] Vrinnevi Hosp, Palliat Educ & Res Ctr, Norrkoping, Sweden; [Milberg, Anna; Friedrichsen, Maria] Vrinnevi Hosp, Dept Adv Home Care, Norrkoping, Sweden	Linkoping University	Eriksson, H (corresponding author), Linkoping Univ, Dept Social & Welf Studies, Norrkoping, Sweden.	Helene.m.eriksson@liu.se			Stroke Riksforbund [2012-00185]; Stahls stiftelse [4813101041]; Forss [479071]	Stroke Riksforbund; Stahls stiftelse; Forss	This work was supported by Stroke Riksforbund (number: 2012-00185) 30 000SEK Stahls stiftelse (number: 4813101041) 200 000 SEK Forss (number: 479071) 150 000 SEK (Helene Eriksson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDINGTONHALL J, 1995, STROKE, V26, P2242, DOI 10.1161/01.STR.26.12.2242; Bito Seiji, 2007, BMC Med Ethics, V8, P7, DOI 10.1186/1472-6939-8-7; Bruera E, 2013, PALLIATIVE MED, V27, P939, DOI 10.1177/0269216313477177; Burton CR, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-22; Creutzfeldt CJ, 2015, STROKE, V46, P2714, DOI 10.1161/STROKEAHA.115.008224; Creutzfeldt CJ, 2012, STROKE, V43, P3405, DOI 10.1161/STROKEAHA.112.673376; de Boer ME, 2015, PALLIATIVE MED, V29, P451, DOI 10.1177/0269216314563427; Epstein RM, 2010, HEALTH AFFAIR, V29, P1489, DOI 10.1377/hlthaff.2009.0888; Eriksson H, 2014, J NEUROSCI NURS, V46, P162, DOI 10.1097/JNN.0000000000000049; Helvig E, 2015, VASC HEALTH RISK MAN, V11, P507, DOI 10.2147/VHRM.S85814; Henoch I, 2016, SCAND J CARING SCI, V30, P5, DOI 10.1111/scs.12253; Holloway RG, 2014, STROKE, V45, P1887, DOI 10.1161/STR.0000000000000015; Kehl KA, 2013, AM J HOSP PALLIAT ME, V30, P601, DOI 10.1177/1049909112468222; Liljehult J, 2015, ACTA NEUROL SCAND; Lindblom AK, 2012, J NURS MANAGE, V20, P206, DOI 10.1111/j.1365-2834.2011.01376.x; Lundstrom S, 2012, PALLIATIVE MED, V26, P313, DOI 10.1177/0269216311414758; Martinsson L, 2011, ACTA ONCOL, V50, P642, DOI 10.3109/0284186X.2011.554434; Mazzocato C, 2010, EUR J NEUROL, V17, P73, DOI 10.1111/j.1468-1331.2009.02744.x; Meleis AI., 2011, THEORETICAL NURSING; Monacelli F, 2013, CLIN TER, V164, pE23, DOI 10.7417/CT.2013.1516; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Norrving Bo, 2007, Int J Stroke, V2, P139, DOI 10.1111/j.1747-4949.2007.00109.x; Ntlholang O, 2015, IRISH J MED SCI; Payne S, 2010, PALLIATIVE MED, V24, P146, DOI 10.1177/0269216309350252; Rejno A, 2013, BMC NURS, V12, DOI 10.1186/1472-6955-12-13; Rejno A, 2012, NURS ETHICS, V19, P642, DOI 10.1177/0969733011412099; Roberts SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131836; San Luis COV, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-21; The National Board of Health and Welfare, 2014, BRYTP; Thomas RL, 2014, MED J AUSTRALIA, V201, P452, DOI 10.5694/mja14.00623; van der Steen JT, 2015, J PAIN SYMPTOM MANAG, V50, P659, DOI 10.1016/j.jpainsymman.2015.05.015; Weil J, 2015, PALLIATIVE MED, V29, P293, DOI 10.1177/0269216314560801; World Health Organization, WHO DEF PALL CAR 201	33	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147694	10.1371/journal.pone.0147694	http://dx.doi.org/10.1371/journal.pone.0147694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845149	Green Submitted, gold, Green Published			2022-12-26	WOS:000369552800013
J	Xiao, J; Chen, D; Lin, XX; Peng, SF; Xiao, MF; Huang, WH; Wang, YC; Peng, JB; Zhang, W; Ouyang, DS; Chen, Y				Xiao, Jian; Chen, Dan; Lin, Xiu-Xian; Peng, Shi-Fang; Xiao, Mei-Fang; Huang, Wei-Hua; Wang, Yi-Cheng; Peng, Jing-Bo; Zhang, Wei; Ouyang, Dong-Sheng; Chen, Yao			Screening of Drug Metabolizing Enzymes for the Ginsenoside Compound K In Vitro: An Efficient Anti-Cancer Substance Originating from Panax Ginseng	PLOS ONE			English	Article							HUMAN LIVER-MICROSOMES; HUMAN CYTOCHROME-P450 ENZYMES; GENETIC POLYMORPHISMS; INHIBITION; CYP; IMPACT; POTENT	Ginsenoside compound K (CK), a rare ginsenoside originating from Panax Ginseng, has been found to possess unique pharmacological activities specifically as anti-cancers. However, the role of cytochrome P450s (CYPs) in the metabolism of CK is unclear. In this study, we screened the CYPs for the metabolism of CK in vitro using human liver microsomes (HLMs) or human recombinant CYPs. The results showed that CK inhibited the enzyme activities of CYP2C9 and CYP3A4 in the HLMs. The K-m and V-max values of CK were 84.20+/-21.92 mu M and 0.28+/-0.04 nmol/mg protein/min, respectively, for the HLMs; 34.63+/-10.48 mu M and 0.45+/-0.05 nmol/nmol P450/min, respectively, for CYP2C9; and 27.03+/-5.04 mu M and 0.68+/-0.04 nmol/nmol P450/min, respectively, for CYP3A4. The IC50 values were 16.00 mu M and 9.83 mu M, and K-i values were 14.92 mu M and 11.42 mu M for CYP2C9 and CYP3A4, respectively. Other human CYP isoforms, including CYP1A2, CYP2A6, CYP2D6, CYP2E1, and CYP2C19, showed minimal or no effect on CK metabolism. The results suggested that CK was a substrate and also inhibitors for both CYP2C9 and CYP3A4. Patients using CK in combination with therapeutic drugs that are substrates of CYP2C9 and CYP3A4 for different reasons should be careful, although the inhibiting potency of CK is much poorer than that of enzyme-specific inhibitors.	[Xiao, Jian; Chen, Dan; Lin, Xiu-Xian; Huang, Wei-Hua; Wang, Yi-Cheng; Peng, Jing-Bo; Zhang, Wei; Ouyang, Dong-Sheng; Chen, Yao] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China; [Xiao, Jian; Chen, Dan; Lin, Xiu-Xian; Huang, Wei-Hua; Wang, Yi-Cheng; Peng, Jing-Bo; Zhang, Wei; Ouyang, Dong-Sheng; Chen, Yao] Cent S Univ, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China; [Peng, Shi-Fang; Xiao, Mei-Fang] Cent S Univ, Xiangya Hosp, Dept Hepatol & Infect Dis, Changsha, Hunan, Peoples R China; [Peng, Shi-Fang; Xiao, Mei-Fang] Cent S Univ, Xiangya Hosp, Hlth Management Ctr, Changsha, Hunan, Peoples R China; [Xiao, Jian] Cent S Univ, Xiangya Hosp, Dept Pharm, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University	Chen, Y (corresponding author), Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China.; Chen, Y (corresponding author), Cent S Univ, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China.	cbohua@163.com	Chen, Yao/AAJ-5658-2020; Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Huang, Wei-Hua/0000-0003-4167-8304; Chen, Yao/0000-0001-7231-9860	National Scientific Foundation of China [81302850, 81300204, 31400306]; China Postdoctoral Science Foundation [2013M531817, 2014T70793]; Science and Technology Plan Projects of Hunan Province [2014RS4011]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Plan Projects of Hunan Province	This work was supported by the National Scientific Foundation of China (Grants 81302850, 81300204, 31400306); the China Postdoctoral Science Foundation (Grants 2013M531817, 2014T70793); and the Science and Technology Plan Projects of Hunan Province (Grant 2014RS4011).	Bourrie M, 1996, J PHARMACOL EXP THER, V277, P321; Chen JZ, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2013.03.02; Chen JY, 2015, J PHARMACOL EXP THER, V353, P71, DOI 10.1124/jpet.114.220665; Chen Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-24; Christensen LP, 2009, ADV FOOD NUTR RES, V55, P1, DOI 10.1016/S1043-4526(08)00401-4; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; Dorado P, 2014, PHARMACOGENOMICS, V15, P261, DOI 10.2217/pgs.13.243; Ghozlan MF, 2015, BLOOD COAGULATION FI; Goey AKL, 2013, CANCER TREAT REV, V39, P773, DOI 10.1016/j.ctrv.2012.12.008; Helms Steve, 2004, Altern Med Rev, V9, P259; Hirota T, 2013, DRUG METAB PHARMACOK, V28, P28, DOI 10.2133/dmpk.DMPK-12-RV-085; Huang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113819; Kim YJ, 2014, J GINSENG RES, V38, P66, DOI 10.1016/j.jgr.2013.11.001; Kong WM, 2011, MOLECULES, V16, P7344, DOI 10.3390/molecules16097344; Lee JI, 2010, CLIN PHARMACOKINET, V49, P295, DOI 10.2165/11319980-000000000-00000; Leggett S, 2015, NUTR CANCER, V67, P373, DOI 10.1080/01635581.2015.1004731; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087810; Li X, 2013, CHEM-BIOL INTERACT, V204, P140, DOI 10.1016/j.cbi.2013.05.007; Lin JH, 2006, PHARM RES-DORDR, V23, P1089, DOI 10.1007/s11095-006-0277-7; Liu Y, 2006, TOXICOL SCI, V91, P356, DOI 10.1093/toxsci/kfj164; Malati CY, 2012, J CLIN PHARMACOL, V52, P932, DOI 10.1177/0091270011407194; Qin CZ, 2014, BIOMED CHROMATOGR, V28, P197, DOI 10.1002/bmc.3003; Smith PJ, 2014, ASIA-PAC J CLIN ONCO, V10, P1, DOI 10.1111/ajco.12115; Taavitsainen P, 2001, DRUG METAB DISPOS, V29, P217; Yamane M, 2015, XENOBIOTICA, V45, P230, DOI 10.3109/00498254.2014.976296; Yang XD, 2015, FITOTERAPIA, V100, P208, DOI 10.1016/j.fitote.2014.11.019; Zhang ZY, 2013, INT J MOL SCI, V14, P2980, DOI 10.3390/ijms14022980	27	18	19	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147183	10.1371/journal.pone.0147183	http://dx.doi.org/10.1371/journal.pone.0147183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845774	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800008
J	Abdin, E; Ong, C; Chong, SA; Vaingankar, JA; Subramaniam, M				Abdin, Edimansyah; Ong, Clarissa; Chong, Siow Ann; Vaingankar, Janhavi Ajit; Subramaniam, Mythily			Days Out of Role Due to Mental and Physical Conditions: Results from the Singapore Mental Health Study	PLOS ONE			English	Article							DISORDERS; BURDEN; COSTS; ORGANIZATION; COMORBIDITY; POPULATION; PREVALENCE; DISABILITY; INFORMATION; DEPRESSION	Objective The aim of the current study was to evaluate the relative contributions of mental and physical conditions to days out of role among adults aged 18 years and above in Singapore. Methods The Singapore Mental Health Study was a cross-sectional epidemiological survey of a nationally representative sample of residents aged 18 years or older. Diagnosis of mental disorders was established using the Composite International Diagnostic Interview; while chronic physical conditions were established using a checklist. Days out of role were assessed using a WHO Disability Assessment Schedule item. Multivariate regression analyses were used to estimate individual-level and societal-level effects of disorders. Results Overall, 8.7% of respondents reported at least one day out of role, with a mean of 5.8 days. The most disabling conditions at the individual level were cancer (118.9 additional days), cardiovascular diseases (93.5), and bipolar disorder (71.0). At the societal level, cardiovascular diseases contributed the highest population attributable risk proportion (45%), followed by cancer (39.3%), and hypertension (13.5%). Conclusions Mental and physical conditions are linked to significant losses in productivity for society as well as role disability for individuals, underscoring the need to enhance prevention and intervention efforts to increase overall productivity and improve individual functioning.	[Abdin, Edimansyah; Ong, Clarissa; Chong, Siow Ann; Vaingankar, Janhavi Ajit; Subramaniam, Mythily] Inst Mental Hlth, Div Res, Singapore, Singapore		Abdin, E (corresponding author), Inst Mental Hlth, Div Res, Singapore, Singapore.	edimansyah_abdin@imh.com.sg	Abdin, Edimansyah/E-6451-2011	Abdin, Edimansyah/0000-0002-1016-3298; Ong, Clarissa W./0000-0002-2318-5453	Singapore Millennium Foundation; Ministry of Health, Singapore	Singapore Millennium Foundation; Ministry of Health, Singapore	This study was supported by funding from the Singapore Millennium Foundation and the Ministry of Health, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo R, 2013, J MENT HEALTH POLICY, V16, P151; Al-Hamzawi AO, 2014, J PSYCHIATR RES, V53, P23, DOI 10.1016/j.jpsychires.2014.02.006; Alonso J, 2011, MOL PSYCHIATR, V16, P1234, DOI 10.1038/mp.2010.101; Alonso J, 2011, PSYCHOL MED, V41, P873, DOI 10.1017/S0033291710001212; Andrade LH, 2013, CLINICS, V68, P1392, DOI 10.6061/clinics/2013(11)02; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Chatterji P, 2011, J HEALTH ECON, V30, P858, DOI 10.1016/j.jhealeco.2011.06.006; Chong SA, 2012, ANN ACAD MED SINGAP, V41, P105; Chong SA, 2012, ANN ACAD MED SINGAP, V41, P49; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Hanly P, 2015, INT J CANCER, V136, pE136, DOI 10.1002/ijc.29105; Hansen H, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-39; Hilbe J.M., 2014, MODELING COUNT DATA; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Mall S, 2015, SOC PSYCH PSYCH EPID, V50, P461, DOI 10.1007/s00127-014-0941-x; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Parker G, 2001, SOC PSYCH PSYCH EPID, V36, P287, DOI 10.1007/s001270170046; Phua HP, 2009, SINGAP MED J, V50, P468; Ryder AG, 2008, J ABNORM PSYCHOL, V117, P300, DOI 10.1037/0021-843X.117.2.300; Schofield DJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-72; Smit F, 2006, J MENT HEALTH POLICY, V9, P193; Stuhldreher N, 2014, J AFFECT DISORDERS, V165, P87, DOI 10.1016/j.jad.2014.04.039; Subramaniam M, 2014, GEN HOSP PSYCHIAT, V36, P375, DOI 10.1016/j.genhosppsych.2014.03.002; Subramaniam M, 2013, COMPR PSYCHIAT, V54, P381, DOI 10.1016/j.comppsych.2012.10.004; Subramaniam M, 2012, INT J METH PSYCH RES, V21, P149, DOI 10.1002/mpr.1351; Von Korff M, 2008, J CLIN EPIDEMIOL, V61, P1132, DOI 10.1016/j.jclinepi.2007.12.009	31	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148248	10.1371/journal.pone.0148248	http://dx.doi.org/10.1371/journal.pone.0148248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840741	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200111
J	McGill, JL; Nair, ADS; Cheng, CM; Rusk, RA; Jaworski, DC; Ganta, RR				McGill, Jodi L.; Nair, Arathy D. S.; Cheng, Chuanmin; Rusk, Rachel A.; Jaworski, Deborah C.; Ganta, Roman R.			Vaccination with an Attenuated Mutant of Ehrlichia chaffeensis Induces Pathogen-Specific CD4(+) T Cell Immunity and Protection from Tick-Transmitted Wild-Type Challenge in the Canine Host	PLOS ONE			English	Article							HUMAN MONOCYTOTROPIC EHRLICHIOSIS; UNITED-STATES; ANAPLASMA-PHAGOCYTOPHILUM; HUMORAL IMMUNITY; ANIMAL-MODEL; IFN-GAMMA; INFECTION; MICE; RESPONSES; INOCULATION	Ehrlichia chaffeensis is a tick-borne rickettsial pathogen and the causative agent of human monocytic ehrlichiosis. Transmitted by the Amblyomma americanum tick, E. chaffeensis also causes disease in several other vertebrate species including white-tailed deer and dogs. We have recently described the generation of an attenuated mutant strain of E. chaffeensis, with a mutation in the Ech_0660 gene, which is able to confer protection from secondary, intravenous-administered, wild-type E. chaffeensis infection in dogs. Here, we extend our previous results, demonstrating that vaccination with the Ech_0660 mutant protects dogs from physiologic, tick-transmitted, secondary challenge with wild-type E. chaffeensis; and describing, for the first time, the cellular and humoral immune responses induced by Ech_0660 mutant vaccination and wild-type E. chaffeensis infection in the canine host. Both vaccination and infection induced a rise in E. chaffeensis-specific antibody titers and a significant Th1 response in peripheral blood as measured by E. chaffeensis antigen-dependent CD4(+) T cell proliferation and IFN. production. Further, we describe for the first time significant IL-17 production by peripheral blood leukocytes from both Ech_0660 mutant vaccinated animals and control animals infected with wild-type E. chaffeensis, suggesting a previously unrecognized role for IL-17 and Th17 cells in the immune response to rickettsial pathogens. Our results are a critical first step towards defining the role of the immune system in vaccine-induced protection from E. chaffeensis infection in an incidental host; and confirm the potential of the attenuated mutant clone, Ech_0660, to be used as a vaccine candidate for protection against tick-transmitted E. chaffeensis infection.	[McGill, Jodi L.; Nair, Arathy D. S.; Cheng, Chuanmin; Jaworski, Deborah C.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Ctr Excellence Vector Borne Dis, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Rusk, Rachel A.] Kansas State Univ, Coll Vet Med, Pathobiol Grad Program, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	McGill, JL (corresponding author), Kansas State Univ, Coll Vet Med, Ctr Excellence Vector Borne Dis, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	jlmcgill@vet.k-state.edu			PHS from the National Institute of Allergy and Infectious Diseases [AI070908]; KSU-CVM; National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103638]; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103638] Funding Source: NIH RePORTER	PHS from the National Institute of Allergy and Infectious Diseases; KSU-CVM; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by PHS grant number AI070908 from the National Institute of Allergy and Infectious Diseases to RRG, and KSU-CVM start-up funds to JLM. Research reported in this publication was also supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20 GM103638 to JLM. This manuscript is contribution number 16-102-J from the Kansas Agricultural Experiment Station. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Andrew DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076664; Bitsaktsis C, 2004, J IMMUNOL, V172, P6894, DOI 10.4049/jimmunol.172.11.6894; Bitsaktsis C, 2007, INFECT IMMUN, V75, P4933, DOI 10.1128/IAI.00705-07; Bitsaktsis C, 2006, J IMMUNOL, V177, P4644, DOI 10.4049/jimmunol.177.7.4644; Breitschwerdt EB, 1998, ANTIMICROB AGENTS CH, V42, P362; BUHLES WC, 1974, J INFECT DIS, V130, P357, DOI 10.1093/infdis/130.4.357; Cheng CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132657; Cheng CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003171; Cheng Chuanmin, 2008, Curr Protoc Microbiol, VChapter 3, DOI 10.1002/9780471729259.mc03a01s9; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; ENG TR, 1990, JAMA-J AM MED ASSOC, V264, P2251, DOI 10.1001/jama.264.17.2251; Feng HM, 2004, INFECT IMMUN, V72, P966, DOI 10.1128/IAI.72.2.966-971.2004; FISHBEIN DB, 1994, ANN INTERN MED, V120, P736, DOI 10.7326/0003-4819-120-9-199405010-00003; Ganta RR, 2007, INFECT IMMUN, V75, P135, DOI 10.1128/IAI.01127-06; Ganta RR, 2004, INFECT IMMUN, V72, P159, DOI 10.1128/IAI.72.1.159-167.2004; Ganta RR, 2002, INFECT IMMUN, V70, P380, DOI 10.1128/IAI.70.1.380-388.2002; Ismail N, 2004, J IMMUNOL, V172, P1786, DOI 10.4049/jimmunol.172.3.1786; Ismail N, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-26; Kawahara M, 1996, MICROBIOL IMMUNOL, V40, P575, DOI 10.1111/j.1348-0421.1996.tb01111.x; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Levin ML, 2004, INFECT IMMUN, V72, P4723, DOI 10.1128/IAI.72.8.4723-4730.2004; McBride JW, 2010, EXPERT REV VACCINES, V9, P1071, DOI [10.1586/erv.10.93, 10.1586/ERV.10.93]; Nair ADS, 2015, INFECT IMMUN, V83, P2827, DOI 10.1128/IAI.00487-15; Nair ADS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109056; O'Meara CP, 2014, IMMUNOL CELL BIOL, V92, P287, DOI 10.1038/icb.2013.92; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Pedersen LG, 2002, VET IMMUNOL IMMUNOP, V88, P111, DOI 10.1016/S0165-2427(02)00139-3; Pretorius A, 2008, VACCINE, V26, P4363, DOI 10.1016/j.vaccine.2008.06.006; Shkap V, 2007, TRENDS PARASITOL, V23, P420, DOI 10.1016/j.pt.2007.07.003; Singu V, 2005, INFECT IMMUN, V73, P79, DOI 10.1128/IAI.73.1.79-87.2005; Sirigireddy KR, 2005, J MOL DIAGN, V7, P308, DOI 10.1016/S1525-1578(10)60559-4; Sotomayor EA, 2001, AM J PATHOL, V158, P757, DOI 10.1016/S0002-9440(10)64018-7; Stevenson HL, 2006, INFECT IMMUN, V74, P4856, DOI 10.1128/IAI.00246-06; Stuen S, 2003, CLIN DIAGN LAB IMMUN, V10, P692, DOI 10.1128/CDLI.10.4.692-695.2003; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; Wikel S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00337; Winslow GM, 2005, ANN NY ACAD SCI, V1063, P395, DOI 10.1196/annals.1355.071; Winslow GM, 2000, INFECT IMMUN, V68, P2187, DOI 10.1128/IAI.68.4.2187-2195.2000; Winslow GM, 1998, INFECT IMMUN, V66, P3892, DOI 10.1128/IAI.66.8.3892-3899.1998; Yabsley MJ, 2010, VET PARASITOL, V167, P136, DOI 10.1016/j.vetpar.2009.09.015; Yager E, 2005, INFECT IMMUN, V73, P8009, DOI 10.1128/IAI.73.12.8009-8016.2005; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Yu XJ, 2007, VET PARASITOL, V143, P337, DOI 10.1016/j.vetpar.2006.08.027; Zhang XF, 2003, J MED MICROBIOL, V52, P1021, DOI 10.1099/jmm.0.05234-0	44	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148229	10.1371/journal.pone.0148229	http://dx.doi.org/10.1371/journal.pone.0148229			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841025	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200103
J	Zhang, Y; Cheng, JJ; Hua, XL; Yu, MJ; Xu, CD; Zhang, F; Xu, JR; Wu, HW				Zhang, Ying; Cheng, Jiejun; Hua, Xiaolan; Yu, Mingji; Xu, Chengdong; Zhang, Feng; Xu, Jianrong; Wu, Huawei			Can Spectral CT Imaging Improve the Differentiation between Malignant and Benign Solitary Pulmonary Nodules?	PLOS ONE			English	Article							DUAL-ENERGY CT; IODINATED CONTRAST MATERIAL; PRIMARY HUMAN CARCINOMAS; INITIAL-EXPERIENCE; MICROVASCULAR BED; LUNG NODULES; ENHANCEMENT; MULTICENTER; MORPHOLOGY; LESIONS	Purpose To quantitatively assess the value of dual-energy CT (DECT) in differentiating malignancy and benignity of solitary pulmonary nodules. Materials and Methods Sixty-three patients with solitary pulmonary nodules detected by CT plain scan underwent contrast enhanced CT scans in arterial phase (AP) and venous phase (VP) with spectral imaging mode for tumor type differentiation. The Gemstone Spectral Imaging (GSI) viewer was used for image display and data analysis. Region of interest was placed on the relatively homogeneous area of the nodule to measure iodine concentration (IC) on iodinebased material decomposition images and CT numbers on monochromatic image sets to generate spectral HU curve. Normalized IC (NIC), slope of the spectral HU curve (lambda(HU)) and net CT number enhancement on 70keV images were calculated. The two-sample t-test was used to compare quantitative parameters. Receiver operating characteristic curves were generated to calculate sensitivity and specificity. Results There were 63 nodules, with 37 malignant nodules (59%) and 26 benign nodules (41%). NIC,lambda(HU) and net CT number enhancement on 70keV images for malignant nodules were all greater than those of benign nodules. NIC and lambda(HU) had intermediate to high performances to differentiate malignant nodules from benign ones with the areas under curve of 0.89 and 0.86 respectively in AP, 0.96 and 0.89 respectively in VP. Using 0.30 as a threshold value for NIC in VP, one could obtain sensitivity of 93.8% and specificity of 85.7% for differentiating malignant from benign solitary pulmonary nodules. These values were statistically higher than the corresponding values of 74.2% and 53.8% obtained with the conventional CT number enhancement. Conclusions DECT imaging with GSI mode provides more promising value in quantitative way for distinguishing malignant nodules from benign ones than CT enhancement numbers.	[Zhang, Ying; Cheng, Jiejun; Hua, Xiaolan; Yu, Mingji; Xu, Chengdong; Zhang, Feng; Xu, Jianrong; Wu, Huawei] Shanghai Jiao Tong Univ, Dept Radiol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wu, HW (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China.	Huaweiwu26@163.com	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X	Shanghai Municipal Health Bureau [20124176]; Shanghai Municipal Science and Technology Commission [14411968100]	Shanghai Municipal Health Bureau; Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported in part by a research project of Shanghai Municipal Health Bureau (20124176) and Shanghai Municipal Science and Technology Commission (14411968100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chae EJ, 2008, RADIOLOGY, V249, P671, DOI 10.1148/radiol.2492071956; Chae EJ, 2010, J THORAC IMAG, V25, P301, DOI 10.1097/RTI.0b013e3181e16232; De Cecco CN, 2012, AM J ROENTGENOL, V199, pS98, DOI 10.2214/AJR.12.9207; Erasmus JJ, 2000, RADIOGRAPHICS, V20, P43, DOI 10.1148/radiographics.20.1.g00ja0343; Fornaro J, 2011, INSIGHTS IMAGING, V2, P149, DOI 10.1007/s13244-010-0057-0; Goodsitt MM, 2009, MED PHYS, V36, P3107, DOI 10.1118/1.3148536; Hou WS, 2015, ACAD RADIOL, V22, P337, DOI 10.1016/j.acra.2014.10.004; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Knoss N, 2011, EUR J RADIOL, V80, pE516, DOI 10.1016/j.ejrad.2010.11.001; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; Patel BN, 2013, CLIN RADIOL, V68, P148, DOI 10.1016/j.crad.2012.06.108; Schaefer JF, 2004, RADIOLOGY, V232, P544, DOI 10.1148/radiol.2322030515; Simons D, 2014, EUR RADIOL, V24, P930, DOI 10.1007/s00330-013-3087-4; SWENSEN SJ, 1992, RADIOLOGY, V182, P343, DOI 10.1148/radiology.182.2.1732947; Swensen SJ, 2000, RADIOLOGY, V214, P81, DOI 10.1148/radiology.214.1.r00ja2681; Swensen SJ, 2000, RADIOLOGY, V214, P73, DOI 10.1148/radiology.214.1.r00ja1473; Swensen SJ, 1996, RADIOLOGY, V201, P447, DOI 10.1148/radiology.201.2.8888239; SWENSEN SJ, 1995, RADIOLOGY, V194, P393, DOI 10.1148/radiology.194.2.7824716; Truong MT, 2014, RADIOGRAPHICS, V34, P1658, DOI 10.1148/rg.346130092; Wang GL, 2014, J COMPUT ASSIST TOMO, V38, P77, DOI 10.1097/RCT.0b013e3182a21633; Winer-Muram HT, 2006, RADIOLOGY, V239, P34, DOI 10.1148/radiol.2391050343; ZERHOUNI EA, 1986, RADIOLOGY, V160, P319, DOI 10.1148/radiology.160.2.3726107; Zhang MM, 1997, RADIOLOGY, V205, P471, DOI 10.1148/radiology.205.2.9356631; ZIELINSKI KW, 1984, PATHOL RES PRACT, V178, P369, DOI 10.1016/S0344-0338(84)80029-1; ZIELINSKI KW, 1984, PATHOL RES PRACT, V178, P243, DOI 10.1016/S0344-0338(84)80106-5	26	46	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147537	10.1371/journal.pone.0147537	http://dx.doi.org/10.1371/journal.pone.0147537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840459	Green Published, Green Submitted, gold			2022-12-26	WOS:000369550200044
J	Reichhardt, MP; Jarva, H; Lokki, AI; Laivuori, H; Vuorela, P; Loimaranta, V; Glasner, A; Siwetz, M; Huppertz, B; Meri, S				Reichhardt, Martin Parnov; Jarva, Hanna; Lokki, Anna Inkeri; Laivuori, Hannele; Vuorela, Piia; Loimaranta, Vuokko; Glasner, Andreas; Siwetz, Monika; Huppertz, Berthold; Meri, Seppo		FINNPEC Study Grp	The Salivary Scavenger and Agglutinin (SALSA) in Healthy and Complicated Pregnancy	PLOS ONE			English	Article							MALIGNANT BRAIN-TUMORS; SURFACTANT PROTEIN-D; EXTRACELLULAR-MATRIX; AMNIOTIC-FLUID; LECTIN PATHWAY; HUMAN PLACENTA; PREECLAMPSIA; COMPLEMENT; DMBT1; MOLECULE	Pre-eclampsia is a leading cause of maternal and perinatal morbidity and mortality worldwide. The etiology is not clear, but an immune attack towards components of placenta or fetus has been indicated. This involves activation of the complement system in the placenta. We have previously described the presence of the complement-regulating protein salivary scavenger and agglutinin (SALSA) in amniotic fluid. In this study we investigated the potential role of SALSA in pregnancy by analyzing its presence in amniotic fluid and placental tissue during healthy and complicated pregnancies. SALSA levels in amniotic fluid increased during pregnancy. Before 20 weeks of gestation the levels were slightly higher in patients who later developed pre-eclampsia than in gestation age-matched controls. In the placenta of pre-eclamptic patients syncytial damage is often followed by the formation of fibrinoid structures. SALSA was found clustered into these fibrinoid structures in partial co-localization with complement C1q and fibronectin. In vitro analysis showed direct protein binding of SALSA to fibronectin. SALSA binds also to fibrin/fibrinogen but did not interfere with the blood clotting process in vitro. Thus, in addition to antimicrobial defense and epithelial differentiation, the data presented here suggest that SALSA, together with fibronectin and C1q, may be involved in the containment of injured placental structures into fibrinoids.	[Reichhardt, Martin Parnov; Jarva, Hanna; Lokki, Anna Inkeri; Meri, Seppo] Univ Helsinki, Fac Med, Res Programs Unit, Immunobiol Res Program, Helsinki, Finland; [Reichhardt, Martin Parnov; Jarva, Hanna; Lokki, Anna Inkeri; Meri, Seppo] Univ Helsinki, Fac Med, Dept Bacteriol & Immunol, Helsinki, Finland; [Jarva, Hanna; Meri, Seppo] Helsinki Univ Hosp Lab HUSLAB, Helsinki, Finland; [Lokki, Anna Inkeri; Laivuori, Hannele] Univ Helsinki, Med Genet, Helsinki, Finland; [Lokki, Anna Inkeri; Laivuori, Hannele; Vuorela, Piia] Helsinki Univ Hosp, Helsinki, Finland; [Laivuori, Hannele; Vuorela, Piia] Univ Helsinki, Obstet & Gynecol, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Vuorela, Piia] Porvoo Hosp, Obstet & Gynecol, Porvoo, Finland; [Loimaranta, Vuokko] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Glasner, Andreas] Femina Med Ctr, Graz, Austria; [Siwetz, Monika; Huppertz, Berthold] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria; [Huppertz, Berthold] Med Univ Graz, Org Unit Res Infrastruct, Biobank Graz, Graz, Austria	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Turku; Medical University of Graz; Medical University of Graz	Reichhardt, MP; Meri, S (corresponding author), Univ Helsinki, Fac Med, Res Programs Unit, Immunobiol Res Program, Helsinki, Finland.; Reichhardt, MP; Meri, S (corresponding author), Univ Helsinki, Fac Med, Dept Bacteriol & Immunol, Helsinki, Finland.; Meri, S (corresponding author), Helsinki Univ Hosp Lab HUSLAB, Helsinki, Finland.	martin.reichhardt@helsinki.fi; seppo.meri@helsinki.fi	Laivuori, Hannele/F-2953-2011; Lokki, A. Inkeri/H-4783-2019; Kere, Juha/A-9179-2008; Huppertz, Berthold/I-2331-2019	Laivuori, Hannele/0000-0003-3212-7826; Lokki, A. Inkeri/0000-0003-4397-8415; Kere, Juha/0000-0003-1974-0271; Huppertz, Berthold/0000-0003-4814-2158; Parnov Reichhardt, Martin/0000-0001-5345-5103; Kivinen, Katja/0000-0002-1135-7625; Jarva, Hanna/0000-0002-9154-354X; Loimaranta, Vuokko/0000-0002-6873-2270; Meri, Seppo/0000-0001-9142-501X	Helsingin Yliopisto [212/51/2011]; Sigrid Juselius saatio [18032015]; Signe ja Ane Gyllenbergin saatio [14052014]; Stockman foundation [05092014]; Varsinais-Suomi rahasto [85121924]; Helsinki University Hospital Funds [TYH2011205]	Helsingin Yliopisto; Sigrid Juselius saatio; Signe ja Ane Gyllenbergin saatio; Stockman foundation; Varsinais-Suomi rahasto; Helsinki University Hospital Funds	This work was supported by Helsingin Yliopisto: (www.helsinki.fi) [Grant number: 212/51/2011 (HJ)], Sigrid Juselius saatio: (http://www.sigridjuselius.fi/foundation) [Grant number: 18032015 (SM)], Signe ja Ane Gyllenbergin saatio: (http:gyllenbergs.fi/fi/) [Grant number: 14052014 (SM)], the Stockman foundation: Postal address: Tempelgatan 1 A 17, 00100 Helsinki, Finland [Grant number: 05092014 (SM)], Varsinais-Suomi rahasto: (https://skr.fi/fi/rahastot/varsinais-suomen-rahasto) [Grant number: 85121924 (VL)], and Helsinki University Hospital Funds: (http://www.hus.fi/en/Pages/default.aspx) [Grant number: TYH2011205 (PV)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates SM, 2005, CIRCULATION, V112, pE53, DOI 10.1161/CIRCULATIONAHA.104.478222; BOACKLE RJ, 1993, MOL IMMUNOL, V30, P309, DOI 10.1016/0161-5890(93)90059-K; Buurma A, 2012, HYPERTENSION, V60, P1332, DOI 10.1161/HYPERTENSIONAHA.112.194324; CADROY Y, 1993, BRIT J OBSTET GYNAEC, V100, P416, DOI 10.1111/j.1471-0528.1993.tb15264.x; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V11, P362, DOI 10.1080/713605565; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; ERICSON T, 1983, EUR J BIOCHEM, V133, P255, DOI 10.1111/j.1432-1033.1983.tb07456.x; Flierman R, 2007, IMMUNOBIOLOGY, V212, P363, DOI 10.1016/j.imbio.2006.11.005; Fukui H, 2011, INFLAMM BOWEL DIS, V17, P1177, DOI 10.1002/ibd.21473; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P792, DOI 10.1067/mob.2001.117311; Gronborg M, 2004, J PROTEOME RES, V3, P1042, DOI 10.1021/pr0499085; Hay ED, 1995, ACTA ANAT, V154, P8; Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743; Holmskov U, 1999, P NATL ACAD SCI USA, V96, P10794, DOI 10.1073/pnas.96.19.10794; Kang W, 2002, CLIN EXP IMMUNOL, V130, P449, DOI 10.1046/j.1365-2249.2002.01992.x; Kaufmann P, 1996, ANN ANAT, V178, P485, DOI 10.1016/S0940-9602(96)80102-6; Leito JTD, 2011, MOL IMMUNOL, V49, P185, DOI 10.1016/j.molimm.2011.08.010; Lokki AI, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00312; Lynch AM, 2010, PLACENTA, V31, P561, DOI 10.1016/j.placenta.2010.03.010; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; MALHOTRA R, 1994, IMMUNOLOGY, V82, P439; Meri S, 1998, VOX SANG, V74, P291, DOI 10.1111/j.1423-0410.1998.tb05434.x; Mollenhauer J, 1997, NAT GENET, V17, P32, DOI 10.1038/ng0997-32; Mollenhauer J, 2001, CANCER RES, V61, P8880; Mollenhauer J, 2000, CANCER RES, V60, P1704; Muller H, 2013, CARDIOVASC PATHOL, V22, P195, DOI 10.1016/j.carpath.2012.10.006; Muller H, 2012, ARTERIOSCL THROM VAS, V32, P442, DOI 10.1161/ATVBAHA.111.239830; Muller H, 2009, J THORAC CARDIOV SUR, V138, P725, DOI 10.1016/j.jtcvs.2009.05.021; Nayak A, 2012, INNATE IMMUN-LONDON, V18, P350, DOI 10.1177/1753425910396252; NELSON DM, 1990, AM J PATHOL, V136, P855; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Reichhardt MP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00205; Reichhardt MP, 2014, J IMMUNOL, V193, P5240, DOI 10.4049/jimmunol.1401631; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; ROMERO R, 1989, AM J PERINAT, V6, P32, DOI 10.1055/s-2007-999540; Rose SL, 2005, J BIOMED MATER RES A, V72A, P269, DOI 10.1002/jbm.a.30222; Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203; Rossez Y, 2011, BIOCHIMIE, V93, P593, DOI 10.1016/j.biochi.2010.12.002; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Schlotzer-Schrehardt U, 2007, EXP EYE RES, V85, P845, DOI 10.1016/j.exer.2007.08.020; Schulz BL, 2002, BIOCHEM J, V366, P511, DOI 10.1042/BJ20011876; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Tino MJ, 1999, AM J RESP CELL MOL, V20, P759, DOI 10.1165/ajrcmb.20.4.3439; Vijayakumar S, 2006, J CELL SCI, V119, P4797, DOI 10.1242/jcs.03269; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2	48	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147867	10.1371/journal.pone.0147867	http://dx.doi.org/10.1371/journal.pone.0147867			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828433	gold, Green Published, Green Submitted			2022-12-26	WOS:000369548200039
J	Soans, RE; Lim, DC; Keenan, BT; Pack, AI; Shackleford, JA				Soans, Rajath E.; Lim, Diane C.; Keenan, Brendan T.; Pack, Allan I.; Shackleford, James A.			Automated Protein Localization of Blood Brain Barrier Vasculature in Brightfield IHC Images	PLOS ONE			English	Article							TRANSPORTERS; RECEPTORS; DELIVERY; TISSUE; PERMEABILITY; EXPRESSION; PROTEOMICS; SIRNA	In this paper, we present an objective method for localization of proteins in blood brain barrier (BBB) vasculature using standard immunohistochemistry (IHC) techniques and bright-field microscopy. Images from the hippocampal region at the BBB are acquired using bright-field microscopy and subjected to our segmentation pipeline which is designed to automatically identify and segment microvessels containing the protein glucose transporter 1 (GLUT1). Gabor filtering and k-means clustering are employed to isolate potential vascular structures within cryosectioned slabs of the hippocampus, which are subsequently subjected to feature extraction followed by classification via decision forest. The false positive rate (FPR) of microvessel classification is characterized using synthetic and non-synthetic IHC image data for image entropies ranging between 3 and 8 bits. The average FPR for synthetic and non-synthetic IHC image data was found to be 5.48% and 5.04%, respectively.	[Soans, Rajath E.; Shackleford, James A.] Drexel Univ, Dept Elect Engn, Philadelphia, PA 19104 USA; [Lim, Diane C.; Pack, Allan I.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Keenan, Brendan T.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA	Drexel University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Shackleford, JA (corresponding author), Drexel Univ, Dept Elect Engn, Philadelphia, PA 19104 USA.	shack@drexel.edu	Soans, Rajath/GOG-8978-2022	Soans, Rajath/0000-0002-2579-1510; Pack, Allan/0000-0002-2879-0484; Shackleford, James/0000-0002-7987-651X	NIH [T32HL07713, K12 HL090021, HL094307]; American Sleep Medicine Foundation [ASMF 56-PA-10]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007713, P01HL094307, K12HL090021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Sleep Medicine Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants T32HL07713 and K12 HL090021; American Sleep Medicine Foundation (Physician Scientist Training Award), ASMF 56-PA-10; and NIH grant HL094307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2012, DRUG METAB DISPOS, V40, P1164, DOI 10.1124/dmd.112.044719; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Brasnjevic I, 2009, PROG NEUROBIOL, V87, P212, DOI 10.1016/j.pneurobio.2008.12.002; Criminisi A., 2011, MSRTR2011114, V5, P12; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; DILLENCOURT MB, 1992, J ACM, V39, P253, DOI 10.1145/128749.128750; Haghighat Mohammad, 2013, Computer Analysis of Images and Patterns. 15th International Conference, CAIP 2013. Proceedings: LNCS 8048, P440, DOI 10.1007/978-3-642-40246-3_55; Hawkins BT, 2005, AM J PHYSIOL-HEART C, V289, pH212, DOI 10.1152/ajpheart.01210.2004; Hoshi Y, 2013, J PHARM SCI-US, V102, P3343, DOI 10.1002/jps.23575; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Lockman PR, 2004, J DRUG TARGET, V12, P635, DOI 10.1080/10611860400015936; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Nicklay JJ, 2013, ANAL CHEM, V85, P7191, DOI 10.1021/ac400902h; Steven RT, 2013, ANAL BIOANAL CHEM, V405, P4719, DOI 10.1007/s00216-013-6899-9; Sturm RM, 2013, ANAL METHODS-UK, V5, P1623, DOI 10.1039/c3ay26067d; Swinehart D., 1962, J CHEM ED, V39, DOI [10.1021/ed039p333, DOI 10.1021/ED039P333]; Ting CY, 2012, BIOMATERIALS, V33, P704, DOI 10.1016/j.biomaterials.2011.09.096; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Yousif S, 2007, BRAIN RES, V1134, P1, DOI 10.1016/j.brainres.2006.11.089; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	23	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148411	10.1371/journal.pone.0148411	http://dx.doi.org/10.1371/journal.pone.0148411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828723	Green Published, gold			2022-12-26	WOS:000369548200099
J	Thieme, S; Muhldorfer, K; Luschow, D; Hafez, HM				Thieme, Susann; Muehldorfer, Kristin; Lueschow, Doerte; Hafez, Hafez M.			Molecular Characterization of the Recently Emerged Poultry Pathogen Ornithobacterium rhinotracheale by Multilocus Sequence Typing	PLOS ONE			English	Article							GENETIC DIVERSITY; CHICKENS; SCHEME; INFECTION; IDENTIFICATION	Ornithobacterium rhinotracheale (ORT) is an economically important bacterial pathogen of turkeys and chickens worldwide. Since its first detection, a variety of typing methods have been used to gain basic knowledge about the bacterial population structure, an issue that still needs to be addressed. Serological characterization revealed at least 18 different serotypes (A-R) with ORT of serotype A to be predominate among poultry. This study aimed to establish a multilocus sequence typing (MLST) scheme for ORT that could easily be used by other laboratories and allows for worldwide comparison of sequence data. For this purpose, 87 ORT strains from different poultry hosts, geographical origins, years of isolation and serotypes were included in the analysis to identify correlations. Fourteen different sequence types (ST) were found. The most common ST1 was identified in 40 ORT strains from turkeys and chickens on 4 continents and in 3 different European countries. Together with ST9, both STs represented over three quarters (77%) of ORT strains used in the MLST analysis and included strains of frequently cross-reacting ORT serotypes A, E and I. Nine STs were only represented by one ORT strain and might indicate possible avian host, disease or serotype-specific relationships. In contrast, discrepancies between serotype and phylogenetic relatedness were clearly demonstrated by ORT strains that belonged to identical serotypes but differed in their ST. The overall identified low genetic diversity among strains isolated from turkeys and chickens independent of host and geographical origins suggests that ORT has only recently been introduced into domestic poultry and dispersed worldwide.	[Thieme, Susann; Muehldorfer, Kristin; Lueschow, Doerte; Hafez, Hafez M.] Free Univ Berlin, Inst Poultry Dis, Berlin, Germany; [Muehldorfer, Kristin] Leibniz Inst Zoo & Wildlife Res, Dept Wildlife Dis, Berlin, Germany	Free University of Berlin; Leibniz Institut fur Zoo und Wildtierforschung	Thieme, S (corresponding author), Free Univ Berlin, Inst Poultry Dis, Berlin, Germany.	Susann.Thieme@fu-berlin.de		Langforth, Susann/0000-0001-8037-8481				Amonsin A, 1997, J CLIN MICROBIOL, V35, P2894, DOI 10.1128/JCM.35.11.2894-2898.1997; Canal CW, 2005, RES VET SCI, V78, P225, DOI 10.1016/j.rvsc.2004.10.003; Chin R. P., 2013, DIS POULTRY, P828; Coffey TJ, 2006, APPL ENVIRON MICROB, V72, P1420, DOI 10.1128/AEM.72.2.1420-1428.2006; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hafez H. M., 2002, International Journal of Poultry Science, V1, P114; Hafez Hafez Mohamed, 2010, Avian Dis, V54, P161, DOI 10.1637/9008-080309-Case.1; Hafez HM, 1999, AVIAN DIS, V43, P1, DOI 10.2307/1592755; Hafez HM, 1993, INT C POULTR DIS; Han JE, 2013, NEW MICROBIOL, V36, P395; Hung AL, 2001, AVIAN DIS, V45, P999, DOI 10.2307/1592880; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jefferies JMC, 2004, J CLIN MICROBIOL, V42, P5681, DOI 10.1128/JCM.42.12.5681-5688.2004; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Leroy-Setrin S, 1998, LETT APPL MICROBIOL, V26, P189, DOI 10.1046/j.1472-765X.1998.00315.x; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Marien M, 2005, AVIAN PATHOL, V34, P204, DOI 10.1080/03079450500096414; Numee S, 2012, AVIAN DIS, V56, P654, DOI 10.1637/10079-021412-Reg.1; Ozbey G, 2005, VET MED-CZECH, V50, P526, DOI 10.17221/5660-VETMED; Pan Q, 2012, AVIAN DIS, V56, P680, DOI 10.1637/10109-030112-Reg.1; Pan Q, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-104; Popp C, 2003, THESIS FREIE U BERLI; Ruiz-Garbajosa P, 2006, J CLIN MICROBIOL, V44, P2220, DOI 10.1128/JCM.02596-05; Sakai E, 2000, VET REC, V146, P502, DOI 10.1136/vr.146.17.502; Schuijffel DF, 2005, INFECT IMMUN, V73, P6812, DOI 10.1128/IAI.73.10.6812-6821.2005; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Spratt BG, 1999, CURR OPIN MICROBIOL, V2, P312, DOI 10.1016/S1369-5274(99)80054-X; Subaaharan S, 2010, VET MICROBIOL, V141, P354, DOI 10.1016/j.vetmic.2010.01.017; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsai HJ, 2006, AVIAN DIS, V50, P502, DOI 10.1637/7527-031906R.1; Van Empel P, 1998, THESIS U UTRECHT; van Veen L, 2004, AVIAN DIS, V48, P233, DOI 10.1637/7012; VANDAMME P, 1994, INT J SYST BACTERIOL, V44, P24, DOI 10.1099/00207713-44-1-24; vanEmpel P, 1996, AVIAN DIS, V40, P858, DOI 10.2307/1592310; vanEmpel P, 1997, J CLIN MICROBIOL, V35, P418, DOI 10.1128/JCM.35.2.418-421.1997; Waldow K, 2009, THESIS FREIE U BERLI; Welchman DD, 2013, AVIAN PATHOL, V42, P171, DOI 10.1080/03079457.2013.778387	40	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148158	10.1371/journal.pone.0148158	http://dx.doi.org/10.1371/journal.pone.0148158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829551	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200073
J	Volkmann, RA; Fanger, CM; Anderson, DR; Sirivolu, VR; Paschetto, K; Gordon, E; Virginio, C; Gleyzes, M; Buisson, B; Steidl, E; Mierau, SB; Fagiolini, M; Menniti, FS				Volkmann, Robert A.; Fanger, Christopher M.; Anderson, David R.; Sirivolu, Venkata Ramana; Paschetto, Kathy; Gordon, Earl; Virginio, Caterina; Gleyzes, Melanie; Buisson, Bruno; Steidl, Esther; Mierau, Susanna B.; Fagiolini, Michela; Menniti, Frank S.			MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; GRIN2A MUTATIONS; ANTAGONISTS; EXPRESSION; METAPLASTICITY; SCHIZOPHRENIA; DIVERSITY; EPILEPSY; APHASIA; NR2A	GluN2A is the most abundant of the GluN2 NMDA receptor subunits in the mammalian CNS. Physiological and genetic evidence implicate GluN2A-containing receptors in susceptibility to autism, schizophrenia, childhood epilepsy and neurodevelopmental disorders such as Rett Syndrome. However, GluN2A-selective pharmacological probes to explore the therapeutic potential of targeting these receptors have been lacking. Here we disclose a novel series of pyrazine-containing GluN2A antagonists exemplified byMPX-004 (5-(((3-chloro-4-fluorophenyl) sulfonamido) methyl)-N-((2-methylthiazol-5-yl) methyl) pyrazine-2-carboxamide) and MPX007 (5-(((3-fluoro-4-fluorophenyl) sulfonamido) methyl)-N-((2-methylthiazol-5-yl) methyl) methylpyrazine-2-carboxamide). MPX-004 and MPX-007 inhibit GluN2A-containing NMDA receptors expressed in HEK cells with IC(50)s of 79 nM and 27 nM, respectively. In contrast, at concentrations that completely inhibited GluN2A activity these compounds have no inhibitory effect on GluN2B or GluN2D receptor-mediated responses in similar HEK cell-based assays. Potency and selectivity were confirmed in electrophysiology assays in Xenopus oocytes expressing GluN2A-D receptor subtypes. Maximal concentrations of MPX-004 and MPX-007 inhibited similar to 30% of the whole-cell current in rat pyramidal neurons in primary culture and MPX-004 inhibited similar to 60% of the total NMDA receptor-mediated EPSP in rat hippocampal slices. GluN2A-selectivity at native receptors was confirmed by the finding that MPX-004 had no inhibitory effect on NMDA receptor mediated synaptic currents in cortical slices from GRIN2A knock out mice. Thus, MPX-004 and MPX-007 offer highly selective pharmacological tools to probe GluN2A physiology and involvement in neuropsychiatric and developmental disorders.	[Volkmann, Robert A.; Fanger, Christopher M.; Anderson, David R.; Menniti, Frank S.] Mnemosyne Pharmaceut Inc Luc Therapeut, 400 Technol Sq, Cambridge, MA 02139 USA; [Sirivolu, Venkata Ramana] Jubilant Biosys Ltd, 96 Ind Suburb 2nd Stage, Bangalore 560022, Karnataka, India; [Paschetto, Kathy; Gordon, Earl] Jubilant Discovery Serv Inc, 365 Phoenixville Pike, Malvern, PA 19355 USA; [Virginio, Caterina] Aptuit Med Res Ctr, Via Fleming 4, I-37135 Verona, Italy; [Gleyzes, Melanie; Buisson, Bruno; Steidl, Esther] Domaine St Hilaire, Neuroserv, 595 Rue Pierre Berthier,CS 30531, F-13593 Aix En Provence 03, France; [Mierau, Susanna B.; Fagiolini, Michela] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA	Jubilant Biosys Limited; Harvard University; Boston Children's Hospital	Menniti, FS (corresponding author), Mnemosyne Pharmaceut Inc Luc Therapeut, 400 Technol Sq, Cambridge, MA 02139 USA.	mennitifs@gmail.com		fagiolini, michela/0000-0003-2807-803X; Menniti, Frank/0000-0003-2612-9534; Mierau, Susanna/0000-0002-1220-6423; Fanger, Christopher/0000-0002-8268-9053	Mnemosyne Pharmaceuticals Inc.; Rett Syndrome Research Trust	Mnemosyne Pharmaceuticals Inc.; Rett Syndrome Research Trust	This work was funded by Mnemosyne Pharmaceuticals Inc. who provided support in the form of salaries for authors RAV, CMF, FSM, and DRA. These authors participated in the study design, data collection and analysis, decision to publish, and preparation of the manuscript as part of their duties as Mnemosyne employees. VRS, KP, EG, CV, MG, RB, and ES are employees of Jubilant Biosys Limited, Jubilant Discovery Services, Inc., Aptuit Medicines Research Centre, and Neuroservice. Each of these authors participated in the research under contract between their respective employers and Mnemosyne Pharmaceuticals. The work of SBM and MF was funded by a grant from the Rett Syndrome Research Trust. These authors participated in the study design, data collection and analysis, and preparation of the manuscript, but did not participate in the decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson DR, 2015, US Patent, Patent No. [20,150,141,433, 20150141433]; Barnby G, 2005, AM J HUM GENET, V76, P950, DOI 10.1086/430454; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bettini E, 2010, J PHARMACOL EXP THER, V335, P636, DOI 10.1124/jpet.110.172544; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Chenard BL, 1999, CURR PHARM DESIGN, V5, P381; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy SG, 2004, SCI STKE, V2004, P16; Dupuis DS, 2005, BASIC CLIN PHARMACOL, V96, P123, DOI 10.1111/j.1742-7843.2005.pto960206.x; Durand S, 2012, NEURON, V76, P1078, DOI 10.1016/j.neuron.2012.12.004; Edman S, 2012, NEUROPHARMACOLOGY, V63, P441, DOI 10.1016/j.neuropharm.2012.04.027; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Gardoni F, 2012, NEUROBIOL AGING, V33, P2138, DOI 10.1016/j.neurobiolaging.2011.06.019; Gipson CD, 2013, P NATL ACAD SCI USA, V110, P9124, DOI 10.1073/pnas.1220591110; Greenwood TA, 2011, AM J PSYCHIAT, V168, P930, DOI 10.1176/appi.ajp.2011.10050723; Hallett PJ, 2005, NEUROPHARMACOLOGY, V48, P503, DOI 10.1016/j.neuropharm.2004.11.008; Hansen KB, 2014, NEURON, V81, P1084, DOI 10.1016/j.neuron.2014.01.035; Hansen KB, 2012, J NEUROSCI, V32, P6197, DOI 10.1523/JNEUROSCI.5757-11.2012; Hansen KB, 2010, J PHARMACOL EXP THER, V333, P650, DOI 10.1124/jpet.110.166256; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kantrowitz JT, 2010, BRAIN RES BULL, V83, P108, DOI 10.1016/j.brainresbull.2010.04.006; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Layton ME, 2006, CURR TOP MED CHEM, V6, P697, DOI 10.2174/156802606776894447; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; Mierau SB, 2016, BIOL PSYCHIAT, V79, P746, DOI 10.1016/j.biopsych.2015.05.018; Monaghan DT, 2012, NEUROCHEM INT, V61, P581, DOI 10.1016/j.neuint.2012.01.004; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; OLNEY JW, 1995, NEUROPSYCHOPHARMACOL, V13, P335, DOI 10.1038/sj.npp.1380292; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Small D, GLUTAMATE RECEPTOR P, P27; Soares C, 2013, J NEUROSCI, V33, P14975, DOI 10.1523/JNEUROSCI.3109-13.2013; STANDAERT DG, 1994, J COMP NEUROL, V343, P1, DOI 10.1002/cne.903430102; Steidl EM, 2006, BRAIN RES, V1096, P70, DOI 10.1016/j.brainres.2006.04.034; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tovar KR, 2013, J NEUROSCI, V33, P9150, DOI 10.1523/JNEUROSCI.0829-13.2013; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wu F, 2013, MOL CELL NEUROSCI, V52, P9, DOI 10.1016/j.mcn.2012.10.001; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zhou Q, 2013, NEUROPHARMACOLOGY, V74, P69, DOI 10.1016/j.neuropharm.2013.03.030	56	37	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148129	10.1371/journal.pone.0148129	http://dx.doi.org/10.1371/journal.pone.0148129			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829109	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200068
J	Miller, RB; Sadek, A; Rodriguez, A; Iannuzzi, M; Giai, C; Senko, JM; Monty, CN				Miller, Robert Bertram, II; Sadek, Anwar; Rodriguez, Alvaro; Iannuzzi, Mariano; Giai, Carla; Senko, John M.; Monty, Chelsea N.			Use of an Electrochemical Split Cell Technique to Evaluate the Influence of Shewanella oneidensis Activities on Corrosion of Carbon Steel	PLOS ONE			English	Article							MICROBIOLOGICALLY INFLUENCED CORROSION; MICROBIAL IRON RESPIRATION; DESULFOVIBRIO-VULGARIS; MILD-STEEL; INHIBITION; BACTERIA; BIOFILM; 304-STAINLESS-STEEL	Microbially induced corrosion (MIC) is a complex problem that affects various industries. Several techniques have been developed to monitor corrosion and elucidate corrosion mechanisms, including microbiological processes that induce metal deterioration. We used zero resistance ammetry (ZRA) in a split chamber configuration to evaluate the effects of the facultatively anaerobic Fe(III) reducing bacterium Shewanella oneidensis MR-1 on the corrosion of UNS G10180 carbon steel. We show that activities of S. oneidensis inhibit corrosion of steel with which that organism has direct contact. However, when a carbon steel coupon in contact with S. oneidensis was electrically connected to a second coupon that was free of biofilm (in separate chambers of the split chamber assembly), ZRA-based measurements indicated that current moved from the S. oneidensis-containing chamber to the cell-free chamber. This electron transfer enhanced the O-2 reduction reaction on the coupon deployed in the cell free chamber, and consequently, enhanced oxidation and corrosion of that electrode. Our results illustrate a novel mechanism for MIC in cases where metal surfaces are heterogeneously covered by biofilms.	[Miller, Robert Bertram, II; Senko, John M.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Miller, Robert Bertram, II; Senko, John M.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Sadek, Anwar; Rodriguez, Alvaro; Iannuzzi, Mariano; Monty, Chelsea N.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA; [Giai, Carla; Senko, John M.] Univ Akron, Dept Geosci, Akron, OH 44325 USA; [Iannuzzi, Mariano; Giai, Carla] Gen Elect, Eyvind Lyches Vei 10,POB 423, NO-1338 Sandvika, Norway	University System of Ohio; University of Akron; University System of Ohio; University of Akron; University System of Ohio; University of Akron; University System of Ohio; University of Akron; General Electric	Monty, CN (corresponding author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.	cm78@uakron.edu	Iannuzzi, Mariano/A-6548-2016	Iannuzzi, Mariano/0000-0001-9202-3696	US Department of Defense Office of Corrosion Policy and Oversight; US Air Force Academy [FY11-TCC 9, FY12-TCC4]	US Department of Defense Office of Corrosion Policy and Oversight(United States Department of Defense); US Air Force Academy(United States Department of Defense)	This work was supported by the US Department of Defense Office of Corrosion Policy and Oversight and the US Air Force Academy (FY11-TCC 9 and FY12-TCC4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Shewanella oneidensis MR-1 was provided by Dr. Yuri Gorby (Rensselaer Polytechnic Institute). This work was supported by the US Department of Defense Office of Corrosion Policy and Oversight and the US Air Force Academy (FY11-TCC 9 and FY12-TCC4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlAbbas FM, 2013, INT BIODETER BIODEGR, V78, P34, DOI 10.1016/j.ibiod.2012.10.014; [Anonymous], 2014, E155809 ASTM; [Anonymous], 2017, G103 ASTM; Baron D, 2009, J BIOL CHEM, V284, P28865, DOI 10.1074/jbc.M109.043455; Beech I.B., 2014, UNDERSTANDING BIOCOR, P33; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Belkaid S, 2012, RES CHEM INTERMEDIAT, V38, P2309, DOI 10.1007/s11164-012-0547-4; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Brennenstuhl AM, 1994, AM SOC TEST MATER, P15; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Chen YJ, 2015, CORROS SCI, V90, P89, DOI 10.1016/j.corsci.2014.09.016; Cote C, 2015, CORROS SCI, V94, P104, DOI 10.1016/j.corsci.2015.01.044; Cottis RA, 2000, NEW TRENDS ELECTROCH, P247; DAUMAS S, 1988, CORROS SCI, V28, P1041, DOI 10.1016/0010-938X(88)90100-X; Davis J.R., 2000, CORROSION UNDERSTAND; De Windt W, 2003, ENVIRON MICROBIOL, V5, P1192, DOI 10.1046/j.1462-2920.2003.00527.x; Dong ZH, 2011, CORROS SCI, V53, P2978, DOI 10.1016/j.corsci.2011.05.041; Dubiel M, 2002, APPL ENVIRON MICROB, V68, P1440, DOI 10.1128/AEM.68.3.1440-1445.2002; Dzierzewicz Z, 1997, RES MICROBIOL, V148, P785, DOI 10.1016/S0923-2508(97)82454-0; Enning D, 2014, APPL ENVIRON MICROB, V80, P1226, DOI 10.1128/AEM.02848-13; Flemming HC, 1996, MICROBIALLY INFLUENCED CORROSION OF MATERIALS, P5; FORD T, 1990, ADV MICROB ECOL, V11, P231; He Z, 2009, ENERG ENVIRON SCI, V2, P215, DOI 10.1039/b814914c; Iannuzzi M, 2007, ELECTROCHIM ACTA, V52, P4032, DOI 10.1016/j.electacta.2006.11.019; Ismail KM, 1999, ELECTROCHIM ACTA, V44, P4685, DOI 10.1016/S0013-4686(99)00218-2; Herrera LK, 2009, INT BIODETER BIODEGR, V63, P891, DOI 10.1016/j.ibiod.2009.06.003; Kip N, 2015, ISME J, V9, P542, DOI 10.1038/ismej.2014.169; Koch G. H., 2002, FHWARD01156, DOI DOI 10.1097/JCE.0B013E3181FB9A65; Lee AK, 2003, APPL MICROBIOL BIOT, V62, P134, DOI 10.1007/s00253-003-1314-7; Lenhart TR, 2014, BIOFOULING, V30, P823, DOI 10.1080/08927014.2014.931379; Li XX, 2015, CORROS SCI, V90, P331, DOI 10.1016/j.corsci.2014.10.028; Lin J, 2015, J BASIC MICROB, V55, P1; Little B, 1998, BIODEGRADATION, V9, P1, DOI 10.1023/A:1008264313065; Little BJ, 2013, RECENT PATENTS MAT S, V6, P20; Little BJ, 2011, NRLPP7303100367; Little BJ., 2007, MICROBIOLOGICALLY IN; MANSFELD F, 1991, CORROS SCI, V32, P247, DOI 10.1016/0010-938X(91)90072-W; Mansfeld F, 2003, MATER CORROS, V54, P489, DOI 10.1002/maco.200390111; MANSFELD F, 1993, J ELECTROCHEM SOC, V140, P2205, DOI 10.1149/1.2220796; McLean JS, 2010, ENVIRON SCI TECHNOL, V44, P2721, DOI 10.1021/es903043p; Moradi M, 2015, ELECTROCHEM COMMUN, V51, P64, DOI 10.1016/j.elecom.2014.12.007; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; Pastore T, 2011, MATER CORROS, V62, P187, DOI 10.1002/maco.201005789; Potekhina JS, 1999, APPL MICROBIOL BIOT, V52, P639, DOI 10.1007/s002530051571; Rutala W.A., 2019, GUIDELINE DISINFECTI; Stadler R, 2008, ELECTROCHIM ACTA, V54, P91, DOI 10.1016/j.electacta.2008.04.082; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Suflita JM, 2014, UNDERSTANDING BIOCOR, V313; Tanner RS, 2007, MANUAL OF ENVIRONMENTAL MICROBIOLOGY, 3RD ED, P69; Thormann KM, 2005, J BACTERIOL, V187, P1014, DOI 10.1128/JB.187.3.1014-1021.2005; Thormann KM, 2004, J BACTERIOL, V186, P8096, DOI 10.1128/JB.186.23.8096-8104.2004; Venzlaff H, 2013, CORROS SCI, V66, P88, DOI 10.1016/j.corsci.2012.09.006; Videla HA, 2005, INT MICROBIOL, V8, P169; Wang HB, 2012, WATER RES, V46, P1070, DOI 10.1016/j.watres.2011.12.001; Xu CM, 2007, MAT SCI ENG A-STRUCT, V443, P235, DOI 10.1016/j.msea.2006.08.110; Xu DK, 2013, CORROS SCI, V77, P385, DOI 10.1016/j.corsci.2013.07.044; Yuan SJ, 2007, COLLOID SURFACE B, V59, P87, DOI 10.1016/j.colsurfb.2007.04.020; Zhang PY, 2015, BIOELECTROCHEMISTRY, V101, P14, DOI 10.1016/j.bioelechem.2014.06.010; Zuo R, 2007, APPL MICROBIOL BIOT, V76, P1245, DOI 10.1007/s00253-007-1130-6	59	11	11	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147899	10.1371/journal.pone.0147899	http://dx.doi.org/10.1371/journal.pone.0147899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824529	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528600069
J	Nakada, S; Ogasawara, R; Kawada, S; Maekawa, T; Ishii, N				Nakada, Satoshi; Ogasawara, Riki; Kawada, Shigeo; Maekawa, Takahiro; Ishii, Naokata			Correlation between Ribosome Biogenesis and the Magnitude of Hypertrophy in Overloaded Skeletal Muscle	PLOS ONE			English	Article							REGENERATING RAT-LIVER; RESISTANCE EXERCISE; PROTEIN-SYNTHESIS; STRUCTURAL PROTEINS; GENE-EXPRESSION; INDUCED GROWTH; RNA SYNTHESIS; TIME-COURSE; YOUNG MEN; ACTIVATION	External loads applied to skeletal muscle cause increases in the protein translation rate, which leads to muscle hypertrophy. Although some studies have demonstrated that increases in the capacity and efficiency of translation are involved in this process, it remains unclear how these two factors are related to the magnitude of muscle hypertrophy. The present study aimed to clarify the roles played by the capacity and efficiency of translation in muscle hypertrophy. We used an improved synergist ablation in which the magnitude of compensatory hypertrophy could be controlled by partial removal of synergist muscles. Male rats were assigned to four groups in which the plantaris muscle was unilaterally subjected to weak (WK), moderate (MO), middle (MI), and strong (ST) overloading by four types of synergist ablation. Fourteen days after surgery, the weight of the plantaris muscle per body weight increased by 8%, 22%, 32% and 45%, in the WK, MO, MI and ST groups, respectively. Five days after surgery, 18+28S rRNA content (an indicator of translational capacity) increased with increasing overload, with increases of 1.8-fold (MO), 2.2-fold (MI), and 2.5-fold (ST), respectively, relative to non-overloaded muscle (NL) in the WK group. rRNA content showed a strong correlation with relative muscle weight measured 14 days after surgery (r = 0.98). The phosphorylated form of p70S6K (a positive regulator of translational efficiency) showed a marked increase in the MO group, but no further increase was observed with further increase in overload (increases of 22.6-fold (MO), 17.4-fold (MI), and 18.2-fold (ST), respectively, relative to NL in the WK group). These results indicate that increases in ribosome biogenesis at the early phase of overloading are strongly dependent on the amount of overloading, and may play an important role in increasing the translational capacity for further gain of muscular size.	[Nakada, Satoshi; Ogasawara, Riki; Maekawa, Takahiro; Ishii, Naokata] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Kawada, Shigeo] Teikyo Univ, Fac Med Technol, Dept Sport & Med Sci, Tokyo 173, Japan	University of Tokyo; Teikyo University	Nakada, S (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	s.nakada.d@gmail.com	Ogasawara, Riki/AAD-7221-2020; 理紀, 小笠原/HGC-1855-2022	Ogasawara, Riki/0000-0002-2600-1613; Nakada, Satoshi/0000-0003-0453-4969	JSPS KAKENHI Grant [15H03078]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 15H03078.	Adams GR, 2002, AM J PHYSIOL-CELL PH, V283, pC1182, DOI 10.1152/ajpcell.00173.2002; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Burd NA, 2010, J PHYSIOL-LONDON, V588, P3119, DOI 10.1113/jphysiol.2010.192856; Chaillou T, 2014, J CELL PHYSIOL, V229, P1584, DOI 10.1002/jcp.24604; Chaillou T, 2013, J APPL PHYSIOL, V115, P1065, DOI 10.1152/japplphysiol.00611.2013; Chaillou T, 2012, AM J PHYSIOL-REG I, V302, pR643, DOI 10.1152/ajpregu.00262.2011; CSIBI A, 2010, PLOS ONE, V5; Figueiredo VC, 2015, AM J PHYSIOL-ENDOC M; GOLDBERG AL, 1968, J CELL BIOL, V36, P653, DOI 10.1083/jcb.36.3.653; Goodfellow SJ, 2006, EMBO J, V25, P1522, DOI 10.1038/sj.emboj.7601040; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Granneman S, 2007, CURR BIOL, V17, pR415, DOI 10.1016/j.cub.2007.04.011; Hannan RD, 1996, J BIOL CHEM, V271, P3213, DOI 10.1074/jbc.271.6.3213; Machida M, 2012, J CELL PHYSIOL, V227, P1569, DOI 10.1002/jcp.22871; Mayhew DL, 2011, J PHYSIOL-LONDON, V589, P3023, DOI 10.1113/jphysiol.2010.202432; Mitchell CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078636; Mitchell CJ, 2012, J APPL PHYSIOL, V113, P71, DOI 10.1152/japplphysiol.00307.2012; Miyazaki M, 2011, J PHYSIOL-LONDON, V589, P1831, DOI 10.1113/jphysiol.2011.205658; Nader GA, 2014, J APPL PHYSIOL, V116, P693, DOI 10.1152/japplphysiol.01366.2013; Nader GA, 2002, CLIN ORTHOP RELAT R, pS178, DOI 10.1097/01.blo.0000031979.92980.2e; Nader GA, 2005, AM J PHYSIOL-CELL PH, V289, pC1457, DOI 10.1152/ajpcell.00165.2005; Ochi E, 2010, J SPORT SCI MED, V9, P170; Ogasawara R, 2013, J APPL PHYSIOL, V114, P934, DOI 10.1152/japplphysiol.01161.2012; Quy PN, 2013, J BIOL CHEM, V288, P1125, DOI 10.1074/jbc.M112.399949; Phillips SM, 2009, APPL PHYSIOL NUTR ME, V34, P403, DOI 10.1139/H09-042; Roy RR, 1999, J APPL PHYSIOL, V87, P634, DOI 10.1152/jappl.1999.87.2.634; TAMAKI T, 1995, PHYSIOL BEHAV, V57, P913, DOI 10.1016/0031-9384(94)00359-D; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; TSURUGI K, 1972, EUR J BIOCHEM, V29, P585, DOI 10.1111/j.1432-1033.1972.tb02025.x; TSURUGI K, 1972, EUR J BIOCHEM, V25, P117, DOI 10.1111/j.1432-1033.1972.tb01675.x; van der Meer SFT, 2011, ANN ANAT, V193, P56, DOI 10.1016/j.aanat.2010.08.004; von Walden F, 2012, AM J PHYSIOL-CELL PH, V302, pC1523, DOI 10.1152/ajpcell.00460.2011; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weigl LG, 2012, CURR OPIN PHARMACOL, V12, P377, DOI 10.1016/j.coph.2012.02.017; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Zhang Z, 2013, J MOL CELL CARDIOL, V59, P139, DOI 10.1016/j.yjmcc.2013.03.006	36	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147284	10.1371/journal.pone.0147284	http://dx.doi.org/10.1371/journal.pone.0147284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824605	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600021
J	Butcher, AJ; Bradley, SJ; Prihandoko, R; Brooke, SM; Mogg, A; Bourgognon, JM; Macedo-Hatch, T; Edwards, JM; Bottrill, AR; Challiss, RAJ; Broad, LM; Felder, CC; Tobin, AB				Butcher, Adrian J.; Bradley, Sophie J.; Prihandoko, Rudi; Brooke, Simon M.; Mogg, Adrian; Bourgognon, Julie-Myrtille; Macedo-Hatch, Timothy; Edwards, Jennifer M.; Bottrill, Andrew R.; Challiss, R. A. John; Broad, Lisa M.; Felder, Christian C.; Tobin, Andrew B.			An Antibody Biosensor Establishes the Activation of the M-1 Muscarinic Acetylcholine Receptor during Learning and Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ANTIPSYCHOTIC-LIKE ACTIVITY; ALLOSTERIC MODULATION; BETA-ARRESTIN; MUTANT MICE; AGONIST; HIPPOCAMPUS; PHOSPHORYLATION; SCOPOLAMINE; XANOMELINE	Establishing the in vivo activation status of G protein-coupled receptors would not only indicate physiological roles of G protein-coupled receptors but would also aid drug discovery by establishing drug/receptor engagement. Here, we develop a phospho-specific antibody-based biosensor to detect activation of the M-1 muscarinic acetylcholine receptor (M-1 mAChR) in vitro and in vivo. Mass spectrometry phosphoproteomics identified 14 sites of phosphorylation on the M-1 mAChR. Phospho-specific antibodies to four of these sites established that serine at position 228 (Ser(228)) on the M-1 mAChR showed extremely low levels of basal phosphorylation that were significantly up-regulated by orthosteric agonist stimulation. In addition, the M-1 mAChR-positive allosteric modulator, 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, enhanced acetylcholine-mediated phosphorylation at Ser(228). These data supported the hypothesis that phosphorylation at Ser(228) was an indicator of M-1 mAChR activation. This was further supported in vivo by the identification of phosphorylated Ser(228) on the M-1 mAChR in the hippocampus of mice following administration of the muscarinic ligands xanomeline and 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. Finally, Ser(228) phosphorylation was seen to increase in the CA1 region of the hippocampus following memory acquisition, a response that correlated closely with up-regulation of CA1 neuronal activity. Thus, determining the phosphorylation status of the M-1 mAChR at Ser(228) not only provides a means of establishing receptor activation following drug treatment both in vitro and in vivo but also allows for the mapping of the activation status of the M-1 mAChR in the hippocampus following memory acquisition thereby establishing a link between M-1 mAChR activation and hippocampus-based memory and learning.	[Butcher, Adrian J.; Bradley, Sophie J.; Prihandoko, Rudi; Brooke, Simon M.; Bourgognon, Julie-Myrtille; Macedo-Hatch, Timothy; Edwards, Jennifer M.; Tobin, Andrew B.] Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England; [Bottrill, Andrew R.] Univ Leicester, Prot & Nucle Acid Chem Lab, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England; [Mogg, Adrian; Broad, Lisa M.] Eli Lilly & Co, Neurosci, Windlesham GU20 6PH, Surrey, England; [Felder, Christian C.] Eli Lilly & Co, Lilly Corp Ctr, Neurosci, Indianapolis, IN 46285 USA; [Challiss, R. A. John] Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England; [Butcher, Adrian J.; Bradley, Sophie J.; Tobin, Andrew B.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Leicester; University of Leicester; Eli Lilly; Eli Lilly; University of Leicester; University of Glasgow	Tobin, AB (corresponding author), Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.; Tobin, AB (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	tba@le.ac.uk	Challiss, R.A. John/A-9412-2008; Bottrill, Andrew/ABD-1459-2021	Bottrill, Andrew/0000-0002-5182-3643; Challiss, John/0000-0001-5506-2848; Felder, Christian/0000-0003-1134-8881	Lilly grants; Lilly LRAP grant; Medical Research Council by Medical Research Council Toxicology Unit; Medical Research Council Integrative Toxicology Training Partnership Ph.D. studentship scheme; Heptares Therapeutics; Biotechnology and Biological Sciences Research Council [BB/L02781X/1]; Medical Research Council [MC_UP_A600_1110, 1382137, G1100712] Funding Source: researchfish; BBSRC [BB/L02781X/1] Funding Source: UKRI; MRC [MC_UP_A600_1110, G1100712] Funding Source: UKRI	Lilly grants; Lilly LRAP grant; Medical Research Council by Medical Research Council Toxicology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Integrative Toxicology Training Partnership Ph.D. studentship scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Heptares Therapeutics; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Lilly grants (to C. C. F., L. M. B., and A. M.), a Lilly LRAP grant (to J. M. B.), a Medical Research Council program leader grant provided by the Medical Research Council Toxicology Unit (to A. B. T., S. J. B., A. J. B., T. M. H., and J. M. E.), a Medical Research Council Integrative Toxicology Training Partnership Ph.D. studentship scheme (to S. M. B.), and the Heptares Therapeutics and Biotechnology and Biological Sciences Research Council Grant BB/L02781X/1 (to R. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdul-Ridha A, 2014, J BIOL CHEM, V289, P6067, DOI 10.1074/jbc.M113.539080; Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Anagnostaras SG, 1999, NEUROPSYCHOPHARMACOL, V21, P731, DOI 10.1016/S0893-133X(99)00083-4; Andersen MB, 2003, NEUROPSYCHOPHARMACOL, V28, P1168, DOI 10.1038/sj.npp.1300151; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Digby GJ, 2010, MOL BIOSYST, V6, P1345, DOI 10.1039/c002938f; Eglen R. M., 2006, Autonomic & Autacoid Pharmacology, V26, P219, DOI 10.1111/j.1474-8673.2006.00368.x; Hudson BD, 2012, FASEB J, V26, P4951, DOI 10.1096/fj.12-213314; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kenakin T, 2014, BIOCHEM PHARMACOL, V87, P40, DOI 10.1016/j.bcp.2013.07.033; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; LEVEY AI, 1995, J NEUROSCI, V15, P4077; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Porter AC, 2002, BRAIN RES, V944, P82, DOI 10.1016/S0006-8993(02)02721-X; Poulin B, 2010, P NATL ACAD SCI USA, V107, P9440, DOI 10.1073/pnas.0914801107; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Shannon HE, 2000, SCHIZOPHR RES, V42, P249, DOI 10.1016/S0920-9964(99)00138-3; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Van der Zee EA, 1999, PROG NEUROBIOL, V58, P409, DOI 10.1016/S0301-0082(98)00092-6; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Waugh MG, 1999, BIOCHEM J, V338, P175, DOI 10.1042/0264-6021:3380175; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Yeatman HR, 2014, J BIOL CHEM, V289, P15856, DOI 10.1074/jbc.M113.536672; YOUNG SL, 1995, NEUROBIOL LEARN MEM, V63, P174, DOI 10.1006/nlme.1995.1018; Ziegler N, 2011, BIOORGAN MED CHEM, V19, P1048, DOI 10.1016/j.bmc.2010.07.060; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	43	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8862	8875		10.1074/jbc.M115.681726	http://dx.doi.org/10.1074/jbc.M115.681726			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26826123	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000374849000001
J	Varier, RA; Pau, ECD; van der Groep, P; Lindeboom, RGH; Matarese, F; Mensinga, A; Smits, AH; Edupuganti, RR; Baltissen, MP; Jansen, PWTC; ter Hoeve, N; van Weely, DR; Poser, I; van Diest, PJ; Stunnenberg, HG; Vermeulen, M				Varier, Radhika A.; Pau, Enrique Carrillo de Santa; van der Groep, Petra; Lindeboom, Rik G. H.; Matarese, Filomena; Mensinga, Anneloes; Smits, Arne H.; Edupuganti, Raghu Ram; Baltissen, Marijke P.; Jansen, Pascal W. T. C.; ter Hoeve, Natalie; van Weely, Danny R.; Poser, Ina; van Diest, Paul J.; Stunnenberg, Hendrik G.; Vermeulen, Michiel			Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN MODIFICATIONS; BREAST-CANCER; MARKS	Recent work from others and us revealed interactions between the Sin3/HDAC complex, the H3K4me3 demethylase KDM5A, GATAD1, and EMSY. Here, we characterize the EMSY/KDM5A/SIN3B complex in detail by quantitative interaction proteomics and ChIP-sequencing. We identify a novel substoichiometric interactor of the complex, transcription factor ZNF131, which recruits EMSY to a large number of active, H3K4me3 marked promoters. Interestingly, using an EMSY knock-out line and subsequent rescue experiments, we show that EMSY is in most cases positively correlated with transcriptional activity of its target genes and stimulates cell proliferation. Finally, by immunohistochemical staining of primary breast tissue microarrays we find that EMSY/KDM5A/SIN3B complex subunits are frequently overexpressed in primary breast cancer cases in a correlative manner. Taken together, these data open venues for exploring the possibility that sporadic breast cancer patients with EMSY amplification might benefit from epigenetic combination therapy targeting both the KDM5A demethylase and histone deacetylases.	[Varier, Radhika A.; Mensinga, Anneloes; Smits, Arne H.; Jansen, Pascal W. T. C.; van Weely, Danny R.; Vermeulen, Michiel] Univ Med Ctr Utrecht, Dept Mol Canc Res, Univ Weg 100, NL-3584 CG Utrecht, Netherlands; [Pau, Enrique Carrillo de Santa; Lindeboom, Rik G. H.; Matarese, Filomena; Smits, Arne H.; Edupuganti, Raghu Ram; Baltissen, Marijke P.; Jansen, Pascal W. T. C.; Stunnenberg, Hendrik G.; Vermeulen, Michiel] Radboud Inst Mol Life Sci, Dept Mol Biol, Geert Grootepl Zuid 30, NL-6525 GA Nijmegen, Netherlands; [van der Groep, Petra; ter Hoeve, Natalie; van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands; [Poser, Ina] Max Planck Inst Mol Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Varier, Radhika A.] Francis Crick Inst, Cell Fate & Gene Regulat Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England; [Pau, Enrique Carrillo de Santa] BBVA Fdn, CNIO Canc Cell Biol Programme, Spanish Natl Canc Res Ctr CNIO, Epithelial Carcinogenesis Grp, Madrid, Spain; [Mensinga, Anneloes] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Cell Biol, Univ Weg 100, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Max Planck Society; Francis Crick Institute; Centro Nacional de Investigaciones Oncologicas (CNIO); Utrecht University; Utrecht University Medical Center	Vermeulen, M (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.; Vermeulen, M (corresponding author), Radboud Inst Mol Life Sci, Dept Mol Biol, Geert Grootepl Zuid 30, NL-6525 GA Nijmegen, Netherlands.	m.vermeulen@ncmls.ru.nl	Stunnenberg, Hendrik G./D-6875-2012; de Santa Pau, Enrique Carrillo/AAV-7544-2021; Edupuganti, Venkata/AAG-6486-2019; Vermeulen, Michiel/C-8883-2013	Stunnenberg, Hendrik G./0000-0002-0066-1576; de Santa Pau, Enrique Carrillo/0000-0002-2310-2267; Edupuganti, Venkata/0000-0001-9414-2672; Vermeulen, Michiel/0000-0003-0836-6894; Lindeboom, Rik/0000-0002-3660-504X; Varier, Radhika/0000-0003-1302-3159; Smits, Arne H/0000-0001-5011-0898	Dutch Cancer Society [UU2009-4488]; Netherlands Organization for Scientific Research (NWO-VIDI) [864.09.003]; Netherlands Organization for Scientific Research (NWO Gravitation program CGC.nl)	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO Gravitation program CGC.nl)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Grant UU2009-4488 from the Dutch Cancer Society (to K. W. F.) and by grants from the Netherlands Organization for Scientific Research (NWO-VIDI, project number 864.09.003 and the NWO Gravitation program CGC.nl). The authors declare that they have no conflicts of interest with the contents of this article.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chikina MD, 2012, BIOINFORMATICS, V28, P607, DOI 10.1093/bioinformatics/bts009; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Donaldson NS, 2010, EXP CELL RES, V316, P1692, DOI 10.1016/j.yexcr.2010.03.011; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; VANDIEST PJ, 1992, HUM PATHOL, V23, P876, DOI 10.1016/0046-8177(92)90398-M; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vire E, 2014, MOL CELL, V53, P806, DOI 10.1016/j.molcel.2014.01.029; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	29	20	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7313	7324		10.1074/jbc.M115.701227	http://dx.doi.org/10.1074/jbc.M115.701227			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26841866	Green Published, hybrid			2022-12-26	WOS:000383447600009
J	Steidle, EA; Chong, LS; Wu, MX; Crooke, E; Fiedler, D; Resnick, AC; Rolfes, RJ				Steidle, Elizabeth A.; Chong, Lucy S.; Wu, Mingxuan; Crooke, Elliott; Fiedler, Dorothea; Resnick, Adam C.; Rolfes, Ronda J.			A Novel Inositol Pyrophosphate Phosphatase in Saccharomyces cerevisiae: Siw14 PROTEIN SELECTIVELY CLEAVES THE -PHOSPHATE FROM 5-DIPHOSPHOINOSITOL PENTAKISPHOSPHATE (5PP-IP5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dual-specificity phosphoprotein phosphatase; inositol phosphate; phosphatase; phosphatidylinositol; Saccharomyces cerevisiae; second messenger; IP7; Siw14; Vip1	DUAL-SPECIFICITY PHOSPHATASES; INORGANIC POLYPHOSPHATE; ESCHERICHIA-COLI; CONSERVED FAMILY; YEAST; METABOLISM; IDENTIFICATION; COMPLEXES; COATOMER; ENZYMES	Inositol pyrophosphates are high energy signaling molecules involved in cellular processes, such as energetic metabolism, telomere maintenance, stress responses, and vesicle trafficking, and can mediate protein phosphorylation. Although the inositol kinases underlying inositol pyrophosphate biosynthesis are well characterized, the phosphatases that selectively regulate their cellular pools are not fully described. The diphosphoinositol phosphate phosphohydrolase enzymes of the Nudix protein family have been demonstrated to dephosphorylate inositol pyrophosphates; however, the Saccharomyces cerevisiae homolog Ddp1 prefers inorganic polyphosphate over inositol pyrophosphates. We identified a novel phosphatase of the recently discovered atypical dual specificity phosphatase family as a physiological inositol pyrophosphate phosphatase. Purified recombinant Siw14 hydrolyzes the -phosphate from 5-diphosphoinositol pentakisphosphate (5PP-IP5 or IP7) in vitro. In vivo, siw14 yeast mutants possess increased IP7 levels, whereas heterologous SIW14 overexpression eliminates IP7 from cells. IP7 levels increased proportionately when siw14 was combined with ddp1 or vip1, indicating independent activity by the enzymes encoded by these genes. We conclude that Siw14 is a physiological phosphatase that modulates inositol pyrophosphate metabolism by dephosphorylating the IP7 isoform 5PP-IP5 to IP6.	[Steidle, Elizabeth A.; Rolfes, Ronda J.] Georgetown Univ, Dept Biol, Reiss Sci Bldg,Rm 406,37th & O St, Washington, DC 20057 USA; [Chong, Lucy S.; Resnick, Adam C.] Childrens Hosp Philadelphia, Div Neurosurg, 4052 CTRB,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Wu, Mingxuan; Fiedler, Dorothea] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Crooke, Elliott] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Chong, Lucy S.; Fiedler, Dorothea] Leibniz Inst Mol Pharmakol Forschungsverbund Berl, Campus Berlin Buch,Robert Roessle Str 10, D-13125 Berlin, Germany; [Wu, Mingxuan] Johns Hopkins Sch Med, Dept Pharmacol, 316 Hunterian,725 N Wolfe St, Baltimore, MD 21205 USA; [Resnick, Adam C.] Childrens Hosp Philadelphia, 4052 CTRB,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA	Georgetown University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Princeton University; Georgetown University; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Johns Hopkins University; Johns Hopkins Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Rolfes, RJ (corresponding author), Georgetown Univ, Dept Biol, Reiss Sci Bldg,Rm 406,37th & O St, Washington, DC 20057 USA.; Resnick, AC (corresponding author), Childrens Hosp Philadelphia, Div Neurosurg, 4052 CTRB,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	resnick@email.chop.edu; rolfesr@georgetown.edu	Wu, Mingxuan/G-8519-2017	Steidle, Elizabeth/0000-0002-8225-7197; Chong, Lucy/0000-0002-5858-9984	National Science Foundation CAREER Grant [MCB-1253809]; Georgetown University Pilot Grant; Div Of Molecular and Cellular Bioscience [1253809] Funding Source: National Science Foundation	National Science Foundation CAREER Grant(National Science Foundation (NSF)); Georgetown University Pilot Grant; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation CAREER Grant MCB-1253809 (to A. C. R.) and a Georgetown University Pilot Grant (to R. J. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Aceti DJ, 2008, PROTEINS, V73, P241, DOI 10.1002/prot.22041; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; ALI N, 1995, BIOCHEM J, V310, P279, DOI 10.1042/bj3100279; Auger K. R., 1990, METHODS INOSITIDE RE, P159; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Capolicchio S, 2014, ANGEW CHEM INT EDIT, V53, P9508, DOI 10.1002/anie.201404398; Care A, 2004, GENETICS, V166, P707, DOI 10.1534/genetics.166.2.707; Cha-Aim Kamonchai, 2012, Methods Mol Biol, V852, P97, DOI 10.1007/978-1-61779-564-0_8; Dove Stephen K., 2009, V462, P59, DOI 10.1007/978-1-60327-115-8_4; FLEISCHER B, 1994, J BIOL CHEM, V269, P17826; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hatch AJ, 2010, CELL, V143, P1030, DOI 10.1016/j.cell.2010.11.045; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kilari RS, 2013, FEBS LETT, V587, P3464, DOI 10.1016/j.febslet.2013.08.035; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; Pohlmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004586; Roma-Mateo C, 2007, J MOL BIOL, V374, P899, DOI 10.1016/j.jmb.2007.10.008; Roma-Mateo C, 2011, MOL GENET GENOMICS, V285, P341, DOI 10.1007/s00438-011-0611-6; Safrany ST, 1999, J BIOL CHEM, V274, P21735, DOI 10.1074/jbc.274.31.21735; SIKORSKI RS, 1989, GENETICS, V122, P19; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Thomas MP, 2014, FEBS J, V281, P14, DOI 10.1111/febs.12575; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Worley J, 2013, CELL REP, V3, P1476, DOI 10.1016/j.celrep.2013.03.043; Wu MX, 2014, ANGEW CHEM INT EDIT, V53, P7192, DOI 10.1002/anie.201402905; Wu MX, 2013, CHEM SCI, V4, P405, DOI 10.1039/c2sc21553e; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564	36	36	37	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6772	6783		10.1074/jbc.M116.714907	http://dx.doi.org/10.1074/jbc.M116.714907			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26828065	Green Published, hybrid			2022-12-26	WOS:000373299700016
J	Krupka, M; Masek, J; Barkocziova, L; Knotigova, PT; Kulich, P; Plockova, J; Lukac, R; Bartheldyova, E; Koudelka, S; Chaloupkova, R; Sebela, M; Zyka, D; Droz, L; Effenberg, R; Ledvina, M; Miller, AD; Turanek, J; Raska, M				Krupka, Michal; Masek, Josef; Barkocziova, Lucia; Knotigova, Pavlina Turanek; Kulich, Pavel; Plockova, Jana; Lukac, Robert; Bartheldyova, Eliska; Koudelka, Stepan; Chaloupkova, Radka; Sebela, Marek; Zyka, Daniel; Droz, Ladislav; Effenberg, Roman; Ledvina, Miroslav; Miller, Andrew D.; Turanek, Jaroslav; Raska, Milan			The Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental Mice	PLOS ONE			English	Article							OUTER SURFACE PROTEIN; LYME-DISEASE VACCINE; BORRELIA-BURGDORFERI; LIPOPHILIC DERIVATIVES; MOLECULAR ANALYSIS; IMMUNE-RESPONSE; GENE-TRANSFER; EPITOPE; EXPRESSION; IMMUNOGENICITY	Lyme disease, Borrelia burgdorferi-caused infection, if not recognized and appropriately treated by antibiotics, may lead to chronic complications, thus stressing the need for protective vaccine development. The immune protection is mediated by phagocytic cells and by Borrelia-specific complement-activating antibodies, associated with the Th1 immune response. Surface antigen OspC is involved in Borrelia spreading through the host body. Previously we reported that recombinant histidine tagged (His-tag) OspC (rOspC) could be attached onto liposome surfaces by metallochelation. Here we report that levels of OspC-specific antibodies vary substantially depending upon whether rOspC possesses an N' or C' terminal His-tag. This is the case in mice immunized: (a) with rOspC proteoliposomes containing adjuvants MPLA or non-pyrogenic MDP analogue MT06; (b) with free rOspC and Montanide PET GEL A; (c) with free rOspC and alum; or (d) with adjuvant-free rOspC. Stronger responses are noted with all N'-terminal His-tag rOspC formulations. OspC-specific Th1-type antibodies predominate post-immunization with rOspC proteoliposomes formulated with MPLA or MT06 adjuvants. Further analyses confirmed that the structural features of soluble N' and C' terminal His-tag rOspC and respective rOspC proteoliposomes are similar including their thermal stabilities at physiological temperatures. On the other hand, a change in the position of the rOspC His-tag from N' to C' terminal appears to affect substantially the immunogenicity of rOspC arguably due to steric hindrance of OspC epitopes by the C' terminal His-tag itself and not due to differences in overall conformations induced by changes in the His-tag position in rOspC variants.	[Krupka, Michal; Barkocziova, Lucia; Raska, Milan] Palacky Univ Olomouc, Fac Med & Dent, Dept Immunol, Olomouc, Czech Republic; [Masek, Josef; Knotigova, Pavlina Turanek; Kulich, Pavel; Plockova, Jana; Lukac, Robert; Bartheldyova, Eliska; Koudelka, Stepan; Turanek, Jaroslav; Raska, Milan] Vet Res Inst, Dept Pharmacol & Immunotherapy, CS-62132 Brno, Czech Republic; [Koudelka, Stepan; Chaloupkova, Radka] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Chaloupkova, Radka] Masaryk Univ, Loschmidt Labs, Dept Expt Biol, Brno, Czech Republic; [Chaloupkova, Radka] Masaryk Univ, Res Ctr Toxic Cpds Environm RECETOX, Brno, Czech Republic; [Sebela, Marek] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic; [Zyka, Daniel; Droz, Ladislav] Apigenex, Prague, Czech Republic; [Effenberg, Roman; Ledvina, Miroslav] Univ Chem & Technol, Dept Chem Nat Cpds, Prague, Czech Republic; [Miller, Andrew D.] Kings Coll London, Inst Pharmaceut Sci, London, England; [Miller, Andrew D.] GlobalAcom Ltd, London, England	Palacky University Olomouc; Czech Veterinary Research Institute; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Masaryk University Brno; Palacky University Olomouc; University of Chemistry & Technology, Prague; University of London; King's College London	Raska, M (corresponding author), Palacky Univ Olomouc, Fac Med & Dent, Dept Immunol, Olomouc, Czech Republic.; Turanek, J; Raska, M (corresponding author), Vet Res Inst, Dept Pharmacol & Immunotherapy, CS-62132 Brno, Czech Republic.	turanek@vuvel.cz; raskamil@uab.edu	Miller, Andrew/G-8291-2019; Mašek, Josef/B-3734-2015; Chaloupkova, Radka/M-5565-2016; Bartheldyová, Eliška/Z-1784-2019; Sebela, Marek/AAL-2747-2020; Raska, Milan/E-9813-2013	Miller, Andrew/0000-0003-0661-249X; Mašek, Josef/0000-0001-6788-8487; Chaloupkova, Radka/0000-0002-3539-7445; Sebela, Marek/0000-0001-9835-1375; Raska, Milan/0000-0002-8572-7246; Effenberg, Roman/0000-0001-9046-2011; Krupka, Michal/0000-0002-9699-7903	Palacky University, Olomouc, Czech Republic [LF_2014_020, LF_2015_009]; CENATOX; European Union FP7 REGPOT - Human Bridge [316345]; Grant Agency of Czech Republic [GAP503/12/G147]; Ministry of Education, Youth and Sports [CZ.1.07/2.3.00/20.0164, LO1304, LO1214, LM2011028]; Czech Ministry of Agriculture [MZE0002716202]; Technological Agency of Czech Republic TACR [TA01011165, TA02010760]; European Social Fund; State Budget of the Czech Republic - Project FNUSA-ICRC [CZ.1.07/2.3.00/30.0043]; Ministry of Education, Youth and Sports	Palacky University, Olomouc, Czech Republic(Czech Republic Government); CENATOX; European Union FP7 REGPOT - Human Bridge; Grant Agency of Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Czech Ministry of Agriculture(Ministry of Agriculture, Czech Republic); Technological Agency of Czech Republic TACR; European Social Fund(European Social Fund (ESF)); State Budget of the Czech Republic - Project FNUSA-ICRC; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	These studies were supported by LF_2014_020 and LF_2015_009 (Palacky University, Olomouc, Czech Republic) (MR, MK); project CENATOX; Grant of the European Union FP7 REGPOT - Human Bridge 316345 (RC); Grant Agency of Czech Republic, GAP503/12/G147 (JT); the Ministry of Education, Youth and Sports CZ.1.07/2.3.00/20.0164 (MR, JT) and LO1304, LO1214 and LM2011028 (RC); MZE0002716202 Czech Ministry of Agriculture (JT); Technological Agency of Czech Republic TACR TA01011165 - Multiepitopic vaccine against boreliosis (to JT, MR, ML); TA02010760 - Development of anticancer immunotherapeutics of new generation (ML, LD). SK was supported by the European Social Fund and the State Budget of the Czech Republic - Project FNUSA-ICRC, support for neurological research and development teams through postdoc position formations CZ.1.07/2.3.00/30.0043. The teams headed by Jaroslav Turanek, Milan Raska, and Andrew D. Miller are obligated to the Ministry of Education, Youth and Sports for supporting of the project "FIT" (Pharmacology, Immunotherapy, nanoToxicology). The funder provided support in the form of salaries for authors (DZ, LD), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altin JG, 2006, METHODS, V40, P39, DOI 10.1016/j.ymeth.2006.05.027; [Anonymous], MOL VACCINES PROPHYL; Bielecka MK, 2015, INFECT IMMUN, V83, P730, DOI 10.1128/IAI.01815-14; Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; Bockenstedt LK, 1996, J IMMUNOL, V157, P5496; BOCKENSTEDT LK, 1993, J IMMUNOL, V151, P900; Buckles EL, 2006, CLIN VACCINE IMMUNOL, V13, P1162, DOI 10.1128/CVI.00099-06; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Comstedt P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113294; Earnhart CG, 2007, HUM VACCINES, V3, P281, DOI 10.4161/hv.4661; Earnhart CG, 2007, CLIN VACCINE IMMUNOL, V14, P628, DOI 10.1128/CVI.00409-06; Earnhart CG, 2007, VACCINE, V25, P3419, DOI 10.1016/j.vaccine.2006.12.051; Earnhart CG, 2007, VACCINE, V25, P466, DOI 10.1016/j.vaccine.2006.07.052; ERDILE LF, 1993, INFECT IMMUN, V61, P81, DOI 10.1128/IAI.61.1.81-90.1993; Figueroa CM, 2010, BIOCHIMIE, V92, P81, DOI 10.1016/j.biochi.2009.09.013; FIKRIG E, 1990, SCIENCE, V250, P553, DOI 10.1126/science.2237407; FUCHS R, 1992, MOL MICROBIOL, V6, P503, DOI 10.1111/j.1365-2958.1992.tb01495.x; Gilmore RD, 1999, INFECT IMMUN, V67, P5463, DOI 10.1128/IAI.67.10.5463-5469.1999; Halperin JJ, 2015, INFECT DRUG RESIST, V8, DOI 10.2147/IDR.S66739; Hipler K, 2013, COMPONDS DERIVED NOR; Jobe DA, 2003, CLIN DIAGN LAB IMMUN, V10, P573, DOI 10.1128/CDLI.10.4.573-578.2003; Knotigova PT, 2015, PHARM RES-DORDR, V32, P1186, DOI 10.1007/s11095-014-1516-y; Koide S, 2005, J MOL BIOL, V350, P290, DOI 10.1016/j.jmb.2005.04.066; Kowalska M, 2010, PHYTOCHEMISTRY, V71, P1970, DOI 10.1016/j.phytochem.2010.08.013; Krupka M, 2015, IMMUNOL LETT, V166, P36, DOI 10.1016/j.imlet.2015.05.010; Krupka Michal, 2005, Biomedical Papers (Olomouc), V149, P261; Krupka M, 2012, J CONTROL RELEASE, V160, P374, DOI 10.1016/j.jconrel.2012.02.017; Krupka M, 2011, ARCH IMMUNOL THER EX, V59, P261, DOI 10.1007/s00005-011-0128-z; Krupka Michal, 2007, Biomedical Papers (Olomouc), V151, P175; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; Lantos PM, 2015, INFECT DIS CLIN N AM, V29, P325, DOI 10.1016/j.idc.2015.02.006; Lovrich SD, 2005, CLIN DIAGN LAB IMMUN, V12, P746, DOI 10.1128/CDLI.12.6.746-751.2005; MA JN, 1994, VACCINE, V12, P925, DOI 10.1016/0264-410X(94)90036-1; Malliaros J, 2004, VACCINE, V22, P3968, DOI 10.1016/j.vaccine.2004.03.054; Masek J, 2011, J CONTROL RELEASE, V151, P193, DOI 10.1016/j.jconrel.2011.01.016; Masek J, 2011, ANAL BIOCHEM, V408, P95, DOI 10.1016/j.ab.2010.08.023; Mayer A, 2004, BRIT J CANCER, V90, P2402, DOI 10.1038/sj.bjc.6601888; Munson EL, 2000, INFECT IMMUN, V68, P5496, DOI 10.1128/IAI.68.10.5496-5501.2000; Petrovska B, 2014, CYTOGENET GENOME RES, V143, P78, DOI 10.1159/000365311; PROBERT WS, 1994, INFECT IMMUN, V62, P1920, DOI 10.1128/IAI.62.5.1920-1926.1994; Rudenko N, 2011, TICKS TICK-BORNE DIS, V2, P123, DOI 10.1016/j.ttbdis.2011.04.002; Schulte-Spechtel U, 2006, INT J MED MICROBIOL, V296, P250, DOI 10.1016/j.ijmm.2006.01.006; Srivastava SY, 2008, J BACTERIOL, V190, P3429, DOI 10.1128/JB.00085-08; Tilly K, 2008, INFECT DIS CLIN N AM, V22, P217, DOI 10.1016/j.idc.2007.12.013; Turanek J, 2011, BIOMEDICAL SCIENCE, ENGINEERING AND TECHNOLOGY, P653; Wang GQ, 1999, FEMS MICROBIOL LETT, V177, P289, DOI 10.1111/j.1574-6968.1999.tb13745.x; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993	47	15	15	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148497	10.1371/journal.pone.0148497	http://dx.doi.org/10.1371/journal.pone.0148497			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848589	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000110
J	Moura-Massari, VO; Cunha, FS; Gomes, LG; Gomes, DBD; Marcondes, JAM; Madureira, G; de Mendonca, BB; Bachega, TASS				Moura-Massari, Vivian Oliveira; Cunha, Flavia Siqueira; Gomes, Larissa Garcia; Diniz Gomes, Diogo Bugano; Miguel Marcondes, Jose Antonio; Madureira, Guiomar; de Mendonca, Berenice Bilharinho; Sartori Sanchez Bachega, Tania A.			The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; X-CHROMOSOME INACTIVATION; POLYCYSTIC-OVARY-SYNDROME; CLINICAL-PRACTICE GUIDELINE; PROSTATE-CANCER; REPEAT POLYMORPHISM; BRAZILIAN PATIENTS; NORMAL WOMEN; RISK; ASSOCIATION	Background In the nonclassical form (NC), good correlation has been observed between genotypes and 17OH-progesterone (17-OHP) levels. However, this correlation was not identified with regard to the severity of hyperandrogenic manifestations, which could depend on interindividual variability in peripheral androgen sensitivity. Androgen action is modulated by the polymorphic CAG tract (nCAG) of the androgen receptor (AR) gene and by polymorphisms in 5 alpha-reductase type 2 (SRD5A2) enzyme, both of which are involved in the severity of hyperandrogenic disorders. Objectives To analyze whether nCAG-AR and SRD5A2 polymorphisms influence the severity of the nonclassical phenotype. Patients NC patients (n = 114) diagnosed by stimulated-17OHP >= 10 ng/mL were divided into groups according to the beginning of hyperandrogenic manifestations (pediatric and adolescent/adult) and CYP21A2 genotypes (C/C: homozygosis for mild mutations; A/C: compound heterozygosis for severe/mild mutations). Methods CYP21A2 mutations were screened by allelic-specific PCR, MLPA and/or sequencing. HpaII-digested and HpaII-undigested DNA samples underwent GeneScan analysis to study nCAG, and the SRD5A2 polymorphisms were screened by RLFP. Results Mean nCAG did not differ among pediatric, adolescent/adult and asymptomatic subjects. In the C/C genotype, we observed a significantly lower frequency of longer CAG alleles in pediatric patients than in adolescent/adults (p = 0.01). In patients carrying the A/C genotype, the frequencies of shorter and longer CAG alleles did not differ between pediatric patients and adolescent/adults (p>0.05). Patients with clitoromegaly had significantly lower weighted CAG biallelic mean than those without it: 19.1 +/- 2.7 and 21.6 +/- 2.5, respectively (p = 0.007), independent of the CYP21A2 genotype's severity. The SRD5A2 polymorphisms were not associated with the variability of hyperandrogenic NC phenotypes. Conclusions In this series, we observed a modulatory effect of the CAG-AR tract on clinical manifestations of the NC form. Although the NC form is a monogenic disorder, our preliminary data suggested that the interindividual variability of the hyperandrogenic phenotype could arise from polygenic interactions.	[Moura-Massari, Vivian Oliveira; Cunha, Flavia Siqueira; Gomes, Larissa Garcia; Miguel Marcondes, Jose Antonio; Madureira, Guiomar; de Mendonca, Berenice Bilharinho; Sartori Sanchez Bachega, Tania A.] Univ Sao Paulo, Fac Med, Lab Hormonios & Genet Mol LIM 42, Unidade Suprarrenal,Disciplina Endocrinol,Hosp Cl, Sao Paulo, Brazil; [Diniz Gomes, Diogo Bugano] Univ Sao Paulo, Fac Med, Hosp Clin, Dept Clin Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Cunha, FS (corresponding author), Univ Sao Paulo, Fac Med, Lab Hormonios & Genet Mol LIM 42, Unidade Suprarrenal,Disciplina Endocrinol,Hosp Cl, Sao Paulo, Brazil.	endoflavia@gmail.com; tbachega@usp.br	Mendonca, Berenice/AAS-3742-2021; Bachega, Tania A S S/C-3361-2013	Mendonca, Berenice/0000-0003-1762-1084; Bachega, Tania A S S/0000-0002-5219-3153; Gomes, Larissa/0000-0002-0902-0142	Sao Paulo Research Foundation (FAPESP) [2014/07878-4, 08/51624-6, 05/04726-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [308318/2012-9, 305743/2011-2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by grants from the Sao Paulo Research Foundation (FAPESP) #2014/07878-4, to Moura-Massari V by FAPESP #08/51624-6 and FAPESP #05/04726-0, and to Bachega TASS and Mendonca BB by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) #308318/2012-9 and 305743/2011-2, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovic T, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-109; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Araujo RS, 2007, J CLIN ENDOCR METAB, V92, P4028, DOI 10.1210/jc.2006-2163; Bachega TASS, 2000, CLIN ENDOCRINOL, V52, P601, DOI 10.1046/j.1365-2265.2000.00995.x; Bachega TASS, 1998, J CLIN ENDOCR METAB, V83, P4416, DOI 10.1210/jc.83.12.4416; Bebermeier JH, 2006, J MOL MED, V84, P919, DOI 10.1007/s00109-006-0081-1; Ben-Shachar S, 2015, HORM METAB RES, V47, P491, DOI 10.1055/s-0034-1389901; Bidet M, 2009, J CLIN ENDOCR METAB, V94, P1570, DOI 10.1210/jc.2008-1582; Billerbeck AEC, 1999, J CLIN ENDOCR METAB, V84, P2870, DOI 10.1210/jc.84.8.2870; Brown J, 2005, J PEDIATR ENDOCR MET, V18, P3; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Cleves MA, 2005, STATA J, V5, P141, DOI 10.1177/1536867X0500500201; Costa-Barbosa FA, 2010, CLIN ENDOCRINOL, V73, P700, DOI 10.1111/j.1365-2265.2010.03871.x; Dasgupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012401; Deneux C, 2001, J CLIN ENDOCR METAB, V86, P207, DOI 10.1210/jc.86.1.207; Ezquieta B, 2002, ACTA PAEDIATR, V91, P892, DOI 10.1080/080352502760148595; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Finkielstain GP, 2011, J CLIN ENDOCR METAB, V96, pE161, DOI 10.1210/jc.2010-0319; GALE RE, 1994, BLOOD, V83, P2899, DOI 10.1182/blood.V83.10.2899.2899; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Goodarzi MO, 2006, J CLIN ENDOCR METAB, V91, P4085, DOI 10.1210/jc.2006-0227; Hickey T, 2002, J CLIN ENDOCR METAB, V87, P161, DOI 10.1210/jc.87.1.161; HIGASHI Y, 1991, J BIOCHEM-TOKYO, V109, P638, DOI 10.1093/oxfordjournals.jbchem.a123433; Hsing AW, 2000, CANCER RES, V60, P5111; Ibanez L, 2003, J CLIN ENDOCR METAB, V88, P3333, DOI 10.1210/jc.2002-021791; Kaupert LC, 2010, HORM RES PAEDIAT, V73, P238, DOI 10.1159/000284387; Krone N, 2000, J CLIN ENDOCR METAB, V85, P1059, DOI 10.1210/jc.85.3.1059; Lappalainen S, 2008, J CLIN ENDOCR METAB, V93, P1304, DOI 10.1210/jc.2007-2707; Li QX, 2013, MOL BIOL REP, V40, P3597, DOI 10.1007/s11033-012-2434-x; Li ZH, 2003, J UROLOGY, V169, P2378, DOI 10.1097/01.ju.0000056152.57018.31; Makridakis NM, 1999, LANCET, V354, P975, DOI 10.1016/S0140-6736(98)11282-5; Martin KA, 2008, J CLIN ENDOCR METAB, V93, P1105, DOI 10.1210/jc.2007-2437; Mifsud A, 2001, FERTIL STERIL, V75, P275, DOI 10.1016/S0015-0282(00)01693-9; Mishra DK, 2005, CLIN GENET, V68, P55, DOI 10.1111/j.1399-0004.2005.00450.x; Moran C, 2000, AM J OBSTET GYNECOL, V183, P1468, DOI 10.1067/mob.2000.108020; Moura-Massari VO, 2013, HORM METAB RES, V45, P301, DOI 10.1055/s-0032-1330007; Nam RK, 2001, UROLOGY, V57, P199, DOI 10.1016/S0090-4295(00)00928-6; New MI, 2004, ANN NY ACAD SCI, V1038, P14, DOI 10.1196/annals.1315.009; Ogata T, 2001, CLIN ENDOCRINOL, V54, P835, DOI 10.1046/j.1365-2265.2001.01205.x; PEGORARO E, 1994, AM J HUM GENET, V54, P989; Ribeiro ML, 2002, BRAZ J MED BIOL RES, V35, P205, DOI 10.1590/S0100-879X2002000200009; Rocha RO, 2008, CLIN ENDOCRINOL, V68, P226, DOI 10.1111/j.1365-2265.2007.03023.x; Samtani R, 2011, J UROLOGY, V185, P2334, DOI 10.1016/j.juro.2011.02.043; Shah NA, 2008, J CLIN ENDOCR METAB, V93, P1939, DOI 10.1210/jc.2008-0038; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Shimbo M, 2005, EUR UROL, V47, P557, DOI 10.1016/j.eururo.2004.10.016; Skrgatic L, 2012, J STEROID BIOCHEM, V128, P107, DOI 10.1016/j.jsbmb.2011.11.006; Speiser PW, 2010, J CLIN ENDOCR METAB, V95, P4133, DOI 10.1210/jc.2009-2631; Speiser PW, 2000, MOL GENET METAB, V71, P527, DOI 10.1006/mgme.2000.3036; SPEISER PW, 1988, NEW ENGL J MED, V319, P19, DOI 10.1056/NEJM198807073190104; SPEISER PW, 1992, HUM GENET, V88, P647, DOI 10.1007/BF02265290; TUSIELUNA MT, 1990, J BIOL CHEM, V265, P20916; VERKAUF BS, 1992, OBSTET GYNECOL, V80, P41; WEDELL A, 1994, J CLIN ENDOCR METAB, V78, P1145, DOI 10.1210/jc.78.5.1145; Weintrob N, 2000, EUR J ENDOCRINOL, V143, P397, DOI 10.1530/eje.0.1430397; White PC, 2012, SEMIN REPROD MED, V30, P400, DOI 10.1055/s-0032-1324724; Wilson RC, 2007, MOL GENET METAB, V90, P414, DOI 10.1016/j.ymgme.2006.12.005; Xita N, 2008, HUM REPROD, V23, P693, DOI 10.1093/humrep/dem382; Zouboulis CC, 2004, EXP DERMATOL, V13, P5, DOI 10.1111/j.1600-0625.2004.00255.x	59	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148548	10.1371/journal.pone.0148548	http://dx.doi.org/10.1371/journal.pone.0148548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848581	Green Published, gold			2022-12-26	WOS:000369554000122
J	Bua, G; Manaresi, E; Bonvicini, F; Gallinella, G				Bua, Gloria; Manaresi, Elisabetta; Bonvicini, Francesca; Gallinella, Giorgio			Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells	PLOS ONE			English	Article							IN-VITRO; CYCLE ARREST; INTERNAL POLYADENYLATION; NONSTRUCTURAL PROTEIN; PRODUCTIVE INFECTION; PERIPHERAL-BLOOD; P-ANTIGEN; VIRUS; APOPTOSIS; RECEPTOR	The pathogenic Parvovirus B19 (B19V) is characterized by a strict adaptation to erythroid progenitor cells (EPCs), a heterogeneous population of differentiating cells with diverse phenotypic and functional properties. In our work, we studied the dynamics of B19V infection in EPCs in dependence on the cell differentiation stage, in terms of distribution of infected cells, synthesis of viral nucleic acids and production of infectious virus. EPCs at early differentiation stage led to an abortive infection, without viral genome replication and a very low transcriptional activity. EPCs at later stages were permissive, with highest levels of viral replicative activity at day 9 (+3.0 Log from 2 to 48 hpi) and lower levels at day 18 (+1.5 Log from 2 to 48 hpi). B19V DNA increment was in accordance with the percentage of cells positive to flow-FISH assay (41.4% at day 9, 1.1% at day 18). Quantitation of total RNA indicated a close association of genome replication and transcription with viral RNA accumulation within infected cells related to viral DNA increase during the course of infection. Analysis of the different classes of mRNAs revealed two distinct pattern of genome expression profile with a fine regulation in the frequency utilization of RNA processing signals: an early phase, when cleavage at the proximal site leading to a higher relative production of mRNA for NS protein, and a late phase, when cleavage at the distal site was more frequent leading to higher relative abundance of mRNA for VP and 11 kDA proteins. Infectious virus was released from cells at day 6-15, but not at day 18. Our results, providing a detailed description of B19V replication and expression profile in differentiating EPCs, highlight the very tight adaptation of B19V to a specific cellular target defined both by its erythroid lineage and its differentiation stage.	[Bua, Gloria; Manaresi, Elisabetta; Bonvicini, Francesca; Gallinella, Giorgio] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Gallinella, Giorgio] Univ Bologna, Orsola Malpighi Hosp Microbiol, Bologna, Italy	University of Bologna; University of Bologna	Gallinella, G (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	giorgio.gallinella@unibo.it	Gallinella, Giorgio/H-6864-2017	Gallinella, Giorgio/0000-0003-1118-6341; BUA, GLORIA/0000-0003-0826-3713				Bonvicini F, 2006, VIROLOGY, V347, P447, DOI 10.1016/j.virol.2005.12.014; Bonvicini F, 2008, VIROLOGY, V381, P168, DOI 10.1016/j.virol.2008.09.002; Bonvicini F, 2015, ANTIVIR RES, V113, P11, DOI 10.1016/j.antiviral.2014.11.004; Bonvicini F, 2013, J CLIN MICROBIOL, V51, P3753, DOI 10.1128/JCM.01970-13; Bonvicini F, 2011, J CLIN MICROBIOL, V49, P3514, DOI 10.1128/JCM.00854-11; BROWN KE, 1994, NEW ENGL J MED, V330, P1192, DOI 10.1056/NEJM199404283301704; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; Brown KE, 2000, BEST PRACT RES CL HA, V13, P245, DOI 10.1053/beha.1999.0071; BROWN KE, 1991, J GEN VIROL, V72, P741, DOI 10.1099/0022-1317-72-3-741; Chen AY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002088; Chen AY, 2010, FUTURE VIROL, V5, P731, DOI 10.2217/FVL.10.56; Chen AY, 2010, J VIROL, V84, P12385, DOI 10.1128/JVI.01229-10; Chen AY, 2010, BLOOD, V115, P1070, DOI 10.1182/blood-2009-04-215756; Chisaka H, 2003, REV MED VIROL, V13, P347, DOI 10.1002/rmv.395; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; Filippone C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009496; Gallinella G, 2004, CLIN CHEM, V50, P759, DOI 10.1373/clinchem.2003.027292; Gallinella G, 2000, VIROLOGY, V278, P361, DOI 10.1006/viro.2000.0673; Gallinella G., 2013, ISRN VIROL, DOI [10.5402/2013/898730, DOI 10.5402/2013/898730]; Guan WX, 2008, J VIROL, V82, P9951, DOI 10.1128/JVI.01162-08; Guan WX, 2011, J BIOL CHEM, V286, P24793, DOI 10.1074/jbc.M111.227439; Guan WX, 2011, J VIROL, V85, P2463, DOI 10.1128/JVI.01708-10; Guo YM, 2010, BLOOD, V115, P4569, DOI 10.1182/blood-2009-08-239202; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Hemauer A, 1999, J GEN VIROL, V80, P627, DOI 10.1099/0022-1317-80-3-627; Leisi R, 2015, BIOCONJUGATE CHEM, V26, P1923, DOI 10.1021/acs.bioconjchem.5b00321; Leisi R, 2013, J VIROL, V87, P13161, DOI 10.1128/JVI.02548-13; Lou S, 2012, J VIROL, V86, P10748, DOI 10.1128/JVI.01007-12; Luo Y, 2015, FUTURE VIROL, V10, P155, DOI 10.2217/FVL.14.103; Luo Y, 2013, J VIROL, V87, P12766, DOI 10.1128/JVI.02333-13; Luo Y, 2013, FUTURE VIROL, V8, P245, DOI 10.2217/FVL.13.5; Luo Y, 2011, J VIROL, V85, P8046, DOI 10.1128/JVI.00831-11; Manaresi E, 2015, J VIROL METHODS, V223, P50, DOI 10.1016/j.jviromet.2015.07.013; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; Moffatt S, 1998, J VIROL, V72, P3018, DOI 10.1128/JVI.72.4.3018-3028.1998; Morita E, 2003, J VIROL, V77, P2915, DOI 10.1128/JVI.77.5.2915-2921.2003; Morita E, 2001, J VIROL, V75, P7555, DOI 10.1128/JVI.75.16.7555-7563.2001; MORTIMER PP, 1983, NATURE, V302, P426, DOI 10.1038/302426a0; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; OZAWA K, 1986, SCIENCE, V233, P883, DOI 10.1126/science.3738514; OZAWA K, 1987, BLOOD, V70, P384, DOI 10.1182/blood.V70.2.384.384; Pillet S, 2004, VIROLOGY, V327, P1, DOI 10.1016/j.virol.2004.06.020; Pillet S, 2008, J VIROL, V82, P8951, DOI 10.1128/JVI.00929-08; Puccetti C, 2012, PRENATAL DIAG, V32, P897, DOI 10.1002/pd.3930; Quattrocchi S, 2012, J VIROL, V86, P9274, DOI 10.1128/JVI.01004-12; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SCHWARZ TF, 1992, J VIROL, V66, P1273, DOI 10.1128/JVI.66.2.1273-1276.1992; SERKE S, 1991, BRIT J HAEMATOL, V79, P6, DOI 10.1111/j.1365-2141.1991.tb07999.x; Sol N, 1999, J VIROL, V73, P8762, DOI 10.1128/JVI.73.10.8762-8770.1999; SRIVASTAVA A, 1988, J VIROL, V62, P3059, DOI 10.1128/JVI.62.8.3059-3063.1988; TAKAHASHI T, 1990, BLOOD, V75, P603; Tewary SK, 2014, VIROLOGY, V449, P297, DOI 10.1016/j.virol.2013.11.031; Tolfvenstam T, 2009, SEMIN FETAL NEONAT M, V14, P218, DOI 10.1016/j.siny.2009.01.007; von Landenberg P, 2007, AUTOIMMUN REV, V6, P278, DOI 10.1016/j.autrev.2006.09.006; Wan ZH, 2010, J CLIN INVEST, V120, P3530, DOI 10.1172/JCI41805; Weigel-Kelley KA, 2003, BLOOD, V102, P3927, DOI 10.1182/blood-2003-05-1522; Weigel-Kelley KA, 2001, J VIROL, V75, P4110, DOI 10.1128/JVI.75.9.4110-4116.2001; Wong S, 2008, J VIROL, V82, P2470, DOI 10.1128/JVI.02247-07; Wong S, 2006, J CLIN VIROL, V35, P407, DOI 10.1016/j.jcv.2005.12.008; Yaegashi N, 1999, J INFECTION, V39, P68, DOI 10.1016/S0163-4453(99)90105-6; YOUNG N, 1984, J CLIN INVEST, V74, P2024, DOI 10.1172/JCI111625; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; YOUNG NS, 1984, J CLIN INVEST, V73, P224, DOI 10.1172/JCI111195; Zhi N, 2006, J VIROL, V80, P5941, DOI 10.1128/JVI.02430-05	64	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148547	10.1371/journal.pone.0148547	http://dx.doi.org/10.1371/journal.pone.0148547			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845771	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800068
J	Kumar, J; Sharma, VK; Singh, DK; Mishra, A; Gond, SK; Verma, SK; Kumar, A; Kharwar, RN				Kumar, Jitendra; Sharma, Vijay K.; Singh, Dheeraj K.; Mishra, Ashish; Gond, Surendra K.; Verma, Satish K.; Kumar, Anuj; Kharwar, Ravindra Nath			Epigenetic Activation of Antibacterial Property of an Endophytic Streptomyces coelicolor Strain AZRA 37 and Identification of the Induced Protein Using MALDI TOF MS/MS	PLOS ONE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; SP NOV.; RAPID IDENTIFICATION; MYCOFLORA; DIVERSITY; BARK; LEAF; NEEM; DNA	The endophytic Streptomyces coelicolor strain AZRA 37 was isolated from the surface sterilized root of Azadirachta indica A. Juss., commonly known as neem plant in India. Since only a few reports are available regarding epigenetic modulations of microbial entities, S. coelicolor was treated with different concentrations of 5-azacytidine for this purpose and evaluated for its antibacterial potential against five human pathogenic bacteria (Aeromonas hydrophila IMS/GN11, Enterococcus faecalis IMS/GN7, Salmonella typhi MTCC 3216, Shigella flexneri ATCC 12022 and Staphylococcus aureus ATCC 25923). The crude extract obtained from cultures treated with 25 mu M concentration of 5-azacytidine, was found effective against all five pathogenic bacteria tested while the untreated control was only active against 3 pathogenic bacteria. HPLC analysis of crude compounds from treated cultures showed a greater number of compounds than that of the control. Extraction of whole cell protein and its SDS PAGE analysis showed an additional major protein band in 25 mu M 5-azacytidine treated culture and MALDI TOF MS/MS analysis revealed that this protein belongs to the porin family.	[Kumar, Jitendra; Sharma, Vijay K.; Singh, Dheeraj K.; Mishra, Ashish; Verma, Satish K.; Kharwar, Ravindra Nath] Banaras Hindu Univ, Dept Bot, Mycopathol & Microbial Technol Lab, Varanasi 221005, Uttar Pradesh, India; [Gond, Surendra K.] Visva Bharati, Dept Bot, Santini Ketan, Bolpur, India; [Kumar, Anuj] Budhha PG Coll, Dept Bot, Kushinagar, India	Banaras Hindu University (BHU); Visva Bharati University	Kharwar, RN (corresponding author), Banaras Hindu Univ, Dept Bot, Mycopathol & Microbial Technol Lab, Varanasi 221005, Uttar Pradesh, India.	rnkharwar@yahoo.com	Sharma, Vijay Kumar/J-5353-2019; Verma, Satish K./J-6398-2019; Gond, Surendra/ABB-6182-2021; Singh, Dheeraj Kumar/ABS-8460-2022; Sharma, Vijay Kumar K/E-3541-2019	Singh, Dheeraj Kumar/0000-0001-8297-5191; Sharma, Vijay Kumar K/0000-0002-2330-5830; Gond, Surendra/0000-0002-2737-9028; Verma, Satish Kumar/0000-0003-4470-5398	CSIR, New Delhi; Department of Science and Technology (Science and Engineering Research Board), New Delhi [SB/EMEQ-121/2014]	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (Science and Engineering Research Board), New Delhi(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	Funded by the CSIR, New Delhi, for financial support as JRF and SRF to JK; the Department of Science and Technology (Science and Engineering Research Board), New Delhi, for financial support to RNK as project (SB/EMEQ-121/2014, 21-7-2014).	Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Beau J, 2012, MAR DRUGS, V10, P762, DOI 10.3390/md10040762; BENSON DR, 1993, MICROBIOL REV, V57, P293, DOI 10.1128/MMBR.57.2.293-319.1993; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Castillo U, 2003, J NAT PRODUCTS, V66, P709; de la Cruz M, 2012, CHEM BIODIVERS, V9, P1095, DOI 10.1002/cbdv.201100362; Du HJ, 2013, INT J SYST EVOL MICR, V63, P900, DOI 10.1099/ijs.0.041491-0; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; FERNANDEZ M, 1995, GENE, V157, P221, DOI 10.1016/0378-1119(94)00672-F; Gangwar M, 2015, INT J ADV RES, V3, P1062; Gangwar M, 2014, AFR J MICOBIOL RES, V92, P182; Genilloud O, 2011, J IND MICROBIOL BIOT, V38, P375, DOI 10.1007/s10295-010-0882-7; Gohain A, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv158; Gond SK, 2010, MANAGEMENT OF FUNGAL PLANT PATHOGENS, P183, DOI 10.1079/9781845936037.0183; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Janso JE, 2010, APPL ENVIRON MICROB, V76, P4377, DOI 10.1128/AEM.02959-09; Kaewkla O, 2013, INT J SYST EVOL MICR, V63, P1249, DOI 10.1099/ijs.0.041343-0; Kaewkla O, 2012, INT J SYST EVOL MICR, V62, P1687, DOI 10.1099/ijs.0.033258-0; Kharwar RN, 2008, CURR SCI INDIA, V95, P228; Klackta C, 2011, BBA-BIOMEMBRANES, V1808, P1601, DOI 10.1016/j.bbamem.2010.11.011; KUSTER E, 1964, NATURE, V202, P928, DOI 10.1038/202928a0; Passardi A, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0139468, 10.1371/journal.pone.0134732]; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; Qin S, 2009, APPL ENVIRON MICROB, V75, P6176, DOI 10.1128/AEM.01034-09; Rajagopal K, 2000, CURR SCI INDIA, V78, P1375; Ruelle V, 2004, RAPID COMMUN MASS SP, V18, P2013, DOI 10.1002/rcm.1584; SCHUMACHER JD, 2014, THESIS, P1; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Udeinya IJ, 2004, T ROY SOC TROP MED H, V98, P435, DOI 10.1016/j.trstmh.2003.10.016; Verma VC, 2007, MICROB ECOL, V54, P119, DOI 10.1007/s00248-006-9179-9; Verma VC, 2006, J AGR TECHNOLOGY, V2, P329; Verma VC, 2013, INT NANO LETT, V3, DOI 10.1186/2228-5326-3-21; Verma VC, 2011, INDIAN J MICROBIOL, V51, P469, DOI 10.1007/s12088-011-0121-6; Verma VC, 2009, MICROB ECOL, V57, P749, DOI 10.1007/s00248-008-9450-3; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Williams TL, 2003, J AM SOC MASS SPECTR, V14, P342, DOI 10.1016/S1044-0305(03)00065-5; Yu ZG, 2011, J ANTIBIOT, V64, P159, DOI 10.1038/ja.2010.147; Zhao GZ, 2011, J NAT PRODUCTS, V74, P862	41	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147876	10.1371/journal.pone.0147876	http://dx.doi.org/10.1371/journal.pone.0147876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844762	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800020
J	Liu, YZ; Qiu, L; Wang, YX; Aimurola, H; Zhao, YY; Li, S; Xu, ZJ				Liu, Yongzhe; Qiu, Lan; Wang, Yanxun; Aimurola, Halimulati; Zhao, Yuyue; Li, Shan; Xu, Zuojun			The Circulating Treg/Th17 Cell Ratio Is Correlated with Relapse and Treatment Response in Pulmonary Sarcoidosis Patients after Corticosteroid Withdrawal	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; REGULATORY T-CELLS; CD4(+); PREDICTION; CYTOKINES; PROGRESS; TH1	Objectives Pulmonary sarcoidosis is an immune-mediated disease, and some patients can be effectively treated with corticosteroids. However, nearly half of all sarcoidosis patients relapse after corticosteroid withdrawal. Different subsets of CD4+ helper T cells participate in the immunopathogenesis of sarcoidosis. Thus, the aims of our study were to investigate whether the circulating subsets of CD4+ helper T cells were associated with sarcoidosis relapse and with its remission after retreatment. Additionally, we identified a useful biomarker for predicting the relapse and remission of sarcoidosis patients. Methods Forty-two patients were enrolled in the present study who had previously been diagnosed with pulmonary sarcoidosis and treated with corticosteroids. The patients were allocated into either a stable group if they exhibited sustained remission (n = 22) or a relapse group if they experienced clinical or radiological recurrence after treatment withdrawal (n = 20). Peripheral blood cells were collected from these patients and analyzed to determine the frequencies of subsets of circulating CD4+ helper T cells by flow cytometry. The patients in the relapse group were retreated with corticosteroids and immunosuppressive agents and were then reevaluated to determine the frequencies of dynamic subsets of circulating CD4+ helper T cells after remission. Results The frequencies of circulating Tregs were significantly increased concomitant with a decrease in the circulating Th17 cell frequency in the relapsed patients compared with the stable patients. The Treg/Th17 ratio was negatively correlated with sarcoidosis activity and was sensitive to retreatment. In addition, the percentage of isolated CD45RO+Ki67+ Tregs was higher in the patients who were stable and in those who recovered after retreatment than in those who relapsed. Conclusions An imbalance between Tregs and Th17 cells is associated with pulmonary sarcoidosis relapse after corticosteroid withdrawal. The circulating Treg/Th17 ratio could serve as an alternative marker for monitoring pulmonary sarcoidosis relapse after the end of corticosteroid treatment and for rapidly predicting the response to retreatment.	[Liu, Yongzhe; Wang, Yanxun; Zhao, Yuyue; Li, Shan; Xu, Zuojun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Med, Beijing 100730, Peoples R China; [Liu, Yongzhe; Wang, Yanxun; Zhao, Yuyue; Li, Shan; Xu, Zuojun] Peking Union Med Coll, Beijing 100730, Peoples R China; [Qiu, Lan] 2 Jikun Hosp, Dept Internal Med, Urumqi 830013, Xinjiang Uyghur, Peoples R China; [Aimurola, Halimulati] Chest Hosp Xinjiang Uyghur Autonomous Reg, Dept Resp Med, Urumqi 830049, Xinjiang Uyghur, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, ZJ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Med, Beijing 100730, Peoples R China.; Xu, ZJ (corresponding author), Peking Union Med Coll, Beijing 100730, Peoples R China.	xuzj@hotmail.com			National Natural Science Foundation of China [81170055]; China Postdoctoral Science Foundation [2015M570973]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (No. 81170055) and China Postdoctoral Science Foundation (No. 2015M570973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou KM, 2006, J INTERF CYTOK RES, V26, P400, DOI 10.1089/jir.2006.26.400; Baughman RP, 2014, EUR RESPIR J, V43, P337, DOI 10.1183/09031936.00138913; Baumer I, 1997, AM J RESP CELL MOL, V16, P171; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Broos CE, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0265-8; Chen ES, 2011, NAT REV RHEUMATOL, V7, P457, DOI 10.1038/nrrheum.2011.93; Erdal BS, 2012, RESP MED, V106, P893, DOI 10.1016/j.rmed.2012.02.007; Facco M, 2011, THORAX, V66, P144, DOI 10.1136/thx.2010.140319; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gottlieb JE, 1997, CHEST, V111, P623, DOI 10.1378/chest.111.3.623; Grunewald Johan, 2007, Proc Am Thorac Soc, V4, P461, DOI 10.1513/pats.200606-130MS; Grutters JC, 2006, EUR RESPIR J, V28, P627, DOI 10.1183/09031936.06.00105805; HOLLINGER WM, 1985, AM REV RESPIR DIS, V132, P65; Huang H, 2013, INT J MOL SCI, V14, P21463, DOI 10.3390/ijms141121463; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Iannuzzi MC, 2011, JAMA-J AM MED ASSOC, V305, P391, DOI 10.1001/jama.2011.10; Idali F, 2008, CLIN EXP IMMUNOL, V152, P127, DOI 10.1111/j.1365-2249.2008.03609.x; Inui N, 2001, J ALLERGY CLIN IMMUN, V107, P337, DOI 10.1067/mai.2001.112273; Ji LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050909; Judson MA, 2015, RESP MED, V109, P526, DOI 10.1016/j.rmed.2015.01.019; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; Milburn HJ, 1997, CLIN EXP IMMUNOL, V108, P105, DOI 10.1046/j.1365-2249.1997.d01-979.x; MITCHELL DN, 1974, AM REV RESPIR DIS, V110, P774; Miyara M, 2006, J EXP MED, V203, P359, DOI 10.1084/jem.20050648; Oda K, 2014, RESPIR INVESTIG, V52, P179, DOI 10.1016/j.resinv.2013.12.003; Ostadkarampour M, 2014, CLIN EXP IMMUNOL, V178, P342, DOI 10.1111/cei.12403; Oswald-Richter KA, 2013, J IMMUNOL, V190, P5446, DOI 10.4049/jimmunol.1202891; Panselinas E, 2012, CHEST, V142, P827, DOI 10.1378/chest.12-1060; Paramothayan NS, 2005, COCHRANE DB SYST REV, V2; Prasse A, 2000, CLIN EXP IMMUNOL, V122, P241, DOI 10.1046/j.1365-2249.2000.01365.x; Ramstein J, 2015, AM J RESP CRIT CARE; Rappl G, 2011, CLIN IMMUNOL, V140, P71, DOI 10.1016/j.clim.2011.03.015; Taflin C, 2009, AM J PATHOL, V174, P497, DOI 10.2353/ajpath.2009.080580; ten Berge B, 2012, RHEUMATOLOGY, V51, P37, DOI 10.1093/rheumatology/ker316; Tondell A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/438070; Urbankowski T, 2012, POL ARCH MED WEWN, V122, P320, DOI 10.20452/pamw.1341; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Vorselaars ADM, 2014, EUR RESPIR J, V43, P602, DOI 10.1183/09031936.00055213; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Zhang JG, 2010, EBM 2010: INTERNATIONAL CONFERENCE ON ENGINEERING AND BUSINESS MANAGEMENT, VOLS 1-8, P5	41	15	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148207	10.1371/journal.pone.0148207	http://dx.doi.org/10.1371/journal.pone.0148207			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845566	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800036
J	Deshpande, D; Kethireddy, S; Janero, DR; Amiji, MM				Deshpande, Dipti; Kethireddy, Sravani; Janero, David R.; Amiji, Mansoor M.			Therapeutic Efficacy of an omega-3-Fatty Acid-Containing 17-beta Estradiol Nano-Delivery System against Experimental Atherosclerosis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MUSCLE-CELL PHENOTYPES; EXPRESSION IN-VIVO; CARDIOVASCULAR-DISEASE; DIETARY FLAXSEED; NANOEMULSION SYSTEM; NITRIC-OXIDE; ESTROGEN; PREVENTION; 17-BETA-ESTRADIOL	Atherosclerosis and its consequences remain prevalent clinical challenges throughout the world. Initiation and progression of atherosclerosis involves a complex, dynamic interplay among inflammation, hyperlipidemia, and endothelial dysfunction. A multicomponent treatment approach targeted for delivery within diseased vessels could prove beneficial in treating atherosclerosis. This study was undertaken to evaluate the multimodal effects of a novel omega-3-fatty acid-rich, 17-beta-estradiol (17-beta E)-loaded, CREKA-peptide-modified nanoemulsion system on experimental atherosclerosis. In vitro treatment of cultured human aortic endothelial cells (ECs) with the 17-beta E-loaded, CREKA-peptide-modified nanoemulsion system increased cellular nitrate/ nitrite, indicating improved nitric oxide formation. In vivo, systemic administration of this nanoemulsion system to apolipoprotein-E knock out (ApoE(-/-)) mice fed a high-fat diet significantly improved multiple parameters related to the etiology and development of occlusive atherosclerotic vasculopathy: lesion area, circulating plasma lipid levels, and expression of aortic-wall inflammatory markers. These salutary effects were attributed selectively to the 17-beta E and/or omega-3 polyunsaturated fatty acid components of the nano-delivery system. At therapeutic doses, the 17-beta E-loaded, CREKA-peptide modified nanoemulsion system appeared to be biocompatible in that it elicited no apparent adverse/toxic effects, as indexed by body weight, plasma alanine aminotransferase/aspartate aminotransferase levels, and liver and kidney histopathology. The study demonstrates the therapeutic potential of a novel, 17-beta E-loaded, CREKA-peptide-modified nanoemulsion system against atherosclerosis in a multimodal fashion by reducing lesion size, lowering the levels of circulating plasma lipids and decreasing the gene expression of inflammatory markers associated with the disease.	[Deshpande, Dipti; Kethireddy, Sravani; Janero, David R.; Amiji, Mansoor M.] Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Janero, David R.] Northeastern Univ, Ctr Drug Discovery, Sch Pharm, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Amiji, Mansoor M.] King Abdulaziz Univ, Fac Pharm, Jeddah 21413, Saudi Arabia	Northeastern University; Northeastern University; King Abdulaziz University	Amiji, MM (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Bouve Coll Hlth Sci, Boston, MA 02115 USA.; Amiji, MM (corresponding author), King Abdulaziz Univ, Fac Pharm, Jeddah 21413, Saudi Arabia.	m.amiji@neu.edu	kethireddy, sravani/J-8511-2019; Deshpande, Dipti/L-2523-2019; Amiji, Mansoor M/AAK-1531-2020	Amiji, Mansoor M/0000-0001-6170-881X				Barton M, 2013, CURR OPIN LIPIDOL, V24, P214, DOI 10.1097/MOL.0b013e3283613a94; Bassett CMC, 2009, APPL PHYSIOL NUTR ME, V34, P965, DOI 10.1139/H09-087; Binsalamah ZM, 2012, EXPERT REV CARDIOVAS, V10, P805, DOI [10.1586/erc.12.41, 10.1586/ERC.12.41]; Bourassa PAK, 1996, P NATL ACAD SCI USA, V93, P10022, DOI 10.1073/pnas.93.19.10022; Brown WV, 2011, J CLIN LIPIDOL, V5, P424, DOI 10.1016/j.jacl.2011.09.006; Casula M, 2013, ATHEROSCLEROSIS SUPP, V14, P243, DOI 10.1016/S1567-5688(13)70005-9; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; Deshpande D, 2014, J CONTROL RELEASE, V180, P117, DOI 10.1016/j.jconrel.2014.02.009; Deshpande D, 2013, NANOMED-NANOTECHNOL, V9, P885, DOI 10.1016/j.nano.2013.02.007; Deshpande DD, 2011, EXPERT OPIN BIOL TH, V11, P1637, DOI 10.1517/14712598.2011.625007; Dimitrow PP, 2009, MINI-REV MED CHEM, V9, P1030, DOI 10.2174/138955709788922638; Duckles SP, 2010, PFLUG ARCH EUR J PHY, V459, P841, DOI 10.1007/s00424-010-0797-1; Dupasquier CMC, 2006, AM J PHYSIOL-HEART C, V291, pH2987, DOI 10.1152/ajpheart.01179.2005; Dupasquier CMC, 2007, AM J PHYSIOL-HEART C, V293, pH2394, DOI 10.1152/ajpheart.01104.2006; Durst R, 2009, GENET TEST MOL BIOMA, V13, P583, DOI 10.1089/gtmb.2009.0048; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Francis AA, 2013, AM J PHYSIOL-HEART C, V304, pH1743, DOI 10.1152/ajpheart.00606.2012; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Godin B, 2010, TRENDS PHARMACOL SCI, V31, P199, DOI 10.1016/j.tips.2010.01.003; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hamzah J, 2011, P NATL ACAD SCI USA, V108, P7154, DOI 10.1073/pnas.1104540108; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007; Iafrati MD, 1997, NAT MED, V3, P545, DOI 10.1038/nm0597-545; Janero DR, 2014, EXPERT OPIN PHARMACO, V15, P5, DOI 10.1517/14656566.2014.852538; Jawien J, 2012, CURR PHARM BIOTECHNO, V13, P2435, DOI 10.2174/1389201011208062435; Jayagopal A, 2010, CURR ATHEROSCLER REP, V12, P209, DOI 10.1007/s11883-010-0106-7; Jin RC, 2010, J BLOOD MED, V1, P147; Kaul S, 2004, J AM COLL CARDIOL, V43, P461, DOI 10.1016/j.jacc.2003.11.010; Kim KH, 2014, MOL CELL ENDOCRINOL, V389, P65, DOI 10.1016/j.mce.2014.02.001; Kitagawa K, 2002, ATHEROSCLEROSIS, V160, P305, DOI 10.1016/S0021-9150(01)00587-1; Knowlton AA, 2012, PHARMACOL THERAPEUT, V135, P54, DOI 10.1016/j.pharmthera.2012.03.007; Komesaroff PA, 2001, HYPERTENSION, V38, P1011, DOI 10.1161/hy1101.095006; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Ley K, 2001, J CLIN INVEST, V107, P1209, DOI 10.1172/JCI13005; LI HM, 1995, J CLIN INVEST, V95, P122, DOI 10.1172/JCI117628; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Madigan M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00174; Makinen PI, 2013, CURR OPIN LIPIDOL, V24, P116, DOI 10.1097/MOL.0b013e32835da13c; Meng J, 2012, CURR DRUG METAB, V13, P1123, DOI 10.2174/138920012802850056; Meyer MR, 2006, HYPERTENSION, V47, P1019, DOI 10.1161/01.HYP.0000223064.62762.0b; Miller VM, 2008, PHARMACOL REV, V60, P210, DOI 10.1124/pr.107.08002; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Napoli C, 2006, NITRIC OXIDE-BIOL CH, V15, P265, DOI 10.1016/j.niox.2006.03.011; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Palmieri D, 2014, ANGIOLOGY, V65, P17, DOI 10.1177/0003319713477909; Pervin S, 1998, ARTERIOSCL THROM VAS, V18, P1575, DOI 10.1161/01.ATV.18.10.1575; Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003; Psarros C, 2012, NANOMED-NANOTECHNOL, V8, pS59, DOI 10.1016/j.nano.2012.05.006; Rizos EC, 2013, EUR J PHARMACOL, V706, P1, DOI 10.1016/j.ejphar.2013.02.050; Rodriguez-Leyva D, 2010, CAN J CARDIOL, V26, P489, DOI 10.1016/S0828-282X(10)70455-4; Ryu SK, 2009, J CARDIOVASC TRANSL, V2, P240, DOI 10.1007/s12265-009-9105-x; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Silvestre-Roig C, 2014, CIRC RES, V114, P214, DOI 10.1161/CIRCRESAHA.114.302355; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Valenzuela P, 2012, NANOMED-NANOTECHNOL, V8, pS83, DOI 10.1016/j.nano.2012.05.008; Volcik KA, 2009, CLIN CHEM, V55, P1076, DOI 10.1373/clinchem.2008.119487; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Xu SP, 2014, REDOX BIOL, V2, P642, DOI 10.1016/j.redox.2014.04.004; Yeap BB, 2014, J AM MED DIR ASSOC, V15, P326, DOI 10.1016/j.jamda.2013.12.004; Yu SS, 2011, WIRES NANOMED NANOBI, V3, P620, DOI 10.1002/wnan.158	62	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147337	10.1371/journal.pone.0147337	http://dx.doi.org/10.1371/journal.pone.0147337			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840601	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200033
J	Vigors, S; O'Doherty, JV; Kelly, AK; O'Shea, CJ; Sweeney, T				Vigors, Stafford; O'Doherty, John V.; Kelly, Alan K.; O'Shea, Cormac J.; Sweeney, Torres			The Effect of Divergence in Feed Efficiency on the Intestinal Microbiota and the Intestinal Immune Response in Both Unchallenged and Lipopolysaccharide Challenged Ileal and Colonic Explants	PLOS ONE			English	Article							GASTROINTESTINAL FERMENTATION; PIGS; QUANTIFICATION; NUTRITION; INFECTION; EMISSIONS; BACTERIA; AMMONIA; SYSTEM; TRACT	Feed efficiency is an important trait in pig production, with evidence to suggest that the efficiencies of a variety of biological systems contribute to variation in this trait. Little work has been conducted on the contribution of the intestinal innate immune response to divergence in feed efficiency. Hence, the objective of this study was to examine select bacterial populations and gene expression profiles of a range of targets relating to gut health and immunity in the intestine of pigs phenotypically divergent in feed efficiency in: a) the basal state; and (b) following an ex-vivo lipopolysaccharide (LPS) challenge of ileal and colonic tissue. Male pigs (initial BW22.4 kg (SD = 2.03)) were fed a standard finishing diet for the final 43 days prior to slaughter to evaluate feed intake and growth for the purpose of calculating residual feed intake (RFI). On day 115, 16 animals (average weight 85 kg, SEM 2.8 kg), designated high RFI (HRFI) and low RFI (LRFI) were slaughtered. The LRFI pigs had increased lactobacillus spp. in the caecum compared to HRFI pigs (P < 0.05). RFI groups did not differ in the expression of the measured genes involved in the innate immune system in the basal ileal or colonic tissues (P > 0.10). Interestingly, there was an interaction between RFI and LPS for the cytokines IL-8, IL-1, IL-6, TNF-alpha, Interferon-gamma (IFN-gamma) and SOCS3, with the LRFI group having consistently lower gene expression in the colon following the LPS challenge, compared to the HRFI group. The lower gene expression of SOCS and cytokines following an ex vivo LPS challenge supports the theory that a possible energy saving mechanism exists in the intestinal innate immune response to an immune challenge in more feed efficient pigs.	[Vigors, Stafford; O'Doherty, John V.; Kelly, Alan K.] Natl Univ Ireland Univ Coll Dublin, Sch Agr & Food Sci, Dublin 4, Ireland; [Sweeney, Torres] Natl Univ Ireland Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland; [O'Shea, Cormac J.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University College Dublin; University College Dublin; University of Sydney	Sweeney, T (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland.	john.vodoherty@ucd.ie	O'Doherty, John/AAS-7261-2021; O'Shea, Cormac/U-7635-2019	O'Doherty, John/0000-0002-0906-4065; Sweeney, Torres/0000-0003-2639-395X; Vigors, Stafford/0000-0002-9304-2925; O'Shea, Cormac/0000-0002-1797-1941	Earth and Natural Sciences Doctoral Studies Programme under programme for Research in Third-Level Institutions; European Regional Development Fund	Earth and Natural Sciences Doctoral Studies Programme under programme for Research in Third-Level Institutions; European Regional Development Fund(European Commission)	This study was funded under the Earth and Natural Sciences Doctoral Studies Programme, which is funded under the programme for Research in Third-Level Institutions and co-funded under the European Regional Development Fund.	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Canny GO, 2008, INFECT IMMUN, V76, P3360, DOI 10.1128/IAI.00187-08; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Cotter PF, 2006, POULTRY SCI, V85, P435, DOI 10.1093/ps/85.3.435; Dunkelberger JR, 2015, LIVEST SCI, V177, P132, DOI 10.1016/j.livsci.2015.04.014; Han GQ, 2012, MOL BIOL REP, V39, P1869, DOI 10.1007/s11033-011-0932-x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; Johnson R.W., 2012, FEED EFFICIENCY SWIN, P211; JOHNSON RW, 1994, J ANIM SCI, V72, P309, DOI 10.2527/1994.722309x; Johnston JA, 2003, NAT IMMUNOL, V4, P507, DOI 10.1038/ni0603-507; Klasing KC, 2007, BRIT POULTRY SCI, V48, P525, DOI 10.1080/00071660701671336; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; LINKAMSTER H, 1994, FEMS IMMUNOL MED MIC, V10, P55, DOI 10.1111/j.1574-695X.1994.tb00011.x; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091091; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lynch MB, 2008, ANIMAL, V2, P425, DOI 10.1017/S1751731107001267; Madara JL, 1989, MONOGR PATHOL, P306; Mair KH, 2014, DEV COMP IMMUNOL, V45, P321, DOI 10.1016/j.dci.2014.03.022; Mani V, 2013, J ANIM SCI, V91, P2141, DOI 10.2527/jas.2012-6053; McKay DM, 1999, GUT, V44, P283, DOI 10.1136/gut.44.2.283; Moncada DM, 2003, TRENDS PARASITOL, V19, P305, DOI 10.1016/S1471-4922(03)00122-3; O'Shea CJ, 2012, J ANIM SCI, V90, P3848, DOI 10.2527/jas.2011-4461; O'Shea CJ, 2010, J ANIM SCI, V88, P1411, DOI 10.2527/jas.2009-2115; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Rakhshandeh A, 2012, J ANIM SCI, V90, P233, DOI 10.2527/jas.53976; Rauw Wendy M., 2012, Frontiers in Genetics, V3, P267, DOI 10.3389/fgene.2012.00267; Richards JD, 2005, CAN J ANIM SCI, V85, P421, DOI 10.4141/A05-049; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Schierack P, 2007, MICROBIOL-SGM, V153, P3830, DOI 10.1099/mic.0.2007/010173-0; Vaughan EE, 1999, CURR OPIN BIOTECH, V10, P505, DOI 10.1016/S0958-1669(99)00018-X; Vigors S, 2014, ADSA ASAS CSAS JOINT	34	35	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148145	10.1371/journal.pone.0148145	http://dx.doi.org/10.1371/journal.pone.0148145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840831	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200086
J	Junaid, M; Almuqri, EA; Liu, JJ; Zhang, HJ				Junaid, Muhammad; Almuqri, Eman Abdullah; Liu, Junjun; Zhang, Houjin			Analyses of the Binding between Water Soluble C60 Derivatives and Potential Drug Targets through a Molecular Docking Approach	PLOS ONE			English	Article							PARTICLE MESH EWALD; LUMAZINE SYNTHASE; ALZHEIMERS-DISEASE; FULLERENE DERIVATIVES; POLYHYDROXYLATED C-60; N-MYRISTOYLTRANSFERASE; GLUTAMATE RACEMASE; CRYSTAL-STRUCTURE; MODEL; INHIBITORS	Fullerene C60, a unique sphere-shaped molecule consisting of carbon, has been proved to have inhibitory effects on many diseases. However, the applications of C60 in medicine have been severely hindered by its complete insolubility in water and low solubility in almost all organic solvents. In this study, the water-soluble C60 derivatives and the C60 binding protein's structures were collected from the literature. The selected proteins fall into several groups, including acetylcholinesterase, glutamate racemase, inosine monophosphate dehydrogenase, lumazine synthase, human estrogen receptor alpha, dihydrofolate reductase and N-myristoyltransferase. The C60 derivatives were docked into the binding sites in the proteins. The binding affinities of the C60 derivatives were calculated. The bindings between proteins and their known inhibitors or native ligands were also characterized in the same way. The results show that C60 derivatives form good interactions with the binding sites of different protein targets. In many cases, the binding affinities of C60 derivatives are better than those of known inhibitors and native ligands. This study demonstrates the interaction patterns of C60 derivatives and their binding partners, which will have good impact on the fullerene-based drug discovery.	[Junaid, Muhammad; Almuqri, Eman Abdullah; Zhang, Houjin] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Hubei, Peoples R China; [Zhang, Houjin] Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China; [Liu, Junjun] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, HJ (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Hubei, Peoples R China.; Zhang, HJ (corresponding author), Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China.	hjzhang@hust.edu.cn	Junaid, Dr. Muhammad/ABF-9669-2021		National Key Basic Research Program of China [2013CB933900]	National Key Basic Research Program of China(National Basic Research Program of China)	This work is financially supported by National Key Basic Research Program of China (No. 2013CB933900).	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Anderson RE, 2013, DALTON T, V42, P2186, DOI 10.1039/c2dt32523c; Babic T, 1999, J NEUROL NEUROSUR PS, V67, P558, DOI 10.1136/jnnp.67.4.558; Bacher A, 2001, VITAM HORM, V61, P1; Bar-On P, 2002, BIOCHEMISTRY-US, V41, P3555, DOI 10.1021/bi020016x; BECKER L, 1993, J ORG CHEM, V58, P7630, DOI 10.1021/jo00079a002; BENSASSON RV, 1994, J PHYS CHEM-US, V98, P3492, DOI 10.1021/j100064a035; Bobylev AG, 2011, ORG BIOMOL CHEM, V9, P5714, DOI 10.1039/c1ob05067b; Bosi S, 2003, BIOORG MED CHEM LETT, V13, P4437, DOI 10.1016/j.bmcl.2003.09.016; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Braun T, 1997, FULLERENE SCI TECHN, V5, P615, DOI 10.1080/15363839708015912; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; BUGG TDH, 1992, NAT PROD REP, V9, P199, DOI 10.1039/np9920900199; Cai XQ, 2008, J NEUROSCI RES, V86, P3622, DOI 10.1002/jnr.21805; Calvaresi M, 2010, ACS NANO, V4, P2283, DOI 10.1021/nn901809b; Case D., 2015, AMBER, V14; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; CHIANG LY, 1992, J AM CHEM SOC, V114, P10154, DOI 10.1021/ja00052a010; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dugan LL, 1997, P NATL ACAD SCI USA, V94, P9434, DOI 10.1073/pnas.94.17.9434; Dugan LL, 1996, NEUROBIOL DIS, V3, P129, DOI 10.1006/nbdi.1996.0013; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fischer M, 2003, J MOL BIOL, V326, P783, DOI 10.1016/S0022-2836(02)01473-0; Fisher SL, 2008, MICROB BIOTECHNOL, V1, P345, DOI 10.1111/j.1751-7915.2008.00031.x; FRIEDMAN SH, 1993, J AM CHEM SOC, V115, P6506, DOI 10.1021/ja00068a005; GALLO KA, 1993, BIOCHEMISTRY-US, V32, P3991, DOI 10.1021/bi00066a020; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Goncalves AD, 2016, J BIOMOL STRUCT DYN, V34, P1307, DOI 10.1080/07391102.2015.1077345; Gottwald, 1999, Expert Opin Investig Drugs, V8, P1673, DOI 10.1517/13543784.8.10.1673; GREGORET LM, 1991, PROTEINS, V9, P99, DOI 10.1002/prot.340090204; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Harer SL, 2014, J PHARM BIOALLIED SC, V6, P285, DOI 10.4103/0975-7406.142962; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; HOWARD JB, 1991, NATURE, V352, P139, DOI 10.1038/352139a0; Hu Z, 2012, CHEM-BIOL INTERACT, V195, P86, DOI 10.1016/j.cbi.2011.11.003; HUNGERBUHLER H, 1993, J AM CHEM SOC, V115, P3386, DOI 10.1021/ja00061a070; HWANG KC, 1992, J AM CHEM SOC, V114, P9705, DOI 10.1021/ja00050a086; Hwang KY, 1999, NAT STRUCT BIOL, V6, P422; Jensen AW, 1996, BIOORGAN MED CHEM, V4, P767, DOI 10.1016/0968-0896(96)00081-8; Jin H, 2000, J NEUROSCI RES, V62, P600, DOI 10.1002/1097-4547(20001115)62:4<600::AID-JNR15>3.0.CO;2-F; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KARFUNKEL HR, 1992, J COMPUT AID MOL DES, V6, P521, DOI 10.1007/BF00130402; Kelly CA, 1997, BRIT MED J, V314, P693, DOI 10.1136/bmj.314.7082.693; KOSHLAND DE, 1991, SCIENCE, V254, P1705, DOI 10.1126/science.254.5039.1705; Kozlikova B, 2014, BIOINFORMATICS, V30, P2684, DOI 10.1093/bioinformatics/btu364; KROTO HW, 1991, CHEM REV, V91, P1213, DOI 10.1021/cr00006a005; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lam T, 2014, J MED CHEM, V57, P651, DOI 10.1021/jm401204g; Lu LH, 1998, BRIT J PHARMACOL, V123, P1097, DOI 10.1038/sj.bjp.0701722; McKenna MT, 1997, J MED CHEM, V40, P3516; Morgunova E, 2005, BIOCHEMISTRY-US, V44, P2746, DOI 10.1021/bi047848a; Morgunova E, 2007, J BIOL CHEM, V282, P17231, DOI 10.1074/jbc.M701724200; Morgunova E, 2006, FEBS J, V273, P4790, DOI 10.1111/j.1742-4658.2006.05481.x; Moussa F, 1996, FULLERENE SCI TECHN, V4, P21, DOI 10.1080/10641229608001534; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Oliveira AA, 2011, J BIOMOL STRUCT DYN, V29, P351, DOI 10.1080/07391102.2011.10507390; Prosise GL, 2002, J BIOL CHEM, V277, P50654, DOI 10.1074/jbc.M208330200; Puig E, 2005, J CHEM THEORY COMPUT, V1, P737, DOI 10.1021/ct049881g; Roberts AJ, 2014, BIOCHEM J, V459, P323, DOI 10.1042/BJ20131033; Russo P, 2013, CURR MED CHEM, V20, P976; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Samal S, 2000, CHEM COMMUN, P1101, DOI 10.1039/b000710m; SCHWEITZER BI, 1990, FASEB J, V4, P2441, DOI 10.1096/fasebj.4.8.2185970; Scott LJ, 2000, DRUGS, V60, P1095, DOI 10.2165/00003495-200060050-00008; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shoji M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066337; SIJBESMA R, 1993, J AM CHEM SOC, V115, P6510, DOI 10.1021/ja00068a006; Sivaraman N, 2001, J CHEM INF COMP SCI, V41, P1067, DOI 10.1021/ci010003a; SRINIVAS R, 1993, J AM SOC MASS SPECTR, V4, P894, DOI 10.1016/1044-0305(93)87007-Y; Tagmatarchis N., 2001, Mini-Reviews in Medicinal Chemistry, V1, P339, DOI 10.2174/1389557013406693; TANNER ME, 1993, BIOCHEMISTRY-US, V32, P3998, DOI 10.1021/bi00066a021; Tate EW, 2014, PARASITOLOGY, V141, P37, DOI 10.1017/S0031182013000450; TEBBE FN, 1992, SCIENCE, V256, P822, DOI 10.1126/science.256.5058.822; TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064; Troshina OA, 2007, ORG BIOMOL CHEM, V5, P2783, DOI 10.1039/b705331b; Tsai MC, 1997, J PHARM PHARMACOL, V49, P438, DOI 10.1111/j.2042-7158.1997.tb06821.x; WALSH CT, 1989, J BIOL CHEM, V264, P2393; Whalen KL, 2010, ACS MED CHEM LETT, V1, P9, DOI 10.1021/ml900005b; Wojciechowski M, 2004, J PHYS CHEM B, V108, P18368, DOI 10.1021/jp046748b; Wright MH, 2014, NAT CHEM, V6, P112, DOI [10.1038/NCHEM.1830, 10.1038/nchem.1830]; Wu J, 2007, J BIOL CHEM, V282, P22185, DOI 10.1074/jbc.M702696200; Xie NZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137113; Xu MM, 2015, CRIT REV EUKAR GENE, V25, P259, DOI 10.1615/CritRevEukaryotGeneExpr.2015013978; YAMAKOSHI YN, 1994, J CHEM SOC CHEM COMM, P517, DOI 10.1039/c39940000517; Zhang XF, 2003, J MOL BIOL, V328, P167, DOI 10.1016/S0022-2836(03)00186-4; Zhang You-wen, 2014, Yaoxue Xuebao, V49, P285; Zhou CS, 2011, CHEM COMMUN, V47, P2982, DOI 10.1039/c0cc04919k; Zwanzig R., 1973, J STAT PHYS, V9, P215, DOI DOI 10.1007/BF01008729	92	22	22	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147761	10.1371/journal.pone.0147761	http://dx.doi.org/10.1371/journal.pone.0147761			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829126	gold, Green Submitted, Green Published			2022-12-26	WOS:000369548200031
J	Lorenz, S; Bhattacharyya, M; Feiler, C; Rape, M; Kuriyan, J				Lorenz, Sonja; Bhattacharyya, Moitrayee; Feiler, Christian; Rape, Michael; Kuriyan, John			Crystal Structure of a Ube2S-Ubiquitin Conjugate	PLOS ONE			English	Article							UBIQUITIN CHAIN ELONGATION; E3 LIGASE; MECHANISM; ENZYME; REVEALS; ACTIVATION; INSIGHTS; COMPLEX; INHIBITION; PROMOTE	Protein ubiquitination occurs through the sequential formation and reorganization of specific protein-protein interfaces. Ubiquitin-conjugating (E2) enzymes, such as Ube2S, catalyze the formation of an isopeptide linkage between the C-terminus of a "donor" ubiquitin and a primary amino group of an "acceptor" ubiquitin molecule. This reaction involves an intermediate, in which the C-terminus of the donor ubiquitin is thioester-bound to the active site cysteine of the E2 and a functionally important interface is formed between the two proteins. A docked model of a Ube2S-donor ubiquitin complex was generated previously, based on chemical shift mapping by NMR, and predicted contacts were validated in functional studies. We now present the crystal structure of a covalent Ube2S-ubiquitin complex. The structure contains an interface between Ube2S and ubiquitin in trans that resembles the earlier model in general terms, but differs in detail. The crystallographic interface is more hydrophobic than the earlier model and is stable in molecular dynamics (MD) simulations. Remarkably, the docked Ube2S-donor complex converges readily to the configuration seen in the crystal structure in 3 out of 8 MD trajectories. Since the crystallographic interface is fully consistent with mutational effects, this indicates that the structure provides an energetically favorable representation of the functionally critical Ube2S-donor interface.	[Lorenz, Sonja; Bhattacharyya, Moitrayee; Rape, Michael; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Lorenz, Sonja; Bhattacharyya, Moitrayee; Rape, Michael; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Lorenz, Sonja; Feiler, Christian] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Rape, Michael; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Wurzburg; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Kuriyan, J (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Kuriyan, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu	Lorenz, Sonja/AAL-4499-2020	Lorenz, Sonja/0000-0002-9639-2381; Rape, Michael/0000-0003-4849-6343	Leukemia and Lymphoma Society [LLS 5509-11]; Emmy Noether Program of the German Research Foundation [LO 2003/1-1]; Human Frontiers Science Program [LT000002/2013]; NHI [NIGMS]; Howard Hughes Medical Institute	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Emmy Noether Program of the German Research Foundation(German Research Foundation (DFG)); Human Frontiers Science Program(Human Frontier Science Program); NHI [NIGMS]; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported in part by the Leukemia and Lymphoma Society [grant number LLS 5509-11 (to SL)], the Emmy Noether Program of the German Research Foundation [grant number LO 2003/1-1 (to SL)], the Human Frontiers Science Program [grant number LT000002/2013 (to MB)], and an NHI RO1 grant [NIGMS (to MR)]. JK and MR are funded by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Brown NG, 2014, MOL CELL, V56, P246, DOI 10.1016/j.molcel.2014.09.009; Buetow L, 2015, MOL CELL, V58, P297, DOI 10.1016/j.molcel.2015.02.017; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Chen ZD, 1998, NUCLEIC ACIDS RES, V26, P1126, DOI 10.1093/nar/26.4.1126; Cohen I, 2015, P NATL ACAD SCI USA, V112, pE625, DOI 10.1073/pnas.1415621112; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gareau JR, 2012, J BIOL CHEM, V287, P4740, DOI 10.1074/jbc.M111.321141; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Grishin AM, 2014, STRUCTURE, V22, P878, DOI 10.1016/j.str.2014.04.010; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Huang H, 2014, NAT CHEM BIOL, V10, P156, DOI [10.1038/NCHEMBIO.1412, 10.1038/nchembio.1412]; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kelly A, 2014, MOL CELL, V56, P232, DOI 10.1016/j.molcel.2014.09.010; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lorenz S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-65; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merkley N, 2005, J BIOL CHEM, V280, P31732, DOI 10.1074/jbc.M505205200; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Page RC, 2012, BIOCHEMISTRY-US, V51, P4175, DOI 10.1021/bi300058m; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Serniwka SA, 2009, BIOCHEMISTRY-US, V48, P12169, DOI 10.1021/bi901686j; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Soss SE, 2013, BIOCHEMISTRY-US, V52, P2991, DOI 10.1021/bi3015949; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	51	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147550	10.1371/journal.pone.0147550	http://dx.doi.org/10.1371/journal.pone.0147550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828794	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200024
J	Rao, Q; You, A; Guo, ZL; Zuo, BF; Gao, XJ; Zhang, T; Du, Z; Wu, CX; Yin, HF				Rao, Quan; You, Abin; Guo, Zhenglong; Zuo, Bingfeng; Gao, Xianjun; Zhang, Ti; Du, Zhi; Wu, Chenxuan; Yin, HaiFang			Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models	PLOS ONE			English	Article							TUMOR-GROWTH; NUDE-MICE; TRANSITION; LIVER; LUNG	Mouse models are commonly used for studying hepatocellular carcinoma (HCC) biology and exploring new therapeutic interventions. Currently three main modalities of HCC mouse models have been extensively employed in pre-clinical studies including chemically induced, transgenic and transplantation models. Among them, transplantation models are preferred for evaluating in vivo drug efficacy in pre-clinical settings given the short latency, uniformity in size and close resemblance to tumors in patients. However methods used for establishing orthotopic HCC transplantation mouse models are diverse and fragmentized without a comprehensive comparison. Here, we systemically evaluate four different approaches commonly used to establish HCC mice in preclinical studies, including intravenous, intrasplenic, intrahepatic inoculation of tumor cells and intrahepatic tissue implantation. Four parameters-the latency period, take rates, pathological features and metastatic rates-were evaluated side-by-side. 100% take rates were achieved in liver with intrahepatic, intrasplenic inoculation of tumor cells and intrahepatic tissue implantation. In contrast, no tumor in liver was observed with intravenous injection of tumor cells. Intrahepatic tissue implantation resulted in the shortest latency with 0.5cm (longitudinal diameter) tumors found in liver two weeks after implantation, compared to 0.1cm for intrahepatic inoculation of tumor cells. Approximately 0.1cm tumors were only visible at 4 weeks after intrasplenic inoculation. Uniform, focal and solitary tumors were formed with intrahepatic tissue implantation whereas multinodular, dispersed and non-uniform tumors produced with intrahepatic and intrasplenic inoculation of tumor cells. Notably, metastasis became visible in liver, peritoneum and mesenterium at 3 weeks post-implantation, and lung metastasis was visible after 7 weeks. T cell infiltration was evident in tumors, resembling the situation in HCC patients. Our study demonstrated that orthotopic HCC mouse models established via intrahepatic tissue implantation authentically reflect clinical manifestations in HCC patients pathologically and immunologically, suggesting intrahepatic tissue implantation is a preferable approach for establishing orthotopic HCC mouse models.	[Rao, Quan; You, Abin; Guo, Zhenglong; Zuo, Bingfeng; Gao, Xianjun; Yin, HaiFang] Tianjin Med Univ, Dept Cell Biol, Qixiangtai Rd, Tianjin 300070, Peoples R China; [Rao, Quan; You, Abin; Guo, Zhenglong; Zuo, Bingfeng; Gao, Xianjun; Yin, HaiFang] Tianjin Med Univ, Res Ctr Basic Med Sci, Qixiangtai Rd, Tianjin 300070, Peoples R China; [Rao, Quan; Du, Zhi; Wu, Chenxuan] Tianjin Med Univ, Cent Clin Coll 3, Jintang Rd, Tianjin 300170, Peoples R China; [You, Abin; Zhang, Ti] Tianjin Med Univ, Tianjin Canc Hosp, Huanhu West Rd, Tianjin 300000, Peoples R China; [Du, Zhi] Tianjin Med Univ, Cent Hosp 3, Inst Hepatobiliary Dis, Dept Hepatobiliary Surg,Key Lab Artificial Cell, Jintang Rd, Tianjin 300170, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Yin, HF (corresponding author), Tianjin Med Univ, Dept Cell Biol, Qixiangtai Rd, Tianjin 300070, Peoples R China.; Yin, HF (corresponding author), Tianjin Med Univ, Res Ctr Basic Med Sci, Qixiangtai Rd, Tianjin 300070, Peoples R China.; Wu, CX (corresponding author), Tianjin Med Univ, Cent Clin Coll 3, Jintang Rd, Tianjin 300170, Peoples R China.	haifangyin@tmu.edu.cn; chenxuanw@aliyun.com			Chinese National Basic Research Program (973) [2012CBA01305, 2012CB932503]; National Natural Science Foundation of China [81273420, 81501531, 81361128013]; Research Fund for the Doctoral Program of Higher Education of China [20111202110002]	Chinese National Basic Research Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by Chinese National Basic Research Program (973) (no. 2012CBA01305, 2012CB932503), National Natural Science Foundation of China (grant no. 81273420, 81501531, and 81361128013), and Research Fund for the Doctoral Program of Higher Education of China (no. 20111202110002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Foster JR, 2005, TOXICOL PATHOL, V33, P63, DOI 10.1080/01926230590890196; Gao YS, 2004, WORLD J GASTROENTERO, V10, P3107; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Kang JH, 2009, VET J, V181, P336, DOI 10.1016/j.tvjl.2008.04.001; Kim J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12315; Leenders MWH, 2008, WORLD J GASTROENTERO, V14, P6915, DOI 10.3748/wjg.14.6915; LeveilleWebster CR, 1996, CLIN CANCER RES, V2, P695; Li JF, 2011, CANCER BIOL THER, V12, P737, DOI 10.4161/cbt.12.8.16442; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Lin SB, 2012, LIVER CANCER, V1, P144, DOI 10.1159/000343828; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048075; Markowitz GJ, 2015, SCI BULL, V60, P762, DOI 10.1007/s11434-015-0772-5; Okubo H, 2007, J GASTROEN HEPATOL, V22, P423, DOI 10.1111/j.1440-1746.2006.04520.x; Sun FX, 1996, INT J CANCER, V66, P239, DOI 10.1002/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.3.CO;2-G; Terada T, 2013, INT J CLIN EXP PATHO, V6, P816; Wang BF, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-43; Yan Y, 2013, HEPATOLOGY, V57, P667, DOI 10.1002/hep.26071; Zhao GJ, 2012, WORLD J GASTROENTERO, V18, P7087, DOI 10.3748/wjg.v18.i47.7087; Zhou X, 2014, TUMOR BIOL, V35, P12561, DOI 10.1007/s13277-014-2576-7	21	9	10	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148263	10.1371/journal.pone.0148263	http://dx.doi.org/10.1371/journal.pone.0148263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824903	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600113
J	Chang, CM; Yin, WY; Wei, CK; Wu, CC; Su, YC; Yu, CH; Lee, CC				Chang, Chun-Ming; Yin, Wen-Yao; Wei, Chang-Kao; Wu, Chin-Chia; Su, Yu-Chieh; Yu, Chia-Hui; Lee, Ching-Chih			Adjusted Age-Adjusted Charlson Comorbidity Index Score as a Risk Measure of Perioperative Mortality before Cancer Surgery	PLOS ONE			English	Article							SHORT-TERM; PATIENT READMISSION; RADICAL CYSTECTOMY; OLDER-ADULTS; MORBIDITY; IMPACT; VALIDATION; OUTCOMES; PANCREATICODUODENECTOMY; PREDICTORS	Background Identification of patients at risk of death from cancer surgery should aid in preoperative preparation. The purpose of this study is to assess and adjust the age-adjusted Charlson comorbidity index (ACCI) to identify cancer patients with increased risk of perioperative mortality. Methods We identified 156,151 patients undergoing surgery for one of the ten common cancers between 2007 and 2011 in the Taiwan National Health Insurance Research Database. Half of the patients were randomly selected, and a multivariate logistic regression analysis was used to develop an adjusted-ACCI score for estimating the risk of 90-day mortality by variables from the original ACCI. The score was validated. The association between the score and perioperative mortality was analyzed. Results The adjusted-ACCI score yield a better discrimination on mortality after cancer surgery than the original ACCI score, with c-statics of 0.75 versus 0.71. Over 80 years of age, 70-80 years, and renal disease had the strongest impact on mortality, hazard ratios 8.40, 3.63, and 3.09 (P < 0.001), respectively. The overall 90-day mortality rates in the entire cohort varied from 0.9%, 2.9%, 7.0%, and 13.2% in four risk groups stratifying by the adjusted-ACCI score; the adjusted hazard ratio for score 4-7, 8-11, and >= 12 was 2.84, 6.07, and 11.17 (P < 0.001), respectively, in 90-day mortality compared to score 0-3. Conclusions The adjusted-ACCI score helps to identify patients with a higher risk of 90-day mortality after cancer surgery. It might be particularly helpful for preoperative evaluation of patients over 80 years of age.	[Chang, Chun-Ming; Yin, Wen-Yao; Wei, Chang-Kao; Wu, Chin-Chia; Yu, Chia-Hui] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Surg, Chiayi, Taiwan; [Lee, Ching-Chih] Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Lee, Ching-Chih] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Su, Yu-Chieh] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Hematol Oncol, Dept Internal Med, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Ctr Canc, Chiayi, Taiwan; [Chang, Chun-Ming; Yin, Wen-Yao; Wei, Chang-Kao; Wu, Chin-Chia] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ching-Chih] Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Kaohsiung Veterans General Hospital; National Defense Medical Center; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Tri-Service General Hospital	Lee, CC (corresponding author), Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan.; Lee, CC (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Lee, CC (corresponding author), Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan.	hematcd2@hotmail.com		Su, Yu-Chieh/0000-0002-1771-9017				Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889; Aust JB, 2005, ANN SURG, V241, P1024, DOI 10.1097/01.sla.0000165196.32207.dd; Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8; Bar B, 2011, STROKE, V42, P2944, DOI 10.1161/STROKEAHA.111.617639; Birnbaum DJ, 2015, ANN SURG ONCOL, V22, P1000, DOI 10.1245/s10434-014-4016-8; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleves MA, 1997, J CLIN EPIDEMIOL, V50, P903, DOI 10.1016/S0895-4356(97)00091-7; Daskivich TJ, 2011, CANCER-AM CANCER SOC, V117, P4642, DOI 10.1002/cncr.26104; Dehal A, 2013, BREAST CANCER RES TR, V139, P469, DOI 10.1007/s10549-013-2543-9; Erichsen R, 2013, BRIT J CANCER, V109, P2005, DOI 10.1038/bjc.2013.541; Extermann M, 2000, EUR J CANCER, V36, P453, DOI 10.1016/S0959-8049(99)00319-6; Frenkel WJ, 2014, J AM GERIATR SOC, V62, P342, DOI 10.1111/jgs.12635; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Hyder O, 2013, JAMA SURG, V148, P1095, DOI 10.1001/jamasurg.2013.2509; Jepsen P, 2008, HEPATOLOGY, V48, P214, DOI 10.1002/hep.22341; Kirkland LL, 2011, AM J MED QUAL, V26, P461, DOI 10.1177/1062860611402188; Koppie TM, 2008, CANCER-AM CANCER SOC, V112, P2384, DOI 10.1002/cncr.23462; Langan RC, 2016, AM J SURG, V211, P70, DOI 10.1016/j.amjsurg.2015.04.014; Langan RC, 2015, SURGERY, V158, P366, DOI 10.1016/j.surg.2015.02.022; Marchena-Gomez J, 2009, ANN VASC SURG, V23, P458, DOI 10.1016/j.avsg.2008.10.008; Mayr R, 2012, EUR UROL, V62, P662, DOI 10.1016/j.eururo.2012.03.057; Neuman HB, 2013, ANN SURG ONCOL, V20, P1427, DOI 10.1245/s10434-012-2721-8; Ng ACC, 2013, RESPIRATION, V85, P408, DOI 10.1159/000342024; Ouellette JR, 2004, J GASTROINTEST SURG, V8, P1061, DOI 10.1016/j.gassur.2004.09.045; Riall TS, 2011, J AM GERIATR SOC, V59, P647, DOI 10.1111/j.1532-5415.2011.03353.x; Riall Taylor S, 2009, Adv Surg, V43, P233; Robbins JR, 2013, GYNECOL ONCOL, V131, P593, DOI 10.1016/j.ygyno.2013.10.007; Schneider EB, 2012, J AM COLL SURGEONS, V215, P607, DOI 10.1016/j.jamcollsurg.2012.07.007; Schneider EB, 2012, J AM COLL SURGEONS, V214, P390, DOI 10.1016/j.jamcollsurg.2011.12.025; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simons JP, 2009, ANN SURG, V250, P929, DOI 10.1097/SLA.0b013e3181bc9c2f; Singh Santosh Kumar, 2015, J Gastrointest Cancer, V46, P399, DOI 10.1007/s12029-015-9766-4; Smith T, 2014, AGE AGEING, V43, P464, DOI 10.1093/ageing/afu065; Taiwan Cancer Registry, 2015, 5 YEARS SURV CANC; Turrentine FE, 2006, J AM COLL SURGEONS, V203, P865, DOI 10.1016/j.jamcollsurg.2006.08.026; Voskuijl T, 2014, CLIN ORTHOP RELAT R, V472, P1638, DOI 10.1007/s11999-013-3394-8; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Wong SL, 2015, ANN SURG, V261, P632, DOI 10.1097/SLA.0000000000000690; World Health Organization, CANC FACT SHEET	40	56	58	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148076	10.1371/journal.pone.0148076	http://dx.doi.org/10.1371/journal.pone.0148076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848761	Green Published, gold			2022-12-26	WOS:000369554000039
J	Li, Y; Cai, XJ; Guan, YQ; Wang, L; Wang, SY; Li, YY; Fu, Y; Gao, XY; Su, GH				Li, Ying; Cai, Xiaojun; Guan, Yuqing; Wang, Lei; Wang, Shuya; Li, Yueyan; Fu, Ying; Gao, Xiaoyuan; Su, Guohai			Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; PROTEIN-KINASE; MYOCARDIAL FIBROSIS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; GLOBULAR DOMAIN; ANGIOTENSIN; MICRORNA-133A; EXPRESSION; INHIBITION	Adiponectin and miR-133a are key regulators in cardiac hypertrophy. However, whether APN has a potential effect on miR-133a remains unclear. In this study, we aimed to investigate whether APN could regulate miR-133a expression in Angiotensin II (Ang II) induced cardiac hypertrophy in vivo and in vitro. Lentiviral-mediated adiponectin treatment attenuated cardiac hypertrophy induced by Ang II infusion in male wistar rats as determined by reduced cell surface area and mRNA levels of atrial natriuretic peptide (ANF) and brain natriuretic peptide (BNP), also the reduced left ventricular end-diastolic posterior wall thickness (LVPWd) and end-diastolic interventricular septal thickness (IVSd). Meanwhile, APN elevated miR-133a level which was downregulated by Ang II. To further investigate the underlying molecular mechanisms, we treated neonatal rat ventricular myocytes (NRVMs) with recombinant rat APN before Ang II stimulation. Pretreating cells with recombinant APN promoted AMP-activated protein kinase (AMPK) phosphorylation and inhibited ERK activation. By using the inhibitor of AMPK or a lentiviral vector expressing AMPK short hairpin RNA (shRNA) cancelled the positive effect of APN on miR-133a. The ERK inhibitor PD98059 reversed the downregulation of miR-133a induced by Ang II. These results indicated that the AMPK activation and ERK inhibition were responsible for the positive effect of APN on miR-133a. Furthermore, adiponectin receptor 1 (AdipoR1) mRNA expression was inhibited by Ang II stimulation. The positive effects of APN on AMPK activation and miR-133a, and the inhibitory effect on ERK phosphorylation were inhibited in NRVMs transfected with lentiviral AdipoR1shRNA. In addition, APN depressed the elevated expression of connective tissue growth factor (CTGF), a direct target of miR-133a, through the AMPK pathway. Taken together, our data indicated that APN reversed miR-133a levels through AMPK activation, reduced ERK1/2 phosphorylation in cardiomyocytes stimulated with Ang II, revealing a previously undemonstrated and important link between APN and miR-133a.	[Li, Ying; Cai, Xiaojun; Guan, Yuqing; Wang, Lei; Li, Yueyan; Gao, Xiaoyuan; Su, Guohai] Shandong Univ, Dept Cardiol, Jinan Cent Hosp, Jinan 250100, Peoples R China; [Li, Ying] Shandong Univ, Jinan Cent Hosp, Cent Lab, Jinan 250100, Peoples R China; [Wang, Shuya; Fu, Ying] Shandong Univ, Sch Med, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Su, GH (corresponding author), Shandong Univ, Dept Cardiol, Jinan Cent Hosp, Jinan 250100, Peoples R China.	guohaisu0531@126.com	wang, shuya/AHD-2495-2022; Li, Ying/GYU-4167-2022	wang, shuya/0000-0002-9360-9194; Li, Ying/0000-0002-4286-876X	National Natural Science Foundation of China [81170087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 81170087), http://www.nsfc.gov.cn/. G Su received the funding.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amin RH, 2010, AM J PHYSIOL-HEART C, V299, pH690, DOI 10.1152/ajpheart.01032.2009; Cao TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103793; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Castoldi G, 2012, J CELL PHYSIOL, V227, P850, DOI 10.1002/jcp.22939; Chang JL, 2010, DIABETES, V59, P2949, DOI 10.2337/db10-0582; Chen TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118909; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Drawnel FM, 2012, J CELL BIOL, V199, P783, DOI 10.1083/jcb.201111095; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Essick EE, 2011, AM J PHYSIOL-HEART C, V301, pH984, DOI 10.1152/ajpheart.00428.2011; Fang F, 2013, AM J PHYSIOL-RENAL, V304, pF1366, DOI 10.1152/ajprenal.00137.2012; Feng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.462; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Koitabashi N, 2007, HYPERTENSION, V49, P1120, DOI 10.1161/HYPERTENSIONAHA.106.077537; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Koutsoulidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125341; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lee YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070246; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CB, 2009, J CELL MOL MED, V13, P4444, DOI 10.1111/j.1582-4934.2008.00484.x; Li GM, 2006, J GENE MED, V8, P889, DOI 10.1002/jgm.894; Li HB, 2015, FREE RADICAL BIO MED, V84, P311, DOI 10.1016/j.freeradbiomed.2015.03.007; Li L, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1155/2013/467245; Li Y, 2013, ACTA PHARMACOL SIN, V34, P960, DOI 10.1038/aps.2013.19; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Liu YL, 2015, CARDIORENAL MED, V5, P79, DOI 10.1159/000371454; Luo J, 2014, ONCOL LETT, V7, P1043, DOI 10.3892/ol.2014.1841; Luo XB, 2010, CELL PHYSIOL BIOCHEM, V25, P571, DOI 10.1159/000315076; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; McCollum LT, 2012, AM J PHYSIOL-HEART C, V302, pH801, DOI 10.1152/ajpheart.00908.2011; Morikawa H, 2007, MOL MED, V13, P240, DOI 10.2119/2006-00093.Morikawa; Myers R, 2015, CIRC-ARRHYTHMIA ELEC, V8, P942, DOI 10.1161/CIRCEP.114.002162; Okamoto Y, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/313179; Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2006, TRENDS CARDIOVAS MED, V16, P141, DOI 10.1016/j.tcm.2006.03.001; Rosin NL, 2013, AM J PATHOL, V182, P714, DOI 10.1016/j.ajpath.2012.11.014; Sang HQ, 2015, BIOMED PHARMACOTHER, V71, P185, DOI 10.1016/j.biopha.2015.02.030; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Sriramula S, 2008, HYPERTENSION, V51, P1345, DOI 10.1161/HYPERTENSIONAHA.107.102152; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Wang J, 2012, CELL MOL LIFE SCI, V69, P3561, DOI 10.1007/s00018-012-1126-y; Wen P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103079; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yin XS, 2013, MOL CELL BIOCHEM, V379, P1, DOI 10.1007/s11010-012-1552-z; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhong L, 2015, CARDIOVASC RES, V106, P261, DOI 10.1093/cvr/cvv108	51	22	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148482	10.1371/journal.pone.0148482	http://dx.doi.org/10.1371/journal.pone.0148482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845040	Green Published, gold, Green Submitted			2022-12-26	WOS:000369552800062
J	Mariotti-Ferrandiz, E; Pham, HP; Dulauroy, S; Gorgette, O; Klatzmann, D; Cazenave, PA; Pied, S; Six, A				Mariotti-Ferrandiz, Encarnita; Pham, Hang-Phuong; Dulauroy, Sophie; Gorgette, Olivier; Klatzmann, David; Cazenave, Pierre-Andre; Pied, Sylviane; Six, Adrien			A TCR beta Repertoire Signature Can Predict Experimental Cerebral Malaria	PLOS ONE			English	Article							CD8(+) T-CELLS; PLASMODIUM-FALCIPARUM; CONTINUOUS CULTURES; MITOGENIC ACTIVITY; MURINE MALARIA; PATHOGENESIS; GENES; ALPHA; MICE; SEQUESTRATION	Cerebral Malaria (CM) is associated with a pathogenic T cell response. Mice infected by P. berghei ANKA clone 1.49 (PbA) developing CM(CM+) present an altered PBL TCR repertoire, partly due to recurrently expanded T cell clones, as compared to non-infected and CM- infected mice. To analyse the relationship between repertoire alteration and CM, we performed a kinetic analysis of the TRBV repertoire during the course of the infection until CM-related death in PbA-infected mice. The repertoires of PBL, splenocytes and brain lymphocytes were compared between infected and non-infected mice using a high-throughput CDR3 spectratyping method. We observed a modification of the whole TCR repertoire in the spleen and blood of infected mice, from the fifth and the sixth day post-infection, respectively, while only three TRBV were significantly perturbed in the brain of infected mice. Using multivariate analysis and statistical modelling, we identified a unique TCR beta signature discriminating CM+ from CTR mice, enriched during the course of the infection in the spleen and the blood and predicting CM onset. These results highlight a dynamic modification and compartmentalization of the TCR diversity during the course of PbA infection, and provide a novel method to identify disease-associated TCR beta signature as diagnostic and prognostic biomarkers.	[Mariotti-Ferrandiz, Encarnita; Dulauroy, Sophie; Gorgette, Olivier; Cazenave, Pierre-Andre; Pied, Sylviane; Six, Adrien] Univ Paris 06, CNRS, Sorbonne Univ, URA 1961, F-75005 Paris, France; [Mariotti-Ferrandiz, Encarnita; Dulauroy, Sophie; Gorgette, Olivier; Cazenave, Pierre-Andre; Pied, Sylviane; Six, Adrien] CNRS, URA 1961, F-75005 Paris, France; [Mariotti-Ferrandiz, Encarnita; Dulauroy, Sophie; Gorgette, Olivier; Cazenave, Pierre-Andre; Pied, Sylviane; Six, Adrien] Inst Pasteur, Immunophysiopathol Infect, F-75015 Paris, France; [Mariotti-Ferrandiz, Encarnita; Pham, Hang-Phuong; Klatzmann, David; Six, Adrien] Univ Paris 06, Sorbonne Univ, UMR 7211, UPMC Immunol Immunopathol Immunotherapy, F-75013 Paris, France; [Mariotti-Ferrandiz, Encarnita; Pham, Hang-Phuong; Klatzmann, David; Six, Adrien] INSERM, U959, Immunol Immunopathol Immunotherapy, F-75013 Paris, France; [Pham, Hang-Phuong] Hop La Pitie Salpetriere, iPEPS ICM, ILTOO Pharma, F-75013 Paris, France; [Dulauroy, Sophie] Inst Pasteur, CNRS, URA 1961, Dev Tissus Lymphoides, F-75015 Paris, France; [Gorgette, Olivier] Inst Pasteur, Plate Forme Microscopie Ultrastruct, F-75015 Paris, France; [Cazenave, Pierre-Andre; Pied, Sylviane] Univ Lille 2, Inst Pasteur Lille, INSERM 1019, CIIL,CNRS 8204, F-59000 Lille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Six, A (corresponding author), Univ Paris 06, CNRS, Sorbonne Univ, URA 1961, F-75005 Paris, France.; Six, A (corresponding author), Inst Pasteur, Immunophysiopathol Infect, F-75015 Paris, France.; Six, A (corresponding author), Univ Paris 06, Sorbonne Univ, UMR 7211, UPMC Immunol Immunopathol Immunotherapy, F-75013 Paris, France.; Six, A (corresponding author), INSERM, U959, Immunol Immunopathol Immunotherapy, F-75013 Paris, France.	adrien.six@upmc.fr	Mariotti-Ferrandiz, Encarnita/O-3262-2019	Mariotti-Ferrandiz, Encarnita/0000-0002-8770-0186; Klatzmann, David/0000-0002-0054-3422; Pied, Sylviane/0000-0003-0642-1423; Six, Adrien/0000-0001-5898-555X; PHAM, Hang-Phuong/0000-0002-7896-7401; Cazenave, Pierre-Andre/0000-0002-1345-8526	Assistance Publique-Hopitaux de Paris; Universite Pierre and Marie Curie (Paris VI); LabEx Transimmunom [ANR-11-IDEX-0004-02]; LabEx Parafrap [ANR-11-LABX-0024]; LIA CNRS DBT SIGID ("Systems Immunology and genetics of infectious diseases"); Ministere de la Recherche et de la Technologie; Fondation de France; Institut Pasteur	Assistance Publique-Hopitaux de Paris; Universite Pierre and Marie Curie (Paris VI); LabEx Transimmunom; LabEx Parafrap; LIA CNRS DBT SIGID ("Systems Immunology and genetics of infectious diseases"); Ministere de la Recherche et de la Technologie; Fondation de France(Fondation de France); Institut Pasteur(European Commission)	This work has been funded by Assistance Publique-Hopitaux de Paris, Universite Pierre and Marie Curie (Paris VI), LabEx Transimmunom (ANR-11-IDEX-0004-02), LabEx Parafrap (ANR-11-LABX-0024) and LIA CNRS DBT SIGID ("Systems Immunology and genetics of infectious diseases"). EMF & HPP have been supported by a doctoral fellowship from Ministere de la Recherche et de la Technologie, as well as by Fondation de France and Institut Pasteur for EMF.	Bagot S, 2004, INFECT IMMUN, V72, P2817, DOI 10.1128/IAI.72.5.2817-2826.2004; BALLET JJ, 1981, INFECT IMMUN, V33, P758, DOI 10.1128/IAI.33.3.758-762.1981; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERENDT AR, 1994, PARASITOL TODAY, V10, P412, DOI 10.1016/0169-4758(94)90238-0; Boubou MI, 1999, INT IMMUNOL, V11, P1553, DOI 10.1093/intimm/11.9.1553; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CHOU HS, 1987, P NATL ACAD SCI USA, V84, P1992, DOI 10.1073/pnas.84.7.1992; Collette A, 2004, J IMMUNOL, V173, P4568, DOI 10.4049/jimmunol.173.7.4568; Collette A, 2003, J IMMUNOL METHODS, V278, P105, DOI 10.1016/S0022-1759(03)00225-4; Collette A, 2002, BIOINFORMATICS, V18, P329, DOI 10.1093/bioinformatics/18.2.329; CURFS JHAJ, 1989, CLIN EXP IMMUNOL, V75, P136; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; FINLEY RW, 1982, J IMMUNOL, V129, P2213; GABRIELSEN AA, 1982, AM J TROP MED HYG, V31, P441, DOI 10.4269/ajtmh.1982.31.441; Gorgette O, 2002, INFECT IMMUN, V70, P3701, DOI 10.1128/IAI.70.7.3701-3706.2002; Gorochov G, 1998, NAT MED, V4, P215, DOI 10.1038/nm0298-215; GRAU GE, 1986, J IMMUNOL, V137, P2348; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1987, IMMUNOLOGY, V61, P521; Guiyedi V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000389; Han M, 1999, J IMMUNOL, V163, P301; Heitjan DF, 1991, APPL STAT, V40, P1329; Hermsen C, 1997, PARASITOLOGY, V114, P7, DOI 10.1017/S0031182096008293; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Lau LS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004135; Lefranc MP, 2007, IMMUNOGENETICS, V59, P899, DOI 10.1007/s00251-007-0260-4; LOUIE MC, 1989, J EXP MED, V170, P1987, DOI 10.1084/jem.170.6.1987; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Miyakoda M, 2008, J IMMUNOL; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Pied S, 1997, INT IMMUNOL, V9, P17, DOI 10.1093/intimm/9.1.17; Poh CM, 2014, INFECT IMMUN, V82, P4854, DOI 10.1128/IAI.02180-14; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; Rubin DB, 2004, MULTIPLE IMPUTATION; Schenker N, 1996, COMPUT STAT DATA AN, V22, P425, DOI 10.1016/0167-9473(95)00057-7; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Buuren S, 2011, J STAT SOFTW, V45, P1; WADE T, 1988, J IMMUNOL, V141, P2165; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yanez DM, 1996, J IMMUNOL, V157, P1620; Zinocker S, 2015, J IMMUNOL, V194, P929, DOI 10.4049/jimmunol.1402168	45	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147871	10.1371/journal.pone.0147871	http://dx.doi.org/10.1371/journal.pone.0147871			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844551	Green Submitted, Green Published, gold			2022-12-26	WOS:000369552800019
J	Aso, K; Tsuruhara, A; Takagaki, K; Oki, K; Ota, M; Nose, Y; Tanemura, H; Urushihata, N; Sasanuma, J; Sano, M; Hirano, A; Aso, R; McGhee, JR; Fujihashi, K				Aso, Kazuyoshi; Tsuruhara, Akitoshi; Takagaki, Kentaro; Oki, Katsuyuki; Ota, Megumi; Nose, Yasuhiro; Tanemura, Hideki; Urushihata, Naoki; Sasanuma, Jinichi; Sano, Masayuki; Hirano, Atsuyuki; Aso, Rio; McGhee, Jerry R.; Fujihashi, Kohtaro			Adipose-Derived Mesenchymal Stem Cells Restore Impaired Mucosal Immune Responses in Aged Mice	PLOS ONE			English	Article							MARROW STROMAL CELLS; VERSUS-HOST-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NALT DENDRITIC CELLS; T-CELLS; CROHNS-DISEASE; LYMPHORETICULAR TISSUE; ORAL TOLERANCE; TH2 CELLS; IN-VITRO	It has been shown that adipose-derived mesenchymal stem cells (AMSCs) can differentiate into adipocytes, chondrocytes and osteoblasts. Several clinical trials have shown the ability of AMSCs to regenerate these differentiated cell types. Age-associated dysregulation of the gastrointestinal (GI) immune system has been well documented. Our previous studies showed that impaired mucosal immunity in the GI tract occurs earlier during agingthan is seen in the systemic compartment. In this study, we examined the potential of AMSCs to restore the GI mucosal immune system in aged mice. Aged (>18 mo old) mice were adoptively transferred with AMSCs. Two weeks later, mice were orally immunized with ovalbumin (OVA) plus cholera toxin (CT) three times at weekly intervals. Seven days after the final immunization, when fecal extract samples and plasma were subjected to OVA-and CT-B-specific ELISA, elevated levels of mucosal secretory IgA (SIgA) and plasma IgG antibody (Ab) responses were noted in aged mouse recipients. Similar results were also seen aged mice which received AMSCs at one year of age. When cytokine production was examined, OVA-stimulated Peyer's patch CD4(+) T cells produced increased levels of IL-4. Further, CD4+ T cells from the lamina propria revealed elevated levels of IL-4 and IFN-gamma production. In contrast, aged mice without AMSC transfer showed essentially no OVA-or CT-B-specific mucosal SIgA or plasma IgG Ab or cytokine responses. Of importance, fecal extracts from AMSC transferred aged mice showed neutralization activity to CT intoxication. These results suggest that AMSCs can restore impaired mucosal immunity in the GI tract of aged mice.	[Aso, Kazuyoshi; Tsuruhara, Akitoshi; Aso, Rio; McGhee, Jerry R.; Fujihashi, Kohtaro] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL USA; [Takagaki, Kentaro; Oki, Katsuyuki; Ota, Megumi; Nose, Yasuhiro; Tanemura, Hideki; Urushihata, Naoki] BioMimet Sympathies Inc, Tokyo, Japan; [Sasanuma, Jinichi] Shinyurigaoka Gen Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan; [Sano, Masayuki; Hirano, Atsuyuki] Sunfield Clin, Koto Ku, Tokyo, Japan	University of Alabama System; University of Alabama Birmingham	Fujihashi, K (corresponding author), Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL USA.	kohtarof@uab.edu		Ota, Megumi/0000-0002-6222-4830; Takagaki, Kentaro/0000-0001-8085-6201	BioMimetics Sympathies Inc.	BioMimetics Sympathies Inc.	This work is supported by funding provided by BioMimetics Sympathies Inc. (http://www.bm-s.biz) to Dr. Kohtaro Fujihashi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Asanuma H, 2012, VACCINE, V30, P803, DOI 10.1016/j.vaccine.2011.10.093; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Casiraghi F, 2013, CURR OPIN ORGAN TRAN, V18, P51, DOI 10.1097/MOT.0b013e32835c5016; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Effros RB, 2003, IMMUNOL ALLERGY CLIN, V23, P41, DOI 10.1016/S0889-8561(02)00055-3; Effros RB, 2007, VACCINE, V25, P599, DOI 10.1016/j.vaccine.2006.08.032; English K, 2008, IMMUNOL LETT, V115, P50, DOI 10.1016/j.imlet.2007.10.002; Figueroa FE, 2012, BIOL RES, V45, P269, DOI 10.4067/S0716-97602012000300008; Forbes GM, 2014, CLIN GASTROENTEROL H, V12, P64, DOI 10.1016/j.cgh.2013.06.021; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Fukuiwa T, 2008, VACCINE, V26, P4849, DOI 10.1016/j.vaccine.2008.06.091; Fukuyama Y, 2012, BIOCHEM BIOPH RES CO, V418, P6, DOI 10.1016/j.bbrc.2011.12.046; Fukuyama Y, 2011, J IMMUNOL, V186, P2454, DOI 10.4049/jimmunol.1002837; Garcia-Olmo D, 2008, EXPERT OPIN BIOL TH, V8, P1417, DOI 10.1517/14712598.8.9.1417 ; Gardner EM, 2006, VACCINE, V24, P1609, DOI 10.1016/j.vaccine.2005.09.058; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Hagiwara Y, 2003, J IMMUNOL, V170, P1754, DOI 10.4049/jimmunol.170.4.1754; Ho MSH, 2015, J CELL PHYSIOL, V230, P2606, DOI 10.1002/jcp.25028; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Kato H, 2003, INT IMMUNOL, V15, P145, DOI 10.1093/intimm/dxg011; Kato H, 2001, J IMMUNOL, V166, P3114, DOI 10.4049/jimmunol.166.5.3114; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Kim MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072544; Knyazev OV, 2013, B EXP BIOL MED+, V156, P139, DOI 10.1007/s10517-013-2297-8; Koga T, 2000, J IMMUNOL, V165, P5352, DOI 10.4049/jimmunol.165.9.5352; Kong QF, 2009, J NEUROIMMUNOL, V207, P83, DOI 10.1016/j.jneuroim.2008.12.005; Kovaiou Rania D., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000221; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Larbi A., 2013, AGING HLTH, V9, P35, DOI [10.2217/ahe.12.78, DOI 10.2217/AHE.12.78]; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee PH, 2008, CLIN PHARMACOL THER, V83, P723, DOI 10.1038/sj.clpt.6100386; Lee PH, 2012, ANN NEUROL, V72, P32, DOI 10.1002/ana.23612; Liang J, 2010, ANN RHEUM DIS, V69, P1423, DOI 10.1136/ard.2009.123463; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liu SY, 2012, CELL IMMUNOL, V278, P35, DOI 10.1016/j.cellimm.2012.06.010; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; McElhaney JE, 2005, VACCINE, V23, pS10, DOI 10.1016/j.vaccine.2005.04.019; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114; Ohta Y, 2008, CELL TRANSPLANT, V17, P877, DOI 10.3727/096368908786576516; Okahashi N, 1996, INFECT IMMUN, V64, P1516, DOI 10.1128/IAI.64.5.1516-1525.1996; Perez-Simon JA, 2011, HAEMATOL-HEMATOL J, V96, P1072, DOI 10.3324/haematol.2010.038356; Prasad VK, 2011, BIOL BLOOD MARROW TR, V17, P534, DOI 10.1016/j.bbmt.2010.04.014; Prevosto C, 2007, HAEMATOLOGICA, V92, P881, DOI 10.3324/haematol.11240; Psaltis PJ, 2008, STEM CELLS, V26, P2201, DOI 10.1634/stemcells.2008-0428; Sato S, 2015, GERONTOLOGY, V61, P336, DOI 10.1159/000368897; Sekine S, 2008, J IMMUNOL, V180, P8126, DOI 10.4049/jimmunol.180.12.8126; TAGUCHI T, 1990, J IMMUNOL, V145, P68; Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316; TAYLOR LD, 1992, IMMUNOLOGY, V75, P614; Tobita M, 2013, CYTOTHERAPY, V15, P1517, DOI 10.1016/j.jcyt.2013.05.007; Tobita M, 2011, DISCOV MED, V11, P160; Tokuhara D, 2010, P NATL ACAD SCI USA, V107, P8794, DOI 10.1073/pnas.0914121107; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; Wang DD, 2013, CELL TRANSPLANT, V22, P2267, DOI [10.3727/096368911X582769c, 10.3727/096368911X582769]; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Yamout B, 2010, J NEUROIMMUNOL, V227, P185, DOI 10.1016/j.jneuroim.2010.07.013; Zhang B, 2009, BLOOD, V113, P46, DOI 10.1182/blood-2008-04-154138	67	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148185	10.1371/journal.pone.0148185	http://dx.doi.org/10.1371/journal.pone.0148185			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840058	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200092
J	Guerrieri, E; Giorgini, M; Cascone, P; Carpenito, S; van Achterberg, C				Guerrieri, Emilio; Giorgini, Massimo; Cascone, Pasquale; Carpenito, Simona; van Achterberg, Cees			Species Diversity in the Parasitoid Genus Asobara (Hymenoptera: Braconidae) from the Native Area of the Fruit Fly Pest Drosophila suzukii (Diptera: Drosophilidae)	PLOS ONE			English	Article							INVASION; DNA	Drosophila suzukii (Matsumura), commonly known as Spotted Wing Drosophila (SWD), is a worldwide serious economic threat to the production of berries and stone fruits. The chemical control widely used against this pest is often not able to preventing yield losses because wild flora offers an abundance of fruits to D. suzukii where the pest is able to reproduce and from where it recolonizes neighbouring cultivated fields. Alternatively, within Integrated Pest Management protocols for D. suzukii, biological control could play a key role by reducing its populations particularly in non-cultivated habitats, thus increasing the effectiveness and reducing the side negative effects of other management strategies. Because of the scarcity and of the low efficiency of autochthonous parasitoids in the new invaded territories, in the last few years, a number of surveys started in the native area of D. suzukii to find parasitoid species to be evaluated in quarantine structures and eventually released in the field, following a classical biological control approach. This paper reports the results of these surveys carried out in South Korea and for the first time in China. Among the parasitoids collected, those belonging to the genus Asobara Foerster resulted dominant both by number and species diversity. By combining morphological characters and the mitochondrial COI gene as a molecular marker, we identified seven species of Asobara, of which two associated with D. suzukii, namely A. japonica and A leveri, and five new to science, namely Asobara brevicauda, A. elongata, A mesocauda, A unicolorata, A. triangulata. Our findings offer new opportunity to find effective parasitoids to be introduced in classical biological control programmes in the territories recently invaded by D. suzukii.	[Guerrieri, Emilio; Giorgini, Massimo; Cascone, Pasquale; Carpenito, Simona] Natl Res Council Italy, Inst Sustainable Plant Protect, Portici, Na, Italy; [van Achterberg, Cees] Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [Guerrieri, Emilio] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); Naturalis Biodiversity Center; Natural History Museum London	Guerrieri, E (corresponding author), Natl Res Council Italy, Inst Sustainable Plant Protect, Portici, Na, Italy.; Guerrieri, E (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	emilio.guerrieri@ipsp.cnr.it	Guerrieri, Emilio/ABB-7498-2020; GIORGINI, MASSIMO/AAX-3458-2020; Cascone, Pasquale/J-7992-2016	GIORGINI, MASSIMO/0000-0001-8670-0945; Cascone, Pasquale/0000-0002-4097-1974	PIRSES [318246]; FP7 project Ameliorating the Sustainable Control of Invasive Insects [PIRSES 318246]	PIRSES; FP7 project Ameliorating the Sustainable Control of Invasive Insects	PIRSES 318246 ASCII Ameliorating the sustainable control of invasive insects https://ec.europa.eu/research/participants/portal4/desktop/en/opportunities/fp7/calls/fp7-people-2012-irses.html vasive insects (2012).; This work has been supported by FP7 project Ameliorating the Sustainable Control of Invasive Insects (PIRSES 318246).	Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; Cini A, 2014, J PEST SCI, V87, P559, DOI 10.1007/s10340-014-0617-z; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; Fischer M., 1988, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V90, P93; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gabarra R, 2015, BIOCONTROL, V60, P331, DOI 10.1007/s10526-014-9646-z; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hernandez-Ortiz V, 2004, B ENTOMOL RES, V94, P487, DOI 10.1079/BER2004325; Kasuya N, 2013, APPL ENTOMOL ZOOL, V48, P87, DOI 10.1007/s13355-012-0156-0; Lasa Rodrigo, 2015, Florida Entomologist, V98, P987, DOI 10.1653/024.098.0332; Lee JC, 2015, ANN ENTOMOL SOC AM, V108, P117, DOI 10.1093/aesa/sau014; Mitsui H, 2007, J NAT HIST, V41, P1731, DOI 10.1080/00222930701504797; Nomano FY, 2015, J APPL ENTOMOL, V139, P105, DOI 10.1111/jen.12141; Novkovic B, 2011, ENTOMOL SCI, V14, P333, DOI 10.1111/j.1479-8298.2011.00459.x; NOYES JS, 1982, J NAT HIST, V16, P315, DOI 10.1080/00222938200770261; Ometto L, 2013, GENOME BIOL EVOL, V5, P745, DOI 10.1093/gbe/evt034; Polaszek A, 2004, ZOOL SCR, V33, P403, DOI 10.1111/j.0300-3256.2004.00161.x; Schulmeister S, 2002, CLADISTICS, V18, P455, DOI 10.1111/j.1096-0031.2002.tb00287.x; Stacconi M. V. Rossi, 2013, Entomologia, V1, P11, DOI 10.4081/entomologia.2013.e3; Stacconi MVR, 2015, BIOL CONTROL, V84, P28, DOI 10.1016/j.biocontrol.2015.02.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Achterberg C., 1993, Zoologische Verhandelingen (Leiden), V283, P1; van Achterberg C, 1988, ZOOL VERH, V249, P1; Walsh DB, 2011, J INTEGRATE PEST MAN, V67, P1358; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wharton RA, 1980, U CALIFORNIA PUBLICA, V88, P1; Yu DSK, 2012, TAXAPAD 2012 ICHNEUM	31	39	42	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147382	10.1371/journal.pone.0147382	http://dx.doi.org/10.1371/journal.pone.0147382			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840953	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200036
J	Homaira, N; Luby, SP; Hossain, K; Islam, K; Ahmed, M; Rahman, M; Rahman, Z; Paul, RC; Bhuiyan, MU; Brooks, WA; Sohel, BM; Banik, KC; Widdowson, MA; Willby, M; Rahman, M; Bresee, J; Ramirez, KS; Azziz-Baumgartner, E				Homaira, Nusrat; Luby, Stephen P.; Hossain, Kamal; Islam, Kariul; Ahmed, Makhdum; Rahman, Mustafizur; Rahman, Ziaur; Paul, Repon C.; Bhuiyan, Mejbah Uddin; Brooks, W. Abdullah; Sohel, Badrul Munir; Banik, Kajal Chandra; Widdowson, Marc-Alain; Willby, Melisa; Rahman, Mahmudur; Bresee, Joseph; Ramirez, Katharine-Sturm; Azziz-Baumgartner, Eduardo			Respiratory Viruses Associated Hospitalization among Children Aged < 5 Years in Bangladesh: 2010-2014	PLOS ONE			English	Article							SYNCYTIAL VIRUS; CHILDHOOD DEATHS; INFLUENZA; INFECTIONS; PNEUMONIA; COST; IMMUNIZATION; PROPHYLAXIS; RHINOVIRUS; RISK	Background We combined hospital-based surveillance and health utilization survey data to estimate the incidence of respiratory viral infections associated hospitalization among children aged <5 years in Bangladesh. Methods Surveillance physicians collected respiratory specimens from children aged <5 years hospitalized with respiratory illness and residing in the primary hospital catchment areas. We tested respiratory specimens for respiratory syncytial virus, parainfluenza viruses, human metapneumovirus, influenza, adenovirus and rhinoviruses using rRT-PCR. During 2013, we conducted a health utilization survey in the primary catchment areas of the hospitals to determine the proportion of all hospitalizations for respiratory illness among children aged <5 years at the surveillance hospitals during the preceding 12 months. We estimated the respiratory virus-specific incidence of hospitalization by dividing the estimated number of hospitalized children with a laboratory confirmed infection with a respiratory virus by the population aged <5 years of the catchment areas and adjusted for the proportion of children who were hospitalized at the surveillance hospitals. Results We estimated that the annual incidence per 1000 children (95% CI) of all cause associated respiratory hospitalization was 11.5 (10-12). The incidences per 1000 children (95% CI) per year for respiratory syncytial virus, parainfluenza, adenovirus, human metapneumovirus and influenza infections were 3(2-3), 0.5(0.4-0.8), 0.4 (0.3-0.6), 0.4 (0.3-0.6), and 0.4 (0.3-0.6) respectively. The incidences per 1000 children (95%CI) of rhinovirus-associated infections among hospitalized children were 5 (3-7), 2 (1-3), 1 (0.6-2), and 3 (2-4) in 2010, 2011, 2012 and 2013, respectively. Conclusion Our data suggest that respiratory viruses are associated with a substantial burden of hospitalization in children aged <5 years in Bangladesh.	[Homaira, Nusrat; Luby, Stephen P.; Hossain, Kamal; Islam, Kariul; Ahmed, Makhdum; Rahman, Mustafizur; Rahman, Ziaur; Paul, Repon C.; Bhuiyan, Mejbah Uddin; Brooks, W. Abdullah; Sohel, Badrul Munir; Banik, Kajal Chandra; Ramirez, Katharine-Sturm; Azziz-Baumgartner, Eduardo] Icddr B, Dhaka, Bangladesh; [Luby, Stephen P.; Widdowson, Marc-Alain; Willby, Melisa; Bresee, Joseph; Ramirez, Katharine-Sturm; Azziz-Baumgartner, Eduardo] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Brooks, W. Abdullah] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ, Baltimore, MD USA; [Rahman, Mahmudur] IEDCR, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Homaira, N (corresponding author), Icddr B, Dhaka, Bangladesh.	nhomaira@icddrb.org	Bhuiyan, Mejbah/AAY-1238-2020; Homaira, Nusrat/U-4526-2019; Islam/AAO-8937-2020; Bhuiyan, Mejbah/ABG-4827-2020; Brooks, W. Abdullah/AAD-3876-2021; Ahmed, Makhdum/D-2615-2012	Bhuiyan, Mejbah/0000-0002-8274-6265; Brooks, W. Abdullah/0000-0001-9871-5546; Ahmed, Makhdum/0000-0002-0772-8710; Islam, Mdkariul/0000-0003-4085-7159; Homaira, Nusrat/0000-0003-3341-7964; Luby, Stephen/0000-0001-5385-899X	Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta [1U01CI000628-01, 1U01CI000628-04]; US CDC [1U01CI000628-04]; National Center for Preparedness, Detection, and Control of Infectious Diseases [U01CI000628] Funding Source: NIH RePORTER	Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta; US CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Preparedness, Detection, and Control of Infectious Diseases(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by the Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta under the co-operative agreement numbers 1U01CI000628-01 and 1U01CI000628-04. Co-authors SPL, MAW, MW, JB, KSR and EAB who work for the funding body were also involved in designing and analyzing of the study.; icddr,b is grateful for the commitment of CDC to its research efforts. US CDC gave financial support for this study (cooperative agreement 1U01CI000628-04). The authors would like to thank all the study participants and the surveillance hospitals for their contribution in the study. We gratefully acknowledge the relentless effort of the field staff involved in data collection and compilation. We also acknowledge the contribution of Dean D. Erdman for the design of the primers and probes for the laboratory testing of the study. We are also very grateful to Diana DiazGranados for her help with editing of the manuscript.	Ahmed SM, 2000, SOC SCI MED, V51, P361, DOI 10.1016/S0277-9536(99)00461-X; Alonso WJ, 2012, PEDIATR INFECT DIS J, V31, pE9, DOI 10.1097/INF.0b013e31823883be; Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; AUSINA V, 1988, EUR J CLIN MICROBIOL, V7, P343, DOI 10.1007/BF01962334; Banerjee S, 2007, J CLIN VIROL, V38, P70, DOI 10.1016/j.jcv.2006.07.003; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Centers for Disease Control and Prevention (CDC), 2009, PROTOCOL OF REALTIME; Clara W, 2012, B WORLD HEALTH ORGAN, V90, P756, DOI 10.2471/BLT.11.098202; Connor E, 1997, PEDIATRICS, V99, P93; Englund JA, 2003, VACCINE, V21, P3460, DOI 10.1016/S0264-410X(03)00351-7; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Fry AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015098; Gurley ES, 2010, CLIN INFECT DIS, V50, P1084, DOI 10.1086/651265; Saborio GG, 2014, EMERG INFECT DIS, V20, P878, DOI 10.3201/eid2005.131775; Halder AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008145; Haque F, 2012, INT J INFECT DIS, V16, pE866, DOI 10.1016/j.ijid.2012.07.016; Hasan K, 2006, SCAND J INFECT DIS, V38, P690, DOI 10.1080/00365540600606473; Haynes LM, 2013, J INFECT DIS, V208, pS177, DOI 10.1093/infdis/jit512; Henrickson Kelly J, 1998, Semin Pediatr Infect Dis, V9, P217, DOI 10.1016/S1045-1870(98)80035-6; Homaira N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032056; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jartti T, 2008, PEDIATR INFECT DIS J, V27, P1103, DOI 10.1097/INF.0b013e31817e695d; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675; Joffe S, 1999, PEDIATRICS, V104, P419, DOI 10.1542/peds.104.3.419; KORPPI M, 1993, EUR J PEDIATR, V152, P24, DOI 10.1007/BF02072512; Miller EK, 2013, J CLIN VIROL, V57, P291, DOI 10.1016/j.jcv.2013.04.015; Mitra S, 2004, BANGLADESH DEMOGRAPH; Montes A, 2005, VACCINE, V23, P4302, DOI 10.1016/j.vaccine.2005.04.006; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nasreen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089978; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Simoes EAF, 2007, J PEDIATR-US, V151, P34, DOI 10.1016/j.jpeds.2007.02.032; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Smyth A, 2002, BRIT MED BULL, V61, P247, DOI 10.1093/bmb/61.1.247; van Benten I, 2003, PEDIAT ALLERG IMM-UK, V14, P363, DOI 10.1034/j.1399-3038.2003.00064.x; WALKER TA, 1994, PEDIATR CLIN N AM, V41, P1365; WANG D, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI DOI 10.1099/vir.0.82282-0; Warren-Gash C., 2012, INFLUENZA OTHER RESP, DOI 10.111/Irv.12015; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Weber MW, 1999, INT J EPIDEMIOL, V28, P157, DOI 10.1093/ije/28.1.157; Weinberg GA, 2013, J CLIN VIROL, V57, P254, DOI 10.1016/j.jcv.2013.03.016; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	50	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147982	10.1371/journal.pone.0147982	http://dx.doi.org/10.1371/journal.pone.0147982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840782	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200074
J	Huang, WC; Ke, MW; Cheng, CC; Chiou, SH; Wann, SR; Shu, CW; Chiou, KR; Tseng, CJ; Pan, HW; Mar, GY; Liu, CP				Huang, Wei-Chun; Ke, Meng-Wei; Cheng, Chin-Chang; Chiou, Shih-Hwa; Wann, Shue-Ren; Shu, Chih-Wen; Chiou, Kuan-Rau; Tseng, Ching-Jiunn; Pan, Hung-Wei; Mar, Guang-Yuan; Liu, Chun-Peng			Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension	PLOS ONE			English	Article							INFLAMMATION; ALPHA-1-ANTITRYPSIN; INTERLEUKIN-6; INHIBITION; SURVIVAL; PROTEIN; FETUIN; MODEL; MICE	Pulmonary arterial hypertension (PAH) is characterized by progressive increases in vascular resistance and the remodeling of pulmonary arteries. The accumulation of inflammatory cells in the lung and elevated levels of inflammatory cytokines in the bloodstream suggest that inflammation may play a role in PAH. In this study, the benefits of induced pluripotent stem cells (iPSCs) and iPSC-conditioned medium (iPSC CM) were explored in monocrotaline (MCT)-induced PAH rats. We demonstrated that both iPSCs and iPSC CM significantly reduced the right ventricular systolic pressure and ameliorated the hypertrophy of the right ventricle in MCT-induced PAH rats in models of both disease prevention and disease reversal. In the prevention of MCT-induced PAH, iPSC-based therapy led to the decreased accumulation of inflammatory cells and down-regulated the expression of the IL-1 beta, IL-6, IL-12 alpha, IL-12 beta, IL-23 and IFN gamma genes in lung specimens, which implied that iPSC-based therapy may be involved in the regulation of inflammation. NF-kappa B signaling is essential to the inflammatory cascade, which is activated via the phosphorylation of the NF-kappa B molecule. Using the chemical inhibitor specifically blocked the phosphorylation of NF-kappa B, and in vitro assays of cultured human M1 macrophages implied that the anti-inflammation effect of iPSC-based therapy may contribute to the disturbance of NF-kappa B activation. Here, we showed that iPSC-based therapy could restore the hemodynamic function of right ventricle with benefits for preventing the ongoing inflammation in the lungs of MCT-induced PAH rats by regulating NF-kappa B phosphorylation.	[Huang, Wei-Chun; Ke, Meng-Wei; Cheng, Chin-Chang; Chiou, Kuan-Rau; Mar, Guang-Yuan; Liu, Chun-Peng] Kaohsiung Vet Gen Hosp, Cardiovasc Med Ctr, Kaohsiung, Taiwan; [Huang, Wei-Chun; Cheng, Chin-Chang; Chiou, Kuan-Rau; Liu, Chun-Peng] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Wei-Chun; Cheng, Chin-Chang] Fooyin Univ, Dept Phys Therapy, Kaohsiung, Taiwan; [Chiou, Shih-Hwa] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Educ & Res, Taipei, Taiwan; [Shu, Chih-Wen; Tseng, Ching-Jiunn; Pan, Hung-Wei] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Wann, Shue-Ren] Kaohsiung Vet Gen Hosp, Dept Emergency, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Fooyin University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital	Liu, CP (corresponding author), Kaohsiung Vet Gen Hosp, Cardiovasc Med Ctr, Kaohsiung, Taiwan.; Liu, CP (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.; Wann, SR (corresponding author), Kaohsiung Vet Gen Hosp, Dept Emergency, Kaohsiung, Taiwan.	srwann@vghks.gov.tw; wchuanglulu.photo@gmail.com	Shu, Chih-Wen/AAE-9652-2019	Shu, Chih-Wen/0000-0002-7774-0002	Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan [VGHKS 102-058, 103-053, 103-121, 103-124, 102-054]; National Science Council, Taiwan [NSC 101-2314-13-075B-008, MOST-103-2314-B-075B-003]	Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Grant No. VGHKS 102-058, 103-053, 103-121, 103-124, 102-054, and National Science Council, Taiwan, NSC 101-2314-13-075B-008, MOST-103-2314-B-075B-003.	Barst RJ, 2009, J AM COLL CARDIOL, V54, pS78, DOI 10.1016/j.jacc.2009.04.017; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Dorronsoro A, 2013, J NEUROSCI RES, V91, P1440, DOI [10.1002/jnr.23267PMID:23996632, DOI 10.1002/JNR.23267]; Ehlers MR, 2014, BIOL CHEM, V395, P1187, DOI 10.1515/hsz-2014-0161; Fang IM, 2014, J OCUL PHARMACOL TH, V30, P757, DOI 10.1089/jop.2014.0020; Frid MG, 2006, AM J PATHOL, V168, P659, DOI 10.2353/ajpath.2006.050599; Gangneux C, 2003, NUCLEIC ACIDS RES, V31, P5957, DOI 10.1093/nar/gkg788; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; Gomez-Arroyo JG, 2012, AM J PHYSIOL-LUNG C, V302, pL363, DOI 10.1152/ajplung.00212.2011; Gu MX, 2012, CIRC RES, V111, P882, DOI 10.1161/CIRCRESAHA.112.269001; Ho WJ, 2014, ACTA CARDIOL SIN, V30, P236; Hsu CH, 2014, ACTA CARDIOL SIN, V30, P401; Hsu CH, 2012, ACTA CARDIOL SIN, V28, P267; Huang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042507; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Jodele S, 2013, BIOL BLOOD MARROW TR, V19, P202, DOI 10.1016/j.bbmt.2012.08.022; Johnson JL, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/276457; Jonigk D, 2013, P NATL ACAD SCI USA, V110, P15007, DOI 10.1073/pnas.1309648110; Keogh AM, 2009, J AM COLL CARDIOL, V54, pS67, DOI 10.1016/j.jacc.2009.04.016; Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li L, 2014, HYPERTENSION, V63, P1260, DOI 10.1161/HYPERTENSIONAHA.114.03220; Liu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066760; Lockett AD, 2013, AM J RESP CELL MOL, V49, P143, DOI 10.1165/rcmb.2012-0515OC; Marecki JC, 2006, AM J RESP CRIT CARE, V174, P437, DOI 10.1164/rccm.200601-005OC; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Morin C, 2014, AM J PHYSIOL-HEART C, V307, pH574, DOI 10.1152/ajpheart.00814.2013; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Ogulur I, 2014, INT IMMUNOPHARMACOL, V22, P31, DOI 10.1016/j.intimp.2014.06.011; Ombrellino M, 2001, SHOCK, V15, P181, DOI 10.1097/00024382-200115030-00004; Ormiston ML, 2010, AM J RESP CELL MOL, V43, P546, DOI 10.1165/rcmb.2009-0152OC; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Reel B, 2011, BRIT J PHARMACOL, V163, P1679, DOI 10.1111/j.1476-5381.2011.01298.x; Ruiter G, 2013, EUR RESPIR J, V42, P553, DOI 10.1183/09031936.00012313; Sahara M, 2007, CIRCULATION, V115, P509, DOI 10.1161/CIRCULATIONAHA.106.655837; Savale L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-6; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tatarishvili J, 2014, RESTOR NEUROL NEUROS, V32, P547, DOI 10.3233/RNN-140404; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Voelkel NF, 2004, CARDIOL CLIN, V22, P343, DOI 10.1016/j.ccl.2004.04.010; Voelkel NF, 2002, CRIT CARE MED, V30, pS251, DOI 10.1097/00003246-200205001-00013; Wang H, 2014, INT IMMUNOPHARMACOL, V22, P31; Woltje M, 2006, J MOL ENDOCRINOL, V36, P261, DOI 10.1677/jme.1.02001; Yang KY, 2011, CHEST, V140, P1243, DOI 10.1378/chest.11-0539; Zhang ZH, 2012, EXP THER MED, V4, P839, DOI 10.3892/etm.2012.691; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338	56	17	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0142476	10.1371/journal.pone.0142476	http://dx.doi.org/10.1371/journal.pone.0142476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840075	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200001
J	Pascoe, S; Tobin, R; Windle, J; Cannard, T; Marshall, N; Kabir, Z; Flint, N				Pascoe, Sean; Tobin, Renae; Windle, Jill; Cannard, Toni; Marshall, Nadine; Kabir, Zobaidul; Flint, Nicole			Developing a Social, Cultural and Economic Report Card for a Regional Industrial Harbour	PLOS ONE			English	Article							MULTICRITERIA DECISION-ANALYSIS; WEIGHT ELICITATION METHODS; BAYESIAN NETWORK; RESOURCE-MANAGEMENT; ECOSYSTEM SERVICES; QUALITY; ALLOCATION; FRAMEWORK; BENEFITS; FISHERY	Report cards are increasingly used to provide ongoing snap-shots of progress towards specific ecosystem health goals, particularly in coastal regions where planners need to balance competing demands for coastal resources from a range of industries. While most previous report cards focus on the biophysical components of the system, there is a growing interest in including the social and economic implications of ecosystem management to provide a greater social-ecological system understanding. Such a report card was requested on the Gladstone Harbour area in central Queensland, Australia. Gladstone Harbour adjoins the southern Great Barrier Reef, and is also a major industrial and shipping port. Balancing social, economic and environmental interests is therefore of great concern to the regional managers. While environmental benchmarking procedures are well established within Australia (and elsewhere), a method for assessing social and economic performance of coastal management is generally lacking. The key aim of this study was to develop and pilot a system for the development of a report card relating to appropriate cultural, social and economic objectives. The approach developed uses a range of multicriteria decision analysis methods to assess and combine different qualitative and quantitative measures, including the use of Bayesian Belief Networks to combine the different measures and provide an overall quantitative score for each of the key management objectives. The approach developed is readily transferable for purposes of similar assessments in other regions.	[Pascoe, Sean; Cannard, Toni] CSIRO Oceans & Atmosphere, Brisbane, Qld, Australia; [Tobin, Renae] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Tobin, Renae] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Windle, Jill; Kabir, Zobaidul; Flint, Nicole] Cent Queensland Univ, Sch Business & Law, Rockhampton, Qld 4702, Australia; [Marshall, Nadine] CSIRO Land & Water, Townsville, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University; James Cook University; Central Queensland University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Pascoe, S (corresponding author), CSIRO Oceans & Atmosphere, Brisbane, Qld, Australia.	sean.pascoe@csiro.au	Marshall, Nadine/D-9339-2011; Cannard, Toni/AAA-8521-2019; Flint, Nicole/AAJ-8538-2021; Cannard, Toni M/D-8005-2012; Pascoe, Sean/D-9710-2011	Marshall, Nadine/0000-0003-4463-3558; Flint, Nicole/0000-0003-4331-4109; Cannard, Toni M/0000-0003-4254-8683; Pascoe, Sean/0000-0001-6581-2649	Gladstone Healthy Harbour Partnership [ISP005]	Gladstone Healthy Harbour Partnership	This work was supported by Gladstone Healthy Harbour Partnership, ISP005 (http://rc.ghhp.org.au/) to SP, RT, and JW. The funders had commissioned previous studies that identified objectives and preliminary indicators that were used in this analysis. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; BARBER W E, 1990, North American Journal of Fisheries Management, V10, P365, DOI 10.1577/1548-8675(1990)010<0365:TIOGOA>2.3.CO;2; Bottomley PA, 2000, J MARKETING RES, V37, P508, DOI 10.1509/jmkr.37.4.508.18794; Bottomley PA, 2001, OMEGA-INT J MANAGE S, V29, P553, DOI 10.1016/S0305-0483(01)00044-5; Cannard T, 2012, EST COAST SCI ASS C, P1; Carroll C, 2012, MAR POLLUT BULL, V65, P136, DOI 10.1016/j.marpolbul.2011.11.022; Chapman D., 1996, WATER QUALITY ASSESS, P59, DOI [10.4324/noe0419216001, DOI 10.4324/NOE0419216001]; Christianson JB, 2010, J GEN INTERN MED, V25, P1235, DOI 10.1007/s11606-010-1438-2; Curtin R, 2010, MAR POLICY, V34, P821, DOI 10.1016/j.marpol.2010.01.003; Diener E., 2006, APPL RES QUAL LIFE, DOI [10.1007/s11482-006-9007-x, DOI 10.1007/S10902-006-9000-Y, DOI 10.1007/S11482-006-9007-X]; Dill DD, 2005, HIGH EDUC, V49, P495, DOI 10.1007/s10734-004-1746-8; Drescher LS, 2014, INT J CONSUM STUD, V38, P217, DOI 10.1111/ijcs.12086; Estevez RA, 2013, DIVERS DISTRIB, V19, P608, DOI 10.1111/ddi.12058; Gladstone Ports Corporation, 2013, ANN REP 2012 13; Grabowski DC, 2011, HEALTH SERV RES, V46, P1698, DOI 10.1111/j.1475-6773.2011.01298.x; Greer L., 2013, GUIDANCE SELECTION S; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hayashi K, 2000, EUR J OPER RES, V122, P486, DOI 10.1016/S0377-2217(99)00249-0; Hayes N., 2007, IMPACT ASSESS PROJ A, V25, P209, DOI [10.3152/146155107x227126, DOI 10.3152/146155107X227126]; Heilman P, 1997, APPL MATH COMPUT, V83, P173, DOI 10.1016/S0096-3003(96)00168-3; HUYLENBROEK GV, 1992, EUROPEAN REV AGR EC, V19, P237, DOI DOI 10.1093/erae/19.2.237; Jacquet J, 2010, ORYX, V44, P45, DOI 10.1017/S0030605309990470; Koschke L, 2012, ECOL INDIC, V21, P54, DOI 10.1016/j.ecolind.2011.12.010; Leigh C, 2013, WATER-SUI, V5, P780, DOI 10.3390/w5020780; Lipton D, 2003, ESTUARIES, V26, P310, DOI 10.1007/BF02695969; Little LR, 2004, ENVIRON MODELL SOFTW, V19, P27, DOI 10.1016/S1364-8152(03)00100-2; Liu S, 2013, J ENVIRON MANAGE, V129, P92, DOI 10.1016/j.jenvman.2013.06.047; Marshall N. A., 2013, SOCIAL EC LONG TERM; McCann RK, 2006, CAN J FOREST RES, V36, P3053, DOI 10.1139/X06-238; McIntosh E. J., 2014, GLADSTONE HARBOUR RE; Naranjo-Madrigal H, 2015, MAR POLICY, V62, P102, DOI 10.1016/j.marpol.2015.09.003; Nolan MA, 2012, LOCAL ECON, V27, P403, DOI 10.1177/0269094212437834; Overton JM, 2013, AMBIO, V42, P100, DOI 10.1007/s13280-012-0342-x; Pascoe S, 2014, PILOTING SOCIAL CULT; Pascoe S, 2014, OCEAN COAST MANAGE, V98, P1, DOI 10.1016/j.ocecoaman.2014.05.014; Pascoe S, 2013, MAR POLICY, V37, P115, DOI 10.1016/j.marpol.2012.02.016; Pollino CA, 2007, ENVIRON MODELL SOFTW, V22, P1140, DOI 10.1016/j.envsoft.2006.03.006; Roberts R., 2002, J MULTI-CRITERIA DEC, V11, P291, DOI [10.1002/mcda.320, DOI 10.1002/mcda.320, DOI 10.1002/MCDA.320]; Saaty TL., 1980, ANAL HIERARCHY PROCE; Sheppard SRJ, 2005, FOREST ECOL MANAG, V207, P171, DOI 10.1016/j.foreco.2004.10.032; Sutton SG, 2009, ENVIRON CONSERV, V36, P245, DOI 10.1017/S0376892909990270; Tobin RC, 2010, 9 J COOK U FISH FISH; Triantafillos L, 2014, FRDC REPORT PROJECT; van Putten I, 2013, MAR POLICY, V37, P96, DOI 10.1016/j.marpol.2012.04.001; Wang JJ, 2009, RENEW SUST ENERG REV, V13, P2263, DOI 10.1016/j.rser.2009.06.021; Yang M, 2011, INT J ENV RES PUB HE, V8, P1368, DOI 10.3390/ijerph8051368	46	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148271	10.1371/journal.pone.0148271	http://dx.doi.org/10.1371/journal.pone.0148271			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26839949	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000369550200117
J	Barb, JJ; Oler, AJ; Kim, HS; Chalmers, N; Wallen, GR; Cashion, A; Munson, PJ; Ames, NJ				Barb, Jennifer J.; Oler, Andrew J.; Kim, Hyung-Suk; Chalmers, Natalia; Wallen, Gwenyth R.; Cashion, Ann; Munson, Peter J.; Ames, Nancy J.			Development of an Analysis Pipeline Characterizing Multiple Hypervariable Regions of 16S rRNA Using Mock Samples	PLOS ONE			English	Article							CLINICAL MICROBIOLOGY; DIVERSITY; SEQUENCES; IDENTIFICATION; PERFORMANCE; BACTERIA; PRIMERS	Objectives There is much speculation on which hypervariable region provides the highest bacterial specificity in 16S rRNA sequencing. The optimum solution to prevent bias and to obtain a comprehensive view of complex bacterial communities would be to sequence the entire 16S rRNA gene; however, this is not possible with second generation standard library design and short-read next-generation sequencing technology. Methods This paper examines a new process using seven hypervariable or V regions of the 16S rRNA (six amplicons: V2, V3, V4, V6-7, V8, and V9) processed simultaneously on the Ion Torrent Personal Genome Machine (Life Technologies, Grand Island, NY). Four mock samples were amplified using the 16S Ion Metagenomics Kit (TM) (Life Technologies) and their sequencing data is subjected to a novel analytical pipeline. Results Results are presented at family and genus level. The Kullback-Leibler divergence (D-KL), a measure of the departure of the computed from the nominal bacterial distribution in the mock samples, was used to infer which region performed best at the family and genus levels. Three different hypervariable regions, V2, V4, and V6-7, produced the lowest divergence compared to the known mock sample. The V9 region gave the highest (worst) average D-KL while the V4 gave the lowest (best) average D-KL. In addition to having a high D-KL, the V9 region in both the forward and reverse directions performed the worst finding only 17% and 53% of the known family level and 12% and 47% of the genus level bacteria, while results from the forward and reverse V4 region identified all 17 family level bacteria. Conclusions The results of our analysis have shown that our sequencing methods using 6 hypervariable regions of the 16S rRNA and subsequent analysis is valid. This method also allowed for the assessment of how well each of the variable regions might perform simultaneously. Our findings will provide the basis for future work intended to assess microbial abundance at different time points throughout a clinical protocol.	[Barb, Jennifer J.; Munson, Peter J.] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bldg 10, Bethesda, MD 20892 USA; [Oler, Andrew J.] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kim, Hyung-Suk; Cashion, Ann] NINR, NIH, Bethesda, MD 20892 USA; [Chalmers, Natalia] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA; [Wallen, Gwenyth R.; Ames, Nancy J.] NIH, Ctr Clin, Dept Nursing, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Barb, JJ (corresponding author), NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bldg 10, Bethesda, MD 20892 USA.	barbj@mail.nih.gov	Natalia I. Chalmers, MHSc/AAI-6870-2021	Barb, Jennifer/0000-0003-3022-0154	NIH; Clinical Center and NIH; National Institute of Nursing Research; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000277, ZIACT000266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [ZIANR000030, ZIANR000015] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Center and NIH; National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was supported by the Intramural Research Program of NIH, Clinical Center and NIH, National Institute of Nursing Research.	[Anonymous], 2014, BBMAP ALIGNER DNA RN; [Anonymous], 2014, 16 RRNA SEQ INT RES; [Anonymous], 2014, BEI RESOURCES; Birtel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125356; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Dassi E, 2014, J BIOTECHNOL, V190, P30, DOI 10.1016/j.jbiotec.2014.03.024; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ghyselinck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071360; Guo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076185; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; He Y, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-208; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Li J, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0316-1; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; McHardy IH, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-17; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Mosher JJ, 2014, J MICROBIOL METH, V104, P59, DOI 10.1016/j.mimet.2014.06.012; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pylro VS, 2014, J MICROBIOL METH, V107, P30, DOI 10.1016/j.mimet.2014.08.018; Pylro VS, 2014, MICROB ECOL, V67, P237, DOI 10.1007/s00248-013-0302-4; Quick J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0677-2; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Tanner A, 1994, Periodontol 2000, V5, P26, DOI 10.1111/j.1600-0757.1994.tb00017.x; Toma I, 2014, J CLIN MICROBIOL, V52, P3913, DOI 10.1128/JCM.01678-14; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x	46	73	74	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148047	10.1371/journal.pone.0148047	http://dx.doi.org/10.1371/journal.pone.0148047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829716	Green Submitted, gold, Green Published			2022-12-26	WOS:000369548200055
J	Fan, LL; Li, HJ; Niu, YW; Chen, QH				Fan, Linlin; Li, Hongji; Niu, Yongwu; Chen, Qihe			Characterization and Inducing Melanoma Cell Apoptosis Activity of Mannosylerythritol Lipids-A Produced from Pseudozyma aphidis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; GLYCOLIPID BIOSURFACTANTS; CANDIDA-ANTARCTICA; DIFFERENTIATION; DEATH; CALCIUM; YEAST; BETA; MITOCHONDRION	Mannosylerythritol lipids (MELs) are natural glycolipid biosurfactants which have potential applications in the fields of food, cosmetic and medicine. In this study, MELs were produced from vegetable oil by Pseudozyma aphidis. Their structural data through LC/MS, GC/MS and NMR analysis revealed that MEL-A with two acetyls was the major compound and the identified homologs of MEL-A contained a length of C8 to C14 fatty acid chains. This glycolipid exhibited a surface tension of 27.69 mN/m at a critical micelle concentration (CMC), self-assembling into particles in the water solution. It was observed to induce cell growth-inhibition and apoptosis of B16 melanoma cells in a dose-dependent manner, as well as cause cell cycle arrest at the S phase. Further quantitative RT-PCR analysis and western blotting revealed an increasing tendency of both mRNA and protein expressions of Caspase-12, CHOP, GRP78 and Caspase-3, and a down-regulation of protein Bcl-2. Combined with the up regulation of signaling IRE1 and ATF6, it can be speculated that MEL-A-induced B16 melanoma cell apoptosis was associated with the endoplasmic reticulum stress (ERS).	[Fan, Linlin; Li, Hongji; Niu, Yongwu; Chen, Qihe] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Qihe] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Chen, QH (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Chen, QH (corresponding author), Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310058, Zhejiang, Peoples R China.	chenqh@zju.edu.cn	Chen, QiHe/G-4425-2012	Chen, QiHe/0000-0003-3862-4356	Zhejiang Provincial Natural Science Foundation of China [LR13C200002];  [LY12C20009]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); 	The study was based upon work funded by Zhejiang Provincial Natural Science Foundation of China under Grant No. LR13C200002, and another foundation under Grant No. LY12C20009. The authors are very grateful for the support.	Antonsson B, 2001, CELL TISSUE RES, V306, P347, DOI 10.1007/s00441-001-0472-0; Arutchelvi JI, 2008, J IND MICROBIOL BIOT, V35, P1559, DOI 10.1007/s10295-008-0460-4; Buckley BJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1298, DOI 10.1152/ajpcell.1997.273.4.C1298; Dai K, 2009, CURR OPIN COLLOID IN, V14, P315, DOI [10.1016/j.cocis.2009.05.009, DOI 10.1016/J.COCIS.2009.05.009]; Dubey KV, 2012, BIORESOURCE TECHNOL, V126, P368, DOI 10.1016/j.biortech.2012.05.024; Fan LL, 2014, CARBOHYD RES, V392, P1, DOI 10.1016/j.carres.2014.04.013; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fouillet A, 2012, AUTOPHAGY, V8, P915, DOI 10.4161/auto.19716; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Imura T, 2006, CHEM-EUR J, V12, P2434, DOI 10.1002/chem.200501199; Imura T, 2007, LANGMUIR, V23, P1659, DOI 10.1021/la0620814; Isoda H, 1997, LIPIDS, V32, P263, DOI 10.1007/s11745-997-0033-0; Isoda H, 1997, CYTOTECHNOLOGY, V25, P191, DOI 10.1023/A:1007982909932; Kim HS, 1999, APPL MICROBIOL BIOT, V52, P713, DOI 10.1007/s002530051583; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kitamoto D, 1998, BIOTECHNOL LETT, V20, P813, DOI 10.1023/A:1005347022247; KITAMOTO D, 1990, AGR BIOL CHEM TOKYO, V54, P31, DOI 10.1080/00021369.1990.10869918; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Morita Y, 2011, BBA-GEN SUBJECTS, V1810, P1302, DOI 10.1016/j.bbagen.2011.07.002; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Onghena M, 2011, ANAL BIOANAL CHEM, V400, P1263, DOI 10.1007/s00216-011-4741-9; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Rau U, 2005, APPL MICROBIOL BIOT, V66, P551, DOI 10.1007/s00253-004-1672-9; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; Takahashi M, 2012, J OLEO SCI, V61, P457, DOI 10.5650/jos.61.457; Wakamatsu Y, 2001, EUR J BIOCHEM, V268, P374, DOI 10.1046/j.1432-1033.2001.01887.x; Wang HMD, 2014, J AGR FOOD CHEM, V62, P1057, DOI 10.1021/jf403730z; Yu MD, 2015, CARBOHYD RES, V407, P63, DOI 10.1016/j.carres.2014.12.012; Zhao XX, 1999, CANCER RES, V59, P482; Zhao XX, 2001, J BIOL CHEM, V276, P39903, DOI 10.1074/jbc.M010281200	36	27	28	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148198	10.1371/journal.pone.0148198	http://dx.doi.org/10.1371/journal.pone.0148198			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828792	gold, Green Published			2022-12-26	WOS:000369548200081
J	Gao, ZZ; Li, LA; Meng, YG				Gao, Zhenzhen; Li, Li'an; Meng, Yuanguang			A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma	PLOS ONE			English	Article							TUMOR MORCELLATION; SURGICAL-PROCEDURE; LEIOMYOSARCOMA; PROGNOSIS; OUTCOMES; SURGERY; MYOMAS	Laparoscopic myomectomy is a minimally invasive, conservative surgical approach commonly used for the treatment of uterine fibroids. However, there is a lack of effective means to distinguish the nature of uterine tumors prior to surgery. The impact of fibroid morcellation during laparoscopic surgery on the dissemination of cancerous uterine fibroids and long-term survival of patients has gained increasing attention. A retrospective cohort study was conducted to analyze the impact of different surgical approaches on recurrence-free survival (RFS) and overall survival (OS) in patients with a postoperative pathological diagnosis of uterine sarcoma at a single medical center. Patients who underwent the first surgery for uterine fibroids (confined to the uterus) and had a postoperative pathological diagnosis of uterine sarcoma were selected in the Chinese PLA General Hospital from January 2005 to January 2014. Based on the use of fibroid morcellation, the subjects were divided into fibroid morcellation (FM) and total hysterectomy (TH, non-morcellation) groups. Follow-up outcomes, including RFS and OS times, were observed. In total, 59 patients were included, with 30 cases in the FM group and 29 cases in the TH group. There were no significant differences in RFS and OS time between the two groups (RFS: P = 0.16, OS: P = 0.09). Multivariate correlation analysis showed that the impact of a higher grade level on RFS and OS was nearly 2-fold the impact of a lower grade level (RFS: P = 0.04, odds ratio (OR) = 1.97; OS: P = 0.03, OR = 2.29). Intraoperative morcellation, postoperative adjuvant therapy, age, tumor size, FIGO stage, and surgical approach were not risk factors affecting RFS and OS. Fibroid morcellation during laparoscopic surgery (including laparoscopic, transvaginal and transabdominal approaches) had no significant impact on RFS and OS time in patients. However, the 5-year RFS and OS rates were both lower in the FM group than in the TH group. Grade level was a significant risk factor for the prognosis of patients with uterine sarcoma.	[Gao, Zhenzhen] Gen Hosp Armed Police Forces, Dept Obstet & Gynecol, Beijing, Peoples R China; [Li, Li'an; Meng, Yuanguang] Chinese Peoples Liberat Army Gen Hosp, Dept Obstet & Gynecol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital	Li, LA; Meng, YG (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Obstet & Gynecol, Beijing 100853, Peoples R China.	llapla@163.com; meng6512@vip.sina.com						[Anonymous], NY TIMES; Anupama R, 2011, J MINIM INVAS GYN, V18, P386, DOI 10.1016/j.jmig.2011.01.014; Bogani G, 2015, GYNECOL ONCOL, V137, P167, DOI 10.1016/j.ygyno.2014.11.011; Bojahr B, 2006, J MINIM INVAS GYN, V13, P183, DOI 10.1016/j.jmig.2006.01.010; Einarsson JI, 2014, J MINIM INVAS GYN, V21, P951, DOI 10.1016/j.jmig.2014.04.010; Fukunishi H, 2007, INT J GYNECOL CANCER, V17, P724, DOI 10.1111/j.1525-1438.2007.00818.x; George S, 2014, CANCER-AM CANCER SOC, V120, P3154, DOI 10.1002/cncr.28844; HARLOW BL, 1986, J NATL CANCER I, V76, P399; Kido A, 2003, RADIOGRAPHICS, V23, P1423, DOI 10.1148/rg.236035033; Larrain D, 2010, J MINIM INVAS GYN, V17, P719, DOI 10.1016/j.jmig.2010.05.013; LEIBSOHN S, 1990, AM J OBSTET GYNECOL, V162, P968, DOI 10.1016/0002-9378(90)91298-Q; Leung F, 2009, GYNECOL OBSTET FERTI, V37, P109, DOI 10.1016/j.gyobfe.2008.09.022; Morice P, 2003, EUR J GYNAECOL ONCOL, V24, P237; OLAH KS, 1992, BRIT J OBSTET GYNAEC, V99, P590, DOI 10.1111/j.1471-0528.1992.tb13827.x; Park JY, 2011, ANN SURG ONCOL, V18, P3453, DOI 10.1245/s10434-011-1751-y; Park JY, 2011, GYNECOL ONCOL, V122, P255, DOI 10.1016/j.ygyno.2011.04.021; PARKER WH, 1994, OBSTET GYNECOL, V83, P414; Perri T, 2009, INT J GYNECOL CANCER, V19, P257, DOI 10.1111/IGC.0b013e31819a1f8f; Siedhoff MT, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.03.006; van Dongen H, 2008, J MINIM INVAS GYN, V15, P466, DOI 10.1016/j.jmig.2008.02.002; Yanazume S, 2012, J OBSTET GYNAECOL RE, V38, P875, DOI 10.1111/j.1447-0756.2011.01784.x	21	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148050	10.1371/journal.pone.0148050	http://dx.doi.org/10.1371/journal.pone.0148050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828206	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200056
J	Liu, YW; Xie, SJ; Yu, JJ				Liu, Yuwei; Xie, Shaojun; Yu, Jingjuan			Genome-Wide Analysis of the Lysine Biosynthesis Pathway Network during Maize Seed Development	PLOS ONE			English	Article							DIHYDRODIPICOLINATE SYNTHASE; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; ASPARTATE-KINASE; RNA-SEQ; PROTEIN; COEXPRESSION; REVEALS; FRAMEWORK; TOOL	Lysine is one of the most limiting essential amino acids for humans and livestock. The nutritional value of maize (Zea mays L.) is reduced by its poor lysine content. To better understand the lysine biosynthesis pathway in maize seed, we conducted a genome-wide analysis of the genes involved in lysine biosynthesis. We identified lysine biosynthesis pathway genes (LBPGs) and investigated whether a diaminopimelate pathway variant exists in maize. We analyzed two genes encoding the key enzyme dihydrodipicolinate synthase, and determined that they contribute differently to lysine synthesis during maize seed development. A coexpression network of LBPGs was constructed using RNA-sequencing data from 21 developmental stages of B73 maize seed. We found a large set of genes encoding ribosomal proteins, elongation factors and zein proteins that were coexpressed with LBPGs. The coexpressed genes were enriched in cellular metabolism terms and protein related terms. A phylogenetic analysis of the LBPGs from different plant species revealed different relationships. Additionally, six transcription factor (TF) families containing 13 TFs were identified as the Hub TFs of the LBPGs modules. Several expression quantitative trait loci of LBPGs were also identified. Our results should help to elucidate the lysine biosynthesis pathway network in maize seed.	[Liu, Yuwei; Xie, Shaojun; Yu, Jingjuan] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China	China Agricultural University	Yu, JJ (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	yujj@cau.edu.cn	Xie, Shaojun/H-3162-2019	Xie, Shaojun/0000-0002-6719-9814	National Transgenic Major Program of China [2014ZX08003-002, 2013ZX08003-002, 2011ZX08003-002]	National Transgenic Major Program of China	This work was supported by the National Transgenic Major Program of China (grant no. 2014ZX08003-002, 2013ZX08003-002 and 2011ZX08003-002).; We thank Jian Chen (China Agricultural University, Prof. Jinsheng Lai's laboratory) for providing eight stages B73 maize seeds. We thank Fei Yi (China Agricultural University, Prof. Jingjuan Yu's laboratory) for useful discussions. This work was supported by the National Transgenic Major Program of China (grant no. 2014ZX08003-002, 2013ZX08003-002 and2011ZX08003-002).	Agarwal P, 2011, BIOESSAYS, V33, P189, DOI 10.1002/bies.201000107; Angelovici R, 2009, PLANT PHYSIOL, V151, P2058, DOI 10.1104/pp.109.145631; ARRUDA P, 1983, PHYTOCHEMISTRY, V22, P2687, DOI 10.1016/S0031-9422(00)97673-8; Atkinson SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038318; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; BRIGHT SWJ, 1983, CRC CR REV PLANT SCI, V1, P49, DOI 10.1080/07352688309382171; BrinchPedersen H, 1996, PLANT MOL BIOL, V32, P611, DOI 10.1007/BF00020202; Broun P, 2004, CURR OPIN PLANT BIOL, V7, P202, DOI 10.1016/j.pbi.2004.01.013; Chen J, 2014, PLANT PHYSL; Clark TJ, 2015, PLANT PHYSIOL, V168, P1512, DOI 10.1104/pp.15.00364; Craciun A, 2000, FEBS LETT, V487, P234, DOI 10.1016/S0014-5793(00)02303-6; DASILVA WJ, 1979, PHYTOCHEMISTRY, V18, P1803, DOI 10.1016/0031-9422(79)83056-3; Davidson RM, 2011, PLANT GENOME-US, V4, P191, DOI 10.3835/plantgenome2011.05.0015; DiLeo MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026683; FALCO SC, 1995, BIO-TECHNOL, V13, P577, DOI 10.1038/nbt0695-577; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; GALILI G, 1995, PLANT CELL, V7, P899, DOI 10.2307/3870045; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Griffin MDW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040318; HABBEN JE, 1995, P NATL ACAD SCI USA, V92, P8640, DOI 10.1073/pnas.92.19.8640; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Huang R, 2006, GENOMICS, V87, P315, DOI 10.1016/j.ygeno.2005.11.011; Huang SS, 2005, PLANT BIOTECHNOL J, V3, P555, DOI 10.1111/j.1467-7652.2005.00146.x; Hudson AO, 2006, PLANT PHYSIOL, V140, P292, DOI 10.1104/pp.105.072629; Jones-Held S, 2012, FUNCT PLANT BIOL, V39, P1058, DOI 10.1071/FP12169; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KARCHI H, 1994, P NATL ACAD SCI USA, V91, P2577, DOI 10.1073/pnas.91.7.2577; Kroj T, 2003, DEVELOPMENT, V130, P6065, DOI 10.1242/dev.00814; KWON T, 1995, J PLANT PHYSIOL, V146, P615, DOI 10.1016/S0176-1617(11)81923-1; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Ledwidge R, 1999, BIOCHEMISTRY-US, V38, P3019, DOI 10.1021/bi982574a; Li CB, 2015, PLANT CELL, V27, P532, DOI 10.1105/tpc.114.134858; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li ZS, 1998, PLANT CELL, V10, P383, DOI 10.1105/tpc.10.3.383; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Mena M, 1998, PLANT J, V16, P53, DOI 10.1046/j.1365-313x.1998.00275.x; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; PERL A, 1992, PLANT MOL BIOL, V19, P815, DOI 10.1007/BF00027077; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Prasanna BM, 2001, CURR SCI INDIA, V81, P1308; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Scapin G, 1998, ADV ENZYMOL RAMB, V72, P279; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song JT, 2004, PLANT CELL, V16, P353, DOI 10.1105/tpc.019372; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team RC, 2005, R LANG ENV STAT COMP; Varisi VA, 2007, PLANT SCI, V173, P458, DOI 10.1016/j.plantsci.2007.07.007; Vauterin M, 1999, PLANT MOL BIOL, V39, P695, DOI 10.1023/A:1006132428623; Velasco AM, 2002, J MOL EVOL, V55, P445, DOI 10.1007/s00239-002-2340-2; Verdier J, 2008, PLANT CELL PHYSIOL, V49, P1263, DOI 10.1093/pcp/pcn116; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Walley JW, 2013, P NATL ACAD SCI USA, V110, pE4808, DOI 10.1073/pnas.1319113110; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WEINBERGER S, 1970, J BACTERIOL, V101, P323, DOI 10.1128/JB.101.1.323-324.1970; WENKO LK, 1985, PLANT MOL BIOL, V4, P197, DOI 10.1007/BF02418236; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yohannes T, 1999, CURR PLANT SCI BIOT, V36, P617; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	82	4	5	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148287	10.1371/journal.pone.0148287	http://dx.doi.org/10.1371/journal.pone.0148287			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829553	Green Published, gold			2022-12-26	WOS:000369548200092
J	Vuong, J; Collard, JM; Whaley, MJ; Bassira, I; Seidou, I; Diarra, S; Ouedraogo, RT; Kambire, D; Taylor, TH; Sacchi, C; Mayer, LW; Wang, X				Vuong, Jeni; Collard, Jean-Marc; Whaley, Melissa J.; Bassira, Issaka; Seidou, Issaka; Diarra, Seydou; Ouedraogo, Rasmata T.; Kambire, Dinanibe; Taylor, Thomas H., Jr.; Sacchi, Claudio; Mayer, Leonard W.; Wang, Xin			Development of Real-Time PCR Methods for the Detection of Bacterial Meningitis Pathogens without DNA Extraction	PLOS ONE			English	Article							NUCLEIC-ACID AMPLIFICATION; CHILDREN YOUNGER; IDENTIFICATION; HAEMOPHILUS; BURDEN; ASSAYS; TESTS; BLOOD	Neisseria meningitidis (Nm), Haemophilus influenzae (Hi), and Streptococcus pneumoniae (Sp) are the lead causes of bacterial meningitis. Detection of these pathogens from clinical specimens using traditional real-time PCR (rt-PCR) requires DNA extraction to remove the PCR inhibitors prior to testing, which is time consuming and labor intensive. In this study, five species-specific (Nm-sodC and -ctrA, Hi-hpd# 1 and -hpd#3 and Sp-lytA) and six serogroup- specific rt-PCR tests (A, B, C, W, X, Y) targeting Nm capsular genes were evaluated in the two direct rt-PCR methods using PerfeCTa and 5x Omni that do not require DNA extraction. The sensitivity and specify of the two direct rt-PCR methods were compared to TaqMan traditional rt-PCR, the current standard rt-PCR method for the detection of meningitis pathogens. The LLD for all 11 rt-PCR tests ranged from 6,227 to 272,229 CFU/ml for TaqMan, 1,824-135,982 for 5x Omni, and 168-6,836 CFU/ml for PerfeCTa. The diagnostic sensitivity using TaqMan ranged from 89.2%-99.6%, except for NmB-csb, which was 69.7%. For 5x Omni, the sensitivity varied from 67.1% to 99.8%, with three tests below 90%. The sensitivity of these tests using PerfeCTa varied from 89.4% to 99.8%. The specificity ranges of the 11 tests were 98.0-99.9%, 97.5-99.9%, and 92.9-99.9% for TaqMan, 5x Omni, and PerfeCTa, respectively. PerfeCTa direct rt-PCR demonstrated similar or better sensitivity compared to 5x Omni direct rt-PCR or TaqMan traditional rt-PCR. Since the direct rt-PCR method does not require DNA extraction, it reduces the time and cost for processing CSF specimens, increases testing throughput, decreases the risk of cross-contamination, and conserves precious CSF. The direct rt-PCR method will be beneficial to laboratories with high testing volume.	[Vuong, Jeni; Whaley, Melissa J.; Taylor, Thomas H., Jr.; Mayer, Leonard W.; Wang, Xin] Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA USA; [Collard, Jean-Marc] Sci Inst Publ Hlth, Brussels, Belgium; [Collard, Jean-Marc; Bassira, Issaka; Seidou, Issaka] Ctr Rech Med & Sanit, Niamey, Niger; [Diarra, Seydou] Inst Natl Rech Sante Publ, Bamako, Mali; [Ouedraogo, Rasmata T.; Kambire, Dinanibe] Ctr Hosp Univ Pediat Charles De Gaulle, Ouagadougou, Burkina Faso; [Sacchi, Claudio] Adolfo Lutz Inst, Sao Paulo, Brazil	Centers for Disease Control & Prevention - USA; Instituto Adolfo Lutz	Wang, X (corresponding author), Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA USA.	gqe8@cdc.gov	Collard, Jean-Marc/Q-2342-2019	Collard, Jean-Marc/0000-0002-1490-3978				AKANE A, 1994, J FORENSIC SCI, V39, P362; Baughman AL, 2008, CLIN VACCINE IMMUNOL, V15, P106, DOI 10.1128/CVI.00223-07; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Hadgu A, 2005, EPIDEMIOLOGY, V16, P604, DOI 10.1097/01.ede.0000173042.07579.17; Kermekchiev MB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1055; LASCOLEA LJ, 1984, J CLIN MICROBIOL, V19, P187, DOI 10.1128/JCM.19.2.187-190.1984; Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004; Norskov-Lauritsen N, 2014, CLIN MICROBIOL REV, V27, P214, DOI 10.1128/CMR.00103-13; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Thomas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019361; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; Wang X, 2011, INT J MED MICROBIOL, V301, P303, DOI 10.1016/j.ijmm.2010.11.004; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	15	53	54	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147765	10.1371/journal.pone.0147765	http://dx.doi.org/10.1371/journal.pone.0147765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829233	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200032
J	AbdulAzeez, S; Borgio, JF				AbdulAzeez, Sayed; Borgio, J. Francis			In-Silico Computing of the Most Deleterious nsSNPs in HBA1 Gene	PLOS ONE			English	Article							HUMAN HEMOGLOBIN-VARIANTS; THALASSEMIA MUTATIONS; STABILIZING RESIDUES; SWISS-MODEL; PROTEIN; ALPHA; DATABASE; PREDICTION; SERVER; ENVIRONMENT	Background alpha-Thalassemia (alpha-thal) is a genetic disorder caused by the substitution of single amino acid or large deletions in the HBA1 and/or HBA2 genes. Method Using modern bioinformatics tools as a systematic in-silico approach to predict the deleterious SNPs in the HBA1 gene and its significant pathogenic impact on the functions and structure of HBA1 protein was predicted. Results and Discussion A total of 389 SNPs in HBA1 were retrieved from dbSNP database, which includes: 201 non-coding synonymous (nsSNPs), 43 human active SNPs, 16 intronic SNPs, 11 mRNA 30' UTR SNPs, 9 coding synonymous SNPs, 9 5' UTR SNPs and other types. Structural homology-based method (PolyPhen) and sequence homology-based tool (SIFT), SNPs&Go, PROVEAN and PANTHER revealed that 2.4% of the nsSNPs are pathogenic. Conclusions A total of 5 nsSNPs (G60V, K17M, K17T, L92F and W15R) were predicted to be responsible for the structural and functional modifications of HBA1 protein. It is evident from the deep comprehensive in-silico analysis that, two nsSNPs such as G60Vand W15R in HBA1 are highly deleterious. These "2 pathogenic nsSNPs" can be considered for wet-lab confirmatory analysis.	[AbdulAzeez, Sayed; Borgio, J. Francis] Univ Dammam, IRMC, Dammam, Saudi Arabia	Imam Abdulrahman Bin Faisal University	Borgio, JF (corresponding author), Univ Dammam, IRMC, Dammam, Saudi Arabia.	borgiomicro@gmail.com	Sayed, Abdulazeez/I-6770-2019; Sayed, Abdul Azeez/A-3234-2015; Borgio, J Francis/P-5586-2014; Azeez, Syed Abdul/AAE-3876-2020	Sayed, Abdulazeez/0000-0002-9763-9446; Sayed, Abdul Azeez/0000-0002-9763-9446; Borgio, J Francis/0000-0001-7199-1540; 				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akhtar MS, 2013, HEMOGLOBIN, V37, P65, DOI 10.3109/03630269.2012.753510; Al-Nafie AN, 2015, BLOOD CELL MOL DIS, V55, P27, DOI 10.1016/j.bcmd.2015.03.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borgio JF, 2015, SAUDI MED J, V36, P1271, DOI 10.15537/smj.2015.11.12704; Borgio JF, 2014, BLOOD CELL MOL DIS, V53, P199, DOI 10.1016/j.bcmd.2014.07.001; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; Chen JJ, 2009, CURR PROTEOMICS, V6, P228, DOI 10.2174/157016409789973734; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Doss CGP, 2012, APPL TRANSL GENOM, V1, P37, DOI 10.1016/j.atg.2012.06.002; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Gromiha MM, 2004, PROTEINS, V55, P316, DOI 10.1002/prot.20052; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han JH, 2006, STRUCTURE, V14, P935, DOI 10.1016/j.str.2006.01.016; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Hecht M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S1; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Khafizov K, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2794-y; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Knudsen B, 2001, P NATL ACAD SCI USA, V98, P14512, DOI 10.1073/pnas.251526398; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Magyar C, 2005, NUCLEIC ACIDS RES, V33, pW303, DOI 10.1093/nar/gki409; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Patrinos GP, 2004, NUCLEIC ACIDS RES, V32, pD537, DOI 10.1093/nar/gkh006; Piel FB, 2014, NEW ENGL J MED, V371, P1908, DOI 10.1056/NEJMra1404415; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tiwari Abhishek, 2007, In Silico Biology, V7, P651; Varfolomeev SD, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1099, DOI 10.1023/A:1020907122341; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366	40	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147702	10.1371/journal.pone.0147702	http://dx.doi.org/10.1371/journal.pone.0147702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824843	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600048
J	Kurkowiak, M; Zietkiewicz, E; Greber, A; Voelkel, K; Wojda, A; Pogorzelski, A; Witt, M				Kurkowiak, Malgorzata; Zietkiewicz, Ewa; Greber, Agnieszka; Voelkel, Katarzyna; Wojda, Alina; Pogorzelski, Andrzej; Witt, Michal			ZMYND10 - Mutation Analysis in Slavic Patients with Primary Ciliary Dyskinesia	PLOS ONE			English	Article							NITRIC-OXIDE MEASUREMENTS; OUTER DYNEIN ARMS; CHILDREN; NASAL; PREDICTION; LRRC6; INNER; AGE	Primary ciliary dyskinesia (PCD) is a rare recessive disease with a prevalence of 1/10,000; its symptoms are caused by a kinetic dysfunction of motile cilia in the respiratory epithelium, flagella in spermatozoids, and primary cilia in the embryonic node. PCD is genetically heterogeneous: genotyping the already known PCD-related genes explains the genetic basis in 60-65% of the cases, depending on the population. While identification of new genes involved in PCD pathogenesis remains crucial, the search for new, population-specific mutations causative for PCD is equally important. The Slavs remain far less characterized in this respect compared to West European populations, which significantly limits diagnostic capability. The main goal of this study was to characterize the profile of causative genetic defects in one of the PCD-causing genes, ZMYND10, in the cohort of PCD patients of Slavic origin. The study was carried out using biological material from 172 unrelated PCD individuals of Polish origin, with no causative mutation found in nine major PCD genes. While none of the previously described mutations was found using the HRM-based screening, a novel frameshift mutation (c.367delC) in ZMYND10, unique for Slavic PCD population, was found in homozygous state in two unrelated PCD patients. Immunofluorescence analysis confirmed the absence of outer and inner dynein arms from the ciliary axoneme, consistent with the already published ZMYND10-mutated phenotype; cDNA analysis revealed the lack of ZMYND10 mRNA, indicating nonsense-mediated decay of the truncated transcript.	[Kurkowiak, Malgorzata; Zietkiewicz, Ewa; Greber, Agnieszka; Voelkel, Katarzyna; Wojda, Alina; Witt, Michal] Polish Acad Sci, Inst Human Genet, Dept Mol & Clin Genet, PL-60479 Poznan, Poland; [Kurkowiak, Malgorzata; Witt, Michal] Int Inst Mol & Cell Biol, Warsaw, Poland; [Pogorzelski, Andrzej] Inst TB & Lung Dis, Dept Pneumol & Cyst Fibrosis, Rabka Zdroj, Poland; [Kurkowiak, Malgorzata] Med Univ Warsaw, Dept Immunol, Ctr Biostruct, Warsaw, Poland	Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Medical University of Warsaw	Kurkowiak, M; Zietkiewicz, E (corresponding author), Polish Acad Sci, Inst Human Genet, Dept Mol & Clin Genet, PL-60479 Poznan, Poland.; Kurkowiak, M (corresponding author), Int Inst Mol & Cell Biol, Warsaw, Poland.; Kurkowiak, M (corresponding author), Med Univ Warsaw, Dept Immunol, Ctr Biostruct, Warsaw, Poland.	mszczepaniak86@gmail.com; zietkiee@man.poznan.pl	Zietkiewicz, Ewa/ABP-3539-2022	Witt, Michal/0000-0003-1729-4159; Zietkiewicz, Ewa/0000-0003-2437-5088; Kurkowiak, Malgorzata/0000-0002-4968-7136	Foundation for Polish Science; National Research Center [2011/01/B/NZ4/04840, 2014/13/B/NZ2/03858]; European Union Seventh Framework Programme (FP7) funds (BESTCILIA) [305404]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); National Research Center(National Research Centre (NRC)); European Union Seventh Framework Programme (FP7) funds (BESTCILIA)	The study was supported by grants from the Foundation for Polish Science to MK (International PhD Projects Programme), from the National Research Center to EZ (2011/01/B/NZ4/04840 and 2014/13/B/NZ2/03858), as well as from the European Union Seventh Framework Programme (FP7/2007-2013) funds to MW (BESTCILIA - grant agreement no. 305404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Boon M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-11; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059436; Karadag B, 1999, EUR RESPIR J, V13, P1402, DOI 10.1034/j.1399-3003.1999.13f28.x; Kharitonov S, 1997, EUR RESPIR J, V10, P1683, DOI 10.1183/09031936.97.10071683; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Kuehni CE, 2010, EUR RESPIR J, V36, P1248, DOI 10.1183/09031936.00001010; Kurkowiak M, 2015, J MED GENET, V52, P1, DOI 10.1136/jmedgenet-2014-102755; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Moore DJ, 2013, AM J HUM GENET, V93, P346, DOI 10.1016/j.ajhg.2013.07.009; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Shoemark A, 2009, RESP MED, V103, P700, DOI 10.1016/j.rmed.2008.12.004; Stillwell PC, 2011, PEDIAT ALLER IMM PUL, V24, P191, DOI 10.1089/ped.2011.0099; Struben VMD, 2005, EUR RESPIR J, V26, P453, DOI 10.1183/09031936.05.00015205; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wodehouse T, 2003, EUR RESPIR J, V21, P43, DOI 10.1183/09031936.03.00305503; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007; Zhao Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03032	20	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148067	10.1371/journal.pone.0148067	http://dx.doi.org/10.1371/journal.pone.0148067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824761	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600095
J	Pervaiz, T; Jia, HF; Haider, MS; Cheng, Z; Cui, MJ; Wang, MQ; Cui, LW; Wang, X; Fang, JG				Pervaiz, Tariq; Jia Haifeng; Haider, Muhammad Salman; Cheng, Zhang; Cui, Mengjie; Wang, Mengqi; Cui, Liwen; Wang, Xicheng; Fang, Jinggui			Transcriptomic Analysis of Grapevine (cv. Summer Black) Leaf, Using the Illumina Platform	PLOS ONE			English	Article							GENE-EXPRESSION; TERPENOID METABOLISM; BERRY DEVELOPMENT; PLANT; BIOSYNTHESIS; SYNTHASE; PATHWAY; PROTEIN; GROWTH; LIGHT	Proceeding to illumina sequencing, determining RNA integrity numbers for poly RNA were separated from each of the four developmental stages of cv. Summer Black leaves by using Illumina HiSeq (TM) 2000. The sums of 272,941,656 reads were generated from vitis vinifera leaf at four different developmental stages, with more than 27 billion nucleotides of the sequence data. At each growth stage, RNA samples were indexed through unique nucleic acid identifiers and sequenced. KEGG annotation results depicted that the highest number of transcripts in 2,963 (2Avs4A) followed by 1Avs4A (2,920), and 3Avs4A (2,294) out of 15,614 (71%) transcripts were recorded. In comparison, a total of 1,532 transcripts were annotated in GOs, including Cellular component, with the highest number in "Cell part" 251 out of 353 transcripts (71.1%), followed by intracellular organelle 163 out of 353 transcripts (46.2%), while in molecular function and metabolic process 375 out of 525 (71.4%) transcripts, multicellular organism process 40 out of 525 (7.6%) transcripts in biological process were most common in 1Avs2A. While in case of 1Avs3A, cell part 476 out of 662 transcripts (71.9%), and membrane-bounded organelle 263 out of 662 transcripts (39.7%) were recorded in Cellular component. In the grapevine transcriptome, during the initial stages of leaf development 1Avs2A showed single transcript was down-regulated and none of them were up-regulated. While in comparison of 1A to 3A showed one up-regulated (photosystem II reaction center protein C) and one down regulated (conserved gene of unknown function) transcripts, during the hormone regulating pathway namely SAUR-like auxin-responsive protein family having 2 up-regulated and 7 down-regulated transcripts, phytochrome-associated protein showed 1 up-regulated and 9 down-regulated transcripts, whereas genes associated with the Leucine-rich repeat protein kinase family protein showed 7 up-regulated and 1 down-regulated transcript, meanwhile Auxin Resistant 2 has single up-regulated transcript in second developmental stage, although 3 were down-regulated at lateral growth stages (3A and 4A). In the present study, 489 secondary metabolic pathways related genes were identified during leaf growth, which mainly includes alkaloid (40), anthocyanins (21), Diterpenoid (144), Monoterpenoid (90) and Flavonoids (93). Quantitative real-time PCR was applied to validate 10 differentially expressed transcripts patterns from flower, leaf and fruit metabolic pathways at different growth stages.	[Pervaiz, Tariq; Jia Haifeng; Haider, Muhammad Salman; Cheng, Zhang; Cui, Mengjie; Wang, Mengqi; Cui, Liwen; Fang, Jinggui] Nanjing Agr Univ, Coll Hort, Key Lab Genet & Fruit Dev, Nanjing 210095, Jiangsu, Peoples R China; [Wang, Xicheng] Jiangsu Acad Agr Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences	Fang, JG (corresponding author), Nanjing Agr Univ, Coll Hort, Key Lab Genet & Fruit Dev, Nanjing 210095, Jiangsu, Peoples R China.	fanggg@njau.edu.cn	Pervaiz, Tariq/AFK-5705-2022; Salman, Haider Muhammad/Y-6129-2018; pervaiz, tariq/GMW-6618-2022; Pervaiz, Tariq/AAG-4135-2022	Salman, Haider Muhammad/0000-0002-4674-4254; pervaiz, tariq/0000-0001-9834-9355; Fang, Jinggui/0000-0003-1975-2715	Important National Science and technology Specific Projects [2012FY110100-3]; Jiangsu Agricultural science and technology innovation fund [CX(14) 2097]; Natural Science Foundation of China, NSFC [31361140358]	Important National Science and technology Specific Projects; Jiangsu Agricultural science and technology innovation fund; Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the Important National Science and technology Specific Projects (No. 2012FY110100-3) and Jiangsu Agricultural science and technology innovation fund (CX(14) 2097), Natural Science Foundation of China, NSFC (No. 31361140358).	Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; Boucher RC, 1999, J PHYSIOL-LONDON, V516, P631, DOI 10.1111/j.1469-7793.1999.0631u.x; Brenner WG, 2005, PLANT J, V44, P314, DOI 10.1111/j.1365-313X.2005.02530.x; BROWN RH, 1975, CROP SCI, V15, P681, DOI 10.2135/cropsci1975.0011183X001500050020x; Connan S, 2011, AQUAT TOXICOL, V104, P1, DOI 10.1016/j.aquatox.2011.03.016; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; De Vos D, 2012, J EXP BOT, V63, P3325, DOI 10.1093/jxb/ers037; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; FERREIRA RB, 1987, PLANT PHYSIOL, V83, P869, DOI 10.1104/pp.83.4.869; Figueiredo A, 2008, J EXP BOT, V59, P3371, DOI 10.1093/jxb/ern187; Fortes AM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-149; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Guenot B, 2012, PLANT PHYSIOL, V159, P1501, DOI 10.1104/pp.112.200402; Kalve S, 2014, FRONT PLANT SCI, P5; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Krishnamurthy A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25761; LANDRY LG, 1995, PLANT PHYSIOL, V109, P1159, DOI 10.1104/pp.109.4.1159; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucker J, 2004, PHYTOCHEMISTRY, V65, P2649, DOI 10.1016/j.phytochem.2004.08.017; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Melidou M, 2005, FREE RADICAL BIO MED, V39, P1591, DOI 10.1016/j.freeradbiomed.2005.08.009; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murakami A, 1997, PLANT CELL PHYSIOL, V38, P188, DOI 10.1093/oxfordjournals.pcp.a029151; Nagegowda DA, 2010, FEBS LETT, V584, P2965, DOI 10.1016/j.febslet.2010.05.045; Ohara K, 2003, J EXP BOT, V54, P2635, DOI 10.1093/jxb/erg300; Ojeda H, 1999, VITIS, V38, P145; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Prasad MNV, 2001, PLANT SCI, V161, P881, DOI 10.1016/S0168-9452(01)00478-2; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Ritter A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-116; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; TANAKA Y, 1989, PLANT PHYSIOL, V90, P1403, DOI 10.1104/pp.90.4.1403; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Upadhyay S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-746; VIRO M, 1980, PLANTA, V150, P41, DOI 10.1007/BF00385613; Vivier MA, 2002, TRENDS BIOTECHNOL, V20, P472, DOI 10.1016/S0167-7799(02)02058-9; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; WANG JL, 1992, PLANT CELL, V4, P173, DOI 10.1105/tpc.4.2.173; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-841; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716	53	17	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147369	10.1371/journal.pone.0147369	http://dx.doi.org/10.1371/journal.pone.0147369			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824474	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528600028
J	Elenbaas, JS; Maitra, D; Liu, Y; Lentz, SI; Nelson, B; Hoenerhoff, MJ; Shavit, JA; Omary, MB				Elenbaas, Jared S.; Maitra, Dhiman; Liu, Yang; Lentz, Stephen I.; Nelson, Bradley; Hoenerhoff, Mark J.; Shavit, Jordan A.; Omary, M. Bishr			A precursor-inducible zebrafish model of acute protoporphyria with hepatic protein aggregation and multiorganelle stress	FASEB JOURNAL			English	Article						autophagy; endoplasmic reticulum stress; protoporphyrin IX; unfolded protein response	ENDOPLASMIC-RETICULUM STRESS; ONE-ELECTRON REDUCTION; ERYTHROPOIETIC PROTOPORPHYRIA; LIVER-DISEASE; IRON CHELATION; BODY FORMATION; ER STRESS; HEME; FERROCHELATASE; PORPHYRIA	Protoporphyria is a metabolic disease that causes excess production of protoporphyrin IX (PP-IX), the final biosynthetic precursor to heme. Hepatic PP-IX accumulationmay leadtoend-stage liver disease. Wetested the hypothesis that systemic administration of porphyrin precursors to zebrafish larvae results in protoporphyrin accumulation and a reproducible nongenetic porphyria model. Retro-orbital infusion of PP-IX or the iron chelator deferoxamine mesylate (DFO), with the first committed heme precursor a-aminolevulinic acid (ALA), generates high levels of PP-IX in zebrafish larvae. Exogenously infused or endogenously produced PP-IX accumulates preferentially in the liver of zebrafish larvae and peaks 1 to 3 d after infusion. Similar to patients with protoporphyria, PP-IX is excreted through the biliary system. Porphyrin accumulation in zebrafish liver causes multiorganelle protein aggregation as determined by mass spectrometry and immunoblotting. Endoplasmic reticulum stress and induction of autophagy were noted in zebrafish larvae and corroborated in 2 mouse models of protoporphyria. Furthermore, electron microscopy of zebrafish livers from larvae administered ALA + DFO showed hepatocyte auto-phagosomes, nuclear membrane ruffling, and porphyrin-containing vacuoles with endoplasmic reticulum distortion. In conclusion, systemic administration of the heme pre-cursors PP-IX or ALA+ DFO into zebrafish larvae provides a new model of acute protoporphyria with consequent hepatocyte protein aggregation and proteotoxic multiorganelle alterations and stress.	[Elenbaas, Jared S.; Maitra, Dhiman; Omary, M. Bishr] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Liu, Yang; Shavit, Jordan A.] Univ Michigan, Dept Pediat & Communicable Dis, Div Pediat Hematol & Oncol, Ann Arbor, MI 48109 USA; [Lentz, Stephen I.; Nelson, Bradley; Omary, M. Bishr] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hoenerhoff, Mark J.] Univ Michigan, Unit Lab Anim Med, In Vivo Anim Core, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Omary, MB (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, 7744 Med Sci Bldg 2,1137 Catherine St, Ann Arbor, MI 48109 USA.	mbishr@med.umich.edu		Liu, Yang/0000-0002-0413-5637; Omary, Bishr/0000-0002-8624-2347; Elenbaas, Jared/0000-0002-9612-7764; Lentz, Stephen/0000-0003-1686-7998; , dhiman/0000-0002-8775-2963	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-DK52951]; Department of Veterans Affairs; NIH National Heart, Lung, and Blood Institute [R01-HL124232]; NIH NIDDK Institutional [DK034933, DK020572]; University of Michigan Protein Folding Diseases Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R01DK052951, P30DK020572, P60DK020572] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs(US Department of Veterans Affairs); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH NIDDK Institutional; University of Michigan Protein Folding Diseases Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant R01-DK52951 and the Department of Veterans Affairs (M.B.O.); NIH National Heart, Lung, and Blood Institute Grant R01-HL124232 (J.A.S.); and NIH NIDDK Institutional Grants DK034933 and DK020572 to the University of Michigan. The authors thank S. E. Whitesall and L. G. D'Alecy for assistance with the HPLC analysis, the University of Michigan Unit for Laboratory Animal Medicine In Vivo Animal Core for their assistance with obtaining histological sections of zebrafish larvae, and V. Basrur for carrying out the MS analysis with support from the University of Michigan Protein Folding Diseases Initiative. The authors declare no conflicts of interest.	Afonso S, 1999, FREE RADICAL RES, V31, P161, DOI 10.1080/10715769900300711; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Balwani M, 2012, BLOOD, V120, P4496, DOI 10.1182/blood-2012-05-423186; Bonkovsky HL, 2013, COMPR PHYSIOL, V3, P365, DOI 10.1002/cphy.c120006; BOTTOMLEY SS, 1975, J LAB CLIN MED, V86, P126; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Childs S, 2000, CURR BIOL, V10, P1001, DOI 10.1016/S0960-9822(00)00653-9; Cinaroglu A, 2011, HEPATOLOGY, V54, P495, DOI 10.1002/hep.24396; Curnow A, 2007, J ENVIRON PATHOL TOX, V26, P89; Davies R, 2005, AM J PATHOL, V166, P1041, DOI 10.1016/S0002-9440(10)62325-5; Dooley K. A., 2008, EXP HEMATOL, V36, P1132; Elder GH, 2009, CELL MOL BIOL, V55, P118, DOI 10.1170/T861; Goldsmith JR, 2013, DIS MODEL MECH, V6, P146, DOI 10.1242/dmm.009852; Gross U, 2000, J INHERIT METAB DIS, V23, P641, DOI 10.1023/A:1005645624262; Gross U, 1998, PHOTODERMATOL PHOTO, V14, P52, DOI 10.1111/j.1600-0781.1998.tb00011.x; GSCHNAIT F, 1975, J INVEST DERMATOL, V65, P290, DOI 10.1111/1523-1747.ep12598357; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kaufman CK, 2009, NAT PROTOC, V4, P1422, DOI 10.1038/nprot.2009.144; Komatsu Hirokazu, 2000, Medical Electron Microscopy, V33, P32, DOI 10.1007/s007950000005; KONINGSBERGER JC, 1995, J HEPATOL, V22, P57, DOI 10.1016/0168-8278(95)80260-6; Kwan R, 2012, FASEB J, V26, P2318, DOI 10.1096/fj.11-198580; Lecha M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-19; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu Y, 2014, BLOOD, V124, P142, DOI 10.1182/blood-2014-03-561027; MACDONALD DM, 1981, BRIT J DERMATOL, V104, P7, DOI 10.1111/j.1365-2133.1981.tb01705.x; MAGNUS IA, 1969, J INVEST DERMATOL, V53, P400, DOI 10.1038/jid.1969.167; Maitra D, 2015, J BIOL CHEM, V290, P23711, DOI 10.1074/jbc.M114.636001; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Meerman L, 2000, SCAND J GASTROENTERO, V35, P79; MOREHOUSE KM, 1990, ARCH BIOCHEM BIOPHYS, V283, P306, DOI 10.1016/0003-9861(90)90647-H; MOREHOUSE KM, 1987, ARCH BIOCHEM BIOPHYS, V257, P276, DOI 10.1016/0003-9861(87)90567-4; NAKAHASHI Y, 1992, P NATL ACAD SCI USA, V89, P281, DOI 10.1073/pnas.89.1.281; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; PLEWINSKA M, 1991, AM J HUM GENET, V49, P167; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rubinstein AL, 2003, CURR OPIN DRUG DI DE, V6, P218; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SARKANY RPE, 1994, LANCET, V343, P1394, DOI 10.1016/S0140-6736(94)92525-9; SASSA S, 1983, J CLIN INVEST, V71, P625, DOI 10.1172/JCI110809; Sassa S, 1996, INT J HEMATOL, V63, P167; SHEMIN D, 1970, NATURWISSENSCHAFTEN, V57, P185, DOI 10.1007/BF00592970; Singla A, 2013, J CELL SCI, V126, P3105, DOI 10.1242/jcs.123026; Singla A, 2012, HEPATOLOGY, V56, P322, DOI 10.1002/hep.25664; TAKETANI S, 1990, J BIOL CHEM, V265, P19377; THOMPSON RP, 1973, GUT, V14, P934, DOI 10.1136/gut.14.12.934; TODD DJ, 1991, AM J DIS CHILD, V145, P971, DOI 10.1001/archpedi.1991.02160090021011; TSUNOO C, 1987, J HEPATOL, V5, P85, DOI 10.1016/S0168-8278(87)80065-X; Vacaru AM, 2014, DIS MODEL MECH, V7, P823, DOI 10.1242/dmm.014472; Valdes PA, 2010, PHOTOCHEM PHOTOBIOL, V86, P471, DOI 10.1111/j.1751-1097.2009.00664.x; VANSTEVENINCK J, 1988, BIOCHEM J, V250, P197, DOI 10.1042/bj2500197; Vo AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074682; Wang H, 1998, NAT GENET, V20, P239, DOI 10.1038/3041; Whatley SD, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016121; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	63	14	15	3	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1798	1810		10.1096/fj.201500111R	http://dx.doi.org/10.1096/fj.201500111R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26839379	Green Submitted, Green Published			2022-12-26	WOS:000374879400011
J	Kapetanovic, R; Bokil, NJ; Achard, MES; Ong, CLY; Peters, KM; Stocks, CJ; Phan, MD; Monteleone, M; Schroder, K; Irvine, KM; Saunders, BM; Walker, MJ; Stacey, KJ; McEwan, AG; Schembri, MA; Sweet, MJ				Kapetanovic, Ronan; Bokil, Nilesh J.; Achard, Maud E. S.; Ong, Cheryl-lynn Y.; Peters, Kate M.; Stocks, Claudia J.; Minh-Duy Phan; Monteleone, Mercedes; Schroder, Kate; Irvine, Katharine M.; Saunders, Bernadette M.; Walker, Mark J.; Stacey, Katryn J.; McEwan, Alastair G.; Schembri, Mark A.; Sweet, Matthew J.			Salmonella employs multiple mechanisms to subvert the TLR-inducible zinc-mediated antimicrobial response of human macrophages	FASEB JOURNAL			English	Article						bacterial pathogens; innate immunity; metal ions; trafficking pathways	ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; GENE-EXPRESSION; MURINE MODEL; TYPHIMURIUM; COPPER; METAL; SUPPLEMENTATION; HOMEOSTASIS; DEFICIENCY	We aimed to characterize antimicrobial zinc trafficking within macrophages and to determine whether the professional intramacrophage pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) subverts this pathway. Using both Escherichia coli and S. Typhimurium, we show that TLR signaling promotes the accumulation of vesicular zinc within primary human macrophages. Vesicular zinc is delivered to E. coli to promote microbial clearance, whereas S. Typhimurium evades this response via Salmonella pathogenicity island (SPI)-1. Even in the absence of SPI-1 and the zinc exporter ZntA, S. Typhimurium resists the innate immune zinc stress response, implying the existence of additional host subversion mechanisms. We also demonstrate the combinatorial antimicrobial effects of zinc and copper, a pathway that S. Typhimurium again evades. Our use of complementary tools and approaches, including confocal microscopy, direct assessment of intramacrophage bacterial zinc stress responses, specific E. coli and S. Typhimurium mutants, and inductively coupled plasma mass spectroscopy, has enabled carefully controlled characterization of this novel innate immune antimicrobial pathway. In summary, our study provides new insights at the cellular level into the well-documented effects of zinc in promoting host defense against infectious disease, as well as the complex host subversion strategies employed by S. Typhimurium to combat this pathway.-Kapetanovic, R., Bokil, N. J., Achard, M. E. S., Ong, C.-L. Y., Peters, K. M., Stocks, C. J., Phan, M.-D., Monteleone, M., Schroder, K., Irvine, K. M., Saunders, B. M., Walker, M. J., Stacey, K. J., McEwan, A. G., Schembri, M. A., Sweet, M. J. Salmonella employs multiple mechanisms to subvert the TLR-inducible zinc-mediated antimicrobial response of human macrophages. www.fasebj.org	[Kapetanovic, Ronan; Bokil, Nilesh J.; Stocks, Claudia J.; Monteleone, Mercedes; Schroder, Kate; Sweet, Matthew J.] Univ Queensland, IMB, Brisbane, Qld, Australia; [Kapetanovic, Ronan; Bokil, Nilesh J.; Stocks, Claudia J.; Monteleone, Mercedes; Schroder, Kate; Irvine, Katharine M.; Sweet, Matthew J.] Univ Queensland, IMB Ctr Inflammat & Dis Res, Brisbane, Qld, Australia; [Kapetanovic, Ronan; Bokil, Nilesh J.; Achard, Maud E. S.; Ong, Cheryl-lynn Y.; Peters, Kate M.; Stocks, Claudia J.; Minh-Duy Phan; Monteleone, Mercedes; Schroder, Kate; Walker, Mark J.; Stacey, Katryn J.; McEwan, Alastair G.; Schembri, Mark A.; Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Achard, Maud E. S.; Ong, Cheryl-lynn Y.; Peters, Kate M.; Minh-Duy Phan; Walker, Mark J.; Stacey, Katryn J.; McEwan, Alastair G.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Irvine, Katharine M.] Univ Queensland, Sch Med, Woolloongabba, Qld, Australia; [Saunders, Bernadette M.] Univ Technol Sydney, Sch Life Sci, Sydney, NSW 2007, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Technology Sydney	Sweet, MJ (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	m.sweet@imb.uq.edu.au	Kapetanovic, Ronan/GRO-1748-2022; kapetanovic, ronan/G-8322-2012; Monteleone, Maria/J-1813-2014; Schembri, Mark A/C-7262-2009; Irvine, Katharine M/A-5559-2011; Phan, Minh-Duy/I-9147-2012; Schroder, Kate/C-6132-2008; Ong, Cheryl-lynn Y/C-5238-2014; Stocks, Claudia J/S-8733-2019; Sweet, Matthew J/F-2229-2011; Stocks, Claudia J/C-8020-2017; Bokil, Nilesh/C-8568-2012	Kapetanovic, Ronan/0000-0002-2908-1014; kapetanovic, ronan/0000-0002-2908-1014; Monteleone, Maria/0000-0003-0777-3965; Schembri, Mark A/0000-0003-4863-9260; Irvine, Katharine M/0000-0002-6716-1605; Phan, Minh-Duy/0000-0002-3426-1044; Schroder, Kate/0000-0001-9261-3805; Ong, Cheryl-lynn Y/0000-0001-6036-6889; Stocks, Claudia J/0000-0001-6120-2851; Sweet, Matthew J/0000-0002-0406-8139; Stocks, Claudia J/0000-0001-6120-2851; McEwan, Alastair/0000-0002-2419-1003; Stacey, Katryn/0000-0002-3992-7802; Bokil, Nilesh/0000-0003-3202-9249; Saunders, Bernadette/0000-0003-0540-4445; Walker, Mark/0000-0001-7423-2769	National Health and Medical Research Council of Australia (NHMRC) [ID631531, APP1065391, ID631386]; NHMRC [APP1107914]; Australian Research Council (ARC) [FT100100662]; ARC Discovery Early Career Researcher Award Fellowship [DE1310470]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); ARC Discovery Early Career Researcher Award Fellowship(Australian Research Council)	This work was supported by project grants (ID631531, APP1065391) from the National Health and Medical Research Council of Australia (NHMRC). M.J.S. is supported by an NHMRC Senior Research Fellowship (APP1107914). M.J.W. is supported by an NHMRC Principal Research Fellowship (ID631386). M.A.S. is supported by an Australian Research Council (ARC) Future Fellowship (FT100100662). R.K. is supported by an ARC Discovery Early Career Researcher Award Fellowship (DE1310470). Microscopy was performed at the Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology, University of Queensland, which was established with the support of the Australian Cancer Research Foundation. The authors thank Dr. Wan-Ping Hu (School of Earth Sciences, University of Queensland) for conducting the ICP-MS analysis, Prof. Paul Bernhardt (School of Chemistry and Molecular Biosciences, University of Queensland) for the synthesis of CS1, Dr. Nick Hamilton for his help with ImageJ software, Claire Pitts for her assistance with some experiments, Dr. Brian Chan (Centenary Institute, NSW, Australia) for critical review of the manuscript, and the Australian Red Cross Blood Service for providing buffy coats for the isolation of human monocytes.	Achard MES, 2012, BIOCHEM J, V444, P51, DOI 10.1042/BJ20112180; Allsopp LP, 2012, INFECT IMMUN, V80, P321, DOI 10.1128/IAI.05322-11; Bao SY, 2010, AM J PHYSIOL-LUNG C, V298, pL744, DOI 10.1152/ajplung.00368.2009; Behnsen J, 2015, TRENDS IMMUNOL, V36, P112, DOI 10.1016/j.it.2014.12.003; Bhandari N, 2008, PEDIATRICS, V121, pE1279, DOI 10.1542/peds.2007-1939; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bokil NJ, 2011, IMMUNOBIOLOGY, V216, P1164, DOI 10.1016/j.imbio.2011.05.011; Botella H, 2011, CELL HOST MICROBE, V10, P248, DOI 10.1016/j.chom.2011.08.006; Brawn LC, 2007, CELL HOST MICROBE, V1, P63, DOI 10.1016/j.chom.2007.02.001; Brieger A, 2013, J IMMUNOL, V191, P1808, DOI 10.4049/jimmunol.1301261; Cerasi M, 2014, METALLOMICS, V6, P845, DOI 10.1039/c3mt00352c; COYLE P, 1994, BIOCHEM J, V303, P781, DOI 10.1042/bj3030781; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diaz-Ochoa VE, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00002; Dieye Y, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-3; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Eijkelkamp BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089427; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gee KR, 2002, J AM CHEM SOC, V124, P776, DOI 10.1021/ja011774y; Giacomodonato MN, 2007, MICROBIOL-SGM, V153, P1221, DOI 10.1099/mic.0.2006/002758-0; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Knoell DL, 2009, CRIT CARE MED, V37, P1380, DOI 10.1097/CCM.0b013e31819cefe4; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Liu MJ, 2013, CELL REP, V3, P386, DOI 10.1016/j.celrep.2013.01.009; Lukacik M, 2008, PEDIATRICS, V121, P326, DOI 10.1542/peds.2007-0921; Lundberg U, 1999, J BACTERIOL, V181, P3433, DOI 10.1128/JB.181.11.3433-3437.1999; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mayer LS, 2014, METALLOMICS, V6, P1288, DOI 10.1039/c4mt00051j; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Miller EW, 2006, NAT PROTOC, V1, P824, DOI 10.1038/nprot.2006.140; Phan MD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003834; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Nowak JE, 2012, PEDIATR CRIT CARE ME, V13, pE323, DOI 10.1097/PCC.0b013e31824fbd90; Ong CLY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10799; Ong CLY, 2014, J INFECT DIS, V209, P1500, DOI 10.1093/infdis/jiu053; Perez JM, 2006, BIOL RES, V39, P661, DOI 10.4067/S0716-97602006000500009; Prasad AS, 2008, MOL MED, V14, P353, DOI 10.2119/2008-00033.Prasad; Prasad AS, 2012, J TRACE ELEM MED BIO, V26, P66, DOI 10.1016/j.jtemb.2012.04.004; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Samanovic MI, 2012, CELL HOST MICROBE, V11, P106, DOI 10.1016/j.chom.2012.01.009; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; Stafford S. L., 2013, BIOSCI REP, V33; Sweet M. J., 2010, REGULATION INNATE IM, P1; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Valavi E, 2011, INDIAN J PEDIATR, V78, P1079, DOI 10.1007/s12098-011-0458-1; van der Heijden J, 2012, FUTURE MICROBIOL, V7, P685, DOI [10.2217/FMB.12.49, 10.2217/fmb.12.49]; Vignesh KS, 2013, IMMUNITY, V39, P697, DOI 10.1016/j.immuni.2013.09.006; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; Xu FF, 2012, APPL ENVIRON MICROB, V78, P3614, DOI 10.1128/AEM.07368-11; Yamamoto K, 2005, J BACTERIOL, V187, P6333, DOI 10.1128/JB.187.18.6333-6340.2005; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	64	50	50	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1901	1912		10.1096/fj.201500061	http://dx.doi.org/10.1096/fj.201500061			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26839376				2022-12-26	WOS:000374879400019
J	Lenartowicz, E; Kesy, J; Ruszkowska, A; Soszynska-Jozwiak, M; Michalak, P; Moss, WN; Turner, DH; Kierzek, R; Kierzek, E				Lenartowicz, Elzbieta; Kesy, Julita; Ruszkowska, Agnieszka; Soszynska-Jozwiak, Marta; Michalak, Paula; Moss, Walter N.; Turner, Douglas H.; Kierzek, Ryszard; Kierzek, Elzbieta			Self-Folding of Naked Segment 8 Genomic RNA of Influenza A Virus	PLOS ONE			English	Article							SELECTIVE 2'-HYDROXYL ACYLATION; SECONDARY STRUCTURE; VIRAL-RNA; THERMODYNAMIC PROPERTIES; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; INTERNAL LOOP; NMR STRUCTURE; NUCLEOPROTEIN; BINDING	Influenza A is a negative sense RNA virus that kills hundreds of thousands of humans each year. Base pairing in RNA is very favorable, but possibilities for RNA secondary structure of the influenza genomic RNA have not been investigated. This work presents the first experimentally-derived exploration of potential secondary structure in an influenza A naked (protein-free) genomic segment. Favorable folding regions are revealed by in vitro chemical structure mapping, thermodynamics, bioinformatics, and binding to isoenergetic microarrays of an entire natural sequence of the 875 nt segment 8 vRNA and of a smaller fragment. Segment 8 has thermodynamically stable and evolutionarily conserved RNA structure and encodes essential viral proteins NEP and NS1. This suggests that vRNA self-folding may generate helixes and loops that are important at one or more stages of the influenza life cycle.	[Lenartowicz, Elzbieta; Kesy, Julita; Ruszkowska, Agnieszka; Soszynska-Jozwiak, Marta; Michalak, Paula; Kierzek, Ryszard; Kierzek, Elzbieta] Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland; [Moss, Walter N.; Turner, Douglas H.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA	Polish Academy of Sciences; University of Rochester	Kierzek, E (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	elzbieta.kierzek@ibch.poznan.pl	Moss, Walter/H-8096-2019; Lenartowicz, Elzbieta/AAG-3134-2021; Piasecka, Julita/AAL-6552-2020; Lenartowicz, Elzbieta/G-3757-2016	Moss, Walter/0000-0001-6419-5570; Piasecka, Julita/0000-0003-1261-3878; Lenartowicz, Elzbieta/0000-0002-3596-4470; Kierzek, Elzbieta/0000-0002-5563-003X; Kierzek, Ryszard/0000-0002-7644-0016	National Science Center [N N301 788 440, UMO-2013/08/M/NZ1/01062, UMO-2011/03/B/NZ1/00576, UMO-2011/03/B/ST5/01098, UMO-2013/08/A/ST5/00295]; National Institutes of Health [R03TW008739, GM22939]; NIH [R03TW008739, GM22939]; FOGARTY INTERNATIONAL CENTER [R03TW008739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022939] Funding Source: NIH RePORTER	National Science Center(National Science Centre, Poland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Center grants: N N301 788 440 and UMO-2013/08/M/NZ1/01062 to EK, UMO-2011/03/B/NZ1/00576, UMO-2011/03/B/ST5/01098 and UMO-2013/08/A/ST5/00295 to RK and by National Institutes of Health grants: R03TW008739 to EK and DHT and GM22939 to DHT.; This work was supported by National Science Center grants: N N301 788 440 and UMO-2013/08/M/NZ1/01062 to EK, UMO-2011/03/B/NZ1/00576, UMO-2011/03/B/ST5/01098 and UMO-2013/08/A/ST5/00295 to RK and by NIH grants: R03TW008739 to EK and DHT and GM22939 to DHT. We thank Prof. Baek Kim for the gift of plasmid containing the sequence of segment 8 and Prof. Luis Martinez-Sobrido for information about the strain used. DHT thanks Prof. Susan Schroeder for insight into interpretation of data.	Afanassiev V, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e66; Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; Bae SH, 2001, P NATL ACAD SCI USA, V98, P10602, DOI 10.1073/pnas.191268798; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; CROTHERS DM, 1974, J MOL BIOL, V87, P63, DOI 10.1016/0022-2836(74)90560-9; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Essere B, 2013, P NATL ACAD SCI USA, V110, pE3840, DOI 10.1073/pnas.1308649110; Flick R, 1999, J GEN VIROL, V80, P2565, DOI 10.1099/0022-1317-80-10-2565; Fournier E, 2012, VACCINE, V30, P7359, DOI 10.1016/j.vaccine.2012.09.079; Fournier E, 2012, NUCLEIC ACIDS RES, V40, P2197, DOI 10.1093/nar/gkr985; Fratczak A, 2011, BIOCHEMISTRY-US, V50, P7647, DOI 10.1021/bi200463p; Fratczak A, 2009, BIOCHEMISTRY-US, V48, P514, DOI 10.1021/bi8021069; Fujii K, 2005, J VIROL, V79, P3766, DOI 10.1128/JVI.79.6.3766-3774.2005; Gavazzi C, 2013, P NATL ACAD SCI USA, V110, P16604, DOI 10.1073/pnas.1314419110; Gavazzi C, 2013, NUCLEIC ACIDS RES, V41, P1241, DOI 10.1093/nar/gks1181; Ge Q, 2006, ANTIMICROB AGENTS CH, V50, P3724, DOI 10.1128/AAC.00644-06; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69; Gultyaev AP, 2014, RNA BIOL, V11, P942, DOI 10.4161/rna.29730; Gultyaev AP, 2010, INT REV IMMUNOL, V29, P533, DOI 10.3109/08830185.2010.507828; Gultyaev AP, 2010, RNA BIOL, V7, P125, DOI 10.4161/rna.7.2.11287; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2004, BIOINFORMATICS, V20, P1495, DOI 10.1093/bioinformatics/bth108; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jiang T, 2014, BIOCHEMISTRY-US, V53, P5236, DOI 10.1021/bi500611j; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kierzek E, 2006, BIOCHEMISTRY-US, V45, P581, DOI 10.1021/bi051409+; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4461, DOI 10.1093/nar/gkg632; Kierzek E, 2008, NUCLEIC ACIDS RES, V36, P1770, DOI 10.1093/nar/gkm1085; Kierzek E, 2009, BIOCHEMISTRY-US, V48, P11344, DOI 10.1021/bi901264v; Kierzek E, 2009, J MOL BIOL, V390, P428, DOI 10.1016/j.jmb.2009.04.048; Kierzek R, 2015, NUCLEIC ACIDS RES, V43, P1, DOI 10.1093/nar/gku1303; Kladwang W, 2014, BIOCHEMISTRY-US, V53, P3063, DOI 10.1021/bi5003426; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; Lerman YV, 2011, RNA, V17, P1664, DOI 10.1261/rna.2641911; Liang RT, 2010, BIOCHEMISTRY-US, V49, P8155, DOI 10.1021/bi100286n; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P3738, DOI 10.1093/nar/gkn266; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Moss WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038323; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; Nguyen-Van-Tam JS, 2003, VACCINE, V21, P1762, DOI 10.1016/S0264-410X(03)00069-0; Pasternak A, 2008, BIOCHEMISTRY-US, V47, P1249, DOI 10.1021/bi701758z; Pasternak A, 2007, NUCLEIC ACIDS RES, V35, P4055, DOI 10.1093/nar/gkm421; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Poland GA, 2007, VACCINE, V25, P3057, DOI 10.1016/j.vaccine.2007.01.050; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Priore SF, 2015, BIOCHEMISTRY-US, V54, P3413, DOI 10.1021/bi501564d; Priore SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070615; Priore SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035989; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schroeder SJ, 2014, BIOCHEMISTRY-US, V53, P6728, DOI 10.1021/bi501051k; Schroeder SJ, 2011, BIOPHYS J, V101, P167, DOI 10.1016/j.bpj.2011.05.053; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Shapshak P, 2011, MOL DIAGN THER, V15, P63, DOI 10.2165/11590660-000000000-00000; Soszynska-Jozwiak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141132; Suspene R, 2011, J VIROL, V85, P2458, DOI 10.1128/JVI.02138-10; Suzuki Y, 2013, INFECT GENET EVOL, V13, P175, DOI 10.1016/j.meegid.2012.10.007; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; YAMANAKA K, 1990, J BIOL CHEM, V265, P11151; Zhang T, 2011, INT IMMUNOPHARMACOL, V11, P2057, DOI 10.1016/j.intimp.2011.08.019; Zheng WJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003624; Znosko BM, 2002, BIOCHEMISTRY-US, V41, P14969, DOI 10.1021/bi020326f; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	82	23	23	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148281	10.1371/journal.pone.0148281	http://dx.doi.org/10.1371/journal.pone.0148281			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848969	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000065
J	Phanthanawiboon, S; Limkittikul, K; Sakai, Y; Takakura, N; Saijo, M; Kurosu, T				Phanthanawiboon, Supranee; Limkittikul, Kriengsak; Sakai, Yusuke; Takakura, Nobuyuki; Saijo, Masayuki; Kurosu, Takeshi			Acute Systemic Infection with Dengue Virus Leads to Vascular Leakage and Death through Tumor Necrosis Factor-alpha and Tie2/Angiopoietin Signaling in Mice Lacking Type I and II Interferon Receptors	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; AG129 MICE; PLASMA LEAKAGE; ANGIOPOIETIN-1; MODEL; DISEASE; IMMUNOPATHOGENESIS; PATHOGENESIS; EXPRESSION; SURVIVAL	Severe dengue is caused by host responses to viral infection, but the pathogenesis remains unknown. This is, in part, due to the lack of suitable animal models. Here, we report a nonmouse-adapted low-passage DENV-3 clinical isolate, DV3P12/08, derived from recently infected patients. DV3P12/08 caused a lethal systemic infection in type I and II IFN receptor KO mice (IFN-alpha/beta/gamma R KO mice), which have the C57/BL6 background. Infection with DV3P12/08 induced a cytokine storm, resulting in severe vascular leakage (mainly in the liver, kidney and intestine) and organ damage, leading to extensive hemorrhage and rapid death. DV3P12/08 infection triggered the release of large amounts of TNF-alpha, IL-6, and MCP-1. Treatment with a neutralizing anti-TNF-alpha antibody (Ab) extended survival and reduced liver damage without affecting virus production. Anti-IL-6 neutralizing Ab partly prolonged mouse survival. The anti-TNF-alpha Ab suppressed IL-6, MCP-1, and IFN-gamma levels, suggesting that the severe response to infection was triggered by TNF-alpha. High levels of TNF-alpha mRNA were expressed in the liver and kidneys, but not in the small intestine, of infected mice. Conversely, high levels of IL-6 mRNA were expressed in the intestine. Importantly, treatment with Angiopoietin-1, which is known to stabilize blood vessels, prolonged the survival of DV3P12/08-infected mice. Taken together, the results suggest that an increased level of TNF-alpha together with concomitant upregulation of Tie2/Angiopoietin signaling have critical roles in severe dengue infection.	[Phanthanawiboon, Supranee; Sakai, Yusuke; Takakura, Nobuyuki; Kurosu, Takeshi] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan; [Limkittikul, Kriengsak] Mahidol Univ, Dept Trop Pediat, Fac Trop Med, Bangkok 10700, Thailand; [Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Shinjyuku Ku, Tokyo, Japan; [Phanthanawiboon, Supranee] Khon Kaen Univ, Fac Med, Dept Microbiol, Res & Diagnost Ctr Emerging Infect Dis, Khon Kaen, Thailand; [Sakai, Yusuke] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pathol, Yamaguchi, Yamaguchi, Japan; [Kurosu, Takeshi] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan	Osaka University; Mahidol University; National Institute of Infectious Diseases (NIID); Khon Kaen University; Yamaguchi University; National Institute of Infectious Diseases (NIID)	Kurosu, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan.	kurosu@niid.go.jp	Saijo, Masayuki/L-2697-2019	Saijo, Masayuki/0000-0001-5458-7298	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21790444, 15K14885]; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by: 1. A grant-in-aid (21790444 and 15K14885) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan for supporting reagents, preparation of the manuscript. 2. A program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) (http://www.crnid.riken.jp/jgrid/) launched by a project commissioned by the MEXT for supporting reagents, preparation of the manuscript.	Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; David S, 2011, CYTOKINE, V55, P251, DOI 10.1016/j.cyto.2011.04.005; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Fuchs J, 2014, VACCINE, V32, P6537, DOI 10.1016/j.vaccine.2014.08.087; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Huang YQ, 2000, BLOOD, V95, P1993, DOI 10.1182/blood.V95.6.1993; Kurane I, 2007, COMP IMMUNOL MICROB, V30, P329, DOI 10.1016/j.cimid.2007.05.010; Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946; Michels M, 2012, AM J TROP MED HYG, V87, P943, DOI 10.4269/ajtmh.2012.12-0020; Milam KE, 2015, TISSUE BARRIERS, V3, DOI DOI 10.4161/21688362.2014.957508; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031; Overbergh L, 2003, J Biomol Tech, V14, P33; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Sancakdar E, 2015, PEDIATR INFECT DIS J, V34, pE200, DOI 10.1097/INF.0000000000000706; Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Setthapramote C, 2012, BIOCHEM BIOPH RES CO, V423, P867, DOI 10.1016/j.bbrc.2012.06.057; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003; Srichaikul T, 2000, BEST PRACT RES CL HA, V13, P261, DOI 10.1053/beha.2000.0073; Stein DA, 2008, J ANTIMICROB CHEMOTH, V62, P555, DOI 10.1093/jac/dkn221; Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; van de Weg CAM, 2014, J CLIN VIROL, V60, P328, DOI 10.1016/j.jcv.2014.05.001; Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008; Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E	35	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148564	10.1371/journal.pone.0148564	http://dx.doi.org/10.1371/journal.pone.0148564			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844767	Green Published, Green Submitted, gold			2022-12-26	WOS:000369552800070
J	Robertson, D; Zanartu, M; Cook, D				Robertson, Daniel; Zanartu, Matias; Cook, Douglas			Comprehensive, Population-Based Sensitivity Analysis of a Two-Mass Vocal Fold Model	PLOS ONE			English	Article							AIR-FLOW; CHAOTIC VIBRATIONS; NONLINEAR DYNAMICS; VOICE; BIFURCATIONS; PARAMETERS; PHONATION; SPEAKERS; TRACT	Previous vocal fold modeling studies have generally focused on generating detailed data regarding a narrow subset of possible model configurations. These studies can be interpreted to be the investigation of a single subject under one or more vocal conditions. In this study, a broad population-based sensitivity analysis is employed to examine the behavior of a virtual population of subjects and to identify trends between virtual individuals as opposed to investigating a single subject or model instance. Four different sensitivity analysis techniques were used in accomplishing this task. Influential relationships between model input parameters and model outputs were identified, and an exploration of the model's parameter space was conducted. Results indicate that the behavior of the selected two-mass model is largely dominated by complex interactions, and that few input-output pairs have a consistent effect on the model. Results from the analysis can be used to increase the efficiency of optimization routines of reduced-order models used to investigate voice abnormalities. Results also demonstrate the types of challenges and difficulties to be expected when applying sensitivity analyses to more complex vocal fold models. Such challenges are discussed and recommendations are made for future studies.	[Robertson, Daniel; Cook, Douglas] New York Univ Abu Dhabi, Div Engn, Abu Dhabi, U Arab Emirates; [Zanartu, Matias] Univ Tecn Federico Santa Maria, Dept Elect Engn, Valparaiso, Chile	Universidad Tecnica Federico Santa Maria	Cook, D (corresponding author), New York Univ Abu Dhabi, Div Engn, Abu Dhabi, U Arab Emirates.	douglascook@nyu.edu	Zañartu, Matías/I-3133-2012; Robertson, Daniel J/F-1864-2018; Cook, Douglas/AAN-2311-2021; Cook, Douglas/B-3318-2017; Zañartu, Matías/N-1338-2019	Zañartu, Matías/0000-0001-5581-4392; Robertson, Daniel J/0000-0003-1089-0249; Cook, Douglas/0000-0002-1731-1978; Zañartu, Matías/0000-0001-5581-4392				Anderson-Cook C.M., 2016, RESPONSE SURFACE MET; Avanzini F, 2006, ACTA ACUST UNITED AC, V92, P731; Baken RJ, 2000, CLIN MEASUREMENT SPE; Berry DA, 1996, J VOICE, V10, P129, DOI 10.1016/S0892-1997(96)80039-7; Birkholz P., 2011, 1 INT WORKSHOP PERFO; Birkholz P, 2011, INTERSPEECH; Birkholz P, 2011, IEEE T AUDIO SPEECH, V19, P1422, DOI 10.1109/TASL.2010.2091632; Chan K., 2000, SENSITIVITY ANAL; CHILDERS DG, 1991, J ACOUST SOC AM, V90, P2394, DOI 10.1121/1.402044; Cook D, 2009, THESIS PURDUE U; Cook D, 2014, J BIOMECH, V47, P1241, DOI 10.1016/j.jbiomech.2014.01.040; Cook DD, 2009, J ACOUST SOC AM, V126, P2002, DOI 10.1121/1.3183592; COTTER SC, 1979, BIOMETRIKA, V66, P317; Czitrom V, 1999, AM STAT, V53, P126, DOI 10.2307/2685731; de Vries MP, 2002, J ACOUST SOC AM, V111, P1847, DOI 10.1121/1.1323716; Dejonckere PH, 2009, FOLIA PHONIATR LOGO, V61, P171, DOI 10.1159/000219952; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; DYKSTRA O, 1971, TECHNOMETRICS, V13, P682; Erath BD, 2013, SPEECH COMMUNICATION; Erath BD, 2011, J ACOUST SOC AM, V130, P389, DOI 10.1121/1.3586785; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; HERZEL H, 1995, CHAOS, V5, P30, DOI 10.1063/1.166078; HILLMAN RE, 1989, J SPEECH HEAR RES, V32, P373, DOI 10.1044/jshr.3202.373; HOLMBERG EB, 1988, J ACOUST SOC AM, V84, P511, DOI 10.1121/1.396829; Horacek J, 2005, J FLUID STRUCT, V20, P853, DOI 10.1016/j.jfluidstructs.2005.05.003; ISHIZAKA K, 1972, AT&T TECH J, V51, P1233, DOI 10.1002/j.1538-7305.1972.tb02651.x; Jiang JJ, 2003, J ACOUST SOC AM, V114, P2198, DOI 10.1121/1.1610462; Jiang JJ, 2001, J ACOUST SOC AM, V110, P2120, DOI 10.1121/1.1395596; Kalos M. H., 2008, MONTE CARLO METHODS; KIEFER J, 1959, J ROY STAT SOC B, V21, P272; Lohscheller J, 2007, MED IMAGE ANAL, V11, P400, DOI 10.1016/j.media.2007.04.005; Lous NJC, 1998, ACUSTICA, V84, P1135; Lucero JC, 2005, J ACOUST SOC AM, V117, P1362, DOI 10.1121/1.1853235; Mehta DD, 2011, J ACOUST SOC AM, V130, P3999, DOI 10.1121/1.3658441; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Osheroff DD, 2004, ORAL SPEECH PURDUE U; PELORSON X, 1994, J ACOUST SOC AM, V96, P3416, DOI 10.1121/1.411449; Perkell J, 1997, SPEECH COMMUN, V22, P227, DOI 10.1016/S0167-6393(97)00026-5; PERKELL JS, 1994, J ACOUST SOC AM, V96, P695, DOI 10.1121/1.410307; Pickup BA, 2011, J ACOUST SOC AM, V129, P2121, DOI 10.1121/1.3557046; Schwarz R, 2008, J ACOUST SOC AM, V123, P2717, DOI 10.1121/1.2902167; Sciamarella D, 2004, ACTA ACUST UNITED AC, V90, P746; Sommer DE, 2012, J ACOUST SOC AM, V132, pEL271, DOI 10.1121/1.4734013; STEINECKE I, 1995, J ACOUST SOC AM, V97, P1874, DOI 10.1121/1.412061; Stevens K.N., 2000, ACOUSTIC PHONETICS, V30; STORY BH, 1995, J ACOUST SOC AM, V97, P1249, DOI 10.1121/1.412234; Su MC, 2002, J LARYNGOL OTOL, V116, P447, DOI 10.1258/0022215021911257; Tao C, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061922; Titze I. R., 2000, PRINCIPLES VOICE PRO; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; TITZE IR, 1992, J ACOUST SOC AM, V91, P2936, DOI 10.1121/1.402929; Titze IR, 2002, J ACOUST SOC AM, V112, P1064, DOI 10.1121/1.1496080; Tokuda IT, 2010, J ACOUST SOC AM, V127, P1528, DOI 10.1121/1.3299201; Ximenes JA, 2005, ANN OTO RHINOL LARYN, V114, P390, DOI 10.1177/000348940511400510; Yang AX, 2010, J ACOUST SOC AM, V127, P1014, DOI 10.1121/1.3277165; Zanartu M, 2007, J ACOUST SOC AM, V121, P1119, DOI 10.1121/1.2409491; Zhang Y, 2004, J ACOUST SOC AM, V115, P1266, DOI 10.1121/1.1648974	57	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148309	10.1371/journal.pone.0148309	http://dx.doi.org/10.1371/journal.pone.0148309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845452	gold, Green Published			2022-12-26	WOS:000369552800045
J	Smith, TB; Parker, M; Steinkamp, PN; Weleber, RG; Smith, N; Wilson, DJ				Smith, Travis B.; Parker, Maria; Steinkamp, Peter N.; Weleber, Richard G.; Smith, Ning; Wilson, David J.		VPA Clinical Trial Study Grp; EZ Working Grp	Structure-Function Modeling of Optical Coherence Tomography and Standard Automated Perimetry in the Retina of Patients with Autosomal Dominant Retinitis Pigmentosa	PLOS ONE			English	Article							VISUAL-FIELD LOSS; USHER-SYNDROME; MULTIFOCAL ELECTRORETINOGRAM; NATURAL COURSE; SENSITIVITY; THICKNESS; TRANSFORMATIONS; BOUNDARIES; THRESHOLD; RECEPTOR	Purpose To assess relationships between structural and functional biomarkers, including new topographic measures of visual field sensitivity, in patients with autosomal dominant retinitis pigmentosa. Methods Spectral domain optical coherence tomography line scans and hill of vision (HOV) sensitivity surfaces from full-field standard automated perimetry were semi-automatically aligned for 60 eyes of 35 patients. Structural biomarkers were extracted from outer retina b-scans along horizontal and vertical midlines. Functional biomarkers were extracted from local sensitivity profiles along the b-scans and from the full visual field. These included topographic measures of functional transition such as the contour of most rapid sensitivity decline around the HOV, herein called HOV slope for convenience. Biomarker relationships were assessed pairwise by coefficients of determination (R-2) from mixed-effects analysis with automatic model selection. Results Structure-function relationships were accurately modeled (conditional R-2>0.8 in most cases). The best-fit relationship models and correlation patterns for horizontally oriented biomarkers were different than vertically oriented ones. The structural biomarker with the largest number of significant functional correlates was the ellipsoid zone (EZ) width, followed by the total photoreceptor layer thickness. The strongest correlation observed was between EZ width and HOV slope distance (marginal R-2 = 0.85, p<10(-10)). The mean sensitivity defect at the EZ edge was 7.6 dB. Among all functional biomarkers, the HOV slope mean value, HOV slope mean distance, and maximum sensitivity along the b-scan had the largest number of significant structural correlates. Conclusions Topographic slope metrics show promise as functional biomarkers relevant to the transition zone. EZ width is strongly associated with the location of most rapid HOV decline.	[Smith, Travis B.; Parker, Maria; Steinkamp, Peter N.; Weleber, Richard G.; Wilson, David J.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Smith, Ning] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA	Oregon Health & Science University; Kaiser Permanente	Smith, TB (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	smittrav@ohsu.edu		Ferris, Frederick/0000-0002-4933-0639; Iannaccone, Alessandro/0000-0001-5737-8424	Foundation Fighting Blindness Clinical Research Institute (FFB-CRI); FFB-CRI; Department of Defense [W81XWH-09-2-0189]	Foundation Fighting Blindness Clinical Research Institute (FFB-CRI); FFB-CRI; Department of Defense(United States Department of Defense)	This work was supported by Maryrose Sylvester and the Foundation Fighting Blindness Clinical Research Institute (FFB-CRI). The VPA Clinical Trial is co-sponsored by the FFB-CRI and the Department of Defense (W81XWH-09-2-0189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa S, 2009, EYE, V23, P304, DOI 10.1038/sj.eye.6703076; Barteselli G, 2013, AM J OPHTHALMOL, V156, P588, DOI 10.1016/j.ajo.2013.04.030; Battu R, 2015, EYE, V29, P895, DOI 10.1038/eye.2015.61; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; Birch DG, 2015, OPHTHALMOLOGY, V122, P833, DOI 10.1016/j.ophtha.2014.11.005; Birch DG, 2013, JAMA OPHTHALMOL, V131, P1143, DOI 10.1001/jamaophthalmol.2013.4160; Birch DG, 2011, INVEST OPHTH VIS SCI, V52, P7141, DOI 10.1167/iovs.11-7509; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burnham KP, 2002, MODEL SELECTION MULT, P81; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Fakin A, 2012, VISION RES, V75, P60, DOI 10.1016/j.visres.2012.08.017; Fishman GA, 2007, RETINA-J RET VIT DIS, V27, P601, DOI 10.1097/01.iae.0000246675.88911.2c; FLAMMER J, 1985, INVEST OPHTH VIS SCI, V26, P176; Grobbel JM, 2011, THESIS U TUBINGEN; HEIJL A, 1987, ARCH OPHTHALMOL-CHIC, V105, P1544; Hood DC, 2011, BIOMED OPT EXPRESS, V2, P1106, DOI 10.1364/BOE.2.001106; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P101, DOI 10.1167/iovs.10-5799; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Iannaccone A, 2004, INVEST OPHTH VIS SCI, V45, P784, DOI 10.1167/iovs.03-0906; Jacobson SG, 2010, INVEST OPHTH VIS SCI, V51, P1079, DOI 10.1167/iovs.09-4372; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P1886, DOI 10.1167/iovs.08-3122; JACOBSON SG, 1986, OPHTHALMOLOGY, V93, P1604; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Lujan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1486, DOI 10.1167/iovs.10-5946; MASSOF RW, 1990, CLIN VISION SCI, V5, P1; McKean-Cowdin R, 2007, AM J OPHTHALMOL, V143, P1013, DOI 10.1016/j.ajo.2007.02.022; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Ramachandran R, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.7.5; Rangaswamy NV, 2010, INVEST OPHTH VIS SCI, V51, P4213, DOI 10.1167/iovs.09-4945; Roman AJ, 2005, EXP EYE RES, V80, P259, DOI 10.1016/j.exer.2004.09.008; Schiefer U, 2009, INVEST OPHTH VIS SCI, V50, P488, DOI 10.1167/iovs.08-2229; Seiple W, 2004, DOC OPHTHALMOL, V109, P255, DOI 10.1007/s10633-005-0567-0; Smith T, 2015, INVEST OPHTHALMOL VI, V56; Spry PGD, 2002, OPTOMETRY VISION SCI, V79, P93, DOI 10.1097/00006324-200202000-00010; Swanson WH, 2000, OPHTHALMOLOGY, V107, P1950, DOI 10.1016/S0161-6420(00)00356-0; TIBSHIRANI R, 1988, J AM STAT ASSOC, V83, P394, DOI 10.2307/2288855; Weleber RG, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.2.14; Wen Y, 2012, INVEST OPHTH VIS SCI, V53, P833, DOI 10.1167/iovs.11-8410; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	40	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148022	10.1371/journal.pone.0148022	http://dx.doi.org/10.1371/journal.pone.0148022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845445	Green Submitted, Green Published, gold			2022-12-26	WOS:000369552800025
J	Chen, ZQ; Yu, K; Zhu, F; Gorczynski, R				Chen, Zhiqi; Yu, Kai; Zhu, Fang; Gorczynski, Reginald			Over-Expression of CD200 Protects Mice from Dextran Sodium Sulfate Induced Colitis	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; INTESTINAL BACTERIA; MOLECULE OX-2; MURINE MODEL; INFLAMMATION; TOLERANCE; PATHOGENESIS; INDUCTION	Background and aim CD200: CD200 receptor (CD200R) interactions lead to potent immunosuppression and inhibition of autoimmune inflammation. We investigated the effect of "knockout" of CD200 or CD200R, or over-expression of CD200, on susceptibility to dextran sodium sulfate (DSS) induced colitis, a mouse model of inflammatory bowel disease (IBD). Methods Acute or chronic colitis was induced by administration of dextran sodium sulfate (DSS) in four groups of age-matched C57BL/6 female mice: (1) CD200-transgenic mice (CD200tg); (2) wild-type (WT) mice; (3) CD200 receptor 1-deficient (CD200R1KO) mice; and (4) CD200-deficient (CD200KO) mice. The extent of colitis was determined using a histological scoring system. Colon tissues were collected for quantitative RT-PCR and Immunohistochemical staining. Supernatants from colonic explant cultures and mononuclear cells isolated from colonic tissue were used for ELISA. Results CD200KO and CD200R1KO mice showed greater sensitivity to acute colitis than WT mice, with accelerated loss of body weight, significantly higher histological scores, more severe infiltration of macrophages, neutrophils and CD3+ cells, and greater expression of macrophage-derived inflammatory cytokines, whose production was inhibited in vitro (in WT/CD200KO mouse cells) by CD200. In contrast, CD200tg mice showed less sensitivity to DSS compared with WT mice, with attenuation of all of the features seen in other groups. In a chronic colitis model, greater infiltration of Foxp3(+) regulatory T (Treg) cells was seen in the colon of CD200tg mice compared to WT mice, and anti-CD25 mAb given to these mice attenuated protection. Conclusions The CD200: CD200R axis plays an immunoregulatory role in control of DSS induced colitis in mice.	[Chen, Zhiqi; Yu, Kai; Zhu, Fang; Gorczynski, Reginald] Univ Toronto, Univ Hlth Network, Toronto Hosp, Transplant Res Div,Dept Surg & Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gorczynski, R (corresponding author), Univ Toronto, Univ Hlth Network, Toronto Hosp, Transplant Res Div,Dept Surg & Immunol, Toronto, ON, Canada.	rgorczynski@uhnres.utoronto.ca	Gorczynski, Reginald/AAA-1435-2019; Zhu, Fang/L-3411-2016		Canadian Institute of Health Research [777532247]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute of Health Research (777532247 to R.M.G.).	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Bain CC, 2012, IMMUNOBIOLOGY, V217, P643, DOI 10.1016/j.imbio.2011.11.004; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Berndt BE, 2007, J IMMUNOL, V179, P6255, DOI 10.4049/jimmunol.179.9.6255; Boudakov I, 2007, TRANSPLANTATION, V84, P251, DOI 10.1097/01.tp.0000269795.04592.cc; Broderick C, 2002, AM J PATHOL, V161, P1669, DOI 10.1016/S0002-9440(10)64444-6; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chitnis T, 2007, AM J PATHOL, V170, P1695, DOI 10.2353/ajpath.2007.060677; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Clark DA, 2003, AM J REPROD IMMUNOL, V50, P187, DOI 10.1034/j.1600-0897.2003.00086.x; Di Sabatino A, 2012, INFLAMM BOWEL DIS, V18, P368, DOI 10.1002/ibd.21735; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Eijkelkamp N, 2007, GUT, V56, P847, DOI 10.1136/gut.2006.107094; Fantini MC, 2006, GUT, V55, P671, DOI 10.1136/gut.2005.072801; Fuchs A, 2013, CURR OPIN GASTROEN, V29, P581, DOI 10.1097/MOG.0b013e328365d339; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Geem D, 2012, JOVE-J VIS EXP, DOI 10.3791/4040; Gorczynski R, 2004, J IMMUNOL, V172, P7744, DOI 10.4049/jimmunol.172.12.7744; Gorczynski RM, 2009, J IMMUNOL, V183, P1560, DOI 10.4049/jimmunol.0900200; Gorczynski RM, 1998, TRANSPLANTATION, V65, P1106, DOI 10.1097/00007890-199804270-00016; Gorczynski RM, 2001, CLIN IMMUNOL, V101, P328, DOI 10.1006/clim.2001.5117; Gorczynski RM, 1999, J IMMUNOL, V163, P1654; Gross P, 2012, INFLAMM BOWEL DIS, V18, P1900, DOI 10.1002/ibd.22900; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim Yoon Suk, 2011, Immune Netw, V11, P416, DOI 10.4110/in.2011.11.6.416; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Li X, 2010, CLIN IMMUNOL, V134, P169, DOI 10.1016/j.clim.2009.09.012; Melgar S, 2008, STRESS, V11, P348, DOI 10.1080/10253890701820166; Melgar S, 2008, INT IMMUNOPHARMACOL, V8, P836, DOI 10.1016/j.intimp.2008.01.036; Mizoguchi E, 2000, INT IMMUNOL, V12, P597, DOI 10.1093/intimm/12.5.597; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Pizarro TT, 2007, ANNU REV MED, V58, P433, DOI 10.1146/annurev.med.58.121205.100607; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Stevceva Liljana, 2001, BMC Clin Pathol, V1, P3, DOI 10.1186/1472-6890-1-3; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Szebeni B, 2008, CLIN EXP IMMUNOL, V151, P34, DOI 10.1111/j.1365-2249.2007.03531.x; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vadasz Z, 2013, FEBS LETT, V587, P2074, DOI 10.1016/j.febslet.2013.05.023; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wong KK, 2012, CANCER RES, V72, P4931, DOI 10.1158/0008-5472.CAN-12-1390; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yu K, 2005, TRANSPLANTATION, V80, P394, DOI 10.1097/01.tp.0000168152.72560.82; Yu K, 2011, IMMUNOL LETT, V141, P116, DOI 10.1016/j.imlet.2011.09.002; Yuan Q, 2007, J EXP MED, V204, P1327, DOI 10.1084/jem.20062076; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	58	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146681	10.1371/journal.pone.0146681	http://dx.doi.org/10.1371/journal.pone.0146681			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841120	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200012
J	Huang, Q; Chen, YP; Wang, RW; Cheng, S; Evans, JD				Huang, Qiang; Chen, Yan Ping; Wang, Rui Wu; Cheng, Shang; Evans, Jay D.			Host-Parasite Interactions and Purifying Selection in a Microsporidian Parasite of Honey Bees	PLOS ONE			English	Article							NOSEMA CERANAE MICROSPORIDIA; APIS-MELLIFERA; PARASITOPHOROUS VACUOLE; APOPTOSIS; INFECTIONS; PROTEIN; GENOME; MITOCHONDRIA; PACKAGE; SINGLE	To clarify the mechanisms of Nosema ceranae parasitism, we deep-sequenced both honey bee host and parasite mRNAs throughout a complete 6-day infection cycle. By time-series analysis, 1122 parasite genes were significantly differently expressed during the reproduction cycle, clustering into 4 expression patterns. We found reactive mitochondrial oxygen species modulator 1 of the host to be significantly down regulated during the entire infection period. Our data support the hypothesis that apoptosis of honey bee cells was suppressed during infection. We further analyzed genome-wide genetic diversity of this parasite by comparing samples collected from the same site in 2007 and 2013. The number of SNP positions per gene and the proportion of non-synonymous substitutions per gene were significantly reduced over this time period, suggesting purifying selection on the parasite genome and supporting the hypothesis that a subset of N. ceranae strains might be dominating infection.	[Huang, Qiang; Wang, Rui Wu] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Huang, Qiang; Chen, Yan Ping; Evans, Jay D.] ARS, USDA, Bee Res Lab, BARC East Bldg 306, Beltsville, MD 20705 USA; [Wang, Rui Wu] Northwestern Polytech Univ, Ctr Ecol & Environm Sci, Xian 710072, Peoples R China; [Cheng, Shang] Chongqing Acad Anim Sci, Chongqing 402460, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; United States Department of Agriculture (USDA); Northwestern Polytechnical University	Huang, Q (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China.; Huang, Q; Evans, JD (corresponding author), ARS, USDA, Bee Res Lab, BARC East Bldg 306, Beltsville, MD 20705 USA.; Wang, RW (corresponding author), Northwestern Polytech Univ, Ctr Ecol & Environm Sci, Xian 710072, Peoples R China.	qiang-huang@live.com; Jay.Evans@ars.usda.gov	Evans, Jay/C-8408-2012	Evans, Jay/0000-0002-0036-4651	United States Department of Agriculture-National Institute of Food and Agriculture [2014-67013-21784]	United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This study was supported by the United States Department of Agriculture-National Institute of Food and Agriculture- 2014-67013-21784.r We thank Dawn Lopez, Michele Hamilton, and Margaret Mulhern for technical support. We appreciate Jiajie Sun and Lingyang Xu for statistical support. The work is supported by USDA-NIFA grant 2014-67013-21784 and USDA-NIFA had no role in study design, analysis, and publication of the work.	Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Bohne W, 2011, INT J MED MICROBIOL, V301, P395, DOI 10.1016/j.ijmm.2011.04.006; Burri L, 2006, P NATL ACAD SCI USA, V103, P15916, DOI 10.1073/pnas.0604109103; Campbell SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003676; Chen YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-451; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; del Aguila C, 2006, INT J PARASITOL, V36, P869, DOI 10.1016/j.ijpara.2006.04.002; Dussaubat C, 2013, J INVERTEBR PATHOL, V113, P42, DOI 10.1016/j.jip.2013.01.002; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Elsik CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-86; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Fokin SI, 2008, J EUKARYOT MICROBIOL, V55, P214, DOI 10.1111/j.1550-7408.2008.00322.x; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Fries I, 2006, J APICULT RES, V45, P230; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Gisder S, 2011, ENVIRON MICROBIOL, V13, P404, DOI 10.1111/j.1462-2920.2010.02346.x; Gomez-Moracho T, 2015, INFECT GENET EVOL, V31, P87, DOI 10.1016/j.meegid.2015.01.002; Gomez-Moracho T, 2014, PARASITOLOGY, V141, P475, DOI 10.1017/S0031182013001790; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2013, ENV MICROBIOL REP, V5, P530, DOI 10.1111/1758-2229.12059; Holt HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-799; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Huang SK, 2014, J ECON ENTOMOL, V107, P54, DOI 10.1603/EC13213; Kurze C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140174; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Li Z, 2014, PLOS ONE, P9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Pelin A, 2015, ENV MICROBIOL; Peyretaillade E, 2011, RES MICROBIOL, V162, P598, DOI 10.1016/j.resmic.2011.03.004; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scanlon M, 1999, J EUKARYOT MICROBIOL, V46, p34S; Scanlon M, 2004, J EUKARYOT MICROBIOL, V51, P81, DOI 10.1111/j.1550-7408.2004.tb00166.x; Schwarz RS, 2013, DEV COMP IMMUNOL, V40, P300, DOI 10.1016/j.dci.2013.03.010; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Wu JH, 2006, BIOCHIMIE, V88, P201, DOI 10.1016/j.biochi.2005.07.007	43	18	27	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147549	10.1371/journal.pone.0147549	http://dx.doi.org/10.1371/journal.pone.0147549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840596	Green Submitted, gold, Green Published			2022-12-26	WOS:000369550200045
J	Rawski, M; Kieronczyk, B; Dlugosz, J; Swiatkiewicz, S; Jozefiak, D				Rawski, Mateusz; Kieronczyk, Bartosz; Dlugosz, Jakub; Swiatkiewicz, Sylwester; Jozefiak, Damian			Dietary Probiotics Affect Gastrointestinal Microbiota, Histological Structure and Shell Mineralization in Turtles	PLOS ONE			English	Article							AKKERMANSIA-MUCINIPHILA; OLIGONUCLEOTIDE PROBES; INTESTINAL MICROFLORA; SALMONELLA-ENTERICA; BACTERIAL GROUPS; PERFORMANCE; HEALTH; REPTILES; TORTOISES; RESPONSES	Probiotics are widely used in nutrition, and their mode of action is intensively studied in mammals and birds; however, it is almost unknown in reptiles. In the present study, Trachemys scripta scripta and Sternotherus odoratus were used to assess the effects of dietary probiotics on chelonian gastrointestinal tract microecology. In the first, 20-week experiment, 40 young T. s. scripta were randomly distributed to four experimental groups: 1st, (CON)-with no additives; 2nd, (SSPA) with Bacillus subtilis PB6; 3rd, (MSP)-with multiple strain probiotic; and 4th, (SSPB) with Bacillus subtilis C-3102. The first study has shown that SSPA and MSP decreased the numbers of total bacteria, Enterobacteriace, Staphylococcus sp. and Streptococcus sp. excreted to water and increased the villous height and mucosa thickness in duodenum. SSPB improved the duodenal microstructure; however, it also increased numbers of kanamycin and vancomycin resistant bacteria, Staphylococcus sp. and Streptococcus sp., in water. In the second, 52-week experiment, 30 S. odoratus were randomly assigned to three dietary treatments. CON, SSPA and MSP groups. The MSP preparation increased the body weight gain, crude ash, Ca and P share in the turtles' shells. Both probiotics affected duodenal histomorphology. SSPA decreased the villous height, while MSP increased the villous height and mucosa thickness, and decreased the crypt depth. SSPA decreased the concentrations of bacteria excreted to water. In the case of intestinal microbiota, bacteria suppressing effects were observed in the case of both probiotics. MSP increased the number of Bifidobacterium sp. and Lactobacillus sp./Enteroccoccus sp., and decreased the number of Clostridium perfringens and Campylobacter sp. in the small intestine. In the large intestine it lowered, amongst others, Bacteroides-Pervotella cluster, Clostridium leptum subgroup and Clostridium perfringens numbers. The above-mentioned results suggest that probiotics are useful in turtle nutrition due to their positive effects on growth performance, shell mineralization, duodenal histomorphology and microbiota.	[Rawski, Mateusz; Kieronczyk, Bartosz; Dlugosz, Jakub; Jozefiak, Damian] Poznan Univ Life Sci, Dept Anim Nutr & Feed Management, Poznan, Poland; [Swiatkiewicz, Sylwester] Natl Res Inst Anim Prod, Dept Anim Nutr & Feed Sci, Balice, Poland	Poznan University of Life Sciences; National Research Institute of Animal Production	Jozefiak, D (corresponding author), Poznan Univ Life Sci, Dept Anim Nutr & Feed Management, Poznan, Poland.	damjo@up.poznan.pl	Swiatkiewicz, Sylwester/H-4807-2011; Swiatkiewicz, Sylwester/O-9967-2019; Kierończyk, Bartosz/I-8760-2019; Swiatkiewicz, Sylwester/K-1623-2019	Swiatkiewicz, Sylwester/0000-0001-8330-2159; Kierończyk, Bartosz/0000-0001-6006-117X; Swiatkiewicz, Sylwester/0000-0001-8330-2159; Rawski, Mateusz/0000-0001-8734-724X; Jozefiak, Damian/0000-0002-6606-7975	National Science Center (Poland) [NCN PRELUDIUM: UMO-2013/11/N/NZ9/04624]	National Science Center (Poland)	The current study was supported by the following grant: NCN PRELUDIUM: UMO-2013/11/N/NZ9/04624, financed by National Science Center (Poland).	Alloui MN, 2013, ANN ANIM SCI, V13, P17, DOI 10.2478/v10220-012-0055-x; AYASAN T, 2006, INT J POULT SCI, V5, P776, DOI DOI 10.3923/IJPS.2006.776.779; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Choct M, 2009, BRIT POULTRY SCI, V50, P9, DOI 10.1080/00071660802538632; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; CONGDON JD, 1994, AM ZOOL, V34, P397; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Dicks LMT, 2010, BENEF MICROBES, V1, P11, DOI 10.3920/BM2009.0012; Ebani VV, 2005, RES VET SCI, V78, P117, DOI 10.1016/j.rvsc.2004.08.002; Fallani M, 2006, J MICROBIOL METH, V67, P150, DOI 10.1016/j.mimet.2006.03.010; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; FRAZER NB, 1991, ECOLOGY, V72, P2218, DOI 10.2307/1941572; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Gaertner JP, 2008, J WILDLIFE DIS, V44, P519, DOI 10.7589/0090-3558-44.2.519; Ganesh BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074963; Geue L, 2002, VET MICROBIOL, V84, P79, DOI 10.1016/S0378-1135(01)00437-0; GIBBONS J.W, 1990, LIFE HIST ECOLOGY SL; Gong SP, 2014, SCI TOTAL ENVIRON, V468, P28, DOI 10.1016/j.scitotenv.2013.08.025; Guban J, 2006, POULTRY SCI, V85, P2186, DOI 10.1093/ps/85.12.2186; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Harris JR, 2010, CLIN INFECT DIS, V50, P554, DOI 10.1086/649932; Hoby S, 2010, J NUTR, V140, P1923, DOI 10.3945/jn.110.120998; JACKSON OF, 1980, J SMALL ANIM PRACT, V21, P409, DOI 10.1111/j.1748-5827.1980.tb01269.x; Jeong JS, 2014, POULTRY SCI, V93, P3097, DOI 10.3382/ps.2014-04086; Jin LZ, 1997, WORLD POULTRY SCI J, V53, P351, DOI 10.1079/WPS19970028; Jozefiak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085347; Jozefiak D, 2013, ANN ANIM SCI, V13, P449, DOI 10.2478/aoas-2013-0031; Keenan SW, 2013, SCI REP-UK, V3, DOI 10.1038/srep02877; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P6425, DOI 10.1128/AEM.68.12.6425-6428.2002; Leary S, 2013, AVMA GUIDELINES EUTH; Lee JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068772; Lei GYZHZ, 2010, CHINESE J ANIMAL NUT, V1, P42; Lei XJ, 2015, ASIAN AUSTRAL J ANIM, V28, P239, DOI 10.5713/ajas.14.0330; Mader D. R., 2005, REPTILE MED SURG; Mali I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139053; Mali I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086478; MANZ W, 1993, APPL ENVIRON MICROB, V59, P2293, DOI 10.1128/AEM.59.7.2293-2298.1993; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; Marubashi T, 2013, J APPL ANIMAL NUTR, V1, P1; Mermin J, 2004, CLIN INFECT DIS, V38, pS253, DOI 10.1086/381594; MILLER TL, 1974, APPL MICROBIOL, V27, P985, DOI 10.1128/AEM.27.5.985-987.1974; Montalban-Arques A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00512; Parvaneh K, 2014, SCI WORLD J, DOI 10.1155/2014/595962; Pees M, 2013, EUROSURVEILLANCE, V18; Rawski M, 2014, ANN ANIM SCI, V14, P573, DOI 10.2478/aoas-2014-0037; Revy R, 2004, ANIM FEED SCI TECH, V116, P93, DOI 10.1016/j.anifeedsci.2004.04.003; SAS Institute, 2011, SAS IML 9 3 US GUID; Schmid MW, 2005, INT J FOOD MICROBIOL, V105, P245, DOI 10.1016/j.ijfoodmicro.2005.04.012; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; Shamoto K, 2000, POULTRY SCI, V79, P718, DOI 10.1093/ps/79.5.718; Shi HT, 2008, ORYX, V42, P147, DOI 10.1017/S0030605308000562; Shi HT, 2007, CONSERV BIOL, V21, P5, DOI 10.1111/j.1523-1739.2006.00622_2.x; Swiatkiewicz S, 2010, ACTA AGR SCAND A-AN, V60, P125, DOI 10.1080/09064702.2010.482593; Swiatkiewicz Sylwester, 2007, Medycyna Weterynaryjna, V63, P1291; Teo AY, 2007, J APPL POULTRY RES, V16, P296, DOI 10.1093/japr/16.3.296; Timmerman HM, 2004, INT J FOOD MICROBIOL, V96, P219, DOI 10.1016/j.ijfoodmicro.2004.05.012; Willemsen RE, 2002, HERPETOL J, V12, P105; Zajac M, 2011, MED WETER, V67, P376; Zhang X, 2014, AQUACULT NUTR, V20, P667, DOI 10.1111/anu.12128	63	27	29	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147859	10.1371/journal.pone.0147859	http://dx.doi.org/10.1371/journal.pone.0147859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828367	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200038
J	Yang, Y; Liu, YL				Yang, Yi; Liu, Yuanli			Iterative Approximation of Basic Belief Assignment Based on Distance of Evidence	PLOS ONE			English	Article							DEMPSTER-SHAFER THEORY; TOTAL UNCERTAINTY	In the theory of belief functions, the approximation of a basic belief assignment (BBA) is for reducing the high computational cost especially when large number of focal elements are available. In traditional BBA approximation approaches, a focal element's own characteristics such as the mass assignment and the cardinality, are usually used separately or jointly as criteria for the removal of focal elements. Besides the computational cost, the distance between the original BBA and the approximated one is also concerned, which represents the loss of information in BBA approximation. In this paper, an iterative approximation approach is proposed based on maximizing the closeness, i.e., minimizing the distance between the approximated BBA in current iteration and the BBA obtained in the previous iteration, where one focal element is removed in each iteration. The iteration stops when the desired number of focal elements is reached. The performance evaluation approaches for BBA approximations are also discussed and used to compare and evaluate traditional BBA approximations and the newly proposed one in this paper, which include traditional time-based way, closeness-based way and new proposed ones. Experimental results and related analyses are provided to show the rationality and efficiency of our proposed new BBA approximation.	[Yang, Yi; Liu, Yuanli] Xi An Jiao Tong Univ, Sch Aerosp, SKLSVMS, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Yang, Y (corresponding author), Xi An Jiao Tong Univ, Sch Aerosp, SKLSVMS, Xian 710049, Shaanxi, Peoples R China.	jiafeiyy@mail.xjtu.edu.cn			Grant for State Key Program for Basic Research of China [2013CB329405]; National Natural Science Foundation [61573275, 61203222]; Science and technology project of Shaanxi Province [2013KJXX-46]; Specialized Research Fund for the Doctoral Program of Higher Education [20120201120036]; Fundamental Research Funds for the Central Universities [xjj2014122]	Grant for State Key Program for Basic Research of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and technology project of Shaanxi Province; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Grant for State Key Program for Basic Research of China (973) No. 2013CB329405, National Natural Science Foundation (No. 61573275, No. 61203222), Science and technology project of Shaanxi Province (No. 2013KJXX-46), Specialized Research Fund for the Doctoral Program of Higher Education (20120201120036), and Fundamental Research Funds for the Central Universities (xjj2014122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan J, 2008, INT J GEN SYST, V37, P733, DOI 10.1080/03081070802082486; Barnett JA, 2008, STUD FUZZ SOFT COMP, V219, P197; Bauer M, 1996, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P73; Bouchard M, 2013, INT J APPROX REASON, V54, P615, DOI 10.1016/j.ijar.2013.01.006; Burger T, 2010, P 1 INT WORKSH THEOR; Burger T, 2012, ADV INTEL SOFT COMPU, V164, P145; Denoeux T, 2001, INT J UNCERTAIN FUZZ, V9, P437, DOI 10.1016/S0218-4885(01)00088-0; Destercke S, 2012, ADV INTEL SOFT COMPU, V164, P153; Dezert J, 2012, ADV INTEL SOFT COMPU, V164, P275; Grabisch M., 1999, PROC 1 INT S IMPRECI, P158; Han DQ, 2015, 2015 18TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION), P428; HARMANEC D, 1994, INT J GEN SYST, V22, P405, DOI 10.1080/03081079408935225; Jousselme AL, 2006, IEEE T SYST MAN CY A, V36, P890, DOI 10.1109/TSMCA.2005.853483; Joussleme A.-L., 2001, Information Fusion, V2, P91, DOI 10.1016/S1566-2535(01)00026-4; KENNES R, 1992, IEEE T SYST MAN CYB, V22, P201, DOI 10.1109/21.148425; Klir GJ, 2008, IEEE T SYST MAN CY A, V38, P995, DOI 10.1109/TSMCA.2008.923066; Laamari W, 2015, LECT NOTES ARTIF INT, V9310, P234, DOI 10.1007/978-3-319-23540-0_16; Lowrance JD, 2008, STUD FUZZ SOFT COMP, V219, P419; Myers J. L., 2010, RES DESIGN STAT ANAL; SHAFER G, 1987, ARTIF INTELL, V33, P271, DOI 10.1016/0004-3702(87)90040-3; Shafer G., 1976, MATH THEORY EVIDENCE, V1; Shah Harsheel R, 2015, THESIS MISSOURI U SC; Smarandache F, 2009, ADV APPL DSMT INFORM, V3, DOI [10.5281/zenodo.8791, DOI 10.5281/ZENODO.8791]; Smarandache F., 2015, ADV APPL DSMT INFORM, V4; SMETS P, 1994, ARTIF INTELL, V66, P191, DOI 10.1016/0004-3702(94)90026-4; Smets P, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P612; TESSEM B, 1993, ARTIF INTELL, V61, P315, DOI 10.1016/0004-3702(93)90072-J; Yang Y, 2013, CHINESE J AERONAUT, V26, P993, DOI 10.1016/j.cja.2013.04.061	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147799	10.1371/journal.pone.0147799	http://dx.doi.org/10.1371/journal.pone.0147799			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829403	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200034
J	Achouiti, A; de Vos, AF; van 't Veer, C; Florquin, S; Tanck, MW; Nawroth, PP; Bierhaus, A; van der Poll, T; van Zoelen, MAD				Achouiti, Ahmed; de Vos, Alex F.; van 't Veer, Cornelis; Florquin, Sandrine; Tanck, Michael W.; Nawroth, Peter P.; Bierhaus, Angelika; van der Poll, Tom; van Zoelen, Marieke A. D.			Receptor for Advanced Glycation End Products (RAGE) Serves a Protective Role during Klebsiella pneumoniae - Induced Pneumonia	PLOS ONE			English	Article							ACUTE LUNG INJURY; VENTILATOR-ASSOCIATED PNEUMONIA; COMMUNITY-ACQUIRED PNEUMONIA; MOBILITY GROUP BOX-1; HOST-DEFENSE; PNEUMOCOCCAL PNEUMONIA; EXPERIMENTAL-MODELS; LIPOTEICHOIC ACID; IMMUNE-RESPONSE; SEVERE SEPSIS	Klebsiella species is the second most commonly isolated gram-negative organism in sepsis and a frequent causative pathogen in pneumonia. The receptor for advanced glycation end products (RAGE) is expressed on different cell types and plays a key role in diverse inflammatory responses. We here aimed to investigate the role of RAGE in the host response to Klebsiella (K.) pneumoniae pneumonia and intransally inoculated rage gene deficient (RAGE(-/-)) and normal wild-type (Wt) mice with K. pneumoniae. Klebsiella pneumonia resulted in an increased pulmonary expression of RAGE. Furthermore, the high-affinity RAGE ligand high mobility group box-1 was upregulated during K. pneumoniae pneumonia. RAGE deficiency impaired host defense as reflected by a worsened survival, increased bacterial outgrowth and dissemination in RAGE(-/-) mice. RAGE(-/-) neutrophils showed a diminished phagocytosing capacity of live K. pneumoniae in vitro. Relative toWt mice, RAGE(-/-) mice demonstrated similar lung inflammation, and slightly elevated-if any-cytokine and chemokine levels and unchanged hepatocellular injury. In addition, RAGE(-/-) mice displayed an unaltered response to intranasally instilled Klebsiella lipopolysaccharide (LPS) with respect to pulmonary cell recruitment and local release of cytokines and chemokines. These data suggest that (endogenous) RAGE protects against K. pneumoniae pneumonia. Also, they demonstrate that RAGE contributes to an effective antibacterial defense during K. pneumoniae pneumonia, at least partly via its participation in the phagocytic properties of professional granulocytes. Additionally, our results indicate that RAGE is not essential for the induction of a local and systemic inflammatory response to either intact Klebsiella or Klebsiella LPS.	[Achouiti, Ahmed; de Vos, Alex F.; van 't Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Achouiti, Ahmed; de Vos, Alex F.; van 't Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, CEMM, NL-1105 AZ Amsterdam, Netherlands; [Florquin, Sandrine] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Tanck, Michael W.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Nawroth, Peter P.; Bierhaus, Angelika] Heidelberg Univ, Dept Internal Med & Clin Chem, Heidelberg, Germany; [van Zoelen, Marieke A. D.] North Shore Long Isl Univ Hosp, Feinstein Inst Med Res, Lab Biomed Sci, Manhassat, NY USA; [van Zoelen, Marieke A. D.] Univ Med Ctr Utrecht, Div Internal Med & Infect Dis, Utrecht, Netherlands; [van Zoelen, Marieke A. D.] Univ Med Ctr Utrecht, LTI, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Ruprecht Karls University Heidelberg; Northwell Health; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Zoelen, MAD (corresponding author), North Shore Long Isl Univ Hosp, Feinstein Inst Med Res, Lab Biomed Sci, Manhassat, NY USA.	M.A.D.vanZoelen@umcutrecht.nl		Florquin, Sandrine/0000-0002-9676-1722; Tanck, Michael/0000-0001-9828-4459	Netherlands Organisation for Scientific Research (NWO); Clinical Research Talent Fellowship grant from the UMCU; Deutsche Forschungsgemeinschaft [SFB405]; IDSA/ID-week International Investigator Award	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Clinical Research Talent Fellowship grant from the UMCU; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IDSA/ID-week International Investigator Award	This work was supported by a VENI grant in the field of biomedical sciences from the Netherlands Organisation for Scientific Research (NWO) and by a Clinical Research Talent Fellowship grant from the UMCU, both to MADvZ, and by a grant from the Deutsche Forschungsgemeinschaft (SFB405 to PPN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been awarded with the IDSA/ID-week International Investigator Award 2012 (to dr. M.A.D. van Zoelen).	BARTLETT JG, 1995, NEW ENGL J MED, V333, P1618, DOI 10.1056/NEJM199512143332408; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brown PD, 1998, LANCET, V352, P1295, DOI 10.1016/S0140-6736(98)02239-9; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Cheng CM, 2005, MODERN PATHOL, V18, P1385, DOI 10.1038/modpathol.3800450; Christaki E, 2012, CURR OPIN INFECT DIS, V25, P304, DOI 10.1097/QCO.0b013e3283519b82; Christaki E, 2011, SHOCK, V35, P492, DOI 10.1097/SHK.0b013e31820b2e1c; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Foell DMD, 2013, AM J RESPIR CRIT CAR; Friggeri A, 2011, J IMMUNOL, V186, P6191, DOI 10.4049/jimmunol.1004134; Fuellen G, 2003, TRENDS IMMUNOL, V24, P622, DOI 10.1016/j.it.2003.10.004; Giamarellou H, 2005, CLIN MICROBIOL INFEC, V11, P1, DOI 10.1111/j.1469-0691.2005.01160.x; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Kang CI, 2011, J INFECTION, V62, P26, DOI 10.1016/j.jinf.2010.10.010; Knapp S, 2005, SHOCK, V24, P12, DOI 10.1097/01.shk.0000191385.41689.f3; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Knapp S, 2008, J IMMUNOL, V180, P3478, DOI 10.4049/jimmunol.180.5.3478; Kollef MH, 2005, CHEST, V128, P2706, DOI 10.1378/chest.128.4.2706; Leemans JC, 2002, AM J RESP CRIT CARE, V165, P1445, DOI 10.1164/rccm.2106045; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Liu R, 2009, ACTA MED OKAYAMA, V63, P203; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Ramsgaard L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020132; Renckens R, 2007, BLOOD, V109, P1593, DOI 10.1182/blood-2006-05-025197; Rijneveld AW, 2004, BLOOD, V103, P1702, DOI 10.1182/blood-2002-05-1380; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004; Srikrishna G, 2010, J CELL BIOCHEM, V110, P645, DOI 10.1002/jcb.22575; Strieter RM, 2003, CURR OPIN INFECT DIS, V16, P193, DOI 10.1097/00001432-200306000-00002; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; van Zoelen MA, 2010, CRIT CARE MED; van Zoelen MAD, 2008, SHOCK, V29, P441, DOI 10.1097/SHK.0b013e318157eddd; van Zoelen MAD, 2007, CRIT CARE MED, V35, P2799, DOI 10.1097/01.CCM.0000287588.69000.97; van Zoelen MAD, 2009, VIROLOGY, V391, P265, DOI 10.1016/j.virol.2009.05.032; van Zoelen MAD, 2009, J INFECT DIS, V200, P765, DOI 10.1086/604730; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; van Zoelen MA, 2011, CRIT CARE, V15, DOI 10.1186/cc9990; VANDERWINDT GJ, 2010, EUR RESP J; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wiersinga WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003494; Wittkowski H, 2007, CRIT CARE MED, V35, P1369, DOI 10.1097/01.CCM.0000262386.32287.29; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253; Zen K, 2007, J IMMUNOL, V178, P2483, DOI 10.4049/jimmunol.178.4.2483	50	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0141000	10.1371/journal.pone.0141000	http://dx.doi.org/10.1371/journal.pone.0141000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824892	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528600001
J	Gwak, SJ; Yun, Y; Yoon, DH; Kim, KN; Ha, Y				Gwak, So-Jung; Yun, Yeomin; Yoon, Do Heum; Kim, Keung Nyun; Ha, Yoon			Therapeutic Use of 3 beta-[N-(N ',N '-Dimethylaminoethane) Carbamoyl] Cholesterol-Modified PLGA Nanospheres as Gene Delivery Vehicles for Spinal Cord Injury	PLOS ONE			English	Article							BIODEGRADABLE NANOPARTICLES; CATIONIC LIPOSOME; LOCAL-DELIVERY; PLASMID DNA; STEM-CELLS; IN-VITRO; FORMULATION; RECOVERY; ACID); TRANSPLANTATION	Gene delivery holds therapeutic promise for the treatment of neurological diseases and spinal cord injury. Although several studies have investigated the use of non-viral vectors, such as polyethylenimine (PEI), their clinical value is limited by their cytotoxicity. Recently, biodegradable poly (lactide-co-glycolide) (PLGA) nanospheres have been explored as non-viral vectors. Here, we show that modification of PLGA nanospheres with 3 beta-[N-(N',N'-dimethylaminoethane) carbamoyl] cholesterol (DC-Chol) enhances gene transfection efficiency. PLGA/DC-Chol nanospheres encapsulating DNA were prepared using a double emulsion-solvent evaporation method. PLGA/DC-Chol nanospheres were less cytotoxic than PEI both in vitro and in vivo. DC-Chol modification improved the uptake of nanospheres, thereby increasing their transfection efficiency in mouse neural stem cells in vitro and rat spinal cord in vivo. Also, transgene expression induced by PLGA nanospheres was higher and longer-lasting than that induced by PEI. In a rat model of spinal cord injury, PLGA/DC-Chol nanospheres loaded with vascular endothelial growth factor gene increased angiogenesis at the injury site, improved tissue regeneration, and resulted in better recovery of locomotor function. These results suggest that DC-Chol-modified PLGA nanospheres could serve as therapeutic gene delivery vehicles for spinal cord injury.	[Gwak, So-Jung; Yun, Yeomin; Yoon, Do Heum; Kim, Keung Nyun; Ha, Yoon] Yonsei Univ, Coll Med, Dept Neurosurg, Spine & Spinal Cord Inst, Seoul 120749, South Korea; [Gwak, So-Jung] Clemson Univ, Dept Bioengn, Clemson, SC USA	Yonsei University; Yonsei University Health System; Clemson University	Ha, Y (corresponding author), Yonsei Univ, Coll Med, Dept Neurosurg, Spine & Spinal Cord Inst, Seoul 120749, South Korea.	HAYOON@yuhs.ac		Yoon, Do Heum/0000-0003-1452-5724	Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI15C0916]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [2015M3A9C6065075]; ICT R&D program of MSIP/IITP [R0190-15-2072]	Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP; ICT R&D program of MSIP/IITP	This work was supported by the Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI15C0916), Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3A9C6065075) and the ICT R&D program of MSIP/IITP. [R0190-15-2072].	Ajmani PS, 1999, NEUROCHEM RES, V24, P699, DOI 10.1023/A:1021012727796; Asasutjarit R, 2007, PHARM RES-DORDR, V24, P1098, DOI 10.1007/s11095-007-9234-3; Benfer M, 2012, EUR J PHARM BIOPHARM, V80, P247, DOI 10.1016/j.ejpb.2011.10.021; Blits B, 2006, J NEUROTRAUM, V23, P508, DOI 10.1089/neu.2006.23.508; Cohen H, 2000, GENE THER, V7, P1896, DOI 10.1038/sj.gt.3301318; Cristiano RJ, 1998, ANTICANCER RES, V18, P3241; Emerich DF, 1999, CELL TRANSPLANT, V8, P47, DOI 10.1177/096368979900800114; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Federici T, 2006, MUSCLE NERVE, V33, P302, DOI 10.1002/mus.20439; Frampton AR, 2005, GENE THER, V12, P891, DOI 10.1038/sj.gt.3302545; Gao J, 2010, BIOMATERIALS, V31, P2655, DOI 10.1016/j.biomaterials.2009.11.112; GAO X, 1991, BIOCHEM BIOPH RES CO, V179, P280, DOI 10.1016/0006-291X(91)91366-K; Griesenbach U, 2010, BIOMATERIALS, V31, P2665, DOI 10.1016/j.biomaterials.2009.12.005; Gwak SJ, 2008, BIOTECHNOL LETT, V30, P1177, DOI 10.1007/s10529-008-9676-7; Jensen DK, 2012, J CONTROL RELEASE, V157, P141, DOI 10.1016/j.jconrel.2011.08.011; Jeon O, 2007, J DRUG TARGET, V15, P190, DOI 10.1080/10611860601143479; Kang SW, 2008, BIOMATERIALS, V29, P1109, DOI 10.1016/j.biomaterials.2007.11.004; Kim IS, 2005, INT J PHARMACEUT, V298, P255, DOI 10.1016/j.ijpharm.2005.04.017; Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077; Kumar MNVR, 2004, BIOMATERIALS, V25, P1771, DOI 10.1016/j.biomaterials.2003.08.069; Lemmouchi Y, 1998, BIOMATERIALS, V19, P1827, DOI 10.1016/S0142-9612(98)00074-X; Mandel RJ, 1997, P NATL ACAD SCI USA, V94, P14083, DOI 10.1073/pnas.94.25.14083; Ning GZ, 2013, REGEN MED, V8, P271, DOI [10.2217/RME.13.26, 10.2217/rme.13.26]; Nishikawa M, 2000, GENE THER, V7, P548, DOI 10.1038/sj.gt.3301140; Oh JS, 2012, NEUROREPORT, V23, P277, DOI 10.1097/WNR.0b013e3283505ae2; Oh J, 2012, NEUROREPORT, V23, P658, DOI 10.1097/WNR.0b013e3283555d1b; Oudega M, 2012, CELL TISSUE RES, V349, P269, DOI 10.1007/s00441-012-1440-6; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Qiao Y, 2011, INT IMMUNOPHARMACOL, V11, P121, DOI 10.1016/j.intimp.2010.10.016; Ren H, 2014, BIOMATERIALS, V35, P6585, DOI 10.1016/j.biomaterials.2014.04.042; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Wang DQ, 1999, J CONTROL RELEASE, V57, P9, DOI 10.1016/S0168-3659(98)00099-6; Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050; Wen XJ, 2006, BIOMATERIALS, V27, P3800, DOI 10.1016/j.biomaterials.2006.02.036; Yang JP, 1997, GENE THER, V4, P950, DOI 10.1038/sj.gt.3300485; Yi F, 2006, J CLIN PHARM THER, V31, P43, DOI 10.1111/j.1365-2710.2006.00702.x; Zhang XY, 2011, RECENT ADVANCE IN STATISTICS APPLICATION AND RELATED AREAS, PTS 1 AND 2, P148	38	22	24	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147389	10.1371/journal.pone.0147389	http://dx.doi.org/10.1371/journal.pone.0147389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824765	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528600031
J	Eichmann, C; Campioni, S; Kowal, J; Maslennikov, I; Gerez, J; Liu, XX; Verasdonck, J; Nespovitaya, N; Choe, S; Meier, BH; Picotti, P; Rizo, J; Stahlberg, H; Riek, R				Eichmann, Cedric; Campioni, Silvia; Kowal, Julia; Maslennikov, Innokentiy; Gerez, Juan; Liu, Xiaoxia; Verasdonck, Joeri; Nespovitaya, Nadezhda; Choe, Senyon; Meier, Beat H.; Picotti, Paola; Rizo, Josep; Stahlberg, Henning; Riek, Roland			Preparation and Characterization of Stable -Synuclein Lipoprotein Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein (-synuclein); apolipoprotein; high-density lipoprotein (HDL); lipid; membrane bilayer; Parkinson disease	BOUND ALPHA-SYNUCLEIN; PHOSPHOLIPID-BILAYER NANODISCS; SOLID-STATE NMR; SECONDARY STRUCTURE; PARKINSONS-DISEASE; CROSS-LINKING; IN-VIVO; BIOLOGICAL MACROMOLECULES; MEMBRANE INTERACTIONS; UNILAMELLAR VESICLES	Multiple neurodegenerative diseases are caused by the aggregation of the human -Synuclein (-Syn) protein. -Syn possesses high structural plasticity and the capability of interacting with membranes. Both features are not only essential for its physiological function but also play a role in the aggregation process. Recently it has been proposed that -Syn is able to form lipid-protein particles reminiscent of high-density lipoproteins. Here, we present a method to obtain a stable and homogeneous population of nanometer-sized particles composed of -Syn and anionic phospholipids. These particles are called -Syn lipoprotein (nano)particles to indicate their relationship to high-density lipoproteins formed by human apolipoproteins in vivo and of in vitro self-assembling phospholipid bilayer nanodiscs. Structural investigations of the -Syn lipoprotein particles by circular dichroism (CD) and magic angle solid-state nuclear magnetic resonance (MAS SS-NMR) spectroscopy establish that -Syn adopts a helical secondary structure within these particles. Based on cryo-electron microscopy (cryo-EM) and dynamic light scattering (DLS) -Syn lipoprotein particles have a defined size with a diameter of approximate to 23 nm. Chemical cross-linking in combination with solution-state NMR and multiangle static light scattering (MALS) of -Syn particles reveal a high-order protein-lipid entity composed of approximate to 8-10 -Syn molecules. The close resemblance in size between cross-linked in vitro-derived -Syn lipoprotein particles and a cross-linked species of endogenous -Syn from SH-SY5Y human neuroblastoma cells indicates a potential functional relevance of -Syn lipoprotein nanoparticles.	[Eichmann, Cedric; Campioni, Silvia; Verasdonck, Joeri; Nespovitaya, Nadezhda; Meier, Beat H.; Riek, Roland] ETH Honggerberg, Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Gerez, Juan; Picotti, Paola] ETH Honggerberg, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland; [Kowal, Julia; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, Mattenstr 26, CH-4058 Basel, Switzerland; [Maslennikov, Innokentiy; Choe, Senyon; Riek, Roland] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Liu, Xiaoxia; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Salk Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Riek, R (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA.	roland.riek@phys.chem.ethz.ch	Eichmann, Cédric/U-1360-2018; Meier, Beat H/K-4066-2016; Stahlberg, Henning/H-1868-2011	Eichmann, Cédric/0000-0002-8476-1936; Meier, Beat H/0000-0002-9107-4464; Stahlberg, Henning/0000-0002-1185-4592; Kowal, Julia/0000-0003-4694-1896; Riek, Roland/0000-0002-6333-066X; Maslennikov, Innokentiy/0000-0003-4292-5821	Swiss National Foundation Sinergia grant	Swiss National Foundation Sinergia grant	This work was supported by a Swiss National Foundation Sinergia grant. The authors declare that they have no conflicts of interest with the contents of this article.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Barcelo-Coblijn G, 2007, J NEUROCHEM, V101, P132, DOI 10.1111/j.1471-4159.2006.04348.x; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayrhuber M, 2011, J MAGN RESON, V209, P310, DOI 10.1016/j.jmr.2011.01.031; Bisaglia M, 2005, BIOCHEMISTRY-US, V44, P329, DOI 10.1021/bi048448q; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bockmann A, 2009, J BIOMOL NMR, V45, P319, DOI 10.1007/s10858-009-9374-3; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Braun AR, 2012, J AM CHEM SOC, V134, P2613, DOI 10.1021/ja208316h; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cabin DE, 2002, J NEUROSCI, V22, P8797; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Cavanagh J., 2010, PROTEIN NMR SPECTROS; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Golovko MY, 2009, MOL CELL BIOCHEM, V326, P55, DOI 10.1007/s11010-008-0008-y; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Halliday GM, 2005, BRAIN, V128, P2654, DOI 10.1093/brain/awh584; Haque F, 2010, J PHYS CHEM B, V114, P4070, DOI 10.1021/jp1006704; Hartman VN, 2001, NEUROREPORT, V12, P943, DOI 10.1097/00001756-200104170-00016; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hogen T, 2012, BIOPHYS J, V102, P1646, DOI 10.1016/j.bpj.2012.01.059; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Lai Y, 2014, BIOCHEMISTRY-US, V53, P3889, DOI 10.1021/bi5002536; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2011, BIOCHEM BIOPH RES CO, V412, P526, DOI 10.1016/j.bbrc.2011.07.028; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Maslennikov Innokentiy, 2009, Journal of Structural and Functional Genomics, V10, P25, DOI 10.1007/s10969-009-9061-3; Melcher K, 2004, CURR PROTEIN PEPT SC, V5, P287, DOI 10.2174/1389203043379701; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Mishra VK, 1998, BIOCHEMISTRY-US, V37, P10313, DOI 10.1021/bi980042o; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Pandey AP, 2011, J PHYS CHEM B, V115, P5886, DOI 10.1021/jp1121917; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Ulusoy A, 2013, MOL NEUROBIOL, V47, P484, DOI 10.1007/s12035-012-8329-y; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Varkey J, 2013, J BIOL CHEM, V288, P17620, DOI 10.1074/jbc.M113.476697; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200	85	39	39	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8516	8527		10.1074/jbc.M115.707968	http://dx.doi.org/10.1074/jbc.M115.707968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26846854	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000374773200017
J	Sun, JJ; Lan, JF; Shi, XZ; Yang, MC; Niu, GJ; Ding, D; Zhao, XF; Yu, XQ; Wang, JX				Sun, Jie-Jie; Lan, Jiang-Feng; Shi, Xiu-Zhen; Yang, Ming-Chong; Niu, Guo-Juan; Ding, Ding; Zhao, Xiao-Fan; Yu, Xiao-Qiang; Wang, Jin-Xing			beta-Arrestins Negatively Regulate the Toll Pathway in Shrimp by Preventing Dorsal Translocation and Inhibiting Dorsal Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME VIRUS-INFECTION; SIGNALING PATHWAY; FENNEROPENAEUS-CHINENSIS; ANTIMICROBIAL PEPTIDES; GENE-EXPRESSION; INNATE IMMUNITY; CHINESE SHRIMP; DROSOPHILA; RECEPTOR; DEFENSE	The Toll signaling pathway plays an important role in the innate immunity of Drosophila melanogaster and mammals. The activation and termination of Toll signaling are finely regulated in these animals. Although the primary components of the Toll pathway were identified in shrimp, the functions and regulation of the pathway are seldom studied. We first demonstrated that the Toll signaling pathway plays a central role in host defense against Staphylococcus aureus by regulating expression of antimicrobial peptides in shrimp. We then found that beta-arrestins negatively regulate Toll signaling in two different ways. beta-Arrestins interact with the C-terminal PEST domain of Cactus through the arrestin-N domain, and Cactus interacts with the RHD domain of Dorsal via the ankyrin repeats domain, forming a heterotrimeric complex of beta-arrestin.Cactus.Dorsal, with Cactus as the bridge. This complex prevents Cactus phosphorylation and degradation, as well as Dorsal translocation into the nucleus, thus inhibiting activation of the Toll signaling pathway. beta-Arrestins also interact withn on-phosphorylated ERK (extracellular signal-regulated protein kinase) through the arrestin-C domain to inhibit ERK phosphorylation, which affects Dorsal translocation into the nucleus and phosphorylation of Dorsal at Ser(276) that impairs Dorsal transcriptional activity. Our study suggests that beta-arrestins negatively regulate the Toll signaling pathway by preventing Dorsal translocation and inhibiting Dorsal phosphorylation and transcriptional activity.	[Sun, Jie-Jie; Lan, Jiang-Feng; Shi, Xiu-Zhen; Yang, Ming-Chong; Niu, Guo-Juan; Ding, Ding; Zhao, Xiao-Fan; Wang, Jin-Xing] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Shandong, Peoples R China; [Yu, Xiao-Qiang] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA	Shandong University; University of Missouri System; University of Missouri Kansas City	Wang, JX (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	jxwang@sdu.edu.cn	YU, XIAO-QIANG/AAL-1797-2021; Yang, Mingchong/AAW-4529-2021; YU, XiaoQiang/GRJ-1077-2022; Wang, Jin-Xing/AAU-1514-2021; Zhao, Xiao-Fan/AGW-9886-2022	YU, XIAO-QIANG/0000-0003-1419-9009; Yang, Mingchong/0000-0003-0912-8417; Wang, Jin-Xing/0000-0003-0283-3930; Zhao, Xiao-Fan/0000-0003-1809-4730	National Natural Science Foundation of China [31130056, 31472303]; National Basic Research Program of China 973 Program [2012CB114405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 31130056 and 31472303 and National Basic Research Program of China 973 Program Grant 2012CB114405. The authors declare that they have no conflicts of interest with the contents of this article.	Anjum SG, 2013, GENETICS, V195, P1307, DOI 10.1534/genetics.113.157859; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Charroux B, 2010, FLY, V4, P40, DOI 10.4161/fly.4.1.10810; Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; Deepika A, 2014, FISH SHELLFISH IMMUN, V41, P441, DOI 10.1016/j.fsi.2014.09.026; Destoumieux D, 2000, CELL MOL LIFE SCI, V57, P1260, DOI 10.1007/PL00000764; Ding D, 2014, DEV COMP IMMUNOL, V46, P246, DOI 10.1016/j.dci.2014.04.016; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Haghayeghi A, 2010, MECH DEVELOP, V127, P301, DOI 10.1016/j.mod.2010.01.004; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Huang HR, 2010, P NATL ACAD SCI USA, V107, P8322, DOI 10.1073/pnas.1004031107; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Ji SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4458; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li FH, 2013, FISH SHELLFISH IMMUN, V34, P973, DOI 10.1016/j.fsi.2012.08.023; Li XP, 2013, FISH SHELLFISH IMMUN, V35, P1882, DOI 10.1016/j.fsi.2013.09.021; Li YX, 2015, J IMMUNOL, V194, P168, DOI 10.4049/jimmunol.1401080; Lindsay SA, 2014, DEV COMP IMMUNOL, V42, P16, DOI 10.1016/j.dci.2013.04.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luttrell LM, 2002, J CELL SCI, V115, P455; Marullo Stefano, 2014, Handb Exp Pharmacol, V219, P361, DOI 10.1007/978-3-642-41199-1_18; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Ren Q, 2014, DEV COMP IMMUNOL, V45, P198, DOI 10.1016/j.dci.2014.02.020; Shi H, 2014, J ORAL PATHOL MED, V43, P785, DOI 10.1111/jop.12209; Shi XZ, 2009, FISH SHELLFISH IMMUN, V27, P610, DOI 10.1016/j.fsi.2009.07.005; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Tamouza H, 2012, KIDNEY INT, V82, P1284, DOI 10.1038/ki.2012.192; Tipping M, 2010, EMBO J, V29, P3222, DOI 10.1038/emboj.2010.202; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Valanne S, 2010, J IMMUNOL, V184, P6188, DOI 10.4049/jimmunol.1000261; Wang DD, 2013, DEV COMP IMMUNOL, V39, P352, DOI 10.1016/j.dci.2012.12.005; Wang PH, 2013, DEV COMP IMMUNOL, V40, P266, DOI 10.1016/j.dci.2013.02.011; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2012, DEV COMP IMMUNOL, V36, P39, DOI 10.1016/j.dci.2011.06.002; Wang XW, 2014, J IMMUNOL, V193, P2106, DOI 10.4049/jimmunol.1400552; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Wang Z, 2015, FISH SHELLFISH IMMUN, V43, P219, DOI 10.1016/j.fsi.2014.12.038; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Yang XH, 2012, APOPTOSIS, V17, P1019, DOI 10.1007/s10495-012-0741-2; Zhang S., 2012, PLOS ONE, V7	50	42	44	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7488	7504		10.1074/jbc.M115.698134	http://dx.doi.org/10.1074/jbc.M115.698134			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26846853	hybrid, Green Published			2022-12-26	WOS:000383447600024
J	Windheim, M; Honing, S; Leppard, KN; Butler, L; Seed, C; Ponnambalam, S; Burgert, HG				Windheim, Mark; Hoening, Stefan; Leppard, Keith N.; Butler, Larissa; Seed, Christina; Ponnambalam, Sreenivasan; Burgert, Hans-Gerhard			Sorting Motifs in the Cytoplasmic Tail of the Immunomodulatory E3/49K Protein of Species D Adenoviruses Modulate Cell Surface Expression and Ectodomain Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenovirus; intracellular trafficking; protein sorting; shedding; viral immunology; Adenovirus E3 proteins; CD45; E3; 49K; Epidemic Keratoconjunctivitis; Immune evasion	AMYLOID PRECURSOR PROTEIN; CLASS-I ANTIGENS; EPIDEMIC KERATOCONJUNCTIVITIS; MOLECULAR EVOLUTION; E3/19K PROTEIN; INFECTED-CELLS; INTRACELLULAR SEQUESTRATION; CLATHRIN ADAPTERS; DOWN-MODULATE; E3 PROTEIN	The E3 transcription unit of human species C adenoviruses (Ads) encodes immunomodulatory proteins that mediate direct protection of infected cells. Recently, we described a novel immunomodulatory function for E3/49K, an E3 protein uniquely expressed by species D Ads. E3/49K of Ad19a/Ad64, a serotype that causes epidemic keratokonjunctivitis, is synthesized as a highly glycosylated type I transmembrane protein that is subsequently cleaved, resulting in secretion of its large ectodomain (sec49K). sec49K binds to CD45 on leukocytes, impairing activation and functions of natural killer cells and T cells. E3/49K is localized in the Golgi/trans-Golgi network (TGN), in the early endosomes, and on the plasma membrane, yet the cellular compartment where E3/49K is cleaved and the protease involved remained elusive. Here we show that TGN-localized E3/49K comprises both newly synthesized and recycled molecules. Full-length E3/49K was not detected in late endosomes/lysosomes, but the C-terminal fragment accumulated in this compartment at late times of infection. Inhibitor studies showed that cleavage occurs in a post-TGN compartment and that lysosomotropic agents enhance secretion. Interestingly, the cytoplasmic tail of E3/49K contains two potential sorting motifs, YXX phi (where phi represents a bulky hydrophobic amino acid) and LL, that are important for binding the clathrin adaptor proteins AP-1 and AP-2 in vitro. Surprisingly, mutating the LL motif, either alone or together with YXX phi, did not prevent proteolytic processing but increased cell surface expression and secretion. Upon brefeldin A treatment, cell surface expression was rapidly lost, even for mutants lacking all known endocytosis motifs. Together with immunofluorescence data, we propose a model for intracellular E3/49K transport whereby cleavage takes place on the cell surface by matrix metalloproteases.	[Windheim, Mark; Leppard, Keith N.; Butler, Larissa; Seed, Christina; Burgert, Hans-Gerhard] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Windheim, Mark] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; [Hoening, Stefan] Inst Biochem 1, D-50931 Cologne, Germany; [Hoening, Stefan] Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Ponnambalam, Sreenivasan] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Warwick; Hannover Medical School; University of Cologne; University of Cologne; University of Leeds	Burgert, HG (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	H-G.Burgert@warwick.ac.uk	Leppard, Keith N/A-1853-2009; Burgert, Hans-Gerhard/AAE-6668-2020; Windheim, Mark/HHR-9135-2022	Leppard, Keith N/0000-0003-2155-7919; Burgert, Hans-Gerhard/0000-0002-1650-9878; Ponnambalam, Sreenivasan/0000-0002-4452-7619; Windheim, Mark/0000-0001-6734-0905	Deutsche Forschungsgemeinschaft [BU 642/1, SFB455]; BBSRC [BB/D002877/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D002877/1] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutsche Forschungsgemeinschaft Grants BU 642/1 and SFB455 (to H.-G. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Arnberg N, 2012, TRENDS PHARMACOL SCI, V33, P442, DOI 10.1016/j.tips.2012.04.005; ARNOLD B, 1984, CELL, V38, P79, DOI 10.1016/0092-8674(84)90528-2; Banting G, 1997, BBA-MOL CELL RES, V1355, P209, DOI 10.1016/S0167-4889(96)00146-2; Blusch JH, 2002, VIROLOGY, V296, P94, DOI 10.1006/viro.2002.1404; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Burgert HG, 2000, VIRUS GENES, V21, P13, DOI 10.1023/A:1008135928310; BURGERT HG, 1985, CELL, V41, P987, DOI 10.1016/S0092-8674(85)80079-9; BURGERT HG, 1987, P NATL ACAD SCI USA, V84, P1356, DOI 10.1073/pnas.84.5.1356; Burgert HG, 2002, CURR TOP MICROBIOL, V269, P273; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CHODOSH J, 1995, CORNEA, V14, P167; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Davison AJ, 2003, J GEN VIROL, V84, P657, DOI 10.1099/vir.0.18856-0; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Deryckere F, 1996, J VIROL, V70, P2832, DOI 10.1128/JVI.70.5.2832-2841.1996; Diettrich O, 1996, EUR J CELL BIOL, V69, P99; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; Dosso AA, 2008, CORNEA, V27, P263, DOI 10.1097/ICO.0b013e31815b7d7d; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Elsing A, 1998, P NATL ACAD SCI USA, V95, P10072, DOI 10.1073/pnas.95.17.10072; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fallon PG, 2006, TRENDS IMMUNOL, V27, P470, DOI 10.1016/j.it.2006.08.002; FOX JP, 1977, AM J EPIDEMIOL, V105, P362, DOI 10.1093/oxfordjournals.aje.a112394; Frietze KM, 2010, J VIROL, V84, P11310, DOI 10.1128/JVI.00512-10; Gabaev I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002432; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; GINSBERG HS, 1989, P NATL ACAD SCI USA, V86, P3823, DOI 10.1073/pnas.86.10.3823; Gregory SM, 2011, FUTURE VIROL, V6, P357, DOI 10.2217/FVL.11.6; Heilker R, 1999, BIOESSAYS, V21, P558, DOI 10.1002/(SICI)1521-1878(199907)21:7<558::AID-BIES4>3.0.CO;2-R; Hendrickx R, 2014, HUM GENE THER, V25, P265, DOI 10.1089/hum.2014.001; Hilgendorf A, 2003, J BIOL CHEM, V278, P51872, DOI 10.1074/jbc.M310038200; Honing S, 1997, J BIOL CHEM, V272, P19884, DOI 10.1074/jbc.272.32.19884; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; Kaneko H, 2011, BRIT J OPHTHALMOL, V95, P32, DOI 10.1136/bjo.2009.178772; KEMP MC, 1983, J INFECT DIS, V148, P24, DOI 10.1093/infdis/148.1.24; King A. M. Q., 2012, VIRUS TAXONOMY CLASS, P213; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KORNER H, 1992, P NATL ACAD SCI USA, V89, P11857, DOI 10.1073/pnas.89.24.11857; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Mallet WG, 1999, J CELL BIOL, V146, P345, DOI 10.1083/jcb.146.2.345; McNees AL, 2002, VIRUS RES, V88, P87, DOI 10.1016/S0168-1702(02)00122-3; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; Meyer-Rusenberg B, 2011, DTSCH ARZTEBL INT, V108, P475, DOI 10.3238/arztebl.2011.0475; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nilsson EC, 2011, NAT MED, V17, P105, DOI 10.1038/nm.2267; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Ponnambalam S, 1996, J CELL SCI, V109, P675; Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812; Robinson CM, 2011, VIRUS RES, V160, P120, DOI 10.1016/j.virusres.2011.05.022; Robinson CM, 2011, INFECT GENET EVOL, V11, P1208, DOI 10.1016/j.meegid.2011.04.031; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Ruzsics Z, 2006, J VIROL, V80, P8100, DOI 10.1128/JVI.00687-06; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; SESTER M, 1994, J VIROL, V68, P5423, DOI 10.1128/JVI.68.9.5423-5432.1994; Sester M, 2013, J VIROL, V87, P6104, DOI 10.1128/JVI.03391-12; Sester M, 2010, J IMMUNOL, V184, P255, DOI 10.4049/jimmunol.0902343; Simonsen A, 1998, EUR J CELL BIOL, V76, P25, DOI 10.1016/S0171-9335(98)80014-9; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Tikkanen R, 2000, TRAFFIC, V1, P631, DOI 10.1034/j.1600-0854.2000.010807.x; Tollefson AE, 1996, J VIROL, V70, P2296, DOI 10.1128/JVI.70.4.2296-2306.1996; Tollefson AE, 1998, NATURE, V392, P726, DOI 10.1038/33712; Tortorella LL, 2007, TRAFFIC, V8, P402, DOI 10.1111/j.1600-0854.2007.00541.x; Towler MC, 2000, EXP CELL RES, V259, P167, DOI 10.1006/excr.2000.4958; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Uchino J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087342; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; Windheim M, 2004, CURR TOP MICROBIOL, V273, P29; Windheim M, 2002, J VIROL, V76, P755, DOI 10.1128/JVI.76.2.755-766.2002; Windheim M, 2013, P NATL ACAD SCI USA, V110, pE4884, DOI 10.1073/pnas.1312420110; WOLD WSM, 2007, FIELD VIROLOGY, P02395; Wu HY, 2003, J BIOL CHEM, V278, P40425, DOI 10.1074/jbc.C300225200; Zhou XH, 2012, INVEST OPHTH VIS SCI, V53, P2804, DOI 10.1167/iovs.12-9656	78	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6796	6812		10.1074/jbc.M115.684787	http://dx.doi.org/10.1074/jbc.M115.684787			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26841862	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000373299700020
J	Haighton, C; Wilson, G; Ling, J; McCabe, K; Crosland, A; Kaner, E				Haighton, Catherine; Wilson, Graeme; Ling, Jonathan; McCabe, Karen; Crosland, Ann; Kaner, Eileen			A Qualitative Study of Service Provision for Alcohol Related Health Issues in Mid to Later Life	PLOS ONE			English	Article							AT-RISK DRINKING; OLDER-ADULTS; USE DISORDERS; SUBSTANCE-ABUSE; ELDERLY-PEOPLE; SOCIAL ECOLOGY; PRIMARY-CARE; INTERVENTION; CONSUMPTION; AGE	Aims Epidemiological surveys over the last 20 years show a steady increase in the amount of alcohol consumed by older age groups. Physiological changes and an increased likelihood of health problems and medication use make older people more likely than younger age groups to suffer negative consequences of alcohol consumption, often at lower levels. However, health services targeting excessive drinking tend to be aimed at younger age groups. The aim of this study was to gain an in-depth understanding of experiences of, and attitudes towards, support for alcohol related health issues in people aged 50 and over. Methods Qualitative interviews (n = 24, 12 male/12 female, ages 51-90 years) and focus groups (n = 27, 6 male/21 female, ages 50-95 years) were carried out with a purposive sample of participants who consumed alcohol or had been dependent. Findings Participants' alcohol misuse was often covert, isolated and carefully regulated. Participants tended to look first to their General Practitioner for help with alcohol. Detoxification courses had been found effective for dependent participants but only in the short term; rehabilitation facilities were appreciated but seen as difficult to access. Activities, informal groups and drop-in centres were endorsed. It was seen as difficult to secure treatment for alcohol and mental health problems together. Barriers to seeking help included functioning at a high level, concern about losing positive aspects of drinking, perceived stigma, service orientation to younger people, and fatalistic attitudes to help-seeking. Facilitators included concern about risk of fatal illness or pressure from significant people. Conclusion Primary care professionals need training on improving the detection and treatment of alcohol problems among older people. There is also a compelling need to ensure that aftercare is in place to prevent relapse. Strong preferences were expressed for support to be provided by those who had experienced alcohol problems themselves.	[Haighton, Catherine; Wilson, Graeme; Kaner, Eileen] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ling, Jonathan; McCabe, Karen; Crosland, Ann] Univ Sunderland, Dept Pharm Hlth & Well Being, Sunderland, England; [Wilson, Graeme] Univ Edinburgh, Reid Sch Mus, Edinburgh, Midlothian, Scotland	Newcastle University - UK; University of Sunderland; University of Edinburgh	Haighton, C (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	katie.haighton@newcastle.ac.uk	Kaner, Eileen/ABF-2444-2020; Wilson, Graeme/AAQ-2499-2020; Ling, Jonathan/AAY-4098-2020; Haighton, Catherine/H-1528-2015	Wilson, Graeme/0000-0003-2587-257X; Ling, Jonathan/0000-0003-2932-4474; Haighton, Catherine/0000-0002-8061-0428; Kaner, Eileen/0000-0002-7169-9344	United Kingdom Charity Age UK South Tyneside; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Medical Research Council [MR/K02325X/1, 1528022] Funding Source: researchfish	United Kingdom Charity Age UK South Tyneside; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are most grateful and extend our sincere thanks to all the people who took part in the study. This research was supported by a grant from the United Kingdom Charity Age UK South Tyneside (http://www.ageuk.org.uk/southtyneside/). The organisation assisted in the identification and recruitment of study participants as described in the methods section of the manuscript. Apart from this, the funders had no role in study design, analysis, decision to publish, or preparation of the manuscript. CH and JL are fully funded staff members and AC and EK are Senior Investigators of Fuse the Centre for Translational Research in Public Health, a UKCRC Public Health Research Centre of Excellence. Funding for Fuse from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, is gratefully acknowledged.	Aira M, 2005, INT J GERIATR PSYCH, V20, P680, DOI 10.1002/gps.1340; Aira M, 2008, FAM PRACT, V25, P445, DOI 10.1093/fampra/cmn065; Alcohol Concern, 2002, ALC MIS OLD PEOPL FA; [Anonymous], NVIVO QUAL DAT AN SO; Bakhshi Savita, 2014, Br J Community Nurs, V19, P370, DOI 10.12968/bjcn.2014.19.8.370; Barrett L. L., 2005, PRESCRIPTION DRUG US; Benshoff JJ, 2003, J REHABIL, V69, P43; Berks J, 2008, INT PSYCHOGERIATR, V20, P1090, DOI 10.1017/S1041610208007497; Blow FC, 2000, J GERIATR PSYCH NEUR, V13, P115, DOI 10.1177/089198870001300304; Caputo F, 2012, EXP GERONTOL, V47, P411, DOI 10.1016/j.exger.2012.03.019; Clarke A. E., 2005, SITUATIONAL ANAL GRO; Cohen DA, 2000, PREV MED, V30, P146, DOI 10.1006/pmed.1999.0609; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Coulson CE., 2014, GERIATRIC MENTAL HLT, V2, P3, DOI [DOI 10.1016/J.GMHC.2014.09.001, 10.1016/j.gmhc.2014.09.001]; Crome I, 2008, AGE AGEING, V37, P120, DOI 10.1093/ageing/afm150; Crome P, 1991, INT HDB ADDICTION BE; Dar K, 2006, ADV PSYCHIAT TREAT, V12, P173, DOI [DOI 10.1192/apt.12.3.173, 10.1192/apt.12.3.173]; Dare J, 2014, SOCIAL ENGAGEMENT SE, DOI 10.111/hsc.12110; Dawson DA, 2005, ADDICTION, V100, P281, DOI 10.1111/j.1360-0443.2004.00964.x; Department of Economic and Social Affairs Population Division, 2013, WORLD POP AG 2013; Department of Health, 2006, MOD CAR ALC MIS DEP; Department of Health, 2012, GOV ALC STRAT; Department of Health, 2001, NAT SERV FRAM OLD PE; Duru OK, 2015, ALCOHOL CLIN EXP RES, V39, P1227, DOI 10.1111/acer.12754; Ettner SL, 2014, J STUD ALCOHOL DRUGS, V75, P447, DOI 10.15288/jsad.2014.75.447; Fingerhood M, 2000, J AM GERIATR SOC, V48, P985, DOI 10.1111/j.1532-5415.2000.tb06900.x; Fleming MF, 1999, J FAM PRACTICE, V48, P378; Gilson KM, 2014, SUBST USE MISUSE, P1; Haarni I., 2010, NORDIC STUDIES ALCOH, V27, P241, DOI DOI 10.1177/145507251002700304; Johnson I, 2000, INT J GERIATR PSYCH, V15, P575, DOI 10.1002/1099-1166(200007)15:7<575::AID-GPS151>3.0.CO;2-0; Kaner EFS, 2001, BRIT J GEN PRACT, V51, P822; Ling J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-892; Lock CA, 2004, FAM PRACT, V21, P270, DOI 10.1093/fampra/cmh310; Lock CA, 2002, J ADV NURS, V39, P333, DOI 10.1046/j.1365-2648.2002.02294.x; Lock CA, 2004, PRIM HEALTH CARE RES, V5, P162, DOI DOI 10.1191/1463423604PC1940A; McCabe KE, 2016, PERSPECT PUBLIC HEAL, V136, P83, DOI 10.1177/1757913915597259; Moore AA, 2003, J AM GERIATR SOC, V51, P44, DOI 10.1034/j.1601-5215.2002.51008.x; Moore Alison A, 2007, Am J Geriatr Pharmacother, V5, P64, DOI 10.1016/j.amjopharm.2007.03.006; Mulinga JD, 1999, INT J GERIATR PSYCH, V14, P564; National Institute on Alcohol Abuse and Alcoholism, 1995, DIAGN CRIT ALC AB DE, P30; O'Connell H, 2004, INT J GERIATR PSYCH, V19, P1074, DOI 10.1002/gps.1214; O'Connell H, 2003, BMJ-BRIT MED J, V327, P664, DOI 10.1136/bmj.327.7416.664; Office for National Statistics, 2013, ALC REL DEATH UK 201; Office for National Statistics, 2010, DRINK AD BEH KNOWL 2; Office for National Statistics, 2013, CHAPT 2 DRINK GEN LI; Oslin DW, 2006, PSYCHIAT SERV, V57, P954, DOI 10.1176/appi.ps.57.7.954; Oslin DW, 2002, AM J GERIAT PSYCHIAT, V10, P740; Reid MC, 1998, J GEN INTERN MED, V13, P729, DOI 10.1046/j.1525-1497.1998.00223.x; Robinson OC, 2014, QUAL RES PSYCHOL, V11, P25, DOI 10.1080/14780887.2013.801543; Royal College of Psychiatrists, 2011, OUR INV ADD; Sacco P, 2015, AGING MENT HEALTH, V19, P279, DOI 10.1080/13607863.2014.933307; Stokols D, 1996, AM J HEALTH PROMOT, V10, P247, DOI 10.4278/0890-1171-10.4.247; Stokols D, 2000, BEHAV MED, V26, P129, DOI 10.1080/08964280009595760; Strauss A, 1997, GROUNDED THEORY PRAC; Thomas VS, 2001, J AM GERIATR SOC, V49, P415, DOI 10.1046/j.1532-5415.2001.49085.x; Wadd S, 2011, WORKING OLDER DRINKE; Ward L, 2011, QUAL AGEING OLDER AD, V12, P239, DOI 10.1108/14717791111191171; Watson JM, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17250; Williams RD, 2006, USE SOCIAL ECOLOGY M, V21, P228; Wilson GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071792; World Health Organisation, 2004, WHAT MAIN RISK FACT; World Health Organization, 2012, GOOD HLTH ADDS LIF Y	62	17	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148601	10.1371/journal.pone.0148601	http://dx.doi.org/10.1371/journal.pone.0148601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26848583	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000369554000134
J	Li, B; Zhao, YH; Liu, H; Meng, B; Wang, JT; Qi, TJ; Zhang, H; Li, T; Zhao, PQ; Sun, H; Xu, J; Song, HB; Dong, Z; An, FS				Li, Bo; Zhao, Yunhe; Liu, Hui; Meng, Bin; Wang, Jitao; Qi, Tianjun; Zhang, Hui; Li, Tao; Zhao, Peiqing; Sun, Hui; Xu, Jia; Song, Haibo; Dong, Zhe; An, Fengshuang			Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-8; ENDOTHELIAL-CELLS; NEUTROPHIL ELASTASE; MMP-2/9 PRODUCTION; IN-VITRO; EXPRESSION; MACROPHAGES; ACTIVATION; STROMELYSIN; NAMPT	Objectives Although there is evidence that visfatin is associated with atherogenesis, the effect of visfatin on plaque stability has not yet been explored. Methods In vivo, vulnerable plaques were established by carotid collar placement in apolipoprotein E-deficient (ApoE(-/-)) mice, and lentivirus expressing visfatin (lenti-visfatin) was locally infused in the carotid artery. The lipid, macrophage, smooth muscle cell (SMC) and collagen levels were evaluated, and the vulnerability index was calculated. In vitro, RAW264.7 cells were stimulated with visfatin, and the MMPs expressions were assessed by western blot and immunofluorescence. And the mechanism that involved in visfatin-induced MMP-8 production was investigated. Results Transfection with lenti-visfatin significantly promoted the expression of visfatin which mainly expressed in macrophages in the plaque. Lenti-visfatin transfection significantly promoted the accumulation of lipids and macrophages, modulated the phenotypes of smooth muscle cells and decreased the collagen levels in the plaques, which significantly decreased the plaque stability. Simultaneously, transfection with lenti-visfatin significantly up-regulated the expression of MMP-8 in vivo, as well as MMP-1, MMP-2 and MMP-9. Recombinant visfatin dose-and time-dependently up-regulated the in vitro expression of MMP-8 in macrophages. Visfatin promoted the translocation of NF-kappa B, and inhibition of NF-kappa B significantly reduced visfatin-induced MMP-8 production. Conclusions Visfatin increased MMP-8 expression, promoted collagen degradation and increased the plaques vulnerability index.	[Li, Bo; Zhao, Yunhe; Meng, Bin; Wang, Jitao; Qi, Tianjun; Zhang, Hui; Li, Tao; Zhao, Peiqing; Sun, Hui] Cent Hosp Zibo, Dept Cardiol, Zibo, Peoples R China; [Liu, Hui; An, Fengshuang] Shandong Univ, Dept Cardiol, Qilu Hosp, Jinan 250100, Peoples R China; [Xu, Jia; Song, Haibo] Zibo Maternal & Child Hlth Hosp, Prenatal Diag Ctr, Zibo, Peoples R China; [Dong, Zhe] China Japan Friendship Hosp, Dept Cardiol, Beijing, Peoples R China	Shandong University; China-Japan Friendship Hospital	An, FS (corresponding author), Shandong Univ, Dept Cardiol, Qilu Hosp, Jinan 250100, Peoples R China.; Dong, Z (corresponding author), China Japan Friendship Hosp, Dept Cardiol, Beijing, Peoples R China.	sdwhdz@hotmail.com; anfengshuang@sina.com	zhao, peiqing/E-6602-2014	Zhao, Peiqing/0000-0002-9311-1927	Science Foundation of Shandong Province [ZR2014HP005]; Natural Science Foundation of China [81370325, 81500286]	Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Science Foundation of Shandong Province (ZR2014HP005) and Natural Science Foundation of China (no. 81370325 and no. 81500286).	Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Adya R, 2008, DIABETES CARE, V31, P758, DOI 10.2337/dc07-1544; Bessa SS, 2010, EUR J INTERN MED, V21, P530, DOI 10.1016/j.ejim.2010.09.011; Cirillo P, 2012, THROMB RES, V130, P403, DOI 10.1016/j.thromres.2012.06.007; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Dalamaga M, 2012, MED HYPOTHESES, V79, P617, DOI 10.1016/j.mehy.2012.07.036; Dollery CM, 2003, CIRCULATION, V107, P2829, DOI 10.1161/01.CIR.0000072792.65250.4A; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Fan YQ, 2011, INT J MOL MED, V27, P607, DOI 10.3892/ijmm.2011.621; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; HASTY KA, 1987, J BIOL CHEM, V262, P10048; ITOH Y, 1995, J BIOL CHEM, V270, P16518, DOI 10.1074/jbc.270.28.16518; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Kadoglou NPE, 2010, EXP CLIN ENDOCR DIAB, V118, P75, DOI 10.1055/s-0029-1237360; Kim SR, 2008, BBA-MOL CELL RES, V1783, P886, DOI 10.1016/j.bbamcr.2008.01.004; Knauper V, 1996, EUR J BIOCHEM, V235, P187, DOI 10.1111/j.1432-1033.1996.00187.x; La VD, 2011, J PERIODONTOL, V82, P122, DOI 10.1902/jop.2010.100342; Laxton RC, 2009, CIRC RES, V105, P921, DOI 10.1161/CIRCRESAHA.109.200279; Lee WJ, 2009, INT J OBESITY, V33, P465, DOI 10.1038/ijo.2009.24; Lenglet S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/659282; Li B, 2014, INT J CARDIOL, V174, P179, DOI 10.1016/j.ijcard.2014.03.186; Li B, 2013, ATHEROSCLEROSIS, V228, P370, DOI 10.1016/j.atherosclerosis.2013.03.023; Li JJ, 2012, ARTERIOSCL THROM VAS, V32, P1158, DOI 10.1161/ATVBAHA.112.246108; Molloy KJ, 2004, CIRCULATION, V110, P337, DOI 10.1161/01.CIR.0000135588.65188.14; Moulton KS, 2003, P NATL ACAD SCI USA, V100, P4736, DOI 10.1073/pnas.0730843100; Nokhbehsaim M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/437123; OKADA Y, 1989, FEBS LETT, V249, P353, DOI 10.1016/0014-5793(89)80657-X; Sandeep S, 2007, METABOLISM, V56, P565, DOI 10.1016/j.metabol.2006.12.005; Segawa K, 2006, BIOCHEM BIOPH RES CO, V349, P875, DOI 10.1016/j.bbrc.2006.07.083; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200; Yang JM, 2011, J CELL MOL MED, V15, P602, DOI 10.1111/j.1582-4934.2010.01028.x; Yilmaz MI, 2009, CLIN TRANSPLANT, V23, P241, DOI 10.1111/j.1399-0012.2008.00921.x; Yu XY, 2010, HORM METAB RES, V42, P507, DOI 10.1055/s-0030-1249059; Zhang XC, 2014, J CARDIOVASCULAR PHA; Zhang XC, 2014, J CARDIOVASC PHARM, V64, P318, DOI 10.1097/FJC.0000000000000117	37	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148273	10.1371/journal.pone.0148273	http://dx.doi.org/10.1371/journal.pone.0148273			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848572	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000062
J	Xie, L; Dolai, S; Kang, YH; Liang, T; Xie, HL; Qin, TR; Yang, L; Chen, LY; Gaisano, HY				Xie, Li; Dolai, Subhankar; Kang, Youhou; Liang, Tao; Xie, Huanli; Qin, Tairan; Yang, Lu; Chen, Liangyi; Gaisano, Herbert Y.			Syntaxin-3 Binds and Regulates Both R- and L-Type Calcium Channels in Insulin-Secreting INS-1832/13 Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; GATED CA2+ CHANNEL; PROTEIN EXPRESSION; EXOCYTOSIS; RELEASE; MEMBRANE; GRANULES; CA(V)1.2; ISLETS; LINES	Syntaxin (Syn)-1A mediates exocytosis of predocked insulin-containing secretory granules (SGs) during first-phase glucose-stimulated insulin secretion (GSIS) in part via its interaction with plasma membrane (PM)-bound L-type voltage-gated calcium channels (Ca-v). In contrast, Syn-3 mediates exocytosis of newcomer SGs that accounts for second-phase GSIS. We now hypothesize that the newcomer SG Syn-3 preferentially binds and modulates R-type Ca-v opening, which was postulated to mediate second-phase GSIS. Indeed, glucose-stimulation of pancreatic islet beta-cell line INS-1 induced a predominant increase in interaction between Syn-3 and Ca(v)a1 pore-forming subunits of R-type Ca(v)2.3 and to lesser extent L-type Ca(v)s, while confirming the preferential interactions between Syn-1A with L-type (Ca(v)1.2, Ca(v)1.3) Ca(v)s. Consistently, direct binding studies employing heterologous HEK cells confirmed that Syn-3 preferentially binds Ca(v)2.3, whereas Syn-1A prefers L-type Ca(v)s. We then used siRNA knockdown (KD) of Syn-3 in INS-1 to study the endogenous modulatory actions of Syn-3 on Ca-v channels. Syn-3 KD enhanced Ca2+ currents by 46% attributed mostly to R-and L-type Ca(v)s. Interestingly, while the transmembrane domain of Syn-1A is the putative functional domain modulating Ca-v activity, it is the cytoplasmic domain of Syn-3 that appears to modulate Ca-v activity. We conclude that Syn-3 may mimic Syn-1A in the ability to bind and modulate Ca(v)s, but preferring Ca(v)2.3 to perhaps participate in triggering fusion of newcomer insulin SGs during second-phase GSIS.	[Xie, Li; Dolai, Subhankar; Kang, Youhou; Liang, Tao; Xie, Huanli; Qin, Tairan; Gaisano, Herbert Y.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; [Yang, Lu; Chen, Liangyi] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	University of Toronto; Peking University	Gaisano, HY (corresponding author), Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada.	herbert.gaisano@utoronto.ca	Chen, Liangyi/F-1352-2010	Chen, Liangyi/0000-0003-1270-7321	Canadian Institute of Health Research [MOP 86544, MOP 69083]; National Science Foundation of China [81222020]; 3D (Diet, Digestive Tract and Disease) Centre - Canadian Foundation for Innovation and Ontario Research Fund [19442]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 3D (Diet, Digestive Tract and Disease) Centre - Canadian Foundation for Innovation and Ontario Research Fund	This work was supported by grants to H. Y. Gaisano from the Canadian Institute of Health Research (MOP 86544 and MOP 69083) and grants to L. Chen from the National Science Foundation of China (81222020). Some of the equipment used in this study was supported by the 3D (Diet, Digestive Tract and Disease) Centre funded by the Canadian Foundation for Innovation and Ontario Research Fund, project number 19442.	Arien H, 2003, J BIOL CHEM, V278, P29231, DOI 10.1074/jbc.M301401200; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Atlas D, 2013, ANNU REV BIOCHEM, V82, P607, DOI 10.1146/annurev-biochem-080411-121438; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Cohen R, 2004, NEUROSCIENCE, V128, P831, DOI 10.1016/j.neuroscience.2004.07.027; Cohen R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001273; Davalli AM, 1996, J ENDOCRINOL, V150, P195, DOI 10.1677/joe.0.1500195; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Gaisano HY, 2014, TRENDS ENDOCRIN MET, V25, P381, DOI 10.1016/j.tem.2014.03.005; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Huang XH, 2001, AM J PHYSIOL-CELL PH, V281, pC740, DOI 10.1152/ajpcell.2001.281.3.C740; Ji JZ, 2002, DIABETES, V51, P1425, DOI 10.2337/diabetes.51.5.1425; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Kang Y, 2002, DIABETOLOGIA, V45, P231, DOI 10.1007/s00125-001-0718-0; Kang YH, 2004, J BIOL CHEM, V279, P47125, DOI 10.1074/jbc.M404954200; Lam PPL, 2013, DIABETES, V62, P2416, DOI 10.2337/db12-1380; Nitert MD, 2008, J MOL ENDOCRINOL, V41, P1, DOI 10.1677/JME-07-0133; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Pedersen MG, 2009, P NATL ACAD SCI USA, V106, P7432, DOI 10.1073/pnas.0901202106; Pfeffer SR, 2013, CELL, V155, P1203, DOI 10.1016/j.cell.2013.11.014; Reinbothe TM, 2013, DIABETOLOGIA, V56, P340, DOI 10.1007/s00125-012-2758-z; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Taylor JT, 2005, AM J PHYSIOL-ENDOC M, V289, pE900, DOI 10.1152/ajpendo.00101.2005; Trus M, 2001, NEUROSCIENCE, V104, P599, DOI 10.1016/S0306-4522(01)00083-5; Trus M, 2007, BIOCHEMISTRY-US, V46, P14461, DOI 10.1021/bi7016816; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Xie L, 2015, DIABETOLOGIA, V58, P1250, DOI 10.1007/s00125-015-3545-4; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067561; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yang SN, 1999, P NATL ACAD SCI USA, V96, P10164, DOI 10.1073/pnas.96.18.10164; Yang SN, 2005, J CLIN INVEST, V115, P16, DOI 10.1172/JCI200523970; Zhu D, 2013, DIABETOLOGIA, V56, P359, DOI 10.1007/s00125-012-2757-0; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	41	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147862	10.1371/journal.pone.0147862	http://dx.doi.org/10.1371/journal.pone.0147862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848587	Green Published, gold			2022-12-26	WOS:000369554000026
J	Xu, G; Huang, J; Yang, Y; Yao, YA				Xu, Gang; Huang, Jian; Yang, Yong; Yao, Yin-an			Transcriptome Analysis of Flower Sex Differentiation in Jatropha curcas L. Using RNA Sequencing	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; SMALL AUXIN; MICROARRAY ANALYSIS; FUNCTIONAL-ANALYSIS; CELL-PROLIFERATION; NEGATIVE REGULATOR; GENE-EXPRESSION; CRABS-CLAW; ARABIDOPSIS; MERISTEM	Background Jatropha curcas is thought to be a promising biofuel material, but its yield is restricted by a low ratio of instaminate / staminate flowers (1/10-1/30). Furthermore, valuable information about flower sex differentiation in this plant is scarce. To explore the mechanism of this process in J. curcas, transcriptome profiling of flower development was carried out, and certain genes related with sex differentiation were obtained through digital gene expression analysis of flower buds from different phases of floral development. Results After Illumina sequencing and clustering, 57,962 unigenes were identified. A total of 47,423 unigenes were annotated, with 85 being related to carpel and stamen differentiation, 126 involved in carpel and stamen development, and 592 functioning in the later development stage for the maturation of staminate or instaminate flowers. Annotation of these genes provided comprehensive information regarding the sex differentiation of flowers, including the signaling system, hormone biosynthesis and regulation, transcription regulation and ubiquitin-mediated proteolysis. A further expression pattern analysis of 15 sex-related genes using quantitative real-time PCR revealed that gibberellin-regulated protein 4-like protein and AMP-activated protein kinase are associated with stamen differentiation, whereas auxin response factor 6-like protein, AGAMOUS-like 20 protein, CLAVATA1, RING-H2 finger protein ATL3J, auxin-induced protein 22D, and r2r3-myb transcription factor contribute to embryo sac development in the instaminate flower. Cytokinin oxidase, Unigene28, auxin repressed-like protein ARP1, gibberellin receptor protein GID1 and auxin-induced protein X10A are involved in both stages mentioned above. In addition to its function in the differentiation and development of the stamens, the gibberellin signaling pathway also functions in embryo sac development for the instaminate flower. The auxin signaling pathway also participates in both stamen development and embryo sac development. Conclusions Our transcriptome data provide a comprehensive gene expression profile for flower sex differentiation in Jatropha curcas, as well as new clues and information for further study in this field.	[Xu, Gang] Guizhou Univ, Res Inst Forest Resources & Environm, Guiyang 550003, Guizhou, Peoples R China; [Huang, Jian; Yang, Yong] Guizhou Univ, Ctr Res & Dev Fine Chem, Minist Educ, Key Lab Green Pesticide & Agr Bioengn, Guiyang 550003, Guizhou, Peoples R China; [Yao, Yin-an] Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Sichuan, Peoples R China; [Xu, Gang] Guizhou Univ, Inst Entomol, Guiyang 550003, Guizhou, Peoples R China	Guizhou University; Guizhou University; Southwest University of Science & Technology - China; Guizhou University	Yao, YA (corresponding author), Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Sichuan, Peoples R China.	yaoya@ms.xjb.ac.cn			National Natural Science Foundation of China [31060103, 31270660]; Social development Research Project of Guizhou Province [20083009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social development Research Project of Guizhou Province	This work was supported by No. 31060103 and No. 31270660 National Natural Science Foundation of China (http://www.nsfc.gov.cn to XG), 20083009 Social development Research Project of Guizhou Province (http://kjt.gzst.gov.cn to XG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Alvarez J, 1999, DEVELOPMENT, V126, P2377; Aubert D, 1998, PLANT MOL BIOL, V36, P871, DOI 10.1023/A:1005938624418; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Borg M, 2011, PLANT CELL, V23, P534, DOI 10.1105/tpc.110.081059; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Carvalho CR, 2008, PLANT SCI, V174, P613, DOI 10.1016/j.plantsci.2008.03.010; Chae K, 2012, PLANT J, V71, P684, DOI 10.1111/j.1365-313X.2012.05024.x; CLARK SE, 1993, DEVELOPMENT, V119, P397; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Dehgan B, 1992, MORPHOLOGY FRAGENERI; Durbak AR, 2011, GENETICS, V189, P177, DOI 10.1534/genetics.111.130930; Foidl N, 1996, BIORESOURCE TECHNOL, V58, P77, DOI 10.1016/S0960-8524(96)00111-3; Francis G, 2005, NAT RESOUR FORUM, V29, P12, DOI 10.1111/j.1477-8947.2005.00109.x; GEE MA, 1991, PLANT CELL, V3, P419, DOI 10.1105/tpc.3.4.419; Gocal GFW, 1999, PLANT PHYSIOL, V119, P1271, DOI 10.1104/pp.119.4.1271; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Heller J, 1996, THESIS INT PLANT GEN; Huang S, 2003, PLANT PHYSIOL, V131, P1270, DOI 10.1104/pp.102.018598; Huang YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-691; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Kant S, 2009, PLANT SIGNAL BEHAV, V4, P1174, DOI 10.4161/psb.4.12.10043; Kant S, 2009, PLANT PHYSIOL, V151, P691, DOI 10.1104/pp.109.143875; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kazama T, 2003, FEBS LETT, V544, P99, DOI 10.1016/S0014-5793(03)00480-0; Kim HB, 2007, MOL CELLS, V23, P115; Kong YY, 2013, PLANT CELL PHYSIOL, V54, P609, DOI 10.1093/pcp/pct028; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lee MW, 2001, MOL PLANT MICROBE IN, V14, P527, DOI 10.1094/MPMI.2001.14.4.527; Liu HZ, 2008, PLANT MOL BIOL, V68, P17, DOI 10.1007/s11103-008-9349-x; Liu LYD, 2014, PLANT CELL PHYSIOL, V55, P942, DOI 10.1093/pcp/pcu029; Lu YQ, 2011, PLANT J, V67, P13, DOI 10.1111/j.1365-313X.2011.04569.x; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Mandaokar A, 2009, PLANT PHYSIOL, V149, P851, DOI 10.1104/pp.108.132597; MCCLURE BA, 1989, SCIENCE, V243, P91, DOI 10.1126/science.11540631; MCCLURE BA, 1987, PLANT MOL BIOL, V9, P611, DOI 10.1007/BF00020537; Molnar G, 2002, PLANTA, V215, P127, DOI 10.1007/s00425-001-0723-z; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Murray F, 2003, PLANT J, V33, P481, DOI 10.1046/j.1365-313X.2003.01641.x; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Nakamura T, 2004, BIOCHEM SOC T, V32, P571, DOI 10.1042/BST0320571; Natarajan P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-606; Pan BZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-974; Park S, 2003, TREE PHYSIOL, V23, P815, DOI 10.1093/treephys/23.12.815; Raffaele S, 2006, FEBS LETT, V580, P3498, DOI 10.1016/j.febslet.2006.05.027; REDDY ASN, 1990, PLANT MOL BIOL, V14, P127, DOI 10.1007/BF00018554; Roxrud I, 2007, PLANT CELL PHYSIOL, V48, P471, DOI 10.1093/pcp/pcm016; Ruonala R, 2006, PLANT J, V46, P628, DOI 10.1111/j.1365-313X.2006.02722.x; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Spartz AK, 2012, PLANT J, V70, P978, DOI 10.1111/j.1365-313X.2012.04946.x; Steiner C, 2003, BBA-GENE STRUCT EXPR, V1625, P123, DOI 10.1016/S0167-4781(02)00598-5; Tewari DN., 2007, JATROPHA BIODIESEL; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wang W, 2011, CHINA BIOTECHNOL, V31, P38; Wang Z, 2005, PLANT MOL BIOL, V58, P721, DOI 10.1007/s11103-005-8267-4; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705	67	29	32	6	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0145613	10.1371/journal.pone.0145613	http://dx.doi.org/10.1371/journal.pone.0145613			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848843	Green Published, Green Submitted, gold			2022-12-26	WOS:000369554000004
J	Zahedi, A; On, V; Lin, SC; Bays, BC; Omaiye, E; Bhanu, B; Talbot, P				Zahedi, Atena; On, Vincent; Lin, Sabrina C.; Bays, Brett C.; Omaiye, Esther; Bhanu, Bir; Talbot, Prue			Evaluating Cell Processes, Quality, and Biomarkers in Pluripotent Stem Cells Using Video Bioinformatics	PLOS ONE			English	Article							FEATURE-SELECTION; IN-VITRO; REGION DETECTION; HUMAN HEALTH; MOUSE; SMOKE; TOXICITY; EXPOSURE; DISEASE; MODEL	There is a foundational need for quality control tools in stem cell laboratories engaged in basic research, regenerative therapies, and toxicological studies. These tools require automated methods for evaluating cell processes and quality during in vitro passaging, expansion, maintenance, and differentiation. In this paper, an unbiased, automated high-content profiling toolkit, StemCellQC, is presented that non-invasively extracts information on cell quality and cellular processes from time-lapse phase-contrast videos. Twenty four (24) morphological and dynamic features were analyzed in healthy, unhealthy, and dying human embryonic stem cell (hESC) colonies to identify those features that were affected in each group. Multiple features differed in the healthy versus unhealthy/dying groups, and these features were linked to growth, motility, and death. Biomarkers were discovered that predicted cell processes before they were detectable by manual observation. StemCellQC distinguished healthy and unhealthy/dying hESC colonies with 96% accuracy by non-invasively measuring and tracking dynamic and morphological features over 48 hours. Changes in cellular processes can be monitored by StemCellQC and predictions can be made about the quality of pluripotent stem cell colonies. This toolkit reduced the time and resources required to track multiple pluripotent stem cell colonies and eliminated handling errors and false classifications due to human bias. StemCellQC provided both user-specified and classifier-determined analysis in cases where the affected features are not intuitive or anticipated. Video analysis algorithms allowed assessment of biological phenomena using automatic detection analysis, which can aid facilities where maintaining stem cell quality and/or monitoring changes in cellular processes are essential. In the future StemCellQC can be expanded to include other features, cell types, treatments, and differentiating cells.	[Zahedi, Atena; Bhanu, Bir] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [On, Vincent; Bhanu, Bir] Univ Calif Riverside, Dept Elect & Comp Engn, Riverside, CA 92521 USA; [On, Vincent; Bhanu, Bir] Univ Calif Riverside, Ctr Res Intelligent Syst, Riverside, CA 92521 USA; [Zahedi, Atena; Lin, Sabrina C.; Omaiye, Esther; Talbot, Prue] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Zahedi, Atena; Lin, Sabrina C.; Omaiye, Esther; Talbot, Prue] Univ Calif Riverside, UCR Stem Cell Ctr & Core, Riverside, CA 92521 USA; [Bays, Brett C.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Talbot, P (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.; Talbot, P (corresponding author), Univ Calif Riverside, UCR Stem Cell Ctr & Core, Riverside, CA 92521 USA.	talbot@ucr.edu	Talbot, Prue/AAY-3896-2021	Omaiye, Esther E./0000-0002-6010-4798; Zahedi, Atena/0000-0002-1005-9845; Bhanu, Bir/0000-0001-8971-6416	NSF IGERT grant in Video Bioinformatics [DGE 0903667]; California Institute for Regenerative Medicine [NE-A0005A-1E]; Tobacco-Related Disease Research Program of CA [22RT-0127, 20PT-0184]	NSF IGERT grant in Video Bioinformatics; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Tobacco-Related Disease Research Program of CA	The authors thank Dr. Albert Cruz (IGERT Fellow) and Dr. Seyyed Farhad Razavi who helped with parts of the software implementation and Jackie Whitehead for her suggestions on the manuscript. This work is supported by a NSF IGERT grant in Video Bioinformatics (DGE 0903667), the California Institute for Regenerative Medicine (# NE-A0005A-1E), and grants from the Tobacco-Related Disease Research Program of CA (# 22RT-0127 and #20PT-0184).	Alworth SV, 2010, J BIOMOL SCREEN, V15, P968, DOI 10.1177/1087057110373546; Barbaric I, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.006; Bermingham ML, 2015, SCI REP-UK, V5, DOI 10.1038/srep10312; Bradley CK, 2011, STEM CELLS DEV, V20, P495, DOI 10.1089/scd.2010.0120; Cawley GC, 2007, ADV NEURAL INFORM PR, P209; Chen KG, 2014, CELL STEM CELL, V14, P13, DOI 10.1016/j.stem.2013.12.005; Cover T. M., 1991, ELEMENTS INFORM THEO; DEBERG M, 2000, COMPUTATIONAL GEOMET; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Duda R.O., 2000, PATTERN CLASSIFICATI; Fogh BS, 2014, J HISTOCHEM CYTOCHEM, V62, P172, DOI 10.1369/0022155413517701; Gini C, 1912, VARIABILITE MUTABILI; Grandjean P, 2008, BASIC CLIN PHARMACOL, V102, P73, DOI 10.1111/j.1742-7843.2007.00114.x; Guan B. X., 2011, 2011 IEEE International Conference on Healthcare Informatics, Imaging and Systems Biology, P307, DOI 10.1109/HISB.2011.30; Guan B. X., 2012, IEEE 2 INT C HEALTHC, P75, DOI DOI 10.1109/HISB.2012.25; Guan BX, 2014, IEEE ACM T COMPUT BI, V11, P604, DOI 10.1109/TCBB.2014.2306836; Guan BX, 2013, I S BIOMED IMAGING, P418; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Ke HN, 2011, CELL ADHES MIGR, V5, P6, DOI 10.4161/cam.5.1.13175; Knoll M, 1998, REPROD TOXICOL, V12, P57, DOI 10.1016/S0890-6238(97)00100-7; KNOLL M, 1995, BIOL REPROD, V53, P29, DOI 10.1095/biolreprod53.1.29; Lin S, 2009, HUM REPROD, V24, P386, DOI 10.1093/humrep/den419; Lin Sabrina, 2010, J Vis Exp, DOI 10.3791/1933; Lin S, 2011, METHODS MOL BIOL, V690, P31, DOI 10.1007/978-1-60761-962-8_2; Lin S, 2010, TOXICOL SCI, V118, P202, DOI 10.1093/toxsci/kfq241; Liu H, 1995, PROC INT C TOOLS ART, P388, DOI 10.1109/TAI.1995.479783; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Megyola CM, 2013, STEM CELLS, V31, P895, DOI 10.1002/stem.1323; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Montgomery D. C., 2001, ENG STAT; Nguyen XV, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P512, DOI 10.1145/2623330.2623611; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Shapiro L., 2001, COMPUTER VISION; Sheehy SP, 2014, STEM CELL REP, V2, P282, DOI 10.1016/j.stemcr.2014.01.015; Smith LA, 1999, INT FLAIRS C, P5, DOI 10.1.1.50.2192; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Talbot P, 2014, HANDBOOK OF NANOTOXICOLOGY, NANOMEDICINE AND STEM CELL USE IN TOXICOLOGY, P379; Talbot P, 2011, CURR TOP MED CHEM, V11, P1638; Tokunaga K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06996; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Wang XL, 2013, SOFT MATTER, V9, P4160, DOI 10.1039/c3sm27818b; WEI LJ, 1981, J AM STAT ASSOC, V76, P1006, DOI 10.2307/2287603; Winter M, 2011, NAT PROTOC, V6, P1942, DOI 10.1038/nprot.2011.422; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Zhao Zheng, 2010, ADV FEATURE SELECTIO; Zhu ZR, 2013, DEVELOPMENT, V140, P705, DOI 10.1242/dev.086165	48	17	17	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148642	10.1371/journal.pone.0148642	http://dx.doi.org/10.1371/journal.pone.0148642			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848582	Green Published, gold			2022-12-26	WOS:000369554000146
J	Hedner, C; Borg, D; Nodin, B; Karnevi, E; Jirstrom, K; Eberhard, J				Hedner, Charlotta; Borg, David; Nodin, Bjorn; Karnevi, Emelie; Jirstrom, Karin; Eberhard, Jakob			Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma	PLOS ONE			English	Article							PHASE-II TRIAL; ADVANCED ESOPHAGOGASTRIC CANCER; GASTROESOPHAGEAL JUNCTION; PROTEIN EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; TISSUE MICROARRAYS; GENE AMPLIFICATION; BIOMARKER ANALYSIS; HER3 EXPRESSION; ERBB EGFR	Background Gastric and esophageal adenocarcinomas are major global cancer burdens. These cancer forms are characterized by a poor prognosis and a modest response to chemo-radio-and targeted treatment. Hence there is an obvious need for further enhanced diagnostic and treatment strategies. The aim of this study was to examine the expression and prognostic impact of human epidermal growth factor receptor 1 (HER1/EGFR) and 3 (HER3), as well as the occurrence of EGFR and KRAS mutations in gastric and esophageal adenocarcinoma. Methods Immunohistochemical expression of EGFR and HER3 was analysed in all primary tumours and a subset of lymph node metastases in a consecutive cohort of 174 patients with adenocarcinoma of the stomach, cardia and esophagus. The anti-HER3 antibody used was validated by siRNA-mediated knockdown, immunohistochemistry and quantitative real-time PCR. EGFR and KRAS mutation status was analysed by pyrosequencing tecchnology. Results and Discussion High EGFR expression was an independent risk factor for shorter overall survival (OS), whereas high HER3 expression was associated with a borderline significant trend towards a longer OS. KRAS mutations were present in only 4% of the tumours and had no prognostic impact. All tumours were EGFR wild-type. These findings contribute to the ongoing efforts to decide on the potential clinical value of different HERs and druggable mutations in gastric and esophageal adenocarcinomas, and attention is drawn to the need for more standardised investigational methods.	[Hedner, Charlotta; Borg, David; Nodin, Bjorn; Karnevi, Emelie; Jirstrom, Karin; Eberhard, Jakob] Lund Univ, Div Oncol & Pathol, Dept Clin Sci Lund, Skane Univ Hosp, S-22185 Lund, Sweden	Lund University; Skane University Hospital	Hedner, C (corresponding author), Lund Univ, Div Oncol & Pathol, Dept Clin Sci Lund, Skane Univ Hosp, S-22185 Lund, Sweden.	charlotta.hedner@med.lu.se		Borg, David/0000-0001-9461-7391	Swedish Cancer Society [KJ 2014/540]; Crafoord Foundation; Olle Engkvist Foundation; Anna Lisa and Sven-Eric Lundgren Foundation; Mrs Berta Kamprad Foundation; Lund University Faculty of Medicine; Lund University Hospital Research Grants; Swedish Government Grant for Clinical Research	Swedish Cancer Society(Swedish Cancer Society); Crafoord Foundation; Olle Engkvist Foundation; Anna Lisa and Sven-Eric Lundgren Foundation; Mrs Berta Kamprad Foundation; Lund University Faculty of Medicine; Lund University Hospital Research Grants; Swedish Government Grant for Clinical Research	This work was supported by Swedish Cancer Society, KJ 2014/540, the Crafoord Foundation, to JE; the Olle Engkvist Foundation, to JE; the Anna Lisa and Sven-Eric Lundgren Foundation, to JE; the Mrs Berta Kamprad Foundation, to JE; Lund University Faculty of Medicine, to KJ; Lund University Hospital Research Grants, to KJ; and the Swedish Government Grant for Clinical Research, to CH JE KJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SM, 2015, ONCOLOGIST, V20, P499, DOI 10.1634/theoncologist.2014-0378; Amin DN, 2010, SEMIN CELL DEV BIOL, V21, P944, DOI 10.1016/j.semcdb.2010.08.007; Anagnostou VK, 2010, CANCER EPIDEM BIOMAR, V19, P982, DOI 10.1158/1055-9965.EPI-10-0097; Baiocchi G, 2009, INT J COLORECTAL DIS, V24, P1059, DOI 10.1007/s00384-009-0702-6; Bang YJ, 2010, LANCET, V376, P1302; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Bhargava R, 2006, CANCER-AM CANCER SOC, V106, P1857, DOI 10.1002/cncr.21782; Bosetti C, 2008, INT J CANCER, V122, P1118, DOI 10.1002/ijc.23232; Buas MF, 2013, SEMIN RADIAT ONCOL, V23, P3, DOI 10.1016/j.semradonc.2012.09.008; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Chen C, 2013, ARCH MED RES, V44, P380, DOI 10.1016/j.arcmed.2013.07.001; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Desai MD, 2013, EXPERT OPIN INV DRUG, V22, P341, DOI 10.1517/13543784.2013.761972; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Dragovich T, 2006, J CLIN ONCOL, V24, P4922, DOI 10.1200/JCO.2006.07.1316; Dutton SJ, 2014, LANCET ONCOL, V15, P894, DOI 10.1016/S1470-2045(14)70024-5; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; FEDI P, 1994, MOL CELL BIOL, V14, P492, DOI 10.1128/MCB.14.1.492; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferry DR, 2007, CLIN CANCER RES, V13, P5869, DOI 10.1158/1078-0432.CCR-06-1970; Fichter CD, 2014, INT J CANCER, V135, P1517, DOI 10.1002/ijc.28771; Fristedt R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-83; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gibson MK, 2003, CLIN CANCER RES, V9, P6461; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; He XX, 2015, J CLIN PATHOL, V68, P374, DOI 10.1136/jclinpath-2014-202657; Hechtman JF, 2012, ARCH PATHOL LAB MED, V136, P691, DOI 10.5858/arpa.2011-0168-RS; Hedner C, 2016, HISTOPATHOLOGY, V68, P230, DOI 10.1111/his.12744; Hedner C, 2014, VIRCHOWS ARCH, V465, P649, DOI 10.1007/s00428-014-1667-6; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Janmaat ML, 2006, J CLIN ONCOL, V24, P1612, DOI 10.1200/JCO.2005.03.4900; Jarde T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138336; Jiang N, 2014, MOL CANCER THER, V13, P1826, DOI 10.1158/1535-7163.MCT-13-1093; Jonsson L, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-11; Kim JS, 2009, BRIT J CANCER, V100, P732, DOI 10.1038/sj.bjc.6604936; Kim MA, 2008, HISTOPATHOLOGY, V52, P738, DOI 10.1111/j.1365-2559.2008.03021.x; Kimura M, 2004, VIRCHOWS ARCH, V445, P255, DOI 10.1007/s00428-004-1048-7; Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lauwers GY, 2009, SURG PATHOLOGY GI TR, P563; Ledel F, 2015, ACTA ONCOL, V54, P480, DOI 10.3109/0284186X.2014.983654; LoRusso P, 2013, CLIN CANCER RES, V19, P3078, DOI 10.1158/1078-0432.CCR-12-3051; Luber B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-509; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Mujoo K, 2014, ONCOTARGET, V5, P10222, DOI 10.18632/oncotarget.2655; Oba K, 2013, EUR J CANCER, V49, P1565, DOI 10.1016/j.ejca.2012.12.016; Ocana A, 2013, JNCI-J NATL CANCER I, V105, P266, DOI 10.1093/jnci/djs501; Okines AFC, 2010, J CLIN ONCOL, V28, P3945, DOI 10.1200/JCO.2010.29.2847; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; QUINN CM, 1994, HISTOPATHOLOGY, V25, P247, DOI 10.1111/j.1365-2559.1994.tb01324.x; Rao S, 2010, ANN ONCOL, V21, P2213, DOI 10.1093/annonc/mdq247; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2; Seo AN, 2015, VIRCHOWS ARCH, V466, P645, DOI 10.1007/s00428-015-1747-2; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Society AC, 2011, GLOB CANC FACTS FIG; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Takahashi Naoki, 2014, BMC Res Notes, V7, P271, DOI 10.1186/1756-0500-7-271; Tao JJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005125; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Thiel A, 2015, APMIS, V123, P365, DOI 10.1111/apm.12359; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Vyberg M, 2016, VIRCHOWS ARCH, V468, P19, DOI 10.1007/s00428-015-1829-1; Wainberg ZA, 2011, BRIT J CANCER, V105, P760, DOI 10.1038/bjc.2011.280; Wang KL, 2007, CANCER-AM CANCER SOC, V109, P658, DOI 10.1002/cncr.22445; Wei QC, 2007, INT J ONCOL, V31, P493; Wilkinson NW, 2004, J GASTROINTEST SURG, V8, P448, DOI 10.1016/j.gassur.2004.01.006; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yoon HH, 2014, CANCER-AM CANCER SOC, V120, P415, DOI 10.1002/cncr.28435	73	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148101	10.1371/journal.pone.0148101	http://dx.doi.org/10.1371/journal.pone.0148101			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844548	gold, Green Published, Green Submitted			2022-12-26	WOS:000369552800029
J	Black, C; Collen, B; Johnston, D; Hart, T				Black, Caitlin; Collen, Ben; Johnston, Daniel; Hart, Tom			Why Huddle? Ecological Drivers of Chick Aggregations in Gentoo Penguins, Pygoscelis papua, across Latitudes	PLOS ONE			English	Article								Aggregations of young animals are common in a range of endothermic and ectothermic species, yet the adaptive behavior may depend on social circumstance and local conditions. In penguins, many species form aggregations (aka. creches) for a variety of purposes, whilst others have never been observed exhibiting this behavior. Those that do form aggregations do so for three known benefits: 1) reduced thermoregulatory requirements, 2) avoidance of unrelated-adult aggression, and 3) lower predation risk. In gentoo penguins, Pygoscelis papua, chick aggregations are known to form during the post-guard period, yet the cause of these aggregations is poorly understood. Here, for the first time, we study aggregation behavior in gentoo penguins, examining four study sites along a latitudinal gradient using time-lapse cameras to examine the adaptive benefit of aggregations to chicks. Our results support the idea that aggregations of gentoo chicks decrease an individual's energetic expenditure when wet, cold conditions are present. However, we found significant differences in aggregation behavior between the lowest latitude site, Maiviken, South Georgia, and two of the higher latitude sites on the Antarctic Peninsula, suggesting this behavior may be colony specific. We provide strong evidence that more chicks aggregate and a larger number of aggregations occur on South Georgia, while the opposite occurs at Petermann Island in Antarctica. Future studies should evaluate multiple seabird colonies within one species before generalizing behaviors based on one location, and past studies may need to be re-evaluated to determine whether chick aggregation and other behaviors are in fact exhibited species-wide.	[Black, Caitlin; Hart, Tom] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England; [Collen, Ben] UCL, Ctr Biodivers & Environm Res, London, England; [Johnston, Daniel] British Antarctic Survey, King Edward Point Res Stn, London, England	University of Oxford; University of London; University College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Black, C (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.	caitlin.black@lincoln.ox.ac.uk	Collen, Ben/F-2543-2016	Collen, Ben/0000-0003-2564-4243; Black, Caitlin/0000-0001-9591-3571	Darwin Initiative [DPLUS002]; Foreign and Commonwealth Office; Quark Expeditions Ltd.; Exodus Travel Ltd.; Natural Environment Research Council [bas010011] Funding Source: researchfish; NERC [bas010011] Funding Source: UKRI	Darwin Initiative; Foreign and Commonwealth Office; Quark Expeditions Ltd.; Exodus Travel Ltd.; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Darwin Initiative (DPLUS002; https://www.gov.uk/government/groups/the-darwin-initiative) awarded to TH and BC, the Foreign and Commonwealth Office (https://www.gov.uk/government/organisations/foreign-commonwealth-office), Quark Expeditions Ltd., (http://www.quarkexpeditions.com/en), and Exodus Travel Ltd., (www.exodustravels.com) awarded to TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel A, 1997, NATURE, V385, P304, DOI 10.1038/385304a0; Aytar Y., 2012, ANNOTATION TOOL; Barbosa A, 2007, POLAR BIOL, V30, P1239, DOI 10.1007/s00300-007-0284-0; Barbosa A, 2012, POLAR BIOL, V35, P725, DOI 10.1007/s00300-011-1117-8; Barbosa A, 2011, POLAR BIOL, V34, P1621, DOI 10.1007/s00300-011-1000-7; BARRE H, 1984, J COMP PHYSIOL, V154, P317, DOI 10.1007/BF02464413; BEAL KG, 1978, AUK, V95, P195; Bost C.-A., 1990, P85; BOST CA, 1991, IBIS, V133, P14, DOI 10.1111/j.1474-919X.1991.tb04804.x; Chesalin M, 2009, MARINE ECOLOGICAL J, VVIII, P5; DAVIS LS, 1982, NEW ZEAL J ZOOL, V9, P279, DOI 10.1080/03014223.1982.10423856; de Leon A, 2002, POLAR BIOL, V25, P355, DOI 10.1007/s00300-001-0350-y; EVANS RM, 1984, CAN J ZOOL, V62, P814, DOI 10.1139/z84-118; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; Janes DN, 1997, PHYSIOL ZOOL, V70, P237, DOI 10.1086/639586; Lawless RM, 2001, J THERM BIOL, V26, P555, DOI 10.1016/S0306-4565(00)00049-8; Le Bohec C, 2005, ANIM BEHAV, V70, P527, DOI 10.1016/j.anbehav.2004.11.012; Lowen J., 2011, ANTARCTIC WILDLIFE V; Lynch HJ, 2010, POLAR BIOL, V33, P493, DOI 10.1007/s00300-009-0726-y; Lynch Heather J., 2008, Marine Ornithology, V36, P83; Martin J, 2006, BEHAV ECOL SOCIOBIOL, V60, P778, DOI 10.1007/s00265-006-0221-1; MESERVEY WR, 1976, AUK, V93, P177; Newbery KB, 2009, COLD REG SCI TECHNOL, V55, P47, DOI 10.1016/j.coldregions.2008.06.001; Penney R. L., 1968, Antarctic Research Series Washington, V12, P83; Penteriani V, 2003, POLAR BIOL, V26, P538, DOI 10.1007/s00300-003-0517-9; Pettingill Jr O. S., 1960, WILSON B, V72, P212; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; R Core Development Team, 2013, R LANG ENV STAT COMP; SEDDON PJ, 1991, AUK, V108, P548, DOI 10.2307/4088094; SMITH SM, 1972, CONDOR, V74, P478, DOI 10.2307/1365903; TAYLOR JRE, 1985, J COMP PHYSIOL B, V155, P615, DOI 10.1007/BF00694453; Trathan PN, 2008, BIOL CONSERV, V141, P3019, DOI 10.1016/j.biocon.2008.09.006; van Heezik Y, 1992, J FIELD ORNITHOL, P90; Venables WN., 2002, MODERN APPL STAT S 4; WILLIAMS TD, 1991, POLAR BIOL, V11, P197; Wilson D, 2009, AUK, V126, P688, DOI 10.1525/auk.2009.9709	36	17	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0145676	10.1371/journal.pone.0145676	http://dx.doi.org/10.1371/journal.pone.0145676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840252	Green Published, gold, Green Accepted			2022-12-26	WOS:000369550200002
J	Lv, X; Xia, L; Ge, DY; Wen, ZX; Qu, YH; Lu, L; Yang, QS				Lv, Xue; Xia, Lin; Ge, Deyan; Wen, Zhixin; Qu, Yanhua; Lu, Liang; Yang, Qisen			Continental Refugium in the Mongolian Plateau during Quaternary Glacial Oscillations: Phylogeography and Niche Modelling of the Endemic Desert Hamster, Phodopus roborovskii	PLOS ONE			English	Article							POSTGLACIAL COLONIZATION; MOLECULAR PHYLOGENY; CYTOCHROME-B; CLIMATE; DIVERSIFICATION; EVOLUTION; SEQUENCE; NEUTRALITY; DIVERSITY; INFERENCE	The Mongolian Plateau (MP), which is situated in the interior of Asia and possesses a typical continental climate, experienced harsh climatic conditions during the Quaternary glacial fluctuations. Although these events likely had huge impacts on the local animal populations, the current effects have hardly been explored. To investigate whether the MP supported a refugium along an oceanic-continental gradient (ROCG), and whether this refugium was glacial or interglacial, we investigated the demographic and phylogeographic history of an endemic mammal species, the desert hamster Phodopus roborovskii. We reconstructed the demographic variation, the phylogeographic diffusion, and modelled the potential habitat during historical periods. The genetic diversity in the MP was the highest among all the localities, and the MP was a suitable habitat throughout the modelled historical periods. A phylogeographic diffusion analysis emphasized the importance of the MP as the centre of origin, preservation and spread for P. roborovskii. The homogeneous landscape provided the opportunity for a wide gene flow, which resulted in low resolution of the phylogenetic relationships. Moreover, P. roborovskii was favoured by the interglacial condition, with both its demographical and geographical ranges expanded within the interglacial periods. The range variation from the Last Glacial Maximum to the current condition reflects a distinct longitudinal shift, while both ranges largely contracted from that of the Last Interglacial. Our results support that the MP served as a refugium and spread centre for P. roborovskii during the Quaternary climate fluctuations. The interglacial expansion and the longitudinal shifts highlighted the important effects of precipitations on the distribution range of species adapted to arid and semi-arid during glacial oscillations.	[Lv, Xue; Xia, Lin; Ge, Deyan; Wen, Zhixin; Qu, Yanhua; Yang, Qisen] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China; [Lv, Xue] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Lu, Liang] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Yang, QS (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China.	yangqs@ioz.ac.cn	Ge, Deyan/AAU-7240-2020; 葛, 德燕/ABB-3018-2021	Wen, Zhixin/0000-0002-8300-4845; Ge, Deyan/0000-0001-8230-8647	Natural Science Foundation of China [31372177]; Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences [Y352D81405]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences	The work was supported by the following: Natural Science Foundation of China (http://www.nsfc.gov.cn): 31372177; and the Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences (http://www.anisys.ioz.cas.cn/): Y352D81405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bao WD, 2002, FOLIA ZOOL, V51, P9; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bouckaert RR, 2015, PHYLOGEOGRAPHY DIFFU; Chen, 1997, QUAT SCI, V2, P158; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Derenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032179; Drummond AJ, 2012, BAYESIAN INFERENCE S, P1; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FLINT V. E., 1961, BYULL MOSKOV OBSHCHESTVA ISPYTAT PRIRODY OTDEL BIOL, V66, P57; Fu YX, 1997, GENETICS, V147, P915; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Guo P, 2011, J BIOGEOGR, V38, P2326, DOI 10.1111/j.1365-2699.2011.02566.x; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, IUCN RED LIST THREAT; Jin LY, 2012, CLIM DYNAM, V38, P1577, DOI 10.1007/s00382-011-1086-1; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lanier HC, 2013, J BIOGEOGR, V40, P466, DOI 10.1111/jbi.12035; Lascoux M, 2010, MOL ECOL, V19, P1075, DOI 10.1111/j.1365-294X.2010.04547.x; Lebedev VS, 2007, ZOOL SCR, V36, P547, DOI 10.1111/j.1463-6409.2007.00300.x; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Li Y, 2012, PALAEOGEOGR PALAEOCL, V365, P263, DOI 10.1016/j.palaeo.2012.09.032; Lu HY, 2013, CHINESE SCI BULL, V58, P2775, DOI 10.1007/s11434-013-5919-7; MADDISON DR, 2000, MACCLADE 4; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Martinez-Freiria F, 2015, DIVERS DISTRIB, V21, P331, DOI 10.1111/ddi.12265; Meng HH, 2013, MOL PHYLOGENET EVOL, V68, P398, DOI 10.1016/j.ympev.2013.04.012; Mescherskii IG, 2011, BIOL BULL+, V38, P82, DOI 10.1134/S1062359011010080; Meschersky IG, 2012, PHYLOGEOGRAPHY UNPUB; Meshchersky I G, 2009, Dokl Biol Sci, V424, P35; Neumann K, 2006, MOL PHYLOGENET EVOL, V39, P135, DOI 10.1016/j.ympev.2006.01.010; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; Qu YH, 2005, MOL ECOL, V14, P1767, DOI 10.1111/j.1365-294X.2005.02528.x; Rambaut A, 2007, TRACER V 1 4; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ricanova S, 2013, MOL ECOL, V22, P4256, DOI 10.1111/mec.12382; Ross Patricia D., 1994, Mammalian Species, V459, P1; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sakka H, 2010, BIOL J LINN SOC, V100, P797, DOI 10.1111/j.1095-8312.2010.01477.x; Shan WJ, 2011, CHINESE SCI BULL, V56, P1370, DOI 10.1007/s11434-011-4460-9; Shi CM, 2013, MOL ECOL, V22, P1700, DOI 10.1111/mec.12205; Shi YF, 2009, ANN GLACIOL, V50, P1, DOI 10.3189/172756410790595831; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Su ZH, 2013, BIOL J LINN SOC, V109, P757, DOI 10.1111/bij.12088; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang LZ, 2010, J BIOGEOGR, V37, P657, DOI 10.1111/j.1365-2699.2009.02232.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang L, 2012, QUATERNARY SCI REV, V32, P131, DOI 10.1016/j.quascirev.2011.11.003; Wang W, 2013, EARTH-SCI REV, V122, P38, DOI 10.1016/j.earscirev.2013.03.005; Wang WJ, 2013, J BIOGEOGR, V40, P1156, DOI 10.1111/jbi.12055; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wiens JJ, 2013, EVOLUTION, V67, P1715, DOI 10.1111/evo.12053; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wilson D.E., 2005, MAMMAL SPECIES WORLD, V1; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yi CL, 2005, QUATERNARY SCI, V05, P609; Zhang QA, 2010, MOL PHYLOGENET EVOL, V57, P1091, DOI 10.1016/j.ympev.2010.10.003	66	11	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148182	10.1371/journal.pone.0148182	http://dx.doi.org/10.1371/journal.pone.0148182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839955	gold, Green Published, Green Submitted			2022-12-26	WOS:000369550200091
J	Tagliarolo, M; McQuaid, CD				Tagliarolo, Morgana; McQuaid, Christopher D.			Field Measurements Indicate Unexpected, Serious Underestimation of Mussel Heart Rates and Thermal Tolerance by Laboratory Studies	PLOS ONE			English	Article							IN-SITU; PERNA-PERNA; INTERTIDAL MUSSELS; BODY TEMPERATURES; GENETIC-STRUCTURE; CARDIAC ACTIVITY; CARCINUS-MAENAS; WAVE EXPOSURE; PHYSIOLOGY; ECOLOGY	Attempts to predict the response of species to long-term environmental change are generally based on extrapolations from laboratory experiments that inevitably simplify the complex interacting effects that occur in the field. We recorded heart rates of two genetic lineages of the brown mussel Perna perna over a full tidal cycle in-situ at two different sites in order to evaluate the cardiac responses of the two genetic lineages present on the South African coast to temperature and the immersion/ emersion cycle. "Robomussel" temperature loggers were used to monitor thermal conditions at the two sites over one year. Comparison with live animals showed that robomussels provided a good estimate of mussel body temperatures. A significant difference in estimated body temperatures was observed between the sites and the results showed that, under natural conditions, temperatures regularly approach or exceed the thermal limits of P. perna identified in the laboratory. The two P. perna lineages showed similar tidal and diel patterns of heart rate, with higher cardiac activity during daytime immersion and minimal values during daytime emersion. Comparison of the heart rates measured in the field with data previously measured in the laboratory indicates that laboratory results seriously underestimate heart rate activity, by as much as 75%, especially during immersion. Unexpectedly, field estimates of body temperatures indicated an ability to tolerate temperatures considered lethal on the basis of laboratory measurements. This suggests that the interaction of abiotic conditions in the field does not necessarily raise vulnerability to high temperatures.	[Tagliarolo, Morgana; McQuaid, Christopher D.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Tagliarolo, Morgana] Univ KwaZulu Natal, Sch Life Sci, Biol Sci Bldg,Westville Campus, ZA-4000 Durban, South Africa	Rhodes University; University of Kwazulu Natal	Tagliarolo, M (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Biol Sci Bldg,Westville Campus, ZA-4000 Durban, South Africa.	morgana.tagliarolo@gmail.com	Tagliarolo, Morgana/H-6303-2019; McQuaid, Christopher/AAT-3725-2020	Tagliarolo, Morgana/0000-0002-9659-4565; McQuaid, Christopher/0000-0002-3473-8308	Rhodes University post doctoral fellowship; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	Rhodes University post doctoral fellowship; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	This work was supported by a Rhodes University post doctoral fellowship, South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation.	Aagaard A, 1996, MAR BIOL, V125, P765, DOI 10.1007/BF00349259; Bozinovic F, 2015, ECOL EVOL, V5, P1025, DOI 10.1002/ece3.1403; Burnett NP, 2013, LIMNOL OCEANOGR-METH, V11, P91, DOI 10.4319/lom.2013.11.91; COLEMAN N, 1971, Journal of Experimental Marine Biology and Ecology, V7, P295, DOI 10.1016/0022-0981(71)90011-6; Cunha RL, 2014, ECOL EVOL, V4, P2070, DOI 10.1002/ece3.1033; Depledge MH, 1996, MAR BIOL, V126, P313, DOI 10.1007/BF00347455; Fitzhenry T, 2004, MAR BIOL, V145, P339, DOI 10.1007/s00227-004-1318-6; Gudimov A V, 2009, Dokl Biol Sci, V427, P335; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Harley CDG, 2008, MAR ECOL PROG SER, V371, P37, DOI 10.3354/meps07711; HELM MM, 1967, COMP BIOCHEM PHYSIOL, V21, P171, DOI 10.1016/0010-406X(67)90126-0; Helmuth B, 2002, INTEGR COMP BIOL, V42, P837, DOI 10.1093/icb/42.4.837; Helmuth B, 2009, INTEGR COMP BIOL, V42, P771; Hicks DW, 2002, MAR BIOL, V140, P1167, DOI 10.1007/s00227-002-0787-8; Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7; LANGTON RW, 1977, MAR BIOL, V41, P53, DOI 10.1007/BF00390581; Lathlean JA, 2011, MAR ECOL PROG SER, V439, P83, DOI 10.3354/meps09317; Lima FP, 2009, LIMNOL OCEANOGR-METH, V7, P347, DOI 10.4319/lom.2009.7.347; Lockwood BL, 2011, J EXP MAR BIOL ECOL, V400, P167, DOI 10.1016/j.jembe.2011.02.022; MARSHALL DJ, 1994, J EXP MAR BIOL ECOL, V179, P1, DOI 10.1016/0022-0981(94)90013-2; MARSHALL DJ, 1993, J EXP MAR BIOL ECOL, V171, P225, DOI 10.1016/0022-0981(93)90005-9; Nicastro KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047382; Nicastro Katy R., 2010, BMC Ecology, V10, P17, DOI 10.1186/1472-6785-10-17; Nicholson S, 2002, J EXP MAR BIOL ECOL, V267, P207, DOI 10.1016/S0022-0981(01)00362-8; Petes LE, 2008, OECOLOGIA, V156, P671, DOI 10.1007/s00442-008-1018-x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Santini G, 1999, PHYSIOL BIOCHEM ZOOL, V72, P198, DOI 10.1086/316656; Santini G, 2000, MAR BIOL, V137, P291, DOI 10.1007/s002270000339; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Styrishave B, 2003, MAR FRESHW BEHAV PHY, V36, P161, DOI 10.1080/10236240310001603215; Tagliarolo M, 2015, MAR ECOL PROG SER, V535, P145, DOI 10.3354/meps11434; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; TSUCHIYA M, 1983, J EXP MAR BIOL ECOL, V66, P101, DOI 10.1016/0022-0981(83)90032-1; Williams EE, 1996, J EXP BIOL, V199, P1587; Zardi GI, 2007, MAR ECOL PROG SER, V337, P135, DOI 10.3354/meps337135; Zardi GI, 2011, OECOLOGIA, V165, P947, DOI 10.1007/s00442-010-1788-9	36	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146341	10.1371/journal.pone.0146341	http://dx.doi.org/10.1371/journal.pone.0146341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840775	Green Submitted, Green Published, gold			2022-12-26	WOS:000369550200008
J	Xie, J; Li, RR; Li, S; Ran, XQ; Wang, JF; Jiang, JC; Zhao, PJ				Xie, Jian; Li, Rongrong; Li, Sheng; Ran, Xueqin; Wang, Jiafu; Jiang, Jicai; Zhao, Pengju			Identification of Copy Number Variations in Xiang and Kele Pigs	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; SNP GENOTYPING ARRAYS; GENOME-WIDE DETECTION; GENETIC DIVERSITY; STRUCTURAL VARIATION; RECEPTOR GENES; KIT-LIGAND; POLYMORPHISM; EXPRESSION; SEQUENCE	Xiang and Kele pigs are two well-known local Chinese pig breeds that possess rich genetic resources and have enormous economic and scientific value. We performed a comprehensive genomic analysis of the copy number variations (CNVs) in these breeds. CNVs are one of the most important forms of genomic variation and have profound effects on phenotypic variation. In this study, PorcineSNP60 genotyping data from 98 Xiang pigs and 22 Kele pigs were used to identify CNVs. In total, 172 candidate CNV regions (CNVRs) were identified, ranging from 3.19 kb to 8175.26 kb and covering 80.41 Mb of the pig genome. Approximately 56.40% (97/172) of the CNVRs overlapped with those identified in seven previous studies, and 43.60% (75/172) of the identified CNVRs were novel. Of the identified CNVRs, 82 (47 gain, 33 loss, and two gain-loss events that covered 4.58 Mb of the pig genome) were found only in a Xiang population with a large litter size. In contrast, 13 CNVRs (8 gain and 5 loss events) were unique to a Xiang population with small litter sizes, and 30 CNVRs (14 loss and 16 gain events) were unique to Kele pigs. The CNVRs span approximately 660 annotated Sus scrofa genes that are significantly enriched for specific biological functions, such as sensory perception, cognition, reproduction, ATP biosynthetic processes, and neurological processes. Many CNVR-associated genes, particularly the genes involved in reproductive traits, differed between the Xiang populations with large and small litter sizes, and these genes warrant further investigation due to their importance in determining the reproductive performance of Xiang pigs. Our results provide meaningful information about genomic variation, which may be useful in future assessments of the associations between CNVs and important phenotypes in Xiang and Kele pigs to ultimately help protect these rare breeds.	[Xie, Jian; Li, Rongrong; Li, Sheng; Wang, Jiafu] Guizhou Univ, Inst Agrobioengn, Guiyang 550003, Peoples R China; [Xie, Jian; Li, Rongrong; Li, Sheng; Wang, Jiafu] Guizhou Univ, Coll Life Sci, Guiyang 550003, Peoples R China; [Ran, Xueqin] Guizhou Univ, Coll Anim Sci, Guiyang 550003, Peoples R China; [Jiang, Jicai; Zhao, Pengju] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	Guizhou University; Guizhou University; Guizhou University; China Agricultural University	Wang, JF (corresponding author), Guizhou Univ, Inst Agrobioengn, Guiyang 550003, Peoples R China.; Wang, JF (corresponding author), Guizhou Univ, Coll Life Sci, Guiyang 550003, Peoples R China.; Ran, XQ (corresponding author), Guizhou Univ, Coll Anim Sci, Guiyang 550003, Peoples R China.	rxueq@aliyun.com; jfwang@gzu.edu.cn		Jiang, Jicai/0000-0001-6890-7539	National High Technology Research and Development Program (863 Program) [2013AA102503]; Guizhou Agricultural Science and Technology research projects [NY[2013]3073]; Guizhou Province Science and Technology Innovation Team Building Special (Guizhou Branch of talent team) [2009-4006]; Guizhou University "undergraduate teaching project" [BKJX2012007]; Innovation Funds of Guizhou University [2015009]; Guizhou University [BKJX2012007]	National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Guizhou Agricultural Science and Technology research projects; Guizhou Province Science and Technology Innovation Team Building Special (Guizhou Branch of talent team); Guizhou University "undergraduate teaching project"; Innovation Funds of Guizhou University; Guizhou University	The present paper was funded by the National High Technology Research and Development Program (863 Program) issue (2013AA102503); Guizhou Agricultural Science and Technology research projects (NY[2013]3073); Guizhou Province Science and Technology Innovation Team Building Special (Guizhou Branch of talent team 2009-4006); Guizhou University "undergraduate teaching project" (BKJX2012007). The authors thank the Congjiang Xiang Pig Development and Management Office for helping with the sample collection.; This study was funded by the National High Technology Research and Development Program (863 Program), grant 2013AA102503, (http://www.most.gov.cn/bszn/new/863/jbxx/), the Guizhou Agricultural Science and Technology research projects (NY[2013]3073), (http://kjt.gzst.gov.cn), the Innovation Funds of Guizhou University (2015009)(http://www.gzu.edu.cn/), the Guizhou Province Science and Technology Innovation Team Building Special (Guizhou Branch of talent team 2009-4006) and the Guizhou University "undergraduate teaching project" (BKJX2012007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amills M, 2010, ORIGIN GENETIC DIVER; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; Ballester M, 2004, BIOTECHNIQUES, V37, P610, DOI 10.2144/04374ST06; Beaudet AL, 2014, NAT GENET, V46, P1046, DOI 10.1038/ng.3106; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Cookingham LM, 2015, J ASSIST REPROD GEN, V32, P737, DOI 10.1007/s10815-015-0447-9; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Dong K, 2015, ANIM GENET, V46, P101, DOI 10.1111/age.12247; Driancourt MA, 2000, REV REPROD, V5, P143, DOI 10.1530/revreprod/5.3.143; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Fernandez AI, 2014, ANIM GENET, V45, P357, DOI 10.1111/age.12137; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fontanesi L, 2011, GENOMICS, V97, P158, DOI 10.1016/j.ygeno.2010.11.005; Fowler KE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-784; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Fujii J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-43; Gazave E, 2011, GENOME RES, V21, P1626, DOI 10.1101/gr.117242.110; Ghosh S, 2014, COPY NUMBER VARIATIO, DOI [10.1371/journal.pgen.1004712, DOI 10.1371/JOURNAL.PGEN.1004712]; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Giuffra E, 2000, ORIGIN DOMESTIC PIG; Graubert TA, 2007, HIGH RESOLUTION MAP; Grimmond S, 2000, HUM MOL GENET, V9, P1553, DOI 10.1093/hmg/9.10.1553; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jiang JC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-85; Joyce IM, 1999, DEV BIOL, V214, P342, DOI 10.1006/dbio.1999.9437; Kim JH, 2012, BIOINFORMATICS, V28, P1790, DOI 10.1093/bioinformatics/bts239; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li SJ, 2004, J ANIM SCI, V82, P368; Li Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-725; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu JS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-229; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Ming T, 2013, BMC GENOMICS, V14; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; Nicholas TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-414; Nozawa M, 2008, CYTOGENET GENOME RES, V123, P263, DOI 10.1159/000184716; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; Paudel Y, 2015, BMC GENOMICS, V16, P1; Paudel Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-449; Phelan JK, 2001, HUM MUTAT, V18, P472, DOI 10.1002/humu.1225; Pielberg GR, 2008, NAT GENET, V40, P1004, DOI 10.1038/ng.185; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shozu M, 2005, J MOL ENDOCRINOL, V35, P343, DOI 10.1677/jme.1.01735; Smyk M, 2007, HUM GENET, V122, P63, DOI 10.1007/s00439-007-0373-8; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Talseth-Palmer BA, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-10; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Walters KA, 2010, HUMAN REPROD UPDATE, pq3; Wang J, 2015, IMPROVED DETECTION C, V5; Wang Jiying, 2013, PLoS One, V8, pe68683, DOI 10.1371/journal.pone.0068683; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang Y, 2014, ANAL GENOME WIDE COP, DOI [10.1371/journal.pone.0106780, DOI 10.1371/JOURNAL.PONE.0106780]; Wen YL, 2013, J COMPUT BIOL, V20, P514, DOI 10.1089/cmb.2011.0102; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Yang HS, 2012, MOL BIOL REP, V39, P1887, DOI 10.1007/s11033-011-0934-8; Yi GQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-962; Yung Y, 2010, MOL CELL ENDOCRINOL, V328, P104, DOI 10.1016/j.mce.2010.07.019; Zhang CY, 2011, CURR GENOMICS, V12, P138, DOI 10.2174/138920211795564386	73	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148565	10.1371/journal.pone.0148565	http://dx.doi.org/10.1371/journal.pone.0148565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840413	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200148
J	Dziadek, B; Brzostek, A; Grzybowski, M; Fol, M; Krupa, A; Kryczka, J; Plocinski, P; Kurdowska, A; Dziadek, J				Dziadek, Bozena; Brzostek, Anna; Grzybowski, Marcin; Fol, Marek; Krupa, Agnieszka; Kryczka, Jakub; Plocinski, Przemyslaw; Kurdowska, Anna; Dziadek, Jaroslaw			Mycobacterium tuberculosis AtsG (Rv0296c), GlmU (Rv1018c) and SahH (Rv3248c) Proteins Function as the Human IL-8-Binding Effectors and Contribute to Pathogen Entry into Human Neutrophils	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; L-HOMOCYSTEINE HYDROLASE; EPITHELIAL-CELLS; INFECTED MONOCYTES; GROWTH-FACTOR; BINDING; EXPRESSION; PATHWAY; ALPHA; IL-8	Mycobacterium tuberculosis is an extremely successful intracellular pathogen that has evolved a broad spectrum of pathogenic mechanisms that enable its manipulation of host defense elements and its survival in the hostile environment inside phagocytes. Cellular influx into the site of mycobacterial entry is mediated by a variety of chemokines, including interleukin-8 (IL-8), and the innate cytokine network is critical for the development of an adaptive immune response and infection control. Using affinity chromatography, liquid chromatography electrospray ionization tandem mass spectrometry and surface plasmon resonance techniques, we identified M. tuberculosis AtsG arylsulphatase, bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyl transferase (GlmU) and S-adenosyl-L-homocysteine hydrolase (SahH) as the pathogen proteins that bind to human IL-8. The interactions of all of the identified proteins (AtsG, GlmU and SahH) with IL-8 were characterized by high binding affinity with K-D values of 6.83x10(-6) M, 5.24x10(-6) M and 7.14x10(-10) M, respectively. Furthermore, the construction of Mtb mutant strains overproducing AtsG, GlmU or SahH allowed determination of the contribution of these proteins to mycobacterial entry into human neutrophils. The significantly increased number of intracellularly located bacilli of the overproducing M. tuberculosis mutant strains compared with those of "wild-type" M. tuberculosis and the binding interaction of AtsG, GlmU and SahH proteins with human IL-8 may indicate that these proteins participate in the modulation of the early events of infection with tubercle bacilli and could affect pathogen attachment to target cells.	[Dziadek, Bozena; Grzybowski, Marcin] Univ Lodz, Fac Biol & Environm Protect, Dept Immunoparasitol, PL-90131 Lodz, Poland; [Brzostek, Anna; Krupa, Agnieszka; Kryczka, Jakub; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Fol, Marek] Univ Lodz, Fac Biol & Environm Protect, Dept Immunol & Infect Biol, PL-90131 Lodz, Poland; [Kurdowska, Anna] Univ Texas Tyler, Hlth Sci Ctr, Dept Cellular & Mol Biol, Tyler, TX 75799 USA; [Plocinski, Przemyslaw] Polish Acad Sci, Inst Biochem & Biophys, Lab RNA Biol & Funct Genom, Warsaw, Poland	University of Lodz; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Lodz; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Dziadek, J (corresponding author), Polish Acad Sci, Inst Med Biol, Lodz, Poland.	jdziadek@cbm.pan.pl	Płociński, Przemysław A/S-5587-2017	Płociński, Przemysław A/0000-0002-6623-3494; Krupa, Agnieszka/0000-0003-1303-4608; /0000-0002-5197-7538; Fol, Marek/0000-0002-8041-1920; Dziadek, Jaroslaw/0000-0003-1427-884X; Kryczka, Jakub/0000-0002-5719-4139; Dziadek, Bozena/0000-0002-4942-7385	National Science Centre, Poland [UMO-2011/01/M/NZ6/01764]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by the National Science Centre (UMO-2011/01/M/NZ6/01764), Poland for JD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUZEID C, 1988, INFECT IMMUN, V56, P3046, DOI 10.1128/IAI.56.12.3046-3051.1988; Alibaud L, 2010, J BIOL CHEM, V285, P21698, DOI 10.1074/jbc.M110.125724; Ameixa C, 2002, INFECT IMMUN, V70, P4743, DOI 10.1128/IAI.70.8.4743-4746.2002; Bartlomiejczyk MA, 2014, CLIN EXP IMMUNOL, V178, P310, DOI 10.1111/cei.12416; Bermudez LE, 1996, INFECT IMMUN, V64, P2917, DOI 10.1128/IAI.64.8.2917-2922.1996; Boggaram V, 2013, J BIOL CHEM, V288, P25500, DOI 10.1074/jbc.M112.448217; Byrd TF, 1997, J CLIN INVEST, V99, P2518, DOI 10.1172/JCI119436; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Corrales RM, 2013, BIOCHEM BIOPH RES CO, V430, P858, DOI 10.1016/j.bbrc.2012.11.038; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; DENIS M, 1992, CELL IMMUNOL, V141, P182, DOI 10.1016/0008-8749(92)90137-E; DENIS M, 1991, CAN J MICROBIOL, V37, P479, DOI 10.1139/m91-080; Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004; Ferguson JS, 1999, J IMMUNOL, V163, P312; FRIEDLAND JS, 1995, CLIN EXP IMMUNOL, V100, P233; Fronseca JD, 2015, INT J INFECT DIS, V32, P94, DOI [10.1016/j.ijid.2015.01.014, DOI 10.1016/J.IJID.2015.01.014]; Fudala R, 2007, AM J PHYSIOL-LUNG C, V293, pL364, DOI 10.1152/ajplung.00179.2006; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hall-Stoodley L, 2006, INFECT IMMUN, V74, P3587, DOI 10.1128/IAI.01644-05; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Heinz Christian, 2003, Methods Mol Biol, V228, P139, DOI 10.1385/1-59259-400-X:139; Hilda JN, 2014, HUM IMMUNOL, V75, P914, DOI 10.1016/j.humimm.2014.06.020; HIRSCH CS, 1994, J INFECT DIS, V170, P1229, DOI 10.1093/infdis/170.5.1229; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Hossain MM, 2009, J BIOCHEM, V146, P767, DOI 10.1093/jb/mvp141; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Jansen HJ, 1999, J MED MICROBIOL, V48, P551, DOI 10.1099/00222615-48-6-551; Jones SA, 1997, J BIOL CHEM, V272, P16166, DOI 10.1074/jbc.272.26.16166; Kisich KO, 2002, INFECT IMMUN, V70, P4591, DOI 10.1128/IAI.70.8.4591-4599.2002; Krupa A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/124762; LEE J, 1992, J BIOL CHEM, V267, P16283; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Migliori GB, 2007, EUROSURVEILLANCE, V12; Miranda MS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139127; Mougous JD, 2002, CHEM BIOL, V9, P767, DOI 10.1016/S1074-5521(02)00175-8; Mueller-Ortiz SL, 2001, INFECT IMMUN, V69, P7501, DOI 10.1128/IAI.69.12.7501-7511.2001; Neufert C, 2001, J IMMUNOL, V167, P1542, DOI 10.4049/jimmunol.167.3.1542; Nibbering PH, 2014, HUM IMMUNOL, V75, P914; Parida SK, 2015, J INTERN MED, V277, P388, DOI 10.1111/joim.12264; Pasula R, 1997, AM J RESP CELL MOL, V17, P209, DOI 10.1165/ajrcmb.17.2.2469; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; Poirier V, 2012, MICROBES INFECT, V14, P1211, DOI 10.1016/j.micinf.2012.07.001; Ragas A, 2007, J BIOL CHEM, V282, P5133, DOI 10.1074/jbc.M610183200; Reddy MCM, 2008, PROTEIN SCI, V17, P2134, DOI 10.1110/ps.038125.108; Sadek MI, 1998, AM J RESP CELL MOL, V19, P513, DOI 10.1165/ajrcmb.19.3.2815; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Schlorke D, 2012, CARBOHYD RES, V356, P196, DOI 10.1016/j.carres.2012.02.025; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sidobre S, 2000, J BIOL CHEM, V275, P2415, DOI 10.1074/jbc.275.4.2415; Singhal N, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-14; Sogi KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065080; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Troegeler A, 2015, PLOS ONE, V14, P1; Velayati AA, 2013, INT J CLIN EXP MED, V6, P307; WHO, 2015, TUBERCULOSIS; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10; Zhang WL, 2008, INT J BIOCHEM CELL B, V40, P2560, DOI 10.1016/j.biocel.2008.05.003; ZHANG YH, 1995, J CLIN INVEST, V95, P586, DOI 10.1172/JCI117702	62	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148030	10.1371/journal.pone.0148030	http://dx.doi.org/10.1371/journal.pone.0148030			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829648	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200054
J	Zhao, ZL; Wang, CD; Lai, JH				Zhao, Zhi-Lin; Wang, Chang-Dong; Lai, Jian-Huang			AUI&GIV: Recommendation with Asymmetric User Influence and Global Importance Value	PLOS ONE			English	Article								The user-based collaborative filtering (CF) algorithm is one of the most popular approaches for making recommendation. Despite its success, the traditional user-based CF algorithm suffers one serious problem that it only measures the influence between two users based on their symmetric similarities calculated by their consumption histories. It means that, for a pair of users, the influences on each other are the same, which however may not be true. Intuitively, an expert may have an impact on a novice user but a novice user may not affect an expert at all. Besides, each user may possess a global importance factor that affects his/her influence to the remaining users. To this end, in this paper, we propose an asymmetric user influence model to measure the directed influence between two users and adopt the PageRank algorithm to calculate the global importance value of each user. And then the directed influence values and the global importance values are integrated to deduce the final influence values between two users. Finally, we use the final influence values to improve the performance of the traditional user-based CF algorithm. Extensive experiments have been conducted, the results of which have confirmed that both the asymmetric user influence model and global importance value play key roles in improving recommendation accuracy, and hence the proposed method significantly outperforms the existing recommendation algorithms, in particular the user-based CF algorithm on the datasets of high rating density.	[Zhao, Zhi-Lin; Wang, Chang-Dong; Lai, Jian-Huang] Sun Yat Sen Univ, Sch Data & Comp Sci, Guangzhou 510275, Guangdong, Peoples R China; [Lai, Jian-Huang] Guangdong Key Lab Informat Secur Technol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Wang, CD (corresponding author), Sun Yat Sen Univ, Sch Data & Comp Sci, Guangzhou 510275, Guangdong, Peoples R China.	changdongwang@hotmail.com			National Natural Science Foundation of China [61502543, 61573387]; Guangdong Natural Science Funds for Distinguished Young Scholar; PhD Start-up Fund of Natural Science Foundation of Guangdong Province, China [2014A030310180]; GuangZhou Program [201508010032]; CCF-Tencent Open Research Fund; Pilot Program of SYSU-CMU Shunde International Joint Research Institute; Undergraduate Innovation Program of Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds for Distinguished Young Scholar; PhD Start-up Fund of Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of China (NSFC)); GuangZhou Program; CCF-Tencent Open Research Fund; Pilot Program of SYSU-CMU Shunde International Joint Research Institute; Undergraduate Innovation Program of Sun Yat-sen University	This work was supported by National Natural Science Foundation of China (No. 61502543 and No. 61573387), Guangdong Natural Science Funds for Distinguished Young Scholar, the PhD Start-up Fund of Natural Science Foundation of Guangdong Province, China (2014A030310180), GuangZhou Program (No. 201508010032), CCF-Tencent Open Research Fund, Pilot Program of SYSU-CMU Shunde International Joint Research Institute, and Undergraduate Innovation Program of Sun Yat-sen University. The funders had no role in study design.	Banerjee Somnath, 2008, WWW, P1135; Bin Wang, 2013, 2013 5th International Conference on Intelligent Human-Machine Systems and Cybernetics (IHMSC 2013), P449, DOI 10.1109/IHMSC.2013.254; Bourquard T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018541; Canny J., 2002, Proceedings of SIGIR 2002. Twenty-Fifth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P238, DOI 10.1145/564376.564419; Chen W, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P892; Davidson J, 2010, P 4 ACM C REC SYST, P293, DOI DOI 10.1145/1864708.1864770; Gan M, 2014, PLOS ONE, P1; GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867; Goldberg K, 2001, INFORM RETRIEVAL, V4, P133, DOI 10.1023/A:1011419012209; Hannon J., 2010, P 4 ACM C REC SYST R, P199, DOI DOI 10.1145/1864708.1864746; Jannach D, 2013, RECOMMENDER SYSTEMS; Kim BM, 2006, J INTELL INF SYST, V27, P79, DOI 10.1007/s10844-006-8771-2; Laureti P, 2006, EUROPHYS LETT, V75, P1006, DOI 10.1209/epl/i2006-10204-8; Lemire D, 2005, SIAM PROC S, P471; Li Sa, 2011, Proceedings of the 2011 International Conference on Business Computing and Global Informatization (BCGIn 2011), P645, DOI 10.1109/BCGIn.2011.170; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Liu B, 2010, PROCEEDINGS OF THE RECSYS'2010 ACM CHALLENGE ON CONTEXT-AWARE MOVIE RECOMMENDATION (CAMRA2010), P53, DOI 10.1145/1869652.1869661; Liu J, 2012, APPL COMPUT REV, V12, P48, DOI 10.1145/2432546.2432550; liu Jiali, 2014, SCI WORLD J, V2014, P1, DOI DOI 10.1016/J.CCLET.2014.06.001; Lu J., 2013, J MACH LEARN RES, P325; Maslov S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.248701; Millan M, 2007, LECT NOTES COMPUT SC, V4881, P663; Nakamura Atsuyoshi., 2015, P ASIAN C MACHINE LE, P315; Onuma K, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P657; Osmanli ON, 2010, SINGULAR VALUE DECOM, P1; Paterek A., 2007, P KDD CUP WORKSH, V2007, P5, DOI DOI 10.1145/1557019.1557072; Pazzani M. J., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P325; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Pirasteh P, 2015, EXPLOITING MATRIX FA, P1; Ren J, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/58007; Ricci F., 2011, P 2011 ACM C REC SYS, P301, DOI DOI 10.1145/2043932.2043988; Ricci F., 2011, INTRO RECOMMENDER SY; Salakhutdinov R., 2007, P 24 INT C MACH LEAR, P1; Sarwar B., 2001, PROC 10 INT WORLD WI, P285, DOI 10.1145/371920.372071; Schafer J. B., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P291; Shi Y, 2014, ACM COMPUT SURV, V47, DOI 10.1145/2556270; Wang J., 2006, Proceedings of the Twenty-Ninth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P501, DOI 10.1145/1148170.1148257; Xiang L, 2012, PRACICE RECOMMENDATI; Yang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030093; Yin B, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P771, DOI 10.1145/2567948.2579237; Yu C, 2006, 2006 ICEC: EIGHTH INTERNATIONAL CONFERENCE ON ELECTRONIC COMMERCE, PROCEEDINGS, P574; Zhang JB, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON NETWORK INFRASTRUCTURE AND DIGITAL CONTENT, PROCEEDINGS, P414, DOI 10.1109/ICNIDC.2009.5360986; Zhou YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065906	45	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147944	10.1371/journal.pone.0147944	http://dx.doi.org/10.1371/journal.pone.0147944			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828803	gold, Green Submitted, Green Published			2022-12-26	WOS:000369548200043
J	Ueda, T; Nakata, Y; Yamasaki, N; Oda, H; Sentani, K; Kanai, A; Onishi, N; Ikeda, K; Sera, Y; Honda, Z; Tanaka, K; Sata, M; Ogawa, S; Yasui, W; Saya, H; Takita, J; Honda, H				Ueda, T.; Nakata, Y.; Yamasaki, N.; Oda, H.; Sentani, K.; Kanai, A.; Onishi, N.; Ikeda, K.; Sera, Y.; Honda, Z-i; Tanaka, K.; Sata, M.; Ogawa, S.; Yasui, W.; Saya, H.; Takita, J.; Honda, H.			ALK(R1275Q) perturbs extracellular matrix, enhances cell invasion and leads to the development of neuroblastoma in cooperation with MYCN	ONCOGENE			English	Article							RECEPTOR TYROSINE KINASE; ALK; GENE; LYMPHOMA; EXPRESSION; SPECTRUM; PROTEIN; TARGET; TUMORS	Overexpression of MYCN is a hallmark of neuroblastoma (NB). ALK(R1275Q), an activating mutation of ALK (anaplastic lymphoma kinase), has been found in sporadic and familial NB patients. In this report, we demonstrated that ALK(R1275Q) knock-in, MYCN transgenic compound mice developed NB with complete penetrance. Transcriptome analysis revealed that ALK(R1275Q) globally downregulated the expression of extracellular matrix (ECM)- and basement membrane (BM)-associated genes in both primary neuronal cells and NB tumors. Accordingly, ALK(R1275Q)/MYCN tumors exhibited reduced expression of ECM/BM-related proteins as compared with MYCN tumors. In addition, on MYCN transduction, ALK(R1275Q)-expressing neuronal cells exhibited increased migratory and invasive activities. Consistently, enhanced invasion and metastasis were demonstrated in ALK(R1275Q)/MYCN mice. These results collectively indicate that ALK(R1275Q) confers a malignant potential on neuronal cells that overexpress MYCN by impairing normal ECM/BM integrity and enhancing tumor growth and dissemination. Moreover, we found that crizotinib, an ALK inhibitor, almost completely inhibited the growth of ALK(R1275Q)/MYCN tumors in an allograft model. Our findings provided insights into the cooperative mechanism of the mutated ALK and overexpressed MYCN in the pathogenesis of NB and demonstrated the effectiveness of crizotinib on ALK(R1275Q)-positive tumors.	[Ueda, T.; Nakata, Y.; Yamasaki, N.; Ikeda, K.; Sera, Y.; Honda, H.] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan; [Oda, H.] Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo, Japan; [Sentani, K.; Yasui, W.] Hiroshima Univ, Dept Mol Pathol, Inst Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Japan; [Kanai, A.] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima, Japan; [Onishi, N.; Saya, H.] Keio Univ, Inst Adv Med Res, Div Gene Regulat, Sch Med, 35 Shinanomachi, Tokyo, Japan; [Honda, Z-i] Ochanomizu Univ, Inst Environm Sci Human Life, Hlth Care Ctr, Bunkyo Ku, 2-1-1 Otsuka, Tokyo, Japan; [Honda, Z-i] Ochanomizu Univ, Inst Environm Sci Human Life, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo, Japan; [Tanaka, K.] Univ Tokyo, Div Hlth Serv Promot, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan; [Sata, M.] Univ Tokushima, Inst Hlth Biosci, Dept Cardiovasc Med, Grad Sch, Tokushima, Japan; [Ogawa, S.] Kyoto Univ, Grad Sch Med, Dept Pathol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan; [Takita, J.] Univ Tokyo, Grad Sch Med, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan	Hiroshima University; Tokyo Women's Medical University; Hiroshima University; Hiroshima University; Keio University; Ochanomizu University; Ochanomizu University; University of Tokyo; Tokushima University; Kyoto University; University of Tokyo	Honda, H (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	hhonda@hiroshima-u.ac.jp	Saya, Hideyuki/J-4325-2013	Saya, Hideyuki/0000-0001-6610-1902; Ueda, Takeshi/0000-0001-9823-6764	Grants-in-Aid for Scientific Research [26293227] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Carpenter EL, 2012, NAT REV CLIN ONCOL, V9, P391, DOI 10.1038/nrclinonc.2012.72; Cazes A, 2014, ONCOTARGET, V5, P2688, DOI 10.18632/oncotarget.1883; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Hasan MK, 2013, SCI REP-UK, V3, DOI 10.1038/srep03450; Heukamp LC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003967; Honda H, 2011, P NATL ACAD SCI USA, V108, P2468, DOI 10.1073/pnas.1003403108; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Nagamachi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087425; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Ribatti D, 2004, ANN NY ACAD SCI, V1028, P133, DOI 10.1196/annals.1322.014; Saito A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1971; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Schonerr C, 2012, ONCOGENE, V31, P5193, DOI 10.1038/onc.2012.12; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	35	19	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	34					4447	4458		10.1038/onc.2015.519	http://dx.doi.org/10.1038/onc.2015.519			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU4AC	26829053				2022-12-26	WOS:000382153100003
J	Chuang, MK; Chang, CH; Chan, CY				Chuang, Min-Kai; Chang, Chin-Hao; Chan, Chih-Yang			The Effect of Haemodialysis Access Types on Cardiac Performance and Morbidities in Patients with Symptomatic Heart Disease	PLOS ONE			English	Article							VASCULAR ACCESS; ARTERIOVENOUS-FISTULAS; FAILURE; OUTPUT; CKD	Background Little is known about whether the arteriovenous type haemodialysis access affects cardiac function and whether it is still advantageous to the uremic patient with symptomatic heart disease. Methods We conducted a retrospective comparative study. Patients with heart disease and end-stage renal disease that had a new chronic access created between January 2007 and December 2008 and met the inclusion criteria were assessed. The endpoint was major adverse event (MAE)-free survivals of arteriovenous access (AVA) and tunneled cuffed double-lumen central venous catheter (CVC) groups. Whether accesses worsened heart failure was also evaluated. Results There were 43 CVC patients and 60 AVA patients. The median follow-up time from access creation was 27.6 months (IQR 34.7, 10.9 similar to 45.6). Although CVC patients were older than AVA patients (median age 78.0, IQR 14.0 vs. 67.5, IQR 16.0, respectively, p = .009), they manifested non-inferior MAE-free survival (mean 17.1, 95% CI 10.3 similar to 24.0 vs. 12.9, 95% CI 8.5 similar to 17.4 months in CVC and AVA patients, respectively, p = .290). During follow-up, more patients in the AVA group than in the CVC group deteriorated in heart failure status (35 of 57 vs. 10 of 42, respectively, odds ratio 5.1, p < .001). Preoperative-postoperative pairwise comparison of echocardiographic scans revealed an increased number of abnormal findings in the AVA group (Z = 3.91, p < .001), but not in the CVC group. Conclusions In patients with both symptomatic heart disease and end stage renal disease (ESRD), CVC patients showed non-inferior MAE-free survival in comparison to those in the AVA group. AV type access could deteriorate heart failure. Accordingly, uremic patients with symptomatic heart disease are not ideal candidates for AV type access creation.	[Chuang, Min-Kai] Natl Taiwan Univ Hosp, Dept Surg, Yun Lin Branch, Yunlin, Taiwan; [Chang, Chin-Hao] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Chan, Chih-Yang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chan, CY (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	chanchihyang@gmail.com		CHAN, CHIH-YANG/0000-0001-6705-1177				Amerling R, 2011, BLOOD PURIFICAT, V31, P113, DOI 10.1159/000322695; [Anonymous], 2007, ABR LIF TABL TAIW 20; Bansal N, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-115; Bansal N, 2013, CLIN J AM SOC NEPHRO, V8, P355, DOI 10.2215/CJN.06020612; Beigi AA, 2009, J VASC ACCESS, V10, P160, DOI 10.1177/112972980901000305; Cai QZ, 2014, J AM SOC NEPHROL, V25, P1599, DOI 10.1681/ASN.2013080899; Ethier J, 2008, NEPHROL DIAL TRANSPL, V23, P3219, DOI 10.1093/ndt/gfn261; Hemodialysis Adequacy 2006, 2006, AM J KIDNEY DIS, V48, pS2, DOI [10.1053/j.ajkd.2006.03.051, DOI 10.1053/J.AJKD.2006.03.051]; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Lok CE, 2007, CLIN J AM SOC NEPHRO, V2, P1043, DOI 10.2215/CJN.01080307; Lok CE, 2006, J AM SOC NEPHROL, V17, P3204, DOI 10.1681/ASN.2006030190; MacRae JM, 2006, SEMIN DIALYSIS, V19, P349, DOI 10.1111/j.1525-139X.2006.00185.x; MacRae JM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2004.01.016; Movilli E, 2010, AM J KIDNEY DIS, V55, P682, DOI 10.1053/j.ajkd.2009.11.008; Murray BM, 2004, AM J KIDNEY DIS, V44, P1090, DOI 10.1053/j.ajkd.2004.06.031; Ng LJ, 2011, NEPHROL DIAL TRANSPL, V26, P3659, DOI 10.1093/ndt/gfr063; Santoro D, 2010, MINERVA UROL NEFROL, V62, P81; Santoro D, 2014, INT J NEPHROL RENOV, V7, P281, DOI 10.2147/IJNRD.S46643; Soleimani MJ, 2012, IRAN J KIDNEY DIS, V6, P198; Valek M, 2010, ASAIO J, V56, P200, DOI 10.1097/MAT.0b013e3181ce6757; Yigla M, 2006, SEMIN DIALYSIS, V19, P353, DOI 10.1111/j.1525-139X.2006.00186.x; Zile MR, 2008, CIRCULATION, V118, P1433, DOI 10.1161/CIRCULATIONAHA.108.783910	22	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148278	10.1371/journal.pone.0148278	http://dx.doi.org/10.1371/journal.pone.0148278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848850	Green Published, gold, Green Submitted			2022-12-26	WOS:000369554000064
J	Lee, YI; Lee, HM; Jo, JK; Lee, S; Hong, SK; Byun, SS; Lee, SE; Oh, JJ				Lee, Young Ik; Lee, Hak Min; Jo, Jung Ki; Lee, Sangchul; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun; Oh, Jong Jin			Association between Seminal Vesicle Invasion and Prostate Cancer Detection Location after Transrectal Systemic Biopsy among Men Who Underwent Radical Prostatectomy	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; MULTIVARIATE-ANALYSIS; ADENOCARCINOMA; INVOLVEMENT; RECURRENCE; PREDICTION; NOMOGRAM; MARGINS; RATES	Background Our hypothesis is that the location of the seminal vesicles near the base of the prostate, the more positive cores are detected in the base, the greater the risk of seminal vesicle invasion. Therefore we investigate the clinical outcomes of base dominant prostate cancer (BDPC) in transrectal ultrasound (TRUS) - guided biopsies compared with anteromiddle dominant prostate cancer (AMPC). Methods From November 2003 to June 2014, a total of 990 intermediate and high risk prostate cancer (PCa) patients who underwent radical prostatectomy (RP) were enrolled and stratified into two groups according to proportion of positive cores-BDPC group had >= 33.3% ratio of positive cores from the prostate base among all positive cores and AMPC group < 33.3% in systemic biopsy. Between two groups, we compared the rate of pathologic outcomes and biochemical recurrence (BCR). We performed multivariate logistic regression model to confirm the significance of BDPC to seminal vesicle invasion (SVI) and Cox proportional hazard analysis to BCR. Results Among these 990 PCa patients, the 487 patients in BDPC group had more advanced clinical stage (p< 0.001), a higher biopsy GS (p = 0.002), and a higher rate of extracapsular extension (ECE), SVI and BCR (all p< 0.001) than AMPC group. The patients in BDPC group had poor BCR free survival rate via Kaplan-meier analysis (p< 0.001). The ratio of the base positive cores was a significant predictor to SVI in multivariate analysis (p < 0.001) and significant predictor of BCR in multivariate Cox proportional analysis (hazard ratio: 1.466, p = 0.004). Conclusions BDPC in TRUS-guided prostate biopsies was significantly associated with SVI and BCR after adjusting for other clinical factors. Therefore, BDPC should be considered to be a more aggressive tumor despite an otherwise similar cancer profile.	[Lee, Young Ik; Lee, Hak Min; Jo, Jung Ki; Lee, Sangchul; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun; Oh, Jong Jin] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea	Seoul National University (SNU)	Oh, JJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea.	bebsuzzang@naver.com			SNUBH (Seoul National University Bundang Hospital) Research Fund [14-2015-031]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2014R1A1A2059658]	SNUBH (Seoul National University Bundang Hospital) Research Fund; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by grant no 14-2015-031 from the SNUBH (Seoul National University Bundang Hospital) Research Fund and supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (NRF-2014R1A1A2059658). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; CATALONA WJ, 1994, J UROLOGY, V152, P1837, DOI 10.1016/S0022-5347(17)32397-2; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chan ESY, 2012, CHINESE MED J-PEKING, V125, P2432, DOI 10.3760/cma.j.issn.0366-6999.2012.14.006; DAMICO AV, 1995, J UROLOGY, V154, P131, DOI 10.1016/S0022-5347(01)67248-3; de Rooij M, 2015, EUR UROL, DOI [10.1016/j.eururo, DOI 10.1016/J.EURURO]; Debras B, 1998, EUR UROL, V33, P271, DOI 10.1159/000019579; EPSTEIN JI, 1993, J UROLOGY, V149, P1040, DOI 10.1016/S0022-5347(17)36291-2; Epstein JI, 1996, AM J SURG PATHOL, V20, P286, DOI 10.1097/00000478-199603000-00004; Guillonneau B, 1997, EUR UROL, V32, P160, DOI 10.1159/000480851; Heidenreich A, 2008, EUR UROL, V53, P68, DOI 10.1016/j.eururo.2007.09.002; Huang L, 2014, WORLD J GASTROENTERO, V20, P17804, DOI 10.3748/wjg.v20.i47.17804; Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7; Irmisch A, 2013, EXP CELL RES, V319, P1604, DOI 10.1016/j.yexcr.2013.02.012; Koh H, 2003, J UROLOGY, V170, P1203, DOI 10.1097/01.ju.0000085074.62960.7b; OHORI M, 1993, AM J SURG PATHOL, V17, P1252, DOI 10.1097/00000478-199312000-00006; OHORI M, 1995, J UROLOGY, V154, P1818, DOI 10.1016/S0022-5347(01)66792-2; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; Pins MR, 2004, PROSTATE CANCER P D, V7, P243, DOI 10.1038/sj.pcan.4500722; Roemeling S, 2007, CANCER-AM CANCER SOC, V110, P2218, DOI 10.1002/cncr.23029; Tefilli MV, 1998, J UROLOGY, V160, P802, DOI 10.1016/S0022-5347(01)62791-5; VandenOuden D, 1997, BRIT J UROL, V79, P203, DOI 10.1046/j.1464-410X.1997.33011.x; VILLERS AA, 1990, J UROLOGY, V143, P1183, DOI 10.1016/S0022-5347(17)40220-5; Yamaguchi H, 2015, CANCERS, V7, P2054, DOI 10.3390/cancers7040876; Yip SKH, 2010, CURR OPIN UROL, V20, P80, DOI 10.1097/MOU.0b013e3283337bf0	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148690	10.1371/journal.pone.0148690	http://dx.doi.org/10.1371/journal.pone.0148690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848747	gold, Green Published, Green Submitted			2022-12-26	WOS:000369554000159
J	Daniyan, MO; Boshoff, A; Prinsloo, E; Pesce, ER; Blatch, GL				Daniyan, Michael O.; Boshoff, Aileen; Prinsloo, Earl; Pesce, Eva-Rachele; Blatch, Gregory L.			The Malarial Exported PFA0660w Is an Hsp40 Co-Chaperone of PfHsp70-x	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CRYSTAL-STRUCTURE; YEAST HSP40; MOLECULAR CHAPERONE; ESCHERICHIA-COLI; HSP70 CHAPERONES; J PROTEINS; DNAJ; DIMERIZATION; PARASITE	Plasmodium falciparum, the human pathogen responsible for the most dangerous malaria infection, survives and develops in mature erythrocytes through the export of proteins needed for remodelling of the host cell. Molecular chaperones of the heat shock protein (Hsp) family are prominent members of the exportome, including a number of Hsp40s and a Hsp70. PFA0660w, a type II Hsp40, has been shown to be exported and possibly form a complex with PfHsp70-x in the infected erythrocyte cytosol. However, the chaperone properties of PFA0660w and its interaction with human and parasite Hsp70s are yet to be investigated. Recombinant PFA0660w was found to exist as a monomer in solution, and was able to significantly stimulate the ATPase activity of PfHsp70-x but not that of a second plasmodial Hsp70 (PfHsp70-1) or a human Hsp70 (HSPA1A), indicating a potential specific functional partnership with PfHsp70-x. Protein binding studies in the presence and absence of ATP suggested that the interaction of PFA0660w with PfHsp70-x most likely represented a co-chaperone/chaperone interaction. Also, PFA0660w alone produced a concentration-dependent suppression of rhodanese aggregation, demonstrating its chaperone properties. Overall, we have provided the first biochemical evidence for the possible role of PFA0660w as a chaperone and as co-chaperone of PfHsp70-x. We propose that these chaperones boost the chaperone power of the infected erythrocyte, enabling successful protein trafficking and folding, and thereby making a fundamental contribution to the pathology of malaria.	[Daniyan, Michael O.; Pesce, Eva-Rachele; Blatch, Gregory L.] Rhodes Univ, Dept Biochem & Microbiol, Biomed Biotechnol Res Unit, ZA-6140 Grahamstown, South Africa; [Boshoff, Aileen; Prinsloo, Earl] Rhodes Univ, Biotechnol Innovat Ctr, ZA-6140 Grahamstown, South Africa; [Pesce, Eva-Rachele; Blatch, Gregory L.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia; [Daniyan, Michael O.] Obafemi Awolowo Univ, Fac Pharm, Dept Pharmacol, Ife, Nigeria	Rhodes University; Rhodes University; Victoria University; Obafemi Awolowo University	Pesce, ER; Blatch, GL (corresponding author), Rhodes Univ, Dept Biochem & Microbiol, Biomed Biotechnol Res Unit, ZA-6140 Grahamstown, South Africa.; Pesce, ER; Blatch, GL (corresponding author), Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia.	eva-rachele.pesce@vu.edu.au; gregory.blatch@vu.edu.au	Blatch, Gregory Lloyd/Q-5900-2019; Prinsloo, Earl/F-9737-2012; Daniyan, Michael/AAO-4661-2020	Blatch, Gregory Lloyd/0000-0003-0778-8577; Prinsloo, Earl/0000-0002-3048-4304; Daniyan, Michael/0000-0003-3669-3542	National Research Foundation (NRF); Medical Research Council (MRC) of South Africa; Department of Science and Technology; NRF of South Africa; Education Trust Fund (ETF) Academic Staff Training and Development (AST&D) scholarship of Obafemi Awolowo University, Ile-Ife, Nigeria; Rhodes University Council research bursary	National Research Foundation (NRF); Medical Research Council (MRC) of South Africa(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Science and Technology(Department of Science & Technology (India)); NRF of South Africa; Education Trust Fund (ETF) Academic Staff Training and Development (AST&D) scholarship of Obafemi Awolowo University, Ile-Ife, Nigeria; Rhodes University Council research bursary	This work was supported by grants from the National Research Foundation (NRF) and Medical Research Council (MRC) of South Africa. The ProteOn XPR36 IAS was purchased from a National Nanotechnology Equipment Programme grant from the Department of Science and Technology and the NRF of South Africa. Michael O. Daniyan was a recipient of the Education Trust Fund (ETF) Academic Staff Training and Development (AST&D) scholarship of Obafemi Awolowo University, Ile-Ife, Nigeria and a Rhodes University Council research bursary.	Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Banumathy G, 2002, J BIOL CHEM, V277, P3902, DOI 10.1074/jbc.M110513200; Batas B, 1999, J BIOTECHNOL, V68, P149, DOI 10.1016/S0168-1656(98)00197-7; BEHR C, 1992, J IMMUNOL, V149, P3321; Bell SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020047; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; Botha M, 2011, CELL STRESS CHAPERON, V16, P389, DOI 10.1007/s12192-010-0250-6; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CHEETHAM ME, 1994, EUR J BIOCHEM, V226, P99, DOI 10.1111/j.1432-1033.1994.tb20030.x; Chiang AN, 2009, BIOORGAN MED CHEM, V17, P1527, DOI 10.1016/j.bmc.2009.01.024; Cockburn IL, 2014, BIOL CHEM, V395, P1353, DOI 10.1515/hsz-2014-0138; Cockburn IL, 2011, BIOL CHEM, V392, P431, DOI 10.1515/BC.2011.040; Curtis CF, 2006, J AM MOSQUITO CONTR, V22, P501, DOI 10.2987/8756-971X(2006)22[501:IBFMMC]2.0.CO;2; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Grover M, 2013, PARASITE, V20, DOI 10.1051/parasite/2012002; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hatherley R, 2014, J BIOMOL STRUCT DYN, V32, P1766, DOI 10.1080/07391102.2013.834849; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hosse RJ, 2009, ANAL BIOCHEM, V385, P346, DOI 10.1016/j.ab.2008.11.026; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; KUMAR N, 1990, INFECT IMMUN, V58, P1408, DOI 10.1128/IAI.58.5.1408-1414.1990; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Matambo TS, 2004, PROTEIN EXPRES PURIF, V33, P214, DOI 10.1016/j.pep.2003.09.010; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Njunge JM, 2013, CURR PHARM DESIGN, V19, P387, DOI 10.2174/138161213804143734; Pesce ER, 2014, PARASITOLOGY, V141, P1167, DOI 10.1017/S003118201300228X; Prinsloo E, 2012, IUBMB LIFE, V64, P266, DOI 10.1002/iub.607; Przyborski JM, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00034; Ramya TNC, 2006, BIOCHEM BIOPH RES CO, V348, P585, DOI 10.1016/j.bbrc.2006.07.082; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Shi YY, 2005, J BIOL CHEM, V280, P22761, DOI 10.1074/jbc.M503643200; Shonhai A, 2008, PROTEIN PEPTIDE LETT, V15, P1117, DOI 10.2174/092986608786071067; Silberg JJ, 1998, J BACTERIOL, V180, P6617, DOI 10.1128/JB.180.24.6617-6624.1998; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stephens LL, 2011, PROTEIN EXPRES PURIF, V77, P159, DOI 10.1016/j.pep.2011.01.005; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Toutain CM, 2003, MOL GENET GENOMICS, V268, P761, DOI 10.1007/s00438-002-0`/93-z; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2014, WHO MDG 6 COMB HIV A; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009	55	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148517	10.1371/journal.pone.0148517	http://dx.doi.org/10.1371/journal.pone.0148517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845441	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000369552800065
J	Kniel, N; Bender, S; Witte, K				Kniel, Nina; Bender, Stefanie; Witte, Klaudia			Sex-Specific Audience Effect in the Context of Mate Choice in Zebra Finches	PLOS ONE			English	Article							TAENIOPYGIA-GUTTATA; PUBLIC INFORMATION; SPERM COMPETITION; MATING PREFERENCES; JAPANESE-QUAIL; MALES; PAIR; BEHAVIOR; ADJUST; COLOR	Animals observing conspecifics during mate choice can gain additional information about potential mates. However, the presence of an observer, if detected by the observed individuals, can influence the nature of the behavior of the observed individuals, called audience effect. In zebra finches (Taeniopygia guttata castanotis), domesticated males show an audience effect during mate choice. However, whether male and female descendants of the wild form show an audience effect during mate choice is unknown. Therefore, we conducted an experiment where male and female focal birds could choose between two distinctive phenotypes of the opposite sex, an artificially adorned stimulus bird with a red feather on the forehead and an unadorned stimulus bird, two times consecutively, once without an audience and once with an audience bird (same sex as test bird). Males showed an audience effect when an audience male was present and spent more time with adorned and less time with unadorned females compared to when there was no audience present. The change in time spent with the respective stimulus females was positively correlated with the time that the audience male spent in front of its cage close to the focal male. Females showed no change in mate choice when an audience female was present, but their motivation to associate with both stimulus males decreased. In a control for mate-choice consistency there was no audience in either test. Here, both focal females and focal males chose consistently without a change in choosing motivation. Our results showed that there is an audience effect on mate choice in zebra finches and that the response to a same-sex audience was sex-specific.	[Kniel, Nina; Bender, Stefanie; Witte, Klaudia] Univ Siegen, Res Grp Ecol & Behav Biol, Inst Biol, Dept Biol & Chem, D-57068 Siegen, Germany	Universitat Siegen	Kniel, N (corresponding author), Univ Siegen, Res Grp Ecol & Behav Biol, Inst Biol, Dept Biol & Chem, D-57068 Siegen, Germany.	kniel@biologie.uni-siegen.de		Kniel, Nina/0000-0002-0858-3912	"Hochschulinterne Forschungsoforderung (HIFF)" of the University of Siegen; University of Siegen	"Hochschulinterne Forschungsoforderung (HIFF)" of the University of Siegen; University of Siegen	This work was supported by the "Hochschulinterne Forschungsoforderung (HIFF)" of the University of Siegen. NK was supported by a Ph.D. scholarship of the University of Siegen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amy M, 2008, ANIM BEHAV, V76, P971, DOI 10.1016/j.anbehav.2008.03.023; Auld HL, 2015, BEHAV ECOL SOCIOBIOL, V69, P1191, DOI 10.1007/s00265-015-1933-x; BALTZ AP, 1994, ANIM BEHAV, V47, P460, DOI 10.1006/anbe.1994.1061; Baltz AP, 1997, ANIM BEHAV, V53, P1017, DOI 10.1006/anbe.1996.0354; Bierbach D, 2011, BIOL LETTERS, V7, P349, DOI 10.1098/rsbl.2010.0982; Birkhead TR, 2010, EMU, V110, P189, DOI 10.1071/MU09086; BIRKHEAD TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P315, DOI 10.1007/BF00164002; BIRKHEAD TR, 1993, J REPROD FERTIL, V99, P593; Bonnie KE, 2007, ANIM BEHAV, V74, P171, DOI 10.1016/j.anbehav.2006.12.009; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; BURLEY N, 1985, AUK, V102, P647, DOI 10.1093/auk/102.3.647; Burley N., 1985, Ornithological Monographs, P22; Burley NT, 1998, AM NAT, V152, P792, DOI 10.1086/286209; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; DeKogel CH, 1996, ANIM BEHAV, V51, P699, DOI 10.1006/anbe.1996.0073; Dosen LD, 2004, ETHOLOGY, V110, P245, DOI 10.1111/j.1439-0310.2004.00965.x; Doucet SM, 2004, CAN J ZOOL, V82, P1, DOI 10.1139/Z03-210; Drullion D, 2008, BEHAV ECOL SOCIOBIOL, V63, P269, DOI 10.1007/s00265-008-0658-5; Dubois F, 2007, ANIM BEHAV, V74, P1785, DOI 10.1016/j.anbehav.2007.03.023; Dubois F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043697; Dzieweczynski TL, 2014, ETHOLOGY, V120, P855, DOI 10.1111/eth.12255; Dzieweczynski TL, 2012, ANIM BEHAV, V83, P1219, DOI 10.1016/j.anbehav.2012.02.013; Fitzsimmons LP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0449; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; HECTOR ACK, 1989, ANIM BEHAV, V38, P262, DOI 10.1016/S0003-3472(89)80088-0; Hoi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032806; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Hoysak DJ, 2007, ETHOLOGY, V113, P1007, DOI 10.1111/j.1439-0310.2007.01413.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jones KM, 2001, ANIM BEHAV, V62, P1021, DOI 10.1006/anbe.2001.1843; Kniel N, 2015, BEHAV ECOL, V26, P647, DOI 10.1093/beheco/aru241; Laporte MNC, 2010, ANIM BEHAV, V80, P467, DOI 10.1016/j.anbehav.2010.06.005; Leaver LA, 2007, ANIM COGN, V10, P23, DOI 10.1007/s10071-006-0026-7; Leboucher G, 2004, ANIM BEHAV, V68, P957, DOI 10.1016/j.anbehav.2003.12.011; Makowicz AM, 2010, BEHAVIOUR, V147, P1657, DOI 10.1163/000579510X528206; Matessi G, 2005, BEHAVIOUR, V142, P507, DOI 10.1163/1568539054012010; Matos Ricardo J., 2005, P63, DOI 10.1017/CBO9780511610363.006; Matos RJ, 2002, BEHAVIOUR, V139, P1211, DOI 10.1163/15685390260437344; McGregor Peter K., 2000, Acta Ethologica, V2, P71, DOI 10.1007/s102110000015; McGregor PK, 2005, ANIMAL COMMUNICATION; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; MOLLER AP, 1991, AM NAT, V137, P882, DOI 10.1086/285199; Monaghan P, 1996, P ROY SOC B-BIOL SCI, V263, P1183, DOI 10.1098/rspb.1996.0173; Nobel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053865; Ophir AG, 2005, J COMP PSYCHOL, V119, P3, DOI 10.1037/0735-7036.119.1.3; Ophir AG, 2003, ANIM BEHAV, V66, P399, DOI 10.1006/anbe.2003.2230; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; Overduin-De Vries AM, 2012, AM J PRIMATOL, V74, P217, DOI 10.1002/ajp.21988; Plath M, 2008, ANIM BEHAV, V75, P21, DOI 10.1016/j.anbehav.2007.05.013; Plath M, 2007, BEHAV ECOL, V18, P680, DOI 10.1093/beheco/arm030; Plath Martin, 2008, Communicative & Integrative Biology, V1, P199; Plath M, 2009, BEHAV ECOL SOCIOBIOL, V63, P381, DOI 10.1007/s00265-008-0672-7; Plenge M, 2000, BEHAVIOUR, V137, P741, DOI 10.1163/156853900502321; Price AC, 2006, ETHOLOGY, V112, P22, DOI 10.1111/j.1439-0310.2006.01142.x; PRUETTJONES S, 1992, AM NAT, V140, P1000, DOI 10.1086/285452; Schlupp I, 1997, BEHAV ECOL, V8, P104, DOI 10.1093/beheco/8.1.104; Simons MJP, 2011, BEHAV ECOL, V22, P755, DOI 10.1093/beheco/arr043; SWADDLE JP, 1994, P ROY SOC B-BIOL SCI, V258, P267, DOI 10.1098/rspb.1994.0172; Swaddle JP, 2005, P ROY SOC B-BIOL SCI, V272, P1053, DOI 10.1098/rspb.2005.3054; Tachon G, 1999, J INSECT BEHAV, V12, P533, DOI 10.1023/A:1020970908541; Townsend Simon, 2009, Communicative & Integrative Biology, V2, P282; Ung D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022686; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; Westneat DF, 2000, ANIM BEHAV, V59, P467, DOI 10.1006/anbe.1999.1341; Williams TH, 2010, ETHOLOGY, V116, P1038, DOI 10.1111/j.1439-0310.2010.01816.x; Witte K, 1999, BEHAV ECOL, V10, P15, DOI 10.1093/beheco/10.1.15; Witte K, 2000, ETHOLOGY, V106, P349, DOI 10.1046/j.1439-0310.2000.00558.x; Witte K, 2003, ANIM BEHAV, V65, P195, DOI 10.1006/anbe.2002.2009; Witte K, 2011, FISH COGNITION BEHAV, P85; Witte K, 2006, BEHAVIOUR, V143, P969, DOI 10.1163/156853906778623626; Witte K, 2006, ETHOL ECOL EVOL, V18, P195, DOI 10.1080/08927014.2006.9522707; Wong BBM, 2009, BEHAV ECOL, V20, P278, DOI 10.1093/beheco/arp010; Wronski T, 2012, BEHAV ECOL, V23, P551, DOI 10.1093/beheco/arr223; Zann R. A., 1996, ZEBRA FINCHES SYNTHE; Ziege M, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-17	77	7	7	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147130	10.1371/journal.pone.0147130	http://dx.doi.org/10.1371/journal.pone.0147130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839957	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200026
J	Wang, M; Moran, AE; Liu, J; Coxson, PG; Penko, J; Goldman, L; Bibbins-Domingo, K; Zhao, D				Wang, Miao; Moran, Andrew E.; Liu, Jing; Coxson, Pamela G.; Penko, Joanne; Goldman, Lee; Bibbins-Domingo, Kirsten; Zhao, Dong			Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study	PLOS ONE			English	Article							TARGETED FOOD TAXES; BLOOD-PRESSURE; MAGNESIUM SUPPLEMENTATION; POTASSIUM EXCRETION; URINARY SODIUM; HEART-DISEASE; METAANALYSIS; REDUCTION; HEALTH; RISK	Objectives To estimate the effects of achieving China's national goals for dietary salt (NaCl) reduction or implementing culturally-tailored dietary salt restriction strategies on cardiovascular disease (CVD) prevention. Methods The CVD Policy Model was used to project blood pressure lowering and subsequent downstream prevented CVD that could be achieved by population-wide salt restriction in China. Outcomes were annual CVD events prevented, relative reductions in rates of CVD incidence and mortality, quality-adjusted life-years (QALYs) gained, and CVD treatment costs saved. Results Reducing mean dietary salt intake to 9.0 g/day gradually over 10 years could prevent approximately 197 000 incident annual CVD events [95% uncertainty interval (UI): 173 000-219 000], reduce annual CVD mortality by approximately 2.5% (2.2-2.8%), gain 303 000 annual QALYs (278 000-329 000), and save approximately 1.4 billion international dollars (Int$) in annual CVD costs (Int$; 1.2-1.6 billion). Reducing mean salt intake to 6.0 g/day could approximately double these benefits. Implementing cooking salt-restriction spoons could prevent 183 000 fewer incident CVD cases (153 000-215 000) and avoid Int$ 1.4 billion in CVD treatment costs annually (1.2-1.7 billion). Implementing a cooking salt substitute strategy could lead to approximately three times the health benefits of the saltrestriction spoon program. More than three-quarters of benefits from any dietary salt reduction strategy would be realized in hypertensive adults. Conclusion China could derive substantial health gains from implementation of population-wide dietary salt reduction policies. Most health benefits from any dietary salt reduction program would be realized in adults with hypertension.	[Wang, Miao; Liu, Jing; Zhao, Dong] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol, Beijing Anzhen Hosp, Beijing, Peoples R China; [Moran, Andrew E.] Columbia Univ, Dept Med, Div Gen Med, New York, NY USA; [Coxson, Pamela G.; Penko, Joanne; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA USA; [Goldman, Lee] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA	Capital Medical University; Columbia University; University of California System; University of California San Francisco; Columbia University	Zhao, D (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol, Beijing Anzhen Hosp, Beijing, Peoples R China.	deezhao@vip.sina.com	Zhao, D/AAX-5040-2021		National Program on Key Basic Research Project of China [2012CB517806]; National Science & Technology Pillar Program [2011BAI09B01, 2011BAI11B03]; Capital Health Research and Development of Special [2011-1005-01]; Mentored Career Development Award from the National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health [K08HL089675]; University of California Pacific Rim Research Program; Beijing Talents Fund [2014000021469G232]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER	National Program on Key Basic Research Project of China(National Basic Research Program of China); National Science & Technology Pillar Program; Capital Health Research and Development of Special; Mentored Career Development Award from the National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health; University of California Pacific Rim Research Program(University of California System); Beijing Talents Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the National Program on Key Basic Research Project of China (contract 2012CB517806, http://program.most.gov.cn) and the National Science & Technology Pillar Program during the 12th Five-Year Plan Period (contracts 2011BAI09B01 and 2011BAI11B03, http://program.most.gov.cn) to Dr. Zhao, the Capital Health Research and Development of Special (contract 2011-1005-01, http://www.bjhbkj.com) to Dr. Liu, Mentored Career Development Award (contract K08HL089675, http://www.nhlbi.nih.gov) from the National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health to Dr. Moran, a University of California Pacific Rim Research Program (http://www.ucsf.edu) grant to Dr. Bibbins-Domingo, and the Beijing Talents Fund (contract 2014000021469G232, http://bjrcgz.gov.cn) to Dr. Wang. The sponsors of this study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 2014, LANCET, DOI DOI 10.1016/S0140-6736(14)60616-4; Chen JJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/658925; Chinese Center for Disease Control and Prevention, 2013, SALT INT LEV WAS REL; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Du SF, 2014, AM J CLIN NUTR, V99, P334, DOI 10.3945/ajcn.113.059121; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ge K, 2011, ASIA PAC J CLIN NUTR, V20, P439; Geleijnse JM, 2003, J HUM HYPERTENS, V17, P471, DOI 10.1038/sj.jhh.1001575; Gillespie DOS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127927; Gu DF, 2008, AM J HYPERTENS, V21, P265, DOI 10.1038/ajh.2007.59; Gu DF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001860; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; He J, 2004, ETHNIC DIS, V14, P260; Hendriksen MAH, 2014, AM J CLIN NUTR, V99, P446, DOI 10.3945/ajcn.113.062018; [胡继宏 Hu Jihong], 2014, [中华高血压杂志, Chinese Journal of Hypertension], V22, P42; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Jee SH, 2002, AM J HYPERTENS, V15, P691, DOI 10.1016/S0895-7061(02)02964-3; Kass L, 2012, EUR J CLIN NUTR, V66, P411, DOI 10.1038/ejcn.2012.4; Li N, 2013, AM HEART J, V166, P815, DOI 10.1016/j.ahj.2013.07.009; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Ministry of Health of the Peoples Republic of China, 2011, CHIN HLTH STAT YB 20; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; The Peoples Republic of China National Health and Family Planning Commission, 2012, CHIN NAT PLAN NCD PR; Wang M, 2015, GLOB HEART, V10, P291, DOI 10.1016/j.gheart.2014.10.009; Wang MA, 2014, CIRC-CARDIOVASC QUAL, V7, P78, DOI 10.1161/CIRCOUTCOMES.113.000674; Wang Y, 2015, EUR J PREV CARDIOL, V22, P380, DOI 10.1177/2047487313516563; World Health Organization, 2014, WORLD HLTH STAT 2013; Xi B, 2014, LANCET, V383, P1128, DOI 10.1016/S0140-6736(14)60567-5; Zhai F., 2006, REPORT CHINESE NATL; Zhang Ji-Guo, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P310; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807	40	15	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146820	10.1371/journal.pone.0146820	http://dx.doi.org/10.1371/journal.pone.0146820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840409	Green Published, gold, Green Submitted			2022-12-26	WOS:000369550200017
J	Martos-Sitcha, JA; Mancera, JM; Calduch-Giner, JA; Yufera, M; Martinez-Rodriguez, G; Perez-Sanchez, J				Antonio Martos-Sitcha, Juan; Miguel Mancera, Juan; Alvar Calduch-Giner, Josep; Yufera, Manuel; Martinez-Rodriguez, Gonzalo; Perez-Sanchez, Jaume			Unraveling the Tissue-Specific Gene Signatures of Gilthead Sea Bream (Sparus aurata L.) after Hyper- and Hypo-Osmotic Challenges	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TIME-COURSE; ENERGY-METABOLISM; FUNDULUS-HETEROCLITUS; OPERCULAR EPITHELIUM; ARGININE VASOTOCIN; RAINBOW-TROUT; UDP-GLUCURONOSYLTRANSFERASE; OREOCHROMIS-MOSSAMBICUS; OSMOREGULATORY RESPONSE	A custom microarray was used for the transcriptomic profiling of liver, gills and hypothalamus in response to hypo-(38% -> 5%) or hyper-(38% -> 55%) osmotic challenges (7 days after salinity transfer) in gilthead sea bream (Sparus aurata) juveniles. The total number of differentially expressed genes was 777. Among them, 341 and 310 were differentially expressed in liver after hypo-and hyper-osmotic challenges, respectively. The magnitude of changes was lower in gills and hypothalamus with around 131 and 160 responsive genes in at least one osmotic stress condition, respectively. Regardless of tissue, a number of genes were equally regulated in either hypo-and hyper-osmotic challenges: 127 out of 524 in liver, 11 out of 131 in gills and 19 out of 160 in hypothalamus. In liver and gills, functional analysis of differentially expressed genes recognized two major clusters of overlapping canonical pathways that were mostly related to "Energy Metabolism" and "Oxidative Stress". The later cluster was represented in all the analyzed tissues, including the hypothalamus, where differentially expressed genes related to "Cell and tissue architecture" were also over-represented. Overall the response for "Energy Metabolism" was the up-regulation, whereas for oxidative stress-related genes the type of response was highly dependent of tissue. These results support common and different osmoregulatory responses in the three analyzed tissues, helping to load new allostatic conditions or even to return to basal levels after hypo-or hyper-osmotic challenges according to the different physiological role of each tissue.	[Antonio Martos-Sitcha, Juan; Yufera, Manuel; Martinez-Rodriguez, Gonzalo] CSIC, Inst Ciencias Marinas Andalucia ICMAN, E-11519 Puerto Real, Cadiz, Spain; [Antonio Martos-Sitcha, Juan; Miguel Mancera, Juan] Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Campus Excelencia Int Mar CEI MAR, E-11519 Puerto Real, Cadiz, Spain; [Alvar Calduch-Giner, Josep; Perez-Sanchez, Jaume] CSIC, IATS, Nutrigen & Fish Growth Endocrinol Grp, E-12595 Ribera De Cabanes, Castellon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS)	Martos-Sitcha, JA (corresponding author), CSIC, Inst Ciencias Marinas Andalucia ICMAN, E-11519 Puerto Real, Cadiz, Spain.; Martos-Sitcha, JA (corresponding author), Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Campus Excelencia Int Mar CEI MAR, E-11519 Puerto Real, Cadiz, Spain.	juanantonio.sitcha@icman.csic.es	Yufera, Manuel/E-1309-2011; Calduch-Giner, Josep/AAY-1475-2021; sanchez, jaume perez/K-3231-2014; MARTINEZ-RODRIGUEZ, GONZALO/A-2564-2009; Sánchez, Jaume Pérez/AAJ-6628-2021; Martos-Sitcha, Juan Antonio/L-6140-2014	Calduch-Giner, Josep/0000-0003-3124-5986; sanchez, jaume perez/0000-0003-2506-1523; MARTINEZ-RODRIGUEZ, GONZALO/0000-0003-3379-580X; Sánchez, Jaume Pérez/0000-0003-2506-1523; Martos-Sitcha, Juan Antonio/0000-0002-0151-7250; Yufera, Manuel/0000-0003-2999-4611	Spanish Ministry of Economic Affairs and Competitiveness (MINECO); FEDER/ERDF [AGL2013-48835-C2-1-R, CDS2007-00002]; Spanish Ministry of Economic Affairs and Competitiveness (MINECO) [FJCI-2014-20161]	Spanish Ministry of Economic Affairs and Competitiveness (MINECO); FEDER/ERDF; Spanish Ministry of Economic Affairs and Competitiveness (MINECO)	This research was funded by the Spanish Ministry of Economic Affairs and Competitiveness (MINECO) with FEDER/ERDF contribution by projects AGL2013-48835-C2-1-R to JMM and AQUAGENOMICS (CDS2007-00002) to MY and JPS. JAMS is supported by a Post-Doctoral contract (Juan de la Cierva-formacion, Reference FJCI-2014-20161) from Spanish Ministry of Economic Affairs and Competitiveness (MINECO).	ANKLEY GT, 1986, AQUAT TOXICOL, V9, P91, DOI 10.1016/0166-445X(86)90016-0; Martos-Sitcha JA, 2015, COMP BIOCHEM PHYS A, V182, P93, DOI 10.1016/j.cbpa.2014.12.027; Martos-Sitcha JA, 2013, GEN COMP ENDOCR, V193, P221, DOI 10.1016/j.ygcen.2013.07.017; Arjona FJ, 2007, COMP BIOCHEM PHYS A, V148, P413, DOI 10.1016/j.cbpa.2007.05.026; Benedito-Palos L, 2010, J ANIM SCI, V88, P1759, DOI 10.2527/jas.2009-2564; Benedito-Palos L, 2014, GENE, V547, P34, DOI 10.1016/j.gene.2014.05.073; Bermejo-Nogales A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122889; Bermejo-Nogales A, 2014, GEN COMP ENDOCR, V205, P305, DOI 10.1016/j.ygcen.2014.04.016; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Boeuf G, 2001, COMP BIOCHEM PHYS C, V130, P411, DOI 10.1016/S1532-0456(01)00268-X; Burbach BJ, 2007, IMMUNOL REV, V218, P65, DOI 10.1111/j.1600-065X.2007.00527.x; Calduch-Giner JA, 2014, MAR BIOTECHNOL, V16, P423, DOI 10.1007/s10126-014-9562-3; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Calduch-Giner JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-470; Calduch-Giner JA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-193; Cuesta A, 2005, FISH SHELLFISH IMMUN, V18, P255, DOI 10.1016/j.fsi.2004.07.009; Davey GC, 2011, MOL IMMUNOL, V48, P2102, DOI 10.1016/j.molimm.2011.07.003; Edwards SL, 2013, FISH PHYSIOL, V32, P1, DOI 10.1016/B978-0-12-396951-4.00001-3; Evans DH, 2008, AM J PHYSIOL-REG I, V295, pR704, DOI 10.1152/ajpregu.90337.2008; Evans David H., 1993, P315; Evans DH, 2004, AM J PHYSIOL-REG I, V286, pR560, DOI 10.1152/ajpregu.00281.2003; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Evans TG, 2008, J EXP BIOL, V211, P3636, DOI 10.1242/jeb.022160; Ferraresso S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-580; Finnson KW, 1997, COMP BIOCHEM PHYS C, V117, P193, DOI 10.1016/S0742-8413(96)00231-9; Finnson KW, 1996, GEN COMP ENDOCR, V101, P145, DOI 10.1006/gcen.1996.0016; Fiol DF, 2007, FEBS J, V274, P5790, DOI 10.1111/j.1742-4658.2007.06099.x; Frische EW, 2010, DEV BIOL, V340, P1, DOI 10.1016/j.ydbio.2009.12.043; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; George Stephen G., 1994, P37; Gregorio SF, 2013, J EXP BIOL, V216, P470, DOI 10.1242/jeb.073742; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Henry RP, 2003, COMP BIOCHEM PHYS A, V136, P243, DOI 10.1016/S1095-6433(03)00113-2; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; Holmes W. N., 1969, P1; Kalujnaia S, 2007, PHYSIOL GENOMICS, V31, P385, DOI 10.1152/physiolgenomics.00059.2007; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kelly SP, 1999, ZOOL SCI, V16, P505, DOI 10.2108/zsj.16.505; Klaren PHM, 2007, GEN COMP ENDOCR, V152, P215, DOI 10.1016/j.ygcen.2007.02.010; Kleszczynska A, 2006, COMP BIOCHEM PHYS A, V145, P268, DOI 10.1016/j.cbpa.2006.06.037; KNOWLES AF, 1971, J BIOL CHEM, V246, P2672; Kulczykowska E, 2002, REV FISH BIOL FISHER, V11, P321; Kulczykowska E, 1998, EXP PHYSIOL, V83, P809, DOI 10.1113/expphysiol.1998.sp004161; KULCZYKOWSKA E, 1995, REV FISH BIOL FISHER, V5, P96, DOI 10.1007/BF01103367; Kultz D, 2001, COMP BIOCHEM PHYS B, V129, P821, DOI 10.1016/S1096-4959(01)00395-5; Laiz-Carrion R, 2005, AQUACULTURE, V250, P849, DOI 10.1016/j.aquaculture.2005.05.021; Laiz-Carrion R, 2005, J EXP ZOOL PART A, V303A, P563, DOI 10.1002/jez.a.183; Lam SH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-921; Lin CH, 2004, J EXP ZOOL PART A, V301A, P85, DOI 10.1002/jez.a.20007; Lionetto MG, 1998, COMP BIOCHEM PHYS A, V120, P89, DOI 10.1016/S1095-6433(98)10014-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Olmeda JF, 2009, COMP BIOCHEM PHYS A, V152, P486, DOI 10.1016/j.cbpa.2008.12.003; Maetz J., 1974, Biochemical biophys Perspect mar Biol, V1, P1; Mancera JM, 2002, GEN COMP ENDOCR, V129, P95, DOI 10.1016/S0016-6480(02)00522-1; Marshall WS, 1999, J EXP BIOL, V202, P1535; Marshall WS, 2005, J EXP BIOL, V208, P1063, DOI 10.1242/jeb.01491; Marshall WS, 2002, J EXP ZOOL, V293, P264, DOI 10.1002/jez.10127; Martos-Sitcha JA, 2014, GEN COMP ENDOCR, V197, P5, DOI 10.1016/j.ygcen.2013.11.026; Martos-Sitcha JA, 2014, COMP BIOCHEM PHYS A, V177, P49, DOI 10.1016/j.cbpa.2014.07.021; McCormick SD, 2013, FISH PHYSIOL, V32, P1; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; NEUWELT EA, 1987, J NEURO-ONCOL, V4, P195, DOI 10.1007/BF00150611; RAPOPORT SI, 1988, ANN NEUROL, V24, P677, DOI 10.1002/ana.410240513; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Salem M, 2005, COMP BIOCHEM PHYS B, V140, P63, DOI 10.1016/j.cbpc.2004.09.007; Sangiao-Alvarellos S, 2005, J EXP BIOL, V208, P4291, DOI 10.1242/jeb.01900; Sangiao-Alvarellos S, 2003, AM J PHYSIOL-REG I, V285, pR897, DOI 10.1152/ajpregu.00161.2003; Sarropoulou E, 2005, PHYSIOL GENOMICS, V23, P182, DOI 10.1152/physiolgenomics.00139.2005; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Soengas JL, 2002, COMP BIOCHEM PHYS B, V131, P271, DOI 10.1016/S1096-4959(02)00022-2; Soengas Jose L., 2007, P277; STRANGE K, 1992, J AM SOC NEPHROL, V3, P12; Takei Y, 2013, FISH PHYSIOL, V32, P69, DOI 10.1016/B978-0-12-396951-4.00003-7; Tanaka M, 2006, J HYPERTENS, V24, P489, DOI 10.1097/01.hjh.0000209985.66853.1e; Tang CH, 2014, FISH PHYSIOL BIOCHEM, V40, P1533, DOI 10.1007/s10695-014-9946-3; Tao T, 2009, J GENET GENOMICS, V36, P325, DOI 10.1016/S1673-8527(08)60121-6; Teles M, 2013, MAR BIOTECHNOL, V15, P104, DOI 10.1007/s10126-012-9467-y; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Vieira FA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-490; Wilson JM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P237, DOI 10.1086/341817; Wu BJ, 2011, J PHARM SCI-US, V100, P3655, DOI 10.1002/jps.22568; Yong JHA, 2013, FRONT PHYSIOL, P1	85	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148113	10.1371/journal.pone.0148113	http://dx.doi.org/10.1371/journal.pone.0148113			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828928	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200064
J	Beckensteiner, J; Kaplan, DM; Potts, WM; Santos, CV; O'Farrell, MR				Beckensteiner, Jennifer; Kaplan, David M.; Potts, Warren M.; Santos, Carmen V.; O'Farrell, Michael R.			Data-Limited Population-Status Evaluation of Two Coastal Fishes in Southern Angola Using Recreational Catch Length-Frequency Data	PLOS ONE			English	Article							BENGUELA FRONTAL ZONE; MARINE PROTECTED AREA; STOCK-ASSESSMENT; MATERNAL-AGE; LIFE-HISTORY; MANAGEMENT; FLUCTUATIONS; RECRUITMENT; SELECTION; SURVIVAL	Excessive truncation of a population's size structure is often identified as an important deleterious effect of exploitation, yet the effect on population persistence of size-structure truncation caused by exploitation is often not quantified due to data limitations. In this study, we estimate changes in eggs per recruit (EPR)using annual length-frequency samples over a 9 year period to assess persistence of the two most important recreational fishes in southern Angola: west coast dusky kob (Argyrosomus coronus) and leerfish (Lichia amia). Using a length-and age-structured model, we improve on an existing method to fit this type of model to length-frequency data and estimate EPR. The objectives of the methodological changes are to add flexibility and robustness to the approach for assessing population status in data-limited situations. Results indicate that dusky kob presents very low levels of EPR (5%-10% of the per recruit reproductive capacity in the absence of fishing) in 2013, whereas large inter-annual variability in leerfish estimates suggest caution must be applied when drawing conclusions about its exploitation status. Using simulated length frequency data with known parameter values, we demonstrate that recruitment decline due to overexploitation leads to overestimation of EPR values. Considering the low levels of EPR estimated for the study species, recruitment limitation is not impossible and true EPR values may be even lower than our estimates. It is, therefore, likely that management action, such as the creation of Marine Protected Areas, is needed to reconstitute the west coast dusky kob population.	[Beckensteiner, Jennifer; Kaplan, David M.] IRD, Ctr Rech Halieut Mediterraneenne & Trop, UMR EME 212, Sete, France; [Beckensteiner, Jennifer; Kaplan, David M.] Virginia Inst Marine Sci, Coll William & Mary, Dept Fisheries, Gloucester Point, VA 23062 USA; [Potts, Warren M.] Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa; [Santos, Carmen V.] FCUAN, Luanda, Angola; [O'Farrell, Michael R.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [O'Farrell, Michael R.] SW Fisheries Sci Ctr, Fisheries Ecol Div, Santa Cruz, CA USA	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; William & Mary; Virginia Institute of Marine Science; Rhodes University; University of California System; University of California Davis; National Oceanic Atmospheric Admin (NOAA) - USA	Beckensteiner, J (corresponding author), IRD, Ctr Rech Halieut Mediterraneenne & Trop, UMR EME 212, Sete, France.; Beckensteiner, J (corresponding author), Virginia Inst Marine Sci, Coll William & Mary, Dept Fisheries, Gloucester Point, VA 23062 USA.	jbeckensteiner@vims.edu	Santos, Carmen Van-Dúnem/O-1778-2014; Kaplan, David/G-5230-2010	Santos, Carmen Van-Dúnem/0000-0003-0643-5462; Kaplan, David/0000-0001-6087-359X; Beckensteiner, Jennifer/0000-0002-3811-6506	AMPED project from French National Research Agency (ANR), Systerra Programme [ANR-08-STRA-03]; National Research Foundation [66957]; National Research Foundations Knowledge Field Development South African Biosystems Initiative [74457]	AMPED project from French National Research Agency (ANR), Systerra Programme(French National Research Agency (ANR)); National Research Foundation; National Research Foundations Knowledge Field Development South African Biosystems Initiative	JB and DMK were supported by the AMPED project (www.amped.ird.fr) through a grant from the French National Research Agency (ANR), Systerra Programme, grant number ANR-08-STRA-03. WP and CVS were supported by the National Research Foundation under grant number 66957 and by the National Research Foundations Knowledge Field Development South African Biosystems Initiative under grant number 74457. This work was performed in part using computational facilities at the College of William and Mary which were provided with the assistance of the National Science Foundation, the Virginia Port Authority, Sun Microsystems, and Virginia's Commonwealth Technology Research Fund.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Ault JS, 2008, ENVIRON CONSERV, V35, P221, DOI 10.1017/S0376892908005043; Barnes JI, 2004, DIR ENV AFF MINIST E; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Beverton RJH, 1957, FISH INVESTIG SER 2, V19; Brodziak J, 2012, WORKSH METH EST TOT; Brouwer SL, 2005, FISH B-NOAA, V103, P258; Clark WG, 2002, N AM J FISH MANAGE, V22, P251, DOI 10.1577/1548-8675(2002)022<0251:FRTYL>2.0.CO;2; Duarte A, 2005, LMRAFSE0301B; FAO, 2007, ANG FISH COUNTR PROF, P17; Gedamke T, 2006, T AM FISH SOC, V135, P476, DOI 10.1577/T05-153.1; Griffiths M. H., 1995, CONTRIBUTION TAXONOM; HILBORN R, 1993, CAN J FISH AQUAT SCI, V50, P874, DOI 10.1139/f93-100; Hordyk A, 2015, ICES J MAR SCI, V72, P217, DOI 10.1093/icesjms/fsu004; Hsieh CH, 2010, AQUAT SCI, V72, P165, DOI 10.1007/s00027-009-0122-2; Hutchings JA, 1996, CAN J FISH AQUAT SCI, V53, P943, DOI 10.1139/f96-097; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; Jennings S., 2001, MARINE FISHERIES ECO; John HC, 2001, J MARINE SYST, V28, P91, DOI 10.1016/S0924-7963(00)00085-3; Kaplan DM, 2009, ECOL APPL, V19, P433, DOI 10.1890/07-1705.1; Klaer NL, 2012, FISH RES, V134, P42, DOI 10.1016/j.fishres.2012.08.010; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Lennert-Cody CE, 2010, FISH RES, V102, P323, DOI 10.1016/j.fishres.2009.11.014; Maunder MN, 2013, FISH RES, V142, P61, DOI 10.1016/j.fishres.2012.07.025; Maunder MN, 2011, FISH RES, V109, P311, DOI 10.1016/j.fishres.2011.02.018; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Monteiro PMS, 2008, DEEP-SEA RES PT I, V55, P435, DOI 10.1016/j.dsr.2007.12.010; Moussa SZ, 2002, APPRAISAL REPORT ART, P58; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; O'Farrell MR, 2006, CAN J FISH AQUAT SCI, V63, P2249, DOI 10.1139/F06-130; O'Farrell MR, 2006, ECOL APPL, V16, P977, DOI 10.1890/1051-0761(2006)016[0977:ETSONR]2.0.CO;2; O'Farrell MR, 2005, CAN J FISH AQUAT SCI, V62, P1626, DOI 10.1139/F05-064; Pauly D, 2001, CAN J FISH AQUAT SCI, V58, P51, DOI 10.1139/cjfas-58-1-51; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Potts WM, 2008, AFR J MAR SCI, V30, P113, DOI 10.2989/AJMS.2008.30.1.11.461; Potts WM, 2010, AFR J MAR SCI, V32, P247, DOI 10.2989/1814232X.2010.501567; Potts WM, 2009, FISHERIES MANAG ECOL, V16, P14, DOI 10.1111/j.1365-2400.2008.00617.x; Potts WM, 2014, GLOBAL CHANGE BIOL, V20, P2765, DOI 10.1111/gcb.12612; Quinn TJI, 1999, BIOL RESOUR MANAG SE; Reboulet AM, 1999, BIRD STUDY, V46, P148; Rouyer T, 2012, ECOL LETT, V15, P658, DOI 10.1111/j.1461-0248.2012.01781.x; Sadovy Y, 2003, FISH FISH, V4, P86, DOI 10.1046/j.1467-2979.2003.00104.x; Sampson DB, 2011, CAN J FISH AQUAT SCI, V68, P1077, DOI 10.1139/F2011-044; SCHNUTE J, 1980, CAN J FISH AQUAT SCI, V37, P1337, DOI 10.1139/f80-172; Schnute JT, 2007, ICES J MAR SCI, V64, P218, DOI 10.1093/icesjms/fsl024; SHEPHERD JG, 1982, J CONSEIL, V40, P67; SISSENWINE MP, 1987, CAN J FISH AQUAT SCI, V44, P913, DOI 10.1139/f87-110; Stenseth NC, 2008, NATURE, V452, P825, DOI 10.1038/452825a; Stewart IJ, 2015, ICES J MAR SCI, V72, P2187, DOI 10.1093/icesjms/fsv061; Thorson JT, 2015, ICES J MAR SCI, V72, P1245, DOI 10.1093/icesjms/fsu213; Thorson JT, 2015, ICES J MAR SCI, V72, P178, DOI 10.1093/icesjms/fst211; Thorson JT, 2014, CAN J FISH AQUAT SCI, V71, P973, DOI 10.1139/cjfas-2013-0645; Van der Elst RP, 1993, BIOL STATUS GARRICK, P28; Veitch JA, 2006, INT J REMOTE SENS, V27, P987, DOI 10.1080/01431160500127914; Veitch J, 2010, J PHYS OCEANOGR, V40, P1942, DOI 10.1175/2010JPO4382.1; Vincenzi S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003828	57	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147834	10.1371/journal.pone.0147834	http://dx.doi.org/10.1371/journal.pone.0147834			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829489	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200035
J	Forat, S; Huettel, B; Reinhardt, R; Fimmers, R; Haidl, G; Denschlag, D; Olek, K				Forat, Sophia; Huettel, Bruno; Reinhardt, Richard; Fimmers, Rolf; Haidl, Gerhard; Denschlag, Dominik; Olek, Klaus			Methylation Markers for the Identification of Body Fluids and Tissues from Forensic Trace Evidence	PLOS ONE			English	Article							COLLABORATIVE EDNAP EXERCISE; RNA/DNA CO-ANALYSIS; DNA METHYLATION; SEMEN; STAINS; BLOOD; RNA; GENOME; CANCER; SALIVA	The identification of body fluids is an essential tool for clarifying the course of events at a criminal site. The analytical problem is the fact that the biological material has been very often exposed to detrimental exogenous influences. Thereby, the molecular substrates used for the identification of the traces may become degraded. So far, most protocols utilize cell specific proteins or RNAs. Instead of measuring these more sensitive compounds this paper describes the application of the differential DNA-methylation. As a result of two genome wide screenings with the Illumina HumanMethylation BeadChips 27 and 450k we identified 150 candidate loci revealing differential methylation with regard to the body fluids venous blood, menstrual blood, vaginal fluid, saliva and sperm. Among them we selected 9 loci as the most promising markers. For the final determination of the methylation degree we applied the SNuPE-method. Because the degree of methylation might be modified by various endogenous and exogenous factors, we tested each marker with approximately 100 samples of each target fluid in a validation study. The stability of the detection procedure is proved in various simulated forensic surroundings according to standardized conditions. We studied the potential influence of 12 relatively common tumors on the methylation of the 9 markers. For this purpose the target fluids of 34 patients have been analysed. Only the cervix carcinoma might have an remarkable effect because impairing the signal of both vaginal markers. Using the Illumina MiSeq device we tested the potential influence of cis acting sequence variants on the methylation degree of the 9 markers in the specific body fluid DNA of 50 individuals. For 4 marker loci we observed such an influence either by sole SNPs or haplotypes. The identification of each target fluid is possible in arbitrary mixtures with the remaining four body fluids. The sensitivity of the individual body fluid tests is in the same range as for the forensic STR-analysis. It is the first forensic body fluid protocol which considers the exogenic and endogenic parameters potentially interfering with the true results.	[Forat, Sophia; Olek, Klaus] Lab Abstammungsbegutachtungen GmbH, Rheinbach, Germany; [Huettel, Bruno; Reinhardt, Richard] Max Planck Genome Ctr Cologne, Inst Breeding Res, Cologne, Germany; [Fimmers, Rolf] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Haidl, Gerhard] Univ Bonn, Dept Dermatol, Androl Unit, Bonn, Germany; [Denschlag, Dominik] Dept OB GYN Hochtaunuskliniken Bad Homburg, Bad Homburg, Germany	Max Planck Society; University of Bonn; University of Bonn	Forat, S; Olek, K (corresponding author), Lab Abstammungsbegutachtungen GmbH, Rheinbach, Germany.	forats@web.de; olek@lfa-gmbh.de		Reinhardt, Richard/0000-0001-9376-2132	ZIM project [KU2117901AJ8.]	ZIM project	SF was supported in part by ZIM project Nr. KU2117901AJ8.	ALLEN SM, 1995, J IMMUNOASSAY, V16, P297, DOI 10.1080/15321819508013564; An JH, 2013, INT J LEGAL MED, V127, P35, DOI 10.1007/s00414-012-0719-1; Barfield RT, 2014, GENET EPIDEMIOL, V38, P231, DOI 10.1002/gepi.21789; Baron U, 2006, EPIGENETICS-US, V1, P55, DOI 10.4161/epi.1.1.2643; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Fiegl H, 2007, DIS MARKERS, V23, P89, DOI 10.1155/2007/293138; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frumkin D, 2011, FORENSIC SCI INT-GEN, V5, P517, DOI 10.1016/j.fsigen.2010.12.001; Haas C, 2014, FORENSIC SCI INT-GEN, V8, P203, DOI 10.1016/j.fsigen.2013.09.009; Haas C, 2013, FORENSIC SCI INT-GEN, V7, P230, DOI 10.1016/j.fsigen.2012.10.011; Haas C, 2012, FORENSIC SCI INT-GEN, V6, P70, DOI 10.1016/j.fsigen.2011.02.004; Haas C, 2011, FORENSIC SCI INT-GEN, V5, P21, DOI 10.1016/j.fsigen.2010.01.003; Haas C, 2009, FORENSIC SCI INT-GEN, V3, P80, DOI 10.1016/j.fsigen.2008.11.003; Hanson EK, 2009, ANAL BIOCHEM, V387, P303, DOI 10.1016/j.ab.2009.01.037; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; James SH, 2003, IDENTIFICATION BIOL; Juusola J, 2007, J FORENSIC SCI, V52, P1252, DOI 10.1111/j.1556-4029.2007.00550.x; Larue BL, 2013, INT J LEGAL MED, V127, P299, DOI 10.1007/s00414-012-0760-0; Lee HY, 2015, FORENSIC SCI INT-GEN, V17, P17, DOI 10.1016/j.fsigen.2015.03.002; Lee HY, 2012, INT J LEGAL MED, V126, P55, DOI 10.1007/s00414-011-0569-2; Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346; Santucci KA, 1999, PEDIATRICS, V104, P1342, DOI 10.1542/peds.104.6.1342; Sato I, 2007, INT J LEGAL MED, V121, P315, DOI 10.1007/s00414-006-0084-z; Setzer M, 2008, J FORENSIC SCI, V53, P296, DOI 10.1111/j.1556-4029.2007.00652.x; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; van den Berge M, 2014, FORENSIC SCI INT-GEN, V10, P40, DOI 10.1016/j.fsigen.2014.01.006; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zubakov D, 2010, INT J LEGAL MED, V124, P217, DOI 10.1007/s00414-009-0402-3	31	41	42	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147973	10.1371/journal.pone.0147973	http://dx.doi.org/10.1371/journal.pone.0147973			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829227	Green Submitted, Green Published, gold			2022-12-26	WOS:000369548200049
J	Mouttet, D; Lae, M; Caly, M; Gentien, D; Carpentier, S; Peyro-Saint-Paul, H; Vincent-Salomon, A; Rouzier, R; Sigal-Zafrani, B; Sastre-Garau, X; Reyal, F				Mouttet, D.; Lae, M.; Caly, M.; Gentien, D.; Carpentier, S.; Peyro-Saint-Paul, H.; Vincent-Salomon, A.; Rouzier, R.; Sigal-Zafrani, B.; Sastre-Garau, X.; Reyal, F.			Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant (TM) Microarray Based Assay	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; GENOMIC GRADE INDEX; CENTRAL LABORATORIES; HORMONE-RECEPTORS; HISTOLOGIC GRADE; MOLECULAR-BASIS; EXPRESSION; PROGNOSIS; CHEMOTHERAPY; SIGNATURES	Background Hormone receptor status and HER2 status are of critical interest in determining the prognosis of breast cancer patients. Their status is routinely assessed by immunohistochemistry (IHC). However, it is subject to intra-laboratory and inter-laboratory variability. The aim of our study was to compare the estrogen receptor, progesterone receptor and HER2 status as determined by the MapQuant (TM) test to the routine immuno-histochemical tests in early stage invasive breast cancer in a large comprehensive cancer center. Patients and Methods We retrospectively studied 163 invasive early-stage breast carcinoma with standard IHC status. The genomic status was determined using the MapQuant (TM) test providing the genomic grade index. Results We found only 4 tumours out of 161 (2.5%) with discrepant IHC and genomic results concerning ER status. The concordance rate between the two methods was 97.5% and the Cohen's Kappa coefficient was 0.89. Comparison between the MapQuant (TM) PR status and the PR IHC status gave more discrepancies. The concordance rate between the two methods was 91.4% and the Cohen's Kappa coefficient was 0.74. The HER2 MapQuant (TM) test was classified as "undetermined" in 2 out of 163 cases (1.2%). One HER2 IHC-negative tumour was found positive with a high HER2 MapQuant (TM) genomic score. The concordance rate between the two methods was 99.3% and the Cohen's Kappa coefficient was 0.86. Conclusion Our results show that the MapQuant (TM) assay, based on mRNA expression assay, provides an objective and quantitative assessment of Estrogen receptor, Progesterone receptor and HER2 status in invasive breast cancer.	[Mouttet, D.; Rouzier, R.; Reyal, F.] Inst Curie, Dept Surg, Paris, France; [Reyal, F.] Inst Curie, Dept Translat Res, Residual Tumor & Response Treatment Team, Paris, France; [Lae, M.; Caly, M.; Vincent-Salomon, A.; Sigal-Zafrani, B.; Sastre-Garau, X.] Inst Curie, Dept Tumor Biol, Paris, France; [Gentien, D.] Inst Curie, Dept Translat Res, Paris, France; [Carpentier, S.; Peyro-Saint-Paul, H.] Marseille SA, QIAGEN, Marseille, SA, Australia	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.; Reyal, F (corresponding author), Inst Curie, Dept Translat Res, Residual Tumor & Response Treatment Team, Paris, France.	fabien.reyal@curie.fr	Gentien, David/L-7757-2017; Gentien, David/O-9356-2019; Rouzier, Roman/G-2953-2018	Gentien, David/0000-0001-8317-5188; Sastre-Garau, Xavier/0000-0001-5992-2083; Rouzier, Roman/0000-0002-8167-6808	QIAGEN	QIAGEN	The authors received no specific funding for this work. Authors SC and HP are employed by QIAGEN. QIAGEN provided support in the form of research material (Affymetrix arrays) and salaries for authors SC and HP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allred DC, 2008, J CLIN ONCOL, V26, P2433, DOI 10.1200/JCO.2007.15.7800; Arihiro K, 2007, AM J CLIN PATHOL, V127, P356, DOI 10.1309/4D1A04NCDK96WFY7; Badve SS, 2008, J CLIN ONCOL, V26, P2473, DOI 10.1200/JCO.2007.13.6424; Baehner FL, 2010, J CLIN ONCOL, V28, P4300, DOI 10.1200/JCO.2009.24.8211; Chebil G, 2003, ACTA ONCOL, V42, P43, DOI 10.1080/02841860300672; Chowdhury Nilotpal, 2011, Patholog Res Int, V2011, P890938, DOI 10.4061/2011/890938; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Dobbe E, 2008, AM J HEALTH-SYST PH, V65, P23, DOI 10.2146/ajhp060352; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Ignatiadis M, 2008, PATHOBIOLOGY, V75, P104, DOI 10.1159/000123848; Ignatiadis M, 2007, PHARMACOGENOMICS, V8, P101, DOI 10.2217/14622416.8.1.101; Lacroix-Triki M, 2006, EUR J CANCER, V42, P2946, DOI 10.1016/j.ejca.2006.06.020; Liedtke C, 2009, J CLIN ONCOL, V27, P3185, DOI 10.1200/JCO.2008.18.5934; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Marchionni L, 2008, ANN INTERN MED, V148, P358, DOI 10.7326/0003-4819-148-5-200803040-00208; Marchionni Luigi, 2007, Evid Rep Technol Assess (Full Rep), P1; Metzger O, 2011, CRIT REV ONCOL HEMAT, V77, P21, DOI 10.1016/j.critrevonc.2010.01.011; Mudduwa Lakmini, 2009, Indian J Med Sci, V63, P21; Naoi Y, 2011, CANCER-AM CANCER SOC, V117, P472, DOI 10.1002/cncr.25626; Paik S, 2002, JNCI-J NATL CANCER I, V94, P852, DOI 10.1093/jnci/94.11.852; Paik S, 2011, BREAST, V20, pS87, DOI 10.1016/S0960-9776(11)70301-0; Penault-Llorca F, 2010, ANN PATHOL, V30, P357, DOI 10.1016/j.annpat.2010.07.001; Perez EA, 2006, J CLIN ONCOL, V24, P3032, DOI 10.1200/JCO.2005.03.4744; Reddy JC, 2006, CLIN BREAST CANCER, V7, P153, DOI 10.3816/CBC.2006.n.025; Reyal F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035184; Rhodes A, 2000, J CLIN PATHOL, V53, P125, DOI 10.1136/jcp.53.2.125; Roepman P, 2009, CLIN CANCER RES, V15, P7003, DOI 10.1158/1078-0432.CCR-09-0449; Romond EH, 2012, J CLIN ONCOL; Ross JS, 2008, ONCOLOGIST, V13, P477, DOI 10.1634/theoncologist.2007-0248; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	33	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0146474	10.1371/journal.pone.0146474	http://dx.doi.org/10.1371/journal.pone.0146474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829108	Green Published, Green Submitted, gold			2022-12-26	WOS:000369548200010
J	Tamura, K; Kawabayashi, T; Shikanai, T; Hara-Nishimura, I				Tamura, Kentaro; Kawabayashi, Takenori; Shikanai, Toshiharu; Hara-Nishimura, Ikuko			Decreased Expression of a Gene Caused by a T-DNA Insertion in an Adjacent Gene in Arabidopsis	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; TRIPLE-A-SYNDROME; WD-REPEAT PROTEIN; ARTIFICIAL MICRORNAS; RIBOSOMAL-PROTEINS; REVERSE GENETICS; THALIANA; MUTAGENESIS; IDENTIFICATION; COLLECTION	ALADIN is a component of the nuclear pore complex in higher eukaryotes. An Arabidopsis knockout line that had a T-DNA insertion in the ALADIN gene was defective in plant growth and thylakoid development and had reduced photosynthetic activity resulting from lower chlorophyll accumulation. The mutation appeared to decrease the level of chloroplast RuBisCO subunits and PSBA and PGL35 proteins. Unexpectedly, the T-DNA insertion in the ALADIN gene decreased the expression of the neighboring gene PSRP5, which functions in translation in chloroplasts. The mutant phenotype was rescued by expressing PSRP5, but not by expressing ALADIN. The abnormal phenotypes were also detected in an artificial microRNA (amiRNA)-mediated PSRPS5 knockdown, but not in an amiRNA-mediated ALADIN knockdown line. Thus, users of T-DNA insertions should be aware that a T-DNA insertion in one gene can have effects on the expression of neighboring genes.	[Tamura, Kentaro; Kawabayashi, Takenori; Shikanai, Toshiharu; Hara-Nishimura, Ikuko] Kyoto Univ, Grad Sch Sci, Kyoto, Japan	Kyoto University	Hara-Nishimura, I (corresponding author), Kyoto Univ, Grad Sch Sci, Kyoto, Japan.	ihnishi@gr.bot.kyoto-u.ac.jp	Tamura, Kentaro/AAU-2354-2021; kawabayashi, takenori/E-2201-2016; Shikanai, Toshiharu/AAK-9112-2020	Tamura, Kentaro/0000-0001-7387-2211; 	Japan Society for the Promotion of Science (JSPS) [15K14545, 26711017, 15H05776, 22000014]; Grants-in-Aid for Scientific Research [22000014] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research to K.T. [nos. 15K14545 (https://kaken.nii ac.jp/d/p/15K14545.en.html) and 26711017 (https://kaken.nii.ac.jp/d/p/26711017.en.html)] and to I.H.N. [no. 15H05776 (https://kaken.nii.ac.jp/d/p/15H05776.en.html)], and a Grant-in-Aid for Specially Promoted Research to I.H.N. [no. 22000014 (https://kaken.nii.ac.jp/d/p/22000014.en.html)] from the Japan Society for the Promotion of Science (JSPS).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; AzpirozLeehan R, 1997, TRENDS GENET, V13, P152, DOI 10.1016/S0168-9525(97)01094-9; Bagga R, 2000, NUCLEIC ACIDS RES, V28, P2541, DOI 10.1093/nar/28.13.2541; Barton MC, 1997, P NATL ACAD SCI USA, V94, P7257, DOI 10.1073/pnas.94.14.7257; Braud C, 2012, PLANT PHYSIOL, V160, P823, DOI 10.1104/pp.112.202192; GHEYSEN G, 1990, GENE, V94, P155, DOI 10.1016/0378-1119(90)90382-2; Goto C, 2014, PLANT CELL, V26, P2143, DOI 10.1105/tpc.113.122168; Handschug K, 2001, HUM MOL GENET, V10, P283, DOI 10.1093/hmg/10.3.283; Hirano M, 2006, P NATL ACAD SCI USA, V103, P2298, DOI 10.1073/pnas.0505598103; Huebner A, 2006, MOL CELL BIOL, V26, P1879, DOI 10.1128/MCB.26.5.1879-1887.2006; Huebner A, 2004, ENDOCR RES, V30, P891, DOI 10.1081/ERC-200044138; LARKIN JC, 1993, PLANT CELL, V5, P1739, DOI 10.1105/tpc.5.12.1739; Lin D, 2015, PLANT BIOLOGY, V17, P599, DOI 10.1111/plb.12271; MacGregor DR, 2013, PLANT CELL, V25, P4391, DOI 10.1105/tpc.113.114959; Nacry P, 1998, GENETICS, V149, P641; O'Malley RC, 2010, PLANT J, V61, P928, DOI 10.1111/j.1365-313X.2010.04119.x; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Parry G, 2006, PLANT CELL, V18, P1590, DOI 10.1105/tpc.106.041566; Romani I, 2012, PLANT J, V72, P922, DOI 10.1111/tpj.12000; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shikanai T, 1999, PLANT CELL PHYSIOL, V40, P1134, DOI 10.1093/oxfordjournals.pcp.a029498; Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x; Tamura K, 2013, J EXP BOT, V64, P823, DOI 10.1093/jxb/ers258; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Tax FE, 2001, PLANT PHYSIOL, V126, P1527, DOI 10.1104/pp.126.4.1527; Thole V, 2012, J EXP BOT, V63, P567, DOI 10.1093/jxb/err333; Tiller N, 2012, PLANT J, V69, P302, DOI 10.1111/j.1365-313X.2011.04791.x; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wang NL, 2013, MOL PLANT, V6, P596, DOI 10.1093/mp/sss142; Woody ST, 2007, J PLANT RES, V120, P157, DOI 10.1007/s10265-006-0048-x	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147911	10.1371/journal.pone.0147911	http://dx.doi.org/10.1371/journal.pone.0147911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828726	gold, Green Published, Green Submitted			2022-12-26	WOS:000369548200042
J	Tang, JJ; Zou, YJ; Ash, J; Zhang, S; Liu, F; Wang, YH				Tang, Jinjun; Zou, Yajie; Ash, John; Zhang, Shen; Liu, Fang; Wang, Yinhai			Travel Time Estimation Using Freeway Point Detector Data Based on Evolving Fuzzy Neural Inference System	PLOS ONE			English	Article							EXTENDED KALMAN FILTER; C-MEANS; IMPUTATION; ALGORITHM; NETWORKS	Travel time is an important measurement used to evaluate the extent of congestion within road networks. This paper presents a new method to estimate the travel time based on an evolving fuzzy neural inference system. The input variables in the system are traffic flow data (volume, occupancy, and speed) collected from loop detectors located at points both upstream and downstream of a given link, and the output variable is the link travel time. A first order Takagi-Sugeno fuzzy rule set is used to complete the inference. For training the evolving fuzzy neural network (EFNN), two learning processes are proposed: (1) a K-means method is employed to partition input samples into different clusters, and a Gaussian fuzzy membership function is designed for each cluster to measure the membership degree of samples to the cluster centers. As the number of input samples increases, the cluster centers are modified and membership functions are also updated; (2) a weighted recursive least squares estimator is used to optimize the parameters of the linear functions in the Takagi-Sugeno type fuzzy rules. Testing datasets consisting of actual and simulated data are used to test the proposed method. Three common criteria including mean absolute error (MAE), root mean square error (RMSE), and mean absolute relative error (MARE) are utilized to evaluate the estimation performance. Estimation results demonstrate the accuracy and effectiveness of the EFNN method through comparison with existing methods including: multiple linear regression (MLR), instantaneous model (IM), linear model (LM), neural network (NN), and cumulative plots (CP).	[Tang, Jinjun; Zhang, Shen] Harbin Inst Technol, Sch Transportat Sci & Engn, Harbin 150001, Peoples R China; [Tang, Jinjun; Ash, John; Wang, Yinhai] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Zou, Yajie] Tongji Univ, Minist Educ, Key Lab Rd & Traff Engn, Shanghai 201804, Peoples R China; [Liu, Fang] Inner Mongolia Agr Univ, Sch Energy & Transportat Engn, Hohhot 010018, Peoples R China	Harbin Institute of Technology; University of Washington; University of Washington Seattle; Tongji University; Inner Mongolia Agricultural University	Wang, YH (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA.	yinhai@uw.edu	Wang, Yinhai/B-5396-2012	Wang, Yinhai/0000-0002-4180-5628	National Natural Science Foundation of China [51138003, 51329801]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This research was funded in part by the National Natural Science Foundation of China (grant nos. 51138003 and 51329801). This research was also funded in part by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydilek IB, 2013, INFORM SCIENCES, V233, P25, DOI 10.1016/j.ins.2013.01.021; Bachmann C, 2013, TRANSPORT RES C-EMER, V26, P33, DOI 10.1016/j.trc.2012.07.003; Bhaskar A, 2010, INT J INTELL TRANSP, V8, P151, DOI 10.1007/s13177-010-0012-y; Bhaskar A, 2009, TRANSPORT RES REC, P41, DOI 10.3141/2121-05; Brockfeld E., 2007, P 11 WCTR C BERK CA, P24; Cherrett T, 2002, J OPER RES SOC, V53, P610, DOI 10.1057/palgrave.jors.2601348; Cherrett T, 2001, P I CIVIL ENG-TRANSP, V147, P23; Cheu RL, 2002, COMPUT-AIDED CIV INF, V17, P53, DOI 10.1111/1467-8667.00252; Coifman B, 2001, TRANSPORT RES A-POL, V35, P863, DOI 10.1016/S0965-8564(00)00028-8; Cortes CE, 2002, TRANSPORT RES REC, P181, DOI 10.3141/1802-20; Daganzo C. F., 1997, FUNDAMENTALS TRANSPO; Demsar J, 2006, J MACH LEARN RES, V7, P1; Gastaldi M, 2014, TRANSPORT RES C-EMER, V47, P86, DOI 10.1016/j.trc.2014.06.002; Goodwin G, 1984, ADAPTIVE FILTERING P; Haghani A., 2010, J TRANSPORTATION RES, V2160, P60, DOI DOI 10.3141/2160-07; Hegyi A., 2006, 2006 IEEE INT TRANSP; Hellinga B, 2008, TRANSPORT RES C-EMER, V16, P768, DOI 10.1016/j.trc.2008.04.002; Hofleitner A, 2012, IEEE T INTELL TRANSP, V13, P1679, DOI 10.1109/TITS.2012.2200474; Hong J, 2007, 2007 IEEE INTELLIGENT VEHICLES SYMPOSIUM, VOLS 1-3, P1030; Hsia T. C., 1977, SYSTEM IDENTIFICATIO; Jenelius E, 2013, TRANSPORT RES B-METH, V53, P64, DOI 10.1016/j.trb.2013.03.008; Kasabov N., 1998, Proceedings of the 5th International Conference on Soft Computing and Information/Intelligent Systems. Methodologies for the Conception, Design and Application of Soft Computing, P271; Kasabov N, 2001, IEEE T SYST MAN CY B, V31, P902, DOI 10.1109/3477.969494; Kasabov NK, 2002, IEEE T FUZZY SYST, V10, P144, DOI 10.1109/91.995117; Kim S., 2007, INT J MULTIMEDIA UBI, V2, P67; Kloot G., 1999, P 6 WORLD C ITS TOR; Kwon J, 2000, TRANSPORT RES REC, P120, DOI 10.3141/1717-15; Li RM, 2006, J TRANSP ENG, V132, P540, DOI 10.1061/(ASCE)0733-947X(2006)132:7(540); Liu H., 2007, P 86 ANN M TRANSP RE; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Martchouk M, 2011, J TRANSP ENG, V137, P697, DOI 10.1061/(ASCE)TE.1943-5436.0000253; Messelodi S, 2009, EXPERT SYST APPL, V36, P4213, DOI 10.1016/j.eswa.2008.04.008; Naranjo JE, 2012, IEEE T INTELL TRANSP, V13, P107, DOI 10.1109/TITS.2011.2180377; Newell G. F, 1982, APPL QUEUING THEORY; Rouphil N. M., 1993, ADVANCE WORKING PAPE, V21; Shin C., 1998, P 5 WORLD C ITS SEOU; Sisiopiku V.P., 1994, TRANSPORT RES REC, V1457, P166; Srinivasan Karthik K., 1996, TRANSPORT RES REC, V1537, P15, DOI [10.3141/1537-03, DOI 10.3141/1537-03]; Tampere Chris M. J., 2007, 2007 IEEE Intelligent Transportation Systems Conference, P209, DOI 10.1109/ITSC.2007.4357755; Tang JJ, 2015, TRANSPORT RES C-EMER, V51, P29, DOI 10.1016/j.trc.2014.11.003; van Lint JWC, 2003, TRANSPORT RES REC, P41, DOI 10.3141/1855-05; Wang YB, 2005, TRANSPORT RES B-METH, V39, P141, DOI 10.1016/j.trb.2004.03.003; Wang YB, 2007, TRANSPORT SCI, V41, P167, DOI 10.1287/trsc.1070.0194; Wang YB, 2008, TRANSPORT RES A-POL, V42, P1340, DOI 10.1016/j.tra.2008.06.001; Wasson JS, 2008, ITE J, V78, P20; Wei C.H., 2003, TRANSPORTATION PLANN, VVol. 32, P651; Yuan YF, 2012, IEEE T INTELL TRANSP, V13, P59, DOI 10.1109/TITS.2011.2178837; Zhang M, 1998, ESTIMATING ARTERIAL; Zheng FF, 2013, TRANSPORT RES C-EMER, V31, P145, DOI 10.1016/j.trc.2012.04.007	49	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147263	10.1371/journal.pone.0147263	http://dx.doi.org/10.1371/journal.pone.0147263			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829639	Green Published, gold, Green Submitted			2022-12-26	WOS:000369548200016
J	Gallant, JL; Viljoen, AJ; van Helden, PD; Wiid, IJF				Gallant, James L.; Viljoen, Albertus J.; van Helden, Paul D.; Wiid, Ian J. F.			Glutamate Dehydrogenase Is Required by Mycobacterium bovis BCG for Resistance to Cellular Stress	PLOS ONE			English	Article							OXIDATIVE STRESS; PHAGOLYSOSOMAL PH; TUBERCULOSIS; SYNTHETASE; METABOLISM; GROWTH; AMMONIA; ANAPLEROSIS; INHIBITION; SOLUTES	We recently reported on our success to generate deletion mutants of the genes encoding glutamate dehydrogenase (GDH) and glutamine oxoglutarate aminotransferase (GOGAT) in M. bovis BCG, despite their in vitro essentiality in M. tuberculosis. We could use these mutants to delineate the roles of GDH and GOGAT in mycobacterial nitrogen metabolism by using M. bovis BCG as a model for M. tuberculosis specifically. Here, we extended our investigation towards the involvement of GDH and GOGAT in other aspects of M. bovis BCG physiology, including the use of glutamate as a carbon source and resistance to known phagosomal stresses, as well as in survival inside macrophages. We find that gdh is indispensable for the utilization of glutamate as a major carbon source, in low pH environments and when challenged with nitric oxide. On the other hand, the gltBD mutant had increased viability under low pH conditions and was unaffected by a challenge with nitric oxide. Strikingly, GDH was required to sustain M. bovis BCG during infection of both murine RAW 264.7 and bone-marrow derived and macrophages, while GOGAT was not. We conclude that the catabolism of glutamate in slow growing mycobacteria may be a crucial function during infection of macrophage cells and demonstrate a novel requirement for M. bovis BCG GDH in the protection against acidic and nitrosative stress. These results provide strong clues on the role of GDH in intracellular survival of M. tuberculosis, in which the essentiality of the gdh gene complicates knock out studies making the study of the role of this enzyme in pathogenesis difficult.	[Gallant, James L.; van Helden, Paul D.; Wiid, Ian J. F.] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,SA MRC Ctr T, Cape Town, South Africa; [Viljoen, Albertus J.] Univ Montpellier, Ctr Etud Agents Pathogenes & Biotechnol Sante, Ctr Natl Rech Sci FRE 3689, 1919 Route Mende, F-34059 Montpellier, France	National Research Foundation - South Africa; Stellenbosch University; Universite de Montpellier	Gallant, JL (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,SA MRC Ctr T, Cape Town, South Africa.	jgallant@sun.ac.za	Viljoen, Albertus/O-6794-2019	Viljoen, Albertus/0000-0001-8949-7401	NRF/MRC; Harry Crossley Foundation; NRF-DAAD; L'Infectionpole Sud	NRF/MRC; Harry Crossley Foundation; NRF-DAAD; L'Infectionpole Sud	JG would like to acknowledge the NRF/MRC for financial assistance through the Allied Health Scholarship. AV would like to acknowledge the Harry Crossley Foundation, the NRF-DAAD and L'Infectionpole Sud for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearson BL, 2009, MICROBIOL-SGM, V155, P805, DOI 10.1099/mic.0.022905-0; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Cheung Y. W., 2011, Hong Kong Medical Journal, V17, P32; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; DeJesus MA, 2013, BIOINFORMATICS, V29, P695, DOI 10.1093/bioinformatics/btt043; EDSON NL, 1951, BACTERIOL REV, V15, P147, DOI 10.1128/MMBR.15.3.147-182.1951; Gising J, 2012, J MED CHEM, V55, P2894, DOI 10.1021/jm201212h; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Goude R, 2004, APPL ENVIRON MICROB, V70, P6535, DOI 10.1128/AEM.70.11.6535-6541.2004; Gouzy A, 2014, NAT REV MICROBIOL, V12, P729, DOI 10.1038/nrmicro3349; Gouzy A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003928; Gouzy A, 2013, NAT CHEM BIOL, V9, P674, DOI [10.1038/NCHEMBIO.1355, 10.1038/nchembio.1355]; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Harth G, 1999, J EXP MED, V189, P1425, DOI 10.1084/jem.189.9.1425; Harth G, 2003, INFECT IMMUN, V71, P456, DOI 10.1128/IAI.71.1.456-464.2003; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kosenko E, 1997, FREE RADICAL RES, V27, P637, DOI 10.3109/10715769709097867; LUNDBORG M, 1992, ENVIRON HEALTH PERSP, V97, P153, DOI 10.2307/3431345; LYON RH, 1967, J BACTERIOL, V94, P92, DOI 10.1128/JB.94.1.92-100.1967; Maksymiuk C, 2015, P NATL ACAD SCI USA, V112, pE5834, DOI 10.1073/pnas.1510932112; Minambres B, 2000, J BIOL CHEM, V275, P39529, DOI 10.1074/jbc.M005136200; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Nilsson MT, 2009, J MOL BIOL, V393, P504, DOI 10.1016/j.jmb.2009.08.028; Nordqvist A, 2012, MEDCHEMCOMM, V3, P620, DOI 10.1039/c2md00310d; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; NYBERG K, 1992, ENVIRON HEALTH PERSP, V97, P149, DOI 10.2307/3431344; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Odell LR, 2009, BIOORG MED CHEM LETT, V19, P4790, DOI 10.1016/j.bmcl.2009.06.045; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rhee KY, 2011, TRENDS MICROBIOL, V19, P307, DOI 10.1016/j.tim.2011.03.008; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Saum SH, 2006, J BACTERIOL, V188, P6808, DOI 10.1128/JB.00781-06; Schultz C, 2007, APPL MICROBIOL BIOT, V76, P691, DOI 10.1007/s00253-007-0933-9; Sinha AK, 2015, COMP BIOCHEM PHYS C, V174, P21, DOI 10.1016/j.cbpc.2015.06.002; Tullius MV, 2003, INFECT IMMUN, V71, P3927, DOI 10.1128/IAI.71.7.3927-3936.2003; Ventura M, 2013, MOL MICROBIOL, V90, P356, DOI 10.1111/mmi.12368; Viljoen AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084452; WHO, GLOB TUB REP 2014; Yang Chul-Su, 2009, Immune Netw, V9, P46, DOI 10.4110/in.2009.9.2.46; Yang W, 2010, J FRESHWATER ECOL, V25, P297, DOI 10.1080/02705060.2010.9665080	45	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147706	10.1371/journal.pone.0147706	http://dx.doi.org/10.1371/journal.pone.0147706			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824899	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600049
J	Naber, SK; Matthijsse, SM; Rozemeijer, K; Penning, C; de Kok, IMCM; van Ballegooijen, M				Naber, Steffie K.; Matthijsse, Suzette M.; Rozemeijer, Kirsten; Penning, Corine; de Kok, Inge M. C. M.; van Ballegooijen, Marjolein			Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; HPV-16/18 AS04-ADJUVANTED VACCINE; CROSS-PROTECTIVE EFFICACY; RISK HUMAN-PAPILLOMAVIRUS; OF-STUDY ANALYSIS; INTRAEPITHELIAL NEOPLASIA; QUADRIVALENT VACCINE; IMPACT; WOMEN; INFECTION	Background Vaccination against the oncogenic human papillomavirus (HPV) types 16 and 18 will reduce the prevalence of these types, thereby also reducing cervical cancer risk in unvaccinated women. This (measurable) herd effect will be limited at first, but is expected to increase over time. At a certain herd immunity level, tailoring screening to vaccination status may no longer be worth the additional effort. Moreover, uniform screening may be the only viable option. We therefore investigated at what level of herd immunity it is cost-effective to also reduce screening intensity in unvaccinated women. Methods We used the MISCAN-Cervix model to determine the optimal screening strategy for a pre-vaccination population and for vaccinated women (similar to 80% decreased risk), assuming a willingness- to-pay of (sic)50,000 per quality-adjusted life year gained. We considered HPV testing, cytology testing and co-testing and varied the start age of screening, the screening interval and the number of lifetime screens. We then calculated the incremental cost-effectiveness ratio (ICER) of screening unvaccinated women with the strategy optimized to the pre-vaccination population as compared to with the strategy optimized to vaccinated women, assuming different herd immunity levels. Results Primary HPV screening with cytology triage was the optimal strategy, with 8 lifetime screens for the pre-vaccination population and 3 for vaccinated women. The ICER of screening unvaccinated women 8 times instead of 3 was (sic)28,085 in the absence of herd immunity. At around 50% herd immunity, the ICER reached (sic)50,000. Conclusion From a herd immunity level of 50% onwards, screening intensity based on the pre-vaccination risk level becomes cost-ineffective for unvaccinated women. Reducing the screening intensity of uniform screening may then be considered.	[Naber, Steffie K.; Matthijsse, Suzette M.; Rozemeijer, Kirsten; Penning, Corine; de Kok, Inge M. C. M.; van Ballegooijen, Marjolein] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Naber, SK (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	s.naber@erasmusmc.nl	Naber, Steffie/A-9758-2015	Naber, Steffie/0000-0001-8357-1738				Accetta G, 2010, J MED SCREEN, V17, P181, DOI 10.1258/jms.2010.010019; [Anonymous], 1985, HOSP DIAGN STAT 1963; [Anonymous], 2013, STATLINE DATABASE; Berkhof J, 2005, INT J CANCER, V115, P268, DOI 10.1002/ijc.20846; Brisson M, 2011, J INFECT DIS, V204, P372, DOI 10.1093/infdis/jir285; Brotherton JML, 2013, MED J AUSTRALIA, V199, P614, DOI 10.5694/mja13.10272; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Burger EA, 2012, BRIT J CANCER, V106, P1571, DOI 10.1038/bjc.2012.94; Casparie M, 2007, CELL ONCOL, V29, P19; Castanon A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001585; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Coupe VMH, 2008, BRIT J CANCER, V98, P646, DOI 10.1038/sj.bjc.6604162; Coupe VMH, 2012, VACCINE, V30, P1813, DOI 10.1016/j.vaccine.2012.01.001; Dempsey AF, 2009, ANN EPIDEMIOL, V19, P531, DOI 10.1016/j.annepidem.2009.03.011; Diaz M, 2010, EUR J CANCER, V46, P2973, DOI 10.1016/j.ejca.2010.06.016; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; European Centre for Disease Prevention and Control, 2012, INTRODUCTION OF HPV; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Goldhaber-Fiebert JD, 2008, JNCI-J NATL CANCER I, V100, P308, DOI 10.1093/jnci/djn019; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; HABBEMA JDF, 1985, COMPUT METH PROG BIO, V20, P79, DOI 10.1016/0169-2607(85)90048-3; Heinonen A, 2013, EUR J OBSTET GYN R B, V169, P387, DOI 10.1016/j.ejogrb.2013.03.033; Herzog TJ, 2007, GYNECOL ONCOL, V107, P572, DOI 10.1016/j.ygyno.2007.09.019; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Lenselink CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003743; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Mandelblatt JS, 2002, JAMA-J AM MED ASSOC, V287, P2372, DOI 10.1001/jama.287.18.2372; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Netherlands Cancer Registry, 2012, CERV CANC INC ON YEA; Netherlands Cancer Registry, 2012, STAG DISTR SURV CERV; Nobbenhuis MAE, 2001, LANCET, V358, P1782, DOI 10.1016/S0140-6736(01)06809-X; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Serrano B, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-38; SHEPHERD JH, 1989, BRIT J OBSTET GYNAEC, V96, P889, DOI 10.1111/j.1471-0528.1989.tb03341.x; Stanley M, 2010, GYNECOL ONCOL, V117, pS5, DOI [10.1016/j.ygyno.2010.01.024, 10.1016/j.ygyno.2010.04.002]; Tabrizi SN, 2014, LANCET INFECT DIS, V14, P958, DOI 10.1016/S1473-3099(14)70841-2; US Food and Drug Administration, 2014, FDA APPR GARD 9 PREV; Van Ballegooijen M, 2006, EFFECTEN KOSTEN BEVO; van Lier EA, 2015, IMMUNISATION COVERAG; van Rosmalen J, 2012, BJOG-INT J OBSTET GY, V119, P699, DOI 10.1111/j.1471-0528.2011.03228.x; van 't Schurink-van 't Klooster TM, 2011, 2100120012011 NAT I; VANBALLEGOOIJEN M, 1998, EFFECTS COSTS CERVIC; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X	53	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0145548	10.1371/journal.pone.0145548	http://dx.doi.org/10.1371/journal.pone.0145548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824771	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600007
J	Tran, NN; Pham, TT; Ozawa, K; Nishijo, M; Anh, T; Nguyet, N; Tran, TQ; Luong, VH; Tran, AH; Phan, VHA; Nakai, A; Nishino, Y; Nishijo, H				Nghi Ngoc Tran; Tai The Pham; Ozawa, Kyoko; Nishijo, Muneko; Anh Thi; Nguyet Nguyen; Tuong Quy Tran; Luong Van Hoang; Anh Hai Tran; Vu Huy Anh Phan; Nakai, Akio; Nishino, Yoshikazu; Nishijo, Hisao			Impacts of Perinatal Dioxin Exposure on Motor Coordination and Higher Cognitive Development in Vietnamese Preschool Children: A Five-Year Follow-Up	PLOS ONE			English	Article							BREAST-MILK; MATERNAL EXPOSURE; AUTISM; PCBS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; SKILLS; NEURODEVELOPMENT; PERFORMANCE; BEHAVIOR; MOTHERS	Dioxin concentrations remain elevated in the environment and in humans residing near former US Air Force bases in South Vietnam. Our previous epidemiological studies showed adverse effects of dioxin exposure on neurodevelopment for the first 3 years of life. Subsequently, we extended the follow-up period and investigated the influence of perinatal dioxin exposure on neurodevelopment, including motor coordination and higher cognitive ability, in preschool children. Presently, we investigated 176 children in a hot spot of dioxin contamination who were followed up from birth until 5 years old. Perinatal dioxin exposure levels were estimated by measuring dioxin levels in maternal breast milk. Dioxin toxicity was evaluated using two indices; toxic equivalent (TEQ)-polychlorinated dibenzo-p-dioxins/furans (PCDDs/Fs) and concentration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Coordinated movements, including manual dexterity, aiming and catching, and balance, were assessed using the Movement Assessment Battery for Children, Second Edition (Movement ABC-2). Cognitive ability was assessed using the nonverbal index (NVI) of the Kaufman Assessment Battery for Children, Second Edition (KABC-II). In boys, total test and balance scores of Movement ABC-2 were significantly lower in the high TEQ-PCDDs/Fs group compared with the moderate and low exposure groups. NVI scores and the pattern reasoning subscale of the KABC-II indicating planning ability were also significantly lower in the high TCDD exposure group compared with the low exposure group of boys. However, in girls, no significant differences in Movement ABC-2 and KABC-II scores were found among the different TEQ-PCDDs/Fs and TCDD exposure groups. Furthermore, in high risk cases, five boys and one girl highly exposed to TEQ-PCDDs/Fs and TCDD had double the risk for difficulties in both neurodevelopmental skills. These results suggest differential impacts of TEQ-PCDDs/Fs and TCDD exposure on motor coordination and higher cognitive ability, respectively. Moreover, high TEQ-PCDDs/Fs exposure combined with high TCDD exposure may increase autistic traits combined with developmental coordination disorder.	[Nghi Ngoc Tran; Nishijo, Muneko; Nishino, Yoshikazu] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan; [Nghi Ngoc Tran; Nguyet Nguyen; Tuong Quy Tran] Vietnam Govt, Minist Hlth, Hanoi, Vietnam; [Tai The Pham; Luong Van Hoang; Anh Hai Tran] Vietnam Mil Med Univ, Biomed & Pharmaceut Res Ctr, Hanoi, Vietnam; [Ozawa, Kyoko; Nishijo, Hisao] Toyama Univ, Syst Emot Sci, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama 9300194, Japan; [Vu Huy Anh Phan] Dong Nai Gen Hosp, Bien Hoa City, Dong Nai Provin, Vietnam; [Nakai, Akio] Hyogo Rehabil Ctr Hosp, Dept Pediat Neurol, Hyogo Childrens Sleep & Dev Med Res Ctr, Nishi Ku, 1070 Akebono, Kobe, Hyogo 6512181, Japan	Kanazawa Medical University; University of Toyama	Nishijo, M (corresponding author), Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	ni-koei@kanazawa-med.ac.jp	Nakai, Akio/AAE-1124-2020		Japan Society for the Promotion of Science Asian Core Program; Ministry of Education, Science, Sports and Culture [25305024, 25290005]; Challenging Exploratory Research [15K15244]	Japan Society for the Promotion of Science Asian Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Challenging Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported partly by the Japan Society for the Promotion of Science Asian Core Program and the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B) (25305024) and (25290005) and Challenging Exploratory Research (15K15244). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported partly by the Japan Society for the Promotion of Science Asian Core Program and the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B) (25305024) and (25290005) and Challenging Exploratory Research (15K15244). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament K, 2015, J AUTISM DEV DISORD, V45, P742, DOI 10.1007/s10803-014-2229-0; Araki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109039; Augustowska K, 2003, REPRODUCTION, V126, P681, DOI 10.1530/rep.0.1260681; Endo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050741; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Green D, 2009, DEV MED CHILD NEUROL, V51, P311, DOI 10.1111/j.1469-8749.2008.03242.x; Hatfield Consultants Office of the National Steering Committee 33 MONRE, 2009, COMPR ASS DIOX CONT; Haugen AC, 2015, J DEV ORIG HLTH DIS, V6, P55, DOI 10.1017/S2040174414000580; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Hill EL, 2006, NEUROPSYCHOLOGIA, V44, P2822, DOI 10.1016/j.neuropsychologia.2006.06.007; Jansiewicz EM, 2006, J AUTISM DEV DISORD, V36, P613, DOI 10.1007/s10803-006-0109-y; Kakeyama M, 2014, ARCH TOXICOL, V88, P789, DOI 10.1007/s00204-013-1161-y; Kaufman AS., 1983, KAUFMAN ASSESSMENT B; Nguyen MN, 2013, TOXICOLOGY, V314, P125, DOI 10.1016/j.tox.2013.09.005; Neugebauer J, 2015, INT J HYG ENVIR HEAL, V218, P153, DOI 10.1016/j.ijheh.2014.09.005; Neurodevelopmental disorders work group, 2013, DIAGN STAT MAN MENT; Nguyen ATN, 2013, ENVIRON HEALTH INSIG, V7, P1, DOI 10.4137/EHI.S10346; Nishijo M, 2014, MOL PSYCHIATR, V19, P1220, DOI 10.1038/mp.2014.18; Nishijo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040273; Papadopoulos N, 2012, AUTISM, V16, P627, DOI 10.1177/1362361311418692; Pellicano E, 2010, CHILD DEV, V81, P1400, DOI 10.1111/j.1467-8624.2010.01481.x; Tai PT, 2013, OCCUP ENVIRON MED, V70, P656, DOI 10.1136/oemed-2012-101021; Tai PT, 2011, ENVIRON SCI TECHNOL, V45, P6625, DOI 10.1021/es201666d; Roze E, 2009, ENVIRON HEALTH PERSP, V117, P1953, DOI 10.1289/ehp.0901015; Schaafsma SM, 2014, FRONT NEUROENDOCRIN, V35, P255, DOI 10.1016/j.yfrne.2014.03.006; Schellart NAM, 2008, CLIN NEUROPHYSIOL, V119, P1486, DOI 10.1016/j.clinph.2008.03.002; Stellman JM, 2003, ENVIRON HEALTH PERSP, V111, P321, DOI 10.1289/ehp.5755; Pham TT, 2015, SCI TOTAL ENVIRON, V536, P575, DOI 10.1016/j.scitotenv.2015.07.055; ten Tusscher GW, 2014, SCI TOTAL ENVIRON, V491, P235, DOI 10.1016/j.scitotenv.2014.02.100; Todaka T, 2010, CHEMOSPHERE, V78, P185, DOI 10.1016/j.chemosphere.2009.09.047; Nghi TN, 2015, ENVIRON SCI TECHNOL, V49, P5732, DOI 10.1021/es506211p; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; van Ede KI, 2014, ARCH TOXICOL, V88, P637, DOI 10.1007/s00204-013-1186-2; Vreugdenhil HJI, 2002, ENVIRON HEALTH PERSP, V110, pA593, DOI 10.1289/ehp.021100593; Whyatt CP, 2012, J AUTISM DEV DISORD, V42, P1799, DOI 10.1007/s10803-011-1421-8; Winneke G, 2014, ENVIRON HEALTH PERSP, V122, P292, DOI 10.1289/ehp.1306533; Wittsiepe J, 2007, CHEMOSPHERE, V67, pS286, DOI 10.1016/j.chemosphere.2006.05.118	37	36	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147655	10.1371/journal.pone.0147655	http://dx.doi.org/10.1371/journal.pone.0147655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824471	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600044
